APPLICATION_ID,ACTIVITY,ADMINISTERING_IC,APPLICATION_TYPE,ARRA_FUNDED,AWARD_NOTICE_DATE,BUDGET_START,BUDGET_END,CFDA_CODE,CORE_PROJECT_NUM,ED_INST_TYPE,OPPORTUNITY NUMBER,FULL_PROJECT_NUM,FUNDING_ICs,FUNDING_MECHANISM,FY,IC_NAME,NIH_SPENDING_CATS,ORG_CITY,ORG_COUNTRY,ORG_DEPT,ORG_DISTRICT,ORG_DUNS,ORG_FIPS,ORG_IPF_CODE,ORG_NAME,ORG_STATE,ORG_ZIPCODE,PHR,PI_IDS,PI_NAMEs,PROGRAM_OFFICER_NAME,PROJECT_START,PROJECT_END,PROJECT_TERMS,PROJECT_TITLE,SERIAL_NUMBER,STUDY_SECTION,STUDY_SECTION_NAME,SUBPROJECT_ID,SUFFIX,SUPPORT_YEAR,DIRECT_COST_AMT,INDIRECT_COST_AMT,TOTAL_COST,TOTAL_COST_SUB_PROJECT
11177353,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000214,NA,NA,1ZIAAG000214-33,NIA:134176\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,Age;Aging;Agonist;Alpha Cell;Anabolism;Animals;Apoptosis;Apoptotic;Beta Cell;Blood Glucose;Cardiovascular Diseases;Cell Count;Cell Line;Cell Nucleus;Cell Physiology;Cell Proliferation;Cells;Clinical;Compensation;cytokine;Diabetes Mellitus;exenatide;Failure;Functional disorder;GLP-I receptor;glucagon-like peptide 1;Glucokinase;glucose sensor;Hormones;Human;Hyperactivity;Insulin;Insulin Resistance;islet;Islets of Langerhans;Kidney Failure;Maintenance;new therapeutic target;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Pancreas;Phenotype;prevent;Process;Proteins;Research;Research Personnel;Rodent;transcription factor;Work,CLINICAL PROJECT:  Aging And The Pancreas,214,NA,NA,NA,NA,33,NA,NA,134176,NA
11177354,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000230,NA,NA,1ZIAAG000230-03,NIA:486642\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Age;age effect;age group;Aging;Animals;Body Surface Area;Cardiac;Cardiac Output;Cardiovascular Models;Cardiovascular system;Clinical;Collaborations;Data;Diameter;Echocardiography;EFRAC;Female;Gender;Heart Atrium;Heart Diseases;heart function;High Cardiac Output;Human;Italy;Left;Left Ventricular Function;Left Ventricular Mass;Macaca mulatta;male;Maryland;Measures;morphometry;nonhuman primate;Right Ventricular Function;sex;Sex Differences;Stroke Volume;Structure;Two-Dimensional Echocardiography;Ventricular;women versus men;Work,An echocardiographic study of age- and sex-dependent differences in cardiac function and morphometry in Non Human Primates,230,NA,NA,NA,NA,3,NA,NA,486642,NA
11177355,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000232,NA,NA,1ZIAAG000232-17,NIA:111232\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Action Potentials;Acute;Adrenergic Agents;Adrenergic Receptor;Adult;Aging;Arrhythmia;Behavior;Biophysical Process;Brain;Calmodulin;calmodulin-dependent protein kinase II;Cardiac pacemaker;Cell Culture Techniques;Cell membrane;Cell Physiology;Cells;Characteristics;Clock protein;Complex;Coupled;Couples;Coupling;Cues;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Data;Data Set;Disease;Environment;Exhibits;experimental study;Felis catus;Heart;Heart Atrium;Heart Rate;heart rhythm;high resolution imaging;imaging study;In Vitro;Individual;Inferior;insight;Ion Channel;Ions;Kinetics;Laws;Length;Link;Measures;Membrane;Membrane Potentials;Modeling;models and simulation;molecular clock;molecular scale;Nodal;nodal myocyte;Oryctolagus cuniculus;Pacemakers;Phosphorylation;Principal Component Analysis;Proteins;Publishing;receptor;Regression Analysis;response;Rest;Sarcoplasmic Reticulum;Signal Transduction;simulation;Sinoatrial Node;Site;Structure;Surface;symposium;System;Testing;Time;Tissues;Variant;voltage,Coherent beat to beat variability of self-similar Ca2+ and surface membrane's signaling mechanisms determines the spontaneous action potential firing rate and rhythm of cardiac pacemaker cells,232,NA,NA,NA,NA,17,NA,NA,111232,NA
11177356,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000236,NA,NA,1ZIAAG000236-17,NIA:48664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Actins;Address;age related;age related changes;aged;Aging;Alkaline Phosphatase;Alzheimer&apos;s Disease;Amyloid Proteins;Amyloidosis;Angiotensin II;animal old age;Animals;Aorta;Area;Arterial Disorder;Arterial Fatty Streak;arterial stiffness;Atherosclerosis;base;Blood Vessels;calcification;calcification inhibitor;Calcium;Calpain;calpastatin;Cardiovascular Diseases;Carotid Arteries;Cartilage;Cd68;Cell Aging;Cell Separation;Cells;cerebrovascular;Cessation of life;Chronic;Collagen;Collagen Fiber;Collagen Receptors;Collagen Type I;Collagen Type II;Crossbreeding;crosslink;Cytoskeleton;Dementia;Deposition;Development;EGF gene;Elastic Fiber;Elderly;Elements;endothelial dysfunction;Exhibits;Experimental Models;Extracellular Matrix;Fibrosis;Foundations;frailty;Friction;GDF15 gene;Genetic Transcription;Growth;Heart failure;Human;human subject;Hypertension;Impaired cognition;In Vitro;in vivo;Individual;Infiltration;Inflammation;Inflammatory;inhibitor;Integrin alphaVbeta3;Invaded;Investigation;juvenile animal;Length;Link;Macrophage;MADH2 gene;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mechanics;Mediating;medin;Membrane;Messenger RNA;migration;milk fat globule;mineralization;Molecular;Mothers;Necrosis;Nodal;Norway;novel;Osteocalcin;Osteonectin;osteopontin;overexpression;Peptide Hydrolases;Phenotype;Physiological;Play;prevent;Production;Proliferating;Property;protein activation;protein expression;Proteins;Rattus;Regulation;response;Role;senescence;Shoulder;Signal Pathway;Signal Transduction;Signaling Molecule;Smooth Muscle Myocytes;Stroke;System;TGFB1 gene;Therapeutic;therapy design;Thoracic aorta;Time;Tissue Inhibitor of Metalloproteinases;Transforming Growth Factor beta;Translations;Vascular calcification;Vascular Smooth Muscle;Vimentin;Vitronectin,Calpain-1 Activity and Central Arterial Aging,236,NA,NA,NA,NA,17,NA,NA,48664,NA
11177357,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000237,NA,NA,1ZIAAG000237-17,NIA:48664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Adverse effects;Age;age related;age related changes;aged;Aging;aging related;Alkaline Phosphatase;Angiotensin II;Animals;Aorta;arterial remodeling;Arteries;Blood Pressure;Bromodeoxyuridine;calcification;Calcium;Cardiovascular Diseases;CCL2 gene;CCR1 gene;CDK4 gene;Cell Cycle;Cell Proliferation;Cell Separation;Cells;Cerebrovascular Disorders;chemokine receptor;Chronic;Collagen;Collagen Type I;Deoxyuridine;Deposition;Disease;Early treatment;EGF gene;Elastic Fiber;Elasticity;Elastin;Elderly;Elements;Exhibits;extracellular;Fluorescence;Gel;gel electrophoresis;Gene Expression;Genetic Transcription;Genotype;Growth;Harvest;Health;healthspan;Human;Hypertension;implantation;In Vitro;in vivo;indexing;Inflammatory;Infusion procedures;Integrins;interest;Invaded;knock-down;Knock-out;Knockout Mice;Life Expectancy;Link;MAPK3 gene;Maps;Matrix Metalloproteinases;Medial;Messenger RNA;milk fat globule;Molecular;monocyte chemoattractant protein 1 receptor;Mothers;Mus;NF-kappa B;nonhuman primate;novel;novel strategies;Nuclear Antigens;osmotic minipump;p65;Pathway Analysis;Phosphorylation;Platelet-Derived Growth Factor beta Receptor;Play;prevent;Proliferating;protein expression;Proteins;Proteome;Proteomics;Rat Protein;Rattus;receptor;Role;Saline;senescence;Signal Transduction;Signaling Molecule;Signaling Protein;Smooth Muscle;Smooth Muscle Myocytes;Stains;TGFB1 gene;Thick;TNF gene;transcription factor;Vascular Smooth Muscle;vascular smooth muscle cell proliferation;Western Blotting;Wild Type Mouse,Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling,237,NA,NA,NA,NA,17,NA,NA,48664,NA
11177358,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000238,NA,NA,1ZIAAG000238-17,NIA:48664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,15 year old;Acetylation;Adult;Age;age effect;age group;age related;Aging;Amyloidosis;animal old age;Annexins;Aorta;Apolipoprotein E;Apolipoproteins C;Apoptosis;Arterial Disorder;Arterial Fatty Streak;arterial remodeling;Atherogenic Diet;Atherosclerosis;atherosclerosis risk;Attenuated;Blood;Blood Coagulation Factor;Blood Pressure;Blood Vessels;calcification;Calmodulin;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;Cardiovascular system;Carotid Arteries;Categories;Cell Death;Cell Nucleus;Cessation of life;Cholesterol;Coagulation Process;Collaborations;Collagen;Common carotid artery;Complement;Complement 1q;Coronary;Cysteine;Cytoskeleton;Deposition;Diagnosis;Diet;dietary control;Dipeptidyl Peptidases;discoidin domain receptor 2;Disease;Drosophila genus;Dynamin;Dyslipidemias;EGF gene;Elastin;Elderly;Environment;Erythrocytes;Event;Exhibits;experimental study;Exposure to;Family;Fatty acid glycerol esters;Fibroblasts;Fibrosis;fly;Functional disorder;Genetic;Glycine;Heart;Heart Contractilities;Heart failure;heart function;hemodynamics;Homologous Gene;Human;Impairment;improved;Inflammation;Inflammatory;Integral Membrane Protein;Investigation;Isocitrate Dehydrogenase;lamin C;Lamin Type A;Lead;life span;Link;Lipids;Lysine;Macaca mulatta;Maintenance;member;Metabolic dysfunction;Microfilaments;milk fat globule;Mitochondria;Molecular;molecular targeted therapies;Monkeys;Morphology;Mus;Mutation;Myelin P0 Protein;myocardial damage;Myocardial dysfunction;Myocardial tissue;Myosin ATPase;NADPH Dehydrogenase;National Institute on Aging;Necrosis;Nicotinamide adenine dinucleotide;nonhuman primate;novel;novel marker;Nuclear;old mice;overexpression;Oxidoreductase;Palmitates;Pathology;periostin;Phenocopy;Phosphorylation;Physiologic pulse;Population;premature;Prevention approach;Prokaryotic Initiation Factor-2;Proteins;Proteome;Proteomics;Rattus;Receptor Protein-Tyrosine Kinases;Regulation;Reporting;Resveratrol;Role;S100 Proteins;S100A4 gene;Sampling;Sarcomeres;senescence;senescence associated secretory phenotype;senescent cell;senolytics;senomorphic;Serine Protease;Serum Amyloid P-Component;SIRT1 gene;Sirtuins;Smooth Muscle Myocytes;Soil;stem;Stress;stress tolerance;Therapeutic;Tissue Harvesting;Tissues;TNF gene;transcription factor;transcriptomics;United States National Institutes of Health;Vascular Smooth Muscle;Vinculin;Vitronectin;Voltage-Dependent Anion Channel,Effects of Aging on Experimental Atherosclerosis in Nonhuman Primates,238,NA,NA,NA,NA,17,NA,NA,48664,NA
11177359,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000239,NA,NA,1ZIAAG000239-17,NIA:48664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,activation-induced cytidine deaminase;Adenoviruses;age effect;Age Months;age related;Aging;Amyloidosis;Angiotensin II;antagonist;Anti-Inflammatory Agents;Antibodies;Antibody Specificity;Antibody titer measurement;Aorta;Apolipoprotein E;arterial remodeling;arterial stiffness;atherogenesis;Atherosclerosis;Attenuated;Autoantibodies;B-Lymphocytes;Biological Aging;Blood Pressure;c-ets1 transcription factor;calcification;Caloric Restriction;Cardiovascular Diseases;cardiovascular health;CCL2 gene;Cell Aging;Cell Separation;Cells;Cellularity;Cholesterol;Chronic;Circulation;Collagen;Collagen Type I;Complementary DNA;Deceleration;density;Deposition;Disease;EGF gene;Elastic Fiber;Elastin;Elastin Fiber;endothelial dysfunction;Evaluation;Extracellular Matrix;Fibrosis;frailty;Gelatinase A;Gelatinases;Genetic Transcription;Harvest;Health;healthspan;Hypertension;Immunoglobulin G;Immunoglobulin M;improved;In Vitro;in vivo;Incidence;Infiltration;Inflammation;Inflammatory;inhibiting antibody;Inhibition of Matrix Metalloproteinases Pathway;Interstitial Collagenase;intimal medial thickening;Invaded;Length;life span;Link;Losartan;Macrophage;Malondialdehyde;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mediating;medin;Metalloproteases;milk fat globule;MMP2 gene;Molecular;mRNA Expression;Mus;NF-kappa B;nuclear factor-erythroid 2;osmotic minipump;overexpression;oxidized low density lipoprotein;Pathogenicity;Phenotype;Phosphorylation;Plasma;Platelet-Derived Growth Factor;platelet-derived growth factor BB;preservation;pressure;prevent;Production;proendothelin 1;Profibrotic signal;Proliferating;protein expression;Protein Glycosylation;Proteins;Rattus;receptor;response;Serum;Signal Transduction;Signaling Molecule;Smooth Muscle Myocytes;Specificity;TGFB1 gene;Tissues;transcription factor;Translations;Up-Regulation;Vascular Smooth Muscle;vascular smooth muscle cell proliferation;young adult,Effect of Metalloprotease Inhibition on Age-Associated Arterial Remodeling,239,NA,NA,NA,NA,17,NA,NA,48664,NA
11177360,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000240,NA,NA,1ZIAAG000240-17,NIA:48664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690831 (contact),"WANG, MINGYI  (contact)",NA,NA,NA,Acceleration;Actins;age related;age related changes;Age-associated memory impairment;aged;Aging;aging related;Angiotensin II;Angiotensin II Receptor;animal old age;antagonist;Aorta;Apoptosis;Apoptotic;Atherosclerosis;Attenuated;Blood Pressure;Blood Vessels;Cardiac;Cardiovascular Diseases;Cardiovascular system;CC chemokine receptor 2;CCL2 gene;Cell Cycle;Cell Separation;Cells;Cellularity;Chest;Chronic;Collagen;Collagen Type I;Crossbreeding;Cytoskeleton;Deceleration;Dementia;Deposition;Development;discoidin domain receptor 2;Down-Regulation;Elastic Fiber;Elastin;Elderly;Elements;Equilibrium;ETS1 gene;Exhibits;Experimental Models;Extracellular Matrix;Fibroblasts;Fibronectins;Fibrosis;Friction;Gelatinases;Genes;Genetic Transcription;Heart Injuries;Heterogeneity;human model;Hypertension;Impaired cognition;In Situ;In Vitro;in vivo;Individual;Inflammatory;inhibitor;Injury;Integrin alphaVbeta3;Integrins;Interstitial Collagenase;Invaded;juvenile animal;knock-down;Knockout Mice;Length;Link;Losartan;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;mechanical properties;Mechanics;Mediating;Messenger RNA;Metalloproteins;MicroRNAs;MMP2 gene;Molecular;Mothers;Myocardial;Myocardial dysfunction;Myocardium;nonhuman primate;novel;novel strategies;Phenotype;Phosphorylation;Physiological;Play;Predisposition;preservation;pressure;prevent;Prevention;Production;proendothelin 1;Proliferating;Proteins;Rattus;Rattus norvegicus;receptor;Reporting;response;Reverse Transcriptase Polymerase Chain Reaction;Role;senescence;senescence associated secretory phenotype;Signal Transduction;Signaling Molecule;Small Interfering RNA;Smooth Muscle Myocytes;Stroke;TGFB1 gene;Therapeutic;therapy design;Time;Translations;Tropoelastin;Up-Regulation;Vascular Smooth Muscle;vascular smooth muscle cell proliferation;Western Blotting;wound healing,Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1  Signaling Loop,240,NA,NA,NA,NA,17,NA,NA,48664,NA
11177361,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000262,NA,NA,1ZIAAG000262-17,NIA:229417\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Activities of Daily Living;Age;Age Months;age related;age related changes;age related decline;age related deterioration;aged;Aging;Attention;Autonomic nervous system;Bioinformatics;Biological Markers;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;cardiovascular disorder risk;Cardiovascular Physiology;cardiovascular risk factor;Cardiovascular system;Cell Physiology;cell type;Cells;Cessation of life;Characteristics;cohort;Compensation;Complex;Constitution;Cross-Sectional Studies;Databases;Deterioration;Disease;Elderly;Electrocardiogram;Epidemic;experience;frailty;Frequencies;Functional disorder;gene discovery;Gene Expression Profile;Genes;Genetic Markers;Genetic Transcription;hallmarks of aging;Heart;heart function;Heart Rate;heart rate variability;Human;indexing;Left ventricular structure;Life;life span;Link;Longevity;longitudinal analysis;Longitudinal cohort;Longitudinal Studies;Maps;Maximum Heart Rate;Measurement;Measures;MicroRNAs;Minor;Modeling;Molecular;mortality;Mus;Pacemakers;Pathway interactions;Physiological;Population;posttranscriptional;Production;Proxy;Publishing;rate of change;Regulation;respiratory;Rest;Sampling;Series;Sinoatrial Node;Structure;Syndrome;therapeutic target;Time;time interval;transcriptome sequencing;Withdrawal;Work,Decreased pacemaker activity in aged sinoatrial node,262,NA,NA,NA,NA,17,NA,NA,229417,NA
11177362,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000263,NA,NA,1ZIAAG000263-17,NIA:41712\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,3-Phosphoinositide Dependent Protein Kinase-1;Acceleration;Action Potentials;analog;antagonist;Biological Process;calmodulin-dependent protein kinase II;Cardiac pacemaker;Cell Cycle;Cell Membrane Permeability;Cells;Characteristics;Confocal Microscopy;Coupled;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Diglycerides;Family;Goals;Heart Hypertrophy;inhibitor;inorganic phosphate;Inositol;Length;Mediating;Muscle Cells;nodal myocyte;NOS1 gene;novel;Oryctolagus cuniculus;Pacemakers;Patch-Clamp Techniques;Pathway interactions;Phosphatidylinositols;Phospholipase C;Phosphorylation;Physiological;Protein Family;Protein Kinase C;Protein Kinase C Inhibitor;Proteins;receptor;Regulation;response;Role;Ryanodine Receptor Calcium Release Channel;Second Messenger Systems;Signal Transduction;Sinoatrial Node;Site;theories;transmission process;Ventricular;Western Blotting;Work,"EPAC, PKC and CaMKII regulate local Ca2+ releases and cardiac pacemaker firing",263,NA,NA,NA,NA,17,NA,NA,41712,NA
11177363,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000291,NA,NA,1ZIAAG000291-17,NIA:340600\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,Acids;Age;Alpha Cell;alpha-gustducin;Animals;Behavior;cell type;Cells;Citric Acid;Clinical;Code;Eating;Elderly;Enhancers;Esthesia;Exhibits;Feeding behaviors;Food;Food Preferences;Future;Gastric Emptying;ghrelin;ghrelin receptor;GLP-I receptor;Glucagon;glucagon-like peptide 1;Glucose;GTP-Binding Protein alpha Subunits;Homeostasis;Hormonal;Hormones;Hypersensitivity;improved;In Vitro;in vivo;insulin secretion;Islet Cell;Knockout Mice;L Cells;Mammals;Mediating;Metabolic;Modality;Molecular;Mus;Peptides;Perception;Peripheral;Persons;Physiological;Play;Population;proglucagon;Quality of life;Regulation;Research;response;Role;Satiation;Site;Sodium Chloride;stem cells;Stimulus;Sucrose;sweet receptor;sweet taste perception;Sweetening Agents;Taste Buds;Taste Perception;taste system;Transgenic Mice;Type II Epithelial Receptor Cell;Type III Epithelial Receptor Cell;Wild Type Mouse;Work,CLINICAL PROJECT: A study of hormone-expressing taste cells: in vivo and in vitro,291,NA,NA,NA,NA,17,NA,NA,340600,NA
11177364,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000295,NA,NA,1ZIAAG000295-23,NIA:309636\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,Affinity;Affinity Chromatography;Agonist;antagonist;Binding;Binding Proteins;Biological;Biological Assay;Blood capillaries;Botanicals;cellular targeting;Chemicals;Chromatography;Column Chromatography;Complex;Computer Models;Data;Development;Disease;drug discovery;Drug Screening;Drug usage;Fishes;high throughput screening;Immobilization;inhibitor;Ligand Binding;Ligands;magnetic beads;Membrane;Methods;Mitochondria;Modeling;Nicotinic Receptors;novel;novel therapeutics;Nuclear;pharmacologic;Pharmacology Study;pharmacophore;Physical condensation;protein protein interaction;Proteins;receptor;screening;small molecule;small molecule libraries;Solid;Sorting;Surface;System;Techniques;Testing;Time;tobacco screening;Tobacco smoke;Tubular formation,Immobilized Proteins In Drug Discovery,295,NA,NA,NA,NA,23,NA,NA,309636,NA
11177365,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000297,NA,NA,1ZIAAG000297-23,NIA:4004627\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,Address;age effect;Aging;Baltimore;Bipolar Depression;Central Nervous System Diseases;Cerebrospinal Fluid;chronic pain;Clinical;clinical effect;Collaborations;Complex Regional Pain Syndromes;Development;Diagnosis;Disease;Dose;drug discovery;drug disposition;Drug Kinetics;drug metabolism;Drug usage;Early identification;high risk;improved;Inflammation;Infusion procedures;Investigation;Ketamine;Laboratories;Longitudinal Studies;Mass Spectrum Analysis;medical schools;Mental Depression;metabolic profile;metabolomics;molecular modeling;mouse model;Muscle;novel;novel therapeutics;pain relief;Patients;Pattern Recognition;Pharmaceutical Preparations;Pharmacodynamics;pharmacologic;Plants;Plasma;Prevention strategy;Proteomics;Research Personnel;Resistance;response;senolytics;Series;Staging;Synthesis Chemistry;Techniques;Therapeutic;United States National Institutes of Health;Wood material,"Bioanalysis, Drug Metabolism and New Drug Discovery",297,NA,NA,NA,NA,23,NA,NA,4004627,NA
11177366,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000298,NA,NA,1ZIAAG000298-09,NIA:90376\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Age;age acceleration;age effect;Age Months;age related changes;Aging;aging biomarker;aging process;Alzheimer&apos;s Disease;Animal Model;Animals;Ants;Atropine;Baltimore;Biological Markers;Blood Vessels;Caloric Restriction;Cardiac;Cardiovascular system;Cessation of life;Clinical;Clinical Research;cohort;Data;Databases;Dementia;Diabetes Mellitus;Echocardiography;efficacy validation;Elderly;Electrocardiogram;Endocrine system;Environment;Equilibrium;Exercise;Food;Gene Expression Profile;Genetic;Goals;Healthcare Systems;healthspan;Heart;Heart failure;Heart Rate;Human;human data;Individual;Intervention;Investigation;Length;life span;Literature;Longitudinal Studies;male;Malignant Neoplasms;Measures;Medical;mouse model;Mus;neural;overexpression;Pathologic;Pattern;Phenotype;Physiological;Population;potential biomarker;pre-clinical;programs;Propranolol;Publishing;quantification of aging;Reporting;Running;Siblings;social;Societies;Speed;Stroke;Study Subject;Surface;Testing;Transgenic Mice;Water,Baltimore Longitudinal Study of Mice Aging,298,NA,NA,NA,NA,9,NA,NA,90376,NA
11177367,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000299,NA,NA,1ZIAAG000299-05,NIA:139041\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,3-Dimensional;Action Potentials;Age;age related;Antibodies;Appearance;Arrhythmia;Binding Proteins;Calcium;Cells;Connexin 43;Coupling;Diameter;electric impedance;external ear auricle;extracellular;Extracellular Space;Goals;HCN4 gene;Heart;heart rhythm;Image;Imaging Techniques;immunoreactivity;in vivo;interstitial;interstitial cell;Laser Scanning Confocal Microscopy;meter;Methods;Monitor;Mus;neurotrophic protein S100beta;nodal myocyte;old mice;Pathway interactions;Pattern;Phenotype;Preparation;Proteins;Rest;Sinoatrial Node;Tissue imaging;Tissues;transcription factor;Transmission Electron Microscopy;Vesicle;vesicular release,Pacemaker cells meshwork the key player in the intercellular vesicles exchange within heart in young and old mice.,299,NA,NA,NA,NA,5,NA,NA,139041,NA
11177368,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000311,NA,NA,1ZIAAG000311-24,NIA:613612\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6978327 (contact),"GREIG, NIGEL H. (contact)",NA,NA,NA,5&apos; Untranslated Regions;Academia;Acetylcholine;Acetylcholinesterase;Acetylcholinesterase Inhibitors;Affect;Aging;alpha synuclein;Alzheimer&apos;s Disease;Amyloid beta-Protein;Amyloid beta-Protein Precursor;analog;Animal Disease Models;Animal Model;Anti-Inflammatory Agents;Apoptosis;Apoptotic;Astrocytes;Basic Science;behavioral impairment;Biochemical;Biochemistry;Biological;Biological Markers;Brain;Brain Injuries;Brain region;Cell Death;Cell model;Cells;Central Nervous System;Chemical Warfare;Chemistry;cholinergic;Cholinesterase Inhibitors;Cholinesterases;Clinic;Clinical;Clinical assessments;clinical development;Clinical Drug Development;Clinical Investigator;clinical translation;Clinical Trials;clinically relevant;Cognition;Collaborations;controlled release;design;Development;Disease;Disease Marker;Disease Progression;Distant;Dose;Down&apos;s Syndrome;drug candidate;Drug Design;drug development;drug discovery;Drug Kinetics;Drug Targeting;early phase clinical trial;Elderly;Elements;Enzyme Inhibitor Drugs;Enzymes;Evaluation;Event;exosome;Extramural Activities;Failure;Formulation;Gatekeeping;Goals;Health;Health Benefit;Human;Impairment;in vivo;in vivo Model;Industry;Inflammation;inhibitor;Investigation;Investigational Therapies;Kinetics;Legal patent;Licensing;Measurement;Mediating;Messenger RNA;Metabolism;Methods;misfolded protein;Molecular;Molecular Target;multidisciplinary;Myasthenia Gravis;Nervous System Disorder;Neurodegenerative Disorders;Neuroglia;Neurologic;neuron apoptosis;neuron loss;Neurons;neuroprotection;neuropsychiatry;Neurotransmitters;New Agents;new therapeutic target;novel;novel therapeutics;Oral;Oxazoles;Parkinson Disease;Pathway interactions;Peptides;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Pharmacology;Pharmacology Study;Phase I Clinical Trials;Phase I/II Clinical Trial;phenserine;Phenylcarbamates;Plasma;Positioning Attribute;posttranscriptional;pre-clinical;Pre-Clinical Model;pressure;Procedures;Process;Production;prophylactic;Protein Precursors;Proteins;reduce symptoms;regenerative;Research;Research Project Grants;Resources;response;Rewards;Risk;Role;Safety;Sampling;Series;Site;Stroke;stroke model;System;tau Proteins;Technology;Testing;Therapeutic;Time;Toxic effect;TP53 gene;transcription factor;Translating;Translational Regulation;Translations;Traumatic Brain Injury;Up-Regulation;X-Ray Crystallography,ALZHEIMERS RESEARCH PROJECT:  Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease),311,NA,NA,NA,NA,24,NA,NA,613612,NA
11177369,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000333,NA,NA,1ZIAAG000333-16,NIA:523375\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6978327 (contact),"GREIG, NIGEL H. (contact)",NA,NA,NA,Academia;Acute;Age;age related;Aging;Agonist;Ally;Alzheimer&apos;s Disease;Anabolism;analog;Animal Disease Models;Animals;Apoptosis;Appetite Regulation;Basic Science;Beta Cell;Binding;Biochemical;Biological;Brain;Cell Culture Techniques;Cell Proliferation;Cell Transplantation;Cells;Central Nervous System;Chronic;Clinic;Clinical;Clinical assessments;clinical development;Clinical Drug Development;Clinical Trials;Collaborations;COVID-19;Degenerative Disorder;demented;Dementia;design;Development;Diabetes Mellitus;Diet;Dipeptidyl Peptidases;Disease;Disease Progression;drug candidate;Drug Design;drug development;drug repurposing;Drug Targeting;Dyskinetic syndrome;early phase clinical trial;effective therapy;Elderly;Elements;Endocrine;Enzymes;Epidemic;epidemiology study;exenatide;Extramural Activities;Fibromyalgia;Food;Formulation;gastric inhibitory polypeptide receptor;Genetic Predisposition to Disease;Genetic Transcription;GLP-I receptor;Glucagon Receptor;glucagon-like peptide 1;Glucose;Goals;Health Benefit;Human;Huntington Disease;Impairment;in vivo;in vivo Model;Industry;Inflammation;Ingestion;inhibitor;Insulin;insulin secretion;insulin signaling;Investigation;Investigational Therapies;Investments;islet;Korea;Legal patent;Licensing;Life;Link;Metabolism;mimetics;Modeling;Molecular Target;Morbidity - disease rate;mortality;multidisciplinary;Nerve Degeneration;Nervous System;Nervous System Disorder;Neurodegenerative Disorders;Neurologic;Neurons;neuroprotection;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutics;Obesity;Oxidative Stress;Pain;Pancreas;Parkinson Disease;Pathogenicity;Peptides;peptidomimetics;Peripheral Nerves;Peripheral Nervous System Diseases;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Pharmacological Treatment;Pharmacology;physical inactivity;Physicians;Plasma;Positioning Attribute;pre-clinical;Pre-Clinical Model;preclinical study;Property;Pseudotumor Cerebri;receptor;Reporting;Research;Research Project Grants;Resources;response;Rewards;Risk Factors;Rodent;Role;Satiation;Serine Protease;Stroke;Structure of beta Cell of islet;Testing;Time;Tissues;Translating;Translations;Traumatic Brain Injury;treatment strategy;trend,ALZHEIMERS RESEARCH PROJECT:  Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease),333,NA,NA,NA,NA,16,NA,NA,523375,NA
11177370,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000335,NA,NA,1ZIAAG000335-08,NIA:323887\RMOD:371054\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,Affect;Age;Age Months;age related;age related changes;age related decline;Aging;aging process;Animals;Atlases;Award;Baltimore;behavioral phenotyping;biobank;Bioinformatics;Biological Markers;Biological Process;Blood;Blood Glucose;Body Composition;Body fat;Body Weight;Brain imaging;Breeding;Cardiovascular Diseases;Cardiovascular Physiology;Cardiovascular system;Cell Aging;Cell Communication;Cells;Chronic;cognitive change;cohort;Computing Methodologies;Contracts;Custom;Development;Disease;Echocardiography;Enrollment;Environment;Epigenetic Process;Erythrocytes;Euthanasia;Evaluation;Fasting;fasting glucose;Fatty acid glycerol esters;Feces;Female;food consumption;Formula Diets;Freezing;functional decline;Functional disorder;gait examination;Gait speed;Genomics;Glucose;Hand Strength;healthspan;Human;imaging modality;in vivo;Infiltration;Inflammation;Infrastructure;Insulin;Insulin Resistance;Learning;Life;life span;Longitudinal Studies;male;Maps;Measures;Memory;Metabolic;metabolic phenotype;Metabolism;metabolomics;microCT;model organism;Molecular;morris water maze;mortality risk;Motor Activity;Mus;Muscle;Neuronal Dysfunction;nonhuman primate;OGTT;Onset of illness;Organism;outcome prediction;Periodicals;Phenotype;Physiological;programs;Proteomics;Psyche structure;Research;Same-sex;Sampling;Schedule;senescence;Serum;sex;subcutaneous;System;Temperature;Testing;The Jackson Laboratory;Thinness;Time;Tissues;transcriptomics;treadmill;Urine;Width;Work;X-Ray Computed Tomography,Study of Longitudinal Aging in Mice,335,NA,NA,NA,NA,8,NA,NA,694941,NA
11177371,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000341,NA,NA,1ZIAAG000341-08,NIA:248690\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690805 (contact),"RESNICK, SUSAN  (contact)",NA,NA,NA,Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Alzheimer’s disease biomarker;Amyloid;Amyloid deposition;amyloid imaging;Baltimore;Binding;Biological Assay;Biological Markers;Cognitive;cognitive change;Collaborations;Data;Deposition;Disease;Failure;Funding;Image;imaging study;Individual;Laboratories;Loneliness;Longitudinal Studies;Magnetic Resonance Imaging;Manuscripts;Measures;Memory;Memory Loss;Nerve Degeneration;neuroimaging;neuroinflammation;Neuronal Injury;Participant;Personality Character;Plasma;Positron-Emission Tomography;pre-clinical;Publications;Questionnaires;radioligand;Research Project Grants;Sampling;Scanning;Spatial Distribution;Staging;tau Proteins;Universities;Washington,ALZHEIMERS RESEARCH PROJECT: PET tau imaging in BLSA and GESTALT as an Early Marker of Alzheimer's Disease,341,NA,NA,NA,NA,8,NA,NA,248690,NA
11177372,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000345,NA,NA,1ZIAAG000345-04,NIA:281641\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78324558 (contact),"BASISTY, NATHAN  (contact)",NA,NA,NA,Adipocytes;age related;age related decline;Aging;aging biomarker;aging population;aging related;biological age;Biological Aging;Biological Markers;biomarker signature;Blood;blood-based biomarker;Cells;circulating biomarkers;Circulation;Clinical;clinical phenotype;cohort;Collection;Coupled;Data Collection;Development;Disease;Elderly;Epithelial Cells;Fibroblasts;frailty;Future;Geroscience;Glucose;Health;Human;Immune;Individual;Inflammation;innovation;Intervention;Intervention Trial;life span;Linear Models;longitudinal human study;Longitudinal Studies;Lymphocyte;machine learning algorithm;Measurement;Measures;Mediating;Metabolic;minimally invasive;Modeling;Molecular;Molecular Profiling;monocyte;Morbidity - disease rate;mortality;multiple chronic conditions;multiple omics;Mus;Myoblasts;nanoparticle;novel;novel marker;novel strategies;obese person;Obesity;Outcome;outcome prediction;Pathology;Phenotype;Physical activity;Physiological;Plasma;Proteins;Proteome;proteomic signature;Proteomics;quantification of aging;senescence;Senotherapeutic;Serum;Solid;Testing;theories;Tissues;tool;trait;treatment strategy,"Development of Sensitive and Specific Proteomic Biomarkers of Aging, Health, Frailty, and Morbidity in Human and Mouse Cohorts",345,NA,NA,NA,NA,4,NA,NA,281641,NA
11177373,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000346,NA,NA,1ZIAAG000346-04,NIA:140820\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78324558 (contact),"BASISTY, NATHAN  (contact)",NA,NA,NA,Adipocytes;Adipose tissue;age related;age-related disease;Aging;aging population;Baltimore;Biological Markers;Biology;Blood;Blood Glucose;Blood Vessels;Body mass index;candidate marker;Cardiac;Cell Culture Techniques;Cell secretion;Cell Separation;Cell surface;cell type;Circulation;Clinical;Cohort Studies;Collaborations;Data;drivers of aging;Excision;experimental study;Fatty acid glycerol esters;Fibroblasts;Flow Cytometry;frailty;High Density Lipoproteins;Hospitals;Human;human tissue;Immunofluorescence Immunologic;improved;in vivo;insight;Institutional Review Boards;Kidney;Longevity;Longitudinal Studies;Low-Density Lipoproteins;Lung;Manuscripts;Metabolic;Methods;Modernization;molecular marker;monocyte;Mus;Musculoskeletal;Neurologic;obese person;Obesity;Older Population;Outcome;Participant;personalized approach;Phenotype;Plasma;Population;Population Heterogeneity;pre-clinical;predictive signature;Preparation;Proteins;Proteome;Proteomics;Resources;Saints;senescence;senescence associated secretory phenotype;senescent cell;Specimen;Spectrometry;subcutaneous;Surface;targeted biomarker;targeted treatment;Technology;Therapeutic;therapy development;Tissues;trait;Translations;Validation;Vascular Endothelial Cell;Work,"Targeting, Quantifying, and Isolating Heterogeneous Populations of Senescent Cells from Tissues via Cell Surface and Secreted Proteomes",346,NA,NA,NA,NA,4,NA,NA,140820,NA
11177374,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000347,NA,NA,1ZIAAG000347-04,NIA:70410\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78324558 (contact),"BASISTY, NATHAN  (contact)",NA,NA,NA,age related;age-related disease;Aging;aging related;Autophagocytosis;Biological;Clinic;Collaborations;Communities;Complex;computational platform;Computer software;computerized tools;Data Analyses;Development;Disease;Equilibrium;Fatty acid glycerol esters;Goals;hallmarks of aging;Human;human study;in vivo;Institutional Review Boards;Isotopes;Journals;Label;Manuscripts;Measurement;Measures;Metabolic;Methods;Mitochondria;Modeling;multicatalytic endopeptidase complex;Mus;Muscle;Muscular Atrophy;Nerve Degeneration;Non-Insulin-Dependent Diabetes Mellitus;open source;Pathology;Peripheral Blood Mononuclear Cell;Process;Protein Biosynthesis;protein degradation;Proteins;Proteome;Proteomics;proteostasis loss;Publishing;Research;Role;sarcopenia;Scientist;skeletal muscle wasting;Skin;Software Tools;System;therapeutic target;Time;Tissues;tool;Translations;Ubiquitin;Universities;user-friendly;Washington;Water;Work,Proteomic Pipelines for the Quantification of Abundance and Turnover of Post-Translationally Modified Proteins in Aging Studies,347,NA,NA,NA,NA,4,NA,NA,70410,NA
11177375,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000348,NA,NA,1ZIAAG000348-04,NIA:388946\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78336180 (contact),"WALKER, KEENAN  (contact)",NA,NA,NA,Acute;Affect;Aging;aging brain;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Alzheimer&apos;s disease risk;Atherosclerosis Risk in Communities;Baltimore;biobank;Biological Markers;Blood Vessels;Brain;Chronic;Circulation;Clinical;Cognition;Cognitive;cohort;Cohort Studies;Data;Dementia;dementia risk;differential expression;Disease Progression;endophenotype;Epidemiologic Methods;Exposure to;Goals;Herpesviridae;Human;Immune;Infection;Inflammatory;Longitudinal cohort study;Longitudinal Studies;Measures;Memory;Nerve Degeneration;neuroimaging;older adult;Proteins;Proteomics;Research Project Grants;Risk;Structure;systemic inflammatory response;vascular risk factor;Women&apos;s Health;Work,ALZHEIMERS RESEARCH PROJECT: Understanding immune/inflammatory and vascular mechanisms in brain aging and Alzheimer's disease,348,NA,NA,NA,NA,4,NA,NA,388946,NA
11177376,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000349,NA,NA,1ZIAAG000349-04,NIA:400732\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78336180 (contact),"WALKER, KEENAN  (contact)",NA,NA,NA,Aging;Alzheimer&apos;s Disease;Amyloid beta-Protein;Atherosclerosis Risk in Communities;Baltimore;Biological;Biological Process;Brain;brain health;brain magnetic resonance imaging;brain volume;burden of illness;Central Nervous System;Cerebral small vessel disease;Cognitive;cognitive testing;cohort;Data;Dementia;differential expression;experience;Funding;Future;Goals;Immune;Impaired cognition;Individual;Longitudinal cohort study;Longitudinal Studies;Measurement;Measures;Methods;neuroimaging;Participant;Pathway interactions;Peripheral;Plasma;Plasma Proteins;Positron-Emission Tomography;Proteins;proteomic signature;Proteomics;Reproducibility;Research Project Grants;tau Proteins;therapeutic target,ALZHEIMER'S RESEARCH PROJECT: Identifying peripheral drivers of Alzheimers disease using plasma proteomics,349,NA,NA,NA,NA,4,NA,NA,400732,NA
11177377,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000350,NA,NA,1ZIAAG000350-16,NIA:907541\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1860367 (contact),"RAPP, PETER R (contact)",NA,NA,NA,Address;Age;age related;age related changes;Age-associated memory impairment;age-related disease;aged;Aging;Alzheimer&apos;s Disease;animal data;Animal Model;animal old age;Animals;Area;Attention;Baltimore;Basic Science;Behavioral;Biochemical;Brain;Brain region;calbindin-D28K;Calcium;Cell Count;Cerebellar Cortex;Cerebellum;Characteristics;Cognitive;Cognitive aging;cognitive capacity;comparative;Data;Dementia;disorder risk;Exhibits;experience;experimental study;Foundations;Health;Human;human old age (65+);Individual;Individual Differences;insight;Investigation;juvenile animal;Kinetics;Link;Longitudinal Studies;Measures;medial temporal lobe;Mediator;Memory;Memory impairment;memory recognition;Modeling;Monkeys;Motor;neural;neural network;Neurobiology;neurochemistry;Neurocognitive;neuroimaging;Neurons;novel;Older Population;Outcome;Output;Pattern;Phenotype;pre-clinical;Pre-Clinical Model;preference;Prefrontal Cortex;preservation;Process;protein biomarkers;Proteins;Publishing;Purkinje Cells;Quality of life;Rattus;Reporting;Research;Research Project Grants;resilience;Role;Series;social;social cognition;Social Interaction;social neuroscience;spatial memory;Stimulus;System;Testing;translational approach;translational study;Work,"ALZHEIMERS RESEARCH PROJECT: Neurocognitive Aging: Experience-Dependent Dynamics, Plasticity and Network Contributions",350,NA,NA,NA,NA,16,NA,NA,907541,NA
11177378,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000352,NA,NA,1ZIAAG000352-16,NIA:259297\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1860367 (contact),"RAPP, PETER R (contact)",NA,NA,NA,Affect;Age;age effect;age related;Age Years;aged;Aging;Alzheimer&apos;s Disease;animal old age;basal forebrain;behavior test;Brain;Cells;cholinergic;cholinergic neuron;Chronology;Cognitive;Cognitive aging;cohort;comparative;comparison group;Desire for food;Elderly;Exhibits;Human;Hypertrophy;Impaired cognition;Impairment;Individual;Individual Differences;lens;Macaca;Macaca mulatta;Maps;mature animal;Measures;medial temporal lobe;Modeling;Monkeys;Neuroanatomy;Neurobiology;Neurocognitive;Neurons;Neuropsychology;Outcome;Pattern;Performance;Persons;Population;Prefrontal Cortex;Primates;Publishing;Rattus;Recording of previous events;Research Project Grants;resilience;Rodent Model;Sampling;sex;System;Testing;translational model;Visit;Work;young adult,ALZHEIMERS RESEARCH PROJECT: Primate Models of Neurocognitive Aging,352,NA,NA,NA,NA,16,NA,NA,259297,NA
11177379,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000353,NA,NA,1ZIAAG000353-05,NIA:360948\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,77834322 (contact),"BOUHRARA, MUSTAPHA  (contact)",NA,NA,NA,Acceleration;Affect;age-related disease;Aging;aging related;Alzheimer&apos;s Disease;Amyloid;autosomal dominant Alzheimer&apos;s disease;Axon;axonal degeneration;biobank;Biological Markers;Brain;cardiovascular fitness;Cerebrum;Cholesterol;Cognitive;cohort;Collaborations;Complex;Data;Dementia;Democracy;Demyelinations;density;Early Diagnosis;Ensure;functional decline;Functional disorder;Functional impairment;Funding;Germany;Goals;Health;Hypertension;Image;imaging biomarker;Impaired cognition;Impairment;improved;insight;Intellectual Property;Intervention;Iron;Lawyers;Legal patent;Link;Longitudinal Studies;Magnetic Resonance Imaging;Maps;Measurement;Measures;Methods;mild cognitive impairment;Modeling;Monitor;Motor;Myelin;Myelin Proteins;myelination;Nerve Degeneration;neuroimaging;neuroinflammation;normal aging;Obesity;Oligodendroglia;Pattern;Positron-Emission Tomography;Prevention;programs;Property;Property Rights;Protocols documentation;Research;Research Project Grants;Risk Factors;Role;Secure;Senile Plaques;Sister;Structure;tau Proteins;Techniques;theories;United States National Institutes of Health;Vascular Dementia;Water;white matter;white matter change;Work,ALZHEIMERS RESEARCH PROJECT: Cerebral Microstructure in Aging and Dementia using Advanced Quantitative MRI,353,NA,NA,NA,NA,5,NA,NA,360948,NA
11177380,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000354,NA,NA,1ZIAAG000354-03,NIA:170901\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826199 (contact),"BENJAMINI, DAN  (contact)",NA,NA,NA,Affect;Age;age related;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Amyloid;Amyloid beta-Protein;Area;Astrocytes;astrogliosis;Autopsy;axon injury;Biological Markers;blind;Brain;brain control;brain dysfunction;Central Nervous System;Cerebral cortex;Cerebrum;Chemicals;Cicatrix;Clinical;Cognition;Cognitive;Complex;Correlation Studies;Data;demented;Dementia;Demyelinations;Deposition;detection method;Diagnostic Imaging;Diffusion;Diffusion Magnetic Resonance Imaging;Dimensions;Disease;Elderly;Evaluation;Exhibits;glial activation;Glial Fibrillary Acidic Protein;Goals;Histologic;histological image;Histology;Histopathology;Image;imaging biomarker;imaging modality;immunoreactivity;Impaired cognition;improved;in vivo;in vivo imaging;Individual;Injury;innovation;interest;Knowledge;Lesion;Linear Regressions;Link;Magnetic Resonance Imaging;Maps;Measurement;Measures;member;meter;Methods;Microscopic;microscopic imaging;Microscopy;millimeter;Modality;multimodality;Nerve Degeneration;Neurofibrillary Tangles;neuroimaging;neuroinflammation;Neuronal Injury;Neurons;neuropathology;non-demented;non-invasive imaging;novel marker;Pathology;Positron-Emission Tomography;Process;quantitative imaging;Radiology Specialty;Reaction;Relaxation;repaired;Research;resilience;Resolution;response;response to injury;Sampling;Sensitivity and Specificity;sex;Signal Transduction;Slice;Specificity;Specimen;Stains;Standardization;Structure;Symptoms;tau Proteins;tau-1;Tauopathies;Techniques;tissue injury;Tissue Sample;Tissues,Alzheimers Disease Project: Quantitative imaging of astrogliosis and neuroinflammation,354,NA,NA,NA,NA,3,NA,NA,170901,NA
11177381,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000359,NA,NA,1ZIAAG000359-03,NIA:140820\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78324558 (contact),"BASISTY, NATHAN  (contact)",NA,NA,NA,Anthocyanins;Apigenin;Biological Assay;Cell Aging;Cell Culture Techniques;Cell Death;Cell membrane;Cell Survival;cell type;Cells;cellular targeting;Cessation of life;chemoproteomics;Dietary Flavonoid;Dose;Drug Screening;efficacy evaluation;epicatechin;Epithelial Cells;fisetin;Flavonoids;Future;genetic manipulation;IFIH1;Intake;Intervention;Ions;kidney cell;Mass Spectrum Analysis;Measures;meter;Methods;Modeling;monocyte;myricetin;Natural Compound;novel;Pathway interactions;POLB gene;Procyanidins;Proteins;Proteomics;Quercetin;renal epithelium;response;screening;senescence;senescent cell;senolytics;Specificity;TXNIP gene;uptake;Work,Evaluating the Cell-Type Specificity and Cellular Targets of Senotherapuetic Compounds with Unknown Mechanisms,359,NA,NA,NA,NA,3,NA,NA,140820,NA
11177382,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000360,NA,NA,1ZIAAG000360-03,NIA:36095\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78324558 (contact),"BASISTY, NATHAN  (contact)",NA,NA,NA,ADAMTS;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Astrocytes;brain cell;Cell Aging;Cell Culture Techniques;cell type;Cells;Conditioned Culture Media;Data;Data Set;Databases;Disease;Dose;Doxorubicin;drivers of aging;Engineering;extracellular vesicles;Future;Genes;Genetic Risk;genetic variant;Genetic Variation;Genotoxic Stress;Hand;Heritability;Human;human data;Image;Individual;induced pluripotent stem cell;Induced pluripotent stem cell derived neurons;insight;Laboratories;Link;Methods;Modeling;multiple omics;Neurodegenerative Disorders;Neuroglia;Neurons;Oligodendroglia;Phenotype;Population;prion-like;Proteins;Proteomics;Protocols documentation;repository;Research Personnel;Research Project Grants;Resolution;Resources;response;Risk;risk variant;Sampling;senescence;senescence associated secretory phenotype;senescent cell;Senotherapeutic;Stress;Testing;transcriptomics;transmission process;Variant;Work,ALZHEIMERS RESEARCH PROJECT:  CARD - Senescent Phenotypes of Isogenic iPSC-Derived Alzheimer's Disease and Related Dementia Models at Cellular Resolution,360,NA,NA,NA,NA,3,NA,NA,36095,NA
11177383,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000373,NA,NA,1ZIAAG000373-17,NIA:780740\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1887759 (contact),"SEN, RANJAN  (contact)",NA,NA,NA,3-Dimensional;activation-induced cytidine deaminase;Age;Aging;Alleles;Antigen Receptors;B-Cell Development;B-Lymphocytes;Bone Marrow;Bone Marrow Transplantation;CCCTC-binding factor;Cell Nucleus;Cells;Cellular biology;Chromatin;Chromatin Structure;chromosome movement;Confocal Microscopy;Defect;derepression;Development;Distant;Ensure;Environment;Enzymes;Epigenetic Process;Gene Expression;Genes;genomic locus;Goals;Heavy-Chain Immunoglobulins;Hematopoiesis;IGH@ gene cluster;Immune response;Immunoglobulin Class Switching;Immunoglobulin Switch Recombination;Lamins;Location;Lymphocyte;Movement;Mus;Mutate;Myelogenous;Myeloid Cells;Nuclear;Nuclear Matrix-Associated Proteins;Paper;Pathway interactions;Positioning Attribute;Process;programs;Publishing;Receptor Gene;recombinase;Role;Scaffolding Protein;single-cell RNA sequencing;stem cells;three dimensional structure;Tissue-Specific Gene Expression;Tissues;transcription factor;V(D)J Recombination;YY1 Transcription Factor,Chromosome movements that regulate tissue-specific gene expression,373,NA,NA,NA,NA,17,NA,NA,780740,NA
11177384,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000376,NA,NA,1ZIAAG000376-17,NIA:379526\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1887759 (contact),"SEN, RANJAN  (contact)",NA,NA,NA,Aging;anti-IgM;Antibodies;Area;B Cell Proliferation;B-Cell Activation;B-Cell Antigen Receptor;B-Cell Lymphomas;B-Lymphocytes;Binding;Cell Adhesion Molecules;Cell Line;Cell Maintenance;Cell Survival;cell type;Cells;chromatin immunoprecipitation;Cleavage Under Targets and Release Using Nuclease;crosslink;cytokine;Cytoplasm;DNA Damage;endoplasmic reticulum stress;Family;Gene Expression;Genes;Genetic Transcription;Genomics;Goals;GTF2I gene;Helper-Inducer T-Lymphocyte;Human;Hypoxia;Immune response;In Vitro;inducible gene expression;Inflammatory;Interleukin-1;Interleukin-6;Mediating;Modeling;Molecular;Mus;NF-kappa B;Nuclear;Nuclear Translocation;Pathway interactions;Population;Procedures;Reactive Oxygen Species;receptor;Receptor Activation;Receptor Signaling;Research;response;Role;sensor;Signal Transduction;Specificity;Spleen;Stimulus;Stress;System;Systems Biology;T cell response;T-Lymphocyte;targeted treatment;TFII Transcription Factors;TNF gene;TNFRSF5 gene;transcription factor;Translating;Work,NF-kB activation and function in B lymphocytes,376,NA,NA,NA,NA,17,NA,NA,379526,NA
11177385,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000380,NA,NA,1ZIAAG000380-09,NIA:4662752\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,14741732 (contact),"SUNG, MYONG-HEE  (contact)",NA,NA,NA,Aging;Behavior;Biochemical;Biology;Bone Marrow;Brain;c-rel Proto-Oncogenes;Cell Physiology;Cell Survival;cell type;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;Data;Ear;Exhibits;Fibroblasts;Frequencies;Gene Expression Regulation;Genetic Transcription;Genome engineering;genome sequencing;genomic locus;Immune;Immunity;improved;in vivo;Incubated;insight;Knock-in Mouse;Label;Lasers;Ligands;Link;live cell imaging;live cell microscopy;machine learning model;Macrophage;Manuscripts;mathematical model;Mediating;Methods;Microbe;Microglia;Microscope;Microscopy;Modeling;Mouse Strains;Mus;novel;Nuclear;Paper;Pathogenicity;Pattern;Process;Proteins;Publications;Publishing;receptor;Reporter;Research;response;Scanning;Signal Transduction;Signaling Molecule;Southern Blotting;Stimulus;System;T-Lymphocyte;Time;Tissues;transcription factor;transmission process;whole genome,Functional decoding of signaling dynamics in single immune cells,380,NA,NA,NA,NA,9,NA,NA,4662752,NA
11177386,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000383,NA,NA,1ZIAAG000383-21,NIA:368683\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1887759 (contact),"SEN, RANJAN  (contact)",NA,NA,NA,Antibody Repertoire;B-Cell Antigen Receptor;B-Cell Development;B-Lymphocytes;Binding;Binding Sites;Characteristics;Chromatin;Chromatin Structure;Code;combinatorial;CRISPR/Cas technology;Development;Distant;E protein;enhancer binding protein;Enhancers;EP300 gene;Epigenetic Process;Event;Gene Activation;Gene Expression;Gene Expression Regulation;gene repression;Generations;Genes;Genetic Recombination;Genetic Transcription;Genomics;Goals;Heavy-Chain Immunoglobulins;Hematopoietic stem cells;histone modification;human disease;IGH@ gene cluster;insight;Lymphocyte;Manuscripts;Molecular Conformation;Mus;Mutate;Mutation;Preparation;Property;Publications;Publishing;Role;Single Nucleotide Polymorphism;Site;Somatic Cell;Study models;T-Cell Receptor;T-Lymphocyte;Tissue-Specific Gene Expression;transcription factor;V(D)J Recombination;virtual;Work;YY1 Transcription Factor,Gene Regulation in Lymphocytes,383,NA,NA,NA,NA,21,NA,NA,368683,NA
11177387,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000386,NA,NA,1ZIAAG000386-18,NIA:368683\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1887759 (contact),"SEN, RANJAN  (contact)",NA,NA,NA,Address;Affect;age related;age related changes;Aging;ATAC-seq;Baltimore;base;CD4 Positive T Lymphocytes;Cell Aging;Cell Physiology;Cells;Characteristics;Chromatin;Chromatin Structure;cohort;Collaborations;COVID-19;cytokine;Cytoplasm;Data;DNA Damage;DNA Methylation;Epigenetic Process;epigenomics;Gene Expression;Genetic;Genetic Transcription;Goals;hallmarks of aging;Human;hypoxia inducible factor 1;Immune;Immune response;In Vitro;Inflammatory;Laboratories;Longitudinal Studies;Lymphocyte;Measures;Memory;Methylation;monocyte;NF-kappa B;Oxidation-Reduction;Oxidative Stress Induction;peripheral blood;Phase;Phenotype;Post-Translational Protein Processing;Procedures;Proliferating;Proteins;Proteomics;Publications;response;RNA;Role;sample collection;Sampling;Signal Transduction;Testing;Tissues;transcription factor;Transcription Factor AP-1;transcriptomics;vaccine evaluation;vaccine response,Age-associated alterations in pro-inflammatory gene expression in humans,386,NA,NA,NA,NA,18,NA,NA,368683,NA
11177388,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000390,NA,NA,1ZIAAG000390-09,NIA:2819339\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,14741732 (contact),"SUNG, MYONG-HEE  (contact)",NA,NA,NA,3-Dimensional;adaptive immune response;Address;Age;age related;age-related disease;Aging;Alzheimer&apos;s disease model;Amyloid beta-Protein;animal old age;Antigen Presentation;ATAC-seq;Bioinformatics;Biology of Aging;Brain;cell behavior;Cells;Characteristics;Chromatin;Chronic;Circulation;Coculture Techniques;Collaborations;computerized tools;cytokine;Data;Defect;Deterioration;Development;Discipline;DNA;DNase I hypersensitive sites sequencing;Elderly;Epigenetic Process;epigenomics;Gene Expression;Gene Expression Regulation;Genes;Genome;genomic tools;High-Throughput Nucleotide Sequencing;Histocompatibility Antigens Class I;HMGN Proteins;HMGN1 gene;HMGN2 gene;Homeostasis;human induced pluripotent stem cells;Immune;Immune system;Immunity;Impairment;improved;Inflammation;Inflammatory;juvenile animal;Knock-in Mouse;knowledge integration;Macrophage;Manuscripts;Mathematics;Methodology;Methods;Microglia;model organism;Molecular Biology;mouse model;Mus;neuroinflammation;Neurons;Nucleosomes;Nucleotides;old mice;Pathogenicity;Pathologic;Pattern;Persons;Play;Process;programs;Proliferating;Protocols documentation;Regulation;Reporting;Role;Signal Transduction;Software Tools;Tissues;tool;transcription factor;Up-Regulation;uptake;Vaccination,Epigenomic analysis of primary immune cells from young and old animals,390,NA,NA,NA,NA,9,NA,NA,2819339,NA
11177389,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000393,NA,NA,1ZIAAG000393-17,NIA:2302338\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Adopted;Affect;age related changes;age-related disease;Aging;aging process;Alternative Splicing;Apoptosis Regulation Gene;Atherosclerosis;Attention;Binding;Binding Proteins;Biological Assay;Biotinylation;Blood Vessels;Brain-Derived Neurotrophic Factor;Cardiovascular system;Cell Aging;Cell Physiology;Cell Survival;Cells;Cellular biology;clinical investigation;Communication;crosslink;Cultured Cells;Cyclin-Dependent Kinase Inhibitor;Cyclins;cytokine;Diploidy;extracellular;extracellular vesicles;Fibroblasts;Gene Expression;Gene Expression Profile;Growth Factor;hallmarks of aging;Human;human tissue;Immunoprecipitation;In Vitro;Individual;Inflammation;insight;interest;Intervention;Journals;life span;Link;Malignant Neoplasms;Measures;Messenger RNA;Metalloproteases;MicroRNAs;Modification;mouse model;mRNA Expression;Mus;muscle form;Muscular Atrophy;mutant;nanopore;Nature;Nucleic Acids;Oncoproteins;Organ;overexpression;Participant;particle;Pathologic;Pathology;Pattern;Phenotype;Physiological;Physiology;Polyribosomes;Post-Transcriptional Regulation;posttranscriptional;Process;Production;programs;Proliferating;protein biomarkers;protein expression;protein function;Proteins;Proteome;Reporter;Research;Ribonucleoproteins;RNA;RNA Interference;RNA-Binding Proteins;Role;Science;senescence;senescence associated secretory phenotype;senescent cell;Signal Pathway;Signal Transduction;skin biopsy;src-Family Kinases;Sweat Glands;System;Tissue Microarray;Tissues;transcriptome;transcriptome sequencing;Translating;Translations;Tumor Suppressor Proteins;Untranslated RNA;Work,Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging,393,NA,NA,NA,NA,17,NA,NA,2302338,NA
11177390,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000394,NA,NA,1ZIAAG000394-17,NIA:1489748\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,age related decline;Aging;aging related;Animals;Area;Autophagocytosis;blood glucose regulation;Cachexia;Cell Nucleus;Cell Physiology;Collaborations;Development;Energy consumption;Energy Metabolism;Event;glucose metabolism;Human;Impairment;insulin regulation;interest;Journals;Knock-out;lipid biosynthesis;lipid metabolism;Messenger RNA;Metabolic;Mitochondria;mitochondrial metabolism;Mitochondrial RNA;Molecular and Cellular Biology;mouse model;Muscle;Muscle Cells;muscle regeneration;Myoblasts;myogenesis;Natural regeneration;Neurons;overexpression;Pancreas;Post-Transcriptional Regulation;posttranscriptional;Process;Production;programs;Reporting;RNA-Binding Protein FUS;RNA-Binding Proteins;Role;sarcopenia;senescence;Structure;Structure of beta Cell of islet;Tissues;transcriptome;Untranslated RNA,Post-transcriptional regulation of energy usage: glucose and lipid metabolism,394,NA,NA,NA,NA,17,NA,NA,1489748,NA
11177391,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000435,NA,NA,1ZIAAG000435-06,NIA:601098\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1860367 (contact),"RAPP, PETER R (contact)",NA,NA,NA,2 year old;Age Months;Aging;aging brain;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Animals;Autopsy;Behavioral;biobank;Biological;Biological Specimen Banks;Brain;Cognitive;Cognitive aging;cognitive function;cognitive reserve;Collection;Data;data centers;data management;data sharing;Dedications;design;Deterioration;Diffusion Magnetic Resonance Imaging;digital data;Disease Progression;effective therapy;Extramural Activities;Female;functional MRI scan;Goals;Individual;Individual Differences;interest;late life;Long-Evans Rats;longitudinal analysis;longitudinal dataset;Magnetic Resonance;male;Measurement;Mediator;Modeling;Neurocognitive;Neurodegenerative Disorders;neuroimaging;neuropathology;Outcome;Pathologic;Peripheral;Persons;Phase;Phenotype;phenotypic data;Physiological;Plasma;Rattus;Research;Research Project Grants;resilience;Resources;Sampling;Scanning;sex;Sex Differences;tissue archive;Tissues;Vaginal Douching,ALZHEIMERS RESEARCH PROJECT: STARRRS: an open rat resource for the study of reserve and resilience against Alzheimer's disease,435,NA,NA,NA,NA,6,NA,NA,601098,NA
11177392,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000436,NA,NA,1ZIAAG000436-06,NIA:130827\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690805 (contact),"RESNICK, SUSAN  (contact)",NA,NA,NA,"AD transgenic mice;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Alzheimer&apos;s disease risk;APP-PS1;Asthma;Big Data;Biochemical Pathway;Biological Assay;Blood;Brain;Cell Culture Techniques;clinical practice;Data;Data Analyses;Data Set;Dementia;Diabetes Mellitus;Drug Prescriptions;drug repurposing;drug testing;Epilepsy;Evaluation;experimental study;Exposure to;Fatty Acids;FDA approved;Glucose;health record;Hippocampus;Hypertension;Impairment;in vivo;Link;Medicare;Medicine;Metabolism;molecular phenotype;mouse model;Mus;novel therapeutics;Older Population;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Phospholipid Metabolism;protective effect;randomized, clinical trials;Research;Research Project Grants;Rheumatoid Arthritis;screening;Services;Signal Transduction;sound;Synaptic plasticity;Testing;transgenic model of alzheimer disease;Validation",ALZHEIMERS RESEARCH PROJECT: New Cures from Old Medicines - Targeting abnormal metabolism in Alzheimer's Disease,436,NA,NA,NA,NA,6,NA,NA,130827,NA
11177393,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000437,NA,NA,1ZIAAG000437-03,NIA:341801\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826199 (contact),"BENJAMINI, DAN  (contact)",NA,NA,NA,Address;Adult;age difference;Aging;aging brain;Amyloid;Architecture;Astrocytes;Atrophic;Axon;Baltimore;Biological;Brain;Cell membrane;Cell Physiology;Cerebrum;Characteristics;Chemicals;Clinical;Cognitive;cognitive function;cohort;Complex;Coupled;Data;data acquisition;Dementia;Dendritic Spines;density;design;Diffusion;Diffusion Magnetic Resonance Imaging;Dimensions;Epigenetic Process;Fiber;Frequencies;Gel;Genetic;Goals;gray matter;healthy volunteer;Histologic;Human;human old age (65+);Image;Impaired cognition;Investigation;Laboratories;life span;Link;Longitudinal Studies;Magnetic Resonance Imaging;Measures;Methods;Microscopic;mild cognitive impairment;millimeter;Morphology;Myelin;neurofilament;neuroimaging;neuroinflammation;Neurons;normal aging;novel;Outcome;Participant;Powder dose form;pre-clinical;Property;Protocols documentation;Relaxation;Reproducibility;Resolution;Scanning;Shapes;Structure;Synapses;Testing;Thick;Time;Tissues,Linking brain micro- and meso-structure with cognitive functioning,437,NA,NA,NA,NA,3,NA,NA,341801,NA
11177394,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000438,NA,NA,1ZIAAG000438-02,NIA:36537\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690805 (contact),"RESNICK, SUSAN  (contact)",NA,NA,NA,"Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Amyloid beta-Protein;APP-PS1;Bile Acids;Biological;Biological Assay;Calcium Signaling;candidate validation;Cell Culture Techniques;Cholesterol;Clinical;Clinical Data;Cytokine Signaling;Data Set;Disease;DNA Repair;Drug Targeting;Drug usage;Electrophysiology (science);experimental study;FDA approved;GPBAR1 gene;Hippocampus;Human;Impaired cognition;Impairment;in vivo;Incidence;Long-Term Potentiation;Methods;Molecular;molecular phenotype;multiple omics;Mus;Neurites;Older Population;Outcome;Pathway interactions;Pharmaceutical Preparations;Pharmacoepidemiology;Phenotype;Randomized, Controlled Trials;receptor;Research Project Grants;Role;screening;Slice;src-Family Kinases;STAT3 gene;Synaptic plasticity;Systems Biology;tau aggregation;tau-1;Testing;Time;TOP1 gene;Toxic effect;transgenic model of alzheimer disease;Validation",ALZHEIMERS RESEARCH PROJECT: Experimental validation of candidate AD treatments identified by multi-OMICS analyses and real-world clinical evidence,438,NA,NA,NA,NA,2,NA,NA,36537,NA
11177395,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000445,NA,NA,1ZIAAG000445-01,NIA:303196\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,8-Oxoguanine DNA Glycosylase;Age;age acceleration;age related;Alzheimer&apos;s Disease;base;Cell Physiology;Chemical Agents;Disease Progression;DNA;DNA Damage;DNA Repair;Endogenous Factors;Ensure;Environmental Risk Factor;Exogenous Factors;Exposure to;genome integrity;Genome Stability;Genomic Instability;Guanine;Health;Impairment;Inherited;Link;Maintenance;Metabolic;Mitochondria;Mitochondrial DNA;Mutation;Nerve Degeneration;Nuclear;OGG1 gene;oxidative damage;oxidative DNA damage;Oxidative Stress;Oxidative Stress Induction;Pathogenesis;Physiology;Play;Predisposition;preservation;prevent;Production;Reactive Oxygen Species;repaired;Research Project Grants;Role;Source;Structure;Ultraviolet Rays,ALZHEIMERS RESEARCH PROJECT: Role of OGG1 in mitochondrial health,445,NA,NA,NA,NA,1,NA,NA,303196,NA
11177396,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000446,NA,NA,1ZIAAG000446-01,NIA:216691\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79326265 (contact),"MARAGKAKIS, MANOLIS  (contact)",NA,NA,NA,Age;age effect;age group;age related changes;Aging;aging process;biological adaptation to stress;Cell Survival;Communities;Data;EIF-2alpha;Extramural Activities;Genetic Transcription;Immune system;insight;Kinetics;Label;Length;Macaca mulatta;Machine Learning;Messenger RNA;Metabolic;Mission;Modification;Names;nanopore;nonhuman primate;Oxidative Stress;Oxidative Stress Induction;Peripheral Blood Mononuclear Cell;Phosphorylation;Poly(A) Tail;Poly(A)+ RNA;Primates;Protein Isoforms;Protocols documentation;Research Project Grants;response;RNA;RNA metabolism;Role;sex;sodium arsenite;Stress;tool;Uridine;Variant;Work,Discover RNA metabolism dynamics during stress response of the aging primate immune system,446,NA,NA,NA,NA,1,NA,NA,216691,NA
11177397,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000447,NA,NA,1ZIAAG000447-01,NIA:216691\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,Address;Adult;age related;Aging;Anti-Inflammatory Agents;autism spectrum disorder;Autoantibodies;Behavior;Behavioral;behavioral impairment;Bone Marrow Cells;Brain;CD36 gene;CD47 gene;Cd68;CD86 gene;Central Nervous System Diseases;Characteristics;cytokine;Data;Defect;Dementia;Development;Disease;DLG4 gene;DNA;enzyme activity;experimental study;FMR1 gene;Genetic Transcription;Heterochromatin;Homeostasis;Host Defense;Housekeeping;Human;IL4 gene;IL6 gene;Immune response;Immune System Diseases;Immunologics;Infection;Inflammatory;Interleukin-10;Knock-in;Knockout Mice;life span;Link;Lipopolysaccharides;Maintenance;Mediating;Membrane;Messenger RNA;Microglia;Molecular;mRNA Translation;Mus;mutant;mutant mouse model;Mutant Strains Mice;Mutate;Mutation;Nervous System Disorder;neurogenesis;neuroinflammation;Neurologic;Neurons;Numerical Chromosomal Abnormality;Phagocytes;Phagocytosis;Phenotype;phenotypic biomarker;Play;postnatal;Proteins;Publishing;Reporting;Research;RNA;RNA Binding;Role;Schizophrenia;Serum;Signal Transduction;Small Interfering RNA;Splenocyte;Stimulus;Synapses;Synaptic plasticity;synaptic pruning;TLR4 gene;TNF gene;Topoisomerase,Investigating roles of Topoisomerase 3b (TOP3B) in LPS-induced microglia-mediated neuroinflammation in mouse,447,NA,NA,NA,NA,1,NA,NA,216691,NA
11177398,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000448,NA,NA,1ZIAAG000448-01,NIA:21669\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Adopted;Adult;Affect;age related;Aging;aging related;Attenuated;Cell Aging;Cells;Dasatinib;differential expression;Disease;Elderly;exhaustion;Fibroblasts;frailty;functional decline;functional loss;Gene Expression;Genes;Genetic;Growth;Hand Strength;Health;Heterogeneity;Human;Impairment;improved;insight;Intervention;Ionizing radiation;Maintenance;Membrane Proteins;Molecular;mortality;Mus;Muscle;muscle aging;Muscle Cells;Muscle Fibers;muscle form;Muscle function;muscle progenitor cell;muscle regeneration;Muscle satellite cell;Muscular Atrophy;Mutagens;Myoblasts;myogenesis;Natural regeneration;old mice;Oncogenes;Pattern;Phenotype;Process;programs;Quercetin;Reactive Oxygen Species;receptor;RNA;Role;sarcopenia;senescence;senescence associated secretory phenotype;senescent cell;senolytics;single cell analysis;Skeletal Muscle;Source;stem cells;Therapeutic;trait;transcriptome;walking speed,Senescence of muscle progenitor cells: impact on human myogenesis and muscle aging,448,NA,NA,NA,NA,1,NA,NA,21669,NA
11177399,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000453,NA,NA,1ZIAAG000453-08,NIA:3612421\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,15193550 (contact),"RAMSDEN, CHRISTOPHER  (contact)",NA,NA,NA,"Affect;age-related disease;Alzheimer&apos;s Disease;Alzheimer’s disease biomarker;Amygdaloid structure;analog;Analytical Chemistry;Astrocytes;Autopsy;Biochemical;Biological;Biological Assay;Biological Markers;Body Composition;Brain Stem;Cell Line;Cell Nucleus;Cellular Assay;Chronic Headaches;chronic pain;chronic pain management;Chronic pain syndrome;Clinical;clinical center;clinical efficacy;Collaborations;craving;design;Diet;Dietary Fatty Acid;Dietary Intervention;dietary manipulation;Disease;Doctor of Medicine;drug candidate;drug discovery;Endocannabinoids;entorhinal cortex;follow-up;Goals;Hippocampus;Human;human tissue;Immunohistochemistry;Induced pluripotent stem cell derived human neuron;Inflammation;insight;Intervention;Link;link protein;lipid mediator;lipid metabolism;Lipid Peroxidation;Lipids;Lipoproteins;Liquid Chromatography;Mediator;Medical;Migraine;mild cognitive impairment;Mission;Modeling;Molecular;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute on Alcohol Abuse and Alcoholism;Nerve Degeneration;Neurodegenerative Disorders;neuroinflammation;Neurologic;novel;older adult;oxidized lipid;Pain;Participant;Patients;Pharmaceutical Preparations;Pharmacotherapy;Physical Medicine;Physical Rehabilitation;prevent;primary endpoint;Proteins;Pruritus;Publications;Publishing;Randomized;randomized trial;Randomized, Controlled Trials;Refractory;Research Personnel;Resistance;Rodent;Role;Satiation;small molecule;Specimen;Synthesis Chemistry;synthetic drug;tandem mass spectrometry;Techniques;Testing;Tissues;Translating;translational approach;Translations;United States National Institutes of Health",Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration,453,NA,NA,NA,NA,8,NA,NA,3612421,NA
11177400,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000454,NA,NA,1ZIAAG000454-06,NIA:216745\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,3xTg-AD mouse;Affect;Age;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Alzheimer&apos;s disease pathology;Amyloid deposition;Animal Model;APP-PS1;Area;Behavior;Blood Glucose;Brain;Breeding;Calcium;Calcium Signaling;Calories;CB1 knockout;Cells;Cerebrum;Clinical;Crossbreeding;Data Collection;Diabetes Mellitus;Diet;Endoplasmic Reticulum;experimental study;Female;Gene Expression Profiling;Genes;Hormones;Human;Hyperglycemia;Hyperinsulinism;Hyperlipidemia;Hypoglycemia;In Situ Hybridization;Insulin;Insulin Receptor;Insulin Resistance;insulin secretion;insulin signaling;Lead;Messenger RNA;Metabolic;Metabolic Pathway;Metabolism;mouse model;Mus;Neurons;novel;Ontology;Pancreas;Pathologic Processes;Pathway interactions;Peripheral;Phenotype;prevent;Proteins;Proteomics;receptor;Structure of choroid plexus;Testing;Tissue-Specific Gene Expression;Wild Type Mouse,CLINICAL PROJECT:  Deconstructing insulin in the brain,454,NA,NA,NA,NA,6,NA,NA,216745,NA
11177401,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000456,NA,NA,1ZIAAG000456-06,NIA:108284\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,15193550 (contact),"RAMSDEN, CHRISTOPHER  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Amygdaloid structure;Amyloid;Antibodies;antibody libraries;Architecture;Biological Markers;Brain region;Brain Stem;Categories;Classification;cohort;Collaborations;Data;Data Set;design;disability;Disease;Disease Progression;effective therapy;entorhinal cortex;Epitopes;Future;Genes;Goals;healthy aging;high resolution imaging;Hippocampus;Human;human tissue;hyperphosphorylated tau;Image;Immune;Immunohistochemistry;Label;Late Onset Alzheimer Disease;Link;lipid metabolism;Lipids;Mediator;Metabolic Pathway;mild cognitive impairment;mitochondrial dysfunction;Molecular;molecular marker;Morphology;National Institute of Neurological Disorders and Stroke;Nerve Degeneration;Neurodegenerative Disorders;novel;novel strategies;novel therapeutics;Pathogenesis;Pathologic;Pathology;Pathway interactions;Play;prevent;Process;Proteins;Protocols documentation;Publishing;Research Project Grants;Risk Factors;RNA;Signal Transduction;societal costs;Source;Specimen;Synapses;Techniques;Tissues;Validation;Variant;Western Blotting,ALZHEIMERS RESEARCH PROJECT: Dysfunctional lipid metabolism in Alzheimer's Disease,456,NA,NA,NA,NA,6,NA,NA,108284,NA
11177402,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000464,NA,NA,1ZIAAG000464-01,NIA:21669\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,age related decline;age-related disease;Aging;BMP2 gene;Cell Aging;Cell division;cell injury;Cells;chemokine;clinical application;Conditioned Culture Media;cost effectiveness;cytokine;Disease;embryo tissue;Exhibits;extracellular vesicles;healthspan;HLA G antigen;Human;Immune;in vivo;Inflammatory;Link;MAP Kinase Gene;Membrane Proteins;Mesenchymal Stem Cells;Molecular Profiling;mouse model;Mus;organ regeneration;Organism;Osteogenesis;Peptide Hydrolases;Physiology;Population;Positioning Attribute;Proliferating;Reporting;Research;response;senescence;senescence associated secretory phenotype;senescent cell;Senotherapeutic;Signal Pathway;Signal Transduction;Therapeutic;therapy development;Time;Tissues;trait;trophoblast;trophoblast stem cell;tumor,Analysis of the Impact Trophoblast-derived Extracellular Vesicles in Cell Senescence,464,NA,NA,NA,NA,1,NA,NA,21669,NA
11177403,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000465,NA,NA,1ZIAAG000465-01,NIA:130014\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Ablation;Acute;age related;aged;Aging;Attenuated;Cell Aging;cell type;Cells;CTSD gene;Diphtheria Toxin;diphtheria toxin receptor;experimental study;extend lifespan;Flow Cytometry;GDF15 gene;glycoprotein NMB;Homeostasis;Immune;improved;inducible Cre;Inflammatory;Injury;injury and repair;Integral Membrane Protein;interest;Knock-in Mouse;Link;Macrophage;male;Mediation;Messenger RNA;Metabolism;Molecular;mouse model;Movement;Mus;muscle aging;Muscle Fibers;muscle form;Muscle function;Muscle satellite cell;Muscular Atrophy;Natural regeneration;Organ;Phenotype;Physiologic Thermoregulation;Play;Population;Process;progenitor;Proteins;Regenerative capacity;repaired;response to injury;Role;senescence;Skeletal Muscle;skeletal muscle growth;Skeletal muscle injury;tissue repair;Tissues;tumor progression;Vaccination,Analysis GPNMB + Macrophages in Skeletal Muscle Aging,465,NA,NA,NA,NA,1,NA,NA,130014,NA
11177404,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000467,NA,NA,1ZIAAG000467-02,NIA:216691\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,age-related disease;Aging;Catalogs;Cell Aging;Cell Lineage;cell type;Cells;chemotherapy;Cultured Cells;Disease;driving force;Goals;Human;human tissue;in vivo;in vivo Model;Knowledge;Learning;Manuscripts;Modeling;Organ;Organism;Physiology;Proteome;Proteomics;senescence;senescent cell;Tissues;transcriptome;transcriptomics;Writing,A broad catalog of transcriptomic and proteomic markers for human cell senescence,467,NA,NA,NA,NA,2,NA,NA,216691,NA
11177405,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000468,NA,NA,1ZIAAG000468-02,NIA:108345\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Age;age related;age-related disease;Blood;Blood Circulation;Body Fluids;Brain;Cardiovascular system;Cellular biology;Development;Diagnostic;diagnostic biomarker;Diameter;differential expression;Disease;disease model;extracellular;extracellular vesicles;FABP1 gene;Fatty acid glycerol esters;Heart;Heterogeneity;International;Journals;Kidney;Knowledge;Label;Liver;Lung;Membrane Proteins;Molecular;Mus;old mice;Organ;particle;Pathology;potential biomarker;protein biomarkers;Proteins;Proteome;Publishing;Serum;Site;Societies;Surface;System;therapeutic target;Tissues;Work,Identification of Organ-Specific Small Extracellular Vesicles in Mouse Serum,468,NA,NA,NA,NA,2,NA,NA,108345,NA
11177406,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000472,NA,NA,1ZIAAG000472-02,NIA:270863\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826225 (contact),"HERMAN, ALLISON  (contact)",NA,NA,NA,Address;Affect;Age;aged;Animal Diseases;Aorta;Arteries;ATAC-seq;Atherosclerosis;Biological Assay;Brain;Cardiovascular Diseases;Cell Aging;Cell Nucleus;Cells;Chromatin;comorbidity;Complex;Disease;Dissociation;DNA;DNA Mutational Analysis;Elements;Fatty acid glycerol esters;feeding;Female;Flow Cytometry;Freezing;Functional disorder;gain of function mutation;Gene Expression;Genes;Heart;Heterogeneity;High Fat Diet;human disease;Immune;Impairment;improved;Individual;Inflammatory;Injections;interest;Kidney;Liver;Lung;male;multiple omics;Mus;Mutation;Older Population;Organ;Organism;Peripheral;Phenotype;programs;Proteomics;Protocols documentation;Resolution;RNA;Role;Sampling;senescence;senescent cell;senolytics;Somatic Mutation;Sorting;Spleen;Surveys;Techniques;Testing;Therapeutic;Tissue Banks;Tissues;transcriptome sequencing;transcriptomics;Transposase;Virus;Wild Type Mouse,Multiomic survey of secondary senescence in peripheral tissues from atherosclerotic mice,472,NA,NA,NA,NA,2,NA,NA,270863,NA
11177407,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000473,NA,NA,1ZIAAG000473-02,NIA:216691\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826225 (contact),"HERMAN, ALLISON  (contact)",NA,NA,NA,Acceleration;Affect;Age;age related;age related decline;aged;Aging;aging process;Animal Model;Apoptotic;Arterial Fatty Streak;arterial stiffness;Arteries;Atherosclerosis;BAX gene;Blood Vessels;Cardiovascular Diseases;Cell Aging;Cell Culture Techniques;Cell Death;Cell Survival;cell type;Cells;Chronology;Development;DNA Damage;Doxorubicin;Effectiveness;Elasticity;Endothelial Cells;experience;Extracellular Matrix;healthy aging;Human;Hypertension;improved;In Vitro;Intervention;knock-down;Link;Location;Macrophage;Messenger RNA;Mus;Organism;Outcome;Pathology;Pathway interactions;Phase;Phosphorylation;Population;prevent;Process;Proteins;RB1 gene;Role;senescence;senescent cell;senolytics;Signal Transduction;Small Interfering RNA;Smooth Muscle Myocytes;Structure;Telomere Shortening;Therapeutic;therapeutic target;Thick;Time;Tissues;transcriptome sequencing;transcriptomics;Transfection;Vascular Diseases;Vascular remodeling;Vascular Smooth Muscle,Determining the Chronological Onset of Senescence in the Aging Vasculature,473,NA,NA,NA,NA,2,NA,NA,216691,NA
11177408,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000474,NA,NA,1ZIAAG000474-02,NIA:108345\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,age related;age-related disease;Aging;aging related;Alternative Splicing;Antisense Oligonucleotides;Aorta;Atherosclerosis;Biological Process;Cell Aging;Cell Culture Techniques;cell type;Cells;Coupled;detection sensitivity;differential expression;Fibroblasts;Funding;Human;improved;in vivo;Intervention;Length;Liver;Messenger RNA;Modeling;Mus;nanopore;normal aging;novel strategies;Organism;Proliferating;Protein Isoforms;Proteome;Ribosomes;RNA Splicing;Role;senescence;senomorphic;single cell analysis;Surveys;Tissues;Transcript;Variant;Work,Splice-switching antisense oligonucleotides (SSOs) as a senomorphic intervention,474,NA,NA,NA,NA,2,NA,NA,108345,NA
11177409,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000475,NA,NA,1ZIAAG000475-02,NIA:216691\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Affect;Age;age-related disease;aging related;Biology;Cell Aging;Cell Proliferation;Coat Protein Complex I;Complex;cytokine;Defect;Exhibits;extracellular vesicles;Fibroblasts;Genes;Golgi Apparatus;Inflammatory;Intracellular Transport;Manuscripts;Mediating;member;Modeling;Morphology;Multiple Abnormalities;Organelles;Phenotype;Production;Proteins;Proteomics;Role;senescence;senescent cell;senomorphic;Structure;trafficking;transcriptomics;uptake;Vesicle,Intracellular vesicle trafficking in senescent cells  role of the Golgi complex?,475,NA,NA,NA,NA,2,NA,NA,216691,NA
11177410,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000486,NA,NA,1ZIAAG000486-04,NIA:108345\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,Ablation;age related;Aging;aging mechanism;aging related disease;Amino Acids;B-Lymphocytes;Biological Assay;Biology;Blood;Cell Aging;Cell division;cell type;Cells;Chromosomes;Chronic;Chronic Lymphocytic Leukemia;Complex;Coupled;Cutaneous Melanoma;Data;Defect;Detection;Disease;DNA Damage;Dyskeratosis Congenita;Ensure;Exhibits;Functional disorder;Genes;Genetic Recombination;Genome;genome integrity;Goals;hallmarks of aging;Heterozygote;Homeostasis;In Situ;in vivo;Individual;Inflammatory;Knock-out;Length;Ligase;Link;Malignant Neoplasms;Mammals;Manuscripts;Mass Spectrum Analysis;Mediating;Mitochondria;Modeling;Mus;mutant;Mutation;Nature;Nerve Degeneration;novel;Nucleoproteins;overexpression;Pathway interactions;Phenotype;Play;protein complex;protein protein interaction;Proteins;Protocols documentation;Publishing;recruit;repaired;Reproducibility;response;Role;Signal Transduction;Skeletal Muscle;Structure;Telomerase;telomere;Telomere Length Maintenance;Telomere Shortening;Telomere-Binding Proteins;TERF1 gene;TINF2 gene;tool;Update;Western Blotting,Investigating a novel shelterin-associated protein complex in telomere protection,486,NA,NA,NA,NA,4,NA,NA,108345,NA
11177411,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000491,NA,NA,1ZIAAG000491-04,NIA:379209\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826225 (contact),"HERMAN, ALLISON  (contact)",NA,NA,NA,Affect;age related;age-related disease;Aging;aging related;Angiogenic Factor;Animal Model;Aorta;Area;arterial stiffness;Arteries;Atherosclerosis;Biology of Aging;Blood Platelets;Blood Vessels;Cardiovascular Diseases;Cardiovascular Pathology;Cardiovascular system;CCL2 gene;Cell Adhesion Molecules;Cell Aging;cell type;Cells;chemokine;clinical investigation;Coagulation Process;Collagen;Communication;cytokine;Deposition;Development;Disease;epigenetic regulation;Exhibits;Extracellular Matrix;Fibroblasts;Gene set enrichment analysis;Genes;Genomics;healthspan;Heart;Heterogeneity;Human;IL8 gene;improved;in vivo;Inflammation;Inflammatory;innovation;Intercellular adhesion molecule 1;interest;Interleukin-1;Interleukin-6;Intervention;Journals;Left;mouse model;Mus;Nature;Nucleic Acids;Organ;Pathway interactions;Pharmaceutical Preparations;Population;Printing;Process;Production;Proteins;Publishing;Research;Role;senescence;senescence associated secretory phenotype;senescent cell;senolytics;Signal Transduction;single molecule;single-cell RNA sequencing;systemic inflammatory response;T-Lymphocyte;Techniques;Technology;Therapeutic;Therapeutic Intervention;therapeutic target;Tissues;tool;transcriptome sequencing;transcriptomics;Transforming Growth Factor beta;Vascular Diseases;Vascular Endothelial Growth Factors,Analysis of vascular cell senescence to identify interventions in atherosclerosis,491,NA,NA,NA,NA,4,NA,NA,379209,NA
11177412,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000492,NA,NA,1ZIAAG000492-03,NIA:612151\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,age related;age-related disease;Aging;aging related;Alternative Splicing;Aorta;aortic arch;ApoE knockout mouse;Apolipoprotein E;Arterial Fatty Streak;Atherosclerosis;Bar Codes;base;Biological Process;biomarker identification;Cell Aging;Cell Culture Techniques;cell type;Cells;Chromium;Complementary DNA;Complex;Cross-Sectional Studies;Data;Development;Disease;disease model;Disease Progression;Elderly;Etoposide;experimental study;Fatty acid glycerol esters;Fatty Liver;Fibroblasts;Foam Cells;functional decline;gain of function;Genetic Transcription;Genomics;Heart;High Fat Diet;Human;Immunologics;In Vitro;in vivo;Individual;Inflammation;Injections;insight;Length;Light;Link;Liver;Low Density Lipoprotein Receptor;male;Maps;Metabolic;Mission;Modeling;Molecular;mouse model;Mus;mutant;nanopore;non-alcoholic fatty liver disease;normal aging;Nucleic Acids;old mice;Organ;Organism;Oxidation-Reduction;Pathway interactions;Proliferating;Proprotein Convertases;Protein Isoforms;Proteome;Protocols documentation;Recombinant adeno-associated virus (rAAV);Regulation;response;Reverse Transcription;Risk Factors;RNA Splicing;Role;Sampling;senescence;single molecule;single-cell RNA sequencing;Subtilisins;Surveys;Suspensions;System;Technology;therapeutic target;Tissues;Transcript;transcriptomics;Variant;WI 38 cell;Work,Profiling splicing isoforms in single cells in the atherosclerosis niche,492,NA,NA,NA,NA,3,NA,NA,612151,NA
11177413,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000493,NA,NA,1ZIAAG000493-03,NIA:577517\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79326265 (contact),"MARAGKAKIS, MANOLIS  (contact)",NA,NA,NA,Aging;aging brain;Alternative Splicing;Alzheimer&apos;s Disease;Amino Acid Sequence Databases;Animals;Brain;Brain region;Cells;Cerebral cortex;Chromium;Coupled;Data;Data Set;Encapsulated;Evaluation;Event;Female;Genomics;Heterogeneity;Hippocampus;Intergenic Sequence;Knowledge;Length;male;Mass Spectrum Analysis;Methods;Mus;nanopore;Nerve Degeneration;novel;novel marker;old mice;Peptides;Protein Isoforms;Proteins;proteogenomics;Proteomics;Research Project Grants;RNA;single cell analysis;single cell sequencing;single-cell RNA sequencing;System;Techniques;Transcript;transcriptome;transcriptome sequencing;Validation;Variant;Work;young adult,ALZHEIMERS RESEARCH PROJECT Single Cell Long Read Sequencing of the Aging Mouse Brain,493,NA,NA,NA,NA,3,NA,NA,577517,NA
11177414,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000495,NA,NA,1ZIAAG000495-03,NIA:325036\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,5&apos; Untranslated Regions;Adult;Age;age related neurodegeneration;aging related;Alleles;Amino Acids;Apoptosis;autism spectrum disorder;Base Pairing;behavior change;behavioral study;Binding;Binding Sites;Biological Assay;C9ORF72;Cell Cycle Arrest;Cell Line;Cell model;Cells;circadian pacemaker;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Compensation;Complex;Cytoplasmic Granules;Data;Defect;Development;Diabetes Mellitus;Disease;disease model;Drosophila eye;Drosophila genus;Drosophila inturned protein;Drosophila Proteins;Eye;Eye Development;fly;frontotemporal lobar dementia amyotrophic lateral sclerosis;Genes;Genetic;genetic manipulation;Genetic Polymorphism;Genetic study;genetic testing;genome-wide;Glass;Hela Cells;Homologous Gene;Housekeeping;Human;Huntington Disease;Huntington gene;Immunoprecipitation;in vivo;interest;Internal Ribosome Entry Site;Intervention;knock-down;Knock-out;Knockout Mice;Link;Mammalian Cell;Manuscripts;Messenger RNA;Modeling;Molecular;mouse model;mRNA Translation;Mus;mutant;Mutation;Nerve Degeneration;neurodevelopment;Neurons;Nucleotides;Open Reading Frames;Orthologous Gene;overexpression;Pathogenesis;Pathogenicity;Phenotype;Pigments;Plasmids;Play;polyglutamine;protein aggregation;Protein Family;protein function;Proteins;Proteomics;Publishing;Puromycin;Quantitative Reverse Transcriptase PCR;recruit;Regulation;Reiterated Genes;Reporter;Research;ribosome profiling;Ribosomes;RNA;RNA Binding;RNA Interference;RNA-Binding Proteins;Role;Schizophrenia;Stress;stress granule;Temperature;Testing;Tissues;tool;Topoisomerase;transcription factor;transcriptome sequencing;Translational Repression;Translations,Investigating the roles of RNA-binding proteins Nocte and PRRC2 in mRNA translation and age-related neurodegeneration using Drosophila and mouse models,495,NA,NA,NA,NA,3,NA,NA,325036,NA
11177415,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000496,NA,NA,1ZIAAG000496-03,NIA:992607\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,16118294 (contact),"SEN, PAYEL  (contact)",NA,NA,NA,age related;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Antibodies;Binding;Blood;Blood - brain barrier anatomy;blood-based biomarker;Brain;cell age;Cell Count;Cell Nucleus;Cells;Chromatin;Collecting Cell;combinatorial;Computer Analysis;Consumption;Data;Data Set;deep learning;Dementia;design;Diagnosis;DNA Methylation;Drug Targeting;Elderly;Enhancers;Environmental Exposure;epigenetic clock;Epigenetic Process;epigenomics;Excision;experimental study;Future;gene environment interaction;Gene Expression;Genes;Goals;health economics;Health Status;Immunophenotyping;Libraries;Measures;multiple omics;Nerve Degeneration;Neurodegenerative Disorders;neuroprotection;novel;Nuclear;older adult;Organ;Participant;peripheral blood;Peripheral Blood Mononuclear Cell;personalized medicine;Persons;Plasma;Population;Predisposition;Process;promoter;protein aggregation;Protocols documentation;Research;Research Project Grants;RNA;Sampling;single-cell RNA sequencing;socioeconomics;Techniques;Time;Titrations;transcription factor;transcriptomics;XCL1 gene,ALZHEIMERS RESEARCH PROJECT - Predicting Chromatin Signatures of Alzheimers Disease and Related Dementia from Peripheral Blood,496,NA,NA,NA,NA,3,NA,NA,992607,NA
11177416,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000497,NA,NA,1ZIAAG000497-03,NIA:180474\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826225 (contact),"HERMAN, ALLISON  (contact)",NA,NA,NA,Age;age related;Alzheimer&apos;s Disease;Animals;Anxiety;Aorta;Area;Arterial Fatty Streak;arterial remodeling;arterial stiffness;Arteries;Atherosclerosis;atherosclerosis risk;Behavioral;Blood Vessels;Brain;Brain region;Cell Aging;Cells;Circulation;Coagulation Process;Cognition;Cognitive;Collagen;Complement;Data;Dementia;Disease;Endothelial Cells;Excision;experience;experimental study;Female;Fibroblasts;fisetin;Galactosidase;Hand Strength;Human;Immune;Impaired cognition;improved;Link;male;Mass Spectrum Analysis;Mitochondria;Mus;Necrosis;old mice;Organ;Pathologic;Pathologic Processes;Pathology;Pharmaceutical Preparations;Pharmacotherapy;Phenotype;Physiological;protein expression;Proteins;remote location;Research Project Grants;Risk Factors;senescence;senescence associated secretory phenotype;senescent cell;senolytics;Smooth Muscle Myocytes;spatial memory;Thick;Tissues;vascular cognitive impairment and dementia;Vascular Diseases;Vascular Smooth Muscle;Wild Type Mouse,ALZHEIMERS RESEARCH PROJECT - Impact of atherosclerosis-induced cellular senescence on vascular cognitive impairment and dementia (VCID) (Alzheimers disease),497,NA,NA,NA,NA,3,NA,NA,180474,NA
11177417,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000498,NA,NA,1ZIAAG000498-03,NIA:325036\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78826225 (contact),"HERMAN, ALLISON  (contact)",NA,NA,NA,age-related disease;Animal Model;antibody test;Antibody-drug conjugates;Aorta;Area;Atherosclerosis;Blood Vessels;cadherin 5;Cell Adhesion;Cell Proliferation;Cell surface;Cell Surface Proteins;cell type;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Cytokine Receptors;deamidation;Development;Effectiveness;experimental study;Flow Cytometry;Fractionation;Genes;Goals;Human;ICAM1 gene;ICAM2 gene;Immune;improved outcome;KDR gene;Mass Spectrum Analysis;Membrane;Membrane Proteins;Metabolism;mouse model;Mus;Ontology;PECAM1 gene;Peptides;Phase;Proliferating;protein biomarkers;Proteins;Proteome;Receptor Signaling;senescence;senescent cell;senolytics;Sorting;Specificity;Surface;Testing;Therapeutic;Therapeutic Intervention;therapeutic target;therapeutically effective;tool;transcriptome;Vascular Diseases;Western Blotting,Cell Surface Indicators of Vascular Senescence,498,NA,NA,NA,NA,3,NA,NA,325036,NA
11177418,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000499,NA,NA,1ZIAAG000499-08,NIA:444588\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6568215 (contact),"WENG, NAN-PING PETER (contact)",NA,NA,NA,2019-nCoV;Adult;Age;age effect;age related;age related changes;Aging;alpha-beta T-Cell Receptor;antigen-specific T cells;Antigens;Binding;cancer cell;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Physiology;Cellular Immunity;chromatin modification;Clonal Expansion;Complex;Cytomegalovirus;cytotoxic;Disease;Epitopes;Frequencies;Genes;Goals;Helper-Inducer T-Lymphocyte;HLA-A2 Antigen;Human;Human body;Immunity;In Vitro;Individual;Infection;influenzavirus;innate immune function;Measures;Memory;Methods;Mus;novel;Nucleocapsid;older adult;pathogen;Peptides;Play;precision medicine;Predisposition;Proliferating;Proteins;Resolution;response;Role;SARS-CoV-2 infection;single cell sequencing;single-cell RNA sequencing;T cell response;T-Cell Antigen Receptor Specificity;T-Cell Development;T-cell diversity;T-Cell Receptor;T-cell receptor repertoire;T-Lymphocyte;T-Lymphocyte Subsets;Thymus Gland;transcriptome;V(D)J Recombination,"TCR repertoire: size, diversity, and function",499,NA,NA,NA,NA,8,NA,NA,444588,NA
11177419,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000501,NA,NA,1ZIAAG000501-02,NIA:433381\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,adult neurogenesis;Affect;age related;age related neurodegeneration;age-related disease;Aging;aging related;aging related disease;Aman;Animal Model;Animals;Antibodies;autism spectrum disorder;Autoimmune Diseases;Autophagocytosis;Binding;biological adaptation to stress;Biological Models;cancer cell;Cell Culture System;Cell Line;Cell model;Cell Physiology;Cells;ChIP-seq;Clinical Trials;Complex;Data;DNA;drivers of aging;Drosophila genus;Eating;Exhibits;Fat Body;fly;Gene Expression;gene repression;Genes;genetic element;Genetic Transcription;Genomics;hallmarks of aging;HCT116 Cells;Health;Hour;Human;improved;Intellectual functioning disability;Knock-in;Larva;life span;Link;LysoTracker;Malignant Neoplasms;Mental disorders;Messenger RNA;Methods;model organism;mouse model;mRNA Translation;Mus;mutant;Mutation;Names;Nature;Nerve Degeneration;Nervous System Disorder;neurodevelopment;Neurons;Nutrient;Organelles;Organism;Paper;Pathway interactions;Premature aging syndrome;prevent;Prevention;Process;Protein Isoforms;Proteins;Publishing;Recycling;Regulation;response;RNA;RNA immunoprecipitation sequencing;Role;Schizophrenia;Signal Transduction;Stains;Starvation;Stress;Testing;therapeutic target;Topoisomerase;Transcription Elongation;transcription factor;transcription factor USF;Transcriptional Activation;Transcriptional Regulation;transcriptome sequencing;Translations;trend;Western Blotting,Investigating the roles of a Topoisomerase complex in autophagy and lifespan regulation,501,NA,NA,NA,NA,2,NA,NA,433381,NA
11177420,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000502,NA,NA,1ZIAAG000502-02,NIA:325036\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,2019-nCoV;Affect;Area;autism spectrum disorder;Autoantibodies;B-Lymphocytes;Bacteria;Bacterial Infections;behavioral impairment;biological adaptation to stress;Blood;Blood Cells;Bone Marrow Cells;Cell Line;Cells;chemokine;Chemotaxis;Clinical Trials;Coagulation Process;Complex;Control Groups;Coronavirus;Coronavirus Infections;COVID-19 patient;COVID-19 treatment;cytokine;cytokine release syndrome;cytotoxic;Data;Diffusion;Disease;DNA;Drosophila genus;Economics;enzyme activity;established cell line;Exhibits;experimental study;extracellular;Family;fly;FMR1 gene;Gene Expression;Gene Expression Profile;Genes;Genetic Transcription;Harvest;Heterochromatin;Human;Immune response;Immune signaling;Immune system;Immune System Diseases;immunoregulation;Infection;Inflammation;Inflammatory Response;inhibitor;Injury;insight;Knockout Mice;Life;life span;Listeria;Listeria monocytogenes;Lung;Lymphocyte;Macrophage;male;Melanins;melanocyte;Messenger RNA;Modeling;mouse model;mRNA Translation;Murine hepatitis virus;Mus;neural;neurodevelopment;neutrophil;Numerical Chromosomal Abnormality;pathogen;pathogenic bacteria;pathogenic virus;Pharmaceutical Preparations;Phenotype;Pigmentation physiologic function;Pigments;prevent;Recovery;response;RNA;Role;Sampling;SARS coronavirus;Schizophrenia;Serum;Signal Pathway;Site;Small Interfering RNA;Splenocyte;Stimulus;Study models;T-Lymphocyte;Testing;Time;TOP1 gene;Topoisomerase;Topoisomerase Inhibitors;Transcriptional Activation;transcriptome sequencing;Update;Viral;Viral hepatitis;Virus;Work;wound response,Investigating roles of Topoisomerase 3b (TOP3B) in immune responses to infection by coronavirus and bacteria,502,NA,NA,NA,NA,2,NA,NA,325036,NA
11177421,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000511,NA,NA,1ZIAAG000511-27,NIA:2779058\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Affect;Age;age-related disease;Aging;angiogenesis;Apoptosis;Archives;Attention;biological adaptation to stress;Biological Models;Biological Sciences;cancer cell;carcinogenesis;Cell Cycle;Cell division;cell injury;Cell Proliferation;Cell Survival;Cells;Cellular biology;circular RNA;Clinical;Collaborations;Development;Drosophila genus;Experimental Ophthalmology;Funding;Gene Expression Profile;Genes;Genetic;Goals;HuR protein;Immune Evasion;Impairment;insight;interest;intestinal epithelium;intestinal homeostasis;Invaded;Link;Liver diseases;Macular degeneration;Malignant Neoplasms;Mammalian Cell;Messenger RNA;Mitogens;Mitosis;Names;Nature;Neoplasm Metastasis;Nucleic Acids;Open Reading Frames;Post-Transcriptional Regulation;posttranscriptional;Process;Proliferating;Proteins;Reporting;response;RNA;RNA-Binding Proteins;Role;Signal Transduction;Stress;Sumoylation Pathway;Tissues;trait;Untranslated RNA,"Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis",511,NA,NA,NA,NA,27,NA,NA,2779058,NA
11177422,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000513,NA,NA,1ZIAAG000513-24,NIA:6772545\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8158694 (contact),"EVANS, MICHELE K (contact)",NA,NA,NA,accelerated epigenetic aging;Address;African American;African American population;Age;age difference;Age Distribution;age related;Age Years;American;Area;Automobile Driving;Baltimore;Behavioral;Binding;Biocompatible Materials;Biological;Biological Factors;Biological Markers;Biology;Blood Chemical Analysis;Blood Vessels;Body Composition;Bone Density;bone quality;brain health;Brain imaging;Cardiovascular Diseases;Censuses;Characteristics;Cities;Clinical;Clinical Research;cofactor;Cognition;Cognitive;cohort;Collection;Communities;Complex;COVID-19 pandemic;COVID-19 testing;Data;demographics;depressive symptoms;design;Development;dietary;Discrimination;Disease;DNA;DNA Methylation;DNA Repair;endothelial dysfunction;Environment;Environmental Exposure;Environmental Risk Factor;Epidemiology;epidemiology study;Epigenetic Process;Evaluation;executive function;extracellular vesicles;Failure;financial literacy;follow-up;frailty;Gender;Genetic;Genomics;Guidelines;Health;health care quality;health disparity;health equality;health literacy;health outcome disparity;health service use;Health Services;Health Status;healthy aging;heart rate variability;Hematology;Home;Home visitation;Household;Housing;Human;Image;Impaired cognition;improved;Incidence;Income;Individual;International;Interview;Laboratories;life span;literacy;Literature;Longevity;Longitudinal Studies;low socioeconomic status;Measurement;Measures;medical examination;Medical History;Medical Research;Methodology;Methods;microbiome;Minority;Molecular;molecular marker;Morbidity - disease rate;mortality;multidisciplinary;muscle strength;Neighborhoods;Neuroanatomy;new pandemic;novel;nutrition;Occupations;Optical Coherence Tomography;Outcome;oxidative damage;pandemic impact;Participant;Pathway interactions;Physical Examination;Physical Function;Physical Performance;Poverty;pre-clinical;Prevalence;prevent;Probability;Probability Samples;prospective;Prospective cohort;Protocols documentation;Proxy;Psychology;Psychophysiology;psychosocial;Psychosocial Factor;Questionnaires;Race;racial difference;racism;Recording of previous events;recruit;Renal function;Reporting;Research;Research Design;Risk;Risk Factors;Role;Sample Size;Sampling;SARS-CoV-2 infection;screening;Sensory;Seroprevalences;Services;sex;Short Waves;Site;Smell Perception;social;social capital;social cohesion;social genomics;Societies;sociodemographics;Socioeconomic Status;socioeconomics;Surveys;systemic inflammatory response;telomere;Testing;Thick;Time;tool;transcriptomics;Translational Research;Treatment/Psychosocial Effects;Ultrasonography;Vision;Visit;Weight;Work,Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS),513,NA,NA,NA,NA,24,NA,NA,6772545,NA
11177423,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000518,NA,NA,1ZIAAG000518-20,NIA:667754\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Abeta synthesis;abeta toxicity;Affect;age acceleration;age related;Age related macular degeneration;age related neurodegeneration;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Amyloid beta-Protein;Amyloid beta-Protein Precursor;Antisense Oligonucleotides;Archives;Area;beta-site APP cleaving enzyme 1;Biochemical;Biology;Blood capillaries;Blood Vessels;Brain;Cells;Chromosome Mapping;circular RNA;Clinical;Collaborations;Data;density;Experimental Ophthalmology;FMR1 gene;founder mutation;Gene Expression;Genes;Goals;Heterogeneous-Nuclear Ribonucleoprotein Group C;Heterogeneous-Nuclear Ribonucleoproteins;Human;Hydroxychloroquine;Malignant Neoplasms;Medicine;Mitochondria;Molecular;Molecular Biology;Mus;Nature;Nerve Degeneration;neurogenesis;Neuronal Differentiation;Neurons;Ophthalmology;Papillary;Parkinson Disease;Pathology;Peptides;Phenotype;Physiology;polygenic risk score;Post-Transcriptional Regulation;Process;Production;programs;Protein Biosynthesis;Psychiatry;Radial;Regulation;Reporting;Research Project Grants;RNA;RNA Binding;RNA-Binding Proteins;Role;senescent cell;Senile Plaques;Sirtuins;Skeletal Muscle;structural biology;Synapses;Testing;transcriptomics;Usher Syndrome;Work,"ALZHEIMER'S RESEARCH PROJECT: RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies",518,NA,NA,NA,NA,20,NA,NA,667754,NA
11177424,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000519,NA,NA,1ZIAAG000519-20,NIA:718611\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8158694 (contact),"EVANS, MICHELE K (contact)",NA,NA,NA,Acceleration;Acute myocardial infarction;Adult;African American;African American population;Age;age acceleration;age group;age related;age related chronic disease;age related decline;Aging;aging biomarker;Anti-Inflammatory Agents;Appearance;Automobile Driving;Basic Science;Behavioral;behavioral health;Biological;Biological Aging;Biological Assay;Biological Factors;Biology;brain health;Cardiac Myocytes;CCL2 gene;Cell Aging;Cell Cycle;Cell Cycle Arrest;Cell Cycle Progression;Chronic;Clinical Research;Code;Cognition;cohort;comparison group;Complex;Coronavirus;COVID-19 mortality;COVID-19 severity;cytokine;cytokine release syndrome;disability;Discrimination;Disease;Disease susceptibility;Disparate;Disparity;Dissection;DNA;DNA Damage;DNA Repair;Early identification;early onset;Elderly;Environmental Risk Factor;epidemiology study;Epigenetic Process;Etiology;Female;frailty;Gene Expression;Gene Expression Profile;Gene set enrichment analysis;Genes;Genetic;Glucocorticoids;Goals;Health;Health Disparities Research;health disparity;Health Status;healthy aging;high risk;Household;Hydrogen Peroxide;IL1A gene;IL8 gene;Immunity;Income;Individual;Inflammaging;Inflammation;Inflammatory;intercellular communication;Interdisciplinary Study;Interleukin-1 beta;Interleukin-10;Interleukin-4;Interleukin-6;Investigation;Laboratories;Leucine Zippers;Life Expectancy;life span;Link;literacy;Literature;low socioeconomic status;male;Medical;men;middle age;Minority;Molecular;Morbidity - disease rate;mortality;Mus;Neighborhoods;novel;nutrition;Outcome;overexpression;oxidation;Oxidative Stress;Participant;Pathogenesis;Pathologic;Pathway Analysis;Pathway interactions;Peripheral Blood Mononuclear Cell;Phenotype;Physiological;Population;population based;Poverty;Predisposition;Prevalence;Probability;Process;Proteins;Psychosocial Factor;Race;repaired;Research;response;Risk;Risk Factors;Role;Scientist;senescence associated secretory phenotype;Serum;severe COVID-19;Severities;sex;Sex Differences;Signal Pathway;Signal Transduction;sociocultural determinant;Socioeconomic Factors;socioeconomics;Structural Racism;Telomere Shortening;Time;Tissue-Specific Gene Expression;TLR2 gene;TNF gene;Toll-like receptors;transcriptome;transcriptome sequencing;transcriptomics;Translational Research;Untranslated RNA;Virus Diseases;Woman;Work,The Underlying Biology of Health Disparities,519,NA,NA,NA,NA,20,NA,NA,718611,NA
11177425,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000520,NA,NA,1ZIAAG000520-05,NIA:131990\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8158694 (contact),"EVANS, MICHELE K (contact)",NA,NA,NA,Affect;African;African American;African American population;African American Women;African ancestry;Age;age related;age related chronic disease;age-related disease;Baltimore;Biological;Biological Markers;Body Fluids;Cardiovascular Diseases;cardiovascular disorder risk;Categories;Caucasians;CCL2 gene;cell injury;Cell Line;Cell secretion;Cells;Cellular Stress;Circulation;Cities;cohort;Complementarity Determining Regions;Complex;Development;Disease;Disparity;DNA;E-Selectin;ethnic diversity;Ethnic Origin;Ethnic Population;European;European ancestry;extracellular vesicles;Fibrinogen;Future;Genetic;Genetic Polymorphism;Genetic Recombination;Genetic Transcription;Haplogroup;Haplotypes;Health;health disparity;health outcome disparity;healthy aging;Histones;Human;human migration;Hypertension;Incidence;Individual;Inflammation;Inflammatory;inflammatory marker;Inherited;Innate Immune Response;intercellular communication;interest;Interferon Type II;Interleukin-6;Introns;Investigation;Knowledge;Lead;life span;Link;Lipid Binding;Lipids;Literature;Longitudinal Studies;middle age;Mitochondria;Mitochondrial DNA;mitochondrial dysfunction;Molecular;Morbidity - disease rate;mortality;Mutation;Neighborhoods;novel;Nuclear;Nucleic Acids;Oxidative Phosphorylation;Oxidative Stress;P-Selectin;Participant;Pathway interactions;Pattern;Phylogenetic Analysis;Plasma;Population;Population Heterogeneity;population migration;Populations at Risk;Predisposition;Prevalence;Production;Proteins;Race;racial difference;racial population;Reactive Oxygen Species;Reporting;Research Personnel;Rest;Risk;Risk Factors;Role;Serum;sex;Single Nucleotide Polymorphism;social;Socioeconomic Status;soluble RAGE;Sorting;System;Time;TNF gene;Trees;United States;Untranslated RNA;Variant;Vesicle;Work,"Interplay between Mitochondrial DNA Haplogroups, Mitochondrial Function, Oxidative Stress, and Hypertension",520,NA,NA,NA,NA,5,NA,NA,131990,NA
11177426,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000521,NA,NA,1ZIAAG000521-05,NIA:324853\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479279 (contact),"LAUNER, LENORE J (contact)",NA,NA,NA,Affect;age acceleration;Alzheimer&apos;s Disease;Cells;Complex;Computer software;Data;Dementia;Disease;DNA Methylation;epigenetic clock;Epigenetic Process;epigenome;Etiology;gene environment interaction;Gene Expression;Genetic;genome sequencing;Heart;large datasets;Longitudinal cohort;Methylation;non-genetic;novel;older men;older women;Participant;Phenotype;Preparation;Process;protein expression;Public Health;public health intervention;Research Project Grants;Resources;Risk;Risk Factors;Role;Sampling;Smoking;Technology;Therapeutic;Tissue-Specific Gene Expression;whole genome,"ALZHEIMER'S RESEARCH PROJECT:  Methylation changes, gene-environment interactions and the occurrence of  Alzheimer's Disease: the AGES-RS Study",521,NA,NA,NA,NA,5,NA,NA,324853,NA
11177427,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000522,NA,NA,1ZIAAG000522-02,NIA:234649\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79326283 (contact),"SONG, MINKYO  (contact)",NA,NA,NA,Adolescence;Adult;Age;age related;age related changes;age-related disease;Aging;Air Pollution;American;Area;Autoantibodies;Autoimmune Diseases;Autoimmunity;Childhood;Complex;design;Diagnosis;Disease;disorder risk;Disproportionately impacts women;Elderly;Epidemiology;Functional disorder;geographic difference;Goals;Immune system;Immunity;immunoreaction;immunosenescence;Individual;Infection;Inflammation;Inflammatory Bowel Diseases;Insulin-Dependent Diabetes Mellitus;Life Cycle Stages;life span;Link;men;Myasthenia Gravis;novel therapeutics;older adult;Onset of illness;Pattern;Persons;Phenotype;pre-clinical;Predisposition;Prospective Studies;Proteins;Research;Rheumatoid Arthritis;Risk Factors;sex;vaccine response;Woman,Autoimmunity and Aging,522,NA,NA,NA,NA,2,NA,NA,234649,NA
11177428,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000526,NA,NA,1ZIAAG000526-02,NIA:252664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6568215 (contact),"WENG, NAN-PING PETER (contact)",NA,NA,NA,3xTg-AD mouse;Adult;Affect;aged;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Alzheimer&apos;s disease patient;Alzheimer’s disease biomarker;Antibodies;Antigens;APP-PS1;Baltimore;Brain;Cancerous;Catchment Area;CD8-Positive T-Lymphocytes;cell killing;Cells;chemokine;Clonal Expansion;cognitive performance;cytokine;Cytomegalovirus;cytotoxic;cytotoxicity;Epidemiology;Herpesvirus Type 3;Human Herpesvirus 4;Immune;Immune response;immunoregulation;Impaired cognition;Individual;Infection;infection burden;Inflammatory;Interferons;mental state;Modeling;mouse model;Mus;neuroinflammation;Pathogenesis;Pathologic;Pathology;perforin;Performance;Phenotype;Production;Research;Research Project Grants;Role;Simplexvirus;T cell infiltration;T-Cell Receptor;Testing;Toxoplasma gondii;verbal,ALZHEIMERS RESEARCH PROJECT:  Role of CD8 T cell in the pathogenesis of Alzheimer's disease,526,NA,NA,NA,NA,2,NA,NA,252664,NA
11177429,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000527,NA,NA,1ZIAAG000527-01,NIA:595899\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,16118294 (contact),"SEN, PAYEL  (contact)",NA,NA,NA,3-Dimensional;Adopted;Age;age related;Aging;ATAC-seq;attenuation;Body Weight;Cell Count;Cell Physiology;Chemical Injury;Chromatin;Cleavage Under Targets and Release Using Nuclease;Collagen;Data Analyses;Down-Regulation;Elderly;Enhancers;Epigenetic Process;epigenome;experimental study;Gene Expression;Genes;Genome;histone acetyltransferase;Histones;Human;Immune;immunoregulation;improved;Inflammation;inhibitor;Investigation;loss of function;Maps;Messenger RNA;Metabolic;Multiomic Data;Mus;Muscle;muscle aging;muscle form;muscle progenitor cell;Natural regeneration;old mice;Organ;Post-Translational Protein Processing;regeneration function;Regenerative capacity;sarcopenia;Skeletal Muscle;stem cell niche;stem cells;Tissue-Specific Gene Expression;Tissues;transcriptome;transcriptome sequencing;Up-Regulation,Epigenetic mechanisms of muscle aging,527,NA,NA,NA,NA,1,NA,NA,595899,NA
11177430,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000528,NA,NA,1ZIAAG000528-01,NIA:397043\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,16118294 (contact),"SEN, PAYEL  (contact)",NA,NA,NA,Acetylation;age group;age related;Age-associated memory impairment;Aging;aging brain;Alzheimer&apos;s Disease;Alzheimer&apos;s Disease Pathway;astrogliosis;Automobile Driving;Autopsy;Biopsy;Brain;Cognitive deficits;cognitive function;Complement Activation;CREBBP gene;design;Disease;Enhancers;EP300 gene;Epigenetic Process;Etiology;Event;expectation;Female;Fiber;Gene Expression;Genomics;glial activation;Histone Acetylation;histone acetyltransferase;Histone Deacetylation;Human;Infiltration;Inflammatory;interest;Learning;machine learning algorithm;Mediating;Memory;Messenger RNA;Molecular;Mus;Myeloid Cells;Paracrine Communication;Pathologic;Play;preservation;Proteins;Publishing;Research Project Grants;Role;sex;spatiotemporal;Tail;Therapeutic;transcription factor;transcriptomics;white matter,ALZHEIMERS RESEARCH PROJECT - Epigenetic mechanisms of brain aging,528,NA,NA,NA,NA,1,NA,NA,397043,NA
11177431,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000530,NA,NA,1ZIAAG000530-01,NIA:263980\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79946377 (contact),"HUANG, TIANYI  (contact)",NA,NA,NA,"Accelerometer;Age;Aging;aging related;Asia;Behavioral;biobank;Biological;Cardiovascular system;Caring;Categories;Cessation of life;Chronic Disease;Cluster Analysis;Cohort Studies;comorbidity;Cox Proportional Hazards Models;Data;Development;Diabetes Mellitus;diabetes risk;Diagnosis;Dimensions;Disease Outcome;disorder risk;Disparity;Drowsiness;Environmental Risk Factor;Factor Analysis;follow-up;Genetic Risk;hazard;Health;health disparity;Hour;Individual;insight;Knowledge;Life Style;Malignant Neoplasms;Measurement;Measures;Medical Records;Metabolic;Methods;Modeling;Multi-Ethnic Study of Atherosclerosis;Neurodegenerative Disorders;novel;Obesity;Participant;Patient Self-Report;personalized intervention;Persons;polygenic risk score;Population;prospective;Prospective Studies;Prospective, cohort study;Publishing;Race;Reproducibility;Risk;Role;Sampling;sex;Sleep;Sleep Apnea Syndromes;Sleep Architecture;sleep health;sleep pattern;sleep quality;Sleep Stages;Snoring;social;social factors;sociodemographics;Time;Variant;Wakefulness;Well in self",Multi-Dimensional Sleep Health and Aging-Related Chronic Disease Risk,530,NA,NA,NA,NA,1,NA,NA,263980,NA
11177432,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000533,NA,NA,1ZIAAG000533-01,NIA:278645\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8158694 (contact),"EVANS, MICHELE K (contact)",NA,NA,NA,Adult;Affect;African American;African American population;age acceleration;age related;aging process;Apoptotic;Attention;Biological Markers;Black American;Body mass index;Body System;Categories;caucasian American;Cell Aging;cell injury;Cell Physiology;Cells;Characteristics;Chronic Kidney Failure;cohort;Communication;comorbidity;Development;Disease;Disparate;Disparity;DNA;End stage renal failure;Endothelial Cells;Environment;exosome;extracellular;Extracellular Space;extracellular vesicles;Functional disorder;Health;health disparity;healthy aging;High Prevalence;human old age (65+);Hypertension;Incidence;Individual;Inflammation;Inflammatory;insight;Kidney Diseases;Kidney Failure;Knowledge;life span;Link;Lipids;Longitudinal cohort;Mediator;microvesicles;minimally invasive;Mitochondrial DNA;Molecular;mortality;Nature;Neighborhoods;Non obese;Nucleic Acids;obese patients;obese person;Obesity;Obstructive Sleep Apnea;Older Population;Overweight;particle;Patients;Pattern;Plasma;Play;Population;Proteins;Proteinuria;racial population;Reporting;Research;Risk;Risk Factors;RNA;Role;socioeconomics;Structure;Tissues;United States,Investigating Extracellular Vesicles as a Link Between Obesity and Chronic Kidney Disease,533,NA,NA,NA,NA,1,NA,NA,278645,NA
11177433,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000534,NA,NA,1ZIAAG000534-06,NIA:16309444\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,Acceleration;Address;Adopted;advanced analytics;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;ancestry analysis;Area;Artificial Intelligence;Attention;Baltimore;base;Bibliography;biobank;Biological Markers;Biological Products;biomarker discovery;Body Composition;brain magnetic resonance imaging;Brain Mapping;Cells;cerebral atrophy;Chromosome Mapping;Clinical;clinical center;Clinical Data;clinical trial recruitment;Code;Cognitive;Cognitive aging;Collaborations;Common Data Element;Communities;Complex;complex data;Computerized Medical Record;cost;CRISPR interference;Data;data access;Data Analyses;data analysis pipeline;Data Files;data harmonization;data integration;data integrity;data management;data privacy;data quality;Data Science;Data Set;data sharing;Data Sources;data visualization;deep learning;Dementia;dementia risk;Democracy;design;Development;Disease;Disease Progression;Disparate;Distal;empowerment;Ensure;Environment;Equipment and supply inventories;Ethics;Extramural Activities;FAIR principles;federated learning;Feedback;follow-up;frailty;frontotemporal lobar dementia amyotrophic lateral sclerosis;Future;Genetic;Genetic Diseases;Genetic Risk;Genetic study;Genetic Variation;genomic data;Genomics;Goals;GP2 gene;Growth;hackathon;Health;Heterogeneity;Home;Hour;Human;human induced pluripotent stem cells;Image;improved;Infrastructure;insight;Institution;interest;invention;Investigation;Knowledge;large language model;Lewy Body Dementia;Libraries;Life;light weight;Longitudinal Studies;Machine Learning;Manuscripts;Maps;Mediation;Medical center;member;Meta-Analysis;Metadata;Methods;Microglia;Mississippi;Modeling;Molecular;multimodal data;multimodality;multiple data types;Multiple Sclerosis;Nature;Nerve Degeneration;Neurodegenerative Disorders;Neurons;novel;online resource;Onset of illness;open source;Outcome;Parkinson Disease;Participant;Patients;Pattern;Persons;Phenotype;Process;Psychiatry;Public Domains;Publications;Publishing;PubMed;Quality Control;Reporting;repository;Research;Research Institute;Research Personnel;Resources;Risk;Risk Factors;risk prediction;risk variant;Sampling;Scientist;serial imaging;sharing platform;Sleep disturbances;Standardization;stem;systematic review;Time;tool;Training;United States National Institutes of Health;United States National Library of Medicine;Universities;unsupervised learning;usability;Viral;Virus Diseases;Vision;Work,Center for Alzheimer's and Related Dementias (CARD):  Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias Community,534,NA,NA,NA,NA,6,NA,NA,16309444,NA
11177434,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000535,NA,NA,1ZIAAG000535-06,NIA:6108838\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,Acceleration;advanced analytics;Alleles;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;analysis pipeline;Area;Back;C9ORF72;Cell Culture Techniques;Cell Differentiation process;Cell Line;Cell Physiology;Cells;cellular imaging;Cellular Morphology;Clustered Regularly Interspaced Short Palindromic Repeats;Code;cohort;complement resource;CRISPR interference;Data;Data Set;Development;Disease;Disease Pathway;Drug Targeting;empowerment;Engineering;Female;Future;gene function;Gene Mutation;Genes;Genetic;genetic variant;Heterozygote;Individual;induced pluripotent stem cell;Inherited;Laboratories;Libraries;Maintenance;male;Manuscripts;Methods;Microglia;Microscopy;Multiomic Data;Mutation;Neurodegenerative Disorders;Neurons;novel;online repository;Paint;Patients;Pharmaceutical Preparations;phenotypic data;Precision medicine trial;Preparation;Proteomics;Protocols documentation;prototype;Publishing;repository;Reproducibility;Resources;screening;Single Nucleotide Polymorphism;single-cell RNA sequencing;supervised learning;Supporting Cell;targeted treatment;tool;transcriptomics;Work,Center for Alzheimer's and Related Dementias (CARD):  iPSC Neurodegenerative Diseases Initiative,535,NA,NA,NA,NA,6,NA,NA,6108838,NA
11177435,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000537,NA,NA,1ZIAAG000537-05,NIA:288153\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Binding;Cell model;Chemicals;drug candidate;Excision;interest;Lead;Ligands;Methods;multicatalytic endopeptidase complex;Neuroanatomy;novel therapeutics;Oncology;pharmacologic;Protac;protein aggregation;protein degradation;Proteins;Research;Risk;scaffold;tau aggregation;tau Proteins;Technology;Testing;Therapeutic,Center for Alzheimer's and Related Dementias (CARD): Pharmacological Targeting of Tau Aggregates for Autophagic Removal in Alzheimer's Disease,537,NA,NA,NA,NA,5,NA,NA,288153,NA
11177436,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000538,NA,NA,1ZIAAG000538-05,NIA:6339360\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,African ancestry;Aging;Algorithms;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease related dementia;Alzheimer&apos;s disease risk;American;Automobile Driving;Benchmarking;Bioinformatics;Blood;Brain;brain tissue;Cell Separation;Cells;Centromere;Clinical;cloud based;Code;cohort;Collection;Communities;community empowerment;computerized tools;Data;Data Analyses;Dideoxy Chain Termination DNA Sequencing;Disease;DNA;DNA sequencing;Elements;Epigenetic Process;European ancestry;experimental study;falls;Freezing;frontal lobe;Frontotemporal Dementia;GC Rich Sequence;Generations;Genetic;genetic architecture;genetic variant;genome sequencing;Genomic Segment;Genomics;Genotype;Human;improved;induced pluripotent stem cell;Infrastructure;insertion/deletion mutation;interest;large datasets;Latin American;Length;Lewy Body Dementia;Manuscripts;Memory;Methods;Names;nanopore;National Human Genome Research Institute;Nature;Neurosciences;Nucleotides;Pathologic;Phase;Population Heterogeneity;Process;Protocols documentation;Publishing;religious order study;Repetitive Sequence;Sampling;sharing platform;Technology;telomere;tool development;Underrepresented Populations;Variant;variant detection;whole genome;Writing,Center for Alzheimer's and Related Dementias (CARD): Long-read DNA sequencing of Alzheimers Disease and Related Dementias cases,538,NA,NA,NA,NA,5,NA,NA,6339360,NA
11177437,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000539,NA,NA,1ZIAAG000539-05,NIA:378995\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,Age;age related;aged;Aging;Alzheimer&apos;s Disease;Apolipoprotein E;Astrocytes;ATAC-seq;Brain;Brain region;Cell Nucleus;cell type;Cells;Characteristics;Communication;Data;Data Analyses;Disease;disorder risk;entorhinal cortex;excitatory neuron;follow-up;Gene Expression;gene synthesis;Genes;Genetic Transcription;genome wide association study;Genomics;Gliosis;healthy aging;Human;inhibitory neuron;Laboratories;life span;LRRK2 gene;Maps;Microglia;Minor;Modality;Neurodegenerative Disorders;Neuroglia;neuroinflammation;neuron loss;Neurons;Nuclear;oligodendrocyte progenitor;Parkinson Disease;Phenotype;precursor cell;Protein Biosynthesis;putamen;Research Project Grants;Resources;risk variant;Sampling;Series;Signal Transduction;single nucleus RNA-sequencing;Stereotyping;Structure of middle temporal gyrus;subventricular zone;targeted treatment;Testing;transcriptome sequencing;transcriptomics;Work,ALZHEIMERS RESARCH PROJECT:  Developing a single cell map of the aging human brain relevant to Alzheimer's disease,539,NA,NA,NA,NA,5,NA,NA,378995,NA
11177438,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000540,NA,NA,1ZIAAG000540-05,NIA:469232\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,Affect;Afferent Neurons;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;arm;Association Learning;Behavior;Behavioral;CAV2 gene;cohort;comparison control;conditioned fear;Cues;Data;Dementia;design;designer receptors exclusively activated by designer drugs;Discrimination;discrimination task;Dopamine;dopaminergic neuron;entorhinal cortex;episodic like memory;Episodic memory;Exhibits;experience;experimental study;Extinction;fear memory;Fiber;Freezing;Fright;Genetic;Glutamate Transporter;Glutamates;Imaging Techniques;Impaired cognition;Impairment;Lateral;Learning;Lesion;Memory;Memory impairment;Midbrain structure;multisensory;Mus;Neurons;non-motor symptom;novel;odor discrimination;Parkinson Disease;Patients;Performance;Phase;Photometry;Play;Population;Protocols documentation;Radial;receptor;Research;Research Project Grants;Rewards;Role;Satiation;Synapses;Tactile;Testing;Time;Transfection;vector;Ventral Tegmental Area;Virus;Visual,ALZHEIMERS RESEARCH PROJECT:  Pathophysiological Study of Dopamine in Alzheimer's Disease and Related Demantia,540,NA,NA,NA,NA,5,NA,NA,469232,NA
11177439,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000544,NA,NA,1ZIAAG000544-03,NIA:3169680\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,ALS patients;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Amyotrophic Lateral Sclerosis;Biological Assay;Biological Markers;case control;Central Nervous System;Cerebrospinal Fluid;Clinical;clinical application;college;Communities;Data;Detection;Disease;Exons;Frontotemporal Dementia;frontotemporal lobar dementia amyotrophic lateral sclerosis;Goals;Human;human tissue;Induced pluripotent stem cell derived neurons;industry partner;Lead;London;Manuscripts;Mass Spectrum Analysis;Monoclonal Antibodies;Nature;novel;Pathology;Patients;Peptides;Plasma;polyclonal antibody;Progressive Supranuclear Palsy;protein biomarkers;protein TDP-43;Proteins;Publications;Publishing;PubMed;Risk;RNA;RNA Splicing;Sampling;Specificity;Transcript;translational medicine;Translational Research;two-dimensional;Universities,Center for Alzheimer's and Related Dementias: Detection of cryptic exons (splicing differences) in TDP-43 as biomarkers for frontotemporal dementia and Alzheimer's disease,544,NA,NA,NA,NA,3,NA,NA,3169680,NA
11177440,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000545,NA,NA,1ZIAAG000545-03,NIA:6627513\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,advanced analytics;Age;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;American;Atlases;biobank;Brain;brain cell;Brain region;brain tissue;cell type;Cells;Clinic;Collaborations;Collection;Communities;Data;Disease;epigenomics;Genetic;genetic variant;Goals;Hippocampus;Human;Individual;Lewy Body Dementia;Manuscripts;Medical;member;Michigan;Molecular;Multiomic Data;multiple omics;Neurodegenerative Disorders;Neurologic;Parkinson Disease;Population;Population Heterogeneity;Prefrontal Cortex;Process;Protocols documentation;Quantitative Trait Loci;Research;Resources;Sampling;Small Nuclear RNA;Source;Substantia nigra structure;Tissues;tool;transcriptome sequencing;transcriptomics;translational genetics;United States National Institutes of Health;Universities;user-friendly;Work,Center for Alzheimer's and Related Dementias: First stage single-cell brain resource for Alzheimer's disease and related dementias,545,NA,NA,NA,NA,3,NA,NA,6627513,NA
11177441,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000546,NA,NA,1ZIAAG000546-03,NIA:4034138\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,African American;Alaska Native;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease related dementia;Apolipoprotein E;Astrocytes;Catalogs;Cell Line;Collaborations;Communities;Data;experimental study;functional genomics;Generations;genetic risk factor;Genotype;Goals;Growth;Hispanic Americans;Indiana;Individual;induced pluripotent stem cell;Inosine Dialdehyde;Latin American;meetings;Microglia;Minority Groups;Native Americans;Native Hawaiian or Other Pacific Islander;neuroimaging;Neuronal Differentiation;Patients;Peripheral Blood Mononuclear Cell;Research;Research Personnel;Resources;Sampling;Underrepresented Minority;United States National Institutes of Health;Universities;whole genome,Center for Alzheimers' and Related Dementias: iPSCs to study Diversity in Alzheimers disease and Alzheimers disease-related dementias (iDA),546,NA,NA,NA,NA,3,NA,NA,4034138,NA
11177442,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000547,NA,NA,1ZIAAG000547-02,NIA:20228321\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79326298 (contact),"RYAN, VERONICA  (contact)",NA,NA,NA,advanced analytics;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Axon;Biology;Cell Line;Code;Communities;CRISPR interference;Data;data analysis pipeline;Data Set;frontotemporal lobar dementia amyotrophic lateral sclerosis;Genetic;Goals;induced pluripotent stem cell;Inherited;knock-down;Messenger RNA;Mutation;Neurodegenerative Disorders;Neurons;Pathway interactions;Pilot Projects;prevent;Proteomics;Research;Research Project Grants;Resources;RNA Transport;RNA-Binding Proteins;therapeutic target;transcriptomics;Translations;Work,ALZHEIMERS RESEARCH PROJECT: RNA Transport and Local Translation in Alzheimer's and Related Dementias (ADRD),547,NA,NA,NA,NA,2,NA,NA,20228321,NA
11177443,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000548,NA,NA,1ZIAAG000548-02,NIA:7203818\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,advanced analytics;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Alzheimer&apos;s disease risk;ancestry analysis;Argentina;Brazil;Chile;clinical research site;cohort;Collaborations;Colombia;Communities;Country;Data;Data Set;Dementia;dementia risk;Foundations;Frontotemporal Dementia;Funding;Future;Genetic;genetic analysis;Genetic Risk;Grant;International;Latin America;Latin American;Leadership;Learning;Manuscripts;Mexico;Participant;Patients;Peru;Population;Population Heterogeneity;posters;Psychiatry;Publications;Publishing;recruit;Research;sabbatical;Sampling;symposium;Training,Center for Alzheimer's and Related Dementias (CARD): Collaboration with the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat),548,NA,NA,NA,NA,2,NA,NA,7203818,NA
11177444,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000549,NA,NA,1ZIAAG000549-02,NIA:4322291\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,Alzheimer&apos;s disease related dementia;Behavioral Mechanisms;Blood Vessels;Cardiovascular system;Cognitive;Collaborations;Complement;Data;data access;Data Analytics;data harmonization;data science resource;Data Set;data sharing;Democracy;Disparity;Future;Generations;Genetic;Genotype;geographic disparity;Goals;improved;Intervention;middle age;Minority Groups;Neurodegenerative Disorders;Pathway interactions;Positioning Attribute;racial disparity;Reasons for Geographic And Racial Differences in Stroke;Reporting;Research;Research Activity;Resources;social;vascular cognitive impairment and dementia;Work,Center for Alzheimer's and Related Dementias (CARD): Collaboration with the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study,549,NA,NA,NA,NA,2,NA,NA,4322291,NA
11177445,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000551,NA,NA,1ZIAAG000551-01,NIA:1728916\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,alpha synuclein;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Alzheimer’s disease biomarker;Biological Assay;Biological Markers;Cognitive;comorbidity;Concha;corticobasal syndrome;Data;Dementia;Development;Disease Progression;Goals;Impaired cognition;Individual;Lewy Bodies;mild cognitive impairment;Molecular;Nerve Degeneration;Neurodegenerative Disorders;neuroimaging;Neurologic;Paralysed;Participant;Pathology;Patients;Prevalence;Printing;Publishing;synuclein;Technology;timeline;Work,Center for Alzheimer's and Related Dementias: -synuclein seed amplification assay in Alzheimer's disease,551,NA,NA,NA,NA,1,NA,NA,1728916,NA
11177446,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000579,NA,NA,1ZIAAG000579-05,NIA:1408489\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691039 (contact),"LIU, YIE  (contact)",NA,NA,NA,Affect;age related biomarkers;age related changes;Age related pathologies;age-related disease;Aging;aging process;aging related;Alzheimer’s disease biomarker;Apoptotic;Biological;Biological Assay;Biological Markers;Biology;Bone Marrow;Brain;CCL2 gene;Cells;Characteristics;chemokine;Chronic;cohort;Communication;Complex;CXCL9 gene;cytokine;Cytokine Network Pathway;Data;Defect;Development;Disease;DNA;Exhibits;exosome;Exposure to;extracellular;extracellular vesicles;Future;Generations;hallmarks of aging;Heart;Human;IL2 gene;IL7 gene;Inflammation;Inflammation Mediators;Inflammatory;inflammatory milieu;Inflammatory Response;interest;Interferon Type II;Investigation;Knockout Mice;Link;Liver;Malignant Neoplasms;Mediating;Mediator;microvesicles;Molecular;mouse model;Mus;Muscle;Nerve Degeneration;Neurons;neurotoxicity;Outcome;particle;Pathology;Plasma;Proliferating;prospective;Proteins;Proteomics;replication stress;Research;response;RNA-Directed DNA Polymerase;Role;Science;Signal Pathway;Signal Transduction;Small Intestines;Source;Spleen;Surface;targeted treatment;Telomerase;telomere;telomere loss;Telomere Shortening;Therapeutic Intervention;Tissues;Up-Regulation;Variant;Work,Investigation of the intracellular and extracellular mechanisms underlying the process of aging,579,NA,NA,NA,NA,5,NA,NA,1408489,NA
11177447,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000580,NA,NA,1ZIAAG000580-05,NIA:915332\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,Aging;Arginine;ATP phosphohydrolase;Autoantibodies;Autoimmune Diseases;cell type;Cellular translocation;Child;Collaborations;Cytoplasm;Development;Disease;DNA Repair;Double-Stranded RNA;Etiology;Genes;helicase;Helicase Gene;Impairment;In Vitro;Inflammation;Interferon Activation;Juvenile Dermatomyositis;Lung Diseases;mutant;Mutate;Mutation;Myositis;National Institute of Allergy and Infectious Disease;National Institute of Environmental Health Sciences;Nucleic Acids;Oxidative Stress Induction;Pathogenicity;Pathway interactions;Patients;protein function;Proteins;Research;response;Role;skin disorder;systemic autoimmune disease;Systemic disease;Viral;Work,Functional Significance of Mutations in Helicase Genes in Patients with Juvenile Dermatomyositis and anti-MDA5 Autoantibodies,580,NA,NA,NA,NA,5,NA,NA,915332,NA
11177448,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000581,NA,NA,1ZIAAG000581-05,NIA:492871\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,2019-nCoV;Age related comorbidities;aging population;Anti-viral Agents;Anti-viral Therapy;Binding;Biochemical;Biological Assay;biophysical properties;Collection;Combined Modality Therapy;Coronavirus;COVID-19;COVID-19 pandemic;COVID-19 vaccine;Development;Elderly;Future;Goals;helicase;high risk;high throughput screening;Immune;Immune System Diseases;Immunologics;immunosenescence;infection risk;inhibitor;Intervention;Life Cycle Stages;Medical;Medicine;Molecular;Molecular Bank;Molecular Target;mortality risk;novel;novel therapeutics;Nucleic Acids;Nucleotides;Nursing Homes;Older Population;Pathogenesis;Polymerase;Proteins;remdesivir;repository;Research Personnel;Research Proposals;Resolution;RNA;RNA-Directed RNA Polymerase;SARS-CoV-2 inhibitor;small molecule;small molecule inhibitor;small molecule libraries;Social Distance;Structure;Structure-Activity Relationship;Therapeutic;Viral;Virus;Virus Replication,Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines,581,NA,NA,NA,NA,5,NA,NA,492871,NA
11177449,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000582,NA,NA,1ZIAAG000582-03,NIA:360948\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690946 (contact),"BIRAGYN, ARYA  (contact)",NA,NA,NA,Ablation;adaptive immunity;Affect;Aging;Alzheimer like pathology;Alzheimer&apos;s Disease;Amyloid;Amyloid beta-Protein;Amyloidosis;Antibodies;astrogliosis;Autopsy;B-Lymphocytes;Brain;brain parenchyma;CD8-Positive T-Lymphocytes;Cells;Complex;CXCR6 gene;Data;Databases;Dementia;Deposition;Disease;Disease associated microglia;Early Onset Alzheimer Disease;ecto-nucleotidase;Event;exhaust;Genetic;Human;Immunization;Infiltration;Link;Mediating;Memory;Microglia;Mus;Nature;Neuronal Dysfunction;neurotoxic;Pathogenicity;Pathologic;Peptides;Peripheral;Phenotype;Play;Publications;Reporting;Research Project Grants;RNA vaccine;Role;Synapses;T cell infiltration;Tauopathies;Testing;Tissues;Work,ALZHEIMERS RESEARCH PROJECT: B cells promote Alzheimers disease via cytolytic CD8+ T cells,582,NA,NA,NA,NA,3,NA,NA,360948,NA
11177450,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000589,NA,NA,1ZIAAG000589-01,NIA:211231\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79946397 (contact),"ACOSTA-RODRÍGUEZ, VICTORIA  (contact)",NA,NA,NA,age related chronic disease;Aging;Behavioral;Chronic Disease;circadian;circadian pacemaker;dietary;Dietary Intervention;Eating;Energy Metabolism;Feeding Patterns;Gene Expression;gene therapy;Genes;Goals;Health;healthspan;Hour;immune function;insight;Intervention;lens;life span;Longevity;Longevity Pathway;multiple omics;novel;novel therapeutic intervention;Nutrient;Periodicity;Personal Satisfaction;pharmacologic;Physiological;Physiology;prevent;Process;Research;response;Role;Sampling;System;Time;Tissues,Understanding the role of circadian clocks on healthy longevity,589,NA,NA,NA,NA,1,NA,NA,211231,NA
11177451,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000594,NA,NA,1ZIAAG000594-04,NIA:278081\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Acceleration;Affect;age acceleration;Age Months;age-related disease;Aging;aging process;Alzheimer&apos;s Disease;Animal Model;Animals;Anxiety;arterial stiffness;Arthritis;ATP phosphohydrolase;Birth;Blood specimen;Blood Vessels;Calcium Signaling;Cardiac;Cardiovascular system;Carpal Tunnel Syndrome;Cell Aging;Cell Separation;Cessation of life;Chronic;Clinical Research;cohort;cytochrome c oxidase;Dentistry;diabetic patient;dosage;Echocardiography;Elderly;Environment;epigenetic clock;Experimental Autoimmune Encephalomyelitis;Female;Fibroblasts;Food;frailty;Gait;Gait speed;Goals;Health;healthspan;Heart;heart function;Heart Rate;heart rate variability;Hemostatic function;Human;Hypertension;In Situ;Inflammation;Leg Ulcer;Length;life span;Light;Long-Term Effects;Major Depressive Disorder;male;Measurement;Mitochondria;mouse model;Mus;Myalgia;Myocardial Infarction;myogenesis;novel therapeutics;oral mucositis;overexpression;Pathway interactions;Phenotype;Physics;Physiological;pre-clinical;Process;programs;Regulation;Reporting;Role;senescence;Siblings;Signal Transduction;Skeletal Muscle;Smooth Muscle Myocytes;Spinal cord injury;stem cells;Stroke;Sunlight;telomere;Testing;Therapeutic Effect;therapeutic evaluation;tissue regeneration;Tissues;Transgenic Mice;Treadmill Tests;Treatment Efficacy;Vascular Smooth Muscle;Water;wound healing,Effect of Long-term Photobiological Modulation Therapy on Aging,594,NA,NA,NA,NA,4,NA,NA,278081,NA
11177452,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000595,NA,NA,1ZIAAG000595-06,NIA:771675\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,"3&apos; Untranslated Regions;Action Potentials;age related changes;Aging;American Heart Association;Angiotensin II;Animal Model;Aorta;Binding;Biological Assay;Blood Vessels;Body Composition;Calcium;Cardiac;Cardiac Myocytes;Cardiovascular system;Carotid Arteries;CCL2 gene;CCR;Cell Separation;Cells;Collaborations;comorbidity;Core Facility;Diabetes Mellitus;diabetic;diabetic cardiomyopathy;Diabetic mouse;diabetic rat;Disease;Doctor of Medicine;Doctor of Philosophy;Dose;Echocardiography;Elderly;Electric Stimulation;Exhibits;Extracellular Matrix;Family;Family member;Fibrosis;Functional disorder;Gene Expression;Genetic Transcription;glucose metabolism;Heart;Heart failure;heart function;High Fat Diet;Human;IL6 gene;Immunohistochemistry;Inflammatory;Insulin Resistance;Knock-out;Knockout Mice;Link;Longitudinal Studies;Luciferases;Macaca mulatta;Magnetic Resonance Imaging;Manuscripts;meetings;Messenger RNA;Metabolism;migration;morphometry;Mus;Myocardial;novel;Obesity;OGTT;old mice;overexpression;Oxidative Stress;Oxidative Stress Induction;Performance;posters;Proteins;Protocols documentation;PTGS2 gene;Publications;Rattus;Receptor, Angiotensin, Type 1;Renin-Angiotensin-Aldosterone System;Role;Science;Signal Transduction;SIRT1 gene;Smooth Muscle Myocytes;Sterility;Streptozocin;Testing;Tissues;transcriptome;transcriptome sequencing;Universities;Untranslated RNA;Vascular Smooth Muscle;vascular smooth muscle cell proliferation;Western Blotting;Wild Type Mouse",Non-coding RNAs (ncRNAs) in Cardiovascular Aging,595,NA,NA,NA,NA,6,NA,NA,771675,NA
11177453,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000596,NA,NA,1ZIAAG000596-06,NIA:410170\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Acceleration;Adenylate Cyclase;Adult;Affect;Age;age acceleration;Age Months;age related;Aging;Appearance;Behavior;behavior test;Bioinformatics;biological adaptation to stress;Brain;brain tissue;Calcium;Cardiac;cardiac aging;Cardiac Myocytes;Cell Survival;Cells;Central Nervous System;Chronic;conditioned fear;coronary fibrosis;Cyclic AMP-Dependent Protein Kinases;cytokine;Darkness;Dopamine;Electrocardiogram;Electroencephalography;Endothelial Cells;Etiology;Exercise;experience;Freezing;gamma-Aminobutyric Acid;Generations;Genes;Genetic Transcription;Genotype;Glutamates;Heart;heart function;Heart Rate;Hippocampus;Immune;immune activation;Immune response;in vivo;Inflammation;Inflammatory;Label;Lead;Left;Left ventricular structure;Light;Locomotion;Longevity;lymphoid organ;MAP Kinase Gene;Mediating;Messenger RNA;Metabolic Pathway;Metabolism;Modeling;Molecular;Motor Activity;Mus;Myocardial;Myocardial dysfunction;new therapeutic target;novel;Output;overexpression;Pathway interactions;PDPK1 gene;Performance;Phosphopeptides;Phosphoproteins;Phosphoric Monoester Hydrolases;Phosphorylation;Phosphotransferases;PI3K/AKT;PIK3CG gene;Post-Translational Protein Processing;Proteins;Proteome;Proteomics;PTK2B gene;Publishing;Quality Control;receptor;Reporting;resilience;response;Role;Serum;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Speed;Stress;Stress Response Signaling;System;systemic inflammatory response;Telemetry;Testing;Time;Tissues;transcription factor;transcriptome;transcriptomics;Travel;Ubiquitin;Up-Regulation;Variant;Ventricular;Wild Type Mouse,"The TGAC8 Mouse, the mouse that roars",596,NA,NA,NA,NA,6,NA,NA,410170,NA
11177454,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000598,NA,NA,1ZIAAG000598-14,NIA:431026\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Action Potentials;Adrenergic Receptor;Age;Animals;Behavior;Binding;Biological Pacemakers;Brain Death;Cardiovascular Diseases;Cell Therapy;Cells;cost;Coupled;Couples;Coupling;Cyclic AMP;Devices;Electrocardiogram;Exhibits;Failure;Fractionation;Frequencies;Generations;Heart;Heart Rate;Human;implantation;in vivo;Ion Channel;Kinetics;Laws;Membrane;Molecular;Mus;Neurons;new therapeutic target;nodal myocyte;Pacemakers;Periodicals;Periodicity;Phase;receptor;Regulation;Research;Rest;Sarcoplasmic Reticulum;Scientist;Signal Transduction;Sinoatrial Node;Sinus;spatiotemporal;Surface;System;Testing;Time;Tissues;voltage,Beat to beat Ca2+-dependent regulation of pacemaker cell rate and rhythm,598,NA,NA,NA,NA,14,NA,NA,431026,NA
11177455,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000609,NA,NA,1ZIAAG000609-32,NIA:1251365\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479117 (contact),"FEDOROVA, OLGA V (contact)",NA,NA,NA,Age;Aging;Animal Model;Animals;Aorta;arterial stiffness;Behavioral;Blood Pressure;blood pressure regulation;Blood Vessels;Brain;Breeding;bufadienolide;Cardiovascular system;cerebrovascular;Chronic;cognitive function;Collagen;Collagen Gene;Complex;connective tissue growth factor;Consumption;Dahl Hypertensive Rats;Dementia;dementia risk;Diet;dietary;dietary control;Dietary intake;dietary salt;early experience;Echocardiography;experimental study;Fibronectins;Fibrosis;Gene Expression;Genes;Genetic;Goals;Heart;high salt diet;Hippocampus;Hypertension;hypertensive;Impaired cognition;Impairment;inhibitor;Intake;Investigation;male;marinobufagenin;Memory;Modeling;morris water maze;Na(+)-K(+)-Exchanging ATPase;new therapeutic target;normotensive;Outcome;Performance;Plasma;Profibrotic signal;Rattus;response;salt intake;salt sensitive hypertension;Sodium Chloride;Sodium-Restricted Diet;spatial memory;Sprague-Dawley Rats;Structure;Testing;TGFB1 gene;Up-Regulation;Urine;Weight,Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging,609,NA,NA,NA,NA,32,NA,NA,1251365,NA
11177456,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000646,NA,NA,1ZIAAG000646-27,NIA:872180\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479141 (contact),"NAGARAJA, RAMAIAH  (contact)",NA,NA,NA,Affect;African;age related;aging related;Agonist;Agreement;Alternative Splicing;American;Amino Acids;Antibodies;Bacterial Artificial Chromosomes;Binding;Biochemical;Bioinformatics;Blood;C-terminal;cancer cell;Cancer cell line;Catalogs;Cell Line;Cells;Centromere;Chromatin;Chromosome 14;Chromosome 21;Chromosome 22;Chromosomes;Cloning;Code;Collaborations;Complement;Complex;Data;Databases;desmoglein;Desmosomes;Developmental Process;Diabetes Mellitus;DNA analysis;DNA Sequence;DNA Structure;East Asian;Embryo;ERR1 protein;Evolution;Exhibits;exosome;falls;follow-up;Future;Gel;Genbank;Gene Expression Regulation;gene repression;Genes;Genetic Recombination;Genetic Transcription;genetic variant;Genome;Gorilla gorilla;Growth;Guanine + Cytosine Composition;Haploidy;Heterogeneity;Homo sapiens;Human;Human Chromosomes;Human Genome;Hybrid Cells;Hybrids;insertion/deletion mutation;interest;Large T Antigen;Leucine;Macaca mulatta;Manuscripts;Mediating;Metabolic Diseases;Mole the mammal;molecular sequence database;Monkey Cell Line;Mothers;mRNA Translation;Mus;nanopore;National Human Genome Research Institute;Nature;nonhuman primate;Nuclear Receptors;Nucleoproteins;Open Reading Frames;Pan Genus;Pan paniscus;pan-genome;Personal Satisfaction;Placenta;Pongo pygmaeus;Population;Positioning Attribute;Pre-Eclampsia;Predisposition;Pregnancy;preservation;programs;promoter;Promoter Regions;Property;Proteins;Publications;Publishing;receptor;Recovery;recruit;Regulation;Repetitive Sequence;Reproduction;Retinoic Acid Receptor;Ribosomal DNA;Ribosomal RNA;Ribosomes;Risk;RNA;Route;rRNA Genes;Sampling;selective expression;senescent cell;Sequence Analysis;Series;SF1;Simian virus 40;Site;South Asian;Stream;Structure;Sucrose;Techniques;telomere;Testing;Tissues;transcriptome sequencing;tumor;tumorigenesis;United States National Institutes of Health;Up-Regulation;Update;Valine;Variant;variant detection;whole genome;WI 38 cell;Work;Yeasts,Placenta specific and ribosomal RNA genes: structure and function,646,NA,NA,NA,NA,27,NA,NA,872180,NA
11177457,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000679,NA,NA,1ZIAAG000679-06,NIA:1273058\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,16118294 (contact),"SEN, PAYEL  (contact)",NA,NA,NA,age related;Age related pathologies;aged;Aging;aging process;ATAC-seq;Binding;Cells;ChIP-seq;Chromatin;cohort;Data;DNA;DNA Modification Process;Elderly;Enhancers;Epigenetic Process;Euchromatin;Event;EZH2 gene;Genetic Transcription;healthy aging;Heterochromatin;Histone Acetylation;histone methylation;Immune response;in vitro Model;insight;Investigation;late life;Liver;Liver Regeneration;Mediating;Metabolic;Methyltransferase;Modeling;Molecular;Multiomic Data;multiple omics;Mus;Natural regeneration;new therapeutic target;novel;Nuclear;Nuclear Lamina;old mice;Organ;paralogous gene;Phenotype;postmitotic;Process;regeneration following injury;Regulation;Role;Testing;Tissues;transcriptome sequencing;Work,Epigenetic mechanisms of liver aging,679,NA,NA,NA,NA,6,NA,NA,1273058,NA
11177458,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000686,NA,NA,1ZIAAG000686-05,NIA:433381\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,19 year old;2019-nCoV;Address;Admission activity;Adult;aged;Aging;Animals;Archaea;Bacteria;Binding Proteins;Biogenesis;Biological Assay;bis-benzimidazole;Catalytic Domain;Cause of Death;Cell Line;Cells;Cessation of life;Chemicals;Collaborations;Communication;Complex;Coronavirus;COVID-19;COVID-19 pandemic;COVID-19 patient;COVID-19 treatment;CRISPR/Cas technology;Data;Dengue;Development;DNA;DNA Binding;DNA metabolism;DNA Topoisomerases;drug candidate;Drug Screening;Drug Targeting;drug testing;Escherichia coli;Eukaryota;Family;FDA approved;FMR1 gene;Genetic Transcription;Goals;Guide RNA;Homologous Gene;Impairment;In Vitro;Individual;Infection;inhibitor;inhibitor therapy;Investigation;Knock-out;Legal patent;Link;link protein;Luciferases;Lung;Malignant Neoplasms;Manuscripts;Mouse Cell Line;mouse model;mRNA Translation;N-terminal;neurodevelopment;Nucleic Acids;Older Population;Outcome;pandemic disease;Paper;Patients;Persons;Pharmaceutical Preparations;prevent;Proliferating;Proteins;Proteomics;Publications;Publishing;remdesivir;Reporting;Retroviridae;Reverse Transcription Inhibition;RNA;RNA Binding;RNA metabolism;RNA replication;RNA Viruses;RNA-Binding Proteins;RNA-Directed DNA Polymerase;RNA-Directed RNA Polymerase;SARS coronavirus;Testing;Time;Topoisomerase;Topoisomerase Inhibitors;Translations;Viral;Viral Proteins;viral RNA;Virus Replication;web site;Work;ZIKA,Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug,686,NA,NA,NA,NA,5,NA,NA,433381,NA
11177459,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000688,NA,NA,1ZIAAG000688-23,NIA:21669\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,age acceleration;Aging;aging process;aging related disease;Atrophic condition of skin;BACH1 gene;Bilateral;Binding;Bone marrow failure;BRCA1 gene;BRCA2 gene;cancer risk;Cancer-Predisposing Gene;Catalytic Domain;Cataract;CDC45L gene;Cell Nucleus;Cells;Characteristics;Chromatin;Collaborations;Complement;Complex;Congenital Abnormality;Core Protein;crosslink;Cruciform DNA;Data;Defect;Diabetes Mellitus;Disease;DNA;DNA Binding;DNA biosynthesis;DNA Crosslinking;DNA Damage;DNA Interstrand Crosslinking;DNA Repair;DNA replication fork;DNA Structure;FANCB;FANCD2 protein;Fanconi Anemia Complementation Group A Protein;Fanconi Anemia pathway;Fanconi anemia protein;Fanconi&apos;s Anemia;Frequencies;Gene Conversion;Genes;Genome;genome integrity;Genome Stability;Genomics;Goals;helicase;Hereditary Disease;Histone Fold;homologous recombination;Human;In Situ;in vitro activity;in vivo;Lesion;Link;Malignant Breast Neoplasm;Malignant Neoplasms;Mediating;Mitomycin C;Modeling;Modification;Monoubiquitination;Mutate;Names;new therapeutic target;Normal Cell;novel;novel therapeutic intervention;Nuclear;Nuclear Protein;Orthologous Gene;Osteopenia;Osteoporosis;PALB2 gene;Paper;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Phosphorylation;Play;Predisposition;premature;Premature aging syndrome;Premature Ovarian Failure;protein function;Proteins;Publications;Reaction;recruit;reduced muscle mass;replication stress;Reporting;Resistance;response;Role;Route;Signal Transduction;Spottings;Structure;Tissues;Transducers;Ubiquitin;ubiquitin ligase;Work;xeroderma pigmentosum group A complementing protein;Yeasts,Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins,688,NA,NA,NA,NA,23,NA,NA,21669,NA
11177460,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000689,NA,NA,1ZIAAG000689-14,NIA:297950\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,Adult;Affect;Animals;Anxiety;Archaea;autism spectrum disorder;Bacteria;behavioral phenotyping;Binding;Biochemical;Biogenesis;Biological Assay;Brain;Cell Nucleus;Cells;Collaborations;Communication;Complex;conditioned fear;CRISPR/Cas technology;crosslink;crosslinking and immunoprecipitation sequencing;Cytoplasm;Data;Defect;Development;Disease;DNA;DNA metabolism;DNA Repair;DNA Topoisomerases;DNA Transposable Elements;dopaminergic neuron;Drosophila genus;Enzymes;Eukaryota;Evolution;Exhibits;Eye;fly;FMR1 gene;Focal Adhesion Kinase 1;Fragile X Syndrome;Fright;Functional disorder;Gene Silencing;Genes;Genetic study;Genetic Transcription;Goals;helicase;Heterochromatin;Hippocampus;Human;Human Genetics;Immunoprecipitation;Impaired cognition;Impairment;inhibitor;Intellectual functioning disability;Journals;Knock-out;Knockout Mice;Learning;Life;life span;Ligase;Link;Longevity;Manuscripts;Memory;Mental disorders;Mental Health;Messenger RNA;Metabolism;Modeling;mRNA Expression;mRNA Translation;Mus;mutant;Mutant Strains Mice;Mutation;Nature;neurodevelopment;neurogenesis;Neurology;Neuromuscular Junction;Neurons;Neurosciences;nuclease;Oocytes;overexpression;paralogous gene;Pathogenesis;Pathway interactions;Patients;Penetrance;Pharmaceutical Preparations;Phenotype;Point Mutation;Polymerase;Polyribosomes;Process;protein p68;Proteins;Psyche structure;PTK2 gene;Publishing;Reaction;repaired;Reporting;Research;response;RNA;RNA Binding;RNA Interference;RNA metabolism;RNA Recognition Motif;Schizophrenia;Single Nucleotide Polymorphism;Small Interfering RNA;Social Interaction;Stress;stress granule;Synapses;Synaptic plasticity;Synaptic Transmission;synaptogenesis;System;telomere;Testing;Topoisomerase;Transgenic Organisms;Translations;Work;Yeasts,An RNA topoisomerase complex interacts with Fragile X syndrome protein to promote neurodevelopment and maintain normal life-span,689,NA,NA,NA,NA,14,NA,NA,297950,NA
11177461,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000692,NA,NA,1ZIAAG000692-05,NIA:180474\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6367697 (contact),"WANG, WEIDONG  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Affect;age related;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Animal Model;Animals;Aubergine;Behavior;Binding;Biochemical;Biogenesis;biological adaptation to stress;Biological Assay;Brain;Cell Death;Cell Line;Cells;Cognition Disorders;Collaborations;Complex;COVID-19;Cytoplasmic Granules;Data;Defect;Dissociation;DNA;DNA Transposable Elements;dominant genetic mutation;Drosophila genus;Drug Targeting;druggable target;Eukaryota;Exhibits;Eye;Eye Development;fly;FMR1 gene;frontotemporal lobar dementia amyotrophic lateral sclerosis;Functional disorder;Genes;Genetic;Genetic Transcription;Goals;Hela Cells;Heterochromatin;Heterozygote;Human;Inflammation;inhibitor;Knockout Mice;life span;Link;Mammalian Cell;Mental disorders;Messenger RNA;misfolded protein;Modeling;Modification;mouse model;mRNA Transcript Degradation;mRNA Translation;Mus;mutant;Mutation;Nerve Degeneration;Nervous System Disorder;Neurologic;neurotoxicity;Optic Nerve;Ovary;pandemic disease;Pathogenicity;Pathologic;Pathway interactions;Phenotype;Phosphotransferases;piRNA;Play;Polyribosomes;protein TDP-43;Proteins;Reporter;Research Project Grants;RNA;RNA Viruses;RNA-Binding Proteins;RNA-Induced Silencing Complex;Role;Science;Secondary to;Stress;stress granule;stress reduction;synaptogenesis;tau mutation;tau Proteins;Tauopathies;therapeutic target;Topoisomerase;Topoisomerase Inhibitors;Toxic effect;Transcriptional Silencer Elements;transcriptome sequencing;Update;Variant;Wing;Work,ALZHEIMERS RESEARCH PROJECT: Investigating the roles of Topoisomerase 3b-TDRD3 complex in neurodegeneration and Alzheimer's disease,692,NA,NA,NA,NA,5,NA,NA,180474,NA
11177462,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000696,NA,NA,1ZIAAG000696-05,NIA:2306291\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79326265 (contact),"MARAGKAKIS, MANOLIS  (contact)",NA,NA,NA,Aging;aging related disease;animal tissue;Biological;Biological Process;Cell Physiology;cell type;Cells;Cellular Stress;Complex;Computer Analysis;Development;Disease;Encapsulated;Gene Expression Regulation;Genes;Genetic Transcription;Genome;Goals;high dimensionality;Homeostasis;Lead;Machine Learning;Malignant Neoplasms;Mediating;Messenger RNA;Modeling;mRNA Decay;nanopore;Nerve Degeneration;Pathway interactions;Phase;Physiology;Post-Transcriptional Regulation;Post-Transcriptional RNA Processing;posttranscriptional;Process;programs;Property;Protein Isoforms;Protocols documentation;Ribosomes;RNA;RNA metabolism;RNA Probes;Signal Transduction;Tissues;tool;Work,RNA dynamics and co-translational decay in aging and aging-related disease,696,NA,NA,NA,NA,5,NA,NA,2306291,NA
11177463,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000698,NA,NA,1ZIAAG000698-06,NIA:1679353\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691039 (contact),"LIU, YIE  (contact)",NA,NA,NA,age-related disease;Biology;Blood;Body Weight;Bone Marrow;Bone marrow failure;Bone Marrow Transplantation;Cell Physiology;Cells;Consumption;Defect;Disease;DNA Damage;DNA Repair;Dyskeratosis Congenita;Enterocolitis;Equilibrium;Exhibits;Fertility;Fibroblasts;fitness;Functional disorder;gastrointestinal;Generations;Genes;Genomic Instability;Germ Lines;Geroscience;hallmarks of aging;Health;healthspan;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Human;Impairment;improved;in vivo;Inherited;Intervention;Journals;Knockout Mice;Length;Life;Link;Liver diseases;Lymphoid;Malignant Neoplasms;Mediating;Metabolism;metabolome;Mitochondria;mitochondrial dysfunction;Modeling;mortality;Mouse Strains;Myelogenous;Nicotinamide adenine dinucleotide;nicotinamide-beta-riboside;oral supplementation;Oxidation-Reduction;Pathogenesis;Pathology;Patients;peer;Pharmacological Treatment;Phenotype;Premature aging syndrome;Prevalence;Production;Publishing;Pulmonary Fibrosis;RNA-Directed DNA Polymerase;SIRT1 gene;Supplementation;Syndrome;systemic inflammatory response;Telomerase;telomere;telomere loss;Telomere Maintenance;Telomere Shortening;therapeutic development;Therapeutic Intervention;Tissues;treatment strategy;Work,Assessing therapeutic intervention of short telomere syndromes,698,NA,NA,NA,NA,6,NA,NA,1679353,NA
11177464,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000699,NA,NA,1ZIAAG000699-07,NIA:492871\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,adduct;Aging;base;Basic Science;Binding Proteins;Biochemical;Bypass;Clinical;clinically relevant;cohort;Computer Analysis;Computer software;Data;Disease;DNA;DNA biosynthesis;DNA Structure;Etiology;G-Quartets;Genetic;Genetic Diseases;genetic risk factor;genome analysis;Genomic Instability;Genomics;Guanine;helicase;Heritability;human disease;In Vitro;Malignant Neoplasms;Mitochondria;Mitochondrial DNA;mitochondrial DNA mutation;mitochondrial genome;Molecular;Mutagenesis;Mutation;Nucleotides;oxidative DNA damage;Point Mutation;Polymerase;Population Database;Recombinant DNA;Recombinant Proteins;reconstitution;Risk;Role;Site;Source;Structure;System;trait;Variant,G-quadruplexes (G4) are potential DNA roadblocks that perturb mitochondrial replication machinery and pose a clinically relevant source of mitochondrial DNA mutation and instability,699,NA,NA,NA,NA,7,NA,NA,492871,NA
11177465,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000723,NA,NA,1ZIAAG000723-17,NIA:18047\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,Acute;age related neurodegeneration;age-related disease;Aging;Alzheimer&apos;s Disease;Caenorhabditis elegans;Cellular Assay;Cellular Stress;Chronic;Disease;DNA;DNA Damage;DNA Repair;DNA Repair Disorder;Functional disorder;Goals;Human;Mitochondria;mouse model;Nematoda;Nerve Degeneration;Neurodegenerative Disorders;novel therapeutic intervention;oxidative DNA damage;Play;Research Project Grants;response;Role;System;theories;Work,ALZHEIMERS RESEARCH PROJECT:  DNA repair dysfunction in neurodegeneration and Alzheimer's Disease,723,NA,NA,NA,NA,17,NA,NA,18047,NA
11177466,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000726,NA,NA,1ZIAAG000726-32,NIA:70410\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,age related;Aging;aging related;Biochemical;Biochemical Process;Cancerous;Cells;Characteristics;Code;Disease;DNA;DNA Damage;DNA Double Strand Break;DNA Repair;DNA Structure;Double Strand Break Repair;Enzymes;Genes;Genetic;Genome;Genome Stability;Genomic Instability;helicase;homologous recombination;Human;Life;Light;Malignant Neoplasms;member;Mendelian disorder;Metabolic Pathway;Molecular;Mutate;Mutation;Nonhomologous DNA End Joining;Pathway interactions;Patients;Play;Premature aging syndrome;prevent;Process;protein function;Proteins;RECQL gene;RECQL4 gene;RECQL5 gene;Research;Role;Syndrome;Time,Function of RecQ helicases in genome stability,726,NA,NA,NA,NA,32,NA,NA,70410,NA
11177467,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000741,NA,NA,1ZIAAG000741-24,NIA:964620\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,Age;Age of Onset;age-related disease;Attention;Binding;Biochemical;Biological;Biological Models;Biological Process;biological systems;cancer predisposition;Cell Physiology;Cells;Chromosomal Instability;Chromosomal Stability;Chromosome Segregation;Complex;Diagnosis;Disease;disease phenotype;DNA;DNA biosynthesis;DNA Damage;DNA Maintenance;DNA metabolism;DNA Repair;DNA replication fork;DNA Structure;Elements;Enzymes;Exonuclease;Family;Functional disorder;gene product;Genes;Genetic;Genetic Models;Genetic Recombination;Genetic Transcription;genome integrity;Genome Stability;Genomic DNA;Genomic Instability;Goals;helicase;Homeostasis;Human;human disease;human DNA;Hydrolysis;in vivo;interest;Kinetics;Maintenance;Malignant Neoplasms;Mismatch Repair;Mitotic Recombination;Molecular;Molecular Motors;Mutation;Nuclear Proteins;nuclease;Nucleic Acids;nucleoside triphosphate;Pathway interactions;Play;preference;Premature aging syndrome;preservation;prevent;Prevention;Property;Protein Biochemistry;Proteins;Regulation;response;Role;Rothmund-Thomson syndrome;RTH-1 Nuclease;Single-Stranded DNA;Structure;System;Time;Werner Syndrome;Work;WRN gene,Roles Of DNA Helicases In Pathways Required For Maintenance Of Genomic Stability,741,NA,NA,NA,NA,24,NA,NA,964620,NA
11177468,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000746,NA,NA,1ZIAAG000746-18,NIA:5389274\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691037 (contact),"SEIDMAN, MICHAEL  (contact)",NA,NA,NA,Address;Aging;aging population;Antigens;Archaea;B Cell Proliferation;Binding;biological adaptation to stress;Biological Models;Cell Differentiation process;Cell Separation;Cells;chromatin remodeling;Chromatin Structure;crosslink;Defect;Detection;Development;Distal;DNA;DNA biosynthesis;DNA Crosslinking;DNA Damage;DNA fiber assay;DNA replication fork;DNA Structure;Elements;Euchromatin;Event;Exposure to;Failure;FANCD2 protein;Fanconi Anemia pathway;Fanconi anemia protein;Fanconi&apos;s Anemia;Fiber;Formaldehyde;Heterochromatin;in utero;Individual;Ionizing radiation;Location;Metabolism;Microscope;Neoplasms;novel;novel strategies;Nucleotides;Organ;Pathway interactions;Pattern;Postpartum Period;Premature aging syndrome;Preparation;Procedures;Process;Property;protein complex;Proteins;Quantum Dots;repaired;replication stress;response;Side;Site;Slide;Source;Stress;Tissues;translocase,Repair of localized DNA damage,746,NA,NA,NA,NA,18,NA,NA,5389274,NA
11177469,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000752,NA,NA,1ZIAAG000752-17,NIA:499912\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,Alkylating Agents;Basic Science;Biological;Biological Models;cancer cell;cancer therapy;Cell Line;Cell Physiology;Cells;chemotherapy;Chickens;Chromosomal Stability;clinically relevant;Complement;Critical Pathways;Diagnosis;Disease;DNA;DNA biosynthesis;DNA Damage;DNA Repair;DNA Repair Gene;DNA Repair Pathway;DNA Structure;Embryo;Evolution;Fanconi&apos;s Anemia;Fibroblasts;G-Quartets;Genetic;Genetic Diseases;Genetic Models;Genome;Genome Stability;Genomic Instability;Genotype;helicase;Helicase Gene;Homeostasis;Human;Human Cell Line;Human Genetics;in vivo;Individual;Inhibition of Cell Proliferation;insight;Knockout Mice;Link;Maintenance;Malignant Neoplasms;Molecular;Mus;mutant;Mutation;Normal Cell;novel;Orthologous Gene;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Premature aging syndrome;Radiation;repair function;repaired;replication stress;Resistance;RNA Interference;Role;small molecule;Stress;Structure;System;tumor;Werner Syndrome;Work;Yeasts,Model Genetic Systems to Study DNA Repair,752,NA,NA,NA,NA,17,NA,NA,499912,NA
11177470,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000753,NA,NA,1ZIAAG000753-17,NIA:436543\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,BACH1 gene;Binding;Biochemical;Biological;BRCA1 gene;Chromosomal Instability;Clinical;Complement;crosslink;Data;Disease;DNA;DNA biosynthesis;DNA Damage;DNA metabolism;DNA Repair;DNA replication fork;DNA Structure;Double Strand Break Repair;early onset;Fanconi Anemia pathway;Fanconi&apos;s Anemia;Genetic;helicase;homologous recombination;insight;Length;Link;Malignant Breast Neoplasm;Mismatch Repair;Molecular;Mutate;Mutation;novel;Patients;Phenotype;Play;protein complex;Proteins;Recombinants;repaired;replication stress;response;Role;SS DNA BP;Substrate Specificity;Tail;Variant;Vertebral column;Work,Fanconi Anemia Pathway,753,NA,NA,NA,NA,17,NA,NA,436543,NA
11177471,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000754,NA,NA,1ZIAAG000754-11,NIA:1408489\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691039 (contact),"LIU, YIE  (contact)",NA,NA,NA,Address;Affect;age related;age-related disease;Aging;Apoptosis;Binding;Biochemical;cancer cell;Cell Aging;Cell division;Cell Proliferation;Cells;Chromosomal Rearrangement;Chromosome Fragility;Chromosomes;Complex;Cytosine;Defect;Disparity;DNA;DNA biosynthesis;DNA Damage;DNA strand break;Equilibrium;Excision;Functional disorder;G-Quartets;Genes;Genetic;Genetic Transcription;Genome;genome integrity;Genomic Instability;Guanine;homologous recombination;Human;Hybrids;insight;Length;Link;Malignant Neoplasms;Mediating;Molecular;novel;nuclease;Nucleic Acids;Nucleotides;Pathway interactions;Phenotype;preservation;prevent;Process;Protein Binding Domain;Proteomics;Publishing;Regulation;replication stress;Research;Resolution;response;RNA;RNA Binding;RNA Splicing;RNA-Binding Proteins;Role;screening;spot 14 protein;Structure;Telomerase;telomere;telomere loss;Telomere Maintenance;Telomere Shortening;Therapeutic;Transcript;trend;Variant;Work,Resolution of telomeric nucleotide structure barriers by specific structure nucleases,754,NA,NA,NA,NA,11,NA,NA,1408489,NA
11177472,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000756,NA,NA,1ZIAAG000756-27,NIA:444588\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6568215 (contact),"WENG, NAN-PING PETER (contact)",NA,NA,NA,Age;Aging;aging related;B-Lymphocytes;Blood;Blood Cells;CD8-Positive T-Lymphocytes;Cell Aging;Cell Cycle;Cell Cycle Progression;Cell division;Cell Physiology;Cell Senescence Induction;Cells;Cultured Cells;Elderly;Gene Expression;Gene Modified;Goals;Human;Immune;Immune response;in vivo;Individual;influenza virus vaccine;Length;Longitudinal cohort;Lymphocyte;Lymphocyte Function;Measurement;Measures;Methods;Molecular;monocyte;mouse model;Mus;Natural Killer Cells;Process;Proliferating;Records;Reporter;Role;single-cell RNA sequencing;T-Lymphocyte;Telomerase;telomere;Testing;transcriptome,Role of Telomere and telomerase In Human Lymphocyte Function and Aging,756,NA,NA,NA,NA,27,NA,NA,444588,NA
11177473,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000757,NA,NA,1ZIAAG000757-27,NIA:769896\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6568215 (contact),"WENG, NAN-PING PETER (contact)",NA,NA,NA,age related;age related changes;Aging;ATAC-seq;Binding Proteins;CD8-Positive T-Lymphocytes;Cell Physiology;Cell Proliferation;Cells;ChIP-seq;Chromatin;comparative;differential expression;DNA Methylation;Gene Expression;Gene Expression Profiling;gene function;Genes;Genetic Transcription;genomic locus;Goals;homeodomain;Human;In Vitro;interest;knock-down;Lymphocyte;Measures;Memory;NR4A1 gene;older adult;overexpression;Play;Process;Proliferating;promoter;protein expression;Protein Isoforms;Proteins;Reporting;Role;single-cell RNA sequencing;T cell differentiation;T memory cell;T-Cell Activation;T-Cell Proliferation;T-Lymphocyte;T-Lymphocyte Subsets;terminally differentiated effector memory (TEM) T cells;Transcriptional Regulation;transcriptome;Up-Regulation,Mechanisms Of Age-related Changes in Transcriptional Regulation in lymphocytes,757,NA,NA,NA,NA,27,NA,NA,769896,NA
11177474,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000768,NA,NA,1ZIAAG000768-21,NIA:412848\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,age related;Aging;Asthma;beta catenin;Bone Marrow;Brain;Cells;Chronic;Cues;Development;Distal;Environment;Event;Generations;Genes;Genetic;Goals;gut microbiota;Human Pathology;Immune;insight;Interleukin-13;Interleukin-4;Maintenance;Mature T-Lymphocyte;Molecular;Molecular Probes;Mus;Mutant Strains Mice;Neurologic;Peripheral;Proteins;Regulation;response;Role;Signal Transduction;Signaling Molecule;systemic inflammatory response;T-Cell Development;T-Cell Receptor;T-Lymphocyte;TCF Transcription Factor;thymocyte;Thymus Gland;transcription factor;Transgenic Mice;Work;γδ T cells,Development and function of conventional and innate T cells,768,NA,NA,NA,NA,21,NA,NA,412848,NA
11177475,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000770,NA,NA,1ZIAAG000770-21,NIA:867489\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690946 (contact),"BIRAGYN, ARYA  (contact)",NA,NA,NA,Ablation;adaptive immunity;Affect;aged;Aging;aging related;aging related disease;anti-PD1 therapy;Antibodies;Antigens;B-Lymphocytes;Blood;breast cancer metastasis;carcinogenesis;CD8-Positive T-Lymphocytes;Cell Physiology;Cells;checkpoint inhibition;Circulation;Clinical;Collaborations;Collection;COVID-19 pandemic;COVID-19 pandemic effects;CXCR6 gene;Data;Disease Outcome;ecto-nucleotidase;Effector Cell;Elderly;Event;experimental study;Growth;gut dysbiosis;gut microbiota;Human;Immune;Immune response;Immunology;immunosenescence;Immunotherapy;improved;Inflammatory;Insulin Resistance;Interruption;Leaky Gut;Link;Longitudinal Studies;Macaca;Macrophage;male;Malignant Breast Neoplasm;Malignant Neoplasms;Metabolic;Metabolic syndrome;Metastasis Induction;microbiome sequencing;microbiota;Midlife women;monocyte;Mus;Nature;novel;old mice;Oral;Outcome;Pathogenicity;Pathology;Pathway interactions;Play;Publications;recruit;Regulatory T-Lymphocyte;Reporting;Role;Safety;Sampling;Science;Solid Neoplasm;Supplementation;systemic inflammatory response;Testing;therapeutic development;Time;tumor;Tumor Expansion;tumor growth;tumor progression;Tumor Promotion;Tumor Tissue,Immunology of aging and immunotherapy of aging-associated diseases,770,NA,NA,NA,NA,21,NA,NA,867489,NA
11177476,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000776,NA,NA,1ZIAAG000776-03,NIA:352051\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,2019-nCoV;Biochemical;Cells;combat;Complex;Coronavirus;COVID-19;Exonuclease;G-Quartets;Genetic Transcription;Genetic Variation;Genome;Genomics;helicase;In Vitro;in vivo;Individual;inhibitor;Libraries;Life Cycle Stages;Maps;Modeling;Molecular;Murine hepatitis virus;Mus;Mutagenesis;Mutation;novel coronavirus;nucleic acid structure;pharmacologic;Point Mutation;Pre-Clinical Model;Proteins;RNA;RNA Helicase;RNA-Directed RNA Polymerase;Role;SARS-CoV-2 genome;stem;Structure;symptom treatment;transmission process;Viral;Virulence;Virulent;Virus,COVID-19 Nsp13 Helicase Analysis: Assessment of Unwinding SARS-CoV-2 Mutagenic RNA Secondary Structures and Pharmacological Modulation in a Preclinical Model,776,NA,NA,NA,NA,3,NA,NA,352051,NA
11177477,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000784,NA,NA,1ZIAAG000784-09,NIA:218272\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,Age;age related;Aging;Cells;Chromosomal Stability;dietary;dietary manipulation;disease phenotype;DNA Damage;Environment;experience;Exposure to;Foundations;Functional disorder;Genome Stability;helicase;Homologous Gene;Human;in vivo;innovation;Knockout Mice;Knowledge;Laboratories;Lesion;Longevity;Mammals;Modeling;molecular pathology;mouse model;Mus;mutant;novel;Organ;Pathway interactions;Phenotype;Principal Investigator;RECQL gene;replication stress;Research;response;Rodent Model;Role;Stress;Tissues,NIA Inter-Lab Project: Analyses of Age-Related Phenotypes Displayed by RECQL1 Deficiency in a Rodent Model,784,NA,NA,NA,NA,9,NA,NA,218272,NA
11177478,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000791,NA,NA,1ZIAAG000791-01,NIA:144379\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,16118294 (contact),"SEN, PAYEL  (contact)",NA,NA,NA,Adopted;Aging;Alzheimer disease detection;Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Alzheimer&apos;s disease related dementia;analysis pipeline;Baltimore;Cell Nucleus;Cells;Clinical;Complementary DNA;Custom;Data Analyses;Data Set;Detection;Development;Disease Progression;early detection biomarkers;Etiology;Excision;experimental study;Future;Genes;genetic variant;Genomics;Incidence;Individual;insight;Longitudinal Studies;Messenger RNA;Methodology;Methods;Molecular;Monitor;multimodality;nanopore;novel;Outcome;Participant;Pathogenesis;Pattern;Peripheral Blood Mononuclear Cell;Population;Prediction of Response to Therapy;Process;Protein Isoforms;Research;Research Project Grants;RNA;Role;single nucleus RNA-sequencing;targeted treatment;Technology;Therapeutic Intervention;Transcript;transcriptomics,ALZHEIMERS RESEARCH PROJECT - Interrogating RNA Isoform Diversity and Function in Alzheimer's Disease by Long-Read Sequencing,791,NA,NA,NA,NA,1,NA,NA,144379,NA
11177479,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000792,NA,NA,1ZIAAG000792-01,NIA:108284\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,16118294 (contact),"SEN, PAYEL  (contact)",NA,NA,NA,3-Dimensional;Age;age related;age related changes;aged;Aging;aging brain;aging mechanism;Alzheimer&apos;s Disease;Animals;Astrocytes;barrier to testing;beta-Galactosidase;Blood - brain barrier anatomy;Brain;brain tissue;cell type;Cells;Coculture Techniques;Cognitive;drug testing;drug use screening;Electrophysiology (science);Epigenetic Process;functional improvement;Galectin 3;Glial Fibrillary Acidic Protein;Goals;In Vitro;insight;Intervention;Link;Microglia;Modeling;Molecular;molecular marker;multiple omics;Nerve Degeneration;Neurologic;Neurons;old mice;Oligodendroglia;Organoids;Output;preservation;Research Project Grants;Resolution;senescence;spatiotemporal;tau-1;Testing;Therapeutic,ALZHEIMERS RESEARCH PROJECT - Exploring neuron-microglia-astrocyte-oligodendrocyte interactions during aging using primary cultures and brain-mimicking and age-relevant organoid models,792,NA,NA,NA,NA,1,NA,NA,108284,NA
11177480,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000793,NA,NA,1ZIAAG000793-01,NIA:243777\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Affect;Age;age-related disease;aging related;Autophagocytosis;Binding Proteins;Biology;Coat Protein Complex I;cytokine;Defect;Exhibits;Fibroblasts;Genes;Golgi Apparatus;Heparan Sulfate Biosynthesis;Impairment;Inflammatory;Intracellular Transport;member;Modeling;Multiple Abnormalities;Organelles;Phenotype;Production;Proliferating;Protein Biosynthesis;Proteins;Proteomics;senescence;senescent cell;Structure;trafficking;uptake;Vesicle,Alteration in function of the Golgi complex in senescent cells,793,NA,NA,NA,NA,1,NA,NA,243777,NA
11177481,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000798,NA,NA,1ZIAAG000798-15,NIA:813387\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Accounting;Action Potentials;Adverse effects;Affect;analog;Arrhythmia;Behavior;cancer cell;cancer therapy;cancer type;Cardiac;Cardiac pacemaker;Cardiotoxicity;Cell Cycle;Cells;Clinical;Confocal Microscopy;Coupled;effective therapy;Endothelial Growth Factors Receptor;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Fire - disasters;Gastrointestinal Stromal Tumors;Goals;Growth Factor Receptors;Heart;heart function;improved outcome;inhibitor;Investigation;KDR gene;kinase inhibitor;Length;Link;Malignant Neoplasms;Mediating;Neoplasm Metastasis;nodal myocyte;Oryctolagus cuniculus;Pacemakers;Patch-Clamp Techniques;Pathway interactions;Patient-Focused Outcomes;Perforation;Periodicity;Pharmaceutical Preparations;Phosphatidylinositols;Phospholipase C;Phosphotransferases;pre-clinical;Protein Isoforms;Protein Kinase C;receptor;Receptor Activation;Receptor Protein-Tyrosine Kinases;Regulation;Role;Sarcoplasmic Reticulum;Sick Sinus Syndrome;side effect;Sinoatrial Node;Sinus Bradycardia;System;Systemic Mastocytosis;targeted cancer therapy;Testing;tumor;tumor microenvironment;tumor progression;Tyrosine Kinase Inhibitor;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factors,"Tyrosine kinase receptors (VEGFR and EGFR) regulate normal automaticity of heart pacemaker, the sinoatrial node.",798,NA,NA,NA,NA,15,NA,NA,813387,NA
11177482,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000799,NA,NA,1ZIAAG000799-16,NIA:20856\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Acceleration;Adult;African American;Age;Aging;Area;arterial stiffness;Blood Pressure;blood pressure regulation;Capillary Endothelial Cell;Cardiovascular system;cell type;Cells;Clinical;Data Set;Diabetes Mellitus;diabetic;Diastolic blood pressure;Endothelial Cells;Erythrocytes;European;European ancestry;fasting plasma glucose;Femur;Follow-Up Studies;G6PD gene;Genes;Genetic;genetic variant;genome wide association study;genome-wide analysis;Genomics;Glucose;Heritability;Human;Hypertension;indexing;Individual;inflammatory marker;Interleukin-6;Kidney;kidney cell;kidney cortex;Linkage Disequilibrium;Myofibroblast;non-diabetic;Odds Ratio;Physiologic pulse;Plasma;polygenic risk score;Population;Precision Health;predictive modeling;Research;Risk;ROC Curve;Role;Sampling;Sardinia;secondary analysis;Single Nucleotide Polymorphism;Solid;trait;Tubular formation,Genome-wide Association Study of Cardiovascular Traits in 6142 Sardinians,799,NA,NA,NA,NA,16,NA,NA,20856,NA
11177483,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000802,NA,NA,1ZIAAG000802-33,NIA:20856\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Aerobic;Aerobic Exercise;Age;age effect;age group;age related;age related decline;age-related disease;Aging;American;Automobile Driving;Baltimore;Biological;Blood;Cardiac;Cardiac Output;Cardiovascular Diseases;cardiovascular disorder prevention;Cardiovascular Physiology;Cardiovascular system;Clinical;Communities;conditioning;Data;design;Detection;Disease;EFRAC;Elderly;Environment;Equation;Ergometry;Exercise;exhaustion;follow-up;Future;Gated Blood-Pool Imaging;Gender;Genetic;Heart;Heart failure;Heart Rate;Homeostasis;Individual;Intervention;Journals;Left;Life;Life Style;Linear Regressions;longitudinal analysis;Longitudinal Studies;male;Measurement;Measures;men;Modeling;Muscle;older patient;Older Population;Oxygen;Oxygen Consumption;Participant;Performance;Peripheral;Persons;Physical Fitness;Physiology;Play;preservation;pressure;Prevention strategy;Publishing;Radionuclide Ventriculography;rate of change;Rest;Role;Sampling;Scanning;sex;Structure;Time;Training;uptake;Variant;Ventricular;VO2max;volunteer;Woman;women subjects;Work;Workload,Effects Of Age And Conditioning Status On Rest And Exercise Cardiac Performance,802,NA,NA,NA,NA,33,NA,NA,20856,NA
11177484,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000846,NA,NA,1ZIAAG000846-09,NIA:1807527\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479117 (contact),"FEDOROVA, OLGA V (contact)",NA,NA,NA,Age;age related;age related changes;Aging;aging related;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Analysis of Variance;Aorta;arterial stiffness;behavior test;Blood Pressure;Blood Vessels;Brain;Breeding;Cardiac;cardiac aging;Cardiovascular Diseases;Cardiovascular Physiology;Cardiovascular system;Clinical;Collagen;Consumption;Dahl Hypertensive Rats;Data Analyses;design;Development;Diet;Echocardiography;Elastin;Elderly;epidemiology study;Exhibits;experimental study;Fibrosis;GDF15 gene;General Population;Genes;hemodynamics;Hippocampus;Histocytochemistry;Hypertension;Impaired cognition;Impairment;indexing;Inflammation;Inflammatory;inhibitor;Left ventricular structure;Life;Linear Regressions;male;marinobufagenin;Measurement;Measures;Memory;Memory Loss;Microvascular Dysfunction;Modeling;morris water maze;mRNA Expression;Na(+)-K(+)-Exchanging ATPase;Nerve Degeneration;Physiologic pulse;Process;Rattus;Risk Factors;senescence;Sodium Chloride;spatial memory;Sprague-Dawley Rats;Testing;TGFB1 gene;Thick;TP53 gene;Vascular Dementia;Weight,Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease,846,NA,NA,NA,NA,9,NA,NA,1807527,NA
11177485,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000856,NA,NA,1ZIAAG000856-23,NIA:20856\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Acceleration;ACE2;Aerobic;Aerobic Exercise;Age;age difference;age effect;age related;age related changes;age related decline;Age Years;Aging;Ankle;Aorta;arterial stiffness;Automobile Driving;Baltimore;biological age;Biomedical Engineering;Blood Pressure;Blood Vessels;Body Size;Body System;Bone Density;calcification;Calibration;Cardiac;cardiac aging;Cardiac Output;cardioprotection;Cardiovascular Diseases;cardiovascular risk factor;Cardiovascular system;Carotid Arteries;Cells;Central obesity;Characteristics;Clinical;cognitive function;cohort;Collaborations;Communities;comorbidity;Complex;Computer software;Coronary;coronary calcium scoring;Coupling;COVID-19 mortality;Data;design;Deterioration;Disease;Doppler Echocardiography;Echocardiography;Elderly;electric impedance;Endothelium;Environment;Erythropoietin;Event;Exercise;Fatty acid glycerol esters;Fibrosis;follow-up;frailty;Functional disorder;functional status;Future;Genes;Genetic;Genetic Determinism;genetic element;Genome;Geometry;Health;healthspan;Heart;Heart failure;heart function;Human;Hypothyroidism;indexing;Individual;Inflammation;Insulin-Like Growth Factor I;International;intimal medial thickening;Intramural Research Program;Laboratories;Left ventricular structure;Life;Life Style;Link;Longitudinal Studies;Magnetic Resonance Imaging;mathematical analysis;Measurement;Measures;Mechanics;Medial;Mediating;Mission;mitochondrial dysfunction;Modification;Muscle;Myocardial;Myocarditis;Nature;neglect;novel;Obesity;older patient;outcome prediction;Oxygen;Oxygen Consumption;Paper;Participant;Pattern;Performance;Peripheral;Peripheral arterial disease;Persons;Phenotype;Physical Fitness;Physiological;Play;Population;Postdoctoral Fellow;preservation;pressure;Prevention;Prevention strategy;Production;programs;Property;protein aminoacid sequence;proteostasis loss;Publishing;rate of aging;recruit;Reporting;Research;Research Project Grants;Risk Factors;Role;Sampling;Sardinia;Signal Transduction;Structure;subcutaneous;Testing;Thick;Tissues;tonometry;tool;Training;trait;translational study;Triglycerides;uptake;validation studies;Ventricular;Visceral;Visit;Vitamin D;VO2max;Work,Age Associated Changes In Structural And Functional Cardio-Vascular  Properties,856,NA,NA,NA,NA,23,NA,NA,20856,NA
11177486,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000869,NA,NA,1ZIAAG000869-17,NIA:1077564\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,age effect;age related;Aging;Agonist;Atrial Natriuretic Factor;Binding;Blood Pressure;blood pressure control;blood pressure elevation;Blood Vessels;Cardiac;Cardiovascular system;cell age;Cells;Collagen;Cyclic GMP;Development;Down-Regulation;Elderly;Excretory function;Exhibits;experimental study;Fibrosis;Friend leukemia;Genes;Goals;Hypertension;hypertensives;Impairment;inhibitor;Intake;Investigation;Kidney;kidney fibrosis;Lead;male;marinobufagenin;Na(+)-K(+)-Exchanging ATPase;Natriuretic Peptides;normotensive;Nuclear;Pathogenesis;prevent;Production;Protein Isoforms;Rattus;Renal tubule structure;response;salt sensitive;Sarcolemma;Signal Transduction;Smooth Muscle Myocytes;Sodium;Sodium Chloride;Sprague-Dawley Rats;Testing;therapeutic target;transcription factor;Vascular Smooth Muscle;Vasoconstrictor Agents;Western Blotting,Marinobufagenin as a therapeutic target,869,NA,NA,NA,NA,17,NA,NA,1077564,NA
11177487,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000928,NA,NA,1ZIAAG000928-14,NIA:1984624\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,Address;Affect;aldehyde dehydrogenases;Area;Axon;Behavior;Behavior Control;Behavioral;Binding;Brain;Calcium;Calcium Signaling;Chloride Channels;Corpus striatum structure;Coupled;Crossbreeding;Cues;cytotoxic;designer receptors exclusively activated by designer drugs;Development;Dopamine;dopaminergic neuron;Etiology;Failure;Feedback;GABA-B Receptor;Genetic;genetic manipulation;Glutamates;Head;Image;Implant;in vivo;insight;Investigation;Knock-in Mouse;Knowledge;Learning;Light;light gated;Maps;Mediating;Memory;Methods;Molecular;Monitor;Motivation;Motor;motor control;motor learning;motor skill learning;Motor Skills;Movement;Mus;neuronal excitability;Neurons;Neurotransmitters;NMDA receptor A1;novel therapeutic intervention;optical fiber;optogenetics;Outcome;Parkinson Disease;pars compacta;Pathogenesis;Patients;Pattern;Performance;Physiological;Play;Population;Predisposition;presynaptic;Process;receptor;receptor expression;Regulation;Research;Resolution;response;Rewards;Role;selective expression;Sensory;Signal Transduction;Silicones;Slice;Source;Substantia nigra structure;Task Performances;Techniques;temporal measurement;Time;treadmill;two-photon;Viral Vector;virtual;Walking,Function and Regulation of ALDH1A1-positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson's disease,928,NA,NA,NA,NA,14,NA,NA,1984624,NA
11177488,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000929,NA,NA,1ZIAAG000929-14,NIA:260975\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,2-arachidonylglycerol;Adult;Affect;Anabolism;anandamide;Animal Model;Astrocytes;Basal Ganglia;Behavior;behavior test;Behavioral;biological adaptation to stress;Brain;brain cell;Brain region;Breeding;Calcium;Cells;China;Chinese;Clustered Regularly Interspaced Short Palindromic Repeats;CNR1 gene;conditional knockout;Corpus striatum structure;Coupled;Data;Dendrites;Development;Disease;Dopamine;dopaminergic neuron;Dorsal;Drug usage;early onset;endocannabinoid signaling;Endocannabinoids;endogenous cannabinoid system;Enzymes;experimental study;Fiber;Functional disorder;Genes;GTP-Binding Proteins;Homologous Gene;Hospitals;Human;Immune response;Impairment;improved;Inflammation;innovation;insight;knock-down;Knockout Mice;Learning;lipoprotein lipase;loss of function mutation;Mediating;Memory;Microglia;Midbrain structure;Motivation;Motor;motor control;motor learning;motor skill learning;Movement;Mus;Mutation;Neuromodulator;neuronal cell body;Neurons;neurotransmitter release;Parkinson Disease;pars compacta;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Performance;Photometry;Physiological Processes;Play;presynaptic;Presynaptic Terminals;prevent;Production;professor;receptor;Research;response;Rod;Role;Rotation;Signal Transduction;Substantia nigra structure;Technology;Testing;time use;transcriptome sequencing;transmission process;treatment strategy;Universities;Ventral Tegmental Area,Function and Pathogenic Mechanism of endocannabinoid synthase DAGLB in Parkinson's Disease,929,NA,NA,NA,NA,14,NA,NA,260975,NA
11177489,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000931,NA,NA,1ZIAAG000931-06,NIA:321244\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,Address;Age;age related neurodegeneration;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Biology;Cell Aging;cell type;Cells;Chromatin;cohort;Data;Dementia;Disease;DNA Methylation;donor stem cell;dopaminergic neuron;Enrollment;Environment;Environmental Exposure;epigenetic clock;epigenetic marker;Epigenetic Process;Event;experimental study;Gene Expression;Genes;Genetic;genetic makeup;genetic risk factor;genetic variant;Genetic Variation;Genome;genome editing;genome wide association study;genome-wide;genome-wide analysis;Human;Human Genetics;Individual;induced pluripotent stem cell;Inherited;Laboratories;large datasets;lifetime risk;Link;Linkage Disequilibrium;Maps;Measures;Mediating;Methylation;Microglia;Modification;Molecular;Neurodegenerative Disorders;Neurons;non-genetic;Output;Parkinson Disease;Peripheral Blood Mononuclear Cell;Phenotype;pluripotency;Population;Population Genetics;Productivity;Quality Control;Quantitative Trait Loci;Research Project Grants;Resources;Risk;Symptoms;System;Testing;trait;transcriptome sequencing;transcriptomics;Translations;Variant;whole genome,ALZHEIMERS RESEARCH PROJECT:  Genetic Variants Associated with Alzheimer's disease and Related Dementias,931,NA,NA,NA,NA,6,NA,NA,321244,NA
11177490,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000932,NA,NA,1ZIAAG000932-17,NIA:339874\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,advanced analytics;Africa;Africa South of the Sahara;Aging;American;Base Pairing;Biological;Biological Assay;Brain;Brain region;brain tissue;Cataloging;Catalogs;Cells;Chromatin;Copy Number Polymorphism;Data;data integration;data management;Data Set;Disease;DNA Methylation;dopaminergic neuron;Epigenetic Process;epigenome;epigenome-wide association studies;exome sequencing;Foundations;Founder Effect;Genetic;Genetic Transcription;genetic variant;Genetic Variation;genome sequencing;genome wide association study;genome-wide;genomic variation;Genomics;Genotype;Geography;Goals;Haplotypes;Human;Human Genetics;Individual;induced pluripotent stem cell;interest;Linkage Disequilibrium;Methylation;Modification;Molecular;Pathway interactions;Pattern;Phase;Population;Quantitative Trait Loci;Regulation;Role;Sampling;Site;SNP genotyping;Structure;Tissues;trait;transcriptome sequencing;transcriptomics;Variant;whole genome;Work,Characterization of Normal Genomic Variability,932,NA,NA,NA,NA,17,NA,NA,339874,NA
11177491,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000933,NA,NA,1ZIAAG000933-17,NIA:315598\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,10268509 (contact),"TRAYNOR, BRYAN  (contact)",NA,NA,NA,Accounting;Adolescent;Affect;Age;age related decline;Aging;Alzheimer&apos;s Disease;American;Amyotrophic Lateral Sclerosis;Base Pairing;Bioinformatics;C9ORF72;Cholesterol;Chromosome 9;Clinical;clinical diagnosis;clinical subtypes;cohort;Collaborations;computing resources;Cost Savings;Data;Dementia;Development;Diagnosis;Disease;disease diagnosis;Disease Progression;DNA;effective therapy;European;familial amyotrophic lateral sclerosis;Family;Frontotemporal Dementia;frontotemporal lobar dementia amyotrophic lateral sclerosis;gain of function;gene discovery;gene-targeted therapy;Genes;Genetic;Genetic Predisposition to Disease;genome sequencing;genome wide association study;Genomics;Genotype;Health Care Costs;innovation;Italy;Journals;Laboratories;late life;Link;Machine Learning;Massachusetts;Medicine;Mendelian randomization;Mobility decline;Molecular;Motor;motor neuron degeneration;Mutation;Myasthenia Gravis;National Institute on Aging;Nerve Degeneration;Nervous System Disorder;Neurodegenerative Disorders;neurogenetics;Neuromuscular Diseases;Neurons;New England;next generation sequencing;novel therapeutics;Paper;Paralysed;Pathologic;Pathway Analysis;Pathway interactions;Patients;Population;Publications;Publishing;Recording of previous events;recruit;Research;Research Subjects;Respiratory Failure;Risk Factors;Role;Sampling;Technology;Therapeutic Agents;therapeutic development;therapeutic target;Time;United States National Institutes of Health;Universities;Western World;whole genome;Work,Genetic etiology of Amyotrophic Lateral Sclerosis,933,NA,NA,NA,NA,17,NA,NA,315598,NA
11177492,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000934,NA,NA,1ZIAAG000934-16,NIA:151598\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,10268509 (contact),"TRAYNOR, BRYAN  (contact)",NA,NA,NA,Accounting;Affect;Age;ALS patients;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;American;Amyotrophic Lateral Sclerosis;Base Pairing;C9ORF72;Chromosome 9;Clinical;clinical diagnosis;cohort;Cost Savings;Data;Dementia;Disease;disease diagnosis;DNA;effective therapy;Epidemiology;European;Family;Frontotemporal Dementia;frontotemporal lobar dementia amyotrophic lateral sclerosis;gene-targeted therapy;Genes;Genetic;Genetic Predisposition to Disease;genetic variant;Health Care Costs;innovation;Journals;Laboratories;late life;Link;Lobe;Medicine;Molecular;Mutation;National Institute on Aging;Nervous System Disorder;Neurodegenerative Disorders;neurogenetics;Neuromuscular Diseases;Neurons;New England;next generation sequencing;Paper;Paralysed;Pathogenesis;Pathologic;Patients;Population;Publications;Publishing;Recording of previous events;Research;Research Project Grants;Respiratory Failure;Technology;therapeutic target;Time;Ubiquitin;United States National Institutes of Health;Variant;Western World;whole genome;Work,"ALZHEIMERS RESEARCH PROJECT: Genetic etiology of Fronto-Temporal Dementia, a dementia related to Alzheimer's disease",934,NA,NA,NA,NA,16,NA,NA,151598,NA
11177493,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000936,NA,NA,1ZIAAG000936-08,NIA:83018\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,15265844 (contact),"MASLIAH, ELIEZER  (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;adaptive immunity;Advanced Development;age effect;aged;Aging;aging population;aging process;alpha synuclein;Alpha-Synuclein transgenic mouse;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Amyloid beta-Protein;Animal Model;Animals;Antibodies;Antigen-Presenting Cells;Antigens;Apolipoprotein E;Astrocytes;Astrocytosis;Behavioral;Binding;Brain;Candidate Disease Gene;CCL4 gene;CD3 Antigens;CD8-Positive T-Lymphocytes;Cell Aging;Cell model;Cell Nucleus;cell type;Cells;Chromatin;Collaborations;Combination immunotherapy;combinatorial;comparison control;conformer;CSF1 gene;CSF1R gene;CSF2 gene;cytokine;data integration;Dementia with Lewy Bodies;Dependovirus;Disease;DNA Damage;epigenomics;Exhibits;Experimental Animal Model;experimental study;extracellular;Functional disorder;Gene Expression Profile;Genes;genetic architecture;Genetic Predisposition to Disease;Genetic Risk;genetic risk factor;Genetic Transcription;Genetically Engineered Mouse;Germany;glial activation;Glial Fibrillary Acidic Protein;Gliosis;Glycoproteins;Goals;Human;human tissue;Hybrids;Immune;immune modulating agents;Immune system;Immunoglobulin G;Immunologic Receptors;immunomodulatory therapies;immunoregulation;Immunotherapeutic agent;Immunotherapy;improved;In Vitro;in vitro Model;in vivo Model;induced pluripotent stem cell;Infiltration;Inflammation;Inflammatory;Inflammatory Response;Innate Immune Response;interest;Interferon Type II;Interleukin-6;Label;Laboratories;Lewy Body Disease;Link;Lipids;LRRK2 gene;Manuscripts;MAP Kinase Gene;Maps;Mediating;Mediator;member;Methods;Microglia;Modeling;Molecular;Molecular Profiling;Motor;motor deficit;Mouse Strains;Multiomic Data;multiple omics;Mus;Mutation;Natural Immunity;Nerve Degeneration;neurogenetics;Neuroimmune;Neuroimmune system;neuroinflammation;neuron loss;Neuronal Differentiation;Neurons;neuropathology;neurotoxic;NF-kappa B;novel;nuclear factors of activated T-cells;Nuclear Translocation;overexpression;p38 Mitogen Activated Protein Kinase;Paper;Parkinson Disease;Pathogenesis;Pathology;Pathway interactions;Patients;pharmacologic;Phenotype;Phosphorylation;Phosphotransferases;Play;Preparation;Production;promoter;protein aggregation;protein TDP-43;Proteins;proteostasis;Publishing;receptor;Regulatory Element;Reporter;Research;Resolution;response;risk variant;Role;Science;Serotyping;Signal Pathway;Signal Transduction;small hairpin RNA;small molecule;South Korea;Substantia nigra structure;Susceptibility Gene;Synapses;synuclein;synucleinopathy;System;T cell infiltration;T cell response;T-Cell Receptor;T-Lymphocyte;targeted treatment;tau Proteins;Testing;Therapeutic;therapeutic target;therapeutically effective;therapy development;TLR2 gene;Toll-like receptors;transcription factor;transcriptomics;Transgenic Mice;translational medicine;Translational Research,Alzheimers Disease Project: Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population,936,NA,NA,NA,NA,8,NA,NA,83018,NA
11177494,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000937,NA,NA,1ZIAAG000937-15,NIA:309528\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,Affect;Affinity;age related;AGFG1 gene;Astrocytes;Binding;Cells;Collaborations;Cryoelectron Microscopy;design;Goals;GTP Binding;Guanosine Triphosphate;Guanosine Triphosphate Phosphohydrolases;Inherited;Intracellular Membranes;Laboratories;LRRK2 gene;Lysosomes;Mus;Mutation;Parkinson Disease;Penetrance;Phosphorylation;Phosphotransferases;protein protein interaction;Proteins;recruit;Role;Signal Pathway;Stimulus;Structure;Work,GTPase function of Leucine rich repeat kinase 2,937,NA,NA,NA,NA,15,NA,NA,309528,NA
11177495,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000939,NA,NA,1ZIAAG000939-17,NIA:855755\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,Affect;alpha synuclein;Back;Brain;Collection;Dementia;Deposition;Disease;Disease Marker;Disease Progression;Evaluation;Functional disorder;Genes;Goals;Incidence;induced pluripotent stem cell;Lewy Bodies;Methodology;Mutation;Neurons;Parkinson Disease;Pathologic;Phosphorylation;Play;protein aggregation;Proteins;Resources;Role;screening;Structure;Techniques;Time;Tissues;Toxic effect;Work,"Alpha Synuclein, cellular dysfunction and Parkinson disease",939,NA,NA,NA,NA,17,NA,NA,855755,NA
11177496,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000943,NA,NA,1ZIAAG000943-16,NIA:722233\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,Affect;Aging;Anatomy;Attention;Autopsy;Behavioral;Brain;Classification;Compensation;Complex;Cues;design;Disease;Dopamine;dopaminergic neuron;Gene Expression Profile;Genetic Markers;Genetic Variation;Individual;innovation;insight;Investigation;Knowledge;Link;Memory;Midbrain structure;Molecular;Molecular Genetics;molecular marker;Motivation;Motor;motor control;motor skill learning;motor symptom;Movement;neuron loss;Neuronal Dysfunction;Neurons;neuroregulation;non-motor symptom;Parkinson Disease;pars compacta;Pathway interactions;Patients;Pattern;Play;presynaptic;Procedures;Regulation;Research;Research Personnel;response;reward processing;Rewards;Role;segregation;Sensory;single-cell RNA sequencing;SOX6 gene;Stimulus;Substantia nigra structure;Technology;Ventral Striatum;Ventral Tegmental Area,Pathophysiological Study of ALDH1A1-negative Nigrostriatal Dopaminergic Neuron Subtypes in Parkinson's disease,943,NA,NA,NA,NA,16,NA,NA,722233,NA
11177497,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000944,NA,NA,1ZIAAG000944-17,NIA:200283\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,Affect;Area;Axon;Binding;Calcium;Categories;comparison control;Control Groups;Corpus striatum structure;Dendrimers;Dendrites;Dopamine;dopaminergic neuron;Dorsal;Drops;Engineering;Exhibits;Feedback;Fiber;Functional disorder;GABA-B Receptor;Genetic;Genetically Engineered Mouse;Globus Pallidus;improved;insight;Learning;Light;LRRK2 gene;Monitor;motor control;motor learning;motor skill learning;Mus;nerve supply;Neurons;optogenetics;Parkinson Disease;pars compacta;Pathway interactions;Pattern;Photometry;Physiological;Play;Presynaptic Terminals;Process;protein biomarkers;Regulation;response;Role;Rotarod Performance Test;Signal Transduction;striosome;Structure;Substantia nigra structure;Techniques;Time;Training;Viral Vector,Striosome Microcircuit Critical for Motor Skill Learning,944,NA,NA,NA,NA,17,NA,NA,200283,NA
11177498,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000945,NA,NA,1ZIAAG000945-17,NIA:430912\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,Adult;Age;Anabolism;Area;Brain;brain cell;Brain region;Corpus striatum structure;Crossbreeding;Dietary Supplementation;Dorsal;Equilibrium;Exhibits;experience;experimental study;Future;Gene Expression;Genetic;Globus Pallidus;Imaging Techniques;improved;Individual;insight;Investigation;Learning Difficulty;Mediating;Methods;Modeling;Modification;motor learning;motor skill learning;Motor Skills;mouse model;Movement;Mus;neuron development;neuron loss;Neurons;Opioid Receptor;optogenetics;Parkinson Disease;Pathogenesis;Pathway interactions;postnatal;postsynaptic;Rotarod Performance Test;single nucleus RNA-sequencing;Stains;striosome;Substantia nigra structure;Synapses;Techniques;Therapeutic;Tretinoin;Up-Regulation,Alterations of Striatal Projection Neurons in Parkinson's disease,945,NA,NA,NA,NA,17,NA,NA,430912,NA
11177499,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000946,NA,NA,1ZIAAG000946-17,NIA:12138\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,alpha synuclein;Alzheimer&apos;s Disease;Amino Acid Substitution;Amyotrophic Lateral Sclerosis;autosome;Axon;Axonal Transport;Base Pairing;Binding;biological adaptation to stress;Brain;Cell Death;Cell Nucleus;Cells;Chemicals;Complex;Corpus striatum structure;Cytoplasm;Cytoskeleton;Cytoskeleton Alteration;DCTN2 gene;Deposition;dimer;DNA Sequence Alteration;Dopamine;dopamine transporter;dopaminergic neuron;dynactin;Dynein ATPase;early embryonic stage;Endoplasmic Reticulum;Functional disorder;Genes;Glycine;Health;Huntington Disease;Hypoventilation;Impairment;in vitro Assay;in vivo;Inflammation;insight;Intracellular Transport;Investigation;Kinesin;Knock-in;Knockout Mice;Link;link protein;Lower Motor Neuron Disease;Mediating;Mental Depression;Microtubules;Midbrain structure;Missense Mutation;Mitosis;Mitotic spindle;Molecular;Motor;motor neuron degeneration;Motor Neuron Disease;Motor Neurons;Movement;Mus;Mutant Strains Mice;Mutation;Nerve Degeneration;Nerve Endings;Nerve Fibers;Nervous System Disorder;Neurodegenerative Disorders;neuron loss;neuronal survival;Neurons;old mice;overexpression;Parkinson Disease;Pathogenicity;Play;Positioning Attribute;Process;Property;protein complex;Protein Export Pathway;Proteins;Research;retrograde transport;Role;Sensory;Serine;Shapes;Signal Transduction;Spinal;Structure;Swelling;Symptoms;Syndrome;TNFRSF5 gene;Transgenic Mice,Pathogenic Mechanisms of Dynactin p150glued in ALS and Parkinson's Disease,946,NA,NA,NA,NA,17,NA,NA,12138,NA
11177500,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000947,NA,NA,1ZIAAG000947-17,NIA:139591\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,Affect;age related neurodegeneration;Alzheimer&apos;s Disease;Area;ATAC-seq;Biological;Biological Models;Brain;Brain region;cell type;Cells;Chromatin;Code;Data;Data Set;Disease;Epigenetic Process;Frontotemporal Dementia;Gene Expression;Genes;Genetic;genetic variant;Genetic Variation;Goals;Human;interest;LRRK2 gene;Measures;Messenger RNA;Methods;Microglia;MicroRNAs;Mutation;Nerve Degeneration;novel;Parkinson Disease;Pattern;Phenotype;Proteins;Research;Series;transcriptome sequencing;Variant;Work,Gene expression in the human brain,947,NA,NA,NA,NA,17,NA,NA,139591,NA
11177501,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000948,NA,NA,1ZIAAG000948-17,NIA:1013554\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,AGFG1 gene;Biological;Biological Models;Cells;Clinical Trials;Data;Endoplasmic Reticulum;Genetic;Growth;Inherited;interest;LRRK2 gene;Lysosomes;Measures;Membrane;Microtubules;mutant;Mutation;Names;new therapeutic target;Parents;Parkinson Disease;pharmacologic;Phosphorylation;Phosphotransferases;Process;protein complex;Proteins;recruit;Research;Sorting;Stimulus;tool,Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease,948,NA,NA,NA,NA,17,NA,NA,1013554,NA
11177502,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000949,NA,NA,1ZIAAG000949-19,NIA:1080315\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,advanced analytics;base;Cloud Computing;Code;cohort;Communities;comorbidity;Complex;computerized data processing;computing resources;Data;data harmonization;Data Set;density;Disease;disease-causing mutation;DNA sequencing;Genes;Genetic;genetic architecture;Genetic Risk;genome sequencing;genome wide association study;genome-wide;Genomic Segment;Genotype;Heritability;Individual;insight;interest;Neurodegenerative Disorders;novel;Parkinson Disease;Population;Population Heterogeneity;pre-clinical;programs;Research;Research Personnel;Resources;Risk Assessment;Risk Factors;risk variant;Science;sex;Time;Tissues;volunteer;whole genome;Work,Genome wide SNP analysis in Parkinson's disease,949,NA,NA,NA,NA,19,NA,NA,1080315,NA
11177503,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000953,NA,NA,1ZIAAG000953-23,NIA:315598\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691135 (contact),"COOKSON, MARK  (contact)",NA,NA,NA,Address;Aging;Area;Bacteria;Cells;Clinical;Drug Metabolic Detoxication;Enzymes;Family;Genes;Goals;hexokinase;Human;interest;Lactoylglutathione Lyase;Mitochondria;Modeling;Molecular;Mutation;Nature;oxidative damage;Oxidative Stress;PARK7 gene;Parkinson Disease;Play;Proteins;Recombinants;Regulation;response;Role;Tissues;Work,DJ-1 and hexokinases,953,NA,NA,NA,NA,23,NA,NA,315598,NA
11177504,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000957,NA,NA,1ZIAAG000957-22,NIA:1553712\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,Age;alpha synuclein;Alzheimer&apos;s Disease;Ataxia;CTSB gene;Data;Disease;Dystonia;experimental study;Family;Frontotemporal Dementia;Gene Expression;Genes;Genetic;genome sequencing;genome wide association study;Individual;induced pluripotent stem cell;insight;Link;LRRK2 gene;Manuscripts;Maps;Modeling;Molecular;Molecular Biology;Motor Neuron Disease;Multiple System Atrophy;Mutation;Nature;Nervous System Disorder;novel;Onset of illness;Outcome;Parkinson Disease;Primary Lateral Sclerosis;Process;Reporting;Risk;risk variant;Role;structural biology;System;tool;Validation;Variant;whole genome;Work,Assessment of Candidate Loci in Neurological diseases,957,NA,NA,NA,NA,22,NA,NA,1553712,NA
11177505,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000958,NA,NA,1ZIAAG000958-22,NIA:946793\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691113 (contact),"SINGLETON, ANDREW  (contact)",NA,NA,NA,Acceleration;Alzheimer&apos;s Disease;Amyotrophic Lateral Sclerosis;arm;Ataxia;autosome;Data;Dementia;Disease;DNA Sequence Alteration;Dystonia;Essential Tremor;exome sequencing;Family;Frontotemporal Dementia;Genes;Genetic;genetic analysis;genetic architecture;Genetic Diseases;genome sequencing;genomic locus;Genotype;Medicine;Movement Disorders;Mutation;Nervous System Disorder;novel;Parents;Parkinson Disease;Patients;Phenotype;Probability;programs;public-private partnership;Recording of previous events;Sampling;Science;tool;volunteer;whole genome;Work,Genetic analysis in families with neurological disease,958,NA,NA,NA,NA,22,NA,NA,946793,NA
11177506,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000959,NA,NA,1ZIAAG000959-21,NIA:637265\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691131 (contact),"CAI, HUAIBIN  (contact)",NA,NA,NA,Ablation;Acceleration;Cell Nucleus;Corpus striatum structure;Darkness;Deceleration;Discrimination;dopaminergic neuron;Dorsal;Genetic;Light;Link;Locomotion;Mediating;Motivation;Motor;motor control;mouse model;Movement;Movement Disorders;Mus;Neurons;Optics;Parkinson Disease;Pathway interactions;Positioning Attribute;response;Speed;striosome;Structure;Testing;walking speed,Striosomes Constrain Locomotor Vigor in Parkinson's disease and Other Movement Disorders,959,NA,NA,NA,NA,21,NA,NA,637265,NA
11177507,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000960,NA,NA,1ZIAAG000960-16,NIA:134176\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8841542 (contact),"CHIA, CHEE W (contact)",NA,NA,NA,21 year old;Agonist;animal data;antagonist;Beta Cell;blood glucose regulation;Brain;cannabinoid receptor;Clinical;CNR1 gene;Cross-Over Studies;Dose;Double-Blind Method;Drug usage;Endocannabinoids;endogenous cannabinoid system;Food;Functional Magnetic Resonance Imaging;Glucose;Glucose Clamp;Homeostasis;hormone regulation;Human;Human Biology;Hyperglycemia;Image;improved;Insulin;insulin secretion;insulin sensitivity;Intervention;Islets of Langerhans;Medical;men;Nabilone;Non-Insulin-Dependent Diabetes Mellitus;novel;OGTT;Outcome;pancreatic juice;Peripheral;Persons;Pharmaceutical Preparations;Placebo Control;Placebos;pre-clinical;Procedures;Randomized;recruit;Regulation;Research Design;response;Role;Tissues;virtual;Visit;visual stimulus,CLINICAL PROJECT:  The endogenous cannabinoid system and glucose homeostasis,960,NA,NA,NA,NA,16,NA,NA,134176,NA
11177508,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000961,NA,NA,1ZIAAG000961-19,NIA:30964\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8841542 (contact),"CHIA, CHEE W (contact)",NA,NA,NA,1 year old;Adult;Adverse effects;Adverse event;age related decline;aged;Arthralgia;Atrophic;Autoimmunity;Bone Density;Bone Marrow;Carpal Tunnel Syndrome;Cellularity;Clinical;Clinical Research;clinically relevant;Data;Data Analyses;Diabetes Mellitus;Dose;Edema;Elderly;Endocrine system;Fatty acid glycerol esters;Female;Frequencies;Future;Glucose Intolerance;Growth;healthy aging;Hormone use;Human;human subject;Hypophysectomy;Immune;immune function;Immune response;Immune system;Incidence;Individual;Infection;Infiltration;Infusion Pumps;Injections;interest;lean body mass;Life;Link;male;Malignant Neoplasms;metabolic profile;Morbidity - disease rate;mortality;Mus;Muscle;Persons;Physiological;Pituitary Gland;Process;Production;progenitor;r-hGH-M;Rattus;recruit;Rodent;Role;side effect;Somatotropin;subcutaneous;T-Lymphocyte;theories;Thymus Gland;Thymus Hyperplasia,CLNICAL PROJECT:  Growth Hormone Administration and the Human Immune System,961,NA,NA,NA,NA,19,NA,NA,30964,NA
11177509,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000969,NA,NA,1ZIAAG000969-17,NIA:30964\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,age group;Anemia;Clinical;Development;Diagnostic;Dysmyelopoietic Syndromes;Elderly;Frequencies;Goals;improved;Inflammation;Kidney Failure;late life;Patients;Physical Function;Physical Performance;Population;Quality of life;Research;stem cells;Testosterone;Therapeutic;young adult,CLINICAL PROJECT:  Understanding Late Life Anemia,969,NA,NA,NA,NA,17,NA,NA,30964,NA
11177510,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000985,NA,NA,1ZIAAG000985-03,NIA:204190\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691047 (contact),"BROSH, ROBERT  (contact)",NA,NA,NA,3-Dimensional;Adenine;Antibodies;Apoptosis;Base Pairing;Binding;Biochemical;Biological;cancer therapy;carboxylate;Cell Aging;Cell Cycle Arrest;Cell Death;Cell Line;cell type;Cells;Centromere;chemical bond;Chromosomes;Clustered Regularly Interspaced Short Palindromic Repeats;Computational algorithm;Cytosine;Detection;DNA;DNA biosynthesis;DNA Damage;DNA fiber assay;DNA Polymerase I;DNA Sequence;DNA Structure;DNA-Directed DNA Polymerase;Enzyme Interaction;Escherichia coli;experimental study;G-Quartets;Gene Expression;Genes;Genomics;Guanine;helicase;Human;Human Genome;Immunofluorescence Immunologic;In Vitro;in vivo;intercalation;Investigation;Knock-out;Ligands;Metabolic Pathway;Metabolism;Molecular;mutant;novel;pharmacologic;Phenotype;preservation;prevent;promoter;Promoter Regions;Proteins;Reagent;Recombinants;Regulation;Reporting;Research;Resolution;response;senescence;single walled carbon nanotube;skills;small molecule;Structure;Techniques;Telomerase;telomere;TERF1 gene;Testing;Thymine;Work,Investigation of Intercalated (I) Motif DNA Structure at Telomeric Cytosine-Rich Strand in Human Cells Genetically Altered for DNA Helicases,985,NA,NA,NA,NA,3,NA,NA,204190,NA
11177511,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000988,NA,NA,1ZIAAG000988-08,NIA:199451\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8158694 (contact),"EVANS, MICHELE K (contact)",NA,NA,NA,"accelerated epigenetic aging;Acceleration;adverse childhood events;Affect;African American;African American population;Age;age acceleration;age effect;age-related disease;Aging;aging clocks;Animal Model;anti aging;Baltimore;base;Biological;biological age;Biological Aging;Biological Markers;Biology;bisulfite;Blinded;Blood;Caucasians;cell type;Chronology;Clinical;Cognitive;cohort;Cohort Studies;CpG dinucleotide;Cytosine;Data;Demographic Factors;deprivation;Development;DNA;DNA Methylation;Education;Environmental Exposure;environmental stressor;epidemiology study;Epigenetic age;epigenetic aging;Epigenetic Process;epigenome;epigenomics;European ancestry;Female;fitness;Gene Expression Regulation;Genetic;Genetic Variation;genome-wide;Genomics;Health;health care availability;health disparity;health outcome disparity;healthspan;healthy aging;Household;Human;human model;human old age (65+);Income;Individual;late life;Lead;Life Experience;life span;lifestyle factors;Linear Regressions;Liver;Longitudinal cohort study;male;Measures;men;Methods;Methylation;methylation biomarker;middle age;Minority Groups;Modeling;Morbidity - disease rate;mortality;Neighborhoods;Obesity;Outcome;Participant;Peripheral Blood Mononuclear Cell;Phenotype;poor health outcome;Population;Positioning Attribute;Poverty;premature;Process;Psychosocial Stress;Publications;Race;racial diversity;randomized, clinical trials;rate of aging;Regression Analysis;Residual state;Role;Sampling;senolytics;sex;Site;social;Social Class;social health determinants;Socioeconomic Status;socioeconomics;Specific qualifier value;stressor;Structural Racism;Students;Time;Tissues;Visit;Whole Blood;Woman;Work",Effects of race and socioeconomic status on the epigenetic aging clock,988,NA,NA,NA,NA,8,NA,NA,199451,NA
11177512,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000989,NA,NA,1ZIAAG000989-08,NIA:557290\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8158694 (contact),"EVANS, MICHELE K (contact)",NA,NA,NA,Adult;African American;African American population;Age;age acceleration;age group;age related chronic disease;age-related disease;Alzheimer&apos;s Disease;Biological;biological age;Biological Assay;Biological Markers;Cancer Patient;Cardiovascular Diseases;CCL2 gene;Cells;Cessation of life;chemokine;Chronic;Chronic Disease;chronic inflammatory disease;Circulation;Communication;COVID-19 pandemic;cytokine;Data;Death Rate;design;Diagnosis;Diagnostic;diagnostic development;Disease;Disparity;E-Selectin;Epidemiology;Ethnic Population;Etiology;exosome;extracellular vesicles;Fibrinogen;frailty;Gene Expression;genetic information;Health;health disparity;healthy aging;Human;Immune response;in utero;Individual;Inflammation;Inflammatory;inflammatory marker;intercellular communication;Interferon Type II;Interleukin-6;Interleukins;Laboratories;Life Expectancy;life span;Link;link protein;Longevity;Longitudinal Studies;low socioeconomic status;Malignant Neoplasms;Medical;men;Messenger RNA;Metabolic Diseases;Methods;MicroRNAs;microvesicles;middle age;Minority;Molecular;mortality;mortality risk;Mothers;Mutation;Neighborhoods;Neurodegenerative Disorders;normal aging;Nucleic Acids;Outcome;P-Selectin;Paper;Participant;Pathologic;Pathway interactions;Phenotype;Physiological;Play;Population;population based;Population Sciences;Populations at Risk;Poverty;Preparation;Probability;Proteins;Race;racial population;receptor;receptor for advanced glycation endproducts;Research;Risk;Risk Factors;RNA;Role;senescence;senescence associated secretory phenotype;senescent cell;Serum;Serum Proteins;sex;Technology;Therapeutic;TNF gene;Translating;trend;United States;Untranslated RNA;Vesicle;Woman;Work,Characterization of Serum Extracellular Vesicles with Human Age,989,NA,NA,NA,NA,8,NA,NA,557290,NA
11177513,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000992,NA,NA,1ZIAAG000992-08,NIA:178770\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,15186888 (contact),"BEERMAN, ISABEL  (contact)",NA,NA,NA,Adult;Age;age related;age related changes;Aging;Animals;Attenuated;Autoimmunity;Automobile Driving;Biological;Biological Models;Blood;Breeding;candidate identification;Categories;Cell Aging;Cell Compartmentation;Cells;Disease;DNA Damage;DNA Methylation;DNA Repair;Dysmyelopoietic Syndromes;Epigenetic Process;epigenetic regulation;experimental study;falls;Genes;Hematopoietic;hematopoietic stem cell aging;Hematopoietic stem cells;Homeostasis;Human;interest;Intervention;leukemia;Lymphoid;Maintenance;mouse model;Mus;nonhuman primate;Norway;Pathway interactions;Phenotype;prevent;primitive cell;Rattus norvegicus;Recording of previous events;regeneration potential;Research;response;restoration;sex;Solid;stem cell aging;stem cells;System;targeted treatment;Therapeutic Intervention;therapeutic target;Work,"Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic intervention",992,NA,NA,NA,NA,8,NA,NA,178770,NA
11177514,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000994,NA,NA,1ZIAAG000994-09,NIA:2323536\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6978327 (contact),"GREIG, NIGEL H. (contact)",NA,NA,NA,3xTg-AD mouse;Acceleration;Acute;Adult;Adverse effects;Affect;Age;age-related disease;Aging;aging brain;aging related disease;Alzheimer&apos;s Disease;Alzheimer&apos;s disease brain;Alzheimer&apos;s disease model;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease related dementia;Amyloid;Amyloid beta-Protein;analog;Animal Model;Animals;Anti-Inflammatory Agents;antiangiogenesis therapy;Antineoplastic Agents;Antioxidants;Appearance;Atrophic;Automobile Driving;Back;Behavioral;Binding;Blood Vessels;Brain;Cell Death;Cell model;Cell Transplantation;Cells;cerebral atrophy;Cerebrovascular system;Chemistry;Chick Embryo;Chronic;Clinic;Clinical;Clinical Research;clinical translation;Clinical Trials;Cognitive deficits;combat;Complex;course development;cytokine;cytokine release syndrome;Degenerative Disorder;Dementia;Deposition;Detection;Development;Disease;Disease Progression;DNA Damage;Dose;Drug Kinetics;Drug Targeting;drug-like compound;effective therapy;efficacy evaluation;Elderly;Elements;Embryo;entorhinal cortex;Evaluation;Event;Excision;Failure;Generations;Genes;glial activation;Growth;hallmarks of aging;healing;Human;Impaired cognition;Impairment;in utero;in vivo;Inflammation;Inflammatory;Innate Immune System;Interruption;Intervention;Ischemic Stroke;Knowledge;Legal patent;Libraries;Lipid Peroxidation;Lymphocytic Infiltrate;Maintenance;Mannans;MAPT gene;Mediating;Messenger RNA;Microglia;Mitochondria;Modeling;Modification;mouse model;Mus;Nature;Nerve Degeneration;Nervous System Disorder;Neurodegenerative Disorders;Neurofibrillary Tangles;neuroinflammation;Neurologic;Neurology;neuron loss;Neurons;neuropathology;neuropsychiatric disorder;neurotoxic;normal aging;novel;Oxidative Stress;Parkinson Disease;Pathologic;Pathology;Peripheral Nervous System Diseases;Pharmaceutical Preparations;pharmacologic;Physiological;Plasma;pomalidomide;Positron-Emission Tomography;posttranscriptional;pre-clinical;preclinical study;Production;protein aggregation;protein oligomer;Proteins;proteostasis loss;Psychiatry;Reactive Oxygen Species;Reporting;resilience;response;Rodent;Rodent Model;Role;screening;Sedation procedure;Source;Structure;Symptoms;Synthesis Chemistry;tau aggregation;tau Proteins;tau-1;Teratogens;Thalidomide;Time;TNF gene;Toxic effect;Toxicology;Traumatic Brain Injury;treatment strategy;Vertebral column;Zebrafish,Pro-inflammatory cytokine lowering anti-inflammatory drugs,994,NA,NA,NA,NA,9,NA,NA,2323536,NA
11177515,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000998,NA,NA,1ZIAAG000998-10,NIA:123854\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8841542 (contact),"CHIA, CHEE W (contact)",NA,NA,NA,21 year old;Adult;Anabolism;animal data;Animals;Blood specimen;Cell Line;Chronic Obstructive Pulmonary Disease;Cilostazol;Clinical;Clinical Data;Cross-Over Studies;Cyclic AMP;Cyclic GMP;Cyclic Nucleotides;Data Analyses;Double-Blind Method;Family;fasting glucose;FDA approved;glucagon-like peptide 1;Glucose;glucose sensor;Glucose Transporter;glycemic control;Hour;Human;Human Biology;Hydrolysis;improved;inhibitor;inorganic phosphate;Intermittent Claudication;Investigation;L Cells;Medical;Multicenter Studies;Newly Diagnosed;Non-Insulin-Dependent Diabetes Mellitus;novel;Oral;Outcome;Pathway interactions;Pentoxifylline;Periodicity;Persons;Pharmaceutical Preparations;Phosphodiesterase Inhibitors;phosphoric diester hydrolase;Phosphoric Monoester Hydrolases;Placebo Control;Placebos;pre-clinical;Process;proglucagon;Randomized;recruit;Regulation;Role;Rolipram;Route;Sodium;sweet taste perception;symporter;Taste Buds;Testing;Visit,CLINICAL PROJECT:  The Role of Phosphodiesterase Inhibitors in Incretin Secretion,998,NA,NA,NA,NA,10,NA,NA,123854,NA
11177516,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG007270,NA,NA,1ZIAAG007270-25,NIA:147989\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479279 (contact),"LAUNER, LENORE J (contact)",NA,NA,NA,African American;Age;Age Years;aging brain;Alabama;Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Alzheimer&apos;s disease related dementia;bioimaging;Blood Vessels;Body Composition;Brain;Brain Diseases;brain health;brain magnetic resonance imaging;Brain region;brain tissue;Cardiovascular Diseases;cardiovascular risk factor;Chicago;Clinical;Cognition;Cognition Disorders;Cognitive;cognitive function;cohort;Cohort Studies;Collaborations;Data;Dementia;Disease;Early identification;Education;endophenotype;Environment;Environmental Exposure;epidemiology study;Ethnic Origin;Evolution;follow-up;Follow-Up Studies;Future;gene environment interaction;Genes;Genetic;genetic architecture;Genetic Markers;Genetic Risk;Genetic study;genetic variant;genome sequencing;genome wide association study;genome-wide analysis;Geographic Locations;Goals;Heart;Hospital Records;human old age (65+);Immune response;International;Investigation;Island;Italy;Joints;Life Cycle Stages;lipid metabolism;Magnetic Resonance Imaging;magnetic resonance imaging biomarker;Measures;men;Mental Depression;Metabolic;Methylation;mild cognitive impairment;Musculoskeletal;Neurocognitive;non-genetic;Nonprofit Organizations;novel;offspring;Outcome;Participant;Pathogenesis;Pathway interactions;Persons;Phenotype;Physiological;Population;population based;Prevention;prospective;Proteomics;Protocols documentation;recruit;Regulation;Research Personnel;Research Project Grants;Risk Factors;Sampling;Sardinia;screening;sex;Stroke;Structure;study population;System;trait;Universities;whole genome;Woman;young adult,ALZHEIMERS RESEARCH PROJECT: Genetic Markers of Brain Aging,7270,NA,NA,NA,NA,25,NA,NA,147989,NA
11177517,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG007390,NA,NA,1ZIAAG007390-16,NIA:58662\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479279 (contact),"LAUNER, LENORE J (contact)",NA,NA,NA,Accelerometer;adjudication;African American;African American Women;aged;Aging;Ancillary Study;Behavioral;Biological Markers;Biopsy;Black race;Body Composition;bone;Cardiovascular Diseases;Cardiovascular system;Cessation of life;Clinic;clinical examination;cognitive function;cohort;Communities;Data;Data Analyses;Dementia;design;Diabetes Mellitus;Disease;Disease susceptibility;Dual-Energy X-Ray Absorptiometry;Eligibility Determination;Environment;Event;Extramural Activities;Fatty acid glycerol esters;follow-up;Fracture;functional decline;functional disability;Funding;gender difference;genetic risk factor;genomic locus;Grant;Health;Hip region structure;Home visitation;Hospitalization;indexing;Interview;Knee Osteoarthritis;Longitudinal cohort;loss of function;Lung Diseases;Malignant Neoplasms;Measurement;Measures;member;men;Mental Depression;Metabolic Diseases;Monitor;Motor Skills;Muscle;muscle strength;older adult;Older Population;Osteoporosis;Outcome;Outcome Study;Parents;Participant;Pathway interactions;Pennsylvania;Physical Function;Protocols documentation;racial difference;Reporting;Research;Research Personnel;secondary analysis;Site;standard measure;Surveys;Telephone;Tennessee;Walking;Weight;Woman;Wrist;X-Ray Computed Tomography,"Health, Aging and Body Composition Study",7390,NA,NA,NA,NA,16,NA,NA,58662,NA
11177518,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG007480,NA,NA,1ZIAAG007480-14,NIA:151598\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479279 (contact),"LAUNER, LENORE J (contact)",NA,NA,NA,"Age;aged;Aging;aging brain;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Arteries;Asia;Auditory;Autopsy;Base Sequence;bioimaging;Biological Markers;biological systems;Blood;Blood Pressure;blood pressure elevation;Blood Vessels;Brain;brain magnetic resonance imaging;brain volume;Cardiovascular Diseases;cardiovascular risk factor;Cerebrovascular Circulation;Cerebrovascular Disorders;Cerebrum;Characteristics;Clinical;Clinical Data;Clinical Distribution;Cognition Disorders;Cognitive;cognitive function;cohort;Cohort Studies;comorbidity;Coronary;Coronary Artery Risk Development in Young Adults Study;Data;Dementia;design;Diabetes Mellitus;Disease;Environment;Epidemic;epidemiology study;Etiology;follow-up;Funding;Genes;Genetic;Glial Fibrillary Acidic Protein;gut microbiome;Heart Diseases;hemodynamics;human old age (65+);Hypertension;imaging biomarker;Intervention;Investigation;Japanese American;Lead;Lesion;Life Experience;Light;Magnetic Resonance Imaging;magnetic resonance imaging biomarker;Measurable;Measures;men;Metabolic;microbiome;Microvascular Dysfunction;middle age;mild cognitive impairment;molecular marker;National Heart, Lung, and Blood Institute;National Institute of Neurological Disorders and Stroke;Nerve Degeneration;Neuroepidemiology;neurofilament;neuropathology;non-genetic;novel;Observational epidemiology;Outcome;Pathogenesis;Pathology;Pathway interactions;Pattern;Perfusion;Persons;Plasma;Population;Positron-Emission Tomography;Predisposition;Prevention;programs;Prospective Studies;public health priorities;Publications;Reporting;Research;Research Design;Research Project Grants;Resources;Retina;Risk;Risk Factors;Risk Reduction;Role;sedentary lifestyle;Shapes;Smoking Behavior;Spatial Distribution;Structure;System;tau Proteins;Testing;Therapeutic;Tissues;trait;Water;white matter;Woman;Work",ALZHEIMER RESEARCH PROJECT: Brain aging and cardiovascular risk factors and disease,7480,NA,NA,NA,NA,14,NA,NA,151598,NA
11177519,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041201,NA,NA,1ZIAAR041201-11,NIAMS:782584\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,10288028 (contact),"HAFNER, MARKUS  (contact)",NA,NA,NA,assay development;Binding;Binding Proteins;Binding Sites;Bioinformatics;Biological Sciences;Breathing;Carrier Proteins;Catalogs;cell type;Cells;combinatorial;crosslink;Data;deep sequencing;Development;Disease;drug development;Elements;Experimental Models;exportin 5;Exportins;Fluorescent in Situ Hybridization;Formalin;Gel;Gene Expression;Gene Expression Regulation;Gene Family;Genes;Genetic Variation;Genome;genome-wide;Goals;Human;Human Genetics;Immunoprecipitation;improved;In Situ Hybridization;Individual;insight;Karyopherins;Libraries;Maps;Mass Spectrum Analysis;member;Messenger RNA;Methods;MicroRNAs;Molecular;Molecular Medicine;Mutation;novel anticancer drug;Nuclear Export;nucleocytoplasmic transport;Nucleocytoplasmic Transport Proteins;Paraffin Embedding;particle;Pathologic Processes;Phenotype;Polyadenylation;Post-Transcriptional Regulation;Process;Property;Protein Export Pathway;Proteins;Proteomics;Regulation;Reporter;Ribonucleic Acid Regulatory Sequences;Ribonucleoproteins;Ribonucleosides;RNA;RNA Binding;RNA Processing;RNA Splicing;RNA Transport;RNA-Binding Proteins;Role;Running;Silver Staining;Site;Specificity;stem;System;Technology;Therapeutic Intervention;Time;Tissue Embedding;Transcript;Translations;Transport Process;Untranslated RNA;Variant;virtual;Visualization,Dissecting the role of shuttling mRNA binding proteins in nucleocytoplasmic RNA transport,41201,NA,NA,NA,NA,11,NA,NA,782584,NA
11177520,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041205,NA,NA,1ZIAAR041205-09,NIAMS:782584\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,10288028 (contact),"HAFNER, MARKUS  (contact)",NA,NA,NA,Adult;Animals;B-Lymphocytes;Binding;Binding Sites;Biological Models;Caenorhabditis elegans;Cell Line;Cells;cis acting element;Code;cofactor;Collaborations;CRISPR/Cas technology;Data;derepression;Development;Disease;embryo tissue;Event;Exhibits;experimental study;Family;Family member;fetal;Future;gain of function;Gene Expression Regulation;Genes;genome editing;genome-wide;Goals;Hematopoietic;hematopoietic stem cell fate;Hematopoietic stem cells;Human;Immunology;insight;Investigation;Maps;member;Messenger RNA;MicroRNAs;Modeling;Molecular;Mus;mutant;National Institute of Allergy and Infectious Disease;Outcome;overexpression;Pattern;Positioning Attribute;Post-Transcriptional Regulation;posttranscriptional;Protein Family;Proteins;Proteomics;Regulation;Repression;Resolution;Ribonucleoproteins;RNA;RNA-Binding Proteins;Role;Shock;Site;Specific qualifier value;stem cells;synergism;System;Technology;Tissues;Transcript;Untranslated RNA,Integration of the results from systems-level determination of cis-acting elements into high-resolution maps of posttranscriptional regulatory events.,41205,NA,NA,NA,NA,9,NA,NA,782584,NA
11177521,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041206,NA,NA,1ZIAAR041206-09,NIAMS:806299\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,10288028 (contact),"HAFNER, MARKUS  (contact)",NA,NA,NA,Affect;Binding;Binding Sites;Biochemical;Biological Assay;Cell Nucleus;Cells;Cellular Stress;Coupled;Cytoplasm;Disease;DNA;Elements;Embryonic Development;Eukaryota;Event;G-Quartets;gain of function;Gene Expression;Genetic Transcription;Genome;genome-wide;helicase;Human Cell Line;In Vitro;Initiator Codon;Knock-out;loss of function;Malignant Breast Neoplasm;Mammalian Cell;Mammals;Maps;Measures;Messenger RNA;Methods;Molecular;Molecular Chaperones;mRNA Precursor;Muscular Dystrophies;nucleic acid binding protein;Nucleic Acids;Nucleotides;Output;Phosphorylation;prevent;Process;programs;Protein Isoforms;protein kinase R;Proteins;Protocols documentation;Regulon;Research;Resolution;ribosome profiling;Ribosomes;RNA;RNA Polymerase II;RNA Stability;RNA-Binding Proteins;stress granule;Structure;System;Tissues;transcription factor;Translating;Translation Initiation;Translational Regulation;Translations;Untranslated Regions;Zinc Fingers,Impact of RNA binding proteins on translation initiation and elongation.,41206,NA,NA,NA,NA,9,NA,NA,806299,NA
11177522,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000140,NA,NA,1ZIAHG000140-26,NHGRI:1065892\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9694205 (contact),"BAXEVANIS, ANDREAS  (contact)",NA,NA,NA,Adult;Ally;Animals;Appearance;Arthropods;Atlases;Binding;Biological;Biological Models;Biology;cell type;Cells;Chromatin;Chromosomes;Cnidaria;Code;comparative;comparative genomics;Complex;Ctenophora;Data;Data Set;data sharing;database structure;Databases;Development;Developmental Biology;Developmental Gene;Disease Outbreaks;DNA Sequence;Elements;Embryonic Development;Enhancers;Epigenetic Process;Evolution;Exhibits;experimental study;Future;Genbank;Gene Expression;Generations;Genes;Genetic Transcription;Genome;genome annotation;genome sequencing;genome-wide;genomic data;Genomics;Glutamate Receptor;Health;Hi-C;homeodomain;Homologous Gene;Human;Human Biology;human disease;Human Genome;innovation;insight;Invertebrates;Knowledge;Laboratories;Light;male;marine;Methods;Methylation;Mnemiopsis;model organism;Modeling;Molecular;Mollusca;Morphology;Muscle Cells;Natural regeneration;neurodevelopment;neurogenesis;Neurons;novel;Organism;Orthologous Gene;Pattern Formation;Phylogenetic Analysis;Play;Positioning Attribute;Process;Property;Protein Family;protein structure;protein structure prediction;Proteins;Proteome;Proteomics;Regenerative capacity;Regenerative Medicine;Regulatory Element;Research;Resources;RNA Sequences;Role;single cell analysis;Sister;Source;Spatial Distribution;Specific qualifier value;stem cell biology;stem cells;Sting Injury;Structure;Supercomputing;Transcript;transcription factor;Transcriptional Regulation;transcriptomics;translational study;Trees;United States National Institutes of Health;Untranslated RNA;vertebrate genome;Vertebrates;Visualization;whole genome;Work,Comparative Genomic Studies on the Evolution of Morphological Complexity,140,NA,NA,NA,NA,26,NA,NA,1065892,NA
11177523,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200398,NA,NA,1ZIAHG200398-09,NHGRI:2047019\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,14765971 (contact),"PHILLIPPY, ADAM  (contact)",NA,NA,NA,Agriculture;Area;arm;Bioinformatics;Blue Whales;Cattle;Centromere;Characteristics;Chromosome Structures;Chromosomes;Collaborations;Collection;comparative;Comparative Genomic Analysis;comparative genomics;Complex;Computing Methodologies;cost;Data;Databases;Development;disease diagnosis;Effectiveness;Exclusion;Fertility;functional genomics;Future;Genes;Genetic study;Genome;genomic data;Genomics;Goals;Haplotypes;Human;Human Genome;Human Genome Project;human reference genome;improved;Informatics;Length;Life;Lifting;Macaca;Maize;Maps;member;metagenome;method development;Methods;methylation pattern;microbial genome;migration;Mus;nanopore;Neurologic;nonhuman primate;novel sequencing technology;pan-genome;Paper;Peer Review;Planet Earth;Play;Pongidae;Population;Printing;Process;Publishing;reference genome;Role;Ruminants;Sampling;scalable algorithms;Sexual Development;Shapes;Shark;single molecule;software development;Surveys;Tandem Repeat Sequences;Techniques;Technology;telomere;Time;Update;Validation;Variant;vertebrate genome;Vertebrate Taxonomy;Visualization;whole genome;Work;Y Chromosome;Zebrafish,Single-molecule sequence assembly and analysis,200398,NA,NA,NA,NA,9,NA,NA,2047019,NA
11177524,ZIC,AG,1,N,NA,NA,NA,NA,ZICAG000613,NA,NA,1ZICAG000613-17,NIA:292532\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690924 (contact),"GOROSPE, MYRIAM  (contact)",NA,NA,NA,Age-associated memory impairment;age-related disease;Aging;aging related;Alzheimer&apos;s Disease;Artificial Intelligence;Bioinformatics;Complex;Computational Biology;Data;Data Analyses;database of Genotypes and Phenotypes;Databases;Deposition;Disease;disease phenotype;Environmental Risk Factor;Functional disorder;Genetic;genetic analysis;genetic association;Goals;High-Throughput Nucleotide Sequencing;human disease;Machine Learning;microbiome;microbiome analysis;Process;public database;RNA;Role;Synapses;System;Untranslated RNA;web page;web-based tool,Bioinformatic Analysis of the Genetics of Common Complex Diseases,613,NA,NA,NA,NA,17,NA,NA,292532,NA
11177525,ZIC,AG,1,N,NA,NA,NA,NA,ZICAG000616,NA,NA,1ZICAG000616-17,NIA:433381\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,77838779 (contact),"DE, SUPRIYO  (contact)",NA,NA,NA,Aging;Algorithmic Analysis;Artificial Intelligence;biomedical data science;Cells;Cloud Computing;Collaborations;Communities;complex biological systems;Computational Biology;Computer Systems;CRISPR screen;Data Analyses;Data Scientist;data sharing;design;epigenomics;Experimental Designs;Extramural Activities;Fostering;functional genomics;Gene Chips;Genomics;Goals;high end computer;Image Analysis;instrument;Interdisciplinary Study;interest;Laboratories;Mission;Multiomic Data;nanopore;next generation sequencing;novel;Preparation;programs;Quality Control;Research;Research Personnel;Sampling;Scientist;Services;single cell genomics;single cell sequencing;Technology;Training;transcriptomics;United States National Institutes of Health,Analysis of complex biological systems by high-throughput genomic technologies,616,NA,NA,NA,NA,17,NA,NA,433381,NA
11177526,ZIC,AG,1,N,NA,NA,NA,NA,ZICAG000618,NA,NA,1ZICAG000618-17,NIA:43374\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6568215 (contact),"WENG, NAN-PING PETER (contact)",NA,NA,NA,Animals;Antigens;Apoptosis;Apoptotic;Baltimore;Biological Assay;Blood Cells;Bone Marrow;Bone Marrow Stem Cell;Bromodeoxyuridine;Cell Cycle;Cell Separation;Cells;Certification;Chromosomes;Color;Complex;complex data;Computers and Advanced Instrumentation;Consult;Continuing Education;cost effective;Data Analyses;daughter cell;Dedications;design;Detection;detector;Effectiveness;Epigenetic Process;Event;exosome;Experimental Designs;experimental study;Extramural Activities;Financial Support;Flow Cytometry;Flow Cytometry Shared Resource;Frequencies;Future;Head;high dimensionality;Hour;Human;Immune;Immunofluorescence Immunologic;Immunologics;Individual;innovation;Institution;instrument;instrumentation;Laboratories;Lasers;Lentivirus;Life Cycle Stages;life span;Longitudinal Studies;Manufacturer;Measurement;member;Methylation;Mission;Modification;monocyte;Mus;muscle progenitor cell;nerve stem cell;Neurons;nonhuman primate;novel;operation;particle;Peripheral Blood Lymphocyte;Physiologic pulse;Policies;Population;Procedures;Process;Productivity;programs;Proliferating;Propidium Diiodide;Proteins;Protocols documentation;Publications;Qualifying;Quality Control;Radial;Rattus;recruit;Reporter;Reporter Genes;Research;research and development;Research Personnel;Research Support;Resource Sharing;Resources;RNA;Sampling;Science;Scientist;Services;Side;skills;Sorting;Speed;Spleen;Stains;stem cell population;submicron;Technical Expertise;Technology;technology development;thymocyte;Training;United States National Institutes of Health;Visit;web page,Flow Cytometry Laboratory (Scientific Core),618,NA,NA,NA,NA,17,NA,NA,43374,NA
11177527,ZID,AG,1,N,NA,NA,NA,NA,ZIDAG000912,NA,NA,1ZIDAG000912-24,NIA:134176\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690861 (contact),"EGAN, JOSEPHINE  (contact)",NA,NA,NA,aging process;American;Blood Banks;Blood Component Removal;Cells;Cellular Structures;Chronic;Clinical;Collection;Complete Blood Count;Cytapheresis;expectation;Genetic study;Hepatitis;HIV;Hour;Human;immune function;Individual;Infection;Laboratories;Laboratory Study;Leukocytes;liver function;Lymphocyte;Magnetic Resonance Imaging;Medical;Molecular;monocyte;National Institute on Aging;Participant;Procedures;Protocols documentation;Qualifying;Renal function;Research;Research Personnel;Sampling;screening;Testing;trend;Urinalysis;volunteer,CLINICAL PROJECT:  Cytapheresis Of Volunteer Donors (MRI 2003-054),912,NA,NA,NA,NA,24,NA,NA,134176,NA
11177528,ZID,AG,1,N,NA,NA,NA,NA,ZIDAG000967,NA,NA,1ZIDAG000967-17,NIA:61927\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,8841542 (contact),"CHIA, CHEE W (contact)",NA,NA,NA,Abdomen;Address;Age;Biomedical Research;Bladder;Blood;Calibration;Caring;Clinical;clinical care;Clinical Research;Clip;Code;Connective Tissue;data acquisition;design;Discipline of Nursing;Disease;Ethnic Origin;Evaluation;Exclusion;Fatty acid glycerol esters;Feces;Gender;Hair;Health Personnel;healthy volunteer;Heart;Hemorrhage;human tissue;Individual;Information Technology;Informed Consent;Infrastructure;interest;Kidney;Laboratories;laboratory equipment;Link;Liquid substance;Liver;Location;Lung;Medical;method development;Muscle;Nail plate;Names;Nose;operation;Operative Surgical Procedures;Organ;Outcome;Participant;participant safety;Pharmacy facility;Physicians;Protocols documentation;Race;Research;Research Personnel;Research Project Grants;Research Subjects;Saliva;Sampling;Secure;Services;Skin;Tissue Sample;Tissues;Urine;Vertebral column,"CLINICAL PROJECT:  Subject Assessment, Sample Procurement and Clinical Operations",967,NA,NA,NA,NA,17,NA,NA,61927,NA
11177532,N01,HD,NA,N,NA,NA,NA,NA,75N94020D00003,NA,NA,75N94020D00003-0-759402400001-1,NICHD:1479511\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,79895596 (contact),"BUNIN, DEBORAH  (contact)",NA,2024-05-31,2026-05-29,ADME Study;Animals;Biological;Biological Assay;Biological Testing;candidate identification;chemical synthesis;Clinical;clinical lot;Clinical Research;Clinical Trials;Clinical Trials Network;Contraceptive Agents;Contraceptive Devices;Contraceptive methods;contraceptive target;Contractor;Contracts;Databases;design;Development;Device or Instrument Development;drug candidate;drug development;Drug Formulations;Endocrine;Enrollment;Evaluation;Female Contraceptive Agents;Formulation;Gel;good laboratory practice;Good Manufacturing Process;Implant;In Vitro;in vivo;Injectable;Investigational New Drug Application;Levonorgestrel;lot production;Male Contraceptive Agents;manufacture;manufacturing test;Manuscripts;men;Methods;Microsomes;Mission;National Institute of Child Health and Human Development;Nestorone;new chemical entity;novel;novel therapeutics;Oral;Oral Administration;Ovulation;Pharmaceutical Preparations;pharmacokinetics and pharmacodynamics;Pharmacologic Substance;Phase;Plasma;Play;population health;pre-clinical;preclinical study;Preparation;Process;Prodrugs;product development;Production;Program Development;programs;Protocols documentation;recruit;Report (document);Research;research and development;research clinical testing;Research Personnel;Research Support;Role;Services;sperm cell;sperm function;stability testing;System;Testing;Testosterone;Time;Toxic effect;Translational Research;Woman;Work,"BIOLOGICAL TESTING FACILITY - DISCOVERY, CLINICAL FORMULATION, AND MANUFACTURE OF CONTRACEPTIVES",0,NA,NA,NA,NA,NA,NA,NA,1479511,NA
11177541,R01,CA,7,N,2024-12-17,2024-09-01,2025-06-30,394,R01CA279667,SCHOOLS OF MEDICINE,PA-24-254,7R01CA279667-03,NCI:408291\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,LA JOLLA,UNITED STATES,UROLOGY,50,804355790,US,577507,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",CA,920930621,"Project Narrative We seek to validate, calibrate, and translate restricted spectrum imaging (RSI-MRI) across vendors to asses in the detection of clinically significant prostate cancer. RSI-MRI is a novel sequence protocol with software post- processing accomplished along with standard of care MRI to improve the quality of prostate MRI imaging. The research has the potential to revolutionize prostate cancer diagnosis and monitoring by providing a non-invasive imaging biomarker with the ability to improve diagnostic accuracy and risk stratification across MRI scanners.",11075558 (contact);15326678,"LISS, MICHAEL ANDRE (contact);WHITE, NATHAN SCOTT","ZHANG, HUIMING",2023-05-17,2028-06-30,"Academic support;Affect;Amendment;Anatomy;Area;Area Under Curve;arm;Biological Markers;biomarker performance;Biopsy;Biopsy Specimen;Calibration;California;cancer biomarkers;cancer cell;cancer diagnosis;Characteristics;Clinical;Clinical Assessment Tool;clinical diagnosis;clinical practice;clinical risk;Clinical Trials;clinically significant;Code;Color;Computer software;Data;Decision Making;Detection;Diagnosis;diagnostic accuracy;diagnostic value;Diffusion;Diffusion Magnetic Resonance Imaging;diffusion weighted;Digital Imaging and Communications in Medicine;Disease;Early Diagnosis;Enrollment;Equipment;FDA approved;Health;High-Risk Cancer;Housing;Image;Image Analysis;imaging biomarker;imaging modality;Imaging technology;improved;in vivo;indexing;Indolent;industry partner;Inflammation;Information Systems;innovation;Institution;interest;Intravenous;intravenous injection;Investigation;Lesion;Location;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Magnetism;Malignant neoplasm of prostate;Malignant Neoplasms;manufacture;Manufacturer;Maps;Measurement;Measures;Medicine;men;Methods;Modality;Modeling;Molds;molecular marker;Monitor;non-invasive imaging;novel;Output;Patients;Pharmaceutical Preparations;Predictive Value;Process;prospective;Prostate;prostate biopsy;prostate cancer cell;prostate cancer risk;Prostatectomy;Protocols documentation;Publishing;radiologist;Radiology Specialty;randomized, clinical trials;Reader;Receiver Operating Characteristics;Reporting;Research;Restriction Spectrum Imaging;risk stratification;Sampling;Sampling Errors;Scanning;Screening for Prostate Cancer;Serum;side effect;Signal Transduction;Source;Specificity;standard of care;Standardization;Statistical Data Interpretation;Structure;System;T2 weighted imaging;Techniques;Time;Tissues;Translating;Translations;tumor;Tumor Markers;ultrasound;United States;Urine;Validation;Variant;Vendor;Water;Work","Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer",279667,ZRG1,Special Emphasis Panel[ZRG1-ISB-S(57)R],NA,NA,3,268649,139642,408291,NA
11177564,N01,AI,NA,N,NA,NA,NA,NA,272201300017I,NA,NA,272201300017I-P00009-27200008-1,NIAID:93126\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,79946559 (contact),"NAGGIE, SUSANNA  (contact)",NA,2015-06-10,2024-12-31,Adult;anti-fungal agents;Antimicrobial Resistance;Coccidioides immitis;Coccidioides posadasii;Coccidioidomycosis;combat;Communicable Diseases;community acquired pneumonia;Conduct Clinical Trials;Contracts;design;Evaluation;Individual;Phase IV Clinical Trials;Pneumonia;Population;programs;Resources;Special Population;Vaccines,Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia,0,NA,NA,NA,NA,NA,NA,NA,93126,NA
11177565,N01,DA,NA,N,NA,NA,NA,NA,75N95023C00016,NA,NA,75N95023C00016-P00002-9999-1,NINDS:298357\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,GALVESTON,UNITED STATES,NA,14,800771149,US,578406,UNIVERSITY OF TEXAS MED BR GALVESTON,TX,775555302,NA,79328380 (contact),"GELMAN, BENJAMIN  (contact)",NA,2023-08-23,2025-08-22,antiretroviral therapy;Autopsy;Biological;Central Nervous System;Clinical Data;clinical research site;Cognitive;Consent;data sharing;Ethics;Functional disorder;Funding;HIV;HIV Seronegativity;human subject protection;interest;Mental Health;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National NeuroAids Tissue Consortium;Neurocognitive;Neurologic;Neuropathogenesis;Organ Donor;Outcome;preservation;Process;Qualifying;Research Personnel;Services;Specimen;Tissues;volunteer,"THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE",0,NA,NA,NA,NA,NA,NA,NA,298357,NA
11177566,N01,MH,NA,N,NA,NA,NA,NA,75N95023C00014,NA,NA,75N95023C00014-P00003-9999-1,NINDS:771740\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,LA JOLLA,UNITED STATES,NA,50,804355790,US,577507,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",CA,920930621,NA,8527376 (contact),"MOORE, DAVID J (contact)",NA,2023-08-23,2025-08-22,antiretroviral therapy;Autopsy;Biological;Central Nervous System;Clinical Data;clinical research site;Cognitive;Consent;data sharing;Ethics;Functional disorder;Funding;HIV;HIV Seronegativity;human subject protection;interest;Mental Health;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National NeuroAids Tissue Consortium;Neurocognitive;Neurologic;Neuropathogenesis;Organ Donor;Outcome;preservation;Process;Qualifying;Research Personnel;Services;Specimen;Tissues;volunteer,"THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE",0,NA,NA,NA,NA,NA,NA,NA,771740,NA
11177567,N01,MH,NA,N,NA,NA,NA,NA,75N95023C00014,NA,NA,75N95023C00014-P00003-9999-2,NIA:412481\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,LA JOLLA,UNITED STATES,NA,50,804355790,US,577507,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",CA,920930621,NA,8527376 (contact),"MOORE, DAVID J (contact)",NA,2023-08-23,2025-08-22,Alzheimer&apos;s Disease;Autopsy;Biological;Clinical Data;HIV;HIV Seronegativity;National NeuroAids Tissue Consortium;Organ Donor;Specimen;Tissues;volunteer,"THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE",0,NA,NA,NA,NA,NA,NA,NA,412481,NA
11177569,N01,MH,NA,N,NA,NA,NA,NA,75N95023C00015,SCHOOLS OF MEDICINE,NA,75N95023C00015-P00002-9999-1,NIMH:642384\NINDS:929903\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,NEW YORK,UNITED STATES,NEUROLOGY,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,NA,1872697 (contact),"MORGELLO, SUSAN  (contact)",NA,2023-08-23,2025-08-22,antiretroviral therapy;Autopsy;Biological;Central Nervous System;Clinical Data;clinical research site;Cognitive;Consent;data sharing;Ethics;Functional disorder;Funding;HIV;HIV Seronegativity;human subject protection;interest;Mental Health;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National NeuroAids Tissue Consortium;Neurocognitive;Neurologic;Neuropathogenesis;Organ Donor;Outcome;preservation;Process;Qualifying;Research Personnel;Services;Specimen;Tissues;volunteer,"THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE",0,NA,NA,NA,NA,NA,NA,NA,1572287,NA
11177571,N01,AI,NA,N,NA,NA,NA,NA,75N93021C00022,NA,NA,75N93021C00022-P00012-9999-1,NIAID:3424537\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,CAMBRIDGE,UNITED STATES,NA,05,078838557; 080161535,US,10034527,"SPERO THERAPEUTICS, INC.",MA,021393309,NA,79946568 (contact),"KANE, BRIAN  (contact)",NA,2021-05-17,2026-12-31,Acinetobacter;Advanced Development;antimicrobial resistant infection;Bacterial Drug Resistance;bacterial resistance;biodefense;candidate selection;Chemistry;Clinical assessments;Combating Antibiotic Resistant Bacteria;efficacy evaluation;Emerging Communicable Diseases;lead optimization;manufacture;pathogen;pre-clinical;product development;Pseudomonas aeruginosa;research and development;Research Support;safety assessment;Therapeutic;therapeutic candidate;therapeutic development,"Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases",0,NA,NA,NA,NA,NA,NA,NA,3424537,NA
11177579,N01,HD,NA,N,NA,NA,NA,NA,75N94020D00016,NA,NA,75N94020D00016-P00003-759402100001-1,NICHD:95077\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PORTLAND,UNITED STATES,NA,01,096997515,US,6297007,OREGON HEALTH & SCIENCE UNIVERSITY,OR,972393098,NA,78052142 (contact),"EDELMAN, ALISON  (contact)",NA,2021-02-09,2026-02-08,Adherence;Age;Biological Assay;Body mass index;Clinical;Clinical Trials;Clinical Trials Network;Contraceptive Agents;contraceptive efficacy;Contraceptive methods;Data;Drug Kinetics;Enrollment;Estrogens;Evaluation;Female Contraceptive Agents;Formulation;Free Will;Hormones;Implant;Injectable;Injections;Intramuscular;Intrauterine Devices;Laboratories;Lactation;Levonorgestrel;Measures;Mission;National Institute of Child Health and Human Development;Obesity;Pharmaceutical Preparations;Pharmacodynamics;pill;Population;Progestins;Protocols documentation;Public Health;Recording of previous events;recruit;Regimen;reproductive;Risk;Risk Reduction;Route;Safety;subcutaneous;Time;United States Food and Drug Administration;venous thromboembolism;Woman,CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION,0,NA,NA,NA,NA,NA,NA,NA,95077,NA
11177974,R56,CA,1,N,2024-09-18,2024-09-18,2025-08-31,396,R56CA280636,SCHOOLS OF MEDICINE,PAR-21-322,1R56CA280636-01A1,NCI:241500\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,DAVIS,UNITED STATES,BIOCHEMISTRY,04,047120084,US,577503,UNIVERSITY OF CALIFORNIA AT DAVIS,CA,956186153,"PROJECT NARRATIVE Gastric cancer is a leading cause of mortality in Latinos. This proposal will characterize the epigenome of common and aggressive genomically stable (GS) gastric tumors in Latinos, model their tumorigenesis using ethnic-appropriate Latino gastric organoids, and identify GS tumor vulnerabilities using a loss of function screen. Our study will generate a body of data that will be useful in understanding GS tumor biology and in addressing cancer disparities in this population.",11805960 (contact),"CARVAJAL CARMONA, LUIS GUILLERMO (contact)","YASSIN, RIHAB R",2024-09-18,2026-08-31,Address;Advanced Malignant Neoplasm;Asian;Asian population;Biological;Biological Assay;Biological Markers;Biology;bisulfite sequencing;California;Cancer Biology;Cancer cell line;cancer health disparity;Cancer health equity;Cancer Patient;CDH1 gene;Cell Adhesion;Cells;Chemoresistance;Classification;Clinic;Country;CpG Islands;Data;Death Rate;Development;Diffuse;Diffuse gastric cancer;Disparity;drug efficacy;druggable target;Epigenetic Process;epigenome;epigenomics;Ethnic Origin;Frequencies;functional genomics;gastric organoids;Genes;Genome engineering;Genome Stability;Genomic approach;health disparity;high throughput screening;Histologic;Histology;Immunologics;In Vitro;in vivo;Infrastructure;Intestinal Neoplasms;Intestines;Invaded;Latino;Latino Population;loss of function;malignant stomach neoplasm;Methods;Methylation;minority patient;Modeling;Molecular;molecular subtypes;mortality;mutant;Mutation;Neoplasm Metastasis;neoplasm registry;Organoids;Pathologic;Pathway interactions;patient derived xenograft model;Patients;Phenotype;PI3K/AKT;Population;preclinical study;Prevalence;Primary Neoplasm;Prognosis;Proliferating;Registries;Research;RHOA gene;Sampling;Signal Transduction;social health determinants;stable cell line;stemness;Stomach Neoplasms;synthetic lethal interaction;Testing;The Cancer Genome Atlas;Therapeutic;therapeutic development;transcriptome;Transforming Growth Factor beta;tumor;Tumor Biology;tumor growth;tumorigenesis;Universities;Work,Understanding the biology of disparity-associated genomically stable gastric tumors,280636,BMCD,Basic Mechanisms of Cancer Health Disparities Study Section[BMCD],NA,A1,1,150000,91500,241500,NA
11177979,R01,HL,3,N,2024-08-29,2024-08-29,2025-07-31,837,R01HL162633,BIOMED ENGR/COL ENGR/ENGR STA,PA-23-189,3R01HL162633-03S1,NHLBI:67516\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,COLLEGE STATION,UNITED STATES,BIOMEDICAL ENGINEERING,10,847205572,US,8266919,TEXAS ENGINEERING EXPERIMENT STATION,TX,778433577,"Project Narrative The objective of this Katz R01 project is to develop a novel multi-scale computational model to: 1) quantify the local and systemic hemodynamics (i.e., pressure, flow rate, shear stress, oxygen transport, etc.) during phases of active hemorrhage, aortic occlusion with REBOA, and resuscitation, 2) identify vascular regions that are vulnerable to ischemic damage as a result of the altered hemodynamics, 3) predict key physiologic responses related to vascular compliance, oxygen delivery and renal autoregulation during hemorrhage and aortic occlusion, and 4) determine optimal aortic occlusion size and duration of partial vs. full REBOA strategies to prevent ischemia-reperfusion injuries and renal failure. At its core, this proposal builds on the PI’s training in cardiovascular fluid mechanics, trauma and shock, but represents an important new direction that has the potential to transform the field of hemorrhagic shock research.",11626137 (contact),"RAHBAR, ELAHEH  (contact)","BERZHANSKAYA, JULIA",2022-08-01,2027-07-31,3-Dimensional;Abdomen;Acceleration;Address;Adopted;Animal Experimentation;Animal Model;Animals;Aorta;Balloon Occlusion;Baroreflex;Behavior;Biological;Biological Markers;Blood flow;Blood Vessels;Blood Volume;Cardiac Output;Cardiovascular system;Catheters;Cessation of life;Chest;Clinical;computer framework;Computer Models;Computer software;computerized tools;Coupled;design;Development;Devices;Distal;Engineering;Environment;Evaluation;Family suidae;Feedback;Growth;hemodynamics;Hemorrhage;Hemorrhagic Shock;Homeostasis;improved;in silico;in vivo;indexing;Injury;innovation;Institution;Intervention;Ischemia;Kidney;Kidney Failure;Knowledge;Liquid substance;Mechanics;Methods;Military Personnel;minimally invasive;Modeling;multi-scale modeling;multidisciplinary;next generation;novel;open source;Oxygen;oxygen transport;Performance;Perfusion;Phase;Physicians;Physiological;porcine model;Pre-Clinical Model;Preclinical Testing;pressure;prevent;preventable death;Renal function;Reperfusion Injury;Reperfusion Therapy;Research;response;Resuscitation;Risk;risk mitigation;Scientist;shear stress;Shock;simulation environment;Stents;Sum;Techniques;Testing;Time;tool;Training;Trauma;Traumatic injury;Validation;Vena Cava Filters;Venous;Work,Development of a multi-scale closed loop model for hemorrhagic shock: a platform to assess REBOA performance,162633,BTSS,"Bioengineering, Technology and Surgical Sciences Study Section[BTSS]",NA,S1,3,67516,0,67516,NA
11177982,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA143728,NA,PA-20-272,3U54CA143728-15S1,NCI:325303\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,MANGILAO,UNITED STATES,NA,98,779908151,US,3087201,UNIVERSITY OF GUAM,GU,969131800,NA,11831643 (contact),"LEON GUERRERO, RACHAEL T (contact)","GHOSH, SANGEETA AHUJA",2009-09-01,2025-08-31,Advisory Committees;anti-cancer research;Cancer Center;Cancer health equity;career development;Collaborations;Communication;community advisory board;design;Development;Educational workshop;Effectiveness;Environment;Evaluation;Goals;Guam;Hawaii;Indigenous;Infrastructure;Institution;Leadership;Malignant Neoplasms;meetings;Mission;NCI-Designated Cancer Center;Office of Administrative Management;Pacific Islander;Pacific Islands;Population;Preparation;programs;Progress Reports;Recommendation;recruit;Research;Research Personnel;Research Project Grants;Research Support;Resource Allocation;Resource Sharing;Science;Services;Universities;Vision,Administrative Core,143728,ZCA1,ZCA1,8279,S1,15,248172,77131,NA,325303
11177989,R01,GM,3,N,2024-09-09,2024-09-01,2025-08-31,859,R01GM144972,SCHOOLS OF ARTS AND SCIENCES,PAR-21-003,3R01GM144972-04S1,NIGMS:49738\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BLACKSBURG,UNITED STATES,BIOLOGY,09,003137015,US,8968001,VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,240616100,"Individual hosts vary in their susceptibility to pathogens, which has important consequences for outbreak dynamics and pathogen evolution. Our work will elucidate relationships between prior exposure of hosts to pathogens, as occurs naturally and via vaccination, and the degree of variability in host susceptibility. The models generated will be broadly useful for understanding and managing any pathogens, including those of humans, where host protection generated by prior exposure is variable, incomplete, or wanes over time.",9300139 (contact),"HAWLEY, DANA M (contact)","ADKINS, RONALD",2021-09-02,2025-08-31,Disease Outbreaks;Epidemic;Epidemiology;Evolution;experience;experimental study;Exposure to;Finches;Heterogeneity;Human;Immune;Immunity;Individual;insight;Modeling;novel;pathogen;pathogen exposure;pathogenic bacteria;Population;Predisposition;Process;Recording of previous events;Role;System;Testing;Theoretical model;theories;Time;trait;Vaccination;Variant;Virulence;Work,Ecological and evolutionary causes and consequences of host heterogeneity induced by prior exposure,144972,ZRG1,Special Emphasis Panel[ZRG1-IDIA-U(55)R],NA,S1,4,31086,18652,49738,NA
11177990,F31,CA,3,N,2024-08-30,2023-09-01,2025-08-31,398,F31CA261110,NA,PA-20-251,3F31CA261110-03S1,NCI:32784\,"TRAINING, INDIVIDUAL",2024,NATIONAL CANCER INSTITUTE,NA,DUARTE,UNITED STATES,NA,31,027176833,US,3058203,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,910103012,"PROJECT NARRATIVE Blood malignancies are characterized by recurrent somatic mutations in RNA splicing factors that drive aberrant splicing to promote leukemogenesis. Recently, a novel species of RNA called circular RNAs (circRNA) was discovered to be aberrantly expressed in many types of liquid cancers, yet the role of RNA splicing factors mutations on the biogenesis of these molecules, if any, in promoting leukemogenesis is not known. Establishing a link between known RNA splicing factor mutations and circRNAs could define a novel regulatory axis that can be exploited for targeted therapy of these diseases.",16254143 (contact),"FERNANDEZ, MIKE  (contact)","GHOSH, SANGEETA AHUJA",2021-09-01,2025-08-31,Address;Alternative Splicing;B-Lymphocytes;Biogenesis;Biological;Biological Assay;Blood;Cancer Biology;cancer cell;cancer diagnosis;Cell Cycle Regulation;Cell Line;Cell Physiology;Cell Survival;Cells;Chemoresistance;Chronic Lymphocytic Leukemia;circular RNA;cis acting element;clinically significant;Clustered Regularly Interspaced Short Palindromic Repeats;Collection;Computer Analysis;CRISPR screen;Critical Pathways;Data;Detection;Development;Diagnostic;Disease;Disease Progression;Engineering;Genes;Genetic Transcription;Genomics;Goals;Hematologic Neoplasms;Hematopoietic Neoplasms;leukemia;leukemogenesis;Link;Liquid substance;Malignant lymphoid neoplasm;Malignant Neoplasms;Messenger RNA;Methods;Molecular;mutant;Mutate;Mutation;Myeloproliferative disease;novel;novel therapeutics;Output;Pathway interactions;Patients;Play;potential biomarker;Production;protein transport;prototype;Recurrence;Regulator Genes;Repetitive Sequence;Reporter;Research;RNA;RNA Splicing;RNA-Binding Proteins;Role;screening;Screening procedure;Signal Transduction;Somatic Mutation;SRSF2 gene;System;targeted treatment;Technology;Therapeutic;therapeutic target;Tissues;tool;transcriptome;tumor;tumorigenesis;U1 small nuclear RNA;United States,Impact of RNA splicing factor mutations on circular RNA biogenesis in leukemia,261110,ZRG1,Special Emphasis Panel[ZRG1-F09A-R(20)L],NA,S1,3,32784,0,32784,NA
11177998,U54,CA,3,N,2024-09-19,2024-09-01,2025-08-31,NA,U54CA163068,NA,PA-20-272,3U54CA163068-12S1,NCI:199349\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,TAMPA,UNITED STATES,NA,15,139301956,US,3736101,H. LEE MOFFITT CANCER CTR & RES INST,FL,336129497,NA,1941323 (contact),"WRIGHT, KENNETH LYNN (contact)","SAN MIGUEL-MAJORS, SANDRA L",2012-09-24,2028-08-31,"Address;American Society of Clinical Oncology;anti-cancer research;Basic Cancer Research;Behavior;Biometry;Bone Marrow Transplantation;Cancer Center;cancer clinical trial;cancer health disparity;cancer therapy;career;Career Choice;career development;Career Mobility;Caring;Clinical;Clinical Oncology;clinical practice;clinical training;Clinical Trials;Communities;cultural competence;design;Development;Diagnosis;Doctor of Philosophy;doctoral student;Education;education research;Educational workshop;Effectiveness;Evaluation;experience;Exposure to;Faculty;faculty mentor;Feedback;Fellowship Program;Florida;Goals;graduate school;Grant;Health Disparities Research;health disparity;Health Sciences;Hematology;Hispanic;HIV;Immersion;improved;Industry;interest;Interest Group;investigator training;Island;Latino;Latino Population;Malignant Neoplasms;Medical;Medical Students;Mentors;Mentorship;minority health;Needs Assessment;Oncologist;Oncology;Operative Surgical Procedures;Outcome;Participant;patient engagement;peer coaching;Persons;Population;Positioning Attribute;post-doctoral training;Postdoctoral Fellow;pre-doctoral;Prevention;programs;Puerto Rican;Puerto Rico;recruit;Research;Research Personnel;Residencies;Rotation;Scholarship;Science, Technology, Engineering and Mathematics;Scientist;Screening for cancer;senior faculty;Series;Site;STEM research;Students;success;summer research;Surgical Oncology;Training;tumor;undergraduate student;Universities;Urology;Vision;Writing",Research Education Core,163068,ZCA1,ZCA1,5643,S1,12,118308,81041,NA,199349
11178008,R01,DK,7,N,2024-11-20,2024-11-20,2025-04-30,847,R01DK047420,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7R01DK047420-30,NIDDK:376800\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,Newark,UNITED STATES,BIOCHEMISTRY,10,090299830,US,10034168,RUTGERS BIOMEDICAL AND HEALTH SCIENCES,NJ,071073001,"This research will investigate how a protein hormone (parathyroid hormone, PTH) is able to interact with the surface of a cell in bone and transmit signals to the cell's DNA to regulate the expression of genes involved in bone breakdown. PTH is essential for maintaining serum calcium levels, but too much of the hormone or genetic diseases that act like PTH can cause major bone loss and disabilities. The results of our research will help develop treatments for hyperparathyroidism and other bone and skeletal disorders in place of surgery.",1966610 (contact),"PARTRIDGE, NICOLA C (contact)","MALOZOWSKI, SAUL N",1994-12-01,2027-04-30,NA,Nuclear Events in PTHR1 Action on Bone,47420,ZRG1,Special Emphasis Panel[ZRG1-MOSS-L(02)M],NA,NA,30,240000,136800,376800,NA
11178032,I21,VA,5,N,2024-09-13,2024-01-01,2024-12-31,999,I21RX002395,NA,RX-17-012,5I21RX002395-07,NA,RESEARCH CENTERS,2024,Veterans Affairs,NA,BOSTON,UNITED STATES,NA,07,034432265,US,481041,VA BOSTON HEALTH CARE SYSTEM,MA,021304817,"The most recent conflicts are creating a new generation of veterans, including an increasing number of women veterans, who present with comorbid PTSD and chronic pain conditions, including Fibromyalgia (FM), from deployment-related physical injuries and exposure to psychological trauma. Health behavior change is important in treating these conditions and proactively preventing long-term negative health sequelae, in order to benefit these veterans directly and reduce the challenges to our healthcare system. The proposed SPiRE application will use an innovative translational research approach to study whether a progressive -based exercise program will reduce FM pain in patients with PTSD and to elucidate and modify potential PTSD- related deficiencies in neurobiological and psychological responses to exercise to optimize the physical and psychological benefits of exercise for these individuals.",10717214 (contact),"CHECKO, ERICA ROSE (contact)",NA,2018-01-01,2024-12-31,actigraphy;Acute;Allopregnanolone;American;Anhedonia;Anti-Inflammatory Agents;antinociception;behavior change;Biological Markers;Boston;Cardiology;Cardiopulmonary;Chronic;chronic musculoskeletal pain;chronic pain;chronic painful condition;Clinical Research;clinically significant;Cognitive;college;comorbidity;cytokine;Data;depressive symptoms;design;Development;disability;Disease;Educational Intervention;Exercise;exercise adherence;exercise intervention;exercise physiologist;exercise prescription;exercise program;exercise regimen;Exercise Test;exercise training;experience;Exposure to;Fibromyalgia;fibromyalgia pain;fibromyalgia patients;follow-up;Fostering;Functional disorder;Funding;Generations;Grant;Guidelines;Health;Health behavior change;Health Benefit;health care service utilization;Healthcare Systems;Heart Rate;Home;Hormones;Hydrocortisone;IL8 gene;immunoregulation;improved;Individual;Inflammation;Inflammatory;Injury;innovation;Interleukin-6;Intervention;intrinsic motivation;Maintenance;Mental Depression;Mental Health;Modification;Monitor;Motivation;neurobiological mechanism;Neurobiology;Neurohormones;Neuromodulator;neuropeptide Y;neurosteroids;Pain;pain reduction;pain sensitivity;Pain Threshold;Participant;Patients;physical conditioning;Physiological;Population;Post-Traumatic Stress Disorders;Pregnanolone;prevent;Problem Solving;Process;Protocols documentation;psychologic;psychological trauma;Publishing;recruit;Research Design;response;Rewards;Running;Self Efficacy;Severities;Stress;Substance P;Symptoms;System;Telephone;Testing;Training;Training Programs;Translational Research;trauma exposure;Treatment Protocols;United States National Institutes of Health;Up-Regulation;Veterans;Walking;Woman;Work,Neurobiological and Psychological Benefits of Exercise in Fibromyalgia and PTSD,2395,RRDS,Rehabilitation Research and Development SPiRE Program[RRDS],NA,NA,7,NA,NA,NA,NA
11178037,R00,HD,4,N,2024-09-13,2024-08-01,2025-07-31,865,R00HD109419,SCHOOLS OF NURSING,PA-20-187,4R00HD109419-03,NICHD:249000\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PHILADELPHIA,UNITED STATES,OTHER HEALTH PROFESSIONS,03,042250712,US,6463801,UNIVERSITY OF PENNSYLVANIA,PA,191046205,"While mothers' adverse childhood experiences (ACEs) can undermine their capacity to provide sensitive care that is essential for healthy child development, positive childhood experiences (PCEs) may be a source of resilience that buffers the deleterious effects of ACEs on parenting and their children's health. The proposed K99/R00 study aims to elucidate the relationships among mothers' ACEs and PCEs, maternal sensitivity, and immune regulation in infants and toddlers of mothers living with opioid-dependence, a high-risk group often exposed to a host of adversities. The expected findings may help explain the heterogeneity in outcomes in populations exposed to substantial adversity and will illuminate potential biobehavioral pathways of intergenerational transmission of adversity and resilience.",78307549 (contact),"YU, ZHIYUAN  (contact)","MAHOLMES, VALERIE",2024-08-01,2027-07-31,"Adult;adverse childhood events;Age;Behavioral;biobehavior;Biological;biological adaptation to stress;Biological Markers;Buffers;C-reactive protein;career;Caring;Cause of Death;Cells;Child;Child Development;Child Health;child neglect;Child Rearing;Childhood;Data;Development;efficacy testing;emotion regulation;Enrollment;experience;Exposure to;Family;Foundations;Funding;Gene Expression;Gene Expression Profile;Generations;Genetic;Genetic Transcription;Genomics;Goals;Health;Health Promotion;Heterogeneity;high risk population;Home;Immune;immune function;Immunologic Markers;immunological intervention;immunoregulation;Infant;Inflammatory;Informal Social Control;Interferon Type I;intergenerational;Intervention;Intervention Studies;Knowledge;Mediating;Mental Health;Methods;Mothers;National Institute of Child Health and Human Development;Opiate Addiction;opioid exposure;Outcome;parenting intervention;Parents;Pathway interactions;Pattern;Perinatal;Personal Satisfaction;Phase;poor health outcome;Population;prevent;promote resilience;prospective;randomized, clinical trials;Recording of previous events;Research;Research Personnel;resilience;response;Safety;Salivary;Secretory Immunoglobulin A;Shapes;skills;Source;Specific qualifier value;substance use;Testing;Time;Toddler;Training;transcriptomics;transmission process;Trauma;violence exposure;Work","Mothers' childhood experiences, maternal sensitivity, and immune regulation in young children",109419,NSS,NSS,NA,NA,3,153231,95769,249000,NA
11178050,R37,MH,3,N,2024-08-30,2024-07-01,2025-06-30,242,R37MH119194,SCHOOLS OF ARTS AND SCIENCES,PA-21-071,3R37MH119194-05S1,NIMH:126268\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,CAMBRIDGE,UNITED STATES,PSYCHOLOGY,05,082359691,US,3212901,HARVARD UNIVERSITY,MA,021385369,"NARRATIVE The proposed research examines neurodevelopmental mechanisms underlying the powerful association of stressful life events (SLEs) with internalizing and externalizing psychopathology during adolescence. We use a novel methodological approach that permits examination of dynamic changes in emotion, cognition, social behavior, and neural function and connectivity following SLEs at a sufficiently fine grained level of temporal specificity to identify mechanisms underlying the link between SLEs and adolescent psychopathology as they unfold in real time. Elucidating these mechanisms will not only build knowledge of how environmental experience shapes development in ways that increase risk for psychopathology, but will also suggest possible targets for interventions to prevent the onset of stress-related psychopathology in children and adolescents.",8546260 (contact),"MCLAUGHLIN, KATIE  (contact)","SMITH, ASHLEY",2020-07-01,2025-06-30,Acceleration;Address;Adolescence;Adolescent;Affect;Affective;Age;Amygdaloid structure;Behavior;Behavioral;Cellular Phone;Child;Cognition;Cognitive;cognitive control;cohort;Cross-Sectional Studies;Cues;design;Development;Developmental Process;digital phenotyping;Dorsal;Emotional;emotional stimulus;Emotions;Etiology;experience;Exposure to;Female;Frequencies;Goals;Grain;improved;Individual;innovation;Institution;Institutionalization;Intervention;Knowledge;Lead;Life Cycle Stages;Link;longitudinal design;Longitudinal Studies;Maps;Measures;media use;Mediating;Mental disorders;Mental Health;Methodology;Methods;Monitor;negative affect;Negative Valence;neglect;neural;neural circuit;neuromechanism;Neurophysiology - biologic function;novel;novel strategies;Onset of illness;Pattern;peer;Performance;Physical activity;Positive Valence;prevent;Prevention;Process;prospective;Psychopathology;Research;Research Domain Criteria;response;Rest;Rewards;Risk;sex;Shapes;sleep behavior;sleep quality;sleep quantity;smartphone based device;social;Social Behavior;social engagement;social media;Social Processes;Specificity;Stress;Stressful Event;Symptoms;System;Technology;Telephone;Text;Theoretical model;Time;Variant;Ventral Striatum;Violence;wearable device;Work;Youth,Neurodevelopmental Mechanisms Underlying Stress Vulnerability during Adolescence,119194,CPDD,Child Psychopathology and Developmental Disabilities Study Section[CPDD],NA,S1,5,74715,51553,126268,NA
11178059,D43,TW,3,N,2024-09-05,2024-08-30,2025-06-30,989,D43TW012274,SCHOOLS OF MEDICINE,PA-20-272,3D43TW012274-03S3,FIC:75000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,BALTIMORE,UNITED STATES,INTERNAL MEDICINE/MEDICINE,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,"NARRATIVE The Integrated Networks of Scholars in Global Health Research Training (INSIGHT) consortium formed between the University of Alabama at Birmingham, the Baylor College of Medicine, the University of Maryland Baltimore, and the University of Pittsburgh supports training for the next generation of global health scholars from the US and low- and middle-income countries (LMICs) through mentored research experiences at 24 established partner LM IC institutions across 19 countries in Africa, Asia, and Latin America and the Caribbean. Strong emphases are on a broad range of global health research areas, including combatting the global HIV epidemic and associated co-morbidities, emerging and re-emerging infectious diseases, non-communicable diseases, and mental health.",7693593 (contact);6106818;1881692;8439210,"CHARURAT, MANHATTAN E (contact);MANDALAKAS, ANNA M;NIMGAONKAR, VISHWAJIT LAXMIKANT;TURAN, JANET M","KATZ, FLORA N",2024-08-30,2025-06-30,Area;career;Educational workshop;experience;Faculty;Funding;Future;global health;International;meetings;Nature;Persons;programs;Research;Training;United States National Institutes of Health,Supplement_INSIGHT_Orientation,12274,NA,NA,NA,S3,3,69444,5556,75000,NA
11178093,OT2,OD,3,N,2024-09-09,2024-09-06,2025-02-28,310,OT2DB000004,SCHOOLS OF ARTS AND SCIENCES,OTA-21-009,3OT2DB000004-01S4,OD:247675\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CAMBRIDGE,UNITED STATES,SOCIAL SCIENCES,05,082359691,US,3212901,HARVARD UNIVERSITY,MA,021385369,NA,11282180 (contact),"KING, GARY  (contact)",NA,2021-09-25,2025-09-24,Adopted;Architecture;Awareness;collaborative approach;Data;Data Commons;data ecosystem;data management;data resource;data reuse;Data Science;data sharing;data submission;Ecosystem;FAIR principles;Funding;generalist repository;Infrastructure;Mission;Modernization;Reporting;repository;Research Personnel;Services;social;Strategic Planning;Training;United States National Institutes of Health;Vision;Work,The Harvard Dataverse repository: A generalist repository integrated with a Data Commons,4,ZDB1,ZDB1-SRC,NA,S4,1,247675,0,247675,NA
11178121,UH3,CA,4,N,2024-09-06,2024-08-01,2025-07-31,396,UH3CA275681,SCHOOLS OF PUBLIC HEALTH,RFA-RM-22-004,4UH3CA275681-03,OD:873648\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,BALTIMORE,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"Narrative To produce the first comprehensive 3D multiscale senescence atlas of tissues across ages, we propose to integrate our recently developed AI-based 3D tissue reconstruction platform CODA with both immunofluorescence and spatial transcriptomics, using pancreatic tissues as a testbed and expanded to breast and ovarian tissues.",11267674 (contact),"WU, PEI-HSUN  (contact)","JHAPPAN, CHAMELLI",2022-08-05,2026-07-31,3-Dimensional;Acinus organ component;Adult;Age;age related;age-related disease;Aging;Algorithms;Architecture;Atherosclerosis;Atlases;Biological Models;Biology;Blood Vessels;Breast;Cell Aging;Cell Cycle;cell type;Cells;cohort;Complex;Cytometry;deep learning;Development;Diabetes Mellitus;digital;Duct (organ) structure;Epithelial Cells;Fatty acid glycerol esters;Fibroblasts;Heterogeneity;HMGB1 gene;Human;human disease;human tissue;Image;imaging platform;Imaging technology;Immune;Immunofluorescence Immunologic;Immunohistochemistry;In Situ;islet;Islets of Langerhans;Label;life span;Link;Liver;Location;Lung;Lung Diseases;Mammary Gland Parenchyma;Maps;Measures;Methods;Molecular;Molecular Profiling;morphological criteria;multi-scale atlas;Natural History;Nature;Nerve;novel;Organ;Ovarian Tissue;Ovary;Pancreas;pathogen;Pathologic;Phase;Physiological;programs;Proteins;Proteomics;repaired;Resolution;response;RNA;Role;Sampling;senescence;senescent cell;Skin;Spatial Distribution;Techniques;Technology;technology platform;Thick;Three-Dimensional Imaging;Tissue atlas;tissue mapping;tissue reconstruction;Tissue Sample;Tissues;tool;transcriptomics,Three-dimensional maps of senescence in the human pancreas,275681,ZRG1,Special Emphasis Panel[ZRG1-CB-K(70)R],NA,NA,3,573406,300242,873648,NA
11178122,UH3,CA,4,N,2024-08-28,2024-08-01,2025-07-31,310,UH3CA275686,SCHOOLS OF MEDICINE,RFA-RM-22-004,4UH3CA275686-03,OD:904750\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,DERMATOLOGY,13,621889815,US,1833205,COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,100323725,"NARRATIVE Human skin, like all other tissues, undergoes an intrinsic aging process during an individual’s lifespan known as chronological aging, as well as photoaging, since the skin is constantly exposed to environmental factors such as UV radiation (UVR), which is recognized as the major risk factor for the development of many skin cancers. In the skin, there is an age-associated accumulation of senescent melanocytes, keratinocytes and fibroblasts capable of expressing the senescence-associated secretory phenotype (SASP), which promotes inflammation and have a profound deleterious effect on skin structure and integrity. We will generate 3D skin models that encompass critical biological variables for mapping senescent cells in tissues, and will include: 1) both genders; 2) the full range of skin pigmentation phototypes; and 3) age ranges across the human lifespan, to investigate the mechanisms leading to senescence in the skin and test new approaches to treat age-related conditions.",6378222 (contact),"CHRISTIANO, ANGELA M (contact)","JHAPPAN, CHAMELLI",2022-08-05,2026-07-31,3-Dimensional;Acceleration;Adopted;Affect;Age;age group;age related;age related chronic disease;age-related disease;Aging;aging process;analytical tool;Asthma;Atopic Dermatitis;Biological;bioprinting;Bystander Effect;Cardiovascular Diseases;Cell Aging;Cell Culture Techniques;cell type;Cells;Characteristics;Chronology;Complex;Controlled Environment;cytokine;Data;Dermal;Dermis;Development;Distant;efficacy evaluation;Environment;Environmental Risk Factor;Epidermis;Evaluation;experimental study;Exposure to;Fibroblasts;Freezing;Frequencies;Gender;Generations;Genes;Goals;Heart;Histologic;Human;Hyperpigmentation;In Vitro;Individual;Inflammation;innovation;Joints;keratinocyte;Kidney;Libraries;life span;Lung;Lupus;Maps;media use;Mediating;melanocyte;Melanoma;metabolomics;Microfluidics;Modeling;multiple omics;multiplex assay;Muscle;novel drug class;novel strategies;Organ;paracrine;Paracrine Communication;Pharmaceutical Preparations;Phase;Phenotype;Physiological;Play;Protocols documentation;Psoriasis;Psoriatic Arthritis;Psychological reinforcement;Public Health;Risk Factors;Role;senescence;senescence associated secretory phenotype;senescent cell;senolytics;sex;Skin;Skin Aging;Skin Cancer;skin disorder;Skin Physiology;Skin Pigmentation;Skin Tissue;Structure;Techniques;Testing;Time;tissue culture;Tissue Engineering;tissue mapping;Tissue Model;Tissues;tool;transcriptomics;Ultraviolet Rays;Universities;Vascular Endothelial Cell,Senescence-on-a-chip: Building a microphysiological 3D skin model,275686,ZRG1,Special Emphasis Panel[ZRG1-CB-K(70)R],NA,NA,3,550000,354750,904750,NA
11178123,UH3,CA,4,N,2024-08-29,2024-09-01,2025-08-31,310,UH3CA275687,BIOMED ENGR/COL ENGR/ENGR STA,RFA-RM-22-004,4UH3CA275687-03,OD:889157\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,CAMBRIDGE,UNITED STATES,ENGINEERING (ALL TYPES),07,001425594,US,4911501,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,021421029,"PROJECT NARRATIVE Single cell multi-omics profiling assays (e.g., single-cell RNA-seq, ATAC-seq, proteomics) have opened new windows into understanding the properties, regulation, dynamics, and function of senescence at unprecedented resolution and scale, however, these assays are inherently destructive, precluding us from tracking the molecular profiles and dynamics of live cells in tissues, whole organisms, or humans. We aim to develop an innovative technology “SenNetRaman” by combining the recent advance in high-resolution and -speed Raman microscopy, single-cell and spatial multi-omics, and machine learning to unbiasedly map the molecular and cellular heterogeneity and spatial information of senescent cells nondestructively. Overall, we believe “SenNetRaman” is highly modular and lays a foundation for future investigations into exploring single-cell genome-wide molecular dynamics of senescent cells in tissues through imaging data, in vitro and in vivo in humans.",1866930 (contact),"SO, PETER T. (contact)","JHAPPAN, CHAMELLI",2022-08-05,2026-08-23,aged;Aging;ATAC-seq;Atlases;Biological Assay;Biological Models;Biology;Biomedical Research;Brain;Cell Aging;Cell Culture Techniques;Cell Physiology;Cells;Clinical Research;Collaborations;Complex;computational platform;computer framework;Confocal Microscopy;Data;data integration;Development;Dimensions;Disease;Dissociation;Endoscopes;Environment;Foundations;Future;Gene Expression;Gene Expression Profile;General Hospitals;Genetic Transcription;genome-wide;genomic biomarker;Genomics;Heterogeneity;Human;Human BioMolecular Atlas Program;human tissue;Image;imaging biomarker;imaging modality;imaging system;improved;in situ sequencing;In Vitro;in vivo;Inflammatory;innovation;innovative technologies;Institutional Review Boards;Intervention;Investigation;Knowledge;Label;Life;Light;Link;lipidomics;Lung;Machine Learning;Malignant Neoplasms;Maps;Massachusetts;medical schools;metabolomics;methylomics;Microscope;microscopic imaging;Microscopy;Mission;Modeling;Molecular;molecular dynamics;Molecular Profiling;Morphology;mouse model;multimodal data;multimodality;Multiomic Data;multiple omics;Mus;New England;new technology;novel;novel marker;Pattern;Phase;predictive marker;Property;Proteomics;Protocols documentation;Raman Spectrum Analysis;Regulation;Reporting;Research Personnel;Resolution;Scanning;senescence;senescent cell;Services;Signal Transduction;single cell ATAC-seq;single cell genomics;single-cell RNA sequencing;Skin;Specimen;Speed;Stress;Structure of parenchyma of lung;System;Technology;Testing;Time;tissue mapping;Tissues;Training;transcriptomics;Translations;tumor;United States National Institutes of Health;Universities;Whole Organism,Single-cell label-free identification of senescence by Raman microscopy and spatial genomics,275687,ZRG1,Special Emphasis Panel[ZRG1-CB-K(70)R],NA,NA,3,747650,141507,889157,NA
11178124,UH3,CA,4,N,2024-08-28,2024-08-01,2025-07-31,310,UH3CA275669,NA,RFA-RM-22-005,4UH3CA275669-03,OD:794647\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,ROCHESTER,UNITED STATES,NA,01,006471700,US,4976101,MAYO CLINIC ROCHESTER,MN,559050001,"PROJECT NARRATIVE New technologies and experimental pipelines are needed to accurately phenotype and quantify senescent cells within their distinct microenvironments. We propose to develop iterative and integrated spatially-resolved imaging mass cytometry and digital-spatial transcriptomics for determination of senescent cell identity and abundance across mouse and human tissues, beginning with analyses in the aged mouse brain. This novel, scalable molecular mapping technology can ultimately be used to facilitate assessment of and extent to which senescent cells contribute to age-related tissue dysfunction, with broad relevance to human therapy development.",10220092 (contact),"SCHAFER, MARISSA JOY (contact)","JHAPPAN, CHAMELLI",2022-08-05,2026-07-31,Address;Age;age related;age related decline;aged;Aging;aging mechanism;antibody conjugate;Apoptotic;Atlases;biological heterogeneity;Biological Markers;biomarker panel;Body System;Brain;brain cell;brain parenchyma;Brain region;Cell Aging;cell type;Cells;Cerebellum;Complex;Corpus striatum structure;Cytometry;Data;design;digital;Dimensions;Disease;experience;Female;Frequencies;Functional disorder;Gene Expression Profile;Goals;Health;Heterogeneity;high dimensionality;Hippocampus;Human;human tissue;Image;imaging biomarker;Individual;innovation;innovative technologies;Intervention;Knowledge;life span;male;Maps;Mediating;Metabolic;Metals;method development;Methods;Microglia;Molecular;molecular phenotype;Morphology;Mus;Neurons;new technology;novel;old mice;Pathology;Pathway interactions;Phase;Phenotype;Prefrontal Cortex;preservation;Process;programs;Property;Proteins;Regenerative capacity;Resolution;response;RNA;senescence;senescence associated secretory phenotype;senescent cell;single cell sequencing;Slice;spatial integration;Standardization;Structure of choroid plexus;Suspensions;Technology;therapeutic development;therapeutically effective;therapy development;Tissues;transcriptome;transcriptomic profiling;transcriptomics;white matter;women versus men;Work,Spatially-resolved protein and transcriptome mapping of senescent cells,275669,ZRG1,Special Emphasis Panel[ZRG1-CB-K(70)R],NA,NA,3,507981,286666,794647,NA
11178136,U18,FD,3,N,2024-08-28,2024-09-01,2025-08-31,103,U18FD005320,NA,RFA-FD-24-027,3U18FD005320-11S1,FDA:13390596\,OTHER RESEARCH-RELATED,2024,FOOD AND DRUG ADMINISTRATION,NA,TUCSON,UNITED STATES,NA,06,175893135,US,10007185,CRITICAL PATH INSTITUTE,AZ,85718,"PROJECT NARRATIVE Critical Path Institute (C-Path) was established in 2005 under the auspices of FDA’s Critical Path Initiative to catalyze advances in medical innovation and regulatory science, by leading teams of stakeholders from industry, government, academia, and advocacy organizations to generate actionable solutions to address unmet needs in drug development. With renewed funding C-Path will be able to continue developing impactful Critical Path Public-Private Partnerships and advancing innovative, collaborative projects in research, education, and outreach for fostering medical product innovation, enabling the acceleration of medical product development.",9782841 (contact),"ROMERO, KLAUS  (contact)","KOUSSIS, PATRICIA",2014-09-05,2029-08-31,NA,Critical Path Public Private Partnerships,5320,ZFD1,ZFD1-CDER-T(10)1,NA,S1,11,10656838,2733758,13390596,NA
11178143,UG1,CA,3,N,2024-08-30,2024-08-01,2025-07-31,399,UG1CA189824,SCHOOLS OF MEDICINE,RFA-CA-18-015,3UG1CA189824-11S1,NINDS:217552\,OTHER RESEARCH-RELATED,2024,NATIONAL CANCER INSTITUTE,NA,WINSTON-SALEM,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,937727907,US,9021205,WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,271570001,The Wake Forest NCORP Research Base develops and implements multi-site Cancer Control and Cancer Care Delivery (CCDR) clinical research studies in partnership with NCORP Community and Minority/Underserved Community Sites to improve patient well-being and the quality of cancer care.,8842460;1880766 (contact);10391553,"DRESSLER, EMILY VAN METER;LESSER, GLENN J (contact);WEAVER, KATHRYN ELIZABETH","HECKMAN-STODDARD, BRANDY",2014-08-01,2025-07-31,Acceleration;Address;Age;Aging;Area;base;Behavioral Sciences;biobank;Biological;Biometry;Blood;cancer care;cancer complication;Cancer Control;cancer health disparity;cancer site;cancer therapy;Cardiology;Cardiovascular system;care delivery;care systems;Caregivers;Caring;chemotherapy;Chemotherapy and/or radiation;clinical investigation;clinical pain;Clinical Research;Collaborations;Collection;Communities;Community Clinical Oncology Program;community partners;Comprehensive Cancer Center;Country;Data;Development;Disparity;Dissemination and Implementation;Early treatment;early-career faculty;Enrollment;ethnic minority;ethnic minority population;evidence base;Faculty;Family;Funding;Future;Goals;health disparity;Health Sciences;Health Services Research;Helping to End Addiction Long-term;Image;improved;Individual;Infrastructure;innovation;Interdisciplinary Study;Intervention;Investigation;knowledge translation;Late Effects;Liquid substance;Malignant Neoplasms;medical schools;Mentors;Minority;multidisciplinary;NCI Center for Cancer Research;NCI-Designated Cancer Center;Neurocognitive;Neurosciences;next generation;novel;Oncology;Outcome;Pain;Pain management;Participant;patient oriented;patient population;Patients;Personal Satisfaction;Postdoctoral Fellow;Prevention;Primary Care;Process;protocol development;Protocols documentation;Public Health;racial minority;Radiation therapy;recruit;Research;Research Activity;Research Design;Research Personnel;research study;Resources;rural dwellers;Salivary;Sampling;Science;Site;Specimen;Speed;Students;Supportive care;survivorship;Symptoms;Toxic effect;Training;Treatment Efficacy;Treatment outcome;underserved community;underserved minority;Underserved Population;United States National Institutes of Health;Urine;Woman;Work,Wake Forest NCORP Research Base,189824,ZCA1,ZCA1-GRB-S(M1),NA,S1,11,140356,77196,217552,NA
11178144,R01,HD,3,N,2024-08-28,2024-04-01,2025-03-31,865,R01HD098258,UNIVERSITY-WIDE,PA-19-056,3R01HD098258-06S1,NICHD:91245\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MINEOLA,UNITED STATES,NONE,03,117393226,US,10059523,NYU LONG ISLAND SCHOOL OF MEDICINE,NY,115014089,"NARRATIVE  Although the intrauterine setting is considered to be a safe environment for the fetus, microbes have been detected in gestational tissues in normal asymptomatic pregnancies. The proposed studies in this grant address novel and cutting-edge concepts regarding the role of placenta-specific microRNAs in regulating exaggerated inflammation after repeated infections during pregnancy. These studies may set the stage to the identification of biomarkers and targets to treat inflammation related to preterm births and other inflammation-associated pathologic pregnancies.",7928701 (contact),"HANNA, NAZEEH N (contact)","ILEKIS, JOHN V",2020-04-02,2025-03-31,Address;Anti-Inflammatory Agents;Attenuated;Bacterial Toxins;Biological Markers;biomarker identification;candidate marker;cell type;Cells;Clinical;Data;Disease;Distant;Dose;Down-Regulation;Endometrial;Environment;Equilibrium;Exhibits;experimental study;Exposure to;extracellular vesicles;fetal;Fetus;Future;Grant;healthy pregnancy;Histologic;Host Defense;Human;human disease;Immune;Immune response;Immune system;Immune Tolerance;Immunosuppression;implantation;Infection;Inflammation;Inflammatory;Inflammatory Response;intraamniotic infection;intrauterine environment;Invaded;Link;Maintenance;Maternal-Fetal Exchange;Mediating;Microbe;MicroRNAs;Modeling;Molecular;mortality;Mothers;Mus;novel;Organism;pathogen;pathogenic microbe;Pathologic;Phenotype;Placenta;placental trophoblasts;Placentation;Play;Pregnancy;Pregnancy Trimesters;Pregnant Women;Premature Birth;prevent;Production;Research;Role;Signal Transduction;Stimulus;Testing;Therapeutic;therapeutic target;tissue injury;Tissues;Uterine Contraction;Woman,Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta,98258,PN,Pregnancy and Neonatology Study Section[PN],NA,S1,6,59250,31995,91245,NA
11178177,U24,MD,3,N,2024-09-10,2024-09-01,2025-06-30,307,U24MD017250,SCHOOLS OF DENTISTRY/ORAL HYGN,PA-20-272,3U24MD017250-04S1,OD:235000\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,SAN FRANCISCO,UNITED STATES,DENTISTRY,11,094878337,US,577508,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,941432510,"This project will leverage and pivot UCSF’s significant expertise, experience, and capacity in community-engaged research, disparities research, program implementation experience with populations that are underserved and vulnerable, data science, and major chronic diseases to create a nationwide research coordinating center and technical assistance center to support a network of NIMHD funded P50 centers to reduce multiple chronic disease related disparities in underserved and vulnerable populations.",7356195;1934839 (contact);10472698,"CHARLEBOIS, EDWIN DUNCAN;GANSKY, STUART A (contact);RHOADS, KIM FELDER","STINSON, NATHANIEL",2021-09-24,2025-06-30,Acceleration;Affect;African American;Alaska Native;Artificial Intelligence;Asian;Awareness;biomedical informatics;California;Case Study;Chronic;Chronic Disease;Cities;Clinical Trials Data Monitoring Committees;Clinical Trials Design;Collaborations;Collection;Common Core;Common Data Element;Communication;Communities;community advisory board;community engaged research;community engagement;Community Networks;Community of Practice;community partners;community partnership;comorbidity;Country;COVID-19;Data;Data Aggregation;data management;Data Science;Data Set;data sharing;data standards;data warehouse;design;Development;disease disparity;Disparity;disparity reduction;Education;education research;Educational workshop;Evaluation;experience;flexibility;Funding;Geography;Goals;Health;health data;Health Disparities Research;health disparity populations;Health Sciences;Hispanic;Homelessness;human subject;implementation science;Individual;instrument;Integrated Health Care Systems;interoperability;Intervention;Intervention Trial;Latino;meetings;member;Mentors;Methods;minority health;minority health disparity;Minority-Serving Institution;Monitor;National Institute on Minority Health and Health Disparities;Native Americans;Neighborhoods;operation;Pacific Islander;Persons;PhenX Toolkit;Population;prevent;Prevention;Process;programs;Race;Records;Research;Research Design;Research Personnel;Resource Sharing;Resources;response;responsible artificial intelligence;Risk;San Francisco;Secure;Sexual and Gender Minorities;Site;skill acquisition;skills;social health determinants;socioeconomics;Standardization;Statistical Data Interpretation;Testing;tool;Training;Underserved Population;United States National Institutes of Health;Universities;Vulnerable Populations;web site;webinar;working group,Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (RCC RD-MCD),17250,NA,NA,NA,S1,4,143292,91708,235000,NA
11178181,R01,TW,3,N,2024-08-30,2024-09-11,2025-06-30,989,R01TW012392,SCHOOLS OF NURSING,PAR-21-344,3R01TW012392-03S1,FIC:100000\,NON-SBIR/STTR RPGS,2024,FOGARTY INTERNATIONAL CENTER,NA,LOS ANGELES,UNITED STATES,NONE,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,"Project Narrative Thailand remains one of the countries with the largest population of people living with HIV (PLWH) in the Asian-Pacific region. In Thailand, as in other middle-income Asian countries, HIV stigma has been impacted in PLWH and their family members is a pressing health concern. The purpose of this study is to culturally adapt and evaluate the feasibility of a 4 weekly 2-hour group-based stigma reduction intervention to promote health engagement.",9286268 (contact),"CHEN, WEI-TI  (contact)","BANSAL, GEETHA PARTHASARATHY",2022-09-11,2025-06-30,"acceptability and feasibility;Address;Adherence;Adult;Affect;Affective;arm;Asia;Asian;Behavior;Belief;Buddhism;Caring;Cognitive;Compassion;Country;culturally appropriate intervention;Data;Death Rate;Deterioration;Discrimination;Epidemic;ethnic minority;evidence base;Family member;feasibility testing;Future;gender minority;Goals;Health;health care availability;Health Promotion;Health Services;HIV;Hour;Image;Income;Individual;innovation;insight;internalized stigma;Intervention;Intervention Studies;Interview;Manuals;marginalization;Measures;men who have sex with men;Mental Health;Methods;mindfulness;Modeling;Modernization;Myanmar;operation;Outcome;Outcome Assessment;Participant;Pathway interactions;Patients;Personal Satisfaction;Persons;Pharmaceutical Preparations;Phase;Philosophy;physical conditioning;Pilot Projects;Population;Prevalence;primary outcome;Procedures;Process;protective behavior;Protocols documentation;psychoeducation;Randomized;Randomized, Controlled Trials;Research;Risk Factors;Role;Sampling;secondary outcome;Self Management;self-compassion;sex;Sexual and Gender Minorities;social;social stigma;Social support;substance user;Thailand;transgender;Treatment Efficacy;treatment group;Underserved Population;United States;Viral Load result;Woman",Buddhism and HIV Stigma in Thailand: An Intervention Study,12392,HIBI,HIV/AIDS Intra- and Inter-personal Determinants and Behavioral Interventions Study Section[HIBI],NA,S1,3,63492,36508,100000,NA
11178183,R00,HD,6,N,2024-09-13,2024-07-01,2026-02-28,865,R00HD099269,SCH ALLIED HEALTH PROFESSIONS,PA-18-398,6R00HD099269-06,NICHD:87651\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NORFOLK,UNITED STATES,NONE,03,041448465,US,6249601,OLD DOMINION UNIVERSITY,VA,235080369,"PROJECT NARRATIVE In this application, I propose a set of genetic, biochemical and bioinformatics studies to understand: 1) the role of ADAR1 RNA editing in regulation of the maternal transcriptome in the oocyte and early embryo in young and old mice, and 2) the effect of ADAR1 RNA editing on RNA stability in oocytes and eggs from young and old mice. These mechanistic studies will advance our basic understanding of how post-transcriptional RNA processing is integral to the oocyte RNA environment, and hence, oocyte quality. The knowledge gained from this proposal could promote a shift in current paradigms and redirect research to accelerate progress in understanding infertility and disease.",12518878 (contact),"BRACHOVA, PAVLA  (contact)","TAYMANS, SUSAN",2019-08-26,2026-02-28,3&apos; Untranslated Regions;Acceleration;Adenosine;adenosine deaminase;age related;age related decline;aging population;Area;Biochemical;Bioinformatics;blastocyst;Cells;Code;Codon Nucleotides;Competence;Congenital Abnormality;Coupled;Data;Deamination;decapping enzyme;Defect;Development;Disease;dosage;Double-Stranded RNA;dsRNA adenosine deaminase;egg;Embryo;Embryonic Development;Environment;Enzymes;experimental study;Female;female fertility;Fertility;Fluorescent in Situ Hybridization;Genetic;Genetic Transcription;Goals;Growth;Human;human embryonic development;Infertility;innovation;Inosine;Knock-out;Knowledge;male;Maternal Age;Maternal Messenger RNA;Mediating;Meiosis;Mentors;Mentorship;Messenger RNA;Modeling;Modification;Morula;mRNA Decay;mRNA Stability;mRNA Transcript Degradation;Mus;mutant;novel;old mice;oocyte quality;Oocytes;Oogenesis;Partner in relationship;Pattern;Phase;Poly(A) Tail;Polyribosomes;Post-Transcriptional Regulation;Post-Transcriptional RNA Processing;Process;Proteins;recruit;Regulation;Reproduction;reproductive;Research;RNA;RNA Editing;RNA Stability;Role;Scientist;spleen exonuclease;Spontaneous abortion;Testing;Training;Transcript;transcriptome;transcriptomics;Translations;Work;zona pellucida glycoprotein,A-to-I RNA modifications in mouse oocytes,99269,NSS,NSS,NA,NA,6,58434,29217,87651,NA
11178188,K43,TW,3,N,2024-09-05,2024-09-13,2025-05-31,989,K43TW011943,NA,PAR-19-051,3K43TW011943-04S1,FIC:95404\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,RONDEBOSCH,SOUTH AFRICA,NA,NA,568227214,SF,1147601,UNIVERSITY OF CAPE TOWN,NA,7700,"PROJECT NARRATIVE The ultimate goal of this research is to evaluate the feasibility, acceptability and preliminary impact of incorporating choice in the delivery of ART support to patients who return to HIV care after an interruption, a growing population who are vulnerable to future interruptions. The development of patient-centered interventions is a key priority area to bridge remaining HIV treatment gaps in high-burden settings like South Africa. If proven to be acceptable, feasible and effective, incorporating choice in the delivery of ART support in routine, high-burden HIV care settings may be an important tool to promote patient empowerment and improve ART adherence and retention.",15607854 (contact),"PHILLIPS, TAMSIN KATE (contact)","BANSAL, GEETHA PARTHASARATHY",2021-08-23,2026-05-31,Acquired Immunodeficiency Syndrome;Adherence;Adult;Africa South of the Sahara;Aftercare;AIDS prevention;antiretroviral therapy;Area;arm;Attention;Award;behavior measurement;Behavioral;behavioral and social science;behavioral economics;Behavioral Research;career;career development;Caring;Clinic;Clinical;Communities;Contraceptive Agents;Data;design;Development;Effectiveness;Effectiveness of Interventions;empowerment;Ensure;Epidemiologist;Epidemiology;Evaluation;evidence base;experience;experimental study;Family Planning;Fellowship;Funding;Future;gender behavior;Goals;Growth;Guidelines;Health;Health behavior;Health Services;high risk;HIV;HIV/AIDS;implementation measures;implementation science;improved;Individual;informant;innovation;International;Interruption;Intervention;Intervention Studies;Interview;Investigation;K-Series Research Career Programs;Leadership;Measurement;Measures;men;Mentors;Mentorship;Methods;mHealth;mhealth interventions;multidisciplinary;North Carolina;Outcome;Output;patient oriented;Patient Preferences;Patients;peer support;Pennsylvania;Persons;pilot trial;Policies;poor health outcome;Population;Postdoctoral Fellow;preference;Public Health;Qualitative Methods;Qualitative Research;Randomized;Research;Research Methodology;Research Personnel;Research Priority;Resources;Role;satisfaction;Scientist;secondary outcome;Self Efficacy;Series;Services;skills;social;South Africa;Structure;Surveys;therapy adherence;therapy design;therapy development;Time;tool;Training;Treatment outcome;United States National Institutes of Health;Universities;Viral;Woman,Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa,11943,ZRG1,Special Emphasis Panel[ZRG1-RPHB-P(02)M],NA,S1,4,88337,7067,95404,NA
11178210,P20,GM,3,N,2024-09-11,2024-02-01,2025-01-31,NA,P20GM139745,NA,PA-20-272,3P20GM139745-04S2,NIGMS:426281\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,PORTLAND,UNITED STATES,NA,01,071732663,US,4757601,MAINEHEALTH,ME,041023175,NA,1887504 (contact),"SAWYER, DOUGLAS B (contact)","ZHOU, YANG",2021-02-10,2026-01-30,Acute;acute care;Advisory Committees;Antibiotic Therapy;Area;Basic Science;Bioethics;Biomedical Research;Cardiopulmonary Resuscitation;Cardiovascular system;care outcomes;care systems;career;Caring;Centers of Research Excellence;Clinical;clinical center;Clinical Research;cohort;Collaborations;Communication;community engagement;community engagement process;Community Hospitals;Community Outreach;Consent;Core Facility;design;Development;Discipline;Disparity;disparity reduction;Doctor of Philosophy;Emergency Situation;Ensure;Ethics;Evaluation;Exhibits;experience;Face;Family;Fostering;Funding;Goals;Growth;Health Personnel;Health Services Research;Healthcare;Healthcare Systems;Heart Arrest;Human Subject Research;improved outcome;Inflammatory Response;Infrastructure;innovation;Institution;Investments;Leadership;Learning;Link;Maine;Medical;Medical center;meetings;Mentors;Mentorship;Modeling;Molecular Analysis;National Institute of General Medical Sciences;neonatal encephalopathy;neonate;New England;organizational structure;outcome disparities;outreach;Patients;Physicians;Pilot Projects;Principal Investigator;Process;Program Development;Program Evaluation;programs;prophylactic;Reporting;Research;Research Methodology;Research Personnel;Research Training;Rural;rural area;Rural Community;rural disparities;rural health disparities;rurality;Scientist;Severities;Strategic Planning;Structure;success;synergism;System;Teacher Professional Development;Telemedicine;Translational Research;translational research program;United States National Institutes of Health;urban area;urgent care,Administrative and Professional Development Core,139745,NA,NA,5487,S2,4,277040,149241,NA,426281
11178221,P20,GM,3,N,2024-09-11,2024-02-01,2025-01-31,NA,P20GM139760,NA,PA-20-272,3P20GM139760-04S3,NIGMS:311051\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,NEWARK,UNITED STATES,NA,00,059007500,US,2076701,UNIVERSITY OF DELAWARE,DE,197160099,NA,2084442 (contact),"ELLIOTT, DAWN M (contact)","BERNAL, FEDERICO",2021-02-15,2026-01-31,Acceleration;Advisory Committees;Aging;Annual Reports;Attention;Basic Science;Biological;BMP2 gene;career development;Clinical Research;Collaborations;Communication;Communities;Complex;Cues;Data;Delaware;Development;Development Plans;Disease;Ensure;Evaluation;Extramural Activities;Faculty;formative assessment;Functional disorder;Funding;Future;Goals;Grant;Growth;Health;improved;Infrastructure;Leadership;meetings;Mentors;Musculoskeletal;Musculoskeletal Diseases;novel;Office of Administrative Management;operation;Periodicals;pre-clinical;pre-clinical research;Program Development;Program Evaluation;programs;recruit;Reporting;Research;Research Personnel;Research Project Grants;Resources;Signal Transduction;Structure;success;Therapeutic Intervention;Tissues;tool;United States National Institutes of Health;Universities;Women&apos;s Health;Work,Delaware Center for Musculoskeletal Research – Administrative Core,139760,ZGM1,ZGM1,6927,S3,4,197293,113758,NA,311051
11178229,P20,GM,3,N,2024-09-11,2024-04-01,2025-03-31,NA,P20GM103440,NA,PA-20-272,3P20GM103440-22S2,NIGMS:265492\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,RENO,UNITED STATES,NA,02,146515460,US,829903,UNIVERSITY OF NEVADA RENO,NV,89557,NA,8897571 (contact),"BAKER, JONATHAN E. (contact)","MATUKUMALLI, LAKSHMI KUMAR",2001-09-01,2026-03-31,Address;Administrative Supplement;Advisory Committees;Annual Reports;Award;Biomedical Research;brain health;Cell Differentiation process;cell growth;Centers of Research Excellence;Characteristics;Clinical;Collaborations;Communication;Data;Data Science Core;Databases;Development;Educational process of instructing;Ensure;Evaluation;Faculty;flexibility;Funding;Goals;improved;Institution;Leadership;Link;meetings;member;Mentors;Mission;Network Infrastructure;Nevada;outreach;outreach program;Program Research Project Grants;programs;Progress Reports;Research;Research Activity;research faculty;Resource Sharing;Resources;Services;Sister;Students;success;Training;undergraduate research experience;undergraduate student;United States National Institutes of Health;web site;Women&apos;s Health;Work,Administrative Core,103440,ZGM1,ZGM1,9081,S2,22,180607,84885,NA,265492
11178288,Y01,DC,NA,N,NA,NA,NA,NA,ADC23002001,NA,NA,ADC23002001-1-0-1,NIDCD:2225000\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,"Extensive research has been done on the measurement and causes of smell and taste disorders.  These disorders can be screened with a series of simple questions with inexpensive, brief odor identification tests and taste intensity tests coupled with further questions (problems past year, since age 25, phantom and altered sensations) that can screen for marked dysfunction. NIH-funded centers and research investigators provide direction for treatment of these disorders.  When properly diagnosed, some causes of impaired taste and smell are treatable. Treatments include: 1) over-the-counter or prescription medications, 2) quitting smoking if a smoker, 3) dental care, 4) changing medications or doses if current medications are causing impaired taste and smell, 5) chronic sinusitis, treated with antibiotics, and 6) surgery to remove nasal polyps. The causes of olfactory dysfunction that are most amenable to treatment include obstructing polyps or other masses (treated by excision) and inflammation (treated with steroids).  Nutritional counseling with enhancement of food flavor and appearance and maintenance of healthful eating and weight can improve quality of life in patients with irreversible dysfunction.  Health care providers should be prepared to offer education (particularly to older adults) about avoiding hazardous events if they have impaired senses of smell and taste.",NA,(contact),NA,NA,NA,Adult;Affect;Age;aged;Agreement;American;Antibiotics;Appearance;Area;Arthritis;Asthma;Behavior;Biological;Cardiovascular Diseases;Censuses;Child;Childhood;Chocolate;Chronic Disease;Chronic Sinusitis;Collaborations;Communication;Communication difficulty;Communication Disability;Communication impairment;Communities;Community Surveys;Consultations;Coronavirus;cost;Counseling;Coupled;COVID-19 diagnosis;Data;Data Collection;Data Files;data quality;Data Set;Deglutition;Deglutition Disorders;Dental Care;design;Development;Diabetes Mellitus;Diagnosis;disability;Disease;Dose;Drug Prescriptions;Eating;Economics;Education;Emotional;Employment Opportunities;Epidemiology;epidemiology study;Esthesia;Etiology;Evaluation;Event;Excision;Family;feeding;flu;Food;food flavor;Functional disorder;Funding;Genus Vanilla;Head;Health;health care availability;health care service;health disparity;Health Personnel;Health Professional;Health Status;Healthcare;Housing;Hypertension;Impairment;improved;Individual;Inflammation;Injury;Institutional Review Boards;instrument;interest;Intervention;Interview;Interviewer;Language;Language disability;Language Disorders;Licensing;Life;lifestyle factors;Link;Maintenance;malformation;Malignant Neoplasms;Measurement;Measures;Medical;Medical Care Team;member;metallicity;Modernization;Nasal Polyps;National Health Interview Survey;National Institute on Deafness and Other Communication Disorders;Neurologic;Nutritional;Occupational;Occupations;Odors;older adult;Olfaction Disorders;Olfactory dysfunction;operation;Operative Surgical Procedures;Oral cavity;Pathologist;Patients;Persons;Pharmaceutical Preparations;Physicians;Polyps;Population;population survey;Preparation;Prevalence;psychologic;Publications;Pulmonary Emphysema;quality assurance;Quality of life;Questionnaire Designs;Questionnaires;Reporting;Research;Research Personnel;Risk;risk mitigation;Sampling;SARS-CoV-2 infection;screening;Series;Services;Smell Perception;Smoker;smoking cessation;social;Social Interaction;Societies;sociodemographic factors;Specialist;Speech;Speech Disorders;Speech Sound;Speech-Language Pathology;Steroids;Strawberries;Stroke;Stuttering;Surgeon;Surveys;sweet taste perception;Symptoms;Taste Disorders;Taste Perception;Technology;Testing;Time;Training;Travel;United States;United States National Center for Health Statistics;United States National Institutes of Health;Voice;Voice Disorders;web site;Weight;Work;Xerostomia,CDC-NCHS-NHIS Taste & Smell Questionnaire Supplement,230020,NA,NA,NA,NA,NA,NA,NA,2225000,NA
11178289,N01,HD,NA,N,NA,NA,NA,NA,75N94020D00003,NA,NA,75N94020D00003-P00005-759402000001-1,NICHD:540341\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,77858356 (contact),"PARMAN, TOUFAN  (contact)",NA,2020-09-04,2025-09-03,Archives;Biological;Biological Testing;Contraceptive Agents;Contraceptive methods;Contractor;Data;data communication;Data Storage and Retrieval;Databases;Equipment;Equipment and supply inventories;Interruption;Maintenance;men;Mission;National Institute of Child Health and Human Development;new product development;preclinical development;product development;Program Development;programs;Research;Woman,"BIOLOGICAL TESTING FACILITY - ADMINISTRATION, MANAGEMENT, AND DATABASE MAINTENANCE FOR CONTRACEPTION RESEARCH",0,NA,NA,NA,NA,NA,NA,NA,540341,NA
11178293,R01,NS,3,N,2024-09-05,2024-09-01,2025-08-31,853,R01NS126504,SCHOOLS OF MEDICINE,PA-20-185,3R01NS126504-03S1,NINDS:80755\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,RICHMOND,UNITED STATES,BIOCHEMISTRY,04,105300446,US,353201,VIRGINIA COMMONWEALTH UNIVERSITY,VA,232980568,"Astrocytes, the most abundant glial cells in the central nervous system, perform a multitude of evolutionary conserved functions including, metabolic support to neurons, regulating blood-brain barrier, and modulating synapse-formation, -function and -plasticity, and are crucial in maintaining normal brain homeostasis. Dynamic crosstalk between astrocytes and neuronal synapses modulates most if not all of these functions, yet the molecular mechanism of neuron-astrocyte cross-communication at the synapse is largely untapped. Based on our preliminary studies, we propose a novel mechanism of neuron-astrocyte crosstalk at the synapse via S1P/S1PR1 signaling that regulates astrocyte function and neuronal synapse formation, function and plasticity.",15787996 (contact),"SINGH, SANDEEP KUMAR (contact)","LEENDERS, MIRIAM",2022-09-27,2027-08-31,Astrocytes;Blood - brain barrier anatomy;Brain;Brain Diseases;Brain Pathology;Calcium;Central Nervous System;Communication;Coupled;Data;Development;Drug Targeting;Excitatory Synapse;Glutamates;Glypican;Goals;GTP-Binding Proteins;hevin;Homeostasis;In Vitro;in vivo;insight;Knock-out;Knowledge;Link;Mediating;Metabolic;Molecular;Morphogenesis;Morphology;Mus;Nervous System Disorder;neural circuit;Neuroglia;neuronal circuitry;neuronal growth;neuronal survival;Neurons;neuropathology;neurotransmission;novel;Process;Protein Secretion;Proteins;Publishing;receptor;Research;Role;Shapes;Signal Pathway;Signal Transduction;Sphingolipids;sphingosine 1-phosphate;sphingosine kinase;Sphingosine-1-Phosphate Receptor;Structure;Synapses;synaptic function;synaptogenesis;Testing;thrombospondin 4;Thrombospondins;vesicular glutamate transporter 2,S1P-S1PR1 in bidirectional Neuron-Astrocyte communications,126504,CMBG,Cellular and Molecular Biology of Glia Study Section[CMBG],NA,S1,3,59760,20995,80755,NA
11178790,R01,NS,3,N,2024-09-20,2024-08-01,2025-07-31,853,R01NS131816,SCHOOLS OF MEDICINE,PA-20-185,3R01NS131816-02S2,NINDS:79238\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,DAYTON,UNITED STATES,PHYSIOLOGY,10,047814256,US,253101,WRIGHT STATE UNIVERSITY,OH,454350001,"Project Narrative Despite much effort to identify mechanisms underlying amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration dementia (FTLD or FTD), effective treatments remain elusive. Motoneuron (MN) excitability dysfunction is tightly linked to disease pathology, yet to date, excitability dysregulation has not been examined in the recent rNLS8 mouse model, which recapitulates pathologic TDP43 inclusions seen in MNs in >90% of ALS patients and in FTD patients. This proposal is relevant to public health because it will examine excitability dysregulation in this highly relevant model of ALS/FTD.",9991930 (contact),"ELBASIOUNY, SHERIF M (contact)","GUBITZ, AMELIE",2023-08-01,2027-03-31,ALS patients;Amygdaloid structure;Amyotrophic Lateral Sclerosis;Animal Model;Area;Automobile Driving;Brain;Cessation of life;cholinergic;comorbidity;Compensation;Conflict (Psychology);Corpus striatum structure;Data;Dementia;Disease;DNA-Binding Proteins;Down-Regulation;Drug Targeting;effective therapy;Electrophysiology (science);Event;Exhibits;FDA approved;Frontotemporal Dementia;Frontotemporal Lobar Degenerations;frontotemporal lobar dementia amyotrophic lateral sclerosis;Functional disorder;Grant;Hippocampus;Hyperactivity;Immunohistochemistry;Individual;Ion Channel;Knowledge;Kv2.1 channel;Life;Link;Measures;Modeling;Motor Neurons;mouse model;Mus;Muscle fasciculation;mutant;Mutation;neuron loss;neuronal excitability;Neurons;neuroprotection;new therapeutic target;novel;Paralysed;Pathogenesis;Pathologic;Pathology;Pathway interactions;Patients;Pharmaceutical Preparations;Play;protein TDP-43;Public Health;Reporting;Research;response;Riluzole;Role;Severities;Spinal;Spinal Cord;Superoxide Dismutase;Symptoms;Synapses;synaptic function;TDP-43 aggregation;Western Blotting,Excitability dysfunction mechanisms underlying the TDP43-dependent ALS and FTD pathogenesis,131816,CNNT,Clinical Neuroplasticity and Neurotransmitters Study Section[CNNT],NA,S2,2,60482,18756,79238,NA
11178795,N01,AI,NA,N,NA,NA,NA,NA,272201800008I,NA,NA,272201800008I-0-759302400001-1,NIAID:1905868\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,ALBANY,UNITED STATES,NA,20,787793900,US,3294801,"ALBANY MOLECULAR RESEARCH, INC.",NY,122035121,NA,79884854 (contact),"SCHLAGER, HEIDI  (contact)",NA,2024-07-19,2026-01-18,Acinetobacter;Antimicrobial Resistance;Bacterial Antibiotic Resistance;Biological;Chemistry;Combating Antibiotic Resistant Bacteria;Communicable Diseases;Development;Development Plans;Drug Kinetics;Evaluation;In Vitro;in vivo;Interventional Agent Development;Lead;manufacture;pathogen;pre-clinical;process optimization;product development;programs;Pseudomonas aeruginosa;Safety;scale up;Services;Therapeutic;therapeutic development;Toxicology;Toxin,Task C24: Process Optimization and Scale Up of an Antibiotic-Resistant Bacterial Agent,0,NA,NA,NA,NA,NA,NA,NA,1905868,NA
11178796,N01,AI,NA,N,NA,NA,NA,NA,75N93019D00011,NA,NA,75N93019D00011-0-759302400001-1,NIAID:342000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NORTH LIBERTY,UNITED STATES,NA,01,010586910,US,10082629,JMI LABORATORIES,IA,523179256,NA,79784125 (contact),"ARENDS, RYAN  (contact)",NA,2024-05-23,2025-05-22,Advanced Development;Anti-Bacterial Agents;Bacteria;Bacterial Antibiotic Resistance;Biological Assay;Collection;combat;Contracts;Development;in vitro testing;Maintenance;therapeutic development;Toxin,Task A27: Antibacterial MICs of a Gram-Negative Targeted Compound Collection,0,NA,NA,NA,NA,NA,NA,NA,342000,NA
11178797,N01,AI,NA,N,NA,NA,NA,NA,75N93019D00011,NA,NA,75N93019D00011-0-759302400002-1,NIAID:70000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NORTH LIBERTY,UNITED STATES,NA,01,010586910,US,10082629,JMI LABORATORIES,IA,523179256,NA,79933118 (contact),"ARENDS, RYAN  (contact)",NA,2024-08-14,2025-08-13,Advanced Development;Anti-Bacterial Agents;Bacteria;Bacterial Antibiotic Resistance;Biological Assay;combat;Contracts;Development;Disease;Gram-Negative Bacteria;Gram-Positive Bacteria;In Vitro;in vitro testing;Maintenance;pathogen;Resistance;screening;therapeutic development;Toxin,Task A28: In Vitro Screening for Antibacterial Activity Against Disease Pathogens,0,NA,NA,NA,NA,NA,NA,NA,70000,NA
11178798,N01,AI,NA,N,NA,NA,NA,NA,272201700020I,NA,NA,272201700020I-0-759302400003-1,NIAID:503403\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW TAIPEI CITY,TAIWAN,NA,NA,658873501; 657591921,TW,10042179,"PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.",NA,24891,NA,79876665 (contact),"MIESEL, LYNN  (contact)",NA,2024-07-10,2025-07-09,Bacterial Antibiotic Resistance;Bacterial Drug Resistance;Bacterial Infections;bacterial resistance;Combating Antibiotic Resistant Bacteria;Contracts;Development;Evaluation;infectious disease model;mouse model;Testing;therapeutic development,Task A94: Testing in Murine Models of Antibiotic-Resistant Bacterial Infection,0,NA,NA,NA,NA,NA,NA,NA,503403,NA
11178799,N01,AI,NA,N,NA,NA,NA,NA,272201700020I,NA,NA,272201700020I-0-759302400002-1,NIAID:331260\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW TAIPEI CITY,TAIWAN,NA,NA,658873501; 657591921,TW,10042179,"PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.",NA,24891,NA,79876904 (contact),"MIESEL, LYNN  (contact)",NA,2024-07-12,2025-07-11,antibiotic resistant infections;Bacterial Drug Resistance;bacterial resistance;Combating Antibiotic Resistant Bacteria;Contracts;Development;Drug-resistant Neisseria Gonorrhoeae;Evaluation;infectious disease model;mouse model;Neisseria gonorrhoeae;therapeutic development;Vaccines,Task A100: Mouse Model of Neisseria Gonorrhoeae Antibiotic Resistant Infection,0,NA,NA,NA,NA,NA,NA,NA,331260,NA
11178801,N01,AI,NA,N,NA,NA,NA,NA,272201800001I,NA,NA,272201800001I-0-759302400003-1,NIAID:45786\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,79772656 (contact),"MIRASILAS, JON  (contact)",NA,2024-05-16,2025-05-15,Antibiotic Resistance;Antimicrobial Resistance;Biological;Chemistry;Combating Antibiotic Resistant Bacteria;Communicable Diseases;Development;Development Plans;Drug Kinetics;Evaluation;In Vitro;in vivo;Interventional Agent Development;Lead;manufacture;pathogen;pre-clinical;product development;programs;Safety;Services;Staphylococcus aureus;Therapeutic;therapeutic development;Toxicology;Toxin,Task D16: Nonclinical Services for the Development of Interventional Agents for Antibiotic Resistant Infectious Diseases,0,NA,NA,NA,NA,NA,NA,NA,45786,NA
11178804,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA261717,NA,PA-20-272,3U54CA261717-04S2,NCI:61760\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,STANFORD,UNITED STATES,NA,16,009214214,US,8046501,STANFORD UNIVERSITY,CA,943052004,NA,10312066 (contact),"HAYDEN GEPHART, MELANIE  (contact)","GRIL, BRUNILDE M",2021-09-21,2026-08-31,3-Dimensional;Affect;Air;Animal Model;Anti-CD47;Antigen Presentation;Architecture;Biological Assay;Bone Marrow Transplantation;Brain;Brain Neoplasms;Busulfan;cancer cell;CD47-SIRPα;Cell Communication;Cell Death;Cells;Cerebrospinal Fluid;Circulation;Clustered Regularly Interspaced Short Palindromic Repeats;Coculture Techniques;colorectal cancer metastasis;Complex;CRISPR library;CSF1 gene;cytokine;Data;Disease Progression;Disseminated Malignant Neoplasm;Distant;Epithelium;Evaluation;Exhibits;Extracellular Matrix;Gene Modified;Generations;Genes;Growth;Human;human disease;Immune;immune cell infiltrate;Immunologic Surveillance;Immunological Models;Immunotherapy;implantation;in vitro Model;Inflammatory;Inflammatory Response;innovation;Interleukin-6;Intrinsic factor;Invaded;Knock-out;Knowledge;Ligands;Liquid substance;Macrophage;Macrophage Activation;Malignant Neoplasms;Measures;Mediating;Messenger RNA;Metalloproteases;Metastatic malignant neoplasm to brain;Methods;Microglia;migration;Modeling;Monitor;mortality;multidisciplinary;Mus;Myeloid Cells;Neoplasm Metastasis;neoplastic cell;Neurologic;neuropathology;novel;novel strategies;Organoids;Phagocytosis;Phenotype;Population;Positioning Attribute;Primary Neoplasm;Production;Prognosis;Proliferating;Property;Protocols documentation;Publishing;receptor;Recurrence;Resistance;RNA analysis;Role;Sampling;Signal Transduction;single-cell RNA sequencing;small molecule;T-Cell Activation;T-Lymphocyte;Technology;Testing;Therapeutic;transcriptome;tumor;Tumor Cell Invasion;Tumor Immunity;tumor microenvironment;tumor progression;Tumor-associated macrophages;tumor-immune system interactions;weapons,Investigate and inhibit microglia support of brain metastases,261717,ZCA1,ZCA1,9201,S2,4,40000,21760,NA,61760
11178808,N01,AI,NA,N,NA,NA,NA,NA,75N93024C00008,NA,NA,75N93024C00008-0-9999-1,NIAID:2475623\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW YORK,UNITED STATES,NA,10,103139841,US,10011831,GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT,NY,100051304,NA,79761701 (contact),"FOTOUHI, NADER  (contact)",NA,2024-05-10,2025-11-09,Advanced Development;antimicrobial resistant infection;Bacterial Drug Resistance;bacterial resistance;biodefense;candidate selection;Chemistry;Clinical assessments;Combating Antibiotic Resistant Bacteria;efficacy evaluation;Emerging Communicable Diseases;lead optimization;manufacture;Mycobacterium tuberculosis;pathogen;pre-clinical;product development;research and development;Research Support;safety assessment;Therapeutic;therapeutic candidate;therapeutic development,"Development of Therapeutic Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases",0,NA,NA,NA,NA,NA,NA,NA,2475623,NA
11178811,U54,CA,3,N,2024-09-17,2024-09-01,2025-08-31,NA,U54CA284110,NA,PA-20-272,3U54CA284110-02S1,NCI:149988\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SAINT LOUIS,UNITED STATES,NA,01,068552207,US,9083901,WASHINGTON UNIVERSITY,MO,631304862,NA,9545342 (contact),"IWELUNMOR, JULIET  (contact)","PARASCANDOLA, MARK",2023-09-19,2028-08-31,Adoption;Africa;anti-cancer research;apprenticeship;Awareness;Cancer Burden;Cancer Control;Cancer Control Research;Cancer Science;cancer type;cancer vaccination;Cancer Vaccines;career;Cervical;Cessation of life;Clinical;cohort;Collaborations;Communities;community organizations;Country;Creativeness;crowdsourcing;design;E-learning;Equity;evidence base;Evidence based intervention;experience;Faculty;faculty mentor;Fostering;Funding;Geography;Goals;Grant;Health;Healthcare;Hepatitis B Vaccines;Human Papilloma Virus Vaccine;Hybrids;Immunization;implementation research;implementation science;improved;Individual;innovation;Institution;Institutionalization;Intervention;Lead;learning community;Malignant Neoplasms;Medical Research;Mentors;Mentorship;Methods;National Institute of Child Health and Human Development;next generation;Nigeria;Nigerian;peer support;Persons;Pilot Projects;Policies;population health;prevent;Primary carcinoma of the liver cells;programs;prototype;recruit;Research;Research Personnel;Research Support;research to practice;Resources;Science;Series;Services;Site;skills;social;supportive environment;Talents;Training;training opportunity;Travel;United States National Institutes of Health;Vaccines;virtual;Writing;Youth,Research and Capacity Building Core,284110,ZCA1,ZCA1,8207,S1,2,100000,49988,NA,149988
11178816,R56,AG,1,N,2024-09-25,2024-09-30,2025-08-31,866,R56AG084730,SCHOOLS OF PHARMACY,PAR-21-029,1R56AG084730-01A1,NIA:833173\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,CHAPEL HILL,UNITED STATES,NONE,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"Project Narrative Kinases are an important class of proteins that are currently targeted by 77 small molecule FDA-approved drugs, more than 85% of which can be used in cancer therapy. Despite them performing essential roles in the brain, modulating kinases to treat neurodegeneration has not been the focus of most programs, leaving their potential to alter or halt the progression of these diseases unknown. This project will create high-quality chemical tools that can be used in animals and will allow researchers around the world to more definitively characterize the suggested role that one of these important kinases plays in driving Alzheimer’s disease pathology and confirm whether it is a good therapeutic target for Alzheimer’s disease.",10602420 (contact),"AXTMAN, ALISON DONNELLY (contact)","GROTHAUS, PAUL G",2024-09-30,2026-08-31,3xTg-AD mouse;Address;Adult;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Alzheimer&apos;s disease pathology;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease therapy;Amyloid;analog;Animal Model;Animals;Anti-Inflammatory Agents;Area;Automobile Driving;Behavioral;Biological Assay;Biology;Blood;blood-brain barrier penetration;Brain;Cancer cell line;cancer therapy;casein kinase II;Cell model;Cells;cellular targeting;Chemicals;Clinical;Clinical Research;Collaborations;Communities;Computer software;cytokine;Data;Dementia;design;Development;Disease;Disease Progression;Dose;Drug Kinetics;Drug Targeting;effective therapy;enzyme activity;Evaluation;Exhibits;experience;FDA approved;Goals;Half-Life;Homeostasis;Human;Human Genome;human old age (65+);human stem cell-derived;human stem cells;imaging study;improved;In Vitro;in vivo;in vivo Model;inhibitor;interest;Investigation;kinase inhibitor;Kinetics;knock-down;Lead;Libraries;lipophilicity;Liver Microsomes;Malignant Neoplasms;Metabolic;Microglia;Microsomes;Modeling;mouse model;multidisciplinary;Mus;Mutation;Nerve Degeneration;Neurodegenerative Disorders;neurofibrillary tangle formation;neuroinflammation;Neurons;novel;Oncology;overexpression;Pathogenicity;Pathologic;Pathway interactions;Penetrance;Penetration;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Phenotype;Phosphotransferases;Play;Process;programs;Property;Protein Kinase;Proteins;Publications;Publishing;Regulation;Research;Research Personnel;response;Role;screening;Signal Pathway;Signal Transduction;simulation;small molecule;Solubility;stem cells;Structure;Symptoms;Synapses;Testing;Therapeutic;therapeutic target;Time;tool;Toxic effect;translation to humans;Validation,Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy,84730,DMPB,Drug Discovery and Molecular Pharmacology B Study Section[DMPB],NA,A1,1,639346,193827,833173,NA
11178817,R56,AG,2,N,2024-09-25,2024-09-30,2025-08-31,866,R56AG067417,SCHOOLS OF MEDICINE,PA-20-185,2R56AG067417-04A1,NIA:794129\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,STONY BROOK,UNITED STATES,RADIATION-DIAGNOSTIC/ONCOLOGY,01,804878247,US,5992612,STATE UNIVERSITY NEW YORK STONY BROOK,NY,117943362,"Narrative: The class-IIa histone deacetylases (class-IIa HDACs) are a key component of the epigenetic machinery in Alzheimer's disease (AD), a devastating neurodegenerative disease. Therefore, developing and validating a novel class-IIa HDAC PET imaging probe will have a significant positive impact on human health by informing on AD progression and may detect AD at an early time point when therapy may be most effective. The success of our imaging studies may delineate a novel role for class-IIa HDAC in pathophysiology and progression of AD and may identify class-IIa HDAC as a novel druggable target in AD.",10868695 (contact),"TURKMAN, NASHAAT  (contact)","ROVESCALLI, ALESSANDRA C",2020-04-15,2026-08-31,abeta accumulation;Acceleration;Address;Alzheimer disease detection;Alzheimer&apos;s Disease;Alzheimer&apos;s disease brain;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease therapy;Amyloid beta-Protein;Automation;Autopsy;Autoradiography;Binding;Biodistribution;Brain;Brain region;brain tissue;Central Nervous System;Central Nervous System Diseases;Clinical;clinical translation;Clinical Trials;cognitive performance;course development;Cyclic GMP;Data;Dementia;density;Development;diagnostic tool;Disease;Disease Progression;Drug Targeting;druggable target;Early Diagnosis;Ensure;Epigenetic Process;Exhibits;Exposure to;Family suidae;first-in-human;Fostering;Functional disorder;Health;Histone Acetylation;Histone Deacetylase;Human;human subject;human tissue;Human Volunteers;imaging probe;imaging study;Immunohistochemistry;Impaired cognition;improved;In Vitro;in vivo;in vivo imaging;Incentives;Institutional Review Boards;interest;Investments;kinetic model;Maintenance;Manuals;Measures;Metabolism;molecular imaging;Molecular Probes;Names;National Institute of Mental Health;Neurodegenerative Disorders;new therapeutic target;novel;novel diagnostics;Organ;Pathogenicity;Pharmacological Treatment;Positron-Emission Tomography;Preparation;Production;Psychotropic Drugs;Public Health;Radiation;Radiolabeled;radioligand;Radiometry;Radiopharmaceuticals;Rattus;Reproducibility;Research;Role;Running;screening program;Senile Plaques;Stains;success;tau aggregation;tau Proteins;Testing;Therapeutic;therapy development;Time;Toxic effect;Tracer;translation to humans;Translational Research;Validation;β-amyloid burden,Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS,67417,IPCA,Imaging Probes and Contrast Agents Study Section[IPCA],NA,A1,4,499995,294134,794129,NA
11178819,U2C,HL,3,N,2024-09-15,2024-09-15,2025-08-31,837,U2CHL156291,NA,RFA-OD-20-007,3U2CHL156291-05S1,OD:200259\,OTHER RESEARCH-RELATED,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PHILADELPHIA,UNITED STATES,NA,03,073757627,US,1499101,CHILDREN'S HOSP OF PHILADELPHIA,PA,191462305,"PROJECT NARRATIVE – Overall. People with Down syndrome are strongly predisposed to develop a wide range of comorbidities that shorten their lifespan and decrease their quality of life, such as Alzheimer’s disease, congenital heart disease, leukemias, autoimmune disorders, and diverse neurological conditions. The proposed activities under this project seek to create a world-class resource for collaborative discovery, data sharing, data access, and integrative analysis that would enable novel investigations into all DS comorbidities across the lifespan and further integrating across datasets for related diseases occurring in the general population, thus paving the way for a precision medicine approach to DS. Furthermore, this resource and associated platforms will also have broader impacts by empowering physicians, educators, government officials, and advocates with the tools required to elicit evidence- based transformative action in the clinic, the classroom, the government, and society at large.",10600717;14376558;8235921;10817313;1869835;9238231 (contact),"CARROLL, ROBERT J;DIGIOVANNA, JACK ;ESPINOSA, JOAQUIN M.;FERRETTI, VINCENT ;HAENDEL, MELISSA A;RESNICK, ADAM CAIN (contact)","SCHRAMM, CHARLENE A",2020-09-26,2025-08-31,"Acceleration;Advocacy;Advocate;Affect;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Amyloid Beta A4 Precursor Protein;Area;autism spectrum disorder;Autoimmune Diseases;Automobile Driving;bench to bedside;biobank;Biomedical Research;Child;Chromosome 21;Chromosomes;Clinic;Clinical;Cohort Studies;Collaborations;Communities;community empowerment;comorbidity;Complex;congenital heart abnormality;Data;data access;Data Coordinating Center;data ecosystem;data integration;data management;data modalities;data portal;data resource;Data Set;data sharing;data sharing networks;design;Development;Discipline;Disease;diverse data;Down&apos;s Syndrome;Ecosystem;Education;empowerment;Ensure;Environment;Environmental Risk Factor;epidemiology study;Epigenetic Process;Epilepsy;evidence base;Family;General Population;Genetic Diseases;Genetic Variation;Goals;Government;Government Officials;Human;Human Biology;Individual;innovation;interoperability;Intuition;Investigation;leukemia;Life Cycle Stages;Life Expectancy;life span;lifestyle factors;Link;Malignant Neoplasms;metabolome;Methods;microbiome;Mission;Multiomic Data;National Heart, Lung, and Blood Institute;Neurologic;novel;novel diagnostics;novel therapeutics;outreach;Participant;Pathogenicity;Persons;Phenotype;Physicians;Population;precision medicine;prenatal;Proteome;Quality of life;Research;Resources;response;Risk;Schools;Scientist;Security;Societies;Solid;Surveys;synergism;Technology;Time;timeline;tool;Training;transcriptome;United States National Institutes of Health;Variant;virtual",Ensuring Data Compliance and Security for the INCLUDE Data Coordinating Center in Response to Emerging NIH/NHLBI Platform Environment Requirements,156291,ZRG1,Special Emphasis Panel[ZRG1-IFCN-U(50)R],NA,S1,5,112505,87754,200259,NA
11178821,U2C,HL,3,N,2024-09-16,2024-09-16,2025-08-31,837,U2CHL156291,NA,RFA-OD-20-007,3U2CHL156291-05S2,OD:798229\,OTHER RESEARCH-RELATED,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PHILADELPHIA,UNITED STATES,NA,03,073757627,US,1499101,CHILDREN'S HOSP OF PHILADELPHIA,PA,191462305,"PROJECT NARRATIVE – Overall. People with Down syndrome are strongly predisposed to develop a wide range of comorbidities that shorten their lifespan and decrease their quality of life, such as Alzheimer’s disease, congenital heart disease, leukemias, autoimmune disorders, and diverse neurological conditions. The proposed activities under this project seek to create a world-class resource for collaborative discovery, data sharing, data access, and integrative analysis that would enable novel investigations into all DS comorbidities across the lifespan and further integrating across datasets for related diseases occurring in the general population, thus paving the way for a precision medicine approach to DS. Furthermore, this resource and associated platforms will also have broader impacts by empowering physicians, educators, government officials, and advocates with the tools required to elicit evidence- based transformative action in the clinic, the classroom, the government, and society at large.",10600717;14376558;8235921;10817313;1869835;9238231 (contact),"CARROLL, ROBERT J;DIGIOVANNA, JACK ;ESPINOSA, JOAQUIN M.;FERRETTI, VINCENT ;HAENDEL, MELISSA A;RESNICK, ADAM CAIN (contact)","SCHRAMM, CHARLENE A",2020-09-26,2025-08-31,Acceleration;Advocacy;Advocate;Affect;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Amyloid Beta A4 Precursor Protein;Area;autism spectrum disorder;Autoimmune Diseases;Automobile Driving;bench to bedside;biobank;Biomedical Research;Child;Chromosome 21;Chromosomes;Clinic;Clinical;Cohort Studies;Collaborations;Communities;community empowerment;comorbidity;Complex;congenital heart abnormality;Data;data access;Data Coordinating Center;data ecosystem;data integration;data management;data modalities;data portal;data resource;Data Set;data sharing;data sharing networks;design;Development;Discipline;Disease;diverse data;Down&apos;s Syndrome;Ecosystem;Education;empowerment;Ensure;Environmental Risk Factor;epidemiology study;Epigenetic Process;Epilepsy;evidence base;Experimental Models;Family;General Population;Genetic Diseases;Genetic Variation;Goals;Government;Government Officials;Human;Human Biology;Individual;innovation;interoperability;Intuition;Investigation;leukemia;Life Cycle Stages;Life Expectancy;life span;lifestyle factors;Link;Malignant Neoplasms;metabolome;Methods;microbiome;Mission;Multiomic Data;Neurologic;novel;novel diagnostics;novel therapeutics;outreach;Participant;Pathogenicity;Persons;Phenotype;Physicians;Population;precision medicine;prenatal;Proteome;Quality of life;Research;Resources;Risk;Schools;Scientist;Societies;Solid;Surveys;synergism;Technology;Time;timeline;tool;Training;transcriptome;United States National Institutes of Health;Variant;virtual,DCC Supplement for Experimental Models Portal,156291,ZRG1,Special Emphasis Panel[ZRG1-IFCN-U(50)R],NA,S2,5,778729,19500,798229,NA
11178828,R56,AG,1,N,2024-09-25,2024-09-30,2025-08-31,866,R56AG088642,SCHOOLS OF OPTOMETRY/OPHT TECH,PAR-22-093,1R56AG088642-01,NIA:583558\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,BIRMINGHAM,UNITED STATES,OTHER HEALTH PROFESSIONS,07,063690705,US,1288803,UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,352940001,"Narra�ve:  Brain diseases such as demen�a and Alzheimer’s disease are a rapidly growing health problem in the United States, and growing evidence shows that the re�na, at the back of the eye, is also being damaged by these diseases. In our proposed experiments we will measure re�nal func�on and anatomy in a mouse model of Alzheimer’s disease, and we will perform parallel tests on human subjects: young, old and in the beginning stages of demen�a. Our goal is to iden�fy and reﬁne a non-invasive, inexpensive clinical test to determine the earliest measurable changes indica�ng the presence or progression of the disease based on these eye tests.",1905128 (contact),"KRAFT, TIMOTHY W (contact)","ST HILLAIRE-CLARKE, CORYSE",2024-09-30,2025-08-31,abeta deposition;Acceleration;Affect;Age;Age Months;age-related disease;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease test;Anatomy;Animal Model;APP-PS1;Area;Autopsy;Back;Blindness;Blood Vessels;Brain;Brain Diseases;capillary bed;Cause of Death;Cell Density;Cell Physiology;Cell Volumes;Cells;Central Nervous System Diseases;Cerebral cortex;Cognitive;Color;Communities;Contrast Sensitivity;curative treatments;Data;Dementia;density;Diagnosis;Diagnostic;Disease;Disease Progression;Early Diagnosis;Early identification;Early Onset Alzheimer Disease;effective therapy;Elderly;Electroretinography;experimental study;Eye;Family;Financial cost;Functional disorder;functional loss;Ganglia;ganglion cell;Ganglion Cell Layer;Genes;Glutamates;Goals;Health;Health Care Costs;Health Personnel;Healthcare Systems;high risk;Histologic;Histopathology;Human;human subject;human tissue;Impaired cognition;improved;Individual;Knowledge;Link;loss of function;macula;Macular degeneration;Maps;Measurable;Measures;Metabolic;mild cognitive impairment;Molecular;mouse model;Mus;Nerve Tissue;Nervous System Trauma;Neurologic;Neurons;normal aging;Normal Range;novel;novel marker;Outcome;outer plexiform layer;Pathologic;Patients;Pattern;Persons;Physiological;Population;pre-clinical;preventive intervention;prospective;Proteins;psychologic;Public Health;recruit;Reporting;Research;research clinical testing;response;Retina;Retinal Ganglion Cells;ribbon synapse;Risk;Rod;Rodent Model;Same-sex;Sensitivity and Specificity;sex;Signal Transduction;social;Structure;Synapses;synaptic function;Techniques;Testing;therapeutic effectiveness;Therapeutic Intervention;Tissue Sample;United States;Vision;visual stimulus;Work,Retinal Manifestations of Alzheimer's Disease,88642,ZRG1,Special Emphasis Panel[ZRG1-NV-P(81)S],NA,NA,1,421709,161849,583558,NA
11178841,U54,CA,3,N,2024-08-29,2024-09-01,2025-08-31,NA,U54CA261719,NA,RFA-CA-20-029,3U54CA261719-04S1,NCI:62921\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,STANFORD,UNITED STATES,NA,16,009214214,US,8046501,STANFORD UNIVERSITY,CA,943052004,NA,2186789 (contact),"BASSIK, MICHAEL C (contact)","NADEAU, CHRISTINE FRANCES",2021-09-14,2026-08-31,3-Dimensional;adaptive immune response;anti-cancer;anticancer activity;biomarker driven;Breast;Breast Cancer Cell;Breast Cancer cell line;breast cancer progression;Breast Cancer Risk Factor;cancer cell;Cancer Model;Cancer Patient;cancer therapy;Candidate Disease Gene;candidate identification;CD47 gene;Cell Communication;Cell Line;Cells;Clinical;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;CRISPR interference;CRISPR screen;CRISPR-mediated transcriptional activation;Dependence;Development;differential expression;Drug resistance;Drug Targeting;druggable target;Effectiveness;Engineering;Estrogen receptor positive;Exhibits;experimental study;Fluorescent Probes;Gene Combinations;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic;Genetic Transcription;genome-wide;Genomics;Growth;high risk;hormone therapy;Immune Evasion;Immune system;Immunosuppression;Immunotherapy;improved;In Vitro;in vivo;Individual;Infiltration;Macrophage;Magnetism;Malignant Breast Neoplasm;Malignant Neoplasms;mammary epithelium;Mass Spectrum Analysis;MCF10A cells;MCF7 cell;Measurement;Measures;Mediating;Metastatic breast cancer;Modeling;Molecular;Nature;Neoplasm Metastasis;neoplastic cell;next generation;novel;Organoids;Outcome;overexpression;Patients;Phagocytes;Phagocytosis;Phenotype;Post-Translational Protein Processing;Process;Property;Proteins;Proteomics;receptor;Relapse;relapse risk;Repression;Resistance;Resistance development;resistance mechanism;Role;sialylation;Signal Transduction;spheroids;Subgroup;System;targeted treatment;Testing;Therapeutic;therapeutic target;therapy resistant;three dimensional cell culture;transcriptomics;Trastuzumab;treatment response;tumor;Tumor Escape;tumor initiation;tumor microenvironment;tumor progression;Tumor-associated macrophages;tumorigenesis,Project 3: Systematic characterization of factors controlling breast cancer progression and resistance,261719,ZCA1,ZCA1-RTRB-Y(M1),6746,S1,4,40752,22169,NA,62921
11178842,Y01,HD,NA,N,NA,NA,NA,NA,AHD24005001,NA,NA,AHD24005001-1-0-1,NICHD:1100000\,INTERAGENCY AGREEMENTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,(contact),NA,NA,NA,Adopted;Age;aged;Aging;Agreement;AIDS prevention;Area;Award;Behavior assessment;Budgets;Calendar;Categories;Communication;Communities;computerized data processing;Consult;Consultations;Contraceptive methods;Contraceptive Usage;Contracts;Cost efficiency;Data;data cleaning;Data Collection;Data Files;Decision Making;design;Development;Disclosure;Family;Family health status;Family Planning;Feedback;Fertility;Funding;Funding Agency;Geography;Growth;Health Planning;HIV Infections;HIV/STD;Household;improved;Infertility;Internet;Interview;Maternal Health;meetings;men;National Institute of Child Health and Human Development;Never Married;perinatal health;Periodicals;Persons;Planned Pregnancy;Policies;Population;Preparation;Procedures;Program Development;programs;Progress Reports;Public Domains;Published Comment;Questionnaires;reproductive;Reproductive Health;Respondent;Risk Factors;Sampling;Schedule;sexual and reproductive health;Sexually Transmitted Diseases;social culture;Staff Development;STI prevention;Surveys;symposium;Telephone;Time;trend;United States National Center for Health Statistics;Update;web page;Woman;women&apos;s reproductive health;Writing,NATIONAL SURVEY OF FAMILY GROWTH (NSFG),240050,NA,NA,NA,NA,NA,NA,NA,1100000,NA
11178853,R00,GM,3,N,2024-08-29,2024-09-01,2025-08-31,859,R00GM140264,SCHOOLS OF MEDICINE,PAR-19-343,3R00GM140264-05S1,NIGMS:75375\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,SAN ANTONIO,UNITED STATES,BIOCHEMISTRY,20,800772162,US,578418,UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,782293901,"PROJECT NARRATIVE The androgen receptor is a type I nuclear hormone receptor and master transcription factor responsible for differentiation and development of the male phenotype. Its hyperactivation is associated with multiple diseases, including metastatic prostate cancer, androgenetic alopecia, androgen insensitivity syndrome, and Kennedy’s disease. This proposal seeks to understand the mechanism of androgen receptor regulation and determinants of its aberrant activity using biochemical, structural, and cellular methods, which can facilitate the development of novel androgen receptor inhibitors and lend mechanistic insight towards other related nuclear hormone receptors.",10565078 (contact),"WASMUTH, ELIZABETH VICTORINA (contact)","SAKALIAN, MICHAEL",2022-09-01,2025-08-31,Acceleration;Affinity;Androgen Antagonists;androgen independent prostate cancer;Androgen Receptor;Androgen-Insensitivity Syndrome;Androgens;Architecture;Atomic Force Microscopy;Binding;Biochemical;Biological;Biological Assay;Biology;Cancer Biology;career;cell growth;Cell Line;Cells;Cellular Morphology;ChIP-seq;Chromatin;cofactor;Communication;Complex;computerized data processing;Consensus;Cryoelectron Microscopy;data acquisition;Dedications;design;Development;Dimerization;Disease;Dissection;DNA;DNA Binding;DNA Binding Domain;Drug Targeting;Electron Microscopy;Electrons;enzalutamide;Etiology;experience;flexibility;functional outcomes;Generations;genetic corepressor;Genetic Transcription;Global Change;Glucocorticoid Receptor;Goals;Growth;Health;human disease;improved;In Vitro;in vivo;inhibitor;innovation;insight;Joints;Kennedy Syndrome;Knowledge;Laboratories;Leadership;Lentivirus;Ligand Binding Domain;Maintenance;male;Male Pattern Baldness;Malignant neoplasm of prostate;Mediating;Memorial Sloan-Kettering Cancer Center;Metastatic Prostate Cancer;Methods;Mineralocorticoid Receptor;Modeling;Molecular;Molecular Conformation;mutant;Mutate;Mutation;N-terminal;National Institute of General Medical Sciences;Negative Staining;novel;Nuclear Hormone Receptors;Nucleoproteins;Output;particle;Phenotype;Phenotypic Sex;post-doctoral training;Process;Progesterone Receptors;Prostate;prostate cancer cell;protein protein interaction;protein purification;Proteins;Receptor Activation;receptor binding;Receptor Inhibition;Receptor Signaling;Recombinant Proteins;Recombinants;Regulation;Reporter;Reporting;Research;Research Personnel;Resolution;Running;Sex Differentiation;Sexual Development;Site;skills;Stanolone;structural biology;structural determinants;Structural Models;Structure;Surface;System;Technology;Testing;Testosterone;three-dimensional modeling;Training;Transactivation;Transcript;transcription factor;Transcriptional Regulation;transcriptome;transcriptome sequencing;Universities;Validation;Variant;Work;X-Ray Crystallography,"Biochemical, structural and molecular dissection of androgen receptor transcriptional activity",140264,ZGM1,ZGM1-SRC(99),NA,S1,5,52000,23375,75375,NA
11178856,R01,HD,3,N,2024-08-29,2024-08-01,2025-07-31,865,R01HD106017,SCHOOLS OF MEDICINE,PA-20-185,3R01HD106017-04S1,NICHD:96206\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NEW YORK,UNITED STATES,OBSTETRICS & GYNECOLOGY,13,621889815,US,1833205,COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,100323725,"NARRATIVE Spontaneous preterm birth is a leading cause of neonatal morbidity and mortality, yet we lack the means to diagnose it in advance, treat, or prevent it, especially in women giving birth for the first time. We will analyze samples from one of the best-phenotyped cohorts of nulliparous pregnant women, the nuMoM2b study, providing the largest sample size of its kind along with detailed clinical data affording a nuanced view of prematurity. Our study will identify new biomarkers for early identification of preterm birth, and potential mechanisms underlying it, through a high-resolution investigation of the microbes and small molecules in the female reproductive tract.",15806637 (contact),"KOREM, TAL  (contact)","ILEKIS, JOHN V",2021-08-03,2026-07-31,16S ribosomal RNA sequencing;adverse pregnancy outcome;Affect;Algorithms;Biological;Biological Markers;biomarker identification;Cervix Incompetence;Characteristics;Clinical;clinical application;Clinical Data;clinical translation;cohort;Communities;computer framework;Data;Data Analyses;Data Set;Demography;Detection;Diagnosis;Early Diagnosis;Early identification;Early treatment;Ecosystem;Etiology;experience;female reproductive tract;First Births;First Pregnancy Trimester;Geography;Goals;Growth;gut microbiome;Heterogeneity;High-Risk Pregnancy;host microbiome;innovation;insight;Investigation;Knowledge;lens;Measures;Mediator;Medical;Metabolic;Metabolic Pathway;Metabolism;metabolome;metabolomics;metagenome;metagenomic sequencing;Metagenomics;Methods;Microbe;microbial;Microbial Genetics;microbial genomics;Microbial Taxonomy;microbiome;microbiome analysis;microbiome research;Modeling;Multicenter Trials;neonatal morbidity;Neonatal Mortality;Nulliparity;Pathology;personalized risk prediction;Phenotype;Pregnancy;Pregnancy Outcome;Pregnant Women;premature;Premature Birth;preterm premature rupture of membranes;Prevalence;prevent;Property;Race;reproductive tract;Research;Research Personnel;Resolution;Resources;Role;Sample Size;Sampling;Second Pregnancy Trimester;small molecule;Swab;System;Taxonomy;Therapeutic;Third Pregnancy Trimester;Time;United States;Vagina;vaginal microbiome;Variant;Woman,A large scale investigation of the vaginal metagenome and metabolome and their role in spontaneous preterm birth,106017,IRAP,"Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]",NA,S1,4,58484,37722,96206,NA
11178858,R01,HL,7,N,2024-09-11,2024-09-15,2025-09-30,839,R01HL151365,SCHOOLS OF MEDICINE,PA-24-254,7R01HL151365-05,NHLBI:348750\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,KANSAS CITY,UNITED STATES,INTERNAL MEDICINE/MEDICINE,03,016060860,US,1484303,UNIVERSITY OF KANSAS MEDICAL CENTER,KS,661608500,"We propose to evaluate the safety, tolerability, and efficacy of a pre- and peri-hematopoietic stem cell transplant (HCT) prebiotic intervention to improve the health of the gut microbiota (bacteria in the gut) and HCT outcomes. Our phase 1/randomized phase 2 clinical trial is accompanied by stool-based correlative studies to understand the impact of our prebiotic intervention on the microbiota and differences in the microbiota that may explain why some patients respond to the prebiotic while others may not; we also include peripheral blood biomarkers to identify potential mechanisms to explain the interaction between the prebiotic, microbiota, and HCT outcomes.",11481860 (contact),"SUNG, ANTHONY  (contact)","FRANK, DANIEL J",2020-07-01,2025-09-30,Affect;Allogenic;anti-microbial peptide;Antibiotic Therapy;Antibiotics;Bacteria;bacterial community;Biological Markers;Blood;Blood Circulation;Blood specimen;Butyrates;Cells;chemotherapy;Clinical;Clinical Trials;Colon;conditioning;Correlative Study;Data;design;diagnostic assay;Disease;Dose;Elements;Energy-Generating Resources;Engraftment;Epithelial Cells;Feces;Fiber;Future;Goals;graft vs host disease;gut bacteria;gut health;gut inflammation;gut microbiota;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;immune reconstitution;Immune system;improved;improved outcome;Infection;Inflammation;Infusion procedures;interest;Intervention;Intestines;islet;leukemia;Link;Lymphoma;Malignant - descriptor;Maximum Tolerated Dose;Mediating;Mediator;Metabolic;Metabolism;microbiome;microbiota;microbiota transplantation;Modeling;Monitor;Morbidity - disease rate;mortality;Mus;Natural regeneration;Non-Malignant;Oligosaccharides;Outcome;Patients;peripheral blood;personalized medicine;Phase;phase I trial;Phase I/II Clinical Trial;Phase II Clinical Trials;phase II trial;phase III trial;Placebo Control;prebiotics;primary endpoint;Probiotics;Process;Proteins;Radiation therapy;Randomized;Regulatory T-Lymphocyte;Relapse;Reporting;response;Role;Safety;Sepsis;Shapes;Stem cell transplant;stem cells;stool sample;Symptoms;systemic inflammatory response;T-Cell Development;Tissues;Toxic effect;Translating;Transplant Recipients;Transplantation Conditioning;Volatile Fatty Acids,Prebiotics to Optimize the Microbiota and Improve Outcomes of AllogeneicHematopoietic Stem Cell Transplantation,151365,ZHL1,ZHL1-CSR-M(F1),NA,NA,5,225000,123750,348750,NA
11178869,R01,GM,3,N,2024-08-30,2024-09-01,2025-08-31,859,R01GM071940,SCHOOLS OF MEDICINE,PA-20-185,3R01GM071940-16S1,NIGMS:85508\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,LOS ANGELES,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,"Project Narratives Building on our success in using novel cryoEM methods to obtain the first near-atomic resolution structures of viral genomes, the largest human viral particles, and small (~120 kDa) membrane protein complexes, this continuation project aims to make atomic resolution structure determination a routine practice for large and transiently stable biological complexes, particularly endogenous cellular complexes and in situ structures in viral genome packaging and gene transcription processes. These new methods will enable investigators to place individual components (proteins, nucleic acids and lipids) within the context of the larger assembly and to visualize chemical interactions among the parts of the complex at atomic detail. Broadly, structural studies of various macromolecular complexes enabled by these new methods will lead to atomic models, help to understand their mechanisms of action, inform efforts to rationally design drugs and vaccines, and suggest novel targets for therapeutic intervention.",6089740 (contact),"ZHOU, Z HONG (contact)","FLICKER, PAULA F",2006-05-01,2026-08-31,Achievement;Actins;Address;Amino Acids;Area;bacteriocin;Binding;Biological;Biological Process;biological systems;Biomedical Research;cell motility;Cell Physiology;Cells;Cellular Structures;Chemicals;Classification;Code;Complement;Complex;Computer Models;Computer software;computerized data processing;Computing Methodologies;convolutional neural network;Cryoelectron Microscopy;Cytoskeletal Filaments;Data;deep learning;density;design;Development;Disease;DNA;DNA Viruses;Double Stranded DNA Virus;Double Stranded RNA Virus;Drug Design;Electrons;Erythrocytes;Flagella;Funding;genetic information;Genetic Transcription;Genome;Geometry;Goals;Heart;Human;Image;In Situ;Individual;Investigation;Learning;Lipids;Macromolecular Complexes;Maintenance;Maps;Mass Spectrum Analysis;Membrane Proteins;Methods;Modeling;Molecular;nanomachine;neural network;new therapeutic target;non-Native;novel;nucleic acid structure;Nucleic Acids;Outcome;particle;polymerization;Polymers;Process;programs;protein complex;protein purification;protein transport;Proteins;Proteome;Proteomics;quantum;rational design;reconstruction;Research Personnel;Resistance;Resolution;RNA;RNA Viruses;Rod;routine practice;Scheme;small molecule;Source;structural biology;Structure;success;Techniques;Testing;Therapeutic Intervention;three dimensional structure;tool;Training;Transcription Process;transmission process;Vaccines;Validation;Viral;Viral Genome;Virus;Virus Assembly;Virus Replication;Visualization;X-Ray Crystallography,High-Resolution CryoEM Reconstruction of Large Complexes,71940,MSFC,Macromolecular Structure and Function C Study Section[MSFC],NA,S1,16,60484,25024,85508,NA
11178892,R01,HL,3,N,2024-08-30,2024-09-01,2025-07-31,840,R01HL166585,SCHOOLS OF MEDICINE,PAR-19-274,3R01HL166585-02S1,NHLBI:69434\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NEW HAVEN,UNITED STATES,INTERNAL MEDICINE/MEDICINE,03,043207562,US,9420201,YALE UNIVERSITY,CT,065208327,"PROJECT NARRATIVE Self-care is an evidence-based strategy that can reduce the high morbidity and mortality associated with heart failure. However, little is known about how to implement self-care for heart failure in low- and middle-income country settings in ways that account for the unique needs of different cultures and contexts. Our study, which is designed to prioritize health equity throughout all phases, will compare the implementation, effectiveness, and cost effectiveness of a digital-first implementation strategy vs. a basic evidence-based package and current standard of care to improve self-care in heart failure.",11814157;11636799 (contact);12510645,"CAFAZZO, JOSEPH ANTONY;SCHWARTZ, JEREMY IAN (contact);SSINABULYA, ISAAC","MINTZER, KEITH A",2023-08-01,2025-07-31,"Address;Adherence;Adoption;Africa South of the Sahara;Algorithms;Area;Cardiac;Caring;Cellular Phone;Center for Translational Science Activities;Cessation of life;Clinical;Clinical effectiveness;Cluster randomized trial;Collaborations;community engaged approach;cost;Cost Analysis;cost effectiveness;Cost Effectiveness Analysis;cost-effectiveness ratio;Country;dashboard;Data;Death Rate;debilitating symptom;design;Diet;digital;digital health;Effectiveness;empowerment;Ensure;Equity;evidence base;Evidence based intervention;Exercise;Goals;Government;Health;health equity;Health Priorities;health related quality of life;Healthcare;Heart failure;Hospital Referrals;Hospitalization;hybrid type 2 design;Hybrids;implementation context;implementation evaluation;implementation facilitation;implementation fidelity;implementation process;implementation science;implementation strategy;implementation/effectiveness;improved;incremental cost-effectiveness;indexing;Inequity;Infrastructure;innovation;insight;International;Internet;Interview;Knowledge;Learning;Location;low and middle-income countries;Maintenance;Mental Health;Metadata;Methods;mHealth;mobile application;Monitor;Morbidity - disease rate;mortality;National Heart, Lung, and Blood Institute;Nurses;Outcome;Outpatients;Patient Education;Patient Outcomes Assessments;patient-level barriers;Patients;Pattern;Pharmaceutical Preparations;Phase;Physicians;pilot trial;primary outcome;Process;process evaluation;Protocols documentation;Provider;provider-level barriers;Reach, Effectiveness, Adoption, Implementation, and Maintenance;Recommendation;Reporting;Research Personnel;Secure;Self Care;Service delivery model;Shapes;Site;social determinants;sociodemographic disparity;Solar Energy;standard of care;Structure;symptom management;Symptoms;Syndrome;Time;tool;treatment arm;Uganda;Universities;uptake;Work",ImpleMEntation of a Digital-first care deLiverY model for heart failure in Uganda (MEDLY Uganda),166585,SIHH,Science of Implementation in Health and Healthcare Study Section[SIHH],NA,S1,2,54550,14884,69434,NA
11178906,R01,MH,7,N,2024-09-19,2024-09-01,2025-04-30,242,R01MH131610,SCHOOLS OF MEDICINE,PA-24-254,7R01MH131610-03,NIMH:267817\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,Newark,UNITED STATES,NEUROSURGERY,10,090299830,US,10034168,RUTGERS BIOMEDICAL AND HEALTH SCIENCES,NJ,071073001,"Narrative Schizophrenia is a highly heritable neurodevelopmental disorder, but the mechanisms behind how schizophrenia genetic risk loci function is not clear. Cortical interneurons are substantially affected in schizophrenia and enriched for schizophrenia heritability during development. The proposed study is aimed at identifying schizophrenia risk loci that are active in these neurons during development, which will provide insights on the developmental mechanisms of SCZ risks, and help identify novel therapeutic targets.",7798212 (contact),"CHUNG, SANGMI  (contact)","PANCHISION, DAVID M",2023-07-01,2028-04-30,3-Dimensional;Address;Adult;Affect;ATAC-seq;Autopsy;Biological;Brain;brain cell;brain tissue;cell type;Cells;ChIP-seq;Chromatin;Chromosomes;Code;cohort;Complement;Complex;CRISPR interference;CRISPR-mediated transcriptional activation;Data;Data Set;Development;Developmental Process;differentiation in vitro;Disease;Distal;Early identification;Embryo;Embryonic Development;fetal;Fetal Development;Gene Expression;Gene Expression Profile;gene regulatory network;Generations;Genes;Genetic;genetic makeup;Genetic Risk;Genetic study;Genome;genome wide association study;genome-wide;Genomics;Genotype;Glean;Goals;Heritability;Human;human fetal brain;In Vitro;in vivo;induced pluripotent stem cell;insight;Interneurons;Libraries;Maps;Medial;Methods;migration;Mus;Neurodevelopmental Disorder;Neurons;new therapeutic target;Parvalbumins;Pathologic;Pathway interactions;Patients;pluripotent stem cell differentiation;Population;Procedures;Qualifying;Quantitative Trait Loci;Regulation;Resolution;risk variant;Role;Schizophrenia;schizophrenia risk;Somatostatin;Synapses;Testing;Time;Tissues;Training;transcription factor;transcriptome;transcriptome sequencing;transcriptomics;Transplantation;Untranslated RNA;Validation;Variant;Weight;Work,Common schizophrenia variants functioning in developmental human cortical interneurons,131610,MNG,Molecular Neurogenetics Study Section[MNG],NA,NA,3,205104,62713,267817,NA
11178909,R36,AG,7,N,2024-11-15,2024-12-01,2025-07-31,866,R36AG088233,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7R36AG088233-02,NIA:52081\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,CHARLOTTESVILLE,UNITED STATES,CHEMISTRY,05,065391526,US,1526402,UNIVERSITY OF VIRGINIA,VA,229044195,"Neurodegenerative diseases, including Alzheimer’s disease (AD) and Alzheimer’s disease related dementias (ADRD) are characterized by accumulation of intrinsically disordered proteins (IDPs) and impairment of proteasome-mediated protein degradation. This R36 proposal aims to investigate small molecule 20S proteasome activation as a novel strategy to resolve both pathogenic events. Successful completion of this work will enable the rapid design, development, and identification of 20S proteasome activators, and elucidate the role of 20S proteasome modulation in neurodegenerative diseases as a novel therapeutic strategy for disease treatment.",77996797 (contact),"COLOMBANI-GARAY, DANIEL JOSE (contact)","COGLIATI, TIZIANA PAOLA",2024-08-01,2026-07-31,NA,Development of N-acyl fluspirilene mediated proteasome enhancement for the treatment of neurodegenerative diseases,88233,AGCD,Career Development for Established Investigators and Conference Grants Study Section[AGCD-4],NA,NA,2,48224,3857,52081,NA
11178913,R01,MH,7,N,2024-09-20,2024-09-01,2025-04-30,242,R01MH133205,SCHOOLS OF MEDICINE,PA-24-254,7R01MH133205-03,NIMH:206530\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,Newark,UNITED STATES,NEUROSURGERY,10,090299830,US,10034168,RUTGERS BIOMEDICAL AND HEALTH SCIENCES,NJ,071073001,"Narrative Human iPSCs can provide unlimited sources of human neurons to study disease mechanisms; but in vitro neuronal cultures lack many important brain components that play crucial roles in neuronal functions. Thus, we will generate brain-region-specific humanized cortical interneuron mice to allow for the study of the role of grafted human neurons in brain circuit and behavioral functions. Such physiological humanized models will facilitate the understanding of cell-type-specific and brain-region-specific disease mechanisms, and the development of novel therapeutics.",7798212 (contact),"CHUNG, SANGMI  (contact)","PANCHISION, DAVID M",2023-07-01,2028-04-30,Ablation;Address;Area;Astrocytes;autism spectrum disorder;Behavior;Behavioral;Behavioral Assay;Biological Models;Blood Vessels;Brain;Brain Diseases;Brain region;Cell Culture Techniques;cell type;Central Nervous System;Chimera organism;cognitive function;cognitive task;cognitive testing;Complex;Data;Development;Disease;disease mechanisms study;Dorsal;Dose;Electrodes;Electrophysiology (science);Environment;experimental study;Failure;Future;Genetic;Graft Survival;Hippocampus;Histologic;Human;human disease;human fetal brain tissue;human induced pluripotent stem cells;Immunohistochemistry;In Vitro;in vivo;in vivo Model;induced pluripotent stem cell;Injections;Interneuron function;Interneurons;Medial;Methods;Microglia;Modeling;Mus;Neurons;neuropsychiatric disorder;novel;novel therapeutics;Oligodendroglia;optogenetics;Pathogenesis;Patients;Phenotype;physiologic model;Physiological;Play;Pluripotent Stem Cells;Population;Prefrontal Cortex;Qualifying;Regulation;restoration;risk variant;Rodent;Rodent Model;Role;Schizophrenia;Slice;Source;stem cells;Synapses;System;Testing;Therapeutic;Titrations;Transplantation;Untranslated RNA;Viral Vector,Brain-region-specific humanized cortical interneuron mice,133205,PMDA,Pathophysiological Basis of Mental Disorders and Addictions Study Section[PMDA],NA,NA,3,134748,71782,206530,NA
11178914,T32,AR,3,N,2024-08-29,2024-07-01,2025-06-30,846,T32AR007080,SCHOOLS OF MEDICINE,PA-20-142,3T32AR007080-45S1,NIAMS:86976\,"TRAINING, INSTITUTIONAL",2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,ANN ARBOR,UNITED STATES,INTERNAL MEDICINE/MEDICINE,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"PROJECT NARRATIVE The University of Michigan's Program for Scientist Training in Rheumatology Research is designed to prepare four outstanding postdoctoral scientists per year, both MD and PhD, for investigative careers in research related to the rheumatic diseases. The goal is to provide a diverse cohort of trainees essential familiarity with state-of-the-art scientific methodologies and analyses, as well as strong roots in the ethical conduction of research and in embracing a culture of diversity, equity, and inclusion.",6438577 (contact),"KNIGHT, JASON  (contact)","VINCENT, ISAAH S",1976-07-01,2028-06-30,Research;Rheumatology;Scientist;Training,Scientist Training in Rheumatology Research,7080,ZAR1,ZAR1-KM(M1),NA,S1,45,80756,6220,86976,NA
11178923,P50,CA,3,N,2024-08-28,2024-08-01,2025-07-31,NA,P50CA211015,NA,PA-23-189,3P50CA211015-08S1,NCI:86121\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,"The studies proposed herein are designed to investigate mechanisms of immune evasion following active immunotherapy with brain cancer vaccines. We will test our hypothesis that clinically relevant anti-tumor immunity to glioblastoma (GBM) must have two cellular components: 1) significant infiltration of tumor-specific  tumor-infiltrating lymphocytes (TIL); and 2) blockade of immunosuppressive tumor infiltrating myeloid cell (TIM) function within the tumor microenvironment. We believe that a combination of active vaccination (ATL-DC; to induce T-cell infiltration into tumors), immune checkpoint inhibition (to enhance T cell function), and CSF-1R inhibition (to block suppressive TIM function) may lead to improved outcomes for the treatment of glioblastoma.",6773147 (contact),"PRINS, ROBERT M (contact)","HUBBARD, LEAH",2017-08-11,2027-07-31,Active Immunization;Active Immunotherapy;Animals;anti-PD-1;anti-tumor immune response;Ants;Attenuated;Autologous;Brain;Brain Neoplasms;Cancer Vaccines;CD8-Positive T-Lymphocytes;Cell Physiology;Cells;Cellular biology;checkpoint inhibition;Chronic;Clinical Trials;clinically relevant;Combination immunotherapy;Combined Modality Therapy;CSF1R gene;dendritic cell vaccination;Dendritic Cells;design;Development;effective therapy;first-in-human;Funding;Glioblastoma;Glioma;Health;Immigration;Immune;Immune Evasion;immune resistance;Immunotherapy;improved outcome;Infiltration;inflammatory milieu;inhibitor;innovation;insight;Malignant neoplasm of brain;Measures;Mediating;Monoclonal Antibodies;Myeloid Cells;Myeloid-derived suppressor cells;neoplasm immunotherapy;neoplastic cell;Newly Diagnosed;novel;Patients;PD-1 blockade;pembrolizumab;Phenotype;Physiologic pulse;preclinical study;programmed cell death protein 1;Recurrence;Resistance;response;Series;T cell infiltration;T cell response;T-Cell Activation;T-Lymphocyte;targeted treatment;Testing;Therapeutic;Translational Research;Treatment outcome;tumor;Tumor Immunity;tumor microenvironment;Tumor-Infiltrating Lymphocytes;vaccination strategy;Virus Diseases,Project 1:  Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition,211015,ZCA1,ZCA1(M1)-S,8737,S1,8,54680,31441,NA,86121
11179019,R01,GM,3,N,2024-08-31,2024-09-01,2025-08-31,859,R01GM148685,SCHOOLS OF ARTS AND SCIENCES,PA-20-185,3R01GM148685-03S1,NIGMS:80575\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,CHAPEL HILL,UNITED STATES,CHEMISTRY,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"Project narrative Production of small molecules that bind metal ions is important for the survival of microbes and the ability of these microbes to cause infections. We study the reaction mechanisms of the enzymes responsible for the production of a unique copper-containing antibiotic, which is produced by a pathogen that can cause serious hospital-acquired infections. Our mechanistic investigations will advance the understanding of enzyme-catalyzed reactions, provide new tools for biocatalysis, and enable studies of how pathogenic bacteria maintain copper balance during infection.",10652468 (contact),"LI, BO  (contact)","SIMONOVIC, MILJAN",2022-09-20,2026-08-31,absorption;adenylosuccinate lyase;Amines;Anabolism;analog;Antibiotics;Binding;Biomedical Engineering;Carbon;carboxylate;Catalysis;Chemical Structure;Chemistry;Collaborations;college;Copper;Cysteine;Data;Decarboxylation;Dioxygenases;Drug Metabolic Detoxication;Electron Spin Resonance Spectroscopy;Engineering;Enzyme Kinetics;enzyme mechanism;Enzymes;Equilibrium;Excision;Exhibits;Family;fluopsin;Formates;Fumarates;Heme;human pathogen;Hydrogen;Industrialization;Infection;innovation;insight;Investigation;Ions;Iron;Lifting;Ligand Binding;Ligands;Lyase;Medicine;Metal Ion Binding;Metals;Microbe;microorganism;Monitor;Multi-Drug Resistance;N hydroxylation;Natural Products;Nature;Nitric Oxide;Nosocomial Infections;novel;Oximes;Oxygen;Oxygenases;pathogen;pathogenic bacteria;Pathway interactions;Pharmacologic Substance;Play;Production;Pseudomonas aeruginosa;Reaction;Recycling;Reducing Agents;Roentgen Rays;Siderophores;small molecule;Spectrum Analysis;stoichiometry;structural biology;Structure;Sulfur;Synthesis Chemistry;synthetic biology;Testing;tool;Variant;Virulence;Work,Mechanisms of unusual enzymes in the biosynthesis of a copper-containing antibiotic,148685,SBCB,Synthetic and Biological Chemistry B Study Section[SBCB],NA,S1,3,55445,25130,80575,NA
11179076,N01,AI,NA,N,NA,NA,NA,NA,75N93022C00023,NA,NA,75N93022C00023-P00003-9999-1,NIAID:500000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,ROCKVILLE,UNITED STATES,NA,08,161157953,US,3601801,"FISHER BIOSERVICES, INC.",MD,208505312,NA,79953724 (contact),"EYLER, DENNIS  (contact)",NA,2022-09-21,2025-09-20,2019-nCoV;Adherence;Clinical;clinical material;Clinical Research;Clinical Trials;Communicable Diseases;Contracts;Ensure;Good Clinical Practice;good laboratory practice;Good Manufacturing Process;Microbiology;programs;Services;Shipping;Specimen,"Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS), SARS-CoV-2",0,NA,NA,NA,NA,NA,NA,NA,500000,NA
11179077,N01,AI,NA,N,NA,NA,NA,NA,75N93022C00023,NA,NA,75N93022C00023-P00003-9999-2,NIAID:200000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,ROCKVILLE,UNITED STATES,NA,08,161157953,US,3601801,"FISHER BIOSERVICES, INC.",MD,208505312,Public Health Relevance: Specific Aims: Specific aims include clinical trial support.,79953724 (contact),"EYLER, DENNIS  (contact)",NA,2022-09-21,2025-09-20,Adherence;Antibiotic Resistance;Clinical;clinical material;Clinical Research;Clinical Trials;Combating Antibiotic Resistant Bacteria;Communicable Diseases;Contracts;Ensure;Good Clinical Practice;good laboratory practice;Good Manufacturing Process;Microbiology;programs;public health relevance;Services;Shipping;Specimen,Division of Microbiology and Infectious Diseases (DMID) Clinical Materials Services: Antibiotic Resistant Clinical Studies,0,NA,NA,NA,NA,NA,NA,NA,200000,NA
11179078,N01,AI,NA,N,NA,NA,NA,NA,75N93023C00040,NA,NA,75N93023C00040-P00001-9999-1,NIAID:1481691\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,BOSTON,UNITED STATES,NA,07,076593722,US,1504801,BOSTON CHILDREN'S HOSPITAL,MA,021155724,NA,79365727 (contact),"HEILHERKER, TYSON  (contact)",NA,2023-09-30,2028-09-29,"Adjuvant;Adjuvanticity;Agonist;analog;Animal Model;Antigens;Austria;Boston;Cells;Chemistry;Contractor;cytokine;Development;Disease;efficacy study;Family suidae;Ferrets;Formulation;good laboratory practice;Good Manufacturing Process;Hemagglutinin;high throughput screening;Human;Immune;immune activation;Immune signaling;immunogenicity;In Vitro;in vivo;in vivo Model;Infection;Influenza;Influenza A Virus, H1N1 Subtype;Influenza A Virus, H3N2 Subtype;influenza virus strain;influenza virus vaccine;Intervention;Investigational New Drug Application;Leukocytes;Licensing;Malignant Neoplasms;manufacture;Mediating;Mus;novel;Pattern recognition receptor;Pediatric Hospitals;Process;Production;Program Development;programs;Proteins;Readiness;Research Activity;response;scale up;small molecule;System;TLR7 gene;Vaccination;Vaccine Adjuvant;vaccine immunogenicity;Vaccines;Wisconsin",VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES,0,NA,NA,NA,NA,NA,NA,NA,1481691,NA
11179081,N01,AI,NA,N,NA,NA,NA,NA,75N93019C00070,NA,NA,75N93019C00070-P00021-9999-1,NIAID:9482062\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,SEATTLE,UNITED STATES,NA,07,048682157,US,1531401,SEATTLE CHILDREN'S HOSPITAL,WA,981053901,NA,16188339 (contact),"URDAHL, KEVIN  (contact)",NA,2019-09-30,2026-09-29,Animals;design;Goals;HIV;HIV Seronegativity;HIV Seropositivity;Human;human subject;Immune;Immune Evasion;Immune response;Immune Targeting;Immunity;Immunologics;improved;multidisciplinary;Mus;Mycobacterium Infections;Mycobacterium tuberculosis;non-tuberculosis mycobacteria;nonhuman primate;programs;protective pathway;Research Activity;Research Personnel;response;SIV;Tissues;Tuberculosis;Tuberculosis Vaccines;vaccine strategy;vaccine-induced immunity,IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB),0,NA,NA,NA,NA,NA,NA,NA,9482062,NA
11179082,N01,AI,NA,N,NA,NA,NA,NA,75N93019C00070,NA,NA,75N93019C00070-P00021-9999-2,NIAID:5443065\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,SEATTLE,UNITED STATES,NA,07,048682157,US,1531401,SEATTLE CHILDREN'S HOSPITAL,WA,981053901,NA,79953721 (contact),"URDAHL, KEVIN  (contact)",NA,2019-09-30,2026-09-29,2019-nCoV;Animals;co-infection;Goals;Human;Immune;Immune response;Immune Targeting;Immunologics;improved;multidisciplinary;Mycobacterium tuberculosis;Natural Immunity;nonhuman primate;Participant;programs;Research Personnel;response;Tissues;Tuberculosis;Tuberculosis Vaccines;vaccine development;vaccine strategy,Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB),0,NA,NA,NA,NA,NA,NA,NA,5443065,NA
11179083,N01,AI,NA,N,NA,NA,NA,NA,75N93019C00070,NA,NA,75N93019C00070-P00021-9999-3,NIAID:378109\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,SEATTLE,UNITED STATES,NA,07,048682157,US,1531401,SEATTLE CHILDREN'S HOSPITAL,WA,981053901,NA,78834687 (contact),"URDAHL, KEVIN  (contact)",NA,2019-09-30,2026-09-29,2019-nCoV;Animal Model;Animals;co-infection;cohort;Disease;Goals;HIV;Human;Immune;Immune response;Immune Targeting;Immunologics;improved;Infection;latent infection;multidisciplinary;Mycobacterium tuberculosis;Natural Immunity;nonhuman primate;Participant;prevent;programs;Research Personnel;response;Tissues;Tuberculosis;Tuberculosis Vaccines;vaccination against tuberculosis;vaccine candidate;vaccine efficacy;vaccine strategy,IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB),0,NA,NA,NA,NA,NA,NA,NA,378109,NA
11179084,N01,AI,NA,N,NA,NA,NA,NA,75N93019C00064,NA,NA,75N93019C00064-P00013-9999-1,NIAID:1108760\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,WORCESTER,UNITED STATES,NA,02,603847393,US,850903,UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,016550002,NA,79953718 (contact),"GAGE, KASIA  (contact)",NA,2019-09-29,2025-09-29,Basic Science;Binding;Blastomyces;Coccidioides immitis;Coccidioides posadasii;Communities;Computer software;Cryptococcus neoformans;Data;Databases;Diagnostic;Epitopes;fungus;Histoplasma capsulatum;Human;Immune;immunogenicity;In Vitro;Mediating;multidisciplinary;Pathogenesis;Research;Resources;Role;Support Contracts;T-Lymphocyte;T-Lymphocyte Epitopes;tool;Validation;validation studies,Large Scale T Cell Epitope Discovery,0,NA,NA,NA,NA,NA,NA,NA,1108760,NA
11179085,N01,HD,NA,N,NA,NA,NA,NA,275201800008I,NA,NA,275201800008I-P00008-759401900125-1,NICHD:55367\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,16167263 (contact),"HUGHES, BRENNA  (contact)",NA,2019-09-06,2024-08-31,"Address;Adolescent Behavior;adolescent health;African American;African American population;African American Women;age acceleration;Aging;Anthropometry;arterial stiffness;Behavioral;behavioral outcome;Behavioral Sciences;Biochemical;Bioinformatics;Biological Process;Biometry;Birth;Black American;Blood Pressure;Body fat;Body mass index;cardiovascular disorder risk;Characteristics;Childhood;Chronic Disease;Clinical;cohort;Cohort Studies;Common Data Element;Complications of Diabetes Mellitus;Contractor;Data Collection;delivery complications;design;Development;Diagnosis;Disease;disorder risk;early life exposure;early pregnancy;Enrollment;Epidemiology;Epigenetic Process;father role;Fetal Development;Fetal Growth;Fetal health;Fetal Mortality Statistics;First Pregnancy Trimester;Gene Expression;Genetic;genomic locus;Gestational Diabetes;Glucose;Glycosylated hemoglobin A;Goals;Health;Human;Individual;Intramural Research;Link;male;Measures;member;Mission;National Institute of Child Health and Human Development;Neonatal;neonatal health;neonatal morbidity;Neonatal Mortality;neonatal outcome;neonate;Newborn Infant;Patient Self-Report;Placenta;population health;Pregnancy;pregnancy health;Pregnant Women;prenatal exposure;Preparation;Procedures;programs;prospective;Public Health;Randomized;Randomized, Controlled Trials;recruit;Reproduction;Research;Research Methodology;Risk Factors;Sampling;Seminal fluid;Site;Social Sciences;Testing;Time;Training;ultrasound;Variant;waist circumference;Woman;women&apos;s diagnosis","START UP, PREPARATION, AND TEST ENROLLMENT FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)",0,NA,NA,NA,NA,NA,NA,NA,55367,NA
11179086,N01,HD,NA,N,NA,NA,NA,NA,75N94023D00006,NA,NA,75N94023D00006-P00001-759402300001-1,NICHD:328838\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,79386415 (contact),"GONG, LEYI  (contact)",NA,2023-09-27,2025-09-25,Adenomyosis;Archives;autism spectrum disorder;Bacterial Infections;Biological;Chemicals;Contraceptive Agents;Contraceptive methods;Data;Databases;Down&apos;s Syndrome;drug development;Dysmenorrhea;endometriosis;Equipment;Equipment and supply inventories;Fetal Growth Retardation;Fibroid Tumor;Gestational Diabetes;Gynecologic;Health;improved;in vivo evaluation;Infertility;Inflammation;Lactation;Maintenance;mastitis;microbiome;Mission;Muscular Dystrophies;National Institute of Child Health and Human Development;Natural Products;Necrotizing Enterocolitis;novel;Pelvic Pain;Perinatal;Pituitary-dependent Cushing&apos;s disease;Placenta;Polycystic Ovary Syndrome;Polymers;Pre-Eclampsia;Premature Birth;Production;Reproductive Health;Research;Rett Syndrome;Role;screening;Sepsis;small molecule;United States National Institutes of Health;Virus Diseases;Vulvodynia,"CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES",0,NA,NA,NA,NA,NA,NA,NA,328838,NA
11179101,U54,OH,6,N,2024-08-27,2024-09-30,2025-09-29,262,U54OH007544,SCHOOLS OF PUBLIC HEALTH,RFA-OH-22-002,6U54OH007544-23M001,NIOSH:255639\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH,NA,SEATTLE,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,605799469,US,9087701,UNIVERSITY OF WASHINGTON,WA,981959472,NA,7552259 (contact),"YOST, MICHAEL G (contact)",NA,2022-09-30,2027-09-29,NA,Pacific Northwest Agricultural Safety and Health Center,7544,ZOH1,ZOH1-DVN(10),NA,M001,23,NA,NA,255639,NA
11179103,U54,OH,6,N,2024-08-27,2024-09-30,2025-09-29,262,U54OH007547,NA,PAR-15-353,6U54OH007547-23M001,NIOSH:290000\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH,NA,LEXINGTON,UNITED STATES,NA,06,939017877,US,2793601,UNIVERSITY OF KENTUCKY,KY,405260001,NA,8433958 (contact),"SANDERSON, WAYNE T. (contact)",NA,2022-09-30,2027-09-29,NA,Southeast Center for Agricultural Health and Injury Prevention,7547,ZOH1,ZOH1-EHG(01),NA,M001,23,NA,NA,290000,NA
11179104,F99,CA,5,N,2024-09-05,2024-08-01,2025-07-31,398,F99CA284252,SCHOOLS OF MEDICINE,RFA-CA-22-041,5F99CA284252-02,NCI:38061\,OTHER RESEARCH-RELATED,2024,NATIONAL CANCER INSTITUTE,NA,CHARLOTTESVILLE,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,065391526,US,1526402,UNIVERSITY OF VIRGINIA,VA,229044195,"PROJECT NARRATIVE Acute myeloid leukemia (AML) remains an incurable malignancy despite the recent approval of molecularly targeted therapies. The Bcl-2 antagonist/BH3 mimetic, venetoclax, is routinely used in combination with chemotherapy or hypomethylating agents in newly diagnosed AML, but incomplete responses demonstrate a need for novel treatment modalities to improve venetoclax efficacy. The F99 phase of this proposal investigates the mechanisms of synergy and in vivo efficacy of co-inhibiting the pro-survival sphingolipid enzyme, acid ceramidase, and Bcl-2 in AML, while the K00 phase leverages CRISPR screening and dynamic BH3 profiling to develop rational sphingolipid-based drug combinations in breast cancer.",78064135 (contact),"UNG, JOHNSON  (contact)","ELJANNE, MARIAM",2023-08-10,2025-07-31,Academia;Acute Myelocytic Leukemia;acute myeloid leukemia cell;Affect;analog;antagonist;anti-cancer research;Apoptosis;Apoptotic;bcl-xlong protein;BCL2 gene;BCL2L1 gene;Bioinformatics;biological adaptation to stress;Biological Assay;Biological Markers;biomarker identification;Bone marrow failure;Breast Cancer Model;Breast Cancer Treatment;Cancer Research Project;cancer therapy;career;Cell Death;Cell Line;Cell Membrane Permeability;Ceramides;chemotherapy;Clinical;combinatorial;Combined Modality Therapy;CRISPR screen;CRISPR/Cas technology;Data;Data Analyses;design;Drug Combinations;drug sensitivity;Electron Microscopy;Engraftment;Enzymes;Equilibrium;Family;FDA approved;galactosylgalactosylglucosylceramidase;Genetic;genomic data;Goals;Grant;Human;Hydrolase;Impairment;improved;In Vitro;in vivo;inhibitor;Isopropyl Thiogalactoside;knock-down;Knock-out;Learning;leukemia;leukemia treatment;Link;Lipids;Malignant Breast Neoplasm;Malignant Neoplasms;MCL1 gene;Mediating;member;Mentors;Metabolism;Methods;mimetics;Mitochondria;Modality;molecular targeted therapies;Mus;Myelogenous;Myeloproliferative disease;N-caproylsphingosine;nanoliposome;Newly Diagnosed;novel;Outcome;Outer Mitochondrial Membrane;overexpression;Patients;Pharmaceutical Preparations;pharmacologic;Phase;Postdoctoral Fellow;pre-doctoral;precision medicine;preclinical efficacy;Productivity;prognostic value;programs;protein expression;Protein Family;Proteins;Relapse;Research;Research Personnel;Research Project Grants;Resistance;Respiration;respiratory;response;Role;Sampling;Series;Signal Transduction;skills;Solid Neoplasm;Sphingolipids;sphingosine 1-phosphate;synergism;Testing;Therapeutic;therapeutic target;Training;transcriptome sequencing;transcriptomics;Treatment Efficacy;treatment strategy;triple-negative invasive breast carcinoma;Up-Regulation;vector;whole genome;Work,Mechanisms and In Vivo Efficacy of Synergistic Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia,284252,ZCA1,ZCA1-RPRB-7(M1),NA,NA,2,38061,0,38061,NA
11179501,U54,CA,3,N,2024-09-17,2024-09-01,2025-08-31,NA,U54CA202995,NA,PA-20-272,3U54CA202995-10S1,NCI:306150\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,CHICAGO,UNITED STATES,NA,05,879331445,US,215501,NORTHEASTERN ILLINOIS UNIVERSITY,IL,606254699,NA,10468677 (contact),"CIECIERSKI, CHRISTINA  (contact)","SAN MIGUEL-MAJORS, SANDRA L",2015-09-24,2025-08-31,Adherence;Advanced Malignant Neoplasm;Advisory Committees;anti-cancer research;Award;Budgets;cancer health disparity;Cancer health equity;career;career development;Chicago;Clinical;Collaborations;Communication;Communities;Comprehensive Cancer Center;conflict resolution;Decision Making;early-career faculty;Education;Ensure;Equity;Evaluation;experience;Faculty;Foundations;Goals;Guidelines;Illinois;improved;Individual;Infrastructure;Institution;Institutional Policy;interest;Lead;Leadership;Logic;Malignant Neoplasms;Manuals;meetings;member;Mentors;Minority;Minority-Serving Institution;Modeling;operation;outreach;Process;programs;Protocols documentation;recruit;Reporting;Research;research facility;Resources;Solid;Stream;Structure;Student recruitment;Students;success;Talents;Time;tool;Universities;Work,Administrative Core,202995,ZCA1,ZCA1,7860,S1,10,250000,56150,NA,306150
11179508,P20,GM,3,N,2024-09-04,2024-09-01,2025-07-31,NA,P20GM130414,NA,PA-20-272,3P20GM130414-06S1,NIGMS:865095\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,PROVIDENCE,UNITED STATES,NA,01,001785542,US,1003201,BROWN UNIVERSITY,RI,029034202,NA,1860310 (contact),"AHLUWALIA, JASJIT SINGH (contact)","BERNAL, FEDERICO",2019-08-01,2029-07-31,addiction;Address;Advisory Committees;alcohol abuse therapy;alcohol and other drug;Alcohols;ARHGEF5 gene;biopsychosocial;career;career development;Centers of Research Excellence;Chronic Disease;Clinical;Communities;Complement;design;Development;Development Plans;Disease;disorder risk;Doctor of Philosophy;early-career faculty;Educational workshop;Effectiveness;Ensure;ethnic minority;Evaluation;experience;Faculty;Feedback;Funding;Goals;Grant;Health;health disparity;high risk population;Hospitals;improved;Individual;innovation;Institution;interest;International;Investments;Journals;Laboratories;Leadership;Link;member;Mentors;Minnesota;minority communities;minority health;minority health disparity;Monitor;multidisciplinary;National Institute on Alcohol Abuse and Alcoholism;National Institute on Minority Health and Health Disparities;Nicotine Dependence;organizational structure;Phase;Physicians;Pilot Projects;Postdoctoral Fellow;Principal Investigator;programs;Psychologist;racial minority;recruit;Research;Research Ethics;Research Personnel;Research Project Grants;Research Training;Resources;Risk;Science;Scientist;Secure;senior faculty;Series;substance use;success;Training;Training Programs;Underrepresented Populations;underserved community;Underserved Population;United States National Institutes of Health;Universities;Work;Writing,Administrative Core,130414,ZGM1,ZGM1,7779,S1,6,567524,297571,NA,865095
11179514,OT2,OD,3,N,2024-09-11,2024-09-01,2025-04-30,368,OT2OD036428,NA,OTA-22-006,3OT2OD036428-01S1,NEI:250000\OD:50147\,OTHERS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,IRVINE,UNITED STATES,NA,47,046705849,US,577504,UNIVERSITY OF CALIFORNIA-IRVINE,CA,926970001,No PHR,78949312;1881795 (contact);79178142;79179266;78815718;10801412;78816226;10801388;78926849;9589509;2202059,"ABRAMOV, DMITRY ;ANTON-CULVER, HODA A (contact);CHOW, EMILIE ;LEE, SCOTT ;LEVERONI-CALVI, MATTEO ;PARK, HANNAH LUI;REIKES, ANDREW ;STAMOS, MICHAEL J;YOUSSEF, FADY A;ZHENG, KAI ;ZIOGAS, ARGYRIOS","PRABHUDAS, IRENE",2024-09-01,2025-04-30,California;Enrollment;Population Heterogeneity,"All of Us Southern California Consortium (AoUSCC): Engagement, Enrollment, and Retention of Diverse Populations",36428,ZOD1,ZOD1-SRC(99),NA,S1,1,191177,108970,300147,NA
11179515,R00,HD,4,N,2024-09-04,2024-11-01,2025-10-31,865,R00HD108392,SCHOOLS OF MEDICINE,PA-20-188,4R00HD108392-03,NICHD:249000\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NEW YORK,UNITED STATES,GENETICS,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,"Narrative Noncoding structural variants (SVs) represent a largely undefined component of the genetic architecture of developmental disorders (DDs). There are a handful of examples of noncoding SVs associated with long-range positional effects (LRPEs) that result in DDs, but the characterization of LRPEs and the delineation of their underlying mechanism has not been systematically investigated. The proposed studies will investigate the prevalence and molecular mechanisms contributing to pathogenic LRPEs in DDs by performing SV association analysis with large case control cohorts as well as paired transcriptomic and chromatin profiling in individuals with large chromosomal abnormalities to identify features predictive of LRPEs across the genome.",15345292 (contact),"LOWTHER, CHELSEA  (contact)","KAU, ALICE S",2024-11-01,2027-10-31,3-Dimensional;Address;Advisory Committees;Appointment;Architecture;Balanced Chromosomal Translocation;Base Pairing;career;case control;Catalogs;Cell Line;Characteristics;Chromatin;Chromatin Structure;Chromosome abnormality;cohort;Collaborations;Collection;college;comparison control;Complex;Cytogenetics;Data;Data Set;developmental disease;Diagnosis;Diagnostic;diagnostic value;Disease;disorder risk;DNA Sequence Alteration;Evolution;exome sequencing;Fellowship;fetal;functional genomics;gene discovery;Gene Expression;Gene Targeting;General Hospitals;Genes;genetic architecture;Genetic Variation;Genome;genome sequencing;genome-wide;Genomic approach;Genomic medicine;Goals;Human;human disease;Human Genetics;improved;Individual;International;Learning;malformation;Massachusetts;medical schools;Medicine;Mentors;Mentorship;Methods;mid-career faculty;model building;Modeling;Molecular;Molecular Conformation;Molecular Genetics;Mutation;neuropsychiatry;novel;Nuclear;Pathogenicity;Pattern;Perinatal mortality demographics;population based;post-doctoral training;Postdoctoral Fellow;postnatal period;prenatal;Prevalence;programs;Protein Truncation;Regulation;Research;Research Personnel;Risk;RNA analysis;Sampling;Statistical Methods;Statistical Models;Structure;Technology;Training;Training Programs;transcriptome sequencing;transcriptomics;Untranslated RNA;Variant;whole genome;Work,Disruption of three-dimensional genome organization as a noncoding mechanism of disease in human developmental disorders,108392,NSS,NSS,NA,NA,3,147337,101663,249000,NA
11179519,R00,HG,4,N,2024-09-23,2024-09-23,2025-07-31,172,R00HG012798,SCHOOLS OF MEDICINE,PA-20-188,4R00HG012798-03,NHGRI:249000\,NON-SBIR/STTR RPGS,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NEW HAVEN,UNITED STATES,INTERNAL MEDICINE/MEDICINE,03,043207562,US,9420201,YALE UNIVERSITY,CT,065208327,"Project Narrative De no!ID haplotype-resolved genome assembly is the most comprehensive solution to understand genomic sequences. This proposal aims to develop cost-effective computational methods for high-quality haplotype-resolved assemblies by utilizing multiple sequencing technologies. The new assembly algorijhms in this proposal not only could be used by large-scale sequencing consortiums such as the Human Pangenome Reference Consortium (HPRC) and the Genome in a Bottle (GIAB), but also could pave the way to personal genome assembly for genomic research and clinical applications.",16317121 (contact),"CHENG, HAOYU  (contact)","GABDANK, IDAN",2023-02-13,2027-07-31,Acceleration;Adopted;Advisory Committees;Algorithm Design;Algorithms;Awareness;Biomedical Research;cancer genome;career;career development;Centromere;Chromosomes;clinical application;Complex;Computing Methodologies;contig;cost;cost effective;Data;design;Diploidy;experience;Focus Groups;Genome;Genomics;Goals;Grant;Graph;Haplotypes;Hi-C;Human;Human Genome;human pangenome;Hybrids;improved;Individual;Infrastructure;International;Laboratories;Large-Scale Sequencing;Lead;Leadership;Length;Life;Mentors;method development;Methods;nanopore;novel;pan-genome;Phase;Plant Genome;Play;Polyploidy;Population;Positioning Attribute;Principal Investigator;Repetitive Sequence;Research;Role;Sampling;scaffold;Technology;tool;Training;Trees;Variant;vertebrate genome;Work;Writing,Robust and cost-effective computational methods for haplotype-resolved genome assemblies,12798,NSS,NSS,NA,NA,3,148657,100343,249000,NA
11179530,P50,HD,3,N,2024-08-30,2024-07-01,2025-06-30,865,P50HD104458,SCHOOLS OF MEDICINE,RFA-HD-20-003,3P50HD104458-05S1,NICHD:73185\,RESEARCH CENTERS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ATLANTA,UNITED STATES,GENETICS,05,066469933,US,2384501,EMORY UNIVERSITY,GA,303221007,"PROJECT NARRATIVE Fragile X syndrome (FXS), the most common inherited form of intellectual disability and a leading genetic cause of autism spectrum disorders (ASD), is caused by the loss of functional fragile X mental retardation protein (FMRP). Recent technological development of 2D and 3D culture derived from human iPSCs provides a new platform to investigate human brain development in a dish, otherwise inaccessible to experimentation. This multi-project Center aims to establish a framework to understand the FMRP-mediated regulation of human brain development at molecular, cellular and system circuitry levels that will enable the development of therapeutic approaches to treat FXS.",7077036 (contact),"JIN, PENG  (contact)","KAU, ALICE S",2020-09-25,2025-06-30,3-Dimensional;5&apos; Untranslated Regions;Adherent Culture;Animal Model;Area;autism spectrum disorder;Behavioral;Binding;Biological Models;Brain;cell type;Cells;CGG repeat;Clinical Trials;crosslinking and immunoprecipitation sequencing;Data;Development;Disease;Dissection;Drosophila genus;drug discovery;Drug Modulation;Electrophysiology (science);FMR1 gene;follow-up;Fragile X Syndrome;Functional disorder;functional loss;GABA Receptor;Gene Expression Regulation;Genetic;genome editing;genome-wide;Goals;Human;Human Development;human disease;human induced pluripotent stem cells;human model;Hypermethylation;In Vitro;in vivo;induced pluripotent stem cell;Induced pluripotent stem cell derived neurons;Inherited;Intellectual functioning disability;Knowledge;Learning;Link;Mediating;messenger ribonucleoprotein;Messenger RNA;Metabotropic Glutamate Receptors;Modeling;Molecular;mouse model;Mus;neural;new therapeutic target;novel;novel therapeutic intervention;novel therapeutics;Organoids;Pharmaceutical Preparations;Polyribosomes;preclinical study;promoter;Protein Biosynthesis;Regulation;Research;Research Personnel;RNA;RNA-Binding Proteins;Rodent;Role;screening;Signal Transduction;single cell genomics;single-cell RNA sequencing;small molecule;stem cell model;stem cells;Synapses;synaptogenesis;synergism;System;Technical Expertise;Technology;technology development;Testing;Therapeutic;therapeutic development;three-dimensional modeling;tool;transcriptome;transcriptomics;Translational Regulation;Translations;translatome;Validation,FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement,104458,ZHD1,ZHD1-DSR-Y(50),NA,S1,5,50626,22559,73185,NA
11179532,P50,HD,3,N,2024-09-26,2024-07-01,2025-06-30,NA,P50HD104458,NA,RFA-HD-20-003,3P50HD104458-05S1,NICHD:73185\,RESEARCH CENTERS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ATLANTA,UNITED STATES,NA,05,066469933,US,2384501,EMORY UNIVERSITY,GA,303221007,NA,1881563 (contact),"BASSELL, GARY J (contact)","KAU, ALICE S",2020-09-25,2025-06-30,3-Dimensional;Address;Adult;Animal Model;Automobile Driving;Behavior;Binding;Brain;Cell Proliferation;cell type;Cells;Clinical Trials;Collaborations;comparative;Coupled;crosslinking and immunoprecipitation sequencing;Data;Defect;Development;Disease;Down-Regulation;drug efficacy;effective therapy;Embryo;experimental study;Failure;fetal;FMR1 gene;Fragile X Syndrome;Hippocampus;Human;human induced pluripotent stem cells;Impairment;induced pluripotent stem cell;insight;Joints;Lentivirus;Mediating;Messenger RNA;migration;Modeling;Molecular;Molecular Target;monolayer;Morphology;mouse model;mRNA Translation;Mus;neural;neural model;neurodevelopment;neurogenesis;neuron development;Neuronal Differentiation;neuronal excitability;Neurons;neurophysiology;neurotransmission;novel;Nuclear Pore Complex;Organoids;Outcome;Pathway interactions;patient derived induced pluripotent stem cells;Patients;Phenotype;Physiological;preclinical study;primary endpoint;Proliferating;Protein Biosynthesis;Proteins;Regulation;Reporting;Retinoic Acid-Binding Proteins;ribosome profiling;RNA;Role;Signal Transduction;single-cell RNA sequencing;small molecule;Synapses;Synaptic plasticity;synergism;System;Testing;Therapeutic;Therapeutic Intervention;three-dimensional modeling;Tissues;tool development;transcriptome sequencing;translating ribosome affinity purification and RNA-sequencing;Translations;translatome;Work,Project 1,104458,ZHD1,ZHD1-DSR-Y,9426,S1,5,50626,22559,NA,73185
11179534,U54,HD,3,N,2024-08-30,2024-07-01,2025-06-30,865,U54HD104461,NA,RFA-HD-20-003,3U54HD104461-05S1,NICHD:84059\,RESEARCH CENTERS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,CINCINNATI,UNITED STATES,NA,01,071284913,US,615001,CINCINNATI CHILDRENS HOSP MED CTR,OH,452293039,"The overarching goal of our Center proposal entitled “Translational Medicine and Mechanistic Studies of Brain Neurophysiology in Fragile X Syndrome” is to utilize highly interrelated research strategies with two primary aims, advancing translational medicine approaches (biomarker development, drug challenge studies, resolving illness heterogeneity) and expanding the mechanistic understanding of Fragile X syndrome (FXS) biology. The goal of this work is to foster the development of new, more effective therapies. We propose to pursue these aims through the establishment of integrated, interdependent research programs from patient-centered research to in vivo animal experiments to cellular sub-type specific and molecular models.",8904584 (contact),"ERICKSON, CRAIG  (contact)","KAU, ALICE S",2020-09-25,2025-06-30,Address;Animal Experiments;Animal Model;Back;Behavior;Behavioral;bench to bedside;Biological Markers;Biology;biomarker development;Brain;brain dysfunction;Cholecystokinin;Clinical;Clinical Research;Clinical Sciences;Clinical Trials;clinically relevant;Cognition;Collaborations;Data;design;Development;Disease;drug development;Drug Monitoring;effective therapy;Electroencephalography;Electrophysiology (science);endocannabinoid signaling;Endocannabinoids;endogenous cannabinoid system;Ensure;Environment;experience;Failure;FMR1 gene;Fostering;Fragile X Syndrome;Future;Gene Proteins;gene therapy;Glutamates;Goals;Heterogeneity;Human;human study;improved;in vivo;individualized medicine;insight;interest;Interneurons;Investigation;Knowledge;Link;Measures;Methodology;Mission;Modeling;Molecular;Molecular Analysis;molecular modeling;multi-electrode arrays;multidisciplinary;Mus;Neocortex;network models;neural circuit;neurobehavioral;Neurobiology;Neurons;neurophysiology;Neurosciences Research;neurotransmission;novel;novel therapeutics;Patient Monitoring;patient oriented;patient stratification;Patients;personalized medicine;Persons;Pharmaceutical Preparations;pharmacologic;Pharmacology;Phenotype;Physiology;pre-clinical;pre-clinical research;preclinical study;predictive marker;Preparation;Principal Investigator;programs;protein expression;receptor;Research;response;Risk;Role;Science;Shapes;Slice;small molecule;Speed;Stimulus;success;Surface;Technology;Testing;Therapeutic Effect;therapy development;Time;translational medicine;translational potential;Translations;Work,Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome,104461,ZHD1,ZHD1-DSR-Y(50),NA,S1,5,55638,28421,84059,NA
11179539,U54,HD,3,N,2024-09-26,2024-07-01,2025-06-30,NA,U54HD104461,NA,RFA-HD-20-003,3U54HD104461-05S1,NICHD:84059\,RESEARCH CENTERS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,CINCINNATI,UNITED STATES,NA,01,071284913,US,615001,CINCINNATI CHILDRENS HOSP MED CTR,OH,452293039,NA,1870435 (contact),"HUBER, KIMBERLY M. (contact)","KAU, ALICE S",2020-09-25,2025-06-30,Acute;Area;base;Behavior;behavioral phenotyping;Biochemical;Brain;cell type;Cholecystokinin;Clinical;CNR1 gene;Collaborations;Contralateral;Coupling;Cre driver;Data;Defect;Electroencephalography;Endocannabinoids;Environment;Excitatory Synapse;experience;experimental study;FMR1 gene;Fragile X Syndrome;Frequencies;Functional disorder;Genetic;genetic manipulation;Glutamates;hippocampal pyramidal neuron;Human;in vivo;inhibitory neuron;Knock-out;Link;loss of function;Measures;Mediating;Methods;Molecular;mouse model;Mus;neocortical;Neurons;neurophysiology;optogenetics;Outcome;Parvalbumins;pharmacologic;Phenotype;Positioning Attribute;postnatal;Process;Proteins;receptor;Regulation;Research Personnel;response;Rest;Ribosomes;RNA;Role;Sensory;sensory cortex;Slice;somatosensory;Somatosensory Cortex;sound;Synapses;targeted treatment;Testing;Thalamic structure;Touch sensation;transcriptome;transcriptome sequencing;Translating;translational medicine;translatome,FMRP regulation of local and long-range neocortical circuits in the mouse:  Links with EEG phenotypes,104461,ZHD1,ZHD1-DSR-Y,7851,S1,5,55638,28421,NA,84059
11179544,N01,AI,NA,N,NA,NA,NA,NA,75N93020D00007,NA,NA,75N93020D00007-0-759302400001-1,NIAID:1540805\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW ORLEANS,UNITED STATES,NA,01,053785812,US,8424601,TULANE UNIVERSITY OF LOUISIANA,LA,701185665,NA,79946565 (contact),"AYE, PYONE  (contact)",NA,2020-04-01,2027-03-31,Adjuvant;AIDS prevention;AIDS Vaccines;Breeding;Cells;clinical efficacy;CXCL10 gene;CXCR3 gene;cytokine;Development;DNA;Evaluation;evaluation/testing;flexibility;Goals;HIV vaccine;HIV-1 vaccine;Housing;IL6 gene;Immune response;immunogenicity;Maintenance;Modality;Modeling;Mucosal Immune Responses;National Institute of Allergy and Infectious Disease;nonhuman primate;preclinical evaluation;preclinical study;prevent;Prevention Research;Prevention strategy;programs;Proteins;research clinical testing;Research Personnel;Resources;Risk;Testing;United States National Institutes of Health;vaccine efficacy;vaccine evaluation;vaccine platform;Vaccine Research;Vaccines;Virus;Virus Diseases,Potent Boosting of Tfh1 Cells to Enhance HIV-1 Vaccine Efficacy,0,NA,NA,NA,NA,NA,NA,NA,1540805,NA
11179549,U54,CA,3,N,2024-09-12,2024-09-01,2025-08-31,NA,U54CA274220,NA,PA-20-272,3U54CA274220-03S1,NCI:177125\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,HOUSTON,UNITED STATES,NA,09,800772139,US,578407,UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,770304009,NA,9939858 (contact),"GAN, BOYI  (contact)","KAI, MIHOKO",2022-09-20,2027-08-31,NA,Ferroptosis resistance as a key driver in acquired radiation resistance,274220,ZCA1,ZCA1(M1),9339,S1,3,129500,47625,NA,177125
11179556,K23,DA,7,N,2024-11-22,2024-09-03,2025-08-31,279,K23DA055209,SCHOOLS OF MEDICINE,PA-24-254,7K23DA055209-04,NIDA:198758\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,CHARLESTON,UNITED STATES,PSYCHIATRY,06,183710748,US,7575301,MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,294074636,"PROJECT NARRATIVE d Opioid use disorder (OUD) frequently co-occurs with posttraumatic stress disorder (PTSD), and there is an imminent need for the development of effective interventions addressing this severe comorbidity. The proposed study will test the preliminary efficacy of combining medications for OUD with an integrated, trauma-focused, behavioral treatment for co-occurring substance use disorders and PTSD while advancing Dr. Saraiya’s goal to become an independent clinical researcher in the field of opioid research. Findings will demonstrate how a combined treatment approach may reduce opioid use and PTSD symptoms, enhance retention on medications for OUD and in behavioral treatment, and decrease public health care costs among a population in dire need.",14473612 (contact),"SARAIYA, TANYA CHANDRESH (contact)","LAO, GUIFANG",2024-09-03,2027-08-31,NA,Integrated Treatment for Co-Occurring Opioid Use Disorder and Posttraumatic Stress Disorder,55209,IPTA,Interventions to Prevent and Treat Addictions Study Section[IPTA],NA,NA,4,184036,14722,198758,NA
11179559,U54,HD,3,N,2024-09-26,2024-08-01,2025-07-31,NA,U54HD113159,NA,PA-20-272,3U54HD113159-02S2,NICHD:210176\,RESEARCH CENTERS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NEW ORLEANS,UNITED STATES,NA,01,053785812,US,8424601,TULANE UNIVERSITY OF LOUISIANA,LA,701185665,NA,8531735 (contact),"HARVILLE, EMILY WHEELER (contact)","CHINN, JUANITA JEANNE",2023-08-17,2030-07-31,Address;Administrative Supplement;Adoption;Age;Area;Birth;Black race;black women;Blood Pressure;Caring;Client satisfaction;Communities;community collaboration;cost effectiveness;County;Data;Data Collection;design;digital;effectiveness evaluation;effectiveness/implementation hybrid;electronic health record system;Eligibility Determination;empowerment;Ethnic Origin;experience;Focus Groups;geographic disparity;Goals;Health;health care availability;Health Services Accessibility;high risk;Home;Hospitals;implementation barriers;implementation evaluation;implementation intervention;implementation outcomes;Improve Access;improved;Infrastructure;innovation;Internet;Intervention;Interview;Leadership;Louisiana;Manuals;Maternal Health;Maternal Health Services;Medicaid;Modeling;Monitor;mortality risk;Not Hispanic or Latino;obstetric care;obstetric services;Outcome;Patient Outcomes Assessments;Patients;Persons;Phase;Postpartum Period;Poverty;Pregnancy;pregnant;Premature Birth;Procedures;Process;programs;Protocols documentation;Provider;Race;racial disparity;remote health care;Rural;rural area;Sampling;Services;Site;Socioeconomic Status;Specialist;Technology;Testing;tool;Training;Underinsured;Underserved Population;Weight;Woman,RP2_Harville,113159,ZRG1,Special Emphasis Panel[ZRG1],9420,S2,2,196926,13250,NA,210176
11179583,U54,CA,3,N,2024-09-03,2024-09-01,2025-08-31,NA,U54CA274506,NA,PA-20-272,3U54CA274506-02S1,NCI:164500\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,NA,13,621889815,US,1833205,COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,100323725,N/A,7827402 (contact),"CALIFANO, ANDREA  (contact)","ZAMISCH, MONICA",2023-09-19,2028-08-31,androgen independent prostate cancer;bone;Cell Line;Cells;Characteristics;curative treatments;Dependence;drug mechanism;Drug Modelings;Drug resistance;Drug Targeting;Evolution;Generations;Genetically Engineered Mouse;Goals;Heterogeneity;in vivo;in vivo Model;insight;Malignant neoplasm of prostate;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Modeling;Morbidity - disease rate;mortality;neoplastic cell;Neuroendocrine Prostate Cancer;novel;Organoids;patient derived xenograft model;Pharmaceutical Preparations;Pharmacotherapy;prostate cancer metastasis;resistance mechanism;response;Series;Site;Technology;tumor;Validation,Drug Mechanism of Action-based targeting of tumor subpopulations,274506,ZCA1,ZCA1(M2),7252,S1,2,100000,64500,NA,164500
11179597,R25,TW,3,N,2024-08-30,2024-09-11,2025-03-31,989,R25TW001605,NA,PAR-19-244,3R25TW001605-25S1,FIC:108000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,BUENOS AIRES,ARGENTINA,NA,NA,972559129,AR,10013343,FACULTAD LATINOAMERICANA DE CIENCIAS SOCIALES,NA,1026,"Project Narrative This program educates researchers and members of research ethics committees from Latin American countries and improves their expertise in research ethics, thereby increasing ethical capabilities in the conduct and review of research. It also provides continuing education in research ethics for former trainees to ensure ongoing sustainability of research ethics in the region.",8528964 (contact),"LUNA, FLORENCIA  (contact)","SINA, BARBARA J",2000-09-30,2026-03-31,Active Learning;Address;Advisory Committees;Americas;Area;Argentina;Attention;Awareness;Career Choice;Collaborations;college;community advisory board;Continuing Education;Country;Critical Thinking;Education;Educational Activities;Educational Status;Ensure;Ethical Issues;Ethicists;Ethics;experience;Health;improved;Individual;innovation;Institution;International;Journals;Latin American;learning strategy;Master of Science;Medicine;meetings;member;Mentors;Persons;post-doctoral training;programs;Publishing;Reading;Research;Research Ethics;Research Ethics Committees;Research Personnel;Resources;responsible research conduct;Scientist;skills;Social Sciences;System;systems research;Time;Training;Training Programs;Work;Workload;Writing,Training Program in Research Ethics in the Americas,1605,ZRG1,Special Emphasis Panel[ZRG1-BDCN-L(56)R],NA,S1,25,100000,8000,108000,NA
11179598,D43,TW,3,N,2024-08-30,2024-09-11,2024-12-31,989,D43TW011240,NA,PAR-19-243,3D43TW011240-05S1,FIC:50000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,DURBAN,SOUTH AFRICA,NA,NA,637360244,SF,5622101,UNIVERSITY OF KWAZULU-NATAL,NA,3630,"The South African Research Ethics Training Initiative (SARETI) is the oldest and most established Africa-based Masters program in the field of health research ethics. The new SARETI PhD program equips African research ethics scholars with advanced theoretical, applied and leadership skills to improve health research systems in Africa, improve effectiveness and efficiency of ethics review systems, and maximize the social value of research in Africa through research ethics leadership and scholarship. Intensive on-site training and home-based research work, including attendance of the Johns Hopkins Intensive Global Bioethics Program, will be facilitated by our experienced local and international multidisciplinary faculty.",10551720;7963109 (contact),"KRUGER, MARIANA ;WASSENAAR, DOUGLAS R (contact)","SINA, BARBARA J",2020-03-15,2024-12-31,Achievement;Adult;Africa;African;Area;Bioethics;career development;cohort;Data Analyses;Doctor of Philosophy;Education;Educational workshop;Effectiveness;Ethical Issues;Ethicists;Ethics;experience;Faculty;Funding;Generations;Grant;Health;Home;improved;Institutional Review Boards;interest;International;Lead;Leadership;Mentors;Mentorship;Mission;multidisciplinary;multimodality;Process;programs;Publications;Qualifying;Research;Research Ethics;Research Methodology;Research Proposals;Running;Scholarship;Selection Criteria;Site;skills;Social Values;South African;Structure;Supervision;symposium;System;systems research;Training;United States National Institutes of Health;Universities;Visit;Writing,South African Research Ethics Training Initiative (SARETI) Leadership Program,11240,ZRG1,Special Emphasis Panel[ZRG1-BDCN-L(56)R],NA,S1,5,46296,3704,50000,NA
11179599,R25,TW,3,N,2024-08-30,2024-09-11,2025-03-31,989,R25TW012217,SCHOOLS OF NURSING,PAR-19-244,3R25TW012217-03S1,FIC:94235\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,COLUMBUS,UNITED STATES,NONE,03,832127323,US,6218701,OHIO STATE UNIVERSITY,OH,432101016,"Project Narrative The program proposed here aims to strengthen the international research ethics training capacity in Kenya while also addressing the specific needs related to One Health research and emergency health research. As a collaboration between the University of Nairobi (UoN) and The Ohio State University (OSU), it will offer in-depth training and experiences in research ethics and integrity through establishing and running both a 1-year postgraduate diploma (PGD) and a 2-year MSc in One Health and Emergency Research Ethics (MOHERE) at UoN. It will also fund and mentor 6 future leaders in bioethics and research ethics to take the OSU MA in Bioethics so that together all these graduates will become leaders in a sustainable, rigorous and exciting culture of research ethics in Kenya.",14657381 (contact),"O'MATHUNA, DONAL  (contact)","SINA, BARBARA J",2022-04-01,2027-03-31,Achievement;Address;Advisory Committees;Agriculture;Animals;Area;Bioethics;Bioethics Consultants;Collaborations;Committee Members;Competence;Complex;Consultations;Country;COVID-19;Development;Disasters;Disease Outbreaks;Education;Educational Activities;Educational process of instructing;Educational workshop;Emergency research;Emergency Situation;Ensure;Environment;Environmental Health;Ethical Issues;Ethics;experience;Feedback;Fostering;Funding;Future;global health;Goals;Government;Growth;Guidelines;Health;Health Professional;Human;human subject;improved;Institution;Institutional Ethics;interdisciplinary approach;International;Investments;Kenya;Knowledge;Leadership;Link;low and middle-income countries;Mentors;microbial;Monitor;multidisciplinary;next generation;Ohio;pandemic disease;Participant;Persons;Plants;Play;Policies;Post Graduate Year;Prevention;Process;programs;Protocols documentation;Regulation;Reporting;Research;Research Ethics;Research Personnel;Research Project Grants;response;Review Committee;Running;Scholarship;Scientist;skills;social;Surveys;System;Time;Training;Training and Education;Travel;Universities;Virus Diseases;webinar;Work,UoN-OSU MSc in One Health and Emergency Research Ethics (MOHERE),12217,ZRG1,Special Emphasis Panel[ZRG1-PSE-L(56)R],NA,S1,3,91792,2443,94235,NA
11179600,R25,TW,3,N,2024-08-30,2024-09-11,2025-03-31,989,R25TW011804,SCHOOLS OF NURSING,PAR-19-244,3R25TW011804-03S1,FIC:108000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,BALTIMORE,UNITED STATES,OTHER HEALTH PROFESSIONS,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,NARRATIVE The proposed research ethics and methods certificate program will have significant impact in the socio-cultural context of The Gambian people by building leadership and expert capacity. The program will enhance the professional growth of health professionals and academic researchers through the strengthening of competence to conduct health research studies with high ethical standards and scientific rigor. These activities will have long term impact in shaping the scientific enterprise and the culture of ethics in The Gambia to improve population health outcomes.,9746869 (contact);16520515;2074435,"NJIE-CARR, VERONICA P.S. (contact);SEY-SAWO, JAINABA ;SILVERMAN, HENRY J","SINA, BARBARA J",2022-04-01,2027-03-31,Adult;African;Applications Grants;apprenticeship;Attitude;Award;Awareness;Baltimore;certificate program;cohort;Collaborations;Committee Members;Competence;Consultations;curriculum development;Data Collection;design;Development;Educational Curriculum;Educational process of instructing;Educational Status;Educational workshop;Enrollment;Ensure;Ethics;Ethics Committees;experience;Faculty;falls;Fogarty International Center;Foundations;Funding;Future;Gambia;Ghana;Goals;graduate student;Grant;Growth;Health;Health Professional;Healthcare;Hybrids;improved;Institution;Institutional Review Boards;Knowledge;Leadership;low and middle-income countries;Maryland;member;Mentors;Modeling;Nigerian;Outcome;pedagogy;Performance;Persons;population health;Preparation;Program Development;programs;Qualifying;recruit;Research;Research Ethics;Research Methodology;Research Personnel;research study;response;Review Committee;Role;Shapes;skills;social culture;success;Surveys;Training;Training Programs;Universities;virtual,Strengthening Capacity in Health Research Ethics and Methodology in The Gambia,11804,ZRG1,Special Emphasis Panel[ZRG1-PSE-L(56)R],NA,S1,3,100000,8000,108000,NA
11179601,U01,TW,3,N,2024-08-30,2024-09-11,2025-02-28,989,U01TW010094,NA,RFA-TW-21-001,3U01TW010094-08S1,FIC:84468\,NON-SBIR/STTR RPGS,2024,FOGARTY INTERNATIONAL CENTER,NA,ADDIS ABABA,ETHIOPIA,NA,NA,850507858,ET,117601,ADDIS ABABA UNIVERSITY,NA,1176,"PROJECT NARRATIVE The primary focus of the proposed research is air pollution, with sub-studies focused on exposure assessment and air pollution impacts on lung function, blood pressure, and cognitive development, as well as a study focused on occupational heat stress. The research will take place at three leading universities in East Africa: Addis Ababa University in Addis Ababa, Ethiopia; Makerere University in Kampala, Uganda, and University of Nairobi in Nairobi, Kenya. The portfolio of studies in the proposed research solidifies and expands work begun in the first funding cycle of the Eastern Africa GEOHealth Hub, and will provide excellent opportunities for the trainees at each institution, as described in the linked GEOHealth Research Training proposal.",7347011;9575884;11323722 (contact);78253793,"BERHANE, KIROS T;JACK, DARBY ;KUMIE, ABERA TAKELE (contact);SIMANE, BELAY","JESSUP, CHRISTINE",2015-09-28,2027-02-28,Accounting;Address;adverse outcome;Africa;African;air monitoring;Air Pollution;air pollution control;ambient air pollution;Awareness;Blood Pressure;burden of illness;Capital;Cessation of life;Child;Child Health;Chronic Kidney Failure;Cities;climate change;cognitive development;cohort;Collaborations;Collection;Country;Data;Data Collection;development policy;disorder risk;Eastern Africa;Environment;Environmental Health;Environmental Illness;Environmental Monitoring;Environmental Policy;Epidemiology;epidemiology study;Ethiopia;evidence base;Exposure to;extreme heat;Face;fine particles;Foundations;Funding;global environment;Goals;Health;Heat Stress;Hospital Mortality;Household;Income;Inequity;Infrastructure;Injury;Institution;interest;Investments;Kenya;Link;low and middle-income countries;low income country;lung development;Measures;Mentors;Modeling;Monitor;Morbidity - disease rate;mortality;Mothers;Needs Assessment;Neurocognitive;Occupational;Occupational Exposure;Occupational Health;Pilot Projects;Policies;Population Characteristics;premature;Productivity;programs;Psychometrics;Public Health;pulmonary function;Records;Renal function;Reproductive Health;Request for Applications;Research;Research Design;Research Personnel;Research Training;Resolution;respiratory health;Respiratory Signs and Symptoms;response;Risk;Risk Factors;Sampling Studies;Series;Shapes;Site;Source;spatiotemporal;Structure;success;Testing;Time;Training;Training Programs;Translations;Uganda;Universities;Woman;women&apos;s reproductive health;Work;Workplace,Global Environmental and Occupational Health Research and Training for Eastern Africa,10094,ZRG1,Special Emphasis Panel[ZRG1-OBT-Q(70)R],NA,S1,8,83100,1368,84468,NA
11179602,R01,TW,3,N,2024-08-30,2024-09-11,2025-05-31,989,R01TW011795,SCHOOLS OF PUBLIC HEALTH,PAR-20-001,3R01TW011795-05S1,FIC:56650\,NON-SBIR/STTR RPGS,2024,FOGARTY INTERNATIONAL CENTER,NA,IOWA CITY,UNITED STATES,BIOSTATISTICS & OTHER MATH SCI,01,062761671,US,3972901,UNIVERSITY OF IOWA,IA,522421320,"The statistical and agent-based model tools developed through this project in urban Kenya will be widely applicable to studying multi-pathogen infectious disease transmission dynamics in low to middle income nations, and will address global needs for evidence to prioritize urban development interventions.",12460948;14570526 (contact),"BAKER, KELLY K;SEWELL, DANIEL  (contact)","JESSUP, CHRISTINE",2020-08-01,2025-05-31,Accounting;Affect;Animals;Area;attributable risk;Behavior;Behavioral;Biological Assay;burden of illness;Caregivers;Cattle;Characteristics;Child;Communicable Diseases;Communities;Complex;Computer Models;Computer software;Computing Methodologies;Country;Data;Defecation;Demographer;design;Detection;Developing Countries;Development;Diarrhea;Diffusion;Disease;Disease Pathway;disease transmission;Domestic Animals;dynamic system;Economic Development;Economics;Ecosystem;effective intervention;Enteral;enteric infection;enteric pathogen;Environment;Epidemiologist;Evolution;experimental study;exposure pathway;Exposure to;Failure;Feces;Floor;Frequencies;gastrointestinal;Geography;Household;Human;improved;Incidence;Income;Individual;Infant;Infection;infection risk;Ingestion;Intervention;Joints;Kenya;large datasets;Latrine;Lead;Long-Term Effects;Low income;Mathematics;Measures;Methods;microbial;microbial community;Microbiology;Milk;model design;Modeling;Morbidity - disease rate;mortality;Movement;multi-scale modeling;Neighborhoods;open source;pathogen;Pathogenicity;Pathway interactions;Pattern;pediatrician;Policies;Pollution;Population Attributable Risks;Positioning Attribute;predictive modeling;Prevalence;prevent;Process;Research;Research Personnel;Risk;Sanitation;Scientist;Seasons;simulation environment;Site;social;Social Development;sociologist;Source;spatiotemporal;Statistical Methods;Statistical Models;stool sample;Structure;Surveys;System;Taxonomy;Testing;therapy development;tool;Training;transmission process;urban area;Urban Community;Urban Developments;urban setting;Urbanization;Viral;virtual laboratory;wasting;Water;Work,Statistical and agent-based modeling of complex microbial systems: a means for..,11795,ZRG1,Special Emphasis Panel[ZRG1-IDM-U(55)R],NA,S1,5,43474,13176,56650,NA
11179615,R00,NS,3,N,2024-09-05,2024-09-01,2025-08-31,853,R00NS129758,SCHOOLS OF MEDICINE,RFA-NS-19-043,3R00NS129758-03S1,NINDS:57979\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,LOS ANGELES,UNITED STATES,PHYSIOLOGY,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,"Project Narrative The area postrema, a brain circumventricular sensory organ regulated by both humoral signals and inputs from the gastrointestinal tract, plays a critical role in nausea and aversive behaviors. During my postdoctoral fellowship, I identified and characterized a population of area postrema neurons which mediates aversive behaviors, and here I will specify and map both humoral and vagal inputs to these area postrema neurons and understand their physiological effects. Acquiring expertise required to achieve these aims, namely hormone signaling and functional circuit mapping, will enable me to establish an independent research program which focuses on the cellular and neural mechanisms of nausea combining mice and vomiting animals, and may lead to the development of novel anti-emetic therapies.",12683915 (contact),"ZHANG, CHUCHU  (contact)","JOHNSON, KARI ANNE",2022-09-15,2026-08-31,Ablation;Adverse effects;Afferent Neurons;Anatomy;Animal Model;Animals;Anti-emetics;Atlases;Behavior;behavioral study;Biological Assay;Blood - brain barrier anatomy;Brain;cancer therapy;career;Cell Surface Receptors;cell type;Cells;Chemoreceptors;Communication;Cues;design;Development;Diabetes Mellitus;Educational process of instructing;Electrophysiology (science);Emetics;Esthesia;excitatory neuron;experimental study;Feeding behaviors;Fellowship;Food Poisoning;Gastrointestinal tract structure;GCG gene;GDF15 gene;Genetic;genetic signature;Genetic study;Goals;hormonal signals;Horns;Human;Hunger;Image;Imaging Techniques;In Vitro;Infection;Ingestion;inhibitory neuron;Knock-in Mouse;learned behavior;Learning;Lesion;Ligands;Location;Malaise;Malignant Neoplasms;Maps;Mediating;Mentors;Mentorship;Midbrain structure;Modeling;Molecular;Motion Sickness;Mus;Nausea;Nausea and Vomiting;neural;neuromechanism;Neurons;Neurosciences;novel;optogenetics;Organ;Orphan;parabrachial nucleus;pathogen;Peripheral;Phase;Physiological;Physiology;Play;Poison;Population;Positioning Attribute;Postdoctoral Fellow;Pregnancy;programs;receptor;Regulation;Research;response;Role;Route;Satiation;Sensory;sensory input;Shrews;side effect;Signal Transduction;single nucleus RNA-sequencing;skills;Specific qualifier value;Stimulus;Structure;Structure of area postrema;Techniques;Testing;Therapeutic;Thirst;Tissues;Toxin;Toxin Conjugates;Training;transcriptome;Viral;Visceral;Vocational Guidance;Vomiting,Molecular and circuit mechanisms of nausea-associated behaviors,129758,ZNS1,ZNS1-SRB-L(03),NA,S1,3,36812,21167,57979,NA
11179622,P50,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,P50CA136393,NA,PA-20-272,3P50CA136393-14S2,NCI:201750\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,ROCHESTER,UNITED STATES,NA,01,006471700,US,4976101,MAYO CLINIC ROCHESTER,MN,559050001,"Uterine serous carcinoma (USC) is associated with treatment resistance and a poor prognosis. Although several  molecular similarities exist between USC and serous ovarian cancer in terms of homologous recombination DNA  repair deficiency, responses of USC to single agent PARP inhibitors are limited. Here we propose to study a  novel combination therapy in an attempt to overcome treatment resistance.",1861030 (contact),"KAUFMANN, SCOTT H (contact)","BASA JANAKIRAM, NAVEENA",2009-07-01,2026-08-31,Address;Carcinoma;Cell Line;Characteristics;Clinical;clinical development;Clinical Trials;Combined Modality Therapy;Complex;Data;design;DNA;DNA Damage;DNA Repair Disorder;DNA Repair Pathway;Endometrial Carcinoma;experience;experimental study;Formulation;Future;Genomic Instability;Histologic;homologous recombination;In Vitro;in vivo;inhibitor;innovation;irinotecan;Knowledge;Malignant neoplasm of ovary;Molecular;Mus;next generation;novel;novel marker;patient derived xenograft model;Patients;Poly(ADP-ribose) Polymerase Inhibitor;pre-clinical;predicting response;Prognosis;Recurrence;response;response biomarker;Schedule;Serous;SN-38;synergism;targeted treatment;Testing;Therapeutic;therapy resistant;Time;TOP1 gene;Toxic effect;Translating;tumor;tumor xenograft;Uterus,Administration Core,136393,ZCA1,ZCA1(M1)-P,8883,S2,14,125000,76750,NA,201750
11179639,K01,TW,3,N,2024-08-30,2024-09-11,2025-04-30,989,K01TW012166,SCHOOLS OF MEDICINE,PAR-21-105,3K01TW012166-03S1,FIC:54000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,ANN ARBOR,UNITED STATES,OBSTETRICS & GYNECOLOGY,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"Project Narrative: This career development proposal leverages an expert multinational mentorship team and rigorous didactics to acquire essential skills for an independent global health research career. The research project addresses a critical knowledge gap, implementing and evaluating a home blood pressure monitoring intervention among women at risk of hypertensive disorders of pregnancy in Ghana. Expertise will be gained in survey questionnaire design, applied mixed methods, advanced quantitative methods, and reproductive health in Sub- saharan Africa.",16586796 (contact),"LAWRENCE, EMMA RACHEL (contact)","LEVINTOVA, MARYA",2022-09-21,2027-04-30,"2 arm randomized control trial;Address;Adherence;Adult;Africa South of the Sahara;arm;Blood Pressure;blood pressure elevation;Blood Pressure Monitors;career;career development;Caring;Cellular Phone;Chronic;Clinic Visits;Clinical;Country;Data;Development Plans;Diagnosis;Discipline of obstetrics;Early Diagnosis;Eclampsia;Education;Effectiveness;effectiveness testing;Electronics;evidence base;Face;Frequencies;Ghana;global health;Goals;Gynecologist;Healthcare Systems;High Risk Woman;Home;Home Blood Pressure Monitoring;Hypertension;improved;Income;informant;innovation;Intervention;intervention refinement;Interview;K-Series Research Career Programs;Knowledge;low and middle-income countries;low health literacy;maternal morbidity;Maternal Mortality;mathematical ability;Measures;Mentorship;Methodology;Methods;Michigan;Morbidity - disease rate;mortality;Neonatal;neonatal outcome;Nurses;Outcome;Paper;Participant;Patients;Population;Pre-Eclampsia;Pregnancy;pregnancy disorder;Pregnancy Outcome;pregnant;Pregnant Women;prenatal;prevent;preventable death;primary outcome;Process;programs;Questionnaire Designs;Randomized, Controlled Trials;Recommendation;recruit;Reporting;Reproductive Health;Research;research and development;Research Personnel;Research Project Grants;Resource-limited setting;Schedule;secondary outcome;Seizures;skills;Stroke;Structure;Surveys;Technology;Telephone;Time;Training;Triage;trial comparing;trial design;Universities;Visit;Woman;Women&apos;s Health",Home blood pressure monitoring among women at risk of hypertensive disorders of pregnancy in Ghana,12166,ZRG1,Special Emphasis Panel[ZRG1-ICP-G(55)R],NA,S1,3,50000,4000,54000,NA
11179640,K01,TW,3,N,2024-09-04,2024-09-11,2025-08-31,989,K01TW012174,SCHOOLS OF PUBLIC HEALTH,PAR-21-105,3K01TW012174-04S1,FIC:56001\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,BOSTON,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,604483045,US,894901,BOSTON UNIVERSITY MEDICAL CAMPUS,MA,021182340,"PROJECT NARRATIVE We aim to adapt and pilot a guided self-help stress management program from the World Health Organization and to incorporate peer cancer survivors in providing psychosocial support to breast cancer patients in Viet Nam. We seek to demonstrate the feasibility of the culturally and contextually adapted intervention in reducing the psychological distress associated with cancer diagnosis and treatment, to ultimately improve cancer patients’ health outcomes. Successful completion of the project begins to fill the gaps in the lack of culturally appropriate evidence-based mental health interventions for cancer patients in many low- and middle-income countries, and in many racial/ethnic groups in the U.S.",15223462 (contact),"LE, PHUONGTHAO DINH (contact)","LEVINTOVA, MARYA",2021-09-23,2026-08-31,Academic Training;Address;Adherence;Affect;anti-cancer research;Area;Behavior Therapy;Behavioral Sciences;Breast;Breast Cancer Patient;Breast Cancer survivor;cancer care;Cancer Center;Cancer Control;cancer diagnosis;Cancer Hospital;Cancer Intervention;Cancer Patient;cancer prevention;Cancer Survivor;cancer therapy;cancer type;care systems;career;career development;Caregivers;Cessation of life;Cities;clinically significant;Cognitive Therapy;Communities;community based participatory approach;community based participatory research;Community Health;coping;Country;design;Development;Diagnosis;Dimensions;Disease;Distress;Doctor of Philosophy;Effectiveness;Elements;Emotional;Ethnic Population;evidence base;Evidence based intervention;experience;Fellowship;Female Breast Carcinoma;flexibility;Focus Groups;Funding;Future;Goals;Health;health management;Health Personnel;Health Policy;Health Sciences;Health Services Research;Hospitals;Hour;implementation science;implementation strategy;improved;Incidence;Individual;informant;International;Intervention;Interview;Knowledge;Language;low and middle-income countries;Malignant Breast Neoplasm;Malignant Neoplasms;Manuals;marginalized population;Mathematics;Medical;Mental disorders;Mental Health;Mental Health Services;Mentored Research Scientist Development Award;Mentors;Mentorship;Modeling;Modification;multidisciplinary;National Cancer Institute;New York;Newly Diagnosed;Oncology;Outcome;Participant;participant observation;peer;peer coaching;peer support;Persons;Pilot Projects;Population;Postdoctoral Fellow;Prevalence;Prevention Guidelines;process evaluation;programs;psychologic;psychological distress;psychosocial;Psychosocial Assessment and Care;psychosocial outcome;Public Health;Qualitative Research;Quality of life;racial population;Recommendation;Reporting;Research;Research Activity;Research Assistant;residence;Resource-limited setting;Schools;Scientist;self help;Site;skills;Social Sciences;Social support;Specific qualifier value;stress management;Structure;Supportive care;Testing;Training;Training Activity;treatment guidelines;Universities;uptake;Vietnam;Vietnamese;Woman;working group;World Health Organization,Adaptation and Pilot of a Peer-Facilitated Self-Help Plus Stress Management Intervention for Breast Cancer Patients in Viet Nam,12174,ZRG1,Special Emphasis Panel[ZRG1-ICP-L(57)R],NA,S1,4,52499,3502,56001,NA
11179641,K01,TW,3,N,2024-09-10,2024-09-16,2025-08-31,989,K01TW012424,SCHOOLS OF PUBLIC HEALTH,PAR-21-105,3K01TW012424-02S1,FIC:54000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,PITTSBURGH,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,"PROJECT NARRATIVE Harmful menstrual practices, such as chhaupadi (menstrual seclusion) in Nepal, are an urgent threat to women’s health, wellbeing, and development. This study will investigate underlying mechanisms of promising aspects of chhaupadi interventions to date and build upon these findings to co-design and pilot test a context- specific intervention in partnership with community members. In the short-term, outcomes from this proposal will advance the field by resulting in 1) a pilot tested intervention that can be further tested in a future randomized controlled trial, 2) a refined approach for engaging communities in sustainable and contextually appropriate intervention co-design that is expected to be applicable to other low- and middle-income country contexts, and 3) in the longer-term support public health efforts aiming to reduce the negative health effects of harmful menstrual practices on women in Nepal.",78010797 (contact),"BAUMANN, SARA ELIZABETH (contact)","LEVINTOVA, MARYA",2023-09-16,2028-08-31,"acceptability and feasibility;Active Learning;Address;Area;Attitude;Attitude to Health;Awareness;Behavior Therapy;behavioral health;Behavioral Model;career;career development;Cessation of life;Clinical Trials;Clinical Trials Design;Collaborations;Communities;community collaboration;community engaged approach;community engaged intervention;community engaged research;community engagement;Community Health;comparison control;Data;design;Development;Development Plans;Discrimination;Educational Curriculum;Educational Models;Educational workshop;Ensure;Environment;Evaluation;Exclusion;Failure;Family;Feedback;Focus Groups;Future;gender-based violence;girls;global health;Goals;Grant;Health;Health behavior;health knowledge;Health Sciences;human centered design;Human Rights;implementation science;improved;Individual;Infection;informant;innovation;International;Intervention;Intervention Studies;Interview;Leadership;Life;Literature;Loneliness;low and middle-income countries;meetings;member;Menstruation;Mental Health;Mentors;Mentorship;Methodology;Modeling;Morbidity - disease rate;mortality;Mothers;multidisciplinary;Nepal;Outcome;Participant;Personal Satisfaction;physical abuse;physical conditioning;Physiological Processes;pilot test;postnatal period;Process;professor;psychosocial;Public Health;Public Health Schools;Randomized;Randomized, Controlled Trials;Religion;Reporting;Reproductive Health;Research;research and development;Research Personnel;Resource-limited setting;Risk;role model;Safety;Schools;Self Efficacy;self esteem;skill acquisition;skills;Sleep;sleep difficulty;Snake Bites;social;social situation;social stigma;standardize measure;Statistical Data Interpretation;Stigmatization;success;Surveys;Testing;Theoretical model;therapy design;therapy development;Training;United States National Institutes of Health;Universities;Update;uptake;Validation;Woman;Women&apos;s Health;women&apos;s reproductive health;Work;Writing;Youth",Improving Menstrual Health Among Women and Girls Using Community Engaged Intervention Development in Nepal,12424,ZRG1,Special Emphasis Panel[ZRG1-ICP-P(55)R],NA,S1,2,50000,4000,54000,NA
11179653,R01,HL,3,N,2024-09-09,2024-09-09,2025-08-31,846,R01HL153095,SCHOOLS OF ARTS AND SCIENCES,PA-19-056,3R01HL153095-05S1,OD:227757\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,IOWA CITY,UNITED STATES,PHYSIOLOGY,01,062761671,US,3972901,UNIVERSITY OF IOWA,IA,522421320,"PROJECT NARRATIVE Moderate to vigorous intensity physical activity is known to reduce the risk of hypertensive disorders of pregnancy and other adverse pregnancy outcomes that increase future maternal cardiovascular disease risk, yet less than 25% of pregnant women meet public health activity guidelines. More than 95% of the 24-hour day is spent in sedentary behavior, sleep, or light-intensity activity; however, the impacts of these lower intensity activities on adverse pregnancy outcomes are unknown. This multi-site observational cohort study will leverage state-of-the-art, 24-hour behavior assessment in each trimester of pregnancy and examine associations with adverse pregnancy outcomes to inform guidelines and future interventions designed to improve women’s pregnancy and long-term cardiovascular health.",11067031 (contact),"WHITAKER, KARA MARIE (contact)","KUNZ, JOHN FREDERIC",2020-09-15,2025-08-31,"actigraphy;Adverse event;adverse outcome;adverse pregnancy outcome;Affect;American Heart Association;Behavior;Behavior assessment;behavior test;Behavior Therapy;Behavioral;Blood Pressure;Blood Vessels;cardiometabolic risk;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular health;cardiovascular risk factor;Clinical;clinically relevant;Cohort Studies;Data;Data Analyses;demographics;Development;Devices;Diabetes Mellitus;early pregnancy;Event;Failure;Foundations;Future;General Population;Gestational Diabetes;glycemic control;Goals;Growth;Guidelines;Health;health difference;Hour;Hypertension;improved;Incidence;Intervention;Intervention Studies;Iowa;light intensity;Link;Maternal Health;Measures;Medical;Metabolic;Methods;Modeling;moderate-to-vigorous physical activity;modifiable behavior;Monitor;mortality;Mothers;National Heart, Lung, and Blood Institute;novel;Obesity;observational cohort study;Outcome;Patient Self-Report;Pattern;Physical activity;Pilot Projects;poor sleep;post pregnancy;Pre-Eclampsia;Pregnancy;pregnancy disorder;pregnancy hypertension;Pregnancy Outcome;Pregnancy Trimesters;Pregnant Women;Premature Birth;Prevalence;primary outcome;Public Health;recruit;Research;Research Priority;response;Risk;Risk Factors;Risk Reduction;Role;secondary outcome;sedentary lifestyle;Site;Sleep;sleep pattern;sleep quality;Small for Gestational Age Infant;Statistical Methods;Subgroup;success;therapy design;Time;Universities;vigorous intensity;Woman;women&apos;s outcomes","Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study",153095,CHSB,"Cancer, Heart, and Sleep Epidemiology B Study Section[CHSB]",NA,S1,5,175625,52132,227757,NA
11179666,U54,EB,3,N,2024-09-12,2024-09-10,2025-07-31,286,U54EB007958,SCHOOLS OF MEDICINE,PAR-22-203,3U54EB007958-17S1,OD:600000\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,BALTIMORE,UNITED STATES,INTERNAL MEDICINE/MEDICINE,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,NARRATIVE Point-of Care tests (POCT) to rapidly and accurately diagnose infectious diseases including sexually transmitted infections (STIs) and other emerging and re-emerging infections will impact global public health and improve outcomes. Our goal is to accelerate the development of affordable POCT innovation.,2089185 (contact),"MANABE, YUKARI C (contact)","LASH, TIFFANI BAILEY",2007-09-11,2028-07-31,Acceleration;accurate diagnosis;Adoption;Algorithms;Antibiotics;biobank;Biological Assay;Clinical;clinical development;clinical encounter;Clinical Research;clinical research site;commercialization;communicable disease diagnosis;Communicable Diseases;Conscious;Consultations;cost;COVID-19;COVID-19 detection;COVID-19 pandemic;COVID-19 point of care;Data;Decision Making;Detection;Development;Device or Instrument Development;Devices;Diagnosis;Diagnostic;diagnostic development;Diagnostic Equipment;diagnostic technologies;Diagnostic tests;disease diagnostic;emerging antimicrobial resistance;Emerging Communicable Diseases;Emerging infection;Engineering;Ensure;Environment;epidemic response;Evaluation;experience;FDA Emergency Use Authorization;Feedback;fitness;Funding;Goals;Health;Home;Human;Hybrids;improved outcome;In Vitro;Infection;innovation;Laboratories;Marketing;Modeling;Molecular;Molecular Target;multidisciplinary;Needs Assessment;overtreatment;Patient Recruitments;Patients;Performance;pilot test;Play;point of care;Point of Care Technology;point of care testing;point-of-care diagnostics;Positioning Attribute;pre-clinical;programs;prospective;Protocols documentation;prototype;Public Health;RADx Tech;rapid diagnosis;Recommendation;Research;research clinical testing;Resource-limited setting;Resources;Rest;Review Committee;Risk Factors;Sampling;self testing;Sexually Transmitted Diseases;success;Syndrome;targeted treatment;technological innovation;Technology;technology development;Test Result;Testing;Time;Training;Treatment Protocols;United States National Institutes of Health;Validation;Work,Center for Innovative Diagnostics for Infectious Diseases,7958,ZEB1,ZEB1-OSR-D(M1)S,NA,S1,17,366412,233588,600000,NA
11179675,U24,HL,3,N,2024-09-04,2024-09-04,2025-06-30,837,U24HL163114,SCHOOLS OF PUBLIC HEALTH,RFA-HL-22-008,3U24HL163114-03S1,OD:100000\,OTHER RESEARCH-RELATED,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,BALTIMORE,UNITED STATES,MISCELLANEOUS,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"NARRATIVE Poor cardiovascular health (CVH) contributes greatly to maternal morbidity and mortality in the United States, and many families enrolled in home visiting are at risk for poor CVH. Improving CVH requires focusing on CVH risk factors, 2-generation strategies addressing mothers and children, and greater use of settings where families already receive care. The Johns Hopkins Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Resource and Coordinating Center will generate rigorous, innovative, timely and actionable new knowledge to promote CVH and reduce CVH disparities in mothers and young children.",6441117;11512399;1974660 (contact),"COOPER, LISA A;EHRHARDT, STEPHAN ;MINKOVITZ, CYNTHIA S (contact)","PRATT, CHARLOTTE A",2022-05-05,2029-06-30,"Address;Applied Research;behavior test;Behavior Therapy;Biometry;Cardiovascular Diseases;cardiovascular health;care seeking;Caring;Child;Clinical;clinical center;clinical practice;clinical research site;clinical trial protocol;Clinical Trials;Communities;Data;Death Rate;design;Discipline of Nursing;Disparity;disparity reduction;dissemination science;early childhood;Early Intervention;Effectiveness;Effectiveness of Interventions;effectiveness testing;Emerging Technologies;Enrollment;Epidemiology;Ethnic Origin;evidence base;Expectancy;experience;Family;forging;Funding;Generations;Geographic Locations;Geography;health disparity;health equity;health of the mother;Health Promotion;Heterogeneity;high risk;Home visitation;Implementation readiness;implementation science;implementation strategy;improved;Individual;Infant;Infrastructure;innovation;Intervention;intervention effect;Investments;Knowledge;Leadership;Life Cycle Stages;lifestyle intervention;maternal morbidity;Maternal Mortality;Mediator;Medicine;member;Methods;mHealth;Modeling;Morbidity - disease rate;mortality;Mothers;Multi-Institutional Clinical Trial;multidisciplinary;National Heart, Lung, and Blood Institute;Obesity;Outcome Assessment;personalized approach;Policies;Preventive service;Primary Care;programs;Protocols documentation;Public Health;racial health disparity;Reduce health disparities;Reporting;Research;research and development;Research Design;Research Personnel;Resources;Risk;Risk Factors;Rural Community;scale up;service delivery;Services;Site;skills;Socioeconomic Status;Structure;success;Techniques;telehealth;Testing;Training;Translating;Translations;tribal community;United States;United States National Institutes of Health;Urban Community;Woman;Work",Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center,163114,ZHL1,ZHL1-CSR-Q(F2),NA,S1,3,60680,39320,100000,NA
11179696,R18,EB,3,N,2024-09-06,2024-09-06,2026-07-31,286,R18EB035004,BIOMED ENGR/COL ENGR/ENGR STA,PA-23-189,3R18EB035004-01S1,NINDS:179818\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,DURHAM,UNITED STATES,BIOMEDICAL ENGINEERING,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,Project Narrative  The proposed research will create a novel diagnostic tool for managing sickle cell disease based on a new high throughput cellular screening technology for evaluating red blood cells. There is currently no objective measure of vaso-occlusive crisis in sickle cell disease but the proposed technology will allow researchers and doctors to examine every single cell in a sample in a short amount of time using holographic images and machine learning. This technology can be used at the point of care to provide better information on the health of red blood cells for sickle cell disease patients.,6272819 (contact),"WAX, ADAM  (contact)","BITTMANN, MORIA FISHER",2024-09-06,2026-07-31,Acute;Acute Pain;Affect;Africa;Africa South of the Sahara;African American;African American population;Algorithms;American;Analgesics;Archives;artificial intelligence algorithm;base;Behavior;Biological Assay;biophysical properties;Birth;Black American;Blood;Blood specimen;Bone Marrow Transplantation;Businesses;Cells;cellular imaging;Clinical;Clinical Research;Clinical Trials;clinically actionable;Complete Blood Count;Computer software;cost;cost efficient;Cytology;Cytometry;Data;data streams;Descriptor;design;Development;Devices;Diagnostic;diagnostic tool;Discrimination;Disease;Economic Burden;economic evaluation;Elements;Erythrocytes;Evaluation;experience;Family;field study;Goals;Hand;Health;Healthcare Systems;Hematological Disease;high throughput analysis;hologram;Holography;Image;imaging approach;imaging capabilities;Imaging Device;implementation cost;improved;Individual;Inherited;instrument;instrumentation;Laboratories;laboratory equipment;laptop;Lasers;Lighting;Machine Learning;machine learning algorithm;Measurement;Measures;Mechanics;Medical Device;Microfluidic Microchips;Microfluidics;Monitor;Morphology;Motion;new technology;Newborn Infant;novel diagnostics;novel strategies;novel therapeutic intervention;Optical Instrument;Outcome;Output;Pain;Pain Measurement;parallel computer;Patient Care;Patient Monitoring;Patients;Performance;Persons;Phase;Physiologic pulse;point of care;point-of-care diagnostics;Population;pressure;Procedures;Property;prototype;Pump;Research;Research Personnel;Resource-limited setting;Risk;Role;Sampling;screening;sensor;Severities;Severity of illness;Sickle Cell;Sickle Cell Anemia;Syringes;System;Systems Analysis;Technology;Testing;Therapeutic;Therapeutic Intervention;time use;tool;Translating;translational potential;vaso-occlusive crisis;Whole Blood;Work,Point of care diagnostic for sickle cell disease,35004,ZRG1,Special Emphasis Panel[ZRG1-MSOS-V(50)R],NA,S1,1,121600,58218,179818,NA
11179697,K23,HL,7,N,2024-09-17,2024-08-01,2025-07-31,837,K23HL168356,NA,PA-24-254,7K23HL168356-02,NHLBI:167722\,OTHER RESEARCH-RELATED,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,PROVIDENCE,UNITED STATES,NA,02,069851913,US,6695601,WOMEN AND INFANTS HOSPITAL-RHODE ISLAND,RI,029052499,"PROJECT NARRATIVE The proposed line of research is relevant to public health in that it represents a novel approach to postpartum management of preeclampsia. Once such an approach has been developed and tested, it would have broad implications for reducing maternal morbidity and improving disparities in postpartum hypertension care. Thus, the proposed research is relevant to the part of the NIH's mission that pertains to reducing illness and disability through innovative research strategies.",15728317 (contact),"HAUSPURG, ALISSE  (contact)","WEBB, STEPHANIE JOHNSON",2024-08-01,2027-07-31,"Adult;age group;antenatal;Anti-Hypertensive Agents;Antiinflammatory Effect;Aspirin;Attention;Award;Blood Pressure;blood pressure control;blood pressure reduction;Blood Vessels;Breast Feeding;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular health;cardiovascular risk factor;Cardiovascular system;career;Career Mobility;Caring;Cause of Death;Chronic;Clinical;Clinical Trials;Data;Death Rate;design;Diagnosis;disability;disparities in morbidity;Disparity;disparity reduction;Dose;effective intervention;Eligibility Determination;Endothelium;Enrollment;Evaluation;evidence base;Evidence based intervention;experience;feasibility testing;Female of child bearing age;Funding;Future;Goals;Health;health care disparity;Home;Hypertension;hypertension control;improved;Individual;innovation;Intention;Intervention;intrapartum;Iontophoresis;Leadership;Link;maternal morbidity;Maternal Mortality;Measures;Mentored Clinical Scientist Development Program;Mentored Patient-Oriented Research Career Development Award;Mentors;Mission;Monitor;Morbidity - disease rate;novel;novel strategies;pathophysiology of preeclampsia;Pathway interactions;patient population;Pharmaceutical Preparations;pharmacologic;Phenotype;pilot test;pilot trial;Placebos;Population;post intervention;Postpartum Hypertension;Postpartum Period;Pre-Eclampsia;Pregnancy;pregnancy disorder;pregnancy health;prevent;Prevention;Primary Prevention;Public Health;Randomized;randomized trial;Randomized, Controlled Trials;Recommendation;Recovery;Research;Research Personnel;Risk;Risk Reduction;Role;Sample Size;Site;skill acquisition;Standardization;success;systemic inflammatory response;Testing;Therapeutic Agents;therapy development;Time;Translational Research;treatment as usual;treatment duration;treatment strategy;United States National Institutes of Health;Vascular Diseases;Vasodilation;Woman;Women&apos;s mortality;Work;young woman",Postpartum low-dose aspirin to augment vascular recovery following a hypertensive disorder of pregnancy,168356,MPOR,NHLBI Mentored Patient-Oriented Research Study Section[MPOR(JA)],NA,NA,2,156458,11264,167722,NA
11179712,F32,HL,3,N,2024-09-09,2024-09-10,2025-03-09,837,F32HL159930,SCHOOLS OF MEDICINE,PA-21-048,3F32HL159930-03S1,NHLBI:38879\,"TRAINING, INDIVIDUAL",2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,COLUMBIA,UNITED STATES,SURGERY,03,153890272,US,578002,UNIVERSITY OF MISSOURI-COLUMBIA,MO,652110001,"PROJECT NARRATIVE Vascular remodeling is process where vascular smooth muscle cells (SMC) transition from a differentiated phenotype to a proliferative state and plays a critical role in the development of diseases such as asthma, atherosclerosis, systemic hypertension and cancer. Here, we propose a combination of molecular, cellular and genetic approaches utilizing gain-of-function or loss-of-function studies to establish a novel mechanism regulating SMC phenotype modulation. Completion of this proposal will increase our understanding of mechanisms that contribute to the progression of proliferative vascular diseases and will result in the identification of a novel protein target to develop therapies to treat such diseases.",14993384 (contact),"KING, SKYLAR DAWN (contact)","SUTLIFF, ROY L",2021-09-10,2025-03-09,alpha Actin;alveolar type II cell;Angioplasty;Animals;Arterial Disorder;Arteries;Asthma;Atherosclerosis;Attenuated;Blood Vessels;Bypass;Carotid Arteries;Cell Differentiation process;Cell Nucleus;Cell Proliferation;Cell Separation;Contractile Proteins;Data;Development;Diabetes Mellitus;Diabetic Angiopathies;Disease;Environment;extracellular;gain of function;Genes;genetic approach;Genetic Markers;Genetic Transcription;Goals;Histologic;Host Defense;human disease;hydrophilicity;Hyperplasia;In Vitro;in vivo;Inflammatory Response;Injury;Knock-out;Knockout Mice;Laboratories;loss of function;Lung;Malignant Neoplasms;Mechanics;Medial;Mediating;Mentors;Missouri;Modeling;Molecular;mouse model;mRNA Expression;Mus;MYH11 gene;myocardin;neointima formation;neutralizing antibody;novel;Operative Surgical Procedures;Pathogenesis;Phenotype;Phosphorylation;Physiological;Play;Process;promoter;Protein Secretion;Proteins;Pulmonary Surfactant-Associated Protein A;Rattus;Recombinants;restenosis;Role;Signal Transduction;Smooth Muscle;Smooth Muscle Myocytes;Stents;Supplementation;Surface Tension;surfactant function;Systemic hypertension;targeted treatment;Testing;therapy development;Time;Tissues;Training;Transforming Growth Factor beta;Transplantation;Universities;Vascular Diseases;vascular injury;Vascular remodeling;Vascular Smooth Muscle,The mechanistic role of surfactant protein A in smooth muscle cell phenotype modulation and vascular remodeling,159930,ZRG1,Special Emphasis Panel[ZRG1-F10C-C(20)L],NA,S1,3,38879,0,38879,NA
11179721,U2R,TW,3,N,2024-09-06,2024-09-11,2025-02-28,989,U2RTW012228,SCHOOLS OF PUBLIC HEALTH,RFA-TW-21-002,3U2RTW012228-03S1,FIC:119235\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,LA JOLLA,UNITED STATES,NONE,50,804355790,US,577507,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",CA,920930621,"Project Narrative  Our proposal will be focused on increasing capacity in the Middle East and North Africa in environmental health research and especially with regards to climate change. There is a major gap in research capacity in this field despite the region is already suffering the health consequences of climate change in terms of increased frequency of heatwaves, desert dust storms, and drought and low frequency of precipitation. The hub will create the platform to expand and sustain this focus as the state-of-art go to entity in the region to help the populations and decisions makers address the climate change health impacts.",78198324;6847641 (contact),"ABDULLA, FAYEZ AHMAD;AL-DELAIMY, WAEL K (contact)","JESSUP, CHRISTINE",2022-06-01,2027-02-28,Address;Air Pollution;Area;Awareness;California;Climate;climate change;climate impact;climate-related health;Collaborations;Communicable Diseases;Communities;Cost Effectiveness Analysis;dissemination science;Doctor of Philosophy;Droughts;Dust;Economic Models;Educational workshop;Environmental Health;Event;extreme weather;Floods;Grant;Health;Health Benefit;Health Policy;Health Sciences;Heat Waves;Human;implementation science;Individual;Institution;institutional capacity;Intervention;Jordan;Lebanon;Link;Local Government;Mental disorders;Mentors;Middle East;Morocco;Northern Africa;Planet Earth;Policies;Policy Maker;Pollution;Precipitation;programs;Research;Research Training;Risk;Science;symposium;Technology;Training;Training Programs;Universities;vector;virtual;Visit;water quality;webinar;Wildfire;Work,2/2 GeoHealth Hub for Climate Change and Health in the Middle East and North Africa-U.S.,12228,ZRG1,Special Emphasis Panel[ZRG1-OBT-Q(70)R],NA,S1,3,115763,3472,119235,NA
11179732,R01,CA,7,N,2024-09-10,2024-09-01,2025-08-31,393,R01CA276594,SCHOOLS OF PUBLIC HEALTH,PA-24-254,7R01CA276594-02,NCI:505345\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,OKLAHOMA CITY,UNITED STATES,MISCELLANEOUS,05,878648294,US,1524003,UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,731043609,"Project Narrative Dual-smoker couples (i.e., both members of a couple) are prevalent and treatment-resistant; they also confront unique challenges that may reduce the impact of standard treatments. The proposed randomized controlled trial systematically examines the efficacy, mechanisms, and cost effectiveness of implementing financial incentive treatments in this population. Support for the efficacy of dyadic financial incentive treatments for dual-smoker couples would be a scalable population-level intervention for a refractory subgroup of smokers.",9014519 (contact),"VANDELLEN, MICHELLE RENEE (contact)","RODITIS, MARIA LEIA",2023-09-08,2028-08-31,"Abstinence;Address;Aftercare;behavior change;Biochemical;Categories;Characteristics;Cigarette;Clinical;clinical risk;Communication;contingency management;cost;Cost Analysis;cost effectiveness;Cost Effectiveness Analysis;cost-effectiveness evaluation;Cotinine;Couples;Data;design;Effectiveness;efficacy evaluation;efficacy outcomes;efficacy testing;efficacy trial;Enrollment;Evidence based intervention;experience;Financial cost;financial incentive;Financial Support;follow-up;High Prevalence;high risk;improved outcome;Incentives;Individual;Intervention;long term abstinence;Maintenance;member;Motivation;nicotine replacement;Outcome;Outcome Study;Participant;Phase;Pilot Projects;pilot trial;Population;predicting response;Prevalence;Prognosis;Protocols documentation;psychoeducation;Randomized;Randomized, Controlled Trials;Refractory;Relapse;relative cost;Reporting;Research;Resistance;Resources;response;secondary endpoint;secondary outcome;Smoker;Smoking;smoking abstinence;smoking cessation;Smoking Cessation Intervention;Smoking treatment;standard care;Subgroup;success;Target Populations;Testing;Time;treatment as usual;treatment comparison;treatment effect;treatment strategy;Underserved Population;Variant","Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness",276594,IPTA,Interventions to Prevent and Treat Addictions Study Section[IPTA],NA,NA,2,392240,113105,505345,NA
11179744,R33,AT,3,N,2024-09-03,2024-09-03,2025-06-30,213,R33AT009990,SCHOOLS OF MEDICINE,PA-23-189,3R33AT009990-05S1,NCCIH:35701\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH,NA,BALTIMORE,UNITED STATES,PSYCHIATRY,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,"PROJECT NARRATIVE  People with schizophrenia are characterized by marked impairments in cognitive function, for which there are no current pharmacological treatments. The development of an effective intervention for cognitive impairments remains a major therapeutic challenge. Prebiotics are dietary fibers that promote the growth or activity of gut microorganisms, which leads to the enhanced well-being of the host. The proposed R61 and R33 projects are designed to evaluate the hypothesis that prebiotic administration will lead to increased production of butyrate, through increased activity of butyrate-producing bacteria in the gut microbiota; the increase in serum butyrate levels will be associated with changes in cognitive function, symptoms, and metabolic measures.",1893403 (contact),"BUCHANAN, ROBERT W (contact)","WEBER, WENDY J",2022-09-15,2025-06-30,Acetates;Affect;Affective Symptoms;Aftercare;Attention;Bacteria;Behavior;Biological;Brain;Butyrates;Cholesterol;Chromatin Structure;Chromosome 6;Clinical;cognitive benefits;cognitive function;cognitive performance;cytokine;Data;design;Development;Dietary Fiber;Disease;Double-Blind Method;effective intervention;effective therapy;efficacy trial;Enzymes;executive function;Family;Fasting;functional outcomes;Gene Expression;Genetic Polymorphism;Glucose;Growth;gut bacteria;gut microbiome;gut microbiota;Histone Deacetylase Inhibitor;Immune system;immune system function;immunoregulation;Impaired cognition;Impairment;improved;Incidence;Inflammatory;interest;Intervention;intestinal barrier;Intestinal permeability;Inulin;Light;Lipids;MATRICS Consensus Cognitive Battery;Measures;Mediating;Memory;Metabolic;microbiota composition;Microglia;microorganism;Multiple Abnormalities;Neurocognitive Deficit;Nonpharmacologic Therapy;novel strategies;Nuclear;Outcome;Participant;Pathway interactions;Performance;Personal Satisfaction;Persons;pharmacologic;Pharmacological Treatment;Placebos;prebiotics;processing speed;Production;Propionates;psychiatric symptom;Randomized;randomized placebo-controlled clinical trial;receptor;recruit;Schizophrenia;Secondary to;Serum;Short-Term Memory;side effect;social cognition;Symptoms;Therapeutic;Triglycerides;Verbal Learning;visual learning;Volatile Fatty Acids,Prebiotic Treatment in People with Schizophrenia,9990,NSS,NSS,NA,S1,5,22959,12742,35701,NA
11179756,R01,CA,7,N,2024-11-06,2024-09-01,2025-05-31,395,R01CA283058,SCHOOLS OF MEDICINE,PA-24-254,7R01CA283058-03,NCI:390028\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,ANN ARBOR,UNITED STATES,PEDIATRICS,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"We have developed and clinically translated the combination of trabectedin and irinotecan as an EWS-FLI1 targeted therapy for Ewing sarcoma. While the clinical evaluation of this combination is promising and multiple tumor regressions have been observed, the activity has been limited by what appears to be intrinsic mechanisms of resistance. The goal of the current study is to exploit these mechanisms to develop novel EWS-FLI1 directed combination therapies with improved activity and less toxicity.",10824831 (contact),"GROHAR, PATRICK J (contact)","GREENBERG, WILLIAM A",2024-09-01,2028-05-31,actinomycin;Binding;Biological Assay;Biology;Cell Nucleolus;Cell Nucleus;Cell Proliferation;Cell Survival;cell type;Cells;Chimeric Proteins;Chromatin;Chromatin Structure;Clinic;Clinical;Clinical Data;Clinical Trials;Combined Modality Therapy;Cytoprotection;Data;Dependence;Development;Disease;DNA;DNA Binding;DNA Binding Agent;DNA Damage;DNA Minor Groove Binding;Dose;Doxorubicin;driver mutation;Drug resistance;effective therapy;Enhancers;Epigenetic Process;epigenetic silencing;Etoposide;Ewings sarcoma;EWS-FLI1 fusion protein;EWSR1 gene;FLI1 Transcription Factor;Genes;Genetic Transcription;Genome;global run on sequencing;Goals;Heat-Shock Proteins 70;Impairment;improved;improved outcome;in vivo;inhibitor;insight;irinotecan;Malignant Neoplasms;Microsatellite Repeats;Modeling;Mutation;Normal Cell;novel;novel strategies;Nucleotides;Oncogenes;Oncogenic;Output;patient derived xenograft model;Patient-Focused Outcomes;Patients;Pharmaceutical Preparations;Phase Transition;Poison;pre-clinical;Proteins;Proteomics;Recovery;recruit;Recurrence;Relapse;Reporting;research clinical testing;resistance mechanism;response;Response Elements;Site;success;targeted agent;targeted treatment;Testing;Therapeutic;Toxic effect;transcription factor;Translating;Treatment Efficacy;tumor;tumor growth;Ultraviolet Rays,"The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factor",283058,MCTB,Mechanisms of Cancer Therapeutics B Study Section[MCTB],NA,NA,3,250018,140010,390028,NA
11179774,Y01,DC,NA,N,NA,NA,NA,NA,ADC24001001,NA,NA,ADC24001001-1-0-1,NIDCD:1720000\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,"Hearing is important. Good hearing ability is an essential aspect of normal communication and plays an important role in safety and awareness in nearly every part of daily life.  Hearing trouble results in a myriad of difficulties, including communication trouble, difficulty at school or work, social isolation and/or stigmatization, potentially accelerated cognitive decline, and economic ramifications at the family, community, and national level.  Adults with hearing impairment are at risk for decreased quality of life, poorer health status, and diminished health care services received. Targeted interventions delivered in a community or medical setting, provided by audiologists, Ear, Nose, and Throat (ENT) doctors [aka, Otolaryngologists-Head and Neck surgeons], neuro-otologists, occupational and physical therapists, pediatricians, gerontologists, and other trained health care workers can potentially mitigate risks for long-term disability.   Hearing loss is a widespread problem. It is the third most common chronic physical condition in the United States and is twice as prevalent as diabetes or cancer.  Recent statistics indicate that 37.5 million U.S. adults aged 18 and older have some degree of hearing impairment.  Approximately 50 million Americans report tinnitus (ringing in the ears), a condition that can be as disabling as hearing loss.  Over 16 million of these individuals suffer frequent tinnitus, and about 2 million experience tinnitus so severe that it interferes with daily living activities.  Nationally, the total cost of first-year hearing loss treatment is projected to multiply five-fold between 2002 and 2030, from $8.2 billion to $51.4 billion. These NHANES epidemiological audiometric data will also provide national reference distributions – normative data – that can be used to screen for deficiencies across the U.S. population, and with the oversampling of minorities and other economically-disadvantaged individuals, it provides a barometer for disparities.   Most adult-onset hearing losses are permanent.  In the U.S., noise exposure is a major cause of preventable hearing loss.  Twenty-two million U.S. workers are exposed to noise annually, and 24% of hearing difficulty among workers is attributable to workplace noise exposure.  Noise-induced hearing loss (NIHL) is the second most commonly reported occupational disease and the most expensive disability for military and Federal workers’ compensation.  In recent years, some factors may have resulted in reduced loud noise exposure, such as better industry compliance with OSHA noise standards, implementation of noise-reducing innovations in the workplace, as well as the continuing shift of jobs away from manufacturing sector in the U.S. economy.  Noise does not just occur on-the-job; approximately 21 million adults have acquired a non-occupational NIHL.  Sources for non-occupational noise exposure include firearms use and many environmental or recreational exposures to loud music or noise, such as frequent attendance at loud sporting events and working with electrical tools or machinery.  As the Nation’s population ages and survival rates for infants and for people with severe injuries and acquired diseases improve, the prevalence of hearing loss and other communication disorders is expected to rise.",NA,(contact),NA,NA,NA,Acceleration;Activities of Daily Living;Adult;Affect;Age;Age Years;aged;Air;American;Area;Auditory Threshold;Awareness;Bilateral;Biological Assay;Blood;Carbon Monoxide;Chemical Exposure;Child;Chronic;cigarette smoking;Collaborations;Communication;Communication impairment;Communities;cost;Dancing;Data;Data Collection;Data Set;Devices;Diabetes Mellitus;digital;disability;Disabling;Disease;Disparity;Ear;Economically Deprived Population;Economics;Epidemiology;Ethnic Origin;Evaluation;Event;experience;Exposure to;External auditory canal;Family;Firearms;Frequencies;Future;Geographic Locations;Goals;Head and Neck Surgeon;Health;health care service;Health Personnel;Health Status;health training;Hearing;Hearing Aids;hearing impairment;hearing loss treatment;Hearing Protection;Hearing Tests;Household;Hyperacusis;Impaired cognition;improved;Individual;Industry;Infant;innovation;Intervention;Interview;Laboratories;lead exposure;Life;Link;Long term disability;Loudness;Malignant Neoplasms;manufacture;Measures;Medical;Medical History;middle ear;Military Personnel;Minority;Monitor;Motorcycles;Movement;Music;National Health and Nutrition Examination Survey;National Institute for Occupational Safety and Health;National Institute on Deafness and Other Communication Disorders;Noise;noise exposure;Noise-Induced Hearing Loss;normal hearing;Nose;Occupational Diseases;Occupational Therapist;Occupations;Otolaryngologist;Otoscopes;Otoscopy;ototoxicity;Participant;Patient Self-Report;pediatrician;permanent hearing loss;Persons;Pharyngeal structure;Physical Examination;physical therapist;Play;Population;pressure;Prevalence;Prevention;Protective Devices;Protocols documentation;Pure-Tone Audiometry;Quality of life;Questionnaires;Race;Recording of previous events;Recreation;Reporting;Research;Research Personnel;response;Risk;Risk Factors;risk mitigation;Role;Safety;Sampling;Schools;Sensory;severe injury;sex;Social isolation;Socioeconomic Status;Solvents;sound;Source;Sports;statistics;Stigmatization;Surveys;Survival Rate;System;Testing;Tinnitus;tool;Tympanic membrane;Tympanometry;United States;United States National Center for Health Statistics;Work;Workers&apos; Compensation;Workplace,CDC-NCHS-NHANES Audiometry Component,240010,NA,NA,NA,NA,NA,NA,NA,1720000,NA
11179795,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000015,NA,NA,1ZIAAG000015-66,NIA:8568920\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1947219 (contact),"SIMONSICK, ELEANOR MARIE (contact)",NA,NA,NA,Acceleration;Address;Affect;Age;age difference;age effect;age related;age related decline;Aging;aging process;aging related;Anatomy;Ancillary Study;Antioxidants;Autonomic nervous system;Baltimore;Biological;Blood;Blood Pressure;Body Weight;bone;Cardiovascular Physiology;Cells;Central Nervous System;Characteristics;Classification;Clinic;Clinical;Clinical Medicine;Clinical Research;Cognitive;cognitive function;cognitive performance;cohort;Cohort Studies;Collection;COVID-19;Data;data cleaning;Dedications;Dementia;design;Development;Diagnosis;disabled;Disease;DNA;DNA Methylation;Documentation;Elderly;Enrollment;Environment;Equilibrium;Equipment and supply inventories;Erythrocytes;experience;Feedback;Feeling;follow-up;frailty;Functional disorder;functional status;Future;gene environment interaction;General Population;Genetic;Genome Scan;Genomics;Genotype;Gerontology;glucose metabolism;Goals;hallmarks of aging;Health;Health behavior;Health Status;high risk;Home visitation;Homeostasis;Hormones;Hospitals;Human;human old age (65+);immune function;Impaired cognition;improved;Individual;inflammatory marker;insight;Intake;interdisciplinary approach;Intramural Research Program;Joints;Laboratories;Life;Life Cycle Stages;life span;Lipids;Longevity;Longitudinal Studies;Maintenance;Malignant neoplasm of prostate;Measurement;Measures;metabolomics;Mobility decline;Mobility disability;mortality;Muscle;muscle strength;Names;Nutritional;older adult;Older Population;Organ;Outcome;Outcome Measure;Oxidative Stress;pandemic impact;Participant;Pathologic Processes;pathological aging;Peripheral Nervous System;Personal Financing;Persons;Phenotype;Physical activity;Physical Function;Physiological;Physiology;Plasma;Process;Production;Prognosis;programs;prospective;prostate cancer risk;Proteomics;Publishing;Quality Control;Quality of life;recruit;Reference Standards;Reporting;Research;Research Personnel;Resources;SARS-CoV-2 exposure;Scientist;sensory system;Serum;Social Interaction;Societies;Specimen;Structure;study population;Surveys;Symptoms;System;Technology;Technology Assessment;Telephone;Time;Tissues;trait;trend;Uric Acid;Urine;Vaccination;Visit;volunteer;Work,The Baltimore Longitudinal Study of Aging,15,NA,NA,NA,NA,66,NA,NA,8568920,NA
11179796,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000334,NA,NA,1ZIAAG000334-05,NIA:108284\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Affect;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease diagnosis;Alzheimer&apos;s disease risk;Baltimore;Behavioral;behavioral phenotyping;Biological Markers;Body Composition;Cognitive;cognitive ability;daily functioning;Data;Dementia;Early identification;Education;executive function;Exhibits;experience;Gait;Goals;Health;health data;high risk;high risk population;Individual;insight;Life Style;Longitudinal Studies;Memory;Memory Loss;Metabolic;Metabolic Diseases;Metabolic Pathway;metabolic phenotype;metabolic profile;metabolomics;Motor;Nature;Neurobehavioral Manifestations;neuroimaging marker;novel marker;Participant;Performance;Persons;Phenotype;phenotypic biomarker;Process;Race;Sample Size;Sampling;Sampling Studies;Subgroup;Testing,Metabolomic Signatures of Dual Cognitive and Gait Decline in relation to High Risk of Alzheimers disease in the Health ABC Study,334,NA,NA,NA,NA,5,NA,NA,108284,NA
11179797,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000343,NA,NA,1ZIAAG000343-06,NIA:14438\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Affect;Aging;Alzheimer&apos;s Disease;Amyloid deposition;Baltimore;Biological;Brain imaging;Cognitive;cognitive ability;cognitive function;cohort;daily functioning;Data;Development;experience;Gait;Goals;high risk;Impaired cognition;Individual;insight;Link;Longitudinal Studies;Lower Extremity;Manuscripts;Memory;Memory Loss;Meta-Analysis;Metabolic;metabolic profile;metabolomics;mild cognitive impairment;Motor;Nerve Degeneration;neuroimaging marker;Outcome;Performance;Phenotype;Physical Function;Plasma;pre-clinical;Process;Reporting;Sampling;Speed;Time,Metabolomic signatures underlying cognitive and motor decline in the development of mild cognitive impairment and Alzheimer's disease,343,NA,NA,NA,NA,6,NA,NA,14438,NA
11179798,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000358,NA,NA,1ZIAAG000358-08,NIA:14082\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Address;Age;Aging;Ancillary Study;Base Excision Repairs;Biological;Cancer Etiology;Cell Aging;Cell Cycle Arrest;Cells;Comparative Biology;Comparative Study;Consumption;coping;design;Development;DNA;DNA amplification;DNA Damage;DNA lesion;DNA redundancy;DNA Repair;DNA sequencing;Environmental Pollutants;Exposure to;Flow Cytometry;Free Radicals;Frequencies;genome sequencing;Genomic Instability;Goals;Growth Factor;hallmarks of aging;hormonal signals;Human;Individual;Induction of Apoptosis;Inflammation;Inflammatory;Innate Immune System;Invertebrates;Ionizing radiation;Lesion;Longevity;Maintenance;Mammals;Metabolism;Methods;Mitochondria;mitochondrial dysfunction;monocyte;Mutation;Nonhomologous DNA End Joining;Nuclear;Nucleotide Excision Repair;Organism;Participant;Pathway interactions;Peripheral Blood Mononuclear Cell;Phenotype;Predisposition;Quality Control;repaired;response;senescence;senescent cell;Somatic Mutation;Stress;Testing;Tissues;Ultraviolet Rays;Variant;whole genome,The Hallmarks of Aging: Assessing accumulation of DNA lesions with age using single cell DNA sequencing in GESTALT,358,NA,NA,NA,NA,8,NA,NA,14082,NA
11179799,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000470,NA,NA,1ZIAAG000470-03,NIA:108284\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,78832228 (contact),"TIAN, QU  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;biobank;Brain;brain based;brain health;Brain Injuries;brain iron;Clinical Trials;Data;Data Correlations;Data Set;data submission;Dementia;Deposition;Development;Diagnostic;DNA copy number;follow-up;frailty;Free Radicals;genome sequencing;Goals;hallmarks of aging;Hemochromatosis;Homozygote;Human;Hydrogen Peroxide;Hydroxyl Radical;improved;Intramural Research Program;Iron;Iron Overload;Magnetic Resonance Imaging;Measures;men;mild cognitive impairment;Mitochondria;Mitochondrial DNA;mitochondrial dysfunction;Motor;motor disorder;motor impairment;Mutation;novel;Oxidative Stress;Participant;Pathogenesis;Pathology;Pharmaceutical Preparations;prevent;Production;Prognostic Marker;Prospective cohort;Proxy;Reaction;Reactive Oxygen Species;reduced muscle strength;Research;Research Project Grants;Role;Testing;Whole Blood;Work,ALZHEIMERS RESEARCH PROJECT: Understanding two novel factors related to motor impairment in the development of dementia - UK Biobank project (Alzheimer's disease concept),470,NA,NA,NA,NA,3,NA,NA,108284,NA
11179800,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000631,NA,NA,1ZIAAG000631-20,NIA:84492\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,absorption;Acute;Adult;Affect;Atherosclerosis;Blood specimen;Cholesterol;cytokine;Data;Data Analyses;Data Collection;design;Diabetes Mellitus;Diet;dietary;Dietary Fats;Eating;Enrollment;fast food;Fatty acid glycerol esters;Food;fruits and vegetables;Glucose;Health;Heart Diseases;Hour;Individual;Inflammation;Inflammatory;inflammatory marker;Ingestion;Intake;intervention effect;Learning;Lipids;monounsaturated fat;Obesity;OGTT;Oxidative Stress;Persons;Reaction;Restaurants;Risk Factors;Sampling Studies;saturated fat;Saturated Fatty Acids;Source;Sterile coverings;Testing;Testosterone;United States;Unsaturated Fats;Unsaturated Fatty Acids,Assessment of Post-Prandial Effects of a Fast-Food Meal on Inflammatory Markers,631,NA,NA,NA,NA,20,NA,NA,84492,NA
11179801,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000693,NA,NA,1ZIAAG000693-14,NIA:1063194\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,11118163 (contact),"DING, JUN  (contact)",NA,NA,NA,"Affect;Age;age effect;Aging;aging mechanism;aging process;aging related;Algorithmic Software;Algorithms;Alleles;Ally;Annual Reports;Baltimore;biobank;Biochemical;Biological;Biological Markers;Biological Process;Case/Control Studies;Cells;Chronology;cohort;Complex;computerized tools;Data;design;Disease;DNA;DNA Methylation;DNA Sequence;efficacy evaluation;Environmental Risk Factor;epigenetic aging;Fatty acid glycerol esters;Genes;Genetic;genetic analysis;Genetic study;Genome;genome sequencing;genome wide association study;genome-wide;genomic locus;Genomics;Genotype;Goals;Heritability;heteroplasmy;high throughput analysis;High-Throughput Nucleotide Sequencing;Individual;Leukocytes;Longitudinal Studies;machine learning method;Measures;Mediating;Mediation;Metabolic;Methods;Mitochondria;Mitochondrial DNA;mortality;mortality risk;National Heart, Lung, and Blood Institute;Nuclear;Participant;Personality;Personality inventories;Personality Traits;Phenotype;phenotypic data;Physiological;Population Control;Process;programs;Proxy;rate of aging;Risk;Sardinia;Single Nucleotide Polymorphism;Site;Speed;Statistical Algorithm;survival prediction;Telomerase;Testing;trait;Trans-Omics for Precision Medicine;Treatment Efficacy;Variant;whole genome;Work",Statistical genetics of aging-related genomic and phenotypic change,693,NA,NA,NA,NA,14,NA,NA,1063194,NA
11179802,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000965,NA,NA,1ZIAAG000965-19,NIA:28164\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Age;age effect;age related;Aging;aging process;Area;Baltimore;bioinformatics resource;Biological;biological age;Body System;Bone Density;Candidate Disease Gene;Cardiovascular Diseases;Clinical;Cognition;cognitive function;cohort;Collaborations;cost;cost effective;Critical Pathways;Data;Dementia;Disease;disorder risk;DNA;early onset;endophenotype;Europe;Exclusion;expectation;falls;father role;Focus Groups;follow-up;Fracture;frailty;functional status;Funding;Gait speed;Generations;Genes;Genetic;Genetic Polymorphism;Genetic Predisposition to Disease;Genetic Transcription;genetic variant;Genetic Variation;Genome;genome wide association study;genome-wide;Genotype;hearing impairment;Human;Human Genome;human old age (65+);Incidence;inflammatory marker;insight;Insulin Resistance;Investments;Label;Laboratories;Life;Link;Literature;Longitudinal Studies;Measurement;Measures;Methods;muscle strength;Nature;neurogenetics;Osteoporosis;Outcome;Participant;Pathway interactions;Pattern;Phenotype;Physical Performance;Population;Prevention;prognostic assays;programs;Proteins;Proteomics;Public Health;Quality of life;rate of change;reference genome;Research Design;Resources;Risk;Sampling;Sampling Studies;sarcopenia;Serum;Staging;Structure;success;Testosterone;trait;United States;United States National Institutes of Health;Variant;whole genome;Work,"The Aging Genome Association Study ""AGE-GAIN""",965,NA,NA,NA,NA,19,NA,NA,28164,NA
11179803,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000971,NA,NA,1ZIAAG000971-17,NIA:28164\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Address;Adult;Affect;age related deterioration;Aging;aging process;Anatomy;Antioxidants;Autonomic nervous system;Baltimore;Basal metabolic rate;Biological;Biological Markers;bone;Cell Respiration;Central Nervous System;Charge;Chronic;Chronic Disease;Clinical;Clinical Research;Cognitive;Collaborations;Complement;Data;Defect;Development;disability;Disease susceptibility;Elderly;Elements;Endocrine system;Energy Metabolism;Environment;Epidemiology;epidemiology study;Equilibrium;Etiology;Evolution;Feedback;frailty;free radical oxygen;Generations;Health;high throughput screening;Homeostasis;Hormones;Immune system;Impairment;improved;Inflammatory;Inflammatory Response;Institution;Intake;Joints;Longitudinal Studies;macromolecule;Measures;Methodology;Modeling;Morbidity - disease rate;mortality;Motivation;Motor;Muscle;Neurologic;Nutrient;nutrition;older adult;Older Population;Outcome;Oxidative Stress;Oxygen;Parasympathetic Nervous System;Pathway interactions;Performance;Peripheral Nervous System;Phase;Physical activity;Physiological;Process;Production;programs;Property;Reactive Oxygen Species;repaired;Research;Research Personnel;Sardinia;Scientist;Signal Transduction;somatosensory;Stress;Stressful Event;System;Testing;Women&apos;s Health,Biomarkers of Homeostatic Dysregulation in Aging and Chronic Disease,971,NA,NA,NA,NA,17,NA,NA,28164,NA
11179804,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000986,NA,NA,1ZIAAG000986-07,NIA:433138\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,11118163 (contact),"DING, JUN  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Alzheimer&apos;s disease risk;case control;cohort;computational pipelines;Data;Data Set;Dementia;design;Disease;DNA;DNA copy number;Etiology;exome;Genetic;genetic approach;genetic association;Genome;genome wide association study;Goals;Haplotypes;Heritability;Individual;interest;Knowledge;Late Onset Alzheimer Disease;Link;Mitochondria;Mitochondrial DNA;mitochondrial genome;Neurodegenerative Disorders;Nuclear;preventive intervention;programs;prospective test;Public Domains;Research Personnel;Risk;Signal Transduction;Susceptibility Gene;Testing;trait;Variant;whole genome,Assessing mitochondrial variation associated with Alzheimer's Disease,986,NA,NA,NA,NA,7,NA,NA,433138,NA
11179805,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000995,NA,NA,1ZIAAG000995-10,NIA:154902\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Activities of Daily Living;Affect;age related;Aging;Architecture;Biomechanics;Correlation Studies;Development;disability;Disability prevention;epidemiology study;Fatty acid glycerol esters;Funding;Gene Expression;Gene Proteins;Goals;Impairment;Infiltration;Link;Longitudinal Studies;Measures;Metabolic;Microcirculation;Mitochondria;mortality;Muscle;muscle form;muscle strength;Muscular Atrophy;Older Population;Performance;preservation;Property;Publishing;reduced muscle strength;Research;Risk Factors;Sampling;Testing;Therapeutic;treatment strategy,Changes in muscle biomechanical quality with aging: causes and consequences,995,NA,NA,NA,NA,10,NA,NA,154902,NA
11179806,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000996,NA,NA,1ZIAAG000996-10,NIA:133779\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Age;age related changes;Age Years;Aging;aging biomarker;aging mechanism;aging process;Algorithms;Alternative Splicing;B-Lymphocytes;Biological;Biological Assay;Biological Markers;biomarker identification;Biopsy;Biotechnology;Blood Cells;Body Composition;CD8-Positive T-Lymphocytes;Cell Aging;cell type;Cells;Chromatin;Chronology;Code;Complex;Cues;cytokine;Data;Data Analyses;design;Dimensions;DNA Methylation;Endotoxins;Epigenetic Process;epigenome;Equation;experience;experimental study;Fibroblasts;Flow Cytometry;fly;follow-up;Functional disorder;Gene Expression;Gene Expression Profiling;Genes;Genetic;Genomic Instability;Goals;hallmarks of aging;Homeostasis;Human;Immune;Inflammaging;Inflammation;Inflammatory;Interleukin-6;Laboratories;Longitudinal Studies;Lymphocyte;Manuscripts;Mass Spectrum Analysis;Measures;Memory;Messenger RNA;metabolome;Methylation;methylome;Microarray Analysis;Mind;Mitochondria;monocyte;Mus;Muscle;Neurons;next generation;NF-kappa B;Noise;Older Population;Organism;Participant;Pathway interactions;Peripheral Blood Mononuclear Cell;Persons;Phenotype;Preparation;Process;Property;Protein Isoforms;Proteins;Proteome;Proteomics;Publications;Publishing;Reaction;Receptor Signaling;recruit;Reproducibility;Research;RNA Splicing;Sampling;Serum;Signal Transduction;Site;Skin;skin biopsy;stem;Testing;Tissues;TNF gene;trait;transcriptome;transcriptome sequencing;Untranslated RNA;Variant;Visit;Whole Blood;Yeasts,GESTALT-Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing,996,NA,NA,NA,NA,10,NA,NA,133779,NA
11179807,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000997,NA,NA,1ZIAAG000997-10,NIA:10828\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,16S ribosomal RNA sequencing;absorption;Actinobacteria class;Adult;Affect;Age;age related;Age Years;Aging;Alzheimer&apos;s Disease;Animals;Area;Bacteria;bacterial community;Bacteriodetes;Baltimore;beta diversity;Biological Factors;Biological Markers;Birth;Brain;brain health;Child;Cognition;cognitive function;Communities;Dentition;Development;Diet;dietary;Digestion;Disease;Ear;Elderly;Enrollment;Environmental Risk Factor;Epidemiology;Eukaryota;Firmicutes;follow-up;frailty;fungus;Gastrointestinal tract structure;Geographic Locations;glyoxylate;gut microbiome;gut-brain axis;Health;Health Status;Human;Human body;human data;Human Microbiome;human microbiota;Individual;Infant;Inflammatory;inter-individual variation;interest;Intestines;Investigation;life span;Location;Longitudinal Studies;men;metagenomic sequencing;Metagenomics;Microbe;microbial community;microbial composition;microbiome;microbiome composition;Mission;muscle strength;older adult;Oral cavity;Pathway interactions;Patients;Phenotype;Pilot Projects;Prokaryotic Cells;Reporting;Research;Resources;Role;Salivary;Sampling;Shotguns;Skin;Specimen;stool sample;Structure of nail of toe;targeted treatment;Technology;Time;trait;United States National Institutes of Health;Vagina;Virus;Visit;walking speed;whole genome;Woman,Alzheimers Disease Project: Microbiome Projects in the Baltimore Longitudinal Study of Aging,997,NA,NA,NA,NA,10,NA,NA,10828,NA
11179808,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG001050,NA,NA,1ZIAAG001050-17,NIA:14082\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Acceleration;Age;age group;aged;aging process;Biological;bone;Central Nervous System;Clinical;Clinical assessments;clinical examination;cohort;Cohort Studies;Collaborations;Data;disability;Disease;Elements;Enrollment;Epidemiology;Evaluation;Event;follow-up;Follow-Up Studies;functional loss;Funding;Goals;Health;Hospitalization;human old age (65+);Impairment;Intervention;Interview;Italy;Joints;Laboratories;Lead;Libraries;Measures;men;Muscle;Normal Range;Older Population;Participant;Performance;Peripheral Nervous System;Persons;Physiological;Population;Population Sciences;preventive intervention;Procedures;Production;Random Allocation;Registries;research clinical testing;Research Personnel;Risk Factors;rural area;Sampling;Site;System;Testing;Time;Update;urban area;Vital Status;Walking;walking performance;Woman,The InChianti Study,1050,NA,NA,NA,NA,17,NA,NA,14082,NA
11179809,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041126,NA,NA,1ZIAAR041126-25,NIAMS:1402817\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691686 (contact),"SARTORELLI, VITTORIO  (contact)",NA,NA,NA,Adipocytes;Adult;Aging;Animal Model;Animals;Area;Atlases;Binding;Cell Differentiation process;Cell Lineage;Cells;Chondrocytes;Chromatin;chromatin modification;chromatin remodeling;Chromatin Structure;Complex;deep sequencing;Development;Enhancers;Enzymes;Epigenetic Process;Equilibrium;Gene Activation;Gene Expression;Gene Expression Profile;gene repression;Genes;Genetic Transcription;Genome;Goals;histone methylation;histone modification;Histones;Homeostasis;Impairment;In Vitro;interest;Intervention;Knock-in Mouse;Knock-out;Maintenance;Mass Spectrum Analysis;Metabolic;metabolomics;Methyltransferase;Modification;Molecular;Muscle;muscle aging;Muscle Fibers;muscle progenitor cell;muscle regeneration;muscle repair;Muscular Dystrophies;myogenesis;Myogenin;Natural regeneration;Neurons;Nucleic Acid Regulatory Sequences;Pathologic;pharmacologic;Phenotype;Physiological;Polycomb;Process;Proliferating;Proteins;recruit;Repression;Research;skeletal;Skeletal Muscle;Skin;small molecule;Specific qualifier value;stem cell function;tissue culture;Totipotent Stem Cells;Transcription Coactivator;Transcriptional Activation;Transcriptional Regulation;Transgenic Organisms;Undifferentiated;Untranslated RNA,Control of Adult and Aging Myogenesis,41126,NA,NA,NA,NA,25,NA,NA,1402817,NA
11179810,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041164,NA,NA,1ZIAAR041164-17,NIAMS:1402817\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691686 (contact),"SARTORELLI, VITTORIO  (contact)",NA,NA,NA,Acetyltransferase;Actins;Adult;Aging;Animal Model;Animals;Atrophic;Biochemical;Breeding;Burn injury;Cell Culture System;Cells;Complex;Conceptions;Deacetylase;Denervation;Development;Dexamethasone;Elderly;Enterobacteria phage P1 Cre recombinase;EP300 gene;Epigenetic Process;Equilibrium;Euthanasia;experimental study;Exposure to;extend lifespan;Female;Fetus;Genetic Transcription;Goals;Harvest;healing;Heart;Histologic;Hormones;in vivo;Infusion procedures;injured;Injury;Kidney;Knock-out;knockout animal;Limb structure;Link;Liver;LoxP-flanked allele;Malignant Neoplasms;Measures;Metabolic;Modeling;Modification;Molecular;Molecular Analysis;Morphology;Mus;Muscle;Muscle Development;Muscle Fibers;muscle form;Muscle function;muscle progenitor cell;muscle regeneration;Muscle Weakness;Muscular Atrophy;Muscular Dystrophies;muscular structure;Myoblasts;Natural regeneration;Nicotinamide adenine dinucleotide;novel;overexpression;Pancreas;Pathway interactions;PCAF gene;pharmacologic;Physiological;pregnant;premature;Process;promoter;Protein Biosynthesis;protein degradation;Proteins;reduced muscle mass;regenerative;Role;Saline;Sampling;sarcopenia;sciatic nerve;SIRT1 gene;skeletal;Skeletal Muscle;skeletal muscle differentiation;Skeletal Muscle Satellite Cells;skeletal muscle wasting;Spleen;Techniques;Therapeutic;Therapeutic Uses;Tissues;Transgenic Animals;Transgenic Mice;Traumatic injury;treatment strategy,"SIRT1 in Skeletal Muscle Development, Regeneration, and Atrophy",41164,NA,NA,NA,NA,17,NA,NA,1402817,NA
11179811,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041170,NA,NA,1ZIAAR041170-17,NIAMS:1529173\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78876939 (contact),"HASNI, SARFARAZ  (contact)",NA,NA,NA,"Adult;Area;Arthritis;Assessment tool;Autoimmune;Autoimmune Diseases;barrier to care;Clinic;Clinical;cohort;Collection;Complementary and alternative medicine;COVID-19;Data;Dedications;Diagnosis;Disease;disease phenotype;District of Columbia;ethnic difference;ethnic minority;Evaluation;experience;Goals;health care disparity;health disparity;Immune;Improve Access;improved;indexing;Informed Consent;Intervention;Methods;metropolitan;minority communities;Minority Groups;Musculoskeletal;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Neighborhood Health Center;Observational Study;Outcome;Outcome Assessment;outreach;Patient Outcomes Assessments;Patient Self-Report;Patients;pediatric patients;primary care provider;Process;Research;Research Personnel;Research Support;response;Rheumatism;Rheumatoid Arthritis;Serology;Site;social health determinants;standard of care;Standardization;Symptoms;systemic autoimmunity;systemic inflammatory response;Systemic Lupus Erythematosus;Vaccines;Vascular Diseases;Viral;Washington;Yoga",Rheumatic and Autoimmune Diseases in Minority Communities,41170,NA,NA,NA,NA,17,NA,NA,1529173,NA
11179812,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041215,NA,NA,1ZIAAR041215-04,NIAMS:877364\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78385762 (contact),"KIM, HANNA  (contact)",NA,NA,NA,adaptive immunity;Adolescent;American;Animals;Arthritis;Autoantibodies;Biological;Biological Markers;Biological Models;cell type;Childhood;Chronic;Clinic;Clinical;Clinical assessments;Clinical Research;cohort;college;Complex;Controlled Study;disability;Disease;Double-Blind Method;Edema;Gene Expression;Genes;Goals;immune function;improved;Inflammation;Inflammatory;inhibitor;insight;interest;Interferon Type I;Interferon Type II;Interferons;Janus kinase;Juvenile Dermatomyositis;kinase inhibitor;Life;Magnetic Resonance Imaging;Measures;meetings;Morbidity - disease rate;Muscle;Myositis;Natural Immunity;novel;novel therapeutics;Organ;Outcome;Pathogenesis;Pathogenicity;Pathway interactions;Patient Outcomes Assessments;Patients;Performance;peripheral blood;Pharmaceutical Preparations;Pilot Projects;Placebo Control;programs;protein biomarkers;protein expression;Protein Kinase;Refractory;Reporting;Research;research clinical testing;response;Rheumatology;Rhubarb food;Risk Factors;Role;Safety;safety assessment;Sampling;Serious Adverse Event;side effect;Signal Transduction;Skin;skin disorder;Subgroup;targeted treatment;Therapeutic;Tissue-Specific Gene Expression;translational medicine;translational study;treatment response;Urine;Vascular Diseases;Writing,Juvenile Myositis Pathogenesis and Translational Medicine,41215,NA,NA,NA,NA,4,NA,NA,877364,NA
11179813,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL000146,NA,NA,1ZIACL000146-31,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6569543 (contact),"KOVACS, JOSEPH A (contact)",NA,NA,NA,Adherence;Alveolar Cell;Animals;Antibodies;Antigens;Automobile Driving;B-Lymphocytes;beta-Glucans;Binding;Biological;Biological Assay;C-Type Lectins;Candida;Caspofungin;CD209 gene;CD3 Antigens;CD4 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Separation;Cells;chemokine;chemokine receptor;Collaborations;CXCR6 gene;Cyst;cytokine;Defect;Dendritic Cells;Development;DNA Sequence Alteration;Endothelium;Enzymes;Epithelium;Exposure to;Flow Cytometry;fungus;glucan synthase;Glucans;Heterozygote;HIV Infections;Human;IL17 gene;Immune;Immune response;Immunocompetent;immunodeficiency;Immunodeficient Mouse;Impairment;improved;In Vitro;Infection;Infection Control;Inflammatory Response;Inhalation;inhibitor;Innate Immune Response;insight;Interferon Type II;Japanese;Kinetics;knock-down;Knockout Mice;Ligands;Lung;Lymphocyte;Macrophage;Mannans;mannose receptor;Masks;Membrane Glycoproteins;Membrane Proteins;Memory;Methods;Microarray Analysis;Modeling;mouse model;Mucin 1 protein;Mucous Membrane;Mus;novel strategies;Organism;pathogen;pathogenic fungus;Patients;Phenotype;Pneumocystis;Pneumocystis carinii;Pneumocystis carinii Pneumonia;Pneumocystis Infections;pneumocyte;Population;Predisposition;Production;programs;promoter;recruit;Regulatory T-Lymphocyte;Research Personnel;response;Riboflavin;Role;Signal Transduction;single-cell RNA sequencing;Structure of parenchyma of lung;Surface;T-Lymphocyte;Therapeutic;Time;TNFSF5 gene;transcription factor;Transfection;Up-Regulation;Wild Type Mouse,Characterization Of Immune Responses During Pneumocystis Pneumonia,146,NA,NA,NA,NA,31,NA,NA,0,NA
11179814,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL000188,NA,NA,1ZIACL000188-27,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6569508 (contact),"DANNER, ROBERT L (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;ACE2;Acute;acute COVID-19;Acute Respiratory Distress Syndrome;Affect;Agonist;Aldosterone;alpha Tubulin;antagonist;apoAI regulatory protein-1;Apoptosis;Apoptotic;Arginine;arteriole;Atherosclerosis;Award;Back;bench to bedside;Biological Models;Biomedical Engineering;Blood;Blood Vessels;BMPR2 gene;Cardiogenic Shock;cardiometabolic risk;cardiovascular risk factor;Cardiovascular system;caveolin 1;Cells;Cessation of life;Chronic;Circulation;cohort;Complication;constriction;Coronavirus;COVID-19;COVID-19 complications;Cyclic AMP-Dependent Protein Kinases;Cyclic GMP;Cytoskeleton;Death Rate;dietary;Disease;Disease Progression;DNA Sequence;Drug Targeting;endothelial dysfunction;Endothelium;EP300 gene;ERCC3 gene;Event;Expression Profiling;Family member;Female;Festival;Fibroblasts;Fish Oils;Flow Cytometry;G-Protein-Coupled Receptors;Gene Expression;Gene Expression Regulation;Generations;Genes;Genetic;Genetic Predisposition to Disease;Genetic Transcription;Genomics;Goals;Growth;Heart;heart preservation;hemodynamics;Hemoglobin;Hemostatic function;HIV;Human;IL8 gene;Immunochemistry;Impairment;In Vitro;indexing;Individual;Inflammation;Inflammatory;Inflammatory Response;Infusion procedures;inhibitor;Injury;Interferons;Interruption;Investigation;knock-down;Laboratory Study;Left;Link;loss of function;loss of function mutation;Lung;lung injury;lung vascular injury;Malignant Neoplasms;MAP Kinase Gene;MAPK3 gene;MAPK8 gene;Mediating;Mediator;Mesenchymal;Messenger RNA;Meta-Analysis;Metabolism;Mitochondria;Modeling;Molecular Conformation;Monounsaturated Fatty Acids;mouse model;Multiple Organ Failure;Mus;Mutation;Myocardial Infarction;Natural History;NF-kappa B;Nitric Oxide;Nitric Oxide Signaling Pathway;Nitric Oxide Synthase;Nitric Oxide Synthase Type I;NOS3 gene;NOTCH1 gene;Nuclear Receptors;Nucleic Acids;organ injury;Outcome;overexpression;Oxidants;p38 Mitogen Activated Protein Kinase;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;phase 3 testing;Phenotype;Phosphorylation;PI3K/AKT;Pilot Projects;Play;Polyunsaturated Fatty Acids;PPAR gamma;Predisposition;Preparation;prevent;primary pulmonary hypertension;Procollagen-Proline Dioxygenase;Production;Proliferating;Proteins;Proto-Oncogene Proteins c-akt;pulmonary arterial hypertension;Pulmonary Hypertension;Ras/Raf;Rattus;Reactive Oxygen Species;Receptor Signaling;Refractory;Relaxation;repaired;Repression;Research;Research Personnel;Resistance;right ventricular failure;Risk Factors;Role;rosiglitazone;Safety;Scleroderma;senescence;Sepsis;Septic Shock;Severe Acute Respiratory Syndrome;severe COVID-19;shear stress;Sickle Cell Anemia;Signal Pathway;Signal Transduction;Signal Transduction Pathway;small molecule inhibitor;Spironolactone;STAT1 gene;Stress;stroke risk;Structure of parenchyma of lung;symposium;System;Tertiary Protein Structure;Therapeutic;Therapeutic Intervention;thrombotic;TMPRSS2 gene;Transcript;Transcription Factor AP-1;transcription factor TFIIH;Translations;United States National Institutes of Health;vascular bed;Vascular Diseases;vascular inflammation;Vascular remodeling;Ventricular End-Diastolic Volumes;Viral Proteins;Virus;Vision;Work,Vascular Dysfunction and Inflammation,188,NA,NA,NA,NA,27,NA,NA,0,NA
11179815,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL000192,NA,NA,1ZIACL000192-27,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6569543 (contact),"KOVACS, JOSEPH A (contact)",NA,NA,NA,Animals;Biological;Biology;Canis familiaris;Centromere;ChIP-seq;Chitin;Chromosomal Rearrangement;Chromosomes;Collaborations;Communities;cross-species transmission;Data;Denmark;Development;Disease Outbreaks;DNA;Electrons;Environment;Epidemiology;Evolution;Family;Frequencies;fungus;Gene Family;Genes;Genetic Variation;Genome;genome sequencing;Genomic Segment;Genotype;Germany;Guanine + Cytosine Composition;Highly Active Antiretroviral Therapy;HIV;Human;Immunocompetent;immunodeficiency;Individual;Infection;Innate Immune Response;Introns;Kidney Transplantation;Lead;Link;Lower Organism;Lung;Mannose;Maps;Medical;medical schools;Membrane Glycoproteins;Methods;Minor;Mitochondria;mitochondrial genome;Molecular;Molecular Analysis;Mus;National Institute of Allergy and Infectious Disease;next generation sequencing;novel;Organism;Patients;Play;Pneumocystis;Pneumocystis carinii;Pneumocystis Infections;Population;Probability;prophylactic;Proteins;Rattus;Recording of previous events;Regimen;Reporting;Research Personnel;Resources;Rest;Restriction Fragment Length Polymorphism Analysis;Rodent;Role;Sampling;Scientist;Site;Source;Species Specificity;Structural Biologist;Surface Antigens;Switzerland;Synteny;Tandem Repeat Sequences;Techniques;therapeutic target;Time;transmission process;transplant centers;Transplant Recipients;Variant,Molecular Studies Of Human and Rodent Pneumocystis,192,NA,NA,NA,NA,27,NA,NA,0,NA
11179816,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002119,NA,NA,1ZIACL002119-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692693 (contact),"STRONCEK, DAVID  (contact)",NA,NA,NA,B-Lymphocytes;Biological Assay;Cell Culture Techniques;Cell Physiology;Cell Therapy;Cells;cellular engineering;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical;Clinical effectiveness;Complex;Dendritic Cells;enzyme linked immunospot assay;Enzyme-Linked Immunosorbent Assay;Flow Cytometry;Gene Expression Profiling;gene therapy;Genes;Genome;Hematologic Neoplasms;Hematopoietic stem cells;improved;Leukocytes;Measures;Messenger RNA;metabolomics;MicroRNAs;miRNA expression profiling;monocyte;next generation sequencing;novel;Outcome;peripheral blood;Production;single cell analysis;Site;sterility testing;T-Lymphocyte;Testing;Time;transcriptome;Transfusion;Unmarried person;vector,Develop novel assays for assessing cellular and gene therapies,2119,NA,NA,NA,NA,17,NA,NA,0,NA
11179817,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002120,NA,NA,1ZIACL002120-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692693 (contact),"STRONCEK, DAVID  (contact)",NA,NA,NA,Autoimmune Diseases;B-Cell Acute Lymphoblastic Leukemia;CAR T cell therapy;CD19 gene;CD22 gene;Cell Separation;Cell Therapy;Cells;cellular engineering;Characteristics;chimeric antigen receptor T cells;Clinical;Clinical Treatment;Deficiency Diseases;Dendritic Cell Therapy;Development;engineered T cells;Failure;gene therapy;Good Manufacturing Process;GPC3 gene;Hematologic Neoplasms;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;Immune System Diseases;improved;induced pluripotent stem cell;instrument;Laboratories;Laboratory Research;Lymphoma;Malignant neoplasm of cervix uteri;Malignant Neoplasms;malignant oropharynx neoplasm;manufacture;Marrow;Methods;MS4A1 gene;novel;novel therapeutics;Oncoproteins;patient oriented;Patients;pediatric patients;Primary carcinoma of the liver cells;Procedures;Process;Production;Reagent;Regenerative Medicine;scale up;T-Cell Receptor;T-Lymphocyte;Tumor Antigens,Development of novel cell and gene therapies,2120,NA,NA,NA,NA,17,NA,NA,0,NA
11179818,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL008060,NA,NA,1ZIACL008060-22,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6569508 (contact),"DANNER, ROBERT L (contact)",NA,NA,NA,2019-nCoV;Acute;Adherence;Admission activity;Adrenal Cortex Hormones;aerosolized;Affect;Aldosterone;Algorithms;Allogenic;Alteplase;Animal Model;Animal Welfare;anthrax lethal factor;Anti-Inflammatory Agents;Antibiotic Therapy;Antibiotics;Anticoagulation;Aorta;Arginine;arm;attributable mortality;Blood;Blood Platelets;Blood Vessels;Bone Marrow Transplantation;Canis familiaris;Cardiac;cardiac repair;Cardiovascular Diseases;Cardiovascular system;Caring;Catecholamines;Ceftazidime;Cell Culture System;Cells;Cessation of life;Characteristics;Chest;Clindamycin;clinical investigation;Colistin;Communities;Comparative Effectiveness Research;comparative effectiveness trial;Comparison arm;Consent Forms;coronary event;Counterpulsation;COVID-19;Critical Care;Critical Illness;Data;Databases;Death Rate;Decision Making;design;Diagnosis;Diagnostic;Dose;drug resistant bacteria;Dryness;Early identification;Ebola;Edema;Elements;Endothelium;Endotoxemia;Endotoxins;Epidemiology;Epinephrine;Equilibrium;Escherichia coli;Etiology;Failure;Fibrinolysis;Functional disorder;Gene Expression;Glucocorticoids;Goals;healthcare burden;Heart;heart function;Heart Injuries;Hemoglobin;Heparin;Histopathology;Hospitalization;Hospitals;Hydrocortisone;Ibuprofen;Impairment;improved;improved outcome;Incidence;indexing;Infection;Inflammation;Informed Consent;Infusion procedures;Injury;innovation;Intensive Care;Interferons;Internships;Intravenous Immunoglobulins;Investigation;Investments;Ischemia;Journals;Left Ventricular Ejection Fraction;lethal factor;Levaquin;Liquid substance;lung injury;Measures;Meningoencephalitis;Mental Depression;Meta-Analysis;Mineralocorticoids;Modeling;Morbidity - disease rate;mortality;mortality risk;mouse model;Multiple Organ Failure;Mus;Myocardial dysfunction;Myocardial Infarction;Necrotizing fasciitis;new therapeutic target;Nitric Oxide;Nitric Oxide Synthetase Inhibitor;Organ;Outcome;Oxygen;p38 Mitogen Activated Protein Kinase;pandemic disease;pathogen;Patient Selection;Patients;Perfusion;Pneumonia;Population;pre-clinical;Prevention;procalcitonin;prophylactic;Public Health;Published Comment;Pulmonary Embolism;Rattus;reparative process;Research Subjects;Resistance;response;Risk;senescence;Sepsis;Septic Shock;severe COVID-19;severe injury;Severity of illness;Shock;Staphylococcal Enterotoxin B;Stem cell transplant;Stenotrophomonas maltophilia;Streptococcal Infections;Stroke;Supportive care;Syndrome;Therapeutic;Thrombus;tigecycline;Toxin;toxoplasmic encephalitis;Tracer;Transfusion;Transplant Recipients;Trauma;treatment as usual;trial design;Trimethoprim-Sulfamethoxazole;Update;Variant;Vascular Diseases;Vasoconstrictor Agents;volunteer,Preclinical and Clinical Investigations of Severe Infection and Critical Illness,8060,NA,NA,NA,NA,22,NA,NA,0,NA
11179819,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL008075,NA,NA,1ZIACL008075-20,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,6569543 (contact),"KOVACS, JOSEPH A (contact)",NA,NA,NA,anti-PD1 antibodies;Anti-Retroviral Agents;antiretroviral therapy;arm;Biological;Biological Markers;biomarker panel;Biopsy Specimen;C-reactive protein;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Count;Cells;Central Nervous System Diseases;Characteristics;Chronic;Clinical;clinically relevant;co-infection;Coagulation Process;cohort;Collaborations;Correlation Studies;COVID-19 pandemic effects;Cross-Sectional Studies;CXCL10 gene;CYP3A4 gene;cytokine;Data;design;Development;Diabetes Mellitus;Diagnosis;Disease;Dose;Drug Interactions;Drug Kinetics;drug metabolism;Eating;efavirenz;Endothelium;Enrollment;Enzymes;Evaluation;exome sequencing;Fibrin fragment D;Fibrosis;Flow Cytometry;flu;Genetic Markers;Genetic Transcription;Goals;Guidelines;healthy volunteer;Heart Diseases;Hepatitis B;Hepatitis C;Hepatitis C co-infection;Hepatitis C virus;Hepatotoxicity;histopathological examination;Histopathology;HIV;HIV Infections;Immune;Immune response;Immunologics;Immunophenotyping;improved;Infection;Inflammation;insight;Interferon Type II;Interleukin-6;Intervention;Kidney Diseases;Leptin;Liver;liver biopsy;Liver diseases;Liver Fibrosis;Lung;Malignant Neoplasms;Measures;Mediating;Medical;Metabolic;Metabolic Diseases;metabolic rate;Methods;Microscopic;monocyte;Morbidity - disease rate;mortality;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;Nature;Nucleotides;Opportunistic Infections;participant enrollment;Pathogenesis;pathogenic virus;Pathway interactions;patient subsets;Patients;pembrolizumab;Pharmaceutical Preparations;Pharmacy facility;Phase;Pilot Projects;placebo controlled trial;platelet function;Predictive Value;premature;Prevalence;prevent;primary endpoint;Process;programmed cell death protein 1;Prophylactic treatment;Protocols documentation;Quality of life;recruit;Reporting;Research Personnel;responders and non-responders;Reverse Transcriptase Inhibitors;rifapentine;Risk;Safety;Series;Severities;single-cell RNA sequencing;Steatohepatitis;Symptoms;System;T-cell receptor repertoire;Tenofovir;Time;TNF gene;Transaminases;Tuberculosis;Viral Load result;Viremia;Virus;volunteer;von Willebrand Factor;Weight Gain,Evaluation of HIV-related Complications,8075,NA,NA,NA,NA,20,NA,NA,0,NA
11179820,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL009022,NA,NA,1ZIACL009022-09,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,2432508 (contact),"SUFFREDINI, ANTHONY F. (contact)",NA,NA,NA,Acute;Adjuvant;Adrenal Cortex Hormones;Alveolar Macrophages;American;Anti-sense RNA;Apoptosis;Archives;arm;Bacteria;Biological Markers;Biological Process;Biological Response Modifiers;Blood;Blood Cells;Bronchoalveolar Lavage;Bronchoscopy;Bronchoscopy with Bronchoalveolar Lavage;Caring;Cell Communication;Cell Culture Techniques;Cell Death;Cell Physiology;Cell surface;Cell Survival;cell type;Cells;Cellularity;chemokine;Chemotaxis;Chest;Code;cohort;Communication;cytokine;Cytokine Signaling;Data;Dependence;design;differential expression;Disease;Distant;Eligibility Determination;Endotoxins;Enrollment;extracellular;Flow Cytometry;Functional disorder;Gene Expression Regulation;Genes;Genetic Transcription;Goals;Gram-Negative Bacteria;granulocyte;Growth;healthy volunteer;Hour;Human;human model;immune function;Immune signaling;Immunophenotyping;Immunotherapy;Infection;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Response;Intercellular adhesion molecule 1;intercellular communication;Interleukins;International;Intervention;Lung;Lymphocyte;Lymphocyte Subset;Macrophage;Malignant Neoplasms;Mediating;Membrane;microbial;MicroRNAs;migration;Modeling;Molecular;monocyte;Movement;neutrophil;next generation sequencing;Organ;pandemic disease;Pathway interactions;pharmacologic;Post-Transcriptional Regulation;prevent;Production;Proliferating;Proteins;Pulmonary Challenge;Pulmonary Inflammation;Regulation;Reporter;Research;Resolution;response;RNA;Role;screening;Signal Pathway;Signal Transduction;Societies;Stimulus;symposium;Time;tissue injury;TNF gene;Toll-like receptors;Transcript;transcriptome;transcriptome sequencing;Untranslated RNA,Pulmonary Effects of Bronchial Segmental Endotoxin Instillation in Humans,9022,NA,NA,NA,NA,9,NA,NA,0,NA
11179821,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060017,NA,NA,1ZIACL060017-34,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,1868881 (contact),"DAMIANO, DIANE L. (contact)",NA,NA,NA,3-Dimensional;Activities of Daily Living;Adult;Affect;Age;Algorithms;Ankle;arm;Artificial Intelligence;Attention;Biomechanics;Body Weight;Brachial plexus structure;Cerebral Palsy;Characteristics;comparative;complex data;Data;Data Analyses;Databases;Development;Devices;digital;disability;Disease;Dystonia;Equilibrium;Evaluation;Exhibits;foot;Gait;Goals;healthy volunteer;Human;Impairment;improved;Individual;insight;Intervention;Joints;Laboratories;Leg;Limb structure;Link;Lower Extremity;Methodology;Motion;Motor;Motor Skills;Movement;movement analysis;Movement Disorders;Muscle;muscle strength;Nature;Neurologic Gait Disorders;neuromusculoskeletal;Orthotic Devices;Paralysed;Patients;Pattern;Performance;Persons;Physical assessment;physical impairment;portability;Positioning Attribute;prevent;Process;Protocols documentation;Recovery of Function;Rehabilitation therapy;Research;Self-Help Devices;Shoes;spasticity;Specialist;Support System;System;Testing;Training;treadmill;ultrasound;Upper Extremity;Walking,A Rigid Body Database On Human Movement,60017,NA,NA,NA,NA,34,NA,NA,0,NA
11179822,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090062,NA,NA,1ZIACL090062-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,2432508 (contact),"SUFFREDINI, ANTHONY F. (contact)",NA,NA,NA,Acute;acute infection;Anosmia;Anti-viral Agents;Blood;Blood specimen;Body Fluids;Brain;Brain imaging;Bronchoalveolar Lavage;Cardiopulmonary;Caring;Cells;Cellular Immunity;Cerebrospinal Fluid;Clinical;clinical center;cohort;Convalescence;Coughing;COVID-19;COVID-19 patient;Cross-Sectional Studies;Data;Diagnosis;Diagnostic;Echocardiography;Evaluation;Fatigue;Fever;Functional disorder;Gene Expression Profile;Goals;Heart;heart function;heart imaging;High Resolution Computed Tomography;Hospitalization;Hospitals;Humoral Immunities;Image;imaging modality;imaging system;Immune;immune function;Immune response;Immunity;Immunophenotyping;In Vitro;Infection;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Response;innovation;insight;Kidney;Lavage;Link;long term consequences of COVID-19;long-term sequelae;Longitudinal Studies;Lung;lung imaging;Magnetic Resonance Imaging;Measures;Mediator;mortality;Myalgia;Myocarditis;Nervous System Physiology;novel;Onset of illness;Organ;participant enrollment;Pathogenesis;Patients;Peptides;Persons;Phase;Population;Prevention;Proteins;Protocols documentation;pulmonary function;Pulmonary Inflammation;radiological imaging;Recovery;recruit;Resolution;Respiratory Disease;Respiratory Signs and Symptoms;response;Sampling;SARS-CoV-2 infection;Series;Severity of illness;single-cell RNA sequencing;Site;Symptoms;systemic inflammatory response;Testing;Therapeutic;Time;ultrasound;United States National Institutes of Health;Urine;Viral;Viral Load result;viral RNA;X-Ray Computed Tomography,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,90062,NA,NA,NA,NA,5,NA,NA,0,NA
11179823,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090079,NA,NA,1ZIACL090079-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414709 (contact),"FRANK, JOSEPH  (contact)",NA,NA,NA,2019-nCoV;Age;Algorithms;analysis pipeline;animal imaging;Architecture;Area;Artificial Intelligence;artificial intelligence method;base editing;Benchmarking;Classification;Code;Collection;Color;Communicable Diseases;convolutional neural network;COVID-19 pandemic;Cowpox;Data;Data Aggregation;Data Set;deep learning;deep learning model;density;dimension reduction;Dimensions;Disease Progression;Dose;Enzymes;Evaluation;experimental study;Exposure to;feature selection;feeding;Future;Generations;Human;human data;Image;imaging Segmentation;imaging study;improved;Infection;Infectious Diseases Research;Influenza A virus;interest;Knowledge;Lassa virus;Lesion;Liver;liver imaging;Lobe;Lung;lung basal segment;lung imaging;lung lesion;lung lobe;Machine Learning;machine learning classification;machine learning method;Measures;medical countermeasure;Medical Imaging;Methodology;Methods;model development;Modeling;Monitor;multimodality;multiple datasets;National Institute of Allergy and Infectious Disease;Neural Network Simulation;Nipah;nonhuman primate;Numerical value;Organ;Pathology;Performance;Persons;Phenotype;pre-trained model;predictive modeling;Process;Protocols documentation;Questionnaires;Radiology Specialty;radiomics;Reporting;Research;research facility;Research Personnel;Route;Running;Scanning;self supervised learning;Severity of illness;software infrastructure;Specialist;Standardization;Statistical Data Interpretation;Structure;Summary Reports;Techniques;TensorFlow;Testing;Time;Training;transfer learning;Validation;Virus;Weight;Work;Writing;X-Ray Computed Tomography,Artificial Intelligence for Infectious Disease Imaging,90079,NA,NA,NA,NA,3,NA,NA,0,NA
11179824,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090081,NA,NA,1ZIACL090081-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,1868881 (contact),"DAMIANO, DIANE L. (contact)",NA,NA,NA,3-Dimensional;Abnormal coordination;Adult;Affect;Age;Algorithms;Ankle;Area;Bilateral;Biofeedback;Brain;Brain imaging;Brain Injuries;brain tissue;Cerebral Palsy;Child;Childhood;cohort;Complex;Contralateral;Custom;Data;design;Detection;Development;Devices;effective therapy;Electroencephalography;Enrollment;functional electrical stimulation;Gait;Goals;Hemiplegia;Hip region structure;Home;Imaging Techniques;Impairment;improved;improved outcome;Individual;Injury;Instruction;Intervention;kinematics;Limb structure;Location;Lower Extremity;Maps;Monitor;Motion;Motor;motor disorder;motor function improvement;Motor Skills;Movement;Muscle;Near-Infrared Spectroscopy;neurofeedback;Observational Study;Paper;Participant;participant enrollment;Pathway interactions;Pattern;Performance;Peripheral;Persons;Process;programs;Protocols documentation;Publishing;recruit;Regional Blood Flow;Research;Residual state;Resolution;response;Sensory;sensory input;Side;Signal Transduction;skills;Specific qualifier value;Speed;Standardization;study population;Surface;System;temporal measurement;Testing;Time;Training;Upper Extremity;Walking,Near-infrared spectroscopy and electroencephalography to assess and train cortical activation during motor tasks,90081,NA,NA,NA,NA,3,NA,NA,0,NA
11179825,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090083,NA,NA,1ZIACL090083-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,1868881 (contact),"DAMIANO, DIANE L. (contact)",NA,NA,NA,Cerebral Palsy;Collaborations;computerized data processing;COVID-19 pandemic;Data;Data Analyses;Data Collection;Dopamine;Enrollment;Epigenetic Process;Gene Combinations;Genes;Genetic;genetic variant;Genetic Variation;Individual;Learning;Left;Manuscripts;Modification;motor learning;motor skill learning;Participant;Persons;Positioning Attribute;Process;Reporting;response;Rewards;Short-Term Memory;Students;Time;Training;transmission process;Universities,Dopamine and Motor Learning in Cerebral Palsy,90083,NA,NA,NA,NA,3,NA,NA,0,NA
11179826,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090084,NA,NA,1ZIACL090084-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,1868881 (contact),"DAMIANO, DIANE L. (contact)",NA,NA,NA,1 year old;3 year old;Adult;Age;Age Years;Area;autism spectrum disorder;Body Weight;Brain;Cerebral Palsy;Child;Childhood;Communities;Cross-Sectional Studies;Data;Data Analyses;Data Collection;Dedications;Development;Devices;disability;Early Diagnosis;Electroencephalography;Enrollment;Family;Force of Gravity;Foundations;Friction;grasp;Hand;high risk;infancy;Infant;Intervention;Laboratories;Leg;Life;Limb structure;longitudinal analysis;mobility aid;Motor;Motor Skills;Movement;Near-Infrared Spectroscopy;Nervous System Disorder;Pattern;Physicians;recruit;Rehabilitation therapy;Research;response;Toddler;Toy;treadmill;Visit;walker;web site;Weight-Bearing state;Work,Near-infrared spectroscopy and electroencephalography to assess cortical activation during motor tasks in infants and toddlers with or at high-risk for Cerebral Palsy and Autism Spectrum Disorder comp,90084,NA,NA,NA,NA,3,NA,NA,0,NA
11179827,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090101,NA,NA,1ZIACL090101-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,2432508 (contact),"SUFFREDINI, ANTHONY F. (contact)",NA,NA,NA,Acceleration;Acute;Acute Disease;Acute Kidney Failure;airway epithelium;Allogenic;Alveolar;Appearance;Biological Markers;Blood;Bronchoalveolar Lavage;Chest imaging;Chronic Disease;Clinical;conditioning;Data;Defect;density;Development;Diagnosis;Early Diagnosis;Early identification;Evaluation;Exclusion;Fluid overload;Future;Goals;graft vs host disease;Hematopoietic Stem Cell Transplantation;Idiopathic pneumonia syndrome;Immune;immune reconstitution;Impairment;improved;Infection;Inflammatory;Injury;Institutional Review Boards;Longevity;Lung;Lung Diseases;lung imaging;lung injury;Measures;Metagenomics;Multicenter Trials;Myocardial dysfunction;participant enrollment;Patients;Pattern;Pilot Projects;prospective;Proteomics;Protocols documentation;pulmonary function;Pulmonary Inflammation;Quality of life;Radiation;radiological imaging;Regimen;response;Risk;Safety;Site;Specimen;Structure of parenchyma of lung;success;Syndrome;targeted treatment;Therapeutic immunosuppression;Time;Tissues;transcriptomics;Transplantation;Vascular Endothelium,A Prospective Approach for the Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation,90101,NA,NA,NA,NA,2,NA,NA,0,NA
11179828,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP000101,NA,NA,1ZIACP000101-20,NCI:586511\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,Age;age related changes;Alcohol consumption;Alcohols;alpha-carotene;Androstenedione;Antioxidants;Ascorbic Acid;Autoantibodies;Beta Carotene;Binding;Biological Availability;Breast Cancer Risk Factor;Calories;cancer chemoprevention;Cardiovascular Diseases;cardiovascular risk factor;Carotenoids;Chemopreventive Agent;Clinical Nutrition;Clinical Trials;Colorectal Cancer;Dehydroepiandrosterone Sulfate;Diet;Diet and Nutrition;Diet Records;dietary;Dietary Alcohol;Dietary Fats;DNA Damage;Dose;doubly-labeled water;Drug Kinetics;Energy Intake;Energy Metabolism;Estradiol;Estrogens;Estrone-Sulfate;Evaluation;feeding;Food;Frequencies;high-fat/low-fiber diet;Hormones;Human;improved;insulin sensitivity;Insulin-Like Growth Factor I;Intake;Intervention;Leptin;Lipids;Lipoproteins;Malignant Breast Neoplasm;Malignant neoplasm of esophagus;Malignant Neoplasms;men;Menstrual cycle;Menstruation;Metabolic;Methodological Studies;Micronutrients;Nulliparity;Nutritional Study;Observational Study;Oxidative Stress;parous;Physical activity;Plasma;Postmenopause;Pregnancy;Premenopause;Questionnaires;Research;Role;Safety;safety assessment;Selenium;Serum;SHBG gene;Statistical Models;Testosterone;United States Department of Agriculture;urinary;Woman;zeaxanthin,Human Studies of Diet and Nutrition,101,NA,NA,NA,NA,20,NA,NA,586511,NA
11179829,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP000112,NA,NA,1ZIACP000112-20,NCI:297760\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,Age;alpha Tocopherol;Beta Carotene;Biological;Blood;Bronchi;Cancer Death Rates;cancer risk;carcinogenesis;Carotenoids;Categories;China;Cohort Studies;Consumption;Cytology;Data Analyses;Death Rate;Dietary Intervention;Disease;Double-Blind Method;Dysplasia;esophageal cancer prevention;Esophagus;Etiology;follow-up;Food;Fumonisins;General Population;Genetic Polymorphism;Genetic Risk;Goiter;Helicobacter pylori;histological specimens;Human Herpesvirus 4;Human Papillomavirus;Human papillomavirus 16;Incidence;Ingestion;Intervention;Intervention Studies;Intervention Trial;Lung;Malignant neoplasm of esophagus;Malignant neoplasm of lung;Malignant Neoplasms;malignant stomach neoplasm;Micronutrients;Millet;Minerals;mortality;Nitrosamines;Nutrient;Participant;Patient Self-Report;Persons;Placebo Control;Pleura;post intervention;Prevention;Probability;Proliferating;Randomized;Risk;Selenium;Serology;Serum;Silicon Dioxide;Specimen;Stomach;stomach cardia;Structure of nail of toe;Supplementation;Testing;Tissues;Tooth Loss;Trachea;Trauma;Vegetables;Vitamin E;Vitamins;Zinc,Nutrition Intervention Trials,112,NA,NA,NA,NA,20,NA,NA,297760,NA
11179830,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP000176,NA,NA,1ZIACP000176-20,NCI:459909\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,Antioxidants;Arsenic;Biochemical;Biological;Biological Specimen Banks;cancer biomarkers;Cancer Etiology;Carotenoids;case control;Cessation of life;cohort;Cohort Studies;data repository;Detection;Diagnostic;dietary;Disease;DNA Sequence Alteration;Early Diagnosis;Environmental and Occupational Exposure;Etiology;Evaluation;experience;Exposure to;follow-up;Future;genetic risk factor;Goals;Heterogeneous-Nuclear Ribonucleoproteins;high risk;Human papilloma virus infection;Incidence;Localized Disease;lung cancer screening;Malignant neoplasm of lung;Malignant Neoplasms;Medical;Methods;microbiome;microbiome research;Modality;Molecular;Monoclonal Antibodies;mortality;Occupational Exposure;Patients;Pilot Projects;Radon;Research;Sampling;screening;screening program;Selenium;serological marker;Serum;Smelts;Smoking;Sputum;Sputum Cytology Screening;Survival Rate;Thoracic Radiography;Tin;Tobacco;Tocopherols;tumor;Update;Validation,Biologic Specimen Bank for Early Lung Cancer Markers,176,NA,NA,NA,NA,20,NA,NA,459909,NA
11179831,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP000185,NA,NA,1ZIACP000185-20,NCI:2270068\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,Ablation;Acetaldehyde;Adult;Age;alpha Tocopherol;Animals;Antibodies;Area;Aromatic Polycyclic Hydrocarbons;Beta Carotene;Beverages;Biopsy;Black Tea;Brazil;Cancer Etiology;cancer risk;cancer therapy;carcinogenesis;Cardiovascular system;Carotenoids;Case/Control Studies;Cessation of life;Characteristics;China;Clinic;Clinical;cohort;Cohort Studies;Consumption;County;Death Rate;Dental Hygiene;design;Development;Diagnosis;Dietary Intervention;Disease;DNA;Dose;drinking;Dryness;Dysplasia;Early Diagnosis;Early treatment;Enrollment;Environmental Risk Factor;Esophageal Squamous Cell Carcinoma;Esophageal Tissue;Esophagus;Ethnic Origin;Etiology;Evaluation;Evaluation Studies;Excision;Feasibility Studies;field study;follow-up;Freezing;Fumonisins;Gastric Cardia Adenocarcinoma;General Population;Genetic Polymorphism;Genetic Risk;genetic risk factor;Geography;Glucuronides;Goiter;Helicobacter pylori;High grade dysplasia;high risk population;human papilloma virus oncogene;Human Papillomavirus;Human papillomavirus 16;Human papillomavirus 18;In complete remission;Individual;insight;Intervention Trial;Iodine;Iran;Kenya;Laboratories;Lesion;low socioeconomic status;Malignant neoplasm of esophagus;Malignant neoplasm of gastrointestinal tract;Malignant Neoplasms;malignant stomach neoplasm;Measures;Methods;microendoscopy;Minerals;modifiable risk;molecular marker;mortality;Neighborhoods;opium use;Participant;Partner in relationship;Patient Self-Report;Patients;Persons;Population;Prevention;Prevention strategy;Probability;Prognosis;Province;Radiofrequency Interstitial Ablation;Randomized;Residual state;Resolution;response;Risk;Risk Factors;Role;Ruminants;Sampling;screening;Selenium;Serology;Serum;Specimen;Stains;Stomach;stomach cardia;Stroke;Supplementation;Symptoms;Tea;Techniques;Temperature;Testing;Tissues;Tobacco use;Tooth Loss;tumor;Upper digestive tract structure;upper gastrointestinal cancer;urinary;Vital Status;Vitamin E;Vitamins;Zinc,Upper Gastrointestinal Cancer Studies,185,NA,NA,NA,NA,20,NA,NA,2270068,NA
11179832,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP004410,NA,NA,1ZIACP004410-48,NCI:3585550\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8849419 (contact),"SAVAGE, SHARON A. (contact)",NA,NA,NA,American;Brachyury protein;Brain;Breast;Bronchi;cancer risk;Categories;CCR;CDK4 gene;CDKN2A gene;Childhood;Chordoma;Chronic Lymphocytic Leukemia;Collaborations;comparative genomic hybridization;Data Collection;Development;Disease;Educational Materials;Environmental Exposure;exome sequencing;Family;Family health status;Family member;Family Study;gene environment interaction;Genes;genetic epidemiology;genetic risk factor;genome sequencing;genome wide association study;Genotype;Goals;Health Professional;Hereditary Malignant Neoplasm;Heritability;Heterozygote;high risk;Hodgkin Disease;Individual;interest;International;Intervention;Investigation;Italy;Lesion;Lung;Malignant Bone Neoplasm;Malignant Neoplasms;Measures;Melanoma;mutation carrier;Natural History;Nervous System;new technology;next generation;next generation sequencing;Non-Hodgkin&apos;s Lymphoma;notochord;Penetrance;Phenotype;Pleura;Predisposition;rate of change;Recommendation;Reporting;Research Personnel;Retinoblastoma;Risk;Risk Assessment;Second Primary Neoplasms;Skin Carcinoma;Spain;Survivors;Susceptibility Gene;Trachea;Tumor-Derived;Waldenstrom Macroglobulinemia;whole genome;Xeroderma Pigmentosum,Family Studies,4410,NA,NA,NA,NA,48,NA,NA,3585550,NA
11179833,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP005782,NA,NA,1ZIACP005782-30,NCI:347215\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,7031165 (contact),"O'BRIEN, THOMAS R (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Area;Blood;Blood Specimen Collection;Cancer Etiology;Categories;Chronic;Chronic Hepatitis C;Cirrhosis;Clinical;clinical examination;clinical research site;Clinical Trials;Cohort Studies;Communities;Data;Development;Disease;DNA;end stage liver disease;Enrollment;Epidemiology;epidemiology study;Etiology;Exposure to;Gene Expression;genetic epidemiology;Genetic Markers;Genetic Polymorphism;genetic variant;Genotype;Goals;Health;Hepatitis B Infection;Hepatitis B Virus;Hepatitis C;Hepatitis C virus;HIV;HIV Infections;Human;Human Genome;Infection;Injecting drug user;interest;Interferons;Kaposi Sarcoma;Liver;liver transplantation;Molecular;Non-Hodgkin&apos;s Lymphoma;Oncogenic Viruses;Participant;Patients;Pharmacogenetics;population based;Population Study;predictive marker;Primary carcinoma of the liver cells;Questionnaires;Research;Research Project Grants;research study;Ribavirin;Risk;San Francisco;Specimen;treatment response;United States;Urban Health;Viral;Virus;Woman;Women&apos;s Interagency HIV Study,Epidemiology of Oncogenic Viruses,5782,NA,NA,NA,NA,30,NA,NA,347215,NA
11179834,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP005803,NA,NA,1ZIACP005803-30,NCI:2347971\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,2062427 (contact),"GOLDSTEIN, ALISA  (contact)",NA,NA,NA,Age;age effect;Area;Asian;Asian Women;Attention;Autoimmune Diseases;Autoimmunity;Blood;BRAF gene;Brain;Breast Cancer Genetics;Breast Cancer Patient;Breast Cancer Risk Factor;Canada;Cancer Hospital;cancer subtypes;cancer type;Candidate Disease Gene;carcinogenesis;case control;Case/Control Studies;Categories;cdc Genes;Cells;Characteristics;Childhood Medulloblastomas;China;Chinese;Chordoma;Chronic;Clinic;Clinical;cohort;Cohort Effect;Collaborations;comorbidity;Complement;Complex;Country;Cutaneous Melanoma;Data;data registry;Dentistry;Development;disorder risk;Disparity;DNA;drinking;Dysplastic Nevus;early onset;Eating;Embryo;environment related cancer;Epidemiologist;Estrogen receptor negative;Estrogen receptor positive;Estrogen Receptor Status;Estrogens;Etiology;exome sequencing;Exposure to;Expression Profiling;Family;Family history of;Family Study;follow-up;General Population;Genes;Genetic;Genetic Diseases;genetic epidemiology;Genetic Research;genome wide association study;Germ Lines;Germ-Line Mutation;Goals;Hematologic Neoplasms;high risk;High-Risk Cancer;Hong Kong;human disease;Human Microbiome;Immune;Incidence;Individual;individualized medicine;Investigation;Italy;Korea;Lesion;Link;Malaysia;Malaysian;Malignant Bone Neoplasm;Malignant Breast Neoplasm;Malignant Neoplasms;Mammary Neoplasms;Mediating;Medical;Medical History;medical schools;Melanocortin 1 Receptor;Melanocytic nevus;Melanoma;Menopausal Status;Metabolism;Metastatic Melanoma;microbiome;Molecular;Molecular Profiling;molecular subtypes;Monoclonal gammopathy of uncertain significance;Morphology;Multiple Myeloma;Mutation;neoplasm registry;Neoplasms;Nervous System;Nevus;non-smoker;Normal tissue morphology;Not Hispanic or Latino;older women;Oncogenes;oral microbiome;Outcome;parity;Pathogenesis;Pathway interactions;Patients;Pattern;Philadelphia;Pilot Projects;Polishes;polygenic risk score;Population;population based;Predisposition;preservation;Process;Prognostic Factor;Protocols documentation;Questionnaires;rare variant;receptor;Receptor Gene;Recording of previous events;Registries;Regulation;Reporting;Research Personnel;Rest;Risk;Risk Assessment;Risk Factors;risk variant;Role;Rural;Sampling;San Francisco;Sarawak;Scandinavia;Singapore;Site;Skeleton;Skin;Smoker;Somatic Mutation;Spain;Specimen;stem cells;Structure;Sun Exposure;Sunscreening Agents;Susceptibility Gene;Taiwan;tanning booths;Tea;telomere;Terminal Ductal Lobular Unit;Testing;Time;Tissue Sample;Tissues;tumor;Tumor Subtype;Tumor Tissue;Ulcerative Colitis;United States;United States National Institutes of Health;Universities;Variant;Woman;young woman,Genetic Epidemiology,5803,NA,NA,NA,NA,30,NA,NA,2347971,NA
11179835,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP005804,NA,NA,1ZIACP005804-30,NCI:39221\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8849419 (contact),"SAVAGE, SHARON A. (contact)",NA,NA,NA,"4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol;Affect;Alcohols;Area;base;Behavior;Biological Markers;Body mass index;breast malignancies;Caffeine;Cancer Etiology;cancer surgery;Candidate Disease Gene;Carcinogens;Case/Control Studies;Cessation of life;Child;Chlamydial pneumonia;Chlamydophila pneumoniae;Chronic Obstructive Pulmonary Disease;Cigarette;cigarette smoking;Cohort Studies;Collection;Colorectal;Complement;Craniofacial Abnormalities;CYP2C9 gene;CYP2D6 gene;Data;Dependence;design;Development;dietary;Dioxins;Disease;Division of Cancer Epidemiology and Genetics;DNA Repair;Dopamine;Drug Metabolic Detoxication;Effectiveness;energy balance;Environment;environmental agent;Environmental Exposure;Environmental Pollutants;EPHX1 gene;Epidemiology;epidemiology study;Ethnic Population;Etiology;Exposure to;Family;Family Study;fetal;follow-up;Follow-Up Studies;Future;gene environment interaction;Gene Mutation;Generations;Genes;Genetic;Genetic Determinism;Genetic Polymorphism;Genetic Predisposition to Disease;Genetic study;genome wide association study;Genomics;Genotype;Geography;GSTM1 gene;Helicobacter pylori;Hospitals;improved;indexing;Individual;Infection;Interdisciplinary Study;Laboratories;Lung;Lung Neoplasms;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of lung;Malignant Neoplasms;Mendelian randomization;metabolomics;microbiome;Minority;Molecular Epidemiology;Monoclonal gammopathy of uncertain significance;Mothers;Mutation;neoplastic;Newly Diagnosed;Nicotine Dependence;non-smoker;Obesity;Occupational Groups;Operative Surgical Procedures;Outcome;Ovarian;Perinatal;Persons;Pharmaceutical Preparations;pharmacogenetic variants;Pharmacogenetics;Pharmacogenomics;Phenotype;Phenytoin;Population;population based;Predisposition;Pregnancy;Prostate;Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;Publishing;receptor;Regulation;Research Design;Risk;Role;side effect;Skin Malignancy;Smoker;Smoking;smoking-related cancer;smoking-related disease;Technology;Time;Tissue Banks;Tissues;Tobacco;Tobacco smoking behavior;Tobacco-Associated Carcinogen;treatment and outcome;Treatment Side Effects;tumor;Variant;Woman;Work",Pharmacogenetic Studies,5804,NA,NA,NA,NA,30,NA,NA,39221,NA
11179836,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010119,NA,NA,1ZIACP010119-29,NCI:1643932\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11613066 (contact),"BEANE FREEMAN, LAURA  (contact)",NA,NA,NA,"2,4-Dichlorophenoxyacetic Acid;Agricultural Health Study;Agriculture;Agrochemicals;Aromatic Amines;Biological;Birth;Blood;cancer risk;Carbaryl;Case/Control Studies;Cells;Chemicals;Child;Chronic Disease;cohort;commercial application;Computer Assisted;Data;Defect;design;Diet;Disease;Dust;early life exposure;Enrollment;epidemiology study;Epigenetic Process;Etiology;Evaluation;Exposure to;Family history of;Farm;farmer;Future;Genomic DNA;Home;Insecta;Insecticides;interest;Iowa;Length;Life;lifestyle factors;Limb structure;Link;Malignant Breast Neoplasm;Malignant neoplasm of liver;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant neoplasm of thyroid;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Medical;men;Methodology;Molecular;Multiple Myeloma;National Institute of Environmental Health Sciences;North Carolina;Occupational Exposure;Occupational Malignant Neoplasm;offspring;Organophosphates;Outcome;Paper;Participant;pesticide exposure;Pesticides;Plants;Population;Productivity;programs;Prospective, cohort study;Public Health;Publishing;Questionnaires;recruit;Research Personnel;Risk;Rodent;Self Administration;Source;Specimen;Spouses;statistics;Telephone Interviews;telomere;Update;vector control;Woman",Studies of Occupational Cancer (Pesticides),10119,NA,NA,NA,NA,29,NA,NA,1643932,NA
11179837,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010120,NA,NA,1ZIACP010120-29,NCI:1318977\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10271053 (contact),"LAN, QING  (contact)",NA,NA,NA,Aircraft;Benzene;Biochemical;Body of uterus;Brain;Cancer Etiology;cancer risk;Carcinogenesis Mechanism;carcinogenicity;Case/Control Studies;Categories;Cessation of life;Chemicals;Chronic;Coast Guard;cohort;Cohort Studies;Colon;combustion product;design;Diesel Exhaust;Electromagnetic Fields;Employment;Etiology;Europe;Exposure to;follow-up;Formaldehyde;improved;Individual;Industrial Health;Industrialization;Industry;Investigation;Iowa;Kidney Diseases;leukemia;Link;Liver Cirrhosis;Maintenance;Malignant Breast Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of lung;Malignant neoplasm of nasopharynx;Malignant neoplasm of pancreas;Malignant neoplasm of urinary bladder;Malignant Neoplasms;marine;Measures;Medical;Meleagris gallopavo;Mesothelioma;Methodological Studies;Methods;mortality;Myeloid Leukemia;Nervous System;Occupational;Occupational Exposure;Occupational Malignant Neoplasm;Occupations;Organic solvent product;Pattern;Pesticides;Poland;Population;Predisposition;Pulmonary Emphysema;Rectum;Renal Carcinoma;repaired;Reporting;response;Rheumatic Heart Disease;Risk;Rubber;Russia;Silicon Dioxide;Spain;Techniques;Telecommunications;Textile Industry;Time;trend;Trichloroethylene;urinary;Uterine Diseases;Woman,Studies of Occupational Cancer,10120,NA,NA,NA,NA,29,NA,NA,1318977,NA
11179838,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010121,NA,NA,1ZIACP010121-29,NCI:1077584\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,6569770 (contact),"ROTHMAN, NATHANIEL  (contact)",NA,NA,NA,"Agriculture;Area;Aromatic Polycyclic Hydrocarbons;Arsenic;Benzene;Biological;Biological Markers;Bladder;Brain;Cancer Etiology;case control;Case/Control Studies;Chemicals;Chlorinated Hydrocarbons;Classification;Coal;cohort;Cohort Studies;combustion product;Diesel Exhaust;Disinfection;Environmental and Occupational Exposure;epidemiology study;Esophagus;Etiology;Evaluation;Exposure to;Formaldehyde;Genetic;Genetic Predisposition to Disease;Graft Rejection;Hematologic Neoplasms;HIV;HIV/AIDS;Iatrogenesis;immunosuppressed;Immunosuppression;Individual;insight;Investigation;kidney cell;Life Style;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant neoplasm of thyroid;Malignant Neoplasms;Methods;Molecular;Molecular Epidemiology;Occupational;Pathogenesis;Pesticides;Population;Population Study;prevent;Prospective, cohort study;Risk;Risk Factors;Role;Solvents;Source;Stomach;Subgroup;Transplantation;Trichloroethylene;tumor;Viral",Molecular Epidemiology Studies of Occupational and Environmental Exposures,10121,NA,NA,NA,NA,29,NA,NA,1077584,NA
11179839,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010122,NA,NA,1ZIACP010122-29,NCI:16559\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10271059 (contact),"FRIESEN, MELISSA  (contact)",NA,NA,NA,"2,4-Dichlorophenoxyacetic Acid;Air;air monitoring;Algorithms;Aromatic Amines;Aromatic Polycyclic Hydrocarbons;Arsenic;Asbestos;Asian;Atrazine;Benzene;Benzene Exposure;Biological Markers;Cadmium;Carbon Black;Carcinogens;case control;Case/Control Studies;Chemicals;Childhood Malignant Brain Tumor;Chlorinated Hydrocarbons;Chromium;Classification;Code;cohort;Cohort Studies;Computer software;Cross-Sectional Studies;Data;data mining;Databases;design;Development;Diesel Exhaust;Dose;Dust;Electromagnetic Fields;Ewings sarcoma;exhaust;Exposure to;farmer;Formaldehyde;Gasoline;gender difference;genotoxicity;Germ cell tumor;Goals;Hormonal;Human;Immune;improved;Individual;Lead;lead exposure;leukemia;Link;Lymphatic;Malignant Breast Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of larynx;Malignant neoplasm of lung;Malignant neoplasm of urinary bladder;Malignant Neoplasms;mathematical model;Measurement;men;Metals;Methodological Studies;Methods;Modeling;Neoplasms;New England;novel;Occupational;Occupational Epidemiology;Occupational Exposure;Occupations;Participant;Particulate;Pattern;Performance;Pesticides;Physical activity;Polychlorinated Biphenyls;population based;Population Study;Procedures;programs;Publishing;Questionnaires;Renal Carcinoma;Reporting;response;Solvents;Spain;Specificity;System;Techniques;Text;Training;Trichloroethylene;urinary;Urine;Validation;Woman;Women&apos;s cohort;Women&apos;s study;Wood material;Work",Occupational Exposure Assessment,10122,NA,NA,NA,NA,29,NA,NA,16559,NA
11179840,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010123,NA,NA,1ZIACP010123-29,NCI:372029\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15666226 (contact),"HOFMANN, JONATHAN  (contact)",NA,NA,NA,"African American population;Agricultural Health Study;Agriculture;Animal Feed;Asian;Benzene;Blood;Breast;California;cancer risk;cancer type;Carcinogens;Case/Control Studies;Cells;Child;Childhood Leukemia;China;cigarette smoking;Collaborations;Colon Carcinoma;Data;Diesel Exhaust;drinking water;Employment;Environmental Exposure;Environmental Pollutants;Environmental Risk Factor;epidemiology study;Equipment;Ethnic Population;European;Evaluation;Exposure to;Farm;farmer;Female;Goals;Hispanic;Incidence;Industrialization;Industry;Iowa;leukemia;leukemia/lymphoma;Lung;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Melatonin;men;Minority;Monitor;mortality;Municipal Government;New England;non-smoking;Occupational;Occupational Exposure;Occupations;operation;Ovarian;Participant;Passive Smoking;pesticide exposure;Pesticides;Population;population based;Prospective, cohort study;racial disparity;racial population;Renal Carcinoma;Renal Cell Carcinoma;Reporting;Research;respiratory;Risk;Risk Factors;Role;Sampling;shift work;Spouses;Thyroid Gland;Universities;Urine;Wife;Woman;Women&apos;s Health;Women&apos;s study;Work",Occupational and Environmental Determinants of Cancer among Women and Minorities,10123,NA,NA,NA,NA,29,NA,NA,372029,NA
11179841,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010124,NA,NA,1ZIACP010124-29,NCI:535504\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11142431 (contact),"WENTZENSEN, NICOLAS  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;AIDS population;Anus;Biological Markers;biomarker identification;Biopsy;California;cancer risk;carcinogenicity;Case/Control Studies;Cervical;cervical cancer prevention;Cervical Cancer Screening;Cervix Neoplasms;Cervix Uteri;Clinical;Clinical Management;Clinical Trials;Collaborations;Colposcopy;Country;Cross-Sectional Studies;Cytology;Detection;Diagnostic;Diagnostic Procedure;Disease;DNA;Early Diagnosis;Endocervix;Etiology;Event;Exercise;Exocervix;follow-up;Freezing;General Population;Genotype;Goals;HIV;HIV Seropositivity;HIV/AIDS;HPV positive;Human;Human papilloma virus infection;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;Immune system;Immunologic Markers;Immunosuppression;improved;India;Individual;Integration Host Factors;Latin American;Malignant neoplasm of anus;Malignant neoplasm of cervix uteri;Malignant Neoplasms;men who have sex with men;Messenger RNA;Methods;Methylation;Minor;Modality;Modeling;Molecular;Natural History;Neoplasms;neoplastic;novel marker;Oklahoma;Persons;Population;population based;premalignant;Prevention Research;Prevention strategy;Process;Progressive Disease;Reproducibility;Research;Research Project Grants;Resolution;Resort;Resources;Risk;Risk Factors;Role;Sampling;screening;Screening for cancer;Screening Result;Secondary Prevention;Seroepidemiologic Studies;Sexually Transmitted Agents;Specimen;Standardization;Testing;Tissues;Triage;Viral;Woman;Women&apos;s study,Human papillomavirus (HPV) infection and cervical and anal cancers,10124,NA,NA,NA,NA,29,NA,NA,535504,NA
11179842,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010125,NA,NA,1ZIACP010125-29,NCI:4962100\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,6803134 (contact),"WARD, MARY H (contact)",NA,NA,NA,absorption;Acute Lymphocytic Leukemia;Adult Non-Hodgkin&apos;s Lymphoma;agricultural pesticide;Agriculture;Air Pollutants;Amish;Area;Aromatic Hydrocarbons;Aromatic Polycyclic Hydrocarbons;Arsenic;Arsenicals;Ascorbic Acid;Biological Markers;Bladder;Body Burden;Brain;California;cancer risk;Carpet;Case/Control Studies;Cementation;Cessation of life;Characteristics;Chemicals;Childhood Leukemia;China;Chlordan;Chlorinated Hydrocarbons;Cities;Coal;cohort;Cohort Studies;colon cancer risk;Colon Carcinoma;Confidence Intervals;Consumption;Data Analyses;Dermal;detector;Dietary intake;dietary nitrate;Dioxins;Disinfection;drinking water;Dust;Environment;Environmental Exposure;Environmental Risk Factor;Exposure to;Furans;General Population;Genes;Genetic;Genotype;Geographic Information Systems;Goals;GSTT1 gene;GSTZ1 gene;hazard;Hazardous Waste;Home;House Dust;Hypothyroidism;IL16 gene;IL4 gene;IL8 gene;Immune;improved;indoor concentrations;indoor pollutant;Industrialization;Industry;Ingestion;Inhalation;Intake;Interferon Type II;Interleukin-10;Interleukin-16;Iowa;Kidney;large cell Diffuse non-Hodgkin&apos;s lymphoma;leukemia/lymphoma;Location;Malignant neoplasm of brain;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant neoplasm of thyroid;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Measurement;Measures;Meat;men;Metals;Methods;Missouri;mortality;Multicenter Studies;Nested Case-Control Study;New England;Nitrates;Nitrosation;Non-Hodgkin&apos;s Lymphoma;novel;Odds Ratio;older women;organochlorine pesticide;Participant;Patient Self-Report;Pennsylvania;Persons;Pesticides;Petroleum;Plasma;Pneumonia;polybrominated diphenyl ether;Polychlorinated Biphenyls;Population Density;Prevalence;Privatization;Prospective cohort;Public Health;Radon;Rectal Cancer;Renal Carcinoma;Reporting;Research;residence;Retrospective cohort study;Risk;Risk Factors;Route;Sampling;Serum;sex;Smokeless;Source;Spain;Subgroup;Sum;Thyroid Gland;time interval;Toxics Release Inventory;trend;United States;United States Environmental Protection Agency;Untranslated Regions;Update;Vacuum;Variant;ventilation;Water;Water Pollutants;Water Supply;Woman;Women&apos;s Health;Wood material,Cancer Risk and Environmental Exposures,10125,NA,NA,NA,NA,29,NA,NA,4962100,NA
11179843,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010126,NA,NA,1ZIACP010126-29,NCI:7540188\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187078 (contact),"GIERACH, GRETCHEN  (contact)",NA,NA,NA,Address;African;African American population;Androgens;anxious;Area;Atypical hyperplasia;base;Biological;Biological Assay;bisphenol A;boys;Breast Cancer Risk Factor;cancer risk;Case/Control Studies;Catechols;Caucasians;Characteristics;Clinical;clinical prognostic;cohort;Collaborations;congenital anomaly;Cryptorchidism;Data;design;Development;Disease;Endometrial Carcinoma;Endometrial Hyperplasia;Epidemiology;Estradiol;Estrogen receptor negative;Estrogens;Etiology;examination questions;Excretory function;Exhibits;Female Genital Neoplasms;Finland;Genetic;genotoxicity;Gestational Diabetes;Ghana;Glucuronides;Gynecologic Oncology Group;Health Maintenance Organizations;Heterogeneity;High Prevalence;Histologic;Hormonal;hormone related cancer;Hormones;Hydroxylation;Hypospadias;Impairment;Incidence;Individual;Inguinal Hernia;interest;Investigation;Israel;Knowledge;Laboratories;Learning;Link;liquid chromatography mass spectrometry;male;Malignant Breast Neoplasm;Malignant neoplasm of cervix uteri;Malignant neoplasm of esophagus;Malignant neoplasm of male breast;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant neoplasm of testis;Malignant Neoplasms;Mammographic Density;Mammography;Measures;Medical Records;Menopause;Metabolic;Metabolic Pathway;Methods;Methylation;Mothers;multidisciplinary;Natural History;Nested Case-Control Study;novel;Parents;Participant;Physical activity;Polishes;Postmenopause;Prepaid Health Plans;Prognosis;Prognostic Factor;programs;Questionnaires;Reporting;reproductive system disorder;Research;Research Personnel;Rest;Risk;Risk Factors;Risk Marker;risk prediction;Role;Sampling;screening;Site;Spermatogenesis;Standardization;Sweden;Syndrome;Terminal Ductal Lobular Unit;Testicular Dysgenesis Syndrome;Testicular Germ Cell Tumor;tumor;urinary;Urine;Woman;women&apos;s diagnosis;Women&apos;s Health,Hormone-Related Cancers,10126,NA,NA,NA,NA,29,NA,NA,7540188,NA
11179844,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010127,NA,NA,1ZIACP010127-29,NCI:125352\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,"Alcohols;Anatomy;Asian;Asian population;Awareness;Breast;Cancer Etiology;cancer risk;Coffee;cohort;Colon;Colorectal;Databases;Diabetes Mellitus;Diet;diet and cancer;dietary;Dietary Component;drinking;energy balance;Etiology;Fatty acid glycerol esters;Fruit;fruits and vegetables;Glioma;Glucose;Goals;Hepatitis B;Hepatitis C;Incidence;Insulin;Iron;Juice;Life Style;lifestyle factors;Link;Liver;Lung;Malignant neoplasm of liver;Malignant Neoplasms;Measures;Meat;Medicare;Melanoma;Metabolic Diseases;mortality;Nested Case-Control Study;Non-Steroidal Anti-Inflammatory Agents;Nutrition Disorders;Obesity;Pernicious Anemia;Physical activity;Process;Prospective, cohort study;Reflux;Resources;Risk Factors;Role;Serum;Smoking;Stomach;Ulcer;United States National Institutes of Health;Vitamin D;Work",Etiologic Studies of Diet and Cancer,10127,NA,NA,NA,NA,29,NA,NA,125352,NA
11179845,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010128,NA,NA,1ZIACP010128-29,NCI:224821\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187078 (contact),"GIERACH, GRETCHEN  (contact)",NA,NA,NA,Acceleration;Age;Anti-diabetic Drugs;Anti-Inflammatory Agents;Aspirin;Benign;bone loss;Breast Cancer Risk Factor;cancer risk;Cardiovascular system;Central Nervous System Neoplasms;Chemopreventive Agent;Chemoprophylaxis;Cholesterol;Chronic;Clinic;clinical practice;Clomiphene;cohort;Collaborations;Consumption;Data;Data Set;demethylation;Development;Diabetes Mellitus;Diagnostic Factor;Dose;Drug usage;Endometrial Carcinoma;endometriosis;Estrogens;Etiology;Evaluation;Event;Exposure to;Fertility;Fertility Agents;Fertilization in Vitro;Fibroid Tumor;follow-up;Fracture;Gender;Gynecologic;Hepatotoxicity;high risk;high risk population;Hormonal;hormone related cancer;Hormones;Hypertension;hypertension treatment;Incidence;Individual;Infertility;Inflammation;insight;interest;International Agency for Research on Cancer;Intervention;Investigation;Link;Literature;liver development;Liver diseases;Long-Term Effects;Malignant Breast Neoplasm;Malignant Childhood Neoplasm;Malignant neoplasm of cervix uteri;Malignant neoplasm of liver;Malignant neoplasm of ovary;Malignant Neoplasms;Medical;Medicare;Menopause;Metabolic syndrome;Metformin;Methodology;Michigan;Modeling;neoplasm registry;Non-Steroidal Anti-Inflammatory Agents;Norway;Obesity;Overweight;Pattern;Persons;Pharmaceutical Preparations;pharmacologic;Population;Preparation;Primary carcinoma of the liver cells;Progestins;prospective;protective effect;Publications;Publishing;rare cancer;Regimen;reproductive;Research;Research Personnel;Risk;Risk Factors;Risk Reduction;Severities;Therapeutic;therapeutic evaluation;Therapeutic Intervention;Thinness;Thyroid Diseases;Time;United States National Institutes of Health;Weight;Woman;Women&apos;s Health,Therapeutic and Diagnostic Factors as Related to Cancer Risk,10128,NA,NA,NA,NA,29,NA,NA,224821,NA
11179846,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010131,NA,NA,1ZIACP010131-29,NCI:5193433\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11142453 (contact),"MORTON, LINDSAY  (contact)",NA,NA,NA,Age;Alkylating Agents;atomic bomb;Benign;bone;Bone Marrow Transplantation;Brachytherapy;Breast Cancer survivor;cancer risk;Cancer Survivor;cancer therapy;Cells;chemotherapy;Chemotherapy and/or radiation;childhood cancer survivor;Childhood Cancer Survivor Study;Chronic;cohort;Contralateral Breast;Data;Databases;Diagnosis;Disease;Dose;dosimetry;Esophagus;Etiology;Evaluation;Exposure to;External Beam Radiation Therapy;Feasibility Studies;follow-up;gastrointestinal;Genes;Genetic;genome wide association study;Gland;Gynecologic;Heart Diseases;Hematologic Neoplasms;Hematopoietic Neoplasms;Hodgkin Disease;Hodgkin Lymphoma survivors;Incidence;Individual;Intensity-Modulated Radiotherapy;interest;internal radiation;International;Ionizing radiation;Japanese;Late Effects;leukemia;Life Style;Localized Malignant Neoplasm;Malignant Breast Neoplasm;Malignant Childhood Neoplasm;Malignant neoplasm of cervix uteri;Malignant neoplasm of esophagus;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of pancreas;Malignant neoplasm of testis;Malignant neoplasm of thyroid;Malignant Neoplasms;malignant stomach neoplasm;mathematical model;Medical;Medicare;Melanoma;Methods;Modeling;Monitor;Monograph;mortality;Multiple Myeloma;Mutation;neoplasm registry;Neoplasms;Nested Case-Control Study;Non-Hodgkin&apos;s Lymphoma;novel;Outcome;Pancreas;Patients;Peptic Ulcer;Pharmaceutical Preparations;Population;Population Study;Probability;Protons;Publications;Publishing;Radiation;Radiation Dose Unit;Radiation exposure;Radiation Interaction;radiation risk;Radiation therapy;RB1 gene;Research Personnel;Resources;response;Retinoblastoma;Risk;Risk Factors;Salivary Glands;Second Primary Cancers;SEER Program;Skin;soft tissue;Solid Neoplasm;Statistical Models;Survivors;Testis;Therapeutic;Thyroid Gland;Tissues;tumor;Uncertainty;Update;Woman;Work,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,10131,NA,NA,NA,NA,29,NA,NA,5193433,NA
11179847,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010132,NA,NA,1ZIACP010132-29,NCI:2915621\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15666236 (contact),"CAHOON, ELIZABETH  (contact)",NA,NA,NA,Accidents;Affect;Animals;Area;Belarus;Benign;cancer risk;Case/Control Studies;Cessation of life;Chernobyl Nuclear Accident;Child;Childhood;Clinical;cohort;Cohort Studies;Collection;computer program;Consumption;Country;Coupled;Dairying;Data;Data Set;Databases;design;Development;Dose;dosimetry;drinking water;Environment;Environmental Exposure;environmental radiation;epidemiology study;Ethnic Population;Etiology;Event;Exposure to;External Beam Radiation Therapy;feeding;Fertility;fetal;field study;Focus Groups;follow-up;General Population;Genes;Genetic Predisposition to Disease;genome wide association study;Glioma;Group Interviews;Gynecologist;Head circumference;Health;Hormones;Human;I131 isotope;improved;in utero;Individual;internal radiation;Interview;Investigation;Ionizing radiation;Kazakhstan;Length;leukemia;Life;Link;Malignant - descriptor;Malignant neoplasm of thyroid;Malignant Neoplasms;Manuscripts;Measurement;Measures;Medical;medical countermeasure;Melanoma;member;Methodology;Milk;mortality;Mothers;National Health and Nutrition Examination Survey;National Institute of Child Health and Human Development;Nature;Neonatal;neoplasm registry;Newborn Infant;Nuclear;Nuclear Accidents;Occupational Exposure;offspring;Organ;Persons;Play;Population;population based;Population Study;Pregnancy;Pregnant Women;prenatal;prenatal exposure;Preparation;Prevention;prospective;Province;Publishing;Questionnaires;racial population;Radiation;Radiation Accidents;Radiation Dose Unit;radiation effect;Radiation exposure;Radiation Protection;Radiation-Induced Cancer;Radioactive;Radioactive Fallout;Radioactive Iodine;Radioactive Waste;Radioisotopes;Radiology Specialty;reconstruction;Records;reproductive function;reproductive outcome;Resources;response;Risk;Risk Assessment;Risk Estimate;Risk Factors;Role;Russia;screening;Seasons;Site;Skin Cancer;Skin Carcinoma;solar ultraviolet radiation;Solid;Source;Statistical Data Interpretation;Structure;study population;Sunlight;System;Techniques;Testing;Testosterone;Thyroid Diseases;Thyroid Gland;Time;Ukraine;ultraviolet;Uncertainty;UV Radiation Exposure;Vitamin D;Vitamins;weapons;Work,Studies of Populations Exposed to Environmental Sources of Radiation,10132,NA,NA,NA,NA,29,NA,NA,2915621,NA
11179848,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010133,NA,NA,1ZIACP010133-29,NCI:2093238\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,14721304 (contact),"KITAHARA, CARI  (contact)",NA,NA,NA,Accidents;Age;Aircraft;Alcohols;atomic bomb;Basal cell carcinoma;Binding Sites;biodosimetry;Biological Markers;Body of uterus;Brain;Breast;Breast Cancer Risk Factor;Bronchi;cancer risk;case control;Case/Control Studies;Categories;Central Nervous System;Certification;Cessation of life;Chernobyl Nuclear Accident;Chromosome abnormality;Chronic;Chronic Lymphocytic Leukemia;Circadian Rhythms;cohort;Cohort Studies;Colon;comparison group;Contracts;Cosmic Radiation;Data;design;Development;Diagnostic Procedure;Diet;Discipline of Nuclear Medicine;Disease;Disease Outcome;Dose;Dose Rate;dosimetry;Employment;Endocrinology;Excess Mortality;experience;Exposure to;External Beam Radiation Therapy;Faculty;Feedback;Female;Fluorescent in Situ Hybridization;Flying body movement;Focus Groups;follow-up;Frequencies;General Population;Hematological Disease;improved;in utero;Incidence;Individual;Interview;Ionizing radiation;Joints;Length;leukemia;Literature;Lung;Malignant Bone Neoplasm;Malignant Breast Neoplasm;malignant mouth neoplasm;Malignant neoplasm of esophagus;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant neoplasm of pharynx;Malignant neoplasm of thyroid;Malignant Neoplasms;Maternal Exposure;Medical;Medicine;Melanoma;Methods;mortality;mortality risk;National Cancer Institute;Nervous System;New York;Nuclear;Occupational;Occupational Exposure;Occupational Groups;Occupations;Organ;Paper;Patients;Pattern;pilot test;Pleura;Plutonium;Population;Population Study;Procedures;Publishing;Radiation;radiation carcinogenesis;Radiation Dose Unit;radiation effect;Radiation exposure;Radiation-Induced Cancer;Radiology Specialty;reconstruction;Recording of previous events;Rectum;Reporting;Research;response;Risk;Role;Scientist;Seasons;Site;Skin;Skin Carcinoma;Solid;Source;Suicide;Survivors;telomere;Testing;Time;Trachea;Travel;trend;Ukraine;United States;Universities;Update;Vitamin D;Vitamins;Woman;Work;work-study,Studies of Populations Exposed to Occupational Sources of Radiation,10133,NA,NA,NA,NA,29,NA,NA,2093238,NA
11179849,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010135,NA,NA,1ZIACP010135-29,NCI:197828\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15666236 (contact),"CAHOON, ELIZABETH  (contact)",NA,NA,NA,Acoustic Neuroma;Adult;Adult women;Agreement;Apoptosis;Behavioral;Benign;Biological;Biological Assay;Brain Neoplasms;cancer diagnosis;Cancer Etiology;Cancer Patient;cancer risk;Carbon Tetrachloride;carcinogenicity;Case/Control Studies;Cell Cycle Regulation;Cellular Phone;Colon;Congresses;cytokine;Data;Diagnostic;diaries;Division of Cancer Epidemiology and Genetics;DNA Damage;DNA Repair;DNA Repair Gene;dosimetry;Electromagnetic Energy;Electromagnetic Fields;Environment;Epidemiology;epidemiology study;Etiology;Exposure to;farmer;Female;follow-up;Future;Genes;Genetic;genetic analysis;Genetic Polymorphism;genome wide association study;Glioma;Hour;improved;Incidence;International Agency for Research on Cancer;Ionizing radiation;Lead;Lung;magnetic field;Malignant - descriptor;Malignant neoplasm of brain;Malignant neoplasm of lung;Malignant Neoplasms;Measures;meningioma;Mutation;Neomycin;Nonionizing Radiation;Occupational;Occupational Exposure;Ovary;Oxidative Stress;Pathway interactions;Pesticides;Phenotype;Pilot Projects;Population;Predictive Value;Prostate;Questionnaires;Radiation;Radiation exposure;Radiation-Induced Cancer;radio frequency;Radiology Specialty;Reporting;Reproducibility;Research Personnel;response;Risk;Sampling;screening;Skin;Skin Cancer;solar ultraviolet radiation;Solvents;Source;Specimen;Testing;Time;Time Study;Time trend;trend;Ultraviolet Rays;UV Radiation Exposure;volunteer,Studies of Non-Ionizing Radiation-Related Cancer,10135,NA,NA,NA,NA,29,NA,NA,197828,NA
11179850,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010136,NA,NA,1ZIACP010136-29,NCI:1277617\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,6569799 (contact),"SILVERMAN, DEBRA  (contact)",NA,NA,NA,Acetaminophen;adipokines;adiponectin;Adolescence;Adult;African American population;Age;Age Years;Alcohol consumption;Animals;Benzo(a)pyrene;Black Populations;Body mass index;Breast;Breast Cancer Risk Factor;cancer diagnosis;cancer risk;Case/Control Studies;Categories;Chinese;Chromosomes;Chronic Kidney Failure;Cigarette;Cigarette Smoker;cigarette smoking;Clear Cell;Clinical;cohort;Cohort Studies;Colorectal Cancer;colorectal cancer risk;Consumption;Diabetes Mellitus;Diagnostic;Dietary Factors;Disease;DNA Methylation;Environmental Risk Factor;environmental tobacco smoke;Estrogens;Exercise;First Births;Folic Acid;Follow-Up Studies;Gastroesophageal reflux disease;gene environment interaction;Genetic;Genetic Determinism;Genetic Diseases;genome wide association study;Hay fever;Head Cancer;Height;high body mass index;high risk;Hip region structure;Human;Hypersensitivity;Hypertension;Hysterectomy;Individual;Intake;Isoflavones;Leisures;Life Style;Link;Malignant neoplasm of brain;Malignant neoplasm of esophagus;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;malignant stomach neoplasm;Measurement;Measures;Meat;Medical History;men;Menarche;Meta-Analysis;Molecular;Multiple Myeloma;Neck;never smoker;New England;Non-Hodgkin&apos;s Lymphoma;non-smoker;Non-Steroidal Anti-Inflammatory Agents;Obesity;Occupational;parity;Participant;Pepsinogens;Pharmaceutical Preparations;Physical activity;Plasma;Population;Population Attributable Risks;Postmenopause;Processed Meats;Progestins;Prospective Studies;Recording of previous events;Renal Carcinoma;Renal Cell Carcinoma;Reporting;Research Personnel;Risk;Risk Factors;sex;Smoker;Smoking;Smoking History;snuff;Spouses;Susceptibility Gene;Time;trait;Transportation;trend;United States National Institutes of Health;Variant;waist circumference;Waist-Hip Ratio;Woman;Women&apos;s Health;young adult,Cancer Risk in Human Populations,10136,NA,NA,NA,NA,29,NA,NA,1277617,NA
11179851,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010142,NA,NA,1ZIACP010142-26,NCI:2646601\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,14721359 (contact),"MIRABELLO, LISA  (contact)",NA,NA,NA,6p21.3;Acute;adenoma;Adolescent;Adult;Alleles;Anabolism;Biological Assay;Biological Availability;Birth Weight;brca gene;BRCA mutations;BRCA1 gene;BRCA2 Mutation;Breast Cancer Risk Factor;Breast Magnetic Resonance Imaging;cancer epidemiology;Cancer Prevention Intervention;cancer risk;cancer therapy;case finding;Case/Control Studies;cell growth regulation;chemical carcinogen;clinical decision-making;Clinical Trials Cooperative Group;cohort;Collaborations;Collection;Colorectal Adenoma;Communities;Counseling;Country;Data;Databases;Dental Schools;Descriptive Epidemiology;design;Diagnosis;Division of Cancer Epidemiology and Genetics;DNA;DNA Repair;Drug Metabolic Detoxication;Early Diagnosis;Educational workshop;Etiology;Event;experience;exposed human population;Exposure to;Extramural Activities;Foundations;Frequencies;Genes;Genetic;Genetic Polymorphism;genetic risk factor;Genetic study;genetic variant;Genetic Variation;genome wide association study;genome-wide;Genotype;Germ-Line Mutation;Goals;Growth;Haplotypes;Height;Hereditary Breast and Ovarian Cancer Syndrome;hormone metabolism;IGF1 gene;IGF1R gene;IGF2 gene;IGFBP3 gene;IGFBP5 gene;improved;Individual;Insulin-Like Growth Factor Binding Protein 3;Insulin-Like Growth Factor I;Insulin-Like Growth Factor II;International;Introns;Investigation;Ionizing radiation;Junk DNA;KRAS2 gene;Malignant - descriptor;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Manuscripts;Meta-Analysis;metabotropic glutamate receptor 4;Modeling;Morbidity - disease rate;Mutation;mutation carrier;Myelosuppression;National Surgical Adjuvant Breast and Bowel Project;Neoplasm Metastasis;NFIB gene;novel;Oncogenes;Osteosarcoma;Outcome;ovarian cancer prevention;Participant;Pathway Analysis;Pathway interactions;Patients;Peer Review;Penetrance;personalized approach;Pharmaceutical Preparations;Phenotype;Pilot Projects;Placebos;Population;predictive marker;primary bone cancer;Productivity;prospective;Protein-Serine-Threonine Kinases;Publications;Publishing;rare cancer;Research Personnel;Resistance;Resources;Risk;Risk Assessment;Risk Factors;risk selection;risk stratification;Sampling;Screening for cancer;Second Primary Cancers;SEER Program;Sequence Analysis;Series;Serine;Signal Pathway;Signaling Protein;Single Nucleotide Polymorphism;Somatomedins;Subgroup;Tamoxifen;Testing;Therapeutic;therapeutic target;thrombotic;Time;TP53 gene;Treatment Efficacy;treatment response;Update;Validation;Variant;Woman;Work,Genetic Modifiers of Cancer Risk,10142,NA,NA,NA,NA,26,NA,NA,2646601,NA
11179852,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010144,NA,NA,1ZIACP010144-26,NCI:4956360\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8849419 (contact),"SAVAGE, SHARON A. (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Adolescent;Adrenal Gland Cancer;Age;Alleles;American;Aplastic Anemia;Award;base;Behavior;Behavioral;behavioral study;bench to bedside;Bilateral;Biogenesis;Biological;bone marrow failure syndrome;Bone Marrow Transplantation;Bone Tissue;BRAF gene;BRCA mutations;BRCA2 gene;Breast Cancer Risk Factor;cancer genetics;cancer predisposition;cancer prevention;cancer risk;CBL gene;CEBPA gene;Cervix Neoplasms;Characteristics;Clinical;clinical center;Clinical Management;clinical phenotype;cohort;Collaborations;Collection;Color;Complex;Consent;Counseling;Cryptorchidism;Decision Making;Development;developmental disease;Diamond;Diamond-Blackfan anemia;DICER1 gene;Disease;Division of Cancer Epidemiology and Genetics;Dubowitz Syndrome;Dyskeratosis Congenita;Dysmyelopoietic Syndromes;early onset;Educational workshop;Enrollment;epidemiologic data;Epidemiology;Etiology;exome sequencing;Exposure to;Family;Fanconi&apos;s Anemia;Foundations;gene discovery;General Population;Genes;Genetic;Genetic Counseling;Genetic Risk;genetic risk assessment;Genetic study;genetic testing;genetic variant;genome wide association study;Genomics;Genotype;genotyping technology;Germ Lines;Germ-Line Mutation;Grant;Gynecologic Oncology Group;Hairy Cell Leukemia;Hamartoma;Hereditary Breast and Ovarian Cancer Syndrome;Hereditary Breast Carcinoma;Hereditary Disease;Hereditary Malignant Neoplasm;Hereditary Neoplastic Syndromes;high risk;high risk population;Human Genetics;Human Papillomavirus;immune function;improved;in vitro Assay;Incidence;Individual;Inherited;Inherited bone marrow failure;International;Jaffe-Campanacci syndrome;Juvenile Myelomonocytic Leukemia;Li-Fraumeni Syndrome;LIG4 gene;Magnetic Resonance Imaging;Malignant Breast Neoplasm;Malignant Childhood Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of ovary;Malignant neoplasm of testis;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Manuscripts;Maps;Medical Genetics;member;men;meningioma;MicroRNAs;Modality;Modeling;Molecular;Molecular Biology;Monitor;Moods;multidisciplinary;Mutation;mutation carrier;Myotonic Dystrophy;Neoplasms;Neurofibromatosis 1;neuropsychiatric disorder;next generation;next generation sequencing;NF1 gene;Nose;novel;Operative Surgical Procedures;Osteosarcoma;Participant;Pathogenesis;Pathogenicity;Pathway Analysis;Pathway interactions;patient advocacy group;Patients;Peer Review;Penetrance;Persons;Phenotype;phosphodiesterase 11a;Play;Pleuropulmonary Blastoma;Plexiform Neurofibroma;polygenic risk score;Predisposition;prenatal exposure;programs;prospective;Prospective cohort;psychosocial;Psychosocial Assessment and Care;Publications;Publishing;Radial;Radiation;Regimen;Registries;Reporting;Research;Research Activity;Research Personnel;Research Project Grants;Resources;Risk;Risk Reduction;Role;Sampling;screening;Screening for cancer;Severe congenital neutropenia;Shwachman-Diamond syndrome;Site;Social Network;Soft tissue sarcoma;Solid Neoplasm;Subgroup;Susceptibility Gene;Syndrome;telomere;Test Result;Testing;Thrombocytopenia;Thyroid Gland;Time;TINF2 gene;tool;TP53 gene;Training;Translational Research;tumor;tumorigenesis;United States National Institutes of Health;Variant;variant of unknown significance;Woman;Work;Writing,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,10144,NA,NA,NA,NA,26,NA,NA,4956360,NA
11179853,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010145,NA,NA,1ZIACP010145-25,NCI:170762\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8849419 (contact),"SAVAGE, SHARON A. (contact)",NA,NA,NA,Adherence;Adrenal Glands;Adult;Affect;Age;Algorithms;Anxiety;arm;Astrocytoma;Atypia;Behavioral trial;Blinded;Blood specimen;Brain;brain magnetic resonance imaging;Brain Neoplasms;brca gene;BRCA mutations;BRCA1 gene;BRCA2 gene;Breast;breast cancer diagnosis;breast imaging;Breast Magnetic Resonance Imaging;CA-125 Antigen;cancer diagnosis;Cancer Genetics Network;cancer predisposition;cancer risk;Cessation of life;Characteristics;Child;Clinical;clinical center;Cognitive;cohort;Collaborations;Computers;coping;Counseling;Data;Data Analyses;Databases;Decision Making;design;Development;Diagnosis;diagnostic criteria;digital;Distress;Duct (organ) structure;Early Diagnosis;Effectiveness;Eligibility Determination;Emotional;Enrollment;Estrogens;Etiology;Evaluation;Face;Family;Family member;follow-up;Frequencies;Friendships;Future;Genetic;Genetic Risk;Germ-Line Mutation;Glioma;Goals;Gynecologic Oncology Group;Hereditary Malignant Neoplasm;high risk population;High Risk Woman;Hormones;Image;imaging study;improved;Individual;Institution;Intervention;Intervention Studies;Intervention Trial;Interview;Lavage;Learning;leukemia;Li-Fraumeni Syndrome;Life;Life Style;Liquid substance;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Mammalian Oviducts;Mammography;Manuscripts;Measures;Medical;Mental Depression;Molecular;Mucous Membrane;Mutation;mutation carrier;Natural History;nipple aspirate fluid;novel;Oncogenes;Operative Surgical Procedures;ovarian cancer prevention;Participant;participant enrollment;Pathogenesis;Pathology;Patients;Performance;Persons;Pilot Projects;Population;Premenopause;Prevalence;prospective;protective effect;Protocols documentation;psychosocial;Psychosocial Assessment and Care;Publications;Publishing;Quality of life;Quantitative Evaluations;Questionnaires;Regimen;Reproducibility;Research Personnel;research study;response;Risk;Risk Management;risk perception;Risk Reduction;Salpingo-Oophorectomy;Schedule;screening;Screening for cancer;Screening for Ovarian Cancer;screening program;Series;Serum;Shapes;Signal Transduction;Social Change;Social support;Source;Special needs;Standardization;Stress;surgical risk;Syndrome;Test Result;Texture;Time;Tissues;TP53 gene;Tumor Debulking;United States National Institutes of Health;uptake;Well in self;Woman;Women&apos;s study;Work,Intervention Trials in Persons at Increased Genetic Risk of Cancer,10145,NA,NA,NA,NA,25,NA,NA,170762,NA
11179854,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010150,NA,NA,1ZIACP010150-25,NCI:2070679\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,7030470 (contact),"ENGELS, ERIC A (contact)",NA,NA,NA,Address;Autoimmunity;cancer risk;cancer transplantation;chronic infection;data registry;Development;Division of Cancer Epidemiology and Genetics;Elderly;HIV;HIV/AIDS;Hodgkin Disease;Human Papillomavirus;Immune;Immunity;Immunologic Epidemiology;immunosuppressed;Immunosuppression;Infection;Inflammation;interest;Kaposi Sarcoma;Link;Malignant neoplasm of anus;Malignant neoplasm of cervix uteri;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant Neoplasms;Medicare;Melanoma;Multiple Myeloma;National Cancer Institute;neoplasm registry;Non-Hodgkin&apos;s Lymphoma;Organ Transplantation;Persons;Population;Population-Based Registry;Renal Carcinoma;Risk;Risk Factors;Role;Skin Carcinoma;Tissues;Transplant Recipients,"Infections, immunity, and inflammation in cancer",10150,NA,NA,NA,NA,25,NA,NA,2070679,NA
11179855,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010152,NA,NA,1ZIACP010152-25,NCI:1182573\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,79341433 (contact),"MOORE, STEVEN  (contact)",NA,NA,NA,"2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine;8q24;Address;adenoma;Age;alpha Tocopherol;arm;Aromatic Amines;biobank;Biochemical;Biocompatible Materials;Biological Assay;Bladder;Blood specimen;Breast;Breast Cancer Risk Factor;Bronchi;calcium intake;Calcium-Sensing Receptors;Cancer Etiology;cancer genetics;Candidate Disease Gene;Categories;Cells;clinical center;cohort;Collaborations;Collection;Colon Carcinoma;Colonic Adenoma;Colorectal;Colorectal Adenoma;Contracts;cooking;Cooking Practices;cruciferous vegetable;Cytogenetics;Data;Databases;Demographic Factors;Development;dietary;Dietary Fiber;Disease;Disease Marker;Division of Cancer Epidemiology and Genetics;Division of Cancer Prevention;DNA Repair;Early Diagnosis;Equipment and supply inventories;Etiology;follow-up;Food;Frequencies;Gene Modified;genetic analysis;Genetic Markers;Genetic Polymorphism;Genetic study;genetic variant;genome wide association study;High temperature of physical object;HIV;Immune system;Incidence;Individual;Insulin-Like Growth Factor I;Intake;Investigation;Kidney;Lung;lycopene;Lymphoma;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant Neoplasms;Meat;Medical;meetings;member;Metabolism;Molecular Epidemiology;mortality;Nutritional;Pancreas;Participant;Pathologic;Pathway interactions;Pleura;Predisposition;Prostate;prostate cancer risk;Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;Questionnaires;randomized trial;recruit;Reporting;Research;Research Activity;Research Personnel;research study;Resources;Risk;Risk Factors;Sampling;Scientist;screening;Screening for cancer;Selenium;Serum;SHBG gene;Smoker;Somatomedins;Special Population;steroid hormone;Tissue Microarray;Tobacco smoke;Tobacco use;Trachea;United States;Validation;Vegetables;Vitamin E;volunteer",PLCO Trial Etiologic and Early Marker Study,10152,NA,NA,NA,NA,25,NA,NA,1182573,NA
11179856,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010158,NA,NA,1ZIACP010158-24,NCI:1307370\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11144751 (contact),"MCGLYNN, KATHERINE  (contact)",NA,NA,NA,Affect;Africa South of the Sahara;Alcohol consumption;Alcoholic Hepatitis;Anti-diabetic Drugs;Area;Asia;attributable risk;Cancer Etiology;Centers for Disease Control and Prevention (U.S.);Developed Countries;Diabetes Mellitus;Etiology;Europe;follow-up;Heavy Drinking;Hepatitis C;Hepatitis C co-infection;Hepatitis C virus;Histologic;HIV;HIV/HCV;Incidence;Infection;insight;interest;Intrahepatic Cholangiocarcinoma;Investigation;Malignant neoplasm of liver;Malignant Neoplasms;mortality;Non-Steroidal Anti-Inflammatory Agents;Obesity;Persons;Pharmaceutical Preparations;Primary carcinoma of the liver cells;Primary Malignant Neoplasm of Liver;rare cancer;Research;research study;Risk;Risk Factors;United States;Viral,Studies of Rare Cancers,10158,NA,NA,NA,NA,24,NA,NA,1307370,NA
11179857,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010167,NA,NA,1ZIACP010167-24,NCI:1297285\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,79341436 (contact),"KRAFT, PETER  (contact)",NA,NA,NA,Area;Breast;case control;Case/Control Studies;Categories;Characteristics;Clinical;cohort;Collaborations;Colon;Development;disorder risk;Environmental Risk Factor;epidemiology study;experience;Exposure to;Follow-Up Studies;Genetic;genetic risk factor;genome wide association study;Health;Hormonal;Hospitals;hyperimmunization;Immune system;Immune System Diseases;Immunization;Immunize;Immunologic Stimulation;Individual;Infectious Agent;Laboratories;Life Style;Long-Term Effects;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Maryland;Medical Staff;mortality;National Cancer Institute;Occupations;Osteosarcoma;pathogen;Persons;Positioning Attribute;Recording of previous events;Rectal Diseases;reproductive;Risk Assessment,General Studies of Epidemiology,10167,NA,NA,NA,NA,24,NA,NA,1297285,NA
11179858,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010168,NA,NA,1ZIACP010168-24,NCI:565112\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187078 (contact),"GIERACH, GRETCHEN  (contact)",NA,NA,NA,Adult Children;AFP gene;Androstenedione;Animal Model;Behavioral;Biological Assay;Birth;Birth Weight;Blood specimen;Body of uterus;Boston;Breast Cancer Risk Factor;cancer risk;Categories;China;cohort;Cohort Studies;Collaborations;Collection;Contractor;Data;Daughter;dehydroepiandrosterone;Dehydroepiandrosterone Sulfate;Diethylstilbestrol;Disease;early life exposure;Electronics;Estradiol;Estriol;Estrogens;Estrone;Europe;Exposure to;Female;follow-up;Functional disorder;Gestational Age;Health Sciences;high risk;Hormones;Immune system;in utero;Insulin-Like Growth Factor Binding Protein 3;Label;Laboratories;Link;Louisiana;male;Malignant Neoplasms;Maternal Age;Medical center;Medical Records;medical schools;member;Mothers;National Institute of Child Health and Human Development;neoplasm registry;offspring;Pathology Report;Perinatal;Pharmaceutical Preparations;Phase;Placenta;Pre-Eclampsia;Pregnancy;Pregnant Women;Premature Birth;prenatal exposure;Preneoplastic Conditions;Prevention;Progesterone;Prolactin;prostate cancer risk;Questionnaires;Reporting;reproductive;Son;Spontaneous abortion;Standardization;Testosterone;Twin Multiple Birth;Umbilical Cord Blood;Umbilical cord structure;Universities;Uterine Diseases;vaginal clear cell adenocarcinoma;Work,Early Life Exposures and Subsequent Cancer Risk,10168,NA,NA,NA,NA,24,NA,NA,565112,NA
11179859,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010169,NA,NA,1ZIACP010169-23,NCI:158624\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187078 (contact),"GIERACH, GRETCHEN  (contact)",NA,NA,NA,Adolescent;Adult;alpha-carotene;Androgens;Asia;Asian;Asian Americans;Asian population;beta-cryptoxanthin;Biochemical Pathway;Biological;Biological Assay;Biological Markers;Blood;Body of uterus;Breast Cancer Cell;Breast Cancer Risk Factor;Breast Carcinogenesis;Cancer Etiology;cancer risk;Carbon;Carotenoids;case control;Case/Control Studies;Categories;Childhood;cohort;Cohort Studies;Collaborations;Colorectal Adenoma;Colorectal Cancer;Communities;Darkness;Data;design;Diagnosis;Diagnostic;Diet;diet and cancer;dietary;Dietary Practices;Disease;DNA biosynthesis;Environmental Exposure;Enzymes;Epidemiology;epidemiology study;Erythrocytes;Estrogen Metabolism;Estrogens;Etiology;Family;Folic Acid;folic acid metabolism;follow-up;Follow-Up Studies;Food;Fruit;fruits and vegetables;Gene Modified;Genes;Genetic;Genetic Markers;Genetic Polymorphism;genetic variant;Genotype;Goals;Hawaiian;Health;Height;Homocysteine;Hormonal;Hormones;Human;Hydroxyestrones;Incidence;Individual;Indolent;Insulin-Like Growth Factor Binding Protein 3;Insulin-Like Growth Factor I;Intake;International;Interview;Japanese;Life Style;liquid chromatography mass spectroscopy;lung cancer prevention;lycopene;Malignant Breast Neoplasm;Malignant neoplasm of cervix uteri;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant Neoplasms;Manuscripts;Measurement;Measures;men;Metabolic;Metabolism;Methionine;methyl group;Methylation;Methylenetetrahydrofolate reductase (NADPH);Micronutrients;Migrant;migration;Mothers;multidisciplinary;Mutation;NCI Center for Cancer Research;Nested Case-Control Study;nutrition;Nutritional;Obesity;Papillomavirus;Participant;Pathway interactions;Pattern;Physiological;Phytoestrogens;Plasma;Play;Population;population based;Postmenopause;pre-clinical;Premenopause;Principal Component Analysis;Procedures;prospective;prostate cancer cell;prostate cancer risk;protective effect;Proteomics;Publishing;Recording of previous events;Relative Risks;repaired;Reproducibility;Riboflavin;Risk;Risk Factors;Role;Sampling;screening;Series;Serum;Sexually Transmitted Diseases;Smoking;Societies;Somatomedins;soy;Specificity;Testing;Tissues;Urine;Variant;Vegetables;Vitamin B6;Weight Gain;Woman,"Nutrition, Metabolism, and Cancer",10169,NA,NA,NA,NA,23,NA,NA,158624,NA
11179860,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010170,NA,NA,1ZIACP010170-24,NCI:74654\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11142453 (contact),"MORTON, LINDSAY  (contact)",NA,NA,NA,Autoimmune Diseases;Behavior;Behavioral;Case/Control Studies;Collaborations;Data;Data Pooling;Environment;Environmental Risk Factor;Epidemiology;Etiology;gene interaction;General Population;Genetic;Genetic Polymorphism;Genetic study;genome wide association study;Graft Rejection;Hematopoietic Neoplasms;Hepatitis C;high risk;HIV;HIV Seropositivity;HIV/AIDS;Iatrogenesis;Immune;immune function;immunosuppressed;Immunosuppression;improved;Individual;International;Journals;lifestyle factors;Lymphoma;Lymphomagenesis;Malignant Neoplasms;Medical;Medical History;Methods;multidisciplinary;Non-Hodgkin&apos;s Lymphoma;Organ Transplantation;Pathology;Pattern;Peer Review;Predisposition;prevent;Prognosis;Publishing;Reporting;Research;Risk;Solid;Source;Transplantation;Virus Diseases;Work,Multidisciplinary Studies of Hematopoietic Malignancies,10170,NA,NA,NA,NA,24,NA,NA,74654,NA
11179861,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010176,NA,NA,1ZIACP010176-24,NCI:1887863\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10693148 (contact),"MBULAITEYE, SAM M (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;African Burkitt&apos;s lymphoma;age group;age related decline;aged;Anogenital cancer;Antibodies;Antigens;Bar Codes;Biological;Biological Markers;Black Populations;Breast;Burkitt Lymphoma;Cancer Etiology;cancer risk;cancer therapy;cancer transplantation;Case/Control Studies;Categories;Cell Cycle Progression;Child;Clinical;Code;cohort;Collaborations;comparative;Comparative Study;Confidence Intervals;Data;Data Analyses;data registry;detection method;Development;Diagnosis;Disease;disorder risk;Enrollment;Epidemiology;Etiology;experience;Extramural Activities;Falciparum Malaria;Fostering;General Population;Genetic Predisposition to Disease;Genetic Variation;Ghana;Goals;Head and Neck Cancer;Helicobacter pylori;Hepatitis B Virus;Hepatitis C virus;high risk;Hispanic Populations;HIV;HIV diagnosis;HIV Seronegativity;HIV Seropositivity;HIV/AIDS;Hodgkin Disease;Human;Human Herpesvirus 4;Human Herpesvirus 8;Human Papillomavirus;Immune response;Immunity;Immunologics;Incidence;Individual;Infection;Infectious Agent;Injecting drug user;Kaposi Sarcoma;Laboratories;Link;Liver;Lymphoma;Malaria;malaria infection;Malawi;Malignant Breast Neoplasm;Malignant neoplasm of anus;Malignant neoplasm of cervix uteri;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant neoplasm of penis;Malignant neoplasm of testis;Malignant Neoplasms;malignant stomach neoplasm;Measures;men who have sex with men;metropolitan;Modeling;Molecular;mortality;multidisciplinary;Mutation;Natural History;Neck Cancer;neoplasm registry;Non-Burkitt&apos;s Lymphoma;Non-Hodgkin&apos;s Lymphoma;novel;Oncornaviruses;Organ Transplant Research;pathogen;Pathogenesis;Pathway interactions;Patients;peripheral blood;Persons;Plasmodium falciparum;Population;Population Attributable Risks;population based;Privatization;prospective;Proteins;rational design;Residual state;Risk;Role;Saliva;SEER Program;seropositive;Specimen;Stomach;T cell factor 3;TCF3 gene;Testing;Time;Tissue Banks;Tissue Microarray;Tissues;Transplant Recipients;tumor;Tumor Tissue;United States;viral transmission;Virus;virus related cancer,Epidemiology and Natural History of Cancer-Associated Viruses,10176,NA,NA,NA,NA,24,NA,NA,1887863,NA
11179862,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010180,NA,NA,1ZIACP010180-23,NCI:169262\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414784 (contact),"ALBANES, DEMETRIUS  (contact)",NA,NA,NA,"8q24;Africa;African;Age;Androgen Metabolism;androgenic;Androgens;Biochemical;Biological;Biological Assay;Biological Markers;Blood;Burkitt Lymphoma;cancer risk;cancer type;candidate identification;Case Series;Central obesity;China;Cities;Classification;Clinical;clinical practice;clinically relevant;cohort;Collection;Colorectal;Consent;Data;Databases;design;Diagnosis;dietary;Dietary Factors;Dietary Practices;Epidemiology;Ethnic Population;Fasting;follow-up;Freezing;Fresh Tissue;Gene Expression;Genes;Genetic;Genetic Markers;genetic risk factor;genetic variant;genome wide association study;Genotype;Ghana;Health;Hormonal;Hormonal Carcinogenesis;Hormones;Human;Human Genetics;indexing;insight;Insulin;Insulin-Like Growth Factor I;Interview;Isoflavones;Life Style;Link;Low-Density Lipoproteins;Lung;Malaria;Malignant neoplasm of prostate;Manuscripts;Maps;Medicare;men;Meta-Analysis;metabolic profile;Methodological Studies;Molecular;Molecular Genetics;mortality;multi-racial;multidisciplinary;Nature;Nested Case-Control Study;Non-Steroidal Anti-Inflammatory Agents;novel;Nutritional;Obesity;Outcome;Ovarian;Pathway interactions;Pharmaceutical Preparations;Population;population based;population survey;Predisposition;Prevalence;Prostate;prostate cancer risk;prostate carcinogenesis;Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;Prostatic Diseases;Publishing;Questionnaires;racial difference;racial population;recruit;Recurrence;Research;resistance gene;Resources;Risk;Risk Assessment;Risk Factors;Risk Marker;Role;Sampling;Series;Serum;soy;Stage at Diagnosis;Stains;Study Subject;Surveys;Techniques;Testosterone;Time;Tissue Banks;Tissue Microarray;Tissue Sample;Tissues;TMPRSS2 gene;tumor;Tumor Markers;Variant;western diet",Prostate Cancer Studies,10180,NA,NA,NA,NA,23,NA,NA,169262,NA
11179863,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010181,NA,NA,1ZIACP010181-22,NCI:489013\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187126 (contact),"ALBERT, PAUL  (contact)",NA,NA,NA,Address;Area;beta diversity;Biological Markers;Biometry;Blood;Breast;Breast Cancer Detection;Breast Cancer Education;Bronchi;Calibration;Cancer Detection;Categories;Cervical Cancer Screening;Colon;Colorectal Cancer;Complex;Computer software;Data;Data Analyses;design;detection limit;Differential Equation;dimension reduction;Disease;disorder risk;Division of Cancer Epidemiology and Genetics;Dose;electronic health data;Electronic Health Record;Environmental Risk Factor;Epidemiologic Methods;epidemiology study;Equilibrium;Family;Genes;Genetic;Genetic Markers;genetic variant;Genomics;Genotype;Household;improved;Individual;International;Left;Lung;Malignant Breast Neoplasm;Malignant neoplasm of lung;Measurement;member;method development;Methods;microbiome;Mission;Modeling;National Health and Nutrition Examination Survey;novel;novel strategies;Observational epidemiology;Outcome;Pathway Analysis;Pleura;population based;Procedures;protective effect;Rectum;Research;response;Risk;Risk Estimate;Sampling;screening guidelines;Seasons;semiparametric;statistics;Surveys;Testing;The Cancer Genome Atlas;Trachea;trait;Vitamin D,Methods for Epidemiology Studies,10181,NA,NA,NA,NA,22,NA,NA,489013,NA
11179864,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010182,NA,NA,1ZIACP010182-22,NCI:618420\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8770483 (contact),"GAIL, MITCHELL H (contact)",NA,NA,NA,Affect;Amoxicillin;Antibiotic Therapy;Biometry;Breast;Breast Cancer Detection;Cancer Control;Case/Control Studies;China;cohort;Cohort Studies;Collaborations;Collection;Consult;Control Groups;Data;Data Collection;Development;digital;Division of Cancer Epidemiology and Genetics;Egypt;Endometrial Carcinoma;Enrollment;Epidemiology;Exclusion;Female;field study;First Degree Relative;follow-up;Follow-Up Studies;Garlic;gastric cancer prevention;gastric carcinogenesis;Helicobacter pylori;Histopathology;Hospitals;Incidence;inflammatory breast cancer;Inpatients;Intervention Trial;Lead;Lesion;Malignant Breast Neoplasm;Malignant neoplasm of nasopharynx;Malignant neoplasm of ovary;Malignant Neoplasms;malignant stomach neoplasm;Measurement;member;Morocco;mortality;National Cancer Institute;Nebraska;Northern Africa;Omeprazole;Paper;Paraffin Embedding;Participant;Population;premalignant;prevent;Procedures;Province;Publishing;Questionnaires;Random Allocation;Randomized;Rural;Saliva;Selenium;Stomach;Subgroup;Supplementation;Time;Translations;Tumor Tissue;Tunisia;Universities;Vitamins;Women&apos;s study;Work,Epidemiologic Field Studies,10182,NA,NA,NA,NA,22,NA,NA,618420,NA
11179865,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010183,NA,NA,1ZIACP010183-22,NCI:578176\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,78858445 (contact),"SHIELS, MEREDITH  (contact)",NA,NA,NA,"Actinic keratosis;Adjuvant;advanced breast cancer;Age;age related;Anatomy;Area;Asian population;Autoimmune Diseases;Breast Cancer Prevention;Breast Cancer Risk Factor;breast cancer survival;cancer diagnosis;Cancer Etiology;cancer invasiveness;Cancer Patient;cancer subtypes;Cancer Surveillance Research;cancer type;Carcinoma in Situ;Cause of Death;Censuses;Cerebrovascular Disorders;Cessation of life;Characteristics;chemotherapy;Clinical;clinically relevant;cohort;Country;Data;Databases;Death Rate;Development;Diabetes Mellitus;Diagnosis;Disease;Dyslipidemias;Epidemiology;Estrogen receptor negative;Estrogen receptor positive;Estrogen Receptor Status;Ethnic Origin;Etiology;Excision;Female Breast Carcinoma;Future;Genetic;Geography;hazard;Head and Neck Cancer;Head and Neck Neoplasms;Health;Health Surveys;Hemolytic Anemia;Hepatitis C virus;high risk;Histologic;Histology;HIV;hormone receptor-negative;hormone receptor-positive;improved;In Situ;Incidence;Individual;inflammatory breast cancer;large cell Diffuse non-Hodgkin&apos;s lymphoma;Malaysia;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant Neoplasms;malignant oropharynx neoplasm;malignant tonsil neoplasm;Medical;Medicare;Metabolic syndrome;Methods;military health system;Modeling;Molecular;mortality;National Cancer Institute;National Health Interview Survey;National Surgical Adjuvant Breast and Bowel Project;neoplasm registry;Non-Hodgkin&apos;s Lymphoma;Non-Small-Cell Lung Carcinoma;Not Hispanic or Latino;novel;Obesity;Odds Ratio;Operative Surgical Procedures;oral HPV;Organ Transplantation;Oropharyngeal;Palatine Tonsil;Patients;Peripheral Vascular Diseases;Population;population based;Population Projection;predictive modeling;Prognosis;Prospective, cohort study;PSA screening;Public Health;Publishing;Race;Resources;Risk;Risk Factors;risk stratification;Role;Sampling;SEER Program;sex;Single Nucleotide Polymorphism;Skin;Skin Carcinoma;SNP genotyping;Solid;Stratification;Subgroup;surveillance data;survival prediction;Sweden;Systemic Therapy;Therapy trial;Time;Tobacco use;Tonsillectomy;Translating;treatment effect;trend;tumor;Tumor stage;United States;Validation;Variant;Viral;Woman",Descriptive Studies and Record Linkage,10183,NA,NA,NA,NA,22,NA,NA,578176,NA
11179866,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010187,NA,NA,1ZIACP010187-20,NCI:470422\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9712952 (contact),"CHANOCK, STEPHEN J. (contact)",NA,NA,NA,Acceleration;Brain Neoplasms;breast cancer progression;cancer genetics;cancer risk;cancer therapy;Carcinogenesis Mechanism;Cessation of life;Colorectal Cancer;Early Diagnosis;Endometrial Carcinoma;gene environment interaction;Genes;Genetic Markers;Genetic Research;Genome Scan;Genomics;Goals;Human Genetics;human genome sequencing;Inherited;insight;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;meetings;new technology;Non-Hodgkin&apos;s Lymphoma;novel strategies;Predisposition;Prevention;Renal Carcinoma;Research Personnel;Single Nucleotide Polymorphism;Susceptibility Gene;Technology;tool;Variant;Work,Cancer Genetic Markers of Susceptibility,10187,NA,NA,NA,NA,20,NA,NA,470422,NA
11179867,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010188,NA,NA,1ZIACP010188-20,NCI:291760\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8770483 (contact),"GAIL, MITCHELL H (contact)",NA,NA,NA,Breast Cancer Risk Assessment Tool;Breast Cancer Risk Factor;Calibration;California;cancer prevention;case control;Cause of Death;Cessation of life;Clinical Research;cohort;Cox Models;Data;data registry;Development;Disease;disorder risk;Electronic Health Record;Evaluation;Family Study;Genotype;Goals;Human Papillomavirus;improved;Incidence;interest;Latina;Left;Literature;Logistics;lung cancer screening;Lung CAT Scan;Malignant Breast Neoplasm;Malignant neoplasm of lung;method development;Methods;Modeling;National Cancer Institute;New Mexico;Pap smear;personalized predictions;population based;Publishing;Registries;Relative Risks;Risk;Risk Estimate;Risk Factors;risk prediction;risk stratification;screening;Single Nucleotide Polymorphism;Smoker;Statistical Methods;Statistical Models;Testing;Validation;Woman,Risk prediction methods,10188,NA,NA,NA,NA,20,NA,NA,291760,NA
11179868,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010190,NA,NA,1ZIACP010190-19,NCI:620698\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8849419 (contact),"SAVAGE, SHARON A. (contact)",NA,NA,NA,Aplastic Anemia;Area;autosome;Biological Specimen Banks;Biology;Blood;bone marrow failure syndrome;Cancer Etiology;cancer predisposition;cancer risk;cancer site;cancer therapy;case control;Case/Control Studies;Cells;Chromosome abnormality;Clinical;clinical phenotype;cohort;Cohort Studies;Collaborations;Complex;Data;Defect;design;Diagnostic;Disease;disorder risk;DNA;Dyskeratosis Congenita;Enrollment;Epidemiology;Epigenetic Process;Etiology;Evaluation;exome sequencing;Family;Family member;Fanconi&apos;s Anemia;Fibroblasts;Gene Expression Regulation;Genes;Genetic;Genetic Determinism;genetic epidemiology;genetic pedigree;Genetic Population Study;genetic variant;genome wide association study;Germ Lines;Germ-Line Mutation;Goals;Head and Neck Cancer;Heterogeneity;Human;human disease;Individual;Inherited bone marrow failure;insight;Length;Leukocytes;Link;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant Neoplasms;Malignant Squamous Cell Neoplasm;malignant stomach neoplasm;Marrow;Measures;medical complication;Meta-Analysis;Methodological Studies;Molecular;Mutation;Nail plate;novel;Oral Leukoplakia;Outcome;Participant;Pathogenesis;Patients;Pattern;peripheral blood;Pigmentation physiologic function;Pilot Projects;Play;Population Genetics;Prior Therapy;programs;Prospective Studies;Proteins;Recording of previous events;Resources;Retrospective Studies;Risk;Risk Factors;Role;sample collection;Site;Stem cell transplant;Syndrome;Telomerase;telomere;Telomere Maintenance;TINF2 gene;Tissues;Universities;Variant;Work,Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,10190,NA,NA,NA,NA,19,NA,NA,620698,NA
11179869,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010193,NA,NA,1ZIACP010193-18,NCI:791000\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414780 (contact),"STOLZENBERG-SOLOMON, RACHAEL  (contact)",NA,NA,NA,Acceleration;access restrictions;biomarker identification;Biomedical Research;cancer risk;Case/Control Studies;cohort;Cohort Studies;Communities;Data;Epidemiology;European;Funding;Genetic Markers;Genetic Risk;genetic variant;Genome;Genome Scan;genome wide association study;genome-wide;Genotype;Individual;Malignant neoplasm of pancreas;National Cancer Institute;novel;Pancreatic Adenocarcinoma;Policies;Predisposition;prospective;Prospective cohort;Quality Control;Research Personnel;Risk;risk variant;Scientist;Susceptibility Gene;United States National Institutes of Health;web site,Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),10193,NA,NA,NA,NA,18,NA,NA,791000,NA
11179870,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010195,NA,NA,1ZIACP010195-18,NCI:705569\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414784 (contact),"ALBANES, DEMETRIUS  (contact)",NA,NA,NA,"Age;All-Trans-Retinol;alpha Tocopherol;Antioxidants;Area;attributable risk;Beta Carotene;Biochemical;Biological;Biological Markers;Bladder;Bronchi;cancer epidemiology;Cancer Etiology;Cancer Intervention;cancer prevention;capsule;Carbon;Carotenoids;case control;Categories;Caucasians;Cessation of life;Chest;Cigarette;cohort;Cohort Analysis;Collaborations;Colon;Colorectal;Colorectal Cancer;Data;design;Diagnosis;Diet;diet and cancer;dietary;Dietary Questionnaires;Dimensions;Disease;effectiveness testing;energy balance;epidemiology study;Erythrocytes;Evaluation;Extramural Activities;Film;Finland;Folic Acid;follow-up;Follow-Up Studies;Food;Freezing;Genetic;genetic analysis;Genetic Polymorphism;genetic variant;Genome Scan;genome wide association study;Genotype;Glioma;Goals;Gonadal Steroid Hormones;group intervention;Growth Factor;Habits;Head and neck structure;Health;High Density Lipoprotein Cholesterol;Human;Human Resources;Insulin;interest;International;Intervention;intervention effect;Investigation;Lung;male;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;malignant stomach neoplasm;Measurement;Medical;Medical Records;men;Metabolic;Metabolism;metabolomics;Molecular;National Cancer Institute;neoplasm registry;Nested Case-Control Study;Nutrient;nutrition;Nutritional;Occupational;Pancreas;Participant;Pathology;Phase;Phenotype;Placebos;Pleura;population based;Population Registers;post intervention;prevent;Procedures;Productivity;Prospective Studies;Prostate;prostate cancer risk;Public Health;Randomized;Randomized, Controlled Trials;recruit;Rectum;Renal Carcinoma;Research;Research Personnel;Research Project Grants;Resources;Sampling;Selenium;Serum;side effect;Slide;Smoker;Smoking;Specialized Center;Specimen;Structure of nail of toe;Supplementation;Surveys;Testing;Thoracic Radiography;Trachea;Visit;Vitamin D;Vitamin E;Vitamin E Acetate;Vitamins;web site;Whole Blood","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study",10195,NA,NA,NA,NA,18,NA,NA,705569,NA
11179871,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010196,NA,NA,1ZIACP010196-18,NCI:387195\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414782 (contact),"SINHA, RASHMI  (contact)",NA,NA,NA,Address;aged;Area;attenuation;Body of uterus;Brain;Breast;Bronchi;California;cancer risk;Case/Control Studies;Categories;Cessation of life;cohort;Colon;Country;Databases;design;Diagnostic;Diet;diet and cancer;dietary;Dietary Assessment;Dietary intake;Disease;environment related cancer;epidemiology study;Florida;follow-up;Health;Health behavior;indexing;Life Style;Louisiana;Lung;Malignant Breast Neoplasm;Malignant Neoplasms;Measurement;member;Methodology;metropolitan;Michigan;mortality;neoplasm registry;Nervous System;New Jersey;news;Newsletter;North Carolina;nutrition;Outcome;Participant;Pennsylvania;Persons;Pleura;Prospective Studies;Questionnaires;Rectum;Relative Risks;Research;Risk Factors;risk selection;Trachea;United States Social Security Administration;Update,Prospective Studies of Diet and Cancer in the AARP Cohort,10196,NA,NA,NA,NA,18,NA,NA,387195,NA
11179872,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010197,NA,NA,1ZIACP010197-18,NCI:1963208\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414784 (contact),"ALBANES, DEMETRIUS  (contact)",NA,NA,NA,Binding Proteins;Biological;Biological Markers;Body Weight decreased;Cancer and Nutrition;cancer prevention;cancer risk;Colorectal Cancer;cytokine;energy balance;Energy Intake;Estrogens;Etiology;Goals;Growth Factor;improved;Incidence;Inflammatory;Insulin-Like Growth Factor Binding Protein 3;Insulin-Like Growth Factor I;Interleukin-6;Malignant Breast Neoplasm;Malignant neoplasm of pancreas;Malignant Neoplasms;metabolomics;multidisciplinary;novel;Obesity;Output;Phenotype;Physical activity;sedentary lifestyle;SHBG gene;steroid hormone;Testosterone;TNF gene;Weight Gain,"Physical Activity, Energy Balance, and Cancer",10197,NA,NA,NA,NA,18,NA,NA,1963208,NA
11179873,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010198,NA,NA,1ZIACP010198-18,NCI:710338\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414782 (contact),"SINHA, RASHMI  (contact)",NA,NA,NA,"Achievement;Adenomatous Polyps;Age;Assessment tool;Biochemical Markers;Blood;Blood specimen;Calories;clinical center;clinical investigation;cohort;Collection;Colon;Colonoscopy;Colorectal;Colorectal Adenoma;colorectal cancer screening;Colorectal Neoplasms;Control Groups;Data;Detection;Diet;Diet Modification;dietary;Dietary Assessment;Dietary Factors;DNA;Eating;effectiveness evaluation;Elements;Energy Intake;epidemiology study;Etiology;Fatty acid glycerol esters;Fiber;Folic Acid;Follow-Up Studies;Food;Frequencies;fruits and vegetables;Future;Genetic Polymorphism;Genetic Predisposition to Disease;Genomics;Goals;Health;High grade dysplasia;Hormones;Hospitals;Hour;Incidence;Intervention;intervention program;Investigation;Lesion;Leukocytes;Malignant neoplasm of gastrointestinal tract;Manuscripts;Meat;Medical center;Methylation;Military Personnel;Minority;Mutagens;neoplastic;Non-Steroidal Anti-Inflammatory Agents;Observational epidemiology;Participant;Polyp Prevention Trial;Preparation;Publishing;Quality of life;Questionnaires;Randomized;Randomized, Controlled Trials;Records;recruit;Recurrence;Reporting;Research Personnel;Risk;Risk Factors;Sample Size;screening;Screening procedure;Sigmoidoscopes;Sigmoidoscopy;Site;Tissue Banks;Tissue Sample;Tobacco;treatment arm;Tubular Adenoma;United States;Villous;Woman",Lower Gastrointestinal Cancer Studies,10198,NA,NA,NA,NA,18,NA,NA,710338,NA
11179874,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010199,NA,NA,1ZIACP010199-18,NCI:615391\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414782 (contact),"SINHA, RASHMI  (contact)",NA,NA,NA,Amines;Area;assessment application;Assessment tool;Benzopyrenes;Biological;Biological Markers;Body of uterus;Breast;Bronchi;Cancer and Nutrition;cancer risk;Categories;cognitive interview;cohort;cold temperature;Colon;Consumption;cooking;Data;Data Collection;Databases;Development;diet and cancer;dietary;Dietary Assessment;Dietary History;Disease;doubly-labeled water;environment related cancer;Etiology;Evaluation;Excretory function;Fishes;Food;Frequencies;Glycemic Index;Heme Iron;High temperature of physical object;Hour;improved;instrument;Intake;Internet;Interview;Iron;Lung;Malignant Breast Neoplasm;Malignant Neoplasms;Measurement;Measures;Meat;Methodological Studies;Methods;Nitrates;Nitrites;Nitrogen;Nitroso Compounds;nutrition;Participant;Physical activity;Pilot Projects;Pleura;Processed Meats;Proteins;Questionnaire Designs;Questionnaires;Rectum;Research Design;Research Methodology;Research Personnel;research study;Review Literature;Sampling;Series;Testing;Time;Trachea;urinary;usability;validation studies;web platform,Methods for Etiologic Studies of Diet and Cancer,10199,NA,NA,NA,NA,18,NA,NA,615391,NA
11179875,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010201,NA,NA,1ZIACP010201-15,NCI:5330994\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,77859978 (contact),"PROKUNINA-OLSSON, LIUDMILA  (contact)",NA,NA,NA,Adult;Bioinformatics;bioinformatics tool;Biological;Biology;Cancer Detection;Cancer Etiology;cancer genetics;cancer genomics;Cancer Patient;cancer risk;cancer survival;cancer type;Candidate Disease Gene;Carcinogenesis Mechanism;carcinogenicity;causal variant;Childhood;cohort;Collaborations;Data;Data Pooling;deep sequencing;density;design;Development;Disease;Division of Cancer Epidemiology and Genetics;DNA;Emerging Technologies;Epidemiology;epidemiology study;Family;Follow-Up Studies;gene environment interaction;Genetic;genetic analysis;genetic linkage analysis;Genetic Markers;genetic variant;Genetic Variation;Genome;genome wide association study;Genotype;Germ Lines;Goals;Health;high risk;High-Throughput Nucleotide Sequencing;Inherited;insight;interdisciplinary approach;International;international partnership;Investigation;Investments;Laboratories;Laboratory Research;Laboratory Study;large scale data;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Maps;methylation pattern;Mission;Molecular Evolution;novel;Outcome;Pathway interactions;Persons;Play;Population Genetics;Population Heterogeneity;Predisposition;programs;public database;Research;Research Personnel;Risk Factors;Role;Scanning;Sequence Analysis;Series;Signal Transduction;Single Nucleotide Polymorphism;Susceptibility Gene;Technology;trait;translational genomics;Validation;validation studies;Variant;Work,Laboratory of Translational Genomics,10201,NA,NA,NA,NA,15,NA,NA,5330994,NA
11179876,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010202,NA,NA,1ZIACP010202-16,NCI:21205\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9414780 (contact),"STOLZENBERG-SOLOMON, RACHAEL  (contact)",NA,NA,NA,Anatomy;Biochemical;Biological Markers;C-Peptide;Cancer Etiology;Cessation of life;chemotherapy;cohort;Cohort Studies;Death Rate;Diagnosis;dietary;Dietary Factors;Dietary Fats;Dietary intake;Effectiveness;Excision;Folic Acid;Glycemic Index;Incidence;Insulin Resistance;Insulin-Like Growth Factor I;Leptin;Lesion;Location;Malignant neoplasm of pancreas;Molecular;molecular marker;mortality;Nested Case-Control Study;nutrition;Operative Surgical Procedures;Pancreas;Prevention;Publishing;Radiation therapy;rare cancer;Resistance;resistance factors;screening;Screening for cancer;Somatomedins;Survival Rate;Transforming Growth Factor beta;United States;Vitamin D,"Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",10202,NA,NA,NA,NA,16,NA,NA,21205,NA
11179877,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010206,NA,NA,1ZIACP010206-15,NCI:260590\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,6569776 (contact),"SCHIFFMAN, MARK  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Address;Africa South of the Sahara;Algorithms;Artificial Intelligence;Biological Assay;California;Cancer Etiology;cancer risk;carcinogenesis;Carcinogens;Cervical;cervical cancer prevention;Cervical Cancer Screening;cervical carcinogenesis;child bearing;Clinical;clinical risk;Clonality;cohort;Coitus;Collaborations;Country;Cytology;Data;design;Division of Cancer Epidemiology and Genetics;DNA;Epigenetic Process;Etiology;Excision;experience;Genes;Genetic;Genome;Genomics;Goals;Guidelines;handheld mobile device;healing;High Prevalence;Histology;HIV;Human;Human Papillomavirus;Image;Immune response;immunosuppressed;improved;Invaded;Learning;Lesion;Link;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Methods;Methylation;microbiome;Microscopic;molecular marker;Monitor;Natural History;New Mexico;Nigeria;Online Systems;open source;Outcome;Penetrance;Population;population based;premalignant;Prevalence;prevent;Recurrence;Registries;Research;Research Project Grants;Reserve Cell;Resource-limited setting;Risk;Risk Assessment;risk prediction;risk prediction model;screening;software systems;Source;Specimen;Syndrome;Testing;Translating;Translations;transmission process;treatment strategy;Triage;United States National Library of Medicine;Vaccination;Variant;viral genomics;Virus;Visual;Visualization;Woman;women&apos;s treatment,"Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",10206,NA,NA,NA,NA,15,NA,NA,260590,NA
11179878,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010207,NA,NA,1ZIACP010207-15,NCI:440245\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,79341433 (contact),"MOORE, STEVEN  (contact)",NA,NA,NA,"aged;Benign Prostatic Hypertrophy;Biochemical;Blood;Cells;Cessation of life;clinical center;cohort;Collaborations;Colonic Polyps;Colorectal Cancer;Computers;Contracts;Data Collection;Data Set;Development;Disease;Division of Cancer Epidemiology and Genetics;Division of Cancer Prevention;effectiveness evaluation;Extramural Activities;follow-up;Genetic;indexing;Individual;Investigation;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;Medical Records;men;NCI Executive Committee;neoplasm registry;Participant;Pathologic;Population;Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;Questionnaires;Randomized;Records;Research Personnel;Risk;Risk Factors;Saliva;Sampling Studies;Scientist;screening;Screening for Prostate Cancer;Study Subject;Support Contracts;Test Result;Tissues;Update;usual care arm;volunteer;Woman",PLCO EEMS and Extended Follow Up,10207,NA,NA,NA,NA,15,NA,NA,440245,NA
11179879,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010209,NA,NA,1ZIACP010209-15,NCI:507330\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10687321 (contact),"KREIMER, AIMEE  (contact)",NA,NA,NA,Address;Agreement;Anus;Biological;Cancer Etiology;cancer recurrence;carcinogenicity;Cervical;Cervix Uteri;cohort;conjunctiva;Cutaneous;Cytology;Data;Diagnosis;efficacy evaluation;Epidemiology;Evaluation;Genotype;Goals;Head and Neck Cancer;Head and Neck Neoplasms;HIV;Human;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;Human papillomavirus 18;immunosuppressed;Individual;Infection;Infection prevention;Infectious Agent;Larynx;malignant mouth neoplasm;Malignant neoplasm of cervix uteri;Malignant Neoplasms;men;Multiple Anatomic Sites;Natural History;Oral;oral HPV infection;Oropharyngeal;penis;Population;Prevalence;Preventive vaccine;prospective;Research;Risk;Role;sample collection;Site;Skin;Specimen;Testing;tumor;vaccine efficacy;vaccine trial;Vagina;Vulva;Work,HPV and cancer at multiple anatomic sites,10209,NA,NA,NA,NA,15,NA,NA,507330,NA
11179880,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010210,NA,NA,1ZIACP010210-15,NCI:440267\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10687321 (contact),"KREIMER, AIMEE  (contact)",NA,NA,NA,Adenocarcinoma Cell;Affect;Antibodies;Case/Control Studies;Cervical;Cervical Adenocarcinoma;cervical cancer prevention;Cervix Neoplasms;cofactor;Cohort Studies;Contraceptive Usage;Development;DNA;epidemiology study;Etiology;Evaluation;Funding;GEM gene;Genes;Genetic;Genetic Polymorphism;Goals;Head and Neck Cancer;Histologic;Histology;HIV;Hormonal;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Immune;Immunity;Immunologic Factors;Individual;Infection;Knowledge;Lesion;Longitudinal Studies;Malignant neoplasm of anus;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Menstrual cycle;Molecular Epidemiology;Mucosal Immunity;Natural History;novel;Oral Contraceptives;Predisposition;premalignant;Prevention;Prevention strategy;response;Risk Factors;Role;screening;Sex Behavior;Squamous cell carcinoma;Taiwan;Testing;Vaccination;Variant;Viral;Virus Diseases;Women&apos;s study;Work,"HPV, cervical neoplasia, and vaccination",10210,NA,NA,NA,NA,15,NA,NA,440267,NA
11179881,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010211,NA,NA,1ZIACP010211-15,NCI:205789\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,7030470 (contact),"ENGELS, ERIC A (contact)",NA,NA,NA,Affect;Antibodies;Antibody Specificity;Behavioral;cancer risk;Case/Control Studies;Caucasians;Childhood;China;Chinese;Chromosome 14;cigarette smoking;Clinical;Clinical Markers;CYP2E1 gene;Development;dietary;DNA Repair;DNA Repair Gene;Dust;Environmental Risk Factor;Enzymes;Ethnic Origin;Etiology;Evaluation;Exposure to;Family;Family Study;follow-up;Formaldehyde;GEM gene;Gene Expression;Gene Expression Profile;General Population;Genes;Genetic;Geography;high risk population;Human Herpesvirus 4;Immune;Immune Evasion;improved;Individual;Infection;Intake;Integration Host Factors;Loss of Heterozygosity;Malignant neoplasm of nasopharynx;Malignant Neoplasms;Nasopharyngeal Neoplasms;neoplastic cell;Nitrites;Nitrosamine Metabolism;Nitrosamines;Normal Cell;Occupational;Occupational Exposure;Pathogenesis;Pattern;Population;Risk;Risk Factors;Serology;Taiwan;telomere;Testing;Tissues;Variant;Viral;Weaning;Wood material,Viral and Host Factors Associated with NPC,10211,NA,NA,NA,NA,15,NA,NA,205789,NA
11179882,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010212,NA,NA,1ZIACP010212-15,NCI:371635\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,6569730 (contact),"RABKIN, CHARLES  (contact)",NA,NA,NA,"Acquired Immunodeficiency Syndrome;AIDS-Related Lymphoma;antiretroviral therapy;Blood;Blood Cells;Chronic;Clonal Expansion;Cytokine Signaling;Data;Descriptive Epidemiology;Disease;Epstein-Barr Virus Infections;Etiology;General Population;Genes;Genetic Polymorphism;Genetic Variation;Helicobacter Infections;HIV Infections;Human Herpesvirus 4;Immunologic Epidemiology;Infection;infection related cancer;Inflammation;Investigation;Laboratories;Lymphocyte;Lymphoma;Malignant Neoplasms;malignant stomach neoplasm;Molecular;Morbidity - disease rate;Mucositis;Non-Hodgkin&apos;s Lymphoma;Outcome;Pathway interactions;Population Analysis;population based;Prospective cohort;Prospective, cohort study;Risk;Role;Source;tumor",Molecular mechanisms of infection-related cancer,10212,NA,NA,NA,NA,15,NA,NA,371635,NA
11179883,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010213,NA,NA,1ZIACP010213-15,NCI:1278411\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10687326 (contact),"CHATURVEDI, ANIL  (contact)",NA,NA,NA,cancer site;Cross-Sectional Studies;Etiology;Goals;Head and Neck Cancer;Human papilloma virus infection;Human Papillomavirus;Incidence;India;International;Lesion;malignant oropharynx neoplasm;molecular marker;National Health and Nutrition Examination Survey;Natural History;oral HPV infection;Population;Prevalence Study;Research Project Grants;screening;trend,Studies of Head and Neck Cancers,10213,NA,NA,NA,NA,15,NA,NA,1278411,NA
11179884,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010215,NA,NA,1ZIACP010215-15,NCI:397266\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,78381917 (contact),"VOGTMANN, EMILY  (contact)",NA,NA,NA,18 year old;Address;Adult;Antibiotic Therapy;Antibiotics;Behavioral;Biological Assay;C-reactive protein;Collection;Colon;colon microbiome;Demographic Factors;Diagnostic;Diet;Disease;Enrollment;Epidemiology;Functional Gastrointestinal Disorders;Future;gastrointestinal symptom;Heterogeneity;human disease;Human Microbiome;Individual;Individual Differences;inflammatory marker;Malignant Neoplasms;Measures;men;microbiome;microbiota;Oral;oral microbiome;Patient Self-Report;penile microbiome;penis;Questionnaires;Reproducibility;Rome;Sampling;Site;Skin;skin microbiome;Specimen;Techniques;Time;Vagina;vaginal microbiome;Woman,Human microbiome and cancer,10215,NA,NA,NA,NA,15,NA,NA,397266,NA
11179885,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010217,NA,NA,1ZIACP010217-14,NCI:3625989\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10687321 (contact),"KREIMER, AIMEE  (contact)",NA,NA,NA,"Acquired Immunodeficiency Syndrome;Age;Antibodies;Antibody Avidity;Anus;Blinded;Cervical;Cervix Neoplasms;Cervix Uteri;Clinical;Collaborations;Communities;Costa Rica;Cytology;DNA;dosage;Dose;Effectiveness;efficacy evaluation;Enrollment;Evaluation;follow-up;Frequencies;Funding;Head and Neck Cancer;high risk;HIV Infections;HIV Seropositivity;Human papilloma virus infection;Human Papilloma Virus Vaccination;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;Human papillomavirus 18;Immune response;immunogenic;immunogenicity;Immunologics;Infection;infection rate;Lesion;Malignant neoplasm of anus;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Measures;Medical;men who have sex with men;Methodology;Molecular Conformation;Natural History;Oncogenic;oral HPV-positive head and neck cancers;Participant;Phase;Phylogenetic Analysis;Population;Population Group;premalignant;prevent;Preventative vaccination;Public Health;Randomized;Randomized, Controlled Trials;Research;Resource-limited setting;Safety;screening program;self assembly;Series;Site;Structural Protein;System;United States National Institutes of Health;unvaccinated;Vaccinated;Vaccination;vaccine formulation;vaccine trial;Vaccinee;Vaccines;Viral;virtual;Virus-like particle;Woman;Women&apos;s Health;Work",HPV Vaccine Trial,10217,NA,NA,NA,NA,14,NA,NA,3625989,NA
11179886,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010218,NA,NA,1ZIACP010218-14,NCI:2767657\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11613123 (contact),"KOSHIOL, JILL  (contact)",NA,NA,NA,Aflatoxins;Bile fluid;Biliary;biliary tract;Biliary Tract Cancer;Biochemical;Biological;Cancer Patient;case control;Chile;Cholelithiasis;cohort;Collection;Complement;Diet;DNA;drinking;Epidemiology;Etiology;Evaluation;Evaluation of Cancer Risk Factors;Gallbladder;Gender;Goals;Individual;insight;Investigation;Lesion;Longitudinal Studies;Malignant neoplasm of gallbladder;Malignant Neoplasms;Medical History;Molecular;multidisciplinary;Participant;Patients;Pilot Projects;Population;population based;prospective;Prospective Studies;Questionnaires;Random Allocation;Reproductive History;Risk Factors;Sampling;Serum;Smoking;Structure;Tissue Sample;Validation;Woman,Etiology of Biliary Tract Cancer,10218,NA,NA,NA,NA,14,NA,NA,2767657,NA
11179887,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010219,NA,NA,1ZIACP010219-14,NCI:273126\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,14721304 (contact),"KITAHARA, CARI  (contact)",NA,NA,NA,Asthma;Back;Body mass index;cancer diagnosis;Cancer Patient;cancer subtypes;case control;Child;Childhood Leukemia;Chinese;Chronic Disease;cohort;community intervention;Conceptions;Country;County;Data;Data Set;Disease;effectiveness evaluation;Enrollment;Environmental Exposure;epidemiology study;Etiology;European;Evaluation;Family;feasibility testing;Folic Acid;folic acid supplementation;Gallbladder;Genetic;Hospitals;Incidence;Individual;intervention program;Interview;Life Style;Link;Malignant Childhood Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of thyroid;Malignant Neoplasms;Mission;mortality;Mothers;Neural Tube Defects;Obesity;offspring;Persons;Pilot Projects;Play;Population Programs;Prospective Studies;Province;Publications;Publishing;Radiation Tolerance;rare cancer;Research;Risk;Risk Factors;Risk Reduction;Role;Sampling;Site;Thyroid Gland;tumor;waist circumference;Work,Studies of other risk factors for radiosensitive tumors,10219,NA,NA,NA,NA,14,NA,NA,273126,NA
11179888,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010220,NA,NA,1ZIACP010220-14,NCI:32861\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,Adenocarcinoma;Algorithms;Androgens;Barrett Epithelium;Barrett Esophagus;Bile Acids and Salts;billing data;cancer epidemiology;cancer risk;Case/Control Studies;Cells;Chemicals;Clinical;clinical practice;cohort;Cohort Studies;comparative;Costs and Benefits;Data;data harmonization;Databases;Diagnosis;diagnostic biomarker;diagnostic value;Disease;disease natural history;disorder control;Endoscopy;Epithelial Cells;Epithelium;Equation;Esophageal Adenocarcinoma;Esophagitis;Esophagus;Estrogens;Etiology;Exposure to;follow-up;Gastroenterology;Gastroesophageal reflux disease;General Population;General Practices;genotoxicity;Goals;Hepatology;high risk;Hormones;Incidence;indexing;Individual;inflammatory marker;Journals;Laboratories;Lesion;Link;Malignant neoplasm of esophagus;Malignant Neoplasms;Manuscripts;Medical History;Medicare;Metabolic syndrome;Metaplasia;Modality;mortality risk;Natural History;Patients;Population;prognostic;Prognostic Marker;Publications;Publishing;Reflux;Research;Research Personnel;Resources;Risk;Risk Factors;Squamous Cell;Staging;Survival Rate;Testing;Tissues;Triage;United States,Barrett's Esophagus,10220,NA,NA,NA,NA,14,NA,NA,32861,NA
11179889,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010222,NA,NA,1ZIACP010222-14,NCI:173742\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,14721304 (contact),"KITAHARA, CARI  (contact)",NA,NA,NA,Adult;Age;Benefits and Risks;Benign;BRAF gene;Brain;Brain Neoplasms;cancer risk;Case/Control Studies;Child;Childhood;Childhood Leukemia;clinical diagnostics;cohort;Cohort Studies;computed tomography screening;Data;Databases;Dose;Epidemiology;Etiology;Exposure to;Gender;Histopathology;Hospitals;improved;in utero;Incidence;Individual;infancy;International;Intervention;Investigation;Ionizing radiation;KRAS2 gene;leukemia;Life;Lymphoma;Malignant - descriptor;Malignant Childhood Neoplasm;Malignant neoplasm of thyroid;Malignant Neoplasms;Methods;Molecular;molecular marker;NRAS gene;Organ;Papillary Carcinoma;Patients;Physicians;Population Study;Predisposition;Procedures;Publications;Publishing;Radiation;Radiation Dose Unit;radiation effect;Radiation exposure;radiation risk;Radiation-Induced Cancer;RAS genes;Research Personnel;response;Risk;Roentgen Rays;Scientist;Statistical Models;Techniques;Technology;thyroid neoplasm;Time;Tissues;tool;Tumor Tissue;United States;X-Ray Computed Tomography,Studies of Populations Exposed to Diagnostic Medical Radiation,10222,NA,NA,NA,NA,14,NA,NA,173742,NA
11179890,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010224,NA,NA,1ZIACP010224-13,NCI:648853\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,2062427 (contact),"GOLDSTEIN, ALISA  (contact)",NA,NA,NA,Area;Biological Specimen Banks;biomarker identification;Blood;Blood specimen;cancer biomarkers;cancer genetics;Cancer-Predisposing Gene;candidate marker;Case/Control Studies;Cells;County;density;Disease;DNA;esophageal cancer prevention;Etiology;exome sequencing;Family;Family Study;Fingers;gene environment interaction;Genetic;Genetic Markers;Genetic Polymorphism;Genome Scan;genome wide association study;genomic biomarker;Goals;high risk population;Hot Spot;Lesion by Morphology;Malignant neoplasm of esophagus;Malignant Neoplasms;malignant stomach neoplasm;microbiome research;Microsatellite Repeats;Molecular;Morphology;Normal Range;Population;premalignant;Risk;Role;Sampling;Specimen;stomach cardia;Testing;tumor;Venous,Esophageal cancer genetic project,10224,NA,NA,NA,NA,13,NA,NA,648853,NA
11179891,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010225,NA,NA,1ZIACP010225-13,NCI:81918\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15187057 (contact),"ABNET, CHRISTIAN  (contact)",NA,NA,NA,Barrett Esophagus;Biological Markers;Biopsy;Biopsy Specimen;Blood;Blood specimen;blood-based biomarker;Clinic;comparison group;Data;Data Analyses;Disease;DNA Sequence Alteration;Dysplasia;Early Diagnosis;Endoscopes;Endoscopy;Esophagus;follow-up;Gastroesophageal reflux disease;Genetic Polymorphism;Genetic Transcription;genotyped patients;Germ Lines;Goals;Hormones;Laboratories;Medical center;patient registry;Patient Selection;Patients;Pattern;Periodicals;Pharmaceutical Preparations;Pilot Projects;Proteomics;Questionnaires;Registries;Risk Factors;Sampling;screening;Serum;stomach cardia;Study of serum;Testing;Time;tissue biomarkers;Tissue Sample;Tissues,Barrett's esophagus early detection project,10225,NA,NA,NA,NA,13,NA,NA,81918,NA
11179892,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010227,NA,NA,1ZIACP010227-10,NCI:630374\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9712952 (contact),"CHANOCK, STEPHEN J. (contact)",NA,NA,NA,Affect;Age;Bioinformatics;Biological;Biology;cancer genomics;cancer heterogeneity;cancer risk;cancer subtypes;Cell Line;Chromosome Fragility;Clinical Research;cohort;Collaborations;Consult;Data;Data Pooling;Data Set;deep sequencing;design;Disease;Disease susceptibility;Division of Cancer Epidemiology and Genetics;Elements;Epidemiologist;Epidemiology;epidemiology study;Epigenetic Process;Etiology;Event;Family;follow-up;gene environment interaction;Gene Mutation;Genes;Genetic;genetic analysis;genetic architecture;genetic epidemiology;Genetic Polymorphism;Genetic Predisposition to Disease;Genetic study;genetic variant;Genome;genome wide association study;genome-wide;Genomics;Genotype-Tissue Expression Project;Germ Lines;Haplotypes;Health;high risk;Human;Human Genome;Individual;Inherited;insight;interdisciplinary approach;Interdisciplinary Study;International;Investigation;Laboratories;Laboratory Research;large scale data;Maintenance;Malignant Neoplasms;Methodological Studies;methylation pattern;MicroRNAs;Modeling;Molecular;Molecular Epidemiology;Molecular Evolution;mosaic;Mosaicism;Mutation;Normal tissue morphology;novel;Outcome;Pathway interactions;Phenotype;Population Genetics;Population Study;Populations at Risk;Predictive Value;Predisposition;public database;Regulatory Element;Research;Research Personnel;Resources;Risk;Risk Factors;Scientist;Series;Signal Transduction;Single Nucleotide Polymorphism;Site;Somatic Mutation;Susceptibility Gene;The Cancer Genome Atlas;Therapeutic Intervention;Time;Transcript;tumor;Tumor Tissue;Uniparental Disomy;validation studies;Variant,Laboratory of Genetic Susceptibility,10227,NA,NA,NA,NA,10,NA,NA,630374,NA
11179893,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010228,NA,NA,1ZIACP010228-09,NCI:1993949\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,14721359 (contact),"MIRABELLO, LISA  (contact)",NA,NA,NA,Anti-viral Agents;Base Pairing;Behavior;Biochemical;Biological;cancer risk;carcinogenesis;carcinogenicity;Carcinogens;Case/Control Studies;Cervical;cervical carcinogenesis;Cervical Intraepithelial Neoplasia;Cohort Studies;Disease;Division of Cancer Epidemiology and Genetics;Genetic;Genetic Variation;Genome;genome sequencing;Genomics;Genotype;HIV;Human;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;Infection;Invaded;Learning;Link;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Natural History;next generation sequencing;Nucleotides;Pathogenesis;premalignant;progression risk;Risk;Satellite Viruses;Technology;translational goal;Variant;Viral;virtual;virus genetics;whole genome,Human Papillomavirus (HPV) Genomics Project,10228,NA,NA,NA,NA,9,NA,NA,1993949,NA
11179894,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010229,NA,NA,1ZIACP010229-07,NCI:244499\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11142431 (contact),"WENTZENSEN, NICOLAS  (contact)",NA,NA,NA,Artificial Intelligence;assay development;Biological Markers;cancer prevention;cancer risk;carcinogenesis;Clinical;clinical epidemiology;Early Diagnosis;Epidemiologic Factors;Etiology;Evaluation;Genetic;Goals;Image;Lesion;Malignant Neoplasms;Methods;Methylation;Molecular;molecular marker;Natural History;novel;population based;Population Study;premalignant;Prevention strategy;Public Health;Public Health Applications Research;Research;research clinical testing;Research Personnel;Risk Marker;Somatic Mutation;Technology;Testing,Clinical Epidemiology,10229,NA,NA,NA,NA,7,NA,NA,244499,NA
11179895,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP010230,NA,NA,1ZIACP010230-07,NCI:6148638\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,6569776 (contact),"SCHIFFMAN, MARK  (contact)",NA,NA,NA,Acceleration;Address;Area;Biological Assay;Cancer Control;carcinogenesis;cervical cancer prevention;Cervical Cancer Screening;cost effectiveness;effectiveness validation;Face;Goals;Guidelines;HPV vaccine acceptance;Human Papilloma Virus Vaccine;Human Papillomavirus;Immunization Programs;improved;International;invention;Malignant neoplasm of cervix uteri;Methods;novel;overtreatment;Prevention;Recommendation;Research Personnel;Resource-limited setting;Resources;screening;screening program;Testing;Triage;Vaccination;Visit,Cervical Cancer Moonshot,10230,NA,NA,NA,NA,7,NA,NA,6148638,NA
11179896,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101231,NA,NA,1ZIACP101231-07,NCI:2981768\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15666293 (contact),"LANDI, MARIA  (contact)",NA,NA,NA,Cancer Etiology;Data;Environmental Epidemiology;Epidemiology;genetic epidemiology;Genomics;Germ Lines;Histologic;Malignant Neoplasms;Methods;Mission;molecular pathology;Molecular Profiling;Research;Risk Factors;tumor;tumor progression,Studies of Genetic and Environmental Epidemiology,101231,NA,NA,NA,NA,7,NA,NA,2981768,NA
11179897,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101233,NA,NA,1ZIACP101233-05,NCI:407021\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,8849419 (contact),"SAVAGE, SHARON A. (contact)",NA,NA,NA,2019-nCoV;Acute;Acute respiratory infection;Authorization documentation;Biological Markers;Cessation of life;China;Clinical;Communicable Diseases;Communities;comorbidity;COVID-19;COVID-19 impact;COVID-19 monitoring;COVID-19 pandemic;COVID-19 risk;COVID-19 susceptibility;Data;data sharing;Death Rate;Deposition;Descriptive Epidemiology;Disease;Division of Cancer Epidemiology and Genetics;effective therapy;Epidemiology;epidemiology study;Genetic Predisposition to Disease;genetic variant;Germ Lines;Individual;Infection;Life;Malignant Neoplasms;multidisciplinary;Multiple Organ Failure;Outcome;pandemic disease;Pneumonia;Population;Prevention Measures;Public Health;reduce symptoms;Research Personnel;respiratory;Respiratory Failure;Risk;SARS-CoV-2 infection;Scientist;severe COVID-19;Symptoms;Syndrome;Testing;United States;United States National Institutes of Health,Epidemiology and Genetics of Susceptibility to COVID-19 Infection,101233,NA,NA,NA,NA,5,NA,NA,407021,NA
11179898,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101235,NA,NA,1ZIACP101235-04,NCI:4200474\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,7030470 (contact),"ENGELS, ERIC A (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Aging;antiretroviral therapy;Behavior;biomarker identification;burden of chronic illness;cancer biomarkers;cancer diagnosis;cancer prevention;cancer therapy;Chronic;Disease;Disparity;Etiology;General Population;Health Services Accessibility;Hepatitis B Virus;Herpesviridae;HIV;HIV Infections;Human Herpesvirus 4;Human Herpesvirus 8;Human Papillomavirus;immunosuppressed;Immunosuppression;improved;Incidence;Individual;Infection;Inflammation;Intervention;Malignant Neoplasms;Natural History;Oncogenic Viruses;Outcome;Persons;prevent;risk stratification;Role;screening;Socioeconomic Status;Tobacco smoking behavior;Virus,Studies of HIV infection and its contribution to the natural history and outcome,101235,NA,NA,NA,NA,4,NA,NA,4200474,NA
11179899,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101236,NA,NA,1ZIACP101236-04,NCI:170228\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,78381935 (contact),"MACHIELA, MITCHELL  (contact)",NA,NA,NA,Alleles;Data;design;Disease susceptibility;flexibility;Genetic Structures;Haplotypes;interactive visualization;interest;Libraries;Link;Linkage Disequilibrium;Maps;Measures;Multiomic Data;open source;Pattern;Population;Population Group;Regional Disease;Research Personnel;Susceptibility Gene;tool;Variant;web app;web-based tool,LDlink webtool for examining patterns of linkage disequilibrium in diverse popul,101236,NA,NA,NA,NA,4,NA,NA,170228,NA
11179900,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101237,NA,NA,1ZIACP101237-03,NCI:1848679\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10687280 (contact),"CASTLE, PHILIP  (contact)",NA,NA,NA,Adult women;Africa South of the Sahara;Anogenital cancer;Antibodies;Anus;Biological Assay;Blood;Cancer Control;Cancer Intervention;cervicovaginal;Country;Development;Dose;Effectiveness;Enrollment;Etiology;Evaluation;Focus Groups;Future;Gardasil;Genotype;Goals;Health;High Risk Woman;HIV;HIV Seronegativity;HIV Seropositivity;Human;Human Papilloma Virus Vaccination;Immune;Immunity;Immunization Programs;low and middle-income countries;malignant mouth neoplasm;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Mass in breast;Natural History;new technology;novel strategies;Observational Study;Oral;Palpable;Participant;Population;Prevalence;prevent;Prevention;programs;prophylactic;Questionnaires;Recording of previous events;Research;Research Project Grants;Risk Factors;risk prediction;Rwanda;screening;Sexual Health;Specimen;symptom science;Testing;Underserved Population;unvaccinated;Upper aerodigestive tract cancer;Vaccinated;Vaccination;Vaccines;vaginal microbiome;Validation;Virus;Woman;Women&apos;s cohort;Women&apos;s Group;Women&apos;s study,Global Cancer Health,101237,NA,NA,NA,NA,3,NA,NA,1848679,NA
11179901,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101238,NA,NA,1ZIACP101238-03,NCI:39221\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,11142431 (contact),"WENTZENSEN, NICOLAS  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Anus;Biological Markers;burden of illness;California;carcinogenesis;Cervical;cervical cancer prevention;Cervix Uteri;cohort;Collaborations;Data;data resource;Disease;Division of Cancer Epidemiology and Genetics;Epithelium;Evaluation;Genotype;Health;HIV;HIV Seropositivity;HIV/AIDS;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Louisiana;Maintenance;Malignant Neoplasms;Medical Genetics;men;men who have sex with men;Michigan;Molecular;neoplasm registry;Outcome Study;Persons;Population;population based;premalignant;Prevalence;programs;Puerto Rico;Research;Research Personnel;screening;Screening for cancer;tissue resource;Tissues;Update;Vagina;Vulva;Woman;Work,HPV related cancers in HIV populations,101238,NA,NA,NA,NA,3,NA,NA,39221,NA
11179902,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101239,NA,NA,1ZIACP101239-01,NCI:2405972\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,79953451 (contact),"JACKSON, SARAH  (contact)",NA,NA,NA,Alcohol consumption;Behavior;Biological;Biology;cancer risk;cancer survival;carcinogenicity;cell growth;Diet;Epigenetic Process;Estrogens;Female;Gene Expression;Genetic;Goals;Gonadal Steroid Hormones;health seeking behavior;Hepatitis B Virus;Hepatitis C virus;high risk;High Risk Woman;Human Herpesvirus 4;Human Papillomavirus;Immune response;Immunity;Incidence;Infection;infection related cancer;infection risk;Intrinsic factor;male;Malignant Neoplasms;men;Oncogenic;Physical activity;Predisposition;Progesterone;programs;Research;Risk;Risk Adjustment;Risk Factors;Risk Taking;sex;Sex Differences;Site;Smoking;Testosterone;Tumor Escape;Tumor Suppressor Genes;Variant;Woman;X Inactivation,Biology of sex and cancer,101239,NA,NA,NA,NA,1,NA,NA,2405972,NA
11179903,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101240,NA,NA,1ZIACP101240-01,NCI:2134016\OD:580000\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,79953453 (contact),"CLARKE, MEGAN  (contact)",NA,NA,NA,Anogenital cancer;Anus;Attitude;Biological Markers;biomarker performance;California;Caring;Cervical Cancer Screening;Clinic;Collection;Data;Detection;Enrollment;Evaluation;experience;General Population;Goals;high risk;HIV;Human Papillomavirus;Incidence;Individual;Infrastructure;Malignant neoplasm of anus;Malignant Neoplasms;medical specialties;men who have sex with men;Nevada;Participant;Persons;Population;premalignant;prevent;Provider;randomized trial;Sampling;screening;Screening for cancer;screening program;Specimen;Testing,Evaluation of anal self-sampling in HIV men-who-have-sex-with-men (HIV MSM) populations,101240,NA,NA,NA,NA,1,NA,NA,2714016,NA
11179904,ZIA,CA,1,N,NA,NA,NA,NA,ZIACP101241,NA,NA,1ZIACP101241-01,NCI:18068\OD:299944\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,10687321 (contact),"KREIMER, AIMEE  (contact)",NA,NA,NA,Age;age stratification;Anogenital cancer;anti-cancer research;Anus;Archives;Biological Markers;Cancerous;Cervical;Cervical Cancer Screening;Cervix Carcinoma;Data Linkages;data registry;Diagnosis;Etiology;Evaluation;Genitalia;Genotype;German population;Goals;HIV;HIV Infections;Hospitals;HPV screening;Human Papilloma Virus Vaccination;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;improved;Individual;insight;Laboratories;Malignant Neoplasms;malignant oropharynx neoplasm;Oncogenic;Oncology;Oropharyngeal;Pathology;penis;Persons;Population Attributable Risks;Prevention strategy;Race;Sampling;sex;Site;South Africa;South African;Squamous cell carcinoma;Tissues;tumor;Vagina;Viral;Vulvar Squamous Cell Carcinoma;Work,"Evaluating Differences in HPV Attributable Fraction and Genotype Distribution in Cervical, Anal, Genital, and Oropharyngeal Cancers among People with and without HIV infection in South Africa",101241,NA,NA,NA,NA,1,NA,NA,318012,NA
11179905,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000021,NA,NA,1ZIADC000021-31,NIDCD:2399351\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,6480359 (contact),"WU, DORIS  (contact)",NA,NA,NA,Acceleration;Address;Afferent Neurons;Age;Alleles;Apical;Area;Auditory;Behavioral;behavioral phenotyping;Bipolar Neuron;Brain;Candidate Disease Gene;Cell Cycle;Clinical;Collaborations;Complex;conditional knockout;Crista ampullaris;Databases;deafness;Defect;Deoxyuridine;design;Development;DNA;Dorsal;Ear;Early identification;emx2 protein;Enzymes;Equilibrium;erection;Etiology;Evoked Potentials;Exhibits;Future;Generations;Genes;Genetic;Goals;Hair;Hair Cells;Head;Head Movements;hearing impairment;Human;Individual;inner ear development;Intervention;Labyrinth;Location;macula;malformation;mechanotransduction;Mitosis;Modeling;Molecular;Morphogenesis;Morphology;Movement;Mus;mutant;Mutant Strains Mice;neuroblast;neuronal cell body;Neurons;Organ;otoconia;Patients;Peripheral;Phenotype;Positioning Attribute;Production;Publishing;Reporting;Reproducibility;response;S phase;Saccule and Utricle;segregation;Sensory;Sensory Hair;sensory system;Shapes;Signal Transduction;single-cell RNA sequencing;sound;Structure;Surface;Swimming;Testing;Time;Tissues;Tremor;Tretinoin;Universities;Vestibular dysfunction;Vestibular ganglion;Vestibular inner ear;vestibular system,Molecular Basis For The Morphogenesis Of The Inner Ear,21,NA,NA,NA,NA,31,NA,NA,2399351,NA
11179906,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000085,NA,NA,1ZIADC000085-11,NIDCD:2268448\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,78824210 (contact),"KINDT, KATIE  (contact)",NA,NA,NA,Affect;Afferent Neurons;Age;Anatomy;Animal Model;Auditory;Behavior;Biological Models;Brain;cell injury;Cell Physiology;Cells;Clinical Treatment;Collection;CRISPR/Cas technology;Data;Defect;density;Development;Ensure;Equilibrium;Event;Fatigue;Functional Imaging;Genes;Genetic;Goals;hair cell regeneration;Hair Cells;Hearing;hearing impairment;Image;imaging approach;Impairment;in vivo;Investigation;Kinesin;Knowledge;Label;lateral line;Light;Link;Mediating;Microscope;Microscopy;Microtubules;Modeling;Molecular;Morphology;Motor;Mus;mutant;Natural regeneration;neuromast;Neurons;Noise-Induced Hearing Loss;Pathology;postsynaptic;Preparation;Presbycusis;presynaptic;Process;Proteins;Publishing;recruit;repaired;Research;Research Project Grants;research study;Resolution;response;restoration;ribbon synapse;Role;Sensory;Sensory Hair;sensory system;Series;Structure;Summary Reports;Synapses;synaptic function;Synaptic Vesicles;synaptogenesis;System;Systems Development;Time;Transgenic Organisms;transmission process;vesicle transport;vesicular release;vestibular system;Visualization;water flow;Work;Zebrafish,In vivo investigation of sensory hair cell function and development,85,NA,NA,NA,NA,11,NA,NA,2268448,NA
11179907,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000088,NA,NA,1ZIADC000088-10,NIDCD:1653998\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,14266184 (contact),"HOA, MICHAEL  (contact)",NA,NA,NA,Adult;Auditory;Autoimmune;Autoimmune Inner Ear disease;autoinflammatory;automated segmentation;Bacterial Artificial Chromosomes;Basal Cell;cell type;Cells;Clinical Data;Clinical Protocols;Cochlea;Cochlear duct;Collaborations;Communities;contrast enhanced;cytokine;Data Set;deep learning;Deposition;Development;Disease;druggable target;effective therapy;Endolymph;Endolymphatic Hydrops;Etiology;experience;Flow Cytometry;Gene Expression Profile;gene regulatory network;Generations;Genetic Transcription;Goals;Hair Cells;Head and neck structure;healthy volunteer;Hearing;hearing restoration;Hearing Tests;Heterogeneity;Homeostasis;Human;human disease;Image;Image Analysis;Immunophenotyping;inner ear diseases;Investigation;Ions;Laboratories;Labyrinth;Lateral;Location;machine learning method;Macrophage;Magnetic Resonance Imaging;Manuscripts;Masks;Measures;mechanotransduction;Meniere&apos;s Disease;Molecular;mouse model;Mus;new therapeutic target;novel;novel therapeutics;Otology;Paper;Pathway interactions;patient subsets;Patients;Pericytes;phenomics;Phenotype;Play;Preparation;Process;programs;progressive hearing loss;Proteomics;Publications;Publishing;recruit;Regulation;Reporter;Reporting;Research;response;restoration;Role;Sensorineural Hearing Loss;single nucleus RNA-sequencing;Steroids;Stria Vascularis;Symptoms;Syndrome;Temporal bone structure;Therapeutic;therapeutic target;tool;Transgenic Mice;treatment trial;Vestibular Aqueduct;Work,Cellular and Molecular Pathways for Hearing Restoration in the Adult Inner Ear,88,NA,NA,NA,NA,10,NA,NA,1653998,NA
11179908,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000094,NA,NA,1ZIADC000094-02,NIDCD:3825696\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,79336343 (contact),"HERTZANO, RONNA  (contact)",NA,NA,NA,Acquired Deafness;Adopted;Advanced Development;Affect;Age;age effect;Animals;Area;Auditory;Biology;cell type;Cells;Clinical Data;Clinical Research;Collaborations;college;Comprehension;congenital hearing loss;Critical Pathways;Data;Data Set;data sharing;Dedications;design;Development;Disabling;Disease;Educational workshop;equilibration disorder;Equilibrium;Estrogens;experience;FDA approved;Feedback;Female;functional genomics;fundamental research;Gender;Gene Expression Profiling;Gene Expression Regulation;gene regulatory network;Genes;Genetic;genomic data;Goals;Hair Cells;Health;Hearing;hearing impairment;hearing preservation;Hearing problem;hearing restoration;hereditary hearing loss;Human;Image;improved;In Vitro;in vivo Model;Incidence;Individual;inner ear development;inner ear injury;innovation;insight;interdisciplinary approach;Investigation;Laboratories;Labyrinth;Light;Maintenance;male;Maryland;Mediator;medical schools;meetings;Mesenchyme;Metformin;Molecular;molecular marker;Multiomic Data;multiple omics;Mus;Mutation;National Institute on Deafness and Other Communication Disorders;Newborn Infant;next generation;Noise;noise exposure;Noise-Induced Hearing Loss;novel;novel therapeutics;Otolaryngology;otoprotectant;Outcome;Outer Hair Cells;Pathogenesis;Pathway interactions;Physiological;Physiology;Population;practical application;Pre-Clinical Model;Predisposition;Presbycusis;prevent;Prevention;programs;Protocols documentation;Publishing;Raloxifene;Research;Resources;Role;Scientist;Selective Estrogen Receptor Modulators;Sex Differences;Signal Pathway;Stria Vascularis;Techniques;Therapeutic;Therapeutic Intervention;tool;transcription factor;transcriptomics;Translational Research;translational study;Universities;Update;Vestibular Hair Cells;vestibular system;Visualization;Work,Multi-Omic and Functional Analyses for Hearing Preservation and Restoration,94,NA,NA,NA,NA,2,NA,NA,3825696,NA
11179909,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000096,NA,NA,1ZIADC000096-02,NIDCD:972727\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,78836562 (contact),"BALLESTEROS, ANGELA  (contact)",NA,NA,NA,Affect;Affinity;Aging;Apical;Apoptotic;Auditory;auditory neuropathy;Axon;Bacteria;Binding Sites;Biochemical;Biophysics;Caspase;cell injury;Cell Maintenance;Cell membrane;Cell Physiology;Cell Survival;cell type;Cells;Cellular biology;Complex;CRISPR/Cas technology;Data;deafness;Development;Diagnostic;Disease;Epitopes;equilibration disorder;Equilibrium;Exhibits;Family;Functional disorder;Future;G-Protein-Coupled Receptors;Generations;Genes;genetic regulatory protein;Goals;grasp;Hair Cells;Head Movements;Health;Hearing;hearing impairment;Hearing problem;Homeostasis;Human;Immunoprecipitation;improved outcome;In Vitro;in vivo;Individual;Inherited;innovation;insight;Integrins;interdisciplinary approach;Investigation;Ion Channel;Kinetics;Knockout Mice;Labyrinth;Link;Lipids;Liposomes;Maintenance;mechanical signal;mechanical stimulus;Mechanics;mechanotransduction;Membrane;Molecular;Molecular Biology;mouse model;Mus;Mutation;neurotransmission;noise exposure;novel;novel therapeutics;Organism;ototoxicity;Pathway interactions;Physiological;Physiology;Play;postnatal development;prevent;Process;Property;Protein Isoforms;Proteins;reconstitution;Research;Research Project Grants;Role;Scientist;Sensory;Sensory Hair;Sensory Physiology;Sensory Process;sound;Specificity;Structure;Summary Reports;System;Techniques;Therapeutic;Therapeutic Intervention;Time;Variant;Vertebrates;Vestibular function;vibration;Work,Sensory Hair Cell Homeostasis,96,NA,NA,NA,NA,2,NA,NA,972727,NA
11179910,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000029,NA,NA,1ZIAHG000029-30,NHGRI:1072270\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,8184969 (contact),"CHANDRASEKHARAPPA, SETTARA  (contact)",NA,NA,NA,acetaldehyde dehydrogenase;Acute Myelocytic Leukemia;Affect;Age;Age of Onset;Alcohols;aldehyde dehydrogenases;Aldehydes;Anemia;Aplastic Anemia;Appearance;Asian population;attenuation;autosome;Biological Markers;Bone marrow failure;bone marrow failure syndrome;Breast Cancer Risk Factor;cancer predisposition;Candidate Disease Gene;Carbon;Case Study;Clinical;Clinical Management;Clinical Treatment;cohort;Complement;Complementary DNA;Congenital Abnormality;Custom;de novo mutation;Defect;deletion detection;density;design;Development;Diagnosis;Disease;disease-causing mutation;DNA;DNA Crosslinking Agent;DNA Sequence Alteration;Dysmyelopoietic Syndromes;Early Diagnosis;Enzymes;Evaluation;Family;Family member;FANCB;Fanconi Anemia Complementation Group A Protein;Fanconi Anemia pathway;Fanconi&apos;s Anemia;founder mutation;Gene Mutation;gene panel;Gene Targeting;Generations;Genes;Genetic Variation;genomic signature;Genomics;Genotype;Goals;Head and Neck Squamous Cell Carcinoma;Hematology;Hematopoietic;Heterozygote;improved;Individual;Inherited;Inherited bone marrow failure;insertion/deletion mutation;Knock-out;knockout gene;Length;Life;Link;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant Neoplasms;Manuscripts;Measurement;Messenger RNA;Metabolism;Methodology;Mitotic Recombination;Modeling;Molecular;Molecular Diagnosis;molecular subtypes;mosaic;Mosaicism;mouth squamous cell carcinoma;mutant;Mutation;Nature;Oral cavity;Pancytopenia;Pathogenicity;Patients;Phenotype;Population;Predisposition;Process;prophylactic;Proteins;Protocols documentation;Publishing;Rare Diseases;Reporting;Risk;RNA;RNA Splicing;Screening for Oral Cancer;Screening procedure;Site;SNP array;Solid Neoplasm;Somatic Mutation;South Asian;Techniques;Technology;Thrombosis;Tissues;TP53 gene;Transcript;transcriptome sequencing;Transgenic Organisms;United States National Institutes of Health;Universities;Variant;Zebrafish,FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS,29,NA,NA,NA,NA,30,NA,NA,1072270,NA
11179911,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000167,NA,NA,1ZIAHG000167-25,NHGRI:1107383\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,6481813 (contact),"BRODY, LAWRENCE C (contact)",NA,NA,NA,Affect;Affinity;Age;Anemia;Animal Model;Animals;anxious behavior;Binding;Bioinformatics;Biological;Biological Assay;Biological Availability;Biology;Blood;Brain;Carbon;Caring;Carrier Proteins;Cell division;cell growth;Cells;cellular targeting;Choline;circulating biomarkers;Circulation;Clinical;Code;Cohort Studies;Collaborations;college;Congenital Abnormality;cost;Data;Defect;Deposition;Development;Diet;dietary;Disease;DNA;DNA Methylation;Embryo;Environment;Environmental Exposure;Environmental Risk Factor;Equilibrium;Exhibits;experimental study;Female;fetus nutrition;Fishes;Folic Acid;Folic Acid Deficiency;Formates;Frequencies;Funding;Future;Gene Expression;Genes;Genetic;Genetic Predisposition to Disease;Genetic Research;genetic variant;Genetic Variation;genome wide association study;Genotype;genotyping technology;Glycine;Goals;Hair Color;Health;Heart Diseases;heteroplasmy;Homocysteine;Human;Human Genome;Impaired cognition;implantation;improved;Individual;Infertility;Inherited;Injections;Inositol;insight;International;Knock-out;Length;Literature;Liver;Location;Malignant Neoplasms;Measures;melanocyte;Metabolic;Metabolic Pathway;Metabolism;Methionine;Methods;Methylmalonic Acid;Micronutrients;Mitochondria;Mitochondrial DNA;Modeling;mouse model;Mus;Nervous System Physiology;Neural Tube Defects;Neurologic;Normal Range;Nutrient;offspring;Other Genetics;Ovulation;Pathway interactions;Population;Pregnancy;Process;Proteins;Publishing;recruit;Reporting;Research;research clinical testing;Research Personnel;Retina;Risk;Role;Sample Size;Sampling;Side;Spinal Dysraphism;System;Testing;Tissues;Transcobalamins;tumor;uptake;Variant;Vitamin B 12;Vitamin B 12 Deficiency;Vitamin B6;vitamin receptor;whole genome;Work;Zebrafish,The contribution folate and vitamin B12 genes to disease.,167,NA,NA,NA,NA,25,NA,NA,1107383,NA
11179912,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000175,NA,NA,1ZIAHG000175-25,NHGRI:198663\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10889677 (contact),"SHAW, WALLACE PHILIP (contact)",NA,NA,NA,11q;11q22;addiction;Adhesions;Adolescent;Adult;Affect;Alcohols;alpha-latrotoxin receptor;ANKK1 gene;Attention deficit hyperactivity disorder;axon guidance;base;Behavior;Behavior Disorders;Binding Sites;Brain;Brain region;Brazil;Canada;cell motility;Child;Chromosomes;cohort;Colombia;comorbidity;Conduct Disorder;Confidence Intervals;Conserved Sequence;Data;Development;Diagnosis;Disease;disease natural history;Disparate;DRD2 gene;Drug Modulation;drug seeking behavior;Drug user;economic implication;Educational Status;Embryonic Development;endophenotype;Enhancers;Epidemiology;Family;FLRT3 gene;Functional disorder;G-Protein-Coupled Receptors;Genes;Genetic;genetic analysis;Genetic Epistasis;Genetic Predisposition to Disease;Genetic Transcription;genetic variant;genome-wide;genome-wide linkage;Genomic Segment;Genotype;Germany;Goals;Haplotypes;Health;Illicit Drugs;Impairment;Incidence;Individual;Investigation;Knock-out;Legal;Ligands;Link;Low income;Maintenance;Manuscripts;Maps;Measures;member;Membrane Proteins;Metabolism;Modeling;Mus;Myelin;myelination;NCAM1 gene;neurodevelopment;Neurons;Neuropsychology;noradrenergic;Norway;Oppositional Defiant Disorder;Paper;Patients;Penetrance;personalized medicine;Persons;Pharmaceutical Preparations;Play;Population Attributable Risks;Postsynaptic Membrane;predicting response;Predisposition;Prevalence;Public Health;Publishing;Reporting;Research;Risk;risk variant;Role;segregation;Severities;Shapes;social relationships;socioeconomic disadvantage;socioeconomics;South Korea;Spain;Sphingolipids;Stimulant;Substance Use Disorder;Surface;Susceptibility Gene;Symptoms;System;Therapeutic;tobacco user;transcription factor;Twin Multiple Birth;Underemployment;Untranslated RNA;Variant;Work;World Health Organization;YY1 Transcription Factor;Zebrafish,Genetic Analysis of Attention Deficit Hyperactivity Disorder,175,NA,NA,NA,NA,25,NA,NA,198663,NA
11179913,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200318,NA,NA,1ZIAHG200318-21,NHGRI:2733586\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,8185772 (contact),"VENDITTI, CHARLES P (contact)",NA,NA,NA,"Acyl Coenzyme A;Adipose tissue;Affect;amino acid metabolism;Animal Model;Area;Australia;autism spectrum disorder;Basal Ganglia;Bezafibrate;Biochemistry;Biological Markers;Blindness;Branched-Chain Amino Acids;Brown Fat;Cardiac;Cardiomyopathies;Categories;Central obesity;Child;Chronic;Chronic Kidney Failure;circulating biomarkers;Clinic;Clinical;clinical care;clinical center;Clinical Protocols;Clinical Research;Clinical Trials Design;Cobalamin;cohort;Collaborations;Communities;Complex;Data;Databases;Dedications;Developed Countries;Development;Developmental Delay Disorders;Diabetes Mellitus;Diagnosis;Disease;disease model;Disease Progression;Drug or chemical Tissue Distribution;Early Intervention;Effectiveness;End stage renal failure;Exhibits;Extrahepatic;Face;Fatty acid glycerol esters;fibroblast growth factor 21;Frequencies;Functional disorder;gene therapy;Gene therapy trial;Genes;Genetic;genetic approach;genome editing;Genomic approach;Genomic medicine;Genomics;Goals;Government;Growth;hearing impairment;Heart failure;HIV-Associated Lipodystrophy Syndrome;human subject;Immunosuppression;Impairment;improved;Inborn Errors of Metabolism;Infant;Inherited;insight;Intellectual functioning disability;Intervention Trial;Investigation;ketotic hyperglycinemia;Kidney;Knock-out;Laboratories;Legal patent;Link;Lipodystrophy;Lipomatosis;Liver;Liver diseases;long-term sequelae;Medical;Messenger RNA;Metabolic;Metabolic Diseases;Metabolism;metabolomics;methylmalonic aciduria;methylmalonyl coA mutase deficiency;Methylmalonyl-CoA Mutase;microbiome;Mitochondria;mitochondrial dysfunction;Modeling;Morbidity - disease rate;mouse model;Myocardial dysfunction;National Center for Advancing Translational Sciences;National Heart, Lung, and Blood Institute;National Institute of Mental Health;Natural History;Neonatal Screening;Neurologic;Newborn Infant;novel;novel therapeutics;NPC1 gene;Obesity;optimal treatments;organ transplant rejection;Organ Transplantation;Osteoporosis;Outcome;Pancreas;Pancreatitis;Pathology;Pathway interactions;Patients;Pattern;Phenotype;Physiology;Plasma;Post-Translational Protein Processing;potential biomarker;Prognosis;programs;propionyl-coenzyme A;Proteomics;Publishing;Reporting;research study;Risk;screening;Severity of illness;small molecule;Stroke;Study Section;subcutaneous;Symptoms;Syndrome;targeted treatment;Testing;Therapeutic Intervention;Thermogenesis;Transgenic Mice;translational research program;Transplantation;treatment effect;Treatment Protocols;United States National Institutes of Health;vector;Visceral fat;Visual impairment;Vitamin B 12;Vitamin B 12 Deficiency;Zebrafish",Investigations of Methylmalonic Acidemia and Related Disorders,200318,NA,NA,NA,NA,21,NA,NA,2733586,NA
11179914,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200324,NA,NA,1ZIAHG200324-20,NHGRI:320508\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,8257645 (contact),"BONHAM, VENCE L (contact)",NA,NA,NA,Address;Algorithms;Anxiety;Attitude;Belief;Biological;Caring;Characteristics;Clinical;clinical care;clinical decision-making;clinical practice;Data;Decision Making;Development;Discipline of Nursing;Disease;Dose;Educational Status;Empirical Research;Ethnic Origin;experimental study;Factor Analysis;Family Practice;Future;Genetic;Genetic Predisposition to Disease;Genetic Risk;genetic testing;Genetic Variation;Genomic medicine;Genomics;Genotype;Health;health assessment;health disparity;health equity;Health Personnel;Health Professional;Health Services Research;Hospitals;HP gene;Human Genetics;human genome sequencing;implicit bias;Individual;Internal Medicine;Internist;Interview;Journals;Knowledge;Measures;Medical;member;Methods;Modeling;Nurse Practitioners;Nurses;Outcome;Patient Self-Report;Patients;personalized medicine;Pharmaceutical Preparations;Phase;Physicians;Politics;precision medicine;Primary Care Physician;primary care practice;Public Health Practice;Publishing;Qualitative Methods;Qualitative Research;Race;Registered nurse;Regression Analysis;Reporting;Research;research clinical testing;Research Methodology;Research Personnel;Residencies;response;Sampling;Scholarship;Serotonin;Students;Surveys;Test Result;Testing;Training;translational genomics;Uncertainty;United States;virtual;Warfarin,"Understanding the Relationships between Race, Ethnicity, Ancestry and Genomics",200324,NA,NA,NA,NA,20,NA,NA,320508,NA
11179915,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200328,NA,NA,1ZIAHG200328-20,NHGRI:817398\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9694209 (contact),"BIESECKER, LESLIE  (contact)",NA,NA,NA,Affect;Agreement;AKT1 gene;Alleles;Animal Model;Animals;Antineoplastic Agents;Award;Behavioral;Biological Models;Biological Process;Biomechanics;Biotechnology;Cell Culture Techniques;Cells;Clinical;Clinical Data;Clinical Research;Clinical Research Protocols;Clinical Trials;cohort;Collaborations;Cooperative Research and Development Agreement;Coupled;Development;Disease;disease model;Dose;Drug Industry;Embryo;Enrollment;Etiology;Experimental Models;feature detection;Gene Abnormality;gene product;Genes;Genetic Diseases;Genomics;Genotype;Growth;Growth Disorders;High-Throughput Nucleotide Sequencing;Human;Human Genetics;human model;In Vitro;inducible Cre;inhibitor;Knock-in;Laboratories;malformation;Malignant Neoplasms;Mediation;Modeling;Modernization;Molecular;Molecular Biology;Molecular Genetics;mosaic;Mosaicism;mouse model;Mus;Mutation;Natural History;novel;novel therapeutics;Other Genetics;Pathogenesis;Patients;Pharmacotherapy;Phase;phase 2 study;phase II trial;Phenotype;PIK3CA gene;positional cloning;Postdoctoral Fellow;prenatal;prenatal therapy;primary outcome;Proteins;Proteus;Proteus Syndrome;Proto-Oncogene Proteins c-akt;Protocols documentation;Publishing;Rare Diseases;recruit;Research;Sampling;Severities;Shapes;Sirolimus;Stress;success;Syndrome;System;targeted treatment;Testing;Therapeutic;Therapeutic Agents;Therapeutic Intervention;Therapeutic Studies;Time;tissue culture;tool;Translational Research;Treatment Protocols;tumor;Vascular remodeling;Work,Rare & Mosaic Disorders Molecular Research,200328,NA,NA,NA,NA,20,NA,NA,817398,NA
11179916,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200335,NA,NA,1ZIAHG200335-19,NHGRI:793108\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,1911104 (contact),"KOEHLY, LAURA M (contact)",NA,NA,NA,Address;Affect;Area;Assessment tool;Behavior;Chronic Disease;Clinic;Collaborations;Communication;Communities;Community Health;Community Health Education;Complex;contextual factors;coping;COVID-19;COVID-19 pandemic;Data;Development;diaries;Disease;disorder risk;Educational process of instructing;Evaluation;experience;Family;Family health status;family influence;Feedback;Female;Florida;follow up assessment;Funding;Genetic Diseases;Goals;health assessment;Health Disparities Research;Helping Behavior;Hereditary Disease;Hispanic;Household;Individual;Inherited;Institutional Review Boards;International;Intervention;Kidney Diseases;Longitudinal Surveys;Malignant Neoplasms;Medical center;Mental Health;Mexican Americans;minority communities;minority health;minority health disparity;National Human Genome Research Institute;National Institute of Drug Abuse;Network-based;Nigeria;Non-Insulin-Dependent Diabetes Mellitus;Participant;Patient Recruitments;Pediatric Hospitals;Pennsylvania;Persons;Phase;Populations at Risk;Process;programs;Protocols documentation;Recording of previous events;recruit;Research;resilience;Risk;Risk Reduction;Rural;Series;Sickle Cell Anemia;social;Social Distance;Social Environment;South Australia;Spanish/English;stressor;Testing;tool;Universities;video module;Washington;Work,The influence of familial social context on risk dissemination and coping,200335,NA,NA,NA,NA,19,NA,NA,793108,NA
11179917,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200338,NA,NA,1ZIAHG200338-18,NHGRI:1690476\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9416424 (contact),"BELL, DAPHNE  (contact)",NA,NA,NA,ACVR1 gene;Affect;American;American Cancer Society;Binding;Biochemical;Biological Markers;Body of uterus;c-myc Genes;Cancer Etiology;cancer genome;Carcinoma;CCNE1 gene;Cell Line;cell type;Cells;Cessation of life;Clinical;clinically relevant;Complex;Cyclin-Dependent Kinase Inhibitor;Data Set;design;Development;Disease;disease-causing mutation;druggable target;Endometrial Carcinoma;Endometrial Neoplasms;Endometrium;Epithelium;Exhibits;experimental study;FBXW7 gene;gain of function;Genes;Genetic;Genome;genomic tools;Genomics;Germ Lines;Goals;Histologic;Human;in silico;Individual;inhibitor;interest;Knock-in;Laboratories;MADH2 gene;Malignant Epithelial Cell;Malignant Neoplasms;Manuscripts;Medicine;meetings;Missense Mutation;Molecular;Molecular Abnormality;Molecular Analysis;Molecular Carcinogenesis;mutant;Mutate;Mutation;mutation correction;Nature;NCOA3 gene;Neural Cell Adhesion Molecule L1;Newly Diagnosed;novel;novel therapeutics;Oncogenic;Outcome;Pathogenicity;Pathology;Pathway interactions;Phosphoproteins;phosphoproteomics;Phosphorylation;Phosphotransferases;predictive modeling;prevent;Prognosis;progressive myositis ossificans;protein function;Protein-Serine-Threonine Kinases;Proteins;Proteomics;Proto-Oncogene Proteins c-akt;Recurrence;Reporting;Research;Series;Serous;Signal Transduction;Somatic Mutation;Structural Models;Tertiary Protein Structure;Testing;TGF-beta type I receptor;TGFBR1 gene;transcription factor;tumor;Tumor Promotion;Tumor Suppressor Proteins;ubiquitin ligase;Ubiquitination;United States;Uterine Corpus Carcinosarcoma;Uterus;Validation;Variant;Woman;Work;Writing,Molecular Analyses of Endometrial Cancer,200338,NA,NA,NA,NA,18,NA,NA,1690476,NA
11179918,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200359,NA,NA,1ZIAHG200359-17,NHGRI:817398\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9694209 (contact),"BIESECKER, LESLIE  (contact)",NA,NA,NA,"Address;Affect;Agreement;American;Area;arm;Automation;Bayesian Modeling;Benign;biobank;Biological Assay;Blood specimen;cascade genetic testing;Classification;Clinical;clinical care;Clinical Medicine;clinical practice;Clinical Research;cohort;Collaborations;Communication;cost;Coupling;Data;Data Analyses;Development;Diagnostic;Disease;Environment;Evaluation;Evaluation Studies;exome sequencing;Family;Family member;Foundations;Functional disorder;Future;Genes;Genetic;genetic variant;Genets;Genome;genome sequencing;genome-wide;genomic data;Genomic medicine;genomic predictors;Genomics;Genotype;Goals;Guidelines;Health Care Costs;Health Services Research;Healthcare;Human;Image;improved;Individual;Infrastructure;Intake;Laboratories;Leadership;Malignant hyperpyrexia due to anesthesia;Medical;Medical Genetics;medical schools;Medicine;Modeling;Molecular;multiplex assay;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Environmental Health Sciences;new technology;novel strategies;Participant;Pathogenicity;Patients;Penetrance;Pharmacogenetics;Phenotype;phenotypic data;Philosophy;Population;precision genomic medicine;Prevalence;Probability;Process;Productivity;programs;Proteins;Protocols documentation;Publications;Publishing;rare variant;Recommendation;Recontacts;Recording of previous events;reproductive;Research;Resources;Risk;Services;Speed;success;System;Testing;Time;tomography;Update;Variant;Vision;Work;working group",Genomic Ascertainment - Molecular and Genetic Aspects,200359,NA,NA,NA,NA,17,NA,NA,817398,NA
11179919,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200378,NA,NA,1ZIAHG200378-13,NHGRI:1787968\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10889677 (contact),"SHAW, WALLACE PHILIP (contact)",NA,NA,NA,Adult;Age;Amygdaloid structure;Anterior;Attention deficit hyperactivity disorder;Behavior;Behavioral;Behavioral Research;Brain;Brain imaging;Brain region;Child;Childhood;cingulate cortex;Clinical;Clinical Research;cohort;comorbidity;Complex;Consensus;Corpus striatum structure;Data;Data Set;Development;Diagnosis;Dorsal;Environment;Functional disorder;Functional Magnetic Resonance Imaging;Genes;Genetic;Genomics;Goals;Health;Image;Individual;Intervention;Link;Modality;Modeling;Motion;Motor;National Human Genome Research Institute;neural;neurobehavioral;neurobehavioral disorder;neuroimaging;novel strategies;Outcome;Phenotype;Publications;Research;Rest;Risk;Sample Size;social;Social Environment;Testing;trait;Youth,"The neurobehavioral, environmental and genetic factors impacting ADHD.",200378,NA,NA,NA,NA,13,NA,NA,1787968,NA
11179920,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200381,NA,NA,1ZIAHG200381-13,NHGRI:2151114\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11613229 (contact),"MCGUIRE, PETER  (contact)",NA,NA,NA,acute infection;Animal Model;Anti-Bacterial Agents;Antibody Repertoire;Antibody Response;B-Lymphocytes;Bacterial Antibodies;Bibliography;Bioenergetics;Biological Markers;Biological Models;Cell model;Cells;Child;Clinical;clinical care;Clinical Protocols;Collaborations;Communities;comparison control;congenital immunodeficiency;Coupled;Data;Dedications;defined contribution;Dimensions;Disease;fatty acid oxidation;Flow Cytometry;Gender;Genes;Glycolysis;Goals;healthy volunteer;human subject;Humoral Immunities;Immune;immune function;immune health;Immune response;improved;Individual;Infection;infection risk;Inflammatory;insight;Interferon Type I;Interferons;Interleukin-1;Intervention;Investigation;Metabolism;Mites;Mitochondria;Mitochondrial Diseases;mitochondrial dysfunction;mitochondrial metabolism;Natural History;Natural Killer Cells;Outcome;Oxidative Phosphorylation;Oxidative Phosphorylation Deficiency;Paper;pathogen;Pathway interactions;Patients;Pattern;Peripheral Blood Mononuclear Cell;Phenotype;policy recommendation;Population;Production;Protocols documentation;response;risk mitigation;Scientific Advances and Accomplishments;Serology;Signal Transduction;single-cell RNA sequencing;Surface;T-Lymphocyte;T-Lymphocyte Subsets;Technology;Therapeutic;Therapeutic Intervention;Translating;translational research program;United States National Institutes of Health;Vaccination;Viral;Viral Antibodies;Virus Diseases;Work,"Metabolism, infection and immunity in inborn errors of mitochondrial metabolism",200381,NA,NA,NA,NA,13,NA,NA,2151114,NA
11179921,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200383,NA,NA,1ZIAHG200383-13,NHGRI:426311\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11613232 (contact),"PERSKY, SUSAN  (contact)",NA,NA,NA,Area;Attitude;Behavior;Clinical;Communication;Communities;Data;Diabetes Mellitus;Diffusion;digital;Discrimination;Disparity;Follow-Up Studies;Genomics;health disparity;Health Promotion;Healthcare;Institutional Review Boards;Knowledge;Medical;Medical Students;Paper;Patients;polygenic risk score;Population;Provider;Publishing;Race;Reaction;Research;risk minimization;Shapes;social media;social stigma;Stigmatization;Technology;virtual reality;Visit;Weight,"Communication of genomic information in clinical, community, and digital contexts",200383,NA,NA,NA,NA,13,NA,NA,426311,NA
11179922,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200387,NA,NA,1ZIAHG200387-12,NHGRI:817398\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9694209 (contact),"BIESECKER, LESLIE  (contact)",NA,NA,NA,Address;adverse outcome;Ally;Amendment;Anxiety;Area;Attitude;Behavioral;biobank;Blood specimen;Clinical;clinical care;Clinical Medicine;clinical practice;clinical sequencing;clinically relevant;Collaborations;Data;data communication;Development;diagnostic value;Disease;exome;exome sequencing;experience;Extramural Activities;Foundations;Fright;Functional disorder;Genes;Genetic Counseling;genetic counselor;genetic variant;Genets;Genome;genome sequencing;genome-wide;genomic data;Genomic medicine;genomic predictors;Genomics;Genotype;Goals;Grant;Health;Health Care Costs;health care settings;Health Services Research;Healthcare;Image;improved;Individual;individual patient;interest;Laboratories;Malignant hyperpyrexia due to anesthesia;Medical;Medicine;member;Mental Depression;Modeling;Molecular;Motivation;Muscle;neurosurgery;new technology;Overutilization of Health Services;Paper;Participant;Penetrance;Persons;Pharmacogenetics;Phenotype;phenotypic data;Physicians;Population;precision genomic medicine;Predisposition;Prevalence;programs;rare variant;Recommendation;Recontacts;Recurrence;reproductive;Research;research clinical testing;Research Personnel;Resources;Risk;screening;Site;Standard Model;Study Section;Surveys;Test Result;Testing;tomography;Variant;Vision;Work,Genomic Ascertainment - Clinical and Behavioral Aspects,200387,NA,NA,NA,NA,12,NA,NA,817398,NA
11179923,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200388,NA,NA,1ZIAHG200388-12,NHGRI:817398\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9694209 (contact),"BIESECKER, LESLIE  (contact)",NA,NA,NA,Agreement;Biopsy Specimen;Clinical;clinical center;Clinical Data;Clinical Research;Clinical Research Protocols;cohort;Collagen nevus of skin;Companions;Cooperative Research and Development Agreement;Coupled;Data;Development;Disease;Dose;efficacy study;Electroencephalography;Enrollment;Etiology;Genes;Genetic;Genetic Diseases;Genetic Research;Genotype;Germ Lines;Growth;Growth Disorders;Human Genetics;imaging study;In Vitro;Inherited;Laboratories;Lenz syndrome 2;Lung Diseases;malformation;Molecular;mosaic;Mosaicism;Mutation Detection;Natural History;novel therapeutics;Oncology;Operative Surgical Procedures;Other Genetics;Outcome Measure;Participant;Patients;Pharmaceutical Preparations;Phase;phase 2 study;Phenotype;Physical Examination;Polydactyly;primary outcome;Productivity;Proteus Syndrome;Publications;Pulmonary function tests;radiological imaging;Rare Diseases;Recording of previous events;research clinical testing;Resources;Safety;Sampling;Severities;Shapes;Structural defect;Syndrome;Therapeutic;Therapeutic Studies;Time;tomography;tumorigenesis;ultrasound;United States National Institutes of Health;Variant;Work,Rare & Mosaic Disorders - Clinical Research,200388,NA,NA,NA,NA,12,NA,NA,817398,NA
11179924,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200394,NA,NA,1ZIAHG200394-11,NHGRI:641016\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,8257645 (contact),"BONHAM, VENCE L (contact)",NA,NA,NA,Address;Adult;Affect;African ancestry;Agreement;All of Us Research Program;American;Anaerobic Bacteria;Anemia;Animals;Attitude;behavioral health;beta Globin;Bibliography;Biological Markers;Cardiomyopathies;carrier status;carrier testing;Case Series;Case Study;Case/Control Studies;Cells;Cessation of life;Childhood;Chronic;Chronic Kidney Failure;Clinical;clinical care;Codon Nucleotides;cohort;Cohort Studies;comorbidity;Complication;Corticosterone;Corynebacterium;COVID-19 pandemic;COVID-19 pandemic effects;Cross-Sectional Studies;current pandemic;Data;Data Collection;Data Set;Databases;Deep Vein Thrombosis;design;Diabetic Foot Ulcer;Disease;editorial;Educational Status;Electronic Health Record;emotional distress;Employment;Erythrocyte Membrane;Etiology;Exclusion;Exertion;Ferritin;Frequencies;Fright;Genes;Genetic;Genetic study;genome sequencing;Genomic approach;Genomics;Genotype;Genus staphylococcus;Goals;Guidelines;Hair;healing;Health;health assessment;Health behavior;health care quality;health care service;health care service utilization;Heart failure;Height;Hemolysis;Hemolytic Anemia;Heterozygote;Hospitalization;Hydrocortisone;Impairment;improved;In Vitro;Incidence;inclusion criteria;Individual;insight;Institution;interest;Internal Medicine;Laboratories;Leg;Leg Ulcer;Logistic Regressions;Marital Status;Medical;meeting abstracts;Mental Health;microbial community;microbial signature;microbiome;Mutation;Nature;nonEnglish language;offspring;opportunistic pathogen;Organ;Outcome;Pain;pandemic disease;Participant;pathogenic bacteria;patient population;Patient Self-Report;Patients;perceived stress;physical conditioning;Physical environment;Physiological;Point Mutation;Population;Predisposition;premature;Prevalence Study;Procedures;Process;programs;Proteinuria;psychologic;psychosocial;psychosocial wellbeing;Public Policy;Published Comment;Publishing;Pulmonary Embolism;Quality of life;Quality of Life Assessment;Random Allocation;Randomized;Recording of previous events;recruit;Recurrence;Reporting;Research;research study;resilience;Resistance;Resources;Rhabdomyolysis;Risk;Role;Sampling;SARS-CoV-2 infection;screening program;Serum;Severities;Severity of illness;Shapes;Sickle Cell;Sickle Cell Anemia;Sickle Cell Trait;Sickle Hemoglobin;skin microbiome;Sleep disturbances;social;Social Environment;Social Functioning;Social Sciences;Stress;Stroke;Surveys;Symptoms;systematic review;Thromboembolism;Time;Transfusion;Ulcer;United States;Vaccine Research;Variant;Weight;Well in self;whole genome;working group,Insights into Sickle Cell Trait and  Sickle Cell Disease,200394,NA,NA,NA,NA,11,NA,NA,641016,NA
11179925,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200395,NA,NA,1ZIAHG200395-10,NHGRI:1359613\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,1911104 (contact),"KOEHLY, LAURA M (contact)",NA,NA,NA,Activities of Daily Living;Affect;Alzheimer&apos;s disease related dementia;Assessment tool;Behavior;Biological;Biological Markers;Blood specimen;care recipients;Caregiver well-being;Caregivers;caregiving;caregiving research;Caring;Chronic;clinical center;CLN3 gene;Cognitive;cohort;Collaborations;Consent;coping;Cross-Sectional Studies;Data;Diagnosis;diaries;Disease;emotional factor;Enrollment;expectation;experience;Family;Family health status;Goals;Health;Hereditary Disease;improved;Inborn Errors of Metabolism;Individual;informal caregiving;informant;Intervention;Interview;Iowa;Life;Longitudinal Studies;loved ones;Manuscripts;Measures;Medical;Mitochondrial Diseases;Paper;Participant;Patients;Personal Satisfaction;Persons;Phase;Pilot Projects;primary caregiver;Process;Publications;Publishing;Recording of previous events;recruit;Reporting;Research;Research Design;Resources;Role;Sampling;social factors;Social Network;social relationships;Spielmeyer-Vogt Disease;Stress;stressor;Structure;Support System;Surveys;System;Testing;United States National Institutes of Health;Universities;Visit;Work,"Inherited Disease, Caregiving, and Social Networks",200395,NA,NA,NA,NA,10,NA,NA,1359613,NA
11179926,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200396,NA,NA,1ZIAHG200396-10,NHGRI:426311\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11613232 (contact),"PERSKY, SUSAN  (contact)",NA,NA,NA,Agonist;Attitude;Behavior;Belief;Biological Process;Child;Communication;Communities;Data;Desire for food;Diabetes Mellitus;Diet Habits;dietary;Disinhibition;Eating;Eating Behavior;Educational Materials;Educational process of instructing;Environment;Epigenetic Process;Etiology;experience;Exposure to;Family;Family history of;Feeding behaviors;Feeding Patterns;Food;gene environment interaction;Genes;Genetic;Genomics;GLP-I receptor;Guilt;Individual;innovation;Internet;Judgment;Learning;Life;Manuscripts;member;nutrition related genetics;nutritional genomics;Obesity;obesity prevention;Outcome;Paper;Parents;Pharmaceutical Preparations;Phenotype;Population;Preparation;Process;programs;psychologic;Publishing;Reaction;Research;response;Risk;Role;Shapes;simulation;social stigma;Stigmatization;Surveys;Technology;Testing;Twitter;virtual reality;Weight;Weight maintenance regimen,Eating and Feeding Behavior: Exploring Phenotypes and Influencing Outcomes,200396,NA,NA,NA,NA,10,NA,NA,426311,NA
11179927,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200397,NA,NA,1ZIAHG200397-09,NHGRI:112282\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,1911104 (contact),"KOEHLY, LAURA M (contact)",NA,NA,NA,Area;Attitude;Behavioral Sciences;caregiving;Communication;Data;Development;disorder risk;Family;Family health status;Future;Genomics;Goals;Hereditary Disease;informant;Institutional Review Boards;instrument;Knowledge;literacy;Measurement;Measures;method development;Methodology;Methods;Modeling;National Human Genome Research Institute;novel;Phase;Protocols documentation;Recording of previous events;recruit;Research;research and development;Risk;Science;Self Efficacy;Social Environment;Social Network;Social Sciences;System;Time;tool;Validation;validation studies;Work,Methodological Development,200397,NA,NA,NA,NA,9,NA,NA,112282,NA
11179928,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200399,NA,NA,1ZIAHG200399-08,NICHD:1423224\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,15265857 (contact),"BIANCHI, DIANA  (contact)",NA,NA,NA,Adoption;Affect;Age;Amniocentesis;Amyloid beta-Protein Precursor;antenatal;Antiinflammatory Effect;Antioxidants;behavioral phenotyping;bioinformatics tool;biological adaptation to stress;Biological Assay;Biological Models;Body System;Brain;Cardiovascular system;Cell Aging;cell growth;Cell Line;Characteristics;Chile;Chorionic Villi Sampling;Chromosome 16;Chromosome 21;Clinical;Clinical Management;Collaborations;Collection;Cytogenetics;cytotoxicity;Data;Data Set;Databases;Development;Diagnosis;Diagnostic Procedure;Disease;diverse data;Down&apos;s Syndrome;drug candidate;Early treatment;Embryo;Evaluation;Exhibits;fetal;Fetal Development;Fetus;Fibroblasts;Future;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Gene Proteins;Genes;Genomics;Goals;Growth;Human;Human Chromosomes;improved;in vitro Model;Individual;induced pluripotent stem cell;Infant;insight;Intellectual functioning disability;inter-individual variation;interest;Interferons;Laboratories;Libraries;Life;life span;Literature;Macrophage;Maps;Measures;Medical center;Microglia;Mitochondria;Modeling;Molecular;mouse model;mouse Trisomy 16;mouse Ts65Dn;Mus;Musculoskeletal System;National Institute on Aging;nerve stem cell;Network-based;Neurocognition;neuroinflammation;Neurologic;novel;Outcome;Oxidative Stress;Pathway interactions;Persons;Pharmaceutical Preparations;Phenotype;Placenta;Placentation;postnatal;pre-clinical;pregnant;prenatal;prenatal testing;prenatal therapy;Proliferating;protein expression;Proteome;Publications;Publishing;Quality of life;racial diversity;Research;response;Role;Safety;Sampling;screening;senescence;sex;Signal Transduction;skills;small molecule;superoxide dismutase 1;Supportive care;Therapeutic;Therapeutic Intervention;Time;transcriptome;transcriptome sequencing;transcriptomics;treatment response;Trisomy;Work,Prenatal Treatment of Down Syndrome to Improve Brain Development and Neurocognition,200399,NA,NA,NA,NA,8,NA,NA,1423224,NA
11179929,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200400,NA,NA,1ZIAHG200400-07,NICHD:74907\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,15265857 (contact),"BIANCHI, DIANA  (contact)",NA,NA,NA,acronyms;Adrenocortical Carcinoma;Algorithms;Amniocentesis;Aneuploidy;Asian;Awareness;Benign;Biochemistry;Biocompatible Materials;Biological;Black race;Blinded;Blood;Canada;cancer diagnosis;cell free DNA;Chorionic Villi Sampling;Chromosomal Gain;Chromosomal Loss;Chromosomes;circulating DNA;Clinical;clinical care;clinical center;Clinical Data;Clinical Management;clinical sequencing;cohort;Colorectal Cancer;continuing medical education;Detection;detection method;Diagnosis;Diagnostic;Diagnostic tests;DNA;DNA analysis;DNA Sequence;DNA sequencing;Eligibility Determination;Enrollment;Evaluation;fetal;Fetus;follow-up;Genetic;Genomics;Guidelines;Hematopoiesis;Hematopoietic System;high risk;Hispanic;Hospitals;Image;Individual;International;Israel;Karyotype;Laboratories;Lymphoma;Magnetic Resonance Imaging;Malignant - descriptor;Malignant Breast Neoplasm;Malignant Neoplasms;Maps;Medical;Medical Oncologist;meetings;Mosaicism;multidisciplinary;Natural History;Nature;Neonatal;Neoplasms;Non-Malignant;Not Hispanic or Latino;obstetric care;Participant;Patau&apos;s syndrome;Pattern;Peer Review;Physical Examination;Physicians;Placenta;Plasma;Plasma Cells;Positive Test Result;Postpartum Period;Predictive Value;Pregnancy;pregnant;Pregnant Women;prenatal;Prenatal care;prenatal testing;Professional Organizations;Provider;Proxy;Publications;Published Comment;Publishing;Race;rare cancer;reference genome;Reporting;Retrospective Studies;Risk;Sampling;screening;Screening for cancer;Serum;symposium;Test Result;Testing;Time;Time Study;tumor;Twin Multiple Birth;Ultrasonography;ultrasound;United States;Uterine Fibroids;whole body imaging;Woman;Work;Writing,Natural history and evaluation of abnormal or nonreportable NIPT results and its association with maternal neoplasia,200400,NA,NA,NA,NA,7,NA,NA,74907,NA
11179930,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200403,NA,NA,1ZIAHG200403-06,NHGRI:320508\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,8257645 (contact),"BONHAM, VENCE L (contact)",NA,NA,NA,Address;Adult;Advocacy;Advocate;Attenuated;Attitude;Awareness;Biomedical Research;black women;Child;Clinical;clinical care;Clinical Data;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Communities;community organizations;Decision Making;Descriptor;Development;Diffusion;Disease;education resources;Educational Materials;Equity;Ethnic Origin;Ethnic Population;Focus Groups;Future;gene therapy;Genes;Genetic;Genetic Variation;Genomic medicine;Genomics;Germ Lines;Goals;Government;Health;Healthcare;Hematologist;Human Genetics;improved;Individual;Industry;Institution;low income country;Medical;Medicine;meetings;Methods;Minority;novel;Parents;Patient Care;Patient Education;Patients;Physicians;Population;preference;prenatal testing;Process;Provider;psychologic;public trust;Publishing;Race;racial population;Recommendation;Recording of previous events;Research;Research Personnel;research study;Resource-limited setting;Resources;Risk;Sampling;Science;Services;Sickle Cell Anemia;Sickle Cell Trait;Social isolation;Social Network;Social Power;Societies;Sociology;US State;Validation;willingness;Woman;Work,Examining the Equitable Integration of Genomics in Health Care and Society,200403,NA,NA,NA,NA,6,NA,NA,320508,NA
11179931,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200409,NA,NA,1ZIAHG200409-05,NHGRI:1178336\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,77884991 (contact),"TIFFT, CYNTHIA  (contact)",NA,NA,NA,Adaptive Behaviors;Adolescent;Adult;Agreement;Alzheimer&apos;s Disease;autosome;base editing;biobank;Blood;blood-brain barrier crossing;Brain;Candidate Disease Gene;candidate validation;Cell model;Cerebrospinal Fluid;Child;Childhood;Clinic;Clinical;Clinical Management;cohort;Collaborations;Compensation;Coupled;Data;data sharing;design;Development;Diagnosis;Disease;Disease Progression;Enrollment;enzyme deficiency;Enzymes;exhaust;extend lifespan;Family;fetal;Fibroblasts;first-in-human;Functional disorder;G(M2) Ganglioside;Galactosialidosis;Gangliosides;Gangliosidoses GM2;Gangliosidosis GM1;Gene Expression;gene therapy;Gene therapy trial;Gene Transfer;Generations;Genes;genome wide screen;GLB1 gene;Glycoprotein Degradation Pathway;Glycoproteins;Glycosphingolipids;Human;humanized mouse;impression;improved;Individual;infancy;Infant;inhibitor;Intervention Trial;Intravenous;Laboratories;Lead;life span;Lipomucopolysaccharidoses;manufacture;Massachusetts;medical schools;Mission;Molecular;mouse model;Multicenter Trials;Mus;Mutation;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;Neurodegenerative Disorders;Neurologist;novel therapeutics;Nursing Research;Outcome;Outcome Measure;Parkinson Disease;Pathogenesis;Pathway interactions;patient expectation;Patients;Phase;Phenotype;Postbaccalaureate;Postdoctoral Fellow;Pregnancy;Process;Production;programs;prospective;Prospective Studies;Publications;Publishing;Rare Diseases;Reporting;Research;Research Design;safe patient;Sandhoff Disease;Site;small molecule;Sphingolipids;Symptoms;Tay-Sachs Disease;Techniques;Testing;Therapeutic;Therapeutic Intervention;Tissues;tractography;trial design;United States National Institutes of Health;Universities;Urine;vector;white matter;Work,Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders,200409,NA,NA,NA,NA,5,NA,NA,1178336,NA
11179932,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200411,NA,NA,1ZIAHG200411-04,NHGRI:177022\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377278 (contact),"GUNTER, CHRISTIE  (contact)",NA,NA,NA,Access to Information;Advocacy;Anniversary;Appearance;Area;Biomedical Research;Collection;Communication;Communication Research;Communities;Complex;demographics;design;Desire for food;Development;Discipline;Educational workshop;effectiveness measure;efficacy evaluation;Ensure;Environment;Evaluation;evidence base;Evidence based practice;expectation;experience;Exposure to;Extramural Activities;Foundations;Frequencies;Funding;Future;General Population;Goals;Government;Health;Health Priorities;Home;Individual;Industry;insight;Institution;interdisciplinary collaboration;interest;Interest Group;Intramural Research;Investments;Journals;Laboratories;Learning;meetings;member;Methodology;Methods;Misinformation;Mission;Modernization;Output;Participant;preference;pressure;Printed Media;Printing;Privatization;Productivity;Proliferating;Publishing;rare condition;Reporting;Research;Research Personnel;Research Priority;Resources;Respondent;response;Rice;Role;Sampling Biases;Scholarship;Science;Scientist;skills;social media;Students;success;Survey Methodology;Surveys;Television;Training;training opportunity;Uncertainty;United States;United States National Institutes of Health;Universities;Work,Mixed-Methods Studies of Science Communication,200411,NA,NA,NA,NA,4,NA,NA,177022,NA
11179933,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200419,NA,NA,1ZIAHG200419-04,NHGRI:679702\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377289 (contact),"MANOLIO, TERI  (contact)",NA,NA,NA,absorption;actionable mutation;Alleles;Area;arm;Biological Assay;Classification;Clinical;clinical care;Clinical Data;clinical diagnosis;Clinical Research;cohort;Collaborations;Consultations;Critical Pathways;Data;Databases;Diagnosis;editorial;Educational Materials;Electronic Health Record;Environment;ethnic difference;European;Excretory function;Frequencies;Funding;Gene Frequency;Genes;genetic testing;Genomic medicine;Genomics;Goals;Guidelines;Health;Hospitals;improved;Indigenous American;informatics tool;Knowledge;Latino;Manuscripts;Maryland;Medical center;Metabolism;non-genetic;Other Genetics;Patients;Pharmaceutical Preparations;pharmacogenetic variants;Pharmacogenetics;Pharmacogenomics;Population;Precision Health;Prevention;Principal Investigator;Provider;racial difference;Reporting;Research;response;symposium;Testing;Translating;Underrepresented Populations;Universities;user-friendly;Variant;Work,Genomic Medicine Implementation Unit,200419,NA,NA,NA,NA,4,NA,NA,679702,NA
11179934,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200422,NA,NA,1ZIAHG200422-01,NHGRI:643051\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377405 (contact),"SHCHELOCHKOV, OLEG  (contact)",NA,NA,NA,Affect;Awareness;Biochemical;Biomedical Research;Blood specimen;Body Fluids;Caring;Clinical;Clinical Management;Clinical Research;Collaborations;Data;Dietary Factors;Disease;DNA;eligible participant;enzyme activity;Enzymes;Frequencies;gastrointestinal;Genes;Genetic;Genetic Diseases;genetic variant;Genomics;Hospitalization;Image;imaging study;improved;Inborn Errors Purine-Pyrimidine Metabolism;industry partner;Laboratories;Laboratory Study;Link;Medical;metabolic abnormality assessment;microbiome;microbiome analysis;Mission;Natural History;next generation;novel;novel marker;Nutritional;Outcome;Participant;Pathogenicity;Pharmaceutical Preparations;pharmacologic;predictive modeling;primary endpoint;purine metabolism;Purines;pyrimidine metabolism;pyrimidine metabolism disorder;Pyrimidines;Quality of life;Recording of previous events;Sampling;secondary endpoint;skin biopsy;Study Subject;Tissue Sample;United States National Institutes of Health;Variant,Purine and Pyrimidine Metabolism Unit,200422,NA,NA,NA,NA,1,NA,NA,643051,NA
11179935,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200423,NA,NA,1ZIAHG200423-01,NHGRI:65093\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11613232 (contact),"PERSKY, SUSAN  (contact)",NA,NA,NA,Caring;Clinical;clinical practice;clinical research site;Clinical Trials;cybersickness;Data;experience;extended reality;Future;Health;Individual;Intervention;Medical;Medical Technology;Medicine;Motion Sickness;Patient Education;Preparation;Publishing;Recommendation;Technology;technology intervention;Therapeutic;Time;tool;Training;Virtual and Augmented reality;virtual reality;Work,Immersive technologies in health and medicine,200423,NA,NA,NA,NA,1,NA,NA,65093,NA
11179936,ZIC,AG,1,N,NA,NA,NA,NA,ZICAG000531,NA,NA,1ZICAG000531-04,NIA:6540836\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Age;age-related disease;aging related;Biology of Aging;Capital;Cloud Computing;disability;Equipment;equipment acquisition;Information Technology;Infrastructure;instrument;Investments;Laboratories;Methylation;programs;Research;Services;single cell genomics;Technology,Capital Equipment  General,531,NA,NA,NA,NA,4,NA,NA,6540836,NA
11179937,ZIC,AG,1,N,NA,NA,NA,NA,ZICAG000970,NA,NA,1ZICAG000970-17,NIA:457666\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Address;Age;Aging;Agreement;Autopsy;Baltimore;Biological;Blood specimen;Cardiovascular system;Cells;Clinic;Clinic Visits;Clinical Chemistry Tests;Clinical Research;Cognitive;Consent;Contracts;Databases;Dedications;Dementia;disability;Disease;Eligibility Determination;end of life;Enrollment;Event;Family;follow-up;frailty;Health;health assessment;Health Status;Healthcare;Home;Home visitation;Hospitals;human old age (65+);Impaired cognition;Individual;Informed Consent;interest;Longitudinal Studies;Malignant Neoplasms;mortality;Nursing Services;Outcome;Outcome Measure;Participant;participant enrollment;Persons;Physiological;Plasma;programs;Resources;Serum;Specimen;Subgroup;Telephone;Telephone Interviews;Time;Update;Visit;Visiting Nurse;willingness,The BLSA Home Visit Program,970,NA,NA,NA,NA,17,NA,NA,457666,NA
11179938,ZIC,CL,1,N,NA,NA,NA,NA,ZICCL040013,NA,NA,1ZICCL040013-17,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414709 (contact),"FRANK, JOSEPH  (contact)",NA,NA,NA,Academic Training;antagonist;Atherosclerosis;Basic Science;Biology;cell motility;Chemistry;Clinical;clinical center;Clinical Sciences;Colonic Polyps;Contrast Media;Core Facility;Development;Diagnostic radiologic examination;Doctor of Philosophy;Equipment;Goals;Image;image guided intervention;imager;imaging scientist;in vivo;Infrastructure;Integrins;Intervention;Intramural Research Program;Laboratories;Liposomes;Magnetic Resonance Imaging;Metabolic;Methods;microPET;Microscopy;Molecular;Molecular Biology;molecular imaging;multidisciplinary;Multimodal Imaging;multimodality;multiparametric imaging;nanoparticle;novel diagnostics;novel therapeutics;Pathologic;Positron-Emission Tomography;programs;Radioactive;radiologist;Radiology Specialty;reflectance confocal microscopy;Research;Research Personnel;Resources;Rodent Model;Science;Scientist;Services;stem cells;Synthesis Chemistry;System;tissue culture;trafficking;Training;Training Programs;Translational Research;X-Ray Computed Tomography,Core Research Services for Molecular Imaging and Imaging Sciences,40013,NA,NA,NA,NA,17,NA,NA,0,NA
11179939,ZIC,CL,1,N,NA,NA,NA,NA,ZICCL090006,NA,NA,1ZICCL090006-30,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9692823 (contact),"LEVIN, RONALD  (contact)",NA,NA,NA,AFP gene;Artificial Intelligence;Bite;Cardiovascular system;Clinical;clinical center;Clinical Sciences;cloud storage;Collaborations;Communities;Computers;Data;data anonymization;Data Storage and Retrieval;deep learning;Digital Imaging and Communications in Medicine;Directories;Disasters;Fostering;Image;Image Analysis;image processing;image visualization;Individual;Information Systems;Libraries;Licensing;Linux;Medical Imaging;member;Metadata;multicore processor;petabyte;Picture Archiving and Communication System;radiological imaging;Radiology Specialty;Recovery;Research;Rest;Security;Site;Speed;System;systems research;tool;United States National Institutes of Health;virtual machine;Visualization,MRIPS,90006,NA,NA,NA,NA,30,NA,NA,0,NA
11179940,ZIC,CA,1,N,NA,NA,NA,NA,ZICCP010178,NA,NA,1ZICCP010178-23,NCI:182736\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,9712952 (contact),"CHANOCK, STEPHEN J. (contact)",NA,NA,NA,Address;Advanced Technology Center;analytical tool;Area;Basic Science;Biological;Biological Assay;Cancer Etiology;cancer genetics;cancer genomics;Candidate Disease Gene;Clinical;Custom;Data;Data Storage and Retrieval;design;Division of Cancer Epidemiology and Genetics;DNA;DNA sequencing;Electronics;Employment;Epidemiologist;Equipment and supply inventories;Family;Gene Chips;Genetic;genetic analysis;Genetic Fingerprintings;genetic linkage analysis;Genetic Markers;Genetic Variation;genome wide association study;Genotype;Germ Lines;Heritability;high risk;Human;Informatics;Information Management;instrument;Intramural Research Program;Laboratories;Laboratory Research;Malignant Neoplasms;Management Information Systems;Mission;NCI Center for Cancer Research;new technology;next generation sequencing;operation;Outcome;population based;Predisposition;Preparation;Principal Investigator;Process;quality assurance;Quality Control;Residual state;Sampling;Scientist;Series;Signal Transduction;Statistical Methods;System;Technology;translational genomics;whole genome;Work,Cancer Genomics Research Laboratory,10178,NA,NA,NA,NA,23,NA,NA,182736,NA
11179942,ZIC,CA,1,N,NA,NA,NA,NA,ZICCP010192,NA,NA,1ZICCP010192-17,NCI:668701\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15188145 (contact),"BLACK, AMANDA  (contact)",NA,NA,NA,biobank;Biological Assay;Biological Specimen Banks;Collection;Division of Cancer Epidemiology and Genetics;DNA;epidemiology study;Genotype;Laboratories;Methods;Molecular Epidemiology;Population;repository;Research;Sampling;Services,"Biorepository Processing, Storage, and Research",10192,NA,NA,NA,NA,17,NA,NA,668701,NA
11179943,ZIC,CA,1,N,NA,NA,NA,NA,ZICCP010223,NA,NA,1ZICCP010223-13,NCI:223045\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,15666502 (contact),"HENDERSON, MARIANNE  (contact)",NA,NA,NA,Androgens;Biological Assay;Biomedical Research;Dedications;Development;Division of Cancer Epidemiology and Genetics;Estrogens;Hormones;Human;Infrastructure;Laboratories;liquid chromatography mass spectrometry;Measurement;Measures;method development;Population Study;Production;Proteomics;Techniques;Technology,Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,10223,NA,NA,NA,NA,13,NA,NA,223045,NA
11179944,ZIC,CA,1,N,NA,NA,NA,NA,ZICCP010226,NA,NA,1ZICCP010226-11,NCI:29608485\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,79341436 (contact),"KRAFT, PETER  (contact)",NA,NA,NA,Address;Adult;Age;biobank;Biological;Biological Markers;Cancer Etiology;cancer risk;clinical infrastructure;cohort;Cohort Studies;Computerized Medical Record;cost effective;Data;Development;Division of Cancer Epidemiology and Genetics;Drug Prescriptions;Electronics;follow-up;Future;Health Maintenance Organizations;Length;Medical;Medical Records;Military Personnel;next generation;novel;Outcome;Participant;Procedures;Productivity;prospective;Questionnaires;Recording of previous events;Records;Research;Resources;Risk Factors;Running;sample collection;Sampling;Stable Populations;System;Time;tissue archive;Tumor Tissue;Vertebral column;Work;working group,Cohort and Biobank Development,10226,NA,NA,NA,NA,11,NA,NA,29608485,NA
11179945,ZIC,HG,1,N,NA,NA,NA,NA,ZICHG200418,NA,NA,1ZICHG200418-04,NHGRI:1444092\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78832335 (contact),"TURNER, CLESSON  (contact)",NA,NA,NA,Address;American;analysis pipeline;Bioinformatics;bioinformatics pipeline;Blood specimen;Cassia;Chicago;CLIA certified;Clinical;clinical center;Clinical Data;Clinical Protocols;Clinical Research;clinically relevant;cohort;Collaborations;Collection;college;Communities;Compensation;Data;data de-identification;data harmonization;Data Storage and Retrieval;Databases;Development;Disease;Electronic Health Record;Eligibility Determination;eligible participant;Enrollment;Ensure;Environment;Evaluation;exome;Festival;Genes;Genetic Counseling;genetic counselor;Genetic Research;genetic variant;Genetic Variation;Genome;genome browser;genomic data;Genomics;Genotype;Goals;Healthcare Systems;human disease;Human Genetics;Individual;Infrastructure;insertion/deletion mutation;interest;Investigation;Joints;Journals;Knowledge;Laboratories;Lead;Leadership;Link;Manuscripts;Measures;Mediation;Medical Genetics;Methodology;Molecular;National Cancer Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Environmental Health Sciences;Nature;novel;Nursing Research;operation;Paper;Participant;Patient Recruitments;Persons;Phase;Phenotype;phenotypic data;posters;Precision Health;precision medicine;Principal Investigator;Process;programs;Protocols documentation;Publishing;Recontacts;recruit;Recruitment Activity;Reporting;Research;Research Activity;research clinical testing;Research Personnel;Research Project Grants;research study;Resources;Schedule;Scientist;Single Nucleotide Polymorphism;Site Visit;Societies;Source;Specialist;success;symposium;Testing;Time;tool;Travel;United States National Institutes of Health;Update;Variant;variant of interest;Washington;web site;Work,Reverse Phenotyping Core,200418,NA,NA,NA,NA,4,NA,NA,1444092,NA
11179946,ZIC,HG,1,N,NA,NA,NA,NA,ZICHG200420,NA,NA,1ZICHG200420-02,NHGRI:1156714\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377287 (contact),"DENNY, JOSHUA  (contact)",NA,NA,NA,17p;6p21;Adult Glioma;African American population;African ancestry;Aftercare;Age;Algorithms;Alleles;Allopurinol;amino acid metabolism;Amyloidosis;analysis pipeline;Anemia;Anus;Atlases;autoimmune rheumatologic disease;BANK1 gene;Behavior;beta Thalassemia;biobank;Biochemical Pathway;Black race;Blood Pressure;Blood Vessels;Bone necrosis;cancer classification;cancer genomics;cancer type;Cardiovascular Diseases;cardiovascular risk factor;Carpal Tunnel Syndrome;Case Series;Catalogs;causal variant;Clinical;clinical heterogeneity;clinical phenotype;cohort;Collaborations;computable phenotypes;Computer Analysis;Data;Diagnosis;Diet;Disease;disease phenotype;Disease Progression;Early identification;Electronic Health Record;enzyme activity;Evaluation;Event;Exclusion;Folic Acid;follow-up;Frequencies;Genes;Genetic;genetic architecture;Genetic Predisposition to Disease;Genetic Risk;genetic variant;Genome;genome wide association study;genomic data;Genomics;Genotype;Goals;Gout;Growth;Guidelines;Head and Neck Cancer;Health;Heart failure;Hemoglobinopathies;Heterozygote;High Prevalence;high risk;Hispanic;HLA-B Antigens;Homocysteine;Hyperparathyroidism;Hypertension;improved;Individual;interest;Iron deficiency anemia;ITGAM gene;Laboratories;Link;Logistic Regressions;Major Depressive Disorder;Malignant Breast Neoplasm;Malignant Neoplasms;Measurement;Mentors;Meta-Analysis;Metabolism;Methylenetetrahydrofolate reductase (NADPH);Micro Array Data;mutant;Mutation;National Human Genome Research Institute;Neoplasms;novel;Online Mendelian Inheritance In Man;Participant;Pattern;Pharmaceutical Preparations;phenome;Phenotype;Polyadenylation;Population;Population Heterogeneity;Prealbumin;Predisposition;Pregnancy;Prevalence;Primary Myocardial Diseases;Prognosis;prognostication;programs;Proxy;Pulmonary Embolism;purine metabolism;Purines;Pyrimidine;pyrimidine metabolism;Rare Diseases;rare mendelian disorder;Rectal Polyp;Renal function;Reporting;Research;Research Personnel;Risk;Role;Scientist;screening;Services;Severities;Sickle Cell Trait;Signal Transduction;social;STAT4 gene;Subgroup;Syndrome;Systemic Lupus Erythematosus;Testing;The Cancer Genome Atlas;Thrombosis;Time;Tissues;TP53 gene;Training;tumor;United States National Institutes of Health;Uric Acid;Uterine Fibroids;Validation;Variant;Work,Cohort Analytics Core,200420,NA,NA,NA,NA,2,NA,NA,1156714,NA
11179947,ZID,HG,1,N,NA,NA,NA,NA,ZIDHG200384,NA,NA,1ZIDHG200384-13,NHGRI:1301870\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,11613232 (contact),"PERSKY, SUSAN  (contact)",NA,NA,NA,alcohol abuse therapy;alcohol use disorder;Attention deficit hyperactivity disorder;Augmented Reality;Behavioral Research;Clinical;clinical center;Communication;Computer software;Consultations;Data;Data Analyses;Data Collection;data wrangling;Education;Environment Design;Family;Future;gene environment interaction;Genetic Diseases;Genetic Risk;Genomics;Healthcare;healthcare community;Industry;innovation;Intervention;Intervention Studies;Libraries;Medical;Methods;Minor;Motion Sickness;National Human Genome Research Institute;Physiological;Play;Preparation;programs;psychologic;Public Health;remote location;Reporting;Research;Research Design;Research Methodology;Research Project Grants;Resources;response;Role;Services;Shapes;simulation;social;Software Design;Stimulus;Technology;tool;United States National Institutes of Health;Virtual and Augmented reality;virtual environment;virtual reality;virtual reality environment;visual tracking;Work,Immersive Simulation Program,200384,NA,NA,NA,NA,13,NA,NA,1301870,NA
11179948,ZIE,AR,1,N,NA,NA,NA,NA,ZIEAR041176,NA,NA,1ZIEAR041176-17,NIAMS:1806306\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,79355707 (contact),"DEMARCO, PAUL  (contact)",NA,NA,NA,"Accreditation;Adult-Onset Still&apos;s Disease;Agonist;American;Ankylosing spondylitis;Antibodies;Area;Arthritis;Autoimmune Diseases;Blood Vessels;Businesses;cardiovascular risk factor;career;case-by-case basis;Certification;Child;Childhood;Cities;Clinic;Clinical;clinical care;clinical center;Clinical Research;clinical training;Community Health;Connective Tissue Diseases;Continuity of Patient Care;cytokine;Dedications;Degenerative polyarthritis;Dermatomyositis;Disease;District of Columbia;Educational Curriculum;Educational process of instructing;Eligibility Determination;Event;Faculty;Fellowship;Fellowship Program;Fever;Fibromyalgia;Functional disorder;Genetic;Gout;graduate medical education;Guidelines;immunoregulation;improved;Inclusion Body Myositis;Infectious Arthritis;Inflammatory;Infusion procedures;Inherited;inhibitor;Inpatients;Institution;Investigation;Journals;Juvenile Dermatomyositis;lectures;Length of Stay;Lupus;matriculation;Medical center;Medical Examiners;medical schools;meetings;Melorheostosis;Mentors;minority communities;Myositis;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;omalizumab;Oral;Osteoporosis;Outcome;Outpatients;participant enrollment;Pathogenesis;Patient Care;Patients;Periodicals;Polymyositis;Positioning Attribute;PPAR gamma;Prevention;programs;Protocols documentation;Pseudogout;Research;Research Activity;Research Project Grants;Research Training;Rheumatism;Rheumatoid Arthritis;Rheumatology;Role;Rotation;Safety;Sarcoidosis;Science;Services;Site;Societies;Spinal Fusion;Spondylarthritis;symposium;Syndrome;systemic juvenile idiopathic arthritis;Systemic Lupus Erythematosus;Systemic Scleroderma;Time;TNF gene;Training;Training Programs;Translational Research;United States National Institutes of Health;Universities;Vasculitis;ward;Washington",Clinical Training in Rheumatology,41176,NA,NA,NA,NA,17,NA,NA,1806306,NA
11179949,ZIE,GM,1,N,NA,NA,NA,NA,ZIEGM000002,NA,NA,1ZIEGM000002-18,NIGMS:1939818\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,NA,NA,78878495 (contact),"FALCON-MORALES, EDGARDO  (contact)",NA,NA,NA,"Amber;Area;Biochemistry;Bioinformatics;Biophysics;career;career development;career networking;Cellular biology;Colon;Developmental Biology;Doctor of Philosophy;Environment;experience;Genetic;Goals;Immunology;Individual;Intramural Research;Laboratory Research;Leadership;Mentors;Mission;Molecular Biology;National Center for Advancing Translational Sciences;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Drug Abuse;National Institute of Environmental Health Sciences;National Institute of General Medical Sciences;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Alcohol Abuse and Alcoholism;Neurosciences;Organism;Pharmacology;Physiology;Positioning Attribute;post-doctoral training;Postdoctoral Fellow;programs;Publications;Reporting;Research;Research Project Grants;Research Training;Science;Structure;technology development;Training;training opportunity;Training Programs;United States National Institutes of Health;United States National Library of Medicine;Veronica;ward",Postdoctoral Research Associate Training Program (PRAT),2,NA,NA,NA,NA,18,NA,NA,1939818,NA
11179950,ZIG,AG,1,N,NA,NA,NA,NA,ZIGAG000621,NA,NA,1ZIGAG000621-17,NIA:10570101\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79332327 (contact),"WILGENBURG, BRIAN  (contact)",NA,NA,NA,Accreditation;Advisory Committees;age related;age-related disease;Aging;animal care;Animal Care and Use Committees;Animal Experimentation;animal old age;Animal Welfare;Animals;Area;behavior test;behavioral phenotyping;Behavioral Research;Biology of Aging;Biomedical Research;biosecurity;Breeding;Caring;Cognitive;comparative;Contractor;Contracts;COVID-19;Educational process of instructing;Ensure;Facility Accesses;Genotype;Guidelines;Health;Housing;improved;International;Investigation;Laboratory Animals;Measures;Medicine;meetings;member;Mission;Motor;Mus;novel;Performance;Periodicals;Personal Satisfaction;Privatization;Procedures;programs;Regulation;Reporting;Reproducibility;Research;Research Personnel;Research Project Grants;Resources;sample collection;Sampling;Science;Services;Site Visit;Special needs;Techniques;Testing;Training;treatment research;United States National Institutes of Health;Update;Work,NIA IRP Comparative Medicine Section,621,NA,NA,NA,NA,17,NA,NA,10570101,NA
11179951,ZIH,AG,1,N,NA,NA,NA,NA,ZIHAG000775,NA,NA,1ZIHAG000775-07,NIA:180474\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Address;Aging;Algorithms;Alzheimer&apos;s Disease;Area;Biological Assay;Biology;Clinical;Cognition;Communication;Data;data archive;data curation;data dictionary;data infrastructure;data ingestion;data management;Data Management Resources;data pipeline;data platform;data quality;Data Science;data sharing;Dedications;Dementia;design;Documentation;Electronic Mail;Electronics;epidemiologic data;experience;Extramural Activities;Feedback;Genetic;Grant;Health Sciences;Human;Human Resources;image archival system;imaging study;Impaired cognition;Improve Access;improved;Individual;Information Systems;Infrastructure;interest;Knowledge;Laboratories;Leadership;Link;Medicine;metabolomics;Methods;Mission;Modernization;Monitor;multidisciplinary;neuroimaging;Occupations;Oral;Persons;Positioning Attribute;Process;Productivity;quality assurance;Quality Control;Reporting;Research;Research Personnel;Research Project Grants;research study;Resources;response;skills;Source;Specimen;System;systems research;Training;Update;web site;Work;Writing,"ALZHEIMER'S RESEARCH PROJECT: Building the Infrastructure for BLSA Data Management, Documentation, and Sharing",775,NA,NA,NA,NA,7,NA,NA,180474,NA
11179952,ZIH,CA,1,N,NA,NA,NA,NA,ZIHCP010205,NA,NA,1ZIHCP010205-16,NCI:7438763\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,78390333 (contact),"TOBIAS, GEOFFREY  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Biological Assay;Biomedical Computing;cancer prevention;Computer software;cost;Data Analytics;data management;Data Reporting;Development;Division of Cancer Epidemiology and Genetics;Documentation;Ensure;Epidemiology;Family;flexibility;Genetic;Laboratories;Malignant Neoplasms;Mission;novel strategies;Population;Population Sciences;Research;Research Activity;Resource Development;Resource Sharing;Resources;response;scientific computing;Support Contracts;System,Scientific Computing,10205,NA,NA,NA,NA,16,NA,NA,7438763,NA
11179953,ZIJ,CA,1,N,NA,NA,NA,NA,ZIJCP010204,NA,NA,1ZIJCP010204-16,NCI:414963\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,78390333 (contact),"TOBIAS, GEOFFREY  (contact)",NA,NA,NA,career development;Communication;Communities;Congresses;design;Development;Division of Cancer Epidemiology and Genetics;editorial;Education;Education and Outreach;Fellowship;Human Resources;Internships;Leadership;lectures;National Cancer Advisory Board;Newsletter;Policies;post-doctoral training;Postdoctoral Fellow;Preparation;Professional counselor;programs;Publishing;Report (document);Reporting;Research;Research Activity;Research Personnel;response;Site Visit;Students;summer student;Training;Training and Education;training opportunity;United States National Institutes of Health,"Communications, Education and Outreach",10204,NA,NA,NA,NA,16,NA,NA,414963,NA
11179954,ZIJ,CA,1,N,NA,NA,NA,NA,ZIJCP010208,NA,NA,1ZIJCP010208-15,NCI:45096\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS,NA,NA,NA,78381943 (contact),"YANG, HANNAH  (contact)",NA,NA,NA,Applied Research;Area;authority;Behavior Therapy;Behavioral;cancer epidemiology;clinical center;Ethical Review;Ethics;Genetic study;Health Services Research;human subject;Information Systems;Institutional Review Boards;Iris;Molecular;National Cancer Institute;Persons;Policies;Prevention;Protocols documentation;psychosocial;Research;Research Project Grants;response;Risk Assessment;Scientist;Social Aspects of Cancer;Support Contracts;System;United States National Institutes of Health;Work,IRB and NCI Ethical Review Panel (ERP) Support,10208,NA,NA,NA,NA,15,NA,NA,45096,NA
11180011,N01,AI,NA,N,NA,NA,NA,NA,272201300003I,NA,NA,272201300003I-P00005-27200010-1,NIAID:11105\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,ROCKVILLE,UNITED STATES,NA,08,012043055,US,1965903,"BIOQUAL, INC.",MD,208503336,NA,14498623 (contact),"LEWIS, MARK  (contact)",NA,2016-04-15,2019-08-14,Advanced Development;AIDS Vaccines;Award;Clinical;Complement;Contracts;Development;DNA;Evaluation Studies;Funding;Grant;HIV;HIV envelope protein;HIV vaccine;immunogenicity;Immunotherapy;Investigator-Initiated Research;Local Microbicides;Modality;Modeling;Mucous Membrane;National Institute of Allergy and Infectious Disease;nonhuman primate;pre-clinical;preclinical evaluation;preclinical study;Prevention;Prevention strategy;programs;Regimen;Research Personnel;Resources;simian human immunodeficiency virus;Vaccination;vaccine candidate;Vaccine Design;vaccine development;vaccine evaluation;Vaccine Research;Vaccines,"Study to investigate the immunogenicity and efficacy of a rVSV-HIVenv Prime, HIV envelope protein boost vaccination regimen and DNA-HIV Prime, rVSV-HIVenv boost vaccination regimen",0,NA,NA,NA,NA,NA,NA,NA,11105,NA
11180012,N01,HD,NA,N,NA,NA,NA,NA,275201400003I,NA,NA,275201400003I-P00002-759402200004-1,NICHD:56062\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ROCKVILLE,UNITED STATES,NA,08,161157953,US,3601801,"FISHER BIOSERVICES, INC.",MD,208505312,NA,78856053 (contact),"MARTIN, BRITTANY  (contact)",NA,2022-09-06,2025-09-05,18 year old;Adolescent;Age;Bar Codes;Biological Specimen Banks;Cataloging;Child;Childhood;Clinical;Clinical Research;Cohort Studies;Communicable Diseases;computerized;Contracts;Data;Database Management Systems;Eligibility Determination;Enrollment;Ensure;Equipment;Equipment and supply inventories;experience;Exposure to;Family;Future;Health;HIV;HIV-exposed uninfected infant;HIV/AIDS;Human;Human Resources;improved;Individual;Infant;Monitor;National Institute of Child Health and Human Development;Online Systems;operation;Outcome;pediatric human immunodeficiency virus;Perinatal;perinatal HIV;Pregnancy;pregnant;programs;Protocols documentation;quality assurance;Regulation;repository;reproductive;Reproductive Health;Research;Research Activity;Sampling;Secure;Services;Shipping;Site;Specimen;Support System;System;Toxic effect;Tube;United States;Woman;young woman;Youth,NICHD HUMAN BIOSPECIMEN REPOSITORY – MPIDB PHACS HOPE SPECIMEN,0,NA,NA,NA,NA,NA,NA,NA,56062,NA
11180016,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00046,NA,NA,75N95019C00046-P00014-9999-2,NIA:267708\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,BELMONT,UNITED STATES,NA,05,046514535,US,1876801,MCLEAN HOSPITAL,MA,024781064,NA,79955964 (contact),"BERRETTA, SABINA  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Alzheimer&apos;s Disease;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;cost;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;Performance;Process;Research;Resources;Site;Tissue Banks;Tissues;United States National Institutes of Health,"NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020",0,NA,NA,NA,NA,NA,NA,NA,267708,NA
11180018,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00046,NA,NA,75N95019C00046-P00014-9999-4,NIMH:1587739\NINDS:1027924\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,BELMONT,UNITED STATES,NA,05,046514535,US,1876801,MCLEAN HOSPITAL,MA,024781064,"This contract is for post-mortem human brain collection sites (i.e. the NIH Brain and Tissue Repositories [NBTR]) for the NIH NeuroBioBank. This contract is part of a strategy by the NIH to maximize availability of post-mortem human biospecimens to the research community while simultaneously achieving greater efficiency and better coordination of brain and tissue repository resources through a centralized approach to brain banking.""",79324360 (contact),"BERRETTA, SABINA  (contact)",NA,2024-09-01,2025-04-30,Autopsy;Brain;Collection;Communities;Contracts;Human;Research;Resources;Site;Tissue Banks;United States National Institutes of Health,NIH NATIONAL BRAIN AND TISSUE REPOSITORY,0,NA,NA,NA,NA,NA,NA,NA,2615663,NA
11180020,N02,CA,NA,N,NA,NA,NA,NA,75N91023C00039,NA,NA,75N91023C00039-P00003-9999-1,NCI:683523\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,LORTON,UNITED STATES,NA,11,146014373,US,10027818,"ARSERVICES, LTD",VA,220791961,NA,79326538 (contact),"BRYANT, WANDA  (contact)",NA,2023-09-24,2025-09-23,Area;Clinical Research;clinical trial protocol;Clinical Trials;Clinical Trials Database;Data;Elements;Human;Performance;Persons;Protocols documentation;Research Personnel;research study;Services,PROTOCOL INFORMATION OFFICE (PIO) SUPPORT SERVICES FOR THE PROCESSING OF CLINICAL TRIAL PROTOCOL DOCUMENTS AND TRACKING THE IMPLEMENTATION AND COMPLETION OF HUMAN CLINICAL RESEARCH STUDIES. PERFORMANC,0,NA,NA,NA,NA,NA,NA,NA,683523,NA
11180021,N01,DA,NA,N,NA,NA,NA,NA,75N95023C00021,NA,NA,75N95023C00021-P00001-9999-1,NIMH:3140878\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,CHAPEL HILL,UNITED STATES,NA,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,"The purpose of the NIMH PDSP is to provide screening of novel synthetic compounds and natural products for potential use as research tools or probes for basic and clinical research, as therapeutic agents for mental disorders, and as positron emission tomography (PET), single photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI) ligands for functional brain imaging.",79341682 (contact),"ROTH, BRYAN  (contact)",NA,2023-08-30,2025-08-29,Award;base;Basic Science;Brain imaging;Clinical Research;Functional Magnetic Resonance Imaging;Imaging ligands;Mental disorders;National Institute of Mental Health;Natural Products;novel;Positron-Emission Tomography;Psychotropic Drugs;Research;screening;screening program;single photon emission computed tomography;Therapeutic Agents;tool,TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024.,0,NA,NA,NA,NA,NA,NA,NA,3140878,NA
11180024,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00049,NA,NA,75N95019C00049-P00015-9999-3,NIA:1287827\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NEW YORK,UNITED STATES,NA,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,NA,79955967 (contact),"MOISE, JESSICA  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Alzheimer&apos;s Disease;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;preservation;Process;Research;Resources;Services;Site;Tissue Banks;Tissues;United States National Institutes of Health,"THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND DISTRIBU",0,NA,NA,NA,NA,NA,NA,NA,1287827,NA
11180025,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00049,NA,NA,75N95019C00049-P00015-9999-4,NIMH:372547\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NEW YORK,UNITED STATES,NA,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,NA,78324882 (contact),"MOISE, JESSICA  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Alzheimer&apos;s Disease;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;preservation;Process;Research;Resources;Services;Site;Tissue Banks;Tissues;United States National Institutes of Health,"THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND DISTRIBU",0,NA,NA,NA,NA,NA,NA,NA,372547,NA
11180027,N02,CA,NA,N,NA,NA,NA,NA,75N91021F00279,NA,NA,75N91021F00279-P00007-0-1,NCI:213096\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,RESEARCH TRIANGLE PARK,UNITED STATES,NA,04,004868105,US,6939101,RESEARCH TRIANGLE INSTITUTE,NC,277092194,NA,78388091 (contact),"BOGGS, ABBEY  (contact)",NA,2021-09-24,2024-09-23,cohort;Data;design;Methodology;National Cancer Institute;SEER Program,SPECIALIZED ANALYTIC DATA SUPPORT for SEER-MHOS DATA EXPANSIONS,0,NA,NA,NA,NA,NA,NA,NA,213096,NA
11180050,R42,CA,5,N,2024-09-09,2024-09-01,2025-08-31,395,R42CA275425,NA,PA-21-262,5R42CA275425-03,NCI:988000\,SBIR-STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,NATICK,UNITED STATES,NA,05,117142176,US,10057848,PACDNA LLC,MA,017606040,"Project Narrative Mutated KRAS is a highly prevalent oncoprotein driving a number of cancers, but pharmacological inhibition is  limited to only the G12C mutant despite over thirty years of research. Here, we propose to develop an  antisense oligonucleotide-based therapeutic agent which takes advantage of our proprietary delivery  technology. Building upon strong efficacy indication in non-small cell carcinoma mouse models, we will perform  additional structure optimizations, conduct toxicology/pharmacology studies in both mice and non-human  primates, and obtain additional indications in advanced preclinical animal models.",11684857 (contact),"ZHANG, KE  (contact)","FRANCA-KOH, JONATHAN C",2022-09-01,2025-08-31,Acceleration;acute toxicity;Address;alternative treatment;Animal Model;Anti-Inflammatory Agents;Antisense Oligonucleotide Therapy;Antisense Oligonucleotides;Area Under Curve;Automobile Driving;Binding;Biological Availability;Biological Products;Blood;Blood Coagulation Disorders;Body Weight;cancer cell;Cells;Characteristics;Chemicals;Clinic;Clinical;Clinical Chemistry;clinical development;Coagulation Process;Complement;cytokine;Data;Deoxyribonucleases;Development;dosage;Drug Kinetics;Exhibits;Gene Expression Regulation;Genes;Goals;Half-Life;Human;Immune system;Immunity;Immunocompetent;Immunologic Stimulation;immunotoxicity;improved;In Vitro;in vivo;Inflammation;inhibitor;Injections;intravenous administration;Kidney;knock-down;KRAS2 gene;Libraries;Liver;Lung;Macaca fascicularis;Malignant Epithelial Cell;Malignant Neoplasms;Marketing;Measurement;Mediating;MEKs;Messenger RNA;Methods;Modality;Modeling;Modification;Molecular;Monitor;Monkeys;Morbidity - disease rate;mortality;mouse model;Mus;mutant;Mutate;Mutation;nanoparticle;neglect;Non-Small-Cell Lung Carcinoma;nonhuman primate;novel;nucleic acid-based therapeutics;Nucleic Acids;Oligonucleotides;Oncogenes;Oncoproteins;patient derived xenograft model;Pharmaceutical Preparations;pharmacologic;Pharmacologic Substance;Pharmacology and Toxicology;Pharmacology Study;Phase;phosphodiester;Plasma;Polyethylene Glycols;Polymers;pre-clinical;Pre-Clinical Model;preclinical toxicity;Property;Proteins;Publishing;Refractory;Research;response;Ribonuclease H;Safety;safety assessment;Side;side effect;Signal Pathway;single molecule;Single-Stranded DNA;small molecule;small molecule inhibitor;stem;Structure;subcutaneous;Technology;Therapeutic;Therapeutic Agents;Therapeutic Intervention;Toll-like receptors;Toxic effect;Translating;Translational Repression;Translations;treatment strategy;tumor;Tumor Suppression;uptake;Urine;Vertebral column;Xenograft Model,Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent,275425,ZRG1,Special Emphasis Panel[ZRG1-OTC-S(12)B],NA,NA,3,770000,188000,988000,NA
11180542,U18,FD,1,N,2024-09-17,2024-09-20,2025-08-31,103,U18FD008488,SCHOOLS OF VETERINARY MEDICINE,RFA-FD-24-042,1U18FD008488-01,FDA:1150000\,OTHER RESEARCH-RELATED,2024,FOOD AND DRUG ADMINISTRATION,NA,ITHACA,UNITED STATES,VETERINARY SCIENCES,19,872612445,US,1514802,CORNELL UNIVERSITY,NY,148502820,"Project Narrative  In the present project we propose to address critical gaps in our understanding of the risk posed by Highly pathogenic avian influenza (HPAI) circulation in dairy cattle and its shedding in milk from affected animals. Our team will investigate the efficacy of raw milk cheese aging- and will determine the kinetics of virus inactivation in several dairy products. Additionally, we will identify products that can inactivate the virus in raw milk, so that these products can be used to mitigate the risks posed by raw milk to other animals and to humans. .",79946103;14731428 (contact);79947814,"ALCAINE, SAMUEL DAVID;DIEL, DIEGO G (contact);MARTIN, NICOLE","BUTLER, KRISTIN",2024-09-20,2025-08-31,NA,Mitigation of Highly pathogenic influenza (HPAI) in milk and dairy products,8488,ZFD1,Special Emphasis Panel[ZFD1 CFSN-T (05)],NA,NA,1,785498,364502,1150000,NA
11180551,U54,CA,3,N,2024-09-04,2024-09-01,2025-08-31,NA,U54CA156734,NA,PAR-18-767,3U54CA156734-14S1,NCI:369198\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,08,808008122,US,850902,UNIVERSITY OF MASSACHUSETTS BOSTON,MA,021253300,NA,77954170 (contact),"ESCALERA, LIYA  (contact)","WALI, ANIL",2010-09-28,2026-08-31,Address;American;Area;behavioral and social science;Behavioral Sciences;Black Populations;Boston;Cancer Center;cancer health disparity;career;career development;Color;Communication;Communities;COVID-19 pandemic;Dana-Farber Cancer Institute;design;Development;Disabled Persons;Discipline;Discipline of Nursing;Disparity;Doctor of Philosophy;Education;education research;Educational Status;Enrollment;Ethnic Population;evidence base;experience;Faculty;Fellowship;Fostering;Genomics;Graduate Degree;graduate school;graduate student;Grant;Group Affiliation;Growth;Health;health communication;Health Disparities Research;health disparity;Healthcare;improved;Individual;Infrastructure;innovation;Institutional Racism;interest;Intervention;Investments;Knowledge;Latinx;Low Income Population;Malignant Neoplasms;Manuscripts;Massachusetts;Mentors;Methods;multidisciplinary;Native Americans;NCI Center for Cancer Research;outreach;Peer Review;personalized cancer therapy;Phase;physical science;Population;Population Heterogeneity;Postbaccalaureate;Postdoctoral Fellow;Preparation;Process;Productivity;programs;Publications;racial population;Research;research and development;Research Design;Research Personnel;Research Project Grants;research study;Science;Science Enrichment;Scientific Advances and Accomplishments;Scientist;skills;Students;success;Training;undergraduate student;Underrepresented Populations;Underrepresented Students;Universities;Work,Research Education Core,156734,ZCA1,ZCA1-SRB-2(A1)S,8821,S1,14,242097,127101,NA,369198
11180574,N01,HD,NA,N,NA,NA,NA,NA,275201800006I,NA,NA,275201800006I-0-759402400001-1,NICHD:576764\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ROCKVILLE,UNITED STATES,NA,08,096360284,US,1381101,"THE EMMES COMPANY, LLC",MD,208501737,NA,14890551 (contact),"SHERMAN, SETH  (contact)",NA,2024-08-16,2025-08-15,18 year old;Address;Affect;Age Months;Beginning of Life;Behavior;Biological;Birth;Characteristics;Child Development;Child Rearing;Childhood;childhood adversity;Clinical;clinical research site;cohort;Collection;COVID-19 pandemic;Data;Data Collection;Data Coordinating Center;data platform;Data Set;Development;Discrimination;Disease;Disparity;economic disparity;Eligibility Determination;Enrollment;Environment;ethnic diversity;Ethnic Origin;Etiology;Family;Fathers;fetal;First Pregnancy Trimester;follow up assessment;follow-up;Generations;Gestational Age;Health;health disparity;improved;Individual;Inequality;Infant;Infant Development;Infant Health;Intervention Studies;Interview;Interviewer;Knowledge;knowledge base;Life;Life Cycle Stages;Link;Literature;Maternal Health;Measurement;Measures;Mediating;Medical Records;Mental Health;Methods;Monitor;Names;Neighborhoods;Neonatal;neurodevelopment;observational cohort study;offspring;Outcome;outcome disparities;pandemic disease;Parents;Participant;participant retention;Patient Self-Report;perceived stress;Performance;Persons;Phenotype;physical conditioning;Play;Population;population health;postnatal;Poverty;Pregnancy;Pregnant Women;prenatal;prospective;protective factors;Psychiatric Diagnosis;Psychopathology;Race;racial disparity;racial diversity;recruit;Research;Research Design;research study;Risk Factors;Role;Sampling;social disparities;Social support;Socioeconomic Status;socioeconomics;Source;Spanish;Strategic Planning;Stressful Event;substance use;System;Testing;theories;Training;Translations;transmission process;Umbilical Cord Blood;United States;United States National Institutes of Health;Update;Woman,DATA COORDINATING CENTER FOR THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES:  RECRUITMENT AND FOLLOW-UP OF SECOND SUBCOHORT OF PREGNANT WOMEN AND THEIR PARTNERS,0,NA,NA,NA,NA,NA,NA,NA,576764,NA
11180583,R33,HD,4,N,2024-09-12,2024-09-12,2025-08-31,865,R33HD109819,SCHOOLS OF MEDICINE,PAR-21-303,4R33HD109819-03,NICHD:298640\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,SALT LAKE CITY,UNITED STATES,INTERNAL MEDICINE/MEDICINE,01,009095365,US,514002,UNIVERSITY OF UTAH,UT,841129049,"Project Narrative Diarrheal diseases are a leading cause of morbidity and mortality in children worldwide. Appropriate management of childhood diarrhea depends on the type of pathogen responsible, but in many cases testing is not affordable or feasible. We propose to develop and validate a tool for rural healthcare workers that predicts etiology for pediatric diarrhea, and supports clinical decision making.",15074261;10349205 (contact);11628096,"KHAN, ASHRAFUL ISLAM;LEUNG, DANIEL TED (contact);NELSON, ERIC JORGE","MAJJI, SAI PRASANNA",2024-09-12,2027-08-31,"5 year old;acceptability and feasibility;Accounting;Acute Diarrhea;Age;Antibiotics;antimicrobial;Antimicrobial Resistance;Bangladesh;Blood;Breast Feeding;care costs;Caregivers;Cause of Death;Cellular Phone;Cessation of life;Child;Childhood;Climate;Clinical;clinical application;clinical decision support;clinical decision-making;Clinical Management;clinical predictive model;Collaborations;cost;Cross-Over Trials;Data;Development;Diagnosis;Diagnostic;Diarrhea;diarrheal disease;Drug Prescriptions;Electronics;Etiology;evidence base;Feasibility Studies;feasibility trial;Feces;Fever;Fostering;Goals;Habits;Health;Health Personnel;health training;Healthcare;Hydration status;implementation strategy;improved;Individual;innovation;Knowledge;Laboratories;Location;low and middle-income countries;Maps;Measures;Medical;Methods;mHealth;Mobile Health Application;Modeling;Modification;Morbidity - disease rate;mortality;pathogen;Patient Care;Patients;Performance;Phase;Physicians;Population;predictive tools;Prevalence;Primary Care;Provider;Randomized;Randomized, Controlled Trials;research and development;respiratory;Rural;rural area;rural healthcare;rural setting;Seasons;Site;support tools;Syndrome;Testing;tool;Toxic effect;Training;Trust;Viral;Vomiting;Work",A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh,109819,NSS,NSS,NA,NA,3,231275,67365,298640,NA
11180587,N01,HD,NA,N,NA,NA,NA,NA,75N94024P00565,NA,NA,75N94024P00565-0-0-1,NICHD:10000\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PHOENIX,UNITED STATES,NA,NA,020115796,US,NA,NA,AZ,85004,NA,NA,(contact),NA,2024-09-14,2025-09-13,Applications Grants;Biological;Contraceptive Agents;Contraceptive methods;Contractor;Contracts;Critiques;experience;Funding;Goals;Grant;Intellectual Property;Laws;Legal patent;men;Methods;Mission;National Institute of Child Health and Human Development;Pharmacologic Substance;prevent;programs;Research;Research Activity;research and development;Services;small molecule;Staff Development;unintended pregnancy;Woman,INTELLECTUAL PROPERTY CONSULTING SERVICE for Contraception Research,0,NA,NA,NA,NA,NA,NA,NA,10000,NA
11180590,N02,HD,NA,N,NA,NA,NA,NA,75N94024P00544,NA,NA,75N94024P00544-0-0-1,NICHD:20000\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,VIENNA,UNITED STATES,NA,NA,NA,US,NA,NA,VA,22181,NA,79933434 (contact),"GAMERMAN, GARY  (contact)",NA,2024-09-30,2025-09-29,Anti-Infective Agents;Antibodies;Authorization documentation;Award;Biological;Biological Products;Biological Sciences;Characteristics;Contraceptive Agents;Contraceptive methods;Contracts;design;Development;Devices;experience;Female;Funding;Gel;Goals;Government;Grant;Human;insight;Investigational New Drug Application;Knowledge;Logistics;male;manufacture;men;National Institute of Child Health and Human Development;novel therapeutics;Pharmaceutical Preparations;Pharmacologic Substance;Polymers;pre-clinical;Preclinical Testing;Prevention;Process;programs;Property;Published Comment;Recommendation;Regulatory Pathway;Reproductive Health;Research;research and development;Services;small molecule;Technology;Testing;Woman,AD HOC CONSULTING AND OPINIONS FOR REGULATORY RELATED SERVICES FOR CONTRACEPTIVE RESEARCH,0,NA,NA,NA,NA,NA,NA,NA,20000,NA
11180591,N02,HD,NA,N,NA,NA,NA,NA,75N94024P00543,NA,NA,75N94024P00543-0-0-1,NICHD:20000\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,DURHAM,UNITED STATES,NA,09,079590879,US,10037765,"LEADING EDGE PHARMTOX, LLC",NC,277135826,NA,79933431 (contact),"KELCE, WILLIAM  (contact)",NA,2024-08-25,2025-08-24,Award;clinical development;Consultations;Contraceptive Agents;Contraceptive methods;Contracts;Data;design;Development Plans;drug development;drug discovery;Ensure;experience;Experimental Designs;Funding;Grant;Knowledge;men;Monitor;National Institute of Child Health and Human Development;participant safety;Pharmacology and Toxicology;Procedures;Program Development;Protocols documentation;Recommendation;Reporting;reproductive;Reproductive Sciences;Research;research facility;Research Personnel;Risk Assessment;Safety;Services;Technology;Toxicology;U-Series Cooperative Agreements;Woman,TOXICOLOGY CONSULTING FOR REPRODUCTIVE SCIENCE and Contraception Research,0,NA,NA,NA,NA,NA,NA,NA,20000,NA
11180594,N02,HD,NA,N,NA,NA,NA,NA,75N94024P00502,NA,NA,75N94024P00502-0-0-1,NICHD:17950\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,SAN DIEGO,UNITED STATES,NA,51,621516145,US,10027826,POLYPEPTIDE LABORATORIES SAN DIEGO,CA,921264310,NA,79912482 (contact),"SCANO, BERNADETTE  (contact)",NA,2024-08-01,2025-07-31,Address;Adolescent;Child Development;Clinical;Clinical Research;Clinical Trials;Collaborations;Contraceptive Agents;Contraceptive methods;Contractor;Contracts;cost;Development;Ethics;Failure;Government;Growth and Development function;Health;Infant;innovation;Investigational Drugs;KISS1 gene;Laboratories;life span;men;Mentors;Methods;Mission;National Institute of Child Health and Human Development;novel;Peptide Synthesis;Peptides;Personal Satisfaction;Pharmaceutical Preparations;Population;population health;Pregnant Women;Program Development;Protocols documentation;Reproduction;Research;research and development;research clinical testing;Research Personnel;Services;Shipping;stability testing;Translating;Translational Research;Vendor;Vial device;Woman,STORAGE AND STABILITY STUDY OF DRUG SUBSTANCES AND PRODUCTS FOR CONTRACEPTIVE DEVELOPMENT,0,NA,NA,NA,NA,NA,NA,NA,17950,NA
11180598,N02,HD,NA,N,NA,NA,NA,NA,75N94024P00469,NA,NA,75N94024P00469-0-0-1,NICHD:50000\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,VIENNA,UNITED STATES,NA,11,117360963,US,10080134,GARDNER PHARMACOLOGY LLC,VA,221821995,NA,79921099 (contact),"GARDNER, ERIN  (contact)",NA,2024-09-14,2025-09-13,clinical development;Clinical Trials;Collaborations;Computer software;Consultations;Contraceptive Agents;Contraceptive methods;Contractor;Contracts;Data;Data Analyses;data modeling;design;Development Plans;Dose;drug development;drug discovery;Drug Kinetics;Ensure;Essential Drugs;Experimental Designs;experimental study;Feedback;Frequencies;Funding;Goals;Grant;improved;men;Methodology;Mission;Monitor;National Institute of Child Health and Human Development;Outcome;participant safety;Pharmaceutical Preparations;pharmacologic;Pharmacology;Plasma;pre-clinical;prevent;Procedures;programs;Protocols documentation;Recommendation;Reporting;Research;research and development;research facility;Research Personnel;Risk Assessment;Route;Safety;Sampling;Services;Staff Development;Time;Toxicology;U-Series Cooperative Agreements;unintended pregnancy;Woman,PHARMACOLOGY CONSULTING SERVICES for Contraception Research,0,NA,NA,NA,NA,NA,NA,NA,50000,NA
11180600,N01,HD,NA,N,NA,NA,NA,NA,75N94024P00145,NA,NA,75N94024P00145-0-0-1,NICHD:8250\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,SAN DIEGO,UNITED STATES,NA,51,621516145,US,10027826,POLYPEPTIDE LABORATORIES SAN DIEGO,CA,921264310,NA,NA,(contact),NA,2024-02-06,2024-07-31,Address;Adolescent;Child Development;Clinical;Clinical Research;Clinical Trials;Collaborations;Contraceptive Agents;Contraceptive methods;Contractor;Contracts;cost;Development;Ethics;Failure;Government;Growth and Development function;Health;Infant;innovation;Investigational Drugs;KISS1 gene;Laboratories;life span;men;Mentors;Methods;Mission;National Institute of Child Health and Human Development;novel;Peptide Synthesis;Personal Satisfaction;Pharmaceutical Preparations;Population;population health;Pregnant Women;Program Development;Protocols documentation;Reproduction;Research;research and development;research clinical testing;Research Personnel;Shipping;stability testing;Translating;Translational Research;Vendor;Vial device;Woman,STORAGE AND STABILITY TEST ON GMP GRADE ACYLINE AND OTHER DRUG SUBSTANCES FOR CONTRACEPTIVE DEVELOPMENT,0,NA,NA,NA,NA,NA,NA,NA,8250,NA
11180642,UG1,DA,5,N,2024-03-07,2024-03-01,2025-02-28,NA,UG1DA040309,NA,RFA-DA-20-024,5UG1DA040309-10,NIDA:136610\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,HANOVER,UNITED STATES,NA,02,041027822,US,2021601,DARTMOUTH COLLEGE,NH,037551421,NA,2102065 (contact),"MARSCH, LISA A. (contact)","DOBBINS, RONALD",2015-09-01,2025-02-28,Alcohols;Artificial Intelligence;Behavior Therapy;behavioral health;Bioinformatics;Cannabis;Caring;chronic pain;Clinical Treatment;Clinical Trials;Clinical Trials Network;Communication;Communities;Community Healthcare;Community Networks;community organizations;comorbidity;Complement;Data Analytics;data privacy;Data Science;design;digital data;digital health;digital technology;digital treatment;disorder prevention;Drug abuse;experience;Experimental Designs;Funding;Health Services Accessibility;Healthcare;Helping to End Addiction Long-term;implementation science;improved;Individual;Infrastructure;innovation;Lead;Maine;marijuana use;Medical;Mental disorders;National Clinical Trials Network;National Institute of Drug Abuse;New Hampshire;Opiate Addiction;Opioid;opioid misuse;opioid use;opioid use disorder;Pharmaceutical Preparations;Pharmacy facility;Policies;predictive modeling;Pregnant Women;Productivity;Protocols documentation;Public Health;randomized trial;Research;Research Personnel;Resources;Rural;Rural Community;scale up;Science;Security;social media;Speed;Stimulant;substance use;Substance Use Disorder;substance use treatment;System;Technology;Time;Tobacco;treatment disparity;Treatment Effectiveness;United States National Institutes of Health;Vermont;Youth,Project-002,40309,ZDA1,ZDA1-GXM-A(09)R,7824,NA,10,83299,53311,NA,136610
11180683,N43,AI,NA,N,NA,NA,NA,NA,75N93024C00028,NA,NA,75N93024C00028-0-9999-1,NIAID:299997\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,CHARLOTTESVILLE,UNITED STATES,NA,05,142252225,US,10069630,"LUNA LABS USA, LLC",VA,229035231,NA,78983908 (contact),"WRIGHT, MELISSA  (contact)",NA,2024-09-01,2025-08-31,Acceleration;acquired factor;Age;Aggressive course;Anti-viral Agents;antiretroviral therapy;burden of illness;Complex;Contracts;Death Rate;Development;drug action;Goals;Hepatitis C Acquisition;Hepatitis C Therapy;Hepatitis C virus;HIV;HIV Seronegativity;HIV/HCV;Hydrogels;Implant;Individual;Liver diseases;Liver Fibrosis;Morbidity - disease rate;mortality;Persons;Pharmaceutical Preparations;Polymers;Primary carcinoma of the liver cells;Risk Factors;Subcutaneous Injections;tumor;United States;Viral;Viral hepatitis,Long-Acting Antiviral Implant for the Treatment of HCV,0,NA,NA,NA,NA,NA,NA,NA,299997,NA
11180735,N01,AI,NA,N,NA,NA,NA,NA,75N93023D00001,NA,NA,75N93023D00001-0-759302400006-1,NIAID:536931\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,KENSINGTON,UNITED STATES,NA,08,094888294,US,319502,"ADVANCED BIOSCIENCE LABORATORIES, INC.",MD,208951042,NA,NA,(contact),NA,2024-09-01,2030-08-31,NA,Expertise in the Product Development Lifecycle,0,NA,NA,NA,NA,NA,NA,NA,536931,NA
11180738,R01,HL,7,N,2024-09-21,2024-09-24,2025-08-31,837,R01HL153384,SCHOOLS OF MEDICINE,PA-24-254,7R01HL153384-05,NHLBI:439526\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,GALVESTON,UNITED STATES,INTERNAL MEDICINE/MEDICINE,14,800771149,US,578406,UNIVERSITY OF TEXAS MED BR GALVESTON,TX,775555302,"Project Narrative Cardiovascular and kidney disease frequently co-exist for reasons that are poorly understood. Soluble urokinase plasminogen active receptor (suPAR) is a recently discovered cause of kidney disease and a strong marker of cardiovascular risk, and we propose studying the role for suPAR in cardiovascular disease and testing the hypothesis that people with high suPAR levels have early and progressive atherosclerosis, independently of its known impact on the kidneys. Understanding the role of suPAR as a novel pathogenic factor of CVD and biomarker of risk will lead to the design and study of therapeutic and preventive interventions with wide reaching impact.",15871513 (contact),"HAYEK, SALIM  (contact)","PUGGAL, MONA A",2020-07-01,2025-08-31,Acceleration;Address;Arterial Fatty Streak;arterial stiffness;Atherosclerosis;Binding;biobank;Biological Markers;Bone Marrow;Brain natriuretic peptide;C-reactive protein;Calcium;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular risk factor;Cardiovascular system;Cause of Death;Chronic;Chronic Kidney Failure;Circulation;clinical practice;cohort;coronary artery calcium;coronary calcium scoring;cytokine;Data;data repository;Data Set;design;Development;Diffuse;Discrimination;Disease;Disease Outcome;disorder risk;Endothelium;Enrollment;Environmental Exposure;Epidemiology;Etiology;experience;Experimental Models;experimental study;follow-up;Foundations;Functional disorder;Funding;Genes;Genetic;Genetic Determinism;genetic variant;genome wide association study;Glycoproteins;Goals;healthy volunteer;high risk;individualized medicine;Inflammation;Inflammatory;Injections;Injury;Injury to Kidney;Innate Immune System;insight;Kidney;Kidney Diseases;kidney dysfunction;Knowledge;Link;Measurement;Measures;Membrane;Mendelian randomization;Meta-Analysis;modifiable risk;Multi-Ethnic Study of Atherosclerosis;multidisciplinary;Myeloid Cells;novel;Outcome;overexpression;Participant;Pathogenicity;Pathway interactions;Patients;Persons;pharmacologic;Placebos;Plasminogen;PLAU gene;PLAUR gene;Population;prevent;preventive intervention;Process;Prospective cohort;Prospective Studies;Randomized;randomized trial;receptor;Recombinant Proteins;Renal function;Research;response;Risk;Risk Factors;Role;rosuvastatin;Sampling;Science;Secure;Signaling Molecule;Surface;Testing;Therapeutic Intervention;Therapeutic Studies;therapeutic target;Troponin I;Tubular formation;United States;United States National Institutes of Health;Urokinase;Urokinase Plasminogen Activator Receptor;Virulence Factors;volunteer;Work,Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease,153384,CHSA,"Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]",NA,NA,5,285861,153665,439526,NA
11180747,R01,HL,7,N,2024-11-01,2024-11-01,2025-11-30,837,R01HL149807,SCHOOLS OF MEDICINE,PA-24-254,7R01HL149807-06,NHLBI:122328\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,MORGANTOWN,UNITED STATES,PEDIATRICS,02,191510239,US,9163701,WEST VIRGINIA UNIVERSITY,WV,265066845,"Project Narrative We seek to understand why some children with single ventricle heart disease fail after surgical procedures. Currently, images from echocardiography, catheterizations, and cardiovascular magnetic resonance are being used to qualitatively choose the best surgical approach for these patients. In this project, we aim to quantitatively determine the most optimal surgical repair for each patient by simulating different surgical repairs and comparing the post-surgical hemodynamics.",10401354 (contact),"HEDJAZI MOGHARI, MEHDI  (contact)","EVANS, FRANK",2020-01-03,2025-11-30,3-Dimensional;Acceleration;Address;Affect;Algorithms;Anastomosis - action;Anatomy;Anesthesia procedures;Applications Grants;automated segmentation;Blood;Blood flow;blood flow measurement;Blood Pressure;Breathing;Cardiac;Cardiac Surgery procedures;Cardiovascular system;Catheterization;Cessation of life;Child;Circulation;Compensation;Complex;Congenital Abnormality;congenital heart abnormality;convolutional neural network;Data;Data Set;Decision Making;design;Echocardiography;Elasticity;Elements;expiration;Friction;Heart;heart function;heart imaging;heart motion;hemodynamics;Image;image registration;imaging modality;improved;Lead;Life;Liquid substance;Lung;Magnetic Resonance;Magnetic Resonance Imaging;mathematical methods;Measures;Methodology;Methods;Modeling;Morbidity - disease rate;mortality;Motion;Myocardium;Newborn Infant;Operative Surgical Procedures;Outcome;Palliative Surgery;Patient Outcomes Assessments;Patients;Phase;Positioning Attribute;Property;Radial;Rationalization;reconstruction;repaired;Research;respiratory;segmentation algorithm;simulation;Single ventricle congenital heart disease;spatial relationship;Surface;Surgeon;Surgical Models;Survival Rate;System;three-dimensional modeling;Time;two-dimensional;United States;vector;Venous system;virtual surgery;viscoelasticity,Simulating Cardiac Surgery for Children with Severe Congenital Heart Disease,149807,IGIS,Imaging Guided Interventions and Surgery Study Section[IGIS],NA,NA,6,80479,41849,122328,NA
11180772,R01,HL,7,N,2024-11-15,2024-08-31,2025-04-30,838,R01HL144718,SCHOOLS OF MEDICINE,PA-24-254,7R01HL144718-06,NHLBI:2168770\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,WORCESTER,UNITED STATES,INTERNAL MEDICINE/MEDICINE,02,603847393,US,850903,UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,016550002,There is a fundamental gap in understanding the early origins of Chronic Obstructive Pulmonary Disease. Our long term goal is to arrest COPD progression by under- standing its earliest stages. We will recruit a new cohort of younger at-risk individuals to link chest imaging and pathologic abnormality with longitudinal disease progression and thus define potentially targetable mechanisms laying the foundation for developing disease-modifying therapies.,1893520;9221095;6090432 (contact),"CURTIS, JEFFREY LOUIS;HAN, MEILAN K;MARTINEZ, FERNANDO J (contact)","POSTOW, LISA",2024-08-31,2025-04-30,"Activities of Daily Living;Age;Age Years;aged;airway epithelium;airway obstruction;airway remodeling;airway surface liquid;Anatomy;Biological;Biological Markers;Biological Process;Bronchoalveolar Lavage;Bronchodilator Agents;Bronchoscopy;Cell Physiology;cell type;chest computed tomography;Chest imaging;Chronic Obstructive Pulmonary Disease;Clinical;Clinical Data;cohort;Cross-Sectional Studies;Data;Data Collection;Dendritic Cells;detector;Development;Diagnosis;Disease;Disease Progression;Distal;early detection biomarkers;Early identification;Enrollment;Epithelium;Exhalation;follow-up;former smoker;Foundations;Funding;genetic signature;Goals;Growth;Histologic;Host Defense;Human;IL17 gene;Image;imaging approach;Immune;Immune response;immunoreaction;Individual;Industry;Infrastructure;innovation;insight;Knowledge;Lead;Leukocytes;Life;Link;Lung;Maps;Measures;Mucins;National Heart, Lung, and Blood Institute;never smoker;novel;Pathologic;Pathology;Phase;Physical condensation;Positioning Attribute;Predisposition;primary outcome;Process;programs;Pulmonary Emphysema;pulmonary function decline;Pulmonary Function Test/Forced Expiratory Volume 1;radiological imaging;recruit;Research;Resolution;Respiratory Signs and Symptoms;response;Risk;secondary analysis;Site;small airways disease;Smoker;Smoking;Smoking History;Spirometry;Sputum;Symptoms;Testing;therapeutic target;Tissues;Visit;X-Ray Computed Tomography",Understanding the Origins of Early COPD,144718,IRAP,"Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]",NA,NA,6,1953052,215718,2168770,NA
11180825,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL000909,NA,NA,1ZIACL000909-07,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414546 (contact),"WALLEN, GWENYTH R (contact)",NA,NA,NA,"18 year old;acceptability and feasibility;actigraphy;Admission activity;Adult;alcohol abuse therapy;Alcohol dependence;alcohol rehabilitation;alcohol use disorder;Alcohols;behavioral sleep intervention;Chronic Insomnia;Clinic;clinical center;Cognitive Therapy;comparative efficacy;Control Groups;cost;Data Collection;data quality;diaries;drinking;Drug Metabolic Detoxication;Education;Effectiveness;Effectiveness of Interventions;Electronics;experience;Goals;group intervention;improved;improved outcome;Individual;Inpatients;Internet;Intervention;Manuscripts;Methods;National Institute on Alcohol Abuse and Alcoholism;Nonpharmacologic Therapy;Online Systems;Outcome;Outcome Measure;Outpatients;Participant;participant enrollment;Persons;Phase;Phase I Clinical Trials;Play;Population;Preparation;Prevalence;primary outcome;Process;Program Effectiveness;programs;Protocols documentation;Randomized;Randomized, Controlled Trials;Recommendation;Recovery;Rehabilitation therapy;Research;response;Rest;screening;secondary outcome;Severities;Sleep;Sleep Disorders;Sleeplessness;sound;Testing;Time;Training;United States National Institutes of Health",Pilot RCT of web-based behavioral sleep intervention for individuals with alcohol use disorder,909,NA,NA,NA,NA,7,NA,NA,0,NA
11180826,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL001196,NA,NA,1ZIACL001196-09,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78381857 (contact),"LEE, LENA  (contact)",NA,NA,NA,18 year old;Address;Aging;Allogenic;American;Anxiety;arm;Behavior Therapy;care giving burden;Caregivers;caregiving;Caring;clinical center;Control Groups;Data Analyses;Data Collection;design;Development;Disease;Education;Effectiveness;effectiveness evaluation;Effectiveness of Interventions;effectiveness study;Eligibility Determination;Enrollment;experience;Family member;Friends;group intervention;Head;Health;Hematopoietic Stem Cell Transplantation;Home;improved;Individual;Intervention;Intervention Studies;Malignant Neoplasms;Meditation;Mental Depression;mindfulness;Nature;open data;Outcome;Pain;Patients;perceived stress;Personal Satisfaction;Population;primary caregiver;prospective;Protocols documentation;Questionnaires;Randomized;recruit;Research;Sampling;skills;Sleep disturbances;Stem cell transplant;Stress;Stress and Coping;stress reduction;Study Subject;Symptoms;Techniques;Testing;Time;Translations;Transplant Recipients;Transplantation Conditioning;treatment arm;United States National Institutes of Health;Yoga,Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients,1196,NA,NA,NA,NA,9,NA,NA,0,NA
11180827,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL001198,NA,NA,1ZIACL001198-09,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414546 (contact),"WALLEN, GWENYTH R (contact)",NA,NA,NA,18 year old;Abstinence;addiction;Admission activity;Adrenal Cortex Hormones;Adult;alcohol abuse therapy;Alcohol consumption;Alcohol dependence;alcohol use disorder;Alcohols;analysis pipeline;Antibiotics;Biological;Characteristics;Clinic;clinical center;comorbidity;Compensation;Complex;Consent;Data;Decision Making;Dental Hygiene;Diet;Diet Records;Dietary History;Disease;drinking;Drug Metabolic Detoxication;Enrollment;Evaluation;Exclusion Criteria;Feces;Gastrointestinal Diseases;Guidelines;gut microbiome;gut-brain axis;healthy volunteer;Human;Human Microbiome;Immunosuppressive Agents;Impairment;Individual;Inflammation Mediators;Informed Consent;Inpatients;interest;Intervention;Liver diseases;Manuscripts;Measures;Mental disorders;Metabolic;microbial;microbiome;microbiome research;next generation sequencing;Oral;oral microbiome;Participant;Patients;Policies;Population;Preparation;Probiotics;Protocols documentation;psychosocial;Publishing;Research;Ribosomal RNA;Sampling;Scientist;screening;Severities;Shotgun Sequencing;Specimen;theories;Tongue;Treatment Protocols;United States National Institutes of Health,Longitudinal Changes in the Oral and Gut Microbiome of Individuals with Alcohol Dependence,1198,NA,NA,NA,NA,9,NA,NA,0,NA
11180828,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002000,NA,NA,1ZIACL002000-09,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414546 (contact),"WALLEN, GWENYTH R (contact)",NA,NA,NA,Abstinence;Accelerometer;Alcohol consumption;Alcohol dependence;alcohol misuse;alcohol rehabilitation;alcohol use disorder;Alcoholism;alcoholism therapy;Back;Behavior;Behavioral;Belief;Cessation of life;Clinical Research;Communities;Complex;craving;Data;Data Analyses;Development;drinking;Expectancy;experience;Home;Individual;Inpatients;Interview;Investigation;Literature;Maintenance;Manuscripts;Measures;Methods;Modeling;National Institute on Alcohol Abuse and Alcoholism;open data;Outcome;Outpatients;Participant;Patients;Perception;Personal Satisfaction;Physical Dependence;Problem behavior;Process;Public Health;Qualitative Methods;Recovery;Rehabilitation therapy;Relapse;relapse prediction;Research;research facility;Schedule;Self Efficacy;Sleep;Sleep disturbances;sleep pattern;sleep quality;social cognitive theory;Structure,Sleep Disturbance and Relapse in Individuals with Alcohol Dependence: An Exploratory Mixed Methods Study,2000,NA,NA,NA,NA,9,NA,NA,0,NA
11180829,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002078,NA,NA,1ZIACL002078-29,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,16149096 (contact),"DE GIORGI, VALERIA  (contact)",NA,NA,NA,Acute Hepatitis C;acute infection;Aging;Antibodies;Antibody Response;Autobiography;autocrine;CCL2 gene;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;cell mediated immune response;chemokine;CHI3L1 gene;Chitinase;Chronic;Chronic Disease;Chronic Hepatitis C;chronic infection;chronic liver disease;circulating microRNA;Cirrhosis;cohort;Collaborations;Collagen;Containment;curative treatments;cytokine;cytotoxic;Disease Outcome;Disease Progression;Dreams;Escape Mutant;Evolution;extracellular vesicles;Fibrosis;Genotype;Goals;Helper-Inducer T-Lymphocyte;Hepatic;Hepatic Stellate Cell;Hepatitis;Hepatitis C;Hepatitis C virus;Heterogeneity;Immune;Immune Evasion;Immune response;Immune system;Immunologic Factors;Immunologics;Impairment;Indolent;Infection;Interferons;lectures;Liver;Liver Fibrosis;liver stiffness;Measurement;Measures;MicroRNAs;Mutation;National Institute of Allergy and Infectious Disease;National Institute of Diabetes and Digestive and Kidney Diseases;neutralizing antibody;next generation sequencing;Nobel Prize;Outcome;outcome prediction;Patients;Plasma;Population;predictive marker;pressure;Process;Publishing;Recovery;Research;response;Science;Serum;Specimen;stellate cell;Testing;Therapeutic;Time;Transforming Growth Factor beta;Variant;Viral;Viral Antigens;Viral Load result;Virus,Viral And Immune Factors That Influence Recovery Or Progression Of Hepatitis C,2078,NA,NA,NA,NA,29,NA,NA,0,NA
11180830,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002110,NA,NA,1ZIACL002110-24,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,16149096 (contact),"DE GIORGI, VALERIA  (contact)",NA,NA,NA,"Acquired Immunodeficiency Syndrome;Acute;Adult;Alloimmunization;American;Antibodies;antibody detection;Appearance;Area;Biological Assay;Blood;Blood Banks;Blood donor;Blood donor screening;blood product;Blood Tests;Blood Transfusion;California;Caribbean region;Chikungunya virus;Child;Childhood;chronic liver disease;Clinical;Cohort Studies;Collaborations;COVID-19 pandemic;Cytomegalovirus;Cytomegalovirus Infections;Data;Dengue;Detection;detection assay;Developed Countries;Development;DNA;Enrollment;Epidemic;Epitopes;Female;follow-up;Gene Chips;Hepatitis;Hepatitis B Transmission;Hepatitis B Virus;Hepatitis C Transmission;Hepatitis C virus;Hepatitis E virus;High Prevalence;high risk behavior;HIV;HIV/HCV;HLA Antigens;Hospitals;Human Herpesvirus 4;Human Herpesvirus 8;Human Parvovirus B19;Immunoglobulin G;Immunoglobulin M;improved;Infection;Infectious Agent;Investigation;Journals;Leukocytes;Light;Link;Lymphocyte;Measures;Medical center;meetings;Methods;Microchimerism;Molecular;Monitor;multiplex assay;Nucleic Acids;Operative Surgical Procedures;Outcome;Parvovirus;pathogen;patient safety;Patients;Phylogenetic Analysis;Population;Prevalence;Process;prospective;Prospective Studies;Prospective, cohort study;Publishing;real time monitoring;Reporting;repository;Reproducibility;Research Institute;Risk;Safety;Sampling;San Francisco;screening;seroconversion;Serology;Seroprevalences;South America;Specimen;suburb;systems research;Techniques;Technology;Testing;Time;Transfusion;Transfusion-Transmitted Virus;transmission process;Trauma;Travel;United States National Institutes of Health;Vascular blood supply;vigilance;Viral;viral detection;Viral Genome;viral RNA;viral transmission;Virus;Virus Diseases;Y Chromosome;Zika Virus",Transfusion-related Infections Prospectively Studied (TRIPS),2110,NA,NA,NA,NA,24,NA,NA,0,NA
11180831,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002121,NA,NA,1ZIACL002121-16,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,16149096 (contact),"DE GIORGI, VALERIA  (contact)",NA,NA,NA,anergy;Antibodies;Antigen-Antibody Complex;Autoimmune Diseases;Autoimmunity;B Cell Proliferation;B-Cell Development;B-Cell NonHodgkins Lymphoma;B-Lymphocyte Subsets;B-Lymphocytes;Binding;Biogenesis;cancer cell;CD19 gene;CD81 gene;Cell Communication;Cell surface;Cells;Chromosomal Duplication;Chromosome Deletion;Chronic;Chronic Hepatitis C;chronic infection;Clinical;Clonal Expansion;co-infection;Collecting Cell;Complement;Complement 3d Receptors;Complement Activation;complement system;Complex;Data;Detection;Development;Disease;Epidemiology;Epigenetic Process;Erythrocytes;Event;Extrahepatic;Fluorescent in Situ Hybridization;Gene Expression;Gene Fusion;gene translocation;Genetic;genetic signature;global health;Grant;Hepatic;Hepatitis B Virus;Hepatitis C;Hepatitis C Therapy;Hepatitis C virus;Hepatology;Host Defense;Immunoglobulin Genes;Immunosuppression;Infection;Innate Immune Response;insight;Interferon Type I;Intervention;Investigation;Link;Liver diseases;Lymphoid Tissue;Lymphoma;Lymphomagenesis;Lymphoproliferative Disorders;Manuscripts;Mediating;Messenger RNA;Molecular;Mongolia;monocyte;MS4A1 gene;Mutation;National Institute of Allergy and Infectious Disease;Natural Immunity;non-Hodgkin&apos;s lymphoma patients;Oncogenic;overexpression;Paraffin Embedding;Pathogenesis;Pathway interactions;Patients;Pattern;Peripheral;Peripheral Blood Mononuclear Cell;Plasma;programs;Proliferating;protein expression;Regulation;Regulator Genes;response;Ribosomes;Risk;RNA;RNA Probes;Role;Sampling;Signal Transduction;Small Nucleolar RNA;transcriptome sequencing;Viral;Viral Proteins;Virus;Virus Diseases;Virus Replication;Visualization;Whole Blood,HCV Infection and Innate Immunity,2121,NA,NA,NA,NA,16,NA,NA,0,NA
11180832,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL009027,NA,NA,1ZIACL009027-07,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414635 (contact),"SOLOMON, MICHAEL  (contact)",NA,NA,NA,Admission activity;Adult;Aging;Arrhythmia;Blood;Body System;Boston;Cardiac;cardiac intensive care unit;Cardiogenic Shock;Cardiology;Cardiovascular Diseases;Caring;Clinical;clinical care;clinical center;Collection;comorbidity;Complex;Coronary Care Units;Critical Care;Critical Illness;Data;Data Collection;Data Coordinating Center;data de-identification;Decision Making;Detection;Diagnostic;Disease;Eligibility Determination;Environment;Evaluation;Functional disorder;Health;Heart;Heart failure;Heart Transplantation;hemodynamics;Hospitals;immunosuppressed;Institutional Review Boards;Intensive Care;Intensive Care Units;Intervention;Ischemia;Laboratories;Length of Stay;Life;Lung;Managed Care;Medical;Medical Records;medical schools;Modernization;Multicenter Studies;multidisciplinary;Myocardial Infarction;Observational Study;Participant;participant enrollment;Patient Care;patient population;Patient-Focused Outcomes;Patients;Privacy;Procedures;Process;prognostication;Protocols documentation;Records;Refractory;Registries;Reporting;Resources;Risk;secondary outcome;Selection for Treatments;Septic Shock;Site;Specimen;Therapeutic;Transplant Recipients;Triage;United States National Institutes of Health;Woman,An Observational Study of Cardiac Critical Care Management in Multidisciplinary and Cardiac Intensive Care Units,9027,NA,NA,NA,NA,7,NA,NA,0,NA
11180833,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL009029,NA,NA,1ZIACL009029-07,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414635 (contact),"SOLOMON, MICHAEL  (contact)",NA,NA,NA,Adult;American;American Heart Association;Antiphospholipid Antibodies;Arteriosclerosis;Ascorbic Acid;assay development;B-Lymphocytes;Basic Science;Bioenergetics;Biological Assay;Biology;Blood;Blood specimen;Blood Vessels;Cardiology;cell free DNA;Cell Line;Cell Physiology;Cell Separation;Cells;clinical center;Clinical Research;Coagulation Process;Collaborations;Collection;college;Communicable Diseases;convalescent plasma;COVID-19;COVID-19 patient;Critical Care;density;Development;DNA;Ebola virus;endothelial dysfunction;Enrollment;Enzymes;Evaluation;extracellular;Fibrinolysis;Flow Cytometry;Generations;Genes;Genetic;Glycoproteins;granulocyte;Guidelines;healthy volunteer;Heart;Human;human subject;Immune;Immunophenotyping;In Vitro;induced pluripotent stem cell;Inflammation;Inflammatory;inflammatory marker;Institution;Institutional Review Boards;Journals;Kinetics;Laboratories;Life;Lipopolysaccharides;Lung;Lymphocyte;Maintenance;Medicine;member;Molecular;Natural Killer Cells;neutrophil;Neutrophil Activation;new therapeutic target;novel marker;operation;Paper;Patients;Peripheral Blood Mononuclear Cell;Plasma;Plasma Cells;Printing;Protocols documentation;Publishing;pulmonary arterial hypertension;Pulmonary Heart Disease;Relapsing polychondritis;Renal Replacement Therapy;Reporting;Research;Research Personnel;research study;Research Subjects;response;RNA;Role;Sampling;Sepsis;Severity of illness;SYK gene;symposium;Therapeutic;Thrombelastography;Thrombosis;Translational Research;Ultrafiltration;United States National Institutes of Health;Urine;Vascular Diseases;Viral Proteins;Virus Shedding;Western Blotting;Whole Blood,"Obtaining Samples from Human Subjects to Facilitate Basic, Translational and Clinical Research",9029,NA,NA,NA,NA,7,NA,NA,0,NA
11180834,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL010304,NA,NA,1ZIACL010304-26,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15700264 (contact),"ROSENZWEIG, SERGIO  (contact)",NA,NA,NA,"Address;Clinical Research Protocols;congenital immunodeficiency;cost effective;Data;Defect;Dideoxy Chain Termination DNA Sequencing;Disease;DNA Resequencing;exome sequencing;experience;Fluorescent Probes;FOXP3 gene;Future;Genes;genome sequencing;Genomic DNA;Host Defense;Hyperimmunoglobulin M Syndrome;IFNGR1 gene;IL7R gene;Immune System Diseases;immunodeficiency;Immunologic Deficiency Syndromes;Interleukin 2 Receptor Gamma;interleukin-12 receptor;Ions;JAK3 gene;Lymphoid;Methods;Mutation;Mutation Analysis;mutation screening;National Human Genome Research Institute;next generation sequencing;novel;Organism;patient screening;Patients;Receptors, Adrenergic, beta-1;recurrent infection;screening;Series;Techniques;Testing;TNFSF5 gene;United States National Institutes of Health;web site;whole genome;Wiskott-Aldrich syndrome protein;Work",Mutation Analysis Of Selected Lymphoid Immune Disorders,10304,NA,NA,NA,NA,26,NA,NA,0,NA
11180835,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL060092,NA,NA,1ZIACL060092-11,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,12471583 (contact),"LAU, ANNA  (contact)",NA,NA,NA,Adopted;Awareness;Biological Products;Cell Therapy;Clinical;Clinical Microbiology;Collaborations;comparative;Cyclic GMP;Data;Dental;Detection;diagnostic platform;Dialysis procedure;Disease;Ensure;Environmental Monitoring;Equipment;Evaluation;Event;Faculty;falls;Goals;Industry;Infusion procedures;International;Laboratories;Letters;Light;Manuscripts;Maryland;Methods;Mucor;Multicenter Studies;Mycoplasma;novel diagnostics;novel therapeutics;Patients;Pharmaceutical Preparations;Pharmacy facility;programs;Qualifying;Regulation;Ribosomal DNA;Safety;Sampling;sterility testing;symposium;T-Lymphocyte;Testing;United States National Institutes of Health;Universities;water testing,Novel Diagnostic Platforms for Sterility Testing of Cellular Therapies and Biopharmaceutical Products,60092,NA,NA,NA,NA,11,NA,NA,0,NA
11180836,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL080017,NA,NA,1ZIACL080017-14,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,11613030 (contact),"SACKS, DAVID  (contact)",NA,NA,NA,Address;Algorithms;alpha helix;Amino Acids;Area;Back;Binding;Biological;Branched-Chain Amino Acids;Breast;Calmodulin;Calmodulin-Binding Proteins;Cancerous;Cell Adhesion;cell motility;Cell Physiology;Cell Proliferation;Cells;Cirrhosis;clinical diagnosis;Compensation;Complex;Data Set;Degradation Pathway;Development;Down-Regulation;Eating;EGF gene;Electrostatics;Epidermal Growth Factor Receptor;ERBB2 gene;Evaluation;expectation;experimental study;Extracellular Signal Regulated Kinases;Fibrosis;Goals;Growth Factor;Hepatic;Hepatitis C virus;Homeostasis;Hydrophobic Interactions;Impairment;in silico;insight;instrument;Ions;KSR gene;Label;Laboratories;Liquid Chromatography;Liver;liver biopsy;Liver diseases;liver function;Malignant - descriptor;mass spectrometer;Measures;Mediating;Metabolic;Methods;microbial;microorganism;migration;Mitogen-Activated Protein Kinases;Modeling;Molecular;Molecular Conformation;molecular modeling;Multiprotein Complexes;Muscle;mutant;Mutation;Neoplastic Cell Transformation;Neurites;Normal Cell;Organ Size;overexpression;pathogen;Pathogenesis;Pathway interactions;Patients;Peripheral;Play;Process;Proteins;Proteomics;Public Health;Publishing;Regulation;Reporter;Research;Role;Running;Safety;Sampling;sarcopenia;Scaffolding Protein;Second Messenger Systems;Sensitivity and Specificity;Shunt Device;Signal Pathway;Signal Transduction;Site-Directed Mutagenesis;Specificity;stressor;structural determinants;Surgical Portosystemic Shunt;tandem mass spectrometry;Time;Tissues;tool;transcriptome;tumor;tumorigenesis;Urinary tract;Veins;Work,IQGAP1 in tumorigenesis,80017,NA,NA,NA,NA,14,NA,NA,0,NA
11180837,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090066,NA,NA,1ZIACL090066-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414635 (contact),"SOLOMON, MICHAEL  (contact)",NA,NA,NA,"Activities of Daily Living;Adult;Age;Algorithms;American;Angiography;antagonist;Antiinflammatory Effect;Apoptotic;Autoimmune Diseases;Biological;Biological Markers;biomarker identification;bisulfite sequencing;Blood;Blood specimen;Blood Vessels;Bone Marrow;Breast;Cardiac;Cardiac Catheterization Procedures;cell free DNA;Cells;Cessation of life;Chest;Chronic;circulating biomarkers;Circulation;Clinical;clinical center;Clinical Data;clinical predictors;clinical translation;clinically relevant;Coagulation Process;cohort;Collaborations;comparison control;congenital heart abnormality;Control Groups;Coronary Arteriosclerosis;Coronary artery;Creatinine;Data;Data Analyses;Diagnosis;Diagnostic;differential expression;Disease;Disease Marker;disease prognosis;Disease Progression;DNA Methylation;Double-Blind Method;Echocardiography;Endothelial Cells;endothelial dysfunction;Endothelium;Enrollment;Epigenetic Process;Evolution;exercise capacity;Expression Profiling;extracellular;Fibrinolysis;Fibrosis;Flow Cytometry;follow up assessment;Functional disorder;Functional impairment;Future;Gender;Gene Expression Profile;Generations;Genes;Genetic;genetic signature;genome-wide;Goals;Gynecomastia;healthy volunteer;Heart failure;heart imaging;Hematology;Hematopoietic stem cells;hemodynamics;Histopathology;HIV Infections;Hospitalization;hyperkalemia;Hypoxemia;Imaging Techniques;improved;Incidence;Individual;Inflammation;Inflammation Mediators;Injury;injury and repair;innovation;interest;International;Intervention Trial;Kidney Failure;Kinetics;Left;Liver diseases;Lung;Lung Diseases;lung pressure;lung vascular injury;Magnetic Resonance Imaging;Manuscripts;material transfer agreement;Measurement;Measures;Medical;Meta-Analysis;Metabolic;Methodology;Mineralocorticoid Receptor;Mixed Connective Tissue Disease;mortality;National Heart, Lung, and Blood Institute;Natural History;neutrophil;new therapeutic target;novel;novel marker;novel therapeutics;open data;Outcome;Oxygen Consumption;Pain;Pathogenesis;patient oriented;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Phase;Phenotype;Pilot Projects;Placebo Control;Placebos;Plasma;Plasma Cells;Population;Portal Hypertension;Potassium;primary endpoint;primary pulmonary hypertension;pro-brain natriuretic peptide (1-76);Process;prognostic value;programs;Protocols documentation;Publishing;pulmonary arterial hypertension;Pulmonary artery structure;Pulmonary Hypertension;pulmonary vascular remodeling;Pulmonary veins;Randomized;Reporting;research clinical testing;Resolution;right ventricular failure;Right Ventricular Function;Right ventricular strain;Risk Factors;risk prediction;risk stratification;RNA;Safety;Sampling;secondary endpoint;Series;Serum;Severity of illness;Side;side effect;Societies;Source;Spironolactone;stem cells;study population;Surrogate Markers;symposium;Symptoms;systemic inflammatory response;Systemic Lupus Erythematosus;Systemic Scleroderma;T-Lymphocyte;Testing;therapeutic target;Thrombelastography;Thrombosis;Time;tissue mapping;Tissues;transcriptomics;translational research program;Transplantation;Treatment Efficacy;treatment group;treatment response;trend;United States National Institutes of Health;Validation;vascular inflammation;Vascular remodeling;Ventricular;VO2max;Walking;X-Ray Computed Tomography","Clinical Translational Research Program in Pulmonary Arterial Hypertension (PAH): Disease Mechanisms, Biomarkers, and Novel Therapeutic Targets",90066,NA,NA,NA,NA,5,NA,NA,0,NA
11180838,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090067,NA,NA,1ZIACL090067-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414635 (contact),"SOLOMON, MICHAEL  (contact)",NA,NA,NA,"Accounting;Acute;Adoptive Transfer;Alloantigen;allograft rejection;Allograft Tolerance;Allografting;Animal Model;Animals;antibody-mediated rejection;base;biobank;Biological Markers;biomarker discovery;biomarker identification;Biopsy;Blood;Blood Vessels;candidate marker;Cardiac Catheterization Procedures;cell free DNA;Cell Therapy;Cells;Cessation of life;chromatin immunoprecipitation;Chronic;Clinical;clinical phenotype;cohort;Collaborations;computerized data processing;Consensus;Cyclosporine;cytokine;Data;Data Analyses;Data Set;Databases;Derivation procedure;design;Detection;diagnosis standard;diagnostic biomarker;Diagnostic tests;diagnostic tool;Disease;Dose;drug development;Dyspnea;Energy Metabolism;Enrollment;Escherichia coli;Fatigue;follow-up;functional genomics;Future;Gene Expression;Genes;genetic signature;Genomic approach;Genomics;Genotype;Goals;Harvest;healthy volunteer;Heart;heart allograft;Heart failure;Heart Transplantation;Histocompatibility Antigens;Histologic;histological slides;Histopathology;human study;Image;Immune system;Immune Tolerance;Immunologics;Immunosuppression;Immunosuppressive Agents;Inbred BN Rats;Incidence;Infection;Inflammation;Inflammatory;Injections;Injury;Investigation;Libraries;Life;Liver;Low Grade Fever;Lung;Lymphocyte;Lymphoid Cell;Maintenance;Malignant Neoplasms;Manuscripts;Metabolic;Methods;methylation pattern;Microarray Analysis;Modeling;Morbidity - disease rate;mortality;nanotechnique;National Heart, Lung, and Blood Institute;novel;open data;Operative Surgical Procedures;Organ Donor;Organ Survival;Organ Transplantation;participant enrollment;Pathogenesis;Pathologist;Pathway interactions;Patients;Pattern;Peptides;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Phenotype;physical property;Plasma;pneumonia model;post-transplant;predictive marker;preservation;Preventive therapy;Procedures;Process;programs;Proteins;Proteomics;protocol development;Protocols documentation;Publishing;Randomized;Rattus;Regulatory Pathway;Regulatory T-Lymphocyte;Reporting;Research;Research Design;Risk;RNA;Saline;sample collection;Sample Size;Sampling;Scheme;Series;Serum;Sirolimus;Solid;Source;Specificity;Specimen;Spleen;Splenocyte;sudden cardiac death;Symptoms;T-Lymphocyte;Techniques;Testing;Th2 Cells;Therapeutic immunosuppression;Thymus Gland;Time;Tissues;Training;transplant model;Transplant Recipients;Transplantation;ultrasound;United States National Institutes of Health;Urine;Validation;Vascular Diseases;Ventricular",Heart Transplantation Research:  Investigation into Cardiac Allograft Rejection,90067,NA,NA,NA,NA,5,NA,NA,0,NA
11180839,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090080,NA,NA,1ZIACL090080-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,12471593 (contact),"FRANK, KAREN  (contact)",NA,NA,NA,Adherence;Adult;Age;Agreement;arm;Automobile Driving;Behavior;Biochemical;Biological;Biological Assay;Biological Markers;Blood;Blood specimen;clinical center;cohort;Consumption;cooking;Cross-Over Studies;data submission;Diet;dietary;dietary adherence;Dietary History;Dietary Intervention;Disease;Eating;Electronics;Feces;Female;Food;Gender;Geographic Locations;gut microbiome;gut microbiota;Health;Health Benefit;healthy volunteer;inclusion criteria;Individual;Intake;Intervention;Intervention Studies;Interview;Longitudinal cohort;Longitudinal Studies;male;Measures;Medical History;Mediterranean Diet;meetings;Metabolic;microbiota composition;nutrition;Outpatients;Paper;Participant;Perceived quality of life;Periodicals;Personal Satisfaction;Persons;Phase;primary endpoint;Psychosocial Factor;Questionnaires;Randomized;recruit;Research Design;Ribosomal RNA;Role;Sample Size;Sampling;Schedule;screening;secondary endpoint;Shotgun Sequencing;Specimen;stool sample;Surveys;telehealth;Telephone;tool;United States National Institutes of Health;Urine;Visit;volunteer;western diet,Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults,90080,NA,NA,NA,NA,3,NA,NA,0,NA
11180840,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090100,NA,NA,1ZIACL090100-02,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78381857 (contact),"LEE, LENA  (contact)",NA,NA,NA,acceptability and feasibility;Adult;Aging;Allogenic;alpha-amylase;American;Anxiety;Area;arm;Biological Markers;cardiometabolism;care recipients;Caregivers;caregiving;Caring;Clinical;clinical center;design;effectiveness evaluation;Emerging Technologies;Enrollment;experience;Family Caregiver;Family member;Fatigue;follow-up;Friends;Health;health care settings;Hematopoietic Stem Cell Transplantation;Hydrocortisone;Impaired cognition;Inflammatory;Institutional Review Boards;Intervention Studies;Interview;Malignant Neoplasms;Mental Depression;Nature;Osteocalcin;Oxytocin;Participant;Patients;perceived stress;Persons;Phase;phase 1 study;phase 2 study;Pilot Projects;Population;primary caregiver;primary outcome;prospective;Psychological Stress;Publishing;Randomized;recruit;Reporting;Role;secondary outcome;Sleep disturbances;sound;Stress;stress management;Symptoms;Therapeutic;Transplant Recipients;Transplantation Conditioning;United States National Institutes of Health;virtual reality;virtual reality headset;virtual reality intervention,A pilot study of a nature-based virtual reality (VR) intervention in family caregivers of allogeneic hematopoietic stem cell transplant (HSCT) recipients,90100,NA,NA,NA,NA,2,NA,NA,0,NA
11180841,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000002,NA,NA,1ZIADC000002-36,NIDCD:2935536\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,6569943 (contact),"KACHAR, BECHARA  (contact)",NA,NA,NA,3-Dimensional;Actins;Adult;Affect;Aging;Anatomy;Antibodies;Architecture;arm;Auditory;Automobile Driving;Binding;Biogenesis;Biological Assay;Biological Models;CBA/J Mouse;Cell Nucleus;Cell Separation;cell type;Cells;Cellular Structures;Characteristics;Cilia;cilium biogenesis;cilium motility;Cochlea;Collaborations;comparative;Complex;COS-7 Cell;Cryo-electron tomography;Cryoelectron Microscopy;Cytoskeleton;Data;deafness;density;design;Development;differential expression;Disease;Dynein ATPase;Electron Microscopy;Encapsulated;Ependymal Cell;Epidermal Growth Factor Receptor Pathway Substrate 8;Epithelium;Exhibits;Family;Filopodia;Flagella;Generations;Genes;genetic regulatory protein;Goals;Hair;Hair Cells;hearing impairment;Homeostasis;Image;Immunofluorescence Immunologic;immunoreactivity;In Situ;information gathering;inner ear diseases;Inner Hair Cells;innovation;Investigation;Kinocilium;Label;Laboratories;Labyrinth;Length;lens;Life;light microscopy;Link;Lipids;Location;Maintenance;Mammalian Cell;Maps;mechanotransduction;member;Membrane;Messenger RNA;Methodology;Methods;Microscopy;Microtubules;Modeling;Molecular;Morphology;Motility;Multivesicular Body;Mus;Mutation;nanoDroplet;Nature;nexin;normal hearing;old mice;Organ;Organ of Corti;Organelles;Organism;Outer Hair Cells;particle;Phase;Physical condensation;Point Mutation;Positioning Attribute;preventive intervention;Process;programs;Property;Protein Databases;Proteins;Proteolipids;Radial;Rattus;Recycling;Regulation;Reporting;Research;residence;Resolution;Respiratory Diaphragm;RFX3;Role;self organization;Semicircular canal structure;Sensory;Sensory Hair;Series;Shapes;Sorting;Source;spatiotemporal;sperm cell;Stereocilium;Structure;Testing;Therapeutic Intervention;Tissues;Tomogram;Trachea;Transcript;Transcriptional Regulation;transcriptome;transcriptomics;Type I Hair Cell;Type II Hair Cell;Universities;Variant;Vesicle;Vestibular Hair Cells;vestibular system;virtual;Visualization;ward,Structural and Molecular Basis of Transduction in Auditory Sensory Organs,2,NA,NA,NA,NA,36,NA,NA,2935536,NA
11180842,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000089,NA,NA,1ZIADC000089-10,NIDCD:51762\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,6981285 (contact),"MORELL, ROBERT J (contact)",NA,NA,NA,Alternative Splicing;causal variant;cell type;Cells;Cochlea;Code;Collection;Data Set;deafness;Disease;DNA sequencing;Elements;Epigenetic Process;Exons;Family;Gene Expression Regulation;Genes;Genomics;Goals;Hair Cells;hearing impairment;hereditary hearing loss;Human;interest;Labyrinth;Mammals;Molecular;Mus;Mutation;mutation screening;National Institute on Deafness and Other Communication Disorders;novel;Pattern;protein function;Protein Isoforms;Proteins;Research;Research Personnel;RNA;RNA Splicing;Role;Sampling;segregation;Sorting;Specificity;spiral ganglion;Stria Vascularis;Techniques;Tissues;Transcript;transcriptome;Untranslated Regions;Utricle structure;validation studies,Molecular and Epigenetic Mechanisms of Hereditary Hearing Loss,89,NA,NA,NA,NA,10,NA,NA,51762,NA
11180843,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000091,NA,NA,1ZIADC000091-09,NIDCD:1792073\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,14747586 (contact),"WEISZ, CATHERINE  (contact)",NA,NA,NA,Acoustic Trauma;Acoustics;Afferent Neurons;Anatomy;Animal Model;Aromatase;Auditory;auditory pathway;Auditory Perception;Auditory system;Automobile Driving;Back;Basilar Membrane;Brain;brain pathway;Brain Stem;Categories;Cell Nucleus;Cells;cholinergic;Cochlea;Cochlear Nerve;Cochlear nucleus;Communication;Complement;Complex;Computer Models;Computing Methodologies;Coupling;Data;Dendrites;Detection;Ear;Efferent Neurons;Electric Conductivity;electrical property;Electrophysiology (science);experimental study;falls;Fluorescence;Genetic;Genetic Techniques;Goals;Hair Cells;Hearing;Histological Techniques;Hyperactivity;Hyperacusis;Imaging Techniques;Immunohistochemistry;improved;In Vitro;in vivo;Internal Ribosome Entry Site;Journals;Knowledge;knowledge integration;Laboratories;Lateral;live cell imaging;Manuscripts;Measures;Mechanics;Medial;Medical;Medical Records;meetings;Methods;Modeling;Molecular Biology;Morphology;Movement;Mus;Nervous System;neural circuit;neuronal circuitry;Neurons;neurotransmitter release;Neurotransmitters;Noise;novel;Optics;optogenetics;Output;patch clamp;Pathologic;Pathway interactions;Perception;Physiology;postsynaptic;Potassium;Preparation;Printing;Property;Proteins;Publications;Publishing;Reporting;Research;response;Role;Serotonergic System;Serotonin;Shapes;Signal Transduction;Slice;sound;Speech;spiral ganglion;Synapses;Synaptic plasticity;Synaptic Potentials;Synaptic Transmission;System;Techniques;Testing;Tinnitus;tool;transcriptomics;trapezoid body;Trauma;Work,Synaptic Circuitry of Auditory Neurons,91,NA,NA,NA,NA,9,NA,NA,1792073,NA
11180844,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000380,NA,NA,1ZIADE000380-41,NIDCR:2118894\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,8153931 (contact),"ROBEY, PAMELA G (contact)",NA,NA,NA,3-Dimensional;Activities of Daily Living;Address;Adipocytes;Adoptive Transfer;Affect;articular cartilage;Behavior;Biological;Biological Assay;Biology;Bioreactors;Blood Cells;blood formation;BMP2 gene;bone;Bone Marrow;Bone Regeneration;bone resorbing activity;bone turnover;burden of illness;Cartilage;Cartilage Diseases;cartilage regeneration;cartilage repair;CD34 gene;cell type;Cells;Cephalic;Characteristics;Chondrocytes;Chondrogenesis;circulating biomarkers;Clinical;Clinical Trials;Coculture Techniques;Collection;Complement;Connective Tissue;craniofacial;Culture Media;Cyclic AMP;cytokine;Cytokine Signaling;Data;Defect;Deposition;Diameter;Dinoprostone;Disease;Embryo;Enzyme-Linked Immunosorbent Assay;Epiphysial cartilage;Exhibits;Exogenous Factors;experimental study;Extracellular Matrix;face bone structure;Fibrin;Fibrous Dysplasia;GDF5 gene;Gene Expression;Gene Modified;Gene Silencing;Genetic Diseases;Genetic Markers;genetic signature;Glycosaminoglycans;Goals;growth differentiation factor 5;Growth Factor;Health;healthy volunteer;Hematopoietic;hematopoietic stem cell formation;Hematopoietic stem cells;Hip region structure;Homeostasis;Human;human embryonic stem cell;human induced pluripotent stem cells;Hyaline Cartilage;Hyaluronic Acid;Hypertrophy;IGFBP5 gene;IL6 gene;Immune;Immunocompromised Host;immunoregulation;Immunosuppression;Impairment;In Vitro;in vivo;Inflammatory;Interleukin-10;Intrinsic factor;Lateral;Lesion;Lipids;long bone;Macrophage;Maintenance;Marrow;Measures;Mediator;member;Mesenchymal Stem Cells;Mesoderm;Metabolism;Microspheres;mineralization;Mixed Lymphocyte Culture Test;Monitor;monocyte;Monocytic leukemia;monolayer;mosaic;mouse model;Mus;Mutation;Myelogenous;Neural Crest;Neuroectoderm;Organ;Organoids;Osteitis Fibrosa Disseminata;Osteoblasts;Osteoclasts;Osteogenesis;osteogenic;Outcome;Paraxial Mesoderm;Pathway interactions;Patients;Periosteum;Phenotype;Plasma;Play;Population;postnatal;preclinical study;Preparation;Process;Production;programmed cell death ligand 1;reconstruction;Regenerative Medicine;Reporting;response;restoration;restraint;Rodent;Role;Sampling;Sclerotome;Signal Transduction;skeletal;skeletal abnormality;skeletal disorder;skeletal stem cell;Skeleton;small hairpin RNA;Source;spheroids;stem cell therapy;stem cells;Stromal Cells;Structure;Study Section;Surgical sutures;T-Cell Proliferation;targeted biomarker;Techniques;TGFB1 gene;therapeutic target;Time;Tissue Engineering;Tissues;transcription factor;transcriptome;transcriptome sequencing;transcriptomics;Transforming Growth Factor beta;Transplantation;Vacuole;Variant;Yolk Sac,The role of stem cells in skeletal health and disease,380,NA,NA,NA,NA,41,NA,NA,2118894,NA
11180845,ZIA,DE,1,N,NA,NA,NA,NA,ZIADE000704,NA,NA,1ZIADE000704-23,NIDCR:1642409\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,NA,NA,16130610 (contact),"WARNER, BLAKE  (contact)",NA,NA,NA,Acinar Cell;Address;Affect;Agonist;Area;Autoimmune Diseases;Autoimmunity;Autonomic nervous system;Biological;Biology;biomarker identification;Biopsy;Body System;Calcium;cancer therapy;candidate marker;Cell Physiology;cell type;Cell Volumes;Cells;checkpoint inhibition;Classification;Clinic;Clinical;Clinical Data;clinical phenotype;Clinical Research;Collaborations;Collection;Complex;Confocal Microscopy;COVID-19 pathogenesis;Data;Defect;design;Development;Diagnosis;Disease;Drug Targeting;Ductal Epithelial Cell;Endocrinology;Epithelial Cells;experience;Fluids and Secretions;Functional disorder;Functional Imaging;Future;Gene Modified;Genetic;genetic analysis;Genetic Materials;Genetic Transcription;Gland;Goals;Health;healthy volunteer;High-Throughput Nucleotide Sequencing;Iatrogenesis;immune activation;Immune checkpoint inhibitor;Immune system;immune-related adverse events;Immunology;immunopathology;Immunotherapy;improved;Individual;Inflammation;insight;interest;Investigation;Laboratories;Laboratory Study;laser capture microdissection;Lymphocyte;Malignant Neoplasms;Masks;Measures;medical specialties;Medicine;Methods;Minor salivary gland structure;molecular imaging;Molecular Profiling;Mutation;Natural History;Nature;novel;novel marker;novel therapeutics;Oral cavity;Organ;Outcome;Parotid Gland;Pathogenesis;Pathogenicity;Pathologic;Pathway interactions;patient subsets;Patients;PD-1/PD-L1;Phenocopy;Phenotype;Prevention;Prognosis;Proteins;Rare Diseases;receptor;Research;research clinical testing;Research Project Grants;Role;Salivary;salivary cell;Salivary Gland Diseases;Salivary Glands;Sampling;Scientist;Severities;single-cell RNA sequencing;Sjogren&apos;s Syndrome;Source;Specimen;Structure;Syndrome;T-Lymphocyte Subsets;Therapeutic;Time;Tissue Sample;Tissues;transcriptome;transcriptome sequencing;tumor;Variant;Xerostomia,Clinical and Mechanistic Investigations of Salivary Gland Dysfunction,704,NA,NA,NA,NA,23,NA,NA,1642409,NA
11180846,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000024,NA,NA,1ZIAHG000024-30,NHGRI:49571\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10480437 (contact),"COLLINS, FRANCIS S. (contact)",NA,NA,NA,Adipose tissue;Adult;Affect;Alleles;ATAC-seq;Beta Cell;Biological Assay;Biopsy;Blood Pressure;Brain;Cadaver;candidate identification;Cell Differentiation process;Cell Line;Cell Physiology;Cell Survival;cell type;Cells;Cessation of life;Chromatin;Chronic Disease;Clustered Regularly Interspaced Short Palindromic Repeats;Code;cohort;Collaborations;comparison control;Complement;Complex;cytokine;Data;data integration;Data Set;Development;Diabetes Mellitus;diabetes mellitus genetics;diabetes risk;diabetic;Diagnosis;Diet;Disease;disorder risk;DNA Integration;DNA Methylation;endocrine pancreas development;Enhancers;Environmental Risk Factor;Epigenetic Process;epigenome;epitranscriptome;exome sequencing;experimental study;fasting glucose;Foundations;Gene Expression;Gene Mutation;Genes;Genetic;genetic analysis;genetic association;Genetic Identity;Genetic Transcription;genome sequencing;genome wide association study;genomic data;Genomics;Genotype;Glucose;glucose tolerance;Goals;Height;Heterozygote;High Density Lipoprotein Cholesterol;high-throughput drug screening;HNF4A gene;Homeostasis;Human;human embryonic stem cell line;Hypothalamic structure;Immunofluorescence Immunologic;impaired glucose tolerance;In Vitro;Individual;induced pluripotent stem cell;Inflammatory;Inherited;Insulin;insulin secretion;Insulin-Dependent Diabetes Mellitus;islet;Islets of Langerhans;Knock-out;Laboratories;LDL Cholesterol Lipoproteins;Link;Lipids;Liver;Machine Learning;Measures;Medicine;men;Meta-Analysis;Metabolic;Metabolism;metabolomics;MicroRNAs;Modeling;Modification;Molecular;multiple omics;Muscle;Mutation;nanopore;National Center for Advancing Translational Sciences;Neuronal Differentiation;Neurons;New York;Non-Insulin-Dependent Diabetes Mellitus;Nucleic Acid Regulatory Sequences;Obesity;OGTT;Paint;Pancreas;pancreas development;Phenotype;Physiological;Plasma;Play;Population;preservation;Prevention;prime editing;Process;Production;progenitor;Proinsulin;promoter;Proteomics;Protocols documentation;Quantitative Trait Loci;rare variant;Reading;Research;response;Risk;risk variant;RNA;Role;Sampling;Series;Signal Transduction;single cell ATAC-seq;single-cell RNA sequencing;Site;Skeletal Muscle;Skin;Stains;stem cells;Stress;Structure of beta Cell of islet;Technology;Testing;Time;Tissue-Specific Gene Expression;Tissues;trait;Transcript;transcriptome sequencing;transcriptomics;Triglycerides;Untranslated RNA;Validation;Variant;Viral;whole genome,Genetic analysis of type II diabetes,24,NA,NA,NA,NA,30,NA,NA,49571,NA
11180847,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200305,NA,NA,1ZIAHG200305-22,NHGRI:22879\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10480437 (contact),"COLLINS, FRANCIS S. (contact)",NA,NA,NA,5&apos; Splice Site;Adenine;adeno-associated virus 9 delivery;Age;Age Months;Aging;aging process;Amino Acids;Antisense Oligonucleotides;Aorta;Arterial Fatty Streak;ATAC-seq;base;base editing;base editor;beta-Galactosidase;Biological Assay;Biological Markers;Biological Sciences;Birth;Blood Vessels;bone;Bone remodeling;Bulla;Bystander Effect;C10;Cardiac;Cardiovascular system;Cell Culture Techniques;Cell Cycle;cell free DNA;Cell Line;cell type;Cells;Cessation of life;Child;Chimeric Proteins;Chromatin;Chromosome Segregation;Chromosome Structures;clinical biomarkers;Clinical Trials;clinically relevant;Clone Cells;Code;Collaborations;comparative;Complementary DNA;Critical Pathways;Deaminase;Defect;Deposition;Dermis;Development;Developmental Bone Diseases;disease phenotype;Disease Progression;DNA;DNA Sequence;DNA sequencing;Doctor of Philosophy;Dominant-Negative Mutation;Dose;Echocardiography;Ectopic Expression;Elements;Engineering;Epigenetic Process;Exhibits;Exons;extend lifespan;Extracellular Matrix;Family;Farnesyl Transferase Inhibitor;farnesylation;Fibroblasts;first-in-human;Formulation;Foundations;Functional disorder;Future;gene correction;Gene Delivery;gene editing technology;Gene Expression Profiling;gene product;gene therapy;gene-targeted therapy;Genes;Genetic;Genetic Models;Genetic Transcription;genetic variant;Growth;Heart Abnormalities;Heart failure;heart function;Hela Cells;Heterozygote;Histones;Human;Impairment;improved;In Vitro;in vivo;induced pluripotent stem cell;Injections;intein;intravenous injection;Investigation;Laboratories;Lamin Type A;Left ventricular structure;Lentivirus Vector;life span;Liver;Lonafarnib;Mechanics;medical schools;Messenger RNA;methylation pattern;mineralization;Molecular;mortality;mouse model;Mus;Muscle Cells;mutant;Mutation;mutation correction;Myocardial Infarction;Myocardium;Names;nanopore;next generation;novel;novel therapeutic intervention;Nuclear;Nuclear Lamina;Nuclear Matrix;Nucleotides;Oligonucleotides;Organism;Osteoblasts;Pathology;Patients;Pediatric Hospitals;Pennsylvania;Peptides;Pharmacologic Substance;Phenotype;Philadelphia;Plasma;potential biomarker;pre-clinical;preclinical trial;Premature aging syndrome;Production;Progeria;programs;Proliferating;promoter;Protein Truncation;Proteins;rare condition;Rare Diseases;Research;response;RNA;RNA Splicing;Sampling;Severity of illness;Signal Pathway;Signal Recognition Particle;Site;Skeletal Muscle;Smooth Muscle Myocytes;Solid;Stains;standard of care;Stroke;Structure;Subcutaneous Injections;Syndrome;System;Testing;Therapeutic;therapeutic gene;therapeutic genome editing;Therapeutic Intervention;Tissues;Toxic effect;transcriptome;transcriptome sequencing;Transfection;Transgenes;Transgenic Mice;Translating;Translations;treatment response;United States National Institutes of Health;Universities;Up-Regulation;Validation;Vascular Smooth Muscle;vector;Viral;Viral Genome;working group,Hutchinson-Gilford Progeria syndrome--a model for the genetics of aging.,200305,NA,NA,NA,NA,22,NA,NA,22879,NA
11180848,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200389,NA,NA,1ZIAHG200389-12,NHGRI:3813\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10480437 (contact),"COLLINS, FRANCIS S. (contact)",NA,NA,NA,abducens nerve;Affect;affection;Age;Amygdaloid structure;Area;Atrophic;Autopsy;autosome;Award;Bilateral;Binding;Biological Models;Birth;Blood;Boston;Brain;brain control;Brain imaging;brain magnetic resonance imaging;Brain Stem;calcification;Candidate Disease Gene;Carey-Fineman-Ziter syndrome;Caring;Case Study;Cell Line;Cell Nucleus;cell type;Cephalic;CHD7 gene;Child;Chromatin;clinical database;clinical phenotype;Code;cohort;Collaborations;Communication;comparison control;Complex;Cranial Nerves;craniofacial;Data;Data Analyses;de novo mutation;Dedications;Deformity;Dental;Deubiquitinating Enzyme;Development;Diagnosis;diagnostic criteria;Disease;disease-causing mutation;DNA;DNA Sequencing Facility;Efferent Neurons;Electrophysiology (science);Embryonic Development;Emotions;Enhancers;Enrollment;Environmental Risk Factor;ethnic diversity;Ethnic Population;Etiology;exome;exome sequencing;Eye;Face;Facial Muscles;Facial nerve structure;Facial paralysis;Facial Paresis;Family;Family history of;Family member;follow-up;Foundations;Functional disorder;Functional Magnetic Resonance Imaging;Funding;Gender;Gene Frequency;Genes;Genetic;Genetic study;genetic variant;Genome;genome analysis;genome sequencing;Germ Lines;Germ-Line Mutation;Gliosis;Goals;Grant;Heterogeneity;Heterozygote;Horizontal Disease Transmission;horizontal gaze;Human;Impairment;Incidence;Individual;Inherited;insertion/deletion mutation;interdisciplinary approach;Ipsilateral;Labyrinth;Limb structure;Location;Manuscripts;Mechanics;MEPE gene;morphometry;Motor;Motor Neurons;mouse model;Movement;multimodality;Mus;Mutate;Mutation;Myoblasts;Myopathy;National Human Genome Research Institute;National Institute of Biomedical Imaging and Bioengineering;National Institute of Dental and Craniofacial Research;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;Nature;nerve stem cell;Netherlands;neuroblastoma cell;neuronal circuitry;New Zealand;Nuclear Import;offspring;Oral health;Organ;Parents;Participant;Pathogenesis;Pathology;Pathway interactions;patient registry;Patients;Pediatric Research;Phenotype;Piezo 2 ion channel;POU2F1 gene;prenatal environmental exposure;proband;programs;Protocols documentation;Public Health;Publishing;Quality of life;Regulatory Element;Reporting;Research;Research Project Grants;Resources;Role;Sampling;segregation;Sensory;Shapes;Siblings;Side;Single Nucleotide Polymorphism;Site;Skeletal Development;social;Somatic Mutation;Somatosensory Evoked Potentials;Standardization;Structure;Susceptibility Gene;Syndrome;System;Texas;ubiquitin isopeptidase;United States National Institutes of Health;Universities;Untranslated RNA;Utah;Variant;variant of unknown significance;Vascular blood supply;Vibrissae;whole genome;Work;Zebrafish,Genetics of Moebius syndrome and other congenital facial weakness disorders,200389,NA,NA,NA,NA,12,NA,NA,3813,NA
11180849,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200401,NA,NA,1ZIAHG200401-06,NHGRI:1615656\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,16180200 (contact),"SADHU, MERU  (contact)",NA,NA,NA,Arkansas;Binding;Biology;Catalytic Domain;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;CRISPR/Cas technology;Genes;Genetic;genetic information;Genetic study;genetic variant;Genetic Variation;Genome engineering;Genomics;Genotype;Goals;Human;Immune;Individual;interest;Learning;Link;Medicine;Methods;Mutagenesis;Mutation;mutation screening;novel;Oligonucleotides;Phenotype;Printing;Proteins;Reporting;resilience;System;Systems Biology;Universities;Variant;vector;Virus Inhibitors;Work;Yeast Model System;Yeasts,High-throughput genome engineering,200401,NA,NA,NA,NA,6,NA,NA,1615656,NA
11180850,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200410,NA,NA,1ZIAHG200410-04,NHGRI:708088\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377278 (contact),"GUNTER, CHRISTIE  (contact)",NA,NA,NA,Ableist;adult with autism spectrum disorder;Affect;Applied Genetics;autism spectrum disorder;autistic;autistic children;Behavioral Research;Communication;Communities;Complex;Comprehension;Critiques;Decision Making;design;Development;Diagnosis;Diagnostic tests;disability;disabled;Disabled Persons;Education;Effectiveness;Elements;Environment;Ethics;experience;Exposure to;Face;Familiarity;Feedback;Funding;General Population;Genetic;genetic information;genetic testing;Genomics;Grant;Individual;individuals with autism spectrum disorder;interest;Intervention;Knowledge;Language;Life;literacy;mathematical ability;Measurement;Measures;Medical;member;Methods;Morbidity - disease rate;mortality;National Human Genome Research Institute;Pain;Participant;Pathology;Personal Satisfaction;Persons;Population;Population Genetics;preference;Prevalence;Provider;Psychometrics;Published Comment;Reporting;Research;Research Personnel;research study;Respondent;Rural;Sampling;Science;Secondary Schools;Series;skills;social;social expectations;social stigma;Societies;Stigmatization;Surveys;United States National Institutes of Health;Update;Validation;Work,Genetics and Autism Literacy Survey (GALS),200410,NA,NA,NA,NA,4,NA,NA,708088,NA
11180851,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200412,NA,NA,1ZIAHG200412-04,NHGRI:1789367\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377281 (contact),"HANCHARD, NEIL  (contact)",NA,NA,NA,"Acute;Africa;African;African ancestry;Agreement;Annual Reports;Antibodies;beta Globin;Birth History;bisulfite;Blood specimen;Carbon;Cell model;Cells;Child;Childhood;Chromosomes;clinical center;clinical phenotype;Clinical Protocols;Clinical Research;cohort;Collaborations;Complex;Computational Biology;Country;Data;Data Collection;design;Development;Disease;DNA;DNA Methylation;DNA sequencing;electronic data;Epidemiology;Erythrocytes;exome;Fatty acid glycerol esters;Fatty Liver;Forms Controls;Functional disorder;Funding;Gene Expression;Gene Expression Regulation;Genes;Genetic;genetic epidemiology;Genetic study;Genetic Transcription;genetic variant;Genetic Variation;Genome;genome sequencing;genome wide association study;genome-wide;genomic locus;Genomic Segment;Genomics;Hemoglobin;High Prevalence;Human;Human Genetics;Human Genome;human genomics;human reference genome;Immune response;Income;Individual;Institutional Review Boards;International;Knowledge;Kwashiorkor;LGR5 gene;Linguistics;Malnutrition;Manuscripts;meetings;Metabolic;Metabolism;metabolomics;Modernization;Molecular;molecular phenotype;multiple omics;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;novel;organizational structure;Participant;Pathway interactions;Patients;Persons;Phenotype;Population;population based;Population Genetics;Population Heterogeneity;Process;Proteins;Publications;Publishing;Reaction;Recontacts;recruit;Reporting;repository;Research;Research Personnel;research study;Risk;risk variant;RNA;Sampling;Schedule;Sickle Cell Anemia;single cell sequencing;Single Nucleotide Polymorphism;Site;Spleen;Starvation;Statistical Data Interpretation;Sterile coverings;Technology;telomere;Testing;Therapeutic;Time;tool;trait;Transfusion;Uganda;United States National Institutes of Health;Variant;Vendor;whole genome;Work",Multi-omics Studies of Childhood Complex Traits in Diverse Populations,200412,NA,NA,NA,NA,4,NA,NA,1789367,NA
11180852,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200414,NA,NA,1ZIAHG200414-04,NHGRI:596455\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377281 (contact),"HANCHARD, NEIL  (contact)",NA,NA,NA,Adolescent;African;Blood Pressure;blood pressure elevation;Candidate Disease Gene;Cell model;Child;Childhood;Clinical;cohort;Collaborations;Communities;comorbidity;Data;Disease;DNA sequencing;Essential Hypertension;Ethics;Etiology;Family;Gene Expression;Genes;Genetic;genetic variant;Genetic Variation;Genome;genome analysis;genome sequencing;Goals;Heritability;high risk;Hypertension;in vivo Model;Individual;Inherited;Kidney Failure;Low Prevalence;Measures;Molecular;Natural History;Parents;Pathogenesis;Pathway interactions;Phenotype;Proteins;Protocols documentation;recruit;Reporting;Risk;Sampling;Stroke;Testing;Therapeutic Intervention;Variant,Genetics of childhood-onset hypertension,200414,NA,NA,NA,NA,4,NA,NA,596455,NA
11180853,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200417,NA,NA,1ZIAHG200417-04,OD:1427000\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377287 (contact),"DENNY, JOSHUA  (contact)",NA,NA,NA,adverse event risk;African;African American population;African ancestry;All of Us Research Program;ancestry analysis;androgen deprivation therapy;Anti-Hypertensive Agents;Anticoagulants;APBA1 gene;APOL1 gene;arthropathies;Atrial Fibrillation;Benign;biobank;Bioinformatics;Biomedical Research;Black race;Blood Platelets;Blood Pressure;Body mass index;burden of illness;Cardiac;Cardiovascular Diseases;cardiovascular risk factor;Cardiovascular system;Cause of Death;Classification;Clinical;Clinical Pharmacology;Clinics and Hospitals;clopidogrel;Code;cohort;Communicable Diseases;Coronary;cost effective;COVID-19;CYP2C19 gene;Cystic Fibrosis;Data;data format;data integration;data modeling;Data Set;data standards;Diagnosis;Disease;disease diagnosis;disease phenotype;disorder risk;Disparity;drug discovery;drug repurposing;Effectiveness;Electronic Health Record;End stage renal failure;endometriosis;Environment;Ethnic Origin;Etiology;European;Evaluation;Event;Fibroid Tumor;follow-up;Gene Frequency;General Population;Genes;Genetic;genetic analysis;genetic architecture;genetic association;Genetic Diseases;Genetic Predisposition to Disease;Genetic Research;genetic variant;Genome;genome wide association study;Genotype;Goals;Graves&apos; Disease;Guillain Barré Syndrome;health disparity;Heterozygote;high risk;Hispanic;Homozygote;Hypertension;Hypothyroidism;improved;Individual;individual variation;Investigation;Laboratories;Life Style;Link;loss of function;loss of function mutation;Malignant neoplasm of prostate;Manuals;Manuscripts;Maps;Mendelian randomization;Meniere&apos;s Disease;Meta-Analysis;Methods;Morbidity - disease rate;mortality;multimodality;Myocardial Infarction;Nature;Not Hispanic or Latino;novel;Paper;Participant;Pathogenicity;Patient Self-Report;Patients;Performance;personalized medicine;Pharmaceutical Preparations;Pharmacogenomics;phenome;Phenotype;phenotypic data;polygenic risk score;Population;Population Heterogeneity;Precision Health;precision medicine;Preparation;Prevalence;prevent;Procedures;programs;Provider;Publishing;Pulmonary Hypertension;Pythons;Race;Rare Diseases;rare variant;Recurrence;Regression Analysis;Report (document);Research;Resources;Respiratory Tract Infections;response;Risk;risk variant;Running;Sample Size;Seasons;Source;Surveys;Temporomandibular Joint Disorders;Test Result;Testing;Therapeutic;Time;Tissues;tool development;trait;translational study;trend;tumor;Uterine Fibroids;Uterus;Variant;variant of unknown significance;Viral Respiratory Tract Infection;Work,Improving precision health approaches through large-scale EHRs and biobanks,200417,NA,NA,NA,NA,4,NA,NA,1427000,NA
11180854,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM000061,NA,NA,1ZIALM000061-31,NLM:411781\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,6482265 (contact),"KOONIN, EUGENE V (contact)",NA,NA,NA,adaptive immunity;Amino Acid Motifs;Amino Acid Sequence;Archaea;Architecture;Artificial Intelligence;ATP phosphohydrolase;Bacteria;Binding;Binding Proteins;Carrier Proteins;Case Study;Cell division;Censuses;Clustered Regularly Interspaced Short Palindromic Repeats;Collection;Complex;computational pipelines;Computing Methodologies;Custom;Cyclic Nucleotides;database structure;deep learning;Detection;Development;Dissection;Distant;DNA;Endosomes;Eukaryota;Eukaryotic Cell;Evolution;Genome;Genomics;Goals;Helix-Turn-Helix Motifs;Homologous Gene;Homologous Protein;Homology Modeling;Immune response;Infection;Investigation;Libraries;Life;markov model;Membrane;Messenger RNA;Methods;Methylation;Modeling;Molecular Chaperones;molecular sequence database;novel;nuclease;Pattern;Periodicity;Phylogenetic Analysis;Play;Positioning Attribute;Prokaryotic Cells;Protein Analysis;Protein Sequence Analysis;Protein Sortings;protein structure;protein structure prediction;Proteins;Resolution;response;Ribonucleases;Ribosomal RNA;RNA;RNA Binding;Running;scaffold;Sequence Analysis;SmpB protein;Sorting;Structural Models;Structure;System;Tertiary Protein Structure;Thermoproteales;Transfer RNA;Translations;Trees;Ubiquitin;viral DNA;Viral Genome;Viral Proteins;viral RNA;Virus;Winged Helix;Work,Finding Protein Sequence Motifs--Methods And Applications,61,NA,NA,NA,NA,31,NA,NA,411781,NA
11180855,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM000071,NA,NA,1ZIALM000071-29,NLM:44119\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,6571657 (contact),"LANDSMAN, DAVID  (contact)",NA,NA,NA,Amino Acid Sequence;analytical tool;Binding;Binding Proteins;Binding Sites;Cell Nucleus;Chemicals;Chromatin;Chromatin Structure;Chromosome Structures;Classification;Competitive Binding;Complex;Consensus Sequence;crosslink;Data;Databases;Defect;DNA;driver mutation;Ensure;epigenetic regulation;Family;Genes;genetic regulatory protein;histone-binding proteins;Histones;HMGN Proteins;Human;Laws;Lead;Linker DNA;Location;Maintenance;Malignant Neoplasms;Maps;Measurement;Mediating;Modification;Molecular;Molecular Conformation;molecular recognition;Mutation;Non-Histone Chromosomal Proteins;Nuclear Proteins;Nucleosomes;Pathway interactions;Play;Post-Translational Protein Processing;Property;protein protein interaction;Proteins;public database;Radial;Regulation;Role;Running;Sequence Alignment;Signal Pathway;simulation;Structural Protein;Structure;Surface;Tail;Technology;Time;Transcription Regulatory Protein;Update;Variant,Structural and Functional Analysis of Gene and Protein Sequence Families,71,NA,NA,NA,NA,29,NA,NA,44119,NA
11180856,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM000073,NA,NA,1ZIALM000073-29,NLM:2058903\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,6482265 (contact),"KOONIN, EUGENE V (contact)",NA,NA,NA,adaptive immunity;Affect;Affinity;Algorithms;Amoeba genus;anti-toxin;Archaea;Archaeal Genome;Archaeal Viruses;ATP phosphohydrolase;Bacteria;Bacterial Genome;Base Sequence;Biochemical;Biogenesis;Biological;biological systems;Biotechnology;Capsid;Capsid Proteins;Catalytic Domain;Cell Nucleus;Censuses;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;comparative;Computing Methodologies;Consensus Sequence;Coupled;Cysteine;Cytoplasm;Data;Data Set;Databases;DNA biosynthesis;DNA Packaging;DNA Transposable Elements;DNA-Directed DNA Polymerase;DNA-Directed RNA Polymerase;Dreams;ds-DNA;endonuclease;Engineering;Environment;Enzymes;Eukaryota;Evolution;Family;Family member;Gene Combinations;Genes;genetic regulatory protein;Genetic Transcription;Genome;genome editing;genome-wide;Genomics;Goals;Growth;Guide RNA;Guilt;Horizontal Gene Transfer;Immune system;in silico;inhibitor;insight;Laboratories;Life Cycle Stages;Link;Maps;mathematical methods;mathematical model;Medical;member;metagenome;Metagenomics;metatranscriptome;Methods;microbial;Mining;Modeling;molecular sequence database;N-terminal;Names;novel;novel virus;nuclease;Organism;Orthologous Gene;ovarian neoplasm;paralogous gene;Phylogenetic Analysis;Phylogeny;Plasmids;polypeptide;Probability;Process;professor;Prokaryotic Cells;promoter;protein structure;Proteins;recruit;Replication Initiation;Research;Rest;RNA;scaffold;Sequence Analysis;Specific qualifier value;System;Time;Toxin;Trees;trend;Validation;Variant;Viral;viral DNA;Virus;Virus Diseases;whole genome;Work,Comparative Analysis Of Completely Sequenced Genomes,73,NA,NA,NA,NA,29,NA,NA,2058903,NA
11180857,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM000084,NA,NA,1ZIALM000084-27,NLM:426487\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,6571657 (contact),"LANDSMAN, DAVID  (contact)",NA,NA,NA,Albumins;analysis pipeline;ATAC-seq;Binding;Binding Proteins;Bioinformatics;Cell Nucleus;cell type;Cells;ChIP-seq;Chromatin;cofactor;Collaborations;Data;DNA;DNA Binding;DNA Sequence;DNA-Binding Proteins;DNase I hypersensitive sites sequencing;Enhancers;Environment;Epigenetic Process;Exhibits;Family;GATA4 gene;Gene Expression Regulation;Genes;Genetic Recombination;Genetic Transcription;Genome;Genomics;Hepatocyte;HepG2;Higher Order Chromatin Structure;Histones;HMGN Proteins;Housekeeping Gene;interest;K562 Cells;Liver;Micrococcal nuclease digestion of chromatin followed by sequencing;Modeling;multidimensional data;National Cancer Institute;Non-Histone Chromosomal Proteins;Nucleic Acid Regulatory Sequences;Nucleosomes;Pattern;Play;Post-Translational Protein Processing;preference;promoter;Proteins;Role;Saccharomyces cerevisiae;Site;Specificity;Structure;transcription factor;Transcription Initiation;Transcriptional Regulation;transcriptome sequencing,Gene Regulatory Sequences And Protein Binding in Genome Sequences,84,NA,NA,NA,NA,27,NA,NA,426487,NA
11180858,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010027,NA,NA,1ZIALM010027-01,NLM:867681\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,79955815 (contact),"NELSON, MARTHA  (contact)",NA,NA,NA,"2019-nCoV;Agriculture;Animals;Back;Birds;Cattle;Chile;Circulation;Colorado;Dairying;Deer;Disease Outbreaks;Ecology;Emerging Communicable Diseases;emerging pathogen;Evolution;Farm;farm worker;Funding;Future;genomic data;Goals;High Prevalence;Human;Infectious disease threat;Influenza;Influenza A virus;Influenza A Virus, H5N1 Subtype;International;Knowledge;Length;Mammals;marine;Methodology;Michigan;Mink;Mirounga;Monitor;Mutation;next generation sequencing;Ohio;pandemic potential;pathogen;Pathogenicity;Pennsylvania;Peru;Polymerase Gene;pressure;Production;Research;Research Project Grants;Risk;RNA Viruses;Sampling;Sea Lions;South America;South American;Tail;Texas;Time;trend;United States National Institutes of Health;Variant;Viral Genome;Virus;wild bird",Phylodynamics of emerging infectious disease threats,10027,NA,NA,NA,NA,1,NA,NA,867681,NA
11180859,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM082713,NA,NA,1ZIALM082713-12,NLM:279423\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,6571657 (contact),"LANDSMAN, DAVID  (contact)",NA,NA,NA,Acceleration;base;Biology;Biomedical Research;Chordata;Classification;Collection;Computing Methodologies;Data;Data Set;database structure;Databases;Decontamination;Detection;Disease;DNA sequencing;Elements;Eukaryota;Excision;Genes;Genome;genome database;Genomics;Genotype;improved;interest;Knowledge;Label;Methods;Organism;Pathway interactions;Phenotype;Phylogenetic Analysis;Play;public database;reference genome;Research;RNA;Role;Sampling;screening;Structure;Taxonomy;Technology;transcriptome;transcriptome sequencing,"Genome Assemblies, Analyses, and Comparisons",82713,NA,NA,NA,NA,12,NA,NA,279423,NA
11180860,ZIB,LM,1,N,NA,NA,NA,NA,ZIBLM622435,NA,NA,1ZIBLM622435-09,NLM:250010\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,15689641 (contact),"NAWROCKI, ERIC  (contact)",NA,NA,NA,2019-nCoV;Algorithmic Software;Base Sequence;Biological;Biotechnology;Code;Computer software;cytochrome c oxidase;Databases;Dengue Virus;Detection;Genbank;Genes;Genome;Goals;improved;Influenza;Introns;Journals;Manuals;Modeling;Monkeypox;Norovirus;Paper;Performance;Proteins;Publications;Publishing;Quality Control;RNA Splicing;Sequence Analysis;Site;Software Tools;tool;Validation;Viral;Viral Genome,Biological Sequence Quality Control and Organization,622435,NA,NA,NA,NA,9,NA,NA,250010,NA
11180861,ZIC,DC,1,N,NA,NA,NA,NA,ZICDC000081,NA,NA,1ZICDC000081-13,NIDCD:1527597\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,78838610 (contact),"WINKLER, DENNIS  (contact)",NA,NA,NA,3-Dimensional;Achievement;Actins;Address;Amber;Auditory;Autophagocytosis;Autophagosome;Biological;Biophysics;Calendar;Calibration;Cells;Cellular biology;Cellular Structures;Chills;Cochlea;Collaborations;Communication;Computer software;Core Facility;Cryo-electron tomography;Cryoelectron Microscopy;Cultured Cells;Cytoskeleton;Data;data acquisition;Dedications;Development;Electron Microscope;Electron Microscopy;Endolymphatic Hydrops;Equipment;Event;experimental study;F-Actin;Freeze Substitution;Freezing;Genetic;Goals;Grant;Hair Cells;Human Resources;Humulus;Image;Immune;immunocytochemistry;Inner Hair Cells;instrument;instrumentation;interest;Intramural Research;Ion Channel;Ions;Journals;Kinesin;Kinocilium;Knockout Mice;Laboratories;Labyrinth;Lacrimal gland structure;Letters;Lipids;Liposomes;Manuscripts;Mediating;Methodology;Microscope;Microtubules;Molecular;Molecular Genetics;mouse model;Mus;mutant;Mutant Strains Mice;National Institute on Deafness and Other Communication Disorders;Nature;Negative Staining;new technology;Organ of Corti;Outer Hair Cells;Performance;Phase;Phenotype;Physiology;Plastic Embedding;Population;posters;Preparation;preservation;pressure;Presynaptic Terminals;programs;Proteins;Publications;Recommendation;reconstruction;Research;Research Personnel;Research Support;Resources;restoration;ribbon synapse;Sampling;Scanning;Scanning Electron Microscopy;Scientist;Sensory;Sensory Physiology;Series;Services;Site;Specialist;Specimen;Structure;Synaptic Vesicles;System;Techniques;Tissues;Titan;tomography;Training;Transducers;Transmission Electron Microscopy;transmission process;United States National Institutes of Health;Visualization;Water;Wild Type Mouse;Work;Writing;Zebrafish,Advanced Imaging Core,81,NA,NA,NA,NA,13,NA,NA,1527597,NA
11180862,ZIC,DC,1,N,NA,NA,NA,NA,ZICDC000086,NA,NA,1ZICDC000086-10,NIDCD:2293698\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,6981285 (contact),"MORELL, ROBERT J (contact)",NA,NA,NA,Bioinformatics;Cells;Computational Biology;Computer Analysis;Data;Data Analyses;Databases;Deposition;design;Epigenetic Process;exome;Experimental Designs;experimental study;genomic data;Genomics;Infrastructure;Intramural Research;Labyrinth;Libraries;Mission;Molecular Biology;National Institute of Dental and Craniofacial Research;National Institute on Deafness and Other Communication Disorders;Principal Investigator;Production;public repository;Reagent;Research Personnel;Tissues;Training;transcriptome sequencing;variant detection;whole genome;Work,Genomic and Computational Biology Support for NIDCD Intramural Research,86,NA,NA,NA,NA,10,NA,NA,2293698,NA
11180863,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000573,NA,NA,1ZICEY000573-04,NEI:1627188\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,78379086 (contact),"MAMINISHKIS, ARVYDAS  (contact)",NA,NA,NA,Adverse event;Animal Model;Basic Science;Clinic;Clinical;Clinical Trials;Collaborations;combat;Data;Elements;Environment;Eye;Eye Injuries;Human;Immunologics;Implant;induced pluripotent stem cell;instrumentation;Methodology;Modeling;Operative Surgical Procedures;Positioning Attribute;pre-clinical;Preparation;Process;Rattus;reconstruction;replacement tissue;Research;Research Personnel;Retina;sight restoration;Soldier;Specialist;success;Surgeon;Techniques;Therapeutic Intervention;tool;Training;Translating;translational goal;Translational Research;United States National Institutes of Health;Validation;Veterinarians,Translational Research Core,573,NA,NA,NA,NA,4,NA,NA,1627188,NA
11180929,R33,HL,7,N,2024-12-10,2024-12-15,2025-04-30,838,R33HL158540,NA,PA-24-254,7R33HL158540-04,NHLBI:1758766\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,WORCESTER,UNITED STATES,NA,02,603847393,US,850903,UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,016550002,"PROJECT NARRATIVE More effective treatments for idiopathic pulmonary fibrosis are urgently needed. In this phase I study, we will assess the safety of a green tea extract, epigallocatechin-3-gallate (EGCG) in combination with nintedanib or pirfenidone, as a novel antifibrotic agent in patients with idiopathic pulmonary fibrosis.",1881986;6090432 (contact);9313677,"CHAPMAN, HAROLD A;MARTINEZ, FERNANDO J (contact);SPINO, CATHERINE A","GOMEZ, CHRISTIAN RENE",2024-08-31,2026-04-30,NA,Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients,158540,ZHL1,ZHL1-CSR-F(F2),NA,NA,4,1637892,120874,1758766,NA
11180930,N01,AI,NA,N,NA,NA,NA,NA,272201600008I,NA,NA,272201600008I-P00006-27200005-1,NIAID:2998\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,KENSINGTON,UNITED STATES,NA,08,094888294,US,319502,"ADVANCED BIOSCIENCE LABORATORIES, INC.",MD,208951042,NA,14922273 (contact),"SWARTZ, GLENN  (contact)",NA,2018-02-01,2019-01-31,Acquired Immunodeficiency Syndrome;AIDS prevention;anti-HIV microbicide;Clinical Trials;Development;Devices;Drug Kinetics;Evaluation;HIV;HIV Infections;Investigational Drugs;Licensure;microbicide;Modeling;National Institute of Allergy and Infectious Disease;novel therapeutics;Pathway interactions;Persons;Play;pre-clinical;pre-exposure prophylaxis;prevent;Prevention;Prevention strategy;Preventive vaccine;product development;research clinical testing;Resources;Role;Safety;Services;sexual HIV transmission;Sheep;sheep model;Technology;United States Food and Drug Administration;United States National Institutes of Health;vaginal microbiome;Work,Ovine Model and Vaginal Microbiome Support for HIV Non-vaccine Biomedical Prevention Product Development,0,NA,NA,NA,NA,NA,NA,NA,2998,NA
11180931,N01,AI,NA,N,NA,NA,NA,NA,272201600008I,NA,NA,272201600008I-P00005-759301900132-1,NIAID:23892\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,KENSINGTON,UNITED STATES,NA,08,094888294,US,319502,"ADVANCED BIOSCIENCE LABORATORIES, INC.",MD,208951042,NA,78724241 (contact),"SILVERA, PETER  (contact)",NA,2022-07-15,2023-07-14,Acquired Immunodeficiency Syndrome;AIDS prevention;anti-HIV microbicide;Clinical Trials;Contracts;Development;HIV Infections;Licensure;microbicide;National Institute of Allergy and Infectious Disease;Persons;Play;pre-clinical;pre-exposure prophylaxis;prevent;Prevention;Prevention strategy;Preventive vaccine;quality assurance;Quality Control;Recurrence;research clinical testing;Resources;Role;sexual HIV transmission;Technology;United States National Institutes of Health;Work,Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC),0,NA,NA,NA,NA,NA,NA,NA,23892,NA
11180935,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00047,NA,NA,75N95019C00047-P00013-9999-3,NIMH:1649674\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,PITTSBURGH,UNITED STATES,NA,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,"""This contract is for post-mortem human brain collection sites (i.e. the NIH Brain and Tissue Repositories [NBTR]) for the NIH NeuroBioBank. This contract is part of a strategy by the NIH to maximize availability of post-mortem human biospecimens to the research community while simultaneously achieving greater efficiency and better coordination of brain and tissue repository resources through a centralized approach to brain banking."" Alzheimer's Disease",79330212 (contact),"LEWIS, DAVID  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Alzheimer&apos;s Disease;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;Process;Research;Resources;Site;Tissue Banks;Tissues;United States National Institutes of Health,NBB BRAIN BANK,0,NA,NA,NA,NA,NA,NA,NA,1649674,NA
11180937,N01,HL,NA,N,NA,NA,NA,NA,75N92019D00010,NA,NA,75N92019D00010-P00002-759202200002-1,NHLBI:26743\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,CHAPEL HILL,UNITED STATES,NA,04,608195277,US,578206,UNIV OF NORTH CAROLINA CHAPEL HILL,NC,275995023,NA,78846487 (contact),"CAI, JIANWEN  (contact)",NA,2022-09-01,2024-11-29,"Accounting;Algorithms;Categories;Cells;Complex;Data;design;Drops;follow-up;Hispanic Community Health Study/Study of Latinos;Longitudinal Studies;Longitudinal Surveys;Methods;Participant;Performance;Prospective, cohort study;Research Project Grants;Sampling;simulation;Surveys;Time;tool;Visit;waist circumference;Weight",HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS COORDINATING CENTER DIVERSITY SUPPLEMENT FOR JOSE LOPEZ,0,NA,NA,NA,NA,NA,NA,NA,26743,NA
11180940,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00048,NA,NA,75N95019C00048-P00014-9999-1,NICHD:736940\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,BALTIMORE,UNITED STATES,NA,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,NA,16188432 (contact),"BLANCHARD, THOMAS  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;Process;Research;Resources;Site;Tissue Banks;Tissues;United States National Institutes of Health,THE NIH NEUROBIOBANK AND TISSUE REPOSITORY,0,NA,NA,NA,NA,NA,NA,NA,736940,NA
11180941,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00048,NA,NA,75N95019C00048-P00014-9999-2,NIMH:1678031\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,BALTIMORE,UNITED STATES,NA,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,NA,78343346 (contact),"THOMAS, BLANCHARD  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Alzheimer&apos;s Disease;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;Process;Research;Resources;Site;Tissue Banks;Tissues;United States National Institutes of Health,THE NIH NEUROBIOBANK AND TISSUE REPOSITORY,0,NA,NA,NA,NA,NA,NA,NA,1678031,NA
11180942,Y01,HD,NA,N,NA,NA,NA,NA,AHD22003001,NA,NA,AHD22003001-1-0-1,NICHD:1000000\,INTERAGENCY AGREEMENTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,(contact),NA,NA,NA,Adolescent;Agreement;Air;Architecture;Big Data;biomedical informatics;Catalogs;Child;Communities;Consultations;Contracts;Data;Data Collection;data ecosystem;data integration;Data Science;Data Set;data sharing;Development;Ecosystem;Fees;Funding;Goals;Government;Human;human centered design;Human Development;improved;Industry;innovation;interoperability;Laboratories;Life Cycle Stages;Massachusetts;Measurable;Mission;National Institute of Child Health and Human Development;Performance;Recommendation;Reproductive Health;Research;research and development;Research Personnel;Resources;Rights;Scientific Advances and Accomplishments;Secure;software development;Specimen;Systems Analysis;Technology;Time;tool;United States National Institutes of Health;Work,NICHD DATA ECOSYSTEM DEVELOPMENT ROADMAP - DASH,220030,NA,NA,NA,NA,NA,NA,NA,1000000,NA
11180943,Y01,OD,NA,N,NA,NA,NA,NA,AOD23077001,NA,NA,AOD23077001-1-0-1,OD:520000\,INTERAGENCY AGREEMENTS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,NA,NA,NA,NA,NA,NA,NA,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,NA,NA,NA,(contact),NA,NA,NA,3-Dimensional;Acute;Award;Biological Models;biological systems;Cardiovascular system;Chronic;Contracts;Exposure to;Federal Government;Heart;Human;Human Pathology;in vivo;Longevity;microphysiology system;National Institute of Allergy and Infectious Disease;Planet Earth;radiation effect;Radiation exposure;Radiation induced damage;response;stressor;Technology;Tissue Microarray;Tissues;United States National Aeronautics and Space Administration;Universities,Extended Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and Chronic Exposures to Stressors,230770,NA,NA,NA,NA,NA,NA,NA,520000,NA
11181129,N01,CA,NA,N,NA,NA,NA,NA,261201500003I,NA,NA,261201500003I-P00012-26100071-1,NCI:21434446\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,FREDERICK,UNITED STATES,NA,06,159990456,US,10008928,"LEIDOS BIOMEDICAL RESEARCH, INC.",MD,217029242,NA,16604152 (contact),"FORQUER, DWAYNE  (contact)",NA,2018-09-14,2027-08-31,analytical tool;anti-cancer research;Authorization documentation;base;cancer genomics;Data;Data Commons;data ecosystem;data framework;data integration;data modeling;data science infrastructure;data sharing;Data Storage and Retrieval;data submission;design;Elements;Environment;experience;genomic data;Genomic Data Commons;genomics cloud;Image;Knowledge;Malignant Neoplasms;Modeling;multimodal data;Ontology;Orphan;Recommendation;repository;Resources;Secure;Semantics;tool;Validation;Vision;Visualization;Vocabulary;working group,NCI CBIIT;EXPAND DATA COMMONS,0,NA,NA,NA,NA,NA,NA,NA,21434446,NA
11181130,N02,CA,NA,N,NA,NA,NA,NA,261201500003I,NA,NA,261201500003I-P00011-26100077-1,NCI:13633885\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,FREDERICK,UNITED STATES,NA,06,159990456,US,10008928,"LEIDOS BIOMEDICAL RESEARCH, INC.",MD,217029242,NA,15718721 (contact),"MITRA, GAUTAM (GEORGE)  (contact)",NA,2018-09-24,2029-08-29,Allogenic;analytical method;Animal Testing;anti-cancer research;Autologous;Biological Assay;Biological Products;Biopsy;Cell Therapy;Cells;Cellular immunotherapy;Clinical;Clinical Research;Clinical Trials;Development;Division of Cancer Treatment and Diagnosis;Evaluable Disease;Exclusion;Freezing;Good Manufacturing Process;Human;Laboratories;Lentivirus;leukemia;Lymphoma;manufacture;manufacturing capabilities;manufacturing process;manufacturing technology;Monitor;Multi-Institutional Clinical Trial;Natural Killer Cells;Needles;novel;participant enrollment;pharmacodynamic biomarker;Pharmacodynamics;Phase;pre-clinical;preclinical study;Process;Production;Program Development;Qualifying;quality assurance;Quality Control;Reference Standards;Regimen;Resources;response;Retroviridae;scale up;Solid Neoplasm;System;T-Lymphocyte;Technology;tumor;Validation;vector,Cell-based Immunotherapy Products,0,NA,NA,NA,NA,NA,NA,NA,13633885,NA
11181131,N01,HL,NA,N,NA,NA,NA,NA,75N92019C00011,NA,NA,75N92019C00011-P00007-9999-1,NHLBI:549999\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,BOSTON,UNITED STATES,NA,07,030811269,US,1080401,BRIGHAM AND WOMEN'S HOSPITAL,MA,021156110,NA,16188267 (contact),"REDLINE, SUSAN  (contact)",NA,2019-09-20,2025-03-19,"Bioinformatics;bioinformatics infrastructure;cloud based;Communities;Contracts;Data;data resource;Data Set;Fostering;Future;Goals;meetings;National Heart, Lung, and Blood Institute;Performance;Productivity;programs;Research;Resources;Services;Sleep;tool",NATIONAL SLEEP RESEARCH RESOURCE (NSRR),0,NA,NA,NA,NA,NA,NA,NA,549999,NA
11181132,N01,HL,NA,N,NA,NA,NA,NA,75N92020D00019,NA,NA,75N92020D00019-P00004-759202000002-1,NHLBI:860651\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,STANFORD,UNITED STATES,NA,16,009214214,US,8046501,STANFORD UNIVERSITY,CA,943052004,NA,78341064 (contact),"WU, JOSEPH  (contact)",NA,2020-09-01,2025-08-31,"African American population;Area;Asian population;biobank;Blood specimen;Cardiotoxicity;Cardiovascular Diseases;Cardiovascular system;Cell Line;cell type;Cells;Collection;Development;Dilated Cardiomyopathy;Disease;disease model;drug discovery;Drug Screening;Drug toxicity;drug use screening;Ethnic Origin;Exhibits;Genotype;Growth;Hispanic Populations;Human;human induced pluripotent stem cells;Hypertrophic Cardiomyopathy;In Vitro;Individual;Individual Differences;induced pluripotent stem cell;induced pluripotent stem cell derived cardiomyocytes;induced pluripotent stem cell technology;Medical History;Minority;National Heart, Lung, and Blood Institute;novel therapeutic intervention;novel therapeutics;patient response;Patients;Phenotype;Property;Protocols documentation;racial diversity;recruit;regenerative therapy;Research;Research Personnel;Resources;self-renewal;Services;Signal Transduction;Standardization;stem;transcriptome;treatment response",BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD) - TASK AREA B,0,NA,NA,NA,NA,NA,NA,NA,860651,NA
11181135,N01,HL,NA,N,NA,NA,NA,NA,75N92020D00019,NA,NA,75N92020D00019-P00004-759202000001-1,NHLBI:152016\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,STANFORD,UNITED STATES,NA,16,009214214,US,8046501,STANFORD UNIVERSITY,CA,943052004,NA,78341061 (contact),"WU, JOSEPH  (contact)",NA,2020-09-01,2025-08-31,"African American population;Area;Asian population;biobank;Blood specimen;Cardiotoxicity;Cardiovascular Diseases;Cardiovascular system;Cell Line;cell type;Cells;Collection;Development;Dilated Cardiomyopathy;Disease;disease model;drug discovery;Drug Screening;Drug toxicity;drug use screening;Ethnic Origin;Exhibits;Genotype;Growth;Hispanic Populations;Human;human induced pluripotent stem cells;Hypertrophic Cardiomyopathy;In Vitro;Individual;Individual Differences;induced pluripotent stem cell;induced pluripotent stem cell derived cardiomyocytes;induced pluripotent stem cell technology;Medical History;Minority;National Heart, Lung, and Blood Institute;novel therapeutic intervention;novel therapeutics;operation;patient response;Patients;Phenotype;Property;Protocols documentation;racial diversity;recruit;regenerative therapy;Research;Research Personnel;Resources;self-renewal;Services;Signal Transduction;Standardization;stem;transcriptome;treatment response",BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD)- TASK A. CORE STUDY OPERATIONS,0,NA,NA,NA,NA,NA,NA,NA,152016,NA
11181140,N01,DA,NA,N,NA,NA,NA,NA,75N95019C00050,NA,NA,75N95019C00050-P00012-9999-3,NIMH:386361\NINDS:998662\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,CORAL GABLES,UNITED STATES,NA,27,052780918,US,5221250,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,331462926,NA,78343349 (contact),"STRICKLAND, BRANDON  (contact)",NA,2024-09-01,2025-04-30,Advocacy;Alzheimer&apos;s Disease;Autopsy;Brain;brain control;brain tissue;Collection;Communities;Contracts;Disease;Goals;Human;human disease;Mental disorders;National Institute of Child Health and Human Development;National Institute of Drug Abuse;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Aging;Nervous System Disorder;Neurodevelopmental Disorder;Patients;preservation;Process;Research;Resources;Services;Site;Tissue Banks;Tissues;United States National Institutes of Health,"THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND DISTRIBU",0,NA,NA,NA,NA,NA,NA,NA,1385023,NA
11181212,R01,MH,7,N,2024-09-10,2024-07-01,2025-06-30,NA,R01MH125868,NA,PA-21-268,7R01MH125868-02,NIMH:766659\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF MENTAL HEALTH,NA,BALTIMORE,UNITED STATES,NA,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,NA,1956757 (contact),"GOLDMAN, HOWARD H (contact)","FREED, MICHAEL",2024-07-01,2028-06-30,NA,ConProject-001,125868,SERV,Mental Health Services Study Section[SERV],7825,NA,2,635430,131229,NA,766659
11181233,R37,AI,7,N,2024-12-04,2024-11-01,2025-02-28,855,R37AI109593,NA,PA-24-254,7R37AI109593-10,NIAID:905866\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,SILVER SPRING,UNITED STATES,NA,08,080507421,US,10052525,"AUTONOMOUS THERAPEUTICS, INC.",MD,209021643,"PROJECT NARRATIVE Stochastic fluctuations in gene expression impact cell-fate specification decisions from embryogenesis to viral infection creating barriers for effective treatment interventions. Based on therapeutic precedents in neuroscience that use fluctuations to improve sensorimotor function, this project will identify centralized molecular and cellular mechanisms of noise modulation, that can be therapeutically targeted, in embryonic stem cells (ESCs). The proposed research will lead to development of new broad-spectrum noise modulators, and propel clinical translation of noise-modulating molecules to guide new therapeutic approaches that overcome barriers to precise cell-fate control in diverse mammalian systems.",8236762 (contact),"WEINBERGER, LEOR S (contact)","LAWRENCE, DIANE M",2014-06-01,2026-02-28,Address;Affect;Architecture;Attenuated;Award;Bacteria;biological systems;Cell Fate Control;cell fate specification;Cells;Cellular biology;Chemosensitization;circadian;Circadian Rhythms;Clinical;clinical translation;Cytoplasm;Data;Development;Disparate;drug repurposing;effective therapy;Electrophysiology (science);Embryonic Development;embryonic stem cell;Engineering;Enhancers;Evolution;FDA approved;Feedback;Flow Cytometry;Gene Expression;Genes;Genetic;Genetic Transcription;Goals;Heterogeneity;HIV;improved;in vivo;Intervention;knock-down;Knowledge;Literature;Malignant Neoplasms;Mammalian Cell;Maps;mathematical model;Modeling;Molecular;molecular modeling;mutant;Neurosciences;Noise;novel;novel therapeutic intervention;Nuclear Export;Outcome;Pathway interactions;pharmacologic;posttranscriptional;predictive modeling;reactivation from latency;Reporter;Research;Rest;Role;Safety;Science;Sensorimotor functions;Source;Specific qualifier value;Starvation;stem cells;Stress;synergism;System;T-Lymphocyte;Testing;Therapeutic;therapeutic development;Therapeutic Effect;therapeutic target;tool;Transcription Coactivator;transcriptome;Translations;Viral;Virus Diseases;Virus Latency;Work;Yeasts,Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics,109593,MABS,Modeling and Analysis of Biological Systems Study Section[MABS],NA,NA,10,286141,619725,905866,NA
11181422,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000241,NA,NA,1ZIAAG000241-17,NIA:6952\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690835 (contact),"STERN, MICHAEL  (contact)",NA,NA,NA,Aging;Algorithms;analog;Animals;asexual;Attention;Behavior;Biochemical Pathway;Biological;Biological Models;Castes;Code;Collaborations;Computer Simulation;Computer software;Computers;computing resources;Coupled;Cultural Evolution;Dedications;Disadvantaged;Economics;Educational process of instructing;Elements;Environment;Epigenetic Process;Equation;Equilibrium;Event;Evolution;Exclusion;Fishes;fitness;frailty;Free Will;Future;Gambling;Generations;Genes;genetic information;Genetic Programming;Genome;Growth;Hand;Heritability;Human;Human Genome;Husband;imprint;Individual;Inferior;Institution;interest;Life Cycle Stages;life span;Marketing;Mediation;Modeling;models and simulation;Mutation;Mythology;Natural Selections;Nature;network models;Noise;Organism;Ownership;parallelization;Pattern;Population;Probability;Problem Solving;Process;Religion;Reporting;reproductive;Research Personnel;Resources;Risk;Risk Taking;Role;Scientist;Sexual Reproduction;social;Societies;Specific qualifier value;Stratification;Structure;System;Territoriality;Time;trait;United States National Institutes of Health;virtual;virtual reality simulation;Work;Y Chromosome,Darwinian Evolution of Virtual Organisms,241,NA,NA,NA,NA,17,NA,NA,6952,NA
11181423,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000250,NA,NA,1ZIAAG000250-17,NIA:3309165\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690843 (contact),"SOLLOTT, STEVEN  (contact)",NA,NA,NA,Aging;Arginine;ATP Hydrolysis;ATP phosphohydrolase;ATP Synthesis Pathway;Automobile Driving;BCL-2 Protein;BCL2 gene;BH3 Domain;Bioenergetics;Bioluminescence;Body Weight;Cations;Cells;Cytoplasm;Cytoprotection;Data;Detection;Development;effective therapy;Elasticity;Elderly;Electron Transport;Electrons;Energy Supply;Enzymes;Exhibits;experimental study;Failure;Family;feature detection;Feedback;Fingers;Guanosine Triphosphate Phosphohydrolases;Heart;Heart failure;Heart Mitochondria;Homeostasis;Individual;inhibitor;Inner mitochondrial membrane;invention;Ions;Ischemia;Lipid Bilayers;Luciferases;Measures;Mechanics;member;Membrane Potentials;metabolic rate;Mitochondria;Mitochondrial Matrix;Modeling;Molecular;molecular recognition;Morphologic artifacts;Motor;novel;Organelles;Osmolalities;Osmosis;Oxidation-Reduction;Oxygen Consumption;Pathology;Performance;Persons;pH gradient;Photons;Phylogenetic Analysis;Physiological;Population;Potassium Channel;Potential Energy;Power stroke;Production;Protein Family;Proteins;proteoliposomes;Proton-Motive Force;Protons;Publications;Pump;Rattus;reconstitution;Regulation;Reperfusion Injury;Respiration;Respiratory Chain;restoration;Rotation;Route;Running;Signal Transduction;single molecule;Source;Specificity;stoichiometry;Stress;Syncope;Techniques;Time;Tissues;Trees;voltage clamp;Water;Workload,Control Mechanisms for Matching ATP Supply and Demand in Heart Mitochondria,250,NA,NA,NA,NA,17,NA,NA,3309165,NA
11181424,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000452,NA,NA,1ZIAAG000452-08,NIA:90237\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691109 (contact),"SPENCER, RICHARD  (contact)",NA,NA,NA,3-Dimensional;Age;age related changes;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Amyloid beta-Protein;Anoxia;Bayesian Analysis;Bayesian Method;biomarker development;Body mass index;Brain;Brain imaging;Brain region;Cartilage;Cerebrovascular Circulation;Cholesterol;Clinical;clinical development;Cognition;Cognitive;cognitive ability;Cognitive deficits;cognitive function;Craniocerebral Trauma;Data Analyses;Data Set;Dementia;Demyelinations;density;Deposition;Development;Diffuse;Diffusion;Diffusion Magnetic Resonance Imaging;Echo-Planar Imaging;Edema;Environmental Risk Factor;Equilibrium;Evaluation;Exhibits;experimental study;Free Radicals;Functional disorder;Funding;genetic risk factor;Genotype;Health;Heterogeneity;high dimensionality;Hospitals;human data;human imaging;Image;Impaired cognition;Impairment;improved;in vivo monitoring;Individual;Inflammation;interest;Investigation;Judgment;Laboratories;Language;Least-Squares Analysis;Lesion;Magnetic Resonance Imaging;Maps;Mathematics;Measures;Memory;Methodology;Methods;mild cognitive impairment;Modeling;Morphologic artifacts;Multiple Sclerosis;Myelin;Myelin Sheath;myelination;Nature;Noise;normal aging;Parameter Estimation;Pathway interactions;Pattern;Performance;Phase;Physiologic pulse;pre-clinical;prognostic;progression risk;Protocols documentation;Publishing;Recovery;Relaxation;remyelination;Research;resilience;Role;Scanning;Signal Transduction;Slice;Speed;Stains;Structure;Symptoms;System;T2 weighted imaging;targeted treatment;Techniques;Testing;Therapeutic Intervention;Time;Toxic effect;treatment response;volunteer;Water;white matter;Work,"Advanced magnetic resonance imaging of the human brain in normative aging, cognitive impairment, and dementia",452,NA,NA,NA,NA,8,NA,NA,90237,NA
11181425,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000525,NA,NA,1ZIAAG000525-05,NIA:252664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1887759 (contact),"SEN, RANJAN  (contact)",NA,NA,NA,Acute;adaptive immunity;Address;Affect;age effect;age related neurodegeneration;Aging;alpha synuclein;Alzheimer&apos;s Disease;Alzheimer&apos;s disease model;Alzheimer&apos;s disease related dementia;Antibodies;Behavior;Behavioral;Biological Assay;Brain;brain behavior;Brain Pathology;Cell Line;Cell Physiology;cell type;Cells;Characteristics;ChIP-seq;Chronic;cohort;Defect;Deposition;Development;Disease;Disease Progression;Dose;experimental study;Female;field study;Functional disorder;Funding;Gene Expression;Genes;Genetically Engineered Mouse;Goals;gut inflammation;Hippocampus;Home;human disease;Human Resources;Immune;immune cell infiltrate;Immune response;Immune system;in vivo;Inflammation;Inflammatory;Inflammatory Response;Injections;Interleukin-1;Interleukin-12;Interleukin-6;Kinetics;Laboratories;male;Microglia;Modeling;Monitor;mouse model;Mouse Strains;Mus;Nature;Nerve Degeneration;neuroinflammation;neuropathology;NF-kappa B;old mice;Pathology;Pathway interactions;pharmacologic;Phase;pre-formed fibril;Process;Proteins;Publishing;recruit;Research Project Grants;RNA;Role;Sodium Dextran Sulfate;stem;Synapses;synuclein;synucleinopathy;System;Testing;Therapeutic;Time;TNF gene;transcription factor;transcriptome sequencing,ALZHEIMERS RESEARCH PROJECT: Immune and inflammatory interactions in Alzheimer's disease-related dementias,525,NA,NA,NA,NA,5,NA,NA,252664,NA
11181426,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000550,NA,NA,1ZIAAG000550-01,NIA:2881527\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,79957112 (contact),"VAN KEUREN-JENSEN, KENDALL  (contact)",NA,NA,NA,Affect;Alzheimer&apos;s disease pathology;Alzheimer&apos;s disease related dementia;Autopsy;Brain;Brain region;cell type;Cells;cingulate cortex;Data;frontal lobe;Genetic Transcription;Goals;Lasers;Occipital lobe;Pathology;Sampling;Series;single cell analysis;single cell genomics;single nucleus RNA-sequencing;transcriptomics,Atlasing single nuclei RNA sequencing from postmortem brain in ADRD,550,NA,NA,NA,NA,1,NA,NA,2881527,NA
11181427,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000714,NA,NA,1ZIAAG000714-17,NIA:151811\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1965015 (contact),"GEARHART, PATRICIA J (contact)",NA,NA,NA,Antibody Diversity;B-Lymphocytes;Binding;Binding Proteins;Cell Line;Cell Nucleus;Cells;ChIP-seq;chromatin protein;Cleavage Under Targets and Release Using Nuclease;Data;design;Development;DNA;flexibility;Freezing;Genetic Transcription;Histones;Measures;non-histone protein;Nuclear;Procedures;Protocols documentation;Reagent;RNA Polymerase II;Role;Sampling;Signal Transduction;Techniques,Roles for Transcription in Antibody Diversity,714,NA,NA,NA,NA,17,NA,NA,151811,NA
11181428,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000732,NA,NA,1ZIAAG000732-29,NIA:151811\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1965015 (contact),"GEARHART, PATRICIA J (contact)",NA,NA,NA,Affinity;Animals;Antibodies;Antibody Diversity;Antibody Response;Antibody Specificity;Antibody titer measurement;antigen binding;Antigens;Aorta;aortic arch;Apolipoprotein E;Arteries;artery occlusion;Atherosclerosis;Autoantibodies;B-Cell Activation;B-cell receptor repertoire sequencing;B-Lymphocytes;Bacteriophages;Binding;Cells;Complex;cytokine;Disease;early onset;Enzyme-Linked Immunosorbent Assay;Fatty acid glycerol esters;Immune system;Immunize;Immunohistochemistry;Immunoprecipitation;Inflammatory;Light;Lipids;Measurement;Mouse Protein;Mus;Necrosis;Proteins;Proteome;Serum;single cell sequencing;western diet,Protein Interactions in Antibody Diversity,732,NA,NA,NA,NA,29,NA,NA,151811,NA
11181429,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000777,NA,NA,1ZIAAG000777-13,NIA:50533\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,1965015 (contact),"GEARHART, PATRICIA J (contact)",NA,NA,NA,Affinity;age effect;Alzheimer&apos;s Disease;animal old age;Antibodies;Antibody Diversity;Antigens;B-Cell Antigen Receptor;B-Lymphocytes;Brain;C57BL/6 Mouse;Cells;Characteristics;Chickens;Disease Progression;disorder prevention;Gamma globulin;Germ Lines;Immune response;Immunization;Immunize;Inflammation;Light;Measurement;Mus;novel;old mice;Pathogenicity;Play;receptor;Recombinant Antibody;reconstruction;Research Project Grants;response;Role;Serum;Severity of illness;single-cell RNA sequencing;Structure of germinal center of lymph node;Time,ALZHEIMER'S RESEARCH PROJECT: Effect of Age on Antibody Diversity,777,NA,NA,NA,NA,13,NA,NA,50533,NA
11181430,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000844,NA,NA,1ZIAAG000844-28,NIA:305889\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690835 (contact),"STERN, MICHAEL  (contact)",NA,NA,NA,"3-Dimensional;Adrenergic Agents;Algebra;Algorithms;Calcium;Calmodulin;Cell Communication;Cell model;Cell Physiology;Cell Separation;Cell surface;Cells;Classification;Collaborations;Computer Simulation;Computer software;Computers;Copyright;Coupled;Coupling;COVID-19;Data;Dedications;Diffusion;Epidemic;Epidemiology;Event;Green Fluorescent Proteins;Heart;Heart Atrium;Heart Rate;heart rhythm;Heterogeneity;Image;Individual;Ion Channel;Journals;L-Type Calcium Channels;Language;link protein;Location;markov model;Mathematics;Methods;Microscopy;Modeling;multi-scale modeling;Mus;Myocardium;nano;nodal myocyte;novel;old mice;open source;operation;Organelles;Oryctolagus cuniculus;Pacemakers;pandemic disease;parallelization;patch clamp;Phase Transition;Photons;Physics;Physiology;Preparation;Process;Professional counselor;programs;Property;Publishing;reconstruction;Records;Research Personnel;Resolution;Role;Running;Ryanodine Receptor Calcium Release Channel;Scheme;sensor;Shapes;simulation;Sinoatrial Node;Skeletal Muscle;software development;solid state;Spectrometry, Mass, Secondary Ion;Statistical Methods;Structure;theories;Thermodynamics;three-dimensional modeling;Time;tool;Translating;United States National Institutes of Health;Update;virtual;voltage;Work;Writing",Stochastic Simulation Of Excitation-contraction Coupling,844,NA,NA,NA,NA,28,NA,NA,305889,NA
11181431,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000891,NA,NA,1ZIAAG000891-09,NIA:20856\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691085 (contact),"LAKATTA, EDWARD  (contact)",NA,NA,NA,Adrenergic Agents;Age;age effect;Age Months;age related changes;Aging;aging biomarker;aging process;Alzheimer&apos;s Disease;Animal Model;Animals;Ants;Biological Markers;Blood Vessels;Brain;Cardiac;Cardiovascular system;Cessation of life;Clinical;Clinical Research;cohort;Dementia;Diabetes Mellitus;Echocardiography;Elderly;Electrocardiogram;Endocrine system;Future;Gene Expression Profile;Goals;Healthcare Systems;healthspan;Heart failure;Heart Rate;heart rate variability;Human;Individual;Intervention;Investigation;life span;Malignant Neoplasms;Medical;Mus;neural;Physiological;Population;pre-clinical;programs;quantification of aging;Research Project Grants;social;Societies;Stroke,CLINICAL PROJECT:  Biomarkers of Cardiovascular Aging,891,NA,NA,NA,NA,9,NA,NA,20856,NA
11181432,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000924,NA,NA,1ZIAAG000924-17,NIA:103212\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691109 (contact),"SPENCER, RICHARD  (contact)",NA,NA,NA,"Adipose tissue;Architecture;Bioenergetics;bone quality;Cartilage;Connective Tissue;design;Diet;dietary restriction;Diffusion;Diffusion Magnetic Resonance Imaging;Fourier Transform;Goals;Health;Human;human subject;improved;in vivo;Investigation;ketogenic diet;Laboratories;Link;Machine Learning;Magnetic Resonance;Magnetic Resonance Imaging;Measures;Metabolic;Methods;Modality;Muscle;Muscle function;muscular structure;Musculoskeletal;Near-Infrared Spectroscopy;neural network;neural network architecture;novel;Older Population;Outcome Measure;primary outcome;Rattus;Research;Sarcomeres;Signal Transduction;Spectroscopy, Fourier Transform Infrared;Tissues;Water;Work",Magnetic Resonance Analysis of Connective Tissue and Muscle,924,NA,NA,NA,NA,17,NA,NA,103212,NA
11181433,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000926,NA,NA,1ZIAAG000926-17,NIA:206424\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691109 (contact),"SPENCER, RICHARD  (contact)",NA,NA,NA,Aerobic;Aerobic Exercise;Age;age related;age related decline;aged;Aging;Attenuated;Baltimore;Biochemical;Bioenergetics;Exercise;Gait speed;Height;human old age (65+);human subject;Longitudinal Studies;Magnetic Resonance Spectroscopy;Measurement;men;Metabolic;Methods;Muscle;Outcome;Outcome Measure;Oxygen Consumption;Participant;Performance;performance tests;Phosphocreatine;Phosphorus;Physiological;Population;Recovery;sex;Testing;Treadmill Tests;Walking;walking speed;Weight,Accurate Quantification in Physiologic Phosphorus MR Spectroscopy,926,NA,NA,NA,NA,17,NA,NA,206424,NA
11181434,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000927,NA,NA,1ZIAAG000927-17,NIA:361242\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691109 (contact),"SPENCER, RICHARD  (contact)",NA,NA,NA,Alzheimer&apos;s disease model;Animals;Area;Base Excision Repairs;Body fat;bone quality;Brain;brain morphology;Caloric Restriction;Cerebellar Ataxia;Cerebrovascular Circulation;Choline;Creatine;Data;Dietary Intervention;dietary restriction;disease model;experimental study;Image;imaging study;interest;Intervention Studies;Investigation;ketogenic diet;knockout animal;Lipids;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Measurement;Measures;Methods;Morphology;mouse model;Mus;Neurons;Participant;Phenotype;preservation;repaired;Rodent Model;Signal Transduction;Single Strand Break Repair;Spectrum Analysis;Structure;Techniques;Transgenic Organisms;Work;XRCC1 gene,Magnetic Resonance Imaging and Spectroscopy of Rodent Models of Disease,927,NA,NA,NA,NA,17,NA,NA,361242,NA
11181435,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000930,NA,NA,1ZIAAG000930-10,NIA:5212207\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691109 (contact),"SPENCER, RICHARD  (contact)",NA,NA,NA,Address;Algorithms;Bayesian Analysis;Bayesian Method;Brain;Cartilage;Clinical;Data;dimension reduction;Dimensions;Equilibrium;experimental study;high dimensionality;Human;human subject;Image;improved;In Vitro;in vivo;Knee;Least-Squares Analysis;Magnetic Resonance Imaging;Maps;marginalization;Measures;Methods;Modeling;Myelin;myelination;Nature;neural network;Noise;novel;novel strategies;Parameter Estimation;Pathway Analysis;Physiologic pulse;Probability;Proteoglycan;Residual state;Signal Transduction;simulation;Spectrum Analysis;Surface;Techniques;Testing;theories;Tissues;Variant;volunteer;Water;Work,Multicompartment quantification of tissue in vitro and in vivo with magnetic resonance imaging and spectroscopy,930,NA,NA,NA,NA,10,NA,NA,5212207,NA
11181436,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000935,NA,NA,1ZIAAG000935-08,NIA:184083\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,10268509 (contact),"TRAYNOR, BRYAN  (contact)",NA,NA,NA,Acceleration;Adult;Age;aging brain;aging process;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Biology;Clinical;cohort;Complex;computing resources;Congresses;cost;Data;database of Genotypes and Phenotypes;Databases;Defect;Dementia;design;Development;Diagnosis;Disease;disease model;drug development;drug discovery;Drug Targeting;effective intervention;Environment;Etiology;Evolution;Frontotemporal Dementia;frontotemporal lobar dementia amyotrophic lateral sclerosis;Genes;Genetic;Genetic Research;Genetic Risk;Genome;genome sequencing;genomic locus;Goals;Health;Human Genome;improved;insight;Intramural Research Program;Knowledge;Laboratories;Learning;Lewy Body Dementia;Molecular;Nerve Degeneration;Nervous System Disorder;Neurodegenerative Disorders;neurogenetics;Neurologic;Neurosciences;novel;online resource;Onset of illness;Paper;Parkinson Disease;Pathogenesis;Patients;Personal Satisfaction;Phenotype;Publishing;Research;Research Personnel;Research Project Grants;Resources;Risk;risk variant;Role;sequencing platform;Syndrome;targeted treatment;Technology;Testing;therapeutic target;Time;United States National Institutes of Health;Variant;web portal;Work,CLINICAL/ALZHEIMERS RESEARCH PROJECT: Genome sequencing of Lewy Body Dementia and Frontotemporal Dementia: a public resource for the study of Alzheimer's disease and related dementias,935,NA,NA,NA,NA,8,NA,NA,184083,NA
11181437,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000966,NA,NA,1ZIAAG000966-17,NIA:72190\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,10268558 (contact),"KAPOGIANNIS, DIMITRIOS  (contact)",NA,NA,NA,Affective;Age;Aging;aging brain;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Amyloid deposition;Area;Atrophic;beta-Hydroxybutyrate;Biological Markers;Brain;Brain Chemistry;brain metabolism;Chemistry;Clinical;Clinical Research;Clinical Trials;Cognitive;cognitive performance;Collaborations;Complex;Data;Diet;dietary control;Disease;Enrollment;Esters;fluorodeoxyglucose positron emission tomography;Functional Magnetic Resonance Imaging;gamma-Aminobutyric Acid;Glucose;glucose metabolism;Glutamates;Glutamine;Image;improved;Insulin Resistance;Intermittent fasting;Intervention;Investigation;ketogenesis;Ketone Bodies;Ketones;Knowledge;Machine Learning;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Measurement;Measures;memory encoding;memory retrieval;Metabolic;metabolic abnormality assessment;Metabolism;Methodology;Mitochondria;multiple sclerosis patient;neurochemistry;neuroimaging marker;neurotransmission;novel;novel marker;Oral;Outcome;Participant;Pathogenesis;Play;Positron-Emission Tomography;Process;Proteins;Publishing;Randomized Controlled Clinical Trials;Reporting;Research;Research Personnel;Research Project Grants;response;Rest;Retina;Role;Structure;Synapses;Techniques,"ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Brain structure, chemistry and function investigations in aging and Alzheimer's disease using MRI/MRS",966,NA,NA,NA,NA,17,NA,NA,72190,NA
11181438,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000975,NA,NA,1ZIAAG000975-16,NIA:1696456\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,10268558 (contact),"KAPOGIANNIS, DIMITRIOS  (contact)",NA,NA,NA,"aging population;aging related disease;Alzheimer disease prevention;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease related dementia;Alzheimer&apos;s disease therapeutic;Alzheimer’s disease biomarker;analog;Animal Model;animal tissue;Animals;Anti-Inflammatory Agents;Astrocytes;Autobiography;Biological;Biological Markers;Biological Models;Biological Products;Bipolar Disorder;Blood;Brain;brain health;brain metabolism;Caloric Restriction;Calories;Cell Respiration;Cells;Cellular Metabolic Process;Clinical;Clinical Research;Clinical Trials;Cognitive;Cognitive aging;cognitive performance;cognitive testing;cohort;Collaborations;comparison control;Conduct Clinical Trials;Consumption;Cooperative Research and Development Agreement;COVID-19 impact;Data;Delaware;design;Development;Diagnosis;Diet;Disease;Drug Targeting;Elderly;Energy Metabolism;Episodic memory;Esters;Event;executive function;exenatide;exosome;Family;Flow Cytometry;Fragile X Syndrome;France;Freezing;frontal lobe function;Frontotemporal Dementia;Functional Magnetic Resonance Imaging;Future;Generations;Genetic;Genotype;Genus Hippocampus;glucagon-like peptide 1;Goals;Growth;Health;Health Personnel;Human;human induced pluripotent stem cells;Human Resources;Impairment;improved;in vitro Model;Individual;Inflammatory;infliximab;Insulin;Insulin Resistance;insulin sensitivity;Intake;Intermittent fasting;Intervention;Ketones;Long COVID;Magnetic Resonance Imaging;Martens;Measurement;Measures;Mental Depression;Metabolic;Metabolic syndrome;Metabolism;method development;Methodology;Methods;Microscopy;middle age;Mitochondria;Molecular;Multiple Sclerosis;Multiple System Atrophy;Nerve Degeneration;Nerve Regeneration;Neural Cell Adhesion Molecule L1;neuroimaging;Neurologic;Neurons;neurotransmission;nicotinamide-beta-riboside;novel;Oral;Overweight;Parkinson Disease;Pathogenicity;Pathologic Processes;Patients;peripheral blood;Pharmacodynamics;Plasma;pre-clinical;preclinical study;prenatal;Process;Psychological Impact;Publishing;randomized, controlled study;Research Personnel;Research Project Grants;Resolution;response;response biomarker;Restless Legs Syndrome;Sampling;Schizophrenia;sex;Sphingomyelinase;Structure;Subgroup;synaptic function;Translations;treatment response;Tremor/Ataxia Syndrome;United States Department of Agriculture;Universities",ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders,975,NA,NA,NA,NA,16,NA,NA,1696456,NA
11181439,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG007380,NA,NA,1ZIAAG007380-18,NIA:90926\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6479279 (contact),"LAUNER, LENORE J (contact)",NA,NA,NA,actigraphy;Address;Age;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Atherosclerosis;Behavioral;biobank;bioimaging;Biological Markers;biological specimen archives;biological systems;Blindness;Blood Vessels;Body Composition;Brain;Brain Diseases;Brain Pathology;cardiovascular risk factor;Cause of Death;Cerebral small vessel disease;Cessation of life;Characteristics;Classification;Clinical;clinical care;clinical epidemiology;Cognitive;cohort;Complex;Coronary heart disease;Data;data streams;Dementia;design;Diagnosis;Diet;Disease;Enrollment;Environment;Environmental Risk Factor;Epidemiology;Epigenetic Process;follow-up;Follow-Up Studies;Fracture;Funding;Future;Genes;Genetic;genetic epidemiology;genetic risk factor;Genetic Variation;genome wide association study;Genomics;Glucose;Grant;Health;Health Status;Healthcare;hearing impairment;Heart;Heart failure;hemodynamics;Hospitalization;human old age (65+);Image;Impaired cognition;Inflammation;Kidney;late life;Life;Life Cycle Stages;Life Style;Longitudinal Studies;Magnetic Resonance Imaging;Measurement;Measures;member;men;Mental Depression;Metabolic;Microvascular Dysfunction;middle age;multiple omics;Musculoskeletal;National Institute of Neurological Disorders and Stroke;Neurocognitive;neuropsychiatry;novel;Nursing Homes;Obesity;offspring;Older Population;Osteoporosis;Parents;Participant;patient home care;Phenotype;Physical activity;Physiological;Plasma;population based;Predisposition;Prevalence;Process;Prognosis;Prospective Studies;Proteins;Proteomics;Publishing;Recording of previous events;Research;Research Design;Research Support;Rheumatism;Risk Factors;Role;Running;Specimen;Standardization;Structure;System;Testing;trait;Vascular Cognitive Impairment;Vascular Diseases;whole genome;Woman;Work,"CLINICAL PROJECT:  Age, Gene/Environment Susceptibility Study on the Multi-omics of Aging: A clinical epidemiologic prospective study",7380,NA,NA,NA,NA,18,NA,NA,90926,NA
11181745,N01,HD,NA,N,NA,NA,NA,NA,275201800008I,NA,NA,275201800008I-0-759402400001-1,NICHD:251625\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,79956385 (contact),"HUGHES, BRENNA  (contact)",NA,2024-09-01,2025-08-31,Adolescent Behavior;adolescent health;Aliquot;Bar Codes;Behavioral;Biological Process;Biometry;Childhood;Chronic Disease;Clinical;cohort;Consent;Continuous Glucose Monitor;Contractor;Contracts;Data;Data Collection;Data Coordinating Center;data exchange;Data Management Resources;design;Development;Devices;Diagnosis;Disease;disorder risk;early life exposure;Electronics;Eligibility Determination;Enrollment;Ensure;Epidemiology;Fetal Development;Fetal Growth;Fetal health;follow-up;Gestational Diabetes;Health;Hospital Records;Human;human subject protection;Individual;individual responsibility;Institution;Label;Laboratories;Lead;Learning;Measurement;Medical;Mission;Monitor;National Institute of Child Health and Human Development;Neonatal;neonatal health;OGTT;Online Systems;Outcome;Participant;Phase;population health;Pregnancy;pregnancy health;Pregnant Women;Prenatal care;prenatal exposure;Procedures;programs;Protocols documentation;Quality Control;Randomized;recruit;repository;Reproduction;Research;Research Methodology;research study;Sampling;Shipping;Site;Standardization;Study Subject;System;Testing;Time;United States National Institutes of Health;Visit;Woman,STAGE 2: RECRUITMENT AND FOLLOW-UP FOR THE TIMING OF DELIVERY (TIME) AIM OF THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) - DUKE UNIV,0,NA,NA,NA,NA,NA,NA,NA,251625,NA
11181749,N01,HD,NA,N,NA,NA,NA,NA,275201800008I,NA,NA,275201800008I-0-759402400002-1,NICHD:1062684\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,79956388 (contact),"HUGHES, BRENNA  (contact)",NA,2024-09-01,2025-08-31,Adolescent Behavior;adolescent health;African American;Aliquot;Bar Codes;Behavioral;Biological Process;Biometry;Black American;Childhood;Chronic Disease;Clinical;clinical examination;cohort;Collaborations;Consent;Contractor;Contracts;Couples;Data;Data Collection;Data Coordinating Center;data exchange;Data Management Resources;design;Development;Devices;Disease;disorder risk;Dual-Energy X-Ray Absorptiometry;early life exposure;Eligibility Determination;Ensure;Epidemiology;Ethnic Origin;father role;Fetal Development;Fetal Growth;Fetal health;follow-up;Follow-Up Studies;Genetic;genetic analysis;Health;Hospital Records;Human;human subject protection;Individual;Institution;Label;Laboratories;male;Measurement;Medical;Mission;Monitor;National Institute of Child Health and Human Development;Neonatal;neonatal health;Newborn Infant;Online Systems;Participant;Patient Self-Report;Placenta;population health;Pregnancy;pregnancy health;Pregnant Women;Prenatal care;prenatal exposure;Procedures;programs;Protocols documentation;Quality Control;Race;recruit;repository;Reproduction;Research;Research Methodology;Shipping;System;Third Pregnancy Trimester;ultrasound;United States National Institutes of Health;Visit;Woman,STAGE 2 RECRUITMENT AND FOLLOW-UP STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) - DUKE UNIV,0,NA,NA,NA,NA,NA,NA,NA,1062684,NA
11181751,N01,HD,NA,N,NA,NA,NA,NA,275201800009I,NA,NA,275201800009I-0-759402400001-1,NICHD:1961467\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,SALT LAKE CITY,UNITED STATES,NA,01,009095365,US,514002,UNIVERSITY OF UTAH,UT,841129049,NA,79963929 (contact),"SILVER, ROBERT  (contact)",NA,NA,NA,Adolescent Behavior;adolescent health;African American;Aliquot;Bar Codes;Behavioral;Biological Process;Biometry;Black American;Childhood;Chronic Disease;Clinical;clinical examination;cohort;Collaborations;Consent;Contractor;Contracts;Couples;Data;Data Collection;Data Coordinating Center;data exchange;Data Management Resources;design;Development;Devices;Disease;disorder risk;Dual-Energy X-Ray Absorptiometry;early life exposure;Eligibility Determination;Ensure;Epidemiology;Ethnic Origin;father role;Fetal Development;Fetal Growth;Fetal health;follow-up;Follow-Up Studies;Genetic;genetic analysis;Health;Hospital Records;Human;human subject protection;Individual;Institution;Label;Laboratories;Lead;Learning;male;Measurement;Medical;Mission;Monitor;National Institute of Child Health and Human Development;Neonatal;neonatal health;Newborn Infant;Online Systems;Participant;Patient Self-Report;Placenta;population health;Pregnancy;pregnancy health;Pregnant Women;Prenatal care;prenatal exposure;Procedures;programs;Protocols documentation;Quality Control;Race;recruit;repository;Reproduction;Research;Research Methodology;research study;Shipping;System;Third Pregnancy Trimester;ultrasound;United States National Institutes of Health;Universities;Utah;Visit;Woman,STAGE 2: RECRUITMENT AND FOLLOW-UP STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) - UNIVERSITY OF UTAH,0,NA,NA,NA,NA,NA,NA,NA,1961467,NA
11181754,N01,HD,NA,N,NA,NA,NA,NA,275201800012I,NA,NA,275201800012I-0-759402400001-1,NICHD:283369\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PHILADELPHIA,UNITED STATES,NA,03,042250712,US,6463801,UNIVERSITY OF PENNSYLVANIA,PA,191046205,NA,79955935 (contact),"DURNWALD, CELESTE  (contact)",NA,2024-09-01,2025-08-31,Adolescent Behavior;adolescent health;Aliquot;Bar Codes;Behavioral;Biological Process;Biometry;Childhood;Chronic Disease;Clinical;cohort;Consent;Continuous Glucose Monitor;Contractor;Contracts;Data;Data Collection;Data Coordinating Center;data exchange;Data Management Resources;design;Development;Devices;Diagnosis;Disease;disorder risk;early life exposure;Electronics;Eligibility Determination;Enrollment;Ensure;Epidemiology;Fetal Development;Fetal Growth;Fetal health;follow-up;Gestational Diabetes;Health;Hospital Records;Human;human subject protection;Individual;individual responsibility;Institution;Label;Laboratories;Lead;Learning;Measurement;Medical;Mission;Monitor;National Institute of Child Health and Human Development;Neonatal;neonatal health;OGTT;Online Systems;Outcome;Participant;Phase;population health;Pregnancy;pregnancy health;Pregnant Women;Prenatal care;prenatal exposure;Procedures;programs;Protocols documentation;Quality Control;Randomized;recruit;repository;Reproduction;Research;Research Methodology;research study;Sampling;Shipping;Standardization;Study Subject;System;Testing;Time;United States National Institutes of Health;Visit;Woman,STAGE 2: RECRUITMENT AND FOLLOW-UP FOR THE TIMING OF DELIVERY (TIME) AIM OF THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) - UPENN,0,NA,NA,NA,NA,NA,NA,NA,283369,NA
11181758,N01,HD,NA,N,NA,NA,NA,NA,7568583,NA,NA,7568583-0-0-1,NICHD:185000\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,(contact),NA,NA,NA,"ableism;Address;Attention;Belief;Clinical Research;Communities;community living;community organizations;Complement;disability;Disabled Persons;Discrimination;Education;Ensure;Event;experience;Funding Opportunities;Health;health disparity;health disparity populations;health equity;Healthcare;improved;Independent Living;Inferior;innovation;Intervention;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute on Deafness and Other Communication Disorders;Outcome;Output;Phase;Prejudice;Prize;programs;Progress Reports;Reduce health disparities;rehabilitation research;Research;Research Project Grants;Services;social;Time;United States National Institutes of Health;webinar",REDUCING HEALTH DISPARITIES FOR PEOPLE WITH DISABILITIES CHALLENGE,0,NA,NA,NA,NA,NA,NA,NA,185000,NA
11181765,N01,HD,NA,N,NA,NA,NA,NA,75N94019D00004,NA,NA,75N94019D00004-P00002-759402300003-1,NICHD:342772\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MORRISVILLE,UNITED STATES,NA,02,803902113,US,1501,"HEALTH DECISIONS, INC.",NC,275606950,NA,79963955 (contact),"DART, CLINT  (contact)",NA,2023-09-01,2024-11-30,Adverse event;Amendment;Area;base;Case Report Form;Clinical;Clinical Management;Clinical Practice Guideline;Clinical Research;clinical research site;clinical training;Clinical Trials;Clinical Trials Data Monitoring Committees;Clinical Trials Network;clinically relevant;Collaborations;Confidentiality of Patient Information;Consent Forms;Contraceptive Agents;Contraceptive Devices;contraceptive efficacy;Contraceptive methods;Contracts;Data;Data Analyses;Data Collection;data management;data submission;design;Development;Devices;Documentation;efficacy study;efficacy trial;Eligibility Determination;Enrollment;Ensure;Female of child bearing age;follow-up;Geographic Locations;Good Clinical Practice;Government regulations;Health;Hormones;Human Resources;innovation;Institutional Review Boards;instrument;International;investigator training;Manuals;Manufacturer;meetings;men;Methods;Mission;Monitor;Multi-Institutional Clinical Trial;National Clinical Trials Network;National Institute of Child Health and Human Development;operation;Pamphlets;patient population;Periodicals;population health;Principal Investigator;Procedures;Program Development;protocol development;Protocols documentation;Qualifying;quality assurance;Randomized;Records;recruit;Regulation;Reporting;Research;research clinical testing;Research Personnel;Services;Site;symposium;tool;Training;Update;Vagina;Visit;Woman;Work,"PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL",0,NA,NA,NA,NA,NA,NA,NA,342772,NA
11181769,N01,HD,NA,N,NA,NA,NA,NA,75N94023D00001,NA,NA,75N94023D00001-0-759402400001-1,NICHD:2505456\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ROCKVILLE,UNITED STATES,NA,08,049508120,US,9611701,"WESTAT, INC.",MD,208503129,NA,79660022 (contact),"DRIVER, BARBARA  (contact)",NA,2024-03-01,2029-02-28,Accountability;Acquired Immunodeficiency Syndrome;Administrative Coordination;Adolescent;adolescent woman;AIDS clinical trial group;AIDS prevention;Area;Biological Assay;Birth;Breast Feeding;Child;clinical care;Clinical Protocols;Clinical Research;clinical research site;Clinical Trials;co-infection;Conduct Clinical Trials;Contractor;Counseling;design;Diagnosis;Discipline of Nursing;Disease;Drug Kinetics;Education;Ensure;Epidemiology;Equipment;experience;Exposure to;Goals;high risk;HIV;HIV Infections;HIV therapy;HIV-1;Human;Human Resources;human subject;Immunologics;Infant;Inpatients;Institution;Institutional Review Boards;International Maternal Pediatric Adolescent AIDS Clinical Trials;Laboratories;laboratory facility;Laboratory Technicians;Mediation;Medical;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;Natural History;Neuropsychology;neutralizing monoclonal antibodies;Office for Human Research Protections;open label;Outpatients;Participant;participant enrollment;patient population;Patients;Perinatal;Pharmaceutical Preparations;Pharmacists;pharmacologic;Phase;phase 1 study;Postpartum Women;Pregnant Women;Prevention;Protocols documentation;Qualifying;recruit;Regulation;Research;Research Activity;Research Personnel;research study;Research Subjects;Safety;safety study;Sampling;Services;Site;Social Work;Specific qualifier value;Specimen;Specimen Handling;subcutaneous;Symptoms;Testing;testing services;transmission process;United States;web site;Work,OPEN-LABEL PHASE I STUDY OF THE SAFETY AND PHARMACOKINETICS OF NEUTRALIZING MONOCLONAL ANTIBODIES IN INFANTS EXPOSED TO HIV-I,0,NA,NA,NA,NA,NA,NA,NA,2505456,NA
11181773,N01,HD,NA,N,NA,NA,NA,NA,75N94023D00005,NA,NA,75N94023D00005-0-759402400001-1,NICHD:1217005\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PROVIDENCE,UNITED STATES,NA,01,001785542,US,1003201,BROWN UNIVERSITY,RI,029034202,NA,8203028 (contact),"SILVERSTEIN, MICHAEL  (contact)",NA,2024-09-03,2025-06-02,Address;Area;Beginning of Life;Biological;Birth;Blood;Blood specimen;Characteristics;Child Development;Child Health;Child health equity;Chronic Disease;Clinical;Collaborations;Collection;Data;Data Collection;Data Coordinating Center;design;Development;Diagnostic;dietary;Dietary Assessment;Discrimination;Disease;Disparity;Disparity population;economic disparity;Economics;Electronic Mail;Enrollment;Ensure;Environmental Exposure;Ethnic Origin;Ethnic Population;Fathers;follow up assessment;follow-up;Foundations;Generations;Hair;health disparity;health outcome disparity;Home visitation;Hospitals;Human Development;Individual;Infant;Instruction;Intellectual functioning disability;interest;Intervention;Interview;Interviewer;Investigation;Knowledge;Life;Life Cycle Stages;Life Expectancy;Link;Location;Longitudinal cohort study;Manuals;Maternal and Child Health;Maternal Health;Measures;Mediating;Mental Health;Mission;Monitor;Mothers;National Institute of Child Health and Human Development;Neighborhoods;Neonatal;neurobehavioral;Outcome;outcome disparities;Parents;Participant;participant retention;Patient Recruitments;Patients;Phase;phase 2 study;Phenotype;Play;Population;population health;postnatal;Postpartum Period;Poverty;Pregnancy;Pregnancy loss;prenatal;prenatal health;Preventive;Procedures;Protocols documentation;Psychopathology;Race;racial population;recruit;Reduce health disparities;Reporting;Research;Research Personnel;residence;response;retention rate;Rhode Island;Role;Sampling;Schedule;Self Administration;Self Assessment;sexual minority status;Silicones;social;social disparities;sociodemographics;Socioeconomic Status;socioeconomics;Specific qualifier value;Strategic Planning;Structure;transmission process;Umbilical Cord Blood;United States;Update;Urine;Visit;Woman,ENRICHED Study: Completion of Follow-up Assessments for Phase 1 and Prenatal and Neonatal Assessments for Phase 2,0,NA,NA,NA,NA,NA,NA,NA,1217005,NA
11181775,N01,HD,NA,N,NA,NA,NA,NA,75N94023D00006,NA,NA,75N94023D00006-0-759402400001-1,NICHD:713993\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,MENLO PARK,UNITED STATES,NA,16,009232752,US,8042701,SRI INTERNATIONAL,CA,940253493,NA,79933127 (contact),"GONG, LEYI  (contact)",NA,2024-08-01,2027-07-31,Active Sites;Affinity;assay development;Binding;Binding Sites;Biochemical;Biological;Biological Assay;Biological Availability;Cellular Assay;Chemicals;computational chemistry;Contraceptive Agents;Contraceptive methods;contraceptive target;Contracts;Decision Making;design;Development;Discipline of obstetrics;Dose;drug development;Generations;Goals;Gynecologic;Health;High Pressure Liquid Chromatography;high throughput screening;Human Resources;improved;in silico;In Vitro;in vivo evaluation;Infertility;instrumentation;Ion Channel;Kilogram;lead series;Ligands;men;Methods;milligram;Mission;Molecular;National Institute of Child Health and Human Development;new chemical entity;Oogenesis;Ovulation;Pediatrics;Peptide Hydrolases;Performance;Perinatology;Pharmaceutical Chemistry;Pharmaceutical Preparations;Pharmacology;Phosphotransferases;Play;preclinical evaluation;Pregnancy;Privatization;Process;Production;Property;protein expression;Protein Isoforms;Qualifying;recombinant peptide;Recombinant Proteins;Reproductive Health;Research;research and development;Research Support;Resources;Role;Safety;screening;Services;Site;small molecule;small molecule libraries;sperm function;Sperm Maturation;Spermatogenesis;Structure;Support Contracts;Testing;Therapeutic;Titrations;Woman;X-Ray Crystallography,CHEMICAL SCREENING AND OPTIMIZATION FACILITY – HIGH THROUGHPUT SCREENING for Contraceptive Targets,0,NA,NA,NA,NA,NA,NA,NA,713993,NA
11181779,N02,HD,NA,N,NA,NA,NA,NA,75N94024P00566,NA,NA,75N94024P00566-0-0-1,NICHD:24875\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,FREDERICK,UNITED STATES,NA,NA,NA,US,NA,NA,MD,21705,NA,79942117 (contact),"TURPIN, JIM  (contact)",NA,2024-08-28,2025-08-27,Adherence;Anti-Infective Agents;Area;Award;Bacterial Vaginosis;biophysical properties;Chlamydia;Clinical;Clinical Trials Design;Communicable Diseases;Consultations;Contraceptive Agents;Contraceptive methods;Contracts;Data;design;Development;Development Plans;drug action;Drug Combinations;Drug Delivery Systems;drug development;Effectiveness;Ensure;Ethics;Event;Experimental Designs;Extramural Activities;Funding;good laboratory practice;Government;Grant;HIV;HIV/AIDS;Individual;Male Contraceptive Agents;meetings;men;Methods;Monitor;National Institute of Child Health and Human Development;participant safety;pathogen;Pattern;Perception;Pharmaceutical Preparations;Pharmacology;Phase;Phase I Clinical Trials;Policies;pre-clinical;preclinical development;Pregnancy;pregnancy prevention;prevent;Prevention;Procedures;product development;Program Development;Property;Protocols documentation;Recommendation;Reporting;reproductive;Research;research facility;Research Personnel;Risk Assessment;Safety;Services;sexual and reproductive health;Sexually Transmitted Diseases;Technology;Toxicology;U-Series Cooperative Agreements;uptake;virology;Woman;Work,SCIENTIFIC AND TECHNICAL CONSULTING SERVICES FOR PRE-CLINICAL AND CLINICAL MULTIPURPOSE PREVENTION TECHNOLOGIES of Contraception Research,0,NA,NA,NA,NA,NA,NA,NA,24875,NA
11181783,N01,AI,NA,N,NA,NA,NA,NA,75N93022D00003,NA,NA,75N93022D00003-0-759302400001-1,NIAID:2456817\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,DURHAM,UNITED STATES,NA,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,NA,NA,(contact),NA,2024-08-31,2028-08-27,NA,Feasibility for Development of a Liposome/LNP Displaying an HIV Env Trimer Protein and Containing/Incorporating an mRNA,0,NA,NA,NA,NA,NA,NA,NA,2456817,NA
11181790,N01,AI,NA,N,NA,NA,NA,NA,75N93022D00004,NA,NA,75N93022D00004-0-759302400001-1,NIAID:1863405\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,KENSINGTON,UNITED STATES,NA,08,094888294,US,319502,"ADVANCED BIOSCIENCE LABORATORIES, INC.",MD,208951042,NA,1945111 (contact),"FOUTS, TIMOTHY R (contact)",NA,2024-08-31,2028-08-27,Address;Antigens;Area;Binding;Contracts;Coupled;Development;Documentation;Feasibility Studies;flexibility;Goals;HIV;HIV envelope protein;HIV vaccine;Investigational Drugs;Lipids;Liposomes;manufacturability;Membrane;Messenger RNA;nanoparticle;National Institute of Allergy and Infectious Disease;Phase;pre-clinical;Preclinical Testing;Process;product development;Production;programs;Property;Proteins;Reporter Genes;research clinical testing;scaffold;Services;vaccine development;vaccine platform;Vaccines,Feasibility for Development of a Liposome/LNP Displaying an HIV Env Trimer Protein and Containing/Incorporating an mRNA,0,NA,NA,NA,NA,NA,NA,NA,1863405,NA
11181795,U54,CA,3,N,2024-09-04,2024-09-01,2025-08-31,NA,U54CA274329,SCHOOLS OF MEDICINE,PA-20-272,3U54CA274329-03S1,NCI:161750\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,OKLAHOMA CITY,UNITED STATES,RADIATION-DIAGNOSTIC/ONCOLOGY,05,878648294,US,1524003,UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,731043609,"Project Narrative: Acquired resistance to therapy contributes to poor survival outcomes in cancer patients. The primary objective of this U54 application is to establish a successful and self-sustaining ARTNet Center for Pancreatic Cancer (ACPC) to explore novel mechanisms and combination therapies to target acquired resistance in pancreatic cancer. We will collaborate and work closely with other ARTNet centers, coordinating center, and the National Cancer Institute to provide novel mechanistic insights and translational opportunities to target therapy resistance with the long-term goal of improving overall patient survival.",10679629 (contact),"SINGH, PANKAJ KUMAR (contact)","BERA, TAPAN K",2022-09-20,2027-08-31,Automobile Driving;cancer cell;Cancer Patient;Cell Compartmentation;Cells;Chemoresistance;chemotherapy;Coculture Techniques;Collaborations;Combination Drug Therapy;Combined Modality Therapy;Complex;cytokine;Diagnosis;Disease;Drug resistance;Fibroblasts;Fluorouracil;gemcitabine;Gene Expression;Genomics;Goals;Human;human model;Immune;improved;insight;intercellular communication;irinotecan;Laboratories;Leucovorin;Macrophage;Malignant neoplasm of pancreas;Malignant Neoplasms;Metabolic;Metabolic Pathway;metabolic profile;Metabolism;metabolome;metabolomics;Methods;Modeling;National Cancer Institute;novel;Organoids;oxaliplatin;Paclitaxel;pancreatic cancer cells;pancreatic cancer model;pancreatic cancer patients;Pancreatic Ductal Adenocarcinoma;pancreatic ductal adenocarcinoma cell;paracrine;patient response;Patients;Phenotype;Regulation;Resistance;Resistance development;response;Stromal Cells;survival outcome;targeted treatment;therapeutically effective;therapy resistant;three dimensional cell culture;transcriptome;transcriptomics;translational potential;treatment response;tumor microenvironment;Tumor-associated macrophages;Work,Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer,274329,ZCA1,ZCA1(M1),9497,S1,3,129500,32250,NA,161750
11181860,UM1,CA,3,N,2024-09-16,2024-09-16,2025-08-31,395,UM1CA181255,SCHOOLS OF MEDICINE,PA-20-272,3UM1CA181255-10S1,NCI:4723702\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,WASHINGTON,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,98,043990498,US,2863301,GEORGE WASHINGTON UNIVERSITY,DC,200520042,"Project Narrative The AIDS and Cancer Specimen Resource (ACSR) will supply biospecimens and clinical data to individuals investigating People Living with HIV and cancer. It also supports the AIDS Malignancy Consortium (AMC) by providing biorepository support for clinical trials in the United States, Sub-Saharan Africa, and Latin America.",7125737 (contact);15721499;2050606,"BETHONY, JEFFREY MICHAEL (contact);COGHILL, ANNA ;RIMSZA, LISA","LIDDELL HUPPI, REBECCA",2013-09-23,2025-08-31,Accountability;Accreditation;Achievement;Acquired Immunodeficiency Syndrome;Adult;Africa South of the Sahara;African American;Aging;AIDS Malignancy Consortium;AIDS related cancer;anti-cancer research;antiretroviral therapy;Arizona;biobank;Biological;Biological Specimen Banks;Blood specimen;Brazil;Cancer Center;cancer risk;cancer specimen resource;Caribbean region;Cessation of life;Clinic;Clinical Data;Clinical Trials;Collaborations;Collection;college;Complex;Data;Data Commons;Data Pooling;Data Set;design;Eligibility Determination;Equipment and supply inventories;Equity;Exhibits;experience;Funding;General Population;Goals;HIV;HIV Infections;HIV/AIDS;Human;improved;Incidence;Individual;Infection;Informatics;Latin America;Latin American;Leadership;Link;Liquid substance;Malignant Neoplasms;Medicine;member;men;National Cancer Institute;novel;pandemic disease;Participant;Patients;Persons;Population;preservation;programs;Protocols documentation;Research Personnel;Research Support;Residual state;Resources;response;Sample Size;Sampling;Secure;Site;Source;South Africa;Specimen;Standardization;Structure;System;Testing;Time;Tissue Sample;trend;Tumor Tissue;United States;United States National Institutes of Health;Universities;Washington;web portal,AIDS and Cancer Specimen Resource (ACSR),181255,NA,NA,NA,S1,10,4169383,554319,4723702,NA
11181873,U54,CA,3,N,2024-09-03,2024-09-01,2025-08-31,NA,U54CA156732,NA,PAR-18-767,3U54CA156732-14S1,NCI:83107\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,07,076580745,US,1464901,DANA-FARBER CANCER INST,MA,022155450,NA,10463030 (contact),"BURNS WHITE, KAREN ANN (contact)","WALI, ANIL",2010-09-27,2026-08-31,Address;American;Area;behavioral and social science;Behavioral Sciences;Black Populations;Boston;Cancer Center;cancer health disparity;career;career development;Color;Communication;Communities;COVID-19 pandemic;Dana-Farber Cancer Institute;design;Development;Disabled Persons;Discipline;Discipline of Nursing;Disparity;Doctor of Philosophy;Education;education research;Educational Status;Enrollment;Ethnic Population;evidence base;experience;Faculty;Fellowship;Fostering;Genomics;Graduate Degree;graduate school;graduate student;Grant;Group Affiliation;Growth;Health;health communication;Health Disparities Research;health disparity;Healthcare;improved;Individual;Infrastructure;innovation;Institutional Racism;interest;Intervention;Investments;Knowledge;Latinx;Low Income Population;Malignant Neoplasms;Manuscripts;Massachusetts;Mentors;Methods;multidisciplinary;Native Americans;NCI Center for Cancer Research;outreach;Peer Review;personalized cancer therapy;Phase;physical science;Population;Population Heterogeneity;Postbaccalaureate;Postdoctoral Fellow;Preparation;Process;Productivity;programs;Publications;racial population;Research;research and development;Research Design;Research Personnel;Research Project Grants;research study;Science;Science Enrichment;Scientific Advances and Accomplishments;Scientist;skills;Students;success;Training;undergraduate student;Underrepresented Populations;Underrepresented Students;Universities;Work,Research Education Core,156732,ZCA1,ZCA1-SRB-2(A1)S,7294,S1,14,83107,NA,NA,83107
11181892,P20,CA,3,N,2024-09-17,2024-09-01,2025-08-31,NA,P20CA264068,NA,PAR-18-911,3P20CA264068-04S1,NCI:39441\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,PETERSBURG,UNITED STATES,NA,04,074744624,US,8969901,VIRGINIA STATE UNIVERSITY,VA,238032520,NA,1923259 (contact);77932986,"FAISON, MILTON O (contact);ROBERTS, DANIEL M.","RODRIGUEZ, LARITZA MARIA",2021-09-20,2025-08-31,NA,SUCCEED Administrative Core,264068,ZCA1,ZCA1-SRB-2(M2),7435,S1,4,30630,8811,NA,39441
11181920,P01,AI,7,N,2024-11-20,2024-11-21,2025-07-31,855,P01AI177688,SCHOOLS OF MEDICINE,PA-24-254,7P01AI177688-03,NIAID:1643486\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,MINNEAPOLIS,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,05,555917996,US,1450402,UNIVERSITY OF MINNESOTA,MN,554552070,"The world is in need of an effective HIV/AIDS vaccine, and the cytomegalovirus (CMV) vector-based HIV/SIV vaccine featured in our studies is highly efficacious and durable to uniquely mediate viral “replication arrest” efficacy in the Rhesus Macaque-SIV model. Vaccine immunity is mediated by unconventional MHC-E-restricted CD8+ T cell responses and induction of IL-15, which correlate with vaccine protection. The work proposed in this application will reveal the molecular mechanisms of immune programming by the CMV-based vaccine and IL- 15 actions to inform human testing of this vaccine concept in ongoing and future phase I/II trials.",1940486 (contact),"GALE, MICHAEL  (contact)","WARREN, JON T",2023-08-01,2028-07-31,NA,Mechanisms programming Protective Immunity from RhCMV-SIV Vaccine and IL-15 actions,177688,ZAI1,ZAI1-DNV-A(M1),NA,NA,3,1349514,293972,1643486,NA
11181924,Y01,DC,NA,N,NA,NA,NA,NA,ADC24002001,NA,NA,ADC24002001-1-0-1,NIDCD:1000000\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,"Communication problems or disorders of voice, speech, and language (VSL) are primary mission areas of the National Institute on Deafness and Other Communication Disorders (NIDCD), NIH.  Disorders involving VSL can have an overwhelming effect on an individual’s health and quality of life. These disorders affect people of all ages with or without hearing impairment, including children with autism, those who stutter, and adults with aphasia or speech disorders. The functions, skills, and abilities of voice, speech, and language are related.  It is important to recognize functional health impairments, including delayed childhood development, and seek early evaluation by health care professionals, e.g., early interventionists and speech-language pathologists (SLP), to identify the problem(s) and select effective treatment(s). The information obtained will become a Public Use dataset approximately six-months following the end of data collection and, hence, available for analysis and dissemination by research investigators and for other purposes, including providing updates to track progress in achieving national objectives formulated for this decade’s Sensory and Communication Disorders topic area of Healthy People 2030.",NA,(contact),NA,NA,NA,Adult;adverse outcome;Affect;Age;American;Aphasia;Area;autistic children;Biological;Categories;Censuses;Child;Childhood;Clinical;Communication;Communication difficulty;Communication Disability;Communication impairment;Communities;Community Surveys;Data Collection;Data Set;Deglutition;Deglutition Disorders;Development;disability;Disease;Economics;Education;effective therapy;Epidemiology;epidemiology study;Ethnic Population;Evaluation;Family;Geographic Locations;Health;health care availability;health care service;Health Professional;Health Status;Healthcare;hearing impairment;Housing;Impaired health;Income;Individual;Intervention;intervention program;Interview;Language;Language disability;Language Disorders;Life;Medical;Mission;National Health Interview Survey;National Institute on Deafness and Other Communication Disorders;Occupational;Pathologist;Persons;Policy Maker;Population;population survey;Prevalence;prevent;Provider;Quality of life;racial population;Research;Research Personnel;Risk;Risk Factors;risk mitigation;Schools;Sensory Disorders;Services;Severities;sex;skills;social;Social Interaction;sociodemographic factors;sociodemographics;Speech;Speech Disorders;Speech-Language Pathology;Stuttering;Surveys;United States;United States National Center for Health Statistics;United States National Institutes of Health;Update;Voice;Voice Disorders;Work,"CDC-NCHS-NHIS Voice, Swallowing, Speech, and Language Components",240020,NA,NA,NA,NA,NA,NA,NA,1000000,NA
11181968,N01,AI,NA,N,NA,NA,NA,NA,75N93019C00003,NA,NA,75N93019C00003-P00020-9999-5,NIAID:365773\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,FREDERICK,UNITED STATES,NA,NA,013872747,US,NA,NA,MD,217039401,NA,NA,(contact),NA,2019-04-01,2024-03-31,Acquired Immunodeficiency Syndrome;AIDS clinical trial group;Alendronate;Biological Products;Cell Aging;Clinical;Clinical Research;Clinical Trials;Contracts;Dasatinib;Funding;HIV;HIV-1;HIV/AIDS;improved;menopausal hormone therapy;National Institute of Allergy and Infectious Disease;Pharmacologic Substance;pilot trial;Placebos;programs;Schedule;Services;Woman,NIAID Clinical Products Center (CPC): HIV/AIDS Study Support,0,NA,NA,NA,NA,NA,NA,NA,365773,NA
11181982,U54,EB,3,N,2024-09-10,2024-09-10,2025-06-30,286,U54EB033650,NA,PAR-21-314,3U54EB033650-03S4,NINDS:2940899\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,BOSTON,UNITED STATES,NA,08,073130411,US,4907701,MASSACHUSETTS GENERAL HOSPITAL,MA,021142621,"Project Narrative The goal of the Center for Innovative NeuroTech Advancement (CINTA) is to rapidly transform emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system as a hub under the NIH Blueprint MedTech: Incubator Hubs program. CINTA will support the advancement of neurotechnology solutions by adapting and improving upon the proven model that CIMIT developed and implemented for RADx Tech to accelerate promising neurotechnologies that address critical areas of unmet needs in the diagnosis and treatment of nervous system disorders to human-grade prototypes. CINTA plans to find, fund, facilitate, and accelerate 15 projects per year through this program.",2092048;8659693 (contact),"BONATO, PAOLO ;SCHACHTER, STEVEN C. (contact)","WOLFSON, MICHAEL",2022-09-30,2027-06-30,"Acceleration;Address;Area;Clinical;Collaborations;commercialization;Committee Members;Communities;Companions;Complex;Development;Diagnosis;Emerging Technologies;Ensure;Environment;equity, diversity, and inclusion;Evaluation;experience;Funding;Goals;Health Technology;Healthcare;Human;improved;Incubators;Infrastructure;innovation;Institution;interest;International;Investments;Laboratories;Leadership;manufacture;Medical;Medicine;Modeling;multidisciplinary;Needs Assessment;Nervous System Disorder;neurological rehabilitation;neurotechnology;Outcome;outreach;Performance;Process;programs;prototype;RADx Tech;Research;Research Personnel;Resources;Risk;Science;sharing platform;success;technological innovation;Technology;tool development;Training;Translational Research;United States National Institutes of Health;virtual technology;web site",Center for Innovative NeuroTech Advancement - CINTA,33650,ZEB1,ZEB1-OSR-D(M1)S,NA,S4,3,2873249,67650,2940899,NA
11182040,U2R,TW,3,N,2024-09-03,2024-09-10,2025-07-31,989,U2RTW012129,SCHOOLS OF MEDICINE,RFA-RM-20-016,3U2RTW012129-04S1,FIC:150000\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,SEATTLE,UNITED STATES,PEDIATRICS,07,605799469,US,9087701,UNIVERSITY OF WASHINGTON,WA,981959472,"PROJECT NARRATIVE The DS-CHANGE training program builds upon long-standing collaborations between Kwame Nkrumah University of Science and Technology (KNUST), the University of Washington (UW), Seattle Children’s Hospital, and the non-profit Smile Train. We propose to (i), develop a cadre of trained Ghanaian scientists who can use data science approaches to tackle prominent child health problems, (ii) build faculty and institutional capacity for data science at KNUST, and (iii) develop competencies to ensure Ghanaian biomedical data science teams work effectively and synergistically. Trainees will develop skills and acquire experience with real world data science problems that address 3 of the top 10 ten causes of child death and disability in Ghana: malaria, injury and congenital malformations.",14783310;10517543;9155240 (contact),"AMOAKO-YIRENKYI, PETER ;DONKOR, PETER ;MCKINNEY, CHRISTY MICHELLE (contact)","POVLICH, LAURA",2021-09-22,2026-07-31,Active Learning;biomedical data science;Biometry;certificate program;Cessation of life;Child;Child Health;Clinical Informatics;Collaborations;Complex;computer science;Congenital Abnormality;congenital anomaly;Data Science;Data Scientist;disability;Discipline;Doctor of Philosophy;Educational process of instructing;Effectiveness;Epidemiology;evidence base;externship;Faculty;Funding;Ghana;Goals;graduate student;Health;Injury;Institution;institutional capacity;Malaria;Mathematics;Mentors;Methodology;Methods;orofacial cleft;Parasitology;Pediatric Hospitals;Pediatrics;Positioning Attribute;programs;Qualifying;Research;Research Institute;Science;Scientist;Smiling;Technology;Training;Training Programs;Universities;Washington,Data Science for Child Health Now in Ghana (DS-CHANGE),12129,ZRG1,Special Emphasis Panel[ZRG1-PSE-C(70)],NA,S1,4,146392,3608,150000,NA
11182102,Y01,AI,NA,N,NA,NA,NA,NA,AAI23069001,NA,NA,AAI23069001-1-0-3,NIAID:18825924\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,(contact),NA,NA,NA,Acceleration;Acquired Immunodeficiency Syndrome;Acute;Basic Science;Biological Assay;cell killing;Clinical Research;cohort;Developing Countries;Development;Disease remission;Dose;Epidemic;HIV;HIV Infections;HIV vaccine;HIV/AIDS;innovation;Intervention;Leadership;manufacture;Medical Research;Military Personnel;Monitor;monoclonal antibody production;National Institute of Allergy and Infectious Disease;pharmacologic;pre-clinical;preclinical development;Program Research Project Grants;programs;Reporting;Research;research and development;Research Institute;T-Lymphocyte;Therapeutic Research;Toxic effect;Tuberculosis;vaccine development;Vaccine Research;Vaccines;Viral,HIV Vaccine Research and Development - NIAID DAIDS Therapeutics Research Program,230690,NA,NA,NA,NA,NA,NA,NA,18825924,NA
11182116,R44,NS,3,N,2024-09-04,2024-08-01,2025-07-31,853,R44NS127667,NA,PAR-21-266,3R44NS127667-03S2,NINDS:103750\,SBIR-STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,EL CERRITO,UNITED STATES,NA,08,117006616,US,10054958,"MAGNETIC TIDES, INC.",CA,94530,"Project Narrative We have recently developed a new non-invasive brain stimulation (NIBS) system, kilohertz transcranial magnetic perturbation (kTMP) that opens up a new experimental space for safely modulating neural excitability in targeted areas of the human brain. This project will characterize the broad parameter space of kTMP in terms of tolerability and efficacy in healthy individuals. The results from this work will set the stage for full-fledged clinical trials in patients with neurological disorders such as stroke or spinal cord injury, two areas in which NIBS methods show promise as tools to facilitate neurorehabilitation.",77785761 (contact),"LABRUNA, LUDOVICA  (contact)","CAPORELLO, EMILY LAURA",2022-08-15,2025-07-31,Acoustics;Amplifiers;Area;Auditory;Basic Science;Behavior;Behavioral;Behavioral Assay;Brain;Cephalic;clinical application;Clinical Trials;cognitive neuroscience;Communities;Coupling;design;Detection;Devices;Double-Blind Method;Earplug;efficacy evaluation;electric field;Electric Stimulation;Electroencephalography;expectation;experimental study;falls;flexibility;Frequencies;Funding;Goals;Grant;Human;Individual;Institution;Institutional Review Boards;interest;Intervention;Lead;Learning;Literature;magnetic field;Magnetism;Measures;Membrane Potentials;Mental Depression;Methods;Motor Cortex;Motor Evoked Potentials;Nervous System Disorder;neural;Neurologic;neurological rehabilitation;Neurons;noninvasive brain stimulation;Occipital lobe;Pain;Participant;Patients;Physiologic pulse;Physiological;Physiology;Pilot Projects;Population;Protocols documentation;Rest;Risk;Safety;Scalp structure;Sensory;Signal Transduction;sound;Specificity;Spinal cord injury;Stroke;stroke rehabilitation;stroke therapy;Surface;Syncope;System;Tactile;Testing;Time;tool;Transcranial magnetic stimulation;translational applications;vibration;voltage;Work,Exploring the Parameter Space of High Frequency Magnetic Perturbation in Manipulating Neural Excitability and Plasticity.,127667,ZRG1,Special Emphasis Panel[ZRG1-ETTN-C(10)B],NA,S2,3,83000,20750,103750,NA
11182172,N44,CA,NA,N,NA,NA,NA,NA,75N91024C00073,NA,NA,75N91024C00073-0-9999-1,NCI:2000000\,SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,AUSTIN,UNITED STATES,NA,10,117165024,US,10056320,VELOXAI LLC,TX,787261455,NA,79944280 (contact),"GHIMIRE, KANCHAN  (contact)",NA,2024-09-04,2026-09-03,Affect;Algorithms;Brachytherapy;Cancer Burden;Clinical;commercialization;Computer software;Disease;Dose Rate;Ensure;High-Dose Rate Brachytherapy;Human;improved;innovation;Institution;low and middle-income countries;Malignant neoplasm of cervix uteri;novel;Phase;Process;Radiation therapy;Recurrence;research and development;Resource-limited setting;Resources;Small Business Innovation Research Grant;software systems;standard of care;Treatment outcome;treatment planning;usability;validation studies;Vendor,"SBIR PHASE II, TOPIC 431: AUTOMATIC TREATMENT PLANNING OF CERVICAL CANCER HIGH-DOSE RATE BRACHYTHERPAY FOR LOW-RESOURCE SETTINGS.",0,NA,NA,NA,NA,NA,NA,NA,2000000,NA
11182199,R01,AR,3,N,2024-09-06,2024-09-01,2025-08-31,846,R01AR081125,SCHOOLS OF MEDICINE,PA-20-185,3R01AR081125-04S1,NIAMS:112219\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,STONY BROOK,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,01,804878247,US,5992612,STATE UNIVERSITY NEW YORK STONY BROOK,NY,117943362,"Urine cadmium and risk of fracture and bone loss Narrative Mechanistic experiments and cross-sectional epidemiologic studies have linked cadmium to low bone mineral density, osteoporosis, and fracture; however, currently lacking are large prospective epidemiologic studies. We propose to leverage existing samples and data from the two largest prospective US osteoporosis cohort studies to perform an in-depth investigation of cadmium, bone loss, and fractures. These studies promise to transform the field of Cd-bone research and have high potential to impact policy decisions in the US and globally.",8483477 (contact),"MELIKER, JAYMIE R (contact)","CHEN, FAYE H",2021-09-20,2026-08-31,adjudication;Affect;Age;aged;Aging;Agreement;Behavioral;Biological Markers;bone;Bone Density;bone loss;bone metabolism;Bone Resorption;Bone structure;bone turnover;Cadmium;Cell Culture System;Clinic Visits;Clinical Data;clinical research site;cohort;Cohort Studies;cost;cost effective;Cotinine;Creatinine;Cross-Sectional Studies;Cyclophosphamide;Data;Diet;dietary;Dual-Energy X-Ray Absorptiometry;Elements;Environment;Environmental sludge;Epidemiology;epidemiology study;Etiology;Excretory function;experimental study;Female;Femur;Fertilizers;Foundations;Fracture;fracture risk;Half-Life;Health;Heavy Metals;hip bone;Human;human old age (65+);Individual;Industrialization;inorganic phosphate;insight;Intake;International;Investigation;Kidney;Link;Longterm Follow-up;male;Measures;Mediating;Mediation;men;Minerals;Morbidity - disease rate;mortality;National Health and Nutrition Examination Survey;Neck;never smoker;novel;Odds Ratio;Organ Culture Techniques;Osmolalities;Osteogenesis;Osteoporosis;osteoporosis with pathological fracture;Persons;Policies;Population;Population Attributable Risks;Prevalence;prospective;Prospective Studies;Public Health;Random Allocation;recruit;Reporting;Research;Research Design;Sampling;Scanning;Serum;Sewage;sex;skeletal;skeletal tissue;Smoking;Smoking History;Soil;Source;Time;Toxic effect;United States;urinary;Urine;Vertebral column;Visit;Woman;working group,Urine cadmium and risk of fracture and bone loss,81125,NAME,"Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]",NA,S1,4,70357,41862,112219,NA
11182272,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002068,NA,NA,1ZIACL002068-33,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,16149096 (contact),"DE GIORGI, VALERIA  (contact)",NA,NA,NA,American;anti-hepatitis C;Anti-viral Agents;Antibodies;Biopsy;Blood Donations;Blood donor;Blood Transfusion;chronic infection;Cirrhosis;Clinic;Clinical;cohort;Counseling;curative treatments;Data Analyses;Development;Donor Selection;Enrollment;Follow-Up Studies;Fright;Goals;Hepatitis C;Hepatitis C virus;Immune response;Infection;Intravenous;Liver;Liver Fibrosis;Longterm Follow-up;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;Notification;Outcome;Patients;Pharmaceutical Preparations;Phase;Positive Test Result;Prospective Studies;Protocols documentation;Publishing;Red Cross;repository;Resources;Risk Factors;RNA;Sampling;Serum;Services;Testing;Time;Toxic effect;transmission process;treatment response;Uncertainty;United States National Institutes of Health;Viral;Viral Load result;viral transmission;Visit,A Prospective Study Of Anti-hepatitis C Virus Positive Blood Donors,2068,NA,NA,NA,NA,33,NA,NA,0,NA
11182273,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL002123,NA,NA,1ZIACL002123-14,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,11612947 (contact),"FLEGEL, WILLY  (contact)",NA,NA,NA,Alleles;Altitude;blood group;Blood Group Antigens;Blood specimen;Blood typing procedure;Communicable Diseases;Complementary DNA;DNA;Environmental Risk Factor;Erythrocytes;Ethiopian;Ethnic Population;Exposure to;Future;Genes;genetic analysis;Genetic Variation;Genotype;Human;immunohematology;insight;Malaria;Methods;Molecular;next generation sequencing;novel;Oxygen;Phenotype;Plasma;Population;population based;pressure;Prevalence;Sampling;Serology;Shapes;Sickle Cell Anemia;United States National Institutes of Health,Molecular Immunohematology in Ethiopian Sub-populations,2123,NA,NA,NA,NA,14,NA,NA,0,NA
11182274,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL080004,NA,NA,1ZIACL080004-19,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414699 (contact),"MARIC, IRINA  (contact)",NA,NA,NA,alanine aminopeptidase;Antibodies;Biological Markers;Blood;Body System;Bone Marrow;Bone Marrow Aspiration;candidate marker;Cardiac;Categories;CD34 gene;CD44 gene;Cell Separation;Cellular Morphology;Chromosomes;Classification;Clinical;cohort;Consensus;Data;Development;Diagnosis;Disease;Disseminated eosinophilic collagen disease;Endomyocardial Fibrosis;eosinophil;Eosinophilia;Etiology;Evaluation;evidence based guidelines;FCGR3B gene;Flow Cytometry;Fluorescence;Fluorescent in Situ Hybridization;fusion gene;Gene Fusion;Heart Transplantation;Hematological Disease;Hematopoietic;HLA-DR Antigens;Human;ICAM1 gene;IL5RA gene;Imatinib;Immunophenotyping;inhibitor;International;interstitial;ITGAM gene;ITGAX gene;Laboratories;Laboratory Study;lymphoid neoplasm;Medical;Metamyelocyte;Molecular;Morbidity - disease rate;mortality;Mutation;Myelocyte;Myelogenous;Myeloproliferative disease;National Institute of Allergy and Infectious Disease;Neoplasms;Neurologic;new therapeutic target;novel;Pathogenicity;Pathology;patient population;Patients;Pattern;PDGFRA gene;PDGFRB gene;Play;Population;Preparation;Prognosis;Progranulocytes;Protein Tyrosine Kinase;Proto-Oncogene Protein c-kit;PTPRC gene;Rare Diseases;Reporting;Reverse Transcriptase Polymerase Chain Reaction;Role;Sampling;SELL gene;sialic acid binding Ig-like lectin;Surface;Systemic Mastocytosis;Testing;Time;treatment response;World Health Organization,Laboratory Assessment of Patients with Hypereosinophilic Syndrome,80004,NA,NA,NA,NA,19,NA,NA,0,NA
11182275,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL080005,NA,NA,1ZIACL080005-19,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414699 (contact),"MARIC, IRINA  (contact)",NA,NA,NA,Adult;Aftercare;Allergic Disease;Biological Assay;Body System;Bone Marrow;Caring;Case/Control Studies;Childhood;Classification;Clinical;cohort;Collaborations;Cutaneous Mastocytosis;Data;detection assay;Diagnosis;Disease;Disease stratification;disease-causing mutation;Evaluation;Flow Cytometry;Gene Frequency;General Population;genetic association;genetic variant;Genome;Genotype;Healthcare Systems;Heterogeneity;Heterozygote;Histopathology;Idiopathic anaphylaxis;IL2RA gene;Immunohistochemistry;improved;Individual;Indolent Systemic Mastocytosis;Inherited;International;Laboratories;mast cell;mastocytosis;Methodology;Molecular;Molecular Diagnosis;Morphology;Mutation;National Institute of Allergy and Infectious Disease;neoplastic cell;novel;Patients;pediatric patients;peripheral blood;Prevalence;Prospective Studies;Proto-Oncogene Protein c-kit;Proto-Oncogenes;Rare Diseases;Receptor Protein-Tyrosine Kinases;Registries;Reporting;Research Personnel;Retrospective Studies;screening;Sensitivity and Specificity;Serum;Skin;Somatic Mutation;Specificity;Standardization;standardized care;symptomatology;Symptoms;Systemic Mastocytosis;Testing;Time;Tissues;Tryptase;Variant,Laboratory Assessment of Patients with Systemic Mastocytosis,80005,NA,NA,NA,NA,19,NA,NA,0,NA
11182276,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090027,NA,NA,1ZIACL090027-15,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,9414699 (contact),"MARIC, IRINA  (contact)",NA,NA,NA,Accounting;Aftercare;Antibody Response;antigen binding;Antigens;aspirate;B-Lymphocytes;beta-Chemokines;Blood;Bone Marrow;Bone marrow biopsy;Bone Marrow Cells;Cell Maturation;Cells;chemokine receptor;chimeric antigen receptor;Clinical;Clinical Trials;Collaborations;Color;cytokine release syndrome;Diagnosis;Disease;Evaluable Disease;first-in-human;Flow Cytometry;Functional disorder;Hematologic Neoplasms;Hematological Disease;Human;Immunoglobulins;Immunohistochemistry;Immunophenotyping;In complete remission;Infusion procedures;insight;Investigation;Light;Malignant Neoplasms;Molecular;Multiple Myeloma;neoplastic;Pathogenesis;Patients;peripheral blood;Plasma Cells;Prognosis;Progression-Free Survivals;Receptor Cell;Refractory;Relapse;Research Personnel;Serum;Serum Markers;single-cell RNA sequencing;Staging;T-Lymphocyte;Time;treatment response;United States;United States National Institutes of Health;Urine,Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic Diseases,90027,NA,NA,NA,NA,15,NA,NA,0,NA
11182277,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD000072,NA,NA,1ZIAHD000072-21,NICHD:2278350\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,8189504 (contact),"BEZRUKOV, SERGEY M (contact)",NA,NA,NA,Aging;alpha helix;alpha Tubulin;Alzheimer&apos;s Disease;Amaze;amphiphilicity;Bacillus anthracis;Behavior;Benchmarking;beta barrel;Binding;Biological Assay;Biological Process;biophysical properties;biophysical techniques;Biophysics;C-terminal;Cell membrane;Cell Proliferation;Cells;Cellular biology;Characteristics;Clostridium botulinum;Clostridium perfringens;comparative;Complement;Complex;Confocal Microscopy;constriction;Data;Development;deviant;Diameter;Diffusion;Dimensions;dimer;Disease;electric field;Electrophysiology (science);Embryonic Development;Escherichia coli;Eukaryotic Cell;Exhibits;experimental study;flexibility;Fluorescence;Functional disorder;Genus Hippocampus;Geometry;Goals;Gram-Negative Bacteria;Gramicidin;gramicidin A;Hemolysin;hydrophilicity;Hydrophobicity;Imaging Techniques;Inclusion Bodies;interest;Ion Channel;Ions;Kinetics;Laboratories;Lateral;Learning;Length;Link;Lipid Bilayers;Lipids;live cell imaging;Location;long term memory;Malignant Neoplasms;Measurement;mechanical properties;Mechanics;Membrane;Membrane Lipids;membrane model;Membrane Potentials;Membrane Proteins;Memory;Metabolic;meter;Methods;Mitochondria;Modeling;Modification;Molecular;Molecular Conformation;Molecular Machines;Molecular Probes;monomer;Motivation;Muscle Cells;Mycobacterium smegmatis;Myocardial Infarction;Neurodegenerative Disorders;Neurons;novel;novel strategies;operation;OprF protein;Organism;Outer Mitochondrial Membrane;Parkinson Disease;Pathologic;Pathology;Permeability;pharmacologic;Play;predictive modeling;preservation;pressure;Probability;Process;Property;protein complex;Protein Denaturation;protein protein interaction;protein structure;Proteins;Pseudomonas aeruginosa;Radial;Recombinant Proteins;reconstitution;Regulation;response;Role;Side;single molecule;solute;Spectrum Analysis;Staphylococcus aureus;Stress;Stroke;Structure;sugar;Surface;synthetic peptide;Tail;Techniques;theories;Thinness;Time;Toxin;Tubulin;Tubulin Interaction;Two-Parameter Model;Variant;VDAC1 gene;Vestibule;voltage;voltage gated channel;Voltage-Dependent Anion Channel;Water,Biophysics of Large Membrane Channels,72,NA,NA,NA,NA,21,NA,NA,2278350,NA
11182278,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD000256,NA,NA,1ZIAHD000256-27,NICHD:1629564\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9416136 (contact),"LEIKIN, SERGEY  (contact)",NA,NA,NA,Affect;Aging;Amniotic Fluid;Anabolism;Animals;Arginine;Autophagocytosis;biological adaptation to stress;Birth;bone;bone fragility;bone scaffold;Breathing;Carpenter&apos;s Syndrome;Cell Culture Techniques;Cell Line;cell type;Cells;Cellular biology;Cellular Stress;Clinical;Clinical Research;Clustered Regularly Interspaced Short Palindromic Repeats;Coat Protein Complex I;Collaborations;Collagen;Collagen Type I;Complex;Connective Tissue;Connective Tissue Diseases;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Deformity;Degenerative polyarthritis;Deposition;Development;Diagnostic;Disease;Ehlers-Danlos Syndrome;Endoplasmic Reticulum;endoplasmic reticulum stress;Enzymes;Epiphysial cartilage;Evaluation;Extracellular Matrix;Failure;fetal;Fibroblasts;Fibrosis;FLP recombinase;Fracture;gene editing technology;Glycine;Goals;Golgi Apparatus;Growth;Heat-Shock Proteins 70;Heterozygote;Human;Hydroxylation;Image;improved;in vivo;interest;Joint Laxity;Knock-out;Knowledge;life span;live cell imaging;Lung;lung failure;Lysosomes;Malignant Neoplasms;McCune-Albright Syndrome;Mitochondria;Modeling;Molecular;molecular pathology;mouse model;Movement;Mus;mutant;Mutation;new therapeutic target;novel;Osteoblasts;Osteogenesis Imperfecta;Osteoporosis;Pathogenicity;Pathology;Pathway interactions;Patients;Perinatal mortality demographics;Positioning Attribute;prevent;Procollagen;Procollagen-Proline Dioxygenase;Proline;Protein Subunits;Proteins;pulmonary hypoplasia;Pulmonary Pathology;Quality Control;recruit;Recycling;Research Personnel;Resources;response;rib bone structure;Role;secretory protein;sensor;Signal Transduction;Site;skeletal;skeletal abnormality;skeletal dysplasia;Skin;Stress;Structure;targeted treatment;Technology;Testing;therapeutic target;Tissues;trafficking;transcriptome sequencing;translational study;Translations;triple helix;United States National Institutes of Health;Uterine Fibroids;Uterus;vesicle transport,Collagen-related diseases,256,NA,NA,NA,NA,27,NA,NA,1629564,NA
11182279,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD000261,NA,NA,1ZIAHD000261-27,NICHD:1312980\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6481519 (contact),"GANDJBAKHCHE, AMIR H (contact)",NA,NA,NA,Abdomen;absorption;Address;Adult;adverse pregnancy outcome;Affect;Air;Algorithms;Anatomy;Anemia;anti-cancer research;Area;Artificial Intelligence;at-risk pregnancies;autoencoder;Awareness;barometric pressure;Behavior;Biological Phenomena;Biophotonics;Biosensor;Blood;Blood Gas Analysis;Blood specimen;Brain;Breathing;Breathing Exercises;Cells;Cerebral Hypoxia;Cerebrovascular Circulation;Cerebrum;chromophore;Classification;Clinical;Clinical effectiveness;Clinical Protocols;Clinical Research;Collaborations;Computer Simulation;convolutional neural network;coronavirus pandemic;Country;COVID-19;Data;Data Set;deep learning algorithm;design;Detection;detector;Devices;Diagnostic Procedure;Disease;Elements;Exhibits;experimental study;Exposure to;fetal;Fetal Development;Fetus;Gases;Heart;Heart Arrest;heart function;Hela Cells;Hemoglobin;Hypotension;Hypoxia;Hypoxic Brain Damage;Image;improved;in vivo;Incubators;Individual;Institutional Review Boards;instrumentation;Intensive Care Units;Interruption;Intervention;Knowledge;Label;Left;Legal patent;Lesion;Localized Skin Lesion;Location;Longitudinal Studies;Measurement;Measures;Medical center;Melanoma;Metabolic;Metabolism;Methodology;Methods;Michigan;miniaturize;Monitor;Morbidity - disease rate;motion sensor;multimodality;National Institute of Child Health and Human Development;Near-Infrared Spectroscopy;Network-based;Neural Network Simulation;novel;novel diagnostics;Nutrient;obstetric care;Optical Coherence Tomography;optical imaging;Optics;Oxygen;Oxyhemoglobin;Partial Pressure;Patient Monitoring;Patients;Pattern;Perinatology;Photography;Physiological;Placenta;Pregnancy;Pregnancy Outcome;Privatization;Property;Protocols documentation;radial artery;relative cost;Reporting;Research;Research Personnel;Research Project Grants;Resolution;Respiratory Disease;response;Risk;Scanning;Scientist;screening;sensor;Shapes;Shortness of Breath;Signal Transduction;Site;Skin Cancer;skin lesion;Source;spectrograph;Spectrum Analysis;Stream;success;Surface;System;Techniques;Technology;Temperature;Testing;Texture;theories;Time;time use;Tissue imaging;tissue oxygenation;Tissues;tomography;tool;Traumatic Brain Injury;Tube;United States National Institutes of Health;Universities;Upper Extremity;Vascular blood supply;volunteer;wearable device;wearable sensor technology;wireless,Quantitative Biophotonics for Tissue Characterization and Function,261,NA,NA,NA,NA,27,NA,NA,1312980,NA
11182280,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD001011,NA,NA,1ZIAHD001011-28,NICHD:1107058\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9416292 (contact),"WEINSTEIN, BRANT  (contact)",NA,NA,NA,Adult;Affect;Anatomy;Animals;Atlases;Axilla;blood vessel development;Blood Vessels;cell type;Cells;Clinical;Collaborations;Cues;Defect;Development;Embryo;Embryonic Development;Endothelial Cells;Endothelium;Epigenetic Process;Ethylnitrosourea;experimental analysis;Fishes;Fresh Water;Gases;Gene Expression;Gene Expression Regulation;Genes;Genetic;genetic analysis;Germ Cells;Gills;Goals;high resolution imaging;Image;Imaging Device;imaging modality;Immune;in vivo;in vivo imaging;insight;interest;Intubation;Investigation;Life;Lung;lymph nodes;Lymphatic Endothelial Cells;lymphatic vessel;lymphoid organ;Maintenance;Meninges;Methodology;Methods;microangiography;microscopic imaging;Modeling;Molecular;Molecular Analysis;Morphogenesis;Mutagenesis;mutant;neuronal guidance;Nutrient;Optics;Organ;Oxygen;Pattern;Phenotype;Play;Population;positional cloning;Proteins;Proteomics;Rapid screening;Reporting;RiboTag;Role;Signal Transduction;Specific qualifier value;Spermatogenesis;Stroke;Testis;Tissues;tool;transcriptomics;Transgenic Organisms;translatome;tumor progression;Universities;Vascular Endothelial Growth Factors;Vascular Endothelium;Venous;Vertebrates;Visualization;Work;wound healing;Zebrafish;zebrafish development,Specification And Patterning of Developing Blood Vessels,1011,NA,NA,NA,NA,28,NA,NA,1107058,NA
11182281,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD001012,NA,NA,1ZIAHD001012-27,NICHD:2153298\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6481600 (contact),"CHITNIS, AJAY B (contact)",NA,NA,NA,Amphibia;antagonist;Apical;Behavior;Binding;Body Surface;Body System;bone morphogenetic protein receptors;cell community;cell fate specification;cell motility;Cells;constriction;Deposition;Development;DUSP6 protein;Ear;Ectopic Expression;Embryo;Environment;Epithelium;Exposure to;Family member;Fertilization;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Fishes;gene function;Genetic;Goals;Growth;Hair Cells;Hour;inhibitor;knock-down;lateral line;Length;Ligands;Mesenchymal;migration;Modeling;Morphogenesis;Morphology;Natural regeneration;Nervous System;neuromast;Organ;Pathway interactions;Pattern;Periodicals;Phosphoric Monoester Hydrolases;prevent;Primordium;Production;progenitor;Proliferating;promoter;receptor;response;Role;self organization;Sensory;Sensory Hair;sensory system;Side;Signal Transduction;Skin;Specific qualifier value;stem cells;Stereotyping;Supporting Cell;System;Tail;Testing;Time;Transgenic Organisms;water flow;WNT Signaling Pathway;Zebrafish,Building the Posterior Lateral Line system In Zebrafish Embryos,1012,NA,NA,NA,NA,27,NA,NA,2153298,NA
11182282,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD001409,NA,NA,1ZIAHD001409-39,NICHD:1356672\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6571121 (contact),"ZIMMERBERG, JOSHUA  (contact)",NA,NA,NA,"2019-nCoV;Abbreviations;Actin-Binding Protein;Actins;Acylation;Adhesions;Affect;Amino Acid Sequence;Amino Acids;Aminoacylation;Anti-Bacterial Agents;Anti-viral Agents;Anti-viral Therapy;antiviral drug development;Area;Arginine;Attention;Avian Influenza A Virus;Basic Amino Acids;betacoronavirus;Binding;Binding Proteins;Buffers;Capsid Proteins;cell fixing;Cell membrane;Cell model;Cell Physiology;Cells;Cellular Structures;Cetylpyridinium Chloride;Charge;Cholesterol;Conserved Sequence;Cysteine;Cytoplasmic Tail;Cytoskeletal Proteins;Cytoskeleton;density;Detergents;Development;Drug Design;Drug resistance;Drug Targeting;Ebola;Ebola virus;Electrostatics;Endoplasmic Reticulum;env Gene Products;Excision;Exocytosis;Face;Family;Fluorescence;Glycine;Glycoproteins;Head;Health;Hemagglutinin;HIV;HIV-1;Human;Hydrophobic Interactions;Hydrophobicity;Impairment;improved outcome;in vivo;Influenza A virus;Influenza B Virus;Influenza Hemagglutinin;influenza virus strain;influenzavirus;interest;Interruption;Ions;Life Cycle Stages;Lipid Bilayers;Lipid Binding;Lipids;Location;Lysine;Mammalian Cell;MARCKS gene;Measles;Mediating;Membrane;Membrane Lipids;Membrane Proteins;Methods;Micelles;Microscopy;Minor;molecular dynamics;Morbidity - disease rate;Morphology;mortality;Mutate;Mutation;nanoscale;novel;palmitoylation;Pathway interactions;Pattern;PH Domain;Phosphatidylinositol 4,5-Diphosphate;Phosphatidylinositol Phosphates;Phosphatidylinositols;Phospholipase C;photoactivation;platelet protein P47;Play;Population;prevent;Process;Property;Proteins;quaternary ammonium compound;Regulation;Reporting;response;Role;Sequence Analysis;Serine;Site;Site-Directed Mutagenesis;superresolution microscopy;Surface;Tail;Techniques;Temperature;Testing;trafficking;Transmembrane Domain;vaccine efficacy;Viral;Viral Proteins;Virus;Virus Assembly;Virus Diseases;Virus-like particle;Water;Work",Membrane Remodeling in Viral Infection and Viral Assembly,1409,NA,NA,NA,NA,39,NA,NA,1356672,NA
11182283,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD001415,NA,NA,1ZIAHD001415-34,NICHD:1356672\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6571121 (contact),"ZIMMERBERG, JOSHUA  (contact)",NA,NA,NA,Acceleration;Adult;age related;age related changes;aged;Aging;Annexin A1;Behavior;Biogenesis;Biological;biomarker discovery;Biophysics;Blood Vessels;Brain;Brain Glioblastoma;brain parenchyma;brain tissue;cancer cell;CD147 antigen;Cell Communication;Cell membrane;cell motility;Cell Physiology;Cell Proliferation;Cell secretion;Cell Survival;Cells;Characteristics;chemotherapy;Classification;Consensus;Cues;Data;Disease Progression;Distal;drug discovery;drug testing;DYSF gene;dysferlinopathies;Electron Microscopy;endosome membrane;Endosomes;Endothelial Cells;Endothelium;Environment;Excision;Exocytosis;exosome;extracellular;extracellular vesicles;Female;Fluorescence Microscopy;Genetic Diseases;Genomics;Glioblastoma;Glioma;Goals;healing;Hela Cells;Heterogeneity;Human;human disease;human migration;human model;human tissue;immune cell infiltrate;Immunohistochemistry;implantation;Individual;Infiltration;Inflammation;inhibitor;Injury;Invaded;Investigation;Label;Laboratories;Left;life span;Ligands;Limb-Girdle Muscular Dystrophies;Lipids;liquid chromatography mass spectrometry;Maintenance;male;Malignant neoplasm of brain;MAP Kinase Gene;Mass Spectrum Analysis;mast cell;Mediating;Membrane;Metalloproteases;Methodology;microvesicles;migration;Mitogens;Modeling;Molecular;Movement;Multivesicular Body;Mus;Muscle;muscle aging;Muscular Dystrophies;Mutation;Myopathy;nanovesicle;Natural regeneration;neoplastic cell;novel;novel therapeutic intervention;Nucleic Acids;Oncogenic;Operative Surgical Procedures;Parasites;Pathway Analysis;Pattern;Pericytes;personalized medicine;Phosphotransferases;PIK3CG gene;Play;Post-Translational Protein Processing;preference;prevent;Primary Brain Neoplasms;Property;protein biomarkers;Proteins;Proteome;Proteomics;quadriceps muscle;Radiation therapy;Receptor Activation;Receptor Protein-Tyrosine Kinases;repaired;Reproducibility;Research Design;Resistance;response;Role;Sarcolemma;Signal Pathway;Signal Transduction;Skeletal Muscle;skeletal muscle wasting;Slice;Speed;Stem Cell Factor;Stress;Structure;Surface;Surgical margins;Surgically-Created Resection Cavity;System;Techniques;Technology;Therapeutic;therapy resistant;Time;Time trend;Tissues;transcriptomics;Tropism;tumor;tumor microenvironment;tumor progression;Variant;Vesicle;virtual;Wild Type Mouse;Work;wound;wound healing,"Biophysical Membrane Mechanisms of Exocytosis inside Extracellular Vesicles, Membrane Repair Failing in Muscular Dystrophy, and Parasite Replication",1415,NA,NA,NA,NA,34,NA,NA,1356672,NA
11182284,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD001602,NA,NA,1ZIAHD001602-40,NICHD:1744349\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,2419579 (contact),"ROUAULT, TRACEY A. (contact)",NA,NA,NA,3&apos; Untranslated Regions;5&apos; Untranslated Regions;Aconitate Hydratase;Adult;aerobic glycolysis;Affect;Alternative Splicing;Anemia;Animals;Attenuated;axonal degeneration;Axonal Transport;axonopathy;behavior test;Behavioral;Binding;Binding Proteins;Blood Vessels;cancer cell;Cancer cell line;Cancer Etiology;Cell Death;Cell Line;Cells;Cessation of life;Child;Cognitive;Collaborations;Compensation;Complex;coronary fibrosis;CRISPR/Cas technology;dietary;Dietary Supplementation;Disease;Duodenum;Electrophysiology (science);Elements;Embryo;embryo cell;Endothelium;Enzymes;Erythroblasts;Erythrocytes;Erythrocytoses;Erythroid Cells;Erythrophagocytosis;Erythropoietin;Fatty Acids;feature detection;Ferritin;Fibroblasts;Fumarate Hydratase Deficiency;Functional disorder;functional loss;Gait abnormality;Gene Expression Profiling;Genes;Glycogen;Goals;H ferritin;Heme;heme oxygenase-1;Hereditary Leiomyomatosis and Renal Cell Cancer;Histocompatibility;homologous recombination;Human;Hypoxia Inducible Factor;In Vitro;Infant;Infusion procedures;Ingestion;Inherited;inhibitor;insight;interstitial;Iron;iron deficiency;iron metabolism;Iron Regulatory Protein 1;Iron Regulatory Protein 2;Iron-Sulfur Proteins;Kidney;Knock-in Mouse;Knockout Mice;Laboratories;Learning;Leiomyomatosis;Life;life span;Liver;loss of function mutation;Lung;Macrophage;Maintenance;Mammals;Mediating;Messenger RNA;Metabolic;Metabolism;metal transporting protein 1;microcytic anemia;Microfluidics;Mitochondria;Mitochondrial Matrix;Molecular;monocyte;Motor;Motor Neurons;mouse model;Mucous Membrane;multicatalytic endopeptidase complex;Mus;Mutation;Neoplasm Metastasis;Nerve Degeneration;Neurodegenerative Disorders;Neurologic;Neurons;Nutrient;Oligodendroglia;Oral;overexpression;oxidation;oxidative damage;Oxidative Stress;Oxygen;Patients;Pentosephosphate Pathway;pharmacologic;Phenotype;Physiological;Physiology;Polycythemia;Population;preservation;prevent;Production;progressive neurodegeneration;protein function;Proteins;Pulmonary Hypertension;Rare Diseases;Regulation;Renal Carcinoma;Reporting;RNA;Role;senescence;sensor;Sensory;shunt pathway;Source;Spleen;stem;Stimulus;Succinates;Sulfur;Syndrome;System;tempol;TFRC gene;Tissues;trafficking;Transcript;Translational Repression;Translations;tumor metabolism;VHL gene;Wild Type Mouse,Regulation Of Intracellular Iron Metabolism,1602,NA,NA,NA,NA,40,NA,NA,1744349,NA
11182285,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD001613,NA,NA,1ZIAHD001613-27,NICHD:1873947\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6571133 (contact),"LILLY, MARY A (contact)",NA,NA,NA,Autophagocytosis;Birt-Hogg-Dube Syndrome;Cancer cell line;Cathepsins;Cell Cycle;Cell Cycle Regulation;Cell Line;Cell model;Cell Nucleus;Cell Proliferation;Cells;Cellular Metabolic Process;Chimeric Proteins;chromosome missegregation;Complement;Complex;Congenital Abnormality;Cytoplasm;Data;Defect;Development;Digestion;DNA Sequence Rearrangement;Drosophila genus;Drosophila melanogaster;egg;Enzymes;Event;event cycle;Failure;Family;Female;Gametogenesis;Genes;Genetic Transcription;Germ Cells;Goals;Growth;Hela Cells;hormonal signals;Human;in vivo;Individual;Invaded;knock-down;Laboratories;Lysosomes;Malignant Epithelial Cell;Malignant Neoplasms;Mediating;Meiosis;member;Metabolic;Metabolism;model organism;multicatalytic endopeptidase complex;Mutation;Oncogenic;Oocytes;Oogenesis;pancreatic ductal adenocarcinoma cell;Phosphorylation;programs;protein structure;Proteins;Regulation;Renal Carcinoma;Renal Cell Carcinoma;Reproductive Biology;Reproductive Medicine;Role;Signal Pathway;Spontaneous abortion;System;TFE3 gene;Therapeutic Intervention;transcription factor;UBE3A gene;Ubiquitin;vacuolar H+-ATPase;Xp11.2,Cell Cycle Regulation In Oogenesis,1613,NA,NA,NA,NA,27,NA,NA,1873947,NA
11182286,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD002400,NA,NA,1ZIAHD002400-33,NICHD:1450543\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6571162 (contact),"ROMERO, ROBERTO  (contact)",NA,NA,NA,adverse outcome;Affect;amniotic cavity;Angiogenesis Inhibitors;Angiogenic Factor;Antibodies;Atlases;Basal Plate;biomarker identification;Birth;CCL26 gene;Cell Communication;cell type;Cells;Cellular Stress;Cervix Incompetence;Cervix Uteri;Characteristics;chemokine;Circulation;Classification;Clinical;Collagen;Communication;comparative;Complex;cost;Coupled;cytokine;Data;Decidual Cell;Diagnosis;Discipline of obstetrics;Disease;Eclampsia;Eotaxin;Etiology;fetal;Fetal Growth;Fetal Growth Retardation;Fetus;fetus cell;Frequencies;Galactose Binding Lectin;genomic tools;Gestational Age;Goals;Growth;high dimensionality;Homeostasis;Human;IL16 gene;IL8 gene;Immune;Immunoassay;improved;Infection;Inflammation;Inflammatory;Injections;Injury;insight;Interferon Type II;Interleukin 6 Receptor;Interleukin-12;Interleukin-15;Interleukin-16;Interleukin-6;Interleukins;Intervention;intraamniotic infection;Life;Ligands;Macrophage Inflammatory Proteins;macrophage-derived chemokine;maternal morbidity;Maternal Mortality;Measures;Medical;Membrane;Meta-Analysis;microbial;Modality;Monitor;Monocyte Chemoattractant Proteins;mortality;Mothers;mouse model;Myeloid Cells;Nature;Necrosis;Neonatal;neonatal morbidity;Neonatal Mortality;neonatal outcome;Nested Case-Control Study;neurodevelopment;Nucleic Acids;Organ;Pathologic Processes;pathophysiology of preeclampsia;Pathway interactions;Patients;perinatal morbidity;Perinatal mortality demographics;Perinatology;PGF gene;Physiological Processes;Physiology;Placenta;Plasma;Pre-Eclampsia;Pregnancy;Pregnancy Complications;premature;Premature Birth;Premature Labor;prenatal;Prevalence;prevent;Prevention;Process;Progesterone;Proteins;Proteomics;rapid diagnosis;rapid technique;Research;Resolution;Role;Rupture;Science;Second Pregnancy Trimester;Signal Transduction;single-cell RNA sequencing;Site;Sterility;Stromal Cells;Subgroup;Syndrome;System;Term Birth;Testing;Thymus Gland;Time;TNF gene;transcriptomic profiling;transcriptomics;Ultrasonography;ultrasound;United States;Vagina;Vascular Endothelial Growth Factor Receptor-1;Work,The Role Of Subclinical Infection And Cytokines In Preterm Parturition,2400,NA,NA,NA,NA,33,NA,NA,1450543,NA
11182287,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD002401,NA,NA,1ZIAHD002401-32,NICHD:76344\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6571162 (contact),"ROMERO, ROBERTO  (contact)",NA,NA,NA,3-Dimensional;actigraphy;Anatomy;Atopobium vaginae;Biometry;Birth;Body Composition;Breathing;Cervical;Cesarean section;clinical decision-making;clinically relevant;Conceptions;Confidence Intervals;congenital anomaly;Data;Diagnosis;Dimensions;Discipline of obstetrics;early pregnancy;Embryo;Embryonic Development;Epidural Anesthesia;Failure;Female;fetal;Fetal Growth;Fetus;Formulation;Frequencies;Geography;Gestational Age;Growth;heart function;Hematopoiesis;Hour;Image;imaging modality;improved;Induced Labor;instrument;intrapartum;Labor Onset;Light;Link;Longitudinal cohort study;Longitudinal Studies;Machine Learning;machine learning method;Magnetic Resonance Imaging;male;Maternal-fetal medicine;Measures;Membrane;Metabolism;Methods;Modality;Modeling;Mothers;Nulliparity;nutrition;obstetrical syndromes;Optical Methods;Organ;Pattern;Physical activity;Physiological;Play;Predictive Value;Pregnancy;Prenatal Diagnosis;Process;prospective;Role;Rupture;sex;Sleep;Statistical Methods;statistics;Time;two-dimensional;ultrasound;Vaginal delivery procedure;Validation;Woman;Yolk Sac,Prenatal Diagnosis Of Congenital Anomalies,2401,NA,NA,NA,NA,32,NA,NA,76344,NA
11182288,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008770,NA,NA,1ZIAHD008770-21,NICHD:330357\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9694101 (contact),"SUNDARAM, RAJESHWARI  (contact)",NA,NA,NA,Acute;Adult;ambient air pollution;Basic Science;Biological Markers;Birth;Blood;Cadmium;Chemicals;Clinical Research;Contraceptive methods;County;Couples;Development;Ensure;Environment;environmental chemical;Environmental Impact;Environmental Risk Factor;epidemiology study;Fertility;Human;Infant;Infertility;Interview;Investigation;Lead;Length;Life Style;lifestyle factors;male;Measures;Mediating;men;Menstrual cycle;Mental disability;Metals;Michigan;Mission;National Institute of Child Health and Human Development;organochlorine pollutant;Parabens;Patient Self-Report;Phenols;phthalates;physically handicapped;Phytoestrogens;Polychlorinated Biphenyls;Pregnancy;Pregnancy loss;pregnant;Pregnant Women;Process;prospective;recruit;Reproduction;reproductive outcome;saliva sample;Sampling;Seminal fluid;Serum;Standardization;Stress;Texas;Time;time-to-pregnancy;Urine;Woman,Longitudinal Investigation of Fertility and the Environment,8770,NA,NA,NA,NA,21,NA,NA,330357,NA
11182289,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008808,NA,NA,1ZIAHD008808-18,NICHD:738038\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9416292 (contact),"WEINSTEIN, BRANT  (contact)",NA,NA,NA,absorption;Anatomy;Animals;Axilla;blind;Blood;Blood Vessels;brain pericytes;Cardiovascular system;Characteristics;Clinical;Development;Drainage procedure;Embryo;Experimental Models;Fatty acid glycerol esters;Fishes;Fluid Balance;Gene Expression;Genes;Genetic;genetic analysis;Goals;Growth;high resolution imaging;Human;Image;Imaging Device;Immune;Immune response;in vivo;in vivo imaging;in vivo Model;insight;interest;Larva;Liquid substance;Lymph;lymph nodes;Lymphangiogenesis;Lymphatic;lymphatic development;Lymphatic Endothelium;Lymphatic System;lymphatic vasculature;lymphatic vessel;Lymphedema;Lymphocyte;lymphoid organ;Malignant Neoplasms;Meninges;microscopic imaging;model organism;Modeling;Molecular;Morphology;mutant;Neoplasm Metastasis;novel;Optics;Pathologic Processes;Pathology;Pattern;Phenotype;Population;progenitor;Regulation;Resolution;Role;Route;Specific qualifier value;Structure;Systems Development;Tissues;tool;Transgenic Organisms;Trees;tumor;Vascular System;Venous;Vertebrates;Visualization;Work;Zebrafish,Specification And Patterning of the Lymphatic System,8808,NA,NA,NA,NA,18,NA,NA,738038,NA
11182290,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008814,NA,NA,1ZIAHD008814-18,NICHD:1427195\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,2419579 (contact),"ROUAULT, TRACEY A. (contact)",NA,NA,NA,2019-nCoV;Aconitate Hydratase;Apoproteins;Attenuated;Binding;Binding Sites;Biogenesis;Biological Assay;Biological Markers;candidate identification;Carrier Proteins;Cell Nucleus;Cells;Citric Acid Cycle;cofactor;Collaborations;Common Cold;Complex;Coronavirus;COVID-19;cysteine desulfurase;Cytosol;Data;Development;Disabling;Disease;Electron Transport Complex III;Enzymes;Exoribonucleases;Ferredoxin;FGF21 gene;fibroblast growth factor 21;Fibroblasts;frataxin;Friedreich Ataxia;gene product;Genes;Genetic Transcription;Goals;Hamsters;helicase;heme biosynthesis;Homeostasis;Human Cell Line;human coronavirus;human disease;In Vitro;Inductively Coupled Plasma Mass Spectrometry;Infection;Informatics;Iron;iron deficiency;Iron Overload;Iron-Sulfur Proteins;Lactic Acidosis;Ligation;lipoic acid synthase;lymphoblast;Mammalian Cell;Mass Spectrum Analysis;Mediating;metabolic abnormality assessment;Metabolic Pathway;Mitochondria;Mitochondrial Diseases;Mitochondrial Matrix;Molecular Chaperones;Mutagenesis;Mutation;Myopathy;Neonatal;neuromuscular;Nonstructural Protein;Nuclear;Oral;overexpression;Oxidants;oxidation;Oxidoreductase;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Peptides;Phenotype;Physiological;Plaque Assay;Porphobilinogen Synthase;Primer Extension;Process;Prosthesis;protein function;Protein Isoforms;Proteins;Publishing;rare genetic disorder;Regulation;replicase;Research;respiratory;Respiratory Chain;Respiratory physiology;RNA;RNA Binding;RNA-Binding Proteins;Role;SARS-CoV-2 infection;scaffold;Scaffolding Protein;Scanning;Sideroblastic Anemia;Skeletal Muscle;skeletal muscle metabolism;Specificity;stem;Structure;Study models;Subgroup;Succinate Dehydrogenase;Sulfur;Sulofenur;System;tempol;Thioctic Acid;tissue/cell culture;Tissues;Translations;Viral;Viral Physiology;Virus;Work;Zinc,Mammalian iron-sulfur cluster biogenesis,8814,NA,NA,NA,NA,18,NA,NA,1427195,NA
11182291,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008856,NA,NA,1ZIAHD008856-17,NICHD:60565\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9694101 (contact),"SUNDARAM, RAJESHWARI  (contact)",NA,NA,NA,Address;adverse outcome;Biomedical Research;Child;Complex;Data;Enrollment;Epidemiology;epidemiology study;Event;Goals;interest;Literature;Methods;Modeling;Names;National Institute of Child Health and Human Development;Nature;novel;Pregnancy;Pregnancy loss;pregnant;Prevention Research;prospective;Recurrence;Risk;Risk Factors;Sexual Maturation;Statistical Methods;statistics;Stress;Study models;Survival Analysis;Time;time-to-pregnancy;Woman;Women&apos;s study,The analysis of survival data,8856,NA,NA,NA,NA,17,NA,NA,60565,NA
11182292,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008875,NA,NA,1ZIAHD008875-16,NICHD:825892\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,7849975 (contact),"LIU, AIYI  (contact)",NA,NA,NA,Address;Area;Area Under Curve;Biological Markers;biomarker evaluation;Biomedical Research;cost;cost effective;Data;Data Analyses;Data Pooling;detection limit;diagnostic accuracy;diagnostic biomarker;Disease;disease diagnosis;epidemiology study;Evaluation;Health;improved;indexing;Individual;innovation;interest;Literature;Maximum Likelihood Estimate;Measurement;Measures;Methodology;Methods;novel;Outcome;Probability;Procedures;Research;Research Personnel;Research Project Grants;ROC Curve;Sampling;sound;Specificity;Statistical Methods;Test Result;Testing;tool;Visually Impaired Persons,Statistical Methods for Evaluation of Biomarkers,8875,NA,NA,NA,NA,16,NA,NA,825892,NA
11182293,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008882,NA,NA,1ZIAHD008882-16,NICHD:1312980\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,6481519 (contact),"GANDJBAKHCHE, AMIR H (contact)",NA,NA,NA,Acute;Adult;Age;Area;Beginning of Life;Behavior;Belief;bioelectricity;bioimaging;Biological Markers;Biophotonics;Brain;Brain imaging;Brain region;Categories;cerebral hemodynamics;Child;Child Development;Classification;Cognitive;cognitive ability;cognitive function;cognitive task;cohort;Collaborations;Collection;Color;Coupled;Critiques;Data;data fusion;Data Set;Development;developmental disease;Dimensions;Electroencephalography;Equilibrium;Exercise;Exhibits;expectation;experimental study;Exposure to;France;frontier;functional magnetic resonance imaging/electroencephalography;functional near infrared spectroscopy;healthy volunteer;hemodynamics;Human;Imagery;Imagination;imaging modality;Infant;Inferior;information processing;insight;Institution;interest;Investigation;Journals;Knowledge;Left;Link;Literature;Machine Learning;Maryland;Measures;Medical center;Methodology;Methods;Military Personnel;mirror neuron;Modality;Modeling;Monitor;Motor;Motor Cortex;multimodal data;multimodality;National Institute of Mental Health;neural;neural network;Neurodevelopmental Disorder;neuroimaging;Neurosciences;Optics;Outcome;Parietal;Pattern;Performance;Photic Stimulation;Physical activity;Positioning Attribute;predictive marker;preference;Primates;Psyche structure;Psychiatry;Publications;Publishing;Regenerative Medicine;rehearsal;Reporting;Research;Research Personnel;Resolution;response;Rest;Risk;Role;Scientist;Sensory;Signal Transduction;Stimulus;Structure;systematic review;Systems Integration;Task Performances;TBI Patients;Techniques;temporal measurement;Testing;Tissues;Toddler;Universities;Urea cycle disorders;Visual;Visual attention;visual information;Visual Perception;visual stimulus;Visual System,Functional and Structural  Optical Brain Imaging,8882,NA,NA,NA,NA,16,NA,NA,1312980,NA
11182294,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008883,NA,NA,1ZIAHD008883-16,NICHD:567112\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9694101 (contact),"SUNDARAM, RAJESHWARI  (contact)",NA,NA,NA,Affect;Behavioral;Biological;Biological Factors;biological heterogeneity;Cervix Mucus;Childbirth;Coitus;Conceptions;Contraceptive Agents;Contraceptive methods;Couples;Data;Demography;Elderly;Elements;Environment;Environmental Exposure;Environmental Risk Factor;Epidemiologist;Epidemiology;Exposure to;Female;Fertility;flexibility;Functional disorder;Heterogeneity;high dimensionality;Hormonal;Human;human model;Impairment;infertility treatment;interest;Investigation;Joints;Length;Longevity;male;Measurement;Medical;Menstrual cycle;Methods;Modeling;Names;New York;Ovulation;parity;Pattern;Physiological;Poison;population based;Pregnancy;Probability;prospective;Prospective cohort;Psychosocial Stress;reproductive;Reproductive Biology;Research;Research Personnel;response;Risk Factors;Source;sperm cell;Statistical Models;time-to-pregnancy;Woman,Statistical Modeling of Human Fecundity,8883,NA,NA,NA,NA,16,NA,NA,567112,NA
11182295,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008915,NA,NA,1ZIAHD008915-14,NICHD:738038\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9416292 (contact),"WEINSTEIN, BRANT  (contact)",NA,NA,NA,Adult;Aging;Alleles;Anatomy;angiogenesis;Animals;Blood - brain barrier anatomy;Blood Vessels;Brain;Brain hemorrhage;cell type;Cells;Cephalic;Cerebral endothelium;Cerebrospinal Fluid;cerebrovascular;Circulation;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Connective Tissue;Craniocerebral Trauma;cranium;Defect;Development;Diabetes Mellitus;Embryo;Endothelium;experimental analysis;Fishes;Fresh Water;Gene Expression Profile;Gene Expression Profiling;Generations;Genes;genetic analysis;genetic regulatory protein;Genetic Screening;Goals;Growth;healing;Image;Immune;Immune response;Impairment;in vivo;Inflammation;Injury;insight;interest;Intubation;Larva;Maintenance;Meningeal;Meninges;Methods;model organism;Modeling;Molecular;Molecular Cloning;Morbidity - disease rate;mortality;mutant;Mutation;Natural regeneration;Neurocognitive Deficit;Neurodegenerative Disorders;new therapeutic target;next generation sequencing;Nutrient;optical imaging;Optics;Organ;Oxygen;Pathology;Pathway interactions;Play;Process;Rapid screening;Reagent;Recovery;Regulation;repaired;Reporting;Resolution;response;rhoA GTP-Binding Protein;Role;Rupture;Series;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Skin wound healing;Stroke;Thinness;Tissues;tool;Trauma;Vascular Diseases;Vascular regeneration;Vertebrates;wasting;wound healing;Wound models;Zebrafish,Regulation of Vascular Integrity,8915,NA,NA,NA,NA,14,NA,NA,738038,NA
11182296,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008928,NA,NA,1ZIAHD008928-12,NICHD:2308507\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,11982843 (contact),"BANERJEE, ANIRBAN  (contact)",NA,NA,NA,Acyl Coenzyme A;Acylation;Anabolism;Anemia;Area;Ataxia;Attention;Binding;Biochemical;Biological;Biological Assay;Biology;biophysical techniques;cancer therapy;Carbon;Catalysis;Cell membrane;Cell Physiology;Cells;Chemicals;cofactor;Collaborations;COVID-19;Cryoelectron Microscopy;Cues;Cysteine;deacylation;design;Disease;Elements;Engineering;enzyme mechanism;Enzymes;Equilibrium;Eukaryota;experimental study;Family;Family member;Genetic;Goals;Heart;Heme;heme biosynthesis;Homeostasis;Human;human disease;Hydrophobicity;In Vitro;in vitro Assay;Individual;inhibitor;insight;Integral Membrane Protein;interest;Intervention;Iron;Iron Overload;knock-down;Knock-out;Knowledge;Lead;Legionella;Legionella pneumophila;Legionnaires&apos; Disease;Link;Lipids;Literature;Macrophage;Maintenance;Malignant Neoplasms;member;Membrane;Membrane Lipids;Membrane Proteins;Membrane Structure and Function;Metabolic;Metal Ion Binding;Metals;Methods;Mitochondria;Molecular;mutant;Mutate;Nature;Neurodegenerative Disorders;neuropsychiatric disorder;novel;Organism;overexpression;oxygen transport;Palmitoyl Coenzyme A;palmitoylation;pathogen;pathogenic bacteria;Peptide Fragments;Pharmacologic Substance;Phosphorylation;Physiological;Play;Pneumonia;Post-Translational Protein Processing;preference;Process;Proliferating;Property;Protein Family;Protein S;Proteins;proteoliposomes;Reaction;Recombinants;reconstitution;Resolution;response;Role;Signal Transduction;Signaling Protein;Starvation;Structure;Sulfur;Surface;synthetic peptide;Time;tool;Touch sensation;Transition Elements;Universities;Vacuole;Virus;X-Ray Crystallography;Zebrafish,Structural and chemical biology,8928,NA,NA,NA,NA,12,NA,NA,2308507,NA
11182297,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008933,NA,NA,1ZIAHD008933-12,NICHD:2234558\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,11982849 (contact),"MACFARLAN, TODD SCOTT (contact)",NA,NA,NA,Alleles;arms race;autism spectrum disorder;Behavior;Binding;Binding Sites;Biochemical;Biological Assay;Birds;Brain;C-terminal;C2H2 Zinc Finger;ChIP-seq;Chromosome Pairing;cohesin;Complex;Data;Defect;Dendrites;Development;Developmental Gene;DNA Binding;DNA Double Strand Break;DNA Repair;driving force;Elements;Endogenous Retroviruses;Ensure;Epigenetic Process;epigenetic silencing;Epitopes;Equilibrium;Evolution;Failure;Family;Female;Fetal Development;Fetal Growth;follow-up;functional genomics;gain of function;gastrulation;Gene Cluster;gene interaction;Gene Proteins;gene repression;Genes;Genetic;genetic corepressor;genetic variant;Genome;Genomic DNA;genomic locus;Germ Lines;Growth Factor;Health;Heart Septal Defects;heterochromatin-specific nonhistone chromosomal protein HP-1;Histone H3;histone methylation;histone methyltransferase;Human;in silico;In Vitro;in vivo;Individual;Infertility;innovation;Insulin-Like Growth Factor II;Knock-out;Knockout Mice;Laboratory Study;Lead;Link;loss of function;male;Male Sterility;Mammals;Mediating;Meiosis;Meiotic Recombination;member;men;Methods;Mouse Strains;Murine leukemia virus;Mus;mutant;Mutation;N-terminal;Neurons;Orthologous Gene;Parasites;Patients;Perinatal;Phenotype;Physiological;Placenta;placental mammal;Placentation;Play;Positioning Attribute;prevent;Production;Proline;proline-tRNA;promoter;Prophase;Protein Family;protein function;Protein Isoforms;Proteins;recruit;reference genome;repaired;Repression;Retrotransposition;Retrotransposon;Retroviridae;Role;SETDB1 gene;Site;Somatic Cell;Somatotropin;Sterility;symbiont;System;Tetrapoda;Time;Tissues;Transcript;transcription factor;Transcription Repressor;Transcriptional Regulation;Viral;Virus Activation;Work;Zinc Fingers,Mammalian Development and Evolution,8933,NA,NA,NA,NA,12,NA,NA,2234558,NA
11182298,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008936,NA,NA,1ZIAHD008936-11,NICHD:110119\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,10672954 (contact),"CHEN, ZHEN  (contact)",NA,NA,NA,"Accounting;Air;Alabama;Asthma;asthmatic;atopy;Biological;Blood Pressure;Breathing;Cells;Chronic Disease;Clinic;Clinic Visits;Clinical;Clinical assessments;clinical center;Clinical Data;Cohort Studies;Data Collection;dietary antioxidant;Dietary intake;Emergency Situation;Environmental Risk Factor;Exhalation;experience;Exposure to;Flow Cytometry;FOXP3 gene;Genetic;Hospitalization;Hypersensitivity;Immune;improved;Inflammation;inflammatory marker;interest;Literature;Mediation;Medical Records;minimal risk;National Heart, Lung, and Blood Institute;neonatal outcome;Nitric Oxide;obstetrical complication;Patients;Pharmaceutical Preparations;Population;Postpartum Period;Predictive Factor;Pregnancy;pregnancy immunology;prenatal;Procedures;Protocols documentation;pulmonary function;Pulmonary Function Test/Forced Expiratory Volume 1;Pulmonary Inflammation;Pulse Oximetry;Questionnaires;Recording of previous events;recruit;Regulatory T-Lymphocyte;Reporting;Risk;Risk Factors;Role;Severities;Specimen;Surveys;Symptoms;Universities;Visit;Woman",B-WELL-Mom Study,8936,NA,NA,NA,NA,11,NA,NA,110119,NA
11182299,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008943,NA,NA,1ZIAHD008943-11,NICHD:27530\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,78830082 (contact),"PERKINS, NEIL  (contact)",NA,NA,NA,18 year old;Affect;Age;aged;American Medical Association;Assisted Reproductive Technology;Birth Rate;Body mass index;Caring;Characteristics;Clinic;Collection;college;cost;Couples;dietary supplements;DNA Fragmentation;Double-Blind Method;efficacy evaluation;Eligibility Determination;Etiology;Female;Fertilization in Vitro;Folic Acid;folic acid supplementation;gastrointestinal symptom;General Population;Height;improved;Infertility;infertility treatment;interest;Intervention;Journals;Live Birth;Magnesium;male;male fertility;Marketing;men;Micronutrients;Morphology;Motility;Observational Study;Outcome;Participant;Placebos;Population;Pregnancy;primary outcome;Process;Publications;Publishing;Randomized;randomized placebo controlled trial;randomized trial;recruit;Reporting;reproductive;Seminal fluid;Site;sperm cell;Sperm Count Procedure;Sperm Motility;Spermatogenesis;subfertility;success;Time;treatment arm;Treatment Efficacy;trial design;Visit;Weight;Woman;Zinc;Zinc supplementation,Folic Acid and Zinc Supplementation Trial,8943,NA,NA,NA,NA,11,NA,NA,27530,NA
11182300,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008948,NA,NA,1ZIAHD008948-10,NICHD:55059\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,78830082 (contact),"PERKINS, NEIL  (contact)",NA,NA,NA,adiponectin;Affect;Alcohols;Anxiety;Biological Markers;Caffeine;Carbohydrates;Collection;Conceptions;Consumption;cost;Couples;Data Analyses;Diet;dietary;Dietary Fiber;Dietary intake;Dietary Practices;Disease;Dual-Energy X-Ray Absorptiometry;Embryonic and Fetal Development;Enrollment;Evaluation;Exercise;Fatty acid glycerol esters;Female;Fertility;fertility improvement;Fertility Study;folic acid supplementation;follow-up;Goals;Gynecologic;implantation;Individual;Infertility;infertility treatment;Intake;interest;intimate partner violence;Journals;Leptin;leptin receptor;Life Style;lifestyle factors;male;Measurement;Measures;Mediterranean Diet;men;Mental Depression;Metabolic;modifiable lifestyle factors;Molecular Weight;Obesity;Outcome;Ovulation;Paper;Participant;Physical activity;Phytoestrogens;Pregnancy;Pregnancy Outcome;pregnant;prospective;Psychosocial Factor;Publishing;Questionnaires;recruit;reproductive success;reproductive system disorder;Research Design;Role;Sex Behavior;sleep pattern;Smoking;Stress;United States;urologic;Visit;Vitamin D;Weight;Woman;Women&apos;s Role;Zinc supplementation,"Impact of Diet, Exercise And Lifestyle on Fertility: The IDEAL Fertility Study",8948,NA,NA,NA,NA,10,NA,NA,55059,NA
11182301,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008955,NA,NA,1ZIAHD008955-09,NICHD:902234\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,14739471 (contact),"SODT, ALEXANDER  (contact)",NA,NA,NA,Affect;Amino Acid Motifs;Biological;Biological Process;Cell Nucleus;Cells;Chemical Structure;Chemicals;cluster computing;Complex;Computer Models;Computer software;Coupling;Cryoelectron Microscopy;Custom;Cytoskeleton;deep ocean;design;Disease;Elements;Environment;Event;Experimental Models;experimental study;Fluorescence Spectroscopy;G-Protein-Coupled Receptors;Goals;Hydrophobicity;Integral Membrane Protein;Intuition;Knowledge;Laboratories;Length;Libraries;Life;lipidome;Lipids;Magnesium;mathematical model;Mechanics;Membrane;Membrane Lipids;meter;Methodology;Methods;Modeling;models and simulation;Molecular;Molecular Biology;Molecular Conformation;molecular dynamics;Movement;nanoscale;National Institute of Child Health and Human Development;Nature;Nervous System Physiology;Neutrons;novel;NUP214 gene;Organelles;Organism;Paper;Pharmaceutical Preparations;physical model;Physics;Post-Translational Protein Processing;pressure;Process;protein function;Proteins;quantum;receptor binding;Research;Resources;response;Role;Running;Sampling;Shapes;side effect;Signal Transduction;Signaling Molecule;Signaling Protein;simulation;software development;Stress;Structure;Techniques;Temperature;Testing;theories;Thick;ultra high resolution;United States National Institutes of Health;Validation;Vesicle;vesicle transport;Viral;Viral Proteins;Virus Replication;Work,Molecular simulations of lipid curvature stress and its effect on transmembrane proteins,8955,NA,NA,NA,NA,9,NA,NA,902234,NA
11182302,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008966,NA,NA,1ZIAHD008966-08,NICHD:2365793\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,15188050 (contact),"LE PICHON, CLAIRE  (contact)",NA,NA,NA,Ablation;activating transcription factor 3;Address;ALS pathology;Anatomy;Animal Model;Apoptotic;Area;Axon;axonal degeneration;Axotomy;Back;Biogenesis;biological adaptation to stress;Brain Concussion;Categories;cell type;Cells;Central Nervous System;Cessation of life;confocal imaging;Cytoprotection;Data;Disease;Dynamin;Early Diagnosis;Early identification;effective therapy;Exhibits;Functional disorder;Genes;Genetic;Genetic Transcription;Goals;Guanosine Triphosphate Phosphohydrolases;Health;Human;Human Development;human imaging;Image;Inherited;Injury;Intervention;Lead;Learning;Leucine Zippers;Methods;Mitochondria;Modeling;Molecular;motor neuron development;Motor Neuron Disease;Motor Neurons;mouse development;mouse model;Mus;Mutation;Nerve Degeneration;nerve injury;Neurodegenerative Disorders;neuron loss;Neurons;novel;Pathology;Pathway interactions;Patients;Peptides;Peripheral Nervous System;Personal Satisfaction;pharmacologic;Phosphorylation;Phosphotransferases;Physiological;Population;Prevalence;prevent;programs;repaired;Research;resilience;response;response to injury;Risk Factors;Role;Signal Transduction;Site;Sphingolipids;stem;Syndrome;therapy development;transcriptional reprogramming;transcriptomics;Traumatic Brain Injury;Traumatic injury;Travel;ward;Work,Mechanisms regulating neuronal degeneration and repair,8966,NA,NA,NA,NA,8,NA,NA,2365793,NA
11182303,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008971,NA,NA,1ZIAHD008971-07,NICHD:1408002\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,2415791 (contact),"BASSER, PETER J. (contact)",NA,NA,NA,Address;Aging;Anatomy;Anisotropy;Architecture;Axon;bench to bedside;Biological;Biological Markers;Biomedical Research;Biopsy;Brain;Brain Neoplasms;brain tissue;cancer diagnosis;cancer imaging;Cell membrane;cell water;Cells;Cellularity;Cerebral cortex;Clinic;Clinical;clinical diagnostics;clinically relevant;Color;Communities;Complex;Contrast Media;Data;Data Science;Detection;Development;Diagnostic Neoplasm Staging;Diameter;Diffusion;diffusion anisotropy;Diffusion Magnetic Resonance Imaging;Dimensions;Disease;Doctor of Philosophy;Dyes;experimental study;extracellular;Foundations;Gel;Glean;Goals;gray matter;Heterogeneity;high dimensionality;Histologic;Histology;Hour;Image;imaging biomarker;imaging modality;improved;in vivo;Individual;innovation;interest;invention;Joints;Length;macromolecule;Magnetic Resonance Imaging;Maps;mathematical model;Mathematics;Measurement;Measures;Methodology;Methods;Microscopic;migration;mild traumatic brain injury;millimeter;Modeling;Monitor;MRI Scans;Multicenter Studies;Multicenter Trials;neural;Neurosciences Research;Normal Statistical Distribution;novel;novel strategies;Outcome;Pathologic;Pathology;Pathway interactions;patient population;physical model;Physiologic pulse;Population;Porosity;pre-clinical;Process;Property;quantitative imaging;Radial;radiologist;reconstruction;Relaxation;Resolution;Scheme;Shapes;Signal Transduction;soft tissue;Specimen;Stains;Statistical Distributions;statistics;Stroke;Structure;submicron;Testing;Time;Tissues;tool;tractography;Translating;Translations;Trauma;tumor;Uncertainty;Visualization;Water;water diffusion;white matter;Work,Quantitative Imaging of Water Transport and Relaxation Processes in the Brain and in Other Soft Tissues,8971,NA,NA,NA,NA,7,NA,NA,1408002,NA
11182304,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008972,NA,NA,1ZIAHD008972-07,NICHD:782224\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,2415791 (contact),"BASSER, PETER J. (contact)",NA,NA,NA,3-Dimensional;Address;Affect;Anatomy;Anisotropy;Antimitotic Agents;Area;Attention;Axon;Basal Cell;Biological;Biophysical Process;Biophysics;Blood flow;blood oxygen level dependent;Brain;Brain region;Categories;Cell Death;Cell division;cell growth;Cell Line;Cell membrane;Cell Physiology;Cells;Cellular Metabolic Process;Characteristics;Clinical;clinical application;Clinical Treatment;Complex;Coupled;Data;Data Compression;daughter cell;density;Deposition;Depressed mood;deprivation;Development;Devices;Diffusion;Diffusion Magnetic Resonance Imaging;Electric Conductivity;electric field;Electrodes;Electromagnetic Fields;Electromagnetics;Elements;Environment;Epilepsy;Exhibits;experimental study;Exudate;falls;fluid flow;Frequencies;Functional Magnetic Resonance Imaging;Glioblastoma;Glucose;Goals;Heterogeneity;Hot Spot;improved;In Situ;In Vitro;in vivo;insight;instrument;interest;Ions;Knowledge;Length;Link;Location;magnetic field;Magnetic Resonance Imaging;Magnetism;Major Depressive Disorder;Malignant neoplasm of brain;Maps;Measurable;Measurement;Measures;Membrane;Methodology;Methods;Microscopic;Microscopy;Migraine;Mitotic spindle;Modeling;Motion;Movement;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;neoplastic cell;Nervous System;Nervous System Physiology;neural;neural stimulation;Neurologic;Neurons;Neurosciences;new technology;novel;Organelles;Organism;Osmotic Pressure;Oxygen;Parents;Pattern;Phase Transition;Physics;Physiology;Population;Process;Proxy;Publishing;Pump;Relaxation;Reporter;Research;Research Activity;response;Safety;Scalp structure;Signal Transduction;Slice;sound;Stimulus;Stream;Stroke;Structure;System;Techniques;Temperature;Testing;Theoretical Studies;theories;Therapeutic;Therapeutic Uses;three-dimensional modeling;Time;tissue culture;Tissues;Transcranial magnetic stimulation;Transport Process;Visit;Water;water flow;Water Movements;water testing;Work,Transport Processes and Nervous System Function,8972,NA,NA,NA,NA,7,NA,NA,782224,NA
11182305,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008977,NA,NA,1ZIAHD008977-07,NICHD:1107058\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9416292 (contact),"WEINSTEIN, BRANT  (contact)",NA,NA,NA,Animals;blastema;Blood Cells;Blood Vessels;Brain;Caenorhabditis elegans;Cell Cycle;cell regeneration;Cell Separation;cell type;Cells;Darkness;Development;DNA;DNA Methylation;Drosophila genus;Endothelium;Epigenetic Process;epigenetic profiling;epigenetic regulation;epigenetic silencing;epigenome;Evolution;Eye;Eye Development;Fatty acid glycerol esters;fatty liver disease;Fishes;Follow-Up Studies;Food;Food deprivation (experimental);Fresh Water;Gametogenesis;Gases;Gene Activation;Gene Expression Regulation;Genes;Genetic Screening;Genome;Goals;Hair Cells;Heart;Hematopoietic stem cells;Histones;Human;Hypoxia;insight;Invertebrates;Laboratories;Liver;Maintenance;Maps;memory retention;Metabolic;Mexican;Mexico;model organism;Molecular;Monitor;multipotent cell;Mus;Muscle;mutant;Mutate;Natural regeneration;Neurons;novel;Nucleotides;Organ;Pathway interactions;Pattern;Phenotype;Pigmentation physiologic function;Pigments;Play;Population;Proteins;reduced muscle mass;regeneration model;Regulation;Reporter;Reporter Genes;Reporting;Reproduction;Role;Salamander;Sampling;Sensory Hair;single-cell RNA sequencing;stem;Surface;Tissue-Specific Gene Expression;Tissues;transcriptome sequencing;transcriptomic profiling;Transgenic Organisms;Vertebrates;Work;wound healing;Zebrafish,Epigenetics of Development,8977,NA,NA,NA,NA,7,NA,NA,1107058,NA
11182306,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008978,NA,NA,1ZIAHD008978-06,NICHD:469334\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,2415791 (contact),"BASSER, PETER J. (contact)",NA,NA,NA,Architecture;Area;Atlases;Axon;Biophysics;Brain;Brain imaging;BRAIN initiative;brain tissue;Callithrix;Clinical;clinical implementation;clinical translation;connectome;Data;Development;Diameter;Diffusion;Diffusion Magnetic Resonance Imaging;Dimensions;Ensure;Experimental Designs;Family;Fractals;Funding;General Hospitals;Goals;Grant;Heterogeneity;histological image;Human;Image;image processing;Imaging Device;in vivo;Infrastructure;Intramural Research Program;invention;Laboratories;Macaca;magnetic field;Magnetic Resonance Imaging;mathematical model;Mathematics;Measures;Methodology;Methods;Microscopic;migration;Modeling;Morphologic artifacts;Morphology;National Institute of Child Health and Human Development;Noise;novel;Performance;physical model;Physiologic pulse;processing speed;prototype;Research;research clinical testing;Research Personnel;Resolution;Role;Scanning;Side;Signal Transduction;Structure;Testing;Time;Tissues;Translating;United States National Institutes of Health;volunteer;Water;water diffusion,Development of the Connectome II MRI Scanner,8978,NA,NA,NA,NA,6,NA,NA,469334,NA
11182307,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008998,NA,NA,1ZIAHD008998-04,NICHD:3299641\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,78351090 (contact),"MATTHIES, DOREEN  (contact)",NA,NA,NA,2019-nCoV;ACE2;Aging;Amino Acids;autism spectrum disorder;Binding;Binding Sites;Biochemical;Biochemistry;Biogenesis;Biological;biophysical techniques;Cells;Child;Child Development;Citric Acid Cycle;Collaborations;combat;Complex;computer studies;Controlled Environment;Couples;COVID-19;COVID-19 pandemic;Cryo-electron tomography;Cryoelectron Microscopy;Cytochrome bc1 Complex;cytochrome c;Data;Detergents;Development;Dissociation;drug development;Electron Microscopy;Electron Transport;Electron Transport Complex III;Environment;extracellular vesicles;Fumarates;Goals;Home;Homologous Gene;Human;human disease;Hydroquinones;Individual;Inner mitochondrial membrane;Investigation;Ions;Lead;Length;light microscopy;lipid transport;Lipids;Liposomes;Magnesium;magnesium ion;Membrane;Membrane Lipids;Membrane Proteins;Membrane Structure and Function;Methods;Micelles;Microscopy;Mitochondria;mitochondrial membrane;Mitochondrial Respiratory Chain Deficiencies;Molecular Biology;Morphology;mutant;Mutate;N-terminal;nanodisk;Oxidative Phosphorylation;particle;Peptides;Pharmaceutical Preparations;Polymers;Primary Prevention;Process;programs;protein complex;Protein Conformation;protein function;protein structure;Proteins;Protomer;Protons;Reaction;receptor;Regulation;Research;Resolution;Respiratory Chain;SARS-CoV-2 spike protein;Scanning Electron Microscopy;Scientist;Shapes;Sodium Chloride;Specificity;structural biology;Structure;Succinate Dehydrogenase;Succinates;Techniques;Testing;Therapeutic;Tissues;Transport Process;tumorigenesis;ubiquinol;Ubiquinone;vaccine development;Vaccines;Variant;Vesicle;vesicle transport;Viral;viral entry inhibitor;Virus;Virus-like particle,Towards high-resolution structural biology of membrane protein complexes in their native lipid environment,8998,NA,NA,NA,NA,4,NA,NA,3299641,NA
11182308,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD009003,NA,NA,1ZIAHD009003-03,NICHD:1992735\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,78832271 (contact),"SHEPPARD, SARAH  (contact)",NA,NA,NA,3-Dimensional;advocacy organizations;Affect;Ascites;Biological Models;Blood;Blood Vessels;bone;cell free DNA;Cell Separation;Cessation of life;Clinical Trials;cohort;Complex;Conduct Clinical Trials;Data;deep sequencing;Dermal;Development;Diagnostic Procedure;Disease;disease phenotype;DNA;Drug Screening;Dysplasia;Edema;efficacious treatment;Etiology;Family;Fertility;Future;Genes;Genetic;genetic disorder diagnosis;genetic manipulation;genetic variant;Genomics;Genotype;Goals;Gorham-Stout disease;Guidelines;Human;Image;improved;in vivo;Individual;inhibitor;KRAS2 gene;Larva;Lesion;Life;liquid biopsy;Lymph;Lymphangiomatosis;Lymphatic;lymphatic development;Lymphatic Diseases;Lymphatic Endothelial Cells;Lymphatic Endothelium;lymphatic malformations;lymphatic vasculature;Lymphedema;Lymphocyte;malformation;MAP Kinase Gene;Medical;Medication Management;MEK inhibition;Modeling;Molecular;Molecular Diagnosis;molecular targeted therapies;Monitor;Morbidity - disease rate;mosaic variant;Mosaicism;Natural History;novel;novel therapeutics;Organoids;Outcome;Parents;Participant;Pathogenicity;Pathway interactions;Patients;PECAM1 gene;Pericardial effusion;Pharmaceutical Preparations;Phenotype;Phosphorylation;PIK3CA gene;Plasma;Pleural effusion disorder;precision medicine;preclinical study;prenatal;prognostication;prospective;Rare Diseases;recruit;Research;screening;Signal Transduction;Somatic Mutation;Symptoms;targeted treatment;Technology;Tissue Sample;Translational Research;tumor;Variant;Venous;Work;Zebrafish,Cellular and Molecular Mechanisms of Vascular Malformations,9003,NA,NA,NA,NA,3,NA,NA,1992735,NA
11182309,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD009011,NA,NA,1ZIAHD009011-03,NICHD:110119\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,10672954 (contact),"CHEN, ZHEN  (contact)",NA,NA,NA,"adipokines;adverse pregnancy outcome;American;biomarker panel;Body fat;cardiometabolism;Clinical Endocrinology;Clinical Nutrition;Data;Development;Diabetes Mellitus;Endocrinology;Epidemiology;Etiology;Fetal Growth;First Pregnancy Trimester;Functional disorder;Future;Gestational Diabetes;Glycosylated hemoglobin A;Growth Factor;High Risk Woman;improved;insight;Insulin;International;Investigation;iron metabolism;Journals;Length;Life Style;Lipids;longitudinal, prospective study;Metabolic;metabolomics;Nested Case-Control Study;Nutrient;Nutritional;Obesity;Outcome;Pathway interactions;Physiological;Pregnancy;Pregnant Women;Reporting;Research;Risk;Risk Factors;Role;Saturated Fatty Acids;screening;telomere;Thyroid Function Tests;Thyroid Gland;Vitamin D;Woman;Work",GDM sub-study of Fetal Growth Studies,9011,NA,NA,NA,NA,3,NA,NA,110119,NA
11182310,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD009013,NA,NA,1ZIAHD009013-03,NICHD:825892\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,10672954 (contact),"CHEN, ZHEN  (contact)",NA,NA,NA,Agreement;Bayesian Analysis;Bayesian Modeling;Chemicals;Data Analyses;Data Set;Development;diagnostic accuracy;epidemiology study;Goals;Measurement;Methodology;Methods;Modeling;multidimensional data;National Institute of Child Health and Human Development;novel;Perinatal Epidemiology;prenatal;public health research;reproductive development;Statistical Methods;United States National Institutes of Health,Statistical methodology development for reproductive and perinatal epidemiology,9013,NA,NA,NA,NA,3,NA,NA,825892,NA
11182311,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD009014,NA,NA,1ZIAHD009014-03,NICHD:99107\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,10672954 (contact),"CHEN, ZHEN  (contact)",NA,NA,NA,Collaborations;data cleaning;Data Collection;Device or Instrument Development;Epidemiologist;Goals;Information Dissemination;National Institute of Child Health and Human Development;Patient Recruitments;Public Health;Research Design;Statistical Data Interpretation;United States National Institutes of Health,General collaborations,9014,NA,NA,NA,NA,3,NA,NA,99107,NA
11182312,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD009018,NA,NA,1ZIAHD009018-02,NICHD:181063\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,9416136 (contact),"LEIKIN, SERGEY  (contact)",NA,NA,NA,1 year old;Acute;Acute Respiratory Distress Syndrome;Affect;Animals;Biological Assay;Birth;Bone Surface;Breathing;Cells;Collaborations;Collagen;Computational algorithm;Connective Tissue;Data Analyses;Deformity;Deposition;Development;Diagnostic;diagnostic tool;Disease;Distress;Early Intervention;Embryo;Evaluation;experimental analysis;Extracellular Matrix;fetal;Fiber;Fluorescent in Situ Hybridization;Fracture;Frequencies;Functional Imaging;Genomics;Goals;Histologic;Histology;Image;imaging approach;imaging modality;Immunofluorescence Immunologic;improved;In Situ;in utero;Knock-out;Life;Lung;Measures;Messenger RNA;Methodology;Methods;microscopic imaging;Microscopy;Modality;mouse model;Movement;Multimodal Imaging;multimodality;Mus;Neonatal;Neonatal lung;neonate;Newborn Infant;Osteoblasts;Osteogenesis Imperfecta;Pathology;Personal Satisfaction;Pregnancy;Prevention;progenitor;Protocols documentation;Publications;pulmonary hypoplasia;Pulmonary Pathology;Resolution;rib bone structure;RNA;Sampling;skeletal dysplasia;spectroscopic imaging;Spectrum Analysis;structural imaging;substantia spongiosa;Technology;Testing;Tissue Fixation;Tissue imaging;Tissues;transcriptome;transcriptomics;ultrasound;Work,Imaging structural and functional relationships between cells and ECM,9018,NA,NA,NA,NA,2,NA,NA,181063,NA
11182313,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200336,NA,NA,1ZIAHG200336-19,NHGRI:2768333\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,9623367 (contact),"SIDRANSKY, ELLEN  (contact)",NA,NA,NA,Affect;alpha synuclein;Alternative Therapies;American;Animals;Ashkenazim;Astrocytes;base;Basic Science;bench to bedside;Biochemical;Biological Assay;Brain;Cell Differentiation process;Cell model;Cell Physiology;Cells;Cellular biology;Cessation of life;Chemicals;Clinical;Clinical Data;clinical phenotype;Clinical Protocols;Clinical Research;Clinical Sciences;cohort;Collaborations;Complex;cost;Defect;Development;Disease;Disease Progression;DNA;dopaminergic neuron;drug development;Engineering;enzyme deficiency;enzyme replacement therapy;Enzymes;Evaluation;experience;Family;Family Study;Fibroblasts;Gaucher Disease;gene therapy;Genes;Genetic Diseases;genetic risk factor;Genetic Screening;Genetic study;genome sequencing;Genomic approach;Genotype;Germ Lines;glucosylceramidase;Glycolipids;Goals;Hereditary Disease;Heterogeneity;Human;Human Genetics;improved;in utero;Incidence;Individual;induced pluripotent stem cell;Inherited;insight;Intravenous infusion procedures;Laboratories;Lead;Lewy Body Disease;Libraries;Link;lipidomics;Lipids;Lysosomal Storage Diseases;Lysosomes;Macrophage;Mendelian disorder;Metabolic;metabolomics;Modeling;Molecular;Molecular Chaperones;mouse model;Mus;mutant;Mutation;National Center for Advancing Translational Sciences;Natural History;Nerve Degeneration;Neuronal Differentiation;Neurons;neuropathology;new technology;next generation sequencing;novel therapeutic intervention;novel therapeutics;Octogenarian;Odds Ratio;Other Genetics;overexpression;Parkinson Disease;Parkinsonian Disorders;Pathogenesis;Pathway interactions;patient derived induced pluripotent stem cells;Patients;Pharmaceutical Preparations;Phenotype;Positron-Emission Tomography;Prevalence;Proteomics;prototype;rare genetic disorder;Relative Risks;Research;research clinical testing;Research Personnel;Risk;Risk Factors;RNA;Role;Sampling;screening;serial imaging;Siblings;small molecule;Solid;Sphingolipidoses;Study Subject;Techniques;Testing;therapeutic evaluation;Time;Tissue Sample;Tissues;tool;transcriptome sequencing;translational approach;Uniparental Disomy;whole genome;Work,Genetic and clinical studies of Gaucher disease and other lysosomal disorders,200336,NA,NA,NA,NA,19,NA,NA,2768333,NA
11182314,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200416,NA,NA,1ZIAHG200416-04,NIAMS:1556968\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,78377284 (contact),"CRISWELL, LINDSEY  (contact)",NA,NA,NA,Adenine;Age;Anti-malarials;apoAI regulatory protein-1;Asian;Asian ancestry;Asian population;autoencoder;Autoimmune Diseases;autoimmune rheumatologic disease;Autoimmunity;Award;B-Lymphocytes;bead chip;biobank;Biologic Characteristic;Biological;Biopsy;Biopsy Specimen;Blood;Blood Cells;California;Candidate Disease Gene;cell type;Cells;Chemical Exposure;Chemicals;climate change;climate-related health;Clinical;clinical care;clinical center;Clinical Data;clinical phenotype;Code;cohort;Cohort Studies;Collaborations;comparison control;Coupled;Data;Databases;design;Development;Diagnosis;differential expression;Disease;Disease remission;disorder risk;DNA;DNA Integration;DNA Methylation;East Asian;Enrollment;environmental chemical;Environmental Exposure;Environmental Risk Factor;epidemiology study;Epigenetic Process;epigenetic profiling;epigenome;Epithelial Cells;Estrogen deficiency;Eugenol;European;exome sequencing;experience;Family;Family member;Fibroblasts;Flare;follow-up;Frequencies;Funding;Gene Expression Regulation;Gene set enrichment analysis;Genes;Genetic;genetic architecture;genetic epidemiology;Genetic Research;Genetic study;genetic variant;genome wide association study;genome-wide;Genomics;Gland;Glutamic Acid;Goals;gut microbiota;Health;Hypermethylation;Immune;improved;Individual;Inflammation;Interferons;International;Laboratories;Lacrimal gland structure;large datasets;Leadership;Link;Lipid Peroxidation;Liquid Chromatography;Longitudinal Studies;Lupus;Lupus Nephritis;Manuscripts;Mass Spectrum Analysis;Measures;metabolome;metabolomics;Methods;Methylation;Modeling;Modification;mouse model;multi-ethnic;multi-racial;National Human Genome Research Institute;National Institute of Dental and Craniofacial Research;National Institute of Environmental Health Sciences;Not Hispanic or Latino;Oleic Acids;Onset of illness;Outcome;Oxidative Stress;Participant;Pathogenesis;Pathway interactions;patient subsets;Patients;Peripheral Blood Mononuclear Cell;Peru;Pharmaceutical Preparations;Phenotype;phthalates;Physicians;Plasma;Production;programs;Protocols documentation;Publishing;Race;rare variant;Rattus;recruit;Registries;repository;Research;Research Project Grants;Rheumatoid Arthritis;rheumatologist;Risk;Saliva;Salivary Glands;sample collection;Sampling;San Francisco;Serum;sex;Site;Sjogren&apos;s Syndrome;small molecule;Smoke;sociodemographic factors;Statistical Methods;Subgroup;Systemic Lupus Erythematosus;targeted treatment;Testing;Time;Tissues;United States National Institutes of Health;Universities;Variant;Visit;Whole Blood;Wildfire,Genomic Studies of Autoimmune Rheumatic Disease,200416,NA,NA,NA,NA,4,NA,NA,1556968,NA
11182315,ZIC,CL,1,N,NA,NA,NA,NA,ZICCL002128,NA,NA,1ZICCL002128-05,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,11612947 (contact),"FLEGEL, WILLY  (contact)",NA,NA,NA,Address;blood group;Blood typing procedure;clinical center;Collaborations;editorial;Erythrocytes;Genotype;Goals;Immunology;Institution;International;Laboratories;Molecular Genetics;patient safety;Publications;Published Comment;Publishing;Reporting;Research;Resources;Serology;Services;Summary Reports;transfusion medicine;United States National Institutes of Health,"Laboratory Services Section, Department of Transfusion Medicine Core Report",2128,NA,NA,NA,NA,5,NA,NA,0,NA
11182316,ZIC,CL,1,N,NA,NA,NA,NA,ZICCL090078,NA,NA,1ZICCL090078-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79959606 (contact),"WEST-MITCHELL, KAMILLE  (contact)",NA,NA,NA,Aliquot;Blood;Blood Component Removal;Blood Donations;Blood donor;clinical center;Code;Collection;Compensation;Consent Forms;Counseling;design;Education;Electronics;Eligibility Determination;Enrollment;healthy volunteer;Human Subject Research;In Vitro;in vivo;Informed Consent;Institutional Review Boards;Laboratories;Link;meetings;Monitor;National Institute of Allergy and Infectious Disease;Nature;Online Systems;Procedures;Process;Protocols documentation;recruit;Research;Research Personnel;Resources;Risk;Safety;Sampling;Schedule;Study Subject;Techniques;transfusion medicine;United States National Institutes of Health;Venous blood sampling;Whole Blood,Collection and Distribution of Blood Components from Healthy Donors for In Vitro Use,90078,NA,NA,NA,NA,3,NA,NA,0,NA
11182317,ZIH,HD,1,N,NA,NA,NA,NA,ZIHHD008868,NA,NA,1ZIHHD008868-17,NICHD:3277305\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,15710968 (contact),"IDRISS, ASMA  (contact)",NA,NA,NA,"Annual Reports;Appointment;Area;biobank;Biological;Businesses;Capital;Cardiac;Certification;Clinical;clinical application;clinical center;Clinical Data;Clinical Informatics;Clinical Medicine;Clinical Trials;Clinical Trials Database;cloud platform;Collaborations;Collection;Communication;Communities;Computer software;Computers;Custom;Data;data integration;Data Mart;Data Reporting;Databases;design;Development;Development Plans;Documentation;Education;Eligibility Determination;Environment;Equipment;Event;Expenditure;Feedback;Funding;Health;Human Resources;improved;Individual;Informatics;informatics tool;Information Systems;Information Technology;Infrastructure;instrument;Internet;Intramural Research;Intranet;Journals;Laboratories;laboratory experience;Libraries;Licensing;Magnetic Resonance;Maintenance;Medical;Mentors;migration;Modernization;Monitor;National Heart, Lung, and Blood Institute;National Institute of Child Health and Human Development;National Institute of Mental Health;Natural History;Newsletter;occupational health/safety;Office of Administrative Management;operation;Patient Self-Report;Postbaccalaureate;posters;Process;Professional counselor;Progress Reports;Protocols documentation;Publications;Publishing;quality assurance;Recovery Support;Reporting;Research;Research Personnel;Research Project Grants;response;Running;Safety;Sampling;satisfaction;Secure;service programs;Services;Site;software development;Surveys;System;Time;Training;Training Programs;translational medicine;Translational Research;Travel;United States National Institutes of Health;Update;Validation;Visualization;web services;web site;Work",Clinical & Research Informatics,8868,NA,NA,NA,NA,17,NA,NA,3277305,NA
11182784,P30,CA,3,N,2024-09-19,2024-09-01,2025-07-31,397,P30CA071789,ORGANIZED RESEARCH UNITS,PAR-21-321,3P30CA071789-23S1,NCI:187303\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,HONOLULU,UNITED STATES,NONE,01,965088057,US,820005,UNIVERSITY OF HAWAII AT MANOA,HI,968222234,"OVERALL – PROJECT NARRATIVE The University of Hawai‘i Cancer Center (UHCC) is dedicated to pioneering cancer research tailored to the distinct ethnic and cultural characteristics of Hawai‘i and the Pacific. Through a blend of innovative research, clinical trials, and robust community outreach and engagement, UHCC prioritizes underserved groups like Native Hawaiians and Pacific Islanders. Supported by many stakeholders, including State and Federal sponsors, our mission is to transform cancer care, emphasizing diversity, equity, and inclusion, ensuring Hawai‘i and the Pacific lead in globally impactful cancer discoveries.",2091993 (contact),"UENO, NAOTO T. (contact)","SHAFIK, HASNAA",1997-07-01,2029-07-31,"Address;Advanced Malignant Neoplasm;Aging;Analytical Biochemistry;anti-cancer research;Area;Asian Americans;authority;Automobile Driving;base;Basic Cancer Research;Biodiversity;Bioinformatics;Biological;Biometry;Body Composition;Cancer Biology;Cancer Burden;cancer care;Cancer Center;Cancer Center Support Grant;cancer clinical trial;Cancer Control;Cancer Etiology;cancer health disparity;Cancer health equity;Cancer Patient;cancer prevention;cancer research center director;Cancer Research Center of Hawaii;cancer risk;cancer therapy;Catchment Area;Characteristics;Clinic;Clinical Investigator;Clinical Research;Clinical Trials;clinically relevant;cohort;Collaborations;collaborative approach;Communities;community engagement;Community Networks;Community Outreach;community setting;Cultural Characteristics;culturally appropriate intervention;Death Rate;Dedications;diversity and equity;Education;Ensure;Environment;equity, diversity, and inclusion;ethnic diversity;ethnic minority population;Ethnic Origin;Ethnic Population;Etiology;experience;Extramural Activities;Fostering;Funding;Genetic;Genomics;Geography;Goals;Growth;Guam;Hawaii;health disparity;health equity;health equity promotion;Health Policy;Health Professional;Health system;Healthcare Systems;improved;Infrastructure;innovation;Institution;inter-institutional;Intervention;Lead;Leadership;Life Style;Location;Malignant Neoplasms;Medical;member;Mission;Monitor;multi-ethnic;National Cancer Institute;Native Hawaiian or Other Pacific Islander;Network-based;next generation;novel;novel strategies;nutrition;Outcome;Pacific Islands;participant enrollment;Patient Care;patient population;Patient Representative;Peer Review;Phase;Policies;Population;Population Heterogeneity;Population Programs;Population Sciences;Positioning Attribute;Prevention;Prevention approach;programs;Provider;Public Health;Public Policy;Publications;Publishing;Race;racial diversity;racial minority;racial population;Recording of previous events;Research;Research Activity;Research Infrastructure;Research Personnel;Research Priority;Research Training;Resource Sharing;Rural;Screening for cancer;Societies;socioeconomics;Students;Therapeutic;Traditional Medicine;Training;Translating;translational cancer research;Translations;Travel;treatment response;underserved area;Underserved Population;Universities;Vision;Vulnerable Populations;Work",University of Hawaii Cancer Center CCSG,71789,NCI,Cancer Centers Study Section (A)[NCI-A],NA,S1,23,123447,63856,187303,NA
11182785,P30,CA,3,N,2024-09-19,2024-07-01,2025-06-30,NA,P30CA071789,NA,PAR-21-321,3P30CA071789-23S1,NCI:187303\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,HONOLULU,UNITED STATES,NA,01,965088057,US,820005,UNIVERSITY OF HAWAII AT MANOA,HI,968222234,NA,8928058 (contact),"MARTIN, CLIFFORD C (contact)","SHAFIK, HASNAA",1997-07-01,2029-07-31,"Achievement;Advisory Committees;anti-cancer research;Automobile Driving;Award;Budgets;Cancer Biology;Cancer Burden;Cancer Center;Cancer Center Support Grant;cancer education;Clinical Trials;Collaborations;Communication;Communication Methods;community engagement;Community Outreach;Data Reporting;Dedications;Development;diversity and equity;diversity and inclusion;Education;Ensure;Environment;equity, diversity, and inclusion;Evaluation;Event;experience;Extramural Activities;fighting;Fostering;Funding;Grant;Hawaii;Hospitals;Human Resources;human subject;Information Technology;Infrastructure;innovation;Institution;Lead;Leadership;Malignant Neoplasms;meetings;member;Mission;Monitor;National Cancer Institute;operation;Outcome;outreach;Patient Care;Pilot Projects;Play;Policies;Population Sciences;Positioning Attribute;Price;Process;programs;Publications;Quality Control;Research;research facility;Research Infrastructure;Research Support;Research Training;Resource Sharing;Resources;Role;satisfaction;Source;Strategic Planning;Strategic vision;Stream;success;symposium;Training and Education;Translational Research;Universities;Vision;Work",Cancer Center Administration,71789,NCI,Cancer Centers Study Section (A)[NCI-A],7094,S1,23,123447,63856,NA,187303
11182809,UG1,CA,3,N,2024-09-06,2023-08-01,2024-07-31,399,UG1CA189997,NA,RFA-CA-18-016,3UG1CA189997-10S1,NCI:153469\,OTHER RESEARCH-RELATED,2024,NATIONAL CANCER INSTITUTE,NA,ATLANTA,UNITED STATES,NA,05,089697395,US,342701,NORTHSIDE HOSPITAL ATLANTA,GA,303421611,"Project Narrative GA NCORP Community Site addresses two important challenges in US public health: expanding cancer research to a broader population and including underserved populations in cancer research. Advances in clinical care and scientific discovery are not currently equally available to all races and ethnic groups. GA NCORP will continue to analyze data to identify areas for potential improvement, identify proven best practices, and utilize the expertise of research network affiliates and disparities experts to develop and enhance efforts to achieve equitable access to clinical trials.",11998942 (contact);78914520,"CANTUARIA, GUILHERME  (contact);HENRY, LEONARD R.","WHITE, VANESSA",2014-08-09,2025-07-31,Address;Adherence;Adolescent;Adolescent and Young Adult;Advocate;Aftercare;anti-cancer research;Area;base;biobank;cancer care;cancer clinical trial;Cancer Control;cancer health disparity;Cancer Hospital;Cancer Patient;care delivery;Caring;clinical care;Clinical Research;clinical trial enrollment;Clinical Trials;clinically significant;Collaborations;Collection;Communities;Community Clinical Oncology Program;community involvement;Contracts;control trial;Data;Development;Diagnosis;Disparity;Education;Elderly;Eligibility Determination;Enrollment;Equity;ethnic minority;Ethnic Population;evidence base;Evidence based practice;gender minority;Genetic Counseling;Goals;Guidelines;health care service organization;human subject;Image;imaging study;Improve Access;improved;Individual;Infrastructure;insight;Institution;Leadership;Maintenance;Malignant neoplasm of ovary;Malignant Neoplasms;medical specialist;Monitor;National Cancer Institute;National Comprehensive Cancer Network;Newly Diagnosed;Oncologist;Oncology;Participant;participant enrollment;Patient Outcomes Assessments;patient population;Patient-Focused Outcomes;Patients;Population;Prevention;Prevention trial;programs;protocol development;Protocols documentation;Public Health;Quality of Care;Quality of life;racial minority;racial population;Recording of previous events;Research;Research Design;Research Personnel;research study;Resources;Risk;rural dwellers;screening;Sexual and Gender Minorities;Side;simulation;Site;Structure;Study Subject;symptom management;treatment trial;Underrepresented Populations;Underserved Population;young adult,Georgia NCI Community Oncology Research Program (GA NCORP),189997,ZCA1,ZCA1-RTRB-E(M1),NA,S1,10,153469,0,153469,NA
11182822,UG3,CA,3,N,2024-09-05,2022-09-01,2025-08-31,393,UG3CA265845,SCHOOLS OF MEDICINE,RFA-CA-20-049,3UG3CA265845-02S1,NCI:622811\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,SAN FRANCISCO,UNITED STATES,OBSTETRICS & GYNECOLOGY,11,094878337,US,577508,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,941432510,"Project Narrative The UCSF Discovering cancer Risks from Environmental exposures And Maternal/child health (DREAM) cohort is designed to fill current gaps in knowledge about the role of environmental exposures in cancer etiology by engaging with a diverse population of pregnant women. Through focusing on this critical, but understudied window of exposure, our study will contribute to an enhanced understanding of the relationships between multiple exposures to environmental contaminants and intermediate cancer risk biomarkers. In the long term, results can support earlier identification of risk factors, allowing for more effective prevention of environmentally mediated cancers.",1870199 (contact);9485654,"REYNOLDS, PEGGY  (contact);WOODRUFF, TRACEY J.","MAHABIR, SOMDAT",2021-09-20,2025-08-31,4 year old;Address;Air;Area;Aromatic Amines;Biological Assay;Biological Markers;Biological Monitoring;Blood;California;cancer diagnosis;cancer epidemiology;Cancer Etiology;cancer risk;Carcinogens;cell immortalization;Characteristics;Chemicals;Child;Chronic;Clinical;cohort;Collaborations;Collection;Common Data Element;Communities;community engagement;consumer product;Data;Data Collection;data management;design;Development;Disparity;DNA Damage;Early identification;Endocrine Disruptors;Enrollment;Environment;environment related cancer;Environmental Carcinogens;environmental chemical;environmental chemical exposure;Environmental Exposure;Environmental Health;Environmental Pollutants;Environmental Risk Factor;epidemiology study;ethnic diversity;Ethnic Origin;experience;Exposure to;Feedback;flexibility;Funding;Future;Geographic Information Systems;Geography;Hair;Health;Hormonal;Hormones;Hospitals;Immune response;immunoregulation;Incidence;Infant;Inflammation;information system analysis;Infrastructure;innovation;insight;Interdisciplinary Study;Knowledge;Laboratories;Life;Link;Longterm Follow-up;Malignant Breast Neoplasm;Malignant Childhood Neoplasm;Malignant Neoplasms;mammary;Maternal and Child Health;Measures;Mediating;Medical;Methods;Modification;Morphology;Mothers;Nail plate;Neighborhoods;neoplasm registry;offspring;Outcome;Oxidative Stress;Participant;Patient Recruitments;Pesticides;Phase;phthalates;Physiological;Plasticizers;pollutant;Poly-fluoroalkyl substances;population based;population health;Population Heterogeneity;Positioning Attribute;Predisposition;Pregnancy;Pregnant Women;prenatal exposure;Prevention;Process;programs;Questionnaires;racial diversity;receptor;Recording of previous events;Records;recruit;reproductive epidemiology;Research;research and development;research data dissemination;Research Priority;Risk;Risk Factors;Role;Saliva;Sampling;San Francisco;Science;Second Pregnancy Trimester;Site;Surveys;System;Testing;Translations;Urine;Water;Woman;Work,DREAM: Discovering cancer Risks from Environmental contaminants And Maternal/child health,265845,ZCA1,ZCA1-SRB-T(O2)R,NA,S1,2,379763,243048,622811,NA
11182832,N01,HD,NA,N,NA,NA,NA,NA,75N94023D00001,NA,NA,75N94023D00001-0-759402400002-1,NICHD:2044287\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,ROCKVILLE,UNITED STATES,NA,08,049508120,US,9611701,"WESTAT, INC.",MD,208503129,NA,79886811 (contact),"DRIVER, BARBARA  (contact)",NA,2024-08-01,2029-07-31,Accountability;Acquired Immunodeficiency Syndrome;Administrative Coordination;Adolescent;adolescent woman;AIDS clinical trial group;AIDS prevention;Anti-Retroviral Agents;antiretroviral therapy;Area;Biological Assay;Child;clinical care;Clinical Protocols;Clinical Research;clinical research site;Clinical Trials;co-infection;cohort;Conduct Clinical Trials;Contractor;Counseling;design;detection assay;detection limit;Diagnosis;Discipline of Nursing;Disease;Disease remission;Drug Kinetics;Education;Enrollment;Ensure;Epidemiology;Equipment;experience;Formulation;Goals;high risk;HIV;HIV Infections;HIV therapy;HIV/AIDS;Human;Human Resources;human subject;Immunologics;in utero;Infant;infant infection;Inpatients;Institution;Institutional Review Boards;International;International Maternal Pediatric Adolescent AIDS Clinical Trials;Intervention;Laboratories;laboratory facility;Laboratory Technicians;Leadership;Longitudinal Studies;Mediation;Medical;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;Natural History;neonate;Neuropsychology;Nevirapine;Nucleosides;Office for Human Research Protections;Outpatients;Participant;participant enrollment;patient population;Patients;Pharmaceutical Preparations;Pharmacists;pharmacologic;Phase;Postpartum Women;Pregnant Women;Prevention;Protocols documentation;Qualifying;recruit;Regulation;Research;Research Activity;Research Personnel;research study;Research Subjects;Reverse Transcriptase Inhibitors;RNA;safety assessment;Sampling;Services;Site;Social Work;Specific qualifier value;Specimen;Specimen Handling;Symptoms;Testing;testing services;Treatment Protocols;United States;Vertical Disease Transmission;web site;Work,P1115 - VERY EARLY INTENSIVE TREATMENT OF HIV-INFECTED INFANTS TO ACHIEVE HIV REMISSION: A PHASE I/II PROOF OF CONCEPT STUDY,0,NA,NA,NA,NA,NA,NA,NA,2044287,NA
11182837,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274321,NA,RFA-CA-21-052,3U54CA274321-03S1,NCI:238959\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,HOUSTON,UNITED STATES,NA,09,800772139,US,578407,UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,770304009,NA,1931297 (contact);10976988,"MYERS, JEFFREY NICHOLAS (contact);SANDULACHE, VLAD C","KAI, MIHOKO",2022-09-20,2027-08-31,Administrative Coordination;Administrator;Advisory Committees;Affect;Agreement;Basic Science;Bioinformatics;Biological Specimen Banks;Cisplatin;Clinical Research;Collaborations;Communication;Communities;Consult;Consultations;cost effective;Data Coordinating Center;data integrity;data management;data quality;Decision Making;Dedications;design;Discipline;Drug resistance;Employment;Ensure;Equilibrium;Event;experience;Future;Goals;Grant;Head and Neck Cancer;Human Resources;Institution;interdisciplinary approach;Leadership;lectures;meetings;Modeling;Monitor;multidisciplinary;Outcome;Performance;Periodicals;Pharmacotherapy;pre-clinical;pre-clinical research;Preparation;Publications;Qualifying;quality assurance;Quality Control;Recommendation;Regulation;Reporting;Research;Research Activity;Research Infrastructure;Research Personnel;Resistance;Resources;Rest;Schedule;Structure;success;symposium;System;Training;Translational Research;tumor;Work,Admin-Core-001,274321,ZCA1,ZCA1-SRB-E(M1),9351,S1,3,237360,1599,NA,238959
11182848,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA156734,NA,PAR-18-767,3U54CA156734-14S2,NCI:325963\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,BOSTON,UNITED STATES,NA,08,808008122,US,850902,UNIVERSITY OF MASSACHUSETTS BOSTON,MA,021253300,NA,77954170 (contact),"ESCALERA, LIYA  (contact)","WALI, ANIL",2010-09-28,2026-08-31,Address;American;Area;behavioral and social science;Behavioral Sciences;Black Populations;Boston;Cancer Center;cancer health disparity;career;career development;Color;Communication;Communities;COVID-19 pandemic;Dana-Farber Cancer Institute;design;Development;Disabled Persons;Discipline;Discipline of Nursing;Disparity;Doctor of Philosophy;Education;education research;Educational Status;Enrollment;Ethnic Population;evidence base;experience;Faculty;Fellowship;Fostering;Genomics;Graduate Degree;graduate school;graduate student;Grant;Group Affiliation;Growth;Health;health communication;Health Disparities Research;health disparity;Healthcare;improved;Individual;Infrastructure;innovation;Institutional Racism;interest;Intervention;Investments;Knowledge;Latinx;Low Income Population;Malignant Neoplasms;Manuscripts;Massachusetts;Mentors;Methods;multidisciplinary;Native Americans;NCI Center for Cancer Research;outreach;Peer Review;personalized cancer therapy;Phase;physical science;Population;Population Heterogeneity;Postbaccalaureate;Postdoctoral Fellow;Preparation;Process;Productivity;programs;Publications;racial population;Research;research and development;Research Design;Research Personnel;Research Project Grants;research study;Science;Science Enrichment;Scientific Advances and Accomplishments;Scientist;skills;Students;success;Training;undergraduate student;Underrepresented Populations;Underrepresented Students;Universities;Work,Research Education Core,156734,ZCA1,ZCA1-SRB-2(A1)S,8821,S2,14,213746,112217,NA,325963
11182850,R33,AG,4,N,2024-09-09,2024-09-15,2025-08-31,866,R33AG068931,SCHOOLS OF NURSING,PAR-20-071,4R33AG068931-03,NIA:751218\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,Newark,UNITED STATES,NONE,10,090299830,US,10034168,RUTGERS BIOMEDICAL AND HEALTH SCIENCES,NJ,071073001,"PROJECT NARRATIVE This research infrastructure project will harmonize and merge multiple data sets needed to answer new and complex questions about the aging trajectories and health of diverse populations during the universal process of aging. This project will explore the interactions of shared risk factors across levels (patient, provider, com- munity, health care system, and society) and domains (biological, behavioral, sociocultural, and physical/ built environments) using state-of-the-art analytic methods. This project is relevant to the National Institute on Ag- ing’s mission to support clinical, social, and economic research on aging.",10603297 (contact);6986084,"JARRÍN MONTANER, OLGA F. (contact);LIN, HAIQUN","NOVAK, PRISCILLA JOY",2021-05-01,2026-08-31,Activities of Daily Living;Acute;Advanced Development;Affect;Age;Age Years;Aging;aging process;Air Pollution;Alzheimer&apos;s disease related dementia;analytical method;Area;Bathing;Behavioral;Behavioral Mechanisms;beneficiary;Biological;built environment;Cancer Institute of New Jersey;care costs;Caregiver Burden;Caring;Censuses;Chronic;Chronic Kidney Failure;Clinical;Clinical Sciences;cohort;Collaborations;Communities;Complex;cost estimate;COVID-19;COVID-19 diagnosis;Data;data infrastructure;data repository;Data Set;decubitus ulcer;Development;Diabetes Mellitus;Diagnosis;Dimensions;disability;Disparity;Disseminated Malignant Neoplasm;Distal;Documentation;Eating;Economics;Elderly;End stage renal failure;Environmental Exposure;experience;Exposure to;falls;functional decline;functional disability;functional independence;functional status;Geography;Goals;Health;health care availability;health care quality;health determinants;Health Disparities Research;health inequalities;Health Policy;Healthcare;Healthcare Systems;Heart failure;HIV;Home;hospice utilization;human old age (65+);Impaired cognition;improved;Incontinence;Independent Living;indexing;Individual;informal care;infrastructure development;innovation;inpatient service;Institution;Institutional Racism;Institutionalization;Institutionalized Persons;Insurance;interest;Intervention;Kidney Diseases;late life;Life;machine learning algorithm;machine learning method;machine learning prediction algorithm;Maintenance;Maps;Measures;Medicare;Mental Depression;Methodology;Methods;Mission;Modeling;mortality;multiple datasets;National Center for Advancing Translational Sciences;National Institute on Aging;Neighborhoods;New Jersey;older adult;Outcome;outcome prediction;Outcomes Research;Pain;Pathway interactions;patient oriented;patient population;Patients;Pattern;person centered;Persons;Physical Function;Policies;Pollution;Population;Population Heterogeneity;Predictive Factor;premature;Process;Provider;Quality of Care;Recording of previous events;Recovery;Recovery of Function;Recovery Support;repository;Research;Research Infrastructure;Research Personnel;resilience in aging;Resources;respiratory;response;Risk Factors;risk sharing;Science;sex;Shapes;skills;social;social culture;Societies;socioeconomics;Source Code;Sterile coverings;Stroke;Surveys;Syndrome;System;Testing;therapy design;Time;Translational Research;United States National Institutes of Health;Variant;Ventilator;Walking;Work,Advanced Development and Utilization of Assembled Aging Trajectory Files from Multiple Datasets,68931,NIA,Behavior and Social Science of Aging Study Section[NIA-S],NA,NA,3,478483,272735,751218,NA
11182852,R00,EB,4,N,2024-09-13,2024-09-01,2025-08-31,286,R00EB034778,BIOMED ENGR/COL ENGR/ENGR STA,PA-20-188,4R00EB034778-02,NIBIB:249000\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,CLEMSON,UNITED STATES,ENGINEERING (ALL TYPES),03,042629816,US,1626401,CLEMSON UNIVERSITY,SC,296340001,"Rapid, inexpensive detection of protein biomarkers of disease at the point of care is critical for many clinical purposes but is currently not possible for many important clinical targets. Here, we propose a new detection technique that uses in vitro, protein-based signaling networks incorporating self-amplifying enzymatic pathways that results in biomarker detection platforms with unparalleled sensing capabilities in less than two minutes. While initial detection designs will be applied for the point-of-care detection of Hepatitis C Virus, the detection system can be applied to sense any protein or small molecule biomarker with known binders, and as such could be used as a platform for the detection of many analytes currently unable to be rapidly detected at the point of care.",16421035 (contact),"MAJORS, CATHERINE E. (contact)","LASH, TIFFANI BAILEY",2024-09-01,2027-08-31,adenylate;Adenylate Cyclase;Affinity;Antibodies;antigen binding;Antigens;Base Pairing;Binding;Biological Assay;Biological Markers;Biology;Biosensor;Blood;Blood specimen;Clinical;clinical biomarkers;clinical translation;Clinical Trials;clinically relevant;Collaborations;Communicable Diseases;Complex;Computer Models;Concentration measurement;Cyclic AMP;Cyclic AMP Receptor Protein;design;Detection;detection method;detection platform;Development;Devices;Diagnosis;Diagnostic;Diagnostic Equipment;diagnostic platform;Disease;DNA;enzyme reconstitution;Enzymes;Equipment;Feedback;Fluorescence;Fluorescence Resonance Energy Transfer;Freeze Drying;Future;Goals;Hepatitis C;Hepatitis C virus;Human;Immunoglobulin Fragments;In Vitro;in vivo;innovation;Investigation;lateral flow assay;Modeling;Nature;novel;nucleic acid detection;Output;Pathway interactions;Phase;point of care;point-of-care detection;point-of-care diagnostics;Post-Translational Protein Processing;prevent;protein biomarkers;Proteins;rapid detection;Rapid diagnostics;Reaction;Reader;Recombinants;reconstitution;Reporter;response;Sampling;scaffold;Serum;Signal Transduction;Signaling Protein;Sirolimus;small molecule;System;Tacrolimus Binding Protein 1A;targeted biomarker;Tertiary Protein Structure;Testing;Validation;Work,Development of a Novel Split Enzyme Diagnostic Platform for Use at the Point of Care,34778,NSS,NSS,NA,NA,2,173510,75490,249000,NA
11182869,R33,HD,4,N,2024-09-15,2024-09-16,2025-08-31,865,R33HD113515,SCHOOLS OF MEDICINE,PAR-22-233,4R33HD113515-02,NICHD:730483\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PITTSBURGH,UNITED STATES,INTERNAL MEDICINE/MEDICINE,12,004514360,US,2059802,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,152133320,"NARRATIVE On June 24, 2022, the U.S. Supreme Court ruled to eliminate federal protections for abortion access through the Dobbs v. Jackson Women’s Health decision. Our study will evaluate the evolving, time-sensitive impact of the Dobbs decision on people with childbearing capacity, particularly those with chronic diseases. This project will examine: 1) experiences of people seeking abortion, to understand the immediate and long-term consequences of abortion receipt or denial on health and well-being; 2) experiences of physicians who provide care for people with chronic diseases, to describe ways in which evolving abortion policy affects medical decision-making and practice; and 3) population-level data, to generate new evidence about the impact of abortion policy on clinical outcomes, including severe maternal morbidity and maternal mortality.",14388983 (contact),"TALABI, MEHRET BIRRU (contact)","POPKIN, RONNA",2023-09-15,2027-08-31,abortion;adverse pregnancy outcome;Advertising;Affect;Age;Birth;Cardiovascular Diseases;Caring;child bearing;Chronic;Chronic Disease;Clinical;clinical center;clinical practice;Complex;Contraceptive methods;court;Dangerousness;Data;Decision Making;disabled;Discipline of obstetrics;Disease;Drug Prescriptions;Eligibility Determination;Epidemiology;Equity;experience;Family Planning;Female;fetal;Health;health equity;Health Policy;health practice;Health Services;Healthcare;healthy pregnancy;high risk;indexing;Individual;Interview;Legal;Life;Low income;Malignant Neoplasms;Maternal Mortality;Medicaid;Medical;Medicine;multidisciplinary;Outcome;Outcome Assessment;Patient Outcomes Assessments;Patients;person centered;Personal Satisfaction;Persons;Pharmaceutical Preparations;Pharmacy facility;Physicians;Policies;Population;population based;Pregnancy;Pregnancy Outcome;pregnant;Primary Care;Procedures;Public Health;Recommendation;Recording of previous events;recruit;Regulation;Reporting;Reproductive Health;Research;Respondent;Risk;Sampling;search engine;severe maternal morbidity;social;socioeconomics;Surveys;Systemic Lupus Erythematosus;Teratogens;Time;Travel;unintended pregnancy;Women&apos;s Health,Time-Sensitive Research to Assess the Effects of Reproductive Health Policy on the Health Outcomes of People with Chronic Diseases,113515,ZRG1,Special Emphasis Panel[ZRG1-HSS-E(56)R],NA,NA,2,459423,271060,730483,NA
11182897,R33,HD,4,N,2024-09-18,2024-09-20,2025-08-31,865,R33HD112921,NA,PAR-22-233,4R33HD112921-02,NICHD:591234\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NEW YORK,UNITED STATES,NA,10,088464730,US,1621601,GUTTMACHER INSTITUTE,NY,100384912,"The landscape of reproductive health care in the United States is in the midst of seismic and rapid shifts; abrupt changes in access to abortion in the US are without precedent in terms of the number of individuals who are affected, the number of states in which there remains substantial uncertainty around abortion policy changes in the near future, and the scale of potential effects on the lives of pregnant people. This project addresses the urgent need to assess the impact of state abortion restrictions on the health of pregnant people, as well as the need for high quality estimates of abortion incidence both within and outside of the formal health care system as these restrictions are implemented. This study will advance the field of abortion measurement by establishing estimation approaches that encompass both facility-based and self-managed procedures and are designed for a context in which the legal status of abortion is hybridized and subject to rapid, ongoing changes, laying the foundation for a new surveillance infrastructure that will be needed for the foreseeable future.",14411360 (contact),"SULLY, ELIZABETH ANNE (contact)","POPKIN, RONNA",2023-09-05,2028-08-31,abortion;Address;Affect;Bayesian Modeling;Caring;Collection;court;critical period;Data;Data Collection;Decision Making;Dedications;design;Elements;evidence base;experience;Face;Family;Family Planning;flexibility;Foundations;Future;Gestational Age;Health;Health care facility;Health Care Sector;health organization;Healthcare;Healthcare Systems;improved;Incidence;Individual;Infrastructure;innovation;Legal;Legal Status;Link;Measurement;Measures;Methodology;Methods;Morbidity - disease rate;mortality;novel;novel strategies;Outcome;Persons;Phase;Policies;Policy Maker;population health;Population Surveillance;Pregnancy;pregnant;Procedures;programs;Provider;Public Health;Publishing;Reporting;Reproductive Health;Research;Research Personnel;Risk;Safety;Sampling;Self Management;service providers;Societies;Surveys;System;Testing;Travel;Uncertainty;United States;Update;Women&apos;s Health,The impact of new state restrictions on abortion incidence and safety in the United States,112921,ZRG1,Special Emphasis Panel[ZRG1-CCHI-M(56)R],NA,NA,2,498091,93143,591234,NA
11182967,U01,CA,3,N,2024-09-06,2024-08-01,2025-07-31,393,U01CA272977,SCHOOLS OF PUBLIC HEALTH,RFA-CA-21-021,3U01CA272977-02S2,NCI:135919\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,COLUMBIA,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,06,041387846,US,1524302,UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,292080001,"Metabolic dysregulation, an important manifestation of inflammation, may hold the key for addressing the growing problem of Early-Onset CRC (EOCRC) (i.e., <50 years), and numerous other obesity-related cancers. The proposed work draws on experience that we have accumulated in working with inflammation, and metabolic dysregulation in particular, in both laboratory animal experiments and human studies and that have contributed many hundreds of papers and thousands of citations to the medical literature over the last 10 years. Results from this work, which meld our wide-ranging experience in transdisciplinary science, have important implications for advancing the science and real, practical implications for addressing cancer-related disparities that have consistently disfavor African Americans, a group that is uniquely metabolically obese (i.e., evince symptoms associated with obesity at lower levels of overall adiposity).",1946358 (contact);7955996;9245307,"HEBERT, JAMES R (contact);HOFSETH, LORNE J;MURPHY, ELIZABETH ANGELA","RISCUTA, GABRIELA",2022-08-16,2028-07-31,3 year old;Address;adenoma;Adipocytes;adiponectin;Adipose tissue;Adult;African American;African American population;Age Years;American;Animal Experiments;Animals;anti-cancer research;Anti-Inflammatory Agents;Antiinflammatory Effect;associated symptom;Bacteria;Biological Assay;C-reactive protein;Cancer Control;cancer epidemiology;cancer health disparity;Cancer Intervention;Cancer Model;cancer prevention;carcinogenesis;Cells;Child;Chronic;Clinical Trials;Colon Carcinoma;Colorectal Cancer;colorectal cancer progression;colorectal cancer risk;Communication;Complement 2;Consumption;cytokine;Diet;dietary;Dietary Intervention;Disparity;early onset colorectal cancer;Enrollment;Epidemiology;epidemiology study;European;experience;experimental study;fecal transplantation;Goals;Grant;gut microbes;gut microbiota;Health;High Fat Diet;high risk;Human;human study;in vivo;Incidence;Inflammation;Inflammation Mediators;Inflammatory;inflammatory marker;Influentials;Infrastructure;Insulin;Insulin Resistance;Insulin-Like Growth Factor I;Interleukin-6;Intervention;Intervention Trial;intestinal barrier;Laboratory Animals;lifestyle intervention;Link;Literature;Macrophage;Malignant Neoplasms;Mediator;Medical;Metabolic;Metabolic dysfunction;microbiome;microbiome signature;microbiota;Modeling;mouse model;Obese Mice;Obesity;Obesity associated cancer;obesity in children;Outcome;Paper;Parents;Pathogenesis;Population;pre-clinical;prevent;programs;protective effect;protective factors;Publishing;Race;racial difference;racial identity;response;Risk;Role;Science;Somatomedins;South Carolina;Study models;System;systemic inflammatory response;Testing;TNF gene;tumorigenesis;Unhealthy Diet;Universities;Work,A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer,272977,ZCA1,ZCA1-SRB-2(M2),NA,S2,2,91221,44698,135919,NA
11183019,UG1,DA,5,N,2024-05-03,2024-03-01,2025-02-28,NA,UG1DA015815,NA,RFA-DA-20-024,5UG1DA015815-23,NIDA:61854\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,PORTLAND,UNITED STATES,NA,01,096997515,US,6297007,OREGON HEALTH & SCIENCE UNIVERSITY,OR,972393098,NA,1879450;8033018 (contact),"HUMPHREYS, KEITH N.;KORTHUIS, PHILIP TODD (contact)","DOBBINS, RONALD",2002-09-30,2025-02-28,addiction;Behavioral;Buprenorphine;California;Caring;Clinical Treatment;Clinical Trials;Clinical Trials Network;Clinics and Hospitals;Cluster randomized trial;Collaborations;Data Science;Drug abuse;Drug usage;Drug Use Disorder;Drug user;effectiveness/implementation trial;Electronic Health Record;experience;Future;Goals;Health;Health system;Healthcare;Helping to End Addiction Long-term;Hybrids;Hydromorphone;implementation trial;improved;Infrastructure;Intervention;Managed Care;Medicaid;medication for opioid use disorder;Methadone;methamphetamine use;Methamphetamine use disorder;mHealth;Mirtazapine;novel;Opiate Addiction;Opioid;opioid misuse;Oral;Oregon;peer;peer support;Persons;Pharmaceutical Preparations;Pharmacotherapy;phase III trial;Placebos;Primary Care;Protocols documentation;Public Health;Randomized;Research;Research Personnel;Resources;San Francisco;Science;Services;Site;Speed;success;Supervision;sustained recovery;Telephone;Testing;Training;trial comparing;Trillium;United States National Institutes of Health;Universities;Veterans;Vulnerable Populations,Project-003,15815,ZDA1,ZDA1-GXM-A(09)R,7869,NA,23,61854,0,NA,61854
11183040,UG1,DA,5,N,2024-05-03,2024-03-01,2025-02-28,NA,UG1DA015815,NA,RFA-DA-20-024,5UG1DA015815-23,NIDA:392559\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,PORTLAND,UNITED STATES,NA,01,096997515,US,6297007,OREGON HEALTH & SCIENCE UNIVERSITY,OR,972393098,NA,1879450;8033018 (contact),"HUMPHREYS, KEITH N.;KORTHUIS, PHILIP TODD (contact)","DOBBINS, RONALD",2002-09-30,2025-02-28,addiction;Behavioral;Buprenorphine;California;Caring;Clinical Treatment;Clinical Trials;Clinical Trials Network;Clinics and Hospitals;Cluster randomized trial;Collaborations;Data Science;Drug abuse;Drug usage;Drug Use Disorder;Drug user;effectiveness/implementation trial;Electronic Health Record;experience;Future;Goals;Health;Health system;Healthcare;Helping to End Addiction Long-term;Hybrids;Hydromorphone;implementation trial;improved;Infrastructure;Intervention;Managed Care;Medicaid;medication for opioid use disorder;Methadone;methamphetamine use;Methamphetamine use disorder;mHealth;Mirtazapine;novel;Opiate Addiction;Opioid;opioid misuse;Oral;Oregon;peer;peer support;Persons;Pharmaceutical Preparations;Pharmacotherapy;phase III trial;Placebos;Primary Care;Protocols documentation;Public Health;Randomized;Research;Research Personnel;Resources;San Francisco;Science;Services;Site;Speed;success;Supervision;sustained recovery;Telephone;Testing;Training;trial comparing;Trillium;United States National Institutes of Health;Universities;Veterans;Vulnerable Populations,Project-004,15815,ZDA1,ZDA1-GXM-A(09)R,7870,NA,23,392559,0,NA,392559
11183041,UG1,DA,5,N,2024-05-03,2024-03-01,2025-02-28,NA,UG1DA015815,NA,RFA-DA-20-024,5UG1DA015815-23,NIDA:183157\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,PORTLAND,UNITED STATES,NA,01,096997515,US,6297007,OREGON HEALTH & SCIENCE UNIVERSITY,OR,972393098,NA,1879450;8033018 (contact),"HUMPHREYS, KEITH N.;KORTHUIS, PHILIP TODD (contact)","DOBBINS, RONALD",2002-09-30,2025-02-28,addiction;Behavioral;Buprenorphine;California;Caring;Clinical Treatment;Clinical Trials;Clinical Trials Network;Clinics and Hospitals;Cluster randomized trial;Collaborations;Data Science;Drug abuse;Drug usage;Drug Use Disorder;Drug user;effectiveness/implementation trial;Electronic Health Record;experience;Future;Goals;Health;Health system;Healthcare;Helping to End Addiction Long-term;Hybrids;Hydromorphone;implementation trial;improved;Infrastructure;Intervention;Managed Care;Medicaid;medication for opioid use disorder;Methadone;methamphetamine use;Methamphetamine use disorder;mHealth;Mirtazapine;novel;Opiate Addiction;Opioid;opioid misuse;Oral;Oregon;peer;peer support;Persons;Pharmaceutical Preparations;Pharmacotherapy;phase III trial;Placebos;Primary Care;Protocols documentation;Public Health;Randomized;Research;Research Personnel;Resources;San Francisco;Science;Services;Site;Speed;success;Supervision;sustained recovery;Telephone;Testing;Training;trial comparing;Trillium;United States National Institutes of Health;Universities;Veterans;Vulnerable Populations,Project-005,15815,ZDA1,ZDA1-GXM-A(09)R,7871,NA,23,173224,9933,NA,183157
11183112,U54,CA,5,N,2024-09-04,2024-08-01,2025-07-31,NA,U54CA242977,NA,RFA-CA-18-018,5U54CA242977-07,NCI:328585\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,"FOREIGN JUSTIFICATION The funding opportunity announcement requires that we partner with Latin American/Caribbean countries. We  have chosen the Dominican Republic and Peru to partner with us. Dr. Robinson Ceballo at Via Libre, in Peru  will act as a multi-PI on this grant, Dr. Lenka Kolevic, at Via Libre, in Peru will co-chair Trial 1, and Dr. Yeyce  Donastorg at Instituto Dermatologico Dominicano y Cirugia, in Santo Domingo, Dominican Republic will co-chair Trials 2 and 3.",2478519 (contact),"MADELEINE, MARGARET M (contact)","FRECH, MARIA SILVINA",2019-09-18,2025-07-31,"Acetic Acids;Address;Adjuvant;Age;Algorithms;Area;automated visual evaluation;Biological Assay;booster vaccine;cancer prevention;Caribbean region;Cervical;cervical cancer prevention;Cervical Cancer Screening;Cervical Intraepithelial Neoplasia;Cessation of life;Child;Clinical;Clinical Trials;Colposcopy;Communities;Correlative Study;Country;Cytology;design;Detection;Disease;Disproportionately impacts women;Dominican Republic;Dose;Enrollment;experience;Funding Opportunities;girls;Goals;Grant;Health;high risk;HIV;HIV Infections;HPV E7;Human papilloma virus infection;Human Papilloma Virus Vaccination;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Imaging technology;Immune;Immunoprevention;implementation facilitation;Improve Access;improved;improved outcome;Incidence;Infrastructure;International;Latin America;Latin American;Lesion;Licensing;low and middle-income countries;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Measures;Memory B-Lymphocyte;Methods;Monoclonal Antibodies;new technology;novel;Operative Surgical Procedures;Outcome;overtreatment;Pap smear;Papillomavirus Transforming Protein E6;Participant;Patients;Persons;Peru;point of care;Population;Populations at Risk;premalignant;prevent;Prevention;prevention service;programs;progression risk;Provider;Quality of life;Randomized, Controlled Trials;Recurrence;Regimen;Repeat Surgery;Reproducibility;Research;Resources;response;Risk;Schedule;screening;Sirolimus;Site;standard of care;Testing;Time;treatment strategy;Triage;tumor microenvironment;Vaccination;Vaccines;Visual;Woman;women&apos;s diagnosis;Youth",Clinical Trials Program,242977,ZCA1,ZCA1-RTRB-R(M2),6471,NA,7,222331,106254,NA,328585
11183113,U54,CA,5,N,2024-09-04,2024-08-01,2025-07-31,NA,U54CA242977,NA,RFA-CA-18-018,5U54CA242977-07,NCI:273439\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,NA,12598528 (contact),"DASGUPTA, SAYAN  (contact)","FRECH, MARIA SILVINA",2019-09-18,2025-07-31,Address;Age;Algorithms;Appointment;automated visual evaluation;Bioinformatics;Biometry;cancer prevention;Caribbean region;cervical cancer prevention;Child;clinical center;Clinical Data;clinical database;Clinical Trials;Clinical Trials Unit;co-clinical trial;Collaborations;collaborative environment;Colposcopy;Communicable Diseases;Data;Data Collection;data management;Data Management Resources;design;Dominican Republic;Dose;electronic data;Enrollment;Ensure;Epidemiology;flexibility;Goals;Health Sciences;HIV;HIV/AIDS;HPV E7;Human Papilloma Virus Vaccination;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Immune;immunogenicity;Immunotherapy;improved;Individual;Information Dissemination;Infrastructure;innovation;International;Interruption;Latin America;Leadership;Lesion;Malignant neoplasm of cervix uteri;member;Methods;Mission;Monitor;new technology;Operative Surgical Procedures;Pap smear;Papillomavirus Transforming Protein E6;Persons;Peru;Physical environment;Play;point of care;Politics;premalignant;Prevention;Prevention Research;Preventive Medicine;primary endpoint;professor;programs;Public Health;Publications;Reporting;Research;Resource-limited setting;response;Role;Safety;Schedule;Science;Scientific Advances and Accomplishments;screening;secondary endpoint;Secure;Security;Services;Sirolimus;standard of care;statistical center;Statistical Data Interpretation;Statistical Methods;Testing;Time;tool;treatment strategy;Triage;trial design;Universities;Vaccination;Vaccines;Visual;Vulnerable Populations;Washington;Woman;women&apos;s diagnosis;Work;Youth,Data Management and Statistical Core,242977,ZCA1,ZCA1-RTRB-R(M2),6473,NA,7,160119,113320,NA,273439
11183114,U54,CA,5,N,2024-09-04,2024-08-01,2025-07-31,NA,U54CA242977,NA,RFA-CA-18-018,5U54CA242977-07,NCI:99618\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,NA,10194844 (contact),"CARTER, JOSEPH JOHN (contact)","FRECH, MARIA SILVINA",2019-09-18,2025-07-31,Anatomy;Anogenital cancer;anti-tumor immune response;Antibodies;Award;Binding;Biological;Biological Assay;Biological Specimen Banks;biomarker development;Biopsy;Blood specimen;Board Certification;cancer prevention;Cells;Cervical;Clinical Data;clinically relevant;Collection;Communication;Complex;Correlative Study;DNA Viruses;Drug or chemical Tissue Distribution;Ensure;epidemiology study;experience;Fred Hutchinson Cancer Research Center;Future;Genotype;Grant;high risk;Histology;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human Resources;Immune;Immune Tolerance;Immunohistochemistry;Immunooncology;immunopathology;Industry;Institution;Laboratories;laboratory experience;Laboratory Research;Laboratory Scientists;Laboratory Study;Leadership;Malignant Neoplasms;Memory B-Lymphocyte;Mission;Names;Papillomavirus;Pathologist;Pathology;Peripheral Blood Mononuclear Cell;Phenotype;Play;predicting response;Procedures;Protocols documentation;quality assurance;Quality Control;Recurrence;Research Personnel;Resource Sharing;response;Role;Running;Sampling;Sampling Studies;Serology test;Services;Shipping;Site;Specific qualifier value;Specimen;Stress;Techniques;Technology Transfer;Testing;Tissue Banks;Tissue Sample;Tissues;Training;tumor;tumor microenvironment;Work,Central Laboratory Core,242977,ZCA1,ZCA1-RTRB-R(M2),6474,NA,7,58334,41284,NA,99618
11183115,U54,CA,5,N,2024-09-04,2024-08-01,2025-07-31,NA,U54CA242977,NA,RFA-CA-18-018,5U54CA242977-07,NCI:192152\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,N/A,10786855;2068561;2478519 (contact),"CABELLO, ROBINSON ;DUERR, ANN C;MADELEINE, MARGARET M (contact)","FRECH, MARIA SILVINA",2019-09-18,2025-07-31,Acetic Acids;Address;Age;Algorithms;automated visual evaluation;cancer prevention;Caribbean region;Cervical;cervical cancer prevention;Cervical Cancer Screening;Cessation of life;Child;Clinical Trials;Colposcopy;Communities;Detection;Diagnosis;Disproportionately impacts women;Dominican Republic;Dose;Enrollment;experience;Goals;Health;high risk;HIV;HIV Infections;HPV E7;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Imaging technology;Immune;Immunoprevention;implementation facilitation;Improve Access;improved;improved outcome;Incidence;Infrastructure;International;Latin America;Lesion;low and middle-income countries;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Methods;new technology;Operative Surgical Procedures;overtreatment;Pap smear;Papillomavirus Transforming Protein E6;Patients;Persons;Peru;point of care;Population;Populations at Risk;premalignant;prevent;Prevention;programs;progression risk;Provider;Quality of life;Research;Resources;response;Schedule;screening;Sirolimus;Site;standard of care;Testing;Time;treatment strategy;Triage;Vaccination;Visual;Woman;Youth,Project-001,242977,ZCA1,ZCA1-RTRB-R(M2),6476,NA,7,175462,16690,NA,192152
11183116,U54,CA,5,N,2024-09-04,2024-08-01,2025-07-31,NA,U54CA242977,NA,RFA-CA-18-018,5U54CA242977-07,NCI:389520\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,N/A,10786855;2068561;2478519 (contact),"CABELLO, ROBINSON ;DUERR, ANN C;MADELEINE, MARGARET M (contact)","FRECH, MARIA SILVINA",2019-09-18,2025-07-31,Acetic Acids;Address;Age;Algorithms;automated visual evaluation;cancer prevention;Caribbean region;Cervical;cervical cancer prevention;Cervical Cancer Screening;Cessation of life;Child;Clinical Trials;Colposcopy;Communities;Detection;Diagnosis;Disproportionately impacts women;Dominican Republic;Dose;Enrollment;experience;Goals;Health;high risk;HIV;HIV Infections;HPV E7;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Imaging technology;Immune;Immunoprevention;implementation facilitation;Improve Access;improved;improved outcome;Incidence;Infrastructure;International;Latin America;Lesion;low and middle-income countries;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Methods;new technology;Operative Surgical Procedures;overtreatment;Pap smear;Papillomavirus Transforming Protein E6;Patients;Persons;Peru;point of care;Population;Populations at Risk;premalignant;prevent;Prevention;programs;progression risk;Provider;Quality of life;Research;Resources;response;Schedule;screening;Sirolimus;Site;standard of care;Testing;Time;treatment strategy;Triage;Vaccination;Visual;Woman;Youth,Project-002,242977,ZCA1,ZCA1-RTRB-R(M2),6477,NA,7,237757,151763,NA,389520
11183152,R01,FD,3,N,2024-09-05,2022-09-20,2025-08-31,103,R01FD007630,SCHOOLS OF MEDICINE,RFA-FD-22-001,3R01FD007630-01S2,FDA:1500000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,MINNEAPOLIS,UNITED STATES,NEUROLOGY,05,555917996,US,1450402,UNIVERSITY OF MINNESOTA,MN,554552070,"PROJECT NARRATIVE – PUBLIC HEALTH RELEVANCE The Clinic-based Multicenter ALS Natural History Data Collection provides critical information about medical history, ALS subtypes, and ALS progression in study participants. The project is deliberately inclusive so as to provide information that is as representative as possible of all people living with ALS. This information will be used by scientists, clinicians, and drug developers to help them improve care, design clinical trials, and assess outcomes in all people living with ALS.",8615347 (contact),"WALK, DAVID  (contact)","XU, LEI",2022-09-20,2027-08-31,NA,Clinic-based Multicenter ALS Natural History Data Collection,7630,ZFD1,ZFD1-OC-S(01)1,NA,S2,1,1150808,349192,1500000,NA
11183153,U24,OD,3,N,2024-09-10,2024-06-01,2025-05-31,310,U24OD023319,SCHOOLS OF MEDICINE,RFA-OD-22-020,3U24OD023319-07S1,OD:2000000\,OTHER RESEARCH-RELATED,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CHICAGO,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,05,005436803,US,6144650,NORTHWESTERN UNIVERSITY AT CHICAGO,IL,606114579,"Environmental exposures profoundly shape lifespan health and disease trajectories. The ECHO Measurement Core will advise, orchestrate, and frame the coordinated, sensitive measurement of exposures, developmental processes, and health outcomes central to achieving ECHO's objective of mapping the impact of early exposures on child health and development. We will develop and refine measures for the ECHO Cohort Protocol (ECP), including methods to implement the measures that are culturally sensitive and valid for diverse populations, assist the ECHO Consortium in implementing and evaluating the ECP, and we will lead strategic decision-making and operational strategies to incorporate new and revised measures to advance ECHO Cohort science while minimizing participant and staff burden.",1865141 (contact);9468639,"CELLA, DAVID  (contact);GERSHON, RICHARD","MASH, CLAY",2016-09-21,2030-05-31,Adoption;Adult;Brain;Child Development;Child Health;Clinical Research;cohort;Cohort Studies;Collaborations;Collection;Communication;Computers;Conceptions;Data;Data Analyses;Data Collection;Data Element;data harmonization;Decision Making;Dedications;Detection;Development;Developmental Process;Disease;Ensure;Environmental Exposure;Environmental Risk Factor;flexibility;Foundations;Goals;Health;implementation fidelity;implementation strategy;improved;innovation;instrument;Investigation;Lead;life span;Link;Manuals;Maps;Measurement;Measures;Methods;mindfulness;Monitor;neurodevelopment;novel;Obesity;Outcome;Participant;participant retention;Perinatal Exposure;Personal Satisfaction;Persons;Population Heterogeneity;postnatal;preclinical study;Predisposition;Procedures;Process;Protocols documentation;Psychometrics;Public Health;Publications;remote assessment;Reproducibility;Resources;Respondent;Risk;Science;Scientist;Shapes;Site;sound;Specific qualifier value;Standardization;standardize measure;Structure;Support System;System;Technology;Testing;Time;Training;Visit;wearable sensor technology;Work,The ECHO Measurement Core: A Framework and Resource for Assessing Environmental Exposure and Child Health,23319,ZRG1,Special Emphasis Panel[ZRG1-EPH-G(51)R],NA,S1,7,1684886,315114,2000000,NA
11183295,R33,HL,3,N,2024-09-07,2024-09-01,2025-08-31,837,R33HL155498,SCHOOLS OF PHARMACY,PAR-19-328,3R33HL155498-04S1,NHLBI:214672\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,ANN ARBOR,UNITED STATES,PHARMACOLOGY,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"PROJECT NARRATIVE High dietary sodium intake is linked to incident hypertension (HTN) and cardiovascular events. Conversely, lower sodium intake has been shown to reduce both blood pressure (BP) and prevent atherosclerotic cardiovascular diseases (ASCVD). American Heart Association guidelines advocate daily sodium intake of less than 2,300 mg, but the estimated average sodium intake for Americans is 3,400 mg per day. In recent years, consumption of pre-processed and restaurant foods has substantially increased, and more than 75% of sodium in the average U.S. diet now comes from these sources. Our overall objectives are to: (1) evaluate the efficacy of a dietary sodium mobile application intervention on reducing BP, (2) establish that the improvement in BP is directly related to the change in diet and body weight, and (3) optimize the intervention to demonstrate sustained effects on BP.",9367645 (contact);6108961,"DORSCH, MICHAEL  (contact);NALLAMOTHU, BRAHMAJEE K","MINTZER, KEITH A",2022-09-05,2026-08-31,"adaptive intervention;Adherence;Advocate;American;American Heart Association;Atherosclerosis;Blood Pressure;blood pressure reduction;Body Weight;Calories;Cardiovascular system;Chronic;Clinical;Consumption;Data;Development;Diagnosis;Diet;dietary;Dietary Component;Dietary Sodium;digital health;Disease;Education;efficacy evaluation;Electronic Health Record;Event;Food;Fostering;Future;Goals;group intervention;Guidelines;habituation;Health behavior;Home;Home Blood Pressure Monitoring;Hypertension;hypertensive;improved;Intake;Intervention;intervention effect;Knowledge;Learning;Life Style;Link;Measures;Mediating;Mediator;Medicine;Michigan;mobile application;Morbidity - disease rate;Notification;novel;nutrition;Participant;participant enrollment;patient engagement;Patient Recruitments;Patients;Potassium;prevent;Probability;Process;programs;prospective;Psychological reinforcement;Randomized;randomized trial;Randomized, Controlled Trials;Research;Restaurants;Self Management;Sodium;Sodium-Restricted Diet;Source;Technology;Testing;theories;Time;tool;trend;wearable device;wireless;Work",A Just-In-Time Adaptive Mobile Application Intervention To Reduce Sodium Intake And Blood Pressure In Hypertensive Patients,155498,SSPT,NHLBI Single-Site and Pilot Clinical Trials Study Section[SSPT(MA)],NA,S1,4,137610,77062,214672,NA
11183413,R56,AG,1,N,2024-09-25,2024-09-30,2025-08-31,866,R56AG083478,SCHOOLS OF MEDICINE,PA-20-185,1R56AG083478-01A1,NIA:866723\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON AGING,NA,BALTIMORE,UNITED STATES,NEUROSCIENCES,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"Correlating structural changes in the region of the brain caused by cognitive impairment with those in shape and molecular in the same region will be important for understanding cognition in aging. In turn, this may help to understand pathological changes associated with cognitive impairment. Such analysis is challenging and can be analyzed by powerful tools that consistently preserve information across scales from the macroscopic one of magnetic resonance scans to the microscopic scales of histologic images and molecular changes.",7062427 (contact);10363652,"MILLER, MICHAEL I (contact);MORRIS, MEAGHAN O'MALLEY","ROVESCALLI, ALESSANDRA C",2024-09-30,2026-08-31,3-Dimensional;abeta deposition;Affect;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease pathology;Alzheimer&apos;s disease patient;Alzheimer’s disease biomarker;American;Amyloid beta-Protein;Anatomy;Area;Atlases;Atrophic;Autopsy;Biological;Brain;Brain region;cell type;Cells;cerebral atrophy;Chronic Disease;Clinical;Cognition;Cognitive;Dementia;Development;digital;Disease;Disease Progression;entorhinal cortex;Exhibits;experience;Future;Gene Expression;Gene Expression Profile;Genetic Transcription;Goals;Histologic;histological image;Image;Impaired cognition;in vivo;indexing;Individual;insight;Investigation;Knowledge;Lateral;Learning;Lesion;Link;Location;Longitudinal Studies;Machine Learning;Magnetic Resonance;Magnetic Resonance Imaging;magnetic resonance imaging biomarker;Maps;Measures;Medial;medial temporal lobe;Memory;meter;Microscopic;mild cognitive impairment;millimeter;minimally invasive;Molecular;Molecular Profiling;morphometry;MRI Scans;Neurites;Neurobehavioral Manifestations;Neurofibrillary Tangles;Neurons;neuropathology;novel;Outcome;Pathologic;Pathology;Pattern;Population;population based;Positioning Attribute;Postmortem Changes;pre-clinical;Predisposition;preservation;progression marker;Protocols documentation;reconstruction;regional atrophy;Scanning;Shapes;Spatial Distribution;Staging;Symptoms;System;tau aggregation;tau Proteins;Technology;Temporal Lobe;Testing;Thick;Time;tool;transcriptome;transcriptomics;Work,Multi-scale MRI-based Diffeomorphometry of Pathology and Molecular Signatures Associated with Entorhinal Cortex Atrophy in Alzheimer's Disease,83478,CNN,Clinical Neuroscience and Neurodegeneration Study Section[CNN],NA,A1,1,563789,302934,866723,NA
11183528,K25,AI,7,N,2024-11-12,2024-11-12,2025-07-31,855,K25AI177810,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7K25AI177810-02,NIAID:120258\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,LEXINGTON,UNITED STATES,CHEMISTRY,06,939017877,US,2793601,UNIVERSITY OF KENTUCKY,KY,405260001,"Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), the causative agent of the Covid-19 pandemic, infects the host cell by binding its spike protein with the angiotensin-converting enzyme 2 (ACE2) on the host receptor cells. Structurally, spike protein has two subunits, S1 and S2, and is a trimer, while the ACE2 protein is a homodimer; however, critical questions about the dynamics of the molecular interactions to activate the membrane fusion remain. This project will determine the dynamics of each molecular interaction associated with the SARS-CoV-2 entry, thus helping to design more effective countermeasures.",15362631 (contact),"SHRESTHA, PRAKASH  (contact)","PLIMACK, MARY KATHERINE BRADFORD",2024-07-11,2029-07-31,NA,Understand the mechanism of SARS-CoV-2 entry by single-molecule approaches,177810,MID,Microbiology and Infectious Diseases Advisory Committee[MID],NA,NA,2,111350,8908,120258,NA
11183570,U54,CA,3,N,2024-09-06,2024-09-01,2025-08-31,NA,U54CA267789,NA,PA-20-272,3U54CA267789-04S1,NCI:371315\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SAN DIEGO,UNITED STATES,NA,51,073371346,US,513614,SAN DIEGO STATE UNIVERSITY,CA,921821901,NA,7985252 (contact),"ZUNIGA DE NUNCIO, MARIA LUISA (contact)","HUSSAIN, SHADAB FATIMA",2021-09-21,2026-08-31,"Academia;Academy;Acceleration;Achievement;addiction;Address;Area;Biomedical Research;career;career life balance;Climate;cohort;college;Communities;community building;community engaged research;Community Networks;community partners;Coupled;curriculum development;Dedications;Development Plans;Disparity;Diverse Workforce;Educational Curriculum;Ensure;Environment;Environmental Health;Equity;equity, diversity, and inclusion;ethnic minority;Event;evidence base;Faculty;faculty community;faculty mentor;faculty research;faculty support;Fostering;Funding;Geography;Goals;Grant;Growth;Health;health disparity;Health Sciences;Human;implementation science;improved;Individual;Institution;Intervention;Knowledge;Latinx;Leadership;Life;Longitudinal cohort;Manuscripts;Mediation;member;Mentors;Mentorship;Mexico;Mind;Minority Health Research;minority scientist;model development;Modeling;Nutritional Study;Obesity;peer;peer coaching;peer networks;Personal Satisfaction;Persons;Physical activity;Positioning Attribute;Privatization;Productivity;programs;racial minority;Recommendation;recruit;Reporting;Research;research and development;research faculty;Research Personnel;Research Training;Resource Development;Resources;retention rate;Role;satisfaction;Schools;Science;Seasons;Self Efficacy;senior faculty;Services;skill acquisition;skills;Spanish;Structure;success;Syndrome;Teacher Professional Development;Time;tool;Training;Training Programs;Underrepresented Minority;United States National Institutes of Health;Universities;Work;Writing",SDSU FUERTE: Faculty Development Core,267789,ZRG1,Special Emphasis Panel[ZRG1],8498,S1,4,246721,124594,NA,371315
11183667,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000139,NA,NA,1ZIAAA000139-02,NIAAA:403983\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78351012 (contact),"JOSEPH, PAULE  (contact)",NA,NA,NA,Affect;Alcohol abuse;Alcohol consumption;alcohol use disorder;Alcohols;Area;Behavior;Biological;Biological Markers;Blood;chronic alcohol ingestion;Clinic;clinical center;Collaborations;comorbidity;Data Collection;design;Development;disorder risk;Enrollment;Equipment and Supplies;Esthesia;exosome;experience;falls;Future;Genotype;gut microbiota;Hour;Human;Impairment;improved;Individual;individual variation;Inflammation;inflammatory marker;innovation;Institutional Review Boards;Measures;Metabolic hormone;microbiome composition;microbiota;National Institute on Alcohol Abuse and Alcoholism;Natural History;Neurons;Nose;operation;oral microbiome;Participant;Perception;Phenotype;prevent;primary endpoint;Public Health;recruit;Reporting;Research;Risk Factors;Saliva;Salivary;Sampling;screening;secondary endpoint;Sensory;sensory system;Series;Shapes;Signal Transduction;Smell Perception;System;Taste Perception;Testing;Texture;tool;Training;United States National Institutes of Health;Variant;Visit,Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD),139,NA,NA,NA,NA,2,NA,NA,403983,NA
11183668,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000140,NA,NA,1ZIAAA000140-01,NIAAA:80796\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78351012 (contact),"JOSEPH, PAULE  (contact)",NA,NA,NA,absorption;Adult;Affect;Age Years;Animals;bariatric surgery;Body Composition;Body Weight decreased;Caffeine;Carbonates;Cardiovascular Diseases;Child;Consumption;Cross-Sectional Studies;Data;Diabetes Mellitus;Diet;Dose;Energy Intake;Enteroendocrine Cell;Family;fatty liver disease;Gastrointestinal tract structure;glucagon-like peptide 1;Glucose;Glucose Transporter;GLUT-2 protein;gut microbiome;Gut Mucosa;healthy volunteer;Hormones;Human;Human Milk;impaired glucose tolerance;Individual;Infant;inhibitor;Insulin Resistance;insulin secretion;Intake;Intestines;L Cells;Link;Lung;Measures;Mediating;Mediator;Metabolic;Metabolic syndrome;Metabolism;microbiome;obesity development;OGTT;Organ;Oropharyngeal;Participant;Persons;Pharmaceutical Preparations;Pharmacy facility;Pilot Projects;Play;Potassium;Protocols documentation;Randomized;rat Gnat3 protein;receptor;Receptor Activation;Research Design;response;Role;Saliva;soft drink;Structure of beta Cell of islet;Sucrose;sugar;sweet taste perception;Sweetening Agents;Taste Buds;Taste Perception;Taste preferences;Testing;Tissues;Tongue;trend;United States National Institutes of Health;Up-Regulation;Water;Weight;Weight Gain,Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study),140,NA,NA,NA,NA,1,NA,NA,80796,NA
11183669,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000301,NA,NA,1ZIAAA000301-26,NIAAA:5808197\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,9413251 (contact),"GOLDMAN, DAVID  (contact)",NA,NA,NA,Acceleration;Accounting;addiction;African American;Aggressive behavior;Aging;Alcohol dependence;alcohol exposure;alcohol response;alcohol use disorder;Alcohol withdrawal syndrome;Alcoholic Hepatitis;Alcohols;Alleles;American Indian Women;Animal Model;Animals;Anterior;anti social;Antipsychotic Agents;Anxiety;Articulation;Autopsy;Behavior;Behavioral;Behavioral Genetics;Brain;Brain imaging;Brain-Derived Neurotrophic Factor;Cell model;Cells;Child;chronic pain;Cirrhosis;Clinical;clinical phenotype;Cocaine;Cognition;Cognitive deficits;cognitive function;Collection;comparative genomics;Corpus striatum structure;Craniocerebral Trauma;craving;Cyclic AMP;decrease resilience;Development;Diagnosis;Diazepam;Disadvantaged;DISC1 gene;Disease;Dopamine;Dopamine D2 Receptor;Dorsal;dosage;DRD2 gene;Drosophila genus;Drug usage;Electroencephalography;Embryo;Emotional;Emotions;Endocrine;Epigenetic Process;Epilepsy;Episodic memory;exome;exome sequencing;externalizing behavior;Family;fatty acid amide hydrolase;Fetal alcohol effects;Founder Generation;functional genomics;gamma-Aminobutyric Acid;Gene Cluster;gene discovery;gene environment interaction;gene network;Genes;Genetic;genetic architecture;Genetic Polymorphism;Genetic study;Genetic Variation;genome wide association study;genome-wide;Genotype;Glutamates;Goals;Growth;GTP Cyclohydrolase;Haplotypes;Hepatocyte;Heritability;high throughput technology;HTR2A gene;Human;imaging genetics;Impulsive Behavior;induced pluripotent stem cell;Inherited;International;Investigation;Knock-out;Knockout Mice;Knowledge;Link;Liver diseases;Locomotion;lymphoblastoid cell line;Maps;Massive Parallel Sequencing;Measures;Medicine;Mental Depression;Mental disorders;Metabolic;metabotropic glutamate receptor 2;Methaqualone;Methods;methylome;Minisatellite Repeats;model organism;Modeling;Molecular;Mus;Naltrexone;National Institute on Alcohol Abuse and Alcoholism;Natural History;Nature;Neurobiology;Neuroglia;neuroimaging;neuroinflammation;neuropeptide Y;Neurosciences;Nicotine;Nicotine Dependence;Nicotine Use Disorder;novel;opioid use disorder;Outcome;Ovarian;Pain;Pathway interactions;Patients;pediatric trauma;Perimenopause;Persons;Pharmaceutical Preparations;Phenotype;Physiological;Placebo Effect;Population;Populations at Risk;Poverty;predictive modeling;preference;Prefrontal Cortex;premenstrual dysphoric disorder;promoter;prospective;Proteins;Rattus;response;Risk;Risk Factors;risk variant;RNA;Role;Sampling;Schizophrenia;schizophrenia risk;Science;serotonin transporter;Sexual abuse;Source;Steroids;Stress;Structure;Study models;Substance Use Disorder;suicidal;Technology;Terminator Codon;Testosterone;theories;trait;transcriptomics;Translational Research;transmission process;treatment response;Variant;Wistar Rats;Withdrawal;Woman,Integrative genetics of behavior with high throughput technologies,301,NA,NA,NA,NA,26,NA,NA,5808197,NA
11183670,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000344,NA,NA,1ZIAAG000344-06,NIA:14438\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,"abeta deposition;Adherence;Adopted;Adult;Age-associated memory impairment;aged;Aging;Alzheimer disease prevention;Alzheimer&apos;s Disease;Alzheimer&apos;s disease brain;Alzheimer&apos;s disease pathology;Alzheimer&apos;s disease risk;Amyloid deposition;Amyloid Proteins;Animals;Atrophic;Attenuated;Behavior;Biological Markers;Body Weight;Brain Pathology;brain tissue;Carbohydrates;Cells;Cellular Stress;Cerebrospinal Fluid;Clinical;Clinical Trials;Cognition;Cognitive;cohort;Consumption;Cytoprotection;Dairying;Data;design;Development;Diet;dietary adherence;Dietary Fiber;Dietary Intervention;Disease;Disease Marker;Disease Outcome;Elderly;Electrons;Environment;Epigenetic Process;Fabaceae;Failure;Fatty acid glycerol esters;Flavin Mononucleotide;Flavin-Adenine Dinucleotide;Fruit;fruits and vegetables;Genes;genetic manipulation;Glucose;Goals;good diet;gut microbiome;Health;Health Personnel;healthy aging;Histologic;Human Amyloid Precursor Protein;Impaired cognition;Individual;Inflammaging;Inflammation;Inflammatory;Language;learning ability;lifestyle factors;lipidomics;Magnetic Resonance Imaging;man;Manuscripts;Mediating;Mediterranean Diet;Memory;Metabolic;metabolomics;Methodology;middle age;Molecular;Molecular Target;mouse model;Mus;mutant;Mutation;NADP;Nerve Degeneration;Neurodegenerative Disorders;Neurofibrillary Tangles;Neurology;neuron loss;novel;novel strategies;nutrition;Nutritional;Nuts;Observational Study;Older Population;Outcome;overexpression;Oxidoreductase;Pathway interactions;phase 1 study;Phenotype;Physiological;Plant Components;Population;presenilin-1;prevent;Prevention;Preventive;Processed Meats;Prospective, cohort study;protein expression;Quinones;Regimen;Research;Research Personnel;Riboflavin;Role;Senile Plaques;Serum;Source;tau Proteins;Testing;Thinking;Time;tool;treatment strategy;Vegetables;Weaning;western diet;Woman;World Health Organization",Cross-Translational nutritional interventions for Alzheimer's Disease: from man to mouse,344,NA,NA,NA,NA,6,NA,NA,14438,NA
11183671,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000356,NA,NA,1ZIAAG000356-12,NIA:3492346\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690896 (contact),"MATTISON, JULIE  (contact)",NA,NA,NA,Age;age related decline;Aging;aging biomarker;AMD3100;Anesthesia procedures;Attenuated;Binding;Biological;Biological Assay;biomarker development;Blood;Blood Component Removal;Bone Marrow;Bone marrow biopsy;Cardiovascular Diseases;cardiovascular risk factor;Cell membrane;Cell Volumes;Cells;Central Nervous System;Clinical;Clinical Treatment;Collection;Complex;Complication;CXCR4 gene;Development;diabetes management;Diabetes Mellitus;Diagnostic;Disease;Drug Compounding;Ensure;Environmental Risk Factor;Enzymes;Epigenetic Process;epigenetic regulation;Exercise;FDA approved;Genetic;Genetic Predisposition to Disease;Goals;Granulocyte Colony-Stimulating Factor;gut microbiome;Harvest;Health Status;Hematopoietic Stem Cell Mobilization;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hormones;Human;Immune response;improved;Incidence;Individual;Inflammatory;Inflammatory Response;Intervention;Intervention Studies;Intervention Trial;Learning;life span;Life Style;Liver diseases;Macaca mulatta;Malignant Neoplasms;Marketing;Mediating;Medicine;Memory;Metabolic dysfunction;Metabolism;migration;Monkeys;multiple omics;Muscle;Muscle function;Muscle Proteins;muscle strength;Non-Insulin-Dependent Diabetes Mellitus;nonhuman primate;novel;novel therapeutics;Obesity;obesity treatment;Outcome Measure;Pathogenesis;Pathway interactions;peripheral blood;Pharmaceutical Preparations;Physical activity;Physiological;Population;Post-Translational Protein Processing;Prediabetes syndrome;preservation;Procedures;Process;programs;Protein Biosynthesis;Proteins;Protocols documentation;rapid growth;receptor;Recovery;Research;Resources;Rhesus;Risk Factors;RNA;RNA Splicing;Role;Running;sedentary;side effect;small molecule;Testing;Therapeutic;therapeutic target;Time;Tissues;Training;treadmill;Vascular blood supply,Aging Intervention Studies,356,NA,NA,NA,NA,12,NA,NA,3492346,NA
11183672,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000361,NA,NA,1ZIAAG000361-16,NIA:63369\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,Adherence;age-related disease;Aging;aging mechanism;Animals;Antioxidants;attenuation;Binding;Bioenergetics;Biological;biological adaptation to stress;Caenorhabditis elegans;Caloric Restriction;carcinogenesis;Carcinogens;Cell membrane;Cell Nucleus;Characteristics;Chemical Agents;Chemopreventive Agent;Coupled;Curcumin;Cytoplasm;Cytoprotection;Development;Diet;Dietary Intervention;dietary restriction;Drosophila genus;Drug Metabolic Detoxication;Electron Transport;Energy Intake;Environment;environmental agent;Enzymes;Equilibrium;Exposure to;extend lifespan;Fasting;feeding;Formulation;functional decline;Genes;Genetic Transcription;Gerontology;Glutathione S-Transferase;Goals;Health;heme oxygenase-1;Human;improved;Insulin;insulin sensitivity;Insulin-Like Growth Factor I;Investments;Knock-out;Knockout Mice;Laboratories;Laboratory Rat;life span;Longevity;Malignant Neoplasms;Mammals;Metformin;mimetics;Mitochondria;Molecular;Mouse Strains;Mus;mutant;Mutation;Neurons;NF-E2-related factor 2;Nuclear;Oxidation-Reduction;Oxidative Stress;Oxidoreductase;Pathway interactions;pharmacologic;Phenotype;Phosphorylation;Physiological;Phytochemical;Prevention strategy;Production;Publishing;Quercetin;Quinones;Regulation;response;Response Elements;Resveratrol;Role;sex;Signal Transduction;Sirtuins;Stress;stress reduction;System;Tissues;transcription factor;Transplantation;tumor,NRF2 interactions with SIRT1 and its role on caloric restriction,361,NA,NA,NA,NA,16,NA,NA,63369,NA
11183673,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000362,NA,NA,1ZIAAG000362-17,NIA:133779\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,3&apos; Untranslated Regions;3T3-L1 Cells;Acetylation;adduct;adipocyte differentiation;Adipocytes;age related decline;aged;Aging;animal facility;Animal Model;Animals;Antioxidants;Binding;Binding Proteins;Bioenergetics;Biological;Biological Assay;Biological Models;blood glucose regulation;Body Composition;Caloric Restriction;Cell membrane;Cell model;Cells;Chromatin Structure;Chronic;Chronic Obstructive Pulmonary Disease;Chronology;Code;cofactor;Collaborations;combat;cytochrome b5 reductase;Data;Deacetylase;Deacetylation;design;Diabetes Mellitus;Diet;diet-induced obesity;Dietary Intervention;Disease;DNA Repair;Electron Transport;Energy Metabolism;Enzymes;Equilibrium;Ethanol;extend lifespan;Family;Family member;Fatty acid glycerol esters;Fatty Acids;Gene Transfer Techniques;Generations;Genetic;Genetic Transcription;Genus Hippocampus;glucose metabolism;Health;HepG2;High Fat Diet;Histologic;Histones;Homologous Gene;Human;Immunoprecipitation;improved;Inflammation;Inflammatory;insight;insulin regulation;Insulin Resistance;insulin sensitivity;Intervention;Knock-out;knockout animal;Laboratories;life span;Link;lipid biosynthesis;lipid metabolism;Lipid Peroxidation;Lipids;Liver Cirrhosis;Longevity;Maintenance;Mammals;Mediating;Mediator;member;Membrane;Messenger RNA;Metabolic;Metabolic Diseases;Metabolic dysfunction;Metabolic syndrome;Metabolism;Microarray Analysis;mimetics;Mitochondria;mitochondrial membrane;Modeling;mouse model;Mus;NADH;non-histone protein;novel;NQO1 gene;Nutrient;Nutritional;Obesity;Obesity associated disease;obesogenic;Outcome;overexpression;Oxidation-Reduction;Oxidative Stress;Oxidoreductase;Pathway interactions;pharmacologic;Phospholipids;Physiological;Physiology;preservation;prevent;Prevention;Primary carcinoma of the liver cells;Production;protein degradation;protein expression;protein function;pyridine nucleotide;Quinones;Rattus;Regulation;Reporting;Resistance;respiratory;response;Ribonucleoproteins;RNA-Binding Proteins;Role;Saccharomyces cerevisiae;Serine Proteinase Inhibitors;Signal Transduction;SIRT1 gene;Sirtuins;Small Interfering RNA;Stress;System;Tissues;tool;Transgenic Mice;Transgenic Organisms;Translations;Trypsin;Ubiquinone;Up-Regulation;Work;Yeasts,Aging and CR effects on the Plasma Membrane Redox System,362,NA,NA,NA,NA,17,NA,NA,133779,NA
11183674,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000363,NA,NA,1ZIAAG000363-17,NIA:1070235\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,1 year old;5&apos;-AMP-activated protein kinase;Address;Adipocytes;Adipose tissue;Affect;Age of Onset;age related;age related decline;Age related pathologies;age-related disease;Aging;aging mechanism;aging process;Agreement;Albuminuria;Animal Feed;Animals;Antioxidants;Aorta;Apoptosis;Behavior Therapy;Behavioral;Body Weight;Bone Density;bone preservation;Caloric Restriction;Calories;Cardiovascular Diseases;Cardiovascular Physiology;Cataract;Cholesterol;Chronic;Clinic;Cognition;comorbidity;comparison control;comparison intervention;Consensus;Coupled;Data;Diet;diet-induced obesity;Dietary Intervention;Disulfiram;Dose;Elasticity;Elderly;Endocrinology;Energy Intake;Energy Metabolism;epidemiologic data;Evaluation;Exercise;extend lifespan;Fatty acid glycerol esters;Fatty Liver;feeding;Female;functional decline;functional improvement;Gender;Gene Expression Profile;genetic manipulation;Genetic Transcription;Gerontology;glucose metabolism;Goals;Health;Health Benefit;healthspan;healthy aging;Human;Hypertrophy;improved;in vivo;Incidence;Inflammation;Inflammatory;Insulin;Insulin Resistance;insulin sensitivity;interest;Intervention;intervention program;Islets of Langerhans;Laboratories;Laboratory Animals;late life;Life;life span;lipid metabolism;Literature;Liver;Longevity;Longitudinal Studies;Low-Density Lipoproteins;Lower Organism;Macaca mulatta;male;Malnutrition;Manuscripts;Metabolic;Metabolic dysfunction;Metabolism;Metformin;middle age;mimetics;Mitochondria;Modeling;Molecular;Monkeys;Morbidity - disease rate;mortality;Motor;mouse model;Mus;NF-kappa B;nicotinamide-beta-riboside;Non obese;Non-Insulin-Dependent Diabetes Mellitus;nonhuman primate;Nutritional;Obesity;obesogenic;old mice;Oral;Outcome;oxidative damage;Pharmaceutical Preparations;pharmacologic;Phenotype;Physical Performance;Physiological;Physiology;preclinical study;prevent;Process;programs;Publishing;rate of aging;Rattus;Recommendation;Regulation;Research;research clinical testing;response;Resveratrol;Rodent;Role;Scientist;Serum;sex;SIRT1 gene;small molecule;sugar;Supplementation;Testing;Tissues;translation to humans;translational model;Vascular Endothelium;Visceral;Weight Gain,Aging Intervention Program,363,NA,NA,NA,NA,17,NA,NA,1070235,NA
11183675,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000368,NA,NA,1ZIAAG000368-20,NIA:521035\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,2 year old;4T1;Affect;age effect;Age of Onset;age related decline;age-related disease;Aging;aging mechanism;aging process;Animals;anti-cancer;Behavioral;Biochemical;Blood Glucose;Board Certification;C57BL/6 Mouse;Caloric Restriction;Calories;Cessation of life;Chronic;Chronic Disease;Cognition;cohort;Collection;Complex;Consumption;Coupled;Data;design;Diet;diet-induced obesity;dietary;Dietary Intervention;dietary restriction;Eating;Energy consumption;energy density;Energy Intake;Euthanasia;Experimental Designs;experimental study;extend lifespan;Fasting;Fatty acid glycerol esters;Fatty Liver;feeding;Feeding Patterns;Female;flexibility;Food;Food deprivation (experimental);Frequencies;functional decline;Gene Expression;Generations;Genetic;Gerontology;Glycine;Goals;Health;health assessment;healthspan;healthy aging;Heritability;Histopathology;Hour;Human;Immune;improved;Incidence;insight;Intake;Intermittent fasting;Intervention;Laboratories;Laboratory mice;Laboratory Study;Lead;Life;life span;Liver;Longevity;Lung;Macronutrients Nutrition;Maintenance;male;Malignant Neoplasms;Malnutrition;Measurement;Mediating;Memory;Metabolic;Metabolism;metabolomics;middle age;Modeling;Molecular;Monkeys;Morbidity - disease rate;mortality;Mouse Strains;multiple omics;Mus;Myeloid-derived suppressor cells;Natural Source;nonhuman primate;Nutrient;nutrition;obesogenic;offspring;Outcome;Paper;Pathologist;Pathology;Pathway interactions;Pattern;Periodicity;Phenotype;phrases;Physical Performance;Physiological;Pilot Projects;Plants;preservation;Primary Neoplasm;Property;Protocols documentation;Regimen;Reporting;response;Role;Scientist;Serine;Serum;Severities;sex;Site;Testing;Thinness;Threonine;Time;Time-restricted feeding;Tissue Banks;Tissues;transcriptomics;triple-negative invasive breast carcinoma;tumor growth;Universities;Weight Gain;Wisconsin;Work,Calorie restriction and aging,368,NA,NA,NA,NA,20,NA,NA,521035,NA
11183676,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000371,NA,NA,1ZIAAG000371-19,NIA:1408204\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690896 (contact),"MATTISON, JULIE  (contact)",NA,NA,NA,Age;Age of Onset;age related changes;age-related disease;Aging;aging biomarker;aging process;Animals;Attenuated;Behavior;Body Composition;Brain;burden of illness;Caloric Restriction;Cardiovascular Physiology;Cells;comparison control;Diet;Disease;DNA;Energy Intake;Energy Metabolism;extend lifespan;Fasting;functional decline;Goals;Health;healthspan;Human;immune function;improved;Incidence;Inflammation;Intervention;Learning;life span;Longitudinal Studies;Macaca mulatta;Macular degeneration;Mammals;Memory;Metabolic;Microglia;Mitochondrial DNA;Monitor;Monkeys;Morphology;Myelin;myelination;nonhuman primate;Oligodendroglia;Outcome;oxidative DNA damage;Primates;programs;Publishing;Reporting;reproductive function;Research;Research Design;Serum;Stress;survival outcome;Testing;Time;Tissue Sample;Tissues;Universities;Wisconsin,Primate Aging Studies,371,NA,NA,NA,NA,19,NA,NA,1408204,NA
11183677,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000458,NA,NA,1ZIAAG000458-01,NIA:72190\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,77834322 (contact),"BOUHRARA, MUSTAPHA  (contact)",NA,NA,NA,Acceleration;Accounting;accurate diagnosis;Affect;Age;age related;age related changes;age-related disease;Aging;Agreement;Alcohol consumption;Alzheimer&apos;s Disease;Alzheimer’s disease biomarker;Amyloid;Amyloid beta-Protein;Analysis of Covariance;Anisotropy;Anterior;Apolipoprotein E;Architecture;Attention;Axon;Behavior;Biological;Biological Markers;Biological Models;Biological Process;Biology;Biomedical Research;Biophysics;Blood Vessels;Brain;Brain region;Cell membrane;cerebral atrophy;Cerebrum;Characteristics;Clinical;Clinical Trials;Cognitive;Cognitive deficits;Complex;Curiosities;Data;Data Set;Dementia;Demyelinations;density;Deposition;design;Deterioration;Development;Diffusion;Diffusion Magnetic Resonance Imaging;Disease;Early Diagnosis;Early Intervention;Exhibits;Failure;Fiber;Gaussian model;Genetic;Goals;gray matter;Human;Hypertension;Image;imaging biomarker;Impaired cognition;improved;indexing;Individual;interest;Intervention;Link;Liquid substance;longitudinal analysis;Longitudinal Studies;Magnetic Resonance Imaging;Mathematics;Measurement;Measures;Metabolic;Methodology;Methods;Microscopic;mild cognitive impairment;Mission;Modeling;modifiable risk;Molecular;Nerve Degeneration;Neurites;Neurofibrillary Tangles;neuroimaging;neuroimaging marker;neuron loss;neuropathology;non-Gaussian model;normal aging;Obesity;Organelles;Outcome;Paper;Participant;Pathologic;Pathology;Phase;Physical activity;prevent;Prevention;Probability;Process;protein aggregation;Protocols documentation;Radial;rate of change;Regression Analysis;Reporting;Research Design;Research Personnel;Research Project Grants;Risk Factors;Role;Seminal;Senile Plaques;Sensitivity and Specificity;Severities;Smoking;specific biomarkers;Specificity;Structure;Synapses;tau aggregation;tau Proteins;Techniques;Technology;Time;Tissue Model;Tissues;Ventricular;Water;white matter;Work,"ALZHEIMERS RESEARCH PROJECT: The mean apparent propagator (MAP) MRI indices as neuroimaging biomarkers of cerebral aging, mild cognitive impairment, Alzheimers disease, and associated risk factors",458,NA,NA,NA,NA,1,NA,NA,72190,NA
11183678,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000469,NA,NA,1ZIAAG000469-06,NIA:902370\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,6978327 (contact),"GREIG, NIGEL H. (contact)",NA,NA,NA,3xTg-AD mouse;Academia;Acceleration;Adult;Adverse effects;Affect;Age;Aging;aging brain;Alzheimer&apos;s Disease;Alzheimer&apos;s disease brain;Alzheimer&apos;s disease model;Alzheimer&apos;s disease patient;Alzheimer&apos;s disease therapeutic;Amino Acids;Amyloid;Amyloid beta-Protein;Amyloid beta-Protein Precursor;analog;Animal Disease Models;Animal Model;Animals;Anti-Inflammatory Agents;Antioxidants;Apolipoprotein E;Basic Science;Behavioral;behavioral impairment;Biological;Blood Vessels;Brain;Cell Death;Cells;Central Nervous System;cerebral atrophy;Cerebrovascular system;Chemistry;Chronic;Clinic;Clinical;Clinical assessments;clinical development;Clinical Drug Development;Clinical Research;Clinical Trials;Cognitive deficits;Collaborations;Complex;course development;cytokine;cytokine release syndrome;Degenerative Disorder;Dementia;Deposition;design;Detection;Development;Disease;Disease Progression;DNA Damage;Dose;drug candidate;drug development;Drug Targeting;drug-like compound;early phase clinical trial;Elderly;Elements;Embryo;entorhinal cortex;Event;Excision;Extramural Activities;Failure;familial Alzheimer disease;Fostering;Generations;Genes;glial activation;Goals;Growth;hallmarks of aging;Health Benefit;Human;Image Analysis;Immunomodulators;Impairment;in utero;in vivo;Industry;Inflammation;Inflammatory;inhibitor;Interruption;Intervention;Intramural Research Program;Investigation;Investigational Therapies;Legal patent;Libraries;Licensing;Lipid Peroxidation;Lymphocytic Infiltrate;Maintenance;MAPT gene;Mediating;Messenger RNA;Microglia;Mitochondria;Modeling;Modification;Molecular Target;mouse model;multidisciplinary;Mus;Mutation;Nature;Nerve Degeneration;Nervous System;Neurodegenerative Disorders;Neurofibrillary Tangles;neuroinflammation;Neurology;neuron apoptosis;neuron loss;Neuronal Dysfunction;Neurons;neuropathology;neurotoxic;normal aging;novel;novel therapeutics;Oxidative Stress;Pathology;Peripheral Nervous System Diseases;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Pharmacology;phenserine;pomalidomide;Population;Positioning Attribute;Positron-Emission Tomography;posttranscriptional;pre-clinical;preclinical study;presenilin;Production;protein aggregation;protein oligomer;Protein Precursors;Proteins;proteostasis loss;Psychiatry;Reactive Oxygen Species;Reporting;Research;Research Project Grants;resilience;Resources;response;Rewards;Rodent;Role;Sedation procedure;Serum;small molecule;Structure;Symptoms;tau Proteins;Teratogens;Testing;Thalidomide;therapeutic candidate;Therapeutic Intervention;Time;TNF gene;Toxic effect;Translating;Translations;United States National Institutes of Health;Variant;Vertebral column,ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development,469,NA,NA,NA,NA,6,NA,NA,902370,NA
11183679,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000588,NA,NA,1ZIAAG000588-03,NIA:180474\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9690888 (contact),"DE CABO, RAFAEL  (contact)",NA,NA,NA,Age;age related;age related changes;Aging;Alzheimer&apos;s Disease;Alzheimer&apos;s disease patient;Amyloid;Amyloid beta-Protein Precursor;Apoptosis;Appearance;Area;Baltimore;Blood;Blood Glucose;Blood Vessels;Body Weight;Brain;brain metabolism;Caloric Restriction;Cell Physiology;Cell Proliferation;Cells;central nervous system vasculature;cerebral atrophy;Chemical Engineering;Chinese;Cholinesterases;Clinical Course of Disease;Clinical Trials;Cognitive;Cognitive Dissonance;cognitive function;cognitive performance;comorbidity;copolymer;cost;cytotoxic;cytotoxicity;Dementia;Deposition;Developed Countries;Diabetes Mellitus;diabetic;Disabling;Disease;Disease Progression;Drug Targeting;Eating;Economic Burden;Endoplasmic Reticulum;Epidemic;Epidemiology;epidemiology study;experimental study;flexibility;Functional disorder;Gastric Emptying;Generations;Glucose;glucose metabolism;Glutamate Receptor;Goals;Health;Heart;Hippocampus;Human;human subject;Hyperglycemia;Hypertension;Impaired cognition;Impairment;improved;In Vitro;in vivo;Incidence;Induction of Apoptosis;Inflammation;Insulin;Insulin Resistance;insulin secretion;Insulin-Dependent Diabetes Mellitus;Intervention;islet amyloid polypeptide;Islet Cell;Islets of Langerhans;Journals;Kidney;Link;Longitudinal Studies;Membrane;Metabolic;Metabolic Diseases;mimetics;Mitochondria;Molecular;Nerve Degeneration;Neurocognitive Deficit;Neurodegenerative Disorders;neurofibrillary tangle formation;neuron loss;neuropathology;Neuropharmacology;Non-Insulin-Dependent Diabetes Mellitus;nonhuman primate;Organ;Pancreas;Pancreatic Hormones;Participant;Pathogenesis;Pathologic;Pathologic Processes;Pathway interactions;Patients;Peptides;Persons;Play;Pramlintide;Prevalence;Prospective Studies;protein aggregation;Proteolysis;proteostasis;Psyche structure;Reactive Oxygen Species;Regulation;Research;Research Project Grants;Role;Satiation;social;Symptoms;Synapses;synergism;tau Proteins;Testing;Therapeutic;treatment strategy;Update;Weight,ALZHEIMERS RESEARCH PROJECT: Amyloidogenic Amylin: Linking Type 2 Diabetes and Alzheimers Disease in Humans and Non-Humans Primates.,588,NA,NA,NA,NA,3,NA,NA,180474,NA
11183680,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090096,NA,NA,1ZIACL090096-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78855912 (contact),"EGGERMAN, THOMAS  (contact)",NA,NA,NA,"2019-nCoV;Acute Lung Injury;age related;antagonist;Antigen Presentation;Apolipoprotein A-I;Apolipoproteins B;Apoptotic;Bacterial Model;Blood Vessels;BODIPY;Brain Injuries;Bronchoalveolar Lavage;Bronchoalveolar Lavage Fluid;CD36 gene;Cell Count;Cell Line;Cells;Chronic Lung Injury;Collaborations;Coronary Arteriosclerosis;coronary plaque;cytokine;Disease;emerging virus;endothelial dysfunction;Endotoxins;Excision;Extravasation;Hepatitis C;high risk;Host Defense;Hour;Human;In Vitro;in vivo;Individual;Infection;Inflammation;Inflammatory;Inflammatory Response;Injections;Injury to Kidney;Knock-out;Lipopolysaccharides;Lipoprotein Receptor;Low Density Lipoprotein Receptor;Lung;Lung infections;lung injury;Mediating;microbial;Molecular;Mus;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;neural;Neutrophil Infiltration;overexpression;pathogen;pathogenic virus;Pattern;Pattern recognition receptor;Peptides;Peripheral;Phagocytosis;Phospholipids;Play;Production;Protein Family;Proteins;Publishing;Pulmonary Inflammation;receptor;Resolution;RNA Splicing;Role;SARS-CoV-2 pathogenesis;SARS-CoV-2 spike protein;scavenger receptor;Sepsis;Septic Shock;SR-B proteins;Structure of parenchyma of lung;System;therapeutic candidate;Tissues;Toll-like receptors;Transgenic Mice;Transgenic Organisms;uptake;Variant;vascular endothelial dysfunction;Viral;Virus;Virus Diseases;Wild Type Mouse","The Role of the Scavenger Receptor B Family Proteins (SR-BI, SR-BII and CD36) in Infection and Sepsis",90096,NA,NA,NA,NA,3,NA,NA,0,NA
11183681,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000039,NA,NA,1ZIADC000039-28,NIDCD:2181247\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,9414950 (contact),"FRIEDMAN, THOMAS  (contact)",NA,NA,NA,Active Sites;Alleles;Alternative Splicing;Amino Acids;Apical;Atomic Force Microscopy;Audiology;Auditory;Auditory system;Basic Science;Biochemistry;Blindness;Brain;causal variant;Cells;Cellular biology;childhood hearing loss;Clinical;clinical center;Clinical Data;Clinical Research;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Complement;Conceptions;conditional knockout;consanguineous family;CRISPR/Cas technology;deaf;Deafblind;deafness;design;Development;Disease;Doctor of Philosophy;DOOR (deafness-onychodystrophy-osteodystrophy-retardation) syndrome;Dystonia;Embryo;Engineering;Enrollment;Epitopes;Exclusion;Exercise;exome sequencing;Exons;F-Actin;Family;Family Study;Female;Functional disorder;gene function;gene therapy;Genes;Genetic;genetic variant;Genetic Variation;Genomic DNA;Genotype;Goals;Hair Cells;Hearing;hearing impairment;Hearing Tests;Human;human disease;Human Genome;human model;human subject;Inherited;inner ear diseases;Institutional Review Boards;interest;Laboratories;Labyrinth;Link;male;male fertility;Maps;Measures;Medical;Medical Genetics;member;Mentors;Michigan;Missense Mutation;Molecular;Molecular Biology;Molecular Genetics;mouse genetics;mouse model;Mus;Mutant Strains Mice;Mutate;Mutation;National Institute on Deafness and Other Communication Disorders;Natural History;normal hearing;Pakistan;Pathogenicity;Pathway interactions;Phenotype;Phosphoric Monoester Hydrolases;Physicians;Protein Isoforms;protein protein interaction;Proteins;Protocols documentation;Puerto Rico;Quinones;recessive genetic trait;Reporting;Research Personnel;Research Project Grants;RNA Splicing;Rolandic Epilepsy;Science;segregation;Seizures;Site;skills;small molecule;SNP array;sperm cell;Splice-Site Mutation;Sterility;structural biology;Supporting Cell;Syndrome;tool;Transcript;United States National Institutes of Health;Universities;Usher Syndrome;Variant;vestibular system;Visual;Zein,Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment,39,NA,NA,NA,NA,28,NA,NA,2181247,NA
11183682,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000048,NA,NA,1ZIADC000048-27,NIDCD:2181247\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,9414950 (contact),"FRIEDMAN, THOMAS  (contact)",NA,NA,NA,Actins;ADAMTS;Adult;age related;Apical;Auditory system;autosome;base;Birds;Brain;Bundling;Cell Physiology;Cells;Collaborations;Communication;Cooperative Research and Development Agreement;deaf;deafness;Detection;Development;Epitopes;Exons;Extramural Activities;Failure;Family;Force of Gravity;gene function;Genes;Genetic;genetic analysis;genetic variant;Goals;Hair;Hair Cells;Head Movements;Hearing;hearing impairment;Human;human model;Image;in vivo;Inner Hair Cells;Knockout Mice;Laboratories;Labyrinth;LoxP-flanked allele;Maintenance;Manuscripts;MAP3K1 gene;Michigan;Molecular Genetics;mouse genome;mouse model;Mus;Mutant Strains Mice;Mutation;Nature;Organ;Organ of Corti;PCDH15 gene;Pharmacologic Substance;Phenotype;protein function;Protein Isoforms;Proteins;Protocols documentation;Publishing;recruit;Reporting;response;RNA Splicing;Role;segregation;Seizures;single molecule;small molecule;sound;superresolution microscopy;Supporting Cell;Surface;Transcript;United States;United States National Institutes of Health;Universities;Variant;vestibular system;Work,"Functional Studies of ""Deafness Genes"" Essential for Hearing",48,NA,NA,NA,NA,27,NA,NA,2181247,NA
11183683,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000532,NA,NA,1ZIAEY000532-12,NEI:3030638\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984470 (contact),"BHARTI, KAPIL  (contact)",NA,NA,NA,Affect;Age related macular degeneration;Aging;Atrophic;Blindness;cell age;Cell Culture Techniques;Cell Death;Cell Membrane Permeability;Cellular Stress;Choroid;Complement;Defect;Deposition;Development;differentiation protocol;Disease;Elderly;electrical measurement;Epithelium;Exhibits;Fibroblasts;Functional disorder;Genetic;geographic atrophy;Goals;Homeostasis;Human;In Vitro;induced pluripotent stem cell;lipid metabolism;lipidomics;Mendelian disorder;Modeling;monolayer;Pathogenesis;Pathology;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Photoreceptors;pluripotency;Population;postmitotic;Process;protein aggregation;Publishing;Resistance;Retinal Degeneration;Retinal Diseases;risk variant;Role;Serum;Signal Pathway;skin biopsy;Stargardt&apos;s disease;Stress;Structure of retinal pigment epithelium;Therapeutic Intervention;Tissues;tool,"Developing an ""aging"" model using iPSC-derived RPE cells",532,NA,NA,NA,NA,12,NA,NA,3030638,NA
11183684,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000533,NA,NA,1ZIAEY000533-12,NEI:1911946\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984470 (contact),"BHARTI, KAPIL  (contact)",NA,NA,NA,Adult;Affect;Animal Model;Antibodies;Aphidicolin;Apical;Biotechnology;Cell Cycle;Cell Therapy;Cell Transplantation;cell type;Cells;Cilia;ciliopathy;cilium biogenesis;Collaborations;Defect;Degenerative Disorder;Development;Dinoprostone;disease model;Dynein ATPase;Electrophysiology (science);Epithelium;Eye diseases;fetal;Gene Expression Profile;Gene Expression Profiling;Goals;high throughput screening;human induced pluripotent stem cells;improved;In Vitro;induced pluripotent stem cell;inhibitor;insight;Label;machine learning algorithm;macula;Mediating;Mediator;member;Methods;monolayer;mouse model;Mus;Mutant Strains Mice;Onset of illness;Pathway interactions;Patients;Peripheral;Pharmaceutical Preparations;Phenotype;Photoreceptors;postnatal;pre-clinical;Process;protein transport;Protocols documentation;Sampling;Shapes;Therapeutic;Tissues;WNT Signaling Pathway;Work,Developing functional and authenticated RPE tissue from iPS cells,533,NA,NA,NA,NA,12,NA,NA,1911946,NA
11183685,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000542,NA,NA,1ZIAEY000542-11,NEI:2237383\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984470 (contact),"BHARTI, KAPIL  (contact)",NA,NA,NA,Acute;Air;Animal Model;Animals;Autologous;Biotechnology;Bulla;Cell Differentiation process;Cell Line;Cell Therapy;cell type;Chronic;Clinical;clinical center;clinical efficacy;Clinical Protocols;Coculture Techniques;Collaborations;Eye;Family suidae;FDA approved;Goals;Histologic;Human;human subject;Immunocompromised Host;induced pluripotent stem cell;Institutional Review Boards;Liquid substance;Nonexudative age-related macular degeneration;Operative Surgical Procedures;Organ;participant enrollment;Patients;Phase;Phase I Clinical Trials;phase I/IIa trial;Photoreceptors;pre-clinical;preclinical efficacy;preclinical safety;Procedures;Process;Retina;Safety;safety assessment;Saline;Sampling;scaffold;stem cells;Technology Transfer;Teratoma;Testing;Therapeutic;Time;Transplantation;tumor;United States National Institutes of Health;Vitrectomy;Work,Developing autologous iPSC-RPE based IND for AMD patients,542,NA,NA,NA,NA,11,NA,NA,2237383,NA
11183686,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000559,NA,NA,1ZIAEY000559-08,NEI:1444129\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984470 (contact),"BHARTI, KAPIL  (contact)",NA,NA,NA,3-Dimensional;Age related macular degeneration;Anatomy;Back;biodegradable scaffold;bioprinting;Blindness;Blood capillaries;Blood Vessels;Blood-Retinal Barrier;Cell Death;Cessation of life;Choroid;Collagen;Complex;Development;Disease;Dryness;Elderly;Encapsulated;Endothelial Cells;Event;Eye;Fibroblasts;Gel;Goals;human model;In Vitro;in vitro Model;induced pluripotent stem cell;induced pluripotent stem cell technology;Macrophage;Modeling;monolayer;Pathology;Pathway interactions;patient derived induced pluripotent stem cells;Patients;Pericytes;Pharmaceutical Preparations;Photoreceptors;Process;Proliferating;Property;Publishing;response;Retinal Degeneration;Role;scaffold;Side;Structure of retinal pigment epithelium;Testing;Therapeutic;Thinness;Tissue Engineering;Tissues;Vascular Endothelial Growth Factors;Work,Developing 3D patient-specific iPS cell derived RPE/choroid models,559,NA,NA,NA,NA,8,NA,NA,1444129,NA
11183687,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL000140,NA,NA,1ZIAHL000140-20,NHLBI:798031\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,12450283 (contact),"PUERTOLLANO-MORO, ROSA  (contact)",NA,NA,NA,Acids;Address;adeno-associated viral vector;Adult;Affect;Animal Disease Models;animal old age;Animals;Antigen Presentation;Arginine;Assessment tool;Atrophic;Autophagocytosis;Birth;Blood Circulation;blood-brain barrier crossing;Bone remodeling;Cardiac;Cardiomyopathies;Cell membrane;Cell Physiology;Cells;cellular pathology;Central Nervous System;Childhood;Cholesterol Homeostasis;Clinic;Clinical;clinical development;Collaborations;Defect;Development;Disease;Disease Progression;Down-Regulation;Effectiveness;effectiveness evaluation;enzyme activity;enzyme replacement therapy;Enzymes;Excision;FDA approved;Financial Hardship;Functional disorder;Future;gallium arsenide;Ganglioside Sialidase Deficiency Disease;gene therapy;Gene Transfer;Glucose;Glycogen;Glycogen storage disease type II;glycosylation;Goals;heart function;Homeostasis;Human;Image;Immune response;improved;Infant;Injections;interest;Intervention;intravital microscopy;knock-down;Knockout Mice;Laboratories;Lysosomal Storage Diseases;Lysosomes;mannose 6 phosphate;Mediating;Metabolic;Metabolic Diseases;Methodology;Miglustat;Molecular;Mus;Muscle;Muscle Fibers;muscle form;Muscular Atrophy;Myocardium;Myopathy;novel;novel therapeutics;Organelles;Organism;Pathogenesis;Pathogenicity;Pathology;Patients;preclinical study;Preclinical Testing;Prevalence;prevent;Proteins;proteostasis;receptor;Recombinants;repaired;Residual state;Resolution;Respiratory Diaphragm;response;restoration;Sampling;Signal Transduction;Site;Skeletal Muscle;standard of care;Stress;Supplementation;Surface;Techniques;Therapeutic;therapeutic enzyme;Therapeutic Intervention;therapeutic target;Tissues;Tongue;trafficking;Translating;uptake;Variant;Visualization;Wasting Syndrome;Work,Lysosomal Diseases,140,NA,NA,NA,NA,20,NA,NA,798031,NA
11183688,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL000225,NA,NA,1ZIAHL000225-47,NHLBI:2537006\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2431349 (contact),"LEVINE, RODNEY L. (contact)",NA,NA,NA,Affect;Age;Aging;Aminoacyl-tRNA Biosynthesis Pathway;Anabolism;Antioxidants;Back;Bacteria;Biological Models;Ca(2+)-Calmodulin Dependent Protein Kinase;Calcium;calmodulin-dependent protein kinase II;Carbon;Cardiac;cell growth regulation;Cell Line;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Cysteine;Disease;disulfide bond;Disulfides;Energy-Generating Resources;Genes;Genetically Engineered Mouse;genome-wide;Guide RNA;Heart;Hepatocyte;Ischemia;Knock-out;Laboratories;Lactate Dehydrogenase;Libraries;Mediating;Metabolic Pathway;Metabolism;metabolomics;Methionine;methionine sulfoxide;methionine sulfoxide reductase;microbiome;Modeling;Modification;Mus;Mutant Strains Mice;Mutate;Mutation;Neurodegenerative Disorders;oxidation;Oxidative Stress;Oxidoreductase;Oxygen Consumption;Paracoccus denitrificans;Pathologic;Pathology;Physiological;Physiology;Post-Translational Protein Processing;prevent;Process;Production;protective pathway;Proteins;Protocols documentation;Quinones;Reactive Oxygen Species;Regulation;repaired;Reperfusion Injury;Reperfusion Therapy;Reporting;Research;Resistance;Respiration;Role;Serine;Signal Transduction;System;Transgenic Mice,Oxidative Modification Of Proteins,225,NA,NA,NA,NA,47,NA,NA,2537006,NA
11183689,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL000340,NA,NA,1ZIAHL000340-19,NHLBI:2109153\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2419643 (contact),"PASTOR, RICHARD WALTER (contact)",NA,NA,NA,"Agreement;algorithm development;anti-microbial peptide;apolipoprotein C-II;Apolipoproteins;Area;Binding;Biopolymers;Carbohydrates;Cell fusion;Cell membrane;Chemistry;Cholesterol;Complement;Complex;Computer Simulation;computer studies;Data;Deuterium;Development;Diffusion;Drug Design;Elasticity;Experimental Models;experimental study;Gangliosides;Glycolipids;Goals;High Density Lipoproteins;improved;insight;interfacial;Ion Channel;Ions;Lateral;Lipids;mechanical force;Membrane;membrane model;Methodology;Methods;mimetics;Modeling;molecular dynamics;molecular mechanics;monolayer;particle;Partition Coefficient;Peptides;Periodicals;Permeability;Pharmaceutical Preparations;Phase;Phase Transition;Phosphatidylinositol 4,5-Diphosphate;Phosphatidylinositols;Physics;pressure;Process;programs;Proteins;Publishing;Quantum Mechanics;Relaxation;Reporting;Research;Roentgen Rays;Signal Transduction;simulation;stapled peptide;Structure;System;Triglycerides;Unsaturated Fats;Very low density lipoprotein;Viscosity;Water;Work",Computer Simulations of Membranes and Biopolymers,340,NA,NA,NA,NA,19,NA,NA,2109153,NA
11183690,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL000659,NA,NA,1ZIAHL000659-32,NHLBI:1591105\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6481999 (contact),"MOSS, JOEL  (contact)",NA,NA,NA,Adenocarcinoma;Adenosine Diphosphate Ribose;ADP Ribose Transferases;ADP ribosylation;Adrenal Glands;Affect;Agar;Age Months;Agreement;Alleles;Amino Acids;anastrozole;Animal Model;Annual Reports;apoptosis inducing factor;Appearance;Arginine;Bacterial Toxins;Biochemical Reaction;biological systems;Brain;breast cancer progression;carcinogenesis;Cell Death;Cell Differentiation process;Cell model;Cell Nucleus;Cell Proliferation;Cells;Cervical lymph node group;Cholera Toxin;Circulation;Cytoplasm;Data;Data Analyses;Deacetylation;Development;Diphtheria Toxin;DNA;DNA Repair;Dose;Embryo;Endometrial adenocarcinoma;endonuclease;enzyme activity;Estrogen Antagonists;Estrogen Therapy;Estrogens;Family;Family member;Female;female sex hormone;Fibroblasts;follow-up;Gender;gender disparity;Genes;Genetically Engineered Mouse;Genotype;Glycoside Hydrolases;Gonadal Steroid Hormones;Growth;Hemangiosarcoma;Heterozygote;hormone deficiency;Hormones;Hydrolase;Hydrolysis;Implant;In Vitro;in vivo;Incidence;intravenous injection;Knockout Mice;Laboratories;Loss of Heterozygosity;Lung Adenocarcinoma;Lymphoma;male;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant Neoplasms;Mammalian Cell;member;Mesentery;Metastatic Neoplasm to the Lung;Mono(ADP-Ribose) Transferases;mortality;mouse model;Mus;Mutate;Mutation;Natural regeneration;Neoplasm Circulating Cells;Neoplasm Metastasis;neoplastic cell;Niacinamide;Non-Steroidal Aromatase Inhibitor;Nude Mice;O-Acetyl-ADP-Ribose;Organ;Ovariectomy;Ovary;Oxidative Stress;Pathway interactions;Peptides;pharmacologic;Poly Adenosine Diphosphate Ribose;Poly(ADP-ribose) Polymerases;Post-Translational Protein Processing;Predisposition;preneoplastic cell;Primary carcinoma of the liver cells;Process;Proliferating;Protein Family;protein function;Proteins;Reaction;Regulation;Reporting;Residual state;Role;Serine;Signal Transduction;Sirtuins;Spleen;subcutaneous;Symptoms;Tamoxifen;Testosterone;Toxin;tumor;Tumor Burden;tumor growth;tumor initiation;Tumor Suppressor Proteins;tumorigenesis;Uterus;Wild Type Mouse;Woman;Xenograft Model,ADP-ribosylation Cycles,659,NA,NA,NA,NA,32,NA,NA,1591105,NA
11183691,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL001048,NA,NA,1ZIAHL001048-27,NHLBI:1836279\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571449 (contact),"TJANDRA, NICO  (contact)",NA,NA,NA,2019-nCoV;Adopted;Anti-viral Agents;Binding;Binding Sites;Biological;Biological Assay;Biological Process;C-terminal;Capsid;Cell membrane;cell motility;Cells;Clinical;Collaborations;Complex;Coronavirus;Cysteine;Degradation Pathway;Dependence;Development;Dimerization;Disease;Environment;Enzyme Activation;Enzymes;Event;Exhibits;experimental study;Family;flexibility;Generations;Goals;Half-Life;High Pressure Liquid Chromatography;HIV-1;imaging probe;improved;inhibitor;Isomerism;Knowledge;Lanthanoid Series Elements;Ligands;Ligase;Link;Lobe;Measures;Metals;Methylation;Molecular;molecular dynamics;Mutation;N-terminal;National Institute of Allergy and Infectious Disease;Nature;new technology;Nitrogen;novel;Nuclear;particle;Pathway interactions;Phase;Physiological;Population;Predisposition;prevent;Process;Production;protein degradation;Protein Dynamics;protein function;protein protein interaction;Proteins;Proton Pump Inhibitors;Protons;recruit;Regulation;Research;Research Project Grants;response;RNA;Scheme;Signal Transduction;Site;small molecule;Specificity;Spin Labels;Stimulus;Structure;System;Technology;Temperature;Testing;trafficking;Tyrosine;UBD protein;Ubiquitin;ubiquitin ligase;ubiquitin-protein ligase;Ubiquitination;Viral;Viral Proteins;Virion;Virus;virus testing;Virus-like particle;Water,Nmr Studies Of The Regulation Of Cell Signaling,1048,NA,NA,NA,NA,27,NA,NA,1836279,NA
11183692,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL001055,NA,NA,1ZIAHL001055-18,NHLBI:1824992\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416468 (contact),"LEE, JENNIFER  (contact)",NA,NA,NA,Address;Adopted;age related;alpha synuclein;Alzheimer&apos;s Disease;Amyloid;amyloid formation;amyloid structure;Amyotrophic Lateral Sclerosis;Binding;Biochemical;biophysical analysis;Cellular Stress;Chemicals;Complex;Cryoelectron Microscopy;Cytosol;Dementia with Lewy Bodies;Development;Disease;disease phenotype;DNA-Binding Proteins;Dose;Electron Microscopy;Electrostatics;Encephalopathies;Environment;Etiology;experimental study;Filament;Fluorescence Recovery After Photobleaching;Fluorescence Spectroscopy;Frontotemporal Dementia;Genetic Code;Goals;Growth;Health;human disease;in vivo;insight;interest;Intervention;Investigation;Light;Lipids;Liquid substance;Lysine;Lysosomes;Magnetic Resonance Spectroscopy;Mass Spectrum Analysis;Membrane;Methods;Molecular;Molecular Biology;Molecular Conformation;Multiple System Atrophy;Nature;Neutrons;NMR Spectroscopy;novel;Nuclear;Nuclear Import;optogenetics;Organelles;Parkinson Disease;Pathologic;Photochemistry;Post-Translational Protein Processing;Process;protein aggregation;protein misfolding;protein structure;protein TDP-43;Protein translocation;Proteins;Proteolysis;proteostasis;Reaction;recruit;Research;response;Role;self assembly;Side;Site;Sodium Chloride;Solid;stress granule;Structure;TDP-43 aggregation;Testing;Time;tool;unnatural amino acids;Work,Protein Misfolding and Aggregation,1055,NA,NA,NA,NA,18,NA,NA,1824992,NA
11183693,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL001056,NA,NA,1ZIAHL001056-18,NHLBI:2302231\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416470 (contact),"NEUMAN, KEIR  (contact)",NA,NA,NA,Aging;Antibiotics;Artificial Intelligence;Bacterial Genome;base;Binding;Biochemical;biophysical model;Cell Death Induction;Cell division;chemotherapy;Chromosomal Instability;chromosome replication;Chromosomes;Ciprofloxacin;Clinical;Collaborations;college;Comparative Study;Complement;COVID-19 pandemic;Darkness;Data;Dependence;Development;DNA;DNA Repair;DNA topoisomerase II alpha;DNA Topoisomerase IV;DNA Topoisomerases;Engineering;Enzymes;Equilibrium;Escherichia coli;experimental study;Florida;Fluorescence;Frequencies;Goals;Gold;helicase;Human;improved;In Vitro;in vivo;Incidence;Individual;inhibitor;instrument;instrumentation;interest;International;Link;Location;Machine Learning;Magnetism;Maintenance;Malignant Neoplasms;Maps;Maryland;Measurement;Measures;Mechanics;Modality;Modeling;Molecular;molecular dynamics;molecular scale;Monitor;Motion;Multienzyme Complexes;next generation sequencing;Nucleotides;particle;Pathway interactions;plasmid DNA;Play;Poison;Poisoning;preference;prevent;professor;Proteins;Relaxation;repair enzyme;Research;Resolution;response;RNA-Directed RNA Polymerase;Role;SARS-CoV-2 inhibitor;simulation;single molecule;Single-Stranded DNA;Sister;Site;small molecule inhibitor;Specificity;Structure;Superhelical DNA;Techniques;temporal measurement;Testing;Time;Topoisomerase;Topoisomerase II;Topoisomerase III;Torque;Type I DNA Topoisomerases;Universities;Washington;Work,Single-molecule measurements of DNA topology and topoisomerases,1056,NA,NA,NA,NA,18,NA,NA,2302231,NA
11183694,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL001285,NA,NA,1ZIAHL001285-38,NHLBI:2585694\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694350 (contact),"KNEPPER, MARK  (contact)",NA,NA,NA,"Ablation;activating transcription factor 1;Animal Model;Animals;antidiuresis;Apical;aquaporin-2;Area;Argipressin;ATAC-seq;Atlases;AVPR2 gene;Binding;Binding Sites;Bioinformatics;Biological;Biology;Biomedical Engineering;Calmodulin;Catalytic Domain;Cell membrane;Cell model;Cell Signaling Process;cell type;Cells;ChIP-seq;Chromosome Mapping;Cirrhosis;Cleavage Under Targets and Release Using Nuclease;Clustered Regularly Interspaced Short Palindromic Repeats;Code;Communities;Computational Technique;computerized tools;Computing Methodologies;Congestive Heart Failure;Coupled;CREB1 gene;CRISPR screen;CRISPR/Cas technology;Custom;Cyclic AMP-Dependent Protein Kinases;Data;Data Analyses;data resource;Data Set;data sharing networks;Databases;deep sequencing;dilutional hyponatremia;Disease;Distal convoluted renal tubule structure;DNA sequencing;Duct (organ) structure;Ductal Epithelial Cell;Ductal Epithelium;Elements;Enhancers;Epithelial Cells;Epithelium;equilibration disorder;Equilibrium;Evaluation;Excretory function;experimental study;Family;Fluorescence-Activated Cell Sorting;G-Protein-Coupled Receptors;Gene Expression;Genes;Genetic Transcription;genome editing;genome-wide;Genomics;Goals;gram-negative sepsis;Hand;Homeobox;Hypokalemia;Individual;Inflammation;Java;Kidney;Laboratories;Limb structure;Link;Lithium;Maps;Mass Spectrum Analysis;mathematical methods;Mediating;Mediator;member;Messenger RNA;method development;Methods;Modeling;Molecular;Mus;mutant;Mutation;Myosin Light Chain Kinase;National Heart, Lung, and Blood Institute;Nephrons;neurophysins;next generation;novel;Nuclear;Nuclear Translocation;Occupations;Persons;Phosphoproteins;phosphoproteomics;Phosphorylation;Phosphorylation Site;Phosphotransferases;Physiological;Polyuria;Post-Translational Protein Processing;Process;protein activation;Protein Kinase;Proteins;Proteome;Proteomics;Proteomics Shared Resource;Pythons;Regulation;renal epithelium;Renal tubule structure;Research;Resources;response;Role;Signal Transduction;single-cell RNA sequencing;Site;Sodium Chloride;Software Tools;solute;Syndrome;Systems Biology;tandem mass spectrometry;Techniques;Testing;Thick;tool;Toxic effect;trafficking;transcription factor;Transcriptional Regulation;transcriptome;transcriptome sequencing;transcriptomics;Ureteral obstruction;urinary tract obstruction;V2 Receptors;validation studies;vasopressin resistant diabetes insipidus;Vasopressins;Water;water channel;Work",Solute And Water Transport In Renal Epithelia,1285,NA,NA,NA,NA,38,NA,NA,2585694,NA
11183695,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL001452,NA,NA,1ZIAHL001452-41,NHLBI:340622\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571467 (contact),"KNUTSON, JAY R (contact)",NA,NA,NA,20p;Amino Acids;aptamer;Behavior;Binding;Biochemical;biochemical tools;Cells;Chemistry;China;chromophore;cofactor;Collaborations;Communication;Complex;Computer software;conformer;Coupled;Darkness;Data;design;Detection;Diffusion;dimer;DNA;Dyes;electric field;Environment;Enzymes;Event;experimental study;Fluorescence;fluorescence lifetime imaging;Fluorescence Resonance Energy Transfer;Fluorescence Spectroscopy;fluorophore;Heme;Heterogeneity;Hybrids;Image;imaging software;insight;Laboratories;Learning;light emission;light microscopy;macromolecular assembly;Macromolecular Complexes;macromolecule;Metabolic;Metabolism;Microscopy;Mitochondria;Modeling;molecular imaging;Motion;Muscle Mitochondria;Myocardium;Myoglobin;NADH;nanosecond;neoplastic cell;Nucleotides;Oxidoreductase;Oxygen;photomultiplier;Population;Process;Protein Dynamics;protein function;Proteins;prototype;Publishing;quantum;Reactive Oxygen Species;Resolution;response;RNA;Scientist;sensor;small molecule;Structure;Tail;Techniques;Time;Tissues;tool;Tryptophan;Universities;Update;Water;Work,Time Resolved Fluorescence Spectroscopy,1452,NA,NA,NA,NA,41,NA,NA,340622,NA
11183696,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL001786,NA,NA,1ZIAHL001786-45,NHLBI:1377184\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694348 (contact),"SELLERS, JAMES  (contact)",NA,NA,NA,Actins;Adopted;Affect;Alternative Splicing;Amino Acid Sequence;analog;Area;Baculoviruses;Binding;Biological Assay;Cells;Collaborations;copolymer;Cryoelectron Microscopy;Crystallization;Data;depolymerization;Enzymes;Filament;Fluorescence Resonance Energy Transfer;force sensor;G Actin;Genes;H-Meromyosin;human disease;Image;In Vitro;in vivo;interest;Isometric Exercise;Kinetics;Label;Length;Light;Link;Mammals;Mechanics;Microfilaments;Microscope;monomer;Motility;Motor;Movement;Mutation;Myosin ATPase;Myosin Regulatory Light Chains;Myosin Rod;Myosin S-2;Myosin Type II;non-muscle myosin;Nonmuscle Myosin Type IIA;optic trap;optical traps;paralogous gene;Pattern;Phosphorylation;polymerization;Polymers;Process;Property;Proteins;Publishing;Regulation;Resolution;RNA Splicing;single molecule;Structure;Surface;System;Tail;Time;Total Internal Reflection Fluorescent;Visit,Regulation Of Smooth and Nonmuscle Myosin,1786,NA,NA,NA,NA,45,NA,NA,1377184,NA
11183697,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL002065,NA,NA,1ZIAHL002065-17,NHLBI:345798\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694255 (contact),"MURPHY, ELIZABETH  (contact)",NA,NA,NA,Acute;Address;adeno-associated viral vector;Age;Animal Model;Animals;attenuation;Binding;Bioenergetics;Calcium;calcium indicator;calcium uniporter;cardioprotection;Cardiovascular Diseases;cardiovascular disorder risk;Cardiovascular system;Cause of Death;Cell Death;Clinical Trials;Confocal Microscopy;Data;Disease;Enzyme Activation;enzyme activity;Estrogen Nuclear Receptor;Estrogens;Female;Fluorescence;Generations;Genes;Goals;Heart;Heart Diseases;Heat shock proteins;Hormone replacement therapy;Infarction;Injections;Injury;Ischemia;ischemic injury;Knock-out;Location;male;Measures;Mediating;Menopause;Methods;Microscopy;Mitochondria;Mitochondrial Matrix;Mitochondrial Membrane Protein;Modeling;Modification;Monitor;Mus;neonate;Nitric Oxide;Nitric Oxide Synthase;non-genomic;Organ;Pathway interactions;Perfusion;PIK3CG gene;Post-Translational Protein Processing;Postmenopause;Premenopause;Process;Proteins;Publishing;Reperfusion Injury;Reperfusion Therapy;Research;Resolution;response;Selective Estrogen Receptor Modulators;Signal Transduction;Spectrum Analysis;Testing;transmission process;uptake;Viral Vector;Woman;Women&apos;s Health;Women&apos;s mortality,Mechanisms involved in male-female differences in cardioprotection,2065,NA,NA,NA,NA,17,NA,NA,345798,NA
11183698,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL002066,NA,NA,1ZIAHL002066-17,NHLBI:1613723\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694255 (contact),"MURPHY, ELIZABETH  (contact)",NA,NA,NA,Acceleration;Adult;Calcium;Cardiac Myocytes;cardioprotection;Cardiovascular Diseases;Cause of Death;Cell Death;Cell division;Cell membrane;Cellular Structures;Cessation of life;Clinic;cyclophilin D;Electron Transport;Failure;Generations;Goals;Heart;Heart Diseases;heart function;Homeostasis;Infarction;Inner mitochondrial membrane;insight;Ion Pumps;Ions;Ischemia;ischemic injury;Isomerase;Location;Measures;Metabolism;Methods;Mitochondria;mitochondrial permeability transition pore;Modeling;mouse model;mutant;Myocardial Ischemia;novel;Oxidation-Reduction;Oxygen;Perfusion;Permeability;Pharmaceutical Preparations;Plasma Cells;Play;Post-Translational Protein Processing;preconditioning;Proteins;Reactive Oxygen Species;Regulation;Reperfusion Injury;Reperfusion Therapy;Reporting;response;Role;Rupture;Sex Differences;Signal Pathway;Signal Transduction;Testing;Translating,Mechanisms of cardiac ischemia-reperfusion injury and cardioprotection,2066,NA,NA,NA,NA,17,NA,NA,1613723,NA
11183699,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL002315,NA,NA,1ZIAHL002315-42,NHLBI:4095914\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571509 (contact),"YOUNG, NEAL S (contact)",NA,NA,NA,Admission activity;Adverse event;Advocate;Aftercare;Age;Anemia;Animal Model;Antithymoglobulin;Aplastic Anemia;Autologous;B-Lymphocytes;Benzene;Biological Products;Blood Cells;Bone Marrow;Bone Marrow Diseases;bone marrow failure syndrome;Bone Marrow Transplantation;CD8-Positive T-Lymphocytes;Cell-Mediated Cytolysis;Cells;Chemical Exposure;Child;Childhood;chronic T-cell leukemia;Classification;Clinical;clinical center;Clinical Data;Clinical Protocols;Clinical Trials;Clonal Evolution;cohort;Collaborations;college;Constitution;Cyclosporine;cytokine;cytotoxic;Data;Development;Diagnosis;Disease;disease classification;Dose;Drug toxicity;Drug usage;Dysmyelopoietic Syndromes;Early Intervention;effector T cell;Elderly;Epitope spreading;Evolution;Failure;Fanconi&apos;s Anemia;Fatty acid glycerol esters;Flow Cytometry;follow-up;Functional disorder;Future;Genetic;Hematology;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Hemorrhage;Hepatitis;high risk;Human;Immune;Immune mediated destruction;Immune response;Immune system;Immune System Diseases;Immunological Models;Immunosuppression;Immunosuppressive Agents;improved;in silico;Induction of Apoptosis;Infection;Infusion procedures;inhibitor;Interferon Type II;International;Intervention;Laboratories;Laboratory Research;large datasets;Ligands;Link;London;Lymphocyte;Machine Learning;Malignant - descriptor;Marrow;Mediating;Medical;member;mimetics;Modeling;Molecular;Morality;mouse model;Mutate;Mutation;Myeloproliferative disease;Natural Killer Cells;novel;Oral;Outcome;Outpatients;Pancytopenia;participant enrollment;Pathway interactions;Patient Compliance;Patients;Pattern;Pattern Recognition;peripheral blood;Persons;Pharmaceutical Preparations;Physicians;Population;Pregnancy;prevent;Prevention trial;programs;progression risk;Proteomics;Protocols documentation;Publications;Pure Red-Cell Aplasia;Race;receptor;Recovery;Refractory;Refractory anemias;Regimen;Regulatory T-Lymphocyte;Relapse;relapse prevention;Reporting;Research;response;Risk;Risk Factors;sample collection;Sample Size;Sampling;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Sirolimus;Specificity;standard of care;Stem cell transplant;stem cells;Survival Rate;T cell clonality;T-Cell Receptor;Techniques;telomere;Testing;Therapeutic immunosuppression;Thrombopoietin;Time;Toxic effect;Transplantation;Treatment Efficacy;Treatment Protocols;Twin Multiple Birth;United States National Institutes of Health;Visit;Work,Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments,2315,NA,NA,NA,NA,42,NA,NA,4095914,NA
11183700,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL002339,NA,NA,1ZIAHL002339-33,NHLBI:2130169\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2479331 (contact),"DUNBAR, CYNTHIA E (contact)",NA,NA,NA,Aging;Alzheimer&apos;s disease risk;Amyloid;Animal Model;animal old age;Animals;Bar Codes;base editing;Biology;Blood;Blood Cells;Blood Platelets;Brain;cardiovascular disorder risk;CD34 gene;Cell Count;Cells;Clinic;Clinical;Clonal Expansion;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Control Animal;COVID-19;COVID-19 severity;CRISPR/Cas technology;Disease;disease model;DNA Double Strand Break;Engineering;Engraftment;Failure;functional loss;gene correction;gene therapy;gene-editing approach;gene-targeted therapy;Generations;Genes;Genetic;Genetic Diseases;genome editing;genotoxicity;Hematopoiesis;Hematopoietic stem cells;Human;human disease;human model;improved;Inflammatory;Inherited;insertion/deletion mutation;Knock-out;Laboratories;lentiviral integration;Lentivirus Vector;leukemia;Link;loss of function;loss of function mutation;Lung;Macaca;Macaca mulatta;Marrow;Mediating;Microglia;Modeling;Modification;mouse model;mutant;Mutate;Mutation;Myeloid Cells;Nonhomologous DNA End Joining;Normal Cell;Other Genetics;Outcome;patient prognosis;Phenotype;Pilot Projects;Pre-Clinical Model;predictive test;Predisposition;prevent;Prognosis;repaired;Reporting;Research;Rhesus;Rodent Model;RUNX1 gene;Safety;SARS-CoV-2 infection;severe COVID-19;Syndrome;System;targeted sequencing;targeted treatment;tau Proteins;therapeutic genome editing;Time;Tissues;Toxic effect;Virus;Work,Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies,2339,NA,NA,NA,NA,33,NA,NA,2130169,NA
11183701,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL002541,NA,NA,1ZIAHL002541-29,NHLBI:2941694\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6481999 (contact),"MOSS, JOEL  (contact)",NA,NA,NA,9-cis-retinal;Abdomen;Actins;Affect;African American;age related;Agreement;aldehyde dehydrogenases;alitretinoin;Alveolar Macrophages;alveolar type II cell;Amino Acids;Angiomyolipoma;Antibodies;Asian;autosome;Benign;Binding;Biological Assay;Biological Markers;Biological Process;Blood;Blood Vessels;Body Fluids;C-terminal;caldesmon;Cardiac Myocytes;Cell Cycle;Cell Differentiation process;Cell Nucleus;Cell Physiology;Cell Proliferation;Cell Separation;Cell Shape;cell type;Cells;chemokine receptor;clinical center;Clone Cells;Complement Factor H;Cultured Cells;Cyclic AMP;Cytoplasm;Cytostatics;Data;density;deprivation;Detection;Diagnosis;Disease;Disease Progression;Disease susceptibility;effusion;endoplasmic reticulum stress;Ethnic Origin;Exhibits;Family;Fibroblasts;FRAP1 gene;Frequencies;Gene Expression;gene product;Genes;Genetic;Genetic Diseases;Genetic Heterogeneity;Genetic Transcription;Growth;Helix-Turn-Helix Motifs;Homo;Hyperplasia;Hypoxia;Hypoxia Inducible Factor;Immune;improved;Inflammation;inhibitor;Invaded;Isotretinoin;Lasers;Lead;Length;Leucine Zippers;Loss of Heterozygosity;Lung;Lung Diseases;lung lesion;Lung Lymphangioleiomyomatosis;Lung nodule;Lung Transplantation;Lymphangioleiomyomatosis;Lymphangiomyoma;Lymphatic;Lymphatic Endothelium;Lymphocyte;male;Malignant Neoplasms;MART-1 Tumor Antigen;mast cell;Measures;Mediating;Meditation;melanocyte;Melanogenesis;Melanoma;Melanoma Cell;Melanosomes;member;Messenger RNA;Metabolism;metastatic process;microphthalmia-associated transcription factor;Molecular Abnormality;Molecular Target;Monoclonal Antibodies;Monophenol Monooxygenase;Motility;Movement;multi-racial;Multivariate Analysis;Mutation;MYO5A gene;Myofibroblast;Neoplasm Metastasis;Nodule;Nuclear Proteins;Nutrient;Organ;Pathogenesis;patient population;Patients;Pattern;PAX3 gene;Pharmaceutical Preparations;Phenotype;Play;Pneumothorax;Process;Proliferating;promoter;Promoter Regions;Protein Isoforms;Proteins;Publishing;pulmonary function;Pulmonary Function Test/Forced Expiratory Volume 1;Quality of life;Reaction;Regulation;Reporting;Resolution;Retina;Retinoic Acid Receptor;Reverse Transcriptase Polymerase Chain Reaction;Role;RXR;Sampling;SDZ RAD;Serum;Shapes;SILV gene;Sirolimus;skin lesion;Smooth Muscle;Smooth Muscle Myocytes;Sorting;Structure;Structure of parenchyma of lung;Syndrome;System;Testing;Therapeutic Trials;Time;Tissues;Transcript;transcription factor;Transcriptional Regulation;Tretinoin;TSC1 gene;TSC1/2 gene;TSC2 gene;Tuberous Sclerosis;tumor;Tumor Suppressor Genes;TYRP1 gene;Undifferentiated;United States National Institutes of Health;Urine;vesicle transport;Visit;Vitamin A;Western Blotting;Woman,Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM),2541,NA,NA,NA,NA,29,NA,NA,2941694,NA
11183702,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL004229,NA,NA,1ZIAHL004229-20,NHLBI:344296\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694348 (contact),"SELLERS, JAMES  (contact)",NA,NA,NA,Actins;Atomic Force Microscopy;Biological Assay;Chemicals;Complex;Disease;Electron Microscopy;Environment;F-Actin;Goals;Image Analysis;Length;Mechanics;Microfilaments;microscopic imaging;Microscopy;Molecular;Molecular Motors;Motility;Motion;Motor;Myosin ATPase;Myosin Type V;nanometer;optic trap;optical traps;Optics;Output;particle;Property;Regulation;Resolution;single molecule;Structure;Techniques;Total Internal Reflection Fluorescent;Walking,Studies Of Myosin V,4229,NA,NA,NA,NA,20,NA,NA,344296,NA
11183703,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL004232,NA,NA,1ZIAHL004232-24,NHLBI:860740\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694348 (contact),"SELLERS, JAMES  (contact)",NA,NA,NA,Actins;Adaptor Signaling Protein;Affinity;Amino Acids;arm;Auditory;Behavior;Binding;Biochemical;Biological;Biological Assay;biophysical techniques;Calmodulin;Cells;Cochlea;Collaborations;Complement;Complex;Deafblind;design;differential expression;Dimerization;Drosophila genus;Electrons;force sensor;Glass;Goals;Hearing;Holoenzymes;Human;Image Analysis;In Vitro;in vivo;Infection;Insecta;Kinetics;Light;Link;Lipid Bilayers;Malaria;mechanical properties;member;Membrane;Membrane Proteins;Microfilaments;microscopic imaging;Mitochondria;Molecular;monomer;Motility;Motor;mutant;Mutation;Myosin ATPase;Nonmuscle Myosin Type IIA;Orthologous Gene;paralogous gene;Parasites;particle;Plasmodium;Play;Process Measure;Property;Protein Isoforms;Proteins;Recombinant Proteins;Recombinants;reconstitution;Regulation;Regulatory Element;Research;RNA Splicing;Role;sensor;sensory system;single molecule;Slide;Structure;Surface;System;Universities;Usher Syndrome Type 1;Vermont;Vision,Expression Studies of Other Unconventional Myosins,4232,NA,NA,NA,NA,24,NA,NA,860740,NA
11183704,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005062,NA,NA,1ZIAHL005062-22,NHLBI:616285\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,7866715 (contact),"LEDERMAN, ROBERT J (contact)",NA,NA,NA,Adopted;Adult;Biological;Cardiology;Cardiovascular system;Catheterization;Catheters;clinical application;clinical center;clinical development;clinical practice;Complex;Development;Devices;Disease;Educational process of instructing;Educational workshop;Europe;Femur;heart function;Human;Image;Intervention;Lesion;Lung;Magnetic Resonance Imaging;Measures;Mechanics;Medical center;Myocardial;North America;novel;Patients;Performance;Pulmonary Artery Catheterization;Radiation;radio frequency;Research;System;Techniques;Time;United States National Institutes of Health;Water;Work;X-Ray Medical Imaging,MRI cardiovascular catheterization applications,5062,NA,NA,NA,NA,22,NA,NA,616285,NA
11183705,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005101,NA,NA,1ZIAHL005101-20,NHLBI:1067169\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,1928065 (contact),"HWANG, PAUL M. (contact)",NA,NA,NA,Affect;bench to bedside;Biology;cancer prevention;cardiovascular health;Cardiovascular system;Chemoprevention;chemotherapy;Chronic;Clinical Research;Collaborations;Disease;early onset;Extramural Activities;Fatigue;Germ-Line Mutation;Heart Diseases;insight;interest;Investigation;Laboratories;Li-Fraumeni Syndrome;Malignant Neoplasms;Mediator;Metabolism;Metformin;Mitochondria;mitochondrial metabolism;Molecular;mouse model;mutant mouse model;novel;Patients;prevent;Regulation;Research Personnel;Role;TP53 gene;translational study;tumorigenesis,Mitochondrial regulation and function in cancer and cardiovascular biology,5101,NA,NA,NA,NA,20,NA,NA,1067169,NA
11183706,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005102,NA,NA,1ZIAHL005102-20,NHLBI:3013549\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416539 (contact),"SACK, MICHAEL  (contact)",NA,NA,NA,Bioinformatics;biological systems;Caloric Restriction;CD4 Positive T Lymphocytes;Cells;Clinical;detection of nutrient;Disease;Fasting;Homeostasis;Human;Immune;immune function;Immune system;Immunity;immunoregulation;Inflammation;Inflammatory;Link;Mediating;Metabolic Pathway;Metabolism;metabolomics;mimetics;Mitochondria;monocyte;novel;Pathway interactions;Play;Proteomics;Regulation;Regulatory Pathway;Role;transcriptome sequencing;Work,Metabolic pathways linked to immunity,5102,NA,NA,NA,NA,20,NA,NA,3013549,NA
11183707,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005104,NA,NA,1ZIAHL005104-17,NHLBI:3092174\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,1929674 (contact),"WATERMAN, CLARE MICHAL (contact)",NA,NA,NA,3-Dimensional;Actins;Actomyosin;Adaptor Signaling Protein;Adhesions;Adhesives;Adopted;advanced prostate cancer;Aneurysm;Apical;Area;Atherosclerosis;Back;Binding Proteins;Biochemical;Biological Models;biophysical techniques;Biophysics;Blood Vessels;Breast;Bulla;Burn injury;Cadherins;cancer cell;Cardiovascular Diseases;CASP1 gene;CD44 gene;Cell Adhesion;cell behavior;Cell Culture Techniques;Cell Cycle Progression;Cell Death;Cell Line;Cell membrane;cell motility;Cell Nucleus;Cell Polarity;Cell Shape;Cells;Centrosome;Cessation of life;Chemotaxis;Cholesterol;chromatin remodeling;Collaborations;Complex;constriction;cytokine;Cytoskeleton;Decision Making;Defect;Development;Diameter;Disease;Disease Progression;Disseminated Malignant Neoplasm;Dissociation;Drug Targeting;EGF gene;Embryonic Development;emerin;endothelial dysfunction;Endothelium;Engineering;Epidermal Growth Factor Receptor;Epigenetic Process;Event;Exhibits;experience;Extracellular Matrix;Failure;first responder;Focal Adhesions;Friction;Generations;Genes;Genetic Heterogeneity;Goals;Growth Factor;Growth Factor Receptors;Hemorrhage;Host Defense;Human;Human Resources;IL18 gene;Image;Immune response;Immune System Diseases;In Vitro;in vitro Model;Infection;Inflammasome;Inflammation;Inflammatory;Inherited;Innate Immune System;innovative technologies;insight;Integrins;lamin B receptor;Lasers;Leukocytes;Leukotriene B4;light microscopy;Liver;Lytic;malformation;Malignant Breast Neoplasm;Malignant Neoplasms;Measurement;Measures;mechanical signal;mechanical stimulus;Mechanics;mechanotransduction;Mediating;melanocyte;Melanoma Cell;Membrane;Metastatic Melanoma;Microfilaments;Microtubule-Organizing Center;Microtubules;migration;Modeling;Molecular;Monitor;Monomeric GTP-Binding Proteins;Morphogenesis;Morphology;Mouse Embryonic Stem Cells;Movement;Mus;nanoscale;natural Blastocyst Implantation;Nervous System;neutrophil;Neutrophil Infiltration;Nuclear;Nuclear Envelope;Organelles;Output;overexpression;Oxidoreductase;Pathology;Pathway interactions;Patients;Peptide Hydrolases;Permeability;Phagocytosis;Phosphotransferases;physical process;Physical shape;Physiological;pluripotency;Pluripotent Stem Cells;polarized cell;Polymers;Printing;Process;programs;Proliferating;Prostate;protein protein interaction;Proteins;Pulse Rates;Pump;receptor;receptor expression;recruit;Regulation;Research;Resolution;response;Role;Scaffolding Protein;segregation;self organization;sensor;Shapes;Signal Transduction;Site;Small Interfering RNA;small molecule inhibitor;SOX1 gene;Speed;Sterols;Stimulus;Stress;Stroke;Study models;Surface;Syndrome;System;temporal measurement;Testing;three dimensional cell culture;Time;tissue culture;Transcriptional Activation;Translating;transmission process;treatment strategy;tumor;tumor progression;Up-Regulation;Vascular Diseases;Vascular System;Work;wound;wound healing,Cell Migration in 3D microenvironments,5104,NA,NA,NA,NA,17,NA,NA,3092174,NA
11183708,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005105,NA,NA,1ZIAHL005105-17,NHLBI:545678\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,1929674 (contact),"WATERMAN, CLARE MICHAL (contact)",NA,NA,NA,"3-Dimensional;Actins;Adhesions;Adhesives;Adopted;Binding;Biochemical;biophysical techniques;C-terminal;Cadherins;CDC2 gene;Cell Adhesion;cell behavior;cell cortex;Cell Culture Techniques;Cell Cycle Progression;Cell membrane;cell motility;Cell Nucleus;Cell Shape;Cells;Cessation of life;Collaborations;Cyclin B;Cytoskeleton;Data;Decision Making;Development;Dissociation;Drops;Drug usage;Embryonic Development;Environment;Event;Excision;Extracellular Matrix;ezrin;Family;Fibroblasts;Focal Adhesions;Friction;Gene Expression;Generations;Goals;Human Resources;Immune response;Immune System Diseases;innovative technologies;insight;Integrins;light microscopy;link protein;Malignant Neoplasms;Measurement;Measures;mechanical properties;mechanical stimulus;Mechanics;mechanotransduction;Mediating;Membrane;Microfilaments;Microtubules;migration;mimetics;Mitosis;Mitotic;Modulus;moesin;Molecular;Molecular Biology;Morphogenesis;Morphology;Mutate;N-terminal;nanoscale;Nervous System;Nuclear;Nuclear Translocation;Organelles;Output;Pathway interactions;Phagocytosis;Phase;Phosphatidylinositol 4,5-Diphosphate;Phosphorylation;Phosphotransferases;Physical condensation;physical process;Physiological;Plasma Cells;polarized cell;polyacrylamide;Polymers;Process;programs;Proliferating;Prophase;Protein Family;protein protein interaction;Proteins;radixin protein;Regulation;Research;Resolution;response;rho;Role;self organization;Signal Pathway;Silicones;Site;Sorting;Stimulus;Surface;Techniques;temporal measurement;tensin;Testing;Time;Traction;Translating;transmission process;Variant;Vascular Diseases;Vascular System;wound healing",Integration of Actin Dynamics and Adhesion in Cell Migration,5105,NA,NA,NA,NA,17,NA,NA,545678,NA
11183709,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005199,NA,NA,1ZIAHL005199-18,NHLBI:215254\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416539 (contact),"SACK, MICHAEL  (contact)",NA,NA,NA,Acetyltransferase;Biology;Calcium;Deacetylase;design;detection of nutrient;Development;Diabetes Mellitus;Disease;Endoplasmic Reticulum;Endosomes;Functional disorder;functional genomics;genetic regulatory protein;Gluconeogenesis;Goals;in vivo;Insulin Resistance;Laboratories;Link;Lipids;Lysine;Lysosomes;Metabolic;Metabolic Pathway;Metabolism;Mitochondria;mitochondrial dysfunction;Mitochondrial Proteins;Modification;mouse model;Nutrient;Obesity;Phenotype;Post-Translational Protein Processing;protein function;Proteins;Quality Control;Regulation;Role;ubiquitin ligase;Work,Metabolic Regulation in the Pathophysiology of Disease,5199,NA,NA,NA,NA,18,NA,NA,215254,NA
11183710,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005401,NA,NA,1ZIAHL005401-33,NHLBI:1845545\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694336 (contact),"LEONARD, WARREN J (contact)",NA,NA,NA,Adoptive Transfer;Adult T-Cell Leukemia/Lymphoma;aerobic glycolysis;Affinity;Agonist;Allergic;Antibodies;Antitumor Response;Autoimmune;Autoimmune Diseases;B-Lymphocytes;Binding;Biological;Biology;CD27 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;cell type;Cells;chimeric antigen receptor T cells;ChIP-seq;Chromatin;Chromatin Interaction Analysis by Paired-End Tag Sequencing;Citric Acid Cycle;Closure by clamp;CRISPR/Cas technology;cytokine;Cytokine Receptors;Data;Development;differentiation in vitro;dimer;Dimerization;Disease;effector T cell;Elements;Engineering;Enhancers;Event;exhaustion;exosome;Experimental Autoimmune Encephalomyelitis;Family;Gene Expression Regulation;Generations;Genes;genetic analysis;genome-wide;Genomic approach;Goals;graft vs host disease;Granulocyte-Macrophage Colony-Stimulating Factor;Haplotypes;Helminths;Host Defense;Human;human disease;Human T-lymphotropic virus 1;IFNG gene;IL2RA gene;IL4R gene;IL6ST gene;IL7 gene;Immune checkpoint inhibitor;Immune response;immune system function;immunodeficiency;in vivo;Inbred Strains Mice;Induction of Apoptosis;Inflammatory;Inflammatory Bowel Diseases;insight;interest;Interferons;Interleukin 2 Receptor;Interleukin 2 Receptor Gamma;Interleukin-15;interleukin-15 receptor;Interleukin-2;interleukin-21;interleukin-21 receptor;Interleukin-4;Interleukin-9;IRF4 gene;Knock-in Mouse;Lactate Dehydrogenase;Legal patent;LIM Domain;Maintenance;Malignant Neoplasms;Mediating;Melanoma;member;Memory;Metabolism;Methodology;Modeling;Molecular;monocyte;Mus;Mutate;Names;Natural Killer Cells;neuroinflammation;novel;novel diagnostics;novel strategies;novel therapeutics;Nuclear Family;Nuclear Receptors;Oncogenic;Outcome;Oxidative Phosphorylation;pathogen;Pathologic;Phenotype;Physiological;Play;PRDM1 gene;prevent;Production;Proliferating;promoter;Promoter Regions;Protein Engineering;Protein Family;Proteins;Proto-Oncogene Proteins c-jun;Pyruvate;receptor;Receptor Signaling;Regulation;Regulatory T-Lymphocyte;Reporting;Repression;response;Role;Severity of illness;Shapes;Signal Induction;Signal Transduction;STAT protein;STAT1 gene;STAT3 gene;Stat5 protein;STAT5B gene;stem cells;stemness;synergism;System;T cell differentiation;T memory cell;T-Cell Activation;T-Lymphocyte;Th1 Cells;Th2 Cells;Time;TP53 gene;Transcription Factor AP-1;Transgenic Mice;translational potential;Transplantation Tolerance;tumor;Tyrosine Phosphorylation;Variant;Virus;X-Linked Severe Combined Immunodeficiency;XBP1 gene,IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system,5401,NA,NA,NA,NA,33,NA,NA,1845545,NA
11183711,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005402,NA,NA,1ZIAHL005402-33,NHLBI:1845545\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694336 (contact),"LEONARD, WARREN J (contact)",NA,NA,NA,3-Dimensional;Adoptive Transfer;adult T-cell leukemia cell;Adult T-Cell Leukemia/Lymphoma;Affect;Agonist;Allergic;Alopecia;Attenuated;Autoimmune;Autoimmune Diseases;Axon;B-Lymphocytes;BCL6 gene;Binding;Biological;Biological Process;biomarker discovery;CD27 Antigens;CD8-Positive T-Lymphocytes;Cell Adhesion Molecules;Cell Differentiation process;Cell Physiology;cell type;Cells;chimeric antigen receptor T cells;chromatin immunoprecipitation;Chromatin Structure;Clathrin;Closure by clamp;Collaborations;Coupled;CRISPR/Cas technology;cytokine;Cytokine Receptors;Data;Defect;Dendritic Cells;Development;dimer;Disease;DNA sequencing;Down-Regulation;effector T cell;EGR2 gene;Elements;Endocytosis;Enhancers;epigenome;Event;exhaustion;Eyelid structure;Family;Functional disorder;Gene Expression;Genes;Genetic;Genetic Enhancer Element;Genetic Transcription;genome-wide;Goals;graft vs host disease;Granulocyte-Macrophage Colony-Stimulating Factor;Helminths;Helper-Inducer T-Lymphocyte;Homing;Host Defense;Human;human disease;Human T-lymphotropic virus 1;IL2 gene;IL2RA gene;IL7 gene;Imides;Immune;Immune response;immune system function;immunodeficiency;Immunologics;immunoregulation;in vivo;Inbred BALB C Mice;Induction of Apoptosis;Inflammatory;insight;Interleukin 2 Receptor;Interleukin 2 Receptor Gamma;Interleukin 4 Receptor;Interleukin-15;interleukin-15 receptor;Interleukin-2;interleukin-21;interleukin-21 receptor;Interleukin-4;Interleukin-9;IRF4 gene;Knock-in Mouse;Link;Malignant - descriptor;Malignant Neoplasms;Maps;Mediating;Melanoma;mimetics;Modeling;Molecular;monocyte;Multiple Myeloma;multiple omics;Mus;mutant;Mutate;myelination;Names;Natural Killer Cells;novel;novel diagnostics;novel strategies;novel therapeutics;pathogen;Pathogenicity;Pathologic;Peripheral;Pharmaceutical Preparations;Phenotype;Physiological;Population;PRDM1 gene;Proliferating;promoter;protein activation;protein expression;Protein Family;Proteins;Proto-Oncogene Proteins c-jun;receptor;receptor expression;Receptor Signaling;Regulation;Regulatory T-Lymphocyte;Reporting;Repression;response;Response Elements;Role;Schwann Cells;Signal Induction;Signal Transduction;STAT protein;STAT1 gene;STAT3 gene;Stat5 protein;STAT5B gene;System;T-Cell Activation;T-Lymphocyte;Therapeutic;three dimensional structure;thymocyte;Thymus Gland;Time;transcription factor;Transcription Factor AP-1;transcriptome sequencing;Transgenic Mice;tumor;Tyrosine Phosphorylation;user-friendly;Variant;Virus;X-Linked Severe Combined Immunodeficiency,IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action,5402,NA,NA,NA,NA,33,NA,NA,1845545,NA
11183712,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005408,NA,NA,1ZIAHL005408-17,NHLBI:1845545\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694336 (contact),"LEONARD, WARREN J (contact)",NA,NA,NA,Adoptive Transfer;aerobic glycolysis;angiogenesis;anti-tumor agent;Antigens;Antineoplastic Agents;Antitumor Response;Apoptosis;Autoimmune Diseases;autoimmune uveitis;Autoimmunity;autosome;B-Cell Activation;B-Lymphocytes;BCL2L11 gene;Biological;Biology;CD27 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Physiology;Cell Survival;cell type;Cells;Cellular immunotherapy;Chronic;Citric Acid Cycle;Collaborations;Collagen Arthritis;cytokine;Cytokine Receptors;cytotoxic;Dendritic Cells;Development;Disease;Dose;Elements;Endothelial Cells;Endothelium;Environment;Event;exhaustion;Exhibits;exosome;extracellular vesicles;Family;gain of function;Genes;Glucocorticoids;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Granzyme;Helper-Inducer T-Lymphocyte;Hindlimb;Human;human disease;Hyper-IgE Syndrome;Hypoxia;IL7 gene;IL7R gene;Immune;Immune response;immune system function;immunodeficiency;Immunoglobulins;Impairment;Induction of Apoptosis;Infection;Insulin-Dependent Diabetes Mellitus;interest;Interferon Type II;Interferons;Interleukin 2 Receptor;Interleukin 2 Receptor Gamma;Interleukin-1;Interleukin-10;Interleukin-15;Interleukin-2;interleukin-21;interleukin-21 receptor;Interleukin-4;Interleukin-9;IRF4 gene;Ischemia;ITGAX gene;JAK3 gene;Knockout Mice;Knowledge;Laboratories;Lactate Dehydrogenase;Legal patent;LIM Domain;Lupus;Lymphocytic choriomeningitis virus;Lymphopenia;Malignant Neoplasms;Mediating;Mediator;Memory;Metabolism;MicroRNAs;mimetics;mouse model;mRNA Expression;Murine pneumonia virus;Mus;Mutate;Mutation;Names;Natural Immunity;Natural Killer Cells;neoplastic;neoplastic cell;neutrophil;NF-kappa B;novel;novel diagnostics;novel therapeutics;Nuclear Family;Nuclear Receptors;Pathogenicity;Pathologic;Pathway interactions;Patients;Perfusion;Peripheral arterial disease;Phenocopy;Phenotype;Phosphotransferases;Physiological;PRDM1 gene;prevent;Process;Production;programs;Proliferating;Property;Proteins;Proto-Oncogene Proteins c-jun;Pyruvate;receptor;Receptor Activation;receptor expression;Recovery;Reporting;response;Role;Signal Induction;Signal Transduction;Staphylococcus aureus;STAT1 gene;STAT3 gene;stem cells;System;T cell differentiation;T memory cell;T-Lymphocyte;Therapeutic;Time;Transcription Factor AP-1;Transgenic Organisms;translational potential;tumor;Tumor Immunity;Uveitis;Work;X-Linked Severe Combined Immunodeficiency;XBP1 gene,IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system,5408,NA,NA,NA,NA,17,NA,NA,1845545,NA
11183713,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005409,NA,NA,1ZIAHL005409-17,NHLBI:615182\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694336 (contact),"LEONARD, WARREN J (contact)",NA,NA,NA,4T1;Acids;Acute;Affect;Allergic;Allergic Disease;Allergic inflammation;aluminum sulfate;Anti-viral Response;Antibody Formation;Asthma;asthma model;Atopic Dermatitis;autocrine;autosome;B-Lymphocytes;Biological Models;Biology;Brain;Breast;Breast Melanoma;CD27 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Physiology;Collaborations;Complement;Complement Activation;cytokine;Cytokine Activation;Cytokine Receptors;Data;Dendritic Cells;Development;Disease;drug induced liver injury;Epithelial Cells;Epithelium;Event;Family;Genes;Goals;Growth;Hair follicle structure;helminth infection;Human;human disease;IL7 gene;IL7R gene;Immune;Immune response;immune system function;Immunity;Immunization;immunodeficiency;Inflammasome;Inflammation;Influenza;Interleukin 2 Receptor;Interleukin 2 Receptor Gamma;Interleukin-10;Interleukin-13;Interleukin-15;Interleukin-2;interleukin-21;Interleukin-4;Interleukin-9;JAK1 gene;JAK2 gene;Link;Literature;Lung;Lymphocytic choriomeningitis virus;Lymphoid Cell;Maintenance;Malignant Breast Neoplasm;Malignant Neoplasms;Manuscripts;Mediating;Memory;methicillin resistant Staphylococcus aureus;microbial;Molecular;mouse model;Mus;Mutate;Mutation;Names;Natural Killer Cells;Neoplasm Metastasis;neoplastic;neutrophil;Papain;Pathogenesis;Pathogenicity;Pathway interactions;Phenotype;Phosphotransferases;Physiology;Play;Production;programs;Proliferating;Publishing;Pulmonary Inflammation;Pyroglyphidae;Reactive Oxygen Species;receptor;Regulatory T-Lymphocyte;Reporting;response;Retinoids;Role;Sebaceous Glands;Secondary to;Signal Transduction;Skin;Solid Neoplasm;Stat5 protein;Streptococcus pyogenes;Surface;Symbiosis;System;T cell response;T memory cell;T-Cell Development;T-Lymphocyte;Th2 Cells;Therapeutic;Time;TSLP gene;tumor;Virus Diseases;Work;X-Linked Severe Combined Immunodeficiency,IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems,5409,NA,NA,NA,NA,17,NA,NA,615182,NA
11183714,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005702,NA,NA,1ZIAHL005702-19,NHLBI:1091898\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361703 (contact),"MUKOUYAMA, YOH-SUKE  (contact)",NA,NA,NA,Address;Adult;Affect;afferent nerve;Afferent Neurons;Anatomy;Animal Model;Arteries;Axon;Binding Proteins;Biology;Blood Vessels;Calcium;calcium indicator;Capsaicin;cell type;Cells;Characteristics;chemokine;Complex;coronary vasculature;CXCR4 gene;CXCR4 Receptors;deep learning;designer receptors exclusively activated by designer drugs;Development;Diameter;diet-induced obesity;Disease;Ear;Embryo;Endothelial Cells;Endothelium;Epidermis;Exhibits;experimental study;Fiber;Fluorescence;Forelimb;Functional disorder;gain of function;Gene Expression Profiling;Genes;Genetic;genetic manipulation;Goals;high resolution imaging;Hypersensitivity;Hypoxia;Image;image processing;imaging modality;imaging system;Impairment;in vivo;inhibitor;insulin signaling;interest;Invaded;Investigation;keratinocyte;Knock-in Mouse;Knock-out;Limb structure;loss of function mutation;Maintenance;Manuscripts;Mediating;Methods;Modeling;Molecular;Morphogenesis;Morphology;mouse model;Mus;Mutation;Nerve;nerve supply;Nervous System;Neuropathy;neurovascular;neutralizing antibody;Nociceptors;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutic intervention;Obesity;Organ;Organ Culture Techniques;Oxygen;pain behavior;Pain Measurement;painful neuropathy;Pathologic;Pathway interactions;Pattern;peripheral blood vessel;Peripheral Nerves;Phenotype;Phosphatidylinositols;PIK3CG gene;Prediabetes syndrome;Preparation;programs;promoter;receptor;recruit;Reporting;Research;Resolution;response;Role;Sensory;Signal Transduction;Skin;Smooth Muscle Myocytes;stem cells;Stromal Cell-Derived Factor 1;Time;Tissues;tool;transcription factor;TRPV1 gene;Tumor Suppressor Proteins;Up-Regulation;Vascular Smooth Muscle;Vascular System;Visualization;wortmannin,The study of stem cell and neuro-vascular development,5702,NA,NA,NA,NA,19,NA,NA,1091898,NA
11183715,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL005801,NA,NA,1ZIAHL005801-22,NHLBI:1665175\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694360 (contact),"ZHAO, KEJI  (contact)",NA,NA,NA,3-Dimensional;Active Sites;Acute;Address;Animals;Architecture;ATP phosphohydrolase;Auxins;Bar Codes;Binding;Biological;Biological Assay;Biological Models;CCL4 gene;CD4 Positive T Lymphocytes;Cell Nucleus;cell type;Cells;Chromatin;Chromatin Loop;chromatin modification;cohesin;Complex;cost;Data;Data Set;Deoxyribonuclease I;Deoxyribonucleases;Development;Disease;DNA;DNA Methylation;DNase I hypersensitive sites sequencing;Elements;embryonic stem cell;Enhancers;Enzymes;EP300 gene;Epigenetic Process;epigenome;epigenomics;experimental study;gene conservation;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Genes;Genome;genome-wide;genome-wide analysis;genomic locus;genomic profiling;Genomics;Goals;Heterochromatin;Heterogeneity;Hi-C;histone modification;host cell factor C1;Human;Hypersensitivity;in vivo;indexing;interest;Knock-in;Leukocytes;Ligation;magnetic beads;Malignant Neoplasms;Maps;Mediating;Memory;Methods;Micrococcal nuclease digestion of chromatin followed by sequencing;Modality;Mouse Embryonic Stem Cells;Mus;Mutation;Names;Nature;novel;Nucleic Acid Regulatory Sequences;Nucleosomes;Pathologic;Play;Population;Positioning Attribute;Production;promoter;Property;Proteins;Regulatory Element;Resolution;RNA;RNA Polymerase II;Role;Sampling;Signal Transduction;single cell ATAC-seq;single molecule;Site;SMARCA4 gene;Structure;System;T4 DNA Ligase;Techniques;Technology;Three-dimensional analysis;tool;transcription factor;Transcription Initiation Site;Transcriptional Regulation;Transferase;Undifferentiated;Variant;Visualization,Genome-wide analysis of chromatin modifications,5801,NA,NA,NA,NA,22,NA,NA,1665175,NA
11183716,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006001,NA,NA,1ZIAHL006001-18,NHLBI:4538289\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416551 (contact),"LEVY, DANIEL  (contact)",NA,NA,NA,"Activities of Daily Living;Adult;Affect;Aging;Airway Disease;Alleles;Alternative Splicing;Animals;Anti-Inflammatory Agents;Area;Asthma;asthmatic patient;Atherosclerosis;biobank;Biological Markers;Biology;biomarker identification;biomarker panel;biomarker signature;Blood;Blood Pressure;blood pressure regulation;Bronchoalveolar Lavage Fluid;C-reactive protein;candidate identification;Cardiovascular Diseases;cardiovascular disorder risk;Cessation of life;Chronic;Chronic lung disease;Chronic Obstructive Pulmonary Disease;chronic respiratory disease;clinical epidemiology;Cloud Computing;comorbidity;Complex;Computational Biology;Coronary heart disease;Data;Data Analyses;data exchange;Data Set;database of Genotypes and Phenotypes;Diabetes Mellitus;diagnostic biomarker;Dimensions;disability;Disease;disorder risk;DNA Methylation;DNA sequencing;early detection biomarkers;Engineering;Environmental Pollutants;environmental tobacco smoke exposure;Epigenetic Process;Fibrinogen;Forced expiratory volume function;Framingham Heart Study;Functional disorder;Genes;Genetic;genetic epidemiology;Genetic Predisposition to Disease;genome-wide;Genomic approach;Genomics;Genotype;Goals;Heart;Heart failure;Histopathology;Human;Hypertension;hypertension treatment;improved;Individual;Infection;Inflammation;Inflammatory;insight;Interstitial Lung Diseases;Intervention;Intramural Research;Knowledge;Laboratories;lipid disorder;Lung;Lung Capacity;Lung Diseases;lung volume;Malignant Neoplasms;Manuscripts;Mathematical Computing;Measures;Mendelian randomization;Metabolic syndrome;Methods;Mission;Molecular;mortality;Mus;National Heart, Lung, and Blood Institute;Nature;novel;Obesity;Paper;Participant;Pathology;Pathway interactions;Pattern;Phase;Phenotype;Plasma;Plasma Proteins;Population;Population Sciences;Population Study;pre-clinical;predictive marker;premature;prevent;Prevention;Prevention strategy;Process;programs;Property;protein biomarkers;Proteins;Proteomics;pulmonary function;Pulmonary Function Test/Forced Expiratory Volume 1;Pulmonary Inflammation;Pulmonary Sarcoidosis;Pulmonary Surfactant-Associated Protein D;Quantitative Trait Loci;receptor for advanced glycation endproducts;Research;Research Personnel;Resources;Respiration Disorders;respiratory;Respiratory Disease;Risk Assessment;Risk Factors;risk stratification;Role;Science;screening;Secretory Cell;secretory protein;Smoking;Spirometry;Statistical Computing;Stroke;Structure;Systems Biology;Testing;therapeutic target;Time;trait;Trans-Omics for Precision Medicine;transcriptome sequencing;transcriptomics;United States National Institutes of Health;Vital capacity;whole genome;Work;working group",Framingham Project/Levy,6001,NA,NA,NA,NA,18,NA,NA,4538289,NA
11183717,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006007,NA,NA,1ZIAHL006007-17,NHLBI:1999033\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694380 (contact),"TISDALE, JOHN  (contact)",NA,NA,NA,Ablation;Acute;Acute Graft Versus Host Disease;Adult;Age;Allogeneic Bone Marrow Transplantation;Allogenic;allograft rejection;Allografting;Amendment;Animal Model;Antibodies;Blood;CD3 Antigens;Child;Chimerism;chronic graft versus host disease;clinical application;Clinical Protocols;Clinical Trials;comorbidity;conditioning;Cross-Sectional Studies;curative treatments;Cyclosporine;Data Analyses;design;Disease;Disease-Free Survival;Disseminated Malignant Neoplasm;Dose;Engraftment;follow-up;Frequencies;Gene Transfer;Genes;Genotype;Globin;Goals;graft vs host disease;heart function;Hematological Disease;Hematopoiesis;Hematopoietic;hematopoietic engraftment;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hemoglobinopathies;Heterozygote;Human;hydroxyurea;Immune response;Immunosuppression;improved;Individual;Institutional Review Boards;Investigation;irradiation;Life Expectancy;Lung Diseases;Marrow;Mathematics;Measures;Mendelian disorder;Modeling;mortality;mouse model;Mus;Neurocognitive;Neuropsychological Tests;Non-Malignant;Organ;Organ failure;Outcome Measure;Pain;Patients;peripheral blood;Peripheral Blood Stem Cell;Phenotype;Production;programs;Prospective Studies;Proto-Oncogene Protein c-kit;Protocols documentation;Publishing;pulmonary function;Quality of life;Regimen;Renal function;Reporting;Risk;safety and feasibility;Second Primary Cancers;secondary analysis;secondary endpoint;secondary outcome;Severities;Siblings;Sickle Cell Anemia;Sickle Cell Trait;Signal Transduction;Sirolimus;Source;Stem Cell Mobilization;Stroke;Supportive care;synergism;T-Lymphocyte;Testing;Thalassemia;Time;Toxic effect;Transplant Recipients;Transplantation;vaso-occlusive crisis,Nonmyeloablative allogeneic PBSC in globin disorders,6007,NA,NA,NA,NA,17,NA,NA,1999033,NA
11183718,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006008,NA,NA,1ZIAHL006008-17,NHLBI:1499275\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694380 (contact),"TISDALE, JOHN  (contact)",NA,NA,NA,absorption;Address;Anemia;Animal Experimentation;Animal Model;Animals;Antibody-drug conjugates;Autologous;B-Lymphocytes;beta Globin;beta Thalassemia;Biological Models;Biotin;Bone Marrow Transplantation;Busulfan;Capsid;Cells;cellular transduction;chemotherapeutic agent;Clinical;clinical application;clinical development;Clinical Research;Clinical Trials;clinically relevant;Clonal Hematopoietic Stem Cell;Communication;conditioning;cross reactivity;Disease;dosage;Dose;Drug Kinetics;endonuclease;Engraftment;Enhancers;Erythrocytes;Erythroid;Fetal Hemoglobin;Formulation;Gene Expression;gene therapy;Gene Transfer;Gene Transfer Techniques;gene transfer vector;gene-editing approach;Genes;genetic manipulation;genetically modified cells;Globin;Hematopoiesis;Hematopoietic stem cells;Hemoglobinopathies;HIV;Homologous Transplantation;Human;human model;improved;in vivo;in vivo Model;individual patient;Infusion procedures;Insertional Mutagenesis;integration site;Intravenous;irradiation;Journals;Label;lentiviral-mediated;Lentivirus Vector;life span;Macaca mulatta;Manuscripts;Marrow;mathematical model;Measures;Medicine;Methods;Modeling;Monitor;mouse model;Myelogenous;Myelosuppression;Nature;neutrophil;New England;nonhuman primate;Oral;peripheral blood;Peripheral Blood Stem Cell;Phenotype;Phylogenetic Analysis;Plasmids;Population;Pre-Clinical Model;preclinical development;preclinical study;Preclinical Testing;Production;promoter;Publishing;Reagent;Regulatory Element;Reporter;Reporting;Retroviral Vector;Rhesus;Risk Assessment;Rodent Model;Series;Sickle Cell;Sickle Cell Anemia;sickling;Single-Gene Defect;SIV;Source;stem cell genes;stem cells;success;T-Lymphocyte;technique development;Technology Transfer;Testing;Thalassemia;transduction efficiency;transgene expression;Transplantation;vector;Viral Vector;Whole-Body Irradiation;Work,Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease,6008,NA,NA,NA,NA,17,NA,NA,1499275,NA
11183719,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006009,NA,NA,1ZIAHL006009-17,NHLBI:1499275\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694380 (contact),"TISDALE, JOHN  (contact)",NA,NA,NA,Affect;Benign;beta Globin;Biological Assay;Blood;Bone Marrow;Bone Marrow Cells;Bone Marrow Transplantation;CD34 Antigens;CD34 gene;Cell Lineage;Cells;Clinic;clinical application;clinical practice;Clinical Trials;Disease;Elements;Engraftment;Erythroid;fitness;Gene Transfer;gene-editing approach;Genes;Genetic;Genetic Diseases;genome editing;Globin;Hematopoietic;hematopoietic differentiation;Hematopoietic stem cells;Human;human disease;insight;Lentivirus Vector;Life;Malignant - descriptor;Methodology;Modeling;Modification;Population;Positioning Attribute;postnatal;Reagent;Series;Sickle Cell Anemia;Source;stem cell engraftment;stem cell therapy;stem cells;System;Techniques;Testing;therapeutic gene;Time;tool;transduction efficiency;Transplantation;vector;Viral Vector;Xenograft Model,"Isolation, characterization, and transplantation of candidate stem cells",6009,NA,NA,NA,NA,17,NA,NA,1499275,NA
11183720,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006030,NA,NA,1ZIAHL006030-16,NHLBI:1248881\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694360 (contact),"ZHAO, KEJI  (contact)",NA,NA,NA,adaptive immune response;Affect;Asthma;Autoimmunity;Bacterial Infections;Binding;Binding Sites;Biological Process;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Differentiation process;Cell Lineage;Cells;ChIP-seq;Chromatin;Chromatin Loop;Chromatin Structure;Collaborations;Complex;cytokine;Cytokine Gene;Data;Dendritic Cells;Deposition;Development;Distant;Elements;Enhancers;Ensure;Enzymes;Epigenetic Process;epigenetic profiling;epigenetic regulation;epigenomics;Family;FOXP3 gene;GATA3 gene;Gene Expression;Genes;Genetic Transcription;genome-wide;genomic locus;Helper-Inducer T-Lymphocyte;Hematopoietic stem cells;Heritability;histone modification;Human;Hypersensitivity;IFNG gene;Immune;Immune system;Immune System Diseases;immune system function;Immunologic Memory;Immunology;Innate Immune Response;insight;interest;Interferon Type II;Interferons;Locus Control Region;Lymphoid;Lymphoid Cell;mammalian genome;Mammals;Memory;Methods;Methylation;Micrococcal nuclease digestion of chromatin followed by sequencing;Modeling;Modification;Multipotent Stem Cells;Natural Killer Cells;Nature;Nucleic Acid Regulatory Sequences;Nucleosomes;pathogen;Pathogenesis;Pathologic;Phase;Play;Population Heterogeneity;prevent;progenitor;programs;promoter;Regulatory Element;Regulatory T-Lymphocyte;Reporting;Repression;response;Rest;restraint;Role;Site;stem cells;Structure;T cell differentiation;T cell response;T memory cell;T-bet protein;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;Techniques;Th2 Cells;Thymus Gland;Trans-Activators;Transcript;transcription factor;Transcription Factor AP-1;Untranslated RNA;Viral,Epigenetic Regulation of T cell differentiation,6030,NA,NA,NA,NA,16,NA,NA,1248881,NA
11183721,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006031,NA,NA,1ZIAHL006031-16,NHLBI:1248881\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694360 (contact),"ZHAO, KEJI  (contact)",NA,NA,NA,Acceleration;Address;Affect;ATP phosphohydrolase;B-Lymphocytes;beta catenin;Binding;Body Regions;Cell Differentiation process;Cells;Chromatin;chromatin modification;chromatin remodeling;Chromatin Remodeling Factor;Chromatin Structure;Collaborations;Complex;Data;Data Set;demethylation;Deposition;derepression;Development;Developmental Gene;Disease;Dissociation;DNA;DNA Sequence;Dominant-Negative Mutation;Elements;Embryo;embryonic stem cell;Enhancers;Epigenetic Process;epigenetic regulation;epigenomics;Epitopes;GATA3 gene;Genes;Genetic Transcription;Genome;genome-wide;Goals;gut homeostasis;gut inflammation;gut-liver axis;Hematopoietic stem cells;Hepatectomy;Heterochromatin;Heterozygote;Hi-C;Higher Order Chromatin Structure;Histone H3;histone methylation;histone modification;Histone-Lysine N-Methyltransferase;Histones;Immunity;Immunology;Induced Mutation;inhibitor;insight;Intestines;KDM1A gene;KDM5B gene;knock-down;Laboratories;LIF gene;Liver;Love;Lymphoid;Lysine;Maintenance;Malignant Neoplasms;Measures;Mediating;Methylation;microbial;Micrococcal nuclease digestion of chromatin followed by sequencing;Missense Mutation;Modification;Mouse Embryonic Stem Cells;mutant;Mutation;Nature;Nervous System Disorder;Nucleic Acid Regulatory Sequences;Nucleosomes;Oncogenic;Pattern;Physiology;pigment epithelium-derived factor;Play;pluripotency;Polycomb;Positioning Attribute;PPAR alpha;Production;progenitor;promoter;Proteins;Proteomics;Regulation;Repression;Residencies;restraint;Role;self-renewal;Signal Pathway;Signal Transduction;Site;SMARCA4 gene;Source;stem;stem cell differentiation;stem cell function;stem cell proliferation;stem cells;Surface;SWI/SNF Family Complex;System;TCF Transcription Factor;Techniques;Tetanus Helper Peptide;tissue repair;Tissue-Specific Gene Expression;Tissues;transcription factor;transcriptomics;tumorigenesis;Variant,Epigenetic Regulation of Embryonic and Hematopoietic Stem Cells,6031,NA,NA,NA,NA,16,NA,NA,1248881,NA
11183722,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006039,NA,NA,1ZIAHL006039-15,NHLBI:616285\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,7866715 (contact),"LEDERMAN, ROBERT J (contact)",NA,NA,NA,Agreement;Cardiovascular system;Caring;Catheterization;Catheters;Collaborations;Dangerousness;Development;Devices;Electrocardiogram;Environment;experimental study;Heating;hemodynamics;Human;Human Subject Research;Image;Industry;interest;Intervention;Iron;Laboratories;Magnetic Resonance Imaging;magnetohydrodynamic;Medical;metallicity;Monitor;novel;Performance;Predisposition;preservation;Property;research and development;Research Personnel;Roentgen Rays;safe patient;Safety;System;technology development;Time;Tissues;tool;Translations;United States National Institutes of Health,MRI cardiovascular catheterization technology development,6039,NA,NA,NA,NA,15,NA,NA,616285,NA
11183723,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006040,NA,NA,1ZIAHL006040-15,NHLBI:2773283\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,7866715 (contact),"LEDERMAN, ROBERT J (contact)",NA,NA,NA,Ablation;Address;Adopted;Animals;Aorta;aortic valve;aortic valve replacement;artery occlusion;Bioprosthesis device;Cardiomyopathies;Catheters;Clinical;Clip;congenital heart abnormality;Coronary artery;design;Devices;Disease;Electrocardiogram;Electrosurgery;Enrollment;Future;Heart;Heart failure;Hypertrophic Cardiomyopathy;Implant;implantation;improved;Industry;industry partner;interstitial;Laboratories;Laceration;Left;Left Ventricular Function;Life;Mediation;Medicine;Mitral Valve;Modeling;Multi-Institutional Clinical Trial;Myocardial;Myocardium;novel;novel strategies;Obstruction;Patient Care;Patients;preclinical development;preservation;prevent;Procedures;Psychological reinforcement;Pump;research clinical testing;Slice;structural heart disease;Techniques;Technology;Testing;Tricuspid Valve Insufficiency;Universities;Ventricular;Ventricular Arrhythmia;ventricular hypertrophy;Ventricular Remodeling;Ventricular Tachycardia,Novel catheter treatment of structural heart and valve disease,6040,NA,NA,NA,NA,15,NA,NA,2773283,NA
11183724,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006041,NA,NA,1ZIAHL006041-15,NHLBI:1232570\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,7866715 (contact),"LEDERMAN, ROBERT J (contact)",NA,NA,NA,Ablation;Agreement;Anatomy;Aorta;aortic valve;aortic valve replacement;Arteries;Businesses;Bypass;Cardiomyopathies;Catheters;Clinical;congenital heart abnormality;Dedications;design;Devices;Electrosurgery;Forcep;Goals;Heart;Heart Atrium;Heart failure;high risk;Implant;Industry;Intervention;invention;Laboratories;Legal patent;Life;Magnetic Resonance Imaging;Medical Device;Mitral Valve;Myocardial;myocardial biopsy;Myocardium;Needles;novel;novel therapeutics;Obstruction;Operative Surgical Procedures;Pathway interactions;Patient Care;Patients;Private Sector;Procedures;prototype;repaired;Research;research and development;research clinical testing;Research Contracts;Roentgen Rays;Slice;Small Business Innovation Research Grant;Technology;tool;Translating;Tricuspid valve structure;Work,MRI and X-ray catheter design and prototyping,6041,NA,NA,NA,NA,15,NA,NA,1232570,NA
11183725,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006047,NA,NA,1ZIAHL006047-15,NHLBI:861014\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416539 (contact),"SACK, MICHAEL  (contact)",NA,NA,NA,Adaptive Immune System;Asthma;Atopic Dermatitis;Biology;Cells;Degenerative Disorder;detection of nutrient;dietary;dietary restriction;Disease;disease model;effector T cell;Enzymes;Homeostasis;Immune;immune function;immunoregulation;Inflammatory;Influenza;Innate Immune System;interest;Intervention;Laboratories;Link;Liver;Macrophage;monocyte;Mus;Organ;Organelles;Process;Protocols documentation;resilience;Role;Signal Transduction;Tissues;Work,Role of intracellular organelle homeostasis in adaptation to dietary restrictive interventions,6047,NA,NA,NA,NA,15,NA,NA,861014,NA
11183726,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006049,NA,NA,1ZIAHL006049-15,NHLBI:860740\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694348 (contact),"SELLERS, JAMES  (contact)",NA,NA,NA,Actins;Adult;Affect;Amoeba genus;Animals;Area;Bacteria;base;Binding;Biological Assay;Birth;Blindness;C-terminal;Cell Adhesion;Cells;Centrioles;Collaborations;Complex;Cytoplasmic Granules;Cytoskeleton;deaf;deafness;Defect;Diffuse;Dimerization;Drosophila genus;Embryo;Event;experience;Eye;Filopodia;fly;Genes;Hemocytes;Hemolymph;Human;Immunofluorescence Immunologic;in vitro Assay;interest;Kinesin;knock-down;Larva;Length;lens;Macrophage;Mammals;Maps;Microfilaments;Microtubules;migration;Molecular;Motility;Motor;mutant;Mutation;MYO7A gene;Myosin ATPase;novel;Organism;particle;Pathway interactions;pericentrin;Phagocytosis;Photoreceptors;Pigments;Play;protein purification;Proteins;Regulation;residence;Retinal Cone;Retinitis;RNA Interference;Role;Running;Scanning;single molecule;Stains;Structure;Time;Tissues;Transgenic Organisms;yeast two hybrid system;Yeasts,Studies of Drosophila Myosins,6049,NA,NA,NA,NA,15,NA,NA,860740,NA
11183727,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006051,NA,NA,1ZIAHL006051-15,NHLBI:1067169\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,1928065 (contact),"HWANG, PAUL M. (contact)",NA,NA,NA,blood pressure elevation;Cardiovascular Diseases;Cardiovascular system;Disease;Exercise;Health;Homeostasis;Human;Immune;Immune signaling;improved;Inflammation;insight;Isoproterenol;Maintenance;Malignant Neoplasms;Mediating;Metabolic;Mitochondria;Molecular;Myocardium;Oxidation-Reduction;Oxygen;Role;Skeletal Muscle;Stress;Translating,Redox and other mechanistic insights into cancer and cardiovascular diseases,6051,NA,NA,NA,NA,15,NA,NA,1067169,NA
11183728,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006055,NA,NA,1ZIAHL006055-15,NHLBI:1180600\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694272 (contact),"LEVINE, STEWART  (contact)",NA,NA,NA,Acute;adaptive immune response;adaptive immunity;Adoptive Transfer;Airway Disease;airway epithelium;airway hyperresponsiveness;airway inflammation;Allergic;allergic airway inflammation;Alveolar Macrophages;Apolipoprotein A-I;Apolipoprotein E;Apolipoproteins;Asthma;asthmatic;ATP binding cassette transporter 1;Attenuated;Binding;Bronchoalveolar Lavage Fluid;Caring;Cell Physiology;Cells;Clinical Immunology;cytokine;Dendritic Cells;Dermatophagoides Antigens;Development;eosinophil;Epithelial Cells;Extrinsic asthma;Genes;Goals;Goblet Cells;Granulocyte Colony-Stimulating Factor;Heterogeneity;Human;Hyperplasia;Hypersensitivity;Immunology;Inflammation;Inflammatory;insight;Interferons;Intranasal Administration;ITGAM gene;ITGAX gene;Journals;Knockout Mice;LCN2 gene;Ligands;Low Density Lipoprotein Receptor;Lung;lung microvascular endothelial cells;Macrophage;Mediating;Metaplasia;Modification;Mucous body substance;Mus;Myelogenous;neutrophil;new therapeutic target;novel;Ovalbumin;Pathogenesis;Pathway interactions;Pharmaceutical Preparations;Physiologic pulse;Play;Printing;Production;Publishing;Pyroglyphidae;receptor;receptor binding;recruit;Research;Role;single-cell RNA sequencing;TLR4 gene;uptake;VLDL receptor;Wild Type Mouse,Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis,6055,NA,NA,NA,NA,15,NA,NA,1180600,NA
11183729,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006059,NA,NA,1ZIAHL006059-15,NHLBI:345798\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694255 (contact),"MURPHY, ELIZABETH  (contact)",NA,NA,NA,Acute;Adult;Brain Hypoxia-Ischemia;C-terminal;Cardiac Myocytes;cardioprotection;Cardiovascular Diseases;Cardiovascular Physiology;Cause of Death;Cell Death;Cell Death Induction;Cell Physiology;Cells;Complex;Crista ampullaris;Cyclic GMP;cyclophilin D;Cysteine;cytochrome c;Data;Fibroblasts;Goals;Heart;Heart Diseases;heart function;Hydrogen Peroxide;Hydrophobicity;Intervention;Ischemia;Ischemic Preconditioning;Mediating;Mitochondria;Mitochondrial Proteins;Modification;Molecular Weight;Mus;Mutate;Mutation;Myocardial Ischemia;Nitric Oxide;nitrogen trioxide;novel therapeutics;OPA1 gene;Organ;oxidation;Oxidation-Reduction;Oxidative Stress;Oxidative Stress Induction;Oxygen;palmitoylation;Pathway interactions;Perfusion;Play;Post-Translational Protein Processing;prevent;Process;protein function;Protein S;protein structure;Proteins;Proteomics;Reactive Oxygen Species;Regulation;Reperfusion Therapy;Role;S-Nitrosoglutathione;SKIL gene;Sulfhydryl Compounds;Transition Elements,Role of S-nitrosylation in regulating cardiac function and disease,6059,NA,NA,NA,NA,15,NA,NA,345798,NA
11183730,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006062,NA,NA,1ZIAHL006062-15,NHLBI:99078\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2479331 (contact),"DUNBAR, CYNTHIA E (contact)",NA,NA,NA,"Adult;Allogenic;Animal Model;Animals;Arrhythmia;Autologous;Biological Assay;Biology;Cardiac;Cardiac Myocytes;CD19 gene;CD34 gene;Cell Differentiation process;Cell Therapy;cell type;Cells;Chronic;Clinical;clinical development;Clone Cells;Collaborations;Country;CRISPR/Cas technology;Derivation procedure;Detection;Development;Disease;Ectoderm Cell;Ectopic Expression;Electrophysiology (science);Endoderm Cell;Engraftment;Ensure;Euthanasia;Excision;experimental study;Exposure to;Fibroblasts;gene therapy;Genes;Genetic;Genetic Markers;Germ Layers;Goals;Health;Heart;heart rhythm;Hematopoietic;Histology;Homing;Human;human induced pluripotent stem cells;Image;Immune response;Immunodeficient Mouse;Implant;improved;in vitro Model;in vivo;induced pluripotent stem cell;induced pluripotent stem cell derived cardiomyocytes;Infarction;Inflammatory Response;intercalation;Investigation;Iodides;Life;Macaca;Macaca mulatta;Magnetic Resonance Imaging;Marrow;Mediating;Medical;Mesoderm Cell;Modeling;mouse model;Mouse Strains;Mus;Mutation;Myocardial Infarction;Myocardium;National Heart, Lung, and Blood Institute;nonhuman primate;novel;PET/CT scan;Phenotype;Physiological;pluripotency;postnatal;Pre-Clinical Model;preclinical development;prevent;Procedures;Property;Protocols documentation;Publications;Publishing;regenerative;Regenerative Medicine;Reporting;Research Personnel;Residual state;Resources;Rhesus;Safety;safety assessment;Signal Transduction;Skin;SLC5A5 gene;Somatic Cell;stem cell fate specification;stem cells;Stromal Cells;System;Teratoma;Therapeutic;Time;Tissues;tool;Tracer;transcription factor;Transplantation;tumor;United States National Institutes of Health;vector;Work;Xenograft procedure",Macaque models for preclinical development of iPSCs,6062,NA,NA,NA,NA,15,NA,NA,99078,NA
11183731,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006063,NA,NA,1ZIAHL006063-15,NHLBI:1981553\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2479331 (contact),"DUNBAR, CYNTHIA E (contact)",NA,NA,NA,Adoptive Cell Transfers;Adoptive Transfer;Aging;Alzheimer&apos;s Disease;Antibodies;ATAC-seq;Autologous;B-Lymphocytes;Bar Codes;Base Pairing;Behavior;Big Data Methods;Blood;Blood donor;Brain;Busulfan;CD34 gene;Cell Lineage;Cell Ontogeny;Cell Therapy;Cells;Central Nervous System Diseases;Characteristics;chemokine;chimeric antigen receptor T cells;Clinical;clinically relevant;Clonality;Clone Cells;Collaborations;conditioning;Cues;Cytomegalovirus;Cytomegalovirus Infections;cytotoxic;Data;Development;differential expression;Disease;Donor person;engineered NK cell;Engineering;Engraftment;Environment;Epigenetic Process;experimental study;FCGR3B gene;fighting;Gene Expression;Gene Expression Profile;gene therapy;gene-targeted therapy;Generations;Genes;Genetic;genetic manipulation;Goals;Growth;Hematopoiesis;Hematopoietic;hematopoietic engraftment;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Homing;Human;Image;Immune;Immunology;improved;In Vitro;in vivo;in vivo evaluation;in vivo imaging;Individual;Infection;insight;Interleukin-15;Investigation;Knowledge;Laboratories;Lentivirus Vector;life history;Link;Liver;Lung;Macaca;Macaca mulatta;Macrophage;Maintenance;Malignant Neoplasms;Mediating;Memory;Methodology;Methods;Microglia;Minor;Modeling;Molecular;Monkeys;mouse model;Mus;Myeloid Cells;Natural Killer Cells;NCAM1 gene;nonhuman primate;novel;novel strategies;Organ;Output;Pattern;Phenotype;Plasma Cells;Population;Positioning Attribute;post-transplant;Primates;Process;Protein Secretion;Reaction;receptor;recruit;Regimen;Reproducibility;Residual state;response;Retrieval;segregation;self-renewal;single-cell RNA sequencing;SLC5A5 gene;Sorting;Spleen;stem cell engraftment;Surface;Techniques;Testing;Time;Tissues;trafficking;Transgenes;Transplantation;tumor;Vaccination;vector;Viral;Virus Diseases;Waxes;Work;Xenograft Model;Xenograft procedure,"Clonal and imaging analyses of in vivo hematopoiesis, immune cell ontogeny and adoptive cell therapies",6063,NA,NA,NA,NA,15,NA,NA,1981553,NA
11183732,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006064,NA,NA,1ZIAHL006064-15,NHLBI:1836279\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571449 (contact),"TJANDRA, NICO  (contact)",NA,NA,NA,Address;Adopted;alpha helix;Amyloid beta-Protein;Antibodies;Apoptosis;Apoptotic;Area;Bax protein;BCL-2 Protein;BCL2 gene;BCL2L1 gene;Binding;biophysical techniques;C-terminal;Cell Death;Cell Physiology;Cell Survival;Cells;Cellular Assay;Classification;Collaborations;Complex;confocal imaging;Coupling;crosslink;Cryoelectron Microscopy;Cytoplasm;Cytosol;Data;design;Detergents;electric field;Electrons;environmental change;expectation;Family;Fiber;Fluorescence Resonance Energy Transfer;fluorophore;Goals;Gold;Heterogeneity;human disease;humanin;Hybrids;Hydrophobicity;in vivo Model;Inhibition of Apoptosis;interdisciplinary approach;interest;Label;Lanthanoid Series Elements;Length;Location;Measurement;Measures;member;Membrane;Methodology;Methods;Micelles;Mitochondria;mitochondrial membrane;Molecular;Molecular Conformation;Morphology;mutant;Neurons;neuroprotection;new technology;Nuclear Magnetic Resonance;Outer Mitochondrial Membrane;Patients;Peptides;Permeability;Physiologic pulse;Physiological;Play;prevent;Property;Protein Family;protein oligomer;protein structure;Proteins;Protocols documentation;reaction rate;Regulation;Relaxation;Research;Residual state;Scheme;Series;Signal Transduction;Site;Structure;Targeted Research;targeted treatment;Testing;therapeutic development;three dimensional structure;Time;two-dimensional;Variant;Vesicle,Regulation of mitochondria morphology,6064,NA,NA,NA,NA,15,NA,NA,1836279,NA
11183733,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006065,NA,NA,1ZIAHL006065-15,NHLBI:844742\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571467 (contact),"KNUTSON, JAY R (contact)",NA,NA,NA,absorption;Binding;Binding Proteins;cancer cell;Cancer Cell Growth;Cell Nucleus;Cells;Chromatin;cofactor;Collaborations;Collection;Color;Correlative Study;Dendrimers;Detection;Development;Device or Instrument Development;Devices;DNA;Dyes;Environment;Equilibrium;flexibility;Fluorescence;Fluorescence Resonance Energy Transfer;Fluorescent Dyes;Glycolysis;Hypoxia;Image;improved;intravital imaging;Label;Light;light emission;macromolecule;Measurement;Measures;Metabolic;Metabolism;Methods;Microscope;Mitochondria;Molecular Conformation;multi-photon;multiphoton microscopy;Muscle Cells;NADH;nanosecond;neoplastic cell;Normal Cell;Organelles;Oxidation-Reduction;Oxygen;Oxygen Consumption;Paclitaxel;Photons;Proteins;Publishing;quantitative imaging;Reactive Oxygen Species;Resolution;Shapes;Signal Transduction;Sorting;Spectrum Analysis;Spottings;submicron;Testing;Time;Tissues;tool;transcription factor;Transfection;two-photon;Water;Work,Multiphoton Microscopy Development,6065,NA,NA,NA,NA,15,NA,NA,844742,NA
11183734,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006066,NA,NA,1ZIAHL006066-15,NHLBI:136249\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571467 (contact),"KNUTSON, JAY R (contact)",NA,NA,NA,Amplifiers;Biological;Calibration;Cells;Code;Color;Compensation;Computer software;Darkness;design;Detection;Development;Diffuse;Dyes;Electron Microscopy;Electronics;Family;Fluorescence;Fluorescent Dyes;Image;in vivo;Individual;instrument;interest;Label;Lasers;Legal patent;Light;Lighting;Lipids;macromolecule;Manuscripts;Methods;Microscope;Microscopy;nano;Nanoscopy;nanosecond;Nature;novel;Nucleic Acids;Occupations;Optics;Paint;Photobleaching;Photons;Physiologic pulse;preservation;Process;Proteins;Publishing;Resolution;Resources;response;Scanning;Scheme;Site;software development;Sorting;spatiotemporal;Spectrum Analysis;Spottings;Structure;superresolution microscopy;Testing;Time;Tubulin;ultra high resolution;Work,Optical Superresolution Microscopy (Nanoscopy),6066,NA,NA,NA,NA,15,NA,NA,136249,NA
11183735,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006067,NA,NA,1ZIAHL006067-15,NHLBI:40875\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571467 (contact),"KNUTSON, JAY R (contact)",NA,NA,NA,aptamer;Binding Sites;Biological Assay;Biological Products;Biotechnology;Cells;Collaborations;Communication;Coupling;design;Detection;detection assay;Development;dimer;Disease;DNA;DNA Probes;DNA-Binding Proteins;Drops;Dyes;experience;Fluorescence;Fluorescence Resonance Energy Transfer;Fluorescence Spectroscopy;Genetic Polymorphism;Heterogeneity;Industry;Knowledge;Metals;Molecular Structure;nanoassay;nanocomposite;nanomolar;nanoparticle;Nanoscopy;Optics;Organelles;Organism;Peptides;Proteins;quantum optics;rapid test;Reporting;RNA;RNA Probes;Site;System;Techniques;Time;ultra high resolution,Nanoassay development,6067,NA,NA,NA,NA,15,NA,NA,40875,NA
11183736,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006075,NA,NA,1ZIAHL006075-15,NHLBI:798031\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,12450283 (contact),"PUERTOLLANO-MORO, ROSA  (contact)",NA,NA,NA,Address;Agonist;Animals;Antigen Presentation;Arsenites;Autophagosome;Bacteria;Binding;biological adaptation to stress;Calcium;Cations;CCL2 gene;Cell Line;Cell Nucleus;Cell Physiology;cell type;Cells;Cessation of life;chemokine;Cholesterol;Cholesterol Homeostasis;Collaborations;Color;Complex;Data;Defect;deprivation;Dominant-Negative Mutation;Dynein ATPase;Early Endosome;Embryo;Endosomes;Epidermal Growth Factor Receptor;Event;Family;Family member;follow-up;Follow-Up Studies;gain of function mutation;Ganglioside Sialidase Deficiency Disease;Genes;Genetic Transcription;genome wide association study;Germany;hearing impairment;Homeostasis;human disease;Human Pathology;Immune response;Immunofluorescence Immunologic;Impairment;In Vitro;in vivo;Injections;Innate Immune Response;Integral Membrane Protein;interest;Invaded;Ions;Kidney;knock-down;Knock-out;Knockout Mice;Laboratories;late endosome;Ligands;Link;lymphoid organ;Lysosomal Storage Diseases;Lysosomes;Macrophage;Magnesium;Malignant Neoplasms;Mammals;Mediating;member;Membrane;Messenger RNA;migration;Minus End of the Microtubule;Molecular;Movement;Mus;Mutation;Nerve Degeneration;novel;nutrient deprivation;Nutritional Immunity;Organ;Organelles;overexpression;Oxidative Stress;Pathway interactions;Peripheral;Peritoneal;Phenotype;Physiological;Physiological Processes;Play;Positioning Attribute;Predisposition;prevent;Production;programs;Proteins;Quantitative Reverse Transcriptase PCR;receptor;recruit;Recycling;Regulation;repaired;response;Rest;Role;Salmonella typhi;sensor;Signal Transduction;Starvation;Stress;Surface;System;TFE3 gene;Tissues;Toxic effect;trafficking;transcription factor;transcriptomics;TRP channel;Ubiquitination;Universities;Vestibular dysfunction;Work;Zebrafish,Regulation of the Endo/Lysosomal pathway,6075,NA,NA,NA,NA,15,NA,NA,798031,NA
11183737,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006077,NA,NA,1ZIAHL006077-15,NHLBI:2072321\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,8155048 (contact),"BOEHM, MANFRED  (contact)",NA,NA,NA,"5&apos;-Nucleotidase;Acceleration;Adhesions;Adult;Affect;Aneurysm;angiogenesis;Arterial Intimas;arterial tortuosity;Arteries;Atherosclerosis;Atherosclerosis Risk in Communities;autoinflammatory diseases;autosome;Benign;biobank;Biological Assay;Biological Models;biomarker identification;Blood flow;Blood Vessels;Body System;CADASIL;calcification;Calcium;Candidate Disease Gene;Cardiac;Cell Line;Cells;Childhood;Choristoma;Chronic;Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature;Chronic Disease;Chronic Kidney Failure;Clinical;Clinical Research;clinical trial analysis;Coculture Techniques;Collaborations;Collagen;Communication;Complex;Complication;Computerized Medical Record;Connective Tissue;COVID-19 patient;Cutaneous;Dasatinib;Data;Data Analyses;database of Genotypes and Phenotypes;Defect;Degos disease;Dermal;Diagnostic;Dilatation - action;Disease;disease model;Disease Outcome;Disease Progression;DNA Sequence Alteration;Drug Screening;Echocardiography;effectiveness testing;Electrocardiogram;Endothelial Cells;Endothelium;Enrollment;Enzymes;Exons;extracellular;Extracellular Matrix;Extravasation;Face;Fatal Outcome;Fibroblasts;Fibrosis;gain of function mutation;Gene Mutation;General Population;Genes;Genetic;Genetic Diseases;genetic testing;Grant;Granulation Tissue;Haplotypes;healing;Health;health care service;health record;Healthcare;Hepatomegaly;Hyper-IgE Syndrome;hypoperfusion;hypoxia inducible factor 1;imaging study;Immune;Immune system;immunodeficiency;improved;In Vitro;in vivo;induced pluripotent stem cell;Infection;Inflammation;inflammatory modulation;Inherited;inhibitor;insight;Integrins;Intellectual functioning disability;Intercellular adhesion molecule 1;Israel;Job&apos;s Syndrome;Joints;kinase inhibitor;large datasets;Life;Liver Fibrosis;Lower Extremity;Lung;LYN gene;Magnetic Resonance Imaging;Manuscripts;Maps;Mediating;Memory Loss;Mesenchymal;Metabolic Pathway;Metabolism;Microvascular Dysfunction;Microvascular Permeability;Migraine;migration;Modeling;Molecular;mouse model;Multiple Abnormalities;Mutation;Myocardial Infarction;National Heart, Lung, and Blood Institute;Nature;Neonatal Onset Multisystem Inflammatory Disease;neutrophil;Neutrophil Infiltration;Non-Insulin-Dependent Diabetes Mellitus;NOTCH3 gene;Nucleotidases;optical imaging;Organ;Oxygen;Pathway interactions;Patients;Perinatal;Perivascular Fibrosis;Pharmaceutical Preparations;Phase;Phenotype;Phosphotransferases;Population;post-COVID-19;programs;Proline;Proteins;Proteomics;psychiatric symptom;Publishing;Pulmonary Hypertension;Purines;Rare Diseases;rare genetic disorder;recessive genetic trait;recurrent infection;Reporting;Research;research clinical testing;Research Technics;Resources;Risk Factors;Role;screening;side effect;Signal Pathway;Signal Transduction;single cell sequencing;Skin;skin ulcer;slug;Spleen;src-Family Kinases;STAT3 gene;Stroke;Subarachnoid Hemorrhage;System;Systemic hypertension;systemic inflammatory response;TBK1 gene;Technology;Testing;Therapeutic;therapeutic target;Time;Tissues;TNF gene;tool;transcriptome sequencing;Treatment Protocols;treatment strategy;vascular abnormality;Vascular blood supply;Vascular calcification;Vascular Diseases;Vascular Endothelial Cell;Vascular remodeling;Vascularization;Vasculitis;whole genome;wound healing;Xaa-Pro dipeptidase",Vascular remodeling in patients with rare genetic disorders,6077,NA,NA,NA,NA,15,NA,NA,2072321,NA
11183738,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006078,NA,NA,1ZIAHL006078-15,NHLBI:828928\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,8155048 (contact),"BOEHM, MANFRED  (contact)",NA,NA,NA,Acceleration;Acute;Affect;angiogenesis;Angiogenic Factor;Angioplasty;Arterial Injury;arterial remodeling;Arteries;Atherosclerosis;autosome;Biological Assay;Blood capillaries;blood perfusion;Blood Vessels;Capillarity;Cell Culture Techniques;Cell Lineage;Cell Proliferation;Cell Survival;cell type;Cells;Clinical;clinically relevant;Compensation;Complex;Coronary Artery Bypass;Cromolyn Sodium;Defect;density;Development;Diabetes Mellitus;Disease;Drug Targeting;Dysplasia;Early Diagnosis;Effectiveness;Endothelial Cells;endothelial dysfunction;Endothelium;Environment;Event;Extracellular Matrix;Faith;femoral artery;Fibroblasts;Fibrosis;graft failure;Granulation Tissue;Growth;healing;HIF1A gene;Hindlimb;Human;Hyper-IgE Syndrome;Hyperplasia;hypoxia inducible factor 1;immune cell infiltrate;Immune response;Immunodeficient Mouse;improved;In Vitro;in vivo;in vivo Model;induced pluripotent stem cell;Inflammation;Inflammatory;Inflammatory Response;Injections;Injury;Intervention;Ischemia;Job&apos;s Syndrome;Knock-out;Legal patent;Ligation;Link;Lung Diseases;mast cell;Mast Cell Stabilizer;Medial;Mediating;Mediator;Mesenchymal;Modeling;Morphology;mouse model;Mus;Muscle;Mutation;novel;Outcome;Pathologic;Pathology;Pathway interactions;Patients;percutaneous coronary intervention;Perioperative;Pharmaceutical Preparations;Phase;Phenotype;Phosphorylation;Physiology;Play;Postoperative Period;prevent;Procedures;Process;Property;restenosis;restoration;revascularization;Role;Signal Pathway;Signal Transduction;Skin;Skin wound healing;slug;Smooth Muscle Myocytes;Splint Device;STAT3 gene;stem cells;Stents;Structural defect;Structure;Subcutaneous Injections;System;Teratoma;Testing;therapeutic target;Thrombosis;Tissues;Topical application;Transforming Growth Factor beta;Tube;vascular abnormality;Vascular calcification;Vascular Diseases;Vascular remodeling;vascular smooth muscle cell migration;Vein graft;vein occlusion;Veins;wound;wound closure;wound healing;Wound models;wound treatment,Murine models of vascular remodeling,6078,NA,NA,NA,NA,15,NA,NA,828928,NA
11183739,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006079,NA,NA,1ZIAHL006079-15,NHLBI:1243393\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,8155048 (contact),"BOEHM, MANFRED  (contact)",NA,NA,NA,"Academy;Address;Adenosine;Adenosine A2B Receptor;adenosine deaminase;adenosine deaminase deficiency;Affect;Animal Model;Arterial Disorder;Atrophic;autoinflammatory;autosome;Benign;biobank;Biological Assay;Biological Models;Biotechnology;Blood;blood vessel occlusion;Blood Vessels;Bone marrow failure;Brain Infarction;Cachexia;calcification;Cardiac Myocytes;Cardiovascular Diseases;CD8-Positive T-Lymphocytes;Cell Line;Cell Lineage;Cell model;cell replacement therapy;cell type;Cells;Central Nervous System;Cerebrum;Characteristics;Chemicals;Chronic;Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature;Cicatrix;Clinical;Coculture Techniques;Collaborations;Core Facility;CRISPR correction;CRISPR/Cas technology;Cutaneous;Death Rate;Degos disease;Dental Porcelain;Development;Diagnosis;differentiation protocol;Disease;disease model;Drug Targeting;early onset;Endothelial Cells;Endothelium;Etiology;Exhibits;experience;experimental study;Eye;Fibrosis;Functional disorder;gastrointestinal perforation;Gastrointestinal tract structure;gene correction;gene editing technology;Gene Expression Profile;Gene Mutation;Genes;Genetic;Genetic study;Germ Layers;healthy volunteer;Heart;Heart failure;Hematopoietic;Human;human induced pluripotent stem cells;Hyper-IgE Syndrome;immunodeficiency;improved;In Vitro;in vivo;induced pluripotent stem cell;induced pluripotent stem cell technology;infancy;Inflammation;Inflammatory;Job&apos;s Syndrome;Lesion;loss of function mutation;Lung;lung failure;Macrophage;Malignant - descriptor;Mesenchymal;Mesenchymal Stem Cells;Mesoderm;Modeling;Molecular;monocyte;Mus;Mutation;National Heart, Lung, and Blood Institute;novel;novel therapeutic intervention;Organ;Organoids;Pathway interactions;patient derived induced pluripotent stem cells;Patients;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;pharmacologic;Pharmacotherapy;Phenotype;Play;Production;Publications;Pulmonary Fibrosis;Pulmonary Inflammation;rare condition;rare genetic disorder;Research;Role;Sampling;Science;self-renewal;Sepsis;Signal Pathway;Skin;small molecule;Smooth Muscle Myocytes;Somatic Cell;Spinal;Stat3 protein;Stem Cell Research;Stimulator of Interferon Genes;STING1 gene;Stroke;Subcortical Infarctions;Subcortical Leukoencephalopathy;Syndrome;System;systemic inflammatory response;Technology;Teratoma;Testing;Therapeutic;Toxicology;transcription factor;Transgenic Mice;Turner&apos;s Syndrome;Up-Regulation;Vascular calcification;Vascular Diseases;Vascular Smooth Muscle;Vascularization;Vasculitis",iPS-technology and patient specific disease models,6079,NA,NA,NA,NA,15,NA,NA,1243393,NA
11183740,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006087,NA,NA,1ZIAHL006087-15,NHLBI:255803\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416470 (contact),"NEUMAN, KEIR  (contact)",NA,NA,NA,Address;Antibodies;Binding;Biological;biomaterial compatibility;Blinking;Canada;cell determination;cell type;Cells;Cellular biology;cellular imaging;Characteristics;Chemical Structure;chemotherapeutic agent;Classification;Collaborations;Detection;Development;Diamond;Doxorubicin;Dyes;Encapsulated;Fingerprint;Fluorescence;fluorescence imaging;fluorophore;Goals;Image;imaging approach;imaging probe;imaging study;improved;In Vitro;in vivo;in vivo evaluation;in vivo imaging;indexing;interest;Kinesin;Label;Laboratories;Lead;Methods;Microtubules;Modification;molecular imaging;Motor;Multimodal Imaging;nanocrystal;nanodiamond;nanoparticle;Neurons;Nitrogen;Noise;Nucleosome Core Particle;optic trap;optical imaging;optical traps;Optics;particle;Pathway interactions;Penetration;perovskite;Postdoctoral Fellow;Property;Protocols documentation;Publishing;Quebec;Research;Scheme;Side;Signal Transduction;single molecule;Small Interfering RNA;South Korea;Surface;Techniques;Testing;Tissues;Toxic effect;United States National Institutes of Health;Universities;Work,Development and characterization of optical imaging probes,6087,NA,NA,NA,NA,15,NA,NA,255803,NA
11183741,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006089,NA,NA,1ZIAHL006089-15,NHLBI:2205492\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571509 (contact),"YOUNG, NEAL S (contact)",NA,NA,NA,"acronyms;Age;Aplastic Anemia;Architecture;Arteritis;Artificial Intelligence;autoinflammation;autoinflammatory;autoinflammatory diseases;B-Lymphocytes;Biology;biomedical referral center;Blood Tests;Bone Marrow;Bone marrow failure;bone marrow failure syndrome;Brazil;Cell Line;Cell surface;Cells;Childhood;Chromosomal Stability;Chromosomes;Clinic;Clinical;clinical diagnosis;Clonal Evolution;Clonal Expansion;Clonality;Collaborations;conditioning;Constitution;Cytokine Gene;cytopenia;Danazol;Data;Decanoates;Degradation Pathway;Dermatologic;Diagnosis;Diamond-Blackfan anemia;Differential Diagnosis;Discrimination;Disease;DNA sequencing;DNMT3a;Dose;Dysmyelopoietic Syndromes;Engraftment;Enzymes;Etiology;Failure;Fanconi&apos;s Anemia;Fatal Outcome;GATA2 deficiency;Genes;Genetic;Genetic Diseases;Genomics;Germ Lines;helicase;Hematological Disease;Hematopoiesis;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;High Prevalence;Human;Immune;Immune system;Immunology;immunosuppressed;improved;in vivo;Individual;Infection;Inflammatory;Inflammatory Response;interest;Interferon Type II;Intervention;Lead;Length;Link;link protein;Lymphoid;Machine Learning;Macrophage;male;Malignant - descriptor;Malignant Neoplasms;Marrow;men;Mendelian disorder;Methodology;middle age;misfolded protein;monocyte;Mutate;Mutation;Myelogenous;Myeloproliferative disease;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;Natural Killer Cells;older men;older patient;Older Population;Organ;Organ failure;Outcome;overexpression;paroxysmal nocturnal hemoglobinuria;Pathway interactions;Patients;Pattern;peripheral blood;Pharmaceutical Preparations;Phenotype;Population;Prognosis;Promoter Regions;Protocols documentation;Publications;Recurrence;Regimen;repaired;Reporting;Research;rheumatologist;Risk;Role;RUNX1 gene;Sampling;Secondary to;Signal Transduction;single-cell RNA sequencing;Stem cell transplant;stem cells;Symptoms;Syndrome;T-Lymphocyte;telomere;Testing;Thrombosis;Time;TINF2 gene;TNF gene;tool;transcriptome sequencing;United States National Institutes of Health;Up-Regulation;Vacuole;Vasculitis;Venous;web site",Telomere Diseases and Other Constitutional and Acquired Genetic Disorders of Hematopoiesis,6089,NA,NA,NA,NA,15,NA,NA,2205492,NA
11183742,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006095,NA,NA,1ZIAHL006095-15,NHLBI:1560188\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9603766 (contact),"REMALEY, ALAN THOMAS (contact)",NA,NA,NA,Animals;Apolipoprotein A-I;Apolipoprotein E;Apolipoproteins;Apolipoproteins C;Biological;Cardiovascular Diseases;Cells;clinical center;Clinical Protocols;Clinical Trials;computerized data processing;Development;Dose;Drug Delivery Systems;drug testing;Excision;Generations;Goals;High Density Lipoproteins;Hydrocarbons;Hypertriglyceridemia;Inflammation;Infusion procedures;Ligands;Lipoproteins;Low Density Lipoprotein Receptor;Paper;Penetration;Peptides;peptidomimetics;Pharmaceutical Preparations;phase 1 study;Property;Proteins;Proteolysis;Protocols documentation;Publishing;receptor;Resistance;Structural Protein;Therapeutic;United States National Institutes of Health;Work,Development of Apo Mimetic Peptides for the Treatment  Cardiovascular Disease,6095,NA,NA,NA,NA,15,NA,NA,1560188,NA
11183743,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006097,NA,NA,1ZIAHL006097-14,NHLBI:69380\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6481999 (contact),"MOSS, JOEL  (contact)",NA,NA,NA,Annual Reports;Clinical Research;Collection;Extramural Activities;Human;human tissue;Individual;information processing;Institutional Review Boards;Principal Investigator;Process;programs;Protocols documentation;Reporting;Research;Research Personnel;Research Subjects;Running;sample collection;Specimen;Surveys;Tissue Sample;Translational Research,Clinical and Translational Research,6097,NA,NA,NA,NA,14,NA,NA,69380,NA
11183744,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006098,NA,NA,1ZIAHL006098-14,NHLBI:2306822\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11136483 (contact),"TARASKA, JUSTIN  (contact)",NA,NA,NA,3-Dimensional;Acute;Adhesions;Apical;Architecture;Area;Biochemistry;Capsid Proteins;Caveolae;Caveolins;Cell Communication;Cell Line;Cell membrane;Cell Physiology;Cell surface;Cells;Chemicals;Clathrin;CLC Gene;Coated vesicle;Color;Complex;cryogenics;Cytosol;Data;Development;Diameter;Disease;Dynamin;Dynamin 2;EGF gene;Electron Microscopy;electron tomography;Electrophysiology (science);Endocytosis;Endocytosis Inhibition;Environment;Epidermal Growth Factor Receptor;EPS15 gene;Exocytosis;extracellular;Extracellular Matrix;Ferritin;FGFR1 gene;Fluorescence;fluorescence imaging;Fluorescence Resonance Energy Transfer;G-Protein-Coupled Receptors;Gene Expression;Genetic;genetic regulatory protein;Goals;Growth;Growth Factor;Heterogeneity;Homeostasis;Human;Human Biology;Image;imaging modality;improved;Individual;Integrins;knock-down;Lifting;Ligands;light microscopy;Lipids;live cell imaging;Location;Mammalian Cell;Maps;Measures;Mediating;Membrane;Membrane Fusion;Membrane Proteins;Methods;microscopic imaging;Microscopy;Modeling;Molecular;Molecular Conformation;Morphology;Names;nanoscale;Nature;Neck;Organelles;particle;pathogen;Pathway interactions;Peptides;Pharmaceutical Preparations;Phosphotransferases;physical property;Platinum;pressure;prevent;Procedures;Process;programs;Proteins;Protocols documentation;receptor;Receptor Signaling;recruit;Regulation;Resolution;Role;Shapes;Signal Pathway;Signal Transduction;Site;small molecule;src-Family Kinases;Standardization;Structure;Surface;System;targeted cancer therapy;Testing;tool;trafficking;Transmission Electron Microscopy;ultra high resolution;Update;uptake;vesicle transport;Visualization;Work,Architecture and control of exocytosis and endocytosis in excitable cells,6098,NA,NA,NA,NA,14,NA,NA,2306822,NA
11183745,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006102,NA,NA,1ZIAHL006102-14,NHLBI:949994\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851437 (contact),"FERRÉ-D'AMARÉ, ADRIAN  (contact)",NA,NA,NA,5&apos; Untranslated Regions;Alternative Splicing;Anti-Bacterial Agents;Antibiotics;Binding;Binding Proteins;Biological Models;Biophysics;Catheters;Cell Aging;Cells;Chemicals;Clinical;Complex;Disease;DNA-Directed RNA Polymerase;Elements;Family member;Future;Gene Expression;Genes;Genetic Transcription;Health;Implant;interest;Major Groove;member;Messenger RNA;Microbial Biofilms;Morbidity - disease rate;mortality;mRNA Decay;nutrition;Nutritional;Operon;Physiological;Physiology;Procedures;Protein Family;Proteins;Reporting;Resolution;response;Ribonucleoproteins;RNA;RNA Binding;small molecule;stem;Structure;Study Subject;Surface;Telomerase;Tissues;Transcriptional Elongation Factors;Transcriptional Regulation;Translations;tumor growth;Vascular Endothelial Growth Factors;Work,"RNA: Structure, Biophysics and Physiology",6102,NA,NA,NA,NA,14,NA,NA,949994,NA
11183746,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006103,NA,NA,1ZIAHL006103-14,NHLBI:1813579\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11136490 (contact),"CAO, HAIMING  (contact)",NA,NA,NA,clinical application;Code;Diabetes Mellitus;Drug Targeting;Dyslipidemias;Exhibits;fatty liver disease;Genes;glucose metabolism;Health Care Costs;Human;Link;lipid metabolism;Mammals;Metabolic;Metabolic Diseases;metabolic rate;Molecular;Mus;novel;Obesity;Obesity Epidemic;obesity treatment;Pathogenesis;Pathologic;Play;Proteins;Role;Therapeutic Agents;therapeutically effective;Translating;Untranslated RNA,Molecular Basis of Obesity and Obesity-induced Metabolic Diseases,6103,NA,NA,NA,NA,14,NA,NA,1813579,NA
11183747,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006115,NA,NA,1ZIAHL006115-14,NHLBI:818924\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361703 (contact),"MUKOUYAMA, YOH-SUKE  (contact)",NA,NA,NA,Astrocytes;Blood - brain barrier anatomy;Blood Circulation;Blood Vessels;Brain;brain endothelial cell;Cell Communication;Cells;Cellular biology;Central Nervous System;Characteristics;Complex;Data;Development;Developmental Biology;Dura Mater;Ectopic Expression;Endothelial Cells;endothelial stem cell;Environment;frontier;Gene Expression Profiling;genetic manipulation;Genetic Transcription;Heart;Hemorrhage;high resolution imaging;IGF1 gene;Immune system;Individual;Link;lymph nodes;Lymphatic;Lymphatic Endothelial Cells;lymphatic vasculature;lymphatic vessel;Macrophage;Mammals;Manuscripts;Membrane;Meningeal;Mitosis;Molecular;Morphology;nerve stem cell;Neuroglia;Neurons;neurovascular;Organ Culture Techniques;Pattern;Pericytes;Peripheral;Preparation;prevent;programs;Radial;Reporting;Repression;Research;Role;Signal Transduction;Skin;Source;Spinal Cord;Structure;Surface;Tight Junctions;Tissues;transcription factor;transdifferentiation;Transgenes;Vascularization;Venous;Zebrafish,The study of neuro-vascular interactions in the central nervous system,6115,NA,NA,NA,NA,14,NA,NA,818924,NA
11183748,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006116,NA,NA,1ZIAHL006116-14,NHLBI:818924\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361703 (contact),"MUKOUYAMA, YOH-SUKE  (contact)",NA,NA,NA,3-Dimensional;Adrenergic Agents;Affect;angiogenesis;Axon;Biological Models;Blood capillaries;Blood Circulation;Blood flow;Blood Vessels;Cardiac Myocytes;Cells;Chick;chorioallantoic membrane;Coculture Techniques;coronary vasculature;Cyclic AMP;Development;Dextrans;Diameter;Embryo;Embryonic Development;embryonic stem cell;Embryonic Stem Cell Transplantation;Endothelial Cells;Exhibits;experimental study;Future;Gene Expression;genetic manipulation;Heart;hemodynamics;Imaging Techniques;In Vitro;in vivo;induced pluripotent stem cell;Injections;Laboratories;Manuscripts;Modeling;Molecular;Mouse Embryonic Stem Cells;Mutation;Myocardial;Nerve;nerve supply;neuronal guidance;Neurons;neurovascular;Organ;Organ Culture Techniques;Organoids;Pattern;Pericytes;Play;postnatal;Preparation;Proliferating;Property;Protocols documentation;Regulation;Role;Signal Pathway;Skin;Smooth Muscle;Smooth Muscle Myocytes;Structure of left gastric vein;Structure of omphalomesenteric vein;System;Transplantation;Vascular remodeling;Vascular Smooth Muscle;vasculogenesis;Venous,The study of neuro-vascular interactions in the developing heart,6116,NA,NA,NA,NA,14,NA,NA,818924,NA
11183749,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006119,NA,NA,1ZIAHL006119-14,NHLBI:4567909\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571505 (contact),"CHUNG, JAY H (contact)",NA,NA,NA,Aging;aging related;Apoptosis;biological adaptation to stress;Chronic;Defect;DNA;endonuclease G;Energy Metabolism;Fatty acid glycerol esters;Genetic Transcription;Heart Diseases;Hybrids;Hypertension;Individual;Inflammation;Liver;Liver diseases;male;Malignant Neoplasms;Metabolic dysfunction;microscopic imaging;Mitochondria;Mitochondrial DNA;mitochondrial dysfunction;Neurodegenerative Disorders;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Oxygen Consumption;prevent;pro-aging;Production;recruit;Respiration;Risk;RNA Helicase;Supplementation;Technology;Threonine-Specific tRNA;Transcript;Transfer RNA;Translations;Visualization,Stress response and energy metabolism as a function of aging,6119,NA,NA,NA,NA,14,NA,NA,4567909,NA
11183750,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006121,NA,NA,1ZIAHL006121-14,NHLBI:2812585\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2074596 (contact),"HAMMER, JOHN A (contact)",NA,NA,NA,3-Dimensional;Actins;Actomyosin;adaptive immune response;Adhesions;Adhesives;Antigen-Presenting Cells;Antigens;Apical;B-Lymphocytes;base;Binding;blebbistatin;Cell Adhesion;Cell division;cell motility;Cell Nucleus;Cell Shape;Cells;Cellular biology;Centrosome;chemokine;cohesion;Complement;Complex;Cytoskeleton;daughter cell;Defect;Dendritic Cells;Dermal;driving force;Embryo;Ensure;Enterocytes;Environment;Epithelium;Exhibits;experimental study;Extracellular Matrix;Fiber;Fibroblasts;Filament;Frequencies;Hela Cells;Image;immunodeficiency;immunological synapse formation;Impairment;In Vitro;Individual;Integrin Binding;Integrins;Interphase;Intestines;knock-down;Knock-in;Knock-in Mouse;Knock-out;Knockout Mice;Lateral;Lead;Light;Link;live cell imaging;Maintenance;Mediating;Mediation;Membrane;Mesenchymal;Metaphase;Microfilaments;Microfluidic Microchips;Microtubule-Organizing Center;Microtubules;migration;Mitosis;Mitotic spindle;Molecular;Molecular Motors;Motor;Mus;Myosin ATPase;Myosin S-2;Nuclear;Organoids;Phenocopy;Play;Positioning Attribute;Proteins;Resolution;Role;Running;Side;Signal Transduction;Skin;small hairpin RNA;Speed;Stains;stem cells;Structure;superresolution imaging;Supporting Cell;Surface;T-Lymphocyte;Tissue Model;Tubulin;uptake;Villus,"Motor proteins and cytoskeletal dynamics in T cells, B cells and mesenchymal cells",6121,NA,NA,NA,NA,14,NA,NA,2812585,NA
11183751,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006123,NA,NA,1ZIAHL006123-12,NHLBI:496339\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2074596 (contact),"HAMMER, JOHN A (contact)",NA,NA,NA,Alleles;Ataxia;Axon;Biological Models;calbindin;CDK6-associated protein p18;Cell Polarity;cell type;Cells;Cerebellar Cortex;Cerebellum;Cessation of life;conditional knockout;Congenital cerebellar hypoplasia;Cre driver;Defect;Demyelinating Diseases;Dendritic Spines;density;design;Development;differentiation in vitro;Electrons;Endoplasmic Reticulum;Equilibrium;Exhibits;Filopodia;Future;Goals;Guanine Nucleotide Exchange Factors;hippocampal pyramidal neuron;Image;In Vitro;in vivo;knock-down;knockout animal;Knockout Mice;Learning;Length;Lobe;Mediating;MicroRNAs;Molecular;Morphology;Motor;motor learning;Mus;mutant;Myelin;Myelin Basic Proteins;Myelin Sheath;myelination;MYO5A gene;Myosin ATPase;nanowire;nerve supply;Neurites;Neurologic;neuronal cell body;Neurons;oligodendrocyte progenitor;Oligodendroglia;Optic Nerve;Organ;Output;Persons;Phenotype;Platelet-Derived Growth Factor alpha Receptor;Process;Proteins;Role;Seizures;Severities;Signal Transduction;Slice;Spasm;Stains;Structure;Symptoms;Synaptic plasticity;Tissues;Tonic - clonic seizures;Vertebral column;Work,Roles of motor proteins in neurons,6123,NA,NA,NA,NA,12,NA,NA,496339,NA
11183752,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006126,NA,NA,1ZIAHL006126-14,NHLBI:3367791\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11136492 (contact),"RUSAN, NASSER  (contact)",NA,NA,NA,Amino Acid Substitution;Amino Acids;Animals;Architecture;Automobile Driving;Binding;biochemical tools;Brain;C-terminal;Cell Cycle;cell motility;Cell Nucleus;Cell Polarity;cell type;Cells;Centrioles;Centrosome;Chromosome Segregation;Complex;Coupling;Data;Daughter;Defect;Development;Disease;Distal;Drosophila genus;Embryo;Ensure;Equilibrium;Event;Evolution;experience;Failure;Fertilization;fly;Future;Gene Duplication;Genetic;germline stem cells;Goals;Growth;Haploid Cells;Head;Homeostasis;Human;Imaging Device;insight;Interphase;kinetosome;Label;Length;Lighting;Link;Location;Malignant - descriptor;Malignant Neoplasms;Maps;Mediating;Meiosis;Microcephaly;Microscopy;Microtubule Polymerization;Microtubule-Organizing Center;Microtubules;Mitosis;Mitotic;Mitotic spindle;model organism;Modeling;Molecular;Mothers;mRNA Transcript Degradation;Mutation;nerve stem cell;novel;Nuclear;Open Reading Frames;Organelles;overexpression;paralogous gene;Physiology;Play;polarized cell;Polycystic Kidney Diseases;Positioning Attribute;Post-Translational Protein Processing;prevent;protein degradation;protein function;Protein Isoforms;Proteins;recruit;Regulation;Relaxation;response;RNA;Role;scaffold;Secure;Side;Site;sperm cell;Sperm Head;Sperm Motility;Sperm Tail;Spermatids;Spermiogenesis;stem cells;Structure;Study models;Surface;Tail;Time;Tissues;Transgenes;Translations;Visualization;Work,Centrosome Regulation in Development and Dysregulation in Disease,6126,NA,NA,NA,NA,14,NA,NA,3367791,NA
11183753,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006129,NA,NA,1ZIAHL006129-14,NHLBI:646423\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694350 (contact),"KNEPPER, MARK  (contact)",NA,NA,NA,Acetylation;Address;Algorithms;Antibodies;Antibody Formation;ATAC-seq;Atlases;Big Data;Bioinformatics;cell type;ChIP-seq;Code;Communities;Computer software;computerized data processing;computerized tools;Data;data integration;data resource;Data Science;Data Set;data sharing;Databases;Democracy;design;Differential Equation;Duct (organ) structure;Enhancers;Ensure;Epithelium;equilibration disorder;Functional disorder;Gene Expression;Gene Expression Regulation;Graph;Histones;improved;indexing;Information Systems;Investigation;Java;Kidney;Knowledge;Laboratories;mass spectrometer;Mass Spectrum Analysis;mathematical model;Measures;member;Messenger RNA;Methodology;Methods;Modeling;Molecular;Multiomic Data;multiple omics;next generation sequencing;novel;Nucleic Acids;Performance;phosphoproteomics;Phosphorylation;Physiological;Physiology;Production;protein aminoacid sequence;Proteins;Proteomics;Pythons;Regional Perfusion;Regulation;renal epithelium;Renal tubule structure;Research;Research Personnel;response;RNA Polymerase II;single-cell RNA sequencing;Sodium Chloride;Software Tools;Structure;synthetic peptide;System;Systems Biology;Techniques;tool;Transcriptional Regulation;transcriptome sequencing;transcriptomics;Transport Process;Urea;user-friendly;Vasopressins;Water;water channel;Work,Computational Tools for Proteomics,6129,NA,NA,NA,NA,14,NA,NA,646423,NA
11183754,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006141,NA,NA,1ZIAHL006141-14,NHLBI:1531012\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571557 (contact),"WEN, HAN  (contact)",NA,NA,NA,"Affect;Agreement;Air;Ankle;Anxiety;Area;Arterial calcification due to deficiency of CD73;autosome;Back;Blood Vessels;calcification;Calibration;Cancer Patient;Clinical;clinical application;clinical care;clinical center;Clinical Protocols;Clinical Research;Code;Collaborations;Computed Tomography Scanners;Computer software;COVID-19 patient;Cyst;Data;Data Analyses;density;Development;Diffusion;Disease;Disease Management;Disease Progression;FDA approved;foot;Future;Genetic Diseases;Growth;Hand;High Resolution Computed Tomography;Human;Hyper-IgE Syndrome;Image;Image Analysis;improved;Job&apos;s Syndrome;Joints;Judgment;Limb structure;long term consequences of COVID-19;Lower Extremity;Lung;Lung Capacity;Lung Diseases;lung volume;Lymphangioleiomyomatosis;Manuals;Measurement;Measures;Medical;Medicine;Methods;Monitor;Mosses;Mucous body substance;Muscle Cramp;National Heart, Lung, and Blood Institute;pain symptom;participant enrollment;Patients;Photons;post-COVID-19;Predisposition;procedure safety;Procedures;Protocols documentation;Publishing;pulmonary function decline;Pulmonary function tests;Radiology Specialty;rare genetic disorder;rate of change;Renal Carcinoma;Reporting;research clinical testing;Residual state;Resolution;routine care;SARS-CoV-2 infection;Scanning;Symptoms;System;Technology;Tissues;tool;Training;Transplantation;treatment effect;treatment response;trend;ultra high resolution;Uncertainty;Update;validation studies;Vascular calcification;Vascular Diseases;Visual;Woman;Work;X-Ray Computed Tomography",quantitative CT development and clinical applications,6141,NA,NA,NA,NA,14,NA,NA,1531012,NA
11183755,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006142,NA,NA,1ZIAHL006142-07,NHLBI:382753\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,6571557 (contact),"WEN, HAN  (contact)",NA,NA,NA,"Animal Model;Aorta;Apolipoprotein E;Apolipoproteins;Atherosclerosis;Blood Vessels;calcification;Cardiovascular Diseases;Collaborations;Computer software;Deposition;Fresh Tissue;Gene Modified;genetic variant;Histopathology;Hydrocephalus;Individual;Knockout Mice;Label;Link;Manuscripts;Measurement;microCT;Modeling;Mus;National Heart, Lung, and Blood Institute;National Institute of Diabetes and Digestive and Kidney Diseases;Pathology;Sampling;Technology;Tissue Sample;Tissues;Variant;Work;X ray microscopy",X-ray micro tomography of pathology tissue samples,6142,NA,NA,NA,NA,7,NA,NA,382753,NA
11183756,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006146,NA,NA,1ZIAHL006146-13,NHLBI:1224404\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11601302 (contact),"HARBISON, SUSAN  (contact)",NA,NA,NA,Alleles;ATAC-seq;Bayesian Modeling;behavioral phenotyping;Biological Assay;Brain;Characteristics;Chest;ChIP-seq;Chromatin;Clustered Regularly Interspaced Short Palindromic Repeats;Collection;Communities;Complex;CRISPR/Cas technology;Data;differential expression;Disease;DNA Sequence;Drosophila genus;Drosophila melanogaster;Effectiveness;experimental study;fitness;fly;Freezing;Frequencies;functional genomics;Gene Expression;Gene Frequency;gene interaction;gene network;Generations;Genes;Genetic Polymorphism;Genetic Research;genetic variant;Genetic Variation;Genome;genome wide association study;Genomic DNA;Genomic Segment;Genotype;Goals;Human;Human Genome;Inbreeding;Indiana;Learning;life history;life span;Linkage Disequilibrium;Locomotion;Manuscripts;Measures;Memory;Memory impairment;Methods;model organism;Modeling;mutant;Mutation;Natural Selections;neural correlate;next generation;Parents;Partner in relationship;Pattern;Performance;Phenotype;Poly(A)+ RNA;Population;Procedures;Process;Publishing;Relaxation;Reporting;Resources;RNA;RNA Sequences;Sampling;Scheme;segregation;Sequence Homologs;sex;Short-Term Memory;Sib Matings;Signal Transduction;Single Nucleotide Polymorphism;Sleep;sleep regulation;SNP genotyping;Speed;Surveys;Testing;Time;trait;transcriptome sequencing;Transposase;Untranslated RNA;Variant;Work,Verification of Polymorphisms Impacting Sleep,6146,NA,NA,NA,NA,13,NA,NA,1224404,NA
11183757,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006150,NA,NA,1ZIAHL006150-13,NHLBI:949994\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851437 (contact),"FERRÉ-D'AMARÉ, ADRIAN  (contact)",NA,NA,NA,Adopted;Alternative Splicing;anti-microbial drug;Antibiotics;antimicrobial;ATP-Binding Cassette Transporters;Bacillus;Bacteria;Biochemical;Bioinformatics;biophysical properties;Catalytic RNA;Clostridium;cold temperature;Complex;Conserved Sequence;design;Development;Elements;functional group;Gene Expression;Genes;Genetic Transcription;Genus staphylococcus;Human;in vivo;insight;interest;Lead;Listeria;Metabolic Pathway;mRNA Decay;novel;novel therapeutics;pathogen;pathogenic bacteria;Reporter;Research;RNA;screening;Signal Pathway;small molecule;Specificity;Streptococcus;Structure;Study Subject;System;Temperature;Thermometers;three dimensional structure;tool;Transition Temperature;Translations;viral RNA;virulence gene,RNA: New Antimicrobial Strategies,6150,NA,NA,NA,NA,13,NA,NA,949994,NA
11183758,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006151,NA,NA,1ZIAHL006151-13,NHLBI:1596063\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,12450283 (contact),"PUERTOLLANO-MORO, ROSA  (contact)",NA,NA,NA,Alanine;Animals;Anisomycin;Antioxidants;Autophagocytosis;betacoronavirus;Binding;Binding Sites;Biogenesis;biological adaptation to stress;Biological Response Modifiers;Caenorhabditis elegans;Cell Nucleus;Cell Physiology;cell type;Cells;chemokine;Chromatin;chromatin remodeling;Complex;Cues;cytokine;Cytosol;Data;DNA Damage;Ensure;epigenetic regulation;Exocytosis;Family;Family member;Gene Expression;Generations;Genes;Genetic Transcription;Goals;Growth Factor;Guanosine Triphosphate Phosphohydrolases;Helix-Turn-Helix Motifs;Heterodimerization;Histones;Homeostasis;Immune;Immune response;Immunoprecipitation;Impairment;Infection;Inflammasome;Inflammatory;Knock-in;Laboratories;Leucine Zippers;Light;Lysosomes;Macrophage;MAP Kinase Gene;Mass Spectrum Analysis;Mediating;member;Mitochondria;Modification;Molecular;Molecular Chaperones;monocyte;Mutate;novel;Nuclear Translocation;Nucleosomes;nutrient deprivation;Organelles;Organism;Output;overexpression;Oxidation-Reduction;Oxidative Stress;p38 Mitogen Activated Protein Kinase;pathogen;Pathway interactions;Phosphoric Monoester Hydrolases;Phosphorylation;Physical Exercise;Play;Post-Translational Protein Processing;preservation;prevent;programs;promoter;Protein Dephosphorylation;Protein-Serine-Threonine Kinases;Proteins;recruit;Regulation;Reporting;Research;response;Role;Serine;Signal Pathway;Stimulus;Stress;stressor;Surface;TFE3 gene;Transcription Coactivator;Transcription Elongation;transcription factor;Transcriptional Regulation;transcriptome sequencing;Up-Regulation;Viral;Work,Lysosome biogenesis and homeostasis,6151,NA,NA,NA,NA,13,NA,NA,1596063,NA
11183759,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006153,NA,NA,1ZIAHL006153-13,NHLBI:2693691\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11136480 (contact),"XU, HONG  (contact)",NA,NA,NA,Adenosine Triphosphate;Anabolism;Animals;Binding;Biogenesis;Bioinformatics;biological adaptation to stress;cell behavior;Cell Nucleus;Cell Physiology;Cellular Structures;Circular DNA;Communication;Complex;Cytoplasm;Defect;Deposition;Development;Disease;DNA amplification;DNA Repair;DNA Restriction Enzymes;Drosophila genus;egg;Electron Transport;Embryo;endoplasmic reticulum stress;Enhancers;Ensure;Enzymes;Excision;Exonuclease;Eye;Female;Fertilization;fly;Free Radicals;Gene Expression;Generations;Genes;Genetic;Genetic Phenomena;Genetic Transcription;Genome;Genomics;Germ Cells;Germ Lines;Goals;Health;Heart Diseases;heart function;Homeostasis;Human;human disease;Impairment;In Situ;insight;knock-down;Length;Life;Link;macromolecule;Maintenance;male;Membrane;Metabolic;Metabolic Pathway;Metabolism;Methods;Mitochondria;Mitochondrial Diseases;Mitochondrial DNA;mitochondrial DNA mutation;mitochondrial genome;Mitochondrial Inheritance;Mitochondrial Proteins;Modeling;Molecular;Morphogenesis;mutant;Mutation;Nature;next generation;novel;Nuclear;nucleotide metabolism;NURF;Organelles;Organism;overexpression;Pattern;Pattern Formation;Phenotype;Physiological;prevent;Process;Protein Isoforms;Protein translocation;Protein Truncation;Proteins;proton-translocating pyrophosphatase;Regulation;Reproduction;Research;Respiration;response;Role;screening;Series;Sexual Reproduction;Signal Transduction;Single Nucleotide Polymorphism;sperm cell;Spermatids;Spermatogenesis;Sterility;Stress;Structure;sudden cardiac death;System;Tissues;transcription factor;Transgenes;transmission process;Variant;Work,Mitochondrial DNA genetics and inheritance,6153,NA,NA,NA,NA,13,NA,NA,2693691,NA
11183760,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006158,NA,NA,1ZIAHL006158-13,NHLBI:1781499\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79963321 (contact),"HOGG, J ROBERT  (contact)",NA,NA,NA,3&apos; Untranslated Regions;Address;Affect;Affinity;Affinity Chromatography;Apoptotic;ATP Hydrolysis;ATP phosphohydrolase;B-Cell Lymphomas;BCL-2 Protein;BCL2 gene;Binding;Binding Sites;Biochemical;Biogenesis;Biological;Biological Assay;biophysical techniques;Cell Nucleus;Cells;Collaborations;Complex;Cytoplasm;Data;Defect;Detection;Dissociation;DNA;Elements;Equilibrium;Event;Exhibits;Exons;flexibility;Gene Expression Regulation;Genetic Transcription;helicase;Heterogeneous-Nuclear Ribonucleoprotein L;Human;human disease;Immobilization;Immune;Impairment;in vitro Assay;inhibitor;insight;interest;Laboratories;Link;Malignant Neoplasms;Mechanics;Mediating;messenger ribonucleoprotein;Messenger RNA;Modeling;mutant;Mutation;National Center for Advancing Translational Sciences;Nonsense Codon;novel;Nucleic Acids;Pathway interactions;Physiological;Polyadenylation;premature;prevent;Process;Proteins;Proteomics;recruit;Repression;Research;Research Personnel;RNA;RNA Binding;RNA Decay;RNA Helicase;RNA interference screen;RNA Splicing;RNA Stability;RNA-Binding Proteins;Role;Rous sarcoma virus;screening;Small Nuclear RNA;System;Terminator Codon;Time;Transcript;transcriptome;Translations;whole genome;Work,Mechanisms of nonsense-mediated mRNA decay target selection,6158,NA,NA,NA,NA,13,NA,NA,1781499,NA
11183761,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006159,NA,NA,1ZIAHL006159-13,NHLBI:1209053\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11136490 (contact),"CAO, HAIMING  (contact)",NA,NA,NA,Address;Genes;Genetic;Genetic Transcription;Human;Human Genome;humanized mouse;Knowledge;Length;Liver;Metabolic;Metabolism;Modification;mouse model;Mus;nanopore;novel;Physiological;Physiology;Production;Reporting;Resources;response;RNA;Role;Sampling;single molecule;Stimulus;System;Tissues;Transcript;transcriptome;transcriptome sequencing;Untranslated RNA;Work,Functional and mechanistic studies of human-specific long noncoding RNAs using a humanized mouse model,6159,NA,NA,NA,NA,13,NA,NA,1209053,NA
11183762,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006166,NA,NA,1ZIAHL006166-12,NHLBI:1106813\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694272 (contact),"LEVINE, STEWART  (contact)",NA,NA,NA,"Adrenal Cortex Hormones;Affect;airway obstruction;American;Apolipoprotein A-I;Asthma;asthmatic;Biological Markers;Chronic;Clinical;Clinical Data;cohort;Collection;comorbidity;cost effective;Critical Care;Data;Disease;disorder control;effective therapy;eosinophil;Extrinsic asthma;Goals;High Density Lipoprotein Cholesterol;High Density Lipoproteins;Individual;Inflammation;Journals;Link;Lipids;Longitudinal, observational study;Manuscripts;Measures;Medicine;Natural History;NMR Spectroscopy;novel;novel therapeutics;Outcome;particle;Pathogenesis;Pathogenicity;Pathway interactions;Patients;periostin;personalized management;personalized medicine;Persons;Phenotype;Physiological;Protocols documentation;Public Health;Publishing;Pulmonary Function Test/Forced Expiratory Volume 1;Research;Resistance;respiratory;Sampling;Serum;Severity of illness;side effect;Specimen;Steroids;Testing;Time;Triglycerides",Longitudinal Observational Study of Severe Asthma,6166,NA,NA,NA,NA,12,NA,NA,1106813,NA
11183763,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006167,NA,NA,1ZIAHL006167-12,NHLBI:612202\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11601302 (contact),"HARBISON, SUSAN  (contact)",NA,NA,NA,Adult;Affect;American;Behavioral;Birds;Body Weight;Candidate Disease Gene;Characteristics;Clustered Regularly Interspaced Short Palindromic Repeats;Collection;comparative;CRISPR/Cas technology;Data;Databases;Defect;Development;Drosophila genus;Drosophila melanogaster;egg;Encyclopedia of DNA Elements;experimental study;falls;Female;Fertility;fitness;fly;FZD1 gene;gene conservation;Gene Expression;Gene Expression Regulation;gene function;Genes;Genetic;genetic architecture;Genetic Polymorphism;genetic testing;genome wide association study;Goals;Heritability;histone modification;Human;in silico;Inbreeding;Intercistronic Region;knock-down;Knock-out;knockout gene;Learning;Life;life history;life span;Link;Manuscripts;Maps;Measures;Mediating;Memory;Modification;Monitor;Morphology;Mus;mutant;Mutant Strains Mice;Mutation;Natural Selections;neurodevelopment;Neurons;novel;novel strategies;Nucleic Acid Regulatory Sequences;Oocytes;Ovary;Paper;Phenotype;pleiotropism;Population;Prevalence;Process;Protocols documentation;Publishing;Relaxation;reproductive fitness;reproductive success;Reptiles;RNA Interference;Role;sex;Site;Sleep;Sleep Architecture;Sleep Disorders;Testing;Time;trait;Transcript;Tube;Work,Inferring the function of sleep-associated polymorphisms across species,6167,NA,NA,NA,NA,12,NA,NA,612202,NA
11183764,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006169,NA,NA,1ZIAHL006169-12,NHLBI:445375\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79963321 (contact),"HOGG, J ROBERT  (contact)",NA,NA,NA,Address;Alternative Splicing;Binding;Binding Proteins;Biochemical;Buffers;candidate identification;Catalogs;Cell Physiology;cell type;Complex;Cytoplasm;Cytoplasmic Granules;Data;Development;Disease;Double-Stranded RNA;ds RNA-Binding Proteins;Elements;Event;Exons;Gene Expression;Genetic Transcription;genetic variant;High-Throughput Nucleotide Sequencing;Histones;Human;In Vitro;Incubated;Innate Immune Response;interest;Interferon-beta;Interferons;macroH2A histone;Macrophage;Mammalian Cell;Mediating;messenger ribonucleoprotein;Messenger RNA;Methods;monocyte;mRNA Decay;mRNA Precursor;mRNA Stability;mRNA Transcript Degradation;mRNA Translation;Nerve Degeneration;novel;Pathway interactions;pharmacologic;Phase;Physiological;Play;Process;programs;protein expression;Protein Overexpression;Proteins;Proteomics;Regulation;Repression;Research;response;Ribonucleoproteins;RNA;RNA Decay;RNA Splicing;RNA-Binding Proteins;RNA-Protein Interaction;Role;Stress;Structure;System;Techniques;Transcription Initiation Site;transcriptome;transcriptome sequencing;Translation Initiation;Translational Repression;Translations;Variant;Zinc Fingers,mRNP assembly in response to translational repression,6169,NA,NA,NA,NA,12,NA,NA,445375,NA
11183765,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006186,NA,NA,1ZIAHL006186-11,NHLBI:743082\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,2479331 (contact),"DUNBAR, CYNTHIA E (contact)",NA,NA,NA,Agonist;Anemia;Annual Reports;Aplastic Anemia;Binding;Biology;Blood;Bone Marrow;Bone marrow failure;Chelating Activity;Clinical;Clinical Research;Clinical Trials;clinically relevant;clinically significant;Clonal Evolution;Cohort Studies;Collaborations;Congenital Disorders;Cyclosporine;Cytogenetics;cytopenia;Data;design;Development;Diamond-Blackfan anemia;Disease;Dose;Dysmyelopoietic Syndromes;Effectiveness;Erythroid;Erythropoiesis;Failure;follow-up;Functional disorder;Gene Proteins;Genes;Globin;Glycine;Hematologic Neoplasms;Hematology;Hematopoiesis;Hematopoietic Neoplasms;Hematopoietic Stem Cell Transplantation;Heme;heme biosynthesis;Human;imaging study;Immunosuppression;improved;In Vitro;in vivo;Incidence Study;Inherited;Inherited bone marrow failure;inhibitor;Investigation;Iron;Iron Chelating Agents;Iron Chelation;iron deficiency;iron metabolism;iron supplementation;Knowledge;Laboratory Study;Link;Malignant - descriptor;Marrow;Molecular;Morbidity - disease rate;mouse model;Mutation;Myeloproliferative disease;New Agents;novel therapeutics;Oral;Outcome;Output;participant enrollment;Pathway interactions;patient response;Patients;Pharmaceutical Preparations;predicting response;Production;progenitor;programs;Property;Protein Biosynthesis;Publishing;Reactive Oxygen Species;receptor;Refractory;Refractory anemias;Regimen;Relapse;Report (document);Reporting;Research;response;Ribosomal Proteins;ribosomopathy;Risk;Role;Safety;Sampling;screening;small molecule;Somatic Mutation;stem;stem cells;telomere;Therapeutic immunosuppression;thrombocytosis;Thrombopoietin;Time;Toxic effect;Translational Research;transport inhibitor;Work,Investigation of underlying mechanisms and novel therapies for human acquired and congenital disorders of hematopoiesis,6186,NA,NA,NA,NA,11,NA,NA,743082,NA
11183766,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006188,NA,NA,1ZIAHL006188-11,NHLBI:978782\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851437 (contact),"FERRÉ-D'AMARÉ, ADRIAN  (contact)",NA,NA,NA,Affinity;analog;aptamer;Binding;Biophysics;Cellular biology;Compensation;Complex;Crystallography;design;Development;Disease;Dissociation;enthalpy;Entropy;Evolution;Family;Fluorescence;fluorophore;Goals;Green Fluorescent Proteins;Image;Imaging Device;improved;In Vitro;in vivo;insight;Ligands;Mango - dietary;Modification;Molecular;Mutation;nanomolar;next generation;novel;Pharmaceutical Preparations;Property;Proteins;Reporting;Research;Research Project Grants;RNA;small molecule;Spinach - dietary;Structure;thiazole orange;Time;tool;Variant;Visualization;Work,RNA: Tools for Cell Biology,6188,NA,NA,NA,NA,11,NA,NA,978782,NA
11183767,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006189,NA,NA,1ZIAHL006189-11,NHLBI:306101\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11601302 (contact),"HARBISON, SUSAN  (contact)",NA,NA,NA,Biological;Biology;Candidate Disease Gene;Cells;Complex;Darkness;Data;Deposition;differential expression;DNA;DNA sequencing;dosage;Drosophila genome;Drosophila genus;Drosophila melanogaster;Environment;Environmental Exposure;Environmental Risk Factor;Etiology;Evolution;experimental study;Face;Female;fly;Food;food environment;Freezing;Gene Expression;gene expression variation;Gene Frequency;Generations;Genes;Genetic;Genetic Polymorphism;genetic risk factor;genetic variant;genome wide association study;Genomics;Genotype;Goals;Guidelines;Harvest;Heritability;Homologous Gene;Hour;Human;Humidity;Inbreeding;Individual;individual variation;Laboratories;large datasets;Libraries;Light;Maintenance;male;Manuscripts;Maps;Measures;Mental disorders;Messenger RNA;Methodology;Methods;Modeling;Mutation;Narcolepsy;Noise;Nutrient;Phenotype;phenotypic data;Population;Publications;Publishing;Quality Control;Regulation;Research;response;RNA;RNA analysis;RNA Sequences;Sampling;sex;Sleep;Sleep Disorders;Statistical Data Interpretation;Sucrose;Testing;Time;trait;Transcript;transcriptome sequencing;Variant;Work;X Chromosome,Assessment of variability in gene expression among genetically identical Drosophila subjected to a common environment,6189,NA,NA,NA,NA,11,NA,NA,306101,NA
11183768,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006197,NA,NA,1ZIAHL006197-10,NHLBI:1217494\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694272 (contact),"LEVINE, STEWART  (contact)",NA,NA,NA,adaptive immune response;ADP Ribose Transferases;Airway Disease;airway epithelium;airway inflammation;Allergens;Alveolar Macrophages;Apical;Apolipoproteins;Asthma;asthmatic;asthmatic patient;Attenuated;Binding;Blood;Blood specimen;bronchial epithelium;Bronchoalveolar Lavage;Bronchoalveolar Lavage Fluid;Bronchoscopy;Brush Cell;CD14 gene;Cell membrane;Cells;chemokine;Chemotaxis;Ciliated Bronchial Epithelial Cell;Clinical Immunology;Collection;cytokine;Cytokine Receptors;Dendritic Cells;eosinophil;eosinophilic asthma;Epithelial Cells;Epithelium;exosome;Extrinsic asthma;Fasting;FPR2 gene;Genes;Goblet Cells;High Density Lipoproteins;HLA-DR Antigens;Human;human neutrophil peptide 1;human old age (65+);human RNA sequencing;Hypersensitivity;Immune;Inflammasome;Inflammation;Inflammatory;Inflammatory Response;Interleukin-1;Interleukin-6;intravenous administration;ITGAX gene;Length;Ligands;Link;Lipids;Liquid substance;Lung;Macrophage;MAP3K7 gene;MAP3K8 gene;MAPK8 gene;Mediating;Membrane;Metaplasia;Microfluidics;Minor;Modification;monocyte;mouse model;mRNA Expression;Mus;Myelogenous;nanoscale;neutrophil;Neutrophil Activation;novel;Nutrient;Obesity;particle;Pathway interactions;patient subsets;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Phenotype;point of care;Population;Prevalence;Production;Protocols documentation;Pyroglyphidae;receptor;Regulation;Research;Role;sample collection;Sampling;Serum;Serum amyloid A protein;Severity of illness;Signal Pathway;Signal Transduction;soluble TNF receptor type I;Sputum;Steroids;systemic inflammatory response;Th2 Cells;Time;Tissue Procurements;TLR4 gene;TNF gene;Transcript;Triglycerides;Tumor Necrosis Factor Receptor;vesicular release;Viral;VLDL receptor;volunteer,Asthma Sample Collection Protocol:  Defining the Role of  Apolipoprotein Pathways in Asthma,6197,NA,NA,NA,NA,10,NA,NA,1217494,NA
11183769,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006210,NA,NA,1ZIAHL006210-09,NHLBI:868262\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,14753614 (contact),"KOZEL, BETH  (contact)",NA,NA,NA,Abdominal Pain;Action Potentials;Adult;Affect;Anesthesia procedures;Animal Model;Animals;Area;Arrhythmia;Arterial Disorder;arterial stiffness;Arteries;bench to bedside;Biological Markers;Blood capillaries;Blood flow;Blood Pressure;Blood Vessels;Body Weight decreased;Brain;Calcium;Cardiac;Cardiac Myocytes;Caring;Cell Count;Cells;Choking;Clinical;Constipation;Coronary;Coronary Vessel Anomalies;Data Collection;Death Rate;Deglutition Disorders;Development;Diameter;Diarrhea;Disease;Dissociation;Effectiveness of Interventions;Elastin;Equilibrium;Evaluation;falls;Feeds;Food;Gagging;Gastroenterologist;Gastrointestinal Diseases;Gastrointestinal tract structure;Health;Heart;Heart Rate;heart rate variability;Hematochezia;hemodynamics;Hospitals;Human;Hypertension;imaging modality;Individual;insight;Investigation;Kidney;Kinetics;Knowledge;Literature;Manuscripts;Mechanics;Mediating;medical specialties;Microvascular Dysfunction;Modeling;mortality;mortality risk;Mus;Myocardial dysfunction;Natural History;normal aging;novel;novel therapeutics;Organ;Paper;Patients;Pattern;Perfusion;Persons;Pharmaceutical Preparations;Phenotype;Physiologic pulse;Population;Potassium;Preparation;Procedures;Process;Protocols documentation;Publishing;Pulse Rates;Rectal Prolapse;Reflux;Reporting;Research Design;Rest;Retina;Risk;Risk Assessment;risk mitigation;Smooth Muscle Myocytes;Stenosis;Sudden Death;Testing;therapy design;Tissues;translational approach;United States National Institutes of Health;vascular contributions;Vascular Diseases;Ventricular Fibrillation;Visualization;Vomiting;wearable device;Williams Syndrome;Work,Williams syndrome: A Translational Approach to Mechanism and Treatment,6210,NA,NA,NA,NA,9,NA,NA,868262,NA
11183770,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006212,NA,NA,1ZIAHL006212-09,NHLBI:992300\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,14753614 (contact),"KOZEL, BETH  (contact)",NA,NA,NA,Adaptive Immune System;Affect;Anatomy;Animal Model;Area;Arterial Disorder;Blood Vessels;Canada;Cardiac;Catheters;Cell Cycle;cell type;Cells;Cessation of life;Characteristics;Child;Chromosome 7;Code;cohort;Collaborations;Data;Development;Disease;disease-causing mutation;disorder risk;Echocardiography;EFRAC;Elastin;Electron Microscopy;Estrogens;exome;Extracellular Matrix;Failure to Thrive;falls;Fatty acid glycerol esters;follow-up;Frequencies;Gastrointestinal tract structure;Genes;Genetic;Genetic Variation;genome sequencing;Genomics;Goals;Growth;GTP-Binding Proteins;Heterozygote;Hour;Human;Human Chromosomes;Hypertension;Immune;improved;Individual;Intervention;Italy;Knockout Mice;lean body mass;Life;lipid metabolism;Location;loss of function;male;Manuscripts;Measures;metabolic abnormality assessment;Mitochondria;Modeling;mouse model;Mus;mutant;Neural Crest;Operative Surgical Procedures;Paper;Pathogenicity;Pathway interactions;Patient-Focused Outcomes;Patients;Persons;Phenotype;Physicians;Publishing;rare variant;Registries;Research;research clinical testing;risk prediction;Sampling;Scientist;Severities;Signal Pathway;Signaling Protein;Source;Stenosis;surgical risk;targeted treatment;Techniques;Texas;Therapeutic;Tissues;transcription factor;United States;Variant;Vascular Diseases;whole genome;Williams Syndrome;Work,Modifiers of elastin arteriopathy,6212,NA,NA,NA,NA,9,NA,NA,992300,NA
11183771,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006213,NA,NA,1ZIAHL006213-09,NHLBI:461506\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851457 (contact),"CAMPBELL-WASHBURN, ADRIENNE  (contact)",NA,NA,NA,cardiac magnetic resonance imaging;Cardiopulmonary;Cardiovascular system;Catheterization;Collaborations;Computer software;Development;Devices;Diagnostic;Electrocardiogram;Environment;Fluoroscopy;Goals;heart imaging;Heating;Image;image guided;imaging approach;imaging modality;Imaging Techniques;improved;industry partner;innovative technologies;Intervention;Ionizing radiation;lung imaging;magnetic field;Magnetic Resonance Imaging;metallicity;Methods;minimally invasive;novel;Patients;Performance;Predisposition;Procedures;real-time images;reconstruction;Roentgen Rays;soft tissue;System;Techniques;Testing;Therapeutic;Time;Visualization,Innovative Technology for MRI Guided Procedures,6213,NA,NA,NA,NA,9,NA,NA,461506,NA
11183772,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006233,NA,NA,1ZIAHL006233-08,NHLBI:986035\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,10 year old;2 year old;Affect;African ancestry;alpha-Thalassemia;Basic Science;biobank;Biochemical;Biological Specimen Banks;Blood;Blood Transfusion;Bone Marrow Transplantation;Bone necrosis;Brain;Brain Infarction;brain magnetic resonance imaging;Caring;Cell Culture Techniques;Cell Separation;Cephalic;cerebrovascular;Cerebrovascular Disorders;Characteristics;Child;Clinical;clinical center;Clinical Data;Clinical Management;clinical phenotype;clinical predictors;comorbidity;Complication;Databases;Development;Disease;disease model;Disparate;Early Intervention;Eligibility Determination;Enrollment;exome sequencing;experience;extend lifespan;extracellular;Fetal Hemoglobin;follow-up;Future;General Anesthesia;Generations;Genes;Genetic;Genetic Markers;genetic variant;Genome Scan;genome sequencing;genome wide association study;Genomics;Genotype;Health system;Healthcare;Heart;Hematological Disease;Hemoglobin concentration result;high risk;Hospitals;Human;Impaired cognition;improved;improved outcome;In Vitro;Individual;Infarction;information gathering;Informed Consent;Inherited;Kidney;Life;Liver;Lung;lung injury;Medical;middle cerebral artery;Minority;Molecular;Morbidity - disease rate;Natural History;novel;novel therapeutics;Nucleic Acids;Organ;Other Genetics;Outcome;Patients;Performance;Phenotype;Population;prevent;Procedures;Process;Protocols documentation;Public Health;Quality of life;Recording of previous events;renal damage;Research;Research Methodology;Research Project Grants;research study;Sampling;Scanning;Schools;Science;Severities;Severity of illness;Sickle Cell;Sickle Cell Anemia;Single Nucleotide Polymorphism;Site;Stroke;stroke incidence;Stroke prevention;stroke risk;Technology;therapy outcome;Transfusion;Translational Research;United States National Institutes of Health;Variant;Vascular Diseases;Washington;whole genome,Studies of the Natural History of Sickle Cell Disease,6233,NA,NA,NA,NA,8,NA,NA,986035,NA
11183773,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006234,NA,NA,1ZIAHL006234-08,NHLBI:3102771\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15265862 (contact),"ALTAN-BONNET, NIHAL  (contact)",NA,NA,NA,2019-nCoV;Adaptive Immune System;Aerosols;Animals;Antigen Presentation;Architecture;Area;Astrovirus;Biophysics;Breast Feeding;Cell Physiology;Cells;Cellular biology;Cooperative Behavior;Coronavirus;COVID-19 pandemic;COVID-19 patient;Cytolysis;Diagnostic;Disabled Persons;Docking;Economics;Enteral;Enterovirus;Enterovirus 68;Environment;Enzymes;Evolution;Exhibits;Exocytosis;extracellular vesicles;Feces;Gastrointestinal tract structure;Genetic Transcription;Golgi Apparatus;Health;Hepatitis C;Human;Human poliovirus;Image;Immune response;Immune System Diseases;Individual;Infant;infant infection;Infection;Inflammatory;Innate Immune System;Intestines;Investigation;Life Cycle Stages;lipid metabolism;Lipids;live cell microscopy;Lung;lysosomal proteins;Lysosomes;Mammary gland;Membrane;Messenger RNA;Molecular;Morbidity - disease rate;mortality;Mothers;mutant;Norovirus;Oral;pandemic disease;particle;pathogen;Pathway interactions;peer;Persons;Pharmacologic Substance;Phosphatidylinositols;Phosphotransferases;Population;Process;protein degradation;Public Health;recruit;response;Rhinovirus;RNA Viruses;Rotavirus;Route;Saliva;Salivary;salivary assay;Salivary Glands;Sanitation;SERPINA4 gene;Side;skills;Small Intestines;small molecule;suckling;System;tool;Translations;transmission process;Travel;Universities;Variant;Vesicle;Viral;Viral Physiology;Viral Proteins;viral transmission;Virion;virology;Virulent;Virus;Virus Assembly;Virus Replication;Water,Virus Egress Pathways,6234,NA,NA,NA,NA,8,NA,NA,3102771,NA
11183774,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006236,NA,NA,1ZIAHL006236-07,NHLBI:1216662\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416468 (contact),"LEE, JENNIFER  (contact)",NA,NA,NA,Adopted;alpha synuclein;Alzheimer&apos;s Disease;Amyloid;Amyloid Fibrils;amyloid formation;Amyloid Proteins;Amyloidosis;Binding;Biological;Biological Process;Cell Nucleus;Cell Physiology;Cells;Chemicals;Coupled;Couples;Coupling;Deposition;Disease;Environment;Exclusion;Extracellular Space;Frequencies;Goals;Human;Hydration status;Image;imaging modality;imaging probe;In Vitro;insight;interest;Intervention;Investigation;Lewy Bodies;Lipids;Liquid substance;Maps;Measures;Methods;Microscope;Microscopy;Molecular;Molecular Conformation;Molecular Target;Motion;Nature;Nerve Degeneration;Neurofibrillary Tangles;novel;novel strategies;Nucleotides;Organ;Parkinson Disease;Pathogenicity;Pathologic;Peptide Hydrolases;Phase;Polymorph;polypeptide;Population;Process;protein aggregation;Protein Conformation;Proteins;Raman Spectrum Analysis;Reporting;Resistance;Resolution;Running;Secondary Protein Structure;Site;Specificity;spectrograph;spectroscopic survey;Spectrum Analysis;Structure;Techniques;Tissues;vibration;Visualization;Water;Work,Raman Spectroscopic Studies of Amyloids,6236,NA,NA,NA,NA,7,NA,NA,1216662,NA
11183775,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006238,NA,NA,1ZIAHL006238-07,NHLBI:2154833\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,10215165 (contact),"JIANG, JIANSEN  (contact)",NA,NA,NA,3-Dimensional;Bicarbonates;Binding;Borates;Boron;Cell Physiology;Characteristics;Classification;computerized data processing;Cryoelectron Microscopy;Data Set;density;Detergents;Development;dimer;Disease;Drug Carriers;Drug Interactions;Drug Transport;experimental study;Family;Goals;Histamine;improved;Integral Membrane Protein;Lead;Ligands;Lipids;Masks;Mediating;Membrane;Membrane Lipids;Membrane Proteins;Membrane Transport Proteins;Metabolite Interaction;method development;Methods;Micelles;microscopic imaging;Molecular Conformation;Molecular Weight;monoamine;Nature;Neurotransmitters;new therapeutic target;Noise;particle;Pharmaceutical Preparations;Plants;prevent;programs;Proteins;Publishing;reconstruction;Regulation;Reporting;Research;Resolution;side effect;Signal Transduction;smoothened signaling pathway;solute;Structure;Synaptic Vesicles;Testing;Therapeutic;Transmembrane Domain;vesicular monoamine transporter 2;Water;WNT Signaling Pathway;X-Ray Crystallography,Structural studies of membrane proteins using high-resolution cryo electron microscopy,6238,NA,NA,NA,NA,7,NA,NA,2154833,NA
11183776,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006239,NA,NA,1ZIAHL006239-06,NHLBI:46954\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,Acute;Acute Pain;Affinity;Alloimmunization;Binding;Biological Availability;Blood;Bone Marrow Transplantation;Cell membrane;Clinical;Complication;curative treatments;Data;Deoxygenated Sickle Hemoglobin;diphosphoglycerate;Disease;Dissociation;Dose;Drug Kinetics;Drug Targeting;Enzyme Activators;enzyme substrate;Enzymes;Erythrocytes;Event;FDA approved;Fetal Hemoglobin;Frequencies;Glycolysis;Hemoglobin;Histocompatibility;Hospitalization;Human;hydroxyurea;in vivo;Iron Overload;Laboratory Study;novel;Oral;Organ;Oxygen;Pain;Pathway interactions;Pharmacodynamics;Phosphoenolpyruvate;Pilot Projects;polymerization;Polymers;pre-clinical;prescription opioid;Process;Production;Pyruvate;Pyruvate Kinase;pyruvate kinase deficiency;Reaction;Reporting;Risk;Role;Safety;Sickle Cell;Sickle Cell Anemia;sickle cell crisis;Sickle Cell Trait;sickling;small molecule;Source;Supportive care;Syndrome;System;Testing;therapeutic target;Transfusion,"A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease",6239,NA,NA,NA,NA,6,NA,NA,46954,NA
11183777,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006240,NA,NA,1ZIAHL006240-06,NHLBI:939081\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,"Acute;Adenosine Triphosphate;Affinity;African;African American population;Anemia;Binding;Biochemical;Biological Assay;Blood specimen;Cell membrane;Chronic;Clinical;Clinical Research;cohort;Deoxygenated Sickle Hemoglobin;diphosphoglycerate;disease phenotype;disorder control;DNA;enzyme substrate;Enzymes;Erythrocytes;Ethnic Origin;Falciparum Malaria;Gene Frequency;Genes;Genetic;Genetic Determinism;genetic variant;Genetic Variation;Genome;Genomic DNA;Genotype;Geographic Locations;Glycolysis;Goals;Hemoglobin;Hemolytic Anemia;Individual;Introns;loss of function;Malaria;metabolomics;Mutation;National Heart, Lung, and Blood Institute;orlistat;Oxygen;Pathology;Pathway interactions;Patients;Phase;Phenotype;Phosphoenolpyruvate;Piezo 1 ion channel;polymerization;Polymers;Population;Production;Proteins;Proteomics;Protocols documentation;Pyruvate;Pyruvate Kinase;pyruvate kinase deficiency;Quantitative Reverse Transcriptase PCR;recruit;Reporting;response;RNA Sequences;Sampling;Severity of illness;Sickle Cell;Sickle Cell Anemia;Sickle Cell Trait;Sickle Hemoglobin;sickling;SLC2A1 gene;Source;Syndrome;therapeutic target;trait;transcriptome;transcriptome sequencing;Variant","Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease",6240,NA,NA,NA,NA,6,NA,NA,939081,NA
11183778,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006241,NA,NA,1ZIAHL006241-06,NHLBI:845173\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,"Acute;Address;Anemia;Antibodies;Anticoagulation;Antisickling Agents;assay development;Autologous;Basic Science;Biochemical;Biological Assay;biological development;Biological Markers;Biology;Biotin;bisulfite sequencing;Blood;Blood Platelets;Blood specimen;Blood Vessels;Bone Marrow;CD34 gene;Cell Adhesion Molecules;cell free DNA;Cell Volumes;Cells;Clinical Research;Clinical Trials;Coagulation Process;Collaborations;Collection;comparison control;cytokine;Data;density;Density Gradient Centrifugation;Development;Disease;DNA;endothelial dysfunction;Engraftment;Equilibrium;Erythrocytes;Ethnic Origin;experimental study;extracellular;extracellular vesicles;Fiber;Flow Cytometry;Functional disorder;Gene Expression Profiling;Gene Transfer;Genetic;genetic approach;genome sequencing;granulocyte;Half-Life;healthy volunteer;Hematopoietic Stem Cell heterogeneity;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hemoglobin;Human;Image;In Vitro;in vitro Assay;Individual;Inflammation;inter-individual variation;Intramural Research Program;Isomerase;Kinetics;Label;Laboratories;Laboratory Chemicals;laboratory development;Laboratory Research;Libraries;life span;luminescence;Marrow;Measurement;Measures;Methodology;Methods;Mitochondrial DNA;Modification;Molecular;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;neutrophil;Neutrophil Activation;Oxygen;Pathogenesis;Pathologic Processes;Patients;PF4 Gene;phase 2 study;Physics;Plasma;Plasma Proteins;Platelet aggregation;Polymerase Chain Reaction;Preparation;progenitor;Protein Disulfide Isomerase;protein expression;protein function;Protocols documentation;Research;research and development;research study;Research Support;Reticulocytes;Saliva;sample collection;Sampling;Serum;Sickle Cell;Sickle Cell Anemia;Sickle Cell Trait;Sickle Hemoglobin;sickling;single-cell RNA sequencing;small molecule inhibitor;Specimen;Standardization;Testing;Thermodynamics;Thrombospondins;Urine;Variant;Vascular Diseases;vaso-occlusive crisis;Venous Thrombosis;volunteer;Whole Blood;whole genome",Human Specimen Collection to Support Basic and Clinical Research,6241,NA,NA,NA,NA,6,NA,NA,845173,NA
11183779,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006243,NA,NA,1ZIAHL006243-06,NHLBI:1607467\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9603766 (contact),"REMALEY, ALAN THOMAS (contact)",NA,NA,NA,Age related macular degeneration;Amendment;Animal Model;Animals;bench to bedside;Biological Markers;Cardiovascular Diseases;cardiovascular risk factor;Cardiovascular system;Clinical Protocols;Clinical Trials;Dietary Supplementation;Disease;Energy Metabolism;fatty acid supplementation;Fatty Acids;Fish Oils;Goals;Grant;Health;Hypertriglyceridemia;improved;Length;Lipids;Lipoproteins;Measures;Metabolism;Patient Recruitments;Patients;Plasma;Polyunsaturated Fatty Acids;Publishing;recruit;Role;Supplementation;Testing;Triglycerides;United States National Institutes of Health;Very Long Chain Fatty Acid;Vision,Role of fatty acids in health and disease.,6243,NA,NA,NA,NA,6,NA,NA,1607467,NA
11183780,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006249,NA,NA,1ZIAHL006249-05,NHLBI:2376536\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,77841540 (contact),"AKERA, TAKASHI  (contact)",NA,NA,NA,Affect;Alleles;Anaphase;Aneuploidy;Animals;Behavior;Biological;Biology;Cell division;Cell Nucleus;Cells;Centromere;Chimeric Proteins;Chromosome 2;Chromosome Condensation;Chromosome Segregation;Chromosome Structures;Chromosomes;Collaborations;Complex;condensin;CRISPR/Cas technology;Defect;Diploidy;DNA Sequence;Drosophila genus;egg;Elements;Embryo;Eukaryota;Evolution;experimental study;Failure;Female;Female sterility;Fertility;Fertility Disorders;fitness;Fluorescent in Situ Hybridization;Gene Frequency;Genes;Genetic;Genetic Diseases;genetic element;Genome;Germ Cells;Germ Lines;Goals;Haploidy;House mice;Human;Hybrids;Image;Infertility;insight;Laws;Link;live cell imaging;Maize;Mammals;Meiosis;Methods;Microtubules;Molecular;Mus;National Institute of Child Health and Human Development;Nature;next generation;Oocytes;Parents;Phenotype;Physical condensation;Pisum sativum;Population;prevent;Process;Production;Reproduction;reproductive;Rest;Rod;rosin;segregation;Selfish DNA;Selfish Genes;sex;Sexual Reproduction;Shapes;Stretching;System;Techniques;transmission process;Visualization;Work,Chromosome Dynamics and Evolution,6249,NA,NA,NA,NA,5,NA,NA,2376536,NA
11183781,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006257,NA,NA,1ZIAHL006257-04,NHLBI:1846024\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851457 (contact),"CAMPBELL-WASHBURN, ADRIENNE  (contact)",NA,NA,NA,3-Dimensional;Algorithms;Award;Breathing;California;Cardiac;cardiac magnetic resonance imaging;Cardiovascular Diseases;Collaborations;Computer software;Data;denoising;Development;Disease;Feedback;Goals;Grant;healthy volunteer;Image;imaging modality;improved;Industry;Institution;Journals;Lung;lung imaging;Magnetic Resonance Imaging;Medical center;Methods;Morphology;novel;Patients;Performance;Physiologic pulse;Prize;Procedures;real-time images;reconstruction;Research Methodology;Research Personnel;Scanning;symposium;System;Technology;Translating;Universities;Water;Work,Development of high-performance low field MRI technology,6257,NA,NA,NA,NA,4,NA,NA,1846024,NA
11183782,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006259,NA,NA,1ZIAHL006259-04,NHLBI:2220966\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79963344 (contact),"MORGAN, ERIC  (contact)",NA,NA,NA,"African American;Amyloidosis;Anatomy;Automobile Driving;Biological Markers;Blood;Blood Vessels;Cardiac;cardiac magnetic resonance imaging;Cardiology;Cardiotoxicity;Cardiovascular system;Caring;Characteristics;Cicatrix;Clinical;clinical implementation;Clinical Research;Collaborations;Competence;Complex;Coronary;coronary fibrosis;Data;Development;Diabetes Mellitus;Diagnostic;Disease;District of Columbia;Drug usage;EFRAC;Etiology;Exercise;Female;follow-up;Functional disorder;Future;Gadolinium;Geographic Locations;Goals;Health;healthy volunteer;Heart;Heart Diseases;Heart failure;Hospitals;Hypertension;Hypertrophic Cardiomyopathy;Image;Infarction;Inflammation;Injury;insight;International;Ionizing radiation;Knowledge;Laboratories;Left Ventricular Function;Long-Term Effects;Lung;Magnetic Resonance;Magnetic Resonance Imaging;male;Malignant neoplasm of esophagus;Manuscripts;Measurement;Measures;Mechanics;meetings;metabolomics;Morbidity - disease rate;mortality;Muscle Cells;Myocardial;Myocardial perfusion;Myocardial tissue;Myocarditis;National Heart, Lung, and Blood Institute;novel;Oncology;Organ;participant enrollment;patient population;Patients;Perfusion;Phenotype;Physiology;Positioning Attribute;preservation;pressure;Probability;Process;programs;Property;Proteomics;Protocols documentation;Publications;Radiation therapy;Research;Research Subjects;response;Rest;Sample Size;Stress;Stretching;System;Technical Expertise;Techniques;Testing;Tissues;treatment strategy;Washington;Work",Technical development of cardiovascular Magnetic Resonance Imaging,6259,NA,NA,NA,NA,4,NA,NA,2220966,NA
11183783,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006262,NA,NA,1ZIAHL006262-04,NHLBI:1516044\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78377381 (contact),"KANTHI, YOGENDRA  (contact)",NA,NA,NA,Autoimmune;autoinflammatory;autoinflammatory diseases;bench to bedside;Blood Vessels;Cardiovascular system;Cause of Death;Clinical;clinical phenotype;Clinical Research;clinically relevant;Coagulation Process;Disease;early-career faculty;Fibrinolytic Agents;Functional disorder;Goals;Hematology;Human;Immune checkpoint inhibitor;In Vitro;Inflammasome;Inflammation;Inflammatory;Inherited;interest;Interleukin-1 beta;Investigation;Laboratories;Malignant Neoplasms;Mendelian disorder;Mentors;Molecular;Morbidity - disease rate;mortality;Mus;Myocardial Infarction;novel therapeutic intervention;Pathway interactions;patient population;Patients;Postdoctoral Fellow;pre-clinical;Process;Public Health;Risk;Role;Science;Signal Transduction;Stroke;Therapeutic;thromboinflammation;Thrombosis;thrombotic;tool;translational study;United States;Vascular Diseases;venous thromboembolism;Venous Thrombosis,Human Translational Studies of Vascular Thrombosis and Inflammation,6262,NA,NA,NA,NA,4,NA,NA,1516044,NA
11183784,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006263,NA,NA,1ZIAHL006263-04,NHLBI:842247\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78377381 (contact),"KANTHI, YOGENDRA  (contact)",NA,NA,NA,"Acute;Animal Model;Anti-phospholipid Syndrome;Antiphospholipid Antibodies;Autoantibodies;Autoimmune;Binding Proteins;Biological Assay;Biological Markers;Blood;Blood Coagulation Disorders;Blood Vessels;Cells;Cessation of life;Clinic;Clinical;Clinical Trials;Coagulation Process;combat;convalescent plasma;coronavirus disease;coronavirus pandemic;COVID-19;COVID-19 pandemic;COVID-19 patient;COVID-19 test;Critical Illness;current pandemic;Cytoplasm;cytotoxic;defense response;Development;Disease;DNA;early-career faculty;Endothelium;Europe;extracellular;extracellular vesicles;Fibrin;fluidity;Foundations;future pandemic;Genetic Transcription;Height;high risk;Hospitalization;Hospitals;Host Defense;Human;human coronavirus;Immune;Immune response;Immunoglobulin G;improved;In Vitro;Individual;Inflammation;Inflammatory;Interruption;Investigation;Leukocyte L1 Antigen Complex;Lymphocyte;Measurement;Measures;Mentors;Mission;monocyte;Morbidity - disease rate;mortality;Myelogenous;National Heart, Lung, and Blood Institute;neutrophil;novel;novel therapeutics;Organ;Organ failure;Outcome;pandemic disease;participant enrollment;Pathologic;Patients;Perfusion;Phenotype;Phospholipids;Physiological;prospective;Public Health;Publishing;Reporting;Resolution;Resources;Respiratory Failure;response;Role;S100A8 gene;Sampling;SARS-CoV-2 infection;Sepsis;Serum;severe COVID-19;Signal Transduction;single-cell RNA sequencing;Study models;Surface;Testing;Therapeutic;therapeutic target;thromboinflammation;Thrombophilia;Thrombosis;thrombotic;Time;Tissues;Translating;translational study;United States National Institutes of Health;Variant;vascular bed;Vascular Diseases;Venous Thrombosis;Viremia;Virus Diseases;Work",Unraveling Cytotoxic and Thrombotic Signals in COVID-19,6263,NA,NA,NA,NA,4,NA,NA,842247,NA
11183785,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006264,NA,NA,1ZIAHL006264-04,NHLBI:3011673\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78333850 (contact),"MIZUNO, NAOKO  (contact)",NA,NA,NA,Actins;Affect;Axon;axon injury;axon regeneration;Axotomy;Behavior;Binding;Biochemical;Biological;biophysical techniques;Biophysics;Brain;Cell membrane;cell motility;Cell Physiology;Cell Shape;Cells;Central Nervous System;Communication;Complex;Cryo-electron tomography;Cryoelectron Microscopy;Cytoskeleton;Cytosol;Decision Making;Deterioration;Development;Distal;Elements;Endoplasmic Reticulum;Environment;Event;F-Actin;Filopodia;Focal Adhesions;Fostering;In Situ;In Vitro;Individual;insight;Integrins;interest;Length;Light Microscope;light microscopy;macromolecular assembly;Maintenance;Mediating;Membrane;Membrane Proteins;Methods;Microfilaments;Microtubules;migration;Mitochondria;Molecular;Molecular Analysis;Morphogenesis;Mus;Natural regeneration;Neoplasm Metastasis;Nerve Degeneration;Nervous System;neural network;Neurofibrillary Tangles;neuron regeneration;Neurons;Organelles;Pathologic;Pathway interactions;Pharmaceutical Preparations;Play;polarized cell;premature;Preparation;Process;Protein Biosynthesis;Proteins;receptor;reconstitution;Regulation;repaired;Resolution;response;Ribosomes;Role;secretory protein;Series;Shapes;Signal Pathway;Signal Transduction;Site;stem;Structure;Surface;Surveys;System;Talin;Testing;Thinness;Time;tumor growth;Validation;Vinculin;Visual,Molecular organization of pathways governing cell-shape formation,6264,NA,NA,NA,NA,4,NA,NA,3011673,NA
11183786,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006266,NA,NA,1ZIAHL006266-04,NHLBI:469540\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,Acute;Acute Pain;Adenosine Triphosphate;Adverse effects;Affinity;Binding;Biological Availability;Blood;Blood Vessels;Cardiopulmonary;Clinical;Complication;Data;Deoxygenated Sickle Hemoglobin;diphosphoglycerate;Disease;Dose;Drug Kinetics;Drug Targeting;enzyme substrate;Enzymes;Erythrocytes;Evaluation;Event;Fetal Hemoglobin;Frequencies;functional status;Glutamine;Glycolysis;health related quality of life;Hemoglobin;Hemoglobin concentration result;Hospitalization;Human;hydroxyurea;improved;Membrane;Monitor;Oral;Organ;Oxygen;Pain;Pathway interactions;Patients;Pharmaceutical Preparations;Pharmacodynamics;phase 1 study;Phase II Clinical Trials;Phase II/III Clinical Trial;Phosphoenolpyruvate;polymerization;Polymers;pre-clinical;prescription opioid;Process;Production;Publishing;Pyruvate;Pyruvate Kinase;pyruvate kinase deficiency;Reporting;response;Role;Safety;Sickle Cell;Sickle Cell Anemia;Sickle Cell Trait;sickling;small molecule;Source;Supportive care;Symptoms;Syndrome;System;Testing;Thalassemia;therapeutic target,"Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease",6266,NA,NA,NA,NA,4,NA,NA,469540,NA
11183787,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006267,NA,NA,1ZIAHL006267-04,NHLBI:673797\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78377381 (contact),"KANTHI, YOGENDRA  (contact)",NA,NA,NA,"Acute;Autoantibodies;Blood Vessels;Clinic;Clinical;Clinical Research;Clinical Trials;clinically relevant;Coagulation Process;Critical Illness;Diagnostic;Disease;early-career faculty;Endothelium;extracellular;FDA approved;Future;Goals;Human;immune modulating agents;Immunobiology;innate immune function;insight;Mentors;Molecular;neutrophil;Outcome;Pathologic;Phenotype;Production;randomized, clinical trials;Research Personnel;Sampling;Signal Transduction;System;therapeutic target;thromboinflammation;translational study;United States National Institutes of Health",Vascular Immunobiology Mechanistic and Translational Studies,6267,NA,NA,NA,NA,4,NA,NA,673797,NA
11183788,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006268,NA,NA,1ZIAHL006268-04,NHLBI:2159104\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78390320 (contact),"AGBOR-ENOH, SEAN  (contact)",NA,NA,NA,"Acute;Admixture;Algorithms;allograft rejection;Allografting;Antibodies;antibody-mediated rejection;Area;biobank;Biological Markers;Biopsy;Blood;Blood Cells;Bronchoscopy;Caring;Cause of Death;cell free DNA;Cells;Cessation of life;Characteristics;Chronic;Circulation;Clinical;Clinical Data;Clinical Research;Cohort Studies;Collection;Complement;COVID-19;Diagnosis;diagnostic tool;DNA;DNA Sequence;Drug Targeting;effective therapy;efficacy testing;Environment;FDA approved;Functional disorder;Generations;Genetic;Genome;Genomics;Goals;Graft Rejection;Heart Transplantation;Histopathology;Hospitals;Immunologics;improved;Infection;inhibitor;Injury;Interobserver Variability;Laboratories;Life;Liquid substance;lung allograft;Lung Diseases;Lung Transplantation;Mediating;Mediator;metropolitan;Mission;Molecular;Monitor;multiple omics;National Heart, Lung, and Blood Institute;Natural History;novel;novel diagnostics;Organ;Organ Transplantation;Outcome;participant enrollment;Pathway interactions;Patient Monitoring;patient population;Patient Recruitments;Patient risk;patient stratification;Patients;Performance;Phagocytes;Placebos;Plasma;post-transplant;Prevention;Principal Investigator;Process;programs;Publishing;pulmonary arterial hypertension;racial disparity;remote monitoring;Research;Research Infrastructure;response;Risk Factors;safety testing;sample collection;Sampling;Series;Site;Solid;SYK gene;targeted treatment;Testing;transplant centers;Transplant Recipients;Transplantation;Treatment Failure;Tyrosine Kinase Inhibitor;Waiting Lists",Cell-free DNA to detect transplant rejection,6268,NA,NA,NA,NA,4,NA,NA,2159104,NA
11183789,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006273,NA,NA,1ZIAHL006273-03,NHLBI:305657\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15197977 (contact),"KEMPER, CLAUDIA  (contact)",NA,NA,NA,Acute;Area;Brain;brain cell;Cells;Complement;complement system;Disease;Experimental Autoimmune Encephalomyelitis;experimental study;Future;gene complementation;Health;Immune;in vivo;Infection;LoxP-flanked allele;Meningeal;Meninges;mouse model;Mouse Strains;Multiple Sclerosis;Mus;Nerve;neuroinflammation;neuron development;Peptides;Reporter;Research;Role;Serum;Severity of illness;System,The complosome in meningeal health and disease,6273,NA,NA,NA,NA,3,NA,NA,305657,NA
11183791,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006275,NA,NA,1ZIAHL006275-03,NHLBI:1560188\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9603766 (contact),"REMALEY, ALAN THOMAS (contact)",NA,NA,NA,Apolipoproteins B;Biological Assay;Biological Markers;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular risk factor;Cardiovascular system;Cells;Cholestasis;Cholesterol;Clinical;Consensus;Development;Diagnosis;Dyslipidemias;Eligibility Determination;Equation;Event;Future;Genetic;Guidelines;High Density Lipoproteins;International;Kidney Diseases;lecithin cholesterol acyltransferase deficiency;Lipids;Lipoproteins;Low-Density Lipoproteins;Measures;Methods;Monitor;novel;particle;Patients;Plasma;Publishing;Recommendation;Testing;Triglycerides;Very low density lipoprotein,Development and assessment of cardiovascular risk biomarkers,6275,NA,NA,NA,NA,3,NA,NA,1560188,NA
11183792,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006276,NA,NA,1ZIAHL006276-03,NHLBI:918303\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,11601302 (contact),"HARBISON, SUSAN  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Breeding;Candidate Disease Gene;Cardiovascular Diseases;circadian;circadian pacemaker;Circadian Rhythms;Complex;Darkness;Data;disorder risk;DNA;Drosophila genus;Drosophila melanogaster;epidemiology study;falls;Female;fly;Gene Expression;gene network;Genes;Genetic;Genetic Polymorphism;genome wide association study;Genomics;Goals;Heritability;Hour;Human;Inbreeding;Light;male;Maps;markov model;Modeling;Mutation;Phenotype;Process;Publishing;Research;response;RNA;Role;Sampling;Sleep;Sleep Deprivation;Sleep Fragmentations;Testing;Time;trait;transcriptomics;Variant;Work,Identification of polymorphic variants impacting sleep in Drosophila,6276,NA,NA,NA,NA,3,NA,NA,918303,NA
11183793,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006277,NA,NA,1ZIAHL006277-03,NHLBI:191787\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851477 (contact),"ROGER, VERONIQUE  (contact)",NA,NA,NA,"Age;American Heart Association;Area;black men;Black race;black women;Cardiovascular Diseases;cardiovascular risk factor;Censuses;Circulation;Code;cohort;Cohort Studies;Communities;Commuting;Data;demographics;design;Enrollment;Epidemiology;experience;follow-up;Goals;hazard;Health behavior;health inequalities;Heart failure;Incidence;Inequity;Low income;Low Income Population;Medicaid;Medicare;meetings;men;Modeling;mortality;Oral;Outcome;Participant;Persons;population based;Primary Prevention;Prospective, cohort study;Publishing;Race;Risk;Rural;rural area;Rural Health;Rural Population;rurality;Services;sex;Socioeconomic Status;Southeastern United States;Standardization;study population;Testing;United States Centers for Medicare and Medicaid Services;Urban Population;White Women;Woman",Rurality and Heart Failure: The Southern Community Cohort Study,6277,NA,NA,NA,NA,3,NA,NA,191787,NA
11183794,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006278,NA,NA,1ZIAHL006278-03,NHLBI:575361\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851477 (contact),"ROGER, VERONIQUE  (contact)",NA,NA,NA,Address;Adrenergic beta-Antagonists;Age;Alanine;Algorithms;American;American Heart Association;Angiotensin Receptor;Angiotensin-Converting Enzyme Inhibitors;biobank;Blood Pressure;Body mass index;Books;Branched-Chain Amino Acids;Cardiovascular Diseases;Cessation of life;Characteristics;Chronic Obstructive Pulmonary Disease;Citrates;Clinic;Clinical;Clinical Data;clinical risk;cohort;Cohort Studies;Communities;Community Health;Complex;Congestive Heart Failure;Creatinine;Data;design;Diabetes Mellitus;Diagnosis;EFRAC;Electronic Health Record;Enrollment;Epidemiology;epidemiology study;Equipment and supply inventories;Evaluation;frailty;Glucose;Guidelines;hazard;Heart;Heart failure;High Density Lipoproteins;high risk;indexing;Individual;Insulin Resistance;Investigation;Isoleucine;Ketone Bodies;Leucine;Life Style;Lipoproteins;Malnutrition;Manuscripts;Measurement;Measures;meetings;Meta-Analysis;Metabolic;metabolomics;Methods;Mission;mortality;mortality risk;New York;novel;Nuclear Magnetic Resonance;Obesity;particle;Patients;Persons;Phenotype;Plasma;Population;Population Study;Preventive;prognostic;prognostic value;prospective;Publishing;Recommendation;Research;Risk;Risk Estimate;risk prediction;risk stratification;Sampling;sex;Smoking;Smoking Status;Societies;Stratification;Survival Rate;Syndrome;systemic inflammatory response;Testing;Therapeutic;Triglycerides;unsupervised learning;Valine;Woman;Work,Heart failure Metabolomics: NMR studies,6278,NA,NA,NA,NA,3,NA,NA,575361,NA
11183795,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006279,NA,NA,1ZIAHL006279-03,NHLBI:2301446\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851477 (contact),"ROGER, VERONIQUE  (contact)",NA,NA,NA,American Heart Association;angiogenesis;aptamer;Attenuated;biobank;Bioinformatics;Biological Markers;Books;Cardiology;Cessation of life;Characteristics;Chronic Kidney Insufficiency;Clinic;Clinical;Clinical Data;cohort;Collaborations;Communities;comorbidity;Complex;Confidence Intervals;Congestive Heart Failure;Data;design;effective therapy;EFRAC;Electronic Health Record;Epidemiology;epidemiology study;Equipment and supply inventories;Etiology;European;Foundations;Framingham Heart Study;Heart failure;imaging program;Immune response;Individual;Inflammation;Infrastructure;International;Ischemia;Kidney Diseases;Machine Learning;Manuscripts;Measurement;meetings;Meta-Analysis;mortality;mortality risk;novel;Pathway Analysis;Pathway interactions;Patients;Phenotype;Plasma Proteins;Play;Population Heterogeneity;Population Study;predictive signature;Preparation;prognostic;prognostic value;Proteins;proteomic signature;Proteomics;Renal function;Risk;risk stratification;Role;Sampling Studies;Societies;Syndrome;Technology;Therapeutic;Validation;Work,Heart failure proteomics: an epidemiology study,6279,NA,NA,NA,NA,3,NA,NA,2301446,NA
11183796,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006280,NA,NA,1ZIAHL006280-03,NHLBI:191787\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851477 (contact),"ROGER, VERONIQUE  (contact)",NA,NA,NA,Address;Age;aged;Anxiety;beneficiary;Black race;Caring;Cause of Death;Characteristics;Circulation;Clinical;Code;Communities;Cross-Sectional Studies;Disparity;Environment;Epidemic;Epidemiology;Ethnic Origin;Event;experience;health care availability;health disparity;Health Services Accessibility;Healthcare;Healthcare Systems;Heart failure;High Prevalence;human old age (65+);Hypertension;ICD-10-CM;Individual;insight;International Classification of Diseases;low socioeconomic status;male;Measures;men;middle age;military health system;Military Personnel;military service;Modeling;Modification;Morbidity - disease rate;mortality;Odds Ratio;Persons;Population;Post-Traumatic Stress Disorders;pre-clinical;Prevalence;Prevention;Proxy;Publishing;Race;Research;Risk Factors;sex;sex disparity;Smoking;sociodemographics;trend;Veterans;Woman,Epidemiology of Heart Failure in a Universal Healthcare system,6280,NA,NA,NA,NA,3,NA,NA,191787,NA
11183797,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006282,NA,NA,1ZIAHL006282-01,NHLBI:234770\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,active comparator;Adult;Adverse event;Anemia;Bilirubin;Binding;Clinical;clinical efficacy;Data;design;Double-Blind Method;Drug Kinetics;Echocardiography;efficacy evaluation;Ensure;Erythrocytes;Erythropoietin;Fatigue;Functional disorder;Genes;Globin;Goals;Heme;Hemoglobin;Hemolysis;Hemolytic Anemia;Human;Hydration status;improved;Investigation;Laboratories;Lactate Dehydrogenase;Membrane;Modeling;Monitor;Multicenter Studies;Mutation;open label;Oxidative Stress;Oxygen;Pain;Patients;Pharmacodynamics;Phase;Placebo Control;Placebos;Play;polymerization;Polymers;Process;Proteins;Pyruvate Kinase;Quality of life;Questionnaires;Randomized;Reporting;Reticulocyte count;Role;Safety;Serious Adverse Event;Sickle Cell;Sickle Cell Anemia;sickling;Sleep;Solubility;Testing;therapeutic candidate;United States National Institutes of Health;Walking,"A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease",6282,NA,NA,NA,NA,1,NA,NA,234770,NA
11183798,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006283,NA,NA,1ZIAHL006283-02,NHLBI:234770\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,Abnormal Hemoglobins;Acute;Adopted;Affect;African American;African ancestry;Amino Acids;beta Globin;Biological Markers;Birth;Blood flow;Blood Vessels;Cardiovascular system;Cerebrum;Chest;Chronic;chronic pain;Clinical;clinical application;clinical center;Data;Devices;Disease;Echocardiography;endothelial dysfunction;Enrollment;Erythrocytes;Ethnic Origin;Evaluation;Exercise;Glutamic Acid;hemodynamics;Hemoglobin;hemoglobin AA;Hemoglobinopathies;Hemolysis;Hemolytic Anemia;Hypoxia;Impairment;Individual;Inflammation;Inherited;Kidney;Lead;life span;Literature;Malignant Breast Neoplasm;Measurement;Minority Groups;Monitor;muscle physiology;Near-Infrared Spectroscopy;Optics;Organ;Outcome;Outpatients;Participant;Patients;Physiological;point of care;Polymers;Protocols documentation;Recurrence;Reperfusion Injury;Reporting;research study;response;Science;screening;Shapes;Sickle Cell;Sickle Cell Anemia;sickling;Site;Structure;Techniques;Technology Assessment;Testing;tissue oxygenation;Tissues;United States;Valine;Variant;Vascular Diseases;Vascular Endothelium;vaso-occlusive crisis;vaso-occlusive pain;Visit;Walking,"Exploring Near Infrared Spectroscopy (NIRS) technologies for assessment of muscle physiology, tissue oxygenation, and blood flow in patients with Sickle Cell Disease (SCD",6283,NA,NA,NA,NA,2,NA,NA,234770,NA
11183799,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006284,NA,NA,1ZIAHL006284-02,NHLBI:234770\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,Acute;Address;Adverse event;Amino Acid Substitution;Animal Disease Models;Animal Model;Animals;Anions;Anticoagulation;Band Cell;beta Globin;Biochemical;Biological Markers;Blood Platelets;Cardiovascular system;Cell membrane;Cell Physiology;Cellular Metabolic Process;Clinical;Coagulation Process;Complex;COVID-19;Data;design;Development;Disease;Dose;Enrollment;Erythrocyte Anion Exchange Protein 1;Erythrocytes;Event;Exhibits;experience;Exposure to;extracellular;Face;FDA approved;Frequencies;Functional disorder;Genes;Glutamic Acid;Goals;Hemoglobin;hemoglobin polymer;Hemolysis;Hemorrhage;Histones;Hypoxia;Idiopathic Thrombocytopenic Purpura;Immune;immunothrombosis;In Vitro;Incidence;Individual;Inflammatory;Institutional Review Boards;Kidney;Laboratories;life span;Lung;Mediator;Molecular;Monitor;mortality;Neurologic;neutrophil;Neutrophil Activation;novel;Oral;Oxygen;particle;Patients;phase 1 study;Phase I Clinical Trials;Phosphorylation;Phosphotransferases;Phosphotyrosine;Platelet Activation;Play;Positioning Attribute;Process;Production;Reactive Oxygen Species;Recurrence;Reperfusion Injury;research study;Risk;Role;Safety;safety assessment;Sampling;Serine Protease;Serious Adverse Event;Severities;Severity of illness;Sickle Cell;Sickle Cell Anemia;Sickle Hemoglobin;sickling;Signal Pathway;Signs and Symptoms;Specific qualifier value;Stroke;Study Subject;SYK gene;symptomatology;thrombogenesis;thromboinflammation;Thrombophilia;Thrombosis;Time;time interval;Tyrosine Kinase Inhibitor;Tyrosine Phosphorylation;United States National Institutes of Health;Valine;Vascular Diseases;vascular injury;vaso-occlusive crisis;Venous;venous thromboembolism;Venous Thrombosis,A Phase 1 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects with stable sickle cell disease,6284,NA,NA,NA,NA,2,NA,NA,234770,NA
11183800,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006285,NA,NA,1ZIAHL006285-02,NHLBI:1548743\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361816 (contact),"WONG, JASON  (contact)",NA,NA,NA,"Aging;Air;American Heart Association;Androgens;Asthma;Atherosclerosis;atmospheric conditions;biobank;Bioinformatics;Biological;Biological Aging;candidate marker;Cardiovascular Diseases;case control;Characteristics;Chemical Exposure;chromosome X loss;chromosome Y loss;Chronic Disease;climate change;Communities;Cross-Sectional Studies;Data;data integration;Diagnostic;DNA Methylation;Environmental Exposure;Environmental Pollutants;Environmental Risk Factor;Epidemiology;epidemiology study;Estradiol;European;exome sequencing;experience;Funding;Future;Genetic;Genetic Predisposition to Disease;Genets;Genome;Genomic Instability;Genotype;Geographic Locations;Goals;Gonadal Steroid Hormones;Heart;heart disease risk;Heart Diseases;Heart failure;high dimensionality;Human;interest;International;Journals;Length;Leukocytes;Lung Diseases;Measurement;Measures;Mediating;men;Metabolic;Methods;Modernization;Molecular;mosaic loss;Mosaicism;multiple omics;Mutagenesis;Mutation;National Heart, Lung, and Blood Institute;Non-Malignant;novel;Paper;Pathogenesis;Persons;Population;programs;Prospective cohort;Prospective, cohort study;Public Health;Publishing;regional difference;Research;Respiratory Disease;Retroelements;Risk;risk prediction;risk stratification;Role;Source;Special Population;telomere;translational potential;United Kingdom;Visit;Woman",Biological mechanisms underlying the relationships between environmental exposures and risk of respiratory and cardiovascular diseases,6285,NA,NA,NA,NA,2,NA,NA,1548743,NA
11183802,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006288,NA,NA,1ZIAHL006288-02,NHLBI:1358122\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361820 (contact),"ELINOFF, JASON  (contact)",NA,NA,NA,"Abbreviations;Adenylate Cyclase;Affect;Animals;Apoptosis;arteriole;Atrial Heart Septal Defects;Attenuated;autosome;blood glucose regulation;BMPR2 gene;Cardiac;cardiac magnetic resonance imaging;Catalytic Domain;caveolin 1;CD44 gene;Cell model;cell motility;Cell Proliferation;Cells;Child;Chronic;Chronic small plaque psoriasis;clinical center;Clinical Research;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Congenital Heart Defects;Control Animal;Core Facility;Cre lox recombination system;CXCL10 gene;Defect;Development;Dideoxy Chain Termination DNA Sequencing;Distal;Dose;Endoplasmic Reticulum;Endothelial Cells;endothelial dysfunction;Endothelin-1;Endothelium;Enzymes;Exhibits;experimental study;Expression Profiling;Fibroblasts;G6PC3 gene;Gene Expression;Genetic;genome-wide;Glucose;glucose metabolism;glucose-6-phosphatase;Glucose-6-Phosphate;Glycogen Storage Disease Type I;Goals;heart function;Homeostasis;Human;Hydrolysis;Hypoxia;immunocytochemistry;Immunofluorescence Immunologic;Impairment;In Vitro;in vivo;Incidence;induced pluripotent stem cell;Infiltration;Inflammation;Inflammatory;Inflammatory Response;inhibitor;insight;Interferon Activation;Interferons;Investigation;Knock-out;Knockout Mice;Lesion;loss of function mutation;Lung;Malignant Neoplasms;Mediating;Membrane Glycoproteins;Metabolic;mimetics;Modeling;Molecular;Monocrotaline;mortality;mouse model;mRNA Expression;Mus;Mutation;National Heart, Lung, and Blood Institute;Neutropenia;neutrophil;new therapeutic target;NOS3 gene;novel therapeutics;Pathologic;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Phenotype;Phosphorylation;PI3K/AKT;PIK3CG gene;Placebos;pre-clinical;Process;Production;programs;protein expression;Protein Isoforms;Proto-Oncogene Proteins c-akt;Protocols documentation;prototype;Psoriasis;pulmonary arterial hypertension;pulmonary artery endothelial cell;Pulmonary artery structure;pulmonary vascular cells;pulmonary vascular remodeling;Rattus;Reproducibility;Resistance;response;RNA Splicing;Role;Serum;Severe congenital neutropenia;Signal Transduction;sildenafil;Site;skin lesion;small molecule inhibitor;Stains;STAT1 gene;Structure;Structure of parenchyma of lung;SU 5416;Syndrome;System;Systolic Pressure;T-Lymphocyte;targeted treatment;Testing;Therapeutic;tool;Transcript;Transgenic Mice;Translating;United States National Institutes of Health;Variant;Vascular remodeling;Vasodilator Agents;Ventricular;Western Blotting",Cellular Models of PAH-Associated Molecular Defects as a Tool for Identifying New Therapeutic Targets,6288,NA,NA,NA,NA,2,NA,NA,1358122,NA
11183803,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006289,NA,NA,1ZIAHL006289-02,NHLBI:194017\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361820 (contact),"ELINOFF, JASON  (contact)",NA,NA,NA,2019-nCoV;ACE2;Acute;Apoptosis;arteriole;Autopsy;Blood Coagulation Disorders;Blood Vessels;Cardiovascular Manifestation;Cardiovascular system;cell type;Cells;Cessation of life;COVID-19 patient;COVID-19 pneumonia;digital;Disease;Distal;Dose;Electron Microscopy;Endothelial Cells;Endothelium;experimental study;Hour;Human;Hypoxemic Respiratory Failure;In Situ Hybridization;In Vitro;Infection;Inflammatory Infiltrate;Injury;Lung;lung microvascular endothelial cells;Microscopy;Molecular;mortality;Multisystem Inflammatory Syndrome in Children;Mutation;novel coronavirus;NRP1 gene;Nucleocapsid;Organ;pandemic disease;particle;permissiveness;Proteins;pulmonary artery endothelial cell;Pulmonary artery structure;Pulmonary Hypertension;Recombinants;RNA;SARS-CoV-2 B.1.617.2;SARS-CoV-2 infection;SARS-CoV-2 spike protein;SARS-CoV-2 variant;Secondary to;Shock;Stroke;Syndrome;systemic inflammatory response;Thrombus;TMPRSS2 gene;Transcript;transcriptomics;Variant;Vascular Endothelium;vascular inflammation;venous thromboembolism;Viral;viral RNA;Virus;Virus Replication,Cellular and Molecular Consequences of SARS-CoV2 Infection in Pulmonary Vascular Endothelium,6289,NA,NA,NA,NA,2,NA,NA,194017,NA
11183804,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006295,NA,NA,1ZIAHL006295-02,NHLBI:388035\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361820 (contact),"ELINOFF, JASON  (contact)",NA,NA,NA,Alleles;antagonist;Anti-Inflammatory Agents;Arteries;Autoimmune Diseases;autoinflammatory diseases;Binding;Biological Assay;Biotin;Biotinylation;Candidate Disease Gene;Cells;Cessation of life;Chemicals;Clinical;Complex;cytotoxicity;Data;Digestion;Disease;Dose;drug development;Drug Industry;Endothelium;experimental study;FDA approved;follow-up;Gene Expression;Gene Library;Gene Targeting;Genes;Genetic Transcription;genome-wide;Heart failure;high throughput screening;Human;improved;In Vitro;Incubated;Inflammation;Inflammatory;innovation;Knock-in;Left;Libraries;liquid chromatography mass spectrometry;luminescence;Lung;Measures;Mineralocorticoid Receptor;miniaturize;Molecular;multicatalytic endopeptidase complex;National Center for Advancing Translational Sciences;novel;novel therapeutics;Patients;Peptides;Pharmaceutical Preparations;Proliferating;protein complex;Proteins;Proteome;prototype;pulmonary arterial hypertension;pulmonary artery endothelial cell;pulmonary vascular cells;Reproducibility;right ventricular failure;RNA Interference;RNA interference screen;Safety;Sampling;screening;side effect;Small Interfering RNA;small molecule libraries;Spironolactone;Streptavidin;System;Testing;Therapeutic;Titrations;transcription factor TFIIH;Transfection;Ubiquitin;vascular inflammation;Xeroderma Pigmentosum,Proteasomal Degradation of XPB as a Novel Mechanism for Treating Inflammation,6295,NA,NA,NA,NA,2,NA,NA,388035,NA
11183805,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006296,NA,NA,1ZIAHL006296-02,NHLBI:704311\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15233859 (contact),"THEIN, SWEE LAY  (contact)",NA,NA,NA,Acute;Acute Pain;Affinity;ANXA5 gene;arm;Biological Markers;Blinded;Blood flow;Blood Vessels;brain magnetic resonance imaging;Cell Survival;cerebral hemodynamics;Cerebrovascular Circulation;Cerebrum;Chronic;Clinical;Companions;Complication;Data;Disease;Dose;Double-Blind Method;Enrollment;Erythrocytes;Event;Flow Cytometry;Fluorescent Probes;follow-up;Frequencies;Glutamine;glycation;Half-Life;Hemoglobin concentration result;Hemolytic Anemia;Hospitalization;hydroxyurea;Hypoxia;imaging modality;Individual;insight;Institution;Label;Laboratories;Mass Spectrum Analysis;Measurement;Measures;metabolic rate;metabolomics;Methodology;muscle physiology;Near-Infrared Spectroscopy;Observational Study;open label;Organ;Osmosis;Oxygen;Oxygen Consumption;Pain;Pathway interactions;Patients;Phase;phase 1 study;Phosphatidylserines;Placebo Control;Placebos;Population;potential biomarker;prescription opioid;primary endpoint;Proteomics;Protocols documentation;Randomized;Reactive Oxygen Species;response;Role;Safety;Sample Size;Sampling;secondary endpoint;Sickle Cell;Sickle Cell Anemia;sickling;Supportive care;System;Technology;Testing;Time;time interval;tissue oxygenation;TNFRSF5 gene;trend;Tyrosine Phosphorylation;United States National Institutes of Health,Observational Study Investigating the Mechanistic Effects of Mitapivat in Subjects with Sickle Cell Disease,6296,NA,NA,NA,NA,2,NA,NA,704311,NA
11183806,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006297,NA,NA,1ZIAHL006297-01,NHLBI:575361\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851477 (contact),"ROGER, VERONIQUE  (contact)",NA,NA,NA,"Area;Calendar;Cessation of life;Clinical;Clinical Data;Communities;Complex;Computerized Medical Record;Data;District of Columbia;Event;Funding;Goals;Heart failure;insight;Institutional Review Boards;Link;Manuals;Maryland;Measures;Molecular;mortality;multiple omics;Participant;Phase;Phenotype;Plasma;Population Heterogeneity;Population Sciences;Population-Based Registry;Prospective, cohort study;Records;recruit;Reporting;Site;Syndrome;United States National Institutes of Health;Universities;Virginia",Multi Scale Phenotyping of Heart Failure in Diverse Populations,6297,NA,NA,NA,NA,1,NA,NA,575361,NA
11183808,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006299,NA,NA,1ZIAHL006299-01,NHLBI:504254\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416551 (contact),"LEVY, DANIEL  (contact)",NA,NA,NA,Address;adverse outcome;Affect;Age;age acceleration;age related;Alleles;Boston;Cardiovascular Diseases;cardiovascular disorder risk;Cells;Chronic lung disease;Clinical;Clonal Expansion;Coronary Arteriosclerosis;Cross-Sectional Studies;Data;Data Analyses;Data Set;Disease;DNA;DNA Sequencing Facility;fitness;Framingham Heart Study;Frequencies;Gene Mutation;Genome;genome sequencing;Grant;Hematologic Neoplasms;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;heteroplasmy;Impairment;Inflammatory;insight;Ischemic Stroke;Jackson Heart Study;Knowledge;Link;Longitudinal Studies;Methods;Mitochondria;Mitochondrial DNA;mitochondrial genome;Molecular Profiling;mortality;mouse model;mutant;Mutate;Mutation;Nature;Nuclear;Observational Study;Participant;Phenotype;Production;programs;Risk;Risk Factors;Sampling;Signal Transduction;Somatic Mutation;Time;timeline;Trans-Omics for Precision Medicine;transcriptome sequencing;Universities;Vermont;Whole Blood;whole genome,The Dynamic Genome,6299,NA,NA,NA,NA,1,NA,NA,504254,NA
11183809,ZIA,HL,1,N,NA,NA,NA,NA,ZIAHL006300,NA,NA,1ZIAHL006300-01,NHLBI:336899\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78377381 (contact),"KANTHI, YOGENDRA  (contact)",NA,NA,NA,Affect;Anatomy;Biological Markers;Blood;Blood flow;Blood Vessels;Clinic;Clinical Data;constriction;Development;Diagnosis;Diagnostic Procedure;diagnostic value;Disease;Early Diagnosis;Environment;Goals;Health;Image;imaging approach;Imaging technology;improved;insight;Magnetic Resonance Imaging;Microvascular Dysfunction;Monitor;Near-Infrared Spectroscopy;novel;organ growth;patient population;Patients;Performance;Research;Role;sensor;sensor technology;Techniques;Therapeutic;therapeutic target;Time;tissue oxygenation;Tissues;Vascular Diseases;X-Ray Computed Tomography,Multi-Functional Assessment of Vascular Networks,6300,NA,NA,NA,NA,1,NA,NA,336899,NA
11183810,ZIC,AG,1,N,NA,NA,NA,NA,ZICAG000615,NA,NA,1ZICAG000615-17,NIA:1738007\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,10274386 (contact),"INDIG, FRED  (contact)",NA,NA,NA,3-Dimensional;Actin-Binding Protein;Aging;Binding;Brain;cannabinoid receptor;Cell Cycle Progression;Cell Membrane Proteins;Cell Nucleus;Cell Physiology;Cells;Cellular biology;cellular imaging;claudin-1 protein;Collaborations;Color;confocal imaging;Confocal Microscopy;Consult;Consultations;Core Facility;Cytoplasm;Cytoplasmic Structures;density;Development;Diagnosis;DNA;DNA biosynthesis;DNA Damage;Emerging Technologies;Endocrinology;Endocytosis;Epidermal Growth Factor Receptor;Equipment;Experimental Designs;experimental study;Extramural Activities;Family;filamin;Freezing;Genes;Glucocorticoid Receptor;GPR55 receptor;Histologic;Histology;Human;Image;Image Analysis;image processing;imaging facilities;imaging study;Imaging Techniques;Immunofluorescence Immunologic;Immunofluorescence Microscopy;Intramural Research;Investigation;Islets of Langerhans;isopentane;Journals;Kinetics;Lasers;late endosome;Ligands;light microscopy;Lighting;Liquid substance;Lysosomes;Malignant Neoplasms;Maryland;Masks;Measures;Melanoma;Melanoma Cell;member;Metastatic Melanoma;Methodology;Methods;MicroRNAs;Microscope;Microscopy;Mission;Mitochondria;Mitosis;Modeling;Modification;Molecular Biology;Muscle;Muscle Mitochondria;National Institute of Biomedical Imaging and Bioengineering;Nature;Nitrogen;novel;Nuclear;Nuclear Protein;operation;Optics;Organelles;Paper;Patients;Peer Review;Phosphoric Monoester Hydrolases;Phosphorylation;Postdoctoral Fellow;protein complex;protein distribution;protein transport;Proteins;Protocols documentation;PTPRC gene;Publications;Publishing;ratiometric;Receptor Activation;receptor binding;Receptor Protein-Tyrosine Kinases;reconstruction;Reporting;Research;Research Personnel;Resolution;Resources;RNA;RNA-Binding Proteins;Sampling;sarcopenia;Scanning;Scientist;Services;Signal Transduction;Sorting;Specimen;src-Family Kinases;stress granule;structural biology;Structure;submicron;sugar;superresolution microscopy;syndecan;System;T-Cell Activation;T-Lymphocyte;Techniques;Technology;technology validation;Testing;Tight Junctions;Time;Tissue Sample;tool;trafficking;Training;tumorigenesis;ubiquitin ligase;ultra high resolution;United States National Institutes of Health;Universities,NIA Confocal Imaging Facility,615,NA,NA,NA,NA,17,NA,NA,1738007,NA
11183811,ZIC,DC,1,N,NA,NA,NA,NA,ZICDC000080,NA,NA,1ZICDC000080-13,NIDCD:1149414\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,11613241 (contact),"FITZGERALD, TRACY  (contact)",NA,NA,NA,Alleles;Auditory;Auditory Brainstem Responses;Auditory Threshold;Biophysics;Calibration;cell regeneration;Cellular biology;cochlear development;Collaborations;Core Facility;Data;Data Analyses;Data Collection;design;Development;Doctor of Medicine;Doctor of Philosophy;Educational workshop;Equipment;Evoked Potentials;Exercise;Experimental Designs;Exposure to;External auditory canal;gene therapy;Head Movements;hearing impairment;hearing screening;Hearing Tests;interest;investigator training;Laboratories;laboratory experience;laboratory experiment;Labyrinth;lectures;Maintenance;Measures;member;microphone;Military Personnel;Missense Mutation;Molecular Genetics;mouse model;Mus;Mutant Strains Mice;National Institute on Deafness and Other Communication Disorders;Nervous System;Nervous System Trauma;Neurosciences;noise exposure;Organ;otoacoustic emission;otoconia;ototoxicity;Outer Hair Cells;Patients;Pharmaceutical Preparations;Physiological;Physiology;Postdoctoral Fellow;Preparation;prevent hearing loss;programs;Protocols documentation;Psychiatry;Publications;remediation;Research;Research Institute;Research Personnel;response;restoration;Saccule and Utricle;Scientist;segregation;Sensory;Sensory Physiology;Services;sound;Sum;Techniques;Testing;Training;Vestibular Aqueduct;Vestibular dysfunction;Vestibular function;Vestibular Function Tests;vestibular system,Mouse Auditory Testing Core Facility,80,NA,NA,NA,NA,13,NA,NA,1149414,NA
11183812,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL000338,NA,NA,1ZICHL000338-24,NHLBI:1899381\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,7364147 (contact),"PISZCZEK, GRZEGORZ  (contact)",NA,NA,NA,"Affinity;Biological;biophysical properties;Biophysics;Categories;Collaborations;Communities;Consultations;Core Facility;detector;Development;DNA;Field Flow Fractionation;fluidity;Fluorescence;Hour;instrument;Kinetics;Laboratories;Lasers;Ligands;light scattering;luminescence;macromolecule;Measurement;Methods;Microfluidics;Mission;Molecular Conformation;Molecular Weight;nanoparticle;National Heart, Lung, and Blood Institute;Postdoctoral Fellow;Principal Investigator;Proteins;Reader;Refractive Indices;Research Personnel;Research Project Grants;Research Support;Resources;RNA;Sampling;Scanning;Scientist;Services;Shapes;stoichiometry;Students;System;Temperature;Thermodynamics;Titrations;Training;Twin Multiple Birth;United States National Institutes of Health;Workload;zeta potential",Biophysics Core Facility,338,NA,NA,NA,NA,24,NA,NA,1899381,NA
11183813,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL005090,NA,NA,1ZICHL005090-19,NHLBI:1522746\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,12450692 (contact),"SWENSON, ROLF  (contact)",NA,NA,NA,"Antibodies;Automation;Binding;Cells;Chemicals;Chemistry;clinical development;clinical imaging;Communities;Databases;Dendrimers;Development;Doctor of Philosophy;drug discovery;Drug Kinetics;experience;Goals;Image;imaging agent;imaging capabilities;imaging modality;imaging probe;imaging study;improved;inhibitor;innovation;interest;Intramural Research;Intramural Research Program;Journals;Knowledge;Label;Laboratories;Ligands;Link;Magnetic Resonance Imaging;meetings;metabolomics;Methods;molecular imaging;nanoparticle;National Heart, Lung, and Blood Institute;next generation;novel;operation;optical imaging;Peer Review;Peptides;Pharmaceutical Chemistry;Positron-Emission Tomography;posters;Problem Solving;Production;programs;protein degradation;Publications;Publishing;Radiolabeled;Reporting;Research;Research Personnel;Resources;scale up;Scientist;single photon emission computed tomography;small molecule;tool;Translations;United States National Institutes of Health;web site;Work",Chemistry and Synthesis Center (formerly IPDC),5090,NA,NA,NA,NA,19,NA,NA,1522746,NA
11183814,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL005905,NA,NA,1ZICHL005905-17,NHLBI:2702156\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851490 (contact),"DAGUR, PRADEEP  (contact)",NA,NA,NA,"advanced analytics;Apoptosis;Biological Assay;Cell Cycle;Cell Separation;Cells;chemokine;Complex;Consultations;Continuing Education;Core Facility;cost;cytokine;Cytometry;Data;Data Analyses;Development;Ensure;Equipment and supply inventories;experience;Experimental Designs;experimental study;Flow Cytometry;Goals;high dimensionality;Hour;Image;Immunoassay;Immunology;Immunology procedure;Immunophenotyping;instrument;instrumentation;Intramural Research;Intranet;Laboratories;Lymphocyte Subset;Manuscripts;Measurement;Methods;Mission;National Heart, Lung, and Blood Institute;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;new technology;novel;operation;Policies;Quality Control;Recovery;Research;Research Personnel;Resources;Safety;Schedule;Science;Services;Site;Technical Expertise;Training;United States National Institutes of Health;Visit;Work",Flow Cytometry Core Facility,5905,NA,NA,NA,NA,17,NA,NA,2702156,NA
11183815,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL005906,NA,NA,1ZICHL005906-17,NHLBI:1063693\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,78851492 (contact),"SYED, ZULFEQHAR  (contact)",NA,NA,NA,"3-Dimensional;Antigens;Biological;Cell Culture Techniques;Cells;chemical fixation;Core Facility;Cryoultramicrotomy;digital imaging;Dryness;Electron Microscope;Electron Microscopy;Equipment;Freeze Substitution;Freezing;Imaging Device;immunocytochemistry;Immunoperoxidase Technics;improved;Ions;Knowledge;Label;Learning;Light Microscope;light microscopy;Lipids;Membrane;Methods;Molecular Structure;Morphology;nanoGold;National Heart, Lung, and Blood Institute;Negative Staining;Organ;Organism;Polymers;Preparation;preservation;pressure;Property;Proteins;Research;Resolution;Sampling;Scanning;Scanning Electron Microscopy;Scientist;Services;Silver;Specimen;Structure;Surface;Techniques;tissue culture;Tissues;tomography;Training;Transmission Electron Microscopy;Vesicle",Electron Microscopy Core,5906,NA,NA,NA,NA,17,NA,NA,1063693,NA
11183816,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL005907,NA,NA,1ZICHL005907-17,NHLBI:2241425\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,14285251 (contact),"LIU, CHENGYU  (contact)",NA,NA,NA,"Animal Model;Biological Assay;Biology;Clustered Regularly Interspaced Short Palindromic Repeats;Embryo;experimental study;Fertilization in Vitro;gene editing technology;Generations;Genes;Genetic Engineering;Genome engineering;human disease;human model;Knock-in Mouse;Knock-out;mature animal;Methods;Microinjections;Micromanipulation;Mission;mouse genome;mouse model;Mus;National Heart, Lung, and Blood Institute;Research Project Grants;Scientist;Services;stem cell differentiation;Technology;technology development;Teratoma;Time;Transgenic Mice;Transgenic Organisms;United States National Institutes of Health;Viral Vector",NHLBI Transgenic Core,5907,NA,NA,NA,NA,17,NA,NA,2241425,NA
11183817,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL006019,NA,NA,1ZICHL006019-16,NHLBI:2434980\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,10274646 (contact),"COMBS, CHRISTIAN  (contact)",NA,NA,NA,"3-Dimensional;Cells;Cellular biology;Collaborations;Comb animal structure;Custom;Data Analyses;Dedications;deep learning;Development;Disease;Equipment;experience;experimental study;flexibility;Goals;Human Resources;Image;image processing;imaging capabilities;imaging modality;improved;instrument;intravital microscopy;light microscopy;Machine Learning;Methodology;Microscope;Microscopy;Mission;National Heart, Lung, and Blood Institute;operation;Paper;Persons;programs;Publishing;reconstruction;Research;Research Personnel;response;Services;Side;superresolution microscopy;Techniques;Tissues;Training;two photon microscopy;two-photon;ultra high resolution;United States National Institutes of Health;Work",Light Microscopy Core,6019,NA,NA,NA,NA,16,NA,NA,2434980,NA
11183818,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL006145,NA,NA,1ZICHL006145-13,NHLBI:2337672\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15191872 (contact),"ZOU, JIZHONG  (contact)",NA,NA,NA,"Acceleration;Affect;Alleles;Allogenic;Autologous;Basic Science;Bibliography;Binding;Biological Assay;Budgets;Cardiac Myocytes;CD34 gene;Cell Culture Techniques;Cell Line;Cells;Chronic;Collaborations;Collection;Consultations;Core Facility;cost;CRISPR/Cas technology;Deposition;Detection;differentiation protocol;Discipline;disease model;Drug Screening;Engraftment;Exhibits;Extramural Activities;Failure;Fee-for-Service Plans;Fibroblasts;Flow Cytometry;G-Banding;gene correction;Gene Deletion;Gene Dosage;gene editing technology;gene function;Gene Transfer Techniques;Generations;Genes;Genetic Fingerprintings;genetic manipulation;Goals;Hematopoietic stem cells;Histologic;human disease;human induced pluripotent stem cells;human pluripotent stem cell;immune cell infiltrate;Immunosuppression;improved;in vivo;Individual;induced pluripotent stem cell;induced pluripotent stem cell derived cardiomyocytes;induced pluripotent stem cell technology;interest;Iodides;Karyotype determination procedure;Knock-in;knockout gene;Laboratory Research;Loss of Heterozygosity;Luciferases;Macaca mulatta;Mediating;Methods;Mutation;Mycoplasma;Myocardial Infarction;Myocardium;National Center for Advancing Translational Sciences;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;novel therapeutic intervention;Paper;Peripheral Blood Mononuclear Cell;Plasmids;pluripotency;Pluripotent Stem Cells;Point Mutation;Positron-Emission Tomography;Procedures;Proteins;Publishing;Quantitative Reverse Transcriptase PCR;Reagent;Recovery;regenerative;Regenerative Medicine;Reporter;Reporter Genes;Research;Research Personnel;Sampling;Scientist;Services;Skin;Sodium;stem cell genes;Stem Cell Research;stem cell self renewal;stem cell technology;stem cells;symporter;Teratoma;Testing;Time;Training;Transplantation;United States National Institutes of Health",NHLBI iPSC Core Facility,6145,NA,NA,NA,NA,13,NA,NA,2337672,NA
11183819,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL006199,NA,NA,1ZICHL006199-10,NHLBI:2753127\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9416539 (contact),"SACK, MICHAEL  (contact)",NA,NA,NA,Angiography;Area;Blinded;Blood Vessels;Cardiac;cardiac magnetic resonance imaging;Cardiology;Cardiovascular system;Carotid Artery Plaques;Chronic;Clinical;Clinical Research;clinical training;contrast enhanced;Coronary;Coronary Arteriosclerosis;detector;Development;Disease;Doctor of Medicine;Echocardiography;efficacy evaluation;Evaluation;Familial Hypercholesterolemia;Functional disorder;gadobutrol;Genes;Genetic;Heart;Hyperlipoproteinemia;Image;Image Analysis;image reconstruction;imaging detection;insight;International;Investigation;Ischemia;lipid disorder;Lipids;Lipoproteins;Magnetic Resonance Imaging;Metabolism;Microvascular Dysfunction;Mitral Valve;Mitral Valve Insufficiency;Myocardial dysfunction;Natural History;neovascularization;new technology;next generation;novel;open label;Operative Surgical Procedures;Outcome;Pathogenesis;Patients;prospective;Protocols documentation;Radiation;Radiation Dose Unit;randomized trial;Rare Diseases;rare genetic disorder;reconstruction;Registries;repaired;Reporting;Research;Research Personnel;Sickle Cell Anemia;Study Section;suburb;System;Techniques;Technology;Ultrasonography;Vascular System;volunteer;Work;X-Ray Computed Tomography,Cardiovascular Clinical Section Studies,6199,NA,NA,NA,NA,10,NA,NA,2753127,NA
11183820,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL006227,NA,NA,1ZICHL006227-08,NHLBI:604485\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,10274648 (contact),"LEE, DUCK-YEON  (contact)",NA,NA,NA,"Acetic Acids;Acetyl-CoA C-Acetyltransferase;Adenosine Diphosphate Ribose;Amino Acids;amyloid formation;Anti-viral Agents;Antibody-drug conjugates;Arachidonic Acids;Betaine;Binding;Biochemical;Biochemistry;Biological;Biological Assay;Blood;Budgets;Cells;Chemicals;Chromatography;Complex;conditioning;Consultations;Contracts;Data Analyses;Detection;Development;Dose;Drosophila genus;Dyes;Enzymes;Epigenetic Process;equipment training;fertility preservation;Fluorescence;gene therapy;genome editing;Glucosylceramides;glucosylsphingosine;Growth;Hematopoietic stem cells;High Pressure Liquid Chromatography;Human;instrumentation;Interferon Type I;ion source;isoquercetin;Kinesin;Label;Laboratories;Ligands;liquid chromatography mass spectrometry;Liver;Macrophage;Maintenance;Mass Spectrum Analysis;Measurement;Metals;Methods;Microtubules;Mitochondria;Modeling;monocyte;mouse model;Mus;National Heart, Lung, and Blood Institute;Nucleotides;Oligonucleotides;operation;Outcome;Peptides;Phase;Photometry;Physiological;placebo controlled trial;Plasma;Polyamines;Post-Translational Protein Processing;Protein Chemistry;protein purification;Proteins;Proto-Oncogene Protein c-kit;Publications;Quercetin;Randomized;Recombinant Proteins;repaired;Research Personnel;Residual state;Rest;Rhesus;Saliva;Sampling;Services;Sickle Cell Anemia;Site;small molecule;Solvents;Sputum;sterol O-acyltransferase 1;Streptavidin;Structure;System;Time;Transplantation;Vitamin E;Xenograft procedure",Biochemistry Core,6227,NA,NA,NA,NA,8,NA,NA,604485,NA
11183821,ZIC,HL,1,N,NA,NA,NA,NA,ZICHL006229,NA,NA,1ZICHL006229-08,NHLBI:2868273\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,15200493 (contact),"LI, YUE-SHENG  (contact)",NA,NA,NA,"Basic Science;ChIP-seq;Clinical Research;cost effectiveness;deep sequencing;DNA sequencing;DNA Sequencing Facility;Ensure;exome sequencing;flexibility;Funding;Genomics;Goals;instrument;Libraries;nanopore;National Heart, Lung, and Blood Institute;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;next generation sequencing;Preparation;Quality Control;Research Personnel;sequencing platform;Services;single cell sequencing;Technology;Time;Training;transcriptome sequencing;United States National Institutes of Health",DNA Sequencing Core,6229,NA,NA,NA,NA,8,NA,NA,2868273,NA
11183823,ZID,HL,1,N,NA,NA,NA,NA,ZIDHL006061,NA,NA,1ZIDHL006061-15,NHLBI:924428\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,7866715 (contact),"LEDERMAN, ROBERT J (contact)",NA,NA,NA,"Aorta;aortic valve replacement;Back;Blood Vessels;Cardiac;Cardiology;cardiology service;cardiovascular emergency;Cardiovascular system;Caring;Catheterization;Catheters;Clinical;clinical center;Collaborations;Diagnostic;District of Columbia;Educational process of instructing;Heart;Hospitals;Hour;image guided;innovation;Inpatients;Intervention;Intramural Research;Medical center;medically necessary care;Medicine;Motivation;National Heart, Lung, and Blood Institute;non-invasive imaging;Nurses;Outpatients;Patients;Physicians;Procedures;programs;Protocols documentation;Reporting;Research;Research Personnel;Services;skills;Techniques;Therapeutic;Translating;Travel;United States National Institutes of Health;University Hospitals;Washington",Diagnostic and interventional cardiovascular catheterization,6061,NA,NA,NA,NA,15,NA,NA,924428,NA
11183824,ZID,HL,1,N,NA,NA,NA,NA,ZIDHL006202,NA,NA,1ZIDHL006202-10,NHLBI:1470372\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,9694272 (contact),"LEVINE, STEWART  (contact)",NA,NA,NA,"Area;Biopsy;Bronchial Provocation Tests;Bronchoscopy;Cardiopulmonary;Certification;Childhood;Clinical;clinical center;Clinical Medicine;Clinical Protocols;Clinical Research;Clinical Services;clinical training;Cold Therapy;Complement component C4;Consult;Consultations;Credentialing;Critical Care;Education;Educational Curriculum;Electromagnetics;Electronics;Environment;Exercise Test;Exhalation;Fellowship;Fellowship Program;Guidelines;Intervention;Intramural Research;Joints;Laboratories;Lasers;Link;Lung;Maryland;Measurement;Medical center;Medicine;microendoscopy;Military Personnel;Modality;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;new technology;Nitric Oxide;Nurse Practitioners;Physician Assistants;Physiological;Physiology;programs;Protocols documentation;Provider;pulmonary function;recruit;Research;Research Personnel;Research Training;Residencies;Rotation;Schedule;Scientist;Services;Shunt Device;Testing;Therapeutic;Therapeutic Intervention;Training;Training Programs;Ultrasonography;ultrasound;United States National Institutes of Health;Universities;Walking","Pulmonary clinical medicine: PFT lab, bronchoscopy, consultation services, and education",6202,NA,NA,NA,NA,10,NA,NA,1470372,NA
11183825,ZIG,HL,1,N,NA,NA,NA,NA,ZIGHL006020,NA,NA,1ZIGHL006020-16,NHLBI:2431187\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,79361844 (contact),"CLARK, TANNIA  (contact)",NA,NA,NA,"Accreditation;American;Anesthesia and Analgesia;animal care;Animal Care and Use Committees;Animal Experimentation;Animal Husbandry;animal model development;animal resource;Animals;Area;Behavioral Research;Biomedical Research;Blood;Caring;Child;comparative;Complex;Consultations;Cryopreservation;Derivation procedure;Educational process of instructing;Educational workshop;environmental enrichment for laboratory animals;Floor;Health;Hour;instructor;investigator training;Laboratory Animal Science;Laboratory Animals;Medicine;member;Mentors;Methodology;Microsurgery;Mission;model development;Monitor;Mus;National Heart, Lung, and Blood Institute;Occupational activity of managing finances;Operative Surgical Procedures;outreach program;Phenotype;Postoperative Care;Preparation;programs;protocol development;Publications;radiological imaging;Research;Research Activity;research and development;Research Personnel;Research Support;Resources;Rodent;Services;skills;surgical service;Techniques;Telemetry;Testing;Tissue Banks;Training;Travel;treatment research;ultrasound;United States National Institutes of Health;Work",NHLBI Animal Program Division,6020,NA,NA,NA,NA,16,NA,NA,2431187,NA
11183826,ZIG,HL,1,N,NA,NA,NA,NA,ZIGHL006190,NA,NA,1ZIGHL006190-11,NHLBI:1509795\,INTRAMURAL RESEARCH,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,NA,NA,NA,NA,NA,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NA,NA,12450735 (contact),"SPRINGER, DANIELLE  (contact)",NA,NA,NA,Anesthetics;Animal Housing;Animals;Applications Grants;behavior observation;Behavioral;Blood Vessels;Body Composition;Calibration;Cardiac Catheterization Procedures;Caring;Complex;Computer software;Data;data acquisition;Dobutamine;Dose;Echocardiography;Electrocardiogram;Equipment;experience;Experimental Designs;follow-up;Fostering;Frequencies;Goals;Home;Hypoxia;implantation;Indirect Calorimetry;Infusion procedures;Intubation;Knowledge;Lead;Maintenance;Manuscripts;Methods;Modeling;Monitor;mouse model;Movement;Mus;Operative Surgical Procedures;Pharmaceutical Preparations;Phenotype;Physiological;Postbaccalaureate;Postdoctoral Fellow;posters;Preparation;Procedures;Process;programs;protocol development;Protocols documentation;Pulmonary function tests;Research Personnel;Research Support;Resources;Running;Scientist;Services;skills;Stress Tests;Students;System;Technical Expertise;Telemetry;Temperature;Testing;Training;ultrasound;United States National Institutes of Health,Murine Phenotyping Core,6190,NA,NA,NA,NA,11,NA,NA,1509795,NA
11184112,N02,HD,NA,N,NA,NA,NA,NA,75N94023P00822,NA,NA,75N94023P00822-P00001-0-1,NICHD:202018\,NON SBIR/STTR CONTRACTS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,OAKLAND,UNITED STATES,NA,12,128663390,US,1618201,PUBLIC HEALTH INSTITUTE,CA,946074046,NA,79365970 (contact),"YOUNG HOLT, BETHANY  (contact)",NA,2024-09-27,2025-09-26,"Academia;Address;Anti-Infective Agents;Bacterial Vaginosis;Biotechnology;career;Chlamydia;clinical development;Collaborations;Communication;Contraceptive Agents;Contraceptive methods;Contracts;Databases;Development;Discipline;equity, diversity, and inclusion;Event;Funding Agency;Funding Opportunities;Future;Government;Health;HIV;Industry;interest;International;Investments;Knowledge;lectures;Maintenance;Marketing;meetings;Modality;National Institute of Child Health and Human Development;news;novel;outreach;pathogen;Persons;posters;pre-clinical;Prevention;product development;Property;Publications;Research;research and development;Research Personnel;Resources;Services;Technology;technology development;Travel;United States National Institutes of Health;Update;Vagina;webinar",NICHD SERVICES: Multipurpose Prevention Technologies (MPT) DATABASE ACCESS AND MAINTENANCE for Contraceptive Research,0,NA,NA,NA,NA,NA,NA,NA,202018,NA
11184113,Y01,AI,NA,N,NA,NA,NA,NA,AAI23070001,NA,NA,AAI23070001-1-0-1,NIAID:85255\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,(contact),NA,NA,NA,Agreement;Anti-viral Agents;Clinical Research;Clinical Trials;COVID-19;COVID-19 pandemic;COVID-19 patient;Emergency Situation;Evaluation;Funding;Immunomodulators;Infrastructure;Inpatients;interest;Investigational Drugs;medical countermeasure;Monoclonal Antibodies;National Institute of Allergy and Infectious Disease;point of care;Research;research study;respiratory;Respiratory Tract Infections;Site;Therapeutic;Vaccination;Veterans Health Administration;Viral,VHA -FUNDING FOR SITE COORDINATION OF COVID-19 CLINICAL TRIALS,230700,NA,NA,NA,NA,NA,NA,NA,85255,NA
11184114,N01,OD,NA,N,NA,NA,NA,NA,75N98022C00018,NA,NA,75N98022C00018-P00002-9999-1,OD:5309613\,NON SBIR/STTR CONTRACTS,2024,"OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH",NA,CLEVELAND,UNITED STATES,NA,11,077758407,US,218601,CASE WESTERN RESERVE UNIVERSITY,OH,441061712,NA,10702324 (contact),"SHOFFSTALL, ANDREW  (contact)",NA,2022-09-21,2025-09-20,Acceleration;Anatomy;Area;Clinical;Computer Models;Cranial Nerves;Data;Data Analyses;data visualization;design;Development;Ensure;Evaluation;experience;Fiber;high resolution imaging;Human;Image;imaging modality;improved;interest;Length;Maps;morphometry;Nerve;Neuroanatomy;neuroregulation;novel;novel therapeutics;Operative Surgical Procedures;Phenotype;Positioning Attribute;Regulation;repository;Resolution;Safety;Sample Size;Site;Tissue Sample;tractography;Translating;vagus nerve stimulation;Vagus nerve structure;Validation;Viscera;Work,RECONSTRUCTING VAGAL ANATOMY,0,NA,NA,NA,NA,NA,NA,NA,5309613,NA
11184653,U2C,DA,3,N,2024-09-06,2024-09-01,2025-08-31,NA,U2CDA057717,NA,PA-23-189,3U2CDA057717-03S1,NIDA:190697\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,STANFORD,UNITED STATES,NA,16,009214214,US,8046501,STANFORD UNIVERSITY,CA,943052004,NA,7355892 (contact),"MCGOVERN, MARK P (contact)","DUCHARME, LORI",2022-09-30,2027-08-31,access disparities;addiction;Address;Adoption;Advocacy;Algorithmic Software;Articulation;Atmosphere;career networking;Categories;Characteristics;Chemistry;Collaborations;Communication;Communities;cost effectiveness;culturally appropriate intervention;Data Collection;Data Element;data infrastructure;data sharing;design;Development;Disease Management;Disparity;Dissemination and Implementation;dissemination science;Economics;Equity;Evaluation;evidence base;Evidence based intervention;experience;Eye;Faculty;Feedback;flexibility;Fostering;Foundations;Funding;Future;Goals;health care delivery;health care quality;health determinants;health disparity;health equity;health inequalities;Heart Research;Helping to End Addiction Long-term;Home;implementation determinants;implementation efforts;implementation research;implementation science;implementation tool;improved;Infrastructure;innovation;Intervention;Intervention Studies;Language;Lead;Leadership;lectures;Logistics;Machine Learning;machine learning model;Maintenance;Maps;marginalization;Measures;Mediation;meetings;member;Mentors;Mentorship;Methods;Modeling;Monitor;multidisciplinary;National Institute of Drug Abuse;National Institute of Mental Health;Needs Assessment;open data;Opiate Addiction;Opioid;opioid epidemic;opioid misuse;opioid use disorder;organizational structure;overdose prevention;Pain;Pain management;Pain Research;parent grant;Persons;Policies;Policy Maker;Population;Prevention strategy;Process;Productivity;programs;Public Domains;Public Health;Publications;Qualifying;Quality Control;repository;Research;Research Institute;Research Personnel;Resource Sharing;Resources;response;Sampling;scale up;Science;service delivery;Services;social media;Speed;substance use;Substance Use Disorder;symposium;synergism;Taxonomy;tool;treatment research;treatment services;Underserved Population;United States National Institutes of Health;United States Substance Abuse and Mental Health Services Administration;unsupervised learning;Update;user-friendly;web portal;web site,HD2A RASC-Administrative Core,57717,ZDA1,ZDA1,9924,S1,3,177197,13500,NA,190697
11184956,R00,HD,4,N,2024-09-14,2024-09-15,2025-08-31,865,R00HD111622,ORGANIZED RESEARCH UNITS,PA-20-188,4R00HD111622-03,NICHD:248988\,NON-SBIR/STTR RPGS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,Newark,UNITED STATES,MISCELLANEOUS,10,090299830,US,10034168,RUTGERS BIOMEDICAL AND HEALTH SCIENCES,NJ,071073001,"PROJECT NARRATIVE Poor postpartum health has implications for maternal mortality and infant outcomes. However, eligibility for pregnancy-related Medicaid ends after 60 days postpartum, leading to high rates of postpartum insurance loss. The proposed project evaluates how the Medicaid continuous coverage requirement during the public health emergency affected postpartum coverage, care, and infant care overall, by maternal race-ethnicity, and during various periods of the COVID-19 pandemic context, with implications for state postpartum Medicaid extensions under the American Rescue Plan.",78252385 (contact),"ELIASON, ERICA L (contact)","CHINN, JUANITA JEANNE",2024-09-15,2027-08-31,Address;Affect;American;Award;Birth;Black Populations;career;career development;Caring;Childbirth;Clinical;Contraceptive methods;Coronavirus;COVID-19;COVID-19 mortality;COVID-19 pandemic;COVID-19 pandemic effects;Data;Data Analyses;Databases;demographics;Department chair;Developed Countries;Development;Discipline of obstetrics;Disparity;disparity reduction;Eligibility Determination;Emergency Medicine;Epidemiology;ethnic disparity;Ethnic Origin;experience;Family;federal poverty level;Freezing;Future;Goals;Gynecology;Health;health care availability;health care disparity;health care service;health disparity;Health Insurance;health outcome disparity;Health Policy;Health Services;Health Services Accessibility;Healthcare;Healthcare promotion;Hispanic Populations;improved;Income;Individual;Infant;Infant Care;Infant Health;infant outcome;Insurance;interest;Link;Low income;Low Income Population;Maternal and Child Health;Maternal Health;Maternal Health Services;maternal morbidity;Maternal Mortality;Measures;Medicaid;Medicaid eligibility;Medicine;Mentors;Mentorship;Methods;National Institute of Child Health and Human Development;Outcome;pandemic disease;Pediatrics;people of color;Persons;Phase;Policies;poor health outcome;Population Study;postpartum care;Postpartum Depression;postpartum health;Postpartum Period;Pregnancy;Pregnancy loss;prevent;professor;public health emergency;Qualifying;Race;racial disparity;Research;Research Assistant;Research Personnel;Research Priority;Research Project Grants;response;Rhode Island;Risk;Severities;skills;Techniques;Testing;Time;Training;treatment effect;United States;Universities;Variant,The Effects of the Medicaid Continuous Coverage Requirement during the Public Health Emergency on Postpartum Coverage and Maternal and Infant Care after Childbirth,111622,NSS,NSS,NA,NA,3,158591,90397,248988,NA
11185001,R01,TW,3,N,2024-09-05,2024-09-12,2025-06-30,989,R01TW012415,SCHOOLS OF MEDICINE,PAR-21-344,3R01TW012415-03S1,FIC:19361\OD:80639\,NON-SBIR/STTR RPGS,2024,FOGARTY INTERNATIONAL CENTER,NA,DURHAM,UNITED STATES,OBSTETRICS & GYNECOLOGY,04,044387793,US,2221101,DUKE UNIVERSITY,NC,277054673,"NARRATIVE HIV, cervical cancer and human papillomavirus (HPV) are interrelated health conditions with intersecting stigmas that may influence women’s uptake of prevention services. We will evaluate the effectiveness of a novel stigma-responsive service delivery model for HPV-based cervical cancer screening called “Elimisha HPV” among women in a high HIV-prevalence area of Kenya. If effective, this may serve as a new model for cervical cancer screening as well as a new paradigm for comprehensive, stigma-responsive service delivery packages for people living with HIV.",8508113 (contact),"HUCHKO, MEGAN J. (contact)","BANSAL, GEETHA PARTHASARATHY",2022-07-20,2025-06-30,"Address;Anti-Retroviral Agents;Area;Awareness;Biological;cancer risk;care outcomes;Caring;cervical cancer prevention;Cervical Cancer Screening;Characteristics;Clinic;Collection;Communication;Communities;Community Health;County;Data;design;Diagnosis;Discrimination;Education;Educational Intervention;Educational Materials;effective therapy;Effectiveness;effectiveness evaluation;effectiveness testing;Epidemiology;Focus Groups;follow-up;Fright;Government;Health;Health care facility;Healthcare;HIV;HPV positive;Human Development;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;implementation strategy;implementation/effectiveness;Individual;infection risk;Infrastructure;Institution;Intervention;Interview;Kenya;Language;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Measurement;Methods;Modeling;novel;Outcome;Outpatients;outreach;Pamphlets;Patient-Centered Care;peer;Perception;Persons;Prevalence;prevent;prevention service;programs;randomized, clinical trials;response;Risk;Risk Factors;screening;Screening for cancer;screening services;service delivery;Service delivery model;Sex Behavior;social stigma;Social support;standard of care;Stigmatization;success;synergism;Testing;Text Messaging;therapy design;tool;Training;treatment arm;uptake;volunteer;Woman;women&apos;s outcomes;Work;World Health Organization",A stigma responsive service delivery model for HPV-based screening among women living with HIV,12415,PPAH,Population and Public Health Approaches to HIV/AIDS Study Section[PPAH],NA,S1,3,62112,37888,100000,NA
11185056,K23,HL,3,N,2024-09-07,2024-09-07,2025-08-31,838,K23HL163394,SCHOOLS OF MEDICINE,PA-20-206,3K23HL163394-03S1,NHLBI:75600\,OTHER RESEARCH-RELATED,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,NEW YORK,UNITED STATES,INTERNAL MEDICINE/MEDICINE,12,060217502,US,1514803,WEILL MEDICAL COLL OF CORNELL UNIV,NY,100654805,"Project Narrative Patients with Hypersensitivity Pneumonitis experience poor health-related quality of life without access to interventions that target improvement in this outcome. The goal of this proposal is to develop and determine the feasibility and acceptability of a stakeholder-engaged behavioral and educational intervention to improve the health-related quality of life of patients with hypersensitivity pneumonitis. Findings from this innovative pilot randomized trial will lay the groundwork for a future, multi-site, randomized trial testing the effectiveness of the intervention developed here.",16222612 (contact),"ARONSON, KERRI  (contact)","VUGA, LOUIS J",2022-09-01,2027-08-31,"acceptability and feasibility;Address;Advisory Committees;American;Antigens;Anxiety;attentional control;Attitude;Behavior Therapy;Behavioral;Benchmarking;career;career development;Chest;Chronic Disease;Clinical Trials;Clinical Trials Design;Cognitive;Cognitive Therapy;Collaborations;coping;design;Development;Development Plans;Disease;Education;Educational Intervention;Educational Materials;Effectiveness;Effectiveness of Interventions;effectiveness testing;effectiveness/implementation trial;eHealth;evidence base;experience;Exposure to;Extrinsic allergic alveolitis;Feeling;fibrotic interstitial lung disease;Focus Groups;Foundational Skills;Foundations;Fright;Frustration;Future;Goals;Health;health administration;health related quality of life;Home environment;Hybrids;implementation evaluation;implementation outcomes;implementation science;improved;Infrastructure;innovation;instrument;International;Interstitial Lung Diseases;Intervention;Investigation;Knowledge;Knowledge acquisition;Learning;Life Style;Measures;Medicine;Mental Depression;Mentors;novel;Observational Study;Outcome;Outcomes Research;Participant;Patient Education;patient oriented;Patient Outcomes Assessments;Patient-Centered Care;Patient-Focused Outcomes;Patients;peer;peer coaching;Peer Group;Persons;pilot test;preference;Protocols documentation;Psychometrics;Qualitative Research;randomized trial;Randomized, Controlled Trials;recruit;Research;Research Design;Research Methodology;Research Personnel;retention rate;Review Literature;Sampling;Scientist;Self Efficacy;Site;skills;Social isolation;Societies;Source;Statistical Data Interpretation;Surveys;System;Testing;theories;therapy development;Thinness;Training;Uncertainty;Universities;Virginia;virtual;Visit;web site;Work",Rise-HP: Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis; A Stakeholder Engaged Intervention to Improve Health-Related Quality of Life,163394,MPOR,NHLBI Mentored Patient-Oriented Research Study Section[MPOR(JA)],NA,S1,3,70000,5600,75600,NA
11185340,R00,DE,4,N,2024-09-13,2024-09-16,2025-08-31,121,R00DE031825,SCHOOLS OF MEDICINE,PA-20-188,4R00DE031825-03,NIDCR:249000\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH,NA,LEXINGTON,UNITED STATES,BIOCHEMISTRY,06,939017877,US,2793601,UNIVERSITY OF KENTUCKY,KY,405260001,"Project Narrative Craniofacial defects are among the most common of all congenital abnormalities. An embryonic population of cells called the neural crest gives rise to a significant portion of the craniofacial complex, including bone and cartilage of the face, pigment cells, and components of the peripheral nervous system. My work seeks to understand how a subfamily of transcription factors (SoxE) help the neural crest form the diversity of cell types in the face and how patient specific SOXE mutations cause Campomelic dysplasia and Waardenburg syndrome.",12157988 (contact),"SCHOCK, ELIZABETH (BETSY)  (contact)","SAIFUDEEN, ZUBAIDA",2024-09-16,2027-08-31,ATAC-seq;Biochemical;Biological Models;Biology;bone;Brightfield Microscopy;campomelic dysplasia;career;Cartilage;Cell Culture Techniques;cell type;Cells;Chick;Chimera organism;Chimeric Proteins;ChIP-seq;Chondrogenesis;Chromatin;clinically significant;Collaborations;Computer Analysis;Congenital Abnormality;Coupled;craniofacial;Craniofacial Abnormalities;craniofacial complex;craniofacial development;craniofacial disorder;Data Analyses;Defect;Development;developmental disease;directed differentiation;Disease;disease phenotype;DNA Binding Domain;Dominant-Negative Mutation;Embryo;Environment;Etiology;experience;experimental study;Face;Family;Future;gain of function;Gene Activation;Gene Family;Genes;Genetic Transcription;Genome;Genotype;Global Change;Goals;Heterogeneity;Human;Individual;insight;interest;Lead;Link;loss of function;malformation;Measurable;Mediating;melanocyte;Mentors;migration;model organism;Molecular;Morphology;Mutation;Neural Crest;Neural Crest Cell;neurodevelopment;Neuroglia;Neurons;novel;Patients;Peripheral;Peripheral Nervous System;Phase;Phenotype;Pigments;Play;Population;Postdoctoral Fellow;programs;Proteins;Research;Role;screening;SOX8 gene;Specificity;Stains;stem cell population;Syndrome;Tadpoles;Techniques;Tertiary Protein Structure;Time;transcription factor;transcriptome sequencing;Universities;Variant;Vertebrates;Waardenburg syndrome;Work;work-study;Xenopus;Xenopus laevis,The Role of SoxE Transcription Factors in Neural Crest Cell Specialization,31825,NSS,NSS,NA,NA,3,174869,74131,249000,NA
11185474,OT2,NS,3,N,2024-09-20,2023-09-25,2025-09-24,853,OT2NS136938,NA,OTA-23-010,3OT2NS136938-01S1,OD:15032251\,OTHERS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,BOSTON,UNITED STATES,NA,08,073130411,US,4907701,MASSACHUSETTS GENERAL HOSPITAL,MA,021142621,NA,9383101;15262695;10702743 (contact);11537967;2079835,"ANDREWS, JINSY ;BABU, SUMA ;BERRY, JAMES DALE (contact);PAGANONI, SABRINA ;SHEFNER, JEREMY M","LYON, DINA MARIE",2023-09-25,2025-09-24,"Advocacy;Agreement;Alaska;ALS patients;Amyotrophic Lateral Sclerosis;Award;biobank;Biological Markers;Blood;Brain;Businesses;career;Caregivers;Cell Line;Cells;Clinic;Clinical;clinical center;Clinical Data;clinical investigation;Clinical Research;clinical research site;Clinical Trials;clinically relevant;cohort;Collaborations;Collection;Committee Members;Communication;Communities;community clinic;community engaged research;community engagement;Community Hospitals;community science;Complex;Conscious;Contracts;Critical Pathways;cultural competence;Data;Data Collection;Data Coordinating Center;data harmonization;data portal;data repository;Data Set;Databases;Dedications;design;digital;Digital biomarker;digital data;Disease;diversity and inclusion;Education;Education and Outreach;educational atmosphere;Electronics;empowerment;Enrollment;Ensure;Equity;equity, diversity, and inclusion;evidence base;experience;flexibility;Fostering;Foundations;Funding;Future;Gene Mutation;General Hospitals;Genes;Geography;Grant;Growth;Hawaii;health inequalities;high risk;Home;Human Resources;Image;imaging biomarker;Industry;Infrastructure;innovation;Institutional Review Boards;interest;Investigation;Knowledge;Lead;Leadership;Link;longitudinal dataset;Longitudinal Studies;Magnetic Resonance Imaging;magnetic resonance imaging biomarker;Maps;Mediation;member;Mentorship;Monitor;multimodality;Neurologic;Neurosciences;Nonprofit Organizations;Observational Study;open data;operation;Outcome;Outcome Measure;outreach;Participant;patient engagement;Peripheral Blood Mononuclear Cell;Persons;Population;Population Heterogeneity;Private Practice;Procedures;prospective;Puerto Rico;Readiness;Recording of previous events;recruit;repository;Research;Research Institute;Research Methodology;Research Personnel;response;Risk;Running;Sampling;Scanning;Scholars Program;Science;Scientist;Shoulder;Site;skills;socioeconomic diversity;Socioeconomic Status;socioeconomics;Structure;success;Therapeutic;Time;Training;Training and Education;training opportunity;Underrepresented Populations;underserved area;United States National Institutes of Health;Universities;Vendor;virtual;Washington;Work",Access for All in ALS (ALL ALS) East Clinical Coordinating Center,136938,ZNS1,ZNS1-SRB-I(06),NA,S1,1,11034162,3998089,15032251,NA
11185475,OT2,NS,3,N,2024-09-20,2023-09-25,2025-09-24,853,OT2NS136939,NA,OTA-23-010,3OT2NS136939-01S1,OD:14234367\,OTHERS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,PHOENIX,UNITED STATES,NA,03,131606022,US,2052813,ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER,AZ,850134409,NA,1857827 (contact);10404446;6099821;10321663;14910524;9797608,"BOWSER, ROBERT P (contact);HARMS, MATTHEW ;HARRIS, BRENT T;PHATNANI, HEMALI ;PROVENZANO, FRANK A;SHNEIDER, NEIL ALAN","LYON, DINA MARIE",2023-09-25,2025-09-24,Acceleration;Advisory Committees;ALS patients;Amendment;Amyotrophic Lateral Sclerosis;amyotrophic lateral sclerosis therapy;Annual Reports;Autopsy;biobank;Biological Markers;Blood;Brain;Budgets;Clinic;Clinic Visits;Clinical;clinical care;Clinical Data;clinical outcome measures;Clinical Research;clinical research site;Clinical Trials;Collaborations;Collection;Common Data Element;Communication;Communities;Community Care Networks;Contracts;Country;Critical Pathways;Data;data curation;data exchange;data integrity;data management;data modeling;data portal;data repository;data resource;Data Set;data sharing;data submission;Databases;Deposition;design;Development;Diagnosis;Digital biomarker;Disease;DNA Sequence Alteration;Documentation;drug development;Educational workshop;effective therapy;end stage disease;Ensure;Equipment and supply inventories;Ethics;ethnic diversity;Ethnic Origin;Ethnic Population;experience;Failure;Family;Foundations;Funding;Funding Agency;Future;Generations;Genome;genome sequencing;genomic data;Geography;Goals;Grant;Healthcare;Home;Hospitals;human error;Human Resources;Image;Improve Access;improved;Individual;Industry;Infrastructure;Institutional Review Boards;International;Knowledge;Laboratories;Leadership;Life;lifetime risk;Link;Location;Longitudinal Studies;Magnetic Resonance Imaging;male;Manuals;Measures;meetings;member;Metadata;Methods;Modeling;Monitor;multimodality;Muscle;mutation carrier;National Institute of Neurological Disorders and Stroke;Natural History;Neurodegenerative Disorders;neuroimaging;Neurologic;New York;Nonprofit Organizations;novel;novel therapeutics;Online Systems;Onset of illness;operation;Outcome Measure;outreach;outreach program;Participant;participant enrollment;patient advocacy group;Patient Participation;Patients;Peer Review;Persons;Phase;Physicians;Population Heterogeneity;Procedures;Process;programs;Protocols documentation;public-private partnership;Quality Control;Race;Records;recruit;Reporting;repository;Request for Applications;Research;research and development;Research Personnel;Research Project Grants;research study;Respiratory physiology;response;Review Committee;Risk;Route;Rural;Rural Community;rural patients;Rural Population;Saliva;Sampling;Schedule;Science;Scientist;Shipping;Site;Specimen;Speech;Spinal Cord;Spirometry;Structure;Subjects Selections;success;Symptoms;System;Tissue Banks;Tissue Procurements;Tissue Sample;Tissues;tool;Training;Training Activity;transcriptome sequencing;transcriptomics;Translating;translational diagnostics;United States;United States National Institutes of Health;Vendor;Vial device;whole genome;women patients;Work,Access for All in ALS (ALL ALS) West Clinical Coordinating Center,136939,ZNS1,ZNS1-SRB-I(06),NA,S1,1,13020009,1214358,14234367,NA
11185622,P20,GM,5,N,2024-06-12,2024-09-05,2025-06-30,NA,P20GM104316,NA,PAR-19-312,5P20GM104316-10,NIGMS:175873\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,NEWARK,UNITED STATES,NA,00,059007500,US,2076701,UNIVERSITY OF DELAWARE,DE,197160099,NA,14600013 (contact),"HADDEN-PERILLA, JODI A (contact)","BERNAL, FEDERICO",2024-09-05,2025-06-30,Address;Anti-viral Agents;antiviral drug development;Awareness;Binding;Binding Sites;Biochemistry;Capsid;Capsid Proteins;Chemicals;Core Protein;design;dimer;drug development;Exhibits;fighting;Hepatitis B Virus;Hydrophobicity;inhibitor;Methods;Molecular Conformation;molecular dynamics;novel;Nuclear Export;Nucleosome Core Particle;Peptides;Pharmaceutical Preparations;Phase;Protein Conformation;Public Health;Shapes;small molecule;structural biology;Structure;Therapeutic;therapeutic target;Validation;Viral hepatitis;virology;virtual screening;Virus;Virus Diseases;Virus Inhibitors,Molecular dynamics of the HBV capsid to advance the search for antivirals,104316,ZGM1,ZGM1-RCB-3(C2),7935,NA,10,110795,65078,NA,175873
11185736,R56,HG,1,N,2024-09-18,2024-09-18,2025-08-31,172,R56HG014415,SCHOOLS OF MEDICINE,PA-20-185,1R56HG014415-01A1,NHGRI:831046\,NON-SBIR/STTR RPGS,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,CLEVELAND,UNITED STATES,SURGERY,11,135781701,US,10000858,CLEVELAND CLINIC LERNER COM-CWRU,OH,441950001,"PROJECT NARRATIVE The goal of this study is to generate supportive scientific evidence for strategies that will facilitate informed decision-making about PS&D by diverse populations of pregnant patients as early as possible in their prenatal care. By achieving the aims of this study, this study will meet the critical need to provide resources to patients as they consider a changing array of PS&D and post-diagnosis options that have significant implications for their health, their pregnancy, and their family. This study is significant for patient care as it will be a critical step toward establishing patient-centric strategies and resources that can effectively support evidence-based reproductive healthcare in an increasingly complex healthcare setting.",9365711 (contact),"FARRELL, RUTH  (contact)","LOCKHART, NICOLE C",2024-09-18,2025-08-31,abortion;Address;Affect;Birth;care delivery;cell free DNA;Child;Childhood;Clinical;Communities;Complex;Data;Decision Making;Development;Diagnosis;Diagnostic tests;Disparity;Education;Ensure;evidence base;experimental study;Face;Family;fetal;Foundations;Genetic Diseases;Genetic Screening;genetic testing;genome sciences;Genomics;Goals;Growth;Health;health care disparity;health care settings;Healthcare;high risk;improved outcome;Information Centers;innovation;interest;Intervention;Interview;Learning;Maternal-fetal medicine;Measures;Medical;Mendelian disorder;Nature;neonatal outcome;obstetric outcomes;Outcome;Outcome Study;Patient Care;patient oriented;Patient Preferences;patient-level barriers;Patients;Pediatrics;Policies;Policy Maker;Population Heterogeneity;Pregnancy;pregnant;prenatal;Prenatal care;Process;Provider;reproductive;Reproductive Health;Resources;response;Series;Services;Technology;Testing;Time;tool;Work,Supporting pregnant patients as they face a changing landscape of prenatal genetic tests and post-diagnosis options,14415,ZRG1,Special Emphasis Panel[ZRG1-SEIR-P(80)R],NA,A1,1,555397,275649,831046,NA
11185827,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA233396,NA,PAR-22-249,3U54CA233396-07S1,NCI:236349\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,TALLAHASSEE,UNITED STATES,NA,02,623751831,US,513802,FLORIDA AGRICULTURAL AND MECHANICAL UNIV,FL,323073105,NA,10712819 (contact),"MOCHONA, BEREKET - (contact)","BARFIELD-STEWARD, WHITNEY",2018-09-19,2028-08-31,Academy;Achievement;Address;Admission activity;Advanced Malignant Neoplasm;African American;anti-cancer research;Applications Grants;Applied Research;Award;Basic Science;Behavioral;Behavioral Research;Benchmarking;Bioinformatics;Biomedical Research;Biometry;Black Populations;Black race;California;cancer health disparity;Cancer health equity;career;Career Choice;career development;Caring;Clinical;Clinical Research;Collaborations;Communities;Comprehensive Cancer Center;cost;Data;Discipline;Discipline of Nursing;Doctor of Philosophy;Education;education research;Educational Activities;Engineering;Ensure;Environment;ethnic diversity;Ethnic Origin;Evaluation;experience;Fellowship;Florida;Funding;Genomics;Goals;Government;graduate student;Grant;Health;health care disparity;Health Disparities Research;health equity;Health Professional;Healthcare Systems;higher education;Hispanic;Historically Black Colleges and Universities;Immersion;Impact evaluation;improved;Individual;Institution;interest;International;K-Series Research Career Programs;Knowledge;Latino;Latino Population;Malignant Neoplasms;Manuscripts;medical schools;Medicine;meetings;Mentors;Mentorship;Minority Graduate Student;Minority Groups;minority trainee;Modeling;Monitor;multidisciplinary;Native American Tribe;Oncology;Outcome;Outcomes Research;Patients;peer;Pharmacy facility;Population;Population Research;Postbaccalaureate;Postdoctoral Fellow;posters;pre-clinical;pre-doctoral;Process;Program Evaluation;programs;Public Health;Publishing;Publishing Peer Reviews;Race;racial diversity;recruit;Research;Research Personnel;Research Training;response;Science;Scientist;Site;Structure;Students;success;Training;training opportunity;Training Programs;Training Support;Tribal group;undergraduate student;Underrepresented Minority;United States National Academy of Sciences;United States National Institutes of Health;Universities;University of Southern California Norris Cancer Center,Research Education Core,233396,ZCA1,ZCA1-SRB-2(A1),5689,S1,7,170272,66077,NA,236349
11186081,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274504,NA,RFA-CA-21-048,3U54CA274504-02S1,NCI:12496\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SCOTTSDALE,UNITED STATES,NA,01,153665211,US,4976104,MAYO CLINIC ARIZONA,AZ,852595499,"NARRATIVE: ADMINISTRATIVE CORE The Administrative Core will be the primary touchpoint of the center, facilitating interactions between the two  projects and three additional cores. The Administrative Core will also actively cultivate collaborations throughout  the consortium with assistance from the Outreach Core, particularly through administering Intra-Center and  Cross-Consortium Pilot Projects, hosting workshops and symposiums, and facilitating visiting faculty all while  enhancing diverse perspectives on this critical topic. Co-PDs Swanson and Canoll will provide the central  leadership in the Administrative Core, while the Center Program Administrator will provide day-to-day business,  administrative and scientific management of Center activities.",6065421 (contact),"SWANSON, KRISTIN R (contact)","DUECK, HANNAH RUTH",2023-09-18,2028-08-31,Administrator;Advisory Committees;Area;Authorization documentation;Award;Biopsy;Businesses;career;clinical imaging;Collaborations;Communication;Communities;Core Biopsy;Data;data access;data integration;data management;data sharing;Discipline;Educational workshop;Ensure;Evaluation;Faculty;Feedback;Funding;Glioma;Grant;Growth;Image;imaging facilities;Institution;interest;Leadership;Logistics;Machine Learning;Magnetic Resonance Imaging;Malignant Neoplasms;Mathematics;Monitor;neuro-oncology;Office of Administrative Management;Oncology;outreach;Pathology;Patients;Phenotype;Pilot Projects;Process;programs;Publications;Radiology Specialty;recruit;Reproducibility;Resources;symposium;Systems Analysis;Systems Biology;Tissues;training opportunity;Visit;web site;Work,MOSAIC: Administrative Core,274504,ZCA1,ZCA1-RTRB-F(M2),7265,S1,2,6387,6109,NA,12496
11186082,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274504,NA,RFA-CA-21-048,3U54CA274504-02S1,NCI:12590\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SCOTTSDALE,UNITED STATES,NA,01,153665211,US,4976104,MAYO CLINIC ARIZONA,AZ,852595499,"NARRATIVE: PROJECT 1: TARGETING GLIOMA TISSUE STATES Glioblastoma (GBM) biopsies are composed of not only molecularly aberrant malignant glioma cells but also a  sizeable abundance of non-malignant cells (including immune, astrocytes, oligodendrocytes, etc.). The goal of  this project is to find targetable cross-talk relationships between these cell compositional networks. Specifically,  we will quantify different cellular compositions in pre- and post- treatment tumors, investigate cross-talk between  the glioma cells and the microenvironmental other cell subpopulations, and, lastly, determine the impact of  targeting this crosstalk to shift the cell community composition into a more favorable/treatable state.",2086855 (contact),"TRAN, NHAN L (contact)","DUECK, HANNAH RUTH",2023-09-18,2028-08-31,Acute;Aftercare;anti-PD-L1;Astrocytes;Biological;Biopsy;Bone Marrow;Brain;cell behavior;cell community;Cell Nucleus;Cell Physiology;Cell Proliferation;Cells;Chemoresistance;Conditioned Culture Media;cytokine;Disease Progression;effective therapy;Endothelial Cells;Extracellular Matrix;Genomics;Glioblastoma;Glioma;Goals;Heterogeneity;Image;imaging facilities;Immune;Immunocompetent;Immunotherapy;In Vitro;in vivo;Infiltration;Inflammatory;insight;Interleukin-10;Interleukin-6;Ligands;Macrophage;Magnetic Resonance Imaging;male;Malignant Glioma;Mathematics;Mediating;member;Mesenchymal;Microglia;Modeling;Molecular;Mutation;Myeloid Cells;neoplastic cell;Neurons;Non-Malignant;novel therapeutic intervention;Oligodendroglia;Oncology;Patients;Pattern;Pericytes;Phenotype;Population;progenitor;radiological imaging;receptor;receptor expression;Receptor Inhibition;recruit;Regimen;Role;Sampling;Signal Pathway;Signal Transduction;single nucleus RNA-sequencing;Slice;Systems Analysis;T-Lymphocyte;temozolomide;Testing;Therapeutic;therapy resistant;Tissues;TNF gene;transcriptome sequencing;Translations;treatment response;tumor;tumor growth;tumor initiation;tumor microenvironment;Tumor Necrosis Factor Receptor;tumor progression;Tumor Promotion;women patients;Xenograft Model,MOSAIC: Targeting the Tissue State,274504,ZCA1,ZCA1-RTRB-F(M2),7266,S1,2,9005,3585,NA,12590
11186083,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274504,NA,RFA-CA-21-048,3U54CA274504-02S1,NCI:13791\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SCOTTSDALE,UNITED STATES,NA,01,153665211,US,4976104,MAYO CLINIC ARIZONA,AZ,852595499,"NARRATIVE: PROJECT 2: IMAGING THE DYNAMIC TISSUE STATE IN PATIENTS IN VIVO Magnetic resonance imaging (MRI) measures many different physical properties of the tissue which may be  correlated with the specific tumor behavior (e.g., proliferation, inflammation, angiogenesis) found in the limited  biopsies available per patient. This project will fuse readily available MRI to spatially localized biopsies to build  predictive models of cellular composition across the unsampled tumor (and brain) to track and validate cell composition changes to standard and immune therapies. Connecting these imaging changes to patient survival  will allow identification of clinically beneficial shifts in cellular cohabitation.",6065421 (contact),"SWANSON, KRISTIN R (contact)","DUECK, HANNAH RUTH",2023-09-18,2028-08-31,Adult;angiogenesis;Automobile Driving;Biological Markers;Biopsy;Brain;Brain Neoplasms;Cell model;Cells;Clinical;clinical imaging;cohort;cost;Diagnosis;Disease;Disease Progression;Epidermal Growth Factor Receptor;Facility Accesses;Genomic Segment;Glioblastoma;Glioma;Guidelines;Human;human imaging;human tissue;Image;Image Analysis;imaging facilities;Immune;Immune response;Immune Targeting;Immunocompetent;Immunooncology;Immunotherapy;immunotherapy clinical trials;improved;in vivo;individual patient;individualized medicine;Inflammation;Inflammatory;Magnetic Resonance Imaging;Malignant - descriptor;Mathematics;Measures;Mediating;Modeling;Molecular;Monitor;Nature;neoplastic cell;noninvasive diagnosis;novel;Oncology;Outcome;patient safety;Patient-Focused Outcomes;Patients;Phenotype;physical property;Physiological;Population;predictive modeling;Primary Brain Neoplasms;Proliferating;quantitative imaging;radiomics;Recurrence;Residual Neoplasm;Resources;response;Sampling;Signal Transduction;standard of care;Study models;Systems Analysis;Therapeutic;Time;Tissue Model;Tissue Sample;Tissues;tool;Treatment Protocols;treatment response;tumor;tumor behavior;Work,MOSAIC: Imaging Human Tissue State Dynamics In Vivo,274504,ZCA1,ZCA1-RTRB-F(M2),7267,S1,2,6898,6893,NA,13791
11186084,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274504,NA,RFA-CA-21-048,3U54CA274504-02S1,NCI:5743\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SCOTTSDALE,UNITED STATES,NA,01,153665211,US,4976104,MAYO CLINIC ARIZONA,AZ,852595499,"NARRATIVE: OUTREACH CORE Getting computational results into the clinic requires a broader understanding of the methods and general  principles by scientists, clinicians, and patients alike. Thus, the primary goal of the Outreach Core is to  disseminate knowledge of the iterative dialogue between mathematical oncology, cancer systems biology and  experimental and clinical oncology to students, colleagues, and the general public. To accomplish our goal, we  will train new cross-disciplinary scientists, inform the research community, engage with the general public, and  assess our outcomes.",11790051 (contact),"JACKSON, PAMELA ROSE (contact)","DUECK, HANNAH RUTH",2023-09-18,2028-08-31,Advocacy;Arizona;Awareness;Biological;Biological Sciences;Biology;Brain Neoplasms;Cancer Biology;cancer education;Cell Physiology;Clinic;Clinical;clinical imaging;Clinical Oncology;clinical translation;Collaborations;Communities;Complex;Computational Science;Consent;design;Discipline;Disease;Education and Outreach;Educational workshop;Engineering;Ensure;experience;Exposure to;Facebook;Family;Future;General Population;Genetic;Glioblastoma;Goals;graduate student;Image;imaging facilities;improved;individual patient;innovation;Institution;Internships;Journals;Knowledge;Language Development;large datasets;Malignant Neoplasms;mathematical learning;mathematical methods;mathematical model;Mathematics;Methodology;Methods;Modeling;neuro-oncology;next generation;novel strategies;Oncology;Outcome;Outcome Assessment;Output;outreach;outreach program;patient advocacy group;Patient Care;Patients;personalized medicine;Postdoctoral Fellow;programs;recruit;Research;Research Project Grants;Scientist;skills;social media;Social Network;Solid;Students;success;summer research;symposium;System;Systems Analysis;Systems Biology;Techniques;Tissues;tool;Training;Twitter;undergraduate student;Universities;Update;web site;Work,Outreach Core,274504,ZCA1,ZCA1-RTRB-F(M2),7268,S1,2,2798,2945,NA,5743
11186186,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274504,NA,RFA-CA-21-048,3U54CA274504-02S1,NCI:11020\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SCOTTSDALE,UNITED STATES,NA,01,153665211,US,4976104,MAYO CLINIC ARIZONA,AZ,852595499,"NARRATIVE: BIOSPECIMEN CORE The Biospecimen Core will assist the Center through two specific aims: Aim 1) collect and store biopsies, Aim  2) run initial tissue characterization of immunohistochemistry and sequencing. The duties of the Biospecimen  Core Mayo Clinic Arizona (MCA) and Columbia University Medical Center (CUMC) and will support both projects.  The data generated by the Biospecimen Core will be transferred to the Data Integration and Computation Core,  where it will be stored, further processed including batch correction and atlas alignment, and integrated into  computational modeling tools.",6065421 (contact),"SWANSON, KRISTIN R (contact)","DUECK, HANNAH RUTH",2023-09-18,2028-08-31,Academic Medical Centers;Aftercare;Arizona;Atlases;Biology;Biopsy;Cell Lineage;Cells;Clinic;Clinical;Complex;Computer Models;Consent;Data;data integration;Detection;Freezing;gene panel;Glioblastoma;Glioma;Goals;Histologic;Histology;Image;Image Guided Biopsy;imaging facilities;Immunohistochemistry;in vivo;machine learning model;Magnetic Resonance Imaging;Malignant Neoplasms;Maps;mathematical model;Mathematics;Mission;Modeling;Molecular;Molecular Analysis;Oncogenes;Oncology;Operative Surgical Procedures;Paraffin Embedding;Pathology;Patients;Phenotype;Process;radiological imaging;recruit;RNA;Running;Sampling;Scanning;single cell sequencing;single-cell RNA sequencing;Site;Slide;Subgroup;System;Systems Analysis;Tissue imaging;tissue preparation;Tissue Stains;Tissues;tool;Training;transcriptome sequencing;treatment response;Validation,MOSAIC: Biospecimen Core,274504,ZCA1,ZCA1-RTRB-F(M2),5025,S1,2,7504,3516,NA,11020
11186187,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA274504,NA,RFA-CA-21-048,3U54CA274504-02S1,NCI:23412\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SCOTTSDALE,UNITED STATES,NA,01,153665211,US,4976104,MAYO CLINIC ARIZONA,AZ,852595499,"NARRATIVE: DATA INTEGRATION AND COMPUTATION CORE The Data Integration and Computation Core will be central to our Mayo/Columbia CSBC Mathematical  Oncology Systems Analysis Imaging Center (MOSAIC), collecting the diverse data types and sources and providing infrastructure for data resource management of the large datasets relied upon and generated through  the center including those provided by the Biospecimen Core. The Data Integration and Computation Core will support both projects with its three aims: Aim 1) collect and store data across all sites, Aim 2) provide  reproducible bioinformatics workflows, and Aim 3) provide computational modeling tools and techniques.",12330142 (contact),"HAWKINS-DAARUD, ANDREA JEANINE (contact)","DUECK, HANNAH RUTH",2023-09-18,2028-08-31,Authorization documentation;Bioinformatics;Biopsy;Calibration;Cancer Patient;Clinical;Clinical Data;clinical imaging;Clinical Research;Code;Collection;Computer Models;Data;data access;data infrastructure;data integration;Data Management Resources;data sharing;Data Sources;demographics;digital;digital data;Disease;diverse data;Ensure;Generations;genomic data;Glioma;Histology;Home;Hybrids;Image;imaging facilities;imaging Segmentation;in vivo;Infrastructure;innovation;Institution;Institutional Review Boards;large datasets;Location;Machine Learning;machine learning model;Magnetic Resonance Imaging;Malignant neoplasm of brain;Mathematics;Measurement;Mission;model development;Modeling;Molecular;Oncology;Online Systems;Outcome;Pathology;Patients;predictive modeling;Process;Reporting;repository;Reproducibility;Resources;response;Scanning;Secure;Services;sex as a biological variable;single-cell RNA sequencing;Site;Source;Specimen;Statistical Data Interpretation;Statistical Models;Structure;success;support tools;Systems Analysis;systems research;Techniques;Texture;Tissues;tool;tumor;Work,MOSAIC: Data Integration and Computation Core,274504,ZCA1,ZCA1-RTRB-F(M2),5026,S1,2,14886,8526,NA,23412
11186260,U54,CA,3,N,2024-09-05,2024-09-01,2025-08-31,NA,U54CA283114,NA,PA-20-272,3U54CA283114-02S1,NCI:158504\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,CAMBRIDGE,UNITED STATES,NA,07,001425594,US,4911501,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,021421029,"Narrative: Biomaterial-enhanced delivery of chemoimmunotherapies represents a promising strategy to safely target multiple immune resistance pathways and induce direct cytotoxic and immune-mediated tumor control. Here, we will identify and quantify changes in the MHC Class I peptide repertoire with cell-type resolution in a genetically engineered GBM mouse model upon treatment with chemoimmunotherapy regimens and correlate these changes with therapy immunomodulatory mechanisms and survival. MHC peptides upregulated after treatment will be used to develop targeted immunotherapies (e.g., genetically engineered T cells, peptide vaccines) that will significantly enhance the efficacy of chemoimmunotherapy.",7837510 (contact),"WHITE, FOREST M (contact)","DUECK, HANNAH RUTH",2023-09-15,2028-08-31,Address;Adhesives;Adjuvant;Affect;Aftercare;anti-tumor immune response;Antigen Targeting;Antigen-Presenting Cells;Antigens;Biocompatible Materials;Brain Neoplasms;Cell Therapy;cell transformation;cell type;Cells;chemotherapy;Complex;Contralateral;cytotoxic;design;Dinucleoside Phosphates;Doxorubicin;dynamical evolution;engineered T cells;Engineering;Evolution;Genetic Engineering;Genetically Engineered Mouse;Glioblastoma;Hydrogels;Immune;immune checkpoint blockade;immune resistance;Immune Targeting;Immuno-Chemotherapy;immunogenic;Immunologic Adjuvants;Immunologic Memory;immunomodulatory therapies;Immunophenotyping;immunoregulation;Immunotherapy;Implant;in situ vaccination;Injectable;interest;Kinetics;liquid chromatography mass spectrometry;Malignant neoplasm of brain;Mediating;Methods;MHC antigen;MHC Class I Genes;Modeling;mouse model;Mus;nanoparticle;neoplastic cell;Pathway interactions;patient prognosis;peptide I;Peptide Vaccines;Peptides;Periodicity;Regimen;Resistance;Resolution;response;STING agonists;Survival Rate;targeted treatment;Therapeutic;tumor;Tumor Antigens;tumor growth;vaccination strategy;Vaccines;Work,Project 2:  Deciphering the Dynamic Evolution of the Tumor-Immune Interface,283114,ZCA1,ZCA1(M2),7194,S1,2,100000,58504,NA,158504
11186678,ZIA,AG,1,N,NA,NA,NA,NA,ZIAAG000590,NA,NA,1ZIAAG000590-01,NIA:144379\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON AGING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON AGING,NA,NA,NA,9691162 (contact),"FERRUCCI, LUIGI  (contact)",NA,NA,NA,Aging;aging mechanism;Alzheimer&apos;s Disease;Baltimore;Biological;Biological Assay;Biological Markers;Biology of Aging;brain volume;Cerebrospinal Fluid;Chronic Disease;cognitive disability;cognitive function;Data;Dementia;Development;Generations;Geroscience;Glial Fibrillary Acidic Protein;Impaired cognition;Impairment;Longitudinal Studies;Magnetic Resonance Imaging;Measures;mild cognitive impairment;Mobility disability;Nerve Degeneration;Older Population;Participant;Pathologic;Pathway interactions;Pattern;Phenotype;Physical Function;physically handicapped;Plasma;Proteins;Proteomics;rate of change;Research Project Grants;Risk;Sampling;Testing;Time;walking speed,ALZHEIMER'S RESEARCH PROJECT: Implementation of a longitudinal proteomic profile in the BLSA,590,NA,NA,NA,NA,1,NA,NA,144379,NA
11186679,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008762,NA,NA,1ZIAHD008762-22,NICHD:5506\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,78830082 (contact),"PERKINS, NEIL  (contact)",NA,NA,NA,Address;Affect;Age;aged;Alcohol consumption;Anovulation;Attention;Behavioral;Biological;Biological Markers;cardiometabolism;Chronic Disease;cigarette smoking;Data;design;Diet;Dietary Factors;disorder risk;Environmental Epidemiology;Estrogens;Exercise;Failure;follow-up;Functional disorder;Goals;Gonadal Steroid Hormones;Health;high risk;Hormonal;Hormones;Impairment;Influentials;insight;Intake;interest;Life Style;Longitudinal cohort study;Luteal Phase;Menstrual cycle;Menstruation;Metabolism;nutritional epidemiology;Oxidative Stress;Paper;Periodicity;Physiological;Premenopause;Premenstrual syndrome;prospective;Public Health;Publishing;reproductive;reproductive hormone;Research;Role;social epidemiology;Symptoms;Variant;Vegetable Proteins;Vitamin D;Woman;Women&apos;s Health,"Oxidative Stress, Hormones and Women s Health",8762,NA,NA,NA,NA,22,NA,NA,5506,NA
11186680,ZIA,HD,1,N,NA,NA,NA,NA,ZIAHD008795,NA,NA,1ZIAHD008795-18,NICHD:22024\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,78830082 (contact),"PERKINS, NEIL  (contact)",NA,NA,NA,Accounting;aged;Aspirin;Blood flow;Cannabis;Characteristics;cohort;Conceptions;disorder prevention;Dose;Double-Blind Method;Exposure to;failure Implantation;Fertility;Fetal Death;Gestational Age;Goals;Home;Human;implantation;improved;Infertility;Inflammation;Link;Live Birth;Menstrual cycle;Menstruation;Monitor;Opioid;Participant;Placebos;Pregnancy;Pregnancy Complications;Pregnancy Histories;Pregnancy loss;Pregnancy Outcome;Pregnancy Tests;pregnant;prevent;primary outcome;prospective;Protocols documentation;Publishing;Randomized;randomized trial;Recording of previous events;Reproduction;reproductive outcome;secondary outcome;Selective Serotonin Reuptake Inhibitor;Site;Spontaneous abortion;subfertility;Time;treatment effect;trial design;Woman;Work,EAGeR Trial - The Effects of Aspirin in Gestation and Reproduction Trial,8795,NA,NA,NA,NA,18,NA,NA,22024,NA
11186681,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000030,NA,NA,1ZIAHG000030-30,NHGRI:504072\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10672960 (contact),"LIU, PAUL  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Address;Adult Acute Myeloblastic Leukemia;Affect;Affinity;Animal Model;Attenuated;Binding;Biological Markers;Biological Process;Bone Marrow Cells;C-terminal;CBFB gene;CBFbeta-MYH11 fusion protein;Cells;Chemicals;Childhood Acute Lymphocytic Leukemia;Chromosome abnormality;clinical center;clinical practice;Clinical Research;Collaborations;Communities;Core-Binding Factor;Data;Development;Diagnosis;differential expression;Disease;DNA;DNA Binding;DNA Methylation;Erythrocytes;fusion gene;Gene Expression;Gene Mutation;Genes;Genetic;genetic approach;Genomic approach;genomic tools;Genomics;Goals;Hematological Disease;Hematopoiesis;Homeostasis;Hypermethylation;improved;Interferometry;Intramural Research Program;Length;leukemia;leukemia treatment;leukemogenesis;Manuscripts;Methylation;methylome;Molecular;Monitor;mouse model;Mus;Mutation;Myeloid Cells;Myeloid Progenitor Cells;MYH11 gene;National Center for Advancing Translational Sciences;National Human Genome Research Institute;Ontology;Pathogenesis;Patients;Play;Preleukemia;Preparation;Prognosis;promoter;Proteins;Proto-Oncogene Protein c-kit;Reporting;Residual Neoplasm;Resources;Role;RUNX1 gene;Scientist;Site;Technology;transcription factor;transcriptome;transcriptome sequencing;transcriptomics;Transgenic Animals;Translating;translational study;tumorigenesis;United States National Institutes of Health;Variant;Vertebrates;Wild Type Mouse;Zebrafish,Mechanistic and translational studies of CBF leukemia,30,NA,NA,NA,NA,30,NA,NA,504072,NA
11186682,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG000102,NA,NA,1ZIAHG000102-28,NHGRI:2016285\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,10672960 (contact),"LIU, PAUL  (contact)",NA,NA,NA,"Address;Affect;Animal Model;Applications Grants;aspirate;autosome;Biological Assay;Biological Markers;biomarker identification;Bleeding time procedure;Blood Cells;Bone marrow biopsy;Books;CBFbeta-MYH11 fusion protein;Clinical;clinical center;clinical phenotype;Clinical Research;Clonal Evolution;Coagulation Process;cohort;Collaborations;Consultations;Cytogenetic Analysis;Defect;Development;Diagnosis;Diagnostic;Disease;Disease Outcome;Disease Progression;Educational process of instructing;Enrollment;epigenomics;Evaluation;exome sequencing;experience;Familial Platelet Disorder;Family;Family member;Funding;fusion gene;Gene Expression;Gene Mutation;Genes;Genetic;genetic approach;Genomic approach;genomic tools;Genomics;Genotype;Germ Lines;Germ-Line Mutation;Goals;Grant;Hematologic Neoplasms;Hematopoiesis;Hematopoietic Neoplasms;hematopoietic tissue;Individual;Innovative Therapy;Institution;Journals;Knowledge;Laboratory Research;leukemia;leukemogenesis;longitudinal, prospective study;Malignant - descriptor;Malignant Neoplasms;Medical;Medical History;Megakaryocytes;Molecular;Monitor;mutant;Mutation;Mutation Detection;Myeloproliferative disease;Natural History;Office Visits;Participant;participant enrollment;Pathogenesis;Pathogenicity;Patients;Peer Review;Penetrance;peripheral blood;Phenotype;Platelet Count measurement;platelet function;Predisposition;Privatization;Procedures;Process;prospective;Prospective Studies;Publishing;Rare Diseases;Research;Research Subjects;Risk;RUNX1 gene;Sample Size;Severity of illness;single-cell RNA sequencing;SNP array;Somatic Mutation;Specialist;Syndrome;Techniques;Technology;Testing;transcriptome sequencing;Transgenic Animals;translational study;tumorigenesis;United States National Institutes of Health;Visit;Work",Clinical and translational studies of RUNX1 and FPDMM,102,NA,NA,NA,NA,28,NA,NA,2016285,NA
11186683,ZIA,HG,1,N,NA,NA,NA,NA,ZIAHG200323,NA,NA,1ZIAHG200323-20,NHGRI:2021115\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,6674897 (contact),"ELNITSKI, LAURA L (contact)",NA,NA,NA,Address;Alternative Splicing;angiogenesis;Anterior;Apoptosis;Area;aspirate;Attention;Attention deficit hyperactivity disorder;Automobile Driving;Base Sequence;Biological;Biological Markers;Biological Process;Biology;biomarker evaluation;Blood;BRAF gene;CA-125 Antigen;cancer biomarkers;Cancer cell line;Cancer Detection;cancer type;Carcinoma;Cell Nucleus;cell type;Cells;Cellular Stress;Characteristics;Chromatin;cingulate cortex;Clinical;clinically relevant;Code;cohort;Collaborations;Colon Carcinoma;Complex;computational pipelines;Computing Methodologies;Corpus striatum structure;CpG Island Methylator Phenotype;Data;detection assay;Development;Diagnostic;diagnostic biomarker;differential expression;Disease;disease model;disease phenotype;Distal;Distant;DNA;DNA Methylation;DNA Sequence Alteration;Down-Regulation;Early Diagnosis;Elements;Endometrioid Tumor;Enhancers;Epigenetic Process;epigenetic regulation;Epithelial ovarian cancer;Epithelium;ESR1 gene;Event;Exhibits;experimental study;Fostering;Future;FYN gene;Gene Expression;Gene Expression Regulation;gene repression;Genes;Genetic;Genome;genomic data;Genomic medicine;Genomics;Genotype;Glutamates;Goals;Health;Healthcare;Human;human disease;Human Genome;human genome sequencing;immune cell infiltrate;Initiator tRNA;innovation;insight;Intervention;Invaded;Investigation;knock-down;Knowledge;Link;Logistic Regressions;loss of function;machine learning classifier;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant Neoplasms;Manuscripts;Measures;Medical;Melanoma;Mendelian disorder;Mesenchymal;Methodology;Methylation;methylation biomarker;Modeling;Modification;Molecular;Molecular Sieve Chromatography;molecular subtypes;Mutate;Mutation;Neoplasm Metastasis;Neurodevelopmental Disorder;neuronal cell body;Neurotransmitters;Non-Invasive Cancer Detection;novel;novel strategies;novel therapeutic intervention;nucleolin;Oncogenes;Open Reading Frames;Outcome;Ovarian;ovarian neoplasm;Pathogenesis;Pathway interactions;Patients;personalized health care;Phenotype;Phosphotransferases;Point Mutation;Preparation;prevent;Primary Neoplasm;Principal Component Analysis;Process;programs;Proliferating;promoter;Protein Isoforms;Protein Tyrosine Kinase;Proteins;Receptor Protein-Tyrosine Kinases;Regulation;Regulator Genes;Regulatory Element;Reporting;Research;response;RNA Splicing;RNA-Binding Proteins;Role;Sampling;Science;Screening for cancer;Screening for Ovarian Cancer;Serous;Site;small molecule;Solid;Somatic Mutation;Specificity;Subgroup;Testing;The Cancer Genome Atlas;Therapeutic;Therapeutic Intervention;therapeutic target;therapeutically effective;Tissue-Specific Gene Expression;trait;Transcript;transcriptome;transcriptomics;Treatment Efficacy;treatment planning;tumor;Tumor Biology;tumor diagnostic;tumor DNA;Tumor Suppressor Genes;Untranslated RNA;Uterus;Validation;Variant;Work,"Regulatory and epigenetic landscapes reveal biological processes, disease mechanisms and diagnostic markers",200323,NA,NA,NA,NA,20,NA,NA,2021115,NA
11186684,ZIC,HD,1,N,NA,NA,NA,NA,ZICHD008912,NA,NA,1ZICHD008912-14,NICHD:60565\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,15708587 (contact),"WECK, JENNIFER  (contact)",NA,NA,NA,Address;Alabama;Best Pharmaceuticals for Children Act;biobank;Biological Assay;Biological Specimen Banks;Calcium;Childhood;Clinical Research;Communicable Diseases;Contracts;Data;data sharing;Dedications;Diabetes Mellitus;Ensure;experience;Extramural Activities;Fetal Growth;Goals;Guidelines;Human Resources;Longitudinal Studies;Maternal-Fetal Medicine Units Network;National Institute of Child Health and Human Development;Norway;Obstetric pharmacology;pediatric pharmacology;Perinatal;Perinatology;population health;Pre-Eclampsia;Pregnancy;premature;Prevention trial;Procedures;Program Development;programs;repository;Research;Research Design;Research Personnel;research study;Resources;Services;Source;Specimen;Testing;Therapeutic;United States National Institutes of Health;Vagina;vaginal infection;Vision;Women&apos;s Health;Work,Biospecimen Repository - Division of Intramural Population Health Research,8912,NA,NA,NA,NA,14,NA,NA,60565,NA
11186685,ZIC,HG,1,N,NA,NA,NA,NA,ZICHG200346,NA,NA,1ZICHG200346-17,NHGRI:1555737\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,8184969 (contact),"CHANDRASEKHARAPPA, SETTARA  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Attention deficit hyperactivity disorder;bead chip;Blood capillaries;bone marrow failure syndrome;Clustered Regularly Interspaced Short Palindromic Repeats;Collection;Coloboma;Colorectal Cancer;Communication;Communities;Computer software;congenic;congenital heart abnormality;Consultations;Copy Number Polymorphism;CRISPR/Cas technology;Data;data access;Data Analyses;Data Set;deletion detection;design;Diagnosis;Diamond-Blackfan anemia;DNA;Dyskeratosis Congenita;Epilepsy;Evaluation;Eye diseases;Fanconi&apos;s Anemia;Fever;Genetic;Genome;genome-wide;Genomic Segment;Genomics;Genotype;Haplotypes;Head and Neck Cancer;Human;Human Cell Line;human DNA;identity by descent;induced pluripotent stem cell;Infection;Inherited bone marrow failure;insertion/deletion mutation;interest;Kidney Diseases;large datasets;Learning;Leber&apos;s amaurosis;Ligation;Linkage Disequilibrium;Loss of Heterozygosity;Malignant Breast Neoplasm;Malignant Neoplasms;meetings;Methylation;Mosaicism;Mus;Mutagenesis;mutation screening;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Mental Health;Oculocutaneous Albinism;Parents;Patients;population stratification;Problem Solving;Process;programs;Research;Research Personnel;research study;Resources;Running;Sampling;service utilization;Services;Smith Magenis syndrome;SNP array;SNP genotyping;Speed;Syndrome;Technology;tool;United States National Institutes of Health;Update;Variant;Zebrafish;zinc finger nuclease technology,NHGRI/DIR Genomics Core,200346,NA,NA,NA,NA,17,NA,NA,1555737,NA
11186686,ZIC,HG,1,N,NA,NA,NA,NA,ZICHG200348,NA,NA,1ZICHG200348-17,NHGRI:1421824\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,79968918 (contact),"WINCOVITCH, STEPHEN  (contact)",NA,NA,NA,3-Dimensional;Abbreviations;Age;Agglutinins;Aging;Alleles;Architecture;Area;Axon;axon guidance;Binding;Biological Assay;Brain;Cardiac;Cell Line;Cell Nucleus;Cells;Cellular Morphology;Cerebellum;Cessation of life;Charge;charge coupled device camera;Child;Clinical Management;Collaborations;Communities;Complex;Computer software;Computer Workstations;computerized tools;confocal imaging;Confocal Microscopy;Core Facility;Cytoplasm;Data;design;Development;Disease;disease-causing mutation;Engineering;Equipment;Excision;experimental study;Familial Platelet Disorder;Fatigue;fluorescence imaging;Fluorescence Recovery After Photobleaching;Fluorescence Resonance Energy Transfer;Four-dimensional;Future;Gaucher Disease;Genes;genetic risk factor;Genotype;Germ Lines;glucosylceramidase;glycosylation;Goals;Green Fluorescent Proteins;Growth;Heart;Heterozygote;Histopathology;Hour;Image;Image Analysis;imager;imaging study;Immunofluorescence Immunologic;In Vitro;Individual;induced pluripotent stem cell;influenza infection;interest;Investigation;investigator training;Knock-in Mouse;Knock-out;Knockout Mice;Laser Scanning Confocal Microscopy;Lasers;Lead;Lectin;Libraries;Link;live cell imaging;Lung;Lysosomes;Maackia amurensis;Measures;Melanins;melanocyte;Melanosomes;Microscope;Microscopy;Minority;Mission;Molecular;Morphology;mouse model;Mus;Mutation;myelination;Myocardial Infarction;National Human Genome Research Institute;National Institute of Neurological Disorders and Stroke;Natural History;Nerve;Nerve Degeneration;nervous system development;neural;Neurodegenerative Disorders;Neurons;novel;novel therapeutics;Nuclear;Oculocutaneous Albinism;Optics;Organelles;Parkinson Disease;Pathogenicity;Pathologic;Patients;Pattern;Peanut Agglutinin;Pharmaceutical Preparations;Phenotype;photoactivation;Principal Investigator;Process;Progeria;progressive neurodegeneration;Protein translocation;Protocols documentation;Purkinje Cells;Reagent;Reporter;Research;Research Personnel;Research Project Grants;Resolution;response;Running;RUNX1 gene;Sambucus nigra;Scanning;screening;Services;Sialic Acids;Siblings;Slide;spatiotemporal;Stains;Stimulus;Stroke;Structure;Structure of parenchyma of lung;Subcellular structure;superresolution microscopy;Syndrome;System;Techniques;Technology;Teenagers;temporal measurement;Time;Tissues;Training;Transfection;two-dimensional;ultra high resolution;Variant;variant of unknown significance;Vesicle;Visualization,NHGRI Advanced Imaging & Analysis Core,200348,NA,NA,NA,NA,17,NA,NA,1421824,NA
11186687,ZIC,HG,1,N,NA,NA,NA,NA,ZICHG200350,NA,NA,1ZICHG200350-17,NHGRI:1252870\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,79320066 (contact),"ANDERSON, STACIE  (contact)",NA,NA,NA,Cell Size;cell type;Cells;cellular engineering;Classification;Color;design;Development;Equipment;experimental analysis;experimental study;Flow Cytometry;Genes;genome editing;Genomics;Goals;Human Resources;instrument;Lasers;magnetic cell separation;Measures;Mus;National Human Genome Research Institute;particle;Population;Research;Research Personnel;Running;Sampling;Services;Surface;Suspensions;Technology;tool;Training,NHGRI/DIR Flow Cytometry Core,200350,NA,NA,NA,NA,17,NA,NA,1252870,NA
11186688,ZIC,HG,1,N,NA,NA,NA,NA,ZICHG200365,NA,NA,1ZICHG200365-15,NHGRI:1028907\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,12465257 (contact),"ELKAHLOUN, ABDEL  (contact)",NA,NA,NA,Cells;Computer software;Copy Number Polymorphism;Core Facility;cost effective;Data;Data Analyses;data mining;data quality;DNA Library;Gene Expression Profile;Generations;Genome;Genomics;Goals;Label;Link;Methylation;MicroRNAs;Mining;National Human Genome Research Institute;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;Output;Protocols documentation;Quality Control;Reagent;Research Personnel;Resources;RNA;Sampling;Services;single cell genomics;single cell sequencing;single-cell RNA sequencing;Summary Reports;Suspensions;Technology;Time;Training;transcriptome sequencing;transcriptomics,NHGRI/DIR Microarray and single-cell Core,200365,NA,NA,NA,NA,15,NA,NA,1028907,NA
11186689,ZID,HG,1,N,NA,NA,NA,NA,ZIDHG200347,NA,NA,1ZIDHG200347-17,NHGRI:1434297\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,12465259 (contact),"HULL, SARA  (contact)",NA,NA,NA,"Accreditation;Address;adjudication;Adult;Alaska;Authorship;Award;base;Bioethics;Brain;Case Study;case-by-case basis;Certification;Charge;Childhood;Clinical;clinical center;Clinical Practice Guideline;Clinical Protocols;Clinical Research;Clinical Research Protocols;Clinical Trials Data Monitoring Committees;Collaborations;Conflict of Interest;Consent;Consent Forms;Consult;Consultations;Data;data management;data sharing;Descriptor;design;Development;Disparate;diversity and equity;Education;education research;Educational process of instructing;Educational workshop;Employee;Enrollment;Ensure;Ethical Issues;Ethical Review;ethical, legal, and social implication;Ethicists;Ethics;Ethics Committees;Ethics Consultation;Ethnic equity;Evaluation;Event;Exclusion;Extramural Activities;Focus Groups;Fostering;Funding;genomic data;Genomics;Good Clinical Practice;health disparity;health equity;Human;human data;human subject;Human Subject Research;Indigenous;indigenous community;Institution;Institutional Review Boards;Instruction;Internships;Intramural Research;Intramural Research Program;Knowledge;Lead;Leadership;Learning;Maintenance;Manuscripts;material transfer agreement;Medical Genetics;Medicine;meetings;member;Mentors;Minor;Mission;Modeling;Modification;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;pandemic disease;Participant;Persons;Policies;Population;Postbaccalaureate;Postdoctoral Fellow;Procedures;Process;programs;Protocol Compliance;Protocols documentation;Publishing;Racial Equity;recruit;repository;Research;Research Activity;Research Ethics;Research Misconduct;Research Personnel;Research Project Grants;Research Support;Research Training;responsible research conduct;Review Committee;Services;symposium;System;Techniques;Technology Transfer;Training;Training Activity;Transfer Agreement;tribal health;Tribes;Trust;United States Indian Health Service;United States National Institutes of Health;Vulnerable Populations;Work;working group;Writing",NHGRI/DIR Bioethics Core,200347,NA,NA,NA,NA,17,NA,NA,1434297,NA
11186690,ZIE,HG,1,N,NA,NA,NA,NA,ZIEHG200353,NA,NA,1ZIEHG200353-17,NHGRI:1415639\,INTRAMURAL RESEARCH,2024,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL HUMAN GENOME RESEARCH INSTITUTE,NA,NA,NA,15720916 (contact),"ERBY, LORI  (contact)",NA,NA,NA,Address;Adoption;Adult;Advocacy;Age;Arrhythmogenic Right Ventricular Dysplasia;Behavior;Belief;Benefits and Risks;Biological;Black race;cancer genetics;Characteristics;Child;Client;Client satisfaction;Clinical;Clinical Management;Clinical Trials;Code;cohort;Collaborations;Communication;Communities;community involvement;Complication;Confusion;congenital immunodeficiency;coping;cost;Cross-Sectional Studies;CTLA4 haploinsufficiency;Data;Decision Making;Development;Diagnosis;Disclosure;Disease;education resources;eligible participant;Ethics;European;Evaluation;Exhibits;expectation;experience;faculty research;Family;Feeling;Future;gain of function;GATA2 deficiency;gene therapy;gene therapy clinical trial;Genetic Counseling;genetic counselor;genetic disorder diagnosis;Genomics;Guide prevention;Guilt;Health;health disparity;Hour;Human;Imagination;Individual;Industry;Informed Consent;Institution;interest;Intervention;Interview;Judgment;Knowledge;Learning;Length;Life;Linear Regressions;Logistic Regressions;Master of Science;Measures;Mediation;Methods;Modeling;National Cancer Institute;National Human Genome Research Institute;Nature;non-verbal;Nonverbal Communication;Oncology;Paper;Participant;patient oriented;Patient-Centered Care;Patients;Pattern;Penetrance;Perception;Persons;Policies;polygenic risk score;Population;Practice Guidelines;Precision Health;Preparation;Prevention strategy;Process;programs;prophylactic mastectomy;Public Health;Public Health Schools;Publications;Publishing;Questionnaires;Race;randomized trial;Recommendation;Relationship-Building;Relative Risks;reproductive;Reproductive Technology;Research;Research Personnel;Resources;response;Risk Assessment;Risk Management;Rotation;Roter;Sampling;satisfaction;Scholarship;screening;Services;Severities;Severity of illness;Shame;Shapes;Slice;social;Societies;standard of care;Standardization;Students;Systems Analysis;telehealth;theories;Therapeutic;Therapeutic Studies;Thinness;Training;Training Programs;Transcript;trial enrollment;Trust;Uncertainty;United States National Institutes of Health;Universities;verbal;Verbal Behavior;video coaching;Work,NHGRI/DIR Genetic Counseling Training Program,200353,NA,NA,NA,NA,17,NA,NA,1415639,NA
11186691,ZII,HD,1,N,NA,NA,NA,NA,ZIIHD008947,NA,NA,1ZIIHD008947-10,NICHD:2097820\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,79968924 (contact),"KING, SARA  (contact)",NA,NA,NA,Address;Affinity;Collaborations;Core Facility;Databases;Fostering;Goals;interest;Intramural Research;Laboratories;Laboratory Research;Liquid substance;Location;Maps;Maryland;multidisciplinary;Regulation;Research;Research Personnel;Resource Sharing;Science;Scientist;United States National Institutes of Health;Update;Work,"Space Renovations, Activation, and Commissioning",8947,NA,NA,NA,NA,10,NA,NA,2097820,NA
11186692,ZIJ,HD,1,N,NA,NA,NA,NA,ZIJHD008867,NA,NA,1ZIJHD008867-17,NICHD:2572750\,INTRAMURAL RESEARCH,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,NA,NA,NA,NA,NA,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,NA,NA,79968926 (contact),"BOHN, MEGAN  (contact)",NA,NA,NA,"Academic support;Accreditation;Address;Affinity;Applications Grants;Area;Arts;Award;Awareness;Biology;Biomedical Research;Bone Diseases;Brazil;career;career development;Career Mobility;career networking;Clinical;cohort;Collaborations;college;Communication;Databases;Development;Development Plans;editorial;Education;Educational process of instructing;Educational workshop;Evaluation;experience;Exposure to;Extracellular Matrix;Fellowship;France;Funding;Funding Mechanisms;Funding Opportunities;Future;Gene Expression Regulation;Genetic Diseases;Goals;graduate student;Grant;health disparity;health equity;Health equity research;high school;improved;Incentives;Individual;Institution;Interview;Intramural Research;Job Application;Laboratories;Learning;Maintenance;medical schools;Medical Students;Medicine;member;Mentors;National Center for Advancing Translational Sciences;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Environmental Health Sciences;National Institute of Neurological Disorders and Stroke;National Institute on Deafness and Other Communication Disorders;Newsletter;Occupational Therapy;Occupations;outreach;Policy Developments;Population;post-doctoral training;Postbaccalaureate;Postdoctoral Fellow;posters;Process;Program Development;programs;Progress Reports;Public Health;Publishing;recruit;Reporting;Research;Research Personnel;Research Project Grants;Resources;Rotation;Running;Scholars Program;Schools;Science;Scientist;Series;Services;Site Visit;skills;Students;summer internship;Surveys;System;Talents;tenure track;Training;Training and Education;Training Programs;undergraduate student;United States National Institutes of Health;Universities;university student;Update;virtual;Visit;Vocational Guidance;webinar;Work;Writing",NICHD Office of Education,8867,NA,NA,NA,NA,17,NA,NA,2572750,NA
11186865,R01,FD,3,N,2024-09-25,2023-09-01,2025-08-31,103,R01FD007461,BIOMED ENGR/COL ENGR/ENGR STA,RFA-FD-21-033,3R01FD007461-03S1,FDA:235000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,HOUGHTON,UNITED STATES,ENGINEERING (ALL TYPES),01,065453268,US,5230701,MICHIGAN TECHNOLOGICAL UNIVERSITY,MI,499311295,"Project Narrative This project will create a continuous manufacturing process for a highly effective influenza vaccine. The novel process will reduce the cost of building a new manufacturing plant and reduce the cost to run the plant. Once production begins, the vaccine can easily be updated so that the vaccine will better match the circulating influenza strains and thus better protect the public from influenza.",1973881;9711779 (contact),"BETENBAUGH, MICHAEL J;HELDT, CARYN  (contact)","OSORIO, MANUEL",2021-09-01,2025-08-31,NA,Integrated and Continuous Manufacturing of an Influenza Vaccine,7461,ZFD1,ZFD1-CBER-G(01)1,NA,S1,3,235000,0,235000,NA
11186935,OT2,HL,1,N,2024-09-26,2024-09-25,2025-09-30,837,OT2HL180049,NA,OTA-24-021,1OT2HL180049-01,NHLBI:40000000\,OTHERS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,ROCKVILLE,UNITED STATES,NA,08,049508120,US,9611701,"WESTAT, INC.",MD,208503129,NA,78492086 (contact),"MONTALVAN, REBECCA  (contact)",NA,2024-09-25,2029-09-30,"Address;Area;Artificial Intelligence;authority;Award;Behavioral;Biological Process;Biomedical Research;catalyst;Chronic lung disease;Clinical;Clinical Data;Collaborations;Data;Data Set;database of Genotypes and Phenotypes;Dedications;Disease;Disparity;Ecosystem;Environmental Exposure;Exhibits;experience;Familiarity;Gender;genome sequencing;Health;Heart Diseases;Hematological Disease;idiopathic pulmonary fibrosis;Image;improved;Infrastructure;innovation;interest;Internet;Intervention;Lung Diseases;Machine Learning;machine learning method;Measures;Medical;Medical Imaging;Methods;Molecular;National Heart, Lung, and Blood Institute;Nature;novel;operation;organizational structure;Outcome;petabyte;Phenotype;Positioning Attribute;Precision Medicine Initiative;Prevention;Procedures;Process;programs;Progress Reports;Radiogenomics;radiomics;Research;Research Institute;Research Personnel;Research Project Grants;Research Proposals;Research Subjects;Risk Factors;Role;Running;sex;Sex Differences;Sleep Disorders;Structure;success;synergism;System;Therapeutic;Time;Trans-Omics for Precision Medicine;Update;whole genome;Woman;Women&apos;s Health;Work",Trans-Omics for Precision Medicine (TOPMed) Artificial Intelligence Coordinating Center (AI-CC),180049,ZHL1,ZHL1-SRC(99),NA,NA,1,40000000,0,40000000,NA
11186938,N01,ES,NA,N,NA,NA,NA,NA,75N96020C00001,NA,NA,75N96020C00001-P00008-9999-1,NIEHS:675000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,RESEARCH TRIANGLE PARK,UNITED STATES,NA,04,130427701,US,1933801,"INTEGRATED LABORATORY SYSTEMS, LLC",NC,277093501,NA,11726821 (contact),"HOBBS, CHERYL A. (contact)",NA,2020-09-06,2025-09-05,Adopted;Adult;Adverse effects;aging process;Animal Model;Animal Testing;Animals;Biological;Biological Assay;Biological Monitoring;Biotechnology;Birth;Blood specimen;Botanicals;Brain;carcinogenicity;Carcinogens;Cells;Chemical Exposure;Chemicals;Clinic;Clinical;Clinical Research;Colon;Comet Assay;Complication;Congenital Abnormality;contaminated water;Contracts;Data;Development;Diagnosis;dietary supplements;Disasters;Disease;DNA Damage;DNA sequencing;Early Diagnosis;early life exposure;Economics;Environment;environmental chemical;Environmental Exposure;Erythrocytes;Event;Evolution;exposed human population;Exposure to;Family suidae;flexibility;Frequencies;Future;Gene Expression;Gene Mutation;Generations;Genes;Genetic;Genetic Induction;Genomics;genotoxicity;Guidelines;Health;Human;human study;In Vitro;in vitro testing;in vivo;Induced Mutation;innovation;interest;International;Kidney;Laboratories;Life;Link;Liver;Malignant Neoplasms;Mammalian Cell;Methods;micronucleus;Micronucleus Tests;Mission;Monitor;multiplex assay;Mus;Mutagenicity Tests;Mutation;mutation assay;Mutation Detection;Mutation Spectra;National Institute of Environmental Health Sciences;novel strategies;Oncology;Outcome;Participant;peripheral blood;Pesticides;Pharmaceutical Preparations;Pharmacologic Substance;Phenotype;Protocols documentation;Rattus;Resources;response;Rodent;Sampling;Source;Stomach;Study models;Symptoms;System;Technology;Testing;Tissues;Toxic effect;Toxicity Tests;Toxicogenetics;Toxicology;Translating;treatment response;tumor;United States Environmental Protection Agency;United States Food and Drug Administration;Update;West Virginia,GENETIC TOXICOLOGY SUPPORT FOR THE NTP AND THE NIEHS,0,NA,NA,NA,NA,NA,NA,NA,675000,NA
11186939,N02,CA,NA,N,NA,NA,NA,NA,91021A00291022F00001,NA,NA,91021A00291022F00001-P00004-0-1,NCI:3053775\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,FAIRFAX,UNITED STATES,NA,11,072648579,US,1644201,"ICF, INC., LLC",VA,220316050,NA,78859097 (contact),"KILGORE, ELIZABETH  (contact)",NA,2022-09-15,2025-09-14,Adoption;Awareness;behavioral health;Communication;Communities;Community Health;Contractor;Development;Division of Cancer Control and Population Sciences;Equipment;Future;Government;Government Agencies;Health Services;Human Resources;improved;insight;Measures;mhealth interventions;National Cancer Institute;outreach;Population Group;Public Health;Qualifying;Research;Research Institute;Research Support;Services;smoking cessation;tool;Work,INTERNAL AND EXTERNAL COMMUNICATIONS AND DISSEMINATION SUPPORT FOR DCCPS,0,NA,NA,NA,NA,NA,NA,NA,3053775,NA
11186966,U01,IP,6,N,2024-09-03,2024-09-01,2025-08-31,185,U01IP001198,SCHOOLS OF MEDICINE,RFA-IP-23-007,6U01IP001198-02M001,NCIRD:350000\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES,NA,ANN ARBOR,UNITED STATES,PEDIATRICS,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"PROJECT NARRATIVE This research study will use economic survey methods to collect data on public/parent/patient preferences for vaccine outcomes and vaccination programs. Using this information, the CDC will be better able to measure the value of future vaccination programs and to design strategies to increase uptake of vaccination.",8341740 (contact),"PROSSER, LISA A. (contact)",NA,2023-09-01,2026-08-31,NA,"RFA-IP-23-007, Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations",1198,ZIP1,ZIP1-GCA(53),NA,M001,2,NA,NA,350000,NA
11187468,U54,CA,3,N,2024-09-09,2024-03-01,2024-08-31,NA,U54CA274374,NA,PA-23-189,3U54CA274374-03S1,NCI:100184\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,"Project Narrative  Adenomas are early lesions of colorectal cancer (CRC), but only a subset of individuals develop adenomas, and only a subset of adenomas progress to cancer. We hypothesize that adenoma development and progression require adenoma autonomous factors (e.g. cancer driver gene mutations) in concert with adenoma nonautonomous factors pertaining to the gut microbial microenvironment. Our proposed studies will examine the direct causal relationships and interactions of adenomas, the colonic microenvironment, and the gut microbiome as “co-conspirators” of adenoma initiation and/or progression.",9311392 (contact),"DEY, NEELENDU  (contact)","PATRIOTIS, CHRISTOS F",2022-09-20,2027-08-31,adenoma;Architecture;Automobile Driving;Basic Science;Behavior;Cells;Colon;Colonoscopy;Colorectal;Colorectal Adenoma;Colorectal Cancer;Data;deep sequencing;Development;Fibroblasts;Gene Mutation;Genetic;Gnotobiotic;gut bacteria;gut microbiome;Human;Image;In Situ;Individual;individualized prevention;Indolent;insight;Knowledge;Lesion;Link;Longitudinal cohort;Machine Learning;Malignant Neoplasms;Mediating;Mediation;Metagenomics;microbial;microbiome;Modeling;Molecular;Molecular Profiling;Monitor;Mus;novel;Oncogenic;Organoids;Role;screening;senescence;senescence associated secretory phenotype;Testing;Tissues;Translations;tumorigenesis;tumorigenic,"The gut microbiome, interactions with primed colon states, and effects on adenoma formation and progression",274374,ZCA1,ZCA1(M1),9335,S1,3,60484,39700,NA,100184
11187481,U54,CA,3,N,2024-09-10,2024-08-01,2025-07-31,NA,U54CA274374,NA,PAR-22-114,3U54CA274374-03S2,NCI:255000\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,"Project Narrative  The Alaska Native community faces a high burden of colorectal cancer (CRC), with the highest incidence and mortality rates in the US. This study aims to investigate the link between the gut microbiome and colorectal adenomas, the early precancerous lesions in CRC, specific to this population. Through microbiome profiling of  unique collections of fecal samples, we will identify gut microbial biomarkers for colorectal adenomas.",9311392 (contact),"DEY, NEELENDU  (contact)","PATRIOTIS, CHRISTOS F",2022-09-20,2027-08-31,Address;adenoma;Administrative Supplement;Alaska Native;Alaska Native population;Architecture;Automobile Driving;Biological Markers;Biology;Cancer Center;cancer health disparity;carcinogenicity;cohort;Collection;Colon;Colonoscopy;Colorectal;Colorectal Adenoma;Colorectal Cancer;colorectal cancer risk;Communities;Data;Death Rate;Deoxycholic Acid;Disparity;Face;Geography;gut microbiome;high risk;improved;Incidence;individualized prevention;Intervention;Investigation;Lesion;Link;metabolomics;Metagenomics;microbial;microbiome;Population;premalignant;prevent;Publishing;Redwood;Reporting;Research;screening;stool sample;Tissues;tribal health,"The gut microbiome, interactions with primed colon states, and effects on adenoma formation and progression",274374,ZCA1,ZCA1(M1),9335,S2,3,144887,110113,NA,255000
11187487,U54,CA,3,N,2024-09-12,2024-08-01,2025-07-31,NA,U54CA274374,NA,PA-20-272,3U54CA274374-03S3,NCI:178226\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,NA,1865649 (contact),"GRADY, WILLIAM MALLORY (contact)","PATRIOTIS, CHRISTOS F",2022-09-20,2027-08-31,NA,Administrative Core,274374,ZCA1,ZCA1(M1),9332,S3,3,121226,57000,NA,178226
11187493,U54,CA,3,N,2024-09-10,2024-09-01,2025-08-31,NA,U54CA261694,NA,PA-20-272,3U54CA261694-04S1,NCI:95400\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,CAMBRIDGE,UNITED STATES,NA,07,001425594,US,4911501,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,021421029,PROJECT NARRATIVE  Patients who have cancer that has spread to distant sites in the body have a poor prognosis. Macrophages are  a type of cell that surrounds the cancer and supports its growth. We will understand how these macrophages  enable cancers to grow in other organs in the body and test treatments against them.,1961918 (contact),"KAMM, ROGER D (contact)","NADEAU, CHRISTINE FRANCES",2021-09-17,2026-08-31,3-Dimensional;Biological Models;Blood - brain barrier anatomy;Blood Vessels;Cause of Death;cell type;Cells;checkpoint therapy;Clustered Regularly Interspaced Short Palindromic Repeats;Colon Carcinoma;colorectal cancer metastasis;Distant;Extracellular Matrix;Fibroblasts;Genetic Markers;Growth;Human;Imaging Techniques;Immune;in vivo;Invaded;Knock-out;Macrophage;Malignant Neoplasms;metastatic colorectal;Metastatic malignant neoplasm to brain;Microfluidic Microchips;Microfluidics;Microscopy;migration;Modeling;Neoplasm Metastasis;neoplastic cell;neutralizing antibody;Organ;Patients;physiologic model;Physiological;Pirfenidone;pressure;Process;Prognosis;Proliferating;Role;shear stress;Site;small molecule;Testing;Therapeutic Intervention;Tumor Cell Invasion;tumor microenvironment;Tumor Promotion;Tumor-associated macrophages;tumorigenic,"Project1: The role of intravascular pressure and shear stress on tumor cell arrest, survival and proliferation in the microvascular niche",261694,ZCA1,ZCA1(M1),5988,S1,4,60000,35400,NA,95400
11187500,U54,CA,3,N,2024-09-13,2024-08-01,2025-07-31,NA,U54CA274374,NA,PA-20-272,3U54CA274374-03S4,NCI:176000\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,SEATTLE,UNITED STATES,NA,07,806433145,US,10068583,FRED HUTCHINSON CANCER CENTER,WA,981094433,NA,9311392 (contact),"DEY, NEELENDU  (contact)","PATRIOTIS, CHRISTOS F",2022-09-20,2027-08-31,NA,"The gut microbiome, interactions with primed colon states, and effects on adenoma formation and progression",274374,ZCA1,ZCA1(M1),9335,S4,3,100000,76000,NA,176000
11187521,U54,HD,3,N,2024-09-12,2023-09-01,2024-08-31,NA,U54HD104392,NA,PA-20-272,3U54HD104392-04S2,NICHD:519999\,RESEARCH CENTERS,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,PHILADELPHIA,UNITED STATES,NA,03,042250712,US,6463801,UNIVERSITY OF PENNSYLVANIA,PA,191046205,NA,2086069 (contact),"BARNHART, KURT T (contact)","TINGEN, CANDACE M",2024-09-13,2025-08-31,3-Dimensional;Adult;Anatomy;annotation  system;Atlases;Biological Assay;Body System;Cardiovascular Diseases;cell community;Cells;Cellular biology;Chromatin;Chromium;Clinical;Collaborations;Communities;Computer software;Data;Data Analyses;Data Collection;data standards;Deposition;digital models;embryo/fetus;Endocrine;Endocrine System Diseases;Endometrium;Ensure;Environment;Epigenetic Process;Female;female reproductive system;Fertilization;Fetus;Generations;Geography;Germ Cells;Goals;Gonadal Steroid Hormones;granulosa cell;Health;Home;Human;Human BioMolecular Atlas Program;Human body;Image;implantation;In Situ;indexing;Informatics;Life;life span;Location;Longevity;Maintenance;Malignant Neoplasms;Mammalian Oviducts;Maps;Medical Records;Metadata;Methods;Modality;Molecular;molecular scale;mortality;natural Blastocyst Implantation;Oocytes;Organ;Ovary;Periodicity;Personal Satisfaction;Population;Procedures;Process;Production;Proteins;Protocols documentation;Records;Reproduction;reproductive;Reproductive Biology;reproductive organ;Resources;RNA;sample collection;Sampling;Scheme;single-cell RNA sequencing;Stromal Cells;Structure;structured data;theca cell;three-dimensional modeling;Time;Tissue Sample;Tissues;Uterus;Validation;Walking;Women&apos;s Health;Work,Penn TMC: Organ-Specific Project,104392,NA,NA,6540,S2,4,325243,194756,NA,519999
11187583,N02,EB,NA,N,NA,NA,NA,NA,75N92022D00010,NA,NA,75N92022D00010-P00002-759202300004-1,NIBIB:125000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,HADLEY,UNITED STATES,NA,02,110907578,US,10041458,VENTUREWELL,MA,010359462,NA,9140781 (contact),"NEAL, REBEKAH ANNE (contact)",NA,2023-06-01,2024-05-31,Acceleration;COVID-19 diagnostic;Diagnostic tests;FDA Emergency Use Authorization;programs;RADx;RADx Tech;research clinical testing;Services;United States National Institutes of Health,RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES -TASK ORDER 06,0,NA,NA,NA,NA,NA,NA,NA,125000,NA
11187657,U54,CA,3,N,2024-09-09,2024-09-01,2025-08-31,NA,U54CA163072,NA,PA-20-272,3U54CA163072-15S1,NCI:200000\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,NASHVILLE,UNITED STATES,NA,07,079917897,US,10040927,VANDERBILT UNIVERSITY MEDICAL CENTER,TN,372320011,NA,10618011 (contact),"WINKFIELD, KAREN MARIE (contact)","WALI, ANIL",2011-09-21,2026-08-31,NA,Cancer Outreach Core,163072,ZCA1,ZCA1(A1)-S,7323,S1,15,114286,85714,NA,200000
11187778,R01,GM,3,N,2024-09-10,2024-08-01,2025-07-31,859,R01GM144595,SCHOOLS OF ARTS AND SCIENCES,PA-20-185,3R01GM144595-03S2,NIGMS:99793\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,LA JOLLA,UNITED STATES,BIOLOGY,50,804355790,US,577507,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",CA,920930621,"Project Narrative Synthetic biology holds the promise of transforming the development of diagnostic and treatment strategies for various diseases. This project applies synthetic biology approaches to reprogram fate decisions toward progressive cellular deterioration, a key factor in many diseases, such as cancers, diabetes, and neurodegenerative diseases. Key insights obtained from this project will define foundations for chemical or gene- based strategies to treating diseases related to progressive cellular deterioration.",10634461 (contact);7622867;1897337;9749522,"HAO, NAN  (contact);HASTY, JEFF M;PILLUS, LORRAINE ;TSIMRING, LEV S","WANG, PEGGY",2022-09-20,2026-07-31,Abscisic Acid;Affect;Behavior;Biological Process;Cell Death;Cell Fate Control;cell injury;Cell Reprogramming;Cells;Cellular Morphology;Cessation of life;Chemicals;Complex;Computer Models;Core Protein;Coupled;Custom;Data;Deacetylase;Decision Making;design;Deterioration;Diabetes Mellitus;diagnostic development;diagnostic strategy;Disease;Dose;Doxycycline;Engineering;Eukaryota;experimental study;Foundations;gene conservation;Gene Expression;gene interaction;Genes;Genetic Engineering;Genetic Recombination;Genetic Transcription;Growth;Heme;improved;insight;Life;Lysine;Malignant Neoplasms;Mammals;Mediating;Microfluidics;Microscopy;Mitochondria;Mitotic;Modeling;models and simulation;Molecular;Mothers;Neurodegenerative Disorders;Organism;Pattern;Periodicals;Phenotype;Physiological;Play;Population;predictive modeling;Process;programs;promoter;protein expression;Proteins;Regulation;Research;Resources;Ribosomal DNA;Role;Saccharomyces cerevisiae;Saccharomycetales;Structure;synthetic biology;Synthetic Genes;System;Testing;Time;tool;treatment strategy;Yeasts,Reprogramming cell-fate decisions through predictive modeling and synthetic biology,144595,MABS,Modeling and Analysis of Biological Systems Study Section[MABS],NA,S2,3,63160,36633,99793,NA
11187792,R01,AI,7,N,2024-11-25,2024-11-01,2025-01-31,855,R01AI152068,NA,PA-24-254,7R01AI152068-05,NIAID:320400\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,DUARTE,UNITED STATES,NA,31,027176833,US,3058203,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,910103012,"T-cells are a type of white blood cell that are needed to fight infections and can be artificially programmed to destroy cancer cells in patients. The goal of this project is to define whether increasing the activity of the gene BCL11B will expedite recovery of T-cells after bone marrow transplantation and improve the ability of programmed T-cells to kill cancer cells. The potential benefit of the knowledge gained from this project is the development of new methods to improve the recovery of the immune system after bone marrow transplantation, and ways to more effectively program T-cells to fight cancer.",9835666 (contact),"PAREKH, CHINTAN  (contact)","PRABHUDAS, MERCY R",2021-02-11,2026-01-31,NA,BCL11B activation as an approach for enhancing the efficacy of immunotherapy,152068,TTT,"Transplantation, Tolerance, and Tumor Immunology Study Section[TTT]",NA,NA,5,180000,140400,320400,NA
11187801,P20,GM,2,N,2024-04-10,2024-05-01,2025-04-30,NA,P20GM113134,NA,PAR-23-063,2P20GM113134-06A1,NIGMS:273875\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,HONOLULU,UNITED STATES,NA,01,965088057,US,820005,UNIVERSITY OF HAWAII AT MANOA,HI,968222234,NA,12675880 (contact),"ORTEGA, MICHAEL A. (contact)","KOVBASNJUK, OLGA NIKOLAEVNA",2024-08-28,2029-04-30,Ablation;Address;Apoptosis Promoter;Autophagocytosis;Cells;Centers of Research Excellence;Chronic;Chronic Kidney Failure;Complication;Diabetic Nephropathy;Disease Management;Disease Progression;effectiveness evaluation;End stage renal failure;Fibroblast Growth Factor Receptors;Fibroblasts;Fibrosis;Functional disorder;Glucose;Hyperglycemia;Hypertension;I-kappa B Proteins;Impairment;improved;Inflammation;Kidney;kidney cell;Kidney Diseases;Molecular;Mus;NF-kappa B;NFKB Signaling Pathway;Non-Insulin-Dependent Diabetes Mellitus;Pathologic;podocyte;prevent;Renal function;Signal Transduction;systemic inflammatory response;therapeutic candidate;TNF gene;Tubular formation,Non-canonical NF-kB signaling in diabetic kidney disease,113134,ZGM1,Special Emphasis Panel[ZGM1 RCB-T (C2)],7961,A1,6,175000,98875,NA,273875
11187858,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000138,NA,NA,1ZIAAA000138-03,NIAAA:80796\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,78351012 (contact),"JOSEPH, PAULE  (contact)",NA,NA,NA,2019-nCoV;Address;Adult;Affect;Ageusia;Alcohol abuse;alcohol craving;alcohol use disorder;Alcohols;Altered Taste;analytical method;Anhedonia;Anosmia;anxiety symptoms;biobank;Biological;Biological Markers;Chemicals;Child;Clinical Protocols;cohort;Collaborations;Community Outreach;coping;cost effective;COVID-19;COVID-19 impact;COVID-19 pandemic;COVID-19 pandemic effects;COVID-19 patient;COVID-19 risk;COVID-19 stress;Data;depressive symptoms;design;drinking;Dysgeusia;Eating Behavior;Education;Esthesia;ethnic minority;exosome;experience;Extramural Activities;Family;Financial Hardship;follow-up;Food;Friends;Genetic;Grouping;Health;Health Personnel;high risk;home test;Household;hyposmia;Immune response;Impairment;Income;Individual;Infection;Inflammation;Institutional Review Boards;Interruption;Intervention;Irritants;Loneliness;Long COVID;Manuscripts;Measures;men;Mental Health;Minority Groups;Modeling;multimodality;nasal obstruction;National Institute on Alcohol Abuse and Alcoholism;Natural History;Neurologic Symptoms;neuromechanism;Neurons;Olfactory dysfunction;Outcome;Paraosmias;Participant;Patient Self-Report;Patients;perceived stress;Perception;Persons;Phenotype;physical conditioning;Post-Acute Sequelae of SARS-CoV-2 Infection;post-COVID-19;Prevalence;psychologic;Psychophysics;Public Health;Publishing;Quality of life;racial minority;Recording of previous events;Regression Analysis;Reporting;Research;Research Personnel;research study;Resolution;response;Risk;Role;SARS coronavirus;SARS-CoV-2 infection;Screening procedure;Sensory;Serology;Smell Perception;social;Standardization;stressor;Sum;Surveys;symptomatic improvement;Symptoms;System;Taste Perception;Testing;Time;Variant;Vulnerable Populations;Woman;Work;Writing,Chemosensation and COVID-19,138,NA,NA,NA,NA,3,NA,NA,80796,NA
11187859,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000281,NA,NA,1ZIAAA000281-35,NIAAA:505061\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,9413251 (contact),"GOLDMAN, DAVID  (contact)",NA,NA,NA,11p;Address;Age;Alaska Native;Alcohol abuse;alcohol consequences;alcohol risk;alcohol use disorder;Alcoholism;Alcohols;Alleles;American Indian community;American Indian Population;American Indian Tribe;American Indians;Antisocial Personality Disorder;Anxiety;Behavioral;Benign;binge drinker;binge drinking;biological adaptation to stress;Candidate Disease Gene;case control;Categories;Centromere;Characteristics;Child;Chromosomes;Clinical;Collaborations;Communities;comorbidity;Complex;Connecticut;Copy Number Polymorphism;Data;Data Linkages;Data Set;density;Development;Diagnosis;Disease;DNA sequencing;DRD2 gene;DRD4 gene;drinking;Electroencephalography;Elements;exome;exome sequencing;experience;Family;Female;follow-up;Frequencies;GABA Receptor;Galanin;gamma-Aminobutyric Acid;gene discovery;gene environment interaction;Genes;Genetic;genetic linkage;genetic linkage analysis;Genetic Variation;Genome Scan;genome wide association study;genome-wide;Genomics;Genotype;Haplotypes;heart rate variability;Heavy Drinking;Heterogeneity;Impulsivity;Indiana;Individual Differences;inter-individual variation;Intermediate Variables;Interview;Laboratories;Linkage Disequilibrium;Low Prevalence;male;Maps;Mediating;Meiosis;Mental disorders;Methaqualone;Morbidity - disease rate;mortality;Naltrexone;Native American population;Native Americans;Neuropsychology;Oklahoma;Pathology;Patients;Pattern;Pharmacogenetics;Phenotype;Population;Prevalence;psychiatric comorbidity;public database;rare variant;receptor;Receptor Gene;Reporting;Research Personnel;Rest;Risk;Robin bird;Role;Scanning;Schizophrenia;Sertraline;sexual trauma;Signal Transduction;SNP genotyping;social;Stress;Structure;Surveys;Symptoms;telomere;trait;Trauma;treatment response;Tribes;Universities;Variant;Violence;whole genome;Woman;Work,Genetic influences on alcohol use disorder in Native Americans,281,NA,NA,NA,NA,35,NA,NA,505061,NA
11187860,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000284,NA,NA,1ZIAAA000284-35,NIAAA:1918307\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,8175417 (contact),"KIM, HEE-YONG  (contact)",NA,NA,NA,Adhesions;Adult;Affect;Agrin;Albumins;Albuminuria;alcohol effect;AMPA Receptors;analog;Animals;Anti-Inflammatory Agents;Anxiety;anxiety reduction;anxiety-like behavior;arm;Behavior;behavior test;Binding;Biochemical;Biological;Biological Assay;Biological Process;Bioluminescence;blood-brain barrier function;Brain;Cell Membrane Structures;Cells;comparative;Cyclic AMP;cytokine;Development;disease model;Docosahexaenoic Acids;Energy Transfer;enteropeptidase;Epithelial Cells;Ethanol;Exhibits;exome sequencing;extracellular;Extravasation;Filtration;Foot Process;Frequencies;Functional disorder;G Protein-Coupled Receptor Signaling;G-Protein Signaling Pathway;G-Protein-Coupled Receptors;glomerular filtration;glomerular function;Goals;GTP-Binding Proteins;Hippocampus;Human;human induced pluripotent stem cells;Immunoprecipitation;Impairment;in vivo;induced pluripotent stem cell;Inflammation;Inflammatory;Inflammatory Response;Injections;Injury;Injury to Kidney;interdisciplinary approach;Interleukin-1 beta;Internal Ribosome Entry Site;Investigation;KDR gene;Kidney;Knock-in;Knock-in Mouse;Knockout Mice;Label;Learning;Ligands;lipid metabolism;Lipopolysaccharides;Mass Spectrum Analysis;Membrane;Memory;Metabolic;Metabolism;Modeling;Modernization;Modification;Molecular;Mouse Strains;Mus;Mutagenesis;mutant;Mutation;N-Methyl-D-Aspartate Receptors;Nervous System;neurite growth;neurodevelopment;neurogenesis;neuron development;neuronal survival;Neurons;neuroprotection;neurotransmission;NF-kappa B;novel;Nuclear Pore Complex;object recognition;Omega-3 Fatty Acids;Orphan;overexpression;Pathway Analysis;Peptides;Phenotype;Phosphorylation;Physiological;Play;podocyte;polyunsaturated fat;Polyunsaturated Fatty Acids;Process;Production;Protein Conformation;protein expression;protein protein interaction;Proteins;Proteinuria;Proteome;Radial;receptor;Receptor Activation;receptor function;Regulation;Renal function;Research;Resolution;Rodent Model;Role;Sampling;Schizophrenia;Signal Transduction;Site;sperm protein;Structure;Synapses;synaptogenesis;Techniques;Testing;Therapeutic;Time;Tissues;TNF gene;Transfection;Transmission Electron Microscopy;Tubular formation;urinary;Urine;Variant;Vascular Permeabilities;VEGFA gene;Western Blotting,Alterations In Lipid Metabolism In The Nervous System By Ethanol,284,NA,NA,NA,NA,35,NA,NA,1918307,NA
11187861,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000452,NA,NA,1ZIAAA000452-22,NIAAA:2373710\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,7858863 (contact),"VOGEL, STEVEN S (contact)",NA,NA,NA,Affinity;Anisotropy;Binding;Biological;biological systems;Biology;Biophotonics;Biosensor;Brain;Ca(2+)-Calmodulin Dependent Protein Kinase;Calcium;calcium-dependent protein kinase;calmodulin-dependent protein kinase II;Cells;Circular Dichroism;Collaborations;Comparative Study;Complex;cost;Coupling;Cyclic AMP;Dendritic Spines;dimer;Energy Transfer;Environment;Evolution;Fiber;Fiber Optics;Fluorescence;Fluorescence Anisotropy;Fluorescence Resonance Energy Transfer;Glutamates;Holoenzymes;Homo;Image;in vivo;instrumentation;interest;Internet;Kinetics;Laboratories;Ligand Binding;Ligands;Measurement;Measures;Methodology;Methods;Michigan;Microscopy;Molecular Conformation;Monitor;multimodality;Mus;Mutagenesis;National Institute of Child Health and Human Development;Organism;Phosphotransferases;Photometry;Photons;Physiological;protein protein interaction;Proteins;quantum;quantum computer;Quantum Mechanics;Site;Spectrum Analysis;Speed;Structure;Synapses;Temperature;Time;time use;Universities,FRET and Excitonic imaging of protein-protein interactions inside living cells,452,NA,NA,NA,NA,22,NA,NA,2373710,NA
11187862,ZIA,AA,1,N,NA,NA,NA,NA,ZIAAA000550,NA,NA,1ZIAAA000550-21,NIAAA:303674\NIDA:10898515\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,NA,NA,7674465 (contact),"VOLKOW, NORA D. (contact)",NA,NA,NA,actigraphy;Acute;addiction;Address;Adult;Affect;Affinity;aged;Alcohol dependence;alcohol exposure;Alcohols;Anesthesia procedures;Appearance;Attention;Attention deficit hyperactivity disorder;barrier to care;Behavior;behavior test;Behavioral;Binding;Brain;Buprenorphine;Carbon;carfentanil;Cerebrovascular Circulation;Chronic;Circadian Rhythms;Clinical Research;Cognitive;cognitive performance;Collaborations;Corpus striatum structure;Cross-Over Studies;Cyclic AMP;Data;Data Analytics;Development;Dopamine;Dopamine D1 Receptor;Dopamine D2 Receptor;dopamine system;Dorsal;Dose;Down-Regulation;Drug Addiction;drug reward;Drug usage;Eligibility Determination;Enrollment;Exhibits;experience;Female;Functional Magnetic Resonance Imaging;Goals;Heart Rate;heroin use;Hour;Human;Impairment;improved;Individual;Intervention;Investigation;Label;Lead;Light;light effects;Maintenance;Measures;medication for opioid use disorder;Methadone;Methods;MRI Scans;mu opioid receptors;multimodal neuroimaging;National Institute of Drug Abuse;National Institute of Mental Health;National Institute on Alcohol Abuse and Alcoholism;Neurobiology;neuropathology;opioid use disorder;Oral;Participant;Patients;PDE4B;Performance;Pharmaceutical Preparations;pharmacologic;Physiological;Placebo Control;Placebos;Play;Population;Positron-Emission Tomography;pre-clinical;Process;Protocols documentation;Proxy;radioligand;radiotracer;Rattus;receptor;Recording of previous events;Recovery;recruit;Reporting;Reproducibility;Research;response;Rest;Ritalin;Role;Scanning;screening;Signal Transduction;Single-Blind Study;Sleep;Sleep disturbances;Stimulant;Structure;Telephone;Testing;Thalamic structure;Time;tool;Tracer;trend;Up-Regulation;uptake;vapor;Ventral Striatum;Visual,Neurobiology of Drug Reward and Addiction,550,NA,NA,NA,NA,21,NA,NA,11202189,NA
11187863,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR027002,NA,NA,1ZIAAR027002-46,NIAMS:106278\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,6479838 (contact),"WINGFIELD, PAUL T (contact)",NA,NA,NA,Adopted;Anti-viral Agents;Antibodies;Archaea;Attention;Bacteria;Binding;Binding Sites;Biomedical Research;Capsid;carboxylate;Cells;Ceruloplasmin;Cessation of life;Clinical;Coupled;Cryoelectron Microscopy;design;diagnosis design;dimer;Drug Delivery Systems;Drug Targeting;Engineering;Environment;Ferritin;Geometry;Goals;Hepatitis B;Hepatitis B Therapy;Hepatitis B Virus;HIV;HIV-1;Human;human pathogen;In Vitro;interest;Intervention;Legal patent;Ligands;Liver diseases;macromolecular assembly;Macromolecular Complexes;Molecular;Molecular Conformation;Myxococcus xanthus;nano;Nature;Oxidative Stress;Peptides;Play;polypeptide;Population;promoter;Proteins;Reaction;Recombinants;Reporting;Research;Retroviridae;structural biology;System;Techniques;Vaccines;Viral;Virus;Virus Assembly;Virus Diseases;X-Ray Crystallography,Structural Biology Of Virus Assembly,27002,NA,NA,NA,NA,46,NA,NA,106278,NA
11187864,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041106,NA,NA,1ZIAAR041106-30,NIAMS:282598\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691690 (contact),"O'SHEA, JOHN  (contact)",NA,NA,NA,"2019-nCoV;Acceleration;Allergic;Alopecia Areata;Ankylosing spondylitis;antagonist;Arthritis;Atherosclerosis;Atopic Dermatitis;Autoimmune Diseases;autoimmune pathogenesis;Bacteria;Binding;cancer therapy;Cardiometabolic Disease;Cell Differentiation process;cell growth;cell type;Chronic Childhood Arthritis;clinical center;Clinical Trials;Collaborations;congenital immunodeficiency;Cooperative Research and Development Agreement;COVID-19;Crohn&apos;s disease;cytokine;cytokine release syndrome;Cytokine Signaling;Dermatomyositis;Development;Disease;Drug Utilization;Family;fungus;gain of function;Generations;Goals;graft vs host disease;Growth and Development function;Hematopoiesis;Host Defense;Human;IL7 gene;Immune;immune checkpoint blockade;immune modulating agents;Immune response;Immune System Diseases;Immunologic Deficiency Syndromes;improved;Inflammatory;Inflammatory Bowel Diseases;Inflammatory Response;inhibitor;insight;Interleukin 2 Receptor Gamma;Interleukin-15;Interleukin-2;interleukin-21;Interleukin-4;Interleukin-9;Janus kinase;Laboratories;Legal patent;Lupus;Lymphoid;Mediating;Metabolism;Modeling;Molecular;Mus;Mutation;Myeloproliferative disease;Myositis;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;new therapeutic target;Pathogenesis;Patients;Phosphotransferases;Pre-Clinical Model;Protein Secretion;Psoriasis;Psoriatic Arthritis;Receptor Activation;response;Rheumatoid Arthritis;risk variant;Series;Severe Combined Immunodeficiency;skin disorder;Spondylarthritis;STAT1 gene;STAT4 gene;STAT6 gene;Systemic Lupus Erythematosus;Testing;tissue repair;Tissues;Ulcerative Colitis;Variant;Viral;Virus;Virus Diseases;Vitiligo",Targeting Janus kinases in the treatment of autoimmune disease,41106,NA,NA,NA,NA,30,NA,NA,282598,NA
11187865,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041115,NA,NA,1ZIAAR041115-29,NIAMS:1594168\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,6479838 (contact),"WINGFIELD, PAUL T (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;Acquired Immunodeficiency Syndrome;Active Sites;Adenosine;Affinity;Alanine;Amino Acids;Aneuploidy;Antibodies;antibody libraries;Antineoplastic Agents;aptamer;Bacteria;Binding;Binding Proteins;Binding Sites;Biological;Biosynthetic Proteins;C-terminal;Cell Nucleus;Cells;chimeric antibody;Chromatids;Communities;Complex;conformer;Cryoelectron Microscopy;Cryptophycin;Crystallization;Cyclic Peptides;cytotoxicity;design;Dexamethasone;dimer;DNA;Drug Design;Electron Microscopy;Exhibits;flexibility;Genetic Transcription;Genome;Glycoside Hydrolases;Hela Cells;HIV;HIV-1;HIV-1 integrase;Human;Immunoglobulin Fragments;improved;In Vitro;Indomethacin;insight;interest;Label;Life Cycle Stages;Malignant Neoplasms;Maps;Melons;Methodological Studies;Methods;Microscopy;Modeling;Molecular;Molecular Conformation;Molecular Structure;Molecular Weight;Momordica charantia;Multidimensional NMR Techniques;Mutation;Nature;Nuclear Magnetic Resonance;Oryctolagus cuniculus;particle;Penetration;Peptides;Phage Display;Preparation;prevent;Process;Production;protein structure;Protein Synthesis Inhibition;Proteins;Publications;Publishing;Recombinant DNA;Research;Resolution;Response Elements;rev Protein;RNA;RNA Conformation;RNA Folding;RNA Sequences;Role;SARS-CoV-2 inhibitor;Shapes;stable isotope;Structure;synergism;System;targeted treatment;Techniques;Therapeutic Intervention;three dimensional structure;Translating;Tubulin;tumor;Tyrosine;Viral;viral DNA;viral RNA;Virus;Virus Inactivation;Virus Replication;Work;X ray diffraction analysis;X-Ray Crystallography,Production Of HIV And HIV Related Proteins For Structural Studies,41115,NA,NA,NA,NA,29,NA,NA,1594168,NA
11187866,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041116,NA,NA,1ZIAAR041116-29,NIAMS:425112\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,6479838 (contact),"WINGFIELD, PAUL T (contact)",NA,NA,NA,analytical ultracentrifugation;Antibodies;Binding;CD4 Antigens;Cell membrane;Cell surface;Cells;chemokine;Complex;Cryoelectron Microscopy;Crystallization;Detergents;Dissociation;Drug Screening;Drug Targeting;Engineering;Epitopes;Equilibrium;Fluorescence;Fluorescence Resonance Energy Transfer;Glycoproteins;gp160;high throughput screening;HIV;HIV Envelope Protein gp120;HIV Infections;improved;inhibitor;Libraries;Mediating;Membrane;Membrane Fusion;Membrane Glycoproteins;Membrane Potentials;Micelles;Modeling;Molecular;Molecular Conformation;monomer;Movement;Play;Process;receptor;Resolution;Role;sedimentation equilibrium;SIV;Solubility;Spectrum Analysis;Structure;System;Transmembrane Domain;Viral;Work,Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41,41116,NA,NA,NA,NA,29,NA,NA,425112,NA
11187867,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041159,NA,NA,1ZIAAR041159-17,NIAMS:2543374\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691690 (contact),"O'SHEA, JOHN  (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;adaptive immune response;Affect;Allergens;Allergic;Allergic Disease;Allergic inflammation;amino acid metabolism;Anaphylaxis;Architecture;Asthma;Atopic Dermatitis;Autoimmune;Autoimmune Diseases;autoimmune pathogenesis;Autoimmunity;autosome;Bacteria;Biochemical Pathway;Boundary Elements;Bromodomain;CD4 Positive T Lymphocytes;Cell Differentiation process;Cells;Central Nervous System;Chromatin;Chromatin Loop;cohesin;Collagen;Complex;cytokine;cytokine release syndrome;Cytokine Signaling;cytopenia;Cytoprotection;Development;Disabling;Disease;DNA-Binding Proteins;EGR2 gene;Enhancers;Epigenetic Process;epigenomics;Exhibits;Family;Fibroblasts;Fibrosis;Food Hypersensitivity;FRAP1 gene;Frequencies;Functional disorder;fungus;gain of function;gain of function mutation;Gastrointestinal Diseases;Gene Expression;Gene Expression Regulation;Generations;Genes;Genetic Transcription;genetic variant;Genome;Goals;Growth and Development function;Helper-Inducer T-Lymphocyte;Hematopoiesis;Hematopoietic;Heterozygote;Hi-C;Homeostasis;Host Defense;Human;human disease;Hypersensitivity;hypogammaglobulinemia;IgE;IL3 Gene;Immune;immune function;Immune response;Immunity;immunodeficiency;immunopathology;immunoregulation;Impaired wound healing;improved;In Situ;In Vitro;in vivo;Infection;infectious disease model;Inflammatory;Inflammatory Bowel Diseases;Inflammatory Response;Inheritance Patterns;Innate Immune Response;insight;Interferon Type II;Interleukin-10;Interleukin-13;interleukin-22;Interleukin-6;Investigation;Janus kinase;Knockout Mice;Lead;Link;loss of function;loss of function mutation;Lymphocyte;Lymphocytic choriomeningitis virus;Lymphoid;mathematical model;Mediating;Mediator;Metabolic;Metabolism;Modification;Molecular;Morphea;mortality;multiple sclerosis patient;Mus;Mutation;Myelin;Myeloid Cells;Natural Killer Cells;neuroinflammation;new therapeutic target;Parasitic infection;pathogen;Pathogenesis;Pathogenicity;Pathology;Pathway interactions;Patients;Peptidoglycan;Peripheral;Phenotype;phosphatidylinositol 3-kinase gamma;Phosphorylation;Phosphotransferases;Play;Population;Predisposition;Process;Production;progenitor;programs;promoter;Proprotein Convertases;Protein Secretion;Proteins;Proto-Oncogene Proteins c-akt;Psoriasis;rare variant;recruit;Regulation;Regulatory Element;response;restraint;Rheumatoid Arthritis;Role;Scleroderma;sensor;Signal Transduction;Skin;Squamous cell carcinoma;STAT protein;STAT1 gene;STAT4 gene;Stat5 protein;STAT6 Transcription Factor;Subtilisins;Systemic Lupus Erythematosus;T cell differentiation;T-Lymphocyte;Th1 Cells;Therapeutic;tissue repair;Tissues;Toxoplasmosis;transcription factor;transcriptome;Transforming Growth Factor beta;Variant;Viral;Viral Load result;Virus;Virus Diseases;Work;wound healing,"Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases",41159,NA,NA,NA,NA,17,NA,NA,2543374,NA
11187868,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041171,NA,NA,1ZIAAR041171-17,NIAMS:149774\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691698 (contact),"MORASSO, MARIA  (contact)",NA,NA,NA,Abscess;Adult;Amelogenesis;Amino Acids;appendage;autosomal dominant mutation;Child;cohort;Defect;Dental caries;Dental Caries Susceptibility;Dental Enamel;Dentin;Development;Ectodermal Dysplasia;Epithelium;Genes;Genetic Polymorphism;Genetic Transcription;Hair;Hair Diseases;Hardness;Homeodomain Proteins;Infection;Keratin;keratinocyte;Knock-in Mouse;Linear Regressions;Loose anagen hair syndrome;mineralization;Mutation;Pathway interactions;Play;Predisposition;Process;Proteins;Regression Analysis;Regulation;Research;Rod;Role;Study models;Tooth structure,Ectodermal Dysplasias and Regulation of Ectodermal Appendage Development,41171,NA,NA,NA,NA,17,NA,NA,149774,NA
11187869,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041184,NA,NA,1ZIAAR041184-16,NIAMS:3467040\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,10269396 (contact),"COLBERT, ROBERT  (contact)",NA,NA,NA,Acceleration;Adolescent;Adult;Affect;Animal Model;Ankylosing spondylitis;Ankylosis;Back Pain;Bone Marrow;Cells;Child;Childhood;Chronic;Chronic Childhood Arthritis;Classification;Clinical;Colonic inflammation;cytokine;de novo mutation;Diagnosis;Disease;disease phenotype;early onset;Early treatment;Edema;Enthesitis-Related Arthritis;Exhibits;exome;Genetic;genetic variant;genome sequencing;Goals;HLA-B Antigens;IL17 gene;Image;improved;Inflammation;Inflammatory;Institution;interleukin-23;joint inflammation;Joints;Laboratories;Lesion;Link;Magnetic Resonance Imaging;Mediating;Mesenchymal;mineralization;Modeling;Morbidity - disease rate;Onset of illness;Osteoblasts;Osteogenesis;osteogenic;Osteomyelitis;Outcome;overexpression;Participant;Pathogenesis;Pathogenicity;Pathway interactions;patient derived induced pluripotent stem cells;Patients;Physicians;Population;Production;Proteins;Rattus;Reporting;research study;response;Role;Sacroiliac joint structure;Specificity;Spondylarthritis;stem cell differentiation;Susceptibility Gene;Symptoms;System;T-Lymphocyte;targeted treatment;transcription factor CHOP;Variant;Vertebral column;Work;Youth,Pathogenic Mechanisms in Spondyloarthritis,41184,NA,NA,NA,NA,16,NA,NA,3467040,NA
11187870,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041204,NA,NA,1ZIAAR041204-10,NIAMS:2975025\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,14282196 (contact),"GRAYSON, PETER  (contact)",NA,NA,NA,"Adult;aged;ANCA vasculitis;Aortitis;Area;Arteries;Autoimmune Diseases;autoinflammatory;biobank;Biological Markers;Biological Specimen Banks;biomarker development;biomarker discovery;Blood Vessels;Bone Marrow;Bone Marrow Transplantation;cartilaginous;chest computed tomography;Chronic Disease;Classification;Clinical;Clinical assessments;clinical care;clinical center;clinical heterogeneity;clinical outcome measures;clinical remission;Clinical Research;Clinical Trials;Clinical Trials Database;cohort;Collaborations;Communication;Complex;COVID-19 impact;Data;Data Collection;data standards;Dedications;design;Development;Diagnosis;diagnostic algorithm;Diagnostic tests;disability;Disease;disease heterogeneity;Disease Management;disease natural history;Disease Progression;Ear;Enzymes;epidemiology study;Ethics;Etiology;Evaluation;Extramural Activities;fluorodeoxyglucose positron emission tomography;Foundations;Future;Genetic;genetic variant;Germ-Line Mutation;Goals;Health behavior;Hearing Tests;Hematology;Image;imaging biomarker;Immune response;Immunologics;indexing;Inflammation;inflammatory marker;Intramural Research;Joints;Laboratories;Laryngoscopy;Lead;Lesion;Life;Light;Link;Magnetic Resonance Imaging;Methods;Molecular;molecular imaging;Monitor;Morbidity - disease rate;mortality;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;Neck;next generation sequencing;North America;Nose;novel;novel marker;observational cohort study;Organ;Oscillometry;Outcome;pandemic disease;pandemic impact;Pathogenesis;patient advocacy group;patient oriented;Patient Selection;patient subsets;Patients;Pattern;personalized medicine;Physical Examination;Physicians;Positron-Emission Tomography;predict clinical outcome;Prediction of Response to Therapy;Prognostic Factor;programs;prospective;Protocols documentation;Publishing;Pulmonary function tests;radiological imaging;Radiology Specialty;randomized, clinical trials;Recording of previous events;recruit;Relapse;Relapsing polychondritis;Reporting;Research;research clinical testing;Research Design;Research Personnel;Rheumatism;Role;Sampling;SARS-CoV-2 exposure;Shapes;Somatic Mutation;Source;standard of care;Steroids;Structure;Surveys;Syndrome;System;Systemic disease;Takayasu&apos;s Arteritis;Temporal Arteritis;therapeutic evaluation;Time;Tissues;Tracheostomy procedure;translational medicine;Translational Research;translational research program;Treatment Efficacy;trial design;United States National Institutes of Health;Vacuole;vascular inflammation;Vasculitis;Work",Vasculitis and Translational Medicine,41204,NA,NA,NA,NA,10,NA,NA,2975025,NA
11187871,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041209,NA,NA,1ZIAAR041209-06,NIAMS:955026\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,16180196 (contact),"GOURH, PRAVITT  (contact)",NA,NA,NA,2019-nCoV;admixture mapping;Affect;African;African American;African American population;African ancestry;Alleles;American;Amino Acids;angiogenesis;Antigen Presentation;Antigens;Antinuclear Antibodies;Autoantibodies;Autoantigens;Autoimmunity;Biological Markers;Blood Vessels;burden of illness;Calcinosis;Calcium;Chronic;Clinical;clinical phenotype;Code;cohort;Collaborations;Collection;Complication;conditioning;Cutaneous;cytokine;Cytokine Signaling;Data;Deposition;Dermis;Development;Dideoxy Chain Termination DNA Sequencing;Diffuse;Disease;disorder risk;DNA;Endothelium;Enrollment;epithelial to mesenchymal transition;European;exome;exome sequencing;Exons;Family;FDA approved;Fibrosis;Frequencies;GDF9 gene;Gene Expression Regulation;Gene Proteins;Genes;Genetic;genetic risk factor;Genetic study;genetic testing;Genome;genome wide association study;genome-wide;Genotype;Goals;health disparity;High Prevalence;HLA Antigens;HLA-DPB1 gene;Inflammation;Inflammatory;inhibitor therapy;inorganic phosphate;insight;Interleukin-1;interleukin-1 receptor accessory protein;Interleukin-1 Receptors;Interleukin-13;Ligands;loss of function;Lung;Mediating;Mesenchymal;Metabolism;MicroRNAs;Molecular;Molecular Mimicry;Morbidity - disease rate;mortality;mouse model;multi-ethnic;National Human Genome Research Institute;NOTCH4 gene;novel;Organ;overexpression;Pathogenesis;Pathway interactions;Patients;Phase;Play;Population;Predisposition;protective effect;Proteins;Quality Control;Quality of life;rare variant;receptor;Regression Analysis;Reporting;Research;Rheumatism;Risk;Risk Factors;risk variant;Role;Sampling;Scleroderma;Sequence Analysis;Signal Transduction;Single Nucleotide Polymorphism;Skin;skin fibrosis;Subcutaneous Tissue;Susceptibility Gene;System;Systemic Scleroderma;T cell receptor repertoire sequencing;T-cell receptor repertoire;targeted treatment;Technology;Testing;TGFB3 gene;Time;Transcriptional Regulation;Underserved Population;United States National Institutes of Health;Untranslated Regions;Variant;Vascular Diseases;Work,Genetics and Pathogenesis of Scleroderma,41209,NA,NA,NA,NA,6,NA,NA,955026,NA
11187872,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041212,NA,NA,1ZIAAR041212-04,NIAMS:299397\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,12449971 (contact),"KAPLAN, MARIANA  (contact)",NA,NA,NA,ANCA vasculitis;Autoantibodies;Autoimmune Diseases;Autoimmune Responses;Autoimmunity;Blood Vessels;Chronic;Clinical;COVID-19;COVID-19 vaccine;Diagnosis;Exposure to;Idiopathic Inflammatory Myopathies;Immune;immunoregulation;Individual;Infection;Inflammation;Inflammatory Response;Kidney Diseases;Mediating;multiple omics;pandemic disease;participant enrollment;Patients;Phenotype;response;Rheumatoid Arthritis;SARS-CoV-2 exposure;SARS-CoV-2 infection;Scleroderma;Sjogren&apos;s Syndrome;Statistical Data Interpretation;systemic autoimmunity;Systemic Lupus Erythematosus;Vaccination;Vaccines;Visit,Modulation of chronic inflammatory responses by COVID19,41212,NA,NA,NA,NA,4,NA,NA,299397,NA
11187873,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041213,NA,NA,1ZIAAR041213-05,NIAMS:954719\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,77865659 (contact),"FRANCO, LUIS  (contact)",NA,NA,NA,Affect;Anti-Inflammatory Agents;Cell Line;cell type;Cells;Clinical;clinical effect;Collaborations;Data;Development;Disease;drug action;drug discovery;Drug Prescriptions;experimental study;Extramural Activities;Flow Cytometry;follow-up;functional genomics;Gene Expression;Genetic Transcription;Genomic approach;Genomics;Glucocorticoids;Goals;healthy volunteer;high throughput screening;Homeostasis;Human;Immune;Immune system;Immunosuppression;In Vitro;in vivo;Individual;Kinetics;Knowledge;Laboratories;Macaca fascicularis;Macaca mulatta;Medicine;Methodology;Methods;Methylprednisolone;migration;Molecular;nanobodies;National Institute of Allergy and Infectious Disease;neutrophil;Pattern;peripheral blood;PET/CT scan;Pharmaceutical Preparations;Physiological;Population;programs;Publishing;Repression;Research;response;RNA;Sampling;Series;side effect;Signal Pathway;single molecule;System;Technology;Testing;Tissues;transcriptome sequencing;Translational Research;Translations;United States National Institutes of Health;Work;X-Ray Computed Tomography,Integrative genomic analysis of the human response to glucocorticoids,41213,NA,NA,NA,NA,5,NA,NA,954719,NA
11187874,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041214,NA,NA,1ZIAAR041214-04,NIAMS:807997\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78385760 (contact),"LEWANDOWSKI, LAURA  (contact)",NA,NA,NA,"Acceleration;Adult;Affect;Age;age group;Autoimmune Diseases;Bioinformatics;Biological;Biological Process;causal variant;Childhood;Clinical;clinical phenotype;cohort;Collaborations;Complex;Country;Data;Data Analyses;Data Set;Disease;DNA Repair Gene;early onset;Equilibrium;European ancestry;Event;exome sequencing;Family;Foundations;Functional disorder;Gene Cluster;Gene Expression;Genes;Genetic;genetic analysis;genetic architecture;genetic association;Genetic Risk;Genetic Structures;Genetic study;genetic variant;Genome;genome sequencing;genome wide association study;genome-wide;genomic data;Goals;health disparity;Heritability;human disease;Individual;insight;Interferons;International;Investigation;Life;Link;Lupus;Methodology;Molecular Diagnosis;molecular phenotype;Movement;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;Nephritis;next generation sequencing;novel;Onset of illness;Parents;participant enrollment;Pathogenesis;Pathway Analysis;Pathway interactions;Patient Selection;patient stratification;Patients;Phenotype;polygenic risk score;Population;Population Heterogeneity;Predisposition;Process;protein function;Proteins;Protocols documentation;rare variant;Reporting;Research;Research Personnel;Risk;risk variant;RNA Processing;Role;Sampling;Severity of illness;Siblings;Single Nucleotide Polymorphism;Site;Susceptibility Gene;System;Systemic Lupus Erythematosus;targeted treatment;Testing;tool;transmission process;Twin Multiple Birth;Validation;Variant;variant of interest;whole genome",Genetics and pathophysiology of systemic lupus erythematosus in global populations,41214,NA,NA,NA,NA,4,NA,NA,807997,NA
11187875,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041218,NA,NA,1ZIAAR041218-03,NCI:21825\NIAMS:336337\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867459 (contact),"KONG, HEIDI  (contact)",NA,NA,NA,Adverse reactions;Alopecia;Autoimmune Diseases;Bacterial Infections;Chronic;clinical center;Collaborations;Communities;congenital immunodeficiency;Cutaneous;Disease;DOCK8 deficiency;Doxycycline;Drug Hypersensitivity;Eczema;Evaluation;GATA2 deficiency;Goals;Hematopoietic Stem Cell Transplantation;Hereditary Disease;Hereditary Leiomyomatosis and Renal Cell Cancer;Hereditary Malignant Neoplasm;Immune system;improved;Individual;Infection;Inflammatory;Ingestion;insight;interest;Intervention;Intramural Research Program;Investigation;Investigational Therapies;Lesion;Malignant Neoplasms;Methods;microbiome;Mycoses;Natural History;Omenn syndrome;Oncology;Pathogenesis;patient population;Patients;Phototoxicity;Polyglandular Autoimmune Syndrome Type I;Research;Research Personnel;Skin;skin disorder;skin lesion;Syndrome;targeted treatment;Therapeutic Intervention;Toxic effect;United States National Institutes of Health;Viral;WHIM syndrome;Work,Investigation of the natural history and pathogenesis of skin diseases,41218,NA,NA,NA,NA,3,NA,NA,358162,NA
11187876,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041219,NA,NA,1ZIAAR041219-03,NCI:140904\NIAMS:1233233\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867459 (contact),"KONG, HEIDI  (contact)",NA,NA,NA,Adult;Affect;Atopic Dermatitis;Autoimmune Diseases;autosome;Bacteria;Child;Collaborations;Communities;congenital immunodeficiency;Disease;DOCK8 deficiency;fungus;Genome;genome sequencing;Genomic approach;Goals;Health;Human;Human body;Human Microbiome;human microbiota;Human Papillomavirus;Hyper-IgE Syndrome;Immunologic Deficiency Syndromes;improved;Individual;Infectious Skin Diseases;Inflammatory;interest;Intervention;Malignant Neoplasms;Merkel Cells;metagenomic sequencing;Microbe;microbial;microbial community;microbiota;Nursing Homes;Omenn syndrome;Patients;Phase;Polyglandular Autoimmune Syndrome Type I;Polyomavirus;Population;Publishing;Research Personnel;Role;Shotguns;Skin;skin disorder;skin microbiome;Technology;United States National Institutes of Health;Virus;WHIM syndrome;whole genome,Studies of human microbes and potential perturbations,41219,NA,NA,NA,NA,3,NA,NA,1374137,NA
11187877,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041220,NA,NA,1ZIAAR041220-03,NCI:51596\NIAMS:336337\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867459 (contact),"KONG, HEIDI  (contact)",NA,NA,NA,antiretroviral therapy;Clinical;Collaborations;comorbidity;Complex;Data;Disease;Goals;HIV;HIV Infections;host microbiota;Human Microbiome;Immune system;Immune System Diseases;Immunity;Individual;Inflammation;Inflammatory;microbial;microbiome;microbiome sequencing;Monitor;Opportunistic Infections;Persons;Predisposition;Research Proposals;Skin;Viral Load result,Investigating the microbiome in persons living with HIV,41220,NA,NA,NA,NA,3,NA,NA,387933,NA
11187878,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041221,NA,NA,1ZIAAR041221-03,NCI:323380\NIAMS:423633\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867464 (contact),"BROWNELL, ISAAC  (contact)",NA,NA,NA,Afferent Neurons;ATAC-seq;Blood Vessels;cell behavior;Cell Differentiation process;Cell Lineage;Development;differentiation in vitro;Embryo;Environment;experimental study;Genetic Transcription;Hair follicle structure;interest;intraepithelial;Maintenance;Merkel cell carcinoma;Merkel Cells;Modeling;mouse genetics;Mus;Neurosecretory Systems;novel;perineural;Process;Regulation;Sensory;Signal Transduction;single-cell RNA sequencing;Skin;stem cell population;stem cells;Touch sensation;Work,Development and regulation of stem cell lineages in skin,41221,NA,NA,NA,NA,3,NA,NA,747013,NA
11187879,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041222,NA,NA,1ZIAAR041222-03,NCI:428859\NIAMS:564844\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867464 (contact),"BROWNELL, ISAAC  (contact)",NA,NA,NA,Animal Model;Biological Markers;Cancer cell line;Cancer Etiology;Cell Culture Techniques;Cell Line;Cell Therapy;cell transformation;Cells;Characteristics;Chromosome abnormality;Chronic Lymphocytic Leukemia;clinical biomarkers;Clinical Protocols;Data;data registry;Development;Diagnosis;Diagnostic;Disease;Disease Progression;Epigenetic Process;Gene Expression Profiling;Gene Mutation;Genetic;genetic manipulation;genetic risk factor;genome-wide;Goals;High-Risk Cancer;HIV Infections;Human;Human Cell Line;Immune response;Immune system;immunogenic;In Vitro;in vivo;Infection;innovation;knock-down;Maintenance;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Merkel cell carcinoma;Merkel Cells;Modification;Molecular;Molecular Analysis;mouse model;Mus;Mutation;neoplasm registry;Neuroendocrine Cell;novel;Oncogenic;Outcome;Pathogenesis;Pathway interactions;Patients;Polyomavirus;Polyomavirus Transforming Antigens;Population;pre-clinical;preclinical development;prevent;prognostic;response;Risk;Risk Factors;Sampling;Skin;Skin Cancer;small molecule;T-Lymphocyte;Testing;therapeutic target;tumor;Tumor Cell Line;Virus;Work;Xenograft procedure,Molecular pathogenesis and therapy innovation for Merkel cell carcinoma,41222,NA,NA,NA,NA,3,NA,NA,993703,NA
11187880,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041223,NA,NA,1ZIAAR041223-03,NCI:217899\NIAMS:282422\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867464 (contact),"BROWNELL, ISAAC  (contact)",NA,NA,NA,Adjuvant Therapy;Alternative Therapies;anti-PD-L1 antibodies;anti-tumor immune response;Biological Assay;Biological Markers;Blood;cancer immunotherapy;cancer therapy;Chronic Lymphocytic Leukemia;Clinical Research;Clinical Treatment;Clinical Trials;Clinical Trials Design;Diagnosis;Disease;Enrollment;Goals;HIV Infections;Immune response;Immune system;Immunotherapy;improved;Institution;interest;Malignant - descriptor;Merkel cell carcinoma;microbiome;Neuroendocrine Cell;open label;Operative Surgical Procedures;Participant;participant enrollment;Patients;Pharmaceutical Preparations;phase 2 study;Protocols documentation;Radiation;Rare Diseases;response;Risk Factors;Sampling;Seminal;Site;Skin;small molecule;Specimen;Testing;therapy resistant;tumor;United States National Institutes of Health,Clinical treatment of advanced Merkel cell carcinoma,41223,NA,NA,NA,NA,3,NA,NA,500321,NA
11187881,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041224,NA,NA,1ZIAAR041224-03,NCI:112420\NIAMS:141211\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78867464 (contact),"BROWNELL, ISAAC  (contact)",NA,NA,NA,Adverse event;Antineoplastic Agents;Cancer Center;cancer immunotherapy;cancer therapy;Chimeric Proteins;Clinical;clinical center;Clinical Management;Collaborations;Complex;Cutaneous;Diagnosis;diagnostic biomarker;Functional disorder;Health;Health Sciences;immune-related adverse events;Immunooncology;Immunosuppression;Inflammatory;interest;Investigation;Malignant Neoplasms;Medical center;melanoma biomarkers;Military Personnel;novel;novel therapeutic intervention;oncology program;Organ;Pathology;Patients;predictive marker;prevent;Prognostic Marker;proteogenomics;Research Personnel;Running;Sebaceous Adenocarcinoma;Skin;Skin Cancer;Skin Carcinoma;skin disorder;Skin Neoplasms;United States National Institutes of Health;University Health Services,Investigation of skin cancer and skin disease,41224,NA,NA,NA,NA,3,NA,NA,253631,NA
11187882,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041226,NA,NA,1ZIAAR041226-03,NCI:1224551\NIAMS:3700955\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78879683 (contact),"NAGAO, KEISUKE  (contact)",NA,NA,NA,"Allergens;Alopecia;Atopic Dermatitis;Bacterial Infections;Bilateral;Biology;cell type;Cells;chemokine;Clinical;clinically relevant;commensal bacteria;Communication;Communities;Complex;congenital immunodeficiency;Corynebacterium;Cutaneous;cytokine;Degos disease;Disease;Drug Hypersensitivity;dysbiosis;Eczema;Ensure;Epidermal Growth Factor Receptor;Epidermis;Epithelium;Exhibits;Exposure to;Extracellular Matrix;Fibroblasts;Foundations;Functional disorder;Hair follicle structure;Homeostasis;host-microbe interactions;Human;Hyaluronic Acid;Immune;Immune system;Immunity;immunological status;Immunologics;Impairment;Inflammation;Inflammatory;Insulin-Like Growth Factor I;Interferon Type I;Invaded;Investments;keratinocyte;Knowledge;Laboratories;Langerhans cell;Leukocytes;Lymphoid Cell;Macrophage;Malignant - descriptor;Mechanical Stress;Mediating;Metalloproteases;Microbe;microbial;microbial host;microbiome;Modeling;mouse model;Mus;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Neurons;notch protein;novel;Organ;Pathologic;Pathway interactions;Poly I-C;Population;Predisposition;pressure;Process;Protocols documentation;Psoriasis;Publishing;receptor;Receptor Signaling;recruit;repaired;Role;Sebaceous Glands;Signal Transduction;Site;Skin;skin disorder;skin microbiome;Sorting;Staphylococcus aureus;Staphylococcus aureus infection;stem cells;Stimulus;Structure;Subcutaneous Tissue;Sunlight;Surface;Symbiosis;T memory cell;Techniques;Tissues;Toxin;transcriptomics",Exploring mechanisms that govern immune homeostasis in skin,41226,NA,NA,NA,NA,3,NA,NA,4925506,NA
11187883,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041227,NA,NA,1ZIAAR041227-03,NCI:272097\NIAMS:84624\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78847857 (contact),"COWEN, EDWARD  (contact)",NA,NA,NA,Annual Reports;Bibliography;Biology;Book Chapters;CCR;Cell Therapy;chronic graft versus host disease;Clinical;clinical outcome assessment;Clinical Trials;Collaborations;Consensus;Cutaneous;Educational workshop;Extramural Activities;genetic signature;Immunologics;immunoreaction;Immunotherapy;innovation;International;Laboratories;multidisciplinary;novel;Outcome Measure;Paper;Patient Outcomes Assessments;Patients;Phenotype;Photography;Skin;skin biopsy;Specimen;Systemic disease;United States National Institutes of Health;Universities,Chronic graft-versus-host disease,41227,NA,NA,NA,NA,3,NA,NA,356721,NA
11187884,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041229,NA,NA,1ZIAAR041229-03,NCI:791803\NIAMS:253872\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78847857 (contact),"COWEN, EDWARD  (contact)",NA,NA,NA,"Annual Reports;Attention;Benign;cancer risk;Clinical;clinical care;Clinical Protocols;Collaborations;Consult;Consultations;Cutaneous;Dermatology;Disease;Event;Exposure to;Genotype;Histologic;Link;Medical Students;Nail plate;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;news;novel;Nurse Practitioners;Phenotype;Physician Assistants;Predisposition;Protocols documentation;Publications;rare condition;Reporting;research clinical testing;Services;Skin;skin disorder;Sweet&apos;s Syndrome;Syndrome;tumor;Visit",Dermatology Consultation Service,41229,NA,NA,NA,NA,3,NA,NA,1045675,NA
11187885,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041230,NA,NA,1ZIAAR041230-03,NIAMS:886603\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78871680 (contact),"MORRISON, TASHA  (contact)",NA,NA,NA,Ablation;Antigens;Architecture;Binding;Bone Marrow;cancer cell;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Death Induction;Cell Maintenance;Cell membrane;cell motility;Cell Physiology;Cell surface;Cell Survival;Cells;Cellular biology;Cellular Structures;Ceramide glucosyltransferase;chemokine receptor;ChIP-seq;Chromatin;Classification;Code;Complex;CRISPR/Cas technology;cytokine;Cytokine Receptors;Cytomegalovirus Infections;Cytoplasmic Granules;cytotoxic;Data;Development;Drug usage;Enhancers;Enzymes;EP300 gene;epigenomics;Excision;Flow Cytometry;Frequencies;Gene Expression;Genes;Genetic Transcription;Genome;Genomics;Glycosphingolipids;glycosylation;Goals;Hematopoietic;Hematopoietic stem cells;High-Throughput Nucleotide Sequencing;Image;Immune;Immune response;Impairment;Infection;Infiltration;interest;Knockout Mice;Length;Link;lipidomics;Location;Lymphocyte;Lymphoid Cell;Lymphoid Tissue;Malignant Neoplasms;Membrane Microdomains;Memory;Microscopy;Mobility decline;Modeling;Molecular;mouse model;Murid herpesvirus 1;Mus;Myocardial Ischemia;Natural Killer Cells;novel;Pattern;Play;Process;progenitor;Proteins;Publishing;Repression;Research;response;RNA Polymerase II;Role;Secondary to;Signal Transduction;Site;Spleen;stem cells;symptomatic improvement;T-Lymphocyte;trafficking;Transcript;Transcription Coactivator;transcription factor;transcriptome sequencing;tumor;Untranslated RNA;Up-Regulation;Viral;Work,Lymphocyte signaling and immune cell response,41230,NA,NA,NA,NA,3,NA,NA,886603,NA
11187886,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041231,NA,NA,1ZIAAR041231-03,NIAMS:443989\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78871682 (contact),"CHISOLM, DANIELLE  (contact)",NA,NA,NA,asthma model;CD4 Positive T Lymphocytes;Cell Differentiation process;Cells;Chromatin;cytotoxic;Data;Data Set;Development;Environment;Exposure to;GATA3 gene;Gene Expression Regulation;Genes;Goals;Immune;In Vitro;Inflammatory;insight;Lymphocyte Subset;Modeling;Molecular;mouse model;muscle progenitor cell;next generation sequencing;novel;Nuclear;pathogen;peripheral lymphoid organ;Play;programs;Role;single cell sequencing;single cell technology;Specific qualifier value;T cell differentiation;T-Cell Development;T-Lymphocyte;Technology;Th2 Cells;Thymus Gland;transcription factor;Transcriptional Regulation,Defining the role of Paxbp1 in T cell development and T helper specification,41231,NA,NA,NA,NA,3,NA,NA,443989,NA
11187887,ZIA,AR,1,N,NA,NA,NA,NA,ZIAAR041234,NA,NA,1ZIAAR041234-02,NIAMS:336337\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,79971538 (contact),"CASTELO-SOCCIO, LESLIE  (contact)",NA,NA,NA,Adult;Alopecia;Biological;Characteristics;Childhood;Clinical;clinical phenotype;cohort;Etiology;Gene Expression;Genetic;Goals;Hair;Immune;Immunologics;Immunology;improved;Individual;interest;Interruption;Mediating;microbiome;Natural History;Pathogenesis;Patient-Focused Outcomes;Patients;Production;Skin;Systemic disease;Treatment outcome;treatment response,"Natural history, pathogenesis, and treatment of alopecia",41234,NA,NA,NA,NA,2,NA,NA,336337,NA
11187888,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC004517,NA,NA,1ZIABC004517-48,NCI:1099456\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568851 (contact),"KRAEMER, KENNETH H (contact)",NA,NA,NA,20 year old;Adult;Affect;Age;Alleles;Autopsy;Big Data;Blood specimen;BRAF gene;brain size;cancer prevention;cancer risk;Cataract;Cessation of life;Child;Clinical;Cockayne Syndrome;cohort;Collaborations;Data Analyses;Databases;Defect;Development;Disease;Disseminated Malignant Neoplasm;Division of Cancer Epidemiology and Genetics;DNA;DNA Repair;DNA Repair Gene;Doctor of Medicine;ERCC1 gene;ERCC3 gene;Eye Abnormalities;Family member;femur head;Fetal Development;Follow-Up Studies;Frequencies;Functional disorder;Gene Modified;gene repair;General Population;Genes;Genetic Diseases;Genetic Transcription;Goals;Gynecologic;Hair;Health;hearing impairment;Hematologic Neoplasms;Heterogeneity;Histologic;Human;Human Development;Hypersensitivity;Immune checkpoint inhibitor;infancy;Infant;insight;Investigation;Italy;Laboratories;Link;Longterm Follow-up;Malignant neoplasm of pancreas;Malignant Neoplasms;Melanoma;member;Messenger RNA;Methods;Molecular;Mothers;Mutation;Natural History;Necrosis;Nerve Degeneration;Nevi and Melanomas;Nucleotide Excision Repair;offspring;Operative Surgical Procedures;Patients;Peripheral Nervous System Diseases;Phenotype;Physicians;Point Mutation;Polymerase;Postoperative Complications;Predisposition;Pregnancy;Pregnancy Complications;Premature aging syndrome;Premature Menopause;Process;Protocols documentation;PTEN gene;Publishing;Rare Diseases;rare genetic disorder;Reporting;Research;response;Risk;RNA Splicing;Role;Series;side effect;Skin;Skin Cancer;Skin Carcinoma;Study Subject;Sun Exposure;Surveys;Thyroid Nodule;Translational Research;Trichothiodystrophy;Tumor Suppressor Genes;Ultraviolet Rays;United States National Institutes of Health;Variant;Walking;Woman;Xeroderma Pigmentosum;XPA gene,DNA Repair in Human Cancer-Prone Genetic Diseases,4517,NA,NA,NA,NA,48,NA,NA,1099456,NA
11187889,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005450,NA,NA,1ZIABC005450-41,NCI:1912649\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777551 (contact),"HAGER, GORDON L (contact)",NA,NA,NA,3-Dimensional;Architecture;Biological Models;Bromodomain;Bromodomains and extra-terminal domain inhibitor;cancer therapy;carcinogenesis;Cell Nucleus;ChIP-seq;Chromatin;Chromatin Loop;chromatin modification;Chromatin Structure;Chromosome Territory;cohesin;Complex;Disease;DNA;Elasticity;Enhancers;Environment;Epigenetic Process;Gene Activation;Gene Expression;Gene Expression Regulation;gene repression;Genes;Genetic Transcription;Genome;genome-wide;Glucocorticoid Receptor;glucose metabolism;Growth;Heterogeneity;Human Genome;Impairment;In Vitro;in vivo;induced pluripotent stem cell;interest;knock-down;Ligands;Link;Lung;lung cancer cell;Malignant neoplasm of lung;Mediator;methylome;Modeling;Modification;Neurosecretory Systems;NFIC gene;novel;Nuclear;Nuclear Receptors;Pathway interactions;patient derived xenograft model;prevent;Process;promoter;Promoter Regions;Property;Protein Family;Proteins;Regulatory Element;Repression;Role;Site;small cell lung carcinoma;stemness;Structure;transcription factor;Transcriptional Regulation;transcriptome;transcriptome sequencing;Work,Chromatin Structure and Gene Expression,5450,NA,NA,NA,NA,41,NA,NA,1912649,NA
11187890,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005522,NA,NA,1ZIABC005522-37,NCI:748540\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568943 (contact),"KIMURA, SHIOKO  (contact)",NA,NA,NA,Acute;Address;adenoma;Adult;adult stem cell;Age;Amitrole;Area;Azoles;Benign;Bone Marrow Cells;Bone Marrow Transplantation;cancer stem cell;carcinogenesis;Cartilage;cell growth;Cell Line;Cell surface;Cells;Characteristics;Development;Diet;differential expression;Differentiation Antigens;Digestion;E-Cadherin;Epithelium;Equilibrium;established cell line;experimental study;Gene Expression Profiling;Gene Mutation;Genes;Genetic Markers;genome sequencing;Genotype;Goals;Goitrogens;Growth;Growth Factor;Herbicides;homeodomain;Homeostasis;Human;Immune;Immunocompromised Host;Immunohistochemistry;In Situ Hybridization;inhibitor;Injury;Insulin-Like Growth Factor I;Insulin-Like-Growth Factor I Receptor;interest;Iodide Peroxidase;laser capture microdissection;Malignant neoplasm of thyroid;Malignant Neoplasms;Mesenchymal;Messenger RNA;Microbial Collagenase;Missense Mutation;Modeling;Mus;Muscle;Mutation;nano-string;Natural regeneration;Nature;Nodule;novel;Organ;overexpression;Pattern;Physiology;Play;Process;Proliferating;promoter;Quantitative Reverse Transcriptase PCR;receptor;RNA;Role;Signal Transduction;Signaling Molecule;single-cell RNA sequencing;stem cells;Stromal Cell-Derived Factor 1;Structure;Subcutaneous Injections;Thinness;Thyroid Diseases;Thyroid Function Tests;Thyroid Gland;thyroid neoplasm;Thyroidectomy;Thyrotropin Receptor;Tissues;tool;Trachea;transcription factor;transcriptome sequencing;Transgenic Mice;tumor;Tumor Suppressor Genes;Vimentin;whole genome;Wild Type Mouse;Xenograft procedure,Thyroid regeneration and carcinogenesis,5522,NA,NA,NA,NA,37,NA,NA,748540,NA
11187891,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005562,NA,NA,1ZIABC005562-37,NCI:2428351\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568962 (contact),"GONZALEZ, FRANK J (contact)",NA,NA,NA,Age;Area Under Curve;Asbestos;Biological Assay;Biological Markers;cancer biomarkers;carcinogenesis;Carcinogenesis Mechanism;Cessation of life;cohort;Collaborations;Colon Carcinoma;computed tomography screening;Creatine;Diagnosis;Disease;Eligibility Determination;Environmental Pollution;Etiology;Experimental Designs;Exposure to;fatty liver disease;Genitourinary system;Goals;high risk;Hospitals;Human;Insulin Resistance;Laboratories;liquid biopsy;liquid chromatography mass spectrometry;low dose computed tomography;lung cancer screening;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant Neoplasms;Measures;Metabolic Diseases;Metastatic Prostate Cancer;Mus;N-Acetylneuraminic Acid;non-smoker;Obesity;Participant;Passive Smoking;Performance;Population Control;programs;Prospective Studies;Radon;receptor;riboside;Risk Factors;ROC Curve;Role;Sampling;sex;Specimen;tobacco smokers;transcription factor;United States;urinary;Urine;Validation;Xenobiotics,Xenobiotic receptors,5562,NA,NA,NA,NA,37,NA,NA,2428351,NA
11187892,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005598,NA,NA,1ZIABC005598-35,NCI:260661\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414470 (contact),"GOTTESMAN, MICHAEL  (contact)",NA,NA,NA,ABCB1 gene;ABCB6 gene;ABCC1 gene;ABCG2 gene;Anti-tumor Natural Products;ATP-Binding Cassette Transporters;Belgium;Binding;Biological Availability;Blood - brain barrier anatomy;Brain;cancer cell;cancer drug resistance;Cause of Death;Cell Death;Cells;chemotherapeutic agent;chemotherapy;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Cytotoxic agent;Dimerization;Doxorubicin;Drug Efflux;Drug Interactions;Enzymes;erastin;Failure;Family;Fluorescence;genetic analysis;Goals;Histone Deacetylase Inhibitor;human tissue;Imidazole;inhibitor;Ketones;kinase inhibitor;Knock-out;Length;Light;Lipid Peroxidation;Malignant Neoplasms;malignant phenotype;Mediating;Melanoma;member;Molecular;multi drug transporter;Multi-Drug Resistance;multidrug resistant cancer;Mutate;nanoluciferase;Natural Product Drug;neoplastic cell;Oral;overexpression;Paclitaxel;Penetration;Pharmaceutical Preparations;Phenotype;Physiological;Piperazines;prevent;promoter;Proteins;Renal Cell Carcinoma;Reporting;Resistance;resistance mechanism;response;Rhodamine 123;Role;Site;small molecule;System;tool;Transcript;Transfection;Universities;uptake;Vinca Alkaloids;Work,Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,5598,NA,NA,NA,NA,35,NA,NA,260661,NA
11187893,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005599,NA,NA,1ZIABC005599-34,NCI:607008\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568841 (contact),"APPELLA, ETTORE  (contact)",NA,NA,NA,Acetylation;Adenocarcinoma Cell;Affect;Amyloidosis;anti-cancer treatment;Apoptosis;Apoptotic;Binding;Biochemical;Biological;Biophysics;Biotin;C-terminal;cancer cell;cancer stem cell;Cell Cycle Arrest;Cells;Cellular Stress;Chronic;cofactor;Collaborations;Colon Carcinoma;Critical Pathways;Cysteine;design;DNA;DNA Binding Domain;DNA Damage;DNA Repair;Enzymes;EP300 gene;Epigenetic Process;Esophageal Adenocarcinoma;Etoposide;Exhibits;experimental study;gain of function;Generations;Genetic Transcription;Goals;Growth;Heat-Shock Response;high throughput screening;Histones;Human;Hydroxylation;Hypoxia;Immune;immune cell infiltrate;improved;in vivo;Inflammatory;inhibitor;Lower Gastrointestinal Tract;Lysine;Mass Spectrum Analysis;MCF7 cell;Measures;Mediating;Metabolic;metabolic profile;Metabolism;Methylation;Modification;Molecular;Molecular Conformation;Mucous Membrane;mutant;Mutation;N-terminal;Neoplasm Metastasis;novel;Nuclear Extract;Nuclear Proteins;Oncogenic;Outcome;Peptides;peptidomimetics;Permeability;Phosphorylation;Point Mutation;Post-Translational Protein Processing;preference;prevent;Prognosis;Proteins;Publishing;Reaction;Regulation;Reporting;Repression;Research;response;Role;senescence;simulation;Site;small molecule;stem cell migration;Stimulus;Stress;Sumoylation Pathway;TP53 gene;Transactivation;Transcription Coactivator;transcription factor;Transcriptional Activation;tumor;tumor growth;tumor microenvironment;tumor progression;Tumor Promotion;Tumor Suppressor Proteins;tumorigenesis;Ubiquitination;Work,"Tumor Suppressor Protein, p53",5599,NA,NA,NA,NA,34,NA,NA,607008,NA
11187894,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005645,NA,NA,1ZIABC005645-35,NCI:249755\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692619 (contact),"FRANCHINI, GENOVEFFA  (contact)",NA,NA,NA,Ablation;Aborigine;Actins;Acute;Adult T-Cell Leukemia/Lymphoma;Affect;Alveolitis;Animals;Apoptotic;Arthritis;Australia;Autoimmune;Automobile Driving;B-Lymphocytes;Blood;Bronchiectasis;Bronchoalveolar Lavage;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cells;Chimeric Proteins;chronic infection;Collaborations;Communities;Coupled;Cytotoxic T-Lymphocytes;Data;Dermatitis;Disease;DNA;DNA Sequence Alteration;druggable target;Early Intervention;Equilibrium;Exons;Exposure to;Fibrosis;fibrotic lung disease;Genetic;Genetic Transcription;Goals;Hemorrhage;Human;human model;Human T-lymphotropic virus 1;Immune;Immunity;Impairment;in silico;In Vitro;in vivo;Indigenous;Individual;Induction of Apoptosis;Infection;Inflammasome;Inflammation;Inflammatory;Inflammatory Response;Initiator Codon;Interstitial Pneumonia;Jurkat Cells;Knock-out;leukemia;Link;Lung;lung development;Lung Diseases;lung injury;Macaca;Measures;Melanesia;Messenger RNA;Modeling;Molecular Cloning;monocyte;Morbidity - disease rate;mortality;Motility;Mucous Membrane;Natural Killer Cells;Nerve Degeneration;Neurodegenerative Disorders;Northern Territory;Onset of illness;Open Reading Frames;pathogen;Pathogenicity;Pathway interactions;Peripheral;Population;prevent;Preventive;Proteins;Pulmonary Inflammation;Research;Resistance;response;Retroviridae;RNA Splicing;RNA vaccine;Role;Seroprevalences;Signal Transduction;Site;Smooth Muscle;Spinal Cord Diseases;T cell infiltration;T-Lymphocyte;Testing;therapeutic evaluation;Tissue-Specific Gene Expression;Translation Initiation;Translations;Tropical Spastic Paraparesis;Uveitis;Vaccines;Variant;Vertebral column;Viral;Viral Proteins;viral rescue;viral transmission;Virus;Virus Diseases,Role of the HTLV-1A and HTLV1-C inflammatory profile in disease,5645,NA,NA,NA,NA,35,NA,NA,249755,NA
11187895,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005708,NA,NA,1ZIABC005708-33,NCI:607087\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568962 (contact),"GONZALEZ, FRANK J (contact)",NA,NA,NA,Bile Acids;cancer biomarkers;cancer chemoprevention;Carbon Tetrachloride;Carcinogens;CCAAT-Enhancer-Binding Protein-alpha;Cell Physiology;Chemicals;Cholesterol;Cirrhosis;cytokine;Dependovirus;Development;Diet;Disease;Embryo;Enterobacteria phage P1 Cre recombinase;Fatty acid glycerol esters;FDA approved;fibrogenesis;Fibrosis;Fructose;Gene Expression;Genes;Goals;Hepatic;Hepatic Stellate Cell;Hepatocyte;Homeostasis;Human;Knock-out;Knockout Mice;lipidomics;Lipids;Liver;liver development;Liver diseases;Liver Fibrosis;liver function;Mass Spectrum Analysis;Messenger RNA;Metabolic Diseases;Metabolic dysfunction;Metabolic Pathway;metabolomics;Modeling;Molecular;mouse model;Mus;Neonatal;non-alcoholic fatty liver disease;novel therapeutic intervention;Onset of illness;osteopontin;overexpression;Pathologic;Pharmaceutical Preparations;Primary carcinoma of the liver cells;programs;Publications;Publishing;Repression;Risk Factors;Role;Serotyping;Steatohepatitis;Tamoxifen;Tissues;toxicant;Xenobiotic Metabolism,"Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers",5708,NA,NA,NA,NA,33,NA,NA,607087,NA
11187896,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005785,NA,NA,1ZIABC005785-30,NCI:1152383\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692189 (contact),"WAKEFIELD, LALAGE  (contact)",NA,NA,NA,Allografting;antagonist;Binding Sites;Biological;breast cancer progression;cancer stem cell;cancer therapy;carcinogenesis;carcinogenicity;Cell Count;cell type;Cells;Characteristics;chemotherapy;Chromatin;Clinical;Complex;Crowding;data acquisition;Development;functional genomics;Functional Imaging;Genetic Enhancer Element;genetic regulatory protein;Goals;Human;imaging approach;In Situ;In Vitro;in vivo;Individual;insight;lung metastatic;Malignant Breast Neoplasm;Maps;Methods;Minority;Modeling;Molecular;Monitor;mouse model;Mus;Neoplasm Metastasis;novel;Nutrient;Patients;Play;Population;Pre-Clinical Model;preservation;prevent;Process;promoter;receptor expression;Recovery;Reporter;Resistance;response;rho GTP-Binding Proteins;Role;Sampling;sensor;Signal Transduction;Site;stem;Testing;Therapeutic;Time;transcription factor;Transducers;Transforming Growth Factor beta;Transforming Growth Factor Beta 2;Transgenic Model;tumor;tumor progression;Tumor Promotion;tumorigenesis;Visualization;Xenograft procedure,TGF-betas in breast cancer progression,5785,NA,NA,NA,NA,30,NA,NA,1152383,NA
11187897,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC005793,NA,NA,1ZIABC005793-30,NCI:310200\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77856862 (contact),"WANG, XIN WEI  (contact)",NA,NA,NA,Adenoviruses;Animal Model;Anti-viral Response;Antigen Presentation;Area;B-Lymphocytes;Binding Proteins;carcinogenesis;Cell Death;Centrosome;Chromosomal Instability;Chronic;chronic liver disease;Complex;Development;Docking;Etiology;Gene Expression;Gene Expression Profile;Genes;Genomic Instability;Goals;Hepatitis;Hepatitis B Virus;Hepatitis C;Hepatitis C virus;Hepatitis Delta Virus;Hepatocarcinogenesis;Hepatocyte;Homeostasis;Human;Immunity;Inflammation;Interferons;Link;Liver;Mediating;microbiota;Mitosis;Mitotic spindle;Molecular;Molecular Profiling;Natural regeneration;novel;Nuclear Export;nucleocytoplasmic transport;nucleophosmin;Oncogenic;Pathogenesis;Pathway interactions;Patients;Pilot Projects;Play;prevent;Primary carcinoma of the liver cells;Proteins;ran-binding protein 1;Research;Role;Running;Sampling;Signal Transduction;Tissues;tool;Viral hepatitis;Viral Physiology;Viral Proteins;Virus;virus core;Virus Diseases,Roles of microbiota-mediated hepatocarcinogenesis,5793,NA,NA,NA,NA,30,NA,NA,310200,NA
11187898,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC006150,NA,NA,1ZIABC006150-43,NCI:1395721\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569088 (contact),"POMMIER, YVES  (contact)",NA,NA,NA,Acyclovir;adduct;Adrenal Gland Cancer;anti-cancer research;Antineoplastic Agents;Antineoplastic Combined Chemotherapy Protocols;APEXL2 Gene;Apoptosis;arginine methyltransferase;Ataxia Telangiectasia;base;Binding;Biochemical;Biological Assay;biomarker signature;cancer cell;Cancer cell line;cancer therapy;carcinogenicity;CCR;CDT1 Gene;Cell Cycle Checkpoint;Cell Death;Cell Line;Cells;CHEK1 gene;Chromatin;Clinic;Clinical;clinical development;Clinical Pharmacology;Clinical Trials;clinically relevant;Collaborations;Communities;Complex;Crystallography;Cytarabine;Databases;Digestion;DNA;DNA biosynthesis;DNA Damage;DNA Markers;DNA Repair;DNA replication fork;DNA Synthesis Inhibitors;DNA-protein crosslink;drug candidate;Drug Combinations;drug response prediction;Drug Targeting;drug testing;endonuclease;Enzymes;epigenetic drug;ERCC1 gene;Excision;FDA approved;Genes;genomic data;genomic signature;Genomics;Glycoside Hydrolases;Histone Deacetylase Inhibitor;homologous recombination;homologous recombination deficiency;Hydrolysis;Immune checkpoint inhibitor;improved;Induction of Apoptosis;inhibitor;kinase inhibitor;Knock-out;Licensing Factor;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Manuscripts;Mediating;Methylation;mitochondrial genome;Molecular;Molecular Mechanisms of Action;molecular modeling;multicatalytic endopeptidase complex;Mutation;National Center for Advancing Translational Sciences;novel;nuclease;Online Systems;Pathway interactions;patient response;Patient Selection;Patients;Peptide Hydrolases;Pharmaceutical Preparations;Pharmacogenomics;Pharmacology;Platinum;Poly(ADP-ribose) Polymerase Inhibitor;precision medicine;predicting response;predictive marker;prevent;protein kinase inhibitor;Proteolysis;proteostasis;proteotoxicity;public database;Publishing;Rationalization;Recombinants;recombinational repair;recruit;Regulation;repaired;Replication Licensing;replication stress;Research;Resistance;Resources;response;RNA;Sarcoma;Site;small cell lung carcinoma;Stress;Structure;Sumoylation Pathway;targeted agent;targeted cancer therapy;temozolomide;Testing;Time;Tissues;tool;TOP1 gene;TOP2A gene;Topoisomerase;Topoisomerase Inhibitors;Tubulin;tumor;Tumor Suppressor Proteins;Tyrosine;tyrosyl-DNA phosphodiesterase;ubiquitin ligase;Ubiquitination;Virus Replication;web app;web site;Work;Zidovudine,"DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",6150,NA,NA,NA,NA,43,NA,NA,1395721,NA
11187899,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC006161,NA,NA,1ZIABC006161-41,NCI:797555\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569088 (contact),"POMMIER, YVES  (contact)",NA,NA,NA,ABCB1 gene;ABCG2 gene;adduct;anti-cancer therapeutic;Antibody-drug conjugates;Antineoplastic Agents;Autoimmune Diseases;Binding;Biochemistry;Biological;Biological Markers;Biology;Blood;Bone Marrow;BRCA deficient;Camptothecin;cancer cell;Carbon Tetrachloride;Cardiotoxicity;Catenanes;Cell membrane;Cell Proliferation;Cells;Chemicals;chromatin remodeling;Chromosome Segregation;Clinic;Clinical;clinical center;clinical development;Clinical Oncology;Clinical Trials;cofactor;Collaborations;Colon Carcinoma;Complement;Complex;Cyclic Nucleotides;cytotoxic;Development;Diarrhea;DNA;DNA biosynthesis;DNA copy number;DNA Damage;DNA Double Strand Break;DNA Repair;DNA replication fork;DNA topoisomerase II alpha;DNA Topoisomerases;Dose Limiting;Doxorubicin;drug development;Drug Efflux;Embryo;endonuclease;Enzymes;Epirubicin;ERCC1 gene;Etoposide;Exatecan;Excision;Exhibits;fatty liver disease;FDA approved;Fibroblasts;Formulation;Genes;Genetic Transcription;Genome;Genomic Instability;Goals;Hematologic Neoplasms;homologous recombination deficiency;Human;Hybrids;hydroxyl group;Idarubicin;Immune;Immune System Diseases;inhibitor;insertion/deletion mutation;insight;Intercalating Agents;interest;irinotecan;Knockout Mice;Laboratories;Legal patent;Lesion;Licensing;Liver;Lung Carcinoma;macromolecule;Malignant Childhood Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;Membrane Transport Proteins;Metabolic stress;Mitochondria;Mitochondrial DNA;mitochondrial genome;Mitochondrial Proteins;Mitoxantrone;Molecular;mouse model;multicatalytic endopeptidase complex;Mus;Mutation;Natural regeneration;NCI Center for Cancer Research;Neurodegenerative Disorders;novel;Nuclear;nuclease;Nucleic Acids;Nucleotides;Obesity;Oncology;Organ;Ovarian Carcinoma;Pathway interactions;patient biomarkers;patient stratification;Patients;Peptide Hydrolases;Pharmaceutical Preparations;pharmacodynamic biomarker;Pharmacology;Pharmacology Study;Phase I Clinical Trials;Phase II Clinical Trials;phase II trial;Phenotype;Plant alkaloid;Poison;Post-Translational Protein Processing;precision medicine;prevent;Program Development;Property;Protein Biosynthesis;Publishing;Relaxation;repaired;Reporting;Resolution;response;Ribonucleotides;RNA;RNA Helicase;Rodent;Role;Site;SN-38;Structure;sugar;Sumoylation Pathway;synergism;therapeutic target;tissue regeneration;TOP1 gene;TOP2A gene;Topoisomerase;Topoisomerase II;Topoisomerase III;topoisomerase IIIalpha;Topoisomerase Inhibitors;Topotecan;Toxic effect;Toxin;transcriptome;Translations;tumor;tumor progression;Type I DNA Topoisomerases;tyrosyl-DNA phosphodiesterase;Universities;Vertebral column;Vertebrates;Water;Work,DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,6161,NA,NA,NA,NA,41,NA,NA,797555,NA
11187900,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC006198,NA,NA,1ZIABC006198-35,NCI:554437\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569096 (contact),"BURKE, TERRENCE  (contact)",NA,NA,NA,Affinity;Aldehydes;Alkynes;Amines;Amino Acids;analog;anti-cancer;Antineoplastic Agents;Azides;Benzoic Acids;Binding;Biological;Biological Assay;Biology;biomaterial compatibility;Cancerous;Catalytic Domain;Cell Cycle Regulation;Cells;chemical stability;Chemicals;Chemistry;Collaborations;Colon Carcinoma;Colorectal Cancer;Complex;cost effective;covalent bond;Derivation procedure;design;Disulfides;DNA;DNA Repair Enzymes;DNA Topoisomerases;Docking;drug-like compound;Excision;Exhibits;Extracellular Domain;Family;flexibility;Fluorescein;Fluorescein-5-isothiocyanate;Fluorescence;Fluorides;G-Protein-Coupled Receptors;Home;inhibitor;inorganic phosphate;Investigation;kinase inhibitor;knock-down;Label;Laboratories;Left;Leucine-Rich Repeat;LGR5 gene;Libraries;Ligand Binding;Ligand Binding Domain;Ligands;Light;Malignant Neoplasms;Mediator;member;Methodology;mimetics;Molecular;Molecular Target;nanomolar;Nature;near infrared dye;Operative Surgical Procedures;Oximes;Parents;Peptide Synthesis;Peptides;peptidomimetics;pharmacologic;Phase;phosphodiester;Phosphotransferases;Phthalic Acids;PLK1 gene;PLK3 gene;Polo-Box Domain;polo-like kinase kinase 1;Positioning Attribute;Process;protein protein interaction;Proteins;quinoline;Quinolones;Reaction;Reagent;Recovery;Resources;Side;Signal Transduction;Site;small molecule;Solid;Stains;Structure;Sulfur;Synthesis Chemistry;System;Tissues;tool;Topoisomerase;Topoisomerase Inhibitors;Tyrosine;Tyrosine Kinase Inhibitor;tyrosyl-DNA phosphodiesterase;Variant;Work;wortmannin;X-Ray Crystallography,Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,6198,NA,NA,NA,NA,35,NA,NA,554437,NA
11187901,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC007363,NA,NA,1ZIABC007363-30,NCI:1663314\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569096 (contact),"BURKE, TERRENCE  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affinity;Amino Acids;anti-cancer research;Anti-HIV Agents;anti-viral efficacy;Binding;Binding Proteins;C-terminal;Caco-2 Cells;Chemicals;Chemistry;Chromatin;Clinical;Collaborations;Contracts;Coupling;Cryoelectron Microscopy;Data;design;Development;DNA;drug structure;Excision;Fasting;FDA approved;Formulation;Foundations;Free Energy;Future;Generations;Genes;Genetic Transcription;Goals;Histone H3.3;histone modification;Histones;HIV;HIV Integrase;HIV therapy;HIV-1;HIV-1 drug resistance;improved;inhibitor;Integrase;Integrase Inhibitors;Intestines;invention;Laboratories;Legal patent;lens epithelium-derived growth factor;Ligation;Liquid substance;Lysine;Macaca;Malignant Neoplasms;Methodology;Microscopy;Microsomes;Modification;mutant;Nanotechnology;National Institute of Diabetes and Digestive and Kidney Diseases;next generation;novel;novel therapeutics;nucleoside analog;Nucleosomes;oxidation;Patients;Permeability;Plasma;Plasma Proteins;Polymers;Positioning Attribute;Process;Prodrugs;Program Development;programs;Proteins;Protocols documentation;PWWP Domain;Recommendation;Reporting;Resistance;resistance mechanism;resistance mutation;Resolution;Resources;Reverse Transcriptase Inhibitors;Salvage Therapy;Side;simulation;Solubility;Stomach;Structure;Testing;Thermodynamics;thioester;Variant;Virus;Work,Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,7363,NA,NA,NA,NA,30,NA,NA,1663314,NA
11187902,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC007365,NA,NA,1ZIABC007365-30,NCI:1928598\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8101887 (contact),"RANDAZZO, PAUL A (contact)",NA,NA,NA,Actins;ADP-Ribosylation Factors;Affect;Ankyrin Repeat;Area;Behavior;Binding;Biochemical;Biochemistry;Biology;Bundling;cancer cell;Catalysis;cell behavior;Cells;childhood sarcoma;Collaborations;Cytoskeleton;Defect;Dorsal;enzyme activity;F-Actin;Focal Adhesions;Goals;GTP Binding;GTP-Binding Proteins;GTPase-Activating Proteins;Guanosine Triphosphate;Hydrolysis;Invaded;Ligands;Link;Lipid Binding;Malignant Neoplasms;Mediating;member;Membrane;Microfilaments;migration;Modeling;Molecular;Molecular Conformation;Myoblasts;Neoplasm Metastasis;novel;Oncoproteins;Pathologic;PH Domain;Phosphatidylinositols;Prognosis;Proliferating;Proline;Property;Proteins;RAS Superfamily Proteins;Regulation;Resolution;Rhabdomyosarcoma;Role;SH3 Domains;Signal Pathway;Signal Transduction;Stress Fibers;Structure;Tertiary Protein Structure;Therapeutic;tumor progression;Work;Xenograft Model,Regulation of ADP-ribosylation factor,7365,NA,NA,NA,NA,30,NA,NA,1928598,NA
11187903,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008710,NA,NA,1ZIABC008710-47,NCI:1808468\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569131 (contact),"WICKNER, SUE H (contact)",NA,NA,NA,Adaptor Signaling Protein;Alzheimer&apos;s Disease;ATP-Dependent Proteases;Bacteria sigma factor KatF protein;Beryllium;Binding;Biological Models;C-terminal;cancer cell;cancer survival;cancer therapy;cell growth;Cellular Stress;Client;Collaborations;Combined Modality Therapy;Complex;Cystic Fibrosis;DNA biosynthesis;DNA-Directed RNA Polymerase;Drug Targeting;endopeptidase Clp;Escherichia coli;Eukaryota;Evolution;Exhibits;Fluorides;Goals;Growth;Homologous Gene;human disease;In Vitro;in vivo;inhibitor;Learning;Length;Malignant Neoplasms;Molecular Chaperones;Molecular Conformation;multicatalytic endopeptidase complex;nanomachine;Non-Insulin-Dependent Diabetes Mellitus;Nucleotides;Parkinson Disease;Pathway interactions;Peptide Hydrolases;Phase;Phosphorylation;Play;premature;prevent;Prion Diseases;protein aggregation;Protein Binding Domain;protein degradation;protein folding;Protein-Folding Disease;Proteins;Proteolysis;proteostasis;Reaction;Recovery;Regulation of Proteolysis;Research;response;Role;sigma-E factor;Signal Transduction;Stress;Structure;Surface;System;Tertiary Protein Structure;Testing;tumor;Universities;Work;Yeasts,Molecular Chaperones and DNA Replication,8710,NA,NA,NA,NA,47,NA,NA,1808468,NA
11187904,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008714,NA,NA,1ZIABC008714-47,NCI:1024388\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2402881 (contact),"GOTTESMAN, SUSAN  (contact)",NA,NA,NA,Acetylation;Affect;Alleles;Antibiotics;Area;Bacteria;Bacteria sigma factor KatF protein;Behavior;Binding;biological adaptation to stress;Biological Assay;Bypass;capsule;cell behavior;Cell Communication;cell growth;Cell membrane;Cells;Collaborations;Complex;Development;Dissection;Distal;Equilibrium;Escherichia coli;Eukaryotic Cell;Evolution;Face;falls;Family;genetic regulatory protein;Genetic Screening;Goals;Growth;In Vitro;in vivo;insight;interest;Investigation;Klebsiella;Laboratories;Mediating;member;Membrane;Messenger RNA;Metabolism;Molecular Chaperones;mRNA Translation;mutant;Mutation;Names;National Institute of Child Health and Human Development;novel;Organism;pathogenic bacteria;Pathway interactions;Physiological;Play;Porifera;posttranscriptional;Process;Proteins;Quality Control;Regulation;Regulon;Reporter;Resistance;response;Ribonucleases;RNA;RNA Binding;RNA Stability;Role;screening;sensor;Series;Sigma Factor;Signal Transduction;Site;small molecule;Small RNA;Stress;symbiont;System;Time;tool;transcription factor;Translation Initiation;Untranslated RNA;Virulence Factors;Visit;Work,Bacterial Functions Involved in Cell Growth Control,8714,NA,NA,NA,NA,47,NA,NA,1024388,NA
11187905,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008751,NA,NA,1ZIABC008751-44,NCI:1025659\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6129912 (contact),"ADHYA, SANKAR  (contact)",NA,NA,NA,Architecture;Binding;Binding Sites;Biochemical;Biological Models;Biological Process;biophysical techniques;cancer cell;Chromatin Loop;Chromosome Structures;Chromosomes;Cryoelectron Microscopy;developmental genetics;DNA;DNA-Directed RNA Polymerase;Elements;Engineering;Escherichia coli;Galactose;Gene Activation;Gene Expression;Gene Expression Profile;Gene Expression Regulation;gene repression;Genes;Genetic;genetic regulatory protein;Genetic Transcription;Geometry;Goals;Laboratories;mathematical methods;Microscopy;Molecular Biology;novel;Operon;Positioning Attribute;Prophages;Refractory;Regulation;Repression;Research;Shapes;System;Systems Biology;Testing;three dimensional structure;Transcriptional Regulation;transcriptome;Work,Regulation of Gene Transcription,8751,NA,NA,NA,NA,44,NA,NA,1025659,NA
11187906,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008752,NA,NA,1ZIABC008752-44,NCI:863438\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569140 (contact),"CHENG, SHEUE-YANN  (contact)",NA,NA,NA,Abdomen;Address;aged;Anemia;Atrophic;Attention deficit hyperactivity disorder;Binding;Biological;bone;Bone Development;Clinical;Complex;Constipation;CRISPR/Cas technology;Development;digital;Disease;Dominant-Negative Mutation;Ectopic Expression;egg;Endometrial;Endometrium;Epithelium;Estrogen Receptors;Estrogens;Exhibits;Failure;Female;female fertility;Female infertility;Fertility;Fibrosis;Fishes;folliculogenesis;Functional disorder;Gene Expression Profiling;Gene Expression Regulation;Genes;genetic corepressor;Genitalia;Genomics;Gland;Growth;Health;hearing impairment;Heterozygote;Histologic;Homeostasis;hormone response element;Human;human disease;Hypertrophy;in vivo;Infertility;insight;keratinocyte differentiation;Laboratories;Lasers;Learning;Maintenance;Mammalian Oviducts;Mediating;Metabolic;Metaplasia;Metaplastic Cell;Modeling;Molecular;Morphogenesis;mouse model;Mus;Mutagenesis;mutant;Mutant Strains Mice;Mutate;Mutation;Nuclear;Nuclear Hormone Receptors;Obstruction;Ovarian;Ovary;Oviposition;Pathway Analysis;Patients;Premature Ovarian Failure;Protein Isoforms;recruit;Regulation;Reporting;Reproduction;reproductive;reproductive tract;Research;Resistance;Role;Serum;Sexual Maturation;Signal Pathway;Signal Transduction;Source;Squamous Metaplasia;Symptoms;T cell infiltration;THRA gene;THRB gene;Thyroid Gland;Thyroid Hormone Receptor;Thyroid hormone receptor alpha;Thyroid Hormone Receptor Gene;Thyroid Hormones;Thyrotropin;Tissues;tongue papilla;Transcriptional Regulation;transcriptome sequencing;transcriptomics;Uterus;Wild Type Mouse;Zebrafish,Thyroid Hormone Nuclear Receptors in Health and Disease,8752,NA,NA,NA,NA,44,NA,NA,863438,NA
11187907,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008753,NA,NA,1ZIABC008753-42,NCI:265247\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8289669 (contact),"PASTAN, IRA  (contact)",NA,NA,NA,acute lymphoblastic leukemia cell;Acute Lymphocytic Leukemia;Agreement;B lymphoid malignancy;CCR;CD22 gene;Clinical;Clinical Protocols;Clinical Trials;Development;efficacy evaluation;Funding;Hairy Cell Leukemia;Hematopoietic Neoplasms;Human;IL2RA gene;Immunotoxin Therapy;Immunotoxins;Injections;LMB-2 Immunotoxin;Lymphoma;Malignant neoplasm of thorax;Malignant Neoplasms;Mus;Patients;Pharmacy facility;preclinical study;Regulatory T-Lymphocyte;Solid Neoplasm;subcutaneous;Supervision;Thoracic Oncology;tumor;Tumor Immunity,Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies,8753,NA,NA,NA,NA,42,NA,NA,265247,NA
11187908,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008756,NA,NA,1ZIABC008756-37,NCI:576453\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569146 (contact),"MERLINO, GLENN T. (contact)",NA,NA,NA,Address;Adult;Animal Model;Architecture;Autophagocytosis;Behavior;BRAF gene;Cancer Biology;cancer genetics;Cancer Model;Cancer Patient;candidate identification;Catalogs;Cause of Death;CDKN2A gene;Cell Line;Cells;Childhood;Clinic;Clustered Regularly Interspaced Short Palindromic Repeats;Communities;Complex;Cutaneous Melanoma;Data;Databases;deep sequencing;design;Development;diagnostic biomarker;Disease;Distant;DNA Sequence Alteration;Dose;Drug resistance;Drug Targeting;drug testing;Ectopic Expression;Embryo;Endoplasmic Reticulum Degradation Pathway;endoplasmic reticulum stress;Etiology;Excision;exome sequencing;Exposure to;Expression Profiling;falls;Fishes;Fluorescence-Activated Cell Sorting;Gene Expression;Gene Expression Profiling;Genes;Genetic;Genetic Engineering;Genetically Engineered Mouse;Genomics;glycosylation;GNAQ gene;Goals;Green Fluorescent Proteins;Growth;Health Hazards;HGF gene;Human;human cancer mouse model;human disease;IGF1R gene;Immune checkpoint inhibitor;Immune mediated destruction;Immunocompetent;Immunotherapy;Impairment;in vivo;Incidence;Inflammatory;Influentials;inhibitor;Injections;insight;interest;Interferon alpha;Interferon Type II;irradiation;KAI1 gene;knock-down;Knock-out;Label;Laboratories;Lesion;Ligands;Link;Macrophage;malignant melanocyte;Malignant Neoplasms;malignant state;MCL1 gene;Mediating;Melanins;melanoblast;melanocyte;Melanocytic Neoplasm;Melanoma;Melanoma Cell;Melanoma patient;member;Metastatic malignant neoplasm to brain;Metastatic Melanoma;Metastatic Neoplasm to the Central Nervous System;MicroRNAs;mitochondrial metabolism;Modeling;Molecular;Molecular Analysis;mouse model;Mus;Mutagenesis;mutant;Mutation;Nature;Neonatal;Neoplasm Metastasis;neurodevelopment;Nevus;new therapeutic target;next generation;NF1 gene;novel;novel diagnostics;Oncogenes;Oncogenic;Organ;oxidative DNA damage;Pathway interactions;Patients;Pattern;Peptide Initiation Factors;Pharmaceutical Preparations;Phenotype;Phosphoric Monoester Hydrolases;Pigments;Play;pre-clinical;preclinical study;prevent;Primary Neoplasm;Process;programs;Proliferating;promoter;Proto-Oncogene Proteins c-akt;PTEN gene;Radiation;Radiation induced damage;Radiation therapy;Receptor Protein-Tyrosine Kinases;Receptor Signaling;recruit;Recurrence;Recurrent disease;Reporting;Research;Resistance;Resources;Retinoblastoma Protein;Risk;Risk Factors;RNA Interference;Role;Signal Pathway;Signal Transduction;Site;Skin;Sorting;Source;success;Sunburn;Sunscreening Agents;Tail;Testing;Tetracyclines;The Cancer Genome Atlas;Therapeutic;therapeutic target;Time;Tissues;tool;TP53 gene;transcriptome sequencing;transcriptomics;Transgenic Mice;Transplantation;tumor;tumor initiation;Ultraviolet B Radiation;Ultraviolet Rays;UV induced;UV Radiation Exposure;UVB induced;Uveal Melanoma;Veins;Zebrafish,Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,8756,NA,NA,NA,NA,37,NA,NA,576453,NA
11187909,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008757,NA,NA,1ZIABC008757-37,NCI:1717588\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569148 (contact),"FITZGERALD, DAVID  (contact)",NA,NA,NA,Affinity;Algorithms;Antibodies;Antibody Therapy;Antibody-drug conjugates;Apoptosis;Bacteria;Bacterial Toxins;BCL-2 Protein;Binding;Binding Sites;Biological Response Modifier Therapy;cancer cell;Cancer cell line;cancer therapy;CCR;cell killing;Cell Line;Cells;chemical synthesis;chemotherapy;chimeric antigen receptor T cells;Clinic;Collaborations;Collection;Complement;cytotoxic;Cytotoxic agent;density;design;Development;dimer;Disulfides;Drug resistance;Drug Screening;Effectiveness;Enzymes;Epidermal Growth Factor Receptor;Exhibits;experimental study;Extracellular Domain;Fab Immunoglobulins;gene product;Genes;Germ Lines;Glioblastoma;Goals;Head and Neck Cancer;Human;Human Cell Line;humanized antibody;Hybridomas;Immunize;Immunotoxins;inhibitor;Investigation;KDR gene;lead candidate;Light;Link;Malignant Neoplasms;Mammalian Cell;Masks;Microtubules;Molecular Weight;Monoclonal Antibodies;Mus;mutant;Mutate;Nature;Neck Cancer;Non-Small-Cell Lung Carcinoma;Normal Cell;Normal tissue morphology;overexpression;Peptides;Pharmaceutical Preparations;Poison;pre-clinical;preclinical development;programs;receptor;Resistance;RNA Interference;screening;Site;Surface;targeted agent;targeted treatment;therapy development;three dimensional structure;Topoisomerase Inhibitors;Toxin;triple-negative invasive breast carcinoma;tumor;whole genome;Xenograft procedure,Bio-Therapies for the Treatment of Cancer,8757,NA,NA,NA,NA,37,NA,NA,1717588,NA
11187910,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC008905,NA,NA,1ZIABC008905-43,NCI:998705\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093670 (contact),"LOWY, DOUGLAS R. (contact)",NA,NA,NA,Binding;cancer therapy;Cell membrane;Cytoplasm;DLEC1 gene;EZH2 gene;Gene Expression;Goals;Growth;Guanosine Triphosphate;Hydrolysis;In Vitro;in vivo;Intervention;KRAS2 gene;Malignant Neoplasms;Mediating;MEKs;Neoplasms;Nuclear Export;Nuclear Protein;Oncogenes;Oncogenic;Pathogenesis;PI3K/AKT;prevent;protein complex;Protein Export Pathway;Ras Inhibitor;Regulation;Research;Signal Transduction;tumor;Tumor Suppressor Genes;Tumor Suppressor Proteins,Tumor gene expression in vitro and in vivo,8905,NA,NA,NA,NA,43,NA,NA,998705,NA
11187911,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC009052,NA,NA,1ZIABC009052-35,NCI:3448564\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1928930 (contact),"SCHILLER, JOHN T. (contact)",NA,NA,NA,Adjuvant;Animal Model;Antigen Targeting;Auras;Basement membrane;Basic Science;Biological Response Modifier Therapy;Breast;cancer cell;cancer therapy;cancer type;Capsid;CCR;CD8B1 gene;Cell Culture Techniques;Cell surface;Clinical Trials;Collaborations;Communicable Diseases;companion animal;comparative;Costa Rican;Cytomegalovirus Vaccines;delivery vehicle;Disease;Dose;Drug Targeting;efficacy evaluation;efficacy trial;Epitopes;gene transfer vector;genetic vaccine;Glioblastoma;Human papilloma virus infection;Human Papilloma Virus Vaccine;Human Papillomavirus;Industry Collaboration;Infection;Injections;Intervention;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Modeling;Mus;Ocular Melanoma;Oncology;Papillomavirus;Pathway interactions;Peptides;Pharmaceutical Preparations;phase 3 study;phase I trial;pre-clinical;prevent;Proteins;Proteoglycan;recruit;Solid Neoplasm;T cell response;T-Lymphocyte;treatment strategy;Tropism;tumor;vaccine evaluation;Vaccines;Viral;Viral Vaccines;Virion;Virus Diseases,Understanding Papillomavirus Virion Proteins and Vaccines,9052,NA,NA,NA,NA,35,NA,NA,3448564,NA
11187912,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC009273,NA,NA,1ZIABC009273-37,NCI:1027078\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692601 (contact),"SINGER, ALFRED  (contact)",NA,NA,NA,Appearance;autoreactive T cell;autoreactivity;CD8-Positive T-Lymphocytes;CD8B1 gene;Clonal Deletion;Development;Down-Regulation;Event;GFI1 gene;Mature T-Lymphocyte;Mus;premature;Reporting;Self Tolerance;Signal Transduction;Sphingosine-1-Phosphate Receptor;T cell differentiation;T-Cell Receptor;T-Lymphocyte;thymocyte;Thymus Gland;Transcription Repressor,T Cell Differentiation and Repertoire Selection,9273,NA,NA,NA,NA,37,NA,NA,1027078,NA
11187913,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC009283,NA,NA,1ZIABC009283-40,NCI:1424074\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692165 (contact),"YOUNG, HOWARD  (contact)",NA,NA,NA,Appearance;Architecture;Autoimmune Diseases;Autoimmunity;B-Lymphocytes;Belief;CD8-Positive T-Lymphocytes;Chronic;Communicable Diseases;cytokine;Development;Effector Cell;Exhibits;Female;female reproductive tract;Functional disorder;Gene Expression;Gene Modified;Genetic;Goals;Homeostasis;Immune;Immune response;Immune system;Immunity;Immunotherapeutic agent;Infection;Infertility;Infiltration;Inflammation;insight;Interferon Type II;Knockout Mice;Laboratories;Liver;Long-Term Effects;lymph nodes;male;Malignant Neoplasms;Memory;Modeling;mouse model;mRNA Stability;Mus;novel;Ovary;Physiological;Physiology;Pituitary Gland;Prolactin;reproductive;reproductive system disorder;response;Role;Sex Differences;Spleen;Systems Biology;T-Lymphocyte;Thymus Gland;Uterus;Work,Consequences of chronic Interferon-gamma expression on the host,9283,NA,NA,NA,NA,40,NA,NA,1424074,NA
11187914,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC009287,NA,NA,1ZIABC009287-40,NCI:1434021\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569217 (contact),"DURUM, SCOTT  (contact)",NA,NA,NA,Acute Lymphocytic Leukemia;Antibodies;Asthma;Autoimmune Diseases;Cell Proliferation;Cell Survival;cytokine;Dermatitis;Diabetes Mellitus;Disease;gain of function mutation;Goals;Health;IL7 gene;immunodeficiency;Interleukin 7 Receptor;Legal patent;leukemia;Licensing;Lymphoblastic Leukemia;Malignant Childhood Neoplasm;Methods;Monoclonal Antibodies;Multi-Institutional Clinical Trial;Multiple Sclerosis;Mus;Pathway interactions;patient derived xenograft model;relapse patients;Sepsis;Stem cell transplant;T-Cell Development;Therapeutic;United States National Institutes of Health,Cytokines and T Cell Development,9287,NA,NA,NA,NA,40,NA,NA,1434021,NA
11187915,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC009392,NA,NA,1ZIABC009392-32,NCI:542239\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569429 (contact),"WEISSMAN, ALLAN M (contact)",NA,NA,NA,26S proteasome;African American Women;Alleles;Apoptosis;Binding;Binding Proteins;cancer therapy;CCR;Cell Death;cell motility;Cell Physiology;Cellular Stress;cellular targeting;Cholesterol;Complex;COVID-19 pandemic;Cues;Data;design;Deubiquitinating Enzyme;Endoplasmic Reticulum;Endoplasmic Reticulum Degradation Pathway;endoplasmic reticulum stress;Enzymes;fatty acid biosynthesis;Federal Government;Genetic;Goals;Golgi Apparatus;Growth;Human;Insulin;Integral Membrane Protein;interest;KAI1 gene;knock-down;Knowledge;Laboratories;Malignant Breast Neoplasm;Malignant Neoplasms;Mammals;MAPK8 gene;Mediating;Membrane;Membrane Fusion;Membrane Proteins;Metabolic;Mitochondria;Mitochondrial Matrix;Mitochondrial Proteins;mouse model;Multiple Myeloma;Mus;Neoplasm Metastasis;novel;Orthologous Gene;Outcome;Outer Mitochondrial Membrane;Pathway interactions;Peptide Hydrolases;Phosphorylation;Play;Predictive Factor;Process;protein degradation;Proteins;Publishing;Quality Control;Race;recruit;Response Elements;Ring Finger Domain;Risk Factors;Role;Sarcoma;SARS-CoV-2 protease;Scientist;Services;Site;Sterols;System;Temperature;Therapeutic;tumor;tumor autocrine motility factor receptor;UBE2G2 gene;Ubiquitin;ubiquitin isopeptidase;ubiquitin ligase;United States National Institutes of Health;Viral;Viral Physiology;Viral Proteins;Virus Activation;Woman;Work;Xenograft procedure;Yeasts,Determining the Fate of Transmembrane Proteins,9392,NA,NA,NA,NA,32,NA,NA,542239,NA
11187916,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC009404,NA,NA,1ZIABC009404-30,NCI:1388918\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692451 (contact),"ROCHE, PAUL  (contact)",NA,NA,NA,Antigen Presentation Pathway;antigen processing;Antigen-Presenting Cells;Antigens;B-Lymphocytes;Binding;Binding Sites;Biology;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell membrane;Cellular biology;Cross Presentation;Dissociation;Endocytosis;Endosomes;Epitopes;Event;Goals;Histocompatibility Antigens Class I;Histocompatibility Antigens Class II;immune function;Immunological Models;invariant chain;Kinetics;Maps;MHC Class I Genes;MHC Class II Genes;Microscopy;Molecular;Molecular Chaperones;Movement;Mus;Pathway interactions;Peptides;Process;Proteins;Recycling;Regulation;Reporting;Resolution;Role;Route;Signal Transduction;T-Cell Activation;TNF Receptor-Associated Factors;TNFRSF5 gene;trafficking;trans-Golgi Network;ubiquitin-protein ligase;Ubiquitination,Regulation of MHC Class II Trafficking in Antigen Presenting Cells,9404,NA,NA,NA,NA,30,NA,NA,1388918,NA
11187917,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010001,NA,NA,1ZIABC010001-29,NCI:501957\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569266 (contact),"KELLER, JONATHAN R (contact)",NA,NA,NA,Apoptosis;Binding;Binding Proteins;Blood Cells;cell growth;cell growth regulation;Cell Line;Cell Lineage;Cell Transplantation;Cells;comparison control;Cytarabine;Developmental Process;DNA;Enzymes;Event;Gene Expression;Genes;Genetic Transcription;Goals;Hematopoiesis;Hematopoietic stem cells;Histones;Human;ID2 gene;in vivo;leukemia;leukemia/lymphoma;MB02;Mediator;Membrane;Mitochondria;Molecular;mouse model;Mus;Mutate;myeloid cell development;Myeloid Cells;Patients;Play;Predisposition;Process;programs;Proteins;Reactive Oxygen Species;recruit;Role;self-renewal;senescence;Signal Transduction;Specific qualifier value;stem cell biology;stem cells;therapeutic target;transcription factor;Transplantation,Molecular-Cellular Regulation of Hematopoietic Stem Cells,10001,NA,NA,NA,NA,29,NA,NA,501957,NA
11187918,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010006,NA,NA,1ZIABC010006-29,NCI:556135\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692315 (contact),"DAAR, IRA  (contact)",NA,NA,NA,Actins;Adaptor Signaling Protein;Adhesions;Affect;angiogenesis;Antigen-Antibody Complex;Apical;Axon;Benign;Binding;Biochemistry;Biological Models;Breast;Cancer cell line;Cell Adhesion;Cell Cycle Progression;cell fixing;Cell Line;cell motility;Cell Shape;Cell-Cell Adhesion;Cell-Matrix Junction;Cells;cellular imaging;Colon;Complex;Congenital Abnormality;constriction;Cues;Cytoplasmic Tail;Development;driving force;Dsh protein;Embryo;Embryonic Development;embryonic stem cell;Eph Family Receptors;Ephrins;epithelial to mesenchymal transition;Event;experimental study;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Frequencies;gain of function;hindbrain;Human;Human Cell Line;human disease;in vivo;insight;Invaded;Laboratories;Ligand Binding;Ligands;Link;loss of function;Malignant neoplasm of gastrointestinal tract;Malignant Neoplasms;Mass Spectrum Analysis;Mediating;Melanoma;member;Membrane;migration;Modification;Morphogenesis;Movement;mutant;Myosin ATPase;Neoplasm Metastasis;neoplastic cell;Neural Crest Cell;Neural tube;Neural Tube Closure;Neuroblastoma;overexpression;Pathway interactions;Pattern;Phenotype;Play;pluripotency;Positioning Attribute;Proliferating;Prostate;Proteins;receptor;Receptor Protein-Tyrosine Kinases;recruit;Regulation;Repression;Research;Retina;retinal progenitor cell;Rho-associated kinase;Robinow syndrome;Role;scaffold;Scaffolding Protein;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Signaling Molecule;skeletal;small cell lung carcinoma;Stem Cell Development;stem cell fate specification;stem cells;System;Tissues;tumor;Tumor Angiogenesis;Tumor Cell Invasion;Tumor Cell Line;Tumor Stem Cells;tumorigenesis;Vertebrates;Visual Fields;WNT Signaling Pathway;Xenopus,Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,10006,NA,NA,NA,NA,29,NA,NA,556135,NA
11187919,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010008,NA,NA,1ZIABC010008-29,NCI:749110\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692507 (contact),"MOCK, BEVERLY  (contact)",NA,NA,NA,Alleles;Amino Acids;Antibody Formation;B-Cell Activation;B-Cell Development;B-Lymphocytes;Biological Models;Body Size;Body Weight decreased;Bone Marrow;Burkitt Lymphoma;Cancer Model;Cell Cycle;cell growth;Cell Line;Cell Lineage;Cell Size;Cells;chemokine;Cloning;Code;Complex Genetic Trait;CRISPR/Cas technology;cytokine;Defect;Development;DNA;Embryo;Event;Exhibits;FOXP3 gene;Genes;Genetic Predisposition to Disease;Genetic Transcription;genetic variant;Genetically Engineered Mouse;Hematopoietic Neoplasms;Homeostasis;Homing;Human;Immune;in vivo;inhibitor;Knock-in;Knock-in Mouse;Knock-out;Laboratories;Lymphoma;Malignant Neoplasms;Mantle Cell Lymphoma;Memory;migration;Modeling;Modification;Multiple Myeloma;Mus;mutant;neutrophil;novel;Nucleic Acid Regulatory Sequences;Organ Size;Phenotype;Phosphorylation;Phosphotransferases;physiologic model;Plasma Cell Neoplasm;Plasmacytoma;Population;Predisposition;Process;Proliferating;Proto-Oncogene Proteins c-akt;Resistance;response;Role;Series;Signal Transduction;Sirolimus;Spleen;Susceptibility Gene;Susceptibility/Resistance Gene;T-Cell Proliferation;T-Lymphocyte;tumor,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,10008,NA,NA,NA,NA,29,NA,NA,749110,NA
11187920,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010013,NA,NA,1ZIABC010013-29,NCI:1368658\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569288 (contact),"ANDERSON, STEPHEN K (contact)",NA,NA,NA,Binding Sites;Bone Marrow Transplantation;Cell Differentiation process;Cell Physiology;Cell-Mediated Cytolysis;Cells;CRISPR/Cas technology;Data;Development;Elements;Family;Future;GATA1 gene;GEM gene;Gene Expression;Genes;Genetic Polymorphism;Genetic Variation;Goals;hematopoietic stem cell differentiation;HLA-C Antigens;Human;Interleukin-15;Introns;Investigation;KLRD1 gene;Ligands;Major Histocompatibility Complex;man;Molecular;Mus;Natural Killer Cells;novel;Phenotype;Population;programs;promoter;receptor;Receptor Cell;receptor expression;Regulation;Research;Role;T-Cell Receptor;Transcript;transcription factor;trophoblast;tumor;Virus;Work,Molecular Studies of Cellular Cytotoxicity,10013,NA,NA,NA,NA,29,NA,NA,1368658,NA
11187921,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010014,NA,NA,1ZIABC010014-29,NCI:1671735\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569290 (contact),"MUEGGE, KATHRIN  (contact)",NA,NA,NA,3-Dimensional;Affect;ATP phosphohydrolase;B-Lymphocytes;Cell Differentiation process;Cells;Childhood;Chromatin;Chromatin Loop;chromatin remodeling;Chromatin Structure;conditional knockout;Defect;DNA;DNA Double Strand Break;Embryonic Development;Enzymes;Epigenetic Process;Failure;Generations;Genetic Recombination;HELLS gene;Human;IgE;IgG1;IgG2;IgG3;Immune;Immune system;Immunocompetent;immunodeficiency;immunodeficiency-centromeric instability-facial anomalies syndrome;Immunoglobulin A;Immunoglobulin Class Switching;Immunoglobulin Switch Recombination;Immunoglobulins;Impairment;Knock-out;Knockout Mice;Lymphoid;Mediating;Molecular;Mutation;Organ;Patients;Play;precursor cell;Process;Production;Regulation;Role;Symptoms;Syndrome;Work,Epigenetic control during embryogenesis,10014,NA,NA,NA,NA,29,NA,NA,1671735,NA
11187922,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010017,NA,NA,1ZIABC010017-29,NCI:1025659\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6129912 (contact),"ADHYA, SANKAR  (contact)",NA,NA,NA,2019-nCoV;Bacterial Infections;Bacteriophages;Biotechnology;cancer cell;Collaborations;Communicable Diseases;COVID-19;developmental genetics;Diagnosis;Disease;Drug resistance;epidermal growth factor receptor VIII;Glioblastoma;human disease;Malignant Neoplasms;mouse model;Mus;nanobodies;Neutralization Tests;Phage Display;prevent;Publishing;Technology;Testing;Vaccines,"Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",10017,NA,NA,NA,NA,29,NA,NA,1025659,NA
11187923,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010027,NA,NA,1ZIABC010027-30,NCI:1912649\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777551 (contact),"HAGER, GORDON L (contact)",NA,NA,NA,Acute;Adrenal Cortex Hormones;Affect;Agonist;antagonist;Binding;Biochemical;Biophysics;Cell Nucleus;Cells;Chromatin;Crystallography;Cues;Development;Disease Progression;DNA;DNA Binding;DNA receptor;Endocrine system;Environment;fluorescence imaging;Gene Expression;Genes;Genetic Transcription;Glucocorticoid Receptor;hormonal signals;hormone response element;Human;Imaging Techniques;Ligand Binding;Ligands;live cell imaging;Mediating;Mediator;Methods;Mineralocorticoid Receptor;Modeling;Nuclear Hormone Receptors;Nuclear Receptors;Nucleoplasm;Population;programs;receptor;receptor function;Regulatory Element;Repression;Signal Transduction;steroid hormone;Steroid Receptors;Structure;System;Time;Transactivation;transcription factor;transmission process,Function of Steroid Receptors in Subcellular Compartments,10027,NA,NA,NA,NA,30,NA,NA,1912649,NA
11187924,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010030,NA,NA,1ZIABC010030-29,NCI:1613818\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569320 (contact),"AMBUDKAR, SURESH  (contact)",NA,NA,NA,ABCB1 gene;ABCC1 gene;ABCG2 gene;Adenine;Adenosine A3 Receptor;Affect;Affinity;Agonist;Antineoplastic Agents;Area;ATP phosphohydrolase;ATP-Binding Cassette Transporters;Baculovirus Expression System;Baculoviruses;Binding;Binding Sites;Biochemical;Biological Assay;Biological Availability;cancer cell;cancer drug resistance;Cancer Etiology;Cancer Patient;cancer therapy;Carrier Proteins;CCR;Cell surface;Cells;Chemicals;Chemoresistance;Chemotherapy-Oncologic Procedure;Chronic Disease;chronic pain;Clinical;Clinical Trials;Collaborations;Complement;Cryoelectron Microscopy;Data;design;Development;Docking;Dose;Drug Efflux;Drug Interactions;Drug Kinetics;drug repurposing;Drug resistance;Drug Transport;drug-sensitive;Exhibits;FDA approved;flexibility;Goals;Hela Cells;Homidium Bromide;Human;improved;in silico;inhibitor;innovation;Insecta;interdisciplinary approach;Ligands;Light;Link;Location;luminescence;Maryland;MDA MB 231;Mediating;Membrane;Mitochondria;Molecular;Molecular Conformation;molecular dynamics;molecular modeling;Multi-Drug Resistance;multidrug resistant cancer;Mutagenesis;mutant;Mutation;Mutation Analysis;Names;National Institute of Diabetes and Digestive and Kidney Diseases;Natural Products;novel therapeutic intervention;Nucleosides;Orphan;overexpression;Pharmaceutical Preparations;Photochemistry;Photosensitizing Agents;Play;prevent;Primary carcinoma of the liver cells;Production;programs;Property;Psoriasis;PUVA Photochemotherapy;Regulation;Resistance;Resolution;Rheumatoid Arthritis;Rhodamine 123;risk mitigation;Role;screening;Series;simulation;Site;small molecule;small molecule libraries;Structure;Substrate Specificity;success;Suppressor Mutations;systemic toxicity;Tariquidar;Testing;Therapeutic;thermostability;Time;triple-negative invasive breast carcinoma;Tyrosine Kinase Inhibitor;United States National Institutes of Health;Universities;uptake;Vinblastine;Work;Xenobiotics,Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,10030,NA,NA,NA,NA,29,NA,NA,1613818,NA
11187925,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010283,NA,NA,1ZIABC010283-27,NCI:1847578\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569413 (contact),"NUSSENZWEIG, ANDRE A. (contact)",NA,NA,NA,Achievement;Affect;Animals;Antigen Receptors;Area;Ataxia Telangiectasia;B-Cell Lymphomas;Burkitt Lymphoma;Cell Proliferation;cell type;Cells;Chimeric Proteins;Chromatin Structure;Chromosomal Instability;Chromosomal translocation;Chromosomes;Common Neoplasm;Complex;Defect;Detection;Development;DNA biosynthesis;DNA Damage;DNA Double Strand Break;DNA lesion;DNA Repair;Double Strand Break Repair;Future;Gene Amplification;Genetic Recombination;Genome Stability;Genomic Instability;Germ Cells;Goals;Hematopoietic Neoplasms;Hereditary Disease;Human;immunodeficiency;Karyotype;Knock-out;Knockout Mice;Lymphocyte;Maintenance;Malignant lymphoid neoplasm;Malignant Neoplasms;Mammalian Cell;Meiotic Recombination;Monitor;mouse model;Mus;Nijmegen Breakage Syndrome;Nonhomologous DNA End Joining;Oncogenes;Oncogenic;Pathway interactions;Physiological;Predisposition;Premature aging syndrome;Proteins;Radiation Tolerance;Reaction;Reciprocal Translocation;repaired;Research;response;Signal Transduction;Solid Neoplasm;System;TP53 Gene Inactivation;Transgenic Mice,DNA repair,10283,NA,NA,NA,NA,27,NA,NA,1847578,NA
11187926,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010292,NA,NA,1ZIABC010292-27,NCI:361492\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569429 (contact),"WEISSMAN, ALLAN M (contact)",NA,NA,NA,Affinity;Antibodies;Area;Back;Binding;Binding Sites;Botulinum Toxins;C-terminal;CCR;Clinical;Deubiquitinating Enzyme;Disease;Dissociation;Endoplasmic Reticulum;Enzymes;Family member;Federal Government;Goals;Heterogeneity;Iatrogenesis;insight;interest;Intoxication;Light;Longevity;Malignant Neoplasms;Membrane;Modality;Molecular;Mutation;Neurotoxins;novel;Play;Poisoning;Protac;protein function;Proteins;Publishing;recruit;response;Ring Finger Domain;Role;Scientist;Serotyping;Services;Site;small molecule;Structure;Structure-Activity Relationship;Substrate Interaction;System;Targeted Toxins;Therapeutic;Toxin;TRAF2 gene;Transfection;UBE2G2 gene;Ubiquitin;ubiquitin isopeptidase;ubiquitin ligase;Ubiquitin-Activating Enzymes;Ubiquitin-Conjugating Enzymes;ubiquitin-protein ligase;Ubiquitination;United States National Institutes of Health;Woman;Work;Yeasts,Enzymes and Substrates of the Ubiquitin Conjugating System,10292,NA,NA,NA,NA,27,NA,NA,361492,NA
11187927,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010300,NA,NA,1ZIABC010300-27,NCI:2343076\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6858519 (contact),"MCVICAR, DANIEL W. (contact)",NA,NA,NA,Aconitic Acid;Animal Model;Animals;Area;Biochemical Pathway;Biological Assay;Biology;cancer therapy;Carbon;Carboxy-Lyases;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Physiology;cell type;Cells;Cellular Metabolic Process;Coenzyme A;Colitis;Colon;Complex;Development;Disadvantaged;Disease;Dissection;engineered T cells;Environment;Enzymatic Biochemistry;Enzymes;experimental study;feeding;Fermentation;Foundations;Generations;Genes;Genetic Transcription;Glucose;glucose tolerance;Glycolysis;Goals;Hepatocyte;High Fat Diet;Host Defense Mechanism;Human;Immune;immune modulating agents;Immune response;Immunologics;Immunosuppression;In Vitro;in vivo;Inflammation;Inflammatory;inhibitor;Insulin Resistance;interest;Investigation;Knockout Mice;Label;Leukocytes;lipid metabolism;Lipids;Liver;Macrophage;Maintenance;Malignant Neoplasms;Mediating;Metabolic;Metabolic Diseases;Metabolic Pathway;metabolomics;Mitochondria;Molecular Biology;Mus;Muscle;Natural Killer Cells;Nature;neoplastic cell;nonalcoholic steatohepatitis;Nutritional Requirements;Obesity;oxidation;Oxidation-Reduction;Oxidative Phosphorylation;Palmitates;Pathogenicity;Patients;Phenotype;Phosphoenolpyruvate;Phosphorylation;Physiological;Physiology;Play;Predisposition;Production;programs;Proliferating;Protein Isoforms;Proteins;Pyruvate;Pyruvate Kinase;Pyruvate Metabolism Pathway;Regulation;Resources;Role;Source;System;T-Cell Proliferation;T-Lymphocyte;Therapeutic;therapeutic target;Time;transcription factor;tumor;Tumor Expansion;tumor growth;tumor microenvironment;tumor progression;Tumor Promotion;Tumor-associated macrophages;Uncertainty;Vascularization;Work,Immunometabolism in Cancer and Inflammation,10300,NA,NA,NA,NA,27,NA,NA,2343076,NA
11187928,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010301,NA,NA,1ZIABC010301-27,NCI:1588137\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6212020 (contact),"KREITMAN, ROBERT  (contact)",NA,NA,NA,Aftercare;Agammaglobulinaemia tyrosine kinase;anaplastic thyroid cancer;anti-CD20;Anti-CD22;B lymphoid malignancy;B-Cell Leukemia;B-Lymphocytes;Biological Assay;Biology;Blood;BRAF gene;Cancer Therapy Evaluation Program;CD22 gene;CD22 Immunotoxin;cell bank;Cells;Chemoresistance;chemotherapy;chimeric antigen receptor T cells;Cladribine;Clinical;clinical development;Clinical Trials;Collaborations;Combination Drug Therapy;COVID-19 pandemic;cytotoxicity;Data Science;Development;Disease;Dose;Drug Combinations;Eligibility Determination;exome;exome sequencing;Exotoxins;experience;FDA approved;Follicular Lymphoma;follow-up;Foundations;genetic profiling;Goals;Hairy Cell Leukemia;hairy cell leukemia cell;Hematologic Neoplasms;high risk population;Histology;immunogenicity;Immunoglobulins;Immunotoxins;inhibitor;Laboratories;large cell Diffuse non-Hodgkin&apos;s lymphoma;leukemia/lymphoma;Leukemic Cell;Licensing;Life;Lymphoma;Malignant Neoplasms;Mantle Cell Lymphoma;Methods;Mitogen-Activated Protein Kinase Inhibitor;Mitogen-Activated Protein Kinases;Molecular;MS4A1 gene;Multicenter Trials;Mutation;Newly Diagnosed;next generation sequencing;Non-Hodgkin&apos;s Lymphoma;novel therapeutic intervention;Ohio;participant enrollment;Pathogenesis;Pathway interactions;Patients;Pentostatin;Pharmaceutical Preparations;Pharmacologic Substance;Phase;phase II trial;Population;Preparation;Prognosis;programs;Progression-Free Survivals;Proteins;Pseudomonas;Publishing;purine analog;randomized trial;Recombinants;Refractory;Regimen;Relapse;Reporting;Residual Neoplasm;response;Retreatment;rituximab;RNA;Sampling;single cell sequencing;small molecule;Solid Neoplasm;standard of care;targeted agent;targeted treatment;Testing;Time;Toxicity due to chemotherapy;Toxin;transcriptome;Treatment Efficacy;Treatment-related toxicity;Tumor Burden;Tumor Markers;Tyrosine Kinase Inhibitor;United States National Institutes of Health;Universities;Variant;Waldenstrom Macroglobulinemia;Work,Development of Recombinant Toxins to Treat Hematologic Malignancies,10301,NA,NA,NA,NA,27,NA,NA,1588137,NA
11187929,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010304,NA,NA,1ZIABC010304-26,NCI:2488197\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692209 (contact),"SAMELSON, LAWRENCE  (contact)",NA,NA,NA,Adaptor Signaling Protein;antigen binding;Antigens;Binding;Biochemical;Biophysics;Cell membrane;Cells;Cellular biology;chimeric antigen receptor;Complex;Coupled;Dissociation;Distal;Elements;Enzyme Activation;enzyme pathway;Enzymes;Genetic Techniques;Human;imaging study;Immune response;improved;In Vitro;in vivo;inorganic phosphate;Kinetics;Link;Lymphocyte;Lymphocyte-Specific p56LCK Tyrosine Protein Kinase;Malignant Neoplasms;Membrane;Microscopic;Microscopy;Molecular;molecular site;mouse model;neoplastic cell;Pathologic;Pathway interactions;Patients;Phosphorylation;Phosphotransferases;Process;Property;Protein Tyrosine Kinase;Proteins;Publishing;receptor;Receptor Protein-Tyrosine Kinases;recruit;Reporting;Signal Transduction;Signaling Molecule;Signaling Protein;Site;src-Family Kinases;Structure;study characteristics;superresolution microscopy;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;Transmembrane Domain;tumor;Tyrosine;ultra high resolution;ZAP-70 Gene,Biochemical Basis of T Cell Activation,10304,NA,NA,NA,NA,26,NA,NA,2488197,NA
11187930,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010307,NA,NA,1ZIABC010307-25,NCI:2051198\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201244 (contact),"STERNECK, GISELA  (contact)",NA,NA,NA,Address;Area;Biological Assay;Biological Models;Breast Cancer Cell;Breast Cancer cell line;Breast Cancer Model;Breast Epithelial Cells;cancer cell;CCAAT-enhancer-binding protein-delta;Cell Adhesion;cell growth;Cell Line;cell transformation;Cell-Cell Adhesion;Cells;Cessation of life;Classification;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;Cues;Development;Dinoprostone;Disseminated Malignant Neoplasm;E-Cadherin;Embolism;Event;Exhibits;Gene Expression;Genes;glycogen synthase kinase 3 beta;Goals;Hematopoiesis;Human;Hypoxia;immune function;Immune response;In Vitro;Inflammation;inflammatory breast cancer;insight;Invaded;Investigation;Knock-out;Knockout Mice;Malignant Breast Neoplasm;Malignant Neoplasms;Mammary gland;Mammary Neoplasms;Mediating;Metabolic;Metastatic breast cancer;Modeling;Modification;Molecular;Molecular Target;mouse model;Mus;Myelogenous;Myeloid Progenitor Cells;Neoplasm Metastasis;neoplastic cell;neutrophil;novel therapeutic intervention;Pathway interactions;patient derived xenograft model;Phenotype;potential biomarker;Property;Proteins;PTGS2 gene;racial disparity;Rare Diseases;Regulation;Research;response;Role;Signal Pathway;Signal Transduction;Skin;socioeconomic disparity;Therapeutic;three dimensional cell culture;Tissues;transcription factor;Transgenic Organisms;tumor;tumor microenvironment;tumor progression;Tumor Promotion;tumorigenic;United States National Institutes of Health;Work,Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,10307,NA,NA,NA,NA,25,NA,NA,2051198,NA
11187931,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010308,NA,NA,1ZIABC010308-26,NCI:425032\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777551 (contact),"HAGER, GORDON L (contact)",NA,NA,NA,Affect;Agonist;Androgens;antagonist;Biological;Biological Assay;Biosensor;cell fixation;Cell Line;Cell Nucleus;Cells;chemical association;Chimera organism;Cytoplasm;Detection;Endocrine Disruptors;Endocrine system;Environment;Environmental Exposure;Estrogens;Exposure to;Glucocorticoid Receptor;Glucocorticoids;Gonadal Steroid Hormones;Green Fluorescent Proteins;Health;Health Hazards;Hormones;Human;human disease;in vivo imaging;Label;Ligand Binding Domain;Ligands;Methods;mimetics;Natural Compound;NF1 gene;novel;Nuclear;Nuclear Receptors;Organism;Penetration;Prevalence Study;Progesterone Receptors;Progestins;Protein Isoforms;receptor;receptor function;Reporting;response;Role;Sampling;screening;Soil;Stains;Steroids;Testing;Time;Water Pollutants;water sampling;Water Supply,In vivo Imaging Analysis of Steroid-Nuclear Receptor Function,10308,NA,NA,NA,NA,26,NA,NA,425032,NA
11187932,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010309,NA,NA,1ZIABC010309-26,NCI:2479954\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8120866 (contact),"MISTELI, THOMAS A (contact)",NA,NA,NA,Affect;Aging;Architecture;Biochemical;Biological;Biological Models;Cell Nucleus;Cells;Development;Disease;Genome;Genome Mappings;Goals;Health;Human;imaging approach;imaging modality;in vivo;Laboratories;Malignant Neoplasms;Maps;Methods;Molecular;Nuclear;Premature aging syndrome;Process;Progeria;Role;Sampling;screening;Syndrome;Tissues,Nuclear Architecture and Disease,10309,NA,NA,NA,NA,26,NA,NA,2479954,NA
11187933,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010313,NA,NA,1ZIABC010313-26,NCI:930599\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77856862 (contact),"WANG, XIN WEI  (contact)",NA,NA,NA,Acceleration;Area Under Curve;arm;Biliary Tract Cancer;Biological Markers;CA-19-9 Antigen;cancer cell;cancer clinical trial;cancer diagnosis;Cancer Etiology;Cancer Patient;Case/Control Studies;Cells;Cessation of life;Characteristics;chronic liver disease;Classification;clinical diagnosis;cohort;curative treatments;Data;Development;Diagnosis;diagnostic strategy;Disease;early detection biomarkers;Early Diagnosis;early onset;Epitopes;exome;exome sequencing;Exposure to;Failure;Formalin;human virome;Image;immune cell infiltrate;Immune checkpoint inhibitor;Immunity;Immunologic Surveillance;Immunoprecipitation;Immunotherapy;improved;improved outcome;Individual;interest;Intrahepatic Cholangiocarcinoma;Lesion;Libraries;liver function;Liver neoplasms;Longitudinal cohort;Longterm Follow-up;machine learning method;Malignant neoplasm of liver;Malignant Neoplasms;Methods;Modality;Molecular;mortality;National Cancer Institute;Neoplasm Circulating Cells;neoplastic cell;Outcome;Paraffin Embedding;Pathogenicity;patient screening;patient subsets;Patient-Focused Outcomes;Patients;Phage Display;Phage ImmunoPrecipitation Sequencing;Population Control;Populations at Risk;precision medicine;Primary carcinoma of the liver cells;Primary Malignant Neoplasm of Liver;Prospective Studies;Recording of previous events;Reporting;Research;response;Risk;Risk Factors;risk stratification;Sampling;screening;Sensitivity and Specificity;Serology;Serum;Site;specific biomarkers;Specimen;Subgroup;Surveillance Program;survival outcome;Time;Tissues;transcriptome;transcriptome sequencing;treatment response;tumor;Tumor Biology;Validation;Viral;Viral Antibodies;Viral hepatitis;Virus;Virus Diseases;virus host interaction;α-Fetoproteins,"Strategies for improving early detection, diagnosis and treatment of liver cancer",10313,NA,NA,NA,NA,26,NA,NA,930599,NA
11187934,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010319,NA,NA,1ZIABC010319-26,NCI:2187700\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8320722 (contact),"XIA, DI S (contact)",NA,NA,NA,3-Dimensional;Aconitate Hydratase;Active Biological Transport;Address;Agriculture;Anabolism;analog;anti-fungal agents;Antibiotics;Area;atovaquone;ATP Hydrolysis;ATP-Binding Cassette Transporters;Automobile Driving;Behavior;Binding;Biochemical;Bioenergetics;Biogenesis;Biological;Blood - brain barrier anatomy;Bos taurus;cancer therapy;Cattle;Cell Physiology;Cell surface;Cells;Cellular biology;Chemotherapy-Oncologic Procedure;Citric Acid Cycle;Clinic;clinical application;Coenzyme Q10;Complex;Core Assembly;Couples;Coupling;Cryoelectron Microscopy;Crystallography;Cytochrome bc1 Complex;cytochrome c;cytotoxicity;Data Set;design;Development;Drug resistance;Electron Transport Complex III;Elements;Energy Metabolism;Enzymes;Family;flexibility;Focus Groups;fungicide;Glycoproteins;Goals;Heavy Metals;Homologous Gene;Human;in silico;Individual;Infection;inhibitor;interest;Intervention;Ion Channel;Knowledge;knowledge integration;Laboratory Animals;Lead;Link;Lobe;Malate Dehydrogenase;Malignant Neoplasms;Medical;Membrane;Membrane Proteins;Membrane Transport Proteins;Methods;Methylation;microbial;Mitochondria;Mitochondrial Membrane Protein;Molecular;Molecular Conformation;Monoclonal Antibodies;Motion;Movement;Multi-Drug Resistance;Mus;mutant;Mutation;novel;Nucleotides;Organism;overexpression;oxidation;Oxidoreductase;Oxygen;pathogen;pathogenic microbe;Pathway interactions;Pharmaceutical Preparations;pharmacologic;photosynthetic bacteria;Pichia;Positioning Attribute;programs;Protein Conformation;Protein Dynamics;protein function;Proteins;Protons;receptor;Regulation;Research;Research Design;Resistance;Resolution;respiratory;Respiratory Chain;Rhodobacter sphaeroides;Role;Rotation;Series;Site;small molecule;small molecule libraries;Structure;Structure-Activity Relationship;Substrate Interaction;success;Succinates;Surface;targeted agent;Tariquidar;Testing;Therapeutic;Therapeutic Agents;therapeutic protein;Time;Transmembrane Domain;ubiquinol;Ubiquinone;Variant;virtual screening;Visualization;Work;Zebrafish,Structural Basis of Biological Membrane Protein Functions and Drug Resistance,10319,NA,NA,NA,NA,26,NA,NA,2187700,NA
11187935,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010326,NA,NA,1ZIABC010326-25,NCI:1303230\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6801952 (contact),"JI, XINHUA  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Amino Acids;Anti-Bacterial Agents;anti-cancer;Anti-HIV Agents;anti-microbial drug;antimicrobial;Basic Science;Binding;Biochemical;Biogenesis;Biological;Biological Assay;Biological Models;Biophysics;Catalysis;Cell division;cell growth;Complex;Couples;Data;design;Development;Dimerization;DNA-Directed RNA Polymerase;Double-Stranded RNA;Drug Design;drug development;endonuclease;Endoribonucleases;enzyme pathway;Eukaryota;Exhibits;Family;Folic Acid;Goals;Guanosine Triphosphate Phosphohydrolases;helicase;Hydrolysis;inhibitor;Ions;macromolecule;Magnesium;magnesium ion;Malignant Neoplasms;Mammals;Maps;member;microorganism;Modeling;Molecular Conformation;novel;Nucleotides;Orthologous Gene;phosphodiester;Play;Prokaryotic Cells;Proteins;Reaction;Recycling;Research;Ribonuclease III;Ribonucleases;RNA;RNA Interference;RNA metabolism;RNA Processing;Role;Side;Site;Site-Directed Mutagenesis;structural biology;Structure;System;targeted agent;therapeutic development;transcription factor;Virus Diseases;Yeasts,"Biomolecular Structure and Mechanism, Structure-Based Drug Design",10326,NA,NA,NA,NA,25,NA,NA,1303230,NA
11187936,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010329,NA,NA,1ZIABC010329-25,NCI:1399918\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692581 (contact),"MORRISON, DEBORAH  (contact)",NA,NA,NA,Affinity;anti-cancer research;Basic Science;Binding;Binding Proteins;Biochemical;Biological Assay;Bioluminescence;BRAF gene;cancer cell;cancer therapy;Cell membrane;Cell Survival;Cells;Cellular Stress;Clinical Research;Collaborations;Collection;Complex;computerized tools;Cryoelectron Microscopy;developmental disease;dimer;Dimerization;Disease;Disease Progression;Division of Cancer Epidemiology and Genetics;Down-Regulation;Drug resistance;Effectiveness;Embryo;Energy Transfer;Environment;Enzymes;Event;Exhibits;Extramural Activities;Family;Family member;Feedback;gain of function;Goals;Growth;Growth and Development function;Guanosine Triphosphate Phosphohydrolases;high resolution imaging;high-throughput drug screening;Human;human disease;inhibitor;kinase inhibitor;KRAS2 gene;Laboratories;Length;Link;Lipids;Malignant Neoplasms;Mammalian Cell;MAP Kinase Gene;Mass Spectrum Analysis;Mediating;MEKs;member;Methodology;Modeling;Molecular;Molecular Target;Monitor;monomer;Movement;mutant;Mutation;Natural Products;NCI Center for Cancer Research;Neoplasm Metastasis;novel;Pathway interactions;patient advocacy group;Pharmacotherapy;Phosphorylation;Positioning Attribute;Post-Translational Protein Processing;preference;programs;Proliferating;Protein Kinase;Proteins;raf Kinases;RAS genes;RAS inhibition;ras Proteins;Ras Signaling Pathway;Ras/Raf;Regulation;Reporting;Research;Research Personnel;Resolution;Role;Route;Severities;Signal Transduction;Signal Transduction Pathway;structural biology;Structure;System;targeted treatment;Techniques;Tertiary Protein Structure;Therapeutic;Therapeutic Intervention;Time;tool;tumor progression;tumorigenesis;Work;Zebrafish,Regulation of Ras-Dependent Signal Transduction Pathways,10329,NA,NA,NA,NA,25,NA,NA,1399918,NA
11187937,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010331,NA,NA,1ZIABC010331-25,NCI:1039810\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802050 (contact),"ACHARYA, JAIRAJ  (contact)",NA,NA,NA,Antineoplastic Agents;Apoptosis;base;Biological Process;Brain;cancer cell;cancer therapy;Cell Death;cell growth;Cells;ceramide 1-phosphate;ceramide kinase;Ceramides;Cessation of life;chemotherapy;Chemotherapy-Oncologic Procedure;Clinical;Development;diabetic;Dietary Fats;Disease;Drosophila genus;drug resistance development;Environment;Enzymes;Etiology;experimental study;Failure;Fat Body;Generations;Genetic;gut-brain axis;Hyperglycemia;Hyperlipidemia;in vivo;Inhibition of Apoptosis;Insulin;insulin secretion;insulin-like peptide;Investigation;Link;Lipase;Lipids;Lipoprotein (a);lipoprotein lipase;Malignant Neoplasms;Mediating;Metabolic Pathway;Metabolism;Midgut;Molecular;Multi-Drug Resistance;mutant;particle;Phospholipids;Physiological;Physiology;Process;Proliferating;Publishing;Regulation;Research;Research Personnel;response;Signal Transduction;Sphingolipids;Structure;success;therapeutically effective,Phospholipid and Sphingolipid Signaling in Drosophila,10331,NA,NA,NA,NA,25,NA,NA,1039810,NA
11187938,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010334,NA,NA,1ZIABC010334-25,NCI:1021081\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802097 (contact),"FELBER, BARBARA K (contact)",NA,NA,NA,Achievement;Acquired Immunodeficiency Syndrome;Address;Adjuvant;AIDS clinical trial group;Antibody Response;Antigens;Chronic;Clinic;clinical development;Clinical Trials;cohort;Collaborations;Combination immunotherapy;combinatorial;COVID-19;cytokine;Cytotoxic T-Lymphocytes;Data;Data Analyses;Development;Disease remission;DNA;DNA delivery;DNA Vaccines;Electroporation;Elements;Epitopes;Exclusion;Exhibits;expression vector;Formulation;frontier;Genes;Goals;Highly Active Antiretroviral Therapy;HIV;HIV Infections;HIV vaccine;HIV Vaccine Trials Network;HIV-1;Homologous Gene;Human;human disease;Immune checkpoint inhibitor;Immune response;Immunization;immunogenic;Immunologics;Immunotherapeutic agent;Immunotherapy;in vivo;Infection;insight;Interleukin-12;Length;lipid nanoparticle;Macaca;Mediating;Memory;Messenger RNA;Methodology;Methods;Modality;Modeling;Molecular;mRNA lipid nano particle vaccine;Mus;National Institute of Allergy and Infectious Disease;novel;novel strategies;novel vaccines;Nucleic Acid Vaccines;Participant;Pathway interactions;Persons;Phase;preclinical trial;prevent;Preventive vaccine;Process;Proteins;Proteome;Publications;Regimen;Research;response;RNA vaccine;Secondary Immunization;SIV;T cell response;T-Lymphocyte;Testing;therapeutic vaccine;tool;Translating;Translations;treatment strategy;vaccin protein;Vaccination;vaccine development;vaccine evaluation;vaccine platform;vaccine strategy;vaccine trial;Vaccines;Variant;Viral;Viral reservoir;Virus;Virus Diseases,Conserved Element DNA Vaccine,10334,NA,NA,NA,NA,25,NA,NA,1021081,NA
11187939,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010338,NA,NA,1ZIABC010338-25,NCI:775415\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123123 (contact),"LEWANDOSKI, MARK B (contact)",NA,NA,NA,Affect;allantois;Apoptotic;Behavior;Biological;Biology;bone;cancer therapy;cardiogenesis;cell behavior;Cell Death;Cell Hypoxia;Cell Maintenance;Cell Survival;Cells;Collaborations;Communities;Complex;Computer Models;Congenital Abnormality;Defect;Dermis;Development;Disease;Embryo;Embryonic Development;external genitalia;Family;FGF17 gene;Fibroblast Growth Factor;fibroblast growth factor 18;Gene Expression;Generations;Genes;Genetic;genetic manipulation;Genetic Models;Genetic study;Genets;Goals;Growth Factor Gene;Health;HIF1A gene;Hindlimb;Human;Hypoxia;innovation;insight;Intermediate Mesoderm;Kidney;Knowledge;Ligands;Link;male;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant Neoplasms;Measures;medical schools;Mesoderm;Messenger RNA;migration;Modeling;Molecular;Morphogenesis;mouse genetics;Mus;Muscle;mutant;nephrogenesis;notch protein;novel;Oxygen;Paper;Pathway interactions;Play;Positioning Attribute;Process;Proliferating;Publications;Publishing;reproductive tract;Role;Series;Signal Transduction;Somites;somitogenesis;spine bone structure;stem cells;Technology;Testicular Neoplasms;Tissues;tool;transcription factor;tumorigenesis;Undifferentiated;vertebra body;vertebrate embryos;WNT Signaling Pathway;Work,The Role of Fgf Signaling in Vertebrate Development,10338,NA,NA,NA,NA,25,NA,NA,775415,NA
11187940,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010345,NA,NA,1ZIABC010345-25,NCI:2274833\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414492 (contact),"YAMAGUCHI, TERENCE  (contact)",NA,NA,NA,3-Dimensional;Adoption;Adult;adult stem cell;beta catenin;Binding;Brain;Cancer Etiology;cancer therapy;Cardiac;Cell Culture Techniques;Cell Reprogramming;Cells;ChIP-seq;Coupled;Data;Development;Developmental Process;DNA;DNA Binding;Embryo;Embryonic Development;embryonic stem cell;Enhancers;Environment;Epiblast;experimental study;Family;Fingers;gastrulation;Gene Expression;Gene Expression Profile;gene regulatory network;gene repression;Genes;Genetic Transcription;Germ Layers;Goals;Head;Heart;Homeobox;In Vitro;insight;Knowledge;Laboratories;Malignant Neoplasms;Manuscripts;member;Mesoderm;Methods;Modeling;Molecular;multiple omics;Mus;Muscle;Musculoskeletal;Mutation;Natural regeneration;nerve stem cell;neural;novel;overexpression;Pathway interactions;Pattern;Play;Pluripotent Stem Cells;Preparation;prevent;Primitive Streaks;progenitor;programs;promoter;recruit;Regenerative Medicine;Regulation;Repression;Reproducibility;response;Role;self renewing cell;self-renewal;Signal Pathway;Signal Transduction;Signaling Molecule;Somites;Spinal Cord;spinal cord regeneration;stem cell biology;Stem Cell Development;stem cell differentiation;stem cell homeostasis;stem cell self renewal;stem cells;Tail;TCF Transcription Factor;Time;Tissues;transcription factor;Transcription Repressor;transcriptome sequencing;tumorigenesis;vertebrate embryos;WNT Signaling Pathway;Work;Xenopus laevis;Zinc Fingers,The Role of Wnt Genes in Vertebrate Development and Cancer,10345,NA,NA,NA,NA,25,NA,NA,2274833,NA
11187941,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010348,NA,NA,1ZIABC010348-25,NCI:1696584\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8121992 (contact),"WLODAWER, ALEXANDER  (contact)",NA,NA,NA,2019-nCoV;Acquired Immunodeficiency Syndrome;AIDS prevention;anti-cancer;Anti-HIV Agents;Anti-malarials;Antibodies;Area;Aspartic Endopeptidases;Binding;Binding Sites;C-terminal;Carbohydrates;CCAAT-Enhancer-Binding Proteins;Chimeric Proteins;Clinical;combat;Complex;COVID-19;Cryoelectron Microscopy;Crystallization;Crystallography;cytokine;Cytokine Receptors;design;dimer;Disaccharides;drug development;Drug resistance;E1A-associated p300 protein;endopeptidase La;Engineering;Enhancers;Enzymes;EP300 gene;Family;Family member;Feline Immunodeficiency Virus;Histones;HIV Infections;HIV Protease;HIV-1;Human;Human T-lymphotropic virus 1;inhibitor;insight;interest;Interferons;interleukin 20;Interleukin-10;interleukin-19;interleukin-22;Interleukin-24;Investigation;JAK1 gene;Lectin;leukemia;Ligands;Malignant Neoplasms;Mannose;member;method development;monomer;neutralizing antibody;Oligosaccharides;Pepsin A;Peptide Hydrolases;peptide structure;Peptides;Pharmaceutical Preparations;Phosphorylation;plasmepsin;preclinical trial;prevent;promoter;Property;protein function;Protein Kinase;protein structure;Proteins;receptor;recruit;Research;Resolution;Serine Proteinase Inhibitors;Source;STAT1 gene;Structure;Structure-Activity Relationship;Subcellular structure;Tandem Repeat Sequences;Techniques;Transcription Coactivator;Transcriptional Activation;Transferase;Variant;Viral;Viral Physiology;Work;X ray diffraction analysis;X-Ray Crystallography;Zinc,Protein Structure,10348,NA,NA,NA,NA,25,NA,NA,1696584,NA
11187942,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010350,NA,NA,1ZIABC010350-25,NCI:1786891\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802097 (contact),"FELBER, BARBARA K (contact)",NA,NA,NA,2019-nCoV;adaptive immunity;Adjuvant;Adverse effects;AIDS prevention;Anatomy;Animals;Antibodies;Antibody titer measurement;antibody-dependent cell cytotoxicity;antibody-dependent cellular phagocytosis;Antigens;B-Lymphocytes;Binding;Biological Markers;Biology;Blood;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Cellular Immunity;Codon Nucleotides;Combined Vaccines;Complex;CXCL10 gene;CXCL13 gene;CXCR3 gene;cytokine;Data;Dendritic Cells;design;Development;Disease;DNA;DNA delivery;DNA Vaccines;draining lymph node;efficacy testing;Electroporation;env Gene Products;Epitopes;experience;expression vector;FCGR3A gene;FLT3 ligand;Gene Expression;Genes;Goals;HIV;HIV Antigens;HIV Envelope Protein gp120;HIV Infections;HIV vaccine;Human;Humoral Immunities;IL7 gene;Immune;Immune response;Immunity;Immunization;immunogenicity;Immunologics;Immunophenotyping;improved;in vivo;Infection;Infection prevention;Interferon Type II;Interleukin-12;Interleukin-15;Interleukin-6;Intramuscular;Liposomes;Longevity;Lower respiratory tract structure;lymph nodes;Macaca;Maintenance;Measurement;Mediating;Messenger RNA;Methodology;Methods;Modality;Modeling;Molecular;mRNA Expression;Mucosal Immune Responses;mucosal site;Myelogenous;nanoparticle;nanoparticle delivery;neutralizing antibody;novel;Nucleic Acid Amplification Tests;Nucleic Acid Vaccines;Nucleic Acids;Pfizer-BioNTech COVID-19 vaccine;plasmid DNA;Play;predictive marker;Production;Proliferating;Proteins;proteomic signature;Proteomics;Protocols documentation;recombinant viral vector;rectal mucosa;Regimen;Relative Risks;Reporting;Research;response;Risk;RNA;RNA vaccination;RNA vaccine;Role;Route;SARS-CoV-2 infection;scaffold;Secondary Immunization;Severe Acute Respiratory Syndrome;Shapes;simian human immunodeficiency virus;Site;SIV;Stromal Cell-Derived Factor 1;Structure of germinal center of lymph node;Structure of mucous membrane of nose;T cell response;T-Lymphocyte Subsets;Testing;TNF gene;Translating;transmission process;treatment strategy;Vaccinated;Vaccination;vaccine delivery;vaccine development;vaccine efficacy;vaccine formulation;vaccine platform;vaccine strategy;vaccine-induced immunity;Vaccines;vaginal mucosa;vector;vector vaccine;Viral reservoir;Virus,Development  testing of nucleic acid-based vaccine for HIV  other indications,10350,NA,NA,NA,NA,25,NA,NA,1786891,NA
11187943,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010379,NA,NA,1ZIABC010379-25,NCI:3332333\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777676 (contact),"WANG, YUN XING M (contact)",NA,NA,NA,Atomic Force Microscopy;Biochemical;Biological;biomacromolecule;Biophysics;clinical application;Collaborations;design;Devices;Event;Gene Expression;Goals;insight;interest;Knowledge;learning network;Machine Learning;Methods;molecular dynamics;Molecular Structure;neural network;NMR Spectroscopy;novel strategies;Nucleic Acids;Proteins;Research;RNA;Roentgen Rays;structural biology;Structure;Translating;Translation Process;Translational Research;X-Ray Crystallography,Search for the Structural Basis of Biomacromolecular Function and Activity,10379,NA,NA,NA,NA,25,NA,NA,3332333,NA
11187944,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010387,NA,NA,1ZIABC010387-25,NCI:947684\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Amino Acid Substitution;Arginine;Benign;Binding;Biological Assay;Biological Process;BRCA2 gene;C-terminal;Cancer-Predisposing Gene;carcinogenesis;Cells;Classification;ClinVar;Codon Nucleotides;Defect;design;Development;DNA Binding Domain;DNA Damage;Embryo;epidemiologic data;Exhibits;Female;Fetal Liver;Fibroblasts;Genes;Genome Stability;Genotype;Glutamine;Hematopoietic;Hepatocyte;Human;In Vitro;inhibitor;Lead;Length;male;Malignant Breast Neoplasm;Malignant Neoplasms;Medicine;Mitomycin C;Mouse Embryonic Stem Cells;mouse model;Mus;Mutant Strains Mice;Mutation;Nature;Oligonucleotides;Oligosaccharides;Pathogenicity;Physiological;Poly(ADP-ribose) Polymerase Inhibitor;Positioning Attribute;Predisposition;Radiation;Reporting;response;tumor;tumorigenesis;Variant;variant of unknown significance,Functional Analysis of Breast Cancer Susceptibility Genes in Mice,10387,NA,NA,NA,NA,25,NA,NA,947684,NA
11187945,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010390,NA,NA,1ZIABC010390-25,NCI:752388\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692419 (contact),"TESSAROLLO, LINO  (contact)",NA,NA,NA,Affinity;Aggressive behavior;Alternative Splicing;Alzheimer&apos;s Disease;Animal Model;Anxiety;Behavior;Binding;Brain-Derived Neurotrophic Factor;Cell Differentiation process;Clinic;Clinical Trials;Complex;Correlative Study;Development;Disease;Environment;Exhibits;Family;frontal lobe;Generations;Genes;Growth Factor;Human;improved;in vivo;interest;Knowledge;Laboratories;Learning;Length;Link;Maintenance;Malignant Neoplasms;Mediating;Mental Depression;Molecular Mechanisms of Action;mouse model;Mus;neoplastic cell;Nephroblastoma;Nerve Growth Factor Receptors;Nervous System;Neuroblastoma;Neurodegenerative Disorders;neurotrophic factor;Neurotrophic Tyrosine Kinase Receptor Type 1;neurotrophin 4;Normal Cell;Organism;overexpression;Pancreatic carcinoma;Parkinson Disease;Pathway interactions;Peptides;Peripheral;Phosphotransferases;Physiological;preclinical study;Prognosis;Prostate carcinoma;Protein Isoforms;receptor;Receptor Protein-Tyrosine Kinases;Receptor Signaling;Regulation;Research;Role;side effect;Signal Pathway;Structure;Suicide;therapeutic target;transcriptional coactivator p75;tumor;Vertebrates,Role of Neurotrophins in the Development of the Mammalian Nervous System,10390,NA,NA,NA,NA,25,NA,NA,752388,NA
11187946,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010391,NA,NA,1ZIABC010391-25,NCI:752388\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692419 (contact),"TESSAROLLO, LINO  (contact)",NA,NA,NA,Address;Adult;Aggressive behavior;Animal Model;Birth;Brain-Derived Neurotrophic Factor;Cardiac;Cardiac Myocytes;Cell Physiology;Development;Glucose;Goals;Human;Immune;Immune system;in vivo;Inflammatory Response;insulin secretion;Intervention;Malignant Neoplasms;Mediating;Molecular;Mus;Nephroblastoma;Nervous System;Neuroblastoma;neurotrophic factor;overexpression;Pancreatic carcinoma;Pathway interactions;pharmacologic;Phase;Physiological;Physiology;Prognosis;Prostate carcinoma;Protein Isoforms;receptor;receptor expression;Reporting;Role;Signal Transduction;Structure;Structure of beta Cell of islet;System,Role of Trk Receptors in the Development and Function of Non-neuronal Structures,10391,NA,NA,NA,NA,25,NA,NA,752388,NA
11187947,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010411,NA,NA,1ZIABC010411-25,NCI:1963523\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8314239 (contact),"ALADJEM, MIRIT  (contact)",NA,NA,NA,Address;Affect;Anaphase;anti-cancer therapeutic;Back;Binding;Biochemical;biochemical tools;Bioinformatics;cancer cell;cancer therapy;Cell Cycle;Cell division;cell growth;Cell Proliferation;cell type;Cells;chemotherapeutic agent;Chromatin;chromatin modification;Chromosome abnormality;chromosome replication;Chromosomes;cis acting element;Clinical;Collaborations;Complex;computerized tools;Consensus;Development;Developmental Therapeutics Program;Distal;DNA;DNA biosynthesis;DNA Damage;DNA Repair Pathway;DNA replication fork;DNA Sequence;DNA-Protein Interaction;Elements;Energy Metabolism;Ensure;Epigenetic Process;Event;Exhibits;Exposure to;Fiber;Future;Genetic;Genome;genome integrity;Genome Stability;genome-wide;Genomic Instability;Health;histone modification;Human;Image;inhibitor;insight;Learning;Link;Location;Malignant Neoplasms;Mammalian Cell;Maps;Mediating;member;Metabolic;Metaphase;Mitosis;Molecular;Molecular Machines;Nature;novel;Oncogenes;Pathway interactions;Phosphotransferases;Play;prevent;programs;Property;protein complex;Protein Family;protein protein interaction;Proteins;recruit;Regulation;Replication Initiation;Replication Origin;replication stress;Replication-Associated Process;Research Personnel;response;Role;segregation;Set protein;Signal Pathway;Signal Transduction;SIRT1 gene;Site;Specificity;Techniques;Testing;tool;TOPBP1 Gene;Translating;translational potential;treatment response;tumorigenesis;ubiquitin ligase;whole genome;Work,Initiation of DNA Replication in Mammalian Cells,10411,NA,NA,NA,NA,25,NA,NA,1963523,NA
11187948,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010413,NA,NA,1ZIABC010413-24,NCI:2200974\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6808478 (contact),"LARIONOV, VLADIMIR  (contact)",NA,NA,NA,Address;Aging;Amino Acids;Aminoglycoside Antibiotics;Aneuploidy;anti-cancer research;Antibodies;Antineoplastic Agents;arm;Artificial Human Chromosomes;Binding;Biogenesis;Bioinformatics;biological adaptation to stress;Biological Assay;BRCA2 gene;cancer cell;cancer therapy;Cancerous;Candidate Disease Gene;Catalogs;Cell Cycle;Cell Cycle Progression;cell growth;Cells;Centromere;centromere protein A;Chromatin;Chromosomal Instability;Chromosomal Stability;Chromosome Segregation;Chromosomes;Cloning;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Collection;cytotoxic;Defect;Development;Diagnostic;Disease;DNA;DNA biosynthesis;DNA Damage;DNA Maintenance;DNA replication fork;Drug Screening;Drug Targeting;early onset;Enhancers;Epigenetic Process;Event;Evolution;experimental study;Foundations;Frameshift Mutation;functional genomics;Future;Gene Duplication;gene function;gene therapy;Generations;Genes;Genetic;Genetic study;Genetic Transcription;genetic variant;Genome;Genomics;Germ-Line Mutation;Goals;Heterogeneity;high throughput screening;Human;Human Chromosomes;Human Genome;Individual;insertion/deletion mutation;Interruption;Journals;Kinetochores;Knock-out;Knowledge;Lead;live cell microscopy;Malignant Neoplasms;Measures;Minor;Mitosis;Modeling;Molecular;mouse genome;Mus;Mutation;Names;National Center for Advancing Translational Sciences;novel;novel therapeutic intervention;Nucleolar Organizer Region;Ontology;Open Reading Frames;Oxidative Stress;PALB2 gene;Patients;Pharmaceutical Preparations;Phenotype;Plant Extracts;plasmid DNA;Plasmids;Play;Poison;Polyploidy;prevent;Process;Productivity;prognostic of survival;Proliferating;Proteins;Publishing;Regulation;Repetitive Sequence;Reporting;Research;Ribosomal DNA;Ribosomal RNA;Ribosomes;Risk;RNA;Role;senescent cell;Signal Transduction;Small Interfering RNA;Structure;synthetic biology;System;Tandem Repeat Sequences;targeted cancer therapy;Technology;Therapeutic;transmission process;treatment strategy;tumor;tumor progression;Universities;Variant;variant detection;vector;Work;Yeasts,Human Artificial Chromosomes for Cancer Research and Functional Genomics,10413,NA,NA,NA,NA,24,NA,NA,2200974,NA
11187949,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010419,NA,NA,1ZIABC010419-25,NCI:1248960\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8122283 (contact),"ZHANG, YING E (contact)",NA,NA,NA,Activins;Alternative Splicing;Apoptosis;Binding;Binding Proteins;Biological;Bone Morphogenetic Proteins;C-terminal;cancer cell;cancer type;CD44 gene;Cell Differentiation process;cell growth;Cell Physiology;Cell Proliferation;Cell surface;Complex;Development;Disease;Drug resistance;Epigenetic Process;Exclusion;Exons;Family;Family member;Genetic;Genetic Transcription;Goals;Growth Factor;Hepatic Stellate Cell;Hepatocyte;Heterogeneous-Nuclear Ribonucleoproteins;Human;Induction of Apoptosis;Investigation;JAK1 gene;MADH3 gene;MADH4 gene;Malignant Neoplasms;MAP Kinase Gene;MAP3K7 gene;MAPK8 gene;Mediating;member;Membrane;Mitogen-Activated Protein Kinases;Molecular;Monoubiquitination;mRNA Precursor;Neoplasm Metastasis;NF-kappa B;Oncogenes;Oncogenic;p38 Mitogen Activated Protein Kinase;Pathway interactions;Pattern;Peptides;Phosphorylation;prevent;promoter;Protein Isoforms;Protein Kinase Interaction;Proteins;Proteomics;receptor;Receptor Serine/Threonine Kinase;Receptor Signaling;Receptor-Interacting Protein;Regulation;Reporting;Research;response;RNA Splicing;RNA-Binding Proteins;Role;Serine;Signal Pathway;Signal Transduction;Site;Smad Proteins;Spliceosome Assembly Pathway;STAT3 gene;TGF-beta type I receptor;Threonine;TRAF6 gene;transcriptome sequencing;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;tumor progression;Tumor Promoters;Tumor Suppressor Proteins;tumorigenesis;Ubiquitination,Molecular Mechanisms of TGF-beta Signaling Pathway,10419,NA,NA,NA,NA,25,NA,NA,1248960,NA
11187950,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010440,NA,NA,1ZIABC010440-23,NCI:953343\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8300611 (contact),"NUSSINOV, RUTH  (contact)",NA,NA,NA,Acceleration;Address;Affect;amyloid formation;Automobile Driving;Binding;Binding Sites;Biochemical;brain cell;Calmodulin;Catalysis;CCNE1 gene;CDK2 gene;CDK4 gene;Cell Cycle;Cell Cycle Progression;Cell Cycle Regulation;Cell Proliferation;cell type;Cells;Chromatin;Clinical;Communities;Complex;Cyclin D1;Cyclin-Dependent Kinases;Cyclins;cytokine;Data;Databases;DNA biosynthesis;Drug Design;drug discovery;Embryo;Entropy;Essential Genes;Feedback;Fibroblast Growth Factor Receptors;G1 Phase;Genes;genomic locus;Germ Lines;GIT1 gene;grasp;Guidelines;Human;Immune system;Immunity;innovation;insight;interest;Interleukin-1;Lead;Life;Lipids;Literature;Malignant Neoplasms;MAP Kinase Gene;Membrane;microbiota;Mission;Modeling;Molecular Conformation;molecular dynamics;monomer;Monomeric GTP-Binding Proteins;morphogens;mutant;Mutation;Mutation Analysis;Nervous System;neurodevelopment;Neurodevelopmental Disorder;Neurons;Noonan Syndrome;Oncogenic;Outcome;overexpression;pathogen;Pathology;Pathway interactions;Pharmaceutical Preparations;Phase;Phase Transition;Phenotype;Phosphorylation;Phosphotransferases;PIK3CG gene;Probability;Proliferating;protein structure;Proteins;PTEN gene;PTPN11 gene;Regulation;Retinoblastoma Protein;S phase;Signal Pathway;Signal Transduction;simulation;Solvents;Somatic Mutation;Specificity;Speed;Structure;Time;Time Factors;tumor;Variant;Vertebral column;Work,"Protein Structure, Stability, and Amyloid Formation",10440,NA,NA,NA,NA,23,NA,NA,953343,NA
11187951,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010441,NA,NA,1ZIABC010441-23,NCI:762675\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8300611 (contact),"NUSSINOV, RUTH  (contact)",NA,NA,NA,Adenocarcinoma;Affinity;Agonist;alpha helix;Alveolar Rhabdomyosarcoma;anti-cancer research;Apoptosis;autocrine;Binding;Binding Sites;Biological;Calcium;Calcium Signaling;Calmodulin;Calmodulin-Binding Proteins;cancer cell;cancer initiation;Cell Cycle;Cell division;Cell Fate Control;cell growth;Cell Proliferation;cell type;Cells;Cellular biology;Chromatin;Code;Colorectal Cancer;Complex;cytokine;Development;driver mutation;Drug resistance;Early Diagnosis;EGF gene;Electrostatics;Event;Fostering;FOXO1A gene;G2/M Transition;Goals;Growth;Growth Factor;GTPase-Activating Proteins;Guanosine Triphosphate;Guanosine Triphosphate Phosphohydrolases;Human Pathology;Hydrolysis;Hydrophobic Interactions;Impairment;in silico;Incidence;innovation;insight;KRAS2 gene;KSR gene;Lead;Lysine;Malignant neoplasm of lung;Malignant Neoplasms;MAP Kinase Gene;Maps;Measures;Mediating;MEKs;Mission;Mitogens;Modeling;Molecular Conformation;molecular modeling;mutant;Mutate;Mutation;nanomolar;Neurodevelopmental Disorder;NF1 gene;Normal tissue morphology;Oncogenes;Oncogenic;Output;overexpression;Pancreatic Ductal Adenocarcinoma;pancreatic tumorigenesis;Pathology;Pathway Analysis;Pathway interactions;PAX3 gene;Pharmaceutical Preparations;Phase;Physiological;PIK3CG gene;Play;Population;Post-Translational Protein Processing;Proliferating;prophylactic;Protein Conformation;Protein Isoforms;Proteins;Publications;ral Guanine Nucleotide Exchange Factor;RALGDS gene;RAS driven cancer;ras GTPase-Activating Proteins;Ras/Raf;Regimen;Regulation;response;RNA Splicing;Role;Sampling;Scaffolding Protein;Second Messenger Systems;senescence;senescence associated secretory phenotype;Signal Pathway;Signal Transduction;Site-Directed Mutagenesis;structural determinants;TBK1 gene;Tissues;transcription factor;tumor;tumor growth;Ubiquitination;Variant;Work,Biomolecular Recognition and Binding Mechanisms,10441,NA,NA,NA,NA,23,NA,NA,762675,NA
11187952,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010442,NA,NA,1ZIABC010442-23,NCI:190669\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8300611 (contact),"NUSSINOV, RUTH  (contact)",NA,NA,NA,3-Dimensional;Adverse effects;Algorithms;anti-cancer;Binding;Binding Sites;Bioinformatics;Biological;biological research;cancer therapy;Cell Physiology;Cells;Characteristics;Chemical Engineering;Clinical;Combination Drug Therapy;combinatorial;comparative;Computational Biology;Computer Vision Systems;computerized tools;data management;detection method;Docking;dosage;Drug Combinations;drug discovery;Drug resistance;Epigenetic Process;experimental study;Face;flexibility;functional group;Gene Expression;Genetic;globular protein;Goals;in silico;instrument;Integral Membrane Protein;Libraries;Ligands;Location;Malignant Neoplasms;Maps;method development;Methodology;Methods;microbial;mimicry;Modeling;Modernization;Molecular;molecular assembly/self assembly;molecular dynamics;Movement;Mutation;Nature;Oncologist;Oncology;operation;Organism;pathogen;Pathway Analysis;Pathway interactions;Patients;Phage Display;Pharmaceutical Preparations;Population;Prevalence;Probability;programs;protein folding;Protein Fragment;protein protein interaction;protein structure;Proteins;Regimen;Resistance;Resources;Robotics;Selection for Treatments;Series;Signal Pathway;Signal Transduction;single molecule;Site;small molecule;Specific qualifier value;Structure;Surface;targeted treatment;Techniques;Technology;Tissues;tool;treatment planning;tumor heterogeneity;tumorigenesis;Validation;Vertebral column,Method Development: Efficient Computer Vision Based Algorithms,10442,NA,NA,NA,NA,23,NA,NA,190669,NA
11187953,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010449,NA,NA,1ZIABC010449-23,NCI:748540\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568943 (contact),"KIMURA, SHIOKO  (contact)",NA,NA,NA,Affinity;Allergic;allergic airway inflammation;Amino Acid Sequence;Amino Acids;Anti-Inflammatory Agents;anticancer activity;Apoptotic;Asthma;Binding;Biological;Biological Assay;Biological Process;Breast;C-terminal;cancer cell;CASP4 gene;Caspase;Cell Culture Techniques;Cell Death;cell growth;Cell surface;Cells;Chronic Obstructive Pulmonary Disease;Complex;cytokine;Cytosol;Disease;Endocytosis;Escherichia coli;Exhibits;experience;experimental study;Family member;FDA approved;Fetal Lung;Genes;Goals;Growth Factor;Heparan Sulfate Proteoglycan;Homo;Human;immunoregulation;In Vitro;in vitro Assay;in vivo;Inflammasome;Inflammatory;Lacrimal gland structure;Lipopolysaccharides;Lung;Lung Diseases;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;mammaglobin;Mammary Neoplasms;Membrane;Methylation;Molecular Chaperones;Molecular Weight;Morphogenesis;mouse model;Mus;novel;Organ Culture Techniques;Pancreas;Pathway interactions;Peptides;Pharmaceutical Preparations;Physiology;Predisposition;Premature Infant;Preparation;promoter;Prostate;Proteins;Pulmonary Emphysema;Pulmonary Fibrosis;Pulmonary Inflammation;receptor;Recombinant Proteins;Recombinants;Research Project Grants;Role;Salivary Glands;syndecan;System;Therapeutic;Tumor Suppressor Proteins;Uterus,Role of Novel Cytokine-like Molecule Secretoglobin (SCGB) 3A2 in Lung,10449,NA,NA,NA,NA,23,NA,NA,748540,NA
11187954,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010451,NA,NA,1ZIABC010451-23,NCI:825904\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777873 (contact),"BARCHI, JOSEPH JOHN (contact)",NA,NA,NA,Adhesives;analog;Annual Reports;Antibodies;Antibody-drug conjugates;Antigens;Award;Binding;Biological Assay;biophysical techniques;C Type Lectin Receptors;Carbohydrates;Cells;chimeric antigen receptor T cells;Collaborations;commercialization;cytotoxicity;Dendritic Cells;design;Development;Diagnostic;Drug Delivery Systems;Epitopes;Extramural Activities;Glucans;Glycopeptides;Gold;Hybrids;Image;in vivo;interest;Lead;Ligands;Magnetism;Malignant neoplasm of pancreas;Malignant Neoplasms;Medical Research;Metals;Methods;mimetics;Modeling;Monoclonal Antibodies;Mucins;Mus;nanoGold;nanoparticle;novel;novel therapeutics;novel vaccines;Organic Synthesis;overexpression;Pancreas;Pancreatic duct;pancreatic neoplasm;particle;patient derived xenograft model;Pharmaceutical Preparations;physical property;pre-clinical research;Proteins;Reproducibility;Research Personnel;Therapeutic;Therapeutic Agents;therapy development;Toxic effect;tumor;Tumor-Associated Carbohydrate Antigens;vaccine platform;Vaccines;Work,Glycopeptide Antigen-bearing Nanoparticles for Passive and Active Antitumor Therapy for Pancreatic Cancer,10451,NA,NA,NA,NA,23,NA,NA,825904,NA
11187955,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010453,NA,NA,1ZIABC010453-23,NCI:760679\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,abiraterone;advanced prostate cancer;Affect;ancestry analysis;androgen deprivation therapy;androgen independent prostate cancer;Androgens;Asian;Automobile Driving;Benign;Binding;Biological;Biology;biomarker discovery;black men;Black race;Cancer Biology;cancer genomics;cancer risk;cancer type;Candidate Disease Gene;candidate identification;Castration;Cell Line;Clinical;clinically relevant;cohort;Collaborations;Complex;Data;Data Set;Development;differential expression;Diffusion;Disease Management;Disease Progression;DNA Sequence Alteration;drug development;Drug Interactions;extracellular vesicles;Family;Frequencies;Future;Genes;Genetic;Genetic Polymorphism;Genetic Predisposition to Disease;Genetic Transcription;Genetic Variation;GENIE;Genomics;Germ Lines;Germ-Line Mutation;Goals;Haplotypes;health disparity;Hereditary Malignant Neoplasm;Heritability;Hyperplasia;Impairment;improved;Incidence;Individual;Institution;interest;Investigation;Kinetics;Knowledge;Laboratories;liquid biopsy;Malignant neoplasm of prostate;Mediating;member;men;microRNA biomarkers;MicroRNAs;minimally invasive;Molecular;Molecular Biology;Molecular Genetics;mortality;mouse model;Mutation;new therapeutic target;novel;Organic Anion Transporters;Outcome;overexpression;Pathway interactions;Patients;Pharmacogenetics;Pharmacogenomics;Plasma;precision medicine;precision oncology;predictive marker;promoter;prostate cancer cell line;prostate cancer progression;prostate cancer risk;Prostatectomy;Race;racial difference;Regulatory Element;Research;Resistance;resistance mechanism;Risk;Risk Assessment;Role;Sample Size;Sampling;Screening for cancer;Single Nucleotide Polymorphism;solute;Source;steroid hormone;targeted treatment;Testing;Testosterone;The Cancer Genome Atlas;Therapeutic;therapy resistant;Time;Tissues;Transcript;transcription factor;Translational Research;treatment response;trend;tumor;Tumor Markers;uptake;Xenograft procedure,Genetics and Molecular Mechanisms of Prostate Cancer,10453,NA,NA,NA,NA,23,NA,NA,760679,NA
11187956,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010476,NA,NA,1ZIABC010476-22,NCI:1113905\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778758 (contact),"CHERUKURI, MURALI  (contact)",NA,NA,NA,Adjuvant;aerobic glycolysis;Aftercare;ascorbate;Biochemical;Cell Nucleus;Chemicals;density;Dependence;Derivation procedure;Dose;Electron Spin Resonance Spectroscopy;experimental study;Hypoxia;Image;imaging study;Implant;improved;in vivo;in vivo imaging;Intravenous;kidney imaging;Label;Leg;magnetic field;Magnetic Resonance Imaging;Magnetism;Maps;Measures;Metabolic;metabolic imaging;Metabolism;molecular imaging;Monitor;Mus;Nature;Normal tissue morphology;normoxia;Oxygen;Oxygen Consumption;Pancreatic Ductal Adenocarcinoma;Pharmaceutical Preparations;Pharmacologic Ascorbate;Physiology;Prodrugs;Protons;Pyruvate;Reactive Oxygen Species;response;Signal Transduction;Techniques;Time;Tracer;treatment effect;treatment response;tumor;tumor hypoxia;Tumor Volume;Water,Time Domian Electron Paramagnetic Resonance Imaging,10476,NA,NA,NA,NA,22,NA,NA,1113905,NA
11187957,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010477,NA,NA,1ZIABC010477-22,NCI:1113905\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778758 (contact),"CHERUKURI, MURALI  (contact)",NA,NA,NA,aerobic glycolysis;Aftercare;Biochemical;Body Water;cancer cell;cancer imaging;Cell Cycle Kinetics;Cell Nucleus;Cell Proliferation;Cells;Chemicals;clinical development;Colorectal;contrast imaging;density;Dependence;Deuterium;Glycolysis;HT29 Cells;Image;In Vitro;in vivo;inhibitor;Label;Magnetic Resonance Imaging;Magnetism;Malignant Childhood Neoplasm;Measures;Metabolic;metabolic imaging;Metabolism;Methods;molecular imaging;Monitor;mouse model;Mus;Nature;nicotinamide phosphoribosyltransferase;Normal tissue morphology;novel;Oxidative Phosphorylation;pancreatic neoplasm;Pathway interactions;Phase;Physiology;Production;Proliferating;Protons;Pyruvate;Research;Rhabdomyosarcoma;Signal Transduction;Techniques;Tissues;Tracer;treatment effect;treatment response;tumor;tumor growth;tumor xenograft;Visualization;Water;Xenograft procedure,Overhauser Enhanced Magnetic Resonance Imaging (OMRI),10477,NA,NA,NA,NA,22,NA,NA,1113905,NA
11187958,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010484,NA,NA,1ZIABC010484-22,NCI:786773\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778042 (contact),"ST CROIX, BRADLEY D (contact)",NA,NA,NA,Adult;angiogenesis;Antibodies;blood vessel development;Cell surface;conditional knockout;Endothelial Cells;Endothelium;Gene Expression Profiling;Genes;Goals;Growth;interest;Knockout Mice;Laboratories;Mus;Neoplasms in Vascular Tissue;Pathologic;Physiological;Physiology;response;Role;Stress;Therapeutic;tumor;Tumor Cell Line;tumor microenvironment;tumorigenesis,Functional Analysis of TEM5 and TEM8,10484,NA,NA,NA,NA,22,NA,NA,786773,NA
11187959,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010487,NA,NA,1ZIABC010487-22,NCI:680049\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123034 (contact),"KEWALRAMANI, VINEET N (contact)",NA,NA,NA,Affect;Anti-viral Therapy;Area;C-terminal;Cell Nucleus;Cells;Chromatin;Companions;Complex;Cytoplasm;Data;Dependence;Equine Infectious Anemia Virus;Event;Excision;experimental study;Feline Immunodeficiency Virus;Genes;Genetic;Genetic Transcription;helicase;HIV;HIV-1;HIV-2;Infection;Integration Host Factors;Karyopherins;Manuscripts;Mutation;Nuclear;Nuclear Pore;Nuclear Pore Complex;Pattern;Physical condensation;Pore Proteins;Proteins;Regulation;RNA;Role;Route;Series;SIV;trafficking;Viral Physiology;viral resistance;Virus;Work,The role of CPSF6 in HIV-1 infection,10487,NA,NA,NA,NA,22,NA,NA,680049,NA
11187960,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010488,NA,NA,1ZIABC010488-22,NCI:340025\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123034 (contact),"KEWALRAMANI, VINEET N (contact)",NA,NA,NA,Affect;Affinity;Anti-viral Agents;Area;Attenuated;Binding;C-terminal;Cell Line;Cell membrane;Cell Nucleus;cell type;Cells;Cellular biology;Complex;Cyclosporine;Cytoplasm;Dependence;Diameter;Diffusion;Dipeptides;Docking;Exhibits;experimental study;Filament;Genes;Genome;genome wide screen;Glycine;Hela Cells;heterokaryon;HIV-1;Host Factor 1 Protein;Human;Human Cell Line;Human immunodeficiency virus test;Impairment;Infection;inhibitor;Integration Host Factors;Interphase Cell;Jurkat Cells;Karyopherins;knock-down;Macromolecular Complexes;macromolecule;Manuscripts;Mediating;Membrane;Membrane Fusion;Modeling;molecular mass;mutant;Mutation;N-terminal;Nature;Night Monkey;Nuclear;Nuclear Envelope;Nuclear Import;Nuclear Pore;Nuclear Pore Complex;Nuclear Pore Complex Proteins;nucleocytoplasmic transport;Nucleoplasm;particle;Pathway interactions;Phenotype;Play;Pore Proteins;prevent;Process;Proline;Property;Proteins;Publishing;receptor;Reporter;Resistance;Retroviridae;Reverse Transcription;RNA;Role;Route;Series;Side;Site;Small Interfering RNA;Testing;trafficking;TRIM5 gene;Variant;Vesicular stomatitis Indiana virus;Viral;Virus;Virus Replication;working group,HIV-1 passage through the nuclear pore complex,10488,NA,NA,NA,NA,22,NA,NA,340025,NA
11187961,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010499,NA,NA,1ZIABC010499-22,NCI:891624\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692197 (contact),"AMBS, STEFAN  (contact)",NA,NA,NA,advanced disease;Affect;African;African American;African American population;African ancestry;Age;allostatic load;American;Area;Award;Baltimore;bead chip;Biological;Blood;California;cancer diagnosis;cancer health disparity;Cancer Patient;cancer survival;Case/Control Studies;Cessation of life;Chemotaxis;Child;Chronic;circulating biomarkers;Cities;Classification;Clinical;cohort;Collaborations;Collection;Control Groups;cooking;Data;database of Genotypes and Phenotypes;Databases;deprivation;design;Development;Diabetes Mellitus;Diagnosis;Diet;Dietary Factors;Disease;disease diagnosis;Disease Marker;Disease Outcome;Disease Progression;disorder risk;DNA Methylation;Enrollment;Environmental Risk Factor;ethnic difference;European;European ancestry;Female;follow-up;Freezing;Frequencies;gene environment interaction;Gene Expression;Gene Expression Profile;Genetic;genetic risk factor;genetic signature;genetic variant;genome-wide;Genotype;Germ Lines;Ghana;Gleason Grade for Prostate Cancer;Goals;Guidelines;Hereditary Malignant Neoplasm;high risk;Hospitals;Household;Household Heads;Immune;immune function;Immune response;Immunooncology;indexing;Individual;Infection;Inflammation;inflammatory marker;Laboratories;Link;male;Malignant neoplasm of prostate;Maps;Maryland;Measures;Mediating;Medical;Medical center;Medical History;Medical Records;men;metabolome;Minor;Molecular;Molecular Profiling;Morehouse School of Medicine;mortality;Motor Vehicles;Mutation Spectra;National Comprehensive Cancer Network;Native American Ancestry;Neighborhoods;Nigerian;Occupational;Operative Surgical Procedures;Outcome;Paraffin Embedding;Participant;Pathologic;Pathology;Pathway interactions;Patients;Pattern;Penetrance;Pharmaceutical Preparations;Phase;Pilot Projects;polygenic risk score;population based;Poverty;precision medicine;Procedures;prospective;prostate cancer risk;Prostatectomy;Prostatic Neoplasms;protein activation;protein expression;Proteins;Protocols documentation;PSA level;Public Assistance;Race;racial difference;Recording of previous events;Records;recruit;Recurrent disease;Reporting;Research;Risk;Risk Factors;risk variant;Role;Secure;Sexually Transmitted Diseases;Signal Pathway;smoking exposure;Socioeconomic Status;socioeconomics;Specimen;Stress;Study Subject;Surveys;survival disparity;Susceptibility Gene;systemic inflammatory response;Time;Tissue Sample;Tissues;TNM;Tobacco use;Tobago;tumor;Tumor Biology;Tumor Immunity;Tumor Markers;Tumor Suppression;Unemployment;United States Department of Veterans Affairs;Universities;Update;Urine;Virus Diseases;West Indies;Work,Maryland Prostate Cancer Case-Control Study,10499,NA,NA,NA,NA,22,NA,NA,891624,NA
11187962,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010504,NA,NA,1ZIABC010504-22,NCI:340340\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1882058 (contact),"HU, WEI-SHAU  (contact)",NA,NA,NA,APOCEC3G gene;Cell Nucleus;Cells;Chromosomes;Collaborations;Complex;Cytoplasm;dimer;Dissociation;DNA;DNA biosynthesis;ds-DNA;Enzymes;Epidemic;Event;Evolution;Family;genetic information;Genetic Recombination;Genome;Goals;HIV;HIV Genome;HIV-1;Human;Infection;Infection prevention;insight;Knowledge;Lentivirus Vector;Location;Molecular;novel;nucleic acid-based therapeutics;Parents;particle;pathogen;Peptides;prevent;Process;Proviruses;Publishing;Research;Resistance;Retroviridae;Reverse Transcription;RNA;Role;Science;Time;Treatment Protocols;Vaccines;vector;vif Gene Products;Viral;viral DNA;Viral Genome;Viral Proteins;viral RNA;Virus;virus genetics;Virus Integration;Virus Replication,"Understanding Retroviral Reverse Transcription, Recombination, and Replication",10504,NA,NA,NA,NA,22,NA,NA,340340,NA
11187963,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010506,NA,NA,1ZIABC010506-22,NCI:1247909\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1882058 (contact),"HU, WEI-SHAU  (contact)",NA,NA,NA,Affect;Behavior;Cell membrane;Cell Nucleus;Cells;Cytoplasm;dimer;Ensure;Epidemic;Event;Evolution;Family;Fluorescence Microscopy;gag Gene Products;genetic information;Genome;Goals;Guanosine;HIV;HIV-1;Human;imaging study;Infection;insight;Kinetics;Knowledge;Length;live cell imaging;Location;Minor;Modeling;novel strategies;Parents;particle;pathogen;Proteins;Proviruses;Research;Retroviridae;RNA;Role;Site;Structure;T-Lymphocyte;Testing;trafficking;Transcription Initiation Site;Travel;Treatment Protocols;Vaccines;Viral;Viral Genome;Viral Packaging;Viral Proteins;viral RNA;Virion;Virus;Virus Assembly;virus genetics;Virus Replication,Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly,10506,NA,NA,NA,NA,22,NA,NA,1247909,NA
11187964,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010511,NA,NA,1ZIABC010511-22,NCI:587433\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2432590 (contact),"REIN, ALAN  (contact)",NA,NA,NA,Affinity;Anti-viral Therapy;Area;Bacteriophages;C-terminal;Cell Nucleus;Cells;Charge;Cultured Cells;Cytoplasm;Data;density;design;dimer;Dimerization;DNA;DNA biosynthesis;Fluorometry;gag Gene Products;Gammaretrovirus;Goals;HIV-1;Impairment;In Vitro;in vivo;Infection;Interphase;Interphase Cell;Isoleucine;Lentivirus;Leucine Zippers;member;Mitosis;Molecular;Molecular Analysis;Moloney Leukemia Virus;Murine leukemia virus;Nuclear Envelope;Nucleocapsid;particle;Penetration;Phytic Acid;Proteins;Recombinants;Reporting;Research;Retroviridae;Role;Scanning;Structure;Viral;Viral Proteins;viral RNA;Virion;Virus Assembly;virus core;Virus Replication,Retrovirus Assembly and Maturation,10511,NA,NA,NA,NA,22,NA,NA,587433,NA
11187965,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010512,NA,NA,1ZIABC010512-22,NCI:587433\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2432590 (contact),"REIN, ALAN  (contact)",NA,NA,NA,Affinity;Anti-viral Therapy;Binding;Binding Proteins;cofactor;DNA;Elements;gag Gene Products;genomic RNA;Goals;HIV-1;Individual;instrument;Investigation;Kinetics;Knowledge;Measures;Messenger RNA;Microbiology;Molecular;Nucleic Acids;particle;Physiological;Proteins;Reverse Transcription;RNA;RNA-Protein Interaction;Role;Signal Transduction;Sodium Chloride;stem;Therapeutic Intervention;trend;Viral Packaging;viral RNA;Virion;Virus Replication,Interactions of Retroviral Proteins with Nucleic Acids,10512,NA,NA,NA,NA,22,NA,NA,587433,NA
11187966,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010516,NA,NA,1ZIABC010516-22,NCI:168013\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,7937849 (contact),"MILLER, ROBERT  (contact)",NA,NA,NA,Biomedical Engineering;Budgets;candidate selection;Cherenkov Radiation;Compensation;Cone;COVID-19;Dependence;detector;Development;Diameter;Dose;dosimetry;electron radiation;experience;falls;Fiber;Generations;in vivo;Individual;Length;Lifting;lightspeed;luminescence;Measurement;Optics;Output;Photons;Physiologic pulse;Process;Radiation;radiation response;Radiation therapy;response;Running;Scanning;Signal Transduction;System;Technology;virtual;Water;Work,Gated Optical Detectors-Dose Guided Radiotherapy,10516,NA,NA,NA,NA,22,NA,NA,168013,NA
11187967,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010518,NA,NA,1ZIABC010518-22,NCI:516943\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123123 (contact),"LEWANDOSKI, MARK B (contact)",NA,NA,NA,Address;Adult;Area;Behavior;Biology;Bone Morphogenetic Proteins;breast cancer progression;Cells;Cellular biology;Data;Development;Disease;Elements;Embryo;Embryonic Development;Family;FGF5 gene;Fibroblast Growth Factor;Forelimb;Gastrointestinal Neoplasms;Gene Expression;Genetic;Goals;Growth;Heart;Hindlimb;Imagery;Limb Development;Limb structure;Malignant neoplasm of prostate;Malignant Neoplasms;Metastatic Neoplasm to the Bone;mutant;neglect;Normal Cell;Pathway interactions;Pattern;Pelvis;Protein Family;Publishing;Research;Role;scapula;Series;Signal Transduction;Signaling Molecule;Structure;tumor;Work,Role of BMP and FGF signaling during limb development,10518,NA,NA,NA,NA,22,NA,NA,516943,NA
11187968,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010523,NA,NA,1ZIABC010523-22,NCI:1883865\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777973 (contact),"GREWAL, SHIVINDER S (contact)",NA,NA,NA,Affect;Anti-sense RNA;Biochemical;cancer therapy;Cell Cycle;Cell Physiology;Cells;Chromatin;Chromatin Modeling;Chromosome Structures;Complex;Coupled;Cues;Development;Double-Stranded RNA;Elements;Ensure;Epigenetic Process;Eukaryota;exosome;Fission Yeast;Foundations;Gametogenesis;Gene Expression Profile;Gene Silencing;Genes;Genetic;Genetic Recombination;Genetic Transcription;Genome;genome integrity;genome-wide;Heterochromatin;Histone H2A;Histone H3;human disease;insight;Introns;Investigation;Large-Scale Sequencing;Link;Location;Lysine;Maintenance;Maps;Measures;Mediating;Messenger RNA;Methylation;Modeling;Modification;novel;Pathway interactions;Play;Polyadenylation;Polycomb;posttranscriptional;preservation;prevent;Process;protein complex;Proteins;recruit;Regulation;Repression;Resolution;response;RNA;RNA Degradation;RNA Interference;RNA Polymerase II;RNA Splicing;Role;S phase;Signal Induction;Site;Small Interfering RNA;Small RNA;Structure;therapeutically effective;Transcript;Variant;Work,RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,10523,NA,NA,NA,NA,22,NA,NA,1883865,NA
11187969,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010524,NA,NA,1ZIABC010524-22,NCI:31792\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123119 (contact),"NICKLAUS, MARC  (contact)",NA,NA,NA,3-Dimensional;AIDS therapy;Anti-HIV Agents;anti-HIV microbicide;Biological;Biological Assay;Biological Testing;Characteristics;Chemicals;Clinical Trials;Collection;comorbidity;Complex;Computer Assisted;Computing Methodologies;Custom;Data;Databases;design;Development;DNA;Docking;Drug Design;drug resistant virus;Drug toxicity;Enzyme Inhibitor Drugs;Enzymes;FDA approved;Genome;Goals;Grant;HIV;HIV drug resistance;HIV Integrase;HIV Integrase Inhibitors;HIV-1;HIV/AIDS;Homologous Gene;Homology Modeling;inhibitor;Integrase;Integrase Inhibitors;Joints;Knowledge;Leadership;Libraries;Life Cycle Stages;Ligands;Methods;microbicide;Modeling;Molecular;Molecular Target;Multi-Drug Resistance;new therapeutic target;novel;Pathogenesis;Patients;Peptide Hydrolases;Perception;Pharmaceutical Preparations;pharmacophore;Phenotype;protein expression;Proteins;Publishing;Replication-Associated Process;Retrieval;Reverse Transcriptase Inhibitors;RNA-Directed DNA Polymerase;Sampling;screening;Services;Side;Source;Structure;System;Therapeutic;Toxic effect;Viral;Virus Replication;Work,HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development,10524,NA,NA,NA,NA,22,NA,NA,31792,NA
11187970,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010538,NA,NA,1ZIABC010538-22,NCI:1721107\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10000506 (contact),"STEEG, PATRICIA SCHRIVER (contact)",NA,NA,NA,Adverse event;Antibodies;Basement membrane;biocytin;Blood - brain barrier anatomy;Blood Vessels;blood-brain tumor barrier;Brain;Brain scan;breast cancer metastasis;Breast Cancer Patient;Collagen Type IV;Drainage procedure;drug development;Drug Exposure;ERBB2 gene;Experimental Models;Goals;Human;Image;Immunofluorescence Immunologic;Immunoglobulin G;improved;Laboratories;Laminin;Lesion;machine learning algorithm;Membrane Proteins;Metastatic breast cancer;Metastatic malignant neoplasm to brain;Metastatic Neoplasm to the Leptomeninges;Molecular Analysis;mortality;mouse model;Mus;Neoplasm Metastasis;Neurocognitive;Pathway interactions;Patients;Penetration;Perfusion;Permeability;Pharmaceutical Preparations;Phase;pre-clinical;Reporting;Role;Site;small molecule;Stains;Testing;Therapeutic;Therapeutic antibodies;Time;Trastuzumab;uptake,Molecular Analysis of Breast Cancer Metastasis to the Brain,10538,NA,NA,NA,NA,22,NA,NA,1721107,NA
11187971,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010547,NA,NA,1ZIABC010547-22,NCI:1014238\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,Algorithms;androgen biosynthesis;androgen independent prostate cancer;Androgen Receptor;Androgens;angiogenesis;Animal Testing;Apoptosis;bench to bedside;Biology;cancer therapy;cBioPortal;Cell Line;chemotherapy;Clinic;clinical development;Clinical Pharmacology;clinically relevant;Combined Modality Therapy;Custom;Data;design;Development;Disease;DNA;DNA Repair;DNA Sequence Alteration;docetaxel;drug candidate;Drug Design;drug development;drug discovery;Drug Screening;efficacy evaluation;gene panel;Gene Targeting;Genetic;Genomics;Goals;inhibitor;interest;Laboratories;Lead;Malignant neoplasm of prostate;metastatic process;Modeling;Molecular;Monitor;Mutation;new therapeutic target;next generation;next generation sequencing;novel;novel therapeutics;Pathway interactions;patient population;Patient Selection;Pharmacology and Toxicology;PI3K/AKT;potential biomarker;pre-clinical;Pre-Clinical Model;precision medicine;preclinical development;Prediction of Response to Therapy;Process;Prognostic Marker;prostate cancer cell line;prostate cancer model;Provenge;PTEN gene;Regimen;Research;research clinical testing;Research Personnel;Resistance;resistance mechanism;screening;Signal Transduction;System;targeted treatment;Testing;Therapeutic;therapy resistant;tool;Translational Research;Treatment Failure;Treatment outcome;treatment response;tumor;Tumor Suppressor Genes;Validation;Work,Drug Development for Prostate Cancer and other Metastatic Processes,10547,NA,NA,NA,NA,22,NA,NA,1014238,NA
11187972,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010578,NA,NA,1ZIABC010578-21,NCI:1573547\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778042 (contact),"ST CROIX, BRADLEY D (contact)",NA,NA,NA,angiogenesis;Angiogenesis Inhibitors;anti-cancer;Antibodies;Antibody-drug conjugates;Antineoplastic Agents;Binding;Blood;Blood Vessels;cancer therapy;Cell surface;Cells;chimeric antigen receptor T cells;Development;Endothelial Cells;Endothelium;Extracellular Domain;Growth;Human;Link;Modeling;Molecular Weight;Monitor;mouse model;Mus;Neoplasm Metastasis;Neoplasm Transplantation;Neoplasms in Vascular Tissue;neutralizing antibody;novel;Pharmaceutical Preparations;potential biomarker;pre-clinical;Property;protein biomarkers;response;screening;Sensitivity and Specificity;small molecule;Solid Neoplasm;targeted agent;Testing;translational study;tumor;Tumor Cell Line,Targeting TEMs in Preclinical Tumor Models,10578,NA,NA,NA,NA,21,NA,NA,1573547,NA
11187973,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010579,NA,NA,1ZIABC010579-21,NCI:537764\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093670 (contact),"LOWY, DOUGLAS R. (contact)",NA,NA,NA,Adjuvant;Affect;Animal Model;cancer risk;Cell Culture Techniques;Cervical;Communicable Diseases;Costa Rica;cross immunity;Disease;follow-up;gene transfer vector;Genes;genetic vaccine;Genotype;global health;Goals;Heterogeneity;Human papilloma virus 31;Human papilloma virus infection;Human Papilloma Virus Vaccine;Human Papillomavirus;Human papillomavirus 16;Human papillomavirus 18;Immune;Infection;Intervention;Malignant Neoplasms;Mediating;Nucleotides;Papillomavirus;Persons;Pharmaceutical Preparations;Phylogenetic Analysis;Positioning Attribute;premalignant;prevent;Prevention;Proteins;Race;Therapeutic Agents;unvaccinated;Vaccinated;vaccine efficacy;vaccine evaluation;vaccine trial;Vaccines;Variant;vector;Virion;Virus;Woman,Papillomavirus Virion Proteins and Vaccines,10579,NA,NA,NA,NA,21,NA,NA,537764,NA
11187974,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010595,NA,NA,1ZIABC010595-21,NCI:671666\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1882188 (contact),"PATHAK, VINAY K. (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Alternative Splicing;Anti-viral Agents;Anti-viral Therapy;APOCEC3G gene;Binding;Biological;Biomedical Research;C-terminal;cancer type;Catalytic Domain;CD34 gene;Cell Cycle Arrest;Cells;cellular transduction;Collaborations;comparative;Complex;Cytidine;Cytidine Deaminase;Deamination;design;Development;Direct Repeats;DNA biosynthesis;DNA Integration;Epidemic;Evolution;Exons;Frequencies;gene therapy;Generations;Genes;Genetic;Goals;Hematopoietic stem cells;HIV;HIV-1;Homologous Protein;homologous recombination;Host Defense;Human;in vivo;Infection;inhibitor;insight;Knowledge;Laboratories;Lentivirus Vector;Malignant Neoplasms;Mediating;Membrane;Molecular;Mutagenesis;mutant;Mutation;Mutation Analysis;N-terminal;novel;novel therapeutic intervention;pathogen;Peptides;Pharmaceutical Preparations;PPP2R5A gene;PPP2R5B gene;Protein phosphatase;Proteins;Reagent;reconstitution;Research;Resistance;Reverse Transcription;RNA Splicing;Single-Stranded DNA;Somatic Mutation;Structure;Testing;translational genomics;Universities;vector;viral DNA;Viral Genome;Viral Physiology;Virion;Virus;Virus Inactivation;Virus Replication,Structure and Function of Vif and APOBEC3 (A3) Proteins,10595,NA,NA,NA,NA,21,NA,NA,671666,NA
11187975,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010598,NA,NA,1ZIABC010598-21,NCI:1755184\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2407138 (contact),"SCHLOM, JEFFREY  (contact)",NA,NA,NA,Advanced Malignant Neoplasm;Adverse effects;Aftercare;androgen independent prostate cancer;anti-PD-L1;anti-PD-L1 antibodies;anti-PD1 therapy;Antibodies;Antigen Presentation;antitumor effect;Appropriateness Review;Area;bevacizumab;Bicalutamide;Biochemical;Biopsy;Brachyury protein;Cancer Center;cancer immunotherapy;Cancer Patient;Cancer Vaccines;Castration;CCR;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Cellular Immunity;checkpoint inhibition;checkpoint therapy;Chimeric Proteins;Clinical;clinical predictors;Clinical Research;Clinical Treatment;Clinical Trials;cohort;Combined Modality Therapy;Complete Blood Count;cytokine;Cytotoxic T-Lymphocytes;cytotoxicity;Dendritic Cells;design;Development;DNA;Dose;Evolution;Extramural Activities;first-in-human;Flutamide;Frequencies;Future;Goals;Histones;Human;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;IgG1;IL8 gene;Immune;immune activation;Immune checkpoint inhibitor;Immune response;Immune system;Immunooncology;Immunosuppression;Immunotherapeutic agent;Immunotherapy;improved;Inflammatory;insight;Interferon Type II;Interleukin-12;Interleukin-12 therapy;intravenous administration;Joints;Link;Lymphocyte;Macrophage;Malignant neoplasm of prostate;Maximum Tolerated Dose;men;Mesenchymal Cell Neoplasm;metastatic colorectal;Metformin;Modeling;monocyte;mouse model;Mus;Myeloid-derived suppressor cells;Natural Killer Cells;Necrosis;Neoplasm Metastasis;neutrophil;Non-Small-Cell Lung Carcinoma;Nonmetastatic;novel;Obesity;open label;Overweight;patient subsets;Patients;Peripheral;peripheral blood;Phase;phase 1 study;phase 2 study;phase I trial;phase II trial;Phenotype;Plasma;pre-clinical;preclinical study;Preparation;Production;prognostic;programmed cell death protein 1;Proliferating;Protocols documentation;Randomized;Recombinants;Recurrence;Refractory;Regimen;Reporting;Research Personnel;Resistance;response;Schedule;Science;Serum;Solid Neoplasm;subcutaneous;T cell response;T-Lymphocyte;TGFB1 gene;Therapeutic;Thymus Epithelial Neoplasm;Time;TNF gene;Transforming Growth Factor beta;treatment effect;Treatment Protocols;tumor;Tumor Antigens;tumor microenvironment;Tumor-associated macrophages;Vaccines,Human Immune Responses to Tumor Antigens for Cancer Immunotherapy,10598,NA,NA,NA,NA,21,NA,NA,1755184,NA
11187976,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010600,NA,NA,1ZIABC010600-21,NCI:937586\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8320722 (contact),"XIA, DI S (contact)",NA,NA,NA,Address;Atomic Force Microscopy;ATP Hydrolysis;ATP phosphohydrolase;ATPase Domain;Back;Binding;Biochemical;Biological;Cancer cell line;cancer therapy;Cell Cycle Regulation;Cell Physiology;Cells;Clinical;Clinical Research;cofactor;Collaborations;Complex;Contracts;Coupled;Coupling;density;Deubiquitination;Devices;Disease;DNA biosynthesis;drug development;Electron Microscopy;Electron Transport Complex III;extracellular;Extravasation;Family;Goals;Hand;Homo;Human;Inclusion Body Myopathy with Early-Onset Paget Disease;Induction of Apoptosis;inhibitor;Inner mitochondrial membrane;insight;Iron-Sulfur Proteins;Kinetics;life span;Link;Location;medical schools;Membrane;Membrane Fusion;Membrane Fusion Activity;Membrane Proteins;Merozoite Surface Protein 1;Mitochondria;Mitochondrial Matrix;mitochondrial membrane;Mitochondrial Proteins;Molecular Conformation;Molecular Machines;Motion;Mus;Mutagenesis;mutant;Mutation;Myopathy;Neurodegenerative Disorders;Nucleic Acids;Nucleotides;Organelles;Pharmaceutical Preparations;Play;prevent;Process;protein complex;protein degradation;protein folding;Protein Subunits;Protein translocation;Proteins;Protons;Quality Control;Reaction;Regulation;Research;respiratory;Respiratory Process;Role;Scanning;seal;segregation;Speed;stress management;Structure;translocase;Ubiquitination;unfoldase;valosin-containing protein;Visualization;Work;Yeasts,"AAA Proteins, Mechanisms of Their Functions and Related Diseases",10600,NA,NA,NA,NA,21,NA,NA,937586,NA
11187977,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010624,NA,NA,1ZIABC010624-21,NCI:891624\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692197 (contact),"AMBS, STEFAN  (contact)",NA,NA,NA,Acids;Address;Affect;African;African American;African American population;African ancestry;American;Anti-Inflammatory Agents;Antibodies;Area;Aspirin;Bacteriophages;Biological Assay;Blood;Blood specimen;blood-based biomarker;cancer health disparity;Case/Control Studies;Censuses;Chromosomes;CLIA certified;clinical diagnosis;cohort;Cohort Studies;Collaborations;Communication;Communities;Data;data integration;Death Rate;deprivation;Detection;Development;Disease;disease disparity;Disseminated Malignant Neoplasm;Environment;environmental agent;Epigenetic Process;Ethnic Population;European;experience;Fatty Acid Desaturases;Fatty Acids;follow-up;Future;Genetic;genetic association;Genetic Predisposition to Disease;genetic signature;genetic variant;genome wide association study;genome-wide;genomic locus;Geographic Locations;Germ Lines;Ghana;Goals;Human;human virome;Immune;immune function;Immune response;Immunobiology;Immunomodulators;Immunooncology;Immunosuppression;Incidence;indexing;Indigenous;Individual Adjustment;Infection;Inflammation;Inflammatory;inflammatory marker;Integration Host Factors;Interferons;Knowledge;lifestyle factors;Link;liver cancer patient;Localized Disease;Low income;Malignant neoplasm of prostate;Malignant Neoplasms;Maps;Maryland;Mass Spectrum Analysis;Medicine;men;men&apos;s group;Methods;mimicry;Minor;Mission;Molecular Profiling;mortality;Nature;neighborhood association;Neighborhoods;new technology;novel;Omega-3 Fatty Acids;Omega-6 Fatty Acids;Outcome;pathogen;Pathology;Pathway interactions;Patients;Peptide Library;Pharmaceutical Preparations;Pollution;Population;Population Control;Population Group;Population Heterogeneity;prevent;programs;Prospective cohort;prostate cancer progression;prostate cancer risk;Prostatic Neoplasms;Proteome;proteomic signature;Publishing;racial population;Recording of previous events;recruit;Recurrent disease;Reduce health disparities;Reporting;Research;research study;Residencies;Resources;Risk;Risk Factors;Role;Seroprevalences;Serum;Signal Transduction;Social Environment;Socioeconomic Status;Stress;Subgroup;Surveys;Survival Analysis;Therapeutic;Thromboxane A2;Tobago;trait;Trans Fatty Acids;tumor;Tumor Biology;Tumor Immunity;Tumor Suppression;United States;Variant;Viral;virome;Virus;Virus Diseases;West Indies,The Molecular Profile of Prostate Tumors in African-American Men,10624,NA,NA,NA,NA,21,NA,NA,891624,NA
11187978,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010627,NA,NA,1ZIABC010627-21,NCI:956582\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,ABCB1 gene;ABCG2 gene;abiraterone;absorption;Adverse reactions;Affect;Age;Alleles;androgen deprivation therapy;anti-epileptic agents;Anti-Retroviral Agents;Antineoplastic Agents;Azathioprine;bevacizumab;Biological;cancer therapy;Candidate Disease Gene;Carboplatin;Central Nervous System;chemotherapy;Chemotherapy-Oncologic Procedure;Clinical;clinical center;CYP1B1 gene;CYP2C19 gene;CYP2D6 gene;CYP3A4 gene;CYP3A5 gene;Development;Differentiation Antigens;Disease;docetaxel;drug development;drug disposition;Drug Kinetics;drug metabolism;Drug Targeting;Drug Transport;Enzymes;Etiology;experimental study;Gender;Genes;Genetic;genetic association;Genetic Determinism;Genetic Markers;Genetic Polymorphism;genetic variant;Genetic Variation;Genotype;Gleason Grade for Prostate Cancer;GNRH2 gene;Goals;HLA Antigens;Hyperplasia;Immune;Immunofluorescence Immunologic;Immunoglobulins;Immunosuppressive Agents;Individual Differences;Inherited;inter-individual variation;interest;Killer Cells;Knowledge;Laboratories;lenalidomide;Link;Local Therapy;Malignant neoplasm of prostate;Malignant Neoplasms;Mammals;Mediating;Membrane;Metabolism;Molecular;Movement;Multivariate Analysis;Mutation;neoplastic;Normal tissue morphology;novel;Organ;Outcome;Paclitaxel;Pathway interactions;patient response;Patients;peptide hormone;Peripheral;Pharmaceutical Preparations;pharmacodynamic biomarker;Pharmacogenetics;Pharmacogenomics;Pharmacological Treatment;Pharmacotherapy;Phenotype;Physiology;Plicamycin;Population;precision medicine;predicting response;Process;programs;Progression-Free Survivals;Prostate;Prostatic hypertrophy;receptor;Research;response;Scanning;Serum;side effect;Testosterone;Therapeutic;Therapeutic Index;therapeutic protein;therapy outcome;Tissue Microarray;Tissues;Toxic effect;Treatment outcome;treatment response;UGT1A1 gene;United States National Institutes of Health;Variant;Work;Xenobiotics,Clinical Pharmacogenetics,10627,NA,NA,NA,NA,21,NA,NA,956582,NA
11187979,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010655,NA,NA,1ZIABC010655-20,NCI:3828981\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778172 (contact),"CHOYKE, PETER L (contact)",NA,NA,NA,Ablation;Affect;American;androgen deprivation therapy;androgen independent prostate cancer;Area;Artificial Intelligence;Biopsy;blind;bone imaging;Cancer Etiology;cancer imaging;cancer recurrence;Cessation of life;clinically significant;Collaborations;Diagnosis;Disease;Focused Ultrasound Therapy;FOLH1 gene;Genomics;Goals;histological specimens;Image;Image Guided Biopsy;imaging modality;Implant;improved;Lasers;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant Neoplasms;men;Metastatic Neoplasm to the Bone;Methods;Natural History;novel;Operative Surgical Procedures;Pathology;Patient-Focused Outcomes;Patients;Pharmaceutical Preparations;Physicians;Positron-Emission Tomography;preservation;prognostic;prognostication;Prostate;prostate biopsy;Prostate Cancer therapy;Protocols documentation;Radiation;radiologist;Reader;Reproducibility;Salivary duct structure;Salivary Glands;Scanning;Screening for Prostate Cancer;Skin Cancer;Sodium Fluoride;Staging;standard of care;targeted agent;Techniques;Testing;Treatment Side Effects;tumor;uptake,Prostate Cancer Imaging,10655,NA,NA,NA,NA,20,NA,NA,3828981,NA
11187980,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010656,NA,NA,1ZIABC010656-20,NCI:1914491\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778172 (contact),"CHOYKE, PETER L (contact)",NA,NA,NA,Adjuvant Study;Adrenal Gland Neoplasms;Aftercare;Amino Acids;analog;Beds;Biopsy;Blocking Antibodies;bone imaging;CD276 gene;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;chemokine;Clinic;Collaborations;CXCL9 gene;CXCR4 gene;Detection;Disease;Early Diagnosis;Endocrine Gland Neoplasms;fibroblast-activating factor;Fibroblasts;FOLH1 gene;Growth Factor;Head and Neck Cancer;Image;imaging agent;imaging probe;immune activation;Immunotherapy;interest;Isotopes;Label;Leucine;Ligand Binding;Logic;Lutetium;Malignant neoplasm of prostate;Malignant Neoplasms;molecular imaging;Multiple Myeloma;Neoadjuvant Therapy;Newly Diagnosed;Pancreas;Patients;Pattern;photoimmunotherapy;Pituitary Gland;pre-clinical;prostate cancer cell;Recurrence;Regulatory T-Lymphocyte;Research;response;Risk;Scanning;Serum;small molecule;Solid Neoplasm;T-Cell Activation;T-Lymphocyte;targeted agent;Technology;Testing;theranostics;Therapeutic;Thromboplastin;tissue biomarkers;Translating;tumor;tumor diagnosis;Universities;Work;X-Ray Computed Tomography,Growth Factor Imaging and Photoimmunotherapy,10656,NA,NA,NA,NA,20,NA,NA,1914491,NA
11187981,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010657,NA,NA,1ZIABC010657-20,NCI:1435868\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778172 (contact),"CHOYKE, PETER L (contact)",NA,NA,NA,Affect;Affinity;Area;Binding;Blood Vessels;Bone Marrow Transplantation;cancer cell;cell killing;Cell surface;Cell Therapy;Cells;Collaborations;constriction;design;Development;Dose;Endothelial Cells;Evaluation;experimental study;Fluorescence;Galactose;galactose receptor;Human;Image;Immune;immunoreaction;Immunotherapy;improved;in vivo;in vivo imaging;Interferon Type II;Ischemia;Label;Lesion;Magnetic Resonance Imaging;Malignant neoplasm of ovary;Mesenchymal Stem Cells;method development;Methods;Modeling;molecular imaging;Molecular Probes;Myocardium;neoplastic cell;nonhuman primate;Normal Cell;Normal tissue morphology;optical imaging;Optics;Permeability;Positron-Emission Tomography;Research;Resolution;response;Route;single photon emission computed tomography;stem cells;T-Lymphocyte;Therapeutic Agents;Time;Translating;tumor;tumor microenvironment;Work,Cellular In vivo Imaging,10657,NA,NA,NA,NA,20,NA,NA,1435868,NA
11187982,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010661,NA,NA,1ZIABC010661-20,NCI:908412\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692343 (contact),"HODGE, JAMES  (contact)",NA,NA,NA,adaptive immunity;Breast;CD8-Positive T-Lymphocytes;chemotherapeutic agent;Cisplatin;Clinical Research;Colorectal;Colorectal Cancer;Combination Drug Therapy;Combined Modality Therapy;Combined Vaccines;Data;design;docetaxel;Down-Regulation;Gene Expression Regulation;Goals;Human;immune checkpoint;improved;in vivo;Interleukin-12;Knock-out;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;MC38;Mediating;Modeling;Mus;Myeloid Cells;Natural Immunity;Necrosis;Necrosis Induction;Pre-Clinical Model;programmed cell death ligand 1;Prostate Cancer therapy;Recombinants;Refractory;Signal Transduction;small molecule inhibitor;T cell response;Therapeutic Effect;transcriptomics;tumor;tumor growth;Tumor Promotion;Tumor-infiltrating immune cells;Tumor-Infiltrating Lymphocytes;Up-Regulation;Vaccines;vector;Vinorelbine,Vaccine and Drug Combination Therapy for Human Cancers,10661,NA,NA,NA,NA,20,NA,NA,908412,NA
11187983,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010666,NA,NA,1ZIABC010666-20,NCI:4195237\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778166 (contact),"GULLEY, JAMES L. (contact)",NA,NA,NA,Acceleration;anti-PD-L1;anti-PD-L1 antibodies;Antibodies;antibody-dependent cell cytotoxicity;Antigen Targeting;Area;Biliary Tract Cancer;Binding;Brachyury protein;cancer cell;cancer immunotherapy;Cancer Patient;Cancer Vaccines;CCR;Cell Physiology;Cell Therapy;Cells;checkpoint modulation;chimeric antigen receptor T cells;Clinic;Clinical;Clinical Data;clinical development;clinical translation;Clinical Trials;cohort;Collaborations;Colorectal Cancer;Combination immunotherapy;Combined Modality Therapy;Combined Vaccines;Conduct Clinical Trials;Data;design;Disease;Enrollment;Epithelium;FDA approved;first-in-human;Goals;Human;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;human study;IL8 gene;Immune;immune checkpoint;Immune checkpoint inhibitor;Immune Evasion;Immune response;immune stimulatory agent;Immune system;immunogenic;Immunologics;Immunooncology;immunoregulation;Immunotherapy;improved;Industry Collaboration;Infiltration;innovation;interest;Interleukin-12;Interleukin-2;International;international center;Intervention;Intravenous;Laboratories;Laboratory Finding;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Measures;Mediating;Merkel cell carcinoma;Modality;Mucin 1 protein;Natural Killer Cells;Neoadjuvant Study;novel;objective response rate;Orphan Drugs;Pathologist;Pathway interactions;Patient Selection;Patients;peripheral blood;Phase;phase 2 study;phase 3 study;Play;Poxviridae;pre-clinical;Pre-Clinical Model;programmed cell death ligand 1;programmed cell death protein 1;Prostate Cancer Vaccine;Proteins;Radiation Oncologist;radiologist;Randomized;Recombinant Vaccines;refractory cancer;Renal Cell Carcinoma;Research;research clinical testing;Research Personnel;response;Role;Route;Safety;safety study;Scientist;side effect;Signal Transduction;subcutaneous;Surgeon;symposium;T-cell inflamed;T-Cell Receptor;T-Lymphocyte;targeted agent;targeted cancer therapy;Testing;therapy design;Tissues;Transforming Growth Factor beta;tumor;Tumor Antigens;tumor microenvironment;vaccine strategy;vaccine trial;Vaccines;Yeasts,Cancer Immunotherapy,10666,NA,NA,NA,NA,20,NA,NA,4195237,NA
11187984,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010668,NA,NA,1ZIABC010668-20,NCI:478623\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778172 (contact),"CHOYKE, PETER L (contact)",NA,NA,NA,animal imaging;Animals;Architecture;Area;Basic Science;Biodistribution;cancer therapy;Charge;Chemicals;clinical diagnostics;Clinical Trials;Code;computerized data processing;cost;Custom;design;Detection;detector;Development;Devices;Disease;drug development;Electronics;Evaluation;Event;flexibility;Future;Gamma Cameras;Gamma Rays;Goals;Growth;Human;human subject;Image;image reconstruction;Imaging Device;imaging system;Imaging technology;improved;instrumentation;Label;Laboratory Animals;Light;magnetic field;Magnetic Resonance Imaging;Measurement;microPET;microSPECT;Mission;molecular imaging;Mus;Names;National Cancer Institute;news;novel;Nuclear;nuclear imaging;optical imaging;Pathway interactions;photomultiplier;Photons;portability;Positioning Attribute;Positron;Positron-Emission Tomography;programs;Radioisotopes;Radionuclide Imaging;Research;Research Personnel;Scanning;Scientist;Side;simulation software;single photon emission computed tomography;Speed;Structure;Support Groups;System;Systems Development;Technology;Testing;thallium-doped sodium iodide;Time;tomography;United States National Institutes of Health;Validation;Work,Instrumentation for microSPECT and microPET imaging,10668,NA,NA,NA,NA,20,NA,NA,478623,NA
11187985,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010670,NA,NA,1ZIABC010670-20,NCI:2111063\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15686950 (contact),"COLEMAN, NORMAN  (contact)",NA,NA,NA,Aftercare;biodosimetry;Biological;Biological Markers;cell killing;Cell Survival;chemoradiation;Clinic;Clinical;Combined Modality Therapy;Data;Dose;Drug Design;Drug usage;Endothelial Cells;Epigenetic Process;Exposure to;fractionated radiation;Gene Expression;Genes;Growth;Heat-Shock Proteins 90;image guided radiation therapy;Immunotherapy;In Vitro;in vivo;inhibitor;Intensity-Modulated Radiotherapy;Laboratories;mass casualty;metabolomics;MicroRNAs;Miniature Swine;Molecular;Molecular Target;Normal tissue morphology;Ontology;Pathway interactions;Pattern;Pharmaceutical Preparations;Pharmacotherapy;Phenotype;Population Heterogeneity;Proteomics;Radiation;Radiation Dose Unit;Radiation Oncology;Radiation therapy;response;survival prediction;targeted agent;targeted treatment;Technology;Testing;tissue injury;Treatment Efficacy;Treatment Protocols;tumor;Update,Radiation-induced molecular targets,10670,NA,NA,NA,NA,20,NA,NA,2111063,NA
11187986,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010671,NA,NA,1ZIABC010671-20,NCI:3035016\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778182 (contact),"BOSSELUT, REMY  (contact)",NA,NA,NA,Address;Affinity;Aging;Allergens;Antigen Presentation;Antigen Receptors;Antigen Targeting;Antigens;Binding;Biochemical;Bone Marrow Transplantation;Cancer Patient;Cause of Death;CD4 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;cell mediated immune response;Cells;Cessation of life;Chromatin;chronic infection;Complex;Computer Analysis;CRISPR/Cas technology;cytokine;Data;Deacetylase;Development;dimer;DNA-Binding Proteins;Experimental Neoplasms;Gene Expression;Gene Expression Profiling;gene regulatory network;Generations;genetic analysis;Genetic Transcription;genome editing;high throughput analysis;HIV;Immune response;Immune system;immunodeficiency;Immunology;in vivo;Infection;interest;Interleukin-13;Interleukin-4;Interleukin-5;intraepithelial;Laboratories;laboratory experiment;Leukocytes;Life;Ligands;Lymphocyte;Major Histocompatibility Complex;Maps;Mature T-Lymphocyte;Membrane Glycoproteins;Modeling;Molecular;Morbidity - disease rate;mortality;Mutant Strains Mice;Myeloablative Chemotherapy;novel;Nucleosomes;Paper;Peptides;Process;programs;Property;Protein Analysis;protein function;Puberty;Publications;recurrent infection;Research;response;Shapes;single cell analysis;single cell ATAC-seq;single-cell RNA sequencing;Surface;T cell differentiation;T cell response;T-Cell Depletion;T-Cell Development;T-Lymphocyte;T-Lymphocyte Subsets;Thymocyte Development;Thymus Gland;transcription factor;Transcriptional Regulation;tumor;Tumor Antigens;Work;Zinc Fingers,Genetic Analysis of T-cell Differentiation,10671,NA,NA,NA,NA,20,NA,NA,3035016,NA
11187987,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010675,NA,NA,1ZIABC010675-20,NCI:352561\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201322 (contact),"GILDERSLEEVE, JEFFREY  (contact)",NA,NA,NA,Adhesions;Antibodies;Antigens;Avidity;Basic Science;Binding;Binding Sites;Biological Assay;Biological Process;Bovine Serum Albumin;carbohydrate binding protein;carbohydrate receptor;Carbohydrates;Carrier Proteins;Cells;Complex;Development;Diagnostic;Enzyme-Linked Immunosorbent Assay;Epoxy Compounds;Family;Glycopeptides;Glycoproteins;Glycosaminoglycans;high throughput analysis;Immobilization;improved;Inflammation;inhibitor;instrument;interest;Lectin;Libraries;Ligands;macromolecule;Methods;Microarray Analysis;Microscope;miniaturize;Neoglycoproteins;Neoplasm Metastasis;novel;Play;Polysaccharides;Printing;Protein-Carbohydrate Interaction;Proteins;Reagent;Robotics;Role;Slide;Solid;Technology;tool;Translational Research;Tumor Antigens;Vaccines;Viral;Virus,Development of a Carbohydrate Microarray,10675,NA,NA,NA,NA,20,NA,NA,352561,NA
11187988,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010677,NA,NA,1ZIABC010677-20,NCI:1201276\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692531 (contact),"DOROSHOW, JAMES  (contact)",NA,NA,NA,analog;cancer cell;cell growth;Cell Proliferation;Colon Carcinoma;Cryoelectron Microscopy;cytokine;Dexamethasone;DNA Damage;Down-Regulation;Genes;Goals;Growth;Human;Inflammatory;interest;knock-down;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of pancreas;Malignant Neoplasms;MAP Kinase Gene;Membrane;Molecular Structure;NADPH Oxidase;NADPH Oxidase 1;neoplastic cell;novel;novel therapeutic intervention;Oxidases;Oxidative Stress;pancreatic cancer cells;Production;Protein Isoforms;Regulation;Role;Series;Signal Transduction;Signal Transduction Pathway;Specificity;targeted cancer therapy;Work;Xenograft procedure,NADPH Oxidases as Novel Targets for Cancer Therapy,10677,NA,NA,NA,NA,20,NA,NA,1201276,NA
11187989,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010681,NA,NA,1ZIABC010681-20,NCI:351718\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10202830 (contact),"LEE, KYUNG  (contact)",NA,NA,NA,Abnormal Cell;Accounting;anti-cancer therapeutic;Binding;Biological Assay;cancer addiction;cancer cell;cancer therapy;Catalytic Domain;Cause of Death;Cell Cycle;Cell division;cell killing;Cell Proliferation;Centrosome;Cessation of life;Collaborations;cross reactivity;Development;Dissociation;drug discovery;Event;expectation;Generations;Goals;histone H1 kinase;Human;inhibitor;Kinetochores;Laboratories;Ligands;Malignant Neoplasms;Mediating;Mission;Mitosis;Mitotic;Molecular;National Center for Advancing Translational Sciences;Nature;Normal Cell;overexpression;Play;PLK1 gene;Polo-Box Domain;Process;Prodrugs;Protein Kinase;protein protein interaction;Reporting;Role;screening;Secure;Series;small molecule;Specificity;Therapeutic Agents;tumorigenesis;Water,Development of inhibitors targeting Plk1 polo-box domain,10681,NA,NA,NA,NA,20,NA,NA,351718,NA
11187990,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010683,NA,NA,1ZIABC010683-20,NCI:678223\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692445 (contact),"NECKERS, LEONARD  (contact)",NA,NA,NA,addiction;androgen independent prostate cancer;Biochemical;Biological Assay;cancer cell;cancer type;Cell Cycle Arrest;Cell Line;Cell Proliferation;Cell Survival;Cells;chimeric antigen receptor T cells;Complex;Cytosol;Dasatinib;Data;Data Analyses;design;Development;Down-Regulation;Drug Targeting;Ewings sarcoma;Exhibits;Fumarate Hydratase;Genetic Transcription;Glycolysis;Glycolysis Inhibition;Growth;Hereditary Leiomyomatosis and Renal Cell Cancer;high throughput screening;Histologic;In Vitro;in vivo;Inherited;inhibitor;Intervention;Kidney Neoplasms;knock-down;Knowledge;Lactate Dehydrogenase;Lead;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Malignant Neoplasms;member;Metabolic;metabolic abnormality assessment;Mitochondria;Modeling;Molecular;Mus;neoplastic cell;Neuroendocrine Prostate Cancer;Neurofibromin 2;novel;novel therapeutic intervention;Papillary;Pathway interactions;Patients;Production;Proteins;Pyrazoles;Pyruvate;Renal Carcinoma;Renal Cell Carcinoma;residence;response;Role;Signal Pathway;Small Interfering RNA;Specimen;src-Family Kinases;Structure;Testing;Therapeutic;Time;treatment strategy;tumor;tumor growth;tumor metabolism;Tumor Suppressor Genes;tumor xenograft;Urogenital Cancer;Xenograft Model,Role of fumarate hydratase loss in development of HLRCC hereditary kidney cancer,10683,NA,NA,NA,NA,20,NA,NA,678223,NA
11187991,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010696,NA,NA,1ZIABC010696-20,NCI:153418\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10686755 (contact),"MERINO, MARIA  (contact)",NA,NA,NA,Cancer Family;Characteristics;Clinical;Defect;Development;Diagnosis;Disease;Disease Progression;Family;Genes;Genetic;Goals;Histologic;Inherited;insight;Kidney;Knowledge;Learning;Morphology;Mutation;novel marker;novel therapeutics;Pathway interactions;Patients;Renal Carcinoma;Renal Cell Carcinoma;Syndrome;treatment response;tumor,Study of Hereditary Renal and Other Familial Syndromes,10696,NA,NA,NA,NA,20,NA,NA,153418,NA
11187992,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010736,NA,NA,1ZIABC010736-19,NCI:262257\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778042 (contact),"ST CROIX, BRADLEY D (contact)",NA,NA,NA,Alleles;angiogenesis;Binding;blood vessel development;Cancer cell line;CD276 gene;Cell surface;conditional knockout;CRISPR-mediated transcriptional activation;CRISPR/Cas technology;Endothelial Cells;Gene Expression Profiling;gene product;Genes;Genetically Engineered Mouse;Growth;Human;interest;Knock-in Mouse;Knockout Mice;Laboratories;Libraries;Ligands;LoxP-flanked allele;Modeling;Mus;Neoplasms in Vascular Tissue;neoplastic cell;Orphan;Physiological;Role;Therapeutic;therapeutic target;tumor;Tumor Cell Line;tumor growth,Unraveling the function of CD276,10736,NA,NA,NA,NA,19,NA,NA,262257,NA
11187993,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010740,NA,NA,1ZIABC010740-19,NCI:1233963\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201322 (contact),"GILDERSLEEVE, JEFFREY  (contact)",NA,NA,NA,Agonist;antagonist;Antibodies;Antibody Specificity;B-Lymphocytes;Basic Science;Binding;cancer cell;carbohydrate binding protein;carbohydrate receptor;Carbohydrates;Child;Clinical;Databases;design;Diagnostic;Directed Molecular Evolution;Disease;Disease Progression;Engineering;Evaluation;FDA approved;Goals;high throughput technology;interest;Lectin;Libraries;Malignant Neoplasms;Microarray Analysis;Monoclonal Antibodies;Neuroblastoma;Polysaccharides;Protein-Carbohydrate Interaction;Proteins;Publishing;Reagent;Research;Therapeutic Agents;tool;tumor;tumor progression,Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,10740,NA,NA,NA,NA,19,NA,NA,1233963,NA
11187994,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010759,NA,NA,1ZIABC010759-19,NCI:1121575\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1940613 (contact),"MELTZER, PAUL S. (contact)",NA,NA,NA,Adult;Alveolar Rhabdomyosarcoma;Aneuploidy;Behavior;Binding;Binding Proteins;Binding Sites;Biochemical;Biological;Biological Process;Biology;bone;Bone Surface (Peripheral) Osteosarcoma;cancer genome;Candidate Disease Gene;Cell Cycle;Cell Line;Cells;Characteristics;Child;Childhood;childhood sarcoma;Chimeric Proteins;Chromatin;chromatin immunoprecipitation;Chromosomal translocation;Chromosomes;Clinical;Collagen;Collagen Type I;Complex;Complex Mixtures;Connective Tissue;Data;DAXX gene;Defect;Dependence;Development;Diagnosis;Disease;DNA Sequence Alteration;DNA sequencing;druggable target;Event;Ewings sarcoma;EWS-FLI1 fusion protein;Extracellular Matrix;FOXO1A gene;functional genomics;fusion gene;Gene Expression;Genes;Genome;Genomic Instability;genomic profiles;Genomics;Goals;Histologic;Image;interest;Investigation;Laboratories;Malignant - descriptor;Malignant Neoplasms;Malignant Osteoblast;Membrane;Modeling;Molecular;monolayer;multiple omics;Mutation;Nature;Nuclear Structure;Oncogenic;Osteoid;Osteosarcoma;Pathway interactions;PAX3 gene;Phenotype;posttranscriptional;precision medicine;Process;Production;Property;Proteins;Publishing;Reporting;RNA Interference;Role;Sarcoma;spheroids;Stromal Cells;Techniques;Technology;telomere;Telomere Pathway;The Cancer Genome Atlas;transcription factor;tumor;Tumor Biology;Xenograft procedure,Functional Genomics of Sarcoma,10759,NA,NA,NA,NA,19,NA,NA,1121575,NA
11187995,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010778,NA,NA,1ZIABC010778-18,NCI:1129032\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9698291 (contact),"FREED, ERIC  (contact)",NA,NA,NA,Adverse effects;analog;Anti-Retroviral Agents;Anti-viral Agents;antiretroviral therapy;Betulinic Acid;Binding;Biochemical;Capsid;Cells;Clinical Trials;Collaborations;Conduct Clinical Trials;Development;forging;gag Gene Products;Generations;Genetic Polymorphism;Goals;HIV-1;inhibitor;insight;Link;Maps;Molecular;multidisciplinary;mutant;Mutation;novel;Pathway interactions;Patients;Peptide Hydrolases;Peptides;Pharmaceutical Preparations;Pharmacologic Substance;Phytic Acid;Play;Polyproteins;Preclinical Testing;Property;Protein Biosynthesis;Research;Resistance;resistance mutation;Resolution;response;Role;Site;SP1 gene;Structural Biologist;structural biology;Structure;Structure-Activity Relationship;Techniques;Time;Toxic effect;Viral;Viral Load result;viral resistance;Virus;Work,HIV-1 Maturation,10778,NA,NA,NA,NA,18,NA,NA,1129032,NA
11187996,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010782,NA,NA,1ZIABC010782-18,NCI:962192\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414375 (contact),"TOSATO, GIOVANNA  (contact)",NA,NA,NA,Adult;Affinity;age related changes;aged;Aging;Anemia;Architecture;Area;Blood Cells;bone cell;Bone Marrow;cancer therapy;Cardiovascular Diseases;Cell Physiology;Cells;Cellular Structures;Circulation;Complex;CXCR4 gene;Development;Disease;Effectiveness;Endothelial Cells;Endothelium;experimental study;Goals;Hematologic Neoplasms;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Hematopoietic System;Heterogeneity;immune cell checkpoints;immune checkpoint;Immunologics;Impairment;inhibitor;Location;Lymphopoiesis;Malignant Neoplasms;mortality;Movement;Mus;Myeloid Cells;Myelopoiesis;Nature;old mice;Peripheral;Phenotype;Population;progenitor;programmed cell death protein 1;Proteins;PTPN11 gene;reconstitution;Research;Research Project Grants;Risk;Role;Signal Transduction;stem;stem cells;Stromal Cell-Derived Factor 1;T-Lymphocyte;Testing;Therapeutic;tumor progression,Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,10782,NA,NA,NA,NA,18,NA,NA,962192,NA
11187997,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010783,NA,NA,1ZIABC010783-18,NCI:737020\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9417013 (contact),"LIU, ZHENG-GANG  (contact)",NA,NA,NA,Achievement;Acquired Immunodeficiency Syndrome;Acute;adaptive immune response;Affect;angiogenesis;Animal Cancer Model;antagonist;Anti-Tumor Necrosis Factor Therapy;Antigen-Antibody Complex;Antigens;Antineoplastic Agents;Apoptotic;arginase;Arthritis;Autoimmune;Autoimmune Diseases;Biological;Blood Vessels;cancer therapy;cancer type;Cell Proliferation;Chronic;chronic inflammatory disease;Collaborations;colon carcinogenesis;COVID-19;Crohn&apos;s disease;cytokine release syndrome;cytotoxicity;Development;Disease;Dose;Emigrations;Exhibits;extracellular;Genes;Glucocorticoids;Growth;Helicobacter Infections;Hepatitis C;Immature Monocyte;In Vitro;in vivo;Infection;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Inflammatory Response;Innate Immune Response;Innate Immune System;Interferons;Interleukin-1;Interleukin-10;Interleukin-13;Interleukin-4;Invaded;Knock-out;Laboratories;leukemia/lymphoma;Lipopolysaccharides;Lymphangiogenesis;Macrophage;Malignant Breast Neoplasm;Malignant neoplasm of gastrointestinal tract;Malignant Neoplasms;malignant stomach neoplasm;Mediating;Mediator;Modeling;Molecular;monocyte;mouse model;Multiple Sclerosis;Mus;Necrosis;Neoplasm Metastasis;neoplastic cell;neutralizing antibody;NF-kappa B;Nitric Oxide;Parasites;Participant;pathogen;Pathogenesis;Pathologic;Pathology;Pathway interactions;Peripheral;Phenotype;Play;Primary carcinoma of the liver cells;Process;Production;Proteins;Regulation;Research;response;Rheumatoid Arthritis;Role;SARS-CoV-2 infection;Septic Shock;Signal Pathway;Site;T-Lymphocyte;Testing;Therapeutic;Thrombosis;Tissue Differentiation;Tissues;TNF gene;TNFR1 Signaling Pathway;transcription factor;Transforming Growth Factors;tumor;tumor growth;tumor initiation;Tumor Promotion;Tumor-associated macrophages;tumorigenesis;Virus Diseases;Whole Organism,"Inflammation, Macrophage Differentiation, and Cancer",10783,NA,NA,NA,NA,18,NA,NA,737020,NA
11187998,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010788,NA,NA,1ZIABC010788-18,NCI:1126424\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8108820 (contact),"THIELE, CAROL J (contact)",NA,NA,NA,"Affect;Automobile Driving;Binding;Binding Proteins;Biological Assay;Biological Models;Bypass;cdc Genes;Cell Cycle Progression;Cell Differentiation process;cell growth;Cell Lineage;Cell Survival;cell type;Characteristics;Child;Classification;Clinical;Clinical Course of Disease;Cues;Development;Differentiated Gene;Differentiation and Growth;DNA;Drosophila genus;effective therapy;Enhancers;Epigenetic Process;experimental study;gangliocytoma;Ganglioneuroblastoma;Gene Expression;Gene set enrichment analysis;Genes;Genetic Transcription;genome-wide;Genomics;Goals;Growth;Histologic;Homologous Gene;Human;Immunoprecipitation;Impairment;improved;indexing;loss of function;Mediating;Mitotic;Molecular;Mutation;MYCN gene;Nature;neoplastic cell;Nerve Growth Factor Receptors;nerve stem cell;neural;Neural Crest;Neural Crest Cell;Neuroblastoma;neuroblastoma cell;Neuroepithelial, Perineurial, and Schwann Cell Neoplasm;Neurotrophic Tyrosine Kinase Receptor Type 2;NFIX gene;novel;Oncogenic;Pathologic;Pattern;pediatric embryonal tumor;PPARG gene;Process;progenitor;Prognosis;programs;promoter;Property;Publishing;RARB gene;Regulation;Research;Retinoic Acid Receptor;Retinoids;Role;self-renewal;Signal Transduction Pathway;SOX11 gene;SOX4 gene;Specimen;Stem Cell Development;stem cells;Supporting Cell;survival outcome;Testing;Time;Tissues;transcription factor;Transcriptional Regulation;Tretinoin;tumor;tumorigenesis;Tumorigenicity;Xenograft procedure",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,10788,NA,NA,NA,NA,18,NA,NA,1126424,NA
11187999,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010791,NA,NA,1ZIABC010791-18,NCI:1166652\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414396 (contact),"CARRINGTON, MARY N. (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;Affinity;Africa;Alleles;Antigen Presentation;antigen test;Antigens;Asian;Autoimmune Diseases;Binding;Biological;Biological Assay;Biological Process;Black Populations;Black race;cancer immunotherapy;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD94 Antigen;Cell surface;Cells;Characteristics;cohort;Cohort Analysis;Communicable Diseases;Complex;Data;Data Set;Databases;Dependence;Development;Disease;Disease Outcome;env Gene Products;Enzyme-Linked Immunosorbent Assay;Freedom;gag Gene Products;Genes;Genetic;genetic association;Genetic Polymorphism;Genotype;Goals;HIV;HIV Antigens;HIV Infections;HIV-1;HLA-B Antigens;human disease;human leukocyte antigen testing;Immune;Immune response;Immune Response Genes;Immunogenetics;immunogenicity;Immunoglobulins;Immunologic Receptors;improved;Individual;Innate Immune Response;interest;Interruption;Killer Cells;KLRD1 gene;Knowledge;Leukocytes;Ligands;Loss of Heterozygosity;Malignant Neoplasms;Measures;Messenger RNA;Molecular;mosaic;Natural History;Natural Killer Cells;neoantigens;novel;Outcome;Participant;Peptide Signal Sequences;Peptides;Phase;Predisposition;Principal Component Analysis;Process;Property;Proteins;receptor;Regimen;Resistance;Resources;response;Risk;Signal Pathway;South Africa;Stains;T cell response;T-Lymphocyte;T-Lymphocyte Subsets;Testing;Thailand;Time;tool;Transplantation;Vaccination;Vaccine Design;vaccine evaluation;vaccine response;vaccine trial;Vaccinee;Variant;vector;Viral Load result;Virus,"Effects of genetic polymorphism in MHC, KIR, and related loci on human disease",10791,NA,NA,NA,NA,18,NA,NA,1166652,NA
11188000,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010792,NA,NA,1ZIABC010792-18,NCI:933322\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414396 (contact),"CARRINGTON, MARY N. (contact)",NA,NA,NA,adaptive immune response;Affect;Affinity;Alleles;Amino Acid Substitution;Binding;Blood donor;C-terminal;CD3 Antigens;CD94 Antigen;Cell Line;Cell surface;Cells;cohort;Complex;CRISPR/Cas technology;Data;Dependence;Development;differential expression;Disease;disorder risk;Down-Regulation;Effector Cell;Endoplasmic Reticulum;Epitopes;experimental study;Flow Cytometry;GEM gene;Genes;Genetic Polymorphism;Genetic study;Genotype;HLA-A gene;HLA-B Antigens;HLA-B57;HLA-C Antigens;human disease;Hydrophobicity;Immunogenetics;In Vitro;Innate Immune Response;insight;interest;Investigation;K562 Cells;KLRD1 gene;Knock-out;lentivirally transduced;Mass Spectrum Analysis;Measures;Messenger RNA;Molecular Genetics;Natural Killer Cells;novel;Peptide Fragments;Peptide Signal Sequences;Peptides;Population Study;preference;Property;Proteins;Publications;receptor;Regulation;Resolution;Role;signal peptide peptidase;Signal Recognition Particle;single-cell RNA sequencing;Surface;T-Lymphocyte;Transcript;Translations;Variant,Molecular genetics and population studies of the KIR and HLA gene complexes,10792,NA,NA,NA,NA,18,NA,NA,933322,NA
11188001,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010793,NA,NA,1ZIABC010793-18,NCI:607045\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2156935 (contact),"TRINCHIERI, GIORGIO  (contact)",NA,NA,NA,Acceleration;acquired immunity;adaptive immunity;Adenocarcinoma;adenoma;Affect;Animal Model;Animals;anti-PD-1;anti-PD1 therapy;Antitumor Response;Attenuated;Automobile Driving;Azoxymethane;Beta-glucuronidase;Biological Assay;Cancer Biology;cancer cell;cancer therapy;carcinogenesis;CD4 Positive T Lymphocytes;Cell Physiology;Cell Proliferation;cell type;Cells;checkpoint therapy;Chemical Models;Chronic;Colitis associated colorectal cancer;Colon;colon carcinogenesis;Communicable Diseases;CSF1R gene;cytokine;Cytokine Signaling;cytotoxic CD8 T cells;Data;Dendritic Cells;Development;dextran sulfate sodium induced colitis;Dichloromethylene Diphosphonate;Disease;Effector Cell;Environment;Equilibrium;exhaustion;Exposure to;Family;fecal transplantation;fibrosarcoma;Fostering;Frequencies;Gene Expression;gene product;Genetic;Genetic Models;Growth;gut microbiome;gut microbiota;healing;Hepatocarcinogenesis;Homeostasis;Human;IL17 gene;IL18 gene;Immune;Immune response;Immunity;improved;In Vitro;in vivo;Infection;Infiltration;Inflammation;Inflammation Mediators;Inflammatory;inflammatory modulation;Inflammatory Response;inhibitor;Interferon Type I;Interferon Type II;Interleukin-1 Receptors;Interleukin-10;Interleukin-12;interleukin-18 receptor;interleukin-22;interleukin-23;ITGAM gene;Knock-out;KRAS2 gene;Kupffer Cells;Lamina Propria;Light;Liver;LoxP-flanked allele;Lung;Lung Adenocarcinoma;Macrophage;Macrophage Activation;Malignant neoplasm of lung;Malignant Neoplasms;Mediating;Melanoma;member;Microbe;microbial;microbial products;microbiome;migration;Modeling;Molecular;monocyte;Morphogenesis;morphogens;mouse model;Mus;mutant;Myelogenous;Myeloid Cells;Myeloid-derived suppressor cells;Natural Killer Cells;Natural Resistance;Neoplasm Metastasis;neutrophil;novel;Oncogenic;oral microbiome;Organism;Paralysed;Patients;pharmacologic;Phenotype;Physiological;Play;pleiotropism;Polyps;Population;Population Sizes;prevent;Preventive;Process;Production;programmed cell death protein 1;programs;Prophylactic treatment;receptor;reconstitution;Regulation;Resistance;Resistance to infection;response;restraint;Role;Signal Pathway;Signal Transduction;Signaling Molecule;single-cell RNA sequencing;Skin Carcinogenesis;small molecule;Solid Neoplasm;Source;Spleen;STAT3 gene;T-Lymphocyte;Therapeutic;Time;Tissues;TNF gene;Toll-like receptors;tumor;tumor growth;Tumor Immunity;tumor microenvironment;tumor progression;Tumor Promotion;tumor xenograft;tumor-immune system interactions;tumorigenesis;tumorigenic;Ulcer;Vaccines;Vancomycin;Wild Type Mouse;Work,"Role of inflammation, innate resistance, and immunity in carcinogenesis",10793,NA,NA,NA,NA,18,NA,NA,607045,NA
11188002,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010795,NA,NA,1ZIABC010795-18,NCI:1793476\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802163 (contact),"KASHLEV, MIKHAIL  (contact)",NA,NA,NA,Alternative Splicing;attenuation;Bacillus subtilis;Bacteria;Biochemical;Bioinformatics;Biological;Biological Assay;Breast Cancer Cell;Breast Cancer cell line;breast cancer progression;cancer cell;cancer recurrence;cancer type;Cells;cleavage factor;Clinical;Code;Codon Nucleotides;Complex;Coupled;Coupling;Disease;Distal;DNA;DNA lesion;DNA Repair;Energy-Generating Resources;Environment;Epigenetic Process;ERBB2 gene;Escherichia coli;Estrogen receptor negative;Eukaryota;Eukaryotic Cell;Event;Exhibits;Failure;Frequencies;Gene Expression;Gene Expression Regulation;Genes;Genetic;genetic approach;Genetic Transcription;genome-wide;Genomic Instability;Growth;hormone therapy;Human;Hypoxia;In Vitro;in vivo;Investigation;Laboratories;Malignant Breast Neoplasm;Malignant Neoplasms;Metabolic;Methodology;Methods;Modeling;Molecular;Nature;Neoplasm Metastasis;Nonsense Mutation;Nucleosomes;Outcome;Oxidative Phosphorylation;Pathway interactions;Pattern;Phosphorylation;Play;Polymerase;Positioning Attribute;Productivity;Progesterone Receptors;Prognosis;Prokaryotic Cells;Proliferating;promoter;Proteins;recruit;Regulation;Reporter Genes;Resolution;RNA;RNA Polymerase II;RNA Processing;Role;Signal Transduction;Site;Solid Neoplasm;Specificity;Structure;Technology;termination factor;Testing;Time;Transcript;Transcription Elongation;transcription factor S-II;Transcription Initiation Site;Transcription Process;transcription termination;Transcriptional Regulation;transcriptome sequencing;Translations;triple-negative invasive breast carcinoma;tumor;tumor progression;tumorigenesis;Woman;Yeasts,Mechanisms of transcription pausing and fidelity in prokaryotes and eukaryotes,10795,NA,NA,NA,NA,18,NA,NA,1793476,NA
11188003,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010806,NA,NA,1ZIABC010806-18,NCI:1148695\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692453 (contact),"KHAN, JAVED  (contact)",NA,NA,NA,Adoptive Cell Transfers;Adoptive Immunotherapy;ALK gene;Animal Model;Antigen Targeting;Antigens;Apoptosis;Automobile Driving;Biological Assay;Biological Products;Blood;Brain Neoplasms;CAR T cell therapy;CD276 gene;Cell Death;cell growth;cell killing;Cell Line;Cell Therapy;Cells;Childhood Solid Neoplasm;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Collaborations;Complex;CRISPR screen;CRISPR/Cas technology;cytotoxicity;density;Detection;Developing Countries;Development;Diagnostic;diagnostic biomarker;Diagnostic Imaging;differential expression;Dominant-Negative Mutation;Down-Regulation;Drug Compounding;Drug Screening;Drug usage;Effectiveness;Enhancers;Epigenetic Process;Evaluation;exhaust;exhaustion;FDA approved;FGFR4 gene;FOXO1A gene;fusion gene;Future;gene repression;Generations;Genes;Genetic;Genetic Transcription;genome-wide;Genomics;Goals;Growth;hazard;high risk;high throughput screening;Human;Immune Targeting;Immunotherapeutic agent;Immunotherapy;In Vitro;in vivo;inhibitor;Investigation;Knock-in;knockout gene;Libraries;Luciferases;Malignant Childhood Neoplasm;Malignant Neoplasms;Mediating;Memory;Methods;Modeling;Monitor;Monoclonal Antibodies;multimodality;Mus;muscle regeneration;Mutate;Mutation;Myoblasts;National Center for Advancing Translational Sciences;neoplastic cell;Neural Cell Adhesion Molecule L1;Neuroblastoma;Normal tissue morphology;novel;novel strategies;novel therapeutics;Organ;Osteosarcoma;overexpression;Pathway interactions;patient derived xenograft model;Patients;PAX3 gene;Penetration;Peptides;Pharmaceutical Preparations;pharmacologic;Phase;Phenotype;Play;Post-Translational Protein Processing;Pre-Clinical Model;preclinical study;preferentially expressed antigen in melanoma;Prognostic Marker;programs;Property;protein protein interaction;Proteins;Reporter;response;Rhabdomyosarcoma;Role;Signal Transduction;Small Interfering RNA;small molecule;Solid Neoplasm;synergism;System;T-Lymphocyte;targeted treatment;Testing;TGFBR2 gene;Therapeutic;therapeutic target;Toxic effect;TP53 gene;Translating;treatment response;tumor;Tumor Antigens;tumor-immune system interactions;Xenograft procedure,Developing Novel Therapies for High Risk Pediatric Cancers,10806,NA,NA,NA,NA,18,NA,NA,1148695,NA
11188004,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010808,NA,NA,1ZIABC010808-18,NCI:2497040\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778148 (contact),"BAI, YAWEN  (contact)",NA,NA,NA,Binding;Chromatin;Chromatin Structure;Cryoelectron Microscopy;DNA;DNA Sequence;Eukaryota;GATA4 gene;gene function;Genome;High Mobility Group Proteins;Histones;insight;interest;Kinetochores;Linker DNA;Mediating;Molecular Chaperones;Nucleosomes;Play;Positioning Attribute;Proteins;Role;Structure;transcription factor,Chromatin structure and dynamics,10808,NA,NA,NA,NA,18,NA,NA,2497040,NA
